PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bruno, EA; Guthrie, JW; Ellwood, SA; Mellanby, RJ; Clements, DN				Bruno, Elizabeth A.; Guthrie, James W.; Ellwood, Stephen A.; Mellanby, Richard J.; Clements, Dylan N.			Global Positioning System Derived Performance Measures Are Responsive Indicators of Physical Activity, Disease and the Success of Clinical Treatments in Domestic Dogs	PLOS ONE			English	Article							OSTEOARTHRITIS; ACCELEROMETER; PREVALENCE; CARPROFEN; LAMENESS; WEIGHT	Objective To assess the use of Global Positioning System receiver (GPS) derived performance measures for differentiating between: 1) different outdoor activities in healthy dogs; 2) healthy dogs and those with osteoarthritis; 3) osteoarthritic dogs before and after treatment with non-steroidal anti-inflammatory analgesia. Design Prospective study. Animals Ten healthy dogs and seven dogs with osteoarthritis of the elbow joint (OA dogs). Procedure Healthy dogs were walked on a standard route on-lead, off-lead and subjected to playing activity (chasing a ball) whilst wearing a GPS collar. Each dog was walked for five consecutive days. Dogs with OA were subjected to a single off-lead walk whilst wearing a GPS collar, and then administered oral Carprofen analgesia daily for two weeks. OA dogs were then subjected to the same walk, again wearing a GPS collar. Results GPS derived measures of physical performance could differentiate between on-lead activity, off-lead activity and playing activity in healthy dogs, and between healthy dogs and OA dogs. Variation in the performance measures analysed was greater between individual dogs than for individual dogs on different days. Performance measures could differentiate healthy dogs from OA dogs. OA Dogs treated with Carprofen analgesia showed improvements in their physical performance, which returned to values indistinguishable from those of healthy dogs on nearly all the measures assessed. Conclusions and Clinical Relevance GPS derived measures of physical performance in dogs are objective, easy to quantify, and can be used to gauge the effects of disease and success of clinical treatments. Specific stimuli can be used to modulate physical performance beyond the self-governed boundaries that dogs will naturally express when allowed to exercise freely without stimulation.	[Bruno, Elizabeth A.; Guthrie, James W.; Mellanby, Richard J.; Clements, Dylan N.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Bruno, Elizabeth A.; Guthrie, James W.; Mellanby, Richard J.; Clements, Dylan N.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Ellwood, Stephen A.] Wildlife Savvy Ltd, Abingdon, Oxon, England; [Mellanby, Richard J.] Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Clements, DN (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.	Dylan.clements@ed.ac.uk		Guthrie, James/0000-0001-5648-8736; Clements, Dylan/0000-0002-0596-1885; Mellanby, Richard John/0000-0002-3467-7007	PetPlan Charitable Trust [08-29]; Wildlife Savvy Ltd.	PetPlan Charitable Trust; Wildlife Savvy Ltd.	This work was funded by the PetPlan Charitable Trust (Grant Number 08-29). Wildlife Savvy Ltd. provided support in the form of a salary for author SAE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ahlstrom O, 2011, BRIT J NUTR, V106, pS158, DOI 10.1017/S0007114511001838; Akos Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003446; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Buchanan JW., 1999, TXB CANINE FELINE CA, V2nd, P458; Burton NJ, 2008, VET COMP ORTHOPAED, V21, P110, DOI 10.3415/VCOT-07-04-0038; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clarke SP, 2005, VET REC, V157, P793, DOI 10.1136/vr.157.25.793; Clements DN, 2005, VET REC, V156, P478, DOI 10.1136/vr.156.15.478; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Hansen BD, 2007, AM J VET RES, V68, P468, DOI 10.2460/ajvr.68.5.468; Hay CW, 1997, AM J VET RES, V58, P1027; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Innes JF, 2000, VET REC, V147, P325, DOI 10.1136/vr.147.12.325; Ireland JL, 2013, RES VET SCI, V95, P418, DOI 10.1016/j.rvsc.2013.05.007; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Mansa S, 2007, VET REC, V160, P427, DOI 10.1136/vr.160.13.427; Marshall WG, 2010, VET RES COMMUN, V34, P241, DOI 10.1007/s11259-010-9348-7; Melanson EL, 1996, CRIT REV FOOD SCI, V36, P385, DOI 10.1080/10408399609527732; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Nuttall T, 2006, VET DERMATOL, V17, P348, DOI 10.1111/j.1365-3164.2006.00537.x; Sibley RJ, 2013, VET REC, V172, P92, DOI 10.1136/vr.f394; Stafford KJ, 2008, NEW ZEAL VET J, V56, P274, DOI 10.1080/00480169.2008.36847; Swimmer RA, 2011, J VET INTERN MED, V25, P405, DOI 10.1111/j.1939-1676.2011.0689.x; THORP BH, 1994, AVIAN PATHOL, V23, P203, DOI 10.1080/03079459408418991; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; VASSEUR PB, 1995, J AM VET MED ASSOC, V206, P807; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x; Wernham BGJ, 2011, J VET INTERN MED, V25, P1298, DOI 10.1111/j.1939-1676.2011.00825.x; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wrigglesworth DJ, 2011, AM J VET RES, V72, P1151, DOI 10.2460/ajvr.72.9.1151	31	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117094	10.1371/journal.pone.0117094	http://dx.doi.org/10.1371/journal.pone.0117094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692761	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500038
J	Lee, CC; Wang, CN; Lee, YL; Tsai, YR; Liu, JJ				Lee, Chen-Chen; Wang, Chien-Neng; Lee, Yueh-Lun; Tsai, Yi-Ru; Liu, Jau-Jin			High Mobility Group Box 1 Induced Human Lung Myofibroblasts Differentiation and Enhanced Migration by Activation of MMP-9	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GLYCATION END-PRODUCTS; MATRIX METALLOPROTEINASES; AIRWAY INFLAMMATION; ENDOTHELIAL-CELLS; MURINE MODEL; B1 HMGB1; ASTHMA; EXPRESSION; FIBROSIS	High mobility group box 1 (HMGB1) is a nuclear protein that involves the binding with DNA and influences chromatin regulation and transcription. HMGB1 is also a cytokine that can activate monocytes and neutrophils involved in inflammation. In this study, we investigated the role of HMGB1 on cellular activation using human fibroblast cell line WI-38. After treatment with 1, 10, and 100 ng/mL of HMGB1 for 24 h, we did not find obviously cytotoxicity and cellular proliferation of WI-38 cells by MTT and BrdU incorporation assay, respectively. However, we found that treatment with 10 and 100 ng/mL of HMGB1 induced the differentiation of lung fibroblasts into myofibroblasts and myofibroblasts showed higher migration ability through activation of matrix metalloproteinase (MMP)-9 activation. To delineate the mechanism underlying HMGB1-induced cellular migration, we examined HMGB1-induced mitogen activated protein kinases (MAPKs), including extracellular signal related kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen activated protein kinase (p38) phosphorylation, as well as nuclear factor (NF)-kappa B nuclear translocation. Using specific inhibitors and shRNAs of protein kinases, we observed that repression of ERK, JNK, p38, and NF-kappa B all inhibited HMGB1-induced cellular differentiation, migration and MMP-9 activation in WI-38 cells. In addition, knocking down of RAGE but not TLR2 and TLR4 by shRNAs attenuated HMGB1-induced myofibroblast differentiation and migration. In conclusion, our study demonstrated that HMGB1 induced lung fibroblasts' differentiation into myofibroblasts and enhanced cell migration through induction of MMP-9 activation and the RAGE-MAPK and NF-kappa B interaction signaling pathways. Targeting HMGB1 might be a potential therapeutic approach for alleviation of airway remodeling seen in chronic airway inflammatory diseases.	[Lee, Chen-Chen; Liu, Jau-Jin] China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Lee, Chen-Chen; Wang, Chien-Neng; Tsai, Yi-Ru] China Med Univ, Coll Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Yueh-Lun] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University	Lee, CC (corresponding author), China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan.	leechenchen@mail.cmu.edu.tw	Lee, Chen-Chen/H-4267-2014		National Science Council in Taiwan [NSC 101-2320-B-039-047]; China medical University [CMU102-S-27, CMU102-BC-10]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); China medical University(China Medical University)	This study was supported by the National Science Council in Taiwan (NSC 101-2320-B-039-047) and China medical University (CMU102-S-27 and CMU102-BC-10).	Alam R, 2011, CLIN EXP ALLERGY, V41, P149, DOI 10.1111/j.1365-2222.2010.03658.x; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aoshiba K, 2004, CLIN REV ALLERG IMMU, V27, P35, DOI 10.1385/CRIAI:27:1:035; BRAMLEY AM, 1994, EUR RESPIR J, V7, P337, DOI 10.1183/09031936.94.07020337; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Lee CC, 2013, BIOCHEM PHARMACOL, V86, P940, DOI 10.1016/j.bcp.2013.08.003; Lee CC, 2012, J AGR FOOD CHEM, V60, P9405, DOI 10.1021/jf2038778; Lee CC, 2012, TOXICOL IN VITRO, V26, P552, DOI 10.1016/j.tiv.2012.01.021; Lee CC, 2011, LIFE SCI, V89, P364, DOI 10.1016/j.lfs.2011.07.002; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Lewis CC, 2005, J ALLERGY CLIN IMMUN, V115, P534, DOI 10.1016/j.jaci.2004.11.051; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin CD, 2014, NANOMEDICINE LOND; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Rao YK, 2013, INT IMMUNOPHARMACOL, V17, P617, DOI 10.1016/j.intimp.2013.08.002; Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC; Shim EJ, 2012, CLIN EXP ALLERGY, V42, P958, DOI 10.1111/j.1365-2222.2012.03998.x; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	40	23	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116393	10.1371/journal.pone.0116393	http://dx.doi.org/10.1371/journal.pone.0116393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692286	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500014
J	Relvas, LJM; Makhoul, M; Dewispelaere, R; Caspers, L; Communi, D; Boeynaems, JM; Robaye, B; Bruyns, C; Willermain, F				Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Caspers, Laure; Communi, Didier; Boeynaems, Jean-Marie; Robaye, Bernard; Bruyns, Catherine; Willermain, Francois			P2Y(2)R Deficiency Attenuates Experimental Autoimmune Uveitis Development	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; EXTRACELLULAR NUCLEOTIDES; RECEPTOR ACTIVATION; CYTOKINE PRODUCTION; LUNG INFLAMMATION; SYSTEM; ENCEPHALOMYELITIS; EXPRESSION; RESPONSES	We aimed to study the role of the nucleotide receptor P2Y(2)R in the development of experimental autoimmune uveitis (EAU). EAU was induced in P2Y(2)(+/+) and P2Y(2)(-/-) mice by immunization with IRBP peptide or by adoptive transfer of in vitro restimulated semi-purified IRBP-specific enriched T lymphocytes from spleens and lymph nodes isolated from native C57BI/6 or P2Y(2)(+/+) and P2Y(2)(-/-) immunized mice. Clinical and histological scores were used to grade disease severity. Splenocytes and lymph node cell phenotypes were analyzed using flow cytometry. Semi-purified lymphocytes and MACS-purified CD4(+) T lymphocytes from P2Y(2)(+/+) and P2Y(2)(-/-) immunized mice were tested for proliferation and cytokine secretion. Our data show that clinical and histological scores were significantly decreased in IRBP-immunized P2Y(2)(-/-) mice as in P2Y(2)(-/-) mice adoptively transfered with enriched T lymphocytes from C57BI/6 IRBP-immunized mice. In parallel, naive C57BI/6 mice adoptively transferred with T lymphocytes from P2Y(2)(-/-) IRBP-immunized mice also showed significantly less disease. No differences in term of spleen and lymph node cell recruitment or phenotype appeared between P2Y(2)(-/-) and P2Y(2)(+/+) immunized mice. However, once restimulated in vitro with IRBP, P2Y(2)(-/-) T cells proliferate less and secrete less cytokines than the P2Y(2)(+/+) one. We further found that antigen-presenting cells of P2Y(2)(-/-) immunized mice were responsible for this proliferation defect. Together our data show that P2Y(2)(-/-) mice are less susceptible to mount an autoimmune response against IRBP. Those results are in accordance with the danger model, which makes a link between autoreactive lymphocyte activation, cell migration and the release of danger signals such as extracellular nucleotides.	[Relvas, Lia Judice M.; Dewispelaere, Remi; Caspers, Laure; Willermain, Francois] CHU St Pierre & Brugmann, Dept Ophthalmol, Brussels, Belgium; [Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Communi, Didier; Boeynaems, Jean-Marie; Bruyns, Catherine; Willermain, Francois] IRIBHM, Inst Interdisciplinary Res, Brussels, Belgium; [Robaye, Bernard] IRIBHM, Inst Interdisciplinary Res, Gosselies, Belgium; [Boeynaems, Jean-Marie] Free Univ Brussels, Erasme Hosp, Dept Lab Med, B-1050 Brussels, Belgium; [Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Caspers, Laure; Communi, Didier; Boeynaems, Jean-Marie; Robaye, Bernard; Bruyns, Catherine; Willermain, Francois] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Relvas, LJM (corresponding author), CHU St Pierre & Brugmann, Dept Ophthalmol, Brussels, Belgium.	ljudiced@ulb.ac.be			Fondation Vesale; Fondation Brugmann; Fond de recherche en ophtalmologie (FRO)	Fondation Vesale; Fondation Brugmann; Fond de recherche en ophtalmologie (FRO)	Funding provided by Fondation Vesale, LJR; Fondation Brugmann, LJR; Fond de recherche en ophtalmologie (FRO), LJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chan CC, 1998, BRIT J OPHTHALMOL, V82, P91, DOI 10.1136/bjo.82.1.91; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Dick AD, 2004, PROG RETIN EYE RES, V23, P617, DOI 10.1016/j.preteyeres.2004.06.005; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kukulski F, 2010, MOL IMMUNOL, V47, P991, DOI 10.1016/j.molimm.2009.11.020; Kunitomi A, 2000, J LEUKOCYTE BIOL, V68, P111; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Relvas LJM, 2009, INVEST OPHTH VIS SCI, V50, P1241, DOI 10.1167/iovs.08-1902; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Vanderstocken G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050385; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; Willermain F, 2000, INVEST OPHTH VIS SCI, V41, P3485; Willermain F, 2012, PROG RETIN EYE RES, V31, P182, DOI 10.1016/j.preteyeres.2011.11.004; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116518	10.1371/journal.pone.0116518	http://dx.doi.org/10.1371/journal.pone.0116518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692550	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500016
J	Smith, TM; Tafforeau, P; Le Cabec, A; Bonnin, A; Houssaye, A; Pouech, J; Moggi-Cecchi, J; Manthi, F; Ward, C; Makaremi, M; Menter, CG				Smith, Tanya M.; Tafforeau, Paul; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra; Pouech, Joane; Moggi-Cecchi, Jacopo; Manthi, Fredrick; Ward, Carol; Makaremi, Masrour; Menter, Colin G.			Dental Ontogeny in Pliocene and Early Pleistocene Homininsl	PLOS ONE			English	Article							HUMAN LIFE-HISTORY; TOOTH DEVELOPMENT; MODERN HUMANS; HISTOLOGICAL RECONSTRUCTION; ENAMEL MICROSTRUCTURE; BRIEF COMMUNICATION; CROSS-STRIATIONS; PAN-TROGLODYTES; FOSSIL HOMINID; AGE	Until recently, our understanding of the evolution of human growth and development derived from studies of fossil juveniles that employed extant populations for both age determination and comparison. This circular approach has led to considerable debate about the humanlike and ape-like affinities of fossil hominins. Teeth are invaluable for understanding maturation as age at death can be directly assessed from dental microstructure, and dental development has been shown to correlate with life history across primates broadly. We employ non-destructive synchrotron imaging to characterize incremental development, molar emergence, and age at death in more than 20 Australopithecus anamensis, Australopithecus africanus, Paranthropus robustus and South African early Homo juveniles. Long-period line periodicities range from at least 6-12 days (possibly 5-13 days), and do not support the hypothesis that australopiths have lower mean values than extant or fossil Homo. Crown formation times of australopith and early Homo postcanine teeth fall below or at the low end of extant human values; Paranthropus robustus dentitions have the shortest formation times. Pliocene and early Pleistocene hominins show remarkable variation, and previous reports of age at death that employ a narrow range of estimated long-period line periodicities, cuspal enamel thicknesses, or initiation ages are likely to be in error. New chronological ages for SK 62 and StW 151 are several months younger than previous histological estimates, while Sts 24 is more than one year older. Extant human standards overestimate age at death in hominins predating Homo sapiens, and should not be applied to other fossil taxa. We urge caution when inferring life history as aspects of dental development in Pliocene and early Pleistocene fossils are distinct from modern humans and African apes, and recent work has challenged the predictive power of primate-wide associations between hominoid first molar emergence and certain life history variables.	[Smith, Tanya M.; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Tafforeau, Paul; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra; Pouech, Joane] ESRF European Synchrotron, Grenoble, France; [Le Cabec, Adeline] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Bonnin, Anne] Swiss Light Source, Paul Scherrer Inst, Villigen, Switzerland; [Houssaye, Alexandra] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversit, UMR 7179, F-75231 Paris, France; [Pouech, Joane] Univ Lyon 1, CNRS, Lab Geol, UMR 5276, Villeurbanne, France; [Moggi-Cecchi, Jacopo] Univ Florence, Dipartimento Biol, Florence, Italy; [Manthi, Fredrick] Natl Museums Kenya, Dept Earth Sci, Nairobi, Kenya; [Ward, Carol] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Makaremi, Masrour] Univ Bordeaux 2, Dept Orthodont, F-33076 Bordeaux, France; [Menter, Colin G.] Univ Johannesburg, Ctr Anthropol Res, Johannesburg, South Africa	Harvard University; European Synchrotron Radiation Facility (ESRF); Max Planck Society; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Florence; University of Missouri System; University of Missouri Columbia; UDICE-French Research Universities; Universite de Bordeaux; University of Johannesburg	Smith, TM (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	tsmith@fas.harvard.edu; paul.tafforeau@esrf.fr	Houssaye, Alexandra/J-5631-2015; Smith, Tanya/T-2683-2017; BONNIN, Anne/J-3633-2014; LE CABEC, Adeline/I-1661-2019	BONNIN, Anne/0000-0001-5537-8682; LE CABEC, Adeline/0000-0001-6948-4726; Ward, Carol/0000-0001-6255-9668; Smith, Tanya M./0000-0001-8175-8208; MOGGI CECCHI, IACOPO/0000-0001-5055-8369; Tafforeau, Paul/0000-0002-5962-1683	National Science Foundation [BCS 1126470]; Radcliffe Institute for Advance Study; Wenner-Gren Hunt Fellowship; Harvard University; National Research Foundation of South Africa; Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology); Italian Embassy and Italian Cultural Institute in Pretoria; European Synchrotron Radiation Facility [EC 275, 697]; Division Of Behavioral and Cognitive Sci [1126470] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Radcliffe Institute for Advance Study; Wenner-Gren Hunt Fellowship; Harvard University; National Research Foundation of South Africa(National Research Foundation - South Africa); Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology); Italian Embassy and Italian Cultural Institute in Pretoria; European Synchrotron Radiation Facility; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by funding from the National Science Foundation, BCS 1126470, T.M.S., P.T.; Radcliffe Institute for Advance Study, T.M.S.; Wenner-Gren Hunt Fellowship, T.M.S.; Harvard University, T.M.S.; the National Research Foundation of South Africa, C.M.; the Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology), J.M-C.; the Italian Embassy and Italian Cultural Institute in Pretoria, J.M-C.; and the European Synchrotron Radiation Facility, EC 275 & 697, T.M.S., C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Anderson D L, 1976, J Forensic Sci, V21, P191; Anemone RL, 2002, HUMAN EVOLUTION THROUGH DEVELOPMENTAL CHANGE, P249; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Beynon A.D., 1992, P295; BEYNON AD, 1987, ARCH ORAL BIOL, V32, P773, DOI 10.1016/0003-9969(87)90002-1; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P189, DOI 10.1002/ajpa.1330860208; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; BEYNON AD, 1987, NATURE, V326, P493, DOI 10.1038/326493a0; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Bromage TG, 2012, J THEOR BIOL, V305, P131, DOI 10.1016/j.jtbi.2012.04.007; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Broom R, 1941, NATURE, V147, P607, DOI 10.1038/147607a0; Broom R, 1950, TRANSVAAL MUSEUM MEM, V4; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P243, DOI 10.1002/ajpa.1330860212; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P137, DOI 10.1002/ajpa.1330860205; Dart RA, 1948, AM J PHYS ANTHROP-NE, V6, P391, DOI 10.1002/ajpa.1330060410; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, ANN HUM BIOL, V36, P545, DOI 10.1080/03014460902956725; DEAN MC, 1987, J HUM EVOL, V16, P197, DOI 10.1016/0047-2484(87)90076-5; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; Dean MC, 1996, ARCH ORAL BIOL, V41, P233, DOI 10.1016/0003-9969(95)00137-9; Dean MC., 1995, STRUCTURE FUNCTION E, P239; Dean MC., 1993, INT J OSTEOARCHAEOL, V3, P249, DOI [10.1002/oa.1390030404, DOI 10.1002/OA.1390030404]; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Green DR, 2011, AM J PHYS ANTHROPOL, V144, P148; GRINE F E, 1982, Annals of the Transvaal Museum, V33, P165; Grine F.E., 1988, P3; Guatelli-Steinberg D, 2009, EVOL ANTHROPOL, V18, P9, DOI 10.1002/evan.20190; Hawkes K, 2006, SCH AM RES, P95; Hochberg Z., 2012, EVODEVO CHILD GROWTH, V1st; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Kelley J, 2003, J HUM EVOL, V44, P307, DOI 10.1016/S0047-2484(03)00005-8; Kelley J, 2014, AM J PHYS ANTHROPOL, V153, P156; Kelley J, 2012, INT J PRIMATOL, V33, P1332, DOI 10.1007/s10764-012-9607-2; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; Keyser AW, 2000, S AFR J SCI, V96, P193; Knott C, 2001, FOUND HUM B, P429; Konner M., 2010, EVOLUTION CHILDHOOD; Kuykendall K.L., 2003, Cambridge Studies in Biological and Evolutionary Anthropology, V37, P191; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; Lacruz RS, 2008, J ANAT, V213, P148, DOI 10.1111/j.1469-7580.2008.00938.x; Lacruz RS, 2007, AM J PHYS ANTHROPOL, V132, P175, DOI 10.1002/ajpa.20506; Lacruz RS, 2006, J HUM EVOL, V51, P580, DOI 10.1016/j.jhevol.2006.05.007; Lacruz RS, 2010, J HUM EVOL, V58, P201, DOI 10.1016/j.jhevol.2009.11.007; Lacruz RS, 2005, S AFR J SCI, V101, P567; Le Cabec A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123019; Liversidge HM, 2008, ANN HUM BIOL, V35, P294, DOI 10.1080/03014460801971445; Liversidge HM, 2006, ANN HUM BIOL, V33, P454, DOI 10.1080/03014460600802387; Liversidge HM, 2010, AM J PHYS ANTHROPOL, V143, P545, DOI 10.1002/ajpa.21349; Liversidge HM, 2004, AM J PHYS ANTHROPOL, V123, P172, DOI 10.1002/ajpa.10318; Macho Gabriele A., 1995, Evolutionary Anthropology, V4, P17, DOI 10.1002/evan.1360040105; MANN A, 1988, NATURE, V333, P123, DOI 10.1038/333123a0; McNulty KP, 2006, J HUM EVOL, V51, P274, DOI 10.1016/j.jhevol.2006.04.005; MIMURA F, 1939, KOBYO SHI, V13, P454; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Moggi-Cecchi J, 2010, J HUM EVOL, V58, P374, DOI 10.1016/j.jhevol.2010.01.006; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Okada M., 1943, SHANGHAI EVENING POS, P26; PUSEY AE, 1983, ANIM BEHAV, V31, P363, DOI 10.1016/S0003-3472(83)80055-4; RAMIREZROZZI FV, 1993, J HUM EVOL, V24, P429, DOI 10.1006/jhev.1993.1030; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 1998, J HUM EVOL, V35, P427, DOI 10.1006/jhev.1998.0248; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Robinson J. T, 1956, TRANSVAAL MUSEUM MEM, V9; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Rozzi FVR, 1997, CR ACAD SCI II A, V325, P231; Schwartz G.T., 1997, THESIS WASHINGTON U; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; Schwartz JH, 2005, HUMAN FOSSIL RECORD, V4; Skinner MM, 2006, SCH AM RES, P331; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Smith TM, 2007, VERTEBR PALEOBIOL PA, P177, DOI 10.1007/978-1-4020-5845-5_12; Smith TM, 2007, J HUM EVOL, V52, P201, DOI 10.1016/j.jhevol.2006.09.004; Smith TM, 2010, J HUM EVOL, V58, P363, DOI 10.1016/j.jhevol.2010.02.008; Smith T. M., 2014, SCLADINA I 4A JUVENI, P155; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2013, ANNU REV ANTHROPOL, V42, P191, DOI 10.1146/annurev-anthro-092412-155550; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Smith Tanya M., 2009, Paleoanthropology, V2009, P117; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; Smith TM, 2004, J HUM EVOL, V46, P551, DOI 10.1016/j.jhevol.2004.01.006; Stoinski TS, 2013, AM J PHYS ANTHROPOL, V152, P165, DOI 10.1002/ajpa.22301; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Thompson ME, 2013, AM J PRIMATOL, V75, P222, DOI 10.1002/ajp.22084; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507	106	48	49	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118118	10.1371/journal.pone.0118118	http://dx.doi.org/10.1371/journal.pone.0118118			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692765	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500098
J	Vanevski, F; Xu, BJ				Vanevski, Filip; Xu, Baoji			HuD Interacts with Bdnf mRNA and Is Essential for Activity-Induced BDNF Synthesis in Dendrites	PLOS ONE			English	Article							LONG-TERM POTENTIATION; BINDING PROTEIN HUD; NEUROTROPHIC FACTOR BDNF; NEURONAL ELAV PROTEINS; KINASE-C ACTIVATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; POSTTRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; DEPENDENT TRANSLATION	Highly specific activity-dependent neuronal responses are necessary for modulating synapses to facilitate learning and memory. We present evidence linking a number of important processes involved in regulating synaptic plasticity, suggesting a mechanistic pathway whereby activity-dependent signaling, likely through protein kinase C (PKC)-mediated phosphorylation of HuD, can relieve basal repression of Bdnf mRNA translation in dendrites, allowing for increased TrkB signaling and synaptic remodeling. We demonstrate that the neuronal ELAV family of RNA binding proteins associates in vivo with several Bdnf mRNA isoforms present in the adult brain in an activity-dependent manner, and that one member, HuD, interacts directly with sequences in the long Bdnf 3' untranslated region (3'UTR) and co-localizes with Bdnf mRNA in dendrites of hippocampal neurons. Activation of PKC leads to increased dendritic translation of mRNAs containing the long Bdnf 3'UTR, a process that is dependent on the presence of HuD and its phosphorylation at threonine residues 149 and/or 165. Thus, we found a direct effect of HuD on regulating translation of dendritic Bdnf mRNAs to mediate local and activity-dependent increases in dendritic BDNF synthesis.	[Vanevski, Filip; Xu, Baoji] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University	Xu, BJ (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	bxu@scripps.edu			US National Institutes of Health [R21 NS066235, R01 NS073930, R01 NS050596, F31 NS060453]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066235, R01NS050596, F31NS060453, R01NS073930] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health to BX (R21 NS066235, R01 NS073930, and R01 NS050596) and FV (F31 NS060453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Allen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055718; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Antic D, 1998, J CELL SCI, V111, P183; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Gomez-Palacio-Schjetnan A, 2008, NEUROSCI LETT, V445, P62, DOI 10.1016/j.neulet.2008.08.069; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Malkovska I, 2006, J NEUROSCI RES, V83, P211, DOI 10.1002/jnr.20728; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Orefice LL, 2013, J NEUROSCI, V33, P11618, DOI 10.1523/JNEUROSCI.0012-13.2013; Pascale A, 2008, CELL MOL LIFE SCI, V65, P128, DOI 10.1007/s00018-007-7017-y; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Poulsen FR, 2004, NEUROSCIENCE, V126, P665, DOI 10.1016/j.neuroscience.2004.04.008; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; Ramakers GMJ, 2000, NEUROSCI LETT, V286, P53, DOI 10.1016/S0304-3940(00)01081-8; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Son H, 1996, NEUROSCIENCE, V72, P1, DOI 10.1016/0306-4522(95)00532-3; Soule J, 2006, BIOCHEM SOC T, V34, P600, DOI 10.1042/BST0340600; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Vaghi V, 2014, J BIOL CHEM, V289, P27702, DOI 10.1074/jbc.M114.586719; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang ZH, 2011, NEUROCHEM RES, V36, P1027, DOI 10.1007/s11064-011-0443-0; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117264	10.1371/journal.pone.0117264	http://dx.doi.org/10.1371/journal.pone.0117264			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692578	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500046
J	Hayasaka, H; Kobayashi, D; Yoshimura, H; Nakayama, EE; Shioda, T; Miyasaka, M				Hayasaka, Haruko; Kobayashi, Daichi; Yoshimura, Hiromi; Nakayama, Emi E.; Shioda, Tatsuo; Miyasaka, Masayuki			The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7	PLOS ONE			English	Article							HIGH ENDOTHELIAL VENULES; VIRUS TYPE-1 GP120; LYMPH-NODES; CHEMOKINE; CXCR4; BINDING; DIMERIZATION; TRAFFICKING; LYMPHOCYTES; ACTIVATION	During human immunodeficiency virus (HIV) infection, enhanced migration of infected cells to lymph nodes leads to efficient propagation of HIV-1. The selective chemokine receptors, including CXCR4 and CCR7, may play a role in this process, yet the viral factors regulating chemokine-dependent T cell migration remain relatively unclear. The functional cooperation between the CXCR4 ligand chemokine CXCL12 and the CCR7 ligand chemokines CCL19 and CCL21 enhances CCR7-dependent T cell motility in vitro as well as cell trafficking into the lymph nodes in vivo. In this study, we report that a recombinant form of a viral CXCR4 ligand, X4-tropic HIV-1 gp120, enhanced the CD4 T cell response to CCR7 ligands in a manner dependent on CXCR4 and CD4, and that this effect was recapitulated by HIV-1 virions. HIV-1 gp120 significantly enhanced CCR7-dependent CD4 T cell migration from the footpad of mice to the draining lymph nodes in in vivo transfer experiments. We also demonstrated that CXCR4 expression is required for stable CCR7 expression on the CD4 T cell surface, whereas CXCR4 signaling facilitated CCR7 ligand binding to the cell surface and increased the level of CCR7 homo-as well as CXCR4/CCR7 hetero-oligomers without affecting CCR7 expression levels. Our findings indicate that HIV-evoked CXCR4 signaling promotes CCR7-dependent CD4 T cell migration by up-regulating CCR7 function, which is likely to be induced by increased formation of CCR7 homo-and CXCR4/CCR7 hetero-oligomers on the surface of CD4 T cells.	[Hayasaka, Haruko; Kobayashi, Daichi; Yoshimura, Hiromi] Osaka Univ, Dept Microbiol & Immunol, WPI Immunol Frontier Res Ctr, Lab Immune Regulat,Grad Sch Med, Suita, Osaka, Japan; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Miyasaka, Masayuki] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Miyasaka, Masayuki] Univ Turku, MediCity Lab, FIN-20520 Turku, Finland	Osaka University; Osaka University; Osaka University; University of Turku	Hayasaka, H (corresponding author), Osaka Univ, Dept Microbiol & Immunol, WPI Immunol Frontier Res Ctr, Lab Immune Regulat,Grad Sch Med, Suita, Osaka, Japan.	hayasaka@orgctl.med.osaka-u.ac.jp	Miyasaka, Masayuki/AAM-6343-2020	Kobayashi, Daichi/0000-0003-0389-0240; ying mei, zhong shan/0000-0002-0477-0980	Ministry of Education, Culture, Sports, Science and Technology [21121007]; Grants-in-Aid for Scientific Research [25460268] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Innovative Areas, 21121007 to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZB, 2009, J IMMUNOL, V182, P1287, DOI 10.4049/jimmunol.182.3.1287; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; Bandres JC, 1998, J VIROL, V72, P2500, DOI 10.1128/JVI.72.3.2500-2504.1998; Bozzini S, 1998, J MED VIROL, V54, P44, DOI 10.1002/(SICI)1096-9071(199801)54:1&lt;44::AID-JMV7&gt;3.0.CO;2-P; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Ebisuno Y, 2003, J IMMUNOL, V171, P1642, DOI 10.4049/jimmunol.171.4.1642; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Green DS, 2009, J VIROL, V83, P5765, DOI 10.1128/JVI.00130-09; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Irhimeh MR, 2007, EXP HEMATOL, V35, P989, DOI 10.1016/j.exphem.2007.02.009; Iyengar S, 1999, J IMMUNOL, V162, P6263; Kanemitsu N, 2005, BLOOD, V106, P2613, DOI 10.1182/blood-2005-01-0133; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Misse D, 1998, J VIROL, V72, P7280; Misse D, 1999, BLOOD, V93, P2454, DOI 10.1182/blood.V93.8.2454.408k35_2454_2462; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Su SB, 1999, J IMMUNOL, V162, P7128; TENNERRACZ K, 1988, AIDS, V2, P299, DOI 10.1097/00002030-198808000-00010; Umemoto E, 2012, J IMMUNOL, V189, P191, DOI 10.4049/jimmunol.1200802; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Wang JM, 1998, J IMMUNOL, V161, P4309; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yoshida R, 1998, INT IMMUNOL, V10, P901, DOI 10.1093/intimm/10.7.901; Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x	48	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117454	10.1371/journal.pone.0117454	http://dx.doi.org/10.1371/journal.pone.0117454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688986	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700046
J	Tancharoen, S; Matsuyama, T; Kawahara, KI; Tanaka, K; Lee, LJ; Machigashira, M; Noguchi, K; Ito, T; Imamura, T; Potempa, J; Kikuchi, K; Maruyama, I				Tancharoen, Salunya; Matsuyama, Takashi; Kawahara, Ko-Ichi; Tanaka, Kenji; Lee, Lyang-Ja; Machigashira, Miho; Noguchi, Kazuyuki; Ito, Takashi; Imamura, Takahisa; Potempa, Jan; Kikuchi, Kiyoshi; Maruyama, Ikuro			Cleavage of Host Cytokeratin-6 by Lysine-Specific Gingipain Induces Gingival Inflammation in Periodontitis Patients	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; PORPHYROMONAS-GINGIVALIS; EPITHELIAL-CELLS; INTERMEDIATE-FILAMENTS; KGP-PROTEINASE; HAIR FOLLICLE; DISEASE; MOUSE; CYTOKINES; MIGRATION	Background/Purpose Lysine-specific gingipain (Kgp) is a virulence factor secreted from Porphyromonas gingivalis (P. gingivalis), a major etiological bacterium of periodontal disease. Keratin intermediate filaments maintain the structural integrity of gingival epithelial cells, but are targeted by Kgp to produce a novel cytokeratin 6 fragment (K6F). We investigated the release of K6F and its induction of cytokine secretion. Methods K6F present in the gingival crevicular fluid of periodontal disease patients and in gingipain-treated rat gingival epithelial cell culture supernatants was measured by matrix-assisted laser desorption/ionization time-of-flight mass spectrometer-based rapid quantitative peptide analysis using BLOTCHIP. K6F in gingival tissues was immunostained, and cytokeratin 6 protein was analyzed by immunofluorescence staining and flow cytometry. Activation of MAPK in gingival epithelial cells was evaluated by immunoblotting. ELISA was used to measure K6F and the cytokines release induced by K6F. Human gingival fibroblast migration was assessed using a Matrigel invasion chamber assay. Results We identified K6F, corresponding to the C-terminus region of human cytokeratin 6 (amino acids 359-378), in the gingival crevicular fluid of periodontal disease patients and in the supernatant from gingival epithelial cells cultured with Kgp. K6F antigen was distributed from the basal to the spinous epithelial layers in gingivae from periodontal disease patients. Cytokeratin 6 on gingival epithelial cells was degraded by Kgp, but not by Arg-gingipain, P. gingivalis lipopolysaccharide or Actinobacillus actinomycetemcomitans lipopolysaccharide. K6F, but not a scrambled K6F peptide, induced human gingival fibroblast migration and secretion of interleukin (IL)-6, IL-8 and monocyte chemoattractant protein-1. These effects of K6F were mediated by activation of p38 MAPK and Jun N-terminal kinase, but not p42/44 MAPK or p-Akt. Conclusion Kgp degrades gingival epithelial cell cytokeratin 6 to K6F that, on release, induces invasion and cytokine secretion by human gingival fibroblasts. Thus, Kgp may contribute to the development of periodontal disease.	[Tancharoen, Salunya] Mahidol Univ, Fac Dent, Dept Pharmacol, Bangkok 10700, Thailand; [Matsuyama, Takashi; Machigashira, Miho; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Kagoshima 890, Japan; [Kawahara, Ko-Ichi] Osaka Inst Technol, Lab Funct Foods, Dept Biomed Engn, Osaka 535, Japan; [Tanaka, Kenji; Lee, Lyang-Ja] Protosera Inc, Membrane Prot & Ligand Anal Ctr, Amagasaki, Hyogo, Japan; [Ito, Takashi; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan; [Imamura, Takahisa] Kumamoto Univ, Dept Mol Pathol, Fac Life Sci, Kumamoto, Japan; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Periodont Endodont & Dent Hyg, Louisville, KY 40292 USA; [Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kikuchi, Kiyoshi] Kurume Univ, Sch Med, Dept Physiol, Fukuoka, Japan	Mahidol University; Kagoshima University; Osaka Institute of Technology; Kagoshima University; Kumamoto University; University of Louisville; Jagiellonian University; Kurume University	Maruyama, I (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan.	rinken@m3.kufm.kagoshima-u.ac.jp	tancharoen, salunya/AAJ-4765-2020; Potempa, Jan/AAA-6850-2021	Potempa, Jan/0000-0002-3600-7461				Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Andrian E, 2006, ORAL MICROBIOL IMMUN, V21, P123, DOI 10.1111/j.1399-302X.2006.00248.x; Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Angelucci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050804; [Anonymous], 2014, NM0055553 NRS; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Araki Y, 2011, PROTEOMICS, V11, P2727, DOI 10.1002/pmic.201000753; Barth K, 2013, J CELL PHYSIOL, V228, P1413, DOI 10.1002/jcp.24299; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Chen T, 2001, INFECT IMMUN, V69, P3048, DOI 10.1128/IAI.69.5.3048-3056.2001; COMOGLIO PM, 1973, J CELL SCI, V13, P415; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dey M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078751; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Ekuni D, 2005, J PERIODONTOL, V76, P43, DOI 10.1902/jop.2005.76.1.43; Elisoa A, 2007, J CELLULAR PHYSL, V211, P56; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fujimura S, 1998, FEMS MICROBIOL LETT, V163, P173, DOI 10.1016/S0378-1097(98)00169-4; Gibson FC, 2005, J PERIODONTOL, V76, P1629, DOI 10.1902/jop.2005.76.10.1629; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Graves DT, 1999, CLIN INFECT DIS, V28, P482, DOI 10.1086/515178; Grenier D, 2001, INFECT IMMUN, V69, P5166, DOI 10.1128/IAI.69.8.5166-5172.2001; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; HANAZAWA S, 1993, INFECT IMMUN, V61, P5219, DOI 10.1128/IAI.61.12.5219-5224.1993; Hirose M, 2001, J PERIODONTOL, V72, P590, DOI 10.1902/jop.2001.72.5.590; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Kamath L, 2001, CANCER RES, V61, P5933; Kayal RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/639368; Kenji T, 2009, BIOCH BIOPHYSICAL RE, V379, P110, DOI [10.1016/j.bbrc.2008.12.016, DOI 10.1016/J.BBRC.2008.12.016]; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Lewis JP, 1999, J BACTERIOL, V181, P4905, DOI 10.1128/JB.181.16.4905-4913.1999; Mezyk-Kopec R, 2005, INFECT IMMUN, V73, P1506, DOI 10.1128/IAI.73.3.1506-1514.2005; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; O'Brien-Simpson NM, 2009, INFECT IMMUN, V77, P1246, DOI 10.1128/IAI.01038-08; Park Hong-Gyu, 2013, International Journal of Oral Biology, V38, P73, DOI 10.11620/IJOB.2013.38.2.073; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Seipelt J, 2000, J BIOL CHEM, V275, P20084, DOI 10.1074/jbc.275.26.20084; Senga Y, 1996, UROLOGY, V48, P703, DOI 10.1016/S0090-4295(96)00253-1; Silva-Boghossian CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075898; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Sroka A, 2001, J BACTERIOL, V183, P5609, DOI 10.1128/JB.183.19.5609-5616.2001; Subrahmanyam M V, 2003, Indian J Clin Biochem, V18, P5, DOI 10.1007/BF02867658; Takahashi K, 1996, P NATL ACAD SCI USA, V93, P14776, DOI 10.1073/pnas.93.25.14776; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tancharoen S, 2005, J IMMUNOL, V174, P5796, DOI 10.4049/jimmunol.174.9.5796; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; UITTO VJ, 1991, CRIT REV ORAL BIOL M, V2, P323, DOI 10.1177/10454411910020030301; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; Watanabe K, 2001, INFECT IMMUN, V69, P6731, DOI 10.1128/IAI.69.11.6731-6737.2001; Wojcik SM, 1999, DIFFERENTIATION, V65, P97, DOI 10.1046/j.1432-0436.1999.6520097.x; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921; Xu Y, 2009, BMB REP, V42, P344, DOI 10.5483/BMBRep.2009.42.6.344; Yasuhara R, 2011, J ORAL BIOSCI, V53, P197, DOI 10.2330/joralbiosci.53.197; Yasuhara R, 2009, BIOCHEM J, V419, P159, DOI 10.1042/BJ20081469	67	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117775	10.1371/journal.pone.0117775	http://dx.doi.org/10.1371/journal.pone.0117775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688865	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700071
J	Brown, RL; Xiong, WH; Peters, JH; Tekmen-Clark, M; Strycharska-Orczyk, I; Reed, BT; Morgans, CW; Duvoisin, RM				Brown, R. Lane; Xiong, Wei-Hong; Peters, James H.; Tekmen-Clark, Merve; Strycharska-Orczyk, Iwona; Reed, Brian T.; Morgans, Catherine W.; Duvoisin, Robert M.			TRPM3 Expression in Mouse Retina	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; NEIBANK PROJECT; GANGLION-CELLS; CHANNEL; RECEPTOR; LIGHT; IDENTIFICATION; RESPONSES; PATHWAY; IRIS	Transient receptor potential (TRP) channels constitute a large family of cation permeable ion channels that serve crucial functions in sensory systems by transducing environmental changes into cellular voltage and calcium signals. Within the retina, two closely related members of the melastatin TRP family, TRPM1 and TRPM3, are highly expressed. TRPM1 has been shown to be required for the depolarizing response to light of ON-bipolar cells, but the role of TRPM3 in the retina is unknown. Immunohistochemical staining of mouse retina with an antibody directed against the C-terminus of TRPM3 labeled the inner plexiform layer (IPL) and a subset of cells in the ganglion cell layer. Within the IPL, TRPM3 immunofluorescence was markedly stronger in the OFF sublamina than in the ON sublamina. Electroretinogram recordings showed that the scotopic and photopic a- and b-waves of TRPM3(-/-) mice are normal indicating that TRPM3 does not play a major role in visual processing in the outer retina. TRPM3 activity was measured by calcium imaging and patch-clamp recording of immunopurified retinal ganglion cells. Application of the TRPM3 agonist, pregnenolone sulfate (PS), stimulated increases in intracellular calcium in similar to 40% of cells from wild type and TRPM1(-/-) mice, and the PS-stimulated increases in calcium were blocked by co-application of mefenamic acid, a TRPM3 antagonist. No PS-stimulated changes in fluorescence were observed in ganglion cells from TRPM3(-/-) mice. Similarly, PS-stimulated currents that could be blocked by mefenamic acid were recorded from wild type retinal ganglion cells but were absent in ganglion cells from TRPM3(-/-) mice.	[Brown, R. Lane; Peters, James H.; Reed, Brian T.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Brown, R. Lane] Washington State Univ, WWAMI Med Educ Program, Pullman, WA 99164 USA; [Xiong, Wei-Hong; Tekmen-Clark, Merve; Strycharska-Orczyk, Iwona; Reed, Brian T.; Morgans, Catherine W.; Duvoisin, Robert M.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Washington State University; Washington State University; Oregon Health & Science University	Brown, RL (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA.	brownla@vetmed.wsu.edu; duvoisin@ohsu.edu		Morgans, Catherine/0000-0002-7287-3447	National Eye Institute [EY019907, EY018625, EY009534]; NATIONAL EYE INSTITUTE [R01EY022369, P30EY010572, R01EY018625, R01EY019907, R01EY009534] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute: EY019907, EY018625, EY009534, http://www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hoffmann A, 2010, J NEUROCHEM, V114, P654, DOI 10.1111/j.1471-4159.2010.06644.x; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Klose C, 2011, BRIT J PHARMACOL, V162, P1757, DOI 10.1111/j.1476-5381.2010.01186.x; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Nilius B, 2008, NAT CELL BIOL, V10, P1383, DOI 10.1038/ncb1208-1383; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SPENCE KT, 1991, LIFE SCI, V49, pPL235, DOI 10.1016/0024-3205(91)90649-V; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Vriens J, 2014, NATURE CHEMICAL BIOL, DOI [10.1038/nchembio.1731, DOI 10.1038/NCHEMBIO.1731]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wistow G, 2002, MOL VIS, V8, P205; Wistow G, 2002, MOL VIS, V8, P185; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	34	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117615	10.1371/journal.pone.0117615	http://dx.doi.org/10.1371/journal.pone.0117615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679224	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600077
J	Hu, HT; Yu, DH; Liu, H				Hu, Hongtao; Yu, Dazhao; Liu, Hong			Bioinformatics Analysis of Small RNAs in Pima (Gossypium barbadense L.)	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; DIRECTED DNA METHYLATION; DOUBLE-STRANDED-RNA; PLANT MICRORNAS; ARABIDOPSIS; SIRNA; POLYMERASE; COTTON; BIOGENESIS; MIRNAS	Small RNAs (sRNAs) are similar to 20 to 24 nucleotide single-stranded RNAs that play crucial roles in regulation of gene expression. In plants, sRNAs are classified into microRNAs (miRNAs), repeat-associated siRNAs (ra-siRNAs), phased siRNAs (pha-siRNAs), cis and trans natural antisense transcript siRNAs (cis- and trans-nat siRNAs). Pima (Gossypium barbadense L.) is one of the most economically important fiber crops, producing the best and longest spinnable fiber. Although some miRNAs are profiled in Pima, little is known about siRNAs, the largest subclass of plant sRNAs. In order to profile these gene regulators in Pima, a comprehensive analysis of sRNAs was conducted by mining publicly available sRNA data, leading to identification of 678 miRNAs, 3,559,126 ra-siRNAs, 627 pha-siRNAs, 136,600 cis-nat siRNAs and 79,994 trans-nat siRNAs. The 678 miRNAs, belonging to 98 conserved and 402 lineage-specific families, were produced from 2,138 precursors, of which 297 arose from introns, exons, or intron/UTR-exon junctions of protein-coding genes. Ra-siRNAs were produced from various repeat loci, while most (97%) were yielded from retrotransposons, especially LTRs (long terminal repeats). The genes encoding auxin-signaling-related proteins, NBS-LRRs and transcription factors were major sources of pha-siRNAs, while two conserved TAS3 homologs were found as well. Most cis-NATs in Pima overlapped in enclosed and convergent orientations, while a few hybridized in divergent and coincided orientations. Most cis- and trans-nat siRNAs were produced from overlapping regions. Additionally, characteristics of length and the 5'-first nucleotide of each sRNA class were analyzed as well. Results in this study created a valuable molecular resource that would facilitate studies on mechanism of controlling gene expression.	[Hu, Hongtao] Hubei Acad Agr Sci, Ctr Biopesticide Res, Wuhan, Hubei, Peoples R China; [Hu, Hongtao] Hubei Vocat Coll Biol Sci & Technol, Dept Biol Engn, Wuhan, Hubei, Peoples R China; [Yu, Dazhao] Hubei Acad Agr Sci, Inst Plant Protect & Soil Fertilizer, Wuhan, Hubei, Peoples R China; [Liu, Hong] Hunan Univ Arts & Sci, Coll Life Sci, Changde, Hunan, Peoples R China; [Liu, Hong] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Hubei Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences; Hunan University of Arts & Science; Huazhong Agricultural University	Liu, H (corresponding author), Hunan Univ Arts & Sci, Coll Life Sci, Changde, Hunan, Peoples R China.	liuhong59@mail.hzau.edu.cn			Fundamental Research Funds for the Central University [2014PY042]	Fundamental Research Funds for the Central University	This project was supported by a grant from Fundamental Research Funds for the Central University (No. 2014PY042). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen DJ, 2012, NUCLEIC ACIDS RES, V40, pD1187, DOI 10.1093/nar/gkr823; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Eun C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025730; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guan XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4050; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jia X, 2011, FRONT BIOL, V6, P133; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim JJ, 2012, PLANT PHYSIOL, V159, P461, DOI 10.1104/pp.111.192369; Koster T, 2014, NUCLEIC ACIDS RES, V42, P9925, DOI 10.1093/nar/gku716; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Melamed Z, 2013, MOL CELL, V50, P869, DOI 10.1016/j.molcel.2013.05.007; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Ramalingam P, 2014, RNA, V20, P76, DOI 10.1261/rna.041814.113; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Tong YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063938; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Visser M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095782; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2014, J EXP BOT, V65, P4723, DOI 10.1093/jxb/eru246; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xu C, 2013, PROTEIN CELL, V4, P656, DOI 10.1007/s13238-013-3052-7; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yan K, 2012, MOL CELL, V48, P521, DOI 10.1016/j.molcel.2012.08.032; Yang GD, 2012, J GENET, V91, P313, DOI 10.1007/s12041-012-0199-6; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang H, 2013, P NATL ACAD SCI USA, V110, P8290, DOI 10.1073/pnas.1300585110; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069743; Zhang XM, 2013, MOL PLANT, V6, P704, DOI 10.1093/mp/sst051; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108	81	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116826	10.1371/journal.pone.0116826	http://dx.doi.org/10.1371/journal.pone.0116826			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679373	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600036
J	Long, WH; Zou, XL; Zhang, XK				Long, Weihua; Zou, Xiling; Zhang, Xuekun			Transcriptome Analysis of Canola (Brassica napus) under Salt Stress at the Germination Stage	PLOS ONE			English	Article							L-ASCORBIC-ACID; SALINITY TOLERANCE; GENE-EXPRESSION; VITAMIN-C; ARABIDOPSIS; OXYGENASE; BIOSYNTHESIS; DROUGHT; ENCODES; PLANTS	Canola (Brassica napus) is one of the most important oil crops in the world. However, its yield has been constrained by salt stress. In this study, transcriptome profiles were explored using Digital Gene Expression (DGE) at 0, 3, 12 and 24 hours after H2O (control) and NaCl treatments on B. napus roots at the germination stage. Comparisons of gene-expression between the control and the treatment were conducted after tag-mapping to the sequenced Brassica rapa genome. The differentially expressed genes during the time course of salt stress were focused on, and 163 genes were identified to be differentially expressed at all the time points. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses revealed that some of the genes were involved in proline metabolism, inositol metabolism, carbohydrate metabolic processes and oxidation-reduction processes and may play vital roles in the salt-stress response at the germination stage. Thus, this study provides new candidate salt stress responding genes, which may function in novel putative nodes in the molecular pathways of salt stress resistance.	[Long, Weihua; Zou, Xiling; Zhang, Xuekun] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, XK (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	seedcq@263.net			Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture [2011-1]; Hi-Tech Research and Development Program of China [2011AA10A104]	Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	Funding provided by the Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture (2011-1), Hi-Tech Research and Development Program of China (2011AA10A104).	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Ali Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048819; Alos E, 2013, PLANT SCI, V207, P2, DOI 10.1016/j.plantsci.2013.02.007; An P, 2014, J AGRON CROP SCI, V200, P212, DOI 10.1111/jac.12060; Ashraf M, 2013, PLANT BREEDING, V132, P10, DOI 10.1111/pbr.12000; Atkinson RG, 2009, POSTHARVEST BIOL TEC, V51, P149, DOI 10.1016/j.postharvbio.2008.06.014; Bak S, 2012, ARABIDOPSIS BOOK, V9, pe0144; Bazakos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042931; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chen L, 2010, ACTA BIOCH BIOPH SIN, V42, P154, DOI 10.1093/abbs/gmp113; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Han YS, 2013, J EXP BOT, V64, P4225, DOI 10.1093/jxb/ert229; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Jamil A, 2011, CRIT REV PLANT SCI, V30, P435, DOI 10.1080/07352689.2011.605739; Jan A, 2001, PLANT PHYSIOL, V136, P3670; Jiang JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-72; Jung JH, 2011, PLANT SIGNAL BEHAV, V6, P1198, DOI 10.4161/psb.6.8.15792; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Khan Taqi Ahmed, 2011, Journal of Agrobiology, V28, P97, DOI 10.2478/v10146-011-0011-x; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; Lee SC, 2008, MOL CELLS, V26, P595; Li MJ, 2011, J AM SOC HORTIC SCI, V136, P231, DOI 10.21273/JASHS.136.4.231; [龙卫华 Long Weihua], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P271; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nishitani K, 1997, INT REV CYTOL, V173, P157; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Saadia M, 2012, MOLECULES, V17, P5803, DOI 10.3390/molecules17055803; Shalata A, 2001, J EXP BOT, V52, P2207, DOI 10.1093/jexbot/52.364.2207; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Zang YX, 2009, BIOTECHNOL BIOPROC E, V14, P467, DOI 10.1007/s12257-008-0294-y; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zou XL, 2013, INT J MOL SCI, V14, P2637, DOI 10.3390/ijms14022637	73	29	33	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116217	10.1371/journal.pone.0116217	http://dx.doi.org/10.1371/journal.pone.0116217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679513	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600016
J	Nagasawa, S; Sedukhina, AS; Nakagawa, Y; Maeda, I; Kubota, M; Ohnuma, S; Tsugawa, K; Ohta, T; Roche-Molina, M; Bernal, JA; Narvaez, AJ; Jeyasekharan, AD; Sato, K				Nagasawa, Satoi; Sedukhina, Anna S.; Nakagawa, Yuko; Maeda, Ichiro; Kubota, Manabu; Ohnuma, Shigeko; Tsugawa, Koichiro; Ohta, Tomohiko; Roche-Molina, Marta; Bernal, Juan A.; Narvaez, Ana J.; Jeyasekharan, Anand D.; Sato, Ko			LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MOLECULAR PORTRAITS; DNA-REPAIR; CARCINOMA; ACTIVATION; REPRESSION; TUMORS	LSD1, a lysine-specific histone demethylase, is overexpressed in several types of cancers and linked to poor outcomes. In breast cancer, the significance of LSD1 overexpression is not clear. We have performed an in silico analysis to assess the relationship of LSD1 expression to clinical outcome. We demonstrate that LSD1 overexpression is a poor prognostic factor in breast cancer, especially in basal-like breast cancer, a subtype of breast cancer with aggressive clinical features. This link is also observed in samples of triple negative breast cancer. Interestingly, we note that overexpression of LSD1 correlates with down-regulation of BRCA1 in triple negative breast cancer. This phenomenon is also observed in in vitro models of basal-like breast cancer, and is associated with an increased sensitivity to PARP inhibitors. We propose therefore that high expression levels of the demethylase LSD1 is a potential prognostic factor of poor outcome in basal-like breast cancer, and that PARP inhibition may be a therapeutic strategy of interest in this poor prognostic subtype with overexpression of LSD1.	[Nagasawa, Satoi; Sedukhina, Anna S.; Nakagawa, Yuko; Ohta, Tomohiko; Sato, Ko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Nagasawa, Satoi; Tsugawa, Koichiro] St Marianna Univ, Sch Med, Div Breast & Endocrine Surg, Dept Surg, Kawasaki, Kanagawa 2168511, Japan; [Nakagawa, Yuko] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa 2168511, Japan; [Maeda, Ichiro; Kubota, Manabu; Ohnuma, Shigeko] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa 2168511, Japan; [Roche-Molina, Marta; Bernal, Juan A.] CNIC, Dept Cardiovasc Dev & Repair, Madrid 28029, Spain; [Narvaez, Ana J.] Univ Cambridge, MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge CB2 OXZ, England; [Jeyasekharan, Anand D.] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, Singapore 117599, Singapore	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Cambridge; National University of Singapore	Sato, K (corresponding author), St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan.	kosato@marianna-u.ac.jp	Roche-Molina, Marta/G-2731-2016; Jeyasekharan, Anand/O-3398-2019; Nagasawa, Satoi/GSJ-2420-2022; Bernal, Juan A/N-4544-2014	Bernal, Juan A/0000-0002-9933-5550; Roche-Molina, Marta/0000-0002-9487-6980; Jeyasekharan, Anand/0000-0001-9816-6137; Nagasawa, Satoi/0000-0003-3967-7644; Ohta, Tomohiko/0000-0002-9700-7342	St. Marianna University; Grants-in-Aid for Scientific Research [26290042, 26670730] Funding Source: KAKEN	St. Marianna University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KS received a grant of St. Marianna University and ASS received a grant of St. Marianna University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Ding J, 2013, DIGEST DIS SCI, V58, P1581, DOI 10.1007/s10620-012-2552-2; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; REMMELE W, 1986, VIRCHOWS ARCH A, V409, P127, DOI 10.1007/BF00708323; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Yokoyama A, 2014, J BIOL CHEM; Yu YY, 2013, BIOCHEM BIOPH RES CO, V437, P192, DOI 10.1016/j.bbrc.2013.05.123; Zhao ZK, 2012, WORLD J GASTROENTERO, V18, P6651, DOI 10.3748/wjg.v18.i45.6651	27	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118002	10.1371/journal.pone.0118002	http://dx.doi.org/10.1371/journal.pone.0118002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679396	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600099
J	Park, MW; Kim, KH; Kim, EY; Lee, SY; Ko, JJ; Lee, KA				Park, Min-Woo; Kim, Kyeoung-Hwa; Kim, Eun-Young; Lee, Su-Yeon; Ko, Jung-Jae; Lee, Kyung-Ah			Associations among Sebox and Other MEGs and Its Effects on Early Embryogenesis	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOGENESIS; EARLY EMBRYONIC-DEVELOPMENT; ZYGOTIC GENE ACTIVATION; MATERNAL-EFFECT GENE; MESSENGER-RNAS; EXPRESSION; OOCYTES; TRANSITION; DEGRADATION; STAGE	In a previous report, we identified Sebox as a new candidate maternal effect gene that is essential for embryonic development and primarily impacts the two-cell (2C) stage. The present study was conducted to determine the mechanism of action for Sebox in this capacity, as shown by changes in the expression levels of other known MEG mRNAs after Sebox RNA interference (RNAi) in oocytes. Sebox-knockdown metaphase II (Mll) oocytes displayed normal morphology, but among the 23 MEGs monitored, 8 genes were upregulated, and 15 genes were unchanged. We hypothesized that the perturbed gene expression of these MEGs may cause the arrest of embryo development at the 2C stage and examined the expression of several marker genes for the degradation of maternal factors and zygotic genome activation. We found that some maternal mRNAs, c-mos, Gbx2, and Gdf9, were not fully degraded in Sebox-knockdown 2C embryos, and that several zygotic genome activation markers, Mt1a, Rpl23, Ube2a and Wee1, were not fully expressed in conjunction with diminished embryonic transcriptional activity. In addition, Sebox may be involved in the formation of the subcortical maternal complex through its regulation of the upstream regulator, Figla. Therefore, we concluded that Sebox is important in preparing oocytes for embryonic development by orchestrating the expression of other important MEGs.	[Park, Min-Woo; Kim, Kyeoung-Hwa; Kim, Eun-Young; Lee, Su-Yeon; Ko, Jung-Jae; Lee, Kyung-Ah] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam 463400, Gyeonggi Do, South Korea	Pochon Cha University	Ko, JJ (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Pangyo Ro 335, Songnam 463400, Gyeonggi Do, South Korea.	highko@cha.ac.kr; leeka@ovary.co.kr			Priority Research Centers Program, through the National Research Foundation of Korea (NRF), - Ministry of Education, Science, and Technology [2009-0093821]	Priority Research Centers Program, through the National Research Foundation of Korea (NRF), - Ministry of Education, Science, and Technology	This work was supported by the Priority Research Centers Program, through the National Research Foundation of Korea (NRF), and funded by the Ministry of Education, Science, and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh Z, 2005, MOL REPROD DEV, V72, P281, DOI 10.1002/mrd.20340; Cinquanta M, 2000, P NATL ACAD SCI USA, V97, P8904, DOI 10.1073/pnas.97.16.8904; GOLBUS MS, 1973, J EXP ZOOL, V186, P207, DOI 10.1002/jez.1401860211; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; Kim KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023304; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Latham KE, 1999, INT REV CYTOL, V193, P71; Lee Hyun-Seo, 2011, Clin Exp Reprod Med, V38, P68, DOI 10.5653/cerm.2011.38.2.68; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Moreno DL, 2014, ZYGOTE, V22, P64, DOI 10.1017/S0967199412000342; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Park Geon Tae, 2013, Clin Exp Reprod Med, V40, P1, DOI 10.5653/cerm.2013.40.1.1; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Qiu JJ, 2003, CELL RES, V13, P179, DOI 10.1038/sj.cr.7290162; Rother F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018310; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tsai TC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-88; Waksmundzka M, 2001, MOL REPROD DEV, V58, P173, DOI 10.1002/1098-2795(200102)58:2&lt;173::AID-MRD6&gt;3.0.CO;2-2; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; ZERNICKAGOETZ M, 1994, MOL REPROD DEV, V38, P30, DOI 10.1002/mrd.1080380106	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115050	10.1371/journal.pone.0115050	http://dx.doi.org/10.1371/journal.pone.0115050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679966	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600004
J	Suzuki, K; Sato, M; Zheng, W; Shinohara, R; Yokomichi, H; Yamagata, Z				Suzuki, Kohta; Sato, Miri; Zheng, Wei; Shinohara, Ryoji; Yokomichi, Hiroshi; Yamagata, Zentaro			Childhood Growth Trajectories According to Combinations of Pregestational Weight Status and Maternal Smoking during Pregnancy: A Multilevel Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; OBESITY; ASSOCIATION; CHILDREN; RISK; OVERWEIGHT; EXPOSURE; BIRTH; WOMEN	Pregestational weight status and maternal smoking during pregnancy are significantly associated with fetal and childhood growth. However, few studies have examined associations between childhood growth and combinations of these factors using multilevel analysis. This study aimed to describe differences in childhood growth trajectories according to these combinations, using data from a prospective cohort study in Japan. The study participants were 1,973 women and their singletons, who were born between April 1, 1991 and March 31, 2003. Children were categorized according to whether they were born to normal-weight, nonsmoking mothers (NN); normal-weight, smoking mothers (NS); underweight, nonsmoking mothers (UN); underweight, smoking mothers (US); overweight, nonsmoking mothers (ON); or overweight, smoking mothers (OS). Birth weight and anthropometric data were collected from 1,965 children at birth (99.6%), 1,655 aged 3 (83.9%), 1,527 aged 5 (77.4%), 1,497 aged 7-8 (75.9%), and 1,501 aged 9-10 (76.1%). Multilevel analysis examining both individual and age as different level variables according to sex was used to describe the trajectories of body mass index z scores for statistical analyses. Although children of the OS group were the leanest at birth, their body mass indices had increased rapidly by 3 years of age. Moreover, body mass index was also likely to increase in boys in the NS and ON groups. A different trend was observed in girls. Body mass index decreased from 5 years of age in girls in the US group. There were no remarkable differences in body mass index trajectories between children in the other groups. In conclusion, childhood growth trajectories differed according to combinations of pregestational weight status and maternal smoking during pregnancy. Further, there were sex-related differences in the associations between childhood growth and factor combinations.	[Suzuki, Kohta; Zheng, Wei; Yokomichi, Hiroshi; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan; [Sato, Miri; Shinohara, Ryoji; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Ctr Birth Cohort Studies, Chuo Ku, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Suzuki, K (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan.	kohtas@yamanashi.ac.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [KAKENHI 23390173, KAKENHI 20590639, KAKENHI 23590785]; Grants-in-Aid for Scientific Research [24790614] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI 23390173, KAKENHI 20590639, and KAKENHI 23590785) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Balding DJ, 2004, APPL LONGITUDINAL AN; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Burstyn I, 2009, NICOTINE TOB RES, V11, P670, DOI 10.1093/ntr/ntp048; CHARNEY E, 1976, NEW ENGL J MED, V295, P6, DOI 10.1056/NEJM197607012950102; Chihara I, 2011, ARCH GYNECOL OBSTET, V284, P1117, DOI 10.1007/s00404-010-1812-7; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Durmus B, 2013, PEDIATR OBES, V8, P339, DOI 10.1111/j.2047-6310.2012.00114.x; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Heaman M, 2013, PAEDIATR PERINAT EP, V27, P54, DOI 10.1111/ppe.12016; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Jang SY, 2012, ASIAN PAC J CANCER P, V13, P1003, DOI 10.7314/APJCP.2012.13.3.1003; Jeric M, 2013, EARLY HUM DEV, V89, P277, DOI 10.1016/j.earlhumdev.2012.10.004; Legler J, 2013, OBESITY, V21, P1084, DOI 10.1002/oby.20478; Levine M D, 2004, Arch Womens Ment Health, V7, P155; Levine MD, 2010, AM J PREV MED, V39, P345, DOI 10.1016/j.amepre.2010.05.023; Lombardo C, 2012, EAT WEIGHT DISORD-ST, V17, pE116, DOI 10.1007/BF03325335; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Phillips DIW, 1996, DIABETOLOGIA, V39, P1119; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73, DOI 10.1007/BF03405567; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Suzuki K, 2011, INT J OBESITY, V35, P53, DOI 10.1038/ijo.2010.198; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Swanson JM, 2009, SEMIN REPROD MED, V27, P391, DOI 10.1055/s-0029-1237427; Toschke AM, 2003, AM J EPIDEMIOL, V158, P1068, DOI 10.1093/aje/kwg258; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Vik T, 1996, EARLY HUM DEV, V45, P245, DOI 10.1016/0378-3782(96)01735-5; Voigt M, 2011, Z GEBURTSH NEONATOL, V215, P23, DOI 10.1055/s-0030-1254142; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; WHO, 2006, WHO CHILD GROWTH STA; Wideroe M, 2003, PAEDIATR PERINAT EP, V17, P171, DOI 10.1046/j.1365-3016.2003.00481.x	36	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118538	10.1371/journal.pone.0118538	http://dx.doi.org/10.1371/journal.pone.0118538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680116	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600124
J	Yu, L; Wang, YJ; Wang, YQ; Sun, SQ; Liu, LZY				Yu, Lei; Wang, Yujie; Wang, Yunqi; Sun, Suqi; Liu, Liziyuan			Quantifying Components of Soil Respiration and Their Response to Abiotic Factors in Two Typical Subtropical Forest Stands, Southwest China	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; LAND-USE CHANGE; ROOT RESPIRATION; CO2 EFFLUX; HETEROTROPHIC RESPIRATION; AUTOTROPHIC COMPONENTS; SEASONAL-VARIATIONS; TEMPORAL VARIATION; FINE ROOTS; CARBON	Separating the components of soil respiration and understanding the roles of abiotic factors at a temporal scale among different forest types are critical issues in forest ecosystem carbon cycling. This study quantified the proportions of autotrophic (R-A) and heterotrophic (R-H) in total soil (R-T) respiration using trenching and litter removal. Field studies were conducted in two typical subtropical forest stands (broadleaf and needle leaf mixed forest; bamboo forest) at Jinyun Mountain, near the Three Georges Reservoir in southwest China, during the growing season (Apr.-Sep.) from 2010 to 2012. The effects of air temperature (AT), soil temperature (ST) and soil moisture (SM) at 6cm depth, solar radiation (SR), pH on components of soil respiration were analyzed. Results show that: 1) SR, AT, and ST exhibited a similar temporal trend. The observed abiotic factors showed slight interannual variability for the two forest stands. 2) The contributions of R-H and R-A to R-T for broadleaf and needle leaf mixed forest were 73.25% and 26.75%, respectively, while those for bamboo forest were 89.02% and 10.98%, respectively; soil respiration peaked from June to July. In both stands, CO2 released from the decomposition of soil organic matter (SOM), the strongest contributor to R-T, accounted for over 63% of R-H. 3) AT and ST were significantly positively correlated with R-T and its components (p<0.05), and were major factors affecting soil respiration. 4) Components of soil respiration were significantly different between two forest stands (p<0.05), indicating that vegetation types played a role in soil respiration and its components.	[Yu, Lei; Wang, Yujie; Wang, Yunqi; Sun, Suqi; Liu, Liziyuan] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Wang, YJ (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	95833797@qq.com			Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China [201104009-03]; CFERN & GENE Award Funds	Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China; CFERN & GENE Award Funds	This study was supported by the funding of Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China(201104009-03), and was supported by CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2002, PLANT PHYSIOL, V128, P212, DOI 10.1104/pp.010326; Bond-Lamberty B, 2004, TREE PHYSIOL, V24, P1387, DOI 10.1093/treephys/24.12.1387; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Burton AJ, 2002, OECOLOGIA, V131, P559, DOI 10.1007/s00442-002-0931-7; Butler A, 2012, PLANT SOIL, V352, P129, DOI 10.1007/s11104-011-0984-7; [常建国 CHANG JianGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P1791; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Chen MQ, 2010, J BAMBOO RES CHINESE, V29, P5, DOI [10.3969/j.issn.1000-6567.2010.03.002, DOI 10.3969/J.ISSN.1000-6567.2010.03.002]; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; [冯华敏 Feng Huamin], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P38; Fenn KM, 2010, SOIL BIOL BIOCHEM, V42, P1685, DOI 10.1016/j.soilbio.2010.05.028; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Grant RF, 2001, SOIL SCI SOC AM J, V65, P205, DOI 10.2136/sssaj2001.651205x; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Heinemeyer A, 2007, GLOBAL CHANGE BIOL, V13, P1786, DOI 10.1111/j.1365-2486.2007.01383.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; John B, 2002, BIOL FERT SOILS, V35, P238, DOI 10.1007/s00374-002-0470-8; Kang SY, 2003, GLOBAL CHANGE BIOL, V9, P1427, DOI 10.1046/j.1365-2486.2003.00668.x; Kara EE, 2004, BIOL FERT SOILS, V39, P474, DOI 10.1007/s00374-004-0729-3; KASPAR TC, 1992, SOIL SCI, V154, P290, DOI 10.1097/00010694-199210000-00005; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Kominami Y, 2012, J FOREST RES-JPN, V17, P296, DOI 10.1007/s10310-011-0315-0; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Landsberg J.J, 1997, APPL PHYSL ECOLOGY F; Lee MS, 2003, PLANT SOIL, V255, P311, DOI 10.1023/A:1026192607512; Li XD, 2010, SOIL BIOL BIOCHEM, V42, P337, DOI 10.1016/j.soilbio.2009.11.013; Liu CX, 2013, SOIL RESP IMPACT FAC, V44, P587; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Yand, 2006, SOIL RESP ENV; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Moyano FE, 2007, SOIL BIOL BIOCHEM, V39, P843, DOI 10.1016/j.soilbio.2006.10.001; Nobel P.S., 2005, PHYSIOCHEMICAL ENV P; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rodeghiero M, 2006, PLANT SOIL, V284, P7, DOI 10.1007/s11104-005-5109-8; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Satomura T, 2006, ECOL RES, V21, P741, DOI 10.1007/s11284-006-0182-x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Shen Xiao-shuai, 2011, Huanjing Kexue, V32, P3181; SITAULA BK, 1995, SOIL BIOL BIOCHEM, V27, P1401, DOI 10.1016/0038-0717(95)00078-S; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vose JM, 2002, GLOBAL CHANGE BIOL, V8, P182, DOI 10.1046/j.1365-2486.2002.00464.x; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080937; Wang YS, 2003, ADV ATMOS SCI, V20, P119, DOI 10.1007/BF03342056; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yi ZG, 2007, FOREST ECOL MANAG, V243, P178, DOI 10.1016/j.foreco.2007.02.022; Zhang Q, 2013, AGR FOREST METEOROL, V180, P34, DOI 10.1016/j.agrformet.2013.04.028; Zhang T, 2013, ATMOS ENVIRON, V77, P856, DOI 10.1016/j.atmosenv.2013.06.011; Zhang Wen-Li, 2010, Chinese Journal of Plant Ecology, V34, P1265, DOI 10.3773/j.issn.1005-264x.2010.11.003; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	65	18	21	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117490	10.1371/journal.pone.0117490	http://dx.doi.org/10.1371/journal.pone.0117490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680112	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600068
J	Chowdhury, PR; Charles, IG; Djordjevic, SP				Chowdhury, Piklu Roy; Charles, Ian G.; Djordjevic, Steven P.			A Role for Tn6029 in the Evolution of the Complex Antibiotic Resistance Gene Loci in Genomic Island 3 in Enteroaggregative Hemorrhagic Escherichia coli O104:H4	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PLASMIDS; TRANSPOSONS; INTEGRONS; TN1696	In enteroaggregative hemorrhagic Escherichia coli (EAHEC) O104 the complex antibiotic resistance gene loci (CRL) found in the region of divergence 1 (RD1) within E. coli genomic island 3 (GI3) contains bla(TEM-1), strAB, sul2, tet(A) A, and dfrA7 genes encoding resistance to ampicillin, streptomycin, sulfamethoxazole, tetracycline and trimethoprim respectively. The precise arrangement of antibiotic resistance genes and the role of mobile elements that drove the evolutionary events and created the CRL have not been investigated. We used a combination of bioinformatics and iterative BLASTn searches to determine the micro-evolutionary events that likely led to the formation of the CRL in GI3 using the closed genome sequences of EAHEC O104:H4 strains 2011C-3493 and 2009EL-2050 and high quality draft genomes of EAHEC E. coli O104:H4 isolates from sporadic cases not associated with the initial outbreak. Our analyses indicate that the CRL in GI3 evolved from a progenitor structure that contained an In2-derived class 1 integron in a Tn21/Tn1721 hybrid backbone. Within the hybrid backbone, a Tn6029-family transposon, identified here as Tn6029C abuts the sul1 gene in the 3'-Conserved Segment (-CS) of a class 1 integron generating a unique molecular signature that has only previously been observed in pASL01a, a small plasmid found in commensal E. coli in West Africa. From this common progenitor, independent IS26-mediated events created two novel transposons identified here as Tn6029D and Tn6222 in 2011C-3493 and 2009EL-2050 respectively. Analysis of RD1 within GI3 reveals IS26 has played a crucial role in the assembly of regions within the CRL.	[Chowdhury, Piklu Roy; Charles, Ian G.; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Chowdhury, Piklu Roy] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Narellan, NSW 2567, Australia	University of Technology Sydney; NSW Department of Primary Industries	Djordjevic, SP (corresponding author), Univ Technol Sydney, Ithree Inst, POB 123 Broadway, Sydney, NSW 2007, Australia.	Steven.Djordjevic@uts.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Charles, Ian/0000-0002-2423-1167; Roy Chowdhury, Piklu/0000-0003-4352-603X	NSW Department of Primary Industries; ithree Institute	NSW Department of Primary Industries; ithree Institute	This work was supported by a joint collaboration between the NSW Department of Primary Industries and the ithree Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Baquero F, 2013, MBIO, V4, DOI 10.1128/mBio.00066-13; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Cain AK, 2012, J ANTIMICROB CHEMOTH, V67, P2848, DOI 10.1093/jac/dks317; Cain AK, 2010, MICROB DRUG RESIST, V16, P197, DOI 10.1089/mdr.2010.0042; Chouikha I, 2006, J BACTERIOL, V188, P977, DOI 10.1128/JB.188.3.977-987.2006; Chowdhury PR, 2011, ANTIMICROB AGENTS CH, V55, P3140, DOI 10.1128/AAC.01529-10; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Dionisi AM, 2009, ANTIMICROB AGENTS CH, V53, P4019, DOI 10.1128/AAC.00294-09; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Guy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063027; Harmer CJ, 2014, MBIO, V5, DOI 10.1128/mBio.01801-14; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Jourdan-da Silva N, 2012, EUROSURVEILLANCE, V17, P10; Kunne C, 2012, J BACTERIOL, V194, P532, DOI 10.1128/JB.06368-11; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; LEE KY, 1990, J BACTERIOL, V172, P3229, DOI 10.1128/jb.172.6.3229-3236.1990; Mariani-Kurkdjian P, 2011, LANCET INFECT DIS, V11, P732, DOI 10.1016/S1473-3099(11)70266-3; MOLLET B, 1985, MOL GEN GENET, V201, P198, DOI 10.1007/BF00425660; Naas T, 2001, J BACTERIOL, V183, P235, DOI 10.1128/JB.183.1.235-249.2001; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Partridge SR, 2001, ANTIMICROB AGENTS CH, V45, P1263, DOI 10.1128/AAC.45.4.1263-1270.2001; Post V, 2010, J ANTIMICROB CHEMOTH, V65, P1162, DOI 10.1093/jac/dkq095; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Ruiz E, 2010, INT J MED MICROBIOL, V300, P464, DOI 10.1016/j.ijmm.2010.04.014; Siebor E, 2013, J ANTIMICROB CHEMOTH, V68, P1750, DOI 10.1093/jac/dkt100; Sjostrand J, 2014, SYST BIOL, V63, P409, DOI 10.1093/sysbio/syu007; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Tamamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077644; Vejborg RM, 2009, MICROBIOL-SGM, V155, P1407, DOI 10.1099/mic.0.026419-0; Venturini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078862; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; Yau S, 2010, MICROB DRUG RESIST, V16, P249, DOI 10.1089/mdr.2010.0033	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115781	10.1371/journal.pone.0115781	http://dx.doi.org/10.1371/journal.pone.0115781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675217	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000004
J	Huang, PT; Chen, CH; Hsu, IU; Salim, SA; Kao, SH; Cheng, CW; Lai, CH; Lee, CF; Lin, YF				Huang, Pai-Tsang; Chen, Chien-Ho; Hsu, I-Uen; Salim, Shaima'a Ahmad; Kao, Shu-Huei; Cheng, Chao-Wen; Lai, Chang-Hao; Lee, Cheng-Fan; Lin, Yung-Feng			Huntingtin-Associated Protein 1 Interacts with Breakpoint Cluster Region Protein to Regulate Neuronal Differentiation	PLOS ONE			English	Article							BCR-ABL; INTRACELLULAR TRAFFICKING; FEEDING-BEHAVIOR; DOMAIN; ACTIVATION; EXPRESSION; TRANSPORT; PATHWAYS; BRAIN; DEATH	Alterations in microtubule-dependent trafficking and certain signaling pathways in neuronal cells represent critical pathogenesis in neurodegenerative diseases. Huntingtin (Htt)-associated protein-1 (Hap1) is a brain-enriched protein and plays a key role in the trafficking of neuronal surviving and differentiating cargos. Lack of Hap1 reduces signaling through tropomyosin-related kinases including extracellular signal regulated kinase (ERK), resulting in inhibition of neurite outgrowth, hypothalamic dysfunction and postnatal lethality in mice. To examine how Hap1 is involved in microtubule-dependent trafficking and neuronal differentiation, we performed a proteomic analysis using taxol-precipitated microtubules from Hap1-null and wild-type mouse brains. Breakpoint cluster region protein (Bcr), a Rho GTPase regulator, was identified as a Hap1-interacting partner. Bcr was co-immunoprecipitated with Hap1 from transfected neuro-2a cells and co-localized with Hap1A isoform more in the differentiated than in the nondifferentiated cells. The Bcr downstream effectors, namely ERK and p38, were significantly less activated in Hap1-null than in wildtype mouse hypothalamus. In conclusion, Hap1 interacts with Bcr on microtubules to regulate neuronal differentiation.	[Huang, Pai-Tsang] Taipei Med Univ, Wan Fang Hosp, Dept Occupat Med, Taipei, Taiwan; [Chen, Chien-Ho; Hsu, I-Uen; Salim, Shaima'a Ahmad; Kao, Shu-Huei; Lee, Cheng-Fan; Lin, Yung-Feng] Taipei Med Univ, Coll Med Sci & Technol, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan; [Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lai, Chang-Hao] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, YF (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan.	yflin@tmu.edu.tw	Lin, Yung-Feng/H-3289-2019	Kao, Shu-Huei/0000-0003-4618-0898	Grants of Taipei Medical University-Wan Fang Hospital [100TMU-WFH-05]; Ministry of Science and Technology in Taiwan [NSC 101-2320-B-038-028, 102-2320-B-038-033]	Grants of Taipei Medical University-Wan Fang Hospital; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Grants of Taipei Medical University-Wan Fang Hospital (100TMU-WFH-05 to PTH) and the Ministry of Science and Technology in Taiwan (NSC 101-2320-B-038-028 and 102-2320-B-038-033 to YFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Dubash AD, 2013, J CELL BIOL, V202, P653, DOI 10.1083/jcb.201304133; Ehrnhoefer DE, 2011, NAT REV DRUG DISCOV, V10, P853, DOI 10.1038/nrd3556; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROCHEM, V71, P2178; Li SH, 1998, J BIOL CHEM, V273, P19220, DOI 10.1074/jbc.273.30.19220; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lin YF, 2010, J BIOL CHEM, V285, P15941, DOI 10.1074/jbc.M110.107318; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; PASCHAL BM, 1991, METHOD ENZYMOL, V196, P181; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Redig AJ, 2011, LEUKEMIA LYMPHOMA, V52, P45, DOI 10.3109/10428194.2010.546919; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xiang JX, 2014, J CLIN INVEST, V124, P85, DOI 10.1172/JCI69206; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang GZ, 2012, J NEUROCHEM, V122, P1010, DOI 10.1111/j.1471-4159.2012.07845.x; Yi SJ, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-8; Yi SJ, 2009, J BIOL CHEM, V284, P35645, DOI 10.1074/jbc.M109.062240; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhou LL, 2008, J EXP MED, V205, P2657, DOI 10.1084/jem.20072316	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116372	10.1371/journal.pone.0116372	http://dx.doi.org/10.1371/journal.pone.0116372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671650	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300020
J	Roy, V; Girondot, M; Harry, M				Roy, Virginie; Girondot, Marc; Harry, Myriam			The Distribution of Wolbachia in Cubitermes (Termitidae, Termitinae) Castes and Colonies: A Modelling Approach	PLOS ONE			English	Article							SP AFFINIS-SUBARQUATUS; INTRODUCED POPULATIONS; EVOLUTIONARY HISTORY; DROSOPHILA-SIMULANS; BEES ANTHOPHILA; INFECTION; DIVERSITY; STRAINS; PCR; ENDOSYMBIONT	Wolbachia are endosymbiotic bacteria of arthropods and nematodes that are able to manipulate host reproduction. Although vertically transmitted via the cytoplasm in eggs, horizontal transmission of Wolbachia among and within arthropod species has been shown to be common. Eusocial insects represent interesting models for studying Wolbachia transmission due to colonial organization and close interaction between nestmates. Here we conducted a detailed screening of Wolbachia infection for 15 colonies of the very common soil-feeding termites Cubitermes spp. affinis subarquatus (Termitidae, Termitinae) that consist of four distinct phylogenetic species in the Lope forest Reserve, Gabon. Infection tests showed that 50% of the individuals were Wolbachia positive (N = 555) with 90% of reproductives and 48% of offspring infected. White soldiers, which are transitional stages preceding mature soldiers, had a significantly higher mean infection rate (74%) than the other castes and stages (63%, 33% and 39% for larvae, workers and mature soldiers, respectively). We used a maximum likelihood method and Akaike's Information Criterion in order to explain the non-expected high rate of Wolbachia infection in white soldiers. The best model included a species effect for the stochastic loss of Wolbachia and a caste effect for the rate of gain. After fitting, the best model selected was for a species-specific rate of loss with a null rate of new gain for larvae, workers and soldiers and a probability of 0.72 whatever the species, that a white soldier becomes newly contaminated during that stage. The mean expected infection rate in white soldiers without a new gain was estimated to 17% instead of the 74% observed. Here we discuss the possible explanations to the high infection rate observed in white soldiers.	[Roy, Virginie] Univ Paris Est Creteil, Fac Sci & Technol, iEES Inst Ecol & Sci Environnement Paris, Dept SOLeO, F-94010 Creteil, France; [Girondot, Marc] Univ Paris 11, Dept Ecol Populat & Communautes, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Harry, Myriam] Univ Paris 11, CNRS, UR IRD 072, Lab Evolut Genomes & Speciat,UPR 9034, F-91198 Gif Sur Yvette, France; [Harry, Myriam] Univ Paris 11, UFR Sci, F-91400 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Harry, M (corresponding author), Univ Paris 11, CNRS, UR IRD 072, Lab Evolut Genomes & Speciat,UPR 9034, Ave Terrasse,Batiment 13, F-91198 Gif Sur Yvette, France.	myriam.harry@u-psud.fr	HARRY, Myriam/AAF-1530-2019	Roy, Virginie/0000-0003-1908-0074	University of Paris-Est Creteil	University of Paris-Est Creteil	MH and VR thank the University of Paris-Est Creteil for the financing of the ABI Prism automated sequencer (Bonus Qualite Recherche Grant and recurring budgets). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ME, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-35; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alibert J., 1963, Insectes Sociaux Paris, V10, P1, DOI 10.1007/BF02223519; Andersen SB, 2012, J EVOLUTION BIOL, V25, P1340, DOI 10.1111/j.1420-9101.2012.02521.x; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; BODOT P, 1970, CR ACAD SCI D NAT, V271, P327; Bordenstein S, 2005, CURR MICROBIOL, V51, P393, DOI 10.1007/s00284-005-0084-0; Bouillon Antoine, 1964, ETUDES TERMITES AFRI, P197; Bouwma AM, 2006, INSECT MOL BIOL, V15, P89, DOI 10.1111/j.1365-2583.2006.00614.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charlat S, 2002, SYMBIOSIS, P624; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; DEJEAN A, 1995, INSECT SOC, V42, P129, DOI 10.1007/BF01242449; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Eggleton P, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P1, DOI 10.1007/978-90-481-3977-4_1; Espino CI, 2009, APPL ENVIRON MICROB, V75, P547, DOI 10.1128/AEM.01665-08; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Frost CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095122; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Gerth M, 2013, MOL ECOL, V22, P6149, DOI 10.1111/mec.12549; Gerth M, 2011, SYST BIODIVERS, V9, P319, DOI 10.1080/14772000.2011.627953; Grasse PP, 1982, TERMITOLOGIA, V1; Guruprasad N. M., 2012, Journal of Entomological Research (New Delhi), V36, P119; HAN SH, 1983, ANN SOC ENTOMOL FR, V19, P413; Han SH, 1987, THESIS DIJON; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hughes GL, 2011, APPL ENVIRON MICROB, V77, P2165, DOI 10.1128/AEM.02878-10; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 2000, GENETICS, V156, P699; Kautz S., 2013, Psyche: A Journal of Entomology, V2013, P936341, DOI 10.1155/2013/936341; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; Keller L, 2001, HEREDITY, V87, P227, DOI 10.1046/j.1365-2540.2001.00918.x; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lo N, 2007, MOL PHYLOGENET EVOL, V44, P461, DOI 10.1016/j.ympev.2006.10.028; Mikac KM, 2007, J STORED PROD RES, V43, P594, DOI 10.1016/j.jspr.2007.01.005; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; Noirot C., 1969, BIOL TERMITES, VI, P311; Noirot C, 1955, RECHERCHES POLYMORPH, V11; Oster G.F., 1978, Monographs in Population Biology, pi; Pattabhiramaiah M., 2011, World Applied Sciences Journal, V15, P1503; Pfarr KM, 2007, TRENDS PARASITOL, V23, P5, DOI 10.1016/j.pt.2006.11.002; Plantard O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030692; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; ROUSSET F, 1995, P NATL ACAD SCI USA, V92, P6389, DOI 10.1073/pnas.92.14.6389; Roy V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-102; Roy V, 2007, FEMS MICROBIOL LETT, V274, P102, DOI 10.1111/j.1574-6968.2007.00815.x; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Salunke BK, 2010, J BIOSCIENCES, V35, P171, DOI 10.1007/s12038-010-0020-8; Salunke BK, 2010, FEMS MICROBIOL LETT, V307, P55, DOI 10.1111/j.1574-6968.2010.01960.x; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Snook RR, 2000, GENETICS, V155, P167; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Tsutsui ND, 2003, MOL ECOL, V12, P3057, DOI 10.1046/j.1365-294X.2003.01979.x; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WILLIAMS R. M. C., 1959, INSECTES SOCIAUX, V6, P291, DOI 10.1007/BF02224412; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	81	10	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116070	10.1371/journal.pone.0116070	http://dx.doi.org/10.1371/journal.pone.0116070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671520	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300016
J	Scheerhagen, M; van Stel, HF; Birnie, E; Franx, A; Bonsel, GJ				Scheerhagen, Marisja; van Stel, Henk F.; Birnie, Erwin; Franx, Arie; Bonsel, Gouke J.			Measuring Client Experiences in Maternity Care under Change: Development of a Questionnaire Based on the WHO Responsiveness Model	PLOS ONE			English	Article							PATIENT SATISFACTION; PERINATAL-MORTALITY; MEASURING QUALITY; HEALTH; NETHERLANDS; VALIDITY; DUTCH; LABOR; HOME	Background Maternity care is an integrated care process, which consists of different services, involves different professionals and covers different time windows. To measure performance of maternity care based on clients' experiences, we developed and validated a questionnaire. Methods and Findings We used the 8-domain WHO Responsiveness model, and previous materials to develop a self-report questionnaire. A dual study design was used for development and validation. Content validity of the ReproQ-version-0 was determined through structured interviews with 11 pregnant women (>= 28 weeks), 10 women who recently had given birth (<= 12 weeks), and 19 maternity care professionals. Structured interviews established the domain relevance to the women; all items were separately commented on. All Responsiveness domains were judged relevant, with Dignity and Communication ranking highest. Main missing topic was the assigned expertise of the health professional. After first adaptation, construct validity of the ReproQ-version-1 was determined through a web-based survey. Respondents were approached by maternity care organizations with different levels of integration of services of midwives and obstetricians. We sent questionnaires to 605 third trimester pregnant women (response 65%), and 810 women 6 weeks after delivery (response 55%). Construct validity was based on: response patterns; exploratory factor analysis; association of the overall score with a Visual Analogue Scale (VAS), known group comparisons. Median overall ReproQ score was 3.70 (range 1-4) showing good responsiveness. The exploratory factor analysis supported the assumed domain structure and suggested several adaptations. Correlation of the VAS rating and overall ReproQ score (antepartum, postpartum) supported validity (r = 0.56; 0.59, p<0.001 Spearman's correlation coefficient). Pre-stated group comparisons confirmed the expected difference following a good vs. adverse birth outcome. Fully integrated organizations performed slightly better (median = 3.78) than less integrated organizations (median = 3.63; p<0.001). Participation rate of women with a low educational level and/or a non-western origin was low. Conclusions The ReproQ appears suitable for assessing quality of maternity care from the clients' perspective. Recruitment of disadvantaged groups requires additional non-digital approaches.	[Scheerhagen, Marisja; Bonsel, Gouke J.] Erasmus MC, Dept Obstet & Gynaecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands; [van Stel, Henk F.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Hlth Technol Assessment, Utrecht, Netherlands; [Birnie, Erwin] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Franx, Arie] Univ Med Ctr Utrecht, Div Women & Baby, Dept Obstet, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Utrecht University; Utrecht University Medical Center	van Stel, HF (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Hlth Technol Assessment, Utrecht, Netherlands.	H.vanStel@umcutrecht.nl	Franx, Arie/AAA-1739-2021	van Stel, Henk/0000-0002-3475-9846	Stichting Miletus	Stichting Miletus	HFVS received funding for this study from Stichting Miletus (www.stichtingmiletus.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2006, PUBLIC HEALTH, V120, P543, DOI 10.1016/j.puhe.2006.03.002; Bobak M, 1998, SOC SCI MED, V47, P269, DOI 10.1016/S0277-9536(98)00095-1; Bonsel GJ, 2010, TRENDS IN THE PERINA; BureauTaal, DICTIONARY LANGUAGE; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; CHRISTENSENSZALANSKI JJJ, 1984, MED DECIS MAKING, V4, P47, DOI 10.1177/0272989X8400400108; Christiaens W, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-109; de Graaf JP, 2012, BJOG-INT J OBSTET GY, V119, P582, DOI 10.1111/j.1471-0528.2012.03283.x; de Graaf JP, 2013, J MATERN-FETAL NEO M, V26, P473, DOI 10.3109/14767058.2012.735722; de Silva A, 2000, GLOBAL PROGRAMME ON; Dzakpasu S, 2008, J OBSTET GYNAECOL CA, V30, P207, DOI 10.1016/S1701-2163(16)32757-8; Egelhard D, 2007, MET KENNIS VAN FEITE; Fransen Mirjam P, 2013, Ned Tijdschr Geneeskd, V157, pA5581; Gostin L, 2002, THE DOMAINS OF HEALT; Graham C., 2012, OVERARCHING QUESTION; Grone O, 2002, TRENDS IN INTEGRATED; Hay H, 2010, REPORT DEV QUESTIONN; Koopman L, 2011, MANUAL CQI DEVELOPME; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; Murray CJ, 2003, HEALTH SYSTEMS PERFO; Offerhaus PM, 2013, BIRTH-ISS PERINAT C, V40, P192, DOI 10.1111/birt.12055; Peterson WE, 2005, J ADV NURS, V52, P672, DOI 10.1111/j.1365-2648.2005.03634.x; Ravelli A C J, 2008, Ned Tijdschr Geneeskd, V152, P2728; Ravelli ACJ, 2009, J EPIDEMIOL COMMUN H, V63, P761, DOI 10.1136/jech.2008.080440; Redshaw M, 2010, DELIVERED WITH CARE; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smith LFP, 2001, QUAL HEALTH CARE, V10, P17, DOI 10.1136/qhc.10.1.17; Smith L, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601334; Stevens J., 2009, APPLIED MULTIVARIATE; Valentine N, 2003, HLTH SYSTEMS PERFORM, P573; Valentine NB, 2007, QUAL LIFE RES, V16, P1107, DOI 10.1007/s11136-007-9189-1; van der Kooy J, 2013, VALIDITY OF THE REPR, P151, DOI [10.1007/s12288-013-0266-z, DOI 10.1007/S12288-013-0266-Z]; van der Velden K, 2009, GOOD START SAFE CARE; van Wagtendonk I, 2010, DEVELOPMENT OF A CON; Wensing M, 1998, SOC SCI MED, V47, P1573, DOI 10.1016/S0277-9536(98)00222-6; Wiegers TA, 1998, BIRTH-ISS PERINAT C, V25, P19, DOI 10.1046/j.1523-536x.1998.00019.x; Wiegers TA, 1996, J CLIN EPIDEMIOL, V49, P319, DOI 10.1016/0895-4356(95)00549-8; Wiegers TA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-18; WILLIAMS B, 1994, SOC SCI MED, V38, P509, DOI 10.1016/0277-9536(94)90247-X; Zeitlin J, 2013, J EPIDEMIOL COMMUN H, V67, P983, DOI 10.1136/jech-2013-203291; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281	42	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117031	10.1371/journal.pone.0117031	http://dx.doi.org/10.1371/journal.pone.0117031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671310	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300030
J	Gomez, E; Alvarez, B; Duchaud, E; Guijarro, JA				Gomez, Esther; Alvarez, Beatriz; Duchaud, Eric; Guijarro, Jose A.			Development of a Markerless Deletion System for the Fish-Pathogenic Bacterium Flavobacterium psychrophilum	PLOS ONE			English	Article							RAINBOW-TROUT; CYSTEINE PROTEASE; GENE REPLACEMENT; COLDWATER DISEASE; GLIDING MOTILITY; CYTOPHAGA; VIRULENCE; CONSTRUCTION; TRANSPOSON; CELLS	Flavobacterium psychrophilum is a Gram-negative fish pathogen that causes important economic losses in aquaculture worldwide. Although the genome of this bacterium has been determined, the function and relative importance of genes in relation to virulence remain to be established. To investigate their respective contribution to the bacterial pathogenesis, effective tools for gene inactivation are required. In the present study, a markerless gene deletion system has been successfully developed for the first time in this bacterium. Using this method, the F. psychrophilum fcpB gene, encoding a predicted cysteine protease homologous to Streptococcus pyogenes streptopain, was deleted. The developed system involved the construction of a conjugative plasmid that harbors the flanking sequences of the fcpB gene and an I-SceI meganuclease restriction site. Once this plasmid was integrated in the genome by homologous recombination, the merodiploid was resolved by the introduction of a plasmid expressing I-SceI under the control of the fpp2 F. psychrophilum inducible promoter. The resulting deleted fcpB mutant presented a decrease in extracellular proteolytic activity compared to the parental strain. However, there were not significant differences between their LD50 in an intramuscularly challenged rainbow trout infection model. The mutagenesis approach developed in this work represents an improvement over the gene inactivation tools existing hitherto for this "fastidious" bacterium. Unlike transposon mutagenesis and gene disruption, gene markerless deletion has less potential for polar effects and allows the mutation of virtually any non-essential gene or gene clusters.	[Gomez, Esther; Guijarro, Jose A.] Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol,IUBA, E-33006 Oviedo, Spain; [Alvarez, Beatriz] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Duchaud, Eric] INRA, Virol & Immunol Mol UR892, F-78350 Jouy En Josas, France	University of Oviedo; Universidad Autonoma de Chile; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guijarro, JA (corresponding author), Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol,IUBA, E-33006 Oviedo, Spain.	jaga@uniovi.es	Alvarez, Beatriz/AAL-5969-2020; Alvarez, Beatriz/L-1266-2014	Alvarez, Beatriz/0000-0002-9613-5473; Alvarez, Beatriz/0000-0002-9613-5473	Spanish Ministerio de Economia y Competitividad [AGL2009-07003]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	Funding provided by grant AGL2009-07003 from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1997, P NATL ACAD SCI USA, V94, P12139, DOI 10.1073/pnas.94.22.12139; Alvarez B, 2007, LETT APPL MICROBIOL, V44, P569, DOI 10.1111/j.1472-765X.2007.02126.x; Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004; Alvarez B, 2008, MICROBIOL-SGM, V154, P1144, DOI 10.1099/mic.0.2007/010900-0; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Borg AF, 1960, STUDIES MYXOBACTERIA, V8; Chakroun C, 1998, DIS AQUAT ORGAN, V33, P167, DOI 10.3354/dao033167; Cipriano R.C., 2005, FLAVOBACTERIUM PSYCH; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Gomez E, 2012, GENE, V497, P263, DOI 10.1016/j.gene.2012.01.069; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Holt, 1987, CYTOPHAGA PSYCHROPHI; Horzempa J, 2010, J MICROBIOL METH, V80, P106, DOI 10.1016/j.mimet.2009.10.013; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; LI LY, 1995, J BACTERIOL, V177, P4992, DOI 10.1128/jb.177.17.4992-4999.1995; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P209, DOI 10.3354/dao031209; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P197, DOI 10.3354/dao031197; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996; McBride MJ, 1996, APPL ENVIRON MICROB, V62, P3017, DOI 10.1128/AEM.62.8.3017-3022.1996; Michel C, 1999, RES MICROBIOL, V150, P351, DOI 10.1016/S0923-2508(99)80061-8; Moller JD, 2003, APPL ENVIRON MICROB, V69, P5275, DOI 10.1128/AEM.69.9.5275-5280.2003; Nematollahi A, 2003, DIS AQUAT ORGAN, V55, P101, DOI 10.3354/dao055101; OHARANEMOTO Y, 1994, CAN J MICROBIOL, V40, P930, DOI 10.1139/m94-149; Ohkuni H, 2004, INDIAN J MED RES, V119, P33; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Patrick S, 2009, MICROBIOL-SGM, V155, P1039, DOI 10.1099/mic.0.025361-0; Perez-Pascual D, 2011, MICROBIOL-SGM, V157, P1196, DOI 10.1099/mic.0.046938-0; Perez-Pascual D, 2009, INT MICROBIOL, V12, P207, DOI 10.2436/20.1501.01.100; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Sambrook J., 2001, MOL CLONING LAB MANU; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Wang HY, 2012, APPL ENVIRON MICROB, V78, P1826, DOI 10.1128/AEM.07230-11	38	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117969	10.1371/journal.pone.0117969	http://dx.doi.org/10.1371/journal.pone.0117969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692569	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500086
J	Griese, M; Kirmeier, HG; Liebisch, G; Rauch, D; Stuckler, F; Schmitz, G; Zarbock, R				Griese, Matthias; Kirmeier, Hannah G.; Liebisch, Gerhard; Rauch, Daniela; Stueckler, Ferdinand; Schmitz, Gerd; Zarbock, Ralf		ILD-BAL Working Grp Kids-Lung-Regi	Surfactant Lipidomics in Healthy Children and Childhood Interstitial Lung Disease	PLOS ONE			English	Article							HIGH-THROUGHPUT QUANTIFICATION; PULMONARY SURFACTANT; PHOSPHATIDYLCHOLINE COMPOSITION; PHOSPHOLIPID-COMPOSITION; YOUNG-CHILDREN; ABCA3; MUTATIONS; CLASSIFICATION; CHOLESTEROL; PROTEINS	Background Lipids account for the majority of pulmonary surfactant, which is essential for normal breathing. We asked if interstitial lung diseases (ILD) in children may disrupt alveolar surfactant and give clues for disease categorization. Methods Comprehensive lipidomics profiles of broncho-alveolar lavage fluid were generated in 115 children by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Two reference populations were compared to a broad range of children with ILD. Results Class and species composition in healthy children did not differ from that in children with ILD related to diffuse developmental disorders, chronic tachypnoe of infancy, ILD related to lung vessels and the heart, and ILD related to reactive lymphoid lesions. As groups, ILDs related to the alveolar surfactant region, ILD related to unclear respiratory distress syndrome in the mature neonate, or in part ILD related to growth abnormalities reflecting deficient alveolarisation, had significant alterations of some surfactant specific phospholipids. Additionally, lipids derived from inflammatory processes were identified and differentiated. In children with ABCA3-deficiency from two ILD causing mutations saturated and monounsaturated phosphatidylcholine species with 30 and 32 carbons and almost all phosphatidylglycerol species were severely reduced. In other alveolar disorders lipidomic profiles may be of less diagnostic value, but nevertheless may substantiate lack of significant involvement of mechanisms related to surfactant lipid metabolism. Conclusions Lipidomic profiling may identify specific forms of ILD in children with surfactant alterations and characterized the molecular species pattern likely to be transported by ABCA3 in vivo.	[Griese, Matthias; Kirmeier, Hannah G.; Rauch, Daniela; Zarbock, Ralf] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Dept Pediat Pulmonol, Member German Ctr Lung Res DZL, D-80337 Munich, Germany; [Liebisch, Gerhard; Stueckler, Ferdinand] Helmholtz Ctr Munich, Inst Computat Biol, Neuherberg, Germany; [Schmitz, Gerd] Univ Regensburg, Inst Clin Chem, D-93053 Regensburg, Germany; [Schmitz, Gerd] Univ Regensburg, Lab Med, D-93053 Regensburg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; University of Regensburg	Griese, M (corresponding author), Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Dept Pediat Pulmonol, Member German Ctr Lung Res DZL, Lindwurmstr 4a, D-80337 Munich, Germany.	Matthias.griese@med.uni-muenchen.de	Liebisch, Gerhard/G-6130-2010; Zarbock, Ralf/K-9031-2019	Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007	kids-lung-register foundation; DFG [970/8-1]; BMBF-Goldnet; chILD-EU (FP7) [305653]	kids-lung-register foundation; DFG(German Research Foundation (DFG)); BMBF-Goldnet; chILD-EU (FP7)	This project was supported by the kids-lung-register foundation. The work of M.G. in this study was supported by DFG-970/8-1, BMBF-Goldnet, and chILD-EU (FP7, No. 305653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON MR, 1992, ARCH DIS CHILD-FETAL, V67, P378, DOI 10.1136/adc.67.4_Spec_No.378; ASHTON MR, 1994, ARCH DIS CHILD-FETAL, V71, pF114, DOI 10.1136/fn.71.2.F114; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Deutsch GH, 2007, AM J RESP CRIT CARE, V176, P1120, DOI 10.1164/rccm.200703-393OC; Garmany TH, 2006, PEDIATR RES, V59, P801, DOI 10.1203/01.pdr.0000219311.14291.df; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Griese M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-121; Griese M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-26; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Hamvas A, 2013, CHEST, V144, P794, DOI 10.1378/chest.12-2502; HUGHES DA, 1990, EUR RESPIR J, V3, P1128; Kleinlein B, 2011, ARCH DIS CHILD-FETAL, V96, pF453, DOI 10.1136/adc.2009.180448; Kurland G, 2013, AM J RESP CRIT CARE, V188, P376, DOI 10.1164/rccm.201305-0923ST; Langston C, 2009, PEDIATR DEVEL PATHOL, V12, P421, DOI 10.2350/08-11-0559.1; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mander A, 2002, AM J RESP CELL MOL, V27, P714, DOI 10.1165/rcmb.4746; Nogee LM, 1998, BBA-MOL BASIS DIS, V1408, P323, DOI 10.1016/S0925-4439(98)00078-7; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; Pynn CJ, 2010, AM J PHYSIOL-REG I, V299, pR1306, DOI 10.1152/ajpregu.00380.2010; Rice A, 2013, HISTOPATHOLOGY, V63, P743, DOI 10.1111/his.12185; Ridsdale R, 2005, AM J RESP CRIT CARE, V172, P225, DOI 10.1164/rccm.200501-109OC; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Schmidt R, 2006, CRIT CARE MED, V34, P2370, DOI 10.1097/01.CCM.0000234036.19145.52; Schuerman FABA, 2008, EUR J MED RES, V13, P281; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Soares JJ, 2013, PEDIATRICS, V132, P684, DOI 10.1542/peds.2013-1780; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Tafel Oliver, 2008, BMC Pulm Med, V8, P6, DOI 10.1186/1471-2466-8-6; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Wambach JA, 2012, PEDIATRICS, V130, pE1575, DOI 10.1542/peds.2012-0918; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325; Wright JR, 2006, AM J PHYSIOL-LUNG C, V291, pL847, DOI 10.1152/ajplung.00261.2006; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283	43	30	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117985	10.1371/journal.pone.0117985	http://dx.doi.org/10.1371/journal.pone.0117985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692779	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500088
J	Kanda, RK; Coulson, T				Kanda, Ravinder K.; Coulson, Tim			The Effect of Life History on Retroviral Genome Invasions	PLOS ONE			English	Article							MOUTH-DISEASE-VIRUS; ENDOGENOUS RETROVIRUSES; EVOLUTION; FAMILY; BETARETROVIRUSES; HERV-K(HML-2); TRANSMISSION; EXPRESSION; RESISTANCE; DIVERSITY	Endogenous retroviruses (ERV), or the remnants of past retroviral infections that are no longer active, are found in the genomes of most vertebrates, typically constituting approximately 10% of the genome. In some vertebrates, particularly in shorter-lived species like rodents, it is not unusual to find active endogenous retroviruses. In longer-lived species, including humans where substantial effort has been invested in searching for active ERVs, it is unusual to find them; to date none have been found in humans. Presumably the chance of detecting an active ERV infection is a function of the length of an ERV epidemic. Intuitively, given that ERVs or signatures of past ERV infections are passed from parents to offspring, we might expect to detect more active ERVs in species with longer generation times, as it should take more years for an infection to run its course in longer than in shorter lived species. This means the observation of more active ERV infections in shorter compared to longer-lived species is paradoxical. We explore this paradox using a modeling approach to investigate factors that influence ERV epidemic length. Our simple epidemiological model may explain why we find evidence of active ERV infections in shorter rather than longer-lived species.	[Kanda, Ravinder K.; Coulson, Tim] Univ Oxford, Dept Zool, Oxford, England	University of Oxford	Kanda, RK (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	ravinder.kanda@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	ERC; Natural Environment Research Council [1221700, NE/I023783/2, 1136795, NE/G004390/2, NE/I023783/1, NE/E015921/1, NE/K014218/1, NE/I023791/2, NE/H007148/1, NE/G004390/1, NE/H007148/2, NE/I023791/1] Funding Source: researchfish; NERC [NE/I023791/2, NE/G004390/2, NE/H007148/2, NE/E015921/1, NE/K014218/1, NE/I023791/1, NE/I023783/1, NE/I023783/2, NE/G004390/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by an ERC grant awarded to Tim Coulson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai Y, 2012, J VIROL, V86, P8634, DOI 10.1128/JVI.00280-12; ANDERSON R M, 1991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Arnaud F, 2008, CELL MOL LIFE SCI, V65, P3422, DOI 10.1007/s00018-008-8500-9; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Best S, 1997, TRENDS MICROBIOL, V5, P313, DOI 10.1016/S0966-842X(97)01086-X; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Boeke JD, 1997, RETROVIRUSES; Burton J, 2012, MATH BIOSCI, V239, P91, DOI 10.1016/j.mbs.2012.05.003; Caswell, 2000, MATRIX POPULATION MO; Downey RF, 2014, INT J CANC; Eble P, 2006, VET RES, V37, P647, DOI 10.1051/vetres:2006026; Elleder D, 2012, J VIROL, V86, P2787, DOI 10.1128/JVI.06859-11; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gold JGR, 2014, J NEUROL NEUROSURG P; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Herniou E, 1998, J VIROL, V72, P5955, DOI 10.1128/JVI.72.7.5955-5966.1998; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Holt MP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00287; Hughes JF, 2004, P NATL ACAD SCI USA, V101, P1668, DOI 10.1073/pnas.0307885100; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kanda RK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0505; Kassiotis G, 2014, J IMMUNOL, V192, P1343, DOI 10.4049/jimmunol.1302972; Katzourakis A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004214; Krylova O, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0098; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawson AB, 2011, SPAT SPATIO-TEMPORAL, V2, P185, DOI 10.1016/j.sste.2011.07.004; Lee A, 2014, J VIROL, V88, P12907, DOI 10.1128/JVI.01825-14; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Muller V, 2006, PLOS PATHOG, V2, P149, DOI 10.1371/journal.ppat.0020015; NELLAKER C, 2012, GENOME BIOL, V13, DOI DOI 10.1186/GB-; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Nissen KK, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-111; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Palmarini M, 2004, J GEN VIROL, V85, P1, DOI 10.1099/vir.0.19547-0; Rebollo R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-159; Rhyu DW, 2014, INT J MOL SCI, V15, P9173, DOI 10.3390/ijms15069173; Ruprecht K, 2008, J VIROL, V82, P10008, DOI 10.1128/JVI.01016-08; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Taylor GM, 2001, J VIROL, V75, P11244, DOI 10.1128/JVI.75.22.11244-11248.2001; Team RDC, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Tikhonenko A T, 1990, Virus Genes, V3, P251, DOI 10.1007/BF00393184; Uziel A, 2012, J THEOR BIOL, V305, P88, DOI 10.1016/j.jtbi.2012.02.031; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	60	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117442	10.1371/journal.pone.0117442	http://dx.doi.org/10.1371/journal.pone.0117442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692467	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500055
J	Salehi, F; Baronio, R; Idrogo-Lam, R; Vu, H; Hall, LV; Kaiser, P; Lathrop, RH				Salehi, Faezeh; Baronio, Roberta; Idrogo-Lam, Ryan; Huy Vu; Hall, Linda V.; Kaiser, Peter; Lathrop, Richard H.			CHOPER Filters Enable Rare Mutation Detection in Complex Mutagenesis Populations by Next-Generation Sequencing	PLOS ONE			English	Article							WILD-TYPE P53; ERROR-CORRECTION; CODON USAGE; SHORT READS; SUPPRESSOR; PROTEIN; GENOME; ONCOGENE; GENES; YEAST	Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification of many genetic variants across many genomes. However, detection of biologically important low-frequency variants within genetically heterogeneous populations remains challenging, because they are difficult to distinguish from intrinsic NGS sequencing error rates. Approaches to overcome these limitations are essential to detect rare mutations in large cohorts, virus or microbial populations, mitochondria heteroplasmy, and other heterogeneous mixtures such as tumors. Modifications in library preparation can overcome some of these limitations, but are experimentally challenging and restricted to skilled biologists. This paper describes a novel quality filtering and base pruning pipeline, called Complex Heterogeneous Overlapped Paired-End Reads (CHOPER), designed to detect sequence variants in a complex population with high sequence similarity derived from All-Codon-Scanning (ACS) mutagenesis. A novel fast alignment algorithm, designed for the specified application, has O(n) time complexity. CHOPER was applied to a p53 cancer mutant reactivation study derived from ACS mutagenesis. Relative to error filtering based on Phred quality scores, CHOPER improved accuracy by about 13% while discarding only half as many bases. These results are a step toward extending the power of NGS to the analysis of genetically heterogeneous populations.	[Salehi, Faezeh; Idrogo-Lam, Ryan; Huy Vu; Lathrop, Richard H.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Baronio, Roberta; Hall, Linda V.; Kaiser, Peter] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Salehi, Faezeh; Baronio, Roberta; Hall, Linda V.; Kaiser, Peter; Lathrop, Richard H.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Kaiser, Peter; Lathrop, Richard H.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Salehi, F (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA.	ssalehia@uci.edu; pkaiser@uci.edu			National Institutes of Health under National Cancer Institute [R01CA112560]; NATIONAL CANCER INSTITUTE [R01CA112560, P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	National Institutes of Health under National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health under National Cancer Institute grant number R01CA112560 to R.H.L. and P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Baronio R, 2010, NUCLEIC ACIDS RES, V38, P7079, DOI 10.1093/nar/gkq571; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Demma M, 2010, J BIOL CHEM, V285, P10198, DOI 10.1074/jbc.M109.083469; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Robison K, 2010, BRIEF BIOINFORM, V11, P524, DOI 10.1093/bib/bbq013; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116877	10.1371/journal.pone.0116877	http://dx.doi.org/10.1371/journal.pone.0116877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692681	Green Published, gold			2022-12-27	WOS:000350061500027
J	Bao, HD; Zhu, F; Wang, F; Liu, Z; Bao, MH; He, SY; Zhu, ZZ; Qiu, Y				Bao, Hongda; Zhu, Feng; Wang, Fei; Liu, Zhen; Bao, Mike H.; He, Shouyu; Zhu, Zezhang; Qiu, Yong			Scoliosis Related Information on the Internet in China: Can Patients Benefit from This Information?	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; MEDICAL INFORMATION; QUALITY	Background There has been an increasing popularity of searching health related information online in recent years. Despite that considerable amount of scoliosis patients have shown interest in obtaining scoliosis information through Internet, previous studies have demonstrated poor quality of online information. However, this conclusion may vary depending on region and culture. Since China has a restricted Internet access outside of its borders, the aim of this study is to evaluate the quality of scoliosis information available online using recognized scoring systems and to analyze the Internet as a source of health information in China. Methods A survey-based questionnaire was distributed to 280 respondents at outpatient clinics. Information on demographics and Internet use was collected. Binary logistic analysis was performed to identify possible predictors for the use of Internet. In addition, the top 60 scoliosis related websites assessed through 4 search engines were reviewed by a surgeon and the quality of online information was evaluated using DISCERN score and JAMA benchmark. Results Use of the Internet as a source for scoliosis related information was confirmed in 87.8% of the respondents. College education, Internet access at home and urban residence were identified as potential predictors for Internet use. However, the quality of online scoliosis related information was poor with an average DISCERN score of 27.9 +/- 11.7 and may be misleading for scoliosis patients. Conclusion The study outlines the profile of scoliosis patients who use the Internet as a source of health information. It was shown that 87.8% of the scoliosis patients in outpatient clinics have searched for scoliosis related information on Internet. Urban patients, higher education and Internet access at home were identified as potential predictors for Internet search. However, the overall quality of online scoliosis related information was poor and confusing. Physician based websites seemed to contain more reliable information.	[Bao, Hongda; Zhu, Feng; Wang, Fei; Liu, Zhen; He, Shouyu; Zhu, Zezhang; Qiu, Yong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Spine Surg, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Mike H.] Geisel Sch Med Dartmouth, Hanover, NH USA	Nanjing University; Dartmouth College	Qiu, Y (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Spine Surg, Nanjing 210008, Jiangsu, Peoples R China.	scoliosis2002@sina.com		Bao, Mike/0000-0002-0909-052X				Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Avraham S, 2014, FERTIL STERIL, V101, P222, DOI 10.1016/j.fertnstert.2013.09.008; Baker JF, 2012, EUR SPINE J, V21, P1972, DOI 10.1007/s00586-012-2429-2; Callejas-Rubio JL, 2013, CLIN RHEUMATOL, DOI [10.1007/s10067-013-2464-3, DOI 10.1007/S10067-013-2464-3]; Cheung KMC, 2007, SPINE, V32, P1141, DOI 10.1097/01.brs.0000261562.48888.e3; China National Network Information Center, 2013, STAT REP INT DEV CHI; de Boer MJ, 2007, PATIENT EDUC COUNS, V68, P86, DOI 10.1016/j.pec.2007.05.012; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Gao LL, 2013, MIDWIFERY, V29, P730, DOI 10.1016/j.midw.2012.07.003; Harris Interactive, 2012, NUMB CYB AD GOING ON; Kummervold PE, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1023; Liu JM, 2013, SEIZURE-EUR J EPILEP, V22, P787, DOI 10.1016/j.seizure.2013.06.007; MacCulloch R, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-13; Mathur S, 2005, SPINE, V30, P2695, DOI 10.1097/01.brs.0000188266.22041.c2; Morr S, 2010, SPINE J, V10, P350, DOI 10.1016/j.spinee.2010.02.009; Nason GJ, 2012, SPINE, V37, pE1364, DOI 10.1097/BRS.0b013e31826619b5; Ohlow MA, 2013, INT J CLIN PRACT, V67, P990, DOI 10.1111/ijcp.12162; Romano M, 2013, SPINE, V38, pE883, DOI 10.1097/BRS.0b013e31829459f8; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Valero-Aguilera B, 2013, SUPPORT CARE CANCER, DOI [10.1007/s00520-013-2020-3, DOI 10.1007/S00520-013-2020-3]; Valero-Aguilera B, 2012, SUPPORT CARE CANCER, V20, P3087, DOI 10.1007/s00520-012-1431-x; Wang C, 2010, SPINE PHILA PA 1976; Wellburn S, 2013, SPINE, V38, P1590, DOI 10.1097/BRS.0b013e31829965bc	23	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118289	10.1371/journal.pone.0118289	http://dx.doi.org/10.1371/journal.pone.0118289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689064	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700112
J	Irvin, R; Vallabhaneni, S; Scott, H; Williams, JK; Wilton, L; Li, X; Buchbinder, S				Irvin, Risha; Vallabhaneni, Snigdha; Scott, Hyman; Williams, John K.; Wilton, Leo; Li, Xin; Buchbinder, Susan		HPTN 061	Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition	PLOS ONE			English	Article							WHITE MEN; INFECTION; DISPARITIES; REDUCTION	Seroadaptation is defined as the practice of modifying sexual behavior based on one's own HIV serostatus, the perceived HIV serostatus of sexual partners, and differences in risk of HIV transmission by sexual acts. Because this definition implies intent, we use the term "seroprotection" to describe HIV negative participants reporting condomless anal sex (CAS) either exclusively with seronegative partners, or only as the insertive partner with HIV positive or unknown serostatus partners. Little is known about seroprotection in Black men who have sex with men (MSM). We evaluated the independent association of seroprotection and HIV acquisition among the 1144 HIV-negative Black MSM enrolled in HPTN 061 using Cox models; we stratified by city of enrollment, and controlled for number of partners, age, and drug use. Behaviors reported at 0, 6, and 12 months were assigned to three mutually exclusive categories: (1) No CAS; (2) Seroprotection; and (3) CAS without seroprotection. In 2,861 six-month intervals; 28 HIV seroconversions occurred. No CAS was reported at 33.3% of visits, seroprotection at 46.6% of visits, and CAS without seroprotection at 20.1% of visits. The seroconversion rate per 100 person-years for no CAS was 0.98 (95% CI: 0.27, 2.51), compared with 2.39 (95% CI: 1.03, 4.71) and 13.33 (95% CI: 7.62, 21.66) for seroprotection and CAS without seroprotection, respectively. Compared to CAS without seroprotection, intervals without CAS were associated with an 87% reduction (aHR: 0.13, 95% CI: 0.03-0.46) in HIV acquisition and intervals with seroprotection with a 78% reduction (aHR: 0.22, 95% CI: 0.09-0.57). No CAS is the safest behavior to prevent HIV acquisition. Seroprotective behaviors significantly reduced risk, but HIV incidence was still >2/100 person-years, suggesting that additional strategies, such as pre-exposure prophylaxis, are warranted for this population.	[Irvin, Risha] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21231 USA; [Irvin, Risha; Scott, Hyman; Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Vallabhaneni, Snigdha] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Williams, John K.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Li, Xin] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Buchbinder, Susan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Irvin, R (corresponding author), Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21231 USA.	rirvin1@jhmi.edu			National Institute of Allergy and Infectious Disease (NIAID) [HPTN 061]; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Fenway Institute CRS: Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA funding [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA funding [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; HPTN Scholars Program - NIAID and NIMH; San Francisco Department of Public Health; Johns Hopkins University Center for AIDS Research [1P30AI094189]; UCLA HIV/AIDS; Substance Abuse; Trauma Training Program [1R25DA035692-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, U01AI069496, UM1AI068613, U01AI069418, UM1AI069496, U01AI069466, P30AI094189, UM1AI068619, UM1AI068617, U01AI069424, P30AI027763, P30AI060354, P30AI050409, UM1AI069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA035692] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute CRS: Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA funding; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA funding; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; HPTN Scholars Program - NIAID and NIMH; San Francisco Department of Public Health; Johns Hopkins University Center for AIDS Research; UCLA HIV/AIDS; Substance Abuse; Trauma Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	HPTN 061 grant support provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding-Fenway Institute CRS: Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The primary author's work on this manuscript was supported through the HPTN Scholars Program funded by NIAID and NIMH. Additional support was provided to the primary author by The San Francisco Department of Public Health, The Johns Hopkins University Center for AIDS Research (1P30AI094189) and the UCLA HIV/AIDS, Substance Abuse, and Trauma Training Program (1R25DA035692-01). The funder had a role in the design of the HPTN 061 study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Eaton LA, 2010, AM J PUBLIC HEALTH, V100, P503, DOI 10.2105/AJPH.2008.155903; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Golden MR, 2012, SEX TRANSM DIS, V39, P659, DOI 10.1097/OLQ.0b013e31825727cb; Jablonski O, AIDS 2008 XVII INTER; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; McFarland W, 2011, AIDS CARE, V23, P261, DOI 10.1080/09540121.2010.507748; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Snowden JM, 2009, SEX TRANSM INFECT, V85, P469, DOI 10.1136/sti.2009.036269; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878	19	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118281	10.1371/journal.pone.0118281	http://dx.doi.org/10.1371/journal.pone.0118281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25688980	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700111
J	Nemcova, E; Cernochova, M; Ruzicka, F; Malisova, B; Freiberger, T; Nemec, P				Nemcova, Eva; Cernochova, Michaela; Ruzicka, Filip; Malisova, Barbora; Freiberger, Tomas; Nemec, Petr			Rapid Identification of Medically Important Candida Isolates Using High Resolution Melting Analysis	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR-IDENTIFICATION; SPECIES IDENTIFICATION; FUNGAL PATHOGENS; ANTIFUNGAL SUSCEPTIBILITY; ACCURATE IDENTIFICATION; INVASIVE CANDIDIASIS; MASS-SPECTROMETRY; CURVE ANALYSIS; EPIDEMIOLOGY	An increasing trend in non albicans infections and various susceptibility patterns to antifungal agents implies a requirement for the quick and reliable identification of a number of medically important Candida species. Real-time PCR followed by high resolution melting analysis (HRMA) was developed, tested on 25 reference Candida collection strains and validated on an additional 143 clinical isolates in this study. All reference strains and clinical isolates inconclusive when using phenotypic methods and/or HRMA were analysed using ITS2 sequencing. Considering reference and clinical strains together, 23 out of 27 Candida species could be clearly distinguished by HRMA, while the remaining 4 species were grouped in 2 pairs, when applying the mean Tm +/- 3 SD values, the shape of the derivative melting curve (dMelt curve) and, in some cases, the normalized and temperature-shifted difference plot against C. krusei. HRMA as a simple, rapid and inexpensive tool was shown to be useful in identifying a wide spectrum of clinically important Candida species. It may complement the current clinical diagnostic approach based on commercially available biochemical kits.	[Nemcova, Eva; Cernochova, Michaela; Malisova, Barbora; Nemec, Petr] Ctr Cardiovasc Surg & Transplantat Brno, Brno, Czech Republic; [Nemcova, Eva; Nemec, Petr] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Cernochova, Michaela; Malisova, Barbora; Freiberger, Tomas] Masaryk Univ, Cent European Inst Technol, Mol Immunol & Microbiol, Brno, Czech Republic; [Ruzicka, Filip] Masaryk Univ, Fac Med, Dept Microbiol, Brno, Czech Republic; [Ruzicka, Filip] St Annes Univ Hosp Brno, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Freiberger, T (corresponding author), Masaryk Univ, Cent European Inst Technol, Mol Immunol & Microbiol, Brno, Czech Republic.	tfreiber@med.muni.cz; petr.nemec@cktch.cz	Freiberger, Tomas/D-8421-2011; Růžička, Filip/K-6360-2015	Freiberger, Tomas/0000-0001-6532-7053; Ruzicka, Filip/0000-0001-5679-0513	European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; grant CKTCH Brno [201211]	European Regional Development Fund-Project FNUSA-ICRC; grant CKTCH Brno	The study was supported by the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the grant CKTCH Brno No. 201211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Alnuaimi AD, 2014, MOL ORAL MICROBIOL, V29, P117, DOI 10.1111/omi.12050; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arancia S, 2011, DIAGN MICR INFEC DIS, V69, P283, DOI 10.1016/j.diagmicrobio.2010.10.003; Bergman A, 2007, EUR J CLIN MICROBIOL, V26, P813, DOI 10.1007/s10096-007-0369-2; Borman AM, 2010, J CLIN MICROBIOL, V48, P3648, DOI 10.1128/JCM.01071-10; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; CBS-KNAW Fungal Biodiversity Centre, CBS FIL FUNG DAT; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Chryssanthou E, 2007, APMIS, V115, P1281, DOI 10.1111/j.1600-0643.2007.00801.x; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Cornet M, 2011, J MOL DIAGN, V13, P12, DOI 10.1016/j.jmoldx.2010.11.014; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; Decat E, 2013, RES MICROBIOL, V164, P110, DOI 10.1016/j.resmic.2012.10.017; Dendis M, 2003, CLIN MICROBIOL INFEC, V9, P1191, DOI 10.1111/j.1469-0691.2003.00719.x; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Dunyach C, 2008, DIAGN MICR INFEC DIS, V60, P263, DOI 10.1016/j.diagmicrobio.2007.09.014; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Ellepola ANB, 2005, J MICROBIOL, V43, P65; Ellepola ANB, 2003, ORAL MICROBIOL IMMUN, V18, P379, DOI 10.1046/j.0902-0055.2003.00103.x; Fricke S, 2010, J APPL MICROBIOL, V109, P1150, DOI 10.1111/j.1365-2672.2010.04736.x; Gharizadeh B, 2004, MYCOSES, V47, P29, DOI 10.1046/j.1439-0507.2003.00949.x; Goldschmidt P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037660; Hachem R, 2008, CANCER, V112, P2493, DOI 10.1002/cncr.23466; Hamal P, 2008, MED MYCOL, V46, P601, DOI 10.1080/13693780802078180; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hrncirova K, 2010, J CLIN MICROBIOL, V48, P3392, DOI 10.1128/JCM.01109-10; Hsu MC, 2003, J MED MICROBIOL, V52, P1071, DOI 10.1099/jmm.0.05302-0; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Klingspor L, 2006, CLIN MICROBIOL INFEC, V12, P745, DOI 10.1111/j.1469-0691.2006.01498.x; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Loeffler J, 2000, J CLIN MICROBIOL, V38, P586, DOI 10.1128/JCM.38.2.586-590.2000; Maaroufi Y, 2004, J CLIN MICROBIOL, V42, P3159, DOI 10.1128/JCM.42.7.3159-3163.2004; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Martin D, 2005, EUR J CLIN MICROBIOL, V24, P329, DOI 10.1007/s10096-005-1321-y; Montero CI, 2008, EUR J CLIN MICROBIOL, V27, P821, DOI 10.1007/s10096-008-0510-x; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P3551, DOI 10.1128/JCM.40.10.3551-3557.2002; Pincus DH, 1999, J CLIN MICROBIOL, V37, P3533, DOI 10.1128/JCM.37.11.3533-3539.1999; Plachy R, 2005, J MICROBIOL METH, V60, P107, DOI 10.1016/j.mimet.2004.09.003; Pryce TM, 2003, DIAGN MICR INFEC DIS, V47, P487, DOI 10.1016/S0732-8893(03)00139-1; Quiles-Melero I, 2012, EUR J CLIN MICROBIOL, V31, P67, DOI 10.1007/s10096-011-1277-z; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Shepard JR, 2008, J CLIN MICROBIOL, V46, P50, DOI 10.1128/JCM.01385-07; Slany M, 2010, CAN J MICROBIOL, V56, P1040, DOI 10.1139/W10-091; Somogyvari F, 2012, IN VIVO, V26, P979; Staib P, 1999, MYCOSES, V42, P521, DOI 10.1046/j.1439-0507.1999.00516.x; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Trtkova J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-234; Valenza G, 2006, MYCOSES, V49, P331, DOI 10.1111/j.1439-0507.2006.01240.x; Wang QM, 2008, APPL ENVIRON MICROB, V74, P2604, DOI 10.1128/AEM.02223-07; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08	67	27	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116940	10.1371/journal.pone.0116940	http://dx.doi.org/10.1371/journal.pone.0116940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689781	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700028
J	Tibber, MS; Anderson, EJ; Bobin, T; Carlin, P; Shergill, SS; Dakin, SC				Tibber, Marc S.; Anderson, Elaine J.; Bobin, Tracy; Carlin, Patricia; Shergill, Sukhwinder S.; Dakin, Steven C.			Local and Global Limits on Visual Processing in Schizophrenia	PLOS ONE			English	Article							MOTION PERCEPTION; CONTOUR INTEGRATION; GABA CONCENTRATION; INTERNAL NOISE; GAIN-CONTROL; ORGANIZATION; IMPAIRMENT; DEFICITS; CONTEXT; FACILITATION	Schizophrenia has been linked to impaired performance on a range of visual processing tasks (e.g. detection of coherent motion and contour detection). It has been proposed that this is due to a general inability to integrate visual information at a global level. To test this theory, we assessed the performance of people with schizophrenia on a battery of tasks designed to probe voluntary averaging in different visual domains. Twenty-three outpatients with schizophrenia (mean age: 40 +/- 8 years; 3 female) and 20 age-matched control participants (mean age 39 +/- 9 years; 3 female) performed a motion coherence task and three equivalent noise (averaging) tasks, the latter allowing independent quantification of local and global limits on visual processing of motion, orientation and size. All performance measures were indistinguishable between the two groups (ps > 0.05, one-way ANCOVAs), with one exception: participants with schizophrenia pooled fewer estimates of local orientation than controls when estimating average orientation (p = 0.01, one-way ANCOVA). These data do not support the notion of a generalised visual integration deficit in schizophrenia. Instead, they suggest that distinct visual dimensions are differentially affected in schizophrenia, with a specific impairment in the integration of visual orientation information.	[Tibber, Marc S.; Anderson, Elaine J.] UCL, Inst Ophthalmol, London, England; [Anderson, Elaine J.] UCL Inst Cognit Neurosci, London, England; [Bobin, Tracy; Shergill, Sukhwinder S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Carlin, Patricia] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England; [Dakin, Steven C.] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand	University of London; University College London; University of London; University College London; University of London; King's College London; University of London; King's College London; University of Auckland	Tibber, MS (corresponding author), UCL, Inst Ophthalmol, London, England.	mtibber@yahoo.com	Dakin, Steven/B-7610-2008	Dakin, Steven/0000-0002-3548-9104; Collier, Tracy/0000-0001-7067-8616; shergill, sukhi/0000-0003-4928-9100	Wellcome Trust [088219]; NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology (SCD)	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology (SCD)	This work was supported by The Wellcome Trust (www.wellcome.ac.uk, grant 088219 toSCD) and by the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology (SCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2012, PERCEPTION, V41, P157; Barch DM, 2012, SCHIZOPHRENIA BULL, V38, P135, DOI 10.1093/schbul/sbr154; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; Bidwell LC, 2006, PSYCHIAT RES, V145, P1, DOI 10.1016/j.psychres.2005.05.019; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Chen Y, 2004, BIOL PSYCHIAT, V55, P834, DOI 10.1016/j.biopsych.2003.12.024; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 2005, SCHIZOPHR RES, V74, P271, DOI 10.1016/j.schres.2004.04.002; Chen Y, 2011, SCHIZOPHRENIA BULL, V37, P709, DOI 10.1093/schbul/sbr020; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Chen Y, 2008, BIOL PSYCHIAT, V64, P74, DOI 10.1016/j.biopsych.2007.11.017; Chen Y, 2006, SCHIZOPHR RES, V88, P208, DOI 10.1016/j.schres.2006.06.004; Chong SC, 2005, VISION RES, V45, P891, DOI 10.1016/j.visres.2004.10.004; Christensen BK, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00605, DOI 10.3389/FPSYG.2013.00605]; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Dakin S, HDB PERCEPTUAL ORG; Dakin SC, 2005, VISION RES, V45, P3027, DOI 10.1016/j.visres.2005.07.037; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.4.2; Delord S, 2006, VISUAL NEUROSCI, V23, P645, DOI 10.1017/S0952523806233017; Dickinson D, 2010, AM J PSYCHIAT, V167, P170, DOI 10.1176/appi.ajp.2009.09020264; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; Hong LE, 2009, BIOL PSYCHIAT, V65, P1079, DOI 10.1016/j.biopsych.2008.10.021; Huang PC, 2006, VISION RES, V46, P3699, DOI 10.1016/j.visres.2006.04.025; Husk JS, 2012, J VISION, V12, DOI 10.1167/12.6.18; Im HY, 2013, ATTEN PERCEPT PSYCHO, V75, P278, DOI 10.3758/s13414-012-0399-4; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keane BP, 2014, PSYCHON B REV; Keane BP, 2014, NEUROPSYCHOLOGIA, V65, P221, DOI 10.1016/j.neuropsychologia.2014.10.031; Keane BP, 2014, NEUROPSYCHOLOGIA, V56, P302, DOI 10.1016/j.neuropsychologia.2014.02.001; Keane BP, 2012, EXP BRAIN RES, V220, P251, DOI 10.1007/s00221-012-3134-4; Kelemen O, 2013, PROG NEURO-PSYCHOPH, V47, P13, DOI 10.1016/j.pnpbp.2013.07.024; Keri S, 2002, J NEUROPSYCH CLIN N, V14, P190, DOI 10.1176/appi.neuropsych.14.2.190; Kim D, 2006, SCHIZOPHR RES, V82, P1, DOI 10.1016/j.schres.2005.10.008; Kim J, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00605, DOI 10.3389/FPSYG.2013.00605]; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019971; Kimhy D, 2007, SCHIZOPHR RES, V97, P25, DOI 10.1016/j.schres.2007.08.022; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Li CSR, 2002, PROG NEURO-PSYCHOPH, V26, P929, DOI 10.1016/S0278-5846(02)00207-5; Lin CY, 2014, CURR PHARM DES; LINDENMAYER JP, 1994, J NERV MENT DIS, V182, P631, DOI 10.1097/00005053-199411000-00006; Manning C, DEV COGNITI IN PRESS; Manning C, 2014, DEV COGN NEUROS-NETH, V10, P44, DOI 10.1016/j.dcn.2014.07.004; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Must A, 2004, NEUROSCI LETT, V357, P131, DOI 10.1016/j.neulet.2003.12.046; Nelson HE., 1982, NATL ADULT READING T; Norton DJ, 2011, BRAIN COGNITION, V77, P248, DOI 10.1016/j.bandc.2011.08.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PHILLIPS ML, 1995, SCHIZOPHR RES, V17, P109, DOI 10.1016/0920-9964(95)00035-K; Phillips WA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00307; Punukollu B, 2006, PSYCHIATR BULL, V30, P297, DOI 10.1192/pb.30.8.297; Robol V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060951; Scargle J. D., 2000, J SCI EXPLORATION, V14, P91; Schallmo MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068090; Silverstein SM, 2000, SCHIZOPHR RES, V43, P11, DOI 10.1016/S0920-9964(99)00180-2; Silverstein Steven M, 2006, Cogn Neuropsychiatry, V11, P112, DOI 10.1080/13546800444000209; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Slaghuis WL, 1998, J ABNORM PSYCHOL, V107, P49, DOI 10.1037/0021-843X.107.1.49; Solomon JA, 2011, J VISION, V11, DOI 10.1167/11.12.13; Stuve TA, 1997, PSYCHOL MED, V27, P143, DOI 10.1017/S0033291796004230; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Tibber MS, 2014, INVEST OPHTH VIS SCI, V55, P2539, DOI 10.1167/iovs.14-13877; Tibber MS, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00088, 10.3389/fpsyt.2013.00027]; Tso IF, 2013, SCHIZOPHRENIA B; Uhlhaas Peter J, 2006, Cogn Neuropsychiatry, V11, P416, DOI 10.1080/13546800444000272; Uhlhaas PJ, 2006, PSYCHIAT RES, V145, P105, DOI 10.1016/j.psychres.2005.10.016; Uhlhaas PJ, 2005, PSYCHOL BULL, V131, P618, DOI 10.1037/0033-2909.131.4.618; Viertio S, 2007, SOC PSYCH PSYCH EPID, V42, P902, DOI 10.1007/s00127-007-0252-6; WALKER E, 1984, BRIT J CLIN PSYCHOL, V23, P37, DOI 10.1111/j.2044-8260.1984.tb00624.x; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Yang E, 2012, CLIN PSYCHOL SCI; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Yoon JH, 2009, SCHIZOPHRENIA BULL, V35, P1078, DOI 10.1093/schbul/sbp064	76	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117951	10.1371/journal.pone.0117951	http://dx.doi.org/10.1371/journal.pone.0117951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689281	Green Published, gold			2022-12-27	WOS:000350322700088
J	Wu, SY; Shao, FJ; Ji, J; Sun, RC; Dong, RZ; Zhou, YK; Xu, SJ; Sui, Y; Hu, JL				Wu, Shunyao; Shao, Fengjing; Ji, Jun; Sun, Rencheng; Dong, Rizhuang; Zhou, Yuanke; Xu, Shaojie; Sui, Yi; Hu, Jianlong			Network Propagation with Dual Flow for Gene Prioritization	PLOS ONE			English	Article							COMMON HOUSEKEEPING GENES; DISEASE-GENES; ASSOCIATIONS; WALKING	Based on the hypothesis that the neighbors of disease genes trend to cause similar diseases, network-based methods for disease prediction have received increasing attention. Taking full advantage of network structure, the performance of global distance measurements is generally superior to local distance measurements. However, some problems exist in the global distance measurements. For example, global distance measurements may mistake non-disease hub proteins that have dense interactions with known disease proteins for potential disease proteins. To find a new method to avoid the aforementioned problem, we analyzed the differences between disease proteins and other proteins by using essential proteins (proteins encoded by essential genes) as references. We find that disease proteins are not well connected with essential proteins in the protein interaction networks. Based on this new finding, we proposed a novel strategy for gene prioritization based on protein interaction networks. We allocated positive flow to disease genes and negative flow to essential genes, and adopted network propagation for gene prioritization. Experimental results on 110 diseases verified the effectiveness and potential of the proposed method.	[Wu, Shunyao; Shao, Fengjing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Wu, Shunyao; Shao, Fengjing; Ji, Jun; Sun, Rencheng; Zhou, Yuanke; Xu, Shaojie; Sui, Yi; Hu, Jianlong] Qingdao Univ, Coll Informat Engn, Qingdao 266071, Peoples R China; [Dong, Rizhuang] Qingdao Technol Univ, Sch Comp Engn, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University of Technology	Shao, FJ (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	sfj@qdu.edu.cn		Wu, Shunyao/0000-0001-7774-9261	The State Key Program of National Natural Science of China [91130035]; National Natural Science Foundation of China; National Science Foundation of Shandong Province [ZR2012FZ003, ZR2012FQ017]; Shandong Provincial Natural Science Foundation, China	The State Key Program of National Natural Science of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	1. The State Key Program of National Natural Science of China (No. 91130035), National Natural Science Foundation of China (http://www.nsfc.gov.cn/), FS; 2. The National Science Foundation of Shandong Province (No. ZR2012FZ003), Shandong Provincial Natural Science Foundation, China (http://www.sdnsf.gov.cn/portal/), FS; 3. The National Science Foundation of Shandong Province (No. ZR2012FQ017), Shandong Provincial Natural Science Foundation, China (http://www.sdnsf.gov.cn/portal/), RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bromberg Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002902; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Congiu M, 2011, LIVER INT, V31, P386, DOI 10.1111/j.1478-3231.2010.02374.x; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Itan Y, 2013, P NATL ACAD SCI USA, V110, P5558, DOI [10.1073/pnas.1218167110, 10.1073/PNAS.1218167110]; Jin WF, 2012, HUM MOL GENET, V21, P1611, DOI 10.1093/hmg/ddr599; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Smalter A, 2007, IEEE INT C BIOINFORM, P209, DOI 10.1109/BIBM.2007.47; Nguyen TP, 2012, ARTIF INTELL MED, V54, P63, DOI 10.1016/j.artmed.2011.09.003; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Wu SY, 2014, PHYSICA A, V398, P217, DOI 10.1016/j.physa.2013.12.046; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang P, 2012, BIOINFORMATICS, V28, P2640, DOI 10.1093/bioinformatics/bts504; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116505	10.1371/journal.pone.0116505	http://dx.doi.org/10.1371/journal.pone.0116505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689268	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700010
J	Hayyan, M; Looi, CY; Hayyan, A; Wong, WF; Hashim, MA				Hayyan, Maan; Looi, Chung Yeng; Hayyan, Adeeb; Wong, Won Fen; Hashim, Mohd Ali			In Vitro and In Vivo Toxicity Profiling of Ammonium-Based Deep Eutectic Solvents	PLOS ONE			English	Article							IMIDAZOLIUM IONIC LIQUIDS; CHOLINE CHLORIDE; CELLS; BIOTRANSFORMATIONS; CYTOTOXICITY; MEDIA; MODEL	The cytotoxic potential of ammonium-based deep eutectic solvents (DESs) with four hydrogen bond donors, namely glycerine (Gl), ethylene glycol (EG), triethylene glycol (TEG) and urea (U) were investigated. The toxicity of DESs was examined using In Vitro cell lines and In Vivo animal model. IC50 and selectivity index were determined for the DESs, their individual components and their combinations as aqueous solutions for comparison purposes. The cytotoxicity effect of DESs varied depending on cell lines. The IC50 for the Gl(DES), EG(DES), U-DES and TEG(DES) followed the sequence of TEG(DES)<Gl(DES)<EG(DES)<U-DES for OKF6, MCF-7, A375, HT29 and H413, respectively. Gl(DES) was selective against MCF-7 and A375, EG(DES) was selective against MCF-7, PC3, HepG2 and HT29, U-DES was selective against MCF-7, PC3, HepG2 and HT29, and TEG(DES) was selective against MCF-7 and A375. However, acute toxicity studies using ICR mice showed that these DESs were relatively toxic in comparison to their individual components. DES did not cause DNA damage, but it could enhance ROS production and induce apoptosis in treated cancer cells as evidenced by marked LDH release. Furthermore, the examined DESs showed less cytotoxicity compared with ionic liquids. To the best of our knowledge, this is the first time that combined In Vitro and In Vivo toxicity profiles of DESs were being demonstrated, raising the toxicity issue of these neoteric mixtures and their potential applicability to be used for therapeutic purposes.	[Hayyan, Maan] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia; [Hayyan, Maan; Hayyan, Adeeb; Hashim, Mohd Ali] Univ Malaya, UMCiL, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Hayyan, Adeeb; Hashim, Mohd Ali] Univ Malaya, Dept Chem Engn, Kuala Lumpur, Malaysia; [Wong, Won Fen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Hayyan, M (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia.	maan_hayyan@yahoo.com	HASHIM, MOHD ALI/B-9065-2010; Wong, Won Fen/D-3087-2012; Looi, Chung Yeng/A-2623-2013; Hayyan, Adeeb/G-6552-2014; Hayyan, Maan/A-1089-2011	HASHIM, MOHD ALI/0000-0002-0570-6788; Wong, Won Fen/0000-0003-1082-1956; Looi, Chung Yeng/0000-0002-4830-3495; Hayyan, Adeeb/0000-0002-3738-8198; Hayyan, Maan/0000-0002-2179-0801	University of Malaya HIR-MOHE [D000003-16001]; University of Malaya Centre for Ionic Liquids (UMCiL)	University of Malaya HIR-MOHE(Universiti Malaya); University of Malaya Centre for Ionic Liquids (UMCiL)	This work was supported by the University of Malaya HIR-MOHE (D000003-16001) and University of Malaya Centre for Ionic Liquids (UMCiL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AP, 2004, J AM CHEM SOC, V126, P9142, DOI 10.1021/ja048266j; Abbott AR, 2006, CHEMPHYSCHEM, V7, P803, DOI 10.1002/cphc.200500489; Badisa RB, 2009, ANTICANCER RES, V29, P2993; Bubalo MC, 2014, ECOTOX ENVIRON SAFE, V99, P1, DOI 10.1016/j.ecoenv.2013.10.019; Choi YH, 2011, PLANT PHYSIOL, V156, P1701, DOI 10.1104/pp.111.178426; Cvjetko M, 2012, ARH HIG RADA TOKSIKO, V63, P15, DOI 10.2478/10004-1254-63-2012-2132; Dai YT, 2013, ANAL CHIM ACTA, V766, P61, DOI 10.1016/j.aca.2012.12.019; de Maria PD, 2011, CURR OPIN CHEM BIOL, V15, P220, DOI 10.1016/j.cbpa.2010.11.008; Desoubzdanne D, 2008, J NAT PROD, V71, P1189, DOI 10.1021/np8000909; Durand E, 2012, PROCESS BIOCHEM, V47, P2081, DOI 10.1016/j.procbio.2012.07.027; Goessel G, 2005, P NATL ACAD SCI USA, V102, P15599, DOI 10.1073/pnas.0409730102; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Gorke JT, 2008, CHEM COMMUN, P1235, DOI 10.1039/b716317g; Guo WJ, 2013, GREEN CHEM, V15, P226, DOI 10.1039/c2gc36602a; Gutierrez MC, 2010, ANGEW CHEM INT EDIT, V49, P2158, DOI 10.1002/anie.200905212; Hayyan A, 2012, THERMOCHIM ACTA, V541, P70, DOI 10.1016/j.tca.2012.04.030; Hayyan M, 2013, CHEMOSPHERE, V93, P455, DOI 10.1016/j.chemosphere.2013.05.013; Hayyan M, 2013, CHEMOSPHERE, V90, P2193, DOI 10.1016/j.chemosphere.2012.11.004; Hayyan M, 2010, FUEL PROCESS TECHNOL, V91, P116, DOI 10.1016/j.fuproc.2009.09.002; Jhong HR, 2009, ELECTROCHEM COMMUN, V11, P209, DOI 10.1016/j.elecom.2008.11.001; Jodynis-Liebert J, 2010, REGUL TOXICOL PHARM, V57, P266, DOI 10.1016/j.yrtph.2010.03.006; Leron RB, 2013, THERMOCHIM ACTA, V551, P14, DOI 10.1016/j.tca.2012.09.041; Leron RB, 2012, J CHEM THERMODYN, V54, P293, DOI 10.1016/j.jct.2012.05.008; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Muhammad N, 2012, J CHEM ENG DATA, V57, P2191, DOI 10.1021/je300086w; Paydar M, 2013, INT J PHARMACEUT, V9, DOI [10.1186/1687-9856-2013-9, DOI 10.1186/1687-9856-2013-9]; Paydar M, 2014, DRUG DES DEV THER, V8, P719, DOI 10.2147/DDDT.S58178; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Radosevic K, 2015, ECOTOX ENVIRON SAFE, V112, P46, DOI 10.1016/j.ecoenv.2014.09.034; Samori C, 2010, ECOTOX ENVIRON SAFE, V73, P1456, DOI 10.1016/j.ecoenv.2010.07.020; Singh BS, 2012, CATAL COMMUN, V24, P70, DOI 10.1016/j.catcom.2012.03.021; Smith EL, 2014, CHEM REV, V114, P11060, DOI 10.1021/cr300162p; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wu SH, 2012, THERMOCHIM ACTA, V544, P1, DOI 10.1016/j.tca.2012.05.031; Zhang QH, 2012, CHEM SOC REV, V41, P7108, DOI 10.1039/c2cs35178a; Zhao H, 2011, J MOL CATAL B-ENZYM, V72, P163, DOI 10.1016/j.molcatb.2011.05.015	38	148	150	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117934	10.1371/journal.pone.0117934	http://dx.doi.org/10.1371/journal.pone.0117934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679975	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600095
J	Li, XF; Zhong, BM; Han, WT; Zhao, N; Liu, W; Sui, Y; Wang, YW; Lu, YP; Wang, H; Li, JX; Jiang, M				Li, Xuefu; Zhong, Bomeng; Han, Weitian; Zhao, Ning; Liu, Wei; Sui, Yu; Wang, Yawen; Lu, Yongping; Wang, Hong; Li, Jianxin; Jiang, Miao			Two Novel Mutations in Myosin Binding Protein C Slow Causing Distal Arthrogryposis Type 2 in Two Large Han Chinese Families May Suggest Important Functional Role of Immunoglobulin Domain C2	PLOS ONE			English	Article							FREEMAN-SHELDON-SYNDROME; WHISTLING-FACE-SYNDROME; CARPO-TARSAL DYSPLASIA; HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE; HALL-SYNDROME; CONTRACTURES; VARIANT; PIEZO2; ECEL1	Distal arthrogryposes (DAs) are a group of disorders that mainly involve the distal parts of the limbs and at least ten different DAs have been described to date. DAs are mostly described as autosomal dominant disorders with variable expressivity and incomplete penetrance, but recently autosomal recessive pattern was reported in distal arthrogryposis type 5D. Mutations in the contractile genes are found in about 50% of all DA patients. Of these genes, mutations in the gene encoding myosin binding protein C slow MYBPC1 were recently identified in two families with distal arthrogryposis type 1B. Here, we described two large Chinese families with autosomal dominant distal arthrogryposis type 2(DA2) with incomplete penetrance and variable expressivity. Some unique overextension contractures of the lower limbs and some distinctive facial features were present in our DA2 pedigrees. We performed follow-up DNA sequencing after linkage mapping and first identified two novel MYBPC1 mutations (c.1075G>A [p.E359K] and c.956C>T [p.P319L]) responsible for these Chinese DA2 families of which one introduced by germline mosacism. Each mutation was found to cosegregate with the DA2 phenotype in each family but not in population controls. Both substitutions occur within C2 immunoglobulin domain, which together with C1 and the M motif constitute the binding site for the S2 subfragment of myosin. Our results expand the phenotypic spectrum of MYBPC1-related arthrogryposis multiplex congenita (AMC). We also proposed the possible molecular mechanisms that may underlie the pathogenesis of DA2 myopathy associated with these two substitutions in MYBPC1.	[Li, Xuefu; Han, Weitian; Zhao, Ning; Liu, Wei; Sui, Yu; Wang, Yawen; Lu, Yongping; Wang, Hong; Li, Jianxin; Jiang, Miao] Key Lab Reprod Hlth Liaoning Prov, Shenyang, Peoples R China; [Zhong, Bomeng] Nanjing First Hosp, Emergency Dept, Nanjing, Jiangsu, Peoples R China		Jiang, M (corresponding author), Key Lab Reprod Hlth Liaoning Prov, Shenyang, Peoples R China.	jiangmiaocpt@aliyun.com			National Natural Science Foundation of China [81071442]; Research Fund of the Liaoning Provincial Department of Science and Technology [2010225031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of the Liaoning Provincial Department of Science and Technology	The National Natural Science Foundation of China to Miao Jiang (Grant No. 81071442) played an important role in study design, data analysis, preparation of the manuscript and decision to publish, the Research Fund of the Liaoning Provincial Department of Science and Technology to Miao Jiang (Grant No. 2010225031) played an important role in the sample collection and diagnosis of the distal arthrogryposis.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ackermann MA, 2013, FASEB J, DOI [10.1096/fj.13-240390, DOI 10.1096/FJ.13-240390]; Ackermann MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/636403; Ackermann MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/652065; Aren G, 2003, QUINTESSENCE INT, V34, P307; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; CERVENKA J, 1970, ARCHIV OTOLARYNGOL, V91, P183; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dieterich K, 2013, HUM MOL GENET, V22, P1483, DOI 10.1093/hmg/dds514; FITZSIMMONS JS, 1984, J MED GENET, V21, P364, DOI 10.1136/jmg.21.5.364; FRASER FC, 1970, J AMER MED ASSOC, V211, P1374, DOI 10.1001/jama.211.8.1374; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Ha K, 2013, HUM MOL GENET, DOI [10.1093/hmg/ddt644, DOI 10.1093/HMG/DDT644]; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; Hegde SS, 2010, INDIAN J PEDIATR, V77, P196, DOI 10.1007/s12098-009-0227-6; Jiang M, 2006, HUM GENET, V120, P238, DOI 10.1007/s00439-006-0183-4; Kimber E, 2012, ACTA PAEDIATR, V101, P877, DOI 10.1111/j.1651-2227.2012.02708.x; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Krakowiak PA, 1997, AM J HUM GENET, V60, P426; Krakowiak PA, 1998, AM J MED GENET, V76, P93, DOI 10.1002/(SICI)1096-8628(19980226)76:1<93::AID-AJMG17>3.0.CO;2-K; LAI MMR, 1991, J MED GENET, V28, P701, DOI 10.1136/jmg.28.10.701; Li XF, 2013, GENE, V527, P630, DOI 10.1016/j.gene.2013.06.082; Markus B, 2012, HUM MUTAT, DOI [10.1002/humu.22247, DOI 10.1002/HUMU.22247]; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; McMillin MJ, 2014, AM J HUM GENET, DOI [10.1016/j.ajhg.2014.12.009, DOI 10.1016/J.AJHG.2014.12.009]; OTTO F M, 1953, Z Kinderheilkd, V73, P240, DOI 10.1007/BF00436029; PFEIFFER RA, 1972, Z KINDERHEILKD, V112, P43, DOI 10.1007/BF00491964; RINTALA AE, 1968, ACTA PAEDIATR SCAND, V57, P553, DOI 10.1111/j.1651-2227.1968.tb06979.x; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SH S S. S, 2009, IRAN J CHILD NEUROLO, P51; Shaaban S, 2013, CLIN GENET, DOI [10.1111/cge.12212, DOI 10.1111/CGE.12212]; Shaheen R, 2013, CLIN GENET, DOI [10.1111/cge.12212, DOI 10.1111/CGE.12212]; Stevenson DA, 2006, AM J MED GENET A, V140A, P2797, DOI 10.1002/ajmg.a.31528; Stevenson DA, 2006, PEDIATRICS, V117, P754, DOI 10.1542/peds.2005-1219; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Tajsharghi H, 2007, NEUROLOGY, V68, P772, DOI 10.1212/01.wnl.0000256339.40667.fb; Toydemir RM, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-11; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; VANEK J, 1986, J MED GENET, V23, P231, DOI 10.1136/jmg.23.3.231; Medrano RFV, 2014, MOL BIOTECHNOL, V56, P599, DOI 10.1007/s12033-014-9734-4; Vydyanath A, 2012, J MUSCLE RES CELL M, V33, P61, DOI 10.1007/s10974-012-9286-9; WEINSTEIN S, 1969, AM J DIS CHILD, V117, P427, DOI 10.1001/archpedi.1969.02100030429007; Weissbrod O, 2011, STAT APPL GENET MOL, V10, DOI [10.2202/1544-6115.1666, DOI 10.2202/1544-6115.1666]; WETTSTEIN A, 1980, HUM GENET, V55, P177, DOI 10.1007/BF00291765; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	52	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117158	10.1371/journal.pone.0117158	http://dx.doi.org/10.1371/journal.pone.0117158			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679999	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600053
J	Luu, BE; Tessier, SN; Duford, DL; Storey, KB				Luu, Bryan E.; Tessier, Shannon N.; Duford, Dianna L.; Storey, Kenneth B.			The Regulation of Troponins I, C and ANP by GATA4 and Nkx2-5 in Heart of Hibernating Thirteen-Lined Ground Squirrels, Ictidomys tridecemlineatus	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; TRANSCRIPTION FACTOR GATA-4; MYOCYTE ENHANCER FACTOR-2; METABOLIC-RATE DEPRESSION; DEPENDENT ACTIVATION; ADAPTIVE-MECHANISMS; GENE-EXPRESSION; TEMPERATURE; PHOSPHORYLATION; MUSCLE	Hibernation is an adaptive strategy used by various mammals to survive the winter under situations of low ambient temperatures and limited or no food availability. The heart of hibernating thirteen-lined ground squirrels (Ictidomys tridecemlineatus) has the remarkable ability to descend to low, near 0 degrees C temperatures without falling into cardiac arrest. We hypothesized that the transcription factors GATA4 and Nkx2-5 may play a role in cardioprotection by facilitating the expression of key downstream targets such as troponin I, troponin C, and ANP (atrial natriuretic peptide). This study measured relative changes in transcript levels, protein levels, protein post-translational modifications, and transcription factor binding over six stages: euthermic control (EC), entrance into torpor (EN), early torpor (ET), late torpor (LT), early arousal (EA), and interbout arousal (IA). We found differential regulation of GATA4 whereby transcript/protein expression, post-translational modification (phosphorylation of serine 261), and DNA binding were enhanced during the transitory phases (entrance and arousal) of hibernation. Activation of GATA4 was paired with increases in cardiac troponin I, troponin C and ANP protein levels during entrance, while increases in p-GATA4 DNA binding during early arousal was paired with decreases in troponin I and no changes in troponin C and ANP protein levels. Unlike its binding partner, the relative mRNA/protein expression and DNA binding of Nkx2-5 did not change during hibernation. This suggests that either Nkx2-5 does not play a substantial role or other regulatory mechanisms not presently studied (e.g. posttranslational modifications) are important during hibernation. The data suggest a significant role for GATA4-mediated gene transcription in the differential regulation of genes which aid cardiac-specific challenges associated with torpor-arousal.	[Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Storey, KB (corresponding author), Carleton Univ, Inst Biochem, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	kenneth_storey@carleton.ca		Luu, Bryan/0000-0002-9271-9324; Tessier, Shannon/0000-0003-2373-232X	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant [6793]; Heart and Stroke Foundation of Canada [G-14-0005874]; NSERC scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (#6793) (www.nserc-crsng.gc.ca) and a grant-in-aid from the Heart and Stroke Foundation of Canada (#G-14-0005874) (http://www.hsf.ca/research/en/grants-aid) to KBS. BEL and SNT were funded by undergraduate and postgraduate NSERC scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Alderman SL, 2012, AM J PHYSIOL-REG I, V303, pR168, DOI 10.1152/ajpregu.00127.2012; Arjamaa Olli, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P191; Armaly Z, 2013, CURR OPIN NEPHROL HY, V22, P713, DOI 10.1097/01.mnh.0000435609.35789.32; Bratincsak A, 2007, J COMP NEUROL, V505, P443, DOI 10.1002/cne.21507; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Chen YF, 2006, LIFE SCI, V79, P1357, DOI 10.1016/j.lfs.2006.03.051; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Engel PL, 2007, J BIOL CHEM, V282, P183, DOI 10.1074/jbc.M512337200; Engel PL, 2009, J MOL CELL CARDIOL, V47, P359, DOI 10.1016/j.yjmcc.2009.04.016; Fahlman A, 2000, CRYOBIOLOGY, V40, P332, DOI 10.1006/cryo.2000.2254; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gallagher JM, 2012, MOL CELL BIOL, V32, P2214, DOI 10.1128/MCB.00218-12; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Genge CE, 2013, PHYSIOL GENOMICS, V45, P866, DOI 10.1152/physiolgenomics.00074.2013; Hasan MK, 2010, GENES CELLS, V15, P439, DOI 10.1111/j.1365-2443.2010.01394.x; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Horio T, 2000, HYPERTENSION, V35, P19, DOI 10.1161/01.HYP.35.1.19; Huang RT, 2013, INT J MOL MED, V31, P1119, DOI 10.3892/ijmm.2013.1316; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Jun JH, 2013, J CELL PHYSIOL, V228, P190, DOI 10.1002/jcp.24121; Klaiman JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024464; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kuzman JA, 2005, J APPL PHYSIOL, V99, P1428, DOI 10.1152/japplphysiol.00515.2005; Li XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024787; Lien CL, 1999, DEVELOPMENT, V126, P75; LIU B, 1993, AM J PHYSIOL, V264, pR104, DOI 10.1152/ajpregu.1993.264.1.R104; Liu BY, 2012, INT SYM COMPUT INTEL, P7, DOI 10.1109/ISCID.2012.10; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; McMullen DC, 2010, J COMP PHYSIOL B, V180, P927, DOI 10.1007/s00360-010-0468-8; MORANO I, 1992, J MUSCLE RES CELL M, V13, P64, DOI 10.1007/BF01738429; Murphy AM, 1997, BIOCHEM J, V322, P393, DOI 10.1042/bj3220393; Nakipova OV, 2007, CRYOBIOLOGY, V55, P173, DOI 10.1016/j.cryobiol.2007.07.001; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shan XH, 2009, INT J CARDIOL, V134, P384, DOI 10.1016/j.ijcard.2008.03.043; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Suzuki YJ, 2004, LIFE SCI, V74, P1829, DOI 10.1016/j.lfs.2003.10.002; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tervonen V, 2001, J PHYSIOL-LONDON, V536, P199, DOI 10.1111/j.1469-7793.2001.00199.x; Tessier SN, 2012, GENE, V501, P8, DOI 10.1016/j.gene.2012.04.004; Tessier SN, 2010, MOL CELL BIOCHEM, V344, P151, DOI 10.1007/s11010-010-0538-y; Thielmann M, 2006, CIRCULATION, V114, pI448, DOI 10.1161/CIRCULATIONAHA.105.001057; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; Wang L.C.H., 1996, HDB PHYSL ENV PHYSL, P507, DOI [10.1002/CPHY.CP040122, DOI 10.1002/CPHY.CP040122]; Wang SQ, 2002, J EXP BIOL, V205, P2957; WICKLER SJ, 1991, AM J PHYSIOL, V261, pR1214, DOI 10.1152/ajpregu.1991.261.5.R1214; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; ZHOU ZQ, 1991, AM J PHYSIOL, V260, pR353, DOI 10.1152/ajpregu.1991.260.2.R353	64	15	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117747	10.1371/journal.pone.0117747	http://dx.doi.org/10.1371/journal.pone.0117747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679215	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600084
J	Monti, L; Donati, D; Menci, E; Cioni, S; Bellini, M; Grazzini, I; Leonini, S; Galluzzi, P; Severi, S; Burroni, L; Casasco, A; Morbidelli, L; Santarnecchi, E; Piu, P				Monti, Lucia; Donati, Donatella; Menci, Elisabetta; Cioni, Samuele; Bellini, Matteo; Grazzini, Irene; Leonini, Sara; Galluzzi, Paolo; Severi, Sauro; Burroni, Luca; Casasco, Alfredo; Morbidelli, Lucia; Santarnecchi, Emiliano; Piu, Pietro			Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; BLOOD-FLOW; ABSOLUTE QUANTIFICATION; COMPUTED-TOMOGRAPHY; VASCULAR-DISEASE; CT PERFUSION; SEGMENTATION; DIFFUSION; LESIONS	Literature has suggested that changes in brain flow circulation occur in patients with multiple sclerosis. In this study, digital subtraction angiography (DSA) was used to measure the absolute CCT value in MS patients and to correlate its value to age at disease onset and duration, and to expand disability status scale (EDSS). DSA assessment was performed on eighty MS patients and on a control group of forty-four age-matched patients. CCT in MS and control groups was calculated by analyzing the angiographic images. Lesion and brain volumes were calculated in a representative group of MS patients. Statistical correlations among CCT and disease duration, age at disease onset, lesion load, brain volumes and EDSS were considered. A significant difference between CCT in MS patients (mean = 4.9s; sd = 1.27s) and control group (mean = 2.8s; sd = 0.51s) was demonstrated. No significant statistical correlation was found between CCT and the other parameters in all MS patients. Significantly increased CCT value in MS patients suggests the presence of microvascular dysfunctions, which do not depend on clinical and MRI findings. Hemodynamic changes may not be exclusively the result of a late chronic inflammatory process.	[Monti, Lucia; Menci, Elisabetta; Cioni, Samuele; Bellini, Matteo; Grazzini, Irene; Leonini, Sara; Galluzzi, Paolo] Azienda Osped Univ Senese, Unit Neuroimaging & Neurointervent, Dept Neurol & Sensorial Sci, Santa Maria Scotte Gen Hosp, Siena, Italy; [Donati, Donatella; Santarnecchi, Emiliano; Piu, Pietro] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Severi, Sauro] Gen Hosp S Donato Arezzo, Dept Neurol, Arezzo, Italy; [Burroni, Luca] Azienda Osped Univ Senese, Santa Maria Scotte Gen Hosp, Nucl Med Unit, Siena, Italy; [Casasco, Alfredo] Clin Nuestra Senora Rosario, Unit Endovasc & Percutaneous Therapy, Madrid, Spain; [Morbidelli, Lucia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Santarnecchi, Emiliano] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Monti, L (corresponding author), Azienda Osped Univ Senese, Unit Neuroimaging & Neurointervent, Dept Neurol & Sensorial Sci, Santa Maria Scotte Gen Hosp, Siena, Italy.	l.monti@ao-siena.toscana.it	Grazzini, Irene/AAL-2260-2020; MONTI, LUCIA/ABF-7076-2021; Morbidelli, Lucia/AAC-7858-2020; Burroni, Luca/AAB-1958-2021; Morbidelli, Lucia/K-4053-2016; Santarnecchi, Emiliano/H-7528-2017	Burroni, Luca/0000-0001-5659-6091; Morbidelli, Lucia/0000-0001-8148-7049; Santarnecchi, Emiliano/0000-0002-6533-7427; Piu, Pietro/0000-0002-7504-1822; Galluzzi, Paolo/0000-0002-7553-5064; Bellini, Matteo/0000-0001-5280-0526				ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; ADAMS CWM, 1989, J NEUROL SCI, V92, P291, DOI 10.1016/0022-510X(89)90144-5; Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; BARTOLINI A, 1981, STROKE, V12, P241, DOI 10.1161/01.STR.12.2.241; Burroni L, 2011, NUCL MED COMMUN, V32, P457, DOI 10.1097/MNM.0b013e3283449330; Cerasa A, 2012, J NEUROSCI METH, V203, P193, DOI 10.1016/j.jneumeth.2011.08.047; Chiu FY, 2012, EUR J RADIOL, V81, P4087, DOI 10.1016/j.ejrad.2012.07.018; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; Debernard L, 2014, J NEUROL NEUROSUR PS, V42, P154; Eisele P, 2012, AM J NEURORADIOL, V33, P1369, DOI 10.3174/ajnr.A2975; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; GILROY J, 1963, AMER J ROENTGENOL RA, V90, P490; GOTHAM JE, 1962, J NEUROL NEUROSUR PS, V25, P292, DOI 10.1136/jnnp.25.4.292; GREITZ T, 1968, ACTA RADIOL DIAGN, V7, P331, DOI 10.1177/028418516800700406; HAMILTON WF, 1947, AM J PHYSIOL, V148, P35, DOI 10.1152/ajplegacy.1947.148.1.35; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Iorio M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00076; Jennett B, 1972, Prog Brain Res, V35, P365; Killeen RP, 2011, ACAD RADIOL, V18, P1094, DOI 10.1016/j.acra.2011.04.004; Knutsson L, 2015, J MAGN RESON IMAGING, V41, P903, DOI 10.1002/jmri.24621; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lieber Baruch B., 2005, Critical Reviews in Biomedical Engineering, V33, P1, DOI 10.1615/CritRevBiomedEng.v33.i1.10; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Mancini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092730; Mancini M, 2012, RADIOLOGY, V262, P947, DOI 10.1148/radiol.11111239; RANEY R. B., 1950, CALIFORNIA MED, V73, P342; Sato K, 2014, J CEREBR BLOOD F MET, V34, P136, DOI 10.1038/jcbfm.2013.176; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Wu MJ, 2006, PSYCHIAT RES-NEUROIM, V148, P133, DOI 10.1016/j.pscychresns.2006.09.003; Ziegelitz D, 2009, MAGN RESON MED, V62, P56, DOI 10.1002/mrm.21975; ZIERLER KL, 1965, CIRC RES, V16, P309, DOI 10.1161/01.RES.16.4.309; Zivadinov R, 2008, NEUROL RES, V30, P816, DOI 10.1179/174313208X341003	37	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116681	10.1371/journal.pone.0116681	http://dx.doi.org/10.1371/journal.pone.0116681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679526	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600030
J	Niranjan, TS; Skinner, C; May, M; Turner, T; Rose, R; Stevenson, R; Schwartz, CE; Wang, T				Niranjan, Tejasvi S.; Skinner, Cindy; May, Melanie; Turner, Tychele; Rose, Rebecca; Stevenson, Roger; Schwartz, Charles E.; Wang, Tao			Affected Kindred Analysis of Human X Chromosome Exomes to Identify Novel X-Linked Intellectual Disability Genes	PLOS ONE			English	Article							FRAGILE-X; RARE VARIANTS; MUTATIONS; FRAMEWORK; CHROMATIN; AUTISM	X-linked Intellectual Disability (XLID) is a group of genetically heterogeneous disorders caused by mutations in genes on the X chromosome. Deleterious mutations in similar to 10% of X chromosome genes are implicated in causing XLID disorders in similar to 50% of known and suspected XLID families. The remaining XLID genes are expected to be rare and even private to individual families. To systematically identify these XLID genes, we sequenced the X chromosome exome (X-exome) in 56 well-established XLID families (a single affected male from 30 families and two affected males from 26 families) using an Agilent SureSelect X-exome kit and the Illumina HiSeq 2000 platform. To enrich for disease-causing mutations, we first utilized variant filters based on dbSNP, the male-restricted portions of the 1000 Genomes Project, or the Exome Variant Server datasets. However, these databases present limitations as automatic filters for enrichment of XLID genes. We therefore developed and optimized a strategy that uses a cohort of affected male kindred pairs and an additional small cohort of affected unrelated males to enrich for potentially pathological variants and to remove neutral variants. This strategy, which we refer to as Affected Kindred/Cross-Cohort Analysis, achieves a substantial enrichment for potentially pathological variants in known XLID genes compared to variant filters from public reference databases, and it has identified novel XLID candidate genes. We conclude that Affected Kindred/Cross-Cohort Analysis can effectively enrich for disease-causing genes in rare, Mendelian disorders, and that public reference databases can be used effectively, but cautiously, as automatic filters for X-linked disorders.	[Niranjan, Tejasvi S.; Turner, Tychele; Rose, Rebecca; Wang, Tao] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Niranjan, Tejasvi S.; Turner, Tychele] Johns Hopkins Univ, Predoctoral Training Program Human Genet, Sch Med, Baltimore, MD 21205 USA; [Skinner, Cindy; May, Melanie; Stevenson, Roger; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Turner, Tychele] Univ Washington, Dept Genom Sci, Seattle, WA 98195 USA; [Wang, Tao] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Greenwood Genetic Center; University of Washington; University of Washington Seattle; Johns Hopkins University	Wang, T (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	twang9@jhmi.edu	Niranjan, Tejasvi/ABD-2892-2020	Niranjan, Tejasvi/0000-0002-6458-2017; Turner, Tychele/0000-0001-8246-6477	National Institutes of Health [R01 HD056780, R01 NS073854]; South Carolina Department of Disabilities and Special Needs (SCDDSN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs (SCDDSN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health, R01 HD056780 (to TW) and R01 NS073854 (to CES and TW), and a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN; http://ddsn.sc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arvanitis DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088325; Athanasakis E, 2014, AM J MED GENET A, V164, P170, DOI 10.1002/ajmg.a.36274; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Caramins M, 2013, HUM MOL GENET, DOI [10.1093/hmg/ddt644, DOI 10.1093/HMG/DDT644]; Chung BHY, 2011, EUR J MED GENET, V54, pE516, DOI 10.1016/j.ejmg.2011.05.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edens AC, 2011, DEV MED CHILD NEUROL, V53, P463, DOI 10.1111/j.1469-8749.2010.03909.x; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gilissen C, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-12-r127, DOI 10.1186/GB-2011-12-12-R127]; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hirata H, 2013, AM J HUM GENET, V92, P681, DOI 10.1016/j.ajhg.2013.03.021; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Piton A, 2013, AM J HUM GENET, DOI [10.1016/j.ajhg.2013.10.002, DOI 10.1016/J.AJHG.2013.10.002]; Purcell S, 2007, PLINK TOOLSET WHOLEG, V81; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simmons AD, 1998, BIOCHEM BIOPH RES CO, V242, P685, DOI 10.1006/bbrc.1997.8027; Twigg SRF, 2013, HUM MOL GENET, V22, P1654, DOI 10.1093/hmg/ddt015; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409	47	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116454	10.1371/journal.pone.0116454	http://dx.doi.org/10.1371/journal.pone.0116454			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679214	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600021
J	Rotschafer, SE; Marshak, S; Cramer, KS				Rotschafer, Sarah E.; Marshak, Sonya; Cramer, Karina S.			Deletion of Fmr1 Alters Function and Synaptic Inputs in the Auditory Brainstem	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; SUPERIOR OLIVE; YOUNG MALES; ABNORMALITIES; AUTISM; HYPEREXCITABILITY; LOCALIZATION; MALFORMATION	Fragile X Syndrome (FXS), a neurodevelopmental disorder, is the most prevalent singlegene cause of autism spectrum disorder. Autism has been associated with impaired auditory processing, abnormalities in the auditory brainstem response (ABR), and reduced cell number and size in the auditory brainstem nuclei. FXS is characterized by elevated cortical responses to sound stimuli, with some evidence for aberrant ABRs. Here, we assessed ABRs and auditory brainstem anatomy in Fmr1(-/-) mice, an animal model of FXS. We found that Fmr1(-/-) mice showed elevated response thresholds to both click and tone stimuli. Amplitudes of ABR responses were reduced in Fmr1(-/-) mice for early peaks of the ABR. The growth of the peak I response with sound intensity was less steep in mutants that in wild type mice. In contrast, amplitudes and response growth in peaks IV and V did not differ between these groups. We did not observe differences in peak latencies or in interpeak latencies. Cell size was reduced in Fmr1(-/-) mice in the ventral cochlear nucleus (VCN) and in the medial nucleus of the trapezoid body (MNTB). We quantified levels of inhibitory and excitatory synaptic inputs in these nuclei using markers for presynaptic proteins. We measured VGAT and VGLUT immunolabeling in VCN, MNTB, and the lateral superior olive (LSO). VGAT expression in MNTB was significantly greater in the Fmr1(-/-) mouse than in wild type mice. Together, these observations demonstrate that FXS affects peripheral and central aspects of hearing and alters the balance of excitation and inhibition in the auditory brainstem.	[Rotschafer, Sarah E.; Marshak, Sonya; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine	Cramer, KS (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	cramerk@uci.edu		Cramer, Karina/0000-0003-3793-4862	National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant [T32DC010775]; University of California Irvine Center for Autism Research and Translation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC008369, T32DC010775] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant; University of California Irvine Center for Autism Research and Translation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant T32DC010775 to SER. The National Institutes of Health, National Institute for Deafness and Other Communication Disorders Core Center P30DC008369, assisted in providing equipment and analysis for SER, SM, and KSC. University of California Irvine Center for Autism Research and Translation provided a seed grant to KSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARINAMI T, 1988, JPN J HUM GENET, V33, P224; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beebe K, 2014, NEUROSCIENCE, V273, P79, DOI 10.1016/j.neuroscience.2014.05.006; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Brown MR, 2011, HEARING RES, V279, P32, DOI 10.1016/j.heares.2011.03.004; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Castren M, 2003, BRAIN TOPOGR, V15, P165, DOI 10.1023/A:1022606200636; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; FERRI R, 1987, INT J NEUROSCI, V34, P172; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GILLBERG C, 1986, J MENT DEFIC RES, V30, P27; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Haas BW, 2009, DEV MED CHILD NEUROL, V51, P593, DOI 10.1111/j.1469-8749.2009.03295.x; Hagerman PJ, 2002, AM J HUM GENET, V71, P259; Hagerman R, 2002, AM J HUM GENET, V71, P287; Hallahan BP, 2011, NEUROIMAGE, V54, P16, DOI 10.1016/j.neuroimage.2010.08.015; Hazlett HC, 2012, J AM ACAD CHILD PSY, V51, P921, DOI 10.1016/j.jaac.2012.07.003; Heard TT, 2014, INT J DEV NEUROSCI; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hoeft F, 2011, ARCH GEN PSYCHIAT, V68, P295, DOI 10.1001/archgenpsychiatry.2010.153; Irwin SA, 2000, NEUROBIOL LEARN MEM, V73, P87, DOI 10.1006/nlme.1999.3914; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Kulesza RJ, 2011, BRAIN RES, V1367, P360, DOI 10.1016/j.brainres.2010.10.015; Lozano R, 2014, NEUROPSYCH DIS TREAT, V10, P1769, DOI 10.2147/NDT.S42919; Lukose R, 2011, BRAIN RES, V1398, P102, DOI 10.1016/j.brainres.2011.05.013; Melcher JR, 1996, HEARING RES, V95, P144, DOI 10.1016/0378-5955(96)00032-9; Miezejeski CM, 1997, AM J MED GENET, V74, P167, DOI 10.1002/(SICI)1096-8628(19970418)74:2<167::AID-AJMG10>3.0.CO;2-G; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Roberts J, 2005, J SPEECH LANG HEAR R, V48, P494, DOI 10.1044/1092-4388(2005/034); Rojas DC, 2001, NEUROREPORT, V12, P2573, DOI 10.1097/00001756-200108080-00056; Rotschafer S, 2013, BRAIN RES, V1506, P12, DOI 10.1016/j.brainres.2013.02.038; Rotschafer SE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00019; Rotschafer SE, 2012, BRAIN RES, V1439, P7, DOI 10.1016/j.brainres.2011.12.041; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; STCLAIR DM, 1987, BIOL PSYCHIAT, V22, P303, DOI 10.1016/0006-3223(87)90148-X; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; Tamminga CA, 2007, AM J PSYCHIAT, V164, P556, DOI 10.1176/appi.ajp.164.4.556; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P720, DOI 10.1016/j.clinph.2011.08.023; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P1309, DOI 10.1016/j.clinph.2011.11.039; Van der Molen MJW, 2012, BRAIN COGNITION, V78, P206, DOI 10.1016/j.bandc.2011.12.008; Wang Y, 2014, J COMP NEUROL, V522, P2107, DOI 10.1002/cne.23520; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	61	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117266	10.1371/journal.pone.0117266	http://dx.doi.org/10.1371/journal.pone.0117266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679778	gold, Green Published			2022-12-27	WOS:000350682600059
J	Cheng, JR; Wang, T; Li, F; Xiao, Y; Bi, JL; Chen, JY; Sun, XM; Wu, LG; Wu, SW; Liu, YY; Luo, R; Zhao, XS				Cheng, Jingru; Wang, Tian; Li, Fei; Xiao, Ya; Bi, Jianlu; Chen, Jieyu; Sun, Xiaomin; Wu, Liuguo; Wu, Shengwei; Liu, Yanyan; Luo, Ren; Zhao, Xiaoshan			Self-Rated Health Status and Subjective Health Complaints Associated with Health-Promoting Lifestyles among Urban Chinese Women: A Cross-Sectional Study	PLOS ONE			English	Article							STRESS; MEN; MANAGEMENT; BEHAVIORS; FATIGUE; PEOPLE	Objective This study aimed to investigate whether self-rated health status (SRH) and subjective health complaints (SHC) of urban Chinese women are associated with their health-promoting lifestyles (HPL). Methods We conducted a cross-sectional study on 8142 eligible Chinese participants between 2012 and 2013. Demographic and SHC data were collected. Each subject completed the SRH questionnaire and the Chinese version of the Health-Promoting Lifestyle Profile-II (HPLP-II). Correlation and binary regression analyses were performed to examine the associations of SRH and SHC with HPL. Results Both SRH and HPL of urban Chinese women were moderate. The most common complaints were fatigue (1972, 24.2%), eye discomfort (1571, 19.3%), and insomnia (1542, 18.9%). Teachers, highly educated subjects and elderly women had lower SRH scores, while college students and married women had better HPL. All items of HPLP-II were positively correlated with SRH (r = 0.127-0.533, P = 0.000) and negatively correlated with SHC to a significant extent (odds ratio [OR] = 1.40-11.37). Conclusions Aspects of HPL, particularly stress management and spiritual growth, are associated with higher SRH and lower SHC ratings among urban Chinese women. Physical activity and health responsibility are additionally related to reduced fatigue and nervousness. We believe that these findings will be instrumental in encouraging researchers and urban women to adopt better health-promoting lifestyles with different priorities in their daily lives.	[Cheng, Jingru; Wang, Tian; Li, Fei; Xiao, Ya; Bi, Jianlu; Chen, Jieyu; Wu, Liuguo; Wu, Shengwei; Luo, Ren; Zhao, Xiaoshan] Southern Med Univ, Nanfang Hosp, Dept Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Cheng, Jingru; Wang, Tian; Li, Fei; Xiao, Ya; Bi, Jianlu; Chen, Jieyu; Sun, Xiaomin; Wu, Liuguo; Wu, Shengwei; Luo, Ren; Zhao, Xiaoshan] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Yanyan] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Rheumat Dis, Guangzhou 510405, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou University of Chinese Medicine	Luo, R (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China.	luoren2014@126.com; zhaoxs0609@163.com	Zhao, Xiaoshan/GPF-7929-2022; liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022		NSFC-Guangdong joint fund [U1132001]; National Science Foundation of China [81173146, 81202622, 81373707, 81403447]; Natural Science Foundation of Guangdong Province, China [S2012010009177, S2011010002941]; Guangdong Provincial Department of Science and Technology; Guangdong Provincial Academy of Traditional Chinese Medicine [2011B032200004, 2012A032500004, 2013A032500008]; Guangdong Provincial Department of Science and Technology fund [2011B031700018]; China Postdoctoral Science Foundation [2014M552187]; Science & Technical Plan of Guangzhou, Guangdong, China [2011 J4300108]	NSFC-Guangdong joint fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Department of Science and Technology; Guangdong Provincial Academy of Traditional Chinese Medicine; Guangdong Provincial Department of Science and Technology fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science & Technical Plan of Guangzhou, Guangdong, China	This work was supported by the NSFC-Guangdong joint fund (No. U1132001), National Science Foundation of China (No. 81173146, 81202622, 81373707 and 81403447), the Natural Science Foundation of Guangdong Province, China (Nos. S2012010009177 and S2011010002941), Guangdong Provincial Department of Science and Technology and Guangdong Provincial Academy of Traditional Chinese Medicine joint fund (No. 2011B032200004, 2012A032500004 and 2013A032500008), Guangdong Provincial Department of Science and Technology fund (No. 2011B031700018), China Postdoctoral Science Foundation(No. 2014M552187), and Science & Technical Plan of Guangzhou, Guangdong, China (No. 2011 J4300108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Palacio I, 2014, GAC SANIT, DOI [10.1016/j.gaceta, DOI 10.1016/J.GACETA]; Alverson EM, 2012, J AM ACAD NURSE PRAC, V24, P364, DOI 10.1111/j.1745-7599.2012.00697.x; Ay S, 2012, ASIAN PAC J CANCER P, V13, P2269, DOI 10.7314/APJCP.2012.13.5.2269; Bauer GF, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-008-7077-2; Bi J, 2014, BMJ OPEN, V4, P1, DOI DOI 10.1155/2014/403515; Borrell C, 2004, SOC SCI MED, V58, P1869, DOI 10.1016/S0277-9536(03)00408-8; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Caetano SC, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-122; Chamberlain J, 2007, INT J GYNECOL OBSTET, V98, P75, DOI 10.1016/j.ijgo.2007.03.019; Chong EYL, 2010, INT J OCCUP SAF ERGO, V16, P23, DOI 10.1080/10803548.2010.11076825; Collijn DH, 1996, J PSYCHOSOM RES, V40, P271, DOI 10.1016/0022-3999(95)00547-1; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; D'Incau P, 2011, GENDER MED, V8, P80, DOI 10.1016/j.genm.2011.03.003; Davis MC, 1999, ANN BEHAV MED, V21, P83, DOI 10.1007/BF02895038; Eckert Sophie, 2014, World Health Popul, V15, P7, DOI 10.12927/whp.2014.23722; Galan I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002644; Glass JM, 2004, J PSYCHOSOM RES, V57, P391, DOI 10.1016/j.jpsychores.2004.04.002; Gokyildiz S, 2014, INT J NURS PRACT, V20, P390, DOI 10.1111/ijn.12187; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hildingh C, 2006, SCAND J CARING SCI, V20, P202, DOI 10.1111/j.1471-6712.2006.00395.x; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Ihlebaek C, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1080/140349401753481547; Ihlebaek C, 2007, OCCUP MED-OXFORD, V57, P43, DOI 10.1093/occmed/kql107; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; KAPLAN JR, 1991, CIRCULATION, V84, P23; Krantz G, 2005, EUR J PUBLIC HEALTH, V15, P209, DOI 10.1093/eurpub/cki079; Lee A, 2006, J EPIDEMIOL COMMUN H, V60, P530, DOI 10.1136/jech.2005.040121; Lee RLT, 2005, PUBLIC HEALTH NURS, V22, P209, DOI 10.1111/j.0737-1209.2005.220304.x; Leung SSK, 2011, J OCCUP HEALTH, V53, P23, DOI 10.1539/joh.L10037; Li HT, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-41; Li Ying-Hua, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P214; Lin Yu-Hua, 2009, Chang Gung Med J, V32, P650; Linardatou C, 2014, J PSYCHIATR RES, V56, P137, DOI 10.1016/j.jpsychires.2014.05.013; MATTHEWS KA, 1992, PSYCHOSOM MED, V54, P686, DOI 10.1097/00006842-199211000-00009; National Bureau of Statistics of China, 2011, 6 NAT POP CENS REP 2; Nazarova I, 2000, SOC SCI MED, V51, P1375, DOI 10.1016/S0277-9536(00)00103-9; NETTERSTROM B, 1991, BRIT J IND MED, V48, P684; Ni J, 2011, TODAY NATURE, V4, P98; Raikkonen K, 1996, METABOLISM, V45, P1533, DOI 10.1016/S0026-0495(96)90184-5; Roebroeck ME, 2014, CLIN REHABIL, DOI [10.1177/0269215514536411, DOI 10.1177/0269215514536411]; Shade ED, 2004, J AM DIET ASSOC, V104, P903, DOI 10.1016/j.jada.2004.03.018; Shuzhuo L, 1998, CHIN J POPUL SCI, V6, P22; SOBOL EG, 1978, NURS RES, V27, P238, DOI 10.1097/00006199-197827040-00011; Sonmezer H, 2012, ASIAN PAC J CANCER P, V13, P1241, DOI 10.7314/APJCP.2012.13.4.1241; Sun Xiao-Min, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P750; Tamanna S, 2013, SOUTH MED J, V106, P470, DOI 10.1097/SMJ.0b013e3182a15af5; Verdonk P, 2010, INT ARCH OCC ENV HEA, V83, P309, DOI 10.1007/s00420-009-0481-y; WALKER SN, 1987, NURS RES, V36, P76; Walker SN, 1995, THE HEALTH PROMOTING; WESSELY S, 1989, J ROY COLL GEN PRACT, V39, P26; Xu Jun, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P33; Yan YX, 2009, J EPIDEMIOL, V19, P333, DOI 10.2188/jea.JE20080086	52	52	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117940	10.1371/journal.pone.0117940	http://dx.doi.org/10.1371/journal.pone.0117940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671578	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300074
J	Wang, ZM; Yang, WL; Jacob, A; Aziz, M; Wang, P				Wang, Zhimin; Yang, Weng Lang; Jacob, Asha; Aziz, Monowar; Wang, Ping			Human Ghrelin Mitigates Intestinal Injury and Mortality after Whole Body Irradiation in Rats	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SECRETAGOGUE RECEPTOR; MESENTERIC ISCHEMIA; ACYLATED PEPTIDE; HORMONE; SECRETION; SEPSIS; REPERFUSION; STOMACH; GH	Widespread use of ionizing radiation has led to the realization of the danger associated with radiation exposure. Although studies in radiation countermeasures were initiated a half century ago, an effective therapy for a radiomitigator has not been identified. Ghrelin is a gastrointestinal hormone, and administration of ghrelin is protective in animal models of injuries including radiation combined injury. To test whether ghrelin can be protective in whole body irradiaton (WBI) alone, male Sprague Dawley (SD) rats were treated with human ghrelin (20 nmol/rat) daily for 6 days starting at either 24 h or 48 h after 10 Gray (Gy) WBI and survival outcome was examined. The 10 Gy WBI produced a LD70/30 model in SD rats (30% survival in 30 days). The survival rate in rats treated with ghrelin starting at 24 h was significantly improved to 63% and when treatment was initiated at 48 h, the survival remained at 61%. At 7 days post WBI, plasma ghrelin was significantly reduced from the control value. Ghrelin treatment starting at 24 h after WBI daily for 6 days improved histological appearance of the intestine, reduced gut permeability, serum endotoxin levels and bacterial translocation to the liver by 38%, 42% and 61%, respectively at day 7 post WBI. Serum glucose and albumin were restored to near control levels with treatment. Ghrelin treatment also attenuated WBI-induced intestinal apoptosis by 62% as evidenced by TUNEL staining. The expression of anti-apoptotic cell regulator Bcl-xl was decreased by 38% in the vehicle and restored to 75% of the control with ghrelin treatment. Increased expression of intestinal CD73 and pAkt were observed with ghrelin treatment, indicating protection of the intestinal epithelium after WBI. These results indicate that human ghrelin attenuates intestinal injury and mortality after WBI. Thus, human ghrelin can be developed as a novel mitigator for radiation injury.	[Yang, Weng Lang; Jacob, Asha; Aziz, Monowar; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA; [Wang, Zhimin; Yang, Weng Lang; Jacob, Asha] TheraSource LLC, Manhasset, NY USA	Northwell Health	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R43A10696777, R33A1080536]; TheraSource LLC	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TheraSource LLC	This work was supported by the National Institutes of Health (NIH) grants R43A10696777 (W.L.Y.) and R33A1080536 (P. W.). PW is a co-founder of TheraSource LLC, and other authors (Z.W., W.L.Y., A.J.) are employed by TheraSource LLC and received salary from TheraSource LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046540; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Cowley MA, 2004, ENDOCRINOLOGY, V145, P2604, DOI 10.1210/en.2004-0346; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Hauer-Jensen Martin, 2007, Curr Opin Support Palliat Care, V1, P23, DOI 10.1097/SPC.0b013e3281108014; Higuchi S, 2008, INT J CLIN EXP PATHO, V1, P409; Khayyal MT, 2014, PHYTOMEDICINE, V21, P1390, DOI 10.1016/j.phymed.2014.04.030; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Liaudet L, 2000, SHOCK, V14, P134, DOI 10.1097/00024382-200014020-00010; MacVittie TJ, 1996, BLOOD, V87, P4129, DOI 10.1182/blood.V87.10.4129.bloodjournal87104129; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Nass R, 2000, J NEUROENDOCRINOL, V12, P1194, DOI 10.1046/j.1365-2826.2000.00586.x; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; PATCHEN ML, 1992, INT J RADIAT ONCOL, V22, P773, DOI 10.1016/0360-3016(92)90522-J; Patchen ML, 1995, EJC SUPPL, V31A, pS17; Petrovic-Djergovic D, 2012, J IMMUNOL, V188, P2387, DOI 10.4049/jimmunol.1003671; Saito T, 2006, SHOCK, V26, P620, DOI 10.1097/01.shk.0000230297.93762.a8; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Singh VK, 2012, INT J RADIAT BIOL, V88, P296, DOI 10.3109/09553002.2012.652726; SUREDA A, 1993, EXP HEMATOL, V21, P1605; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wattanasirichaigoon S, 1999, SHOCK, V12, P127, DOI 10.1097/00024382-199908000-00006; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	35	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118213	10.1371/journal.pone.0118213	http://dx.doi.org/10.1371/journal.pone.0118213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671547	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300088
J	Cabezas, A; Ribeiro, JM; Rodrigues, JR; Lopez-Villamizar, I; Fernandez, A; Canales, J; Pinto, RM; Costas, MJ; Cameselle, JC				Cabezas, Alicia; Meireles Ribeiro, Joao; Rodrigues, Joaquim Rui; Lopez-Villamizar, Iralis; Fernandez, Ascension; Canales, Jose; Maria Pinto, Rosa; Jesus Costas, Maria; Carlos Cameselle, Jose			Molecular Bases of Catalysis and ADP-Ribose Preference of Human Mn2+-Dependent ADP-Ribose/CDP-Alcohol Diphosphatase and Conversion by Mutagenesis to a Preferential Cyclic ADP-Ribose Phosphohydrolase	PLOS ONE			English	Article							LINEAR CONSTRAINT SOLVER; STRUCTURAL BASIS; NUCLEOTIDE PHOSPHODIESTERASE; CYCLASE ACTIVITY; HUMAN PLACENTA; IMMUNE-SYSTEM; ANTIGEN CD38; PROTEIN; HYDROLYSIS; PYROPHOSPHATASE	Among metallo-dependent phosphatases, ADP-ribose/CDP-alcohol diphosphatases form a protein family (ADPRibase-Mn-like) mainly restricted, in eukaryotes, to vertebrates and plants, with preferential expression, at least in rodents, in immune cells. Rat and zebrafish ADPRibase-Mn, the only biochemically studied, are phosphohydrolases of ADP-ribose and, somewhat less efficiently, of CDP-alcohols and 2', 3'-cAMP. Furthermore, the rat but not the zebrafish enzyme displays a unique phosphohydrolytic activity on cyclic ADP-ribose. The molecular basis of such specificity is unknown. Human ADPRibase-Mn showed similar activities, including cyclic ADP-ribose phosphohydrolase, which seems thus common to mammalian ADPRibase-Mn. Substrate docking on a homology model of human ADPRibase-Mn suggested possible interactions of ADP-ribose with seven residues located, with one exception (Cys(253)), either within the metallo-dependent phosphatases signature (Gln(27), Asn(110), His(111)), or in unique structural regions of the ADPRibase-Mn family: s2s3 (Phe(37) and Arg(43)) and h7h8 (Phe(210)), around the active site entrance. Mutants were constructed, and kinetic parameters for ADP-ribose, CDP-choline, 2', 3'-cAMP and cyclic ADP-ribose were determined. Phe(37) was needed for ADP-ribose preference without catalytic effect, as indicated by the increased ADP-ribose K-m and unchanged k(cat) of F37A-ADPRibase-Mn, while the K-m values for the other substrates were little affected. Arg(43) was essential for catalysis as indicated by the drastic efficiency loss shown by R43A-ADPRibase-Mn. Unexpectedly, Cys(253) was hindering for cADPR phosphohydrolase, as indicated by the specific tenfold gain of efficiency of C253A-ADPRibase-Mn with cyclic ADP-ribose. This allowed the design of a triple mutant (F37A+L196F+C253A) for which cyclic ADP-ribose was the best substrate, with a catalytic efficiency of 3.5'10(4) M(-1)s(-1) versus 4'10(3) M(-1)s(-1) of the wild type.	[Cabezas, Alicia; Meireles Ribeiro, Joao; Lopez-Villamizar, Iralis; Fernandez, Ascension; Canales, Jose; Maria Pinto, Rosa; Jesus Costas, Maria; Carlos Cameselle, Jose] Univ Extremadura, Fac Med, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Badajoz, Spain; [Rodrigues, Joaquim Rui] Inst Politecn Leiria, Escola Super Tecnol & Gestao, Leiria, Portugal	Universidad de Extremadura; Polytechnic Institute of Leiria; Polytechnic Institute of Porto	Cameselle, JC (corresponding author), Univ Extremadura, Fac Med, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Badajoz, Spain.	camselle@unex.es	Ribeiro, João Meireles/K-6555-2014; Rodrigues, Joaquim Rui/L-4137-2014; Canales, Jose/K-8793-2014; Cameselle, Jose Carlos/K-6421-2014; Pinto, Rosa M/K-6560-2014; Cabezas, Alicia/K-6564-2014; Costas, Maria Jesus/K-7394-2014	Ribeiro, João Meireles/0000-0002-6548-1402; Rodrigues, Joaquim Rui/0000-0002-9756-1124; Canales, Jose/0000-0002-7897-9832; Cameselle, Jose Carlos/0000-0003-0005-081X; Pinto, Rosa M/0000-0003-4594-8113; Cabezas, Alicia/0000-0002-2908-9147; Costas, Maria Jesus/0000-0001-8815-1839	Ministerio de Ciencia e Innovacion del Gobierno de Espana [BFU2009-07296]; Junta de Extremadura or Gobierno de Extremadura [GRU09135, GR10133]; Fondo Europeo de Desarrollo Regional; Fondo Social Europeo	Ministerio de Ciencia e Innovacion del Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura or Gobierno de Extremadura; Fondo Europeo de Desarrollo Regional(European Commission); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The work was supported by grants from the Ministerio de Ciencia e Innovacion del Gobierno de Espana (BFU2009-07296), and from the Junta de Extremadura or Gobierno de Extremadura (GRU09135, GR10133), cofinanced by Fondo Europeo de Desarrollo Regional and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; ASH DE, 1982, J BIOL CHEM, V257, P9261; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANALES J, 1995, BBA-PROTEIN STRUCT M, V1246, P167, DOI 10.1016/0167-4838(94)00191-I; Canales J, 2008, BIOCHEM J, V413, P103, DOI 10.1042/BJ20071471; Canales J, 2009, FEBS LETT, V583, P1593, DOI 10.1016/j.febslet.2009.04.023; Carloto A, 2006, BBA-GEN SUBJECTS, V1760, P1545, DOI 10.1016/j.bbagen.2006.06.003; Clementi E, 1996, J BIOL CHEM, V271, P17739, DOI 10.1074/jbc.271.30.17739; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Egea PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034918; Fehrst A, 1998, STRUCTURE MECH PROTE; Ferrero E, 2014, FRONT BIOSCI-LANDMRK, V19, P986, DOI 10.2741/4262; Funhoff EG, 2005, FEBS J, V272, P2968, DOI 10.1111/j.1742-4658.2005.04686.x; GARCIADIAZ M, 1993, EUR J BIOCHEM, V213, P1139, DOI 10.1111/j.1432-1033.1993.tb17864.x; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GU QM, 1994, J AM CHEM SOC, V116, P7481, DOI 10.1021/ja00096a002; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 2002, BIOCHEMISTRY-US, V41, P6744, DOI 10.1021/bi020171b; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Huang XC, 2010, MOLECULES, V15, P8689, DOI 10.3390/molecules15128689; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; INAGEDA K, 1995, J BIOCHEM-TOKYO, V117, P125, DOI 10.1093/oxfordjournals.jbchem.a124698; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Khorana HG, 1961, ENZYMES, V5, P79; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kukimoto I, 1996, EUR J BIOCHEM, V239, P177, DOI 10.1111/j.1432-1033.1996.0177u.x; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Markley John L., 2009, Journal of Structural and Functional Genomics, V10, P165, DOI 10.1007/s10969-008-9057-4; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moreau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066247; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; RAZZELL WE, 1963, METHOD ENZYMOL, V6, P236, DOI 10.1016/0076-6879(63)06169-3; Ribeiro JM, 2001, BBA-GEN SUBJECTS, V1526, P86, DOI 10.1016/S0304-4165(01)00113-1; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodrigues JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042249; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sana TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060840; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shrimp JH, 2014, J AM CHEM SOC, V136, P5656, DOI 10.1021/ja411046j; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Swarbrick JM, 2014, CHEM COMMUN, V50, P2458, DOI 10.1039/c3cc49249d; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Wu HM, 2010, NEW J CHEM, V34, P956, DOI 10.1039/b9nj00595a; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071212; Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051028; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	82	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118680	10.1371/journal.pone.0118680	http://dx.doi.org/10.1371/journal.pone.0118680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692488	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500125
J	Jobsri, J; Allen, A; Rajagopal, D; Shipton, M; Kanyuka, K; Lomonossoff, GP; Ottensmeier, C; Diebold, SS; Stevenson, FK; Savelyeva, N				Jobsri, Jantipa; Allen, Alex; Rajagopal, Deepa; Shipton, Michael; Kanyuka, Kostya; Lomonossoff, George P.; Ottensmeier, Christian; Diebold, Sandra S.; Stevenson, Freda K.; Savelyeva, Natalia			Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody	PLOS ONE			English	Article							B-CELL LYMPHOMA; TOBACCO-MOSAIC-VIRUS; FOLLICULAR LYMPHOMA; CONJUGATE VACCINES; COAT PROTEIN; SELF-ANTIGEN; DNA VACCINES; IN-VIVO; VACCINATION; IMMUNITY	Induction of potent antibody is the goal of many vaccines targeted against infections or cancer. Modern vaccine designs that use virus-like particles (VLP) have shown efficacy for prophylactic vaccination against virus-associated cancer in the clinic. Here we used plant viral particles (PVP), which are structurally analogous to VLP, coupled to a weak idiotypic (Id) tumour antigen, as a conjugate vaccine to induce antibody against a murine B-cell malignancy. The Id-PVP vaccine incorporates a natural adjuvant, the viral ssRNA, which acts via TLR7. It induced potent protective anti-Id antibody responses in an in vivo mouse model, superior to the "gold standard" Id vaccine, with prevalence of the IgG2a isotype. Combination with alum further increased antibody levels and maintained the IgG2a bias. Engagement of TLR7 in vivo was followed by secretion of IFN-alpha by plasmacytoid dendritic cells and by activation of splenic CD11c(hi) conventional dendritic cells. The latter was apparent from up-regulation of co-stimulatory molecules and from secretion of a wide range of inflammatory cytokines and chemokines including the Th1-governing cytokine IL-12, in keeping with the IgG2a antibody isotype distribution. PVP conjugates are a novel cancer vaccine design, offering an attractive molecular form, similar to VLP, and providing T-cell help. In contrast to VLP, they also incorporate a safe "in-built" ssRNA adjuvant.	[Jobsri, Jantipa; Allen, Alex; Shipton, Michael; Ottensmeier, Christian; Stevenson, Freda K.; Savelyeva, Natalia] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England; [Rajagopal, Deepa] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London, England; [Kanyuka, Kostya] Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden, Herts, England; [Lomonossoff, George P.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England	University of Southampton; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Savelyeva, N (corresponding author), Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England.	N.Savelyeva@soton.ac.uk	Ottensmeier, Christian H/E-8131-2012; Kanyuka, Kostya/F-9156-2016; Ottensmeier, Christian/ABE-9056-2020	Ottensmeier, Christian H/0000-0003-3619-1657; Kanyuka, Kostya/0000-0001-6324-4123; Ottensmeier, Christian/0000-0003-3619-1657; Stevenson, Freda/0000-0002-0933-5021; Shipton, Michael/0000-0002-3031-5447	Leukaemia Research Fund U.K in Southampton; Cancer Research U.K. at King's College, London (DR SSD); strategic programme grant [BB/J004561/1]; Biotechnology and Biological Sciences Research Council; John Innes Foundation; Biotechnology and Biological Sciences Research Council through the Institute Strategic Program; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203, BBS/E/J/00000166] Funding Source: researchfish; Cancer Research UK [15951, 20613] Funding Source: researchfish; BBSRC [BBS/E/C/00005203] Funding Source: UKRI	Leukaemia Research Fund U.K in Southampton; Cancer Research U.K. at King's College, London (DR SSD); strategic programme grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council through the Institute Strategic Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by The Leukaemia Research Fund U.K. (http:// leukaemialymphomaresearch.org.uk/) in Southampton (NS MS AA) and by Cancer Research U.K. (http://www.cancerresearchuk.org/) at King's College, London (DR SSD). At the John Innes Centre (GPL), funding was received from a strategic programme grant (BB/J004561/1) made by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) and from the John Innes Foundation (http://www. johninnesfoundation.org.uk/). KK was supported by the Biotechnology and Biological Sciences Research Council through the Institute Strategic Program 20: 20 Wheat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WYZ, 2009, BLOOD, V113, P5743, DOI 10.1182/blood-2009-01-201988; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; BAULCOMBE D, 1984, PLANT PATHOL, V33, P361, DOI 10.1111/j.1365-3059.1984.tb01331.x; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Benvenuti F, 2001, GENE THER, V8, P1555, DOI 10.1038/sj.gt.3301546; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cruz SS, 1996, P NATL ACAD SCI USA, V93, P6286, DOI 10.1073/pnas.93.13.6286; Dalsgaard K, 1997, NAT BIOTECHNOL, V15, P248, DOI 10.1038/nbt0397-248; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; GEORGE AJT, 1988, J IMMUNOL, V141, P2168; GEORGE AJT, 1987, J IMMUNOL, V138, P628; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; KAMINSKI MS, 1987, J IMMUNOL, V138, P1289; KAMINSKI MS, 1986, J IMMUNOL, V136, P1123; Kemnade JO, 2014, VACCINE, V32, P4228, DOI 10.1016/j.vaccine.2014.04.051; King CA, 1998, NAT MED, V4, P1281, DOI 10.1038/3266; Klamp T, 2011, CANCER RES, V71, P516, DOI 10.1158/0008-5472.CAN-10-2292; Li QL, 2007, J VIROL METHODS, V140, P212, DOI 10.1016/j.jviromet.2006.10.011; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Lim SH, 2010, HAEMATOL-HEMATOL J, V95, P135, DOI 10.3324/haematol.2008.001628; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; McCarthy H, 2003, BRIT J HAEMATOL, V123, P770, DOI 10.1046/j.1365-2141.2003.04698.x; McCormick AA, 2006, BIOCONJUGATE CHEM, V17, P1330, DOI 10.1021/bc060124m; Nanni P, 2001, J EXP MED, V194, P1195, DOI 10.1084/jem.194.9.1195; Palmer KE, 2006, VACCINE, V24, P5516, DOI 10.1016/j.vaccine.2006.04.058; PORTA C, 1994, VIROLOGY, V202, P949, DOI 10.1006/viro.1994.1417; Porta C, 1998, REV MED VIROL, V8, P25, DOI 10.1002/(SICI)1099-1654(199801/03)8:1&lt;25::AID-RMV212&gt;3.0.CO;2-V; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Savelyeva N, 2005, P NATL ACAD SCI USA, V102, P10987, DOI 10.1073/pnas.0505108102; Savelyeva N, 2001, NAT BIOTECHNOL, V19, P760, DOI 10.1038/90816; Savelyeva N, 2011, BLOOD, V118, P650, DOI 10.1182/blood-2011-01-328864; SCHODEL F, 1992, J VIROL, V66, P106; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Scotti N, 2013, EXPERT REV VACCINES, V12, P211, DOI [10.1586/erv.12.147, 10.1586/ERV.12.147]; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Timmerman JM, 2009, HUM VACCINES, V5, P181, DOI 10.4161/hv.5.3.7476; Tollin P, 1988, THE PLANT VIRUSES, V4, P51; Werner S, 2006, P NATL ACAD SCI USA, V103, P17678, DOI 10.1073/pnas.0608869103	52	49	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118096	10.1371/journal.pone.0118096	http://dx.doi.org/10.1371/journal.pone.0118096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692288	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500094
J	Na, T; Liu, J; Zhang, KH; Ding, M; Yuan, BZ				Na, Tao; Liu, Jing; Zhang, Kehua; Ding, Min; Yuan, Bao-Zhu			The Notch Signaling Regulates CD105 Expression, Osteogenic Differentiation and Immunomodulation of Human Umbilical Cord Mesenchymal Stem Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; GAMMA-SECRETASE; STROMAL CELLS; INHIBITS INVASION; GENE-EXPRESSION; CANCER CELLS; PROTEIN; PATHWAY; GROWTH; ADIPOGENESIS	Mesenchymal stem cells (MSCs) are a group of multipotent cells with key properties of multi-lineage differentiation, expressing a set of relatively specific surface markers and unique immunomodulatory functions. IDO1, a catabolic enzyme of tryptophan, represents a critical molecule mediating immunomodulatory functions of MSCs. However, the signaling pathways involved in regulating these key properties still remain elusive. To investigate the involvement of Notch signaling as well as other potential signaling pathway(s) in regulating these critical properties of MSCs, we treated human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) with gamma-secreatase inhibitor I (GSI-I), which inhibits both Notch signaling and ubiquitin-proteasome activities. It was shown that the GSI-I treatment resulted in apoptosis, reduced expression of surface markers CD73, CD90 and CD105, reduced osteogenic differentiation, and reduction of the hUC-MSCs-mediated suppression of Th1 lymphocyte proliferation and the IFN-gamma-induced IDO1 expression. Through distinguishing the effects of GSI-I between Notch inhibition and proteasome inhibition, it was further observed that, whereas both Notch inhibition and proteasome inhibition were attributable to the reduced CD105 expression and osteogenic differentiation, but not to the induced apoptosis. However, Notch inhibition, but not proteasome inhibition, only contributed to the significant effect of GSI-I on Th1 proliferation probably through reducing IDO1 promoter activity. In conclusion, the Notch signaling may represent a very important cell signaling capable of regulating multiple critical properties, especially the immunomodulatory functions of MSCs.	[Na, Tao; Liu, Jing; Zhang, Kehua; Yuan, Bao-Zhu] Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing 100050, Peoples R China; [Ding, Min] NIOSH, Morgantown, WV 26505 USA	National Institute of Food & Drug Control - China; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Yuan, BZ (corresponding author), Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing 100050, Peoples R China.	ybao4356@gmail.com			Chinese National Science and Technology Fund [H1609-81172102]	Chinese National Science and Technology Fund	The study was supported by Chinese National Science and Technology Fund (H1609-81172102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Biskup E, 2013, BRIT J DERMATOL, V168, P504, DOI 10.1111/bjd.12071; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Charoenpanich A, 2011, TISSUE ENG PT A, V17, P2615, DOI 10.1089/ten.tea.2011.0107; Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; Del Papa B, 2013, EUR J IMMUNOL, V43, P182, DOI 10.1002/eji.201242643; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Koorella C, 2014, J BIOL CHEM, V289, P7747, DOI 10.1074/jbc.M113.519686; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kosmacheva SM, 2008, B EXP BIOL MED+, V145, P141, DOI 10.1007/s10517-008-0028-3; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lotfinejad P, 2014, ADV PHARM BULL, V4, P5, DOI 10.5681/apb.2014.002; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Mark P, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/698076; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Meng X, 2011, LEUKEMIA, V25, P1135, DOI 10.1038/leu.2011.50; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Osathanon T, 2013, STEM CELLS DEV, V22, P1220, DOI 10.1089/scd.2012.0430; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Rosu-Myles M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038954; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Soichot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025470; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Ugarte F, 2009, EXP HEMATOL, V37, P867, DOI 10.1016/j.exphem.2009.03.007; VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4; Wiesmann Anne, 2006, Head Face Med, V2, P8, DOI 10.1186/1746-160X-2-8; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yuan BZ, 2009, ONCOGENE, V28, P3775, DOI 10.1038/onc.2009.240; Yuan BZ, 2014, FRONT MED-PRC, V8, P190, DOI 10.1007/s11684-014-0323-5; Yuan BZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-140; Yuan BZ, 2008, TRANSL ONCOL, V1, P129, DOI 10.1593/tlo.08133; Zhang K, 2014, VACCINE, DOI [10.1016/j.vaccine.2014.12.013, DOI 10.1016/J.VACCINE.2014.12.013]; Zhu FC, 2013, STEM CELLS, V31, P1181, DOI 10.1002/stem.1353	53	18	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118168	10.1371/journal.pone.0118168	http://dx.doi.org/10.1371/journal.pone.0118168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692676	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500107
J	Wang, Q; Wang, D; Wen, XF; Yu, GR; He, NP; Wang, RF				Wang, Qing; Wang, Dan; Wen, Xuefa; Yu, Guirui; He, Nianpeng; Wang, Rongfu			Differences in SOM Decomposition and Temperature Sensitivity among Soil Aggregate Size Classes in a Temperate Grasslands	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; CARBON DECOMPOSITION; MICROBIAL BIOMASS; FRACTIONS; QUALITY; RESPIRATION; DEPENDENCE; TURNOVER; OLD; SEQUESTRATION	The principle of enzyme kinetics suggests that the temperature sensitivity (Q10) of soil organic matter (SOM) decomposition is inversely related to organic carbon (C) quality, i.e., the C quality-temperature (CQT) hypothesis. We tested this hypothesis by performing laboratory incubation experiments with bulk soil, macroaggregates (MA, 250-2000 mu m), microaggregates (MI, 53-250 mu m), and mineral fractions (MF, < 53 mu m) collected from an Inner Mongolian temperate grassland. The results showed that temperature and aggregate size significantly affected on SOM decomposition, with notable interactive effects (P < 0.0001). For 2 weeks, the decomposition rates of bulk soil and soil aggregates increased with increasing incubation temperature in the following order: MA > MF > bulk soil > MI(P < 0.05). The Q10 values were highest for MA, followed (in decreasing order) by bulk soil, MF, and MI. Similarly, the activation energies (Ea) for MA, bulk soil, MF, and MI were 48.47, 33.26, 27.01, and 23.18 KJ mol(-1), respectively. The observed significant negative correlations between Q10 and C quality index in bulk soil and soil aggregates (P < 0.05) suggested that the CQT hypothesis is applicable to soil aggregates. Cumulative C emission differed significantly among aggregate size classes (P < 0.0001), with the largest values occurring in MA (1101 mu g g(-1)), followed by MF (976 mu g g(-1)) and MI (879 mu g g(-1)). These findings suggest that feedback from SOM decomposition in response to changing temperature is closely associated withsoil aggregation and highlights the complex responses of ecosystem C budgets to future warming scenarios.	[Wang, Qing; Wang, Dan; Wang, Rongfu] Anhui Agr Univ, Resources & Environm Coll, Hefei, Peoples R China; [Wang, Qing; Wen, Xuefa; Yu, Guirui; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Anhui Agricultural University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	henp@igsnrr.ac.cn; rfwang@ahau.edu.cn	于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	Environmental Public Welfare Scientific Research Project [201209028]; Natural Science Foundation of China [31270519]; Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Environmental Public Welfare Scientific Research Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Funding for this work partly supported by the Environmental Public Welfare Scientific Research Project (201209028), the Natural Science Foundation of China (31270519), and the Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Boddy E, 2008, SOIL BIOL BIOCHEM, V40, P1557, DOI 10.1016/j.soilbio.2008.01.030; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; CHENG WX, 1993, SOIL BIOL BIOCHEM, V25, P135, DOI 10.1016/0038-0717(93)90251-6; Chiu CY, 2006, GEODERMA, V130, P265, DOI 10.1016/j.geoderma.2005.01.025; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Creamer CA, 2013, SOIL BIOL BIOCHEM, V57, P496, DOI 10.1016/j.soilbio.2012.09.007; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Gryze S, 2005, SOIL BIOL BIOCHEM, V37, P55, DOI 10.1016/j.soilbio.2004.07.024; Dou S, 1992, CHIN J SOIL SCI, V22, P52; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Farrar J, 2012, SOIL BIOL BIOCHEM, V49, P52, DOI 10.1016/j.soilbio.2012.02.018; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; He NP, 2013, ECOL EVOL, V3, P5045, DOI 10.1002/ece3.881; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kleber M, 2011, GLOBAL CHANGE BIOL, V17, P1097, DOI 10.1111/j.1365-2486.2010.02278.x; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Manna MC, 2013, FIELD CROP RES, V145, P10, DOI 10.1016/j.fcr.2013.02.004; Mikutta R, 2006, BIOGEOCHEMISTRY, V77, P25, DOI 10.1007/s10533-005-0712-6; Monreal CM, 1997, CAN J SOIL SCI, V77, P379, DOI 10.4141/S95-064; Plante AF, 2010, SOIL BIOL BIOCHEM, V42, P1991, DOI 10.1016/j.soilbio.2010.07.022; Qin SP, 2010, APPL SOIL ECOL, V45, P152, DOI 10.1016/j.apsoil.2010.03.007; Riffaldi R, 1996, BIOL FERT SOILS, V22, P293, DOI 10.1007/BF00334572; Roland B, 2003, J PLANT NUTR SOIL SC, V166, P300; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SEECH AG, 1988, SOIL SCI SOC AM J, V52, P1616, DOI 10.2136/sssaj1988.03615995005200060019x; Sequaris JM, 2010, EUR J SOIL SCI, V61, P940, DOI 10.1111/j.1365-2389.2010.01299.x; Sey BK, 2008, SOIL BIOL BIOCHEM, V40, P2468, DOI 10.1016/j.soilbio.2008.05.012; Sierra CA, 2012, BIOGEOCHEMISTRY, V108, P1, DOI 10.1007/s10533-011-9596-9; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tan WB, 2013, CHINESE SCI BULL, V58, P1936, DOI 10.1007/s11434-012-5660-7; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Wagai R, 2013, GLOBAL CHANGE BIOL, V19, P1114, DOI 10.1111/gcb.12112; Wang X, 2001, SOIL SCI SOC AM J, V65, P139, DOI 10.2136/sssaj2001.651139x; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Whitby TG, 2013, SOIL BIOL BIOCHEM, V60, P202, DOI 10.1016/j.soilbio.2013.01.014; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Yamashita T, 2006, SOIL BIOL BIOCHEM, V38, P3222, DOI 10.1016/j.soilbio.2006.04.013; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zimmermann M, 2012, BIOGEOCHEMISTRY, V107, P423, DOI 10.1007/s10533-010-9562-y	53	19	24	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117033	10.1371/journal.pone.0117033	http://dx.doi.org/10.1371/journal.pone.0117033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692291	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500034
J	Brigham, EP; McCormack, MC; Takemoto, CM; Matsui, EC				Brigham, Emily P.; McCormack, Meredith C.; Takemoto, Clifford M.; Matsui, Elizabeth C.			Iron Status is Associated with Asthma and Lung Function in US Women	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; EARLY-CHILDHOOD; DEFICIENCY; FERRITIN; DIAGNOSIS; ANEMIA; RISK; SUPPLEMENTATION; HYPERTENSION; CHILDREN	Background Asthma and iron deficiency are common conditions. Whether iron status affects the risk of asthma is unclear. Objective To determine the relationship between iron status and asthma, lung function, and pulmonary inflammation. Methods Relationships between measures of iron status (serum ferritin, serum soluble transferrin receptor (sTfR), and sTfR/log10ferritin (sTfR-F Index)) and asthma, lung function, and pulmonary inflammation were examined in women 20-49 years in the National Health and Nutrition Examination Survey. Logistic, linear, and quadratic regression models accounting for the survey design of NHANES were used to evaluate associations between iron status and asthma-related outcomes and were adjusted for race/ethnicity, age, smoking status, income, and BMI. Results Approximately 16% reported a lifetime history of asthma, 9% reported current asthma, and 5% reported a recent asthma episode/attack (n = 2906). Increased ferritin (iron stores) was associated with decreased odds of lifetime asthma, current asthma, and asthma attacks/episodes in the range of ferritin linearly correlated with iron stores (20-300ng/ml). The highest quintile of ferritin (>76 ng/ml) was also associated with a decreased odds of asthma. Ferritin levels were not associated with FEV1. Increased values of the sTfR-F Index and sTfR, indicating lower body iron and higher tissue iron need, respectively, were associated with decreased FEV1, but neither was associated with asthma. None of the iron indices were associated with FeNO. Conclusion In US women, higher iron stores were inversely associated with asthma and lower body iron and higher tissue iron need were associated with lower lung function. Together, these findings suggest that iron status may play a role in asthma and lung function in US women.	[Brigham, Emily P.; McCormack, Meredith C.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [McCormack, Meredith C.; Matsui, Elizabeth C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Takemoto, Clifford M.] Johns Hopkins Univ, Sch Med, Div Pediat Hematol, Baltimore, MD USA; [Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Matsui, EC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	ematsui@jhmi.edu	Takemoto, Clifford M/Y-7558-2018	McCormack, Meredith/0000-0003-1702-3201; Brigham, Emily/0000-0002-8449-5420; Matsui, Elizabeth/0000-0001-8134-5593; Koehl, Rachelle/0000-0002-7797-7456; Pham, Hewlett/0000-0003-0330-6104; Ayers, Andrew/0000-0001-5305-7156	National Institute of Environmental Health Sciences [P50ES015903, P01ES018176, K23ES016819]; Environmental Protection Agency [R832139]; National Institute of Allergy and Infectious Diseases [R01AI070630, U01AI083238]; National Heart, Blood, and Lung Institute [R21HL117772, F32 HL120396-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL120396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070630, U01AI083238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES016819, P01ES018176, P50ES015903] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (P50ES015903, P01ES018176, K23ES016819), the Environmental Protection Agency (R832139), the National Institute of Allergy and Infectious Diseases (R01AI070630 and U01AI083238), and the National Heart, Blood, and Lung Institute (R21HL117772 and F32 HL120396-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; Balanos GM, 2002, J APPL PHYSIOL, V92, P2501, DOI 10.1152/japplphysiol.00965.2001; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Brotanek JM, 2007, PEDIATRICS, V120, P568, DOI 10.1542/peds.2007-0572; Bucca C, 2012, INT J CLIN PRACT, V66, P1095, DOI 10.1111/ijcp.12001; Castel R, 2012, CLIN CHEM LAB MED, V50, P1343, DOI 10.1515/cclm-2011-0594; Cavill I, 1999, AM J KIDNEY DIS, V34, pS12, DOI 10.1053/ajkd.1999.v34.aajkd0344b0012; CDC National Center for Environmental Health: Division of Environmental Hazards and Health Effects, 2013, ASTHM IMP NAT DAT CD; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W; Centers for Disease Control and Prevention, 2011, IR IR DEF; CHARLTON RW, 1977, CLIN SCI MOL MED, V53, P537, DOI 10.1042/cs0530537; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; COOK JD, 1982, SEMIN HEMATOL, V19, P6; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Hale LP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045802PMID:23071848, DOI 10.1371/JOURNAL.PONE.0045802]; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Howard LSGE, 2013, PULM CIRC, V3, P100, DOI 10.4103/2045-8932.109923; JACOBS A, 1972, BRIT MED J, V4, P206, DOI 10.1136/bmj.4.5834.206; Jian J, 2013, BMC CANCER, V13, DOI [10.1186/1471-2407-13-619, DOI 10.1186/1471-2407-13-619]; Kantor J, 2003, J INVEST DERMATOL, V121, P985, DOI 10.1046/j.1523-1747.2003.12540.x; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Kon N, 2010, BRAIN DEV-JPN, V32, P849, DOI 10.1016/j.braindev.2009.12.003; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Leschziner G, 2012, BRIT MED J, DOI [10.1136/bmj.e6430, DOI 10.1136/BMJ.E6430]; Maazi H, 2011, CLIN EXP IMMUNOL, V166, P80, DOI 10.1111/j.1365-2249.2011.04448.x; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Ramakrishnan K, 2010, LUNG INDIA, V27, P51, DOI 10.4103/0970-2113.63605; Rhodes CJ, 2011, EUR RESPIR J, V38, P1453, DOI 10.1183/09031936.00037711; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shaheen SO, 2004, EUR RESPIR J, V24, P292, DOI 10.1183/09031936.04.00117803; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; SKIKNE BS, 1990, BLOOD, V75, P1870; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Tamura T, 2002, J PEDIATR-US, V140, P165, DOI 10.1067/mpd.2002.120688; Trost LB, 2006, J AM ACAD DERMATOL, V54, P824, DOI 10.1016/j.jaad.2005.11.1104; van Empel VPM, 2014, HEART LUNG CIRC, V23, P287, DOI 10.1016/j.hlc.2013.08.007; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; WHO, 2011, SER FERR CONC ASS IR; WHO, 2001, IRON DEFICIENCY ANAE	43	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117545	10.1371/journal.pone.0117545	http://dx.doi.org/10.1371/journal.pone.0117545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689633	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700052
J	Brito-Santos, F; Barbosa, GG; Trilles, L; Nishikawa, MM; Wanke, B; Meyer, W; Carvalho-Costa, FA; Lazera, MD				Brito-Santos, Fabio; Barbosa, Glaucia Goncalves; Trilles, Luciana; Nishikawa, Marilia Martins; Wanke, Bodo; Meyer, Wieland; Carvalho-Costa, Filipe Anibal; Lazera, Marcia dos Santos			Environmental Isolation of Cryptococcus gattii VGII from Indoor Dust from Typical Wooden Houses in the Deep Amazonas of the Rio Negro Basin	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; AIDS-ASSOCIATED CRYPTOCOCCOSIS; VANCOUVER-ISLAND; FUNGAL PATHOGENS; NATURAL HABITAT; DECAYING WOOD; BUJUMBURA; OUTBREAK; TREE	Cryptococcosis is a human fungal infection of significant mortality and morbidity, especially in the meningoencephalitis form. Cryptococcosis is distributed worldwide and its agents, C. neoformans and C. gattii, present eight major molecular types-VNI-VNIV and VGI-VGIV respectively. The primary cryptococcosis caused by molecular type VGII (serotype B, MAT alpha) prevails in immunocompetent patients in the North and Northeast of Brazil, revealing an endemic regional pattern to this molecular type. Since 1999, C. gattii VGII has been involved in an ongoing outbreak in Canada, and is expanding to the Northwest of the United States, two temperate regions. Exposure to propagules dispersed in the environment, related to various organic substrates, mainly decomposing wood in and around dwellings, initiates the infection process. The present study investigated the presence of the agents of cryptococcosis in dust from dwellings in the upper Rio Negro, municipality of Santa Isabel do Rio Negro in Amazonas state. Indoor dust was collected from 51 houses, diluted and plated on bird seed agar. Dark brown colonies were identified phenotypically, and genotypically by URA5 restriction fragment length polymorphism analysis and multilocus sequence typing (MLST). The mating type was identified using pheromone-specific primers. Three of the 51 houses were positive for C. gattii molecular type VGII, MAT alpha and MATa, showing a high prevalence of this agent. MLST studies identified eight subtypes, VGIIb (ST7), VGIIa (ST20), (ST5) and 5 new subtypes unique to the region. For the first time in the state of Amazonas, C. gattii VGII MAT alpha and MATa were isolated from the environment and correlates with endemic cryptococcosis in this state. This is the first description of MLST subtypes on environmental isolates in the Brazilian Amazon, indicating domiciliary dust as a potential source for human infection with different subtypes of C. gattii VGII MAT alpha and MATa.	[Brito-Santos, Fabio; Barbosa, Glaucia Goncalves; Trilles, Luciana; Wanke, Bodo; Meyer, Wieland; Lazera, Marcia dos Santos] Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil; [Meyer, Wieland] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Sydney Med Sch,Westmead Hosp,We, Sydney, NSW 2006, Australia; [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Epidemiol & Systemat, BR-21045900 Rio De Janeiro, Brazil; [Nishikawa, Marilia Martins] INCQS FIOCRUZ, Natl Inst Qual Control Hlth, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; University of Sydney; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lazera, MD (corresponding author), Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil.	marcia.lazera@ipec.fiocruz.br	Meyer, Wieland/G-1204-2015	Meyer, Wieland/0000-0001-9933-8340	"Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil [098/2012]	"Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil	The work was supported by the "Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil, grant # 098/2012 to BW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Byrnes Edmond J, 2009, F1000 Biol Rep, V1, DOI 10.3410/B1-62; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; Correa MP, 1999, BRAZIL REV SOC BRAS, V32, P505, DOI DOI 10.1590/S0037-86821999000500006.(IN; Costa SDSE, 2009, MEM I OSWALDO CRUZ, V104, P662, DOI 10.1590/S0074-02762009000400023; dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gomes FS, 2010, REV PAN AMAZ SAUDE, V4, P43, DOI [10.1016/j.rbr.2014.04.003, DOI 10.1016/J.RBR.2014.04.003]; Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09; Kwon-Chung KJ, 1992, MED MYCOL, P397; Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957; Lazera MS, 1998, MED MYCOL, V36, P119, DOI 10.1080/02681219880000191; Lazera MS, 1996, J MED VET MYCOL, V34, P127; Freire AKL, 2012, MYCOSES, V55, pe145, DOI 10.1111/j.1439-0507.2012.02173.x; Lockhart SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074737; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mitchell TG, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P237; Passoni LFC, 1998, MED MYCOL, V36, P305, DOI 10.1080/02681219880000481; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; Martins LMS, 2011, MEM I OSWALDO CRUZ, V106, P725, DOI 10.1590/S0074-02762011000600012; STAIB F, 1966, ANN I PASTEUR PARIS, V110, P792; SWINNE D, 1991, J MED VET MYCOL, V29, P25; SWINNE D, 1989, AIDS, V3, P389, DOI 10.1097/00002030-198906000-00009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008	34	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115866	10.1371/journal.pone.0115866	http://dx.doi.org/10.1371/journal.pone.0115866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688971	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700007
J	Guess, MG; Barthel, KKB; Harrison, BC; Leinwand, LA				Guess, Martin G.; Barthel, Kristen K. B.; Harrison, Brooke C.; Leinwand, Leslie A.			miR-30 Family microRNAs Regulate Myogenic Differentiation and Provide Negative Feedback on the microRNA Pathway	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; DUCHENNE; EXPRESSION; MIR-206; PROTEIN; TARGET; PROLIFERATION; REGENERATION; BODIES	microRNAs (miRNAs) are short non-coding RNAs that can mediate changes in gene expression and are required for the formation of skeletal muscle (myogenesis). With the goal of identifying novel miRNA biomarkers of muscle disease, we profiled miRNA expression using miRNA-seq in the gastrocnemius muscles of dystrophic mdx4cv mice. After identifying a down-regulation of the miR-30 family (miR-30a-5p, -30b, -30c, -30d and -30e) when compared to C57Bl/6 (WT) mice, we found that overexpression of miR-30 family miRNAs promotes differentiation, while inhibition restricts differentiation of myoblasts in vitro. Additionally, miR-30 family miRNAs are coordinately down-regulated during in vivo models of muscle injury (barium chloride injection) and muscle disuse atrophy (hindlimb suspension). Using bioinformatics tools and in vitro studies, we identified and validated Smarcd2, Snai2 and Tnrc6a as miR-30 family targets. Interestingly, we show that by targeting Tnrc6a, miR-30 family miRNAs negatively regulate the miRNA pathway and modulate both the activity of muscle-specific miR-206 and the levels of protein synthesis. These findings indicate that the miR-30 family may be an interesting biomarker of perturbed muscle homeostasis and muscle disease.	[Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu		BJORKMAN, KRISTEN/0000-0002-9540-6657	National Institutes of Health [5R01GM029090-30]; Research Scientist Development Award [K01AR055676]; American Heart Association Postdoctoral Fellowship [13POST14410014];  [2T32HL007822-11A2];  [5T32GM007135-35]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Scientist Development Award; American Heart Association Postdoctoral Fellowship(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Project Grant (5R01GM029090-30 to LAL), Postdoctoral Training Grant (2T32HL007822-11A2 to KKBB), Predoctoral Training Grant (5T32GM007135-35 to MGG), Research Scientist Development Award (K01AR055676 to BCH), and American Heart Association Postdoctoral Fellowship (13POST14410014 to KKBB). The funding agencies had no role in the study's conception, design, data collection, interpretation, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Alteri A, 2013, CELL CYCLE, V12, P3781, DOI 10.4161/cc.26674; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guess MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-19; Guglieri M, 2010, CURR OPIN PHARMACOL, V10, P331, DOI 10.1016/j.coph.2010.03.005; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Ketley A, 2013, PLOS ONE, DOI [10.1371/journal.pone.0065170.s005, DOI 10.1371/J0URNAL.P0NE.0065170.S005]; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; NICHOLSON LVB, 1990, ACTA NEUROPATHOL, V80, P239, DOI 10.1007/BF00294640; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Philipot O, 2010, PLOS ONE, V5, pe9425, DOI [10.1371/journal.pone.0009425, DOI 10.1371/J0URNAL.P0NE.0009425]; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121	53	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118229	10.1371/journal.pone.0118229	http://dx.doi.org/10.1371/journal.pone.0118229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689854	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700107
J	Jeong, JJ; Kim, KA; Jang, SE; Woo, JY; Han, MJ; Kim, DH				Jeong, Jin-Ju; Kim, Kyung-Ah; Jang, Se-Eun; Woo, Jae-Yeon; Han, Myung Joo; Kim, Dong-Hyun			Orally Administrated Lactobacillus pentosus var. plantarum C29 Ameliorates Age-Dependent Colitis by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway via the Regulation of Lipopolysaccharide Production by Gut Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; OXIDATIVE STRESS; FECAL MICROBIOTA; MICE; PROBIOTICS; PROFILES; PROTEIN; MAPK	To evaluate the anti-inflammaging effect of lactic acid bacteria (LAB) on age-dependent inflammation, we first screened and selected a tumor necrosis factor (TNF)-alpha and reactive oxygen species (ROS)-inhibitory LAB, Lactobacillus pentosus var. plantarum C29, among the LABs isolated from fermented vegetables using LPS-stimulated mouse peritoneal macrophages. Oral administration of C29 (2 x 10(9) CFU/rat) for 8 weeks in aged Fischer 344 rats (age, 16 months) inhibited the expression of the inflammatory markers myeloperoxidase, inducible nitric oxide (NO) synthase, cyclooxygenase-2, pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha and IL-6 and the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), activator protein 1 (AP1), and mitogen-activated protein kinases (MAPKs). Treatment with C29 induced the expression of tight junction proteins ZO-1, occludin, and claudin-1, and reduced intestinal microbial LPS and plasmatic LPS levels and ROS, as well as the Firmicutes to Bacteroidetes ratio, which is significantly higher in aged rats than in young rats. C29 treatment also reduced plasmatic reactive oxygen species, malondialdehyde, C-reactive protein, and TNF-alpha, and suppressed expression of senescence markers p16 and p53 in the colon of the aged rats, but increased SIRT 1 expression. Based on these findings, we concluded that C29 treatment may suppress aging-dependent colitis by inhibiting NF-kappa B, AP1, and MAPK activation via the inhibition of gut microbiota LPS production and the induction of tight junction protein expression.	[Jeong, Jin-Ju; Kim, Kyung-Ah; Jang, Se-Eun; Woo, Jae-Yeon; Kim, Dong-Hyun] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Jang, Se-Eun; Han, Myung Joo] Kyung Hee Univ, Dept Food & Nutr, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Kim, DH (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, 1 Hoegi, Seoul 130701, South Korea.	dhkim@khu.ac.kr		Jang, Se-Eun/0000-0003-3279-0871	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIP) [2013M3A9B6076413]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIP)(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was supported by grants from the Bio & Medical Technology Development Program (2013M3A9B6076413) of the National Research Foundation (NRF) funded by the Korean government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Fernandez Patricia, 2011, Curr Aging Sci, V4, P78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Campieri M, 1999, GASTROENTEROLOGY, V116, P1246, DOI 10.1016/S0016-5085(99)70029-6; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Collins MD, 1999, AM J CLIN NUTR, V69, p1052S, DOI 10.1093/ajcn/69.5.1052s; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Ghosh S, 2014, J GERONTOL A; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Jang SE, 2013, J APPL MICROBIOL, V115, P888, DOI 10.1111/jam.12273; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Jung IH, 2012, J APPL MICROBIOL, V113, P1498, DOI 10.1111/j.1365-2672.2012.05437.x; Kennedy BJ, 2000, ONCOLOGY-NY, V14, P1731; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; McGeer EG, 1999, CURR PHARM DESIGN, V5, P821; MITSUOKA T, 1990, J IND MICROBIOL, V6, P263, DOI 10.1007/BF01575871; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Park EJ, 2010, J PEDIATR GASTR NUTR, V50, P321, DOI 10.1097/MPG.0b013e3181ae2ba0; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Rafii F, 1999, DIGEST DIS SCI, V44, P637, DOI 10.1023/A:1026634229934; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Trivedi PP, 2013, DIGEST DIS SCI, V58, P3460, DOI 10.1007/s10620-013-2831-6; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263; Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x	39	54	57	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116533	10.1371/journal.pone.0116533	http://dx.doi.org/10.1371/journal.pone.0116533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689583	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700013
J	Jia, YQ; Zeng, Z; Li, YY; Li, ZW; Jin, L; Zhang, Z; Wang, LF; Wang, FS				Jia, Yiqiong; Zeng, Zhen; Li, Yuanyuan; Li, Zhiwei; Jin, Lei; Zhang, Zheng; Wang, Lifeng; Wang, Fu-Sheng			Impaired Function of CD4+T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELLS; IMMUNE LANDSCAPE; POOR SURVIVAL; B-CELLS; CANCER; DISEASE; AUTOIMMUNITY; INFECTION; FREQUENCY	Background and Aims CD4+ T follicular helper (Tfh) cells, a new subset of immune cells, have been demonstrated to be involved in the development and prognosis of tumors. However, their functional role in human hepatocellular carcinoma (HCC) is relatively unknown, and the detailed mechanisms in HCC development remain to be described. Methods A total of 85 HCC patients with hepatitis B virus (HBV) infection, 25 HBV-relative liver cirrhosis (LC) patients, and 20 healthy controls (HC) were randomly enrolled. Flow cytometric analysis, immunohistochemical staining, and relative function (i.e., cytokine secretion, B cell maturation) assays were used to analyze the properties of CXCR5+CD4+T cells. In addition, the relationship between the frequency of CXCR5+CD4+T cells and overall survival rates or disease-free survival rates was also analyzed by the Kaplan-Meier method. Results The frequency of circulating CXCR5+CD4+T cells was significantly decreased in HCC patients compared with HBV-relative liver cirrhosis (LC) patients and healthy controls, and the decrease in circulating CXCR5+CD4+T cells correlated with disease progression. The proportion of infiltrated CXCR5+CD4+T cells was significantly decreased in tumor regions compared with nontumor regions. Furthermore, compared with healthy controls, the function of circulating CXCR5+CD4+T cells in HCC was impaired, with reduced IL-21 secretion and dysfunction in promoting B cell maturation. Importantly, follow-up data indicated that a decreased frequency of circulating CXCR5+CD4+T cells was also associated with reduced disease-free survival time in HCC patients. Conclusions Impairment of CD4+T follicular helper cells may influence the development of HBV-associated HCC. Decreased CD4+T follicular helper cells may represent a potential prognostic marker and serve as a novel therapeutic target for HCC patients.	[Jia, Yiqiong; Wang, Fu-Sheng] Peking Univ, Mil Hosp China 302, Teaching Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China; [Zeng, Zhen; Li, Yuanyuan; Li, Zhiwei; Jin, Lei; Zhang, Zheng; Wang, Lifeng; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Peking University; Fifth Medical Center of Chinese PLA General Hospital	Wang, FS (corresponding author), Peking Univ, Mil Hosp China 302, Teaching Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China.	biowanglf@163.com; fswang302@163.com	li, yuanyuan/GZA-4435-2022	Wang, Lifeng/0000-0001-5095-6842	National Natural Science Foundation of China [81101589]; National Grand Program on Key Infectious Disease [2012ZX10001006-003-003]; Beijing Municipal & Technology Commission [Z131100004013041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease; Beijing Municipal & Technology Commission	This work was supported by the National Natural Science Foundation of China (81101589), National Grand Program on Key Infectious Disease (2012ZX10001006-003-003) and Beijing Municipal & Technology Commission (Z131100004013041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne MJ, 2013, BRIT J HAEMATOL, V162, P360, DOI 10.1111/bjh.12401; Ahearne MJ, 2014, BRIT J HAEMATOL, DOI [10.1111/bjh.13234, DOI 10.1111/BJH.13234]; Alisa A, 2005, CLIN CANCER RES, V11, P6686, DOI 10.1158/1078-0432.CCR-05-0382; Aravalli RN, 2013, WORLD J GASTROENTERO, V19, P7500, DOI 10.3748/wjg.v19.i43.7500; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bao Y, 2014, J AUTOIMMUN, DOI [10.1016/j.jaut.2014.11.009, DOI 10.1016/J.JAUT.2014.11.009]; Behboudi S, 2010, WORLD J HEPATOL, V2, P256, DOI 10.4254/wjh.v2.i7.256; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cha ZS, 2013, TUMOR BIOL, V34, P3579, DOI 10.1007/s13277-013-0937-2; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Deneys V, 2001, J IMMUNOL METHODS, V253, P23, DOI 10.1016/S0022-1759(01)00338-6; Ding ZC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890178; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Grimm CF, 2000, GASTROENTEROLOGY, V119, P1104, DOI 10.1053/gast.2000.18157; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hu TT, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-54; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Liu SM, 2013, J IMMUNOL, V191, P3501, DOI 10.4049/jimmunol.1301454; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mossanen JC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26468; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pallikkuth S, 2012, CRIT REV IMMUNOL, V32, P173; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Shi WW, 2014, DNA CELL BIOL, V33, P355, DOI 10.1089/dna.2013.2332; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tellier J, 2013, CELL MOL LIFE SCI, V70, P4771, DOI 10.1007/s00018-013-1420-3; Um SH, 2004, J IMMUNOL, V173, P1772, DOI 10.4049/jimmunol.173.3.1772; Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang XD, 2012, J INT MED RES, V40, P307, DOI 10.1177/147323001204000131; Wu S, 2014, MOD RHEUMATOL; Xiao F, 2013, J RHEUMATOL, V40, P2029, DOI 10.3899/jrheum.130125; Xing TJ, 2013, EXP THER MED, V5, P885, DOI 10.3892/etm.2012.864; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zhao Y, 2014, RHEUMATOLOGY, V53, P621, DOI 10.1093/rheumatology/ket406	50	62	69	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117458	10.1371/journal.pone.0117458	http://dx.doi.org/10.1371/journal.pone.0117458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689070	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700047
J	Kui, B; Balla, Z; Vasas, B; Vegh, ET; Pallagi, P; Kormanyos, ES; Venglovecz, V; Ivanyi, B; Takacs, T; Hegyi, P; Rakonczay, Z				Kui, Balazs; Balla, Zsolt; Vasas, Bela; Vegh, Eszter T.; Pallagi, Petra; Kormanyos, Eszter S.; Venglovecz, Viktoria; Ivanyi, Bela; Takacs, Tamas; Hegyi, Peter; Rakonczay, Zoltan, Jr.			New Insights into the Methodology of L-Arginine-Induced Acute Pancreatitis	PLOS ONE			English	Article							MICE; INJURY; NECROSIS; CELLS; MODEL	Animal models are ideal to study the pathomechanism and therapy of acute pancreatitis (AP). The use of L-arginine-induced AP model is nowadays becoming increasingly popular in mice. However, carefully looking through the literature, marked differences in disease severity could be observed. In fact, while setting up the L-arginine (2x4 g/kg i.p.)-induced AP model in BALB/c mice, we found a relatively low rate (around 15%) of pancreatic necrosis, whereas others have detected much higher rates (up to 55%). We suspected that this may be due to differences between mouse strains. We administered various concentrations (5-30%, pH = 7.4) and doses (2x4, 3x3, or 4x2.5 g/kg) of L-arginine-HCl in BALB/c, FVB/n and C57BL/6 mice. The potential gender-specific effect of L-arginine was investigated in C57BL/6 mice. The fate of mice in response to the i.p. injections of L arginine followed one of three courses. Some mice (1) developed severe AP or (2) remained AP-free by 72 h, whereas others (3) had to be euthanized (to avoid their death, which was caused by the high dose of L-arginine and not AP) within 12 h., In FVB/n and C57BL/6 mice, the pancreatic necrosis rate (about 50%) was significantly higher than that observed in BALB/c mice using 2x4 g/kg 10% L-arginine, but euthanasia was necessary in a large proportion of animals, The i.p. injection of lower L-arginine concentrations (e.g. 5-8%) in case of the 2x4 g/kg dose, or other L-arginine doses (3x3 or 4x2.5 g/kg, 10%) were better for inducing AP. We could not detect any significant differences between the AP severity of male and female mice. Taken together, when setting up the L-arginine-induced AP model, there are several important factors that are worth consideration such as the dose and concentration of the administered L arginine-HCl solution and also the strain of mice.	[Kui, Balazs; Balla, Zsolt; Vegh, Eszter T.; Pallagi, Petra; Kormanyos, Eszter S.; Takacs, Tamas; Hegyi, Peter; Rakonczay, Zoltan, Jr.] Univ Szeged, Dept Med 1, Szeged, Hungary; [Vasas, Bela; Ivanyi, Bela] Univ Szeged, Dept Pathol, Szeged, Hungary; [Venglovecz, Viktoria] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Translat Gastroenterol Res Grp, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences; Szeged University	Rakonczay, Z (corresponding author), Univ Szeged, Dept Med 1, Szeged, Hungary.	rakonczay.zoltan@med.u-szeged.hu		Rakonczay Jr., Zoltan/0000-0002-1499-3416	Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/KONV-2012-0035, TAMOP-4.2.2-A-11/1/KONV-2012-0052, TAMOP-4.2.2.A-11/1/KONV-2012-0073]; Hungarian Scientific Research Fund [NF105758, NF100677, K101116]; Hungarian Academy of Sciences [BO 00174/10/5, LP2014-10/2014]	Hungarian National Development Agency; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Funding from the Hungarian National Development Agency (TAMOP-4.2.2.A-11/1/KONV-2012-0035, TAMOP-4.2.2-A-11/1/KONV-2012-0052 TAMOP-4.2.2.A-11/1/KONV-2012-0073), the Hungarian Scientific Research Fund (NF105758, NF100677, K101116), and the Hungarian Academy of Sciences (BO 00174/10/5, LP2014-10/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Biczo G, 2011, ANTIOXID REDOX SIGN, V15, P2669, DOI 10.1089/ars.2011.4065; Bohus E, 2008, J PROTEOME RES, V7, P4435, DOI 10.1021/pr800407j; Cui HF, 2003, WORLD J GASTROENTERO, V9, P2274; Dawra R, 2012, PANCREAPEDIA EXOCRIN; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; Hegyi P, 2013, PANCREAPEDIA EXOCRIN; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; HUANG L, 2012, CHIN J INTEGR MED; Kuebler W, 1996, INT J MICROCIRC CLIN, P89; Kui B, 2014, LAB INVEST, V94, P138, DOI 10.1038/labinvest.2013.143; LOMBARDI B, 1975, AM J PATHOL, V79, P465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039972; MIZUNUMA T, 1984, J NUTR, V114, P467, DOI 10.1093/jn/114.3.467; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Rakonczay Z, 2003, FREE RADICAL BIO MED, V34, P696, DOI 10.1016/S0891-5849(02)01373-4; Sakai A, 2012, ARCH BIOCHEM BIOPHYS, V522, P107, DOI 10.1016/j.abb.2012.03.025; Sharif R, 2009, GUT, V58, P813, DOI 10.1136/gut.2008.170423; Shen JQ, 2012, CYTOKINE, V60, P294, DOI 10.1016/j.cyto.2012.05.005; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Su Kim Hue, 2006, HPB (Oxford), V8, P264, DOI 10.1080/13651820500467358; TANI S, 1990, DIGEST DIS SCI, V35, P367, DOI 10.1007/BF01537416; Toth L A, 2000, ILAR J, V41, P72; TOTH LA, 1995, J NEUROIMMUNOL, V58, P89, DOI 10.1016/0165-5728(94)00193-R; Wang J, 2010, LAB INVEST, V90, P654, DOI 10.1038/labinvest.2010.44; Yuan H, 2009, PANCREAS, V38, P143, DOI 10.1097/MPA.0b013e31818166b4	28	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117588	10.1371/journal.pone.0117588	http://dx.doi.org/10.1371/journal.pone.0117588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688985	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700059
J	Lee, IS; Lee, YS; Park, HJ; Lee, H; Chae, Y				Lee, In-Seon; Lee, Ye-Seul; Park, Hi-Joon; Lee, Hyejung; Chae, Younbyoung			Evaluation of Phantom-Based Education System for Acupuncture Manipulation	PLOS ONE			English	Article							NEEDLE MANIPULATION; CHINESE ACUPUNCTURE; HAPTIC SIMULATION; SKILLS	Background Although acupuncture manipulation has been regarded as one of the important factors in clinical outcome, it has been difficult to train novice students to become skillful experts due to a lack of adequate educational program and tools. Objectives In the present study, we investigated whether newly developed phantom acupoint tools would be useful to practice-naive acupuncture students for practicing the three different types of acupuncture manipulation to enhance their skills. Methods We recruited 12 novice students and had them practice acupuncture manipulations on the phantom acupoint (5% agarose gel). We used the Acusensor 2 and compared their acupuncture manipulation techniques, for which the target criteria were depth and time factors, at acupoint LI11 in the human body before and after 10 training sessions. The outcomes were depth of needle insertion, depth error from target criterion, time of rotating, lifting, and thrusting, time error from target criteria and the time ratio. Results After 10 training sessions, the students showed significantly improved outcomes in depth of needle, depth error (rotation, reducing lifting/thrusting), thumb-forward time error, thumbbackward time error (rotation), and lifting time (reinforcing lifting/thrusting). Conclusions The phantom acupoint tool could be useful in a phantom-based education program for acupuncture-manipulation training for students. For advanced education programs for acupuncture manipulation, we will need to collect additional information, such as patient responses, acupoint-specific anatomical characteristics, delicate tissue-like modeling, haptic and visual feedback, and data from an acupuncture practice simulator.	[Lee, In-Seon; Lee, Ye-Seul; Park, Hi-Joon; Lee, Hyejung; Chae, Younbyoung] Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Coll Korean Med, Seoul, South Korea	Kyung Hee University	Chae, Y (corresponding author), Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Coll Korean Med, Seoul, South Korea.	ybchae@khu.ac.kr	Park, Hi-Joon/AAG-1196-2021; Chae, Younbyoung/AAM-1243-2020; Lee, In-Seon/AAM-1252-2020	Lee, In-Seon/0000-0001-9275-3111; Lee, Ye-Seul/0000-0001-6127-5401	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0009913, 2013R1A6A6029251]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP)(No. 2011-0009913 & 2013R1A6A6029251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baak JPA, 2002, J PATHOL, V198, P277, DOI 10.1002/path.1233; Gerovich Oleg, 2004, Comput Aided Surg, V9, P243, DOI 10.3109/10929080500190441; Heng PA, 2006, IEEE T INF TECHNOL B, V10, P28, DOI 10.1109/TITB.2005.855567; Hu Yin'e, 2010, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V27, P991; Kim GH, 2010, NEUROL RES, V32, pS92, DOI 10.1179/016164109X12537002794327; Lee IS, 2014, J ALTERN COMPLEM MED, V20, P654, DOI 10.1089/acm.2013.0475; Leung KM, 2003, ST HEAL T, V94, P187; Li J, 2013, ACUPUNCT MED, V31, P172, DOI 10.1136/acupmed-2012-010265; Liu Tang-yi, 2008, Zhongguo Zhen Jiu, V28, P356; Luciano C, 2009, VIRTUAL REAL-LONDON, V13, P69, DOI 10.1007/s10055-009-0112-7; Riener R, 2004, IEEE T INF TECHNOL B, V8, P208, DOI 10.1109/TITB.2004.828885; Seo Y, 2014, ACUPUNCT MED, V32, P394, DOI 10.1136/acupmed-2014-010585; Shi GX, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-42; Sturm LP, 2008, ANN SURG, V248, P166, DOI 10.1097/SLA.0b013e318176bf24; Wang Hai-sheng, 2009, Zhongguo Zhen Jiu, V29, P745; White A, 2008, ACUPUNCT MED, V26, P111, DOI 10.1136/aim.26.2.111	16	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117992	10.1371/journal.pone.0117992	http://dx.doi.org/10.1371/journal.pone.0117992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689598	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700091
J	Slepkov, AD; Ironside, KB; DiBattista, D				Slepkov, Aaron D.; Ironside, Kevin B.; DiBattista, David			Benford's Law: Textbook Exercises and Multiple-Choice Testbanks	PLOS ONE			English	Article							SIGNIFICANT FIGURES; NUMBERS; DIGITS; FACTS	Benford's Law describes the finding that the distribution of leading (or leftmost) digits of innumerable datasets follows a well-defined logarithmic trend, rather than an intuitive uniformity. In practice this means that the most common leading digit is 1, with an expected frequency of 30.1%, and the least common is 9, with an expected frequency of 4.6%. Currently, the most common application of Benford's Law is in detecting number invention and tampering such as found in accounting-, tax-, and voter-fraud. We demonstrate that answers to end-of-chapter exercises in physics and chemistry textbooks conform to Benford's Law. Subsequently, we investigate whether this fact can be used to gain advantage over random guessing in multiple-choice tests, and find that while testbank answers in introductory physics closely conform to Benford's Law, the testbank is nonetheless secure against such a Benford's attack for banal reasons.	[Slepkov, Aaron D.; Ironside, Kevin B.] Trent Univ, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada; [DiBattista, David] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada	Trent University; Brock University	Slepkov, AD (corresponding author), Trent Univ, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada.	aaronslepkov@trentu.ca	Slepkov, Aaron/C-6483-2008	Slepkov, Aaron/0000-0001-5699-1403	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded in part by an NSERC Discovery Grant (ADS). The funders no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A. K., 1968, SANKHYA B, V30, P47; Alexander J., 2009, WORKING PAPER; ASHCRAFT MH, 1995, J RES MATH EDUC, V26, P396, DOI 10.2307/749430; Attali Y, 2003, J EDUC MEAS, V40, P109, DOI 10.1111/j.1745-3984.2003.tb01099.x; BARLOW JL, 1985, COMPUTING, V34, P325, DOI 10.1007/BF02251833; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Berger A, 2011, PROBAB SURV, V8, P1, DOI 10.1214/11-PS175; Buck B, 1993, EUR J PHYS, V14, P59, DOI DOI 10.1088/0143-0807/14/2/003; Busta B, 1992, W9310694 ST CLOUD ST; Diekmann A, 2010, GER ECON REV, V11, P397, DOI 10.1111/j.1468-0475.2010.00510.x; Durtschi C., 2004, J FORENSIC ACCOUNT, V5, P17; Formann AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010541; Giles DE, 2007, APPL ECON LETT, V14, P157, DOI 10.1080/13504850500425667; Goudsmit SA, 1944, NATURE, V154, P800, DOI 10.1038/154800a0; Hamann MS, 1986, COGNITION INSTRUCT, V3, P173, DOI [10.1207/s1532690xci0303_2., DOI 10.1207/S1532690XCI0303_2, 10.1207/s1532690xci0303_2]; Hickman MJ, 2010, J QUANT CRIMINOL, V26, P333, DOI 10.1007/s10940-010-9094-6; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; Hoppe FM, 2013, ARXIV13117606; Kossovsky A.E., 2014, BENFORDS LAW THEORY; LEMONS DS, 1986, AM J PHYS, V54, P816, DOI 10.1119/1.14453; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; Nigrini M.J., 2012, BENFORDS LAW APPL FO; Nigrini MJ, 2007, MATH GEOL, V39, P469, DOI 10.1007/s11004-007-9109-5; PINKHAM RS, 1961, ANN MATH STAT, V32, P1223, DOI 10.1214/aoms/1177704862; RAIMI RA, 1985, P AM PHILOS SOC, V129, P211; RAIMI RA, 1969, AM MATH MON, V76, P342, DOI 10.2307/2316424; RODRIGUEZ M. C., 2005, EDUC MEAS-ISSUES PRA, V24, P3, DOI [10.1111/J.1745-3992.2005.00006.X, DOI 10.1111/J.1745-3992.2005.00006.X]; Shao LJ, 2010, PHYSICA A, V389, P3109, DOI 10.1016/j.physa.2010.04.021; Shao LJ, 2009, MOD PHYS LETT A, V24, P3275, DOI 10.1142/S0217732309031223; Stigler Stephen M., 1980, SCI SOCIAL STRUCTURE, P147, DOI [10.1111/j.2164-0947.1980.tb02775.x, DOI 10.1111/J.2164-0947.1980.TB02775.X]; Wlodarski J, 1970, FIBONACCI QUART, V9, P87	31	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117972	10.1371/journal.pone.0117972	http://dx.doi.org/10.1371/journal.pone.0117972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689468	Green Submitted, gold, Green Published			2022-12-27	WOS:000350322700090
J	Wiewiora, B; Zurek, G; Panka, D				Wiewiora, Barbara; Zurek, Grzegorz; Panka, Dariusz			Is the Vertical Transmission of Neotyphodium lolii in Perennial Ryegrass the Only Possible Way to the Spread of Endophytes?	PLOS ONE			English	Article							ACREMONIUM ENDOPHYTES; FUNGAL ENDOPHYTES; MEADOW FESCUE; TALL FESCUE; RED FESCUE; GRASSES; ASSOCIATIONS; DROUGHT; ABILITY; CONIDIA	Endophytic fungi live their whole life within host tissues usually without any visible symptoms. Their vertical transmission (seed-plant-seed) has been well described and documented. However, horizontal transmission (plant-plant) needs more clarification. The aim of this study was to assess the extent to which endophytes move vertically in ecotypes of perennial ryegrass and whether there is evidence for the horizontal transmission of endophytes. Ecotypes from grasslands in Poland were collected in the form of living plants and used for vertical transmission analysis. Plants, the seed collected from these plants and plants grown from this collected seed were tested for endophytic infection. Provided that all produced seeds were viable and able to germinate and produce seedlings, the vertical transmission of Neotyphodium endophytes in perennial ryegrass ecotypes was nearly complete. For the horizontal transmission experiment, endophyte-hosting plants (E+) and endophyte-free plants (E-) of four cultivars were planted in the field in close proximity on small plots that were frequently mown. These studies revealed that after 7 months of growth next to E+ plants, the characteristic Neotyphodium spp. mycelia were found in E- plants, which was especially true for plants growing in close proximity to the infected plants. The occurrence of horizontal transmission of endophytes has not been previously demonstrated.	[Wiewiora, Barbara] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Seed Sci & Technol, Radzikow, Poland; [Zurek, Grzegorz] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Grasses Legumes & Energy Plants, Radzikow, Poland; [Panka, Dariusz] Univ Technol & Life Sci, Dept Mol Phytopathol, Bydgoszcz, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization; Bydgoszcz University of Science & Technology	Zurek, G (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Grasses Legumes & Energy Plants, Radzikow, Poland.	g.zurek@ihar.edu.pl	Zurek, Grzegorz/F-3493-2013; Wiewióra, Barbara/AAT-7572-2020; Pańka, Dariusz/AAS-3182-2021	Wiewióra, Barbara/0000-0003-3969-6968; Pańka, Dariusz/0000-0001-5979-0287; Zurek, Grzegorz/0000-0003-2359-2232				Bacon C.W., 1994, BIOTECHNOLOGY ENDOPH, P47; Ball D., 2007, FORAGE MANAGEMENT GR; Cagas B., 2005, RECENT ADV GENETICS, P177; Cheplick G. P., 2009, ECOLOGY EVOLUTION GR, P1; Chlebicki A., 2004, KOSMOS, V53, P33, DOI DOI 10.1371/JOURNAL; CHRISTENSEN MJ, 1995, MYCOL RES, V99, P466, DOI 10.1016/S0953-7562(09)80647-3; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Cross D.L., 2000, P 4 INT NEOT GRASS I, P219; DAPPRICH P, 1994, IOBC WRPS B, V17, P131; Dombrowski JE, 2006, CROP SCI, V46, P1064, DOI 10.2135/cropsci2005.05-0054; Eerens JPJ, 1998, NEW ZEAL J AGR RES, V41, P39, DOI 10.1080/00288233.1998.9513286; Faeth SH, 1997, ECOLOGY, V78, P810, DOI 10.1890/0012-9658(1997)078[0810:FEIOTL]2.0.CO;2; Gwinn KD, 1998, CROP SCI, V38, P201, DOI 10.2135/cropsci1998.0011183X003800010033x; Hill NS, 2002, SEED SCI TECHNOL, V30, P347; Hume D, 2000, P 4 INT NEOT GRASS I, P97; Hume DE, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, P201; Humphreys M, 2010, HANDB PLANT BREED, V5, P211, DOI 10.1007/978-1-4419-0760-8_10; Iannone LJ, 2009, MYCOLOGIA, V101, P340, DOI 10.3852/08-156; International Rules for Seed Testing, INT RUL SEED TEST; JUNG GA, 1996, AGRON MONOGR, V34, P605; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Lewis G.C., 1996, IOBC WPRS B, V19, P17; Lewis GC, 2000, P 4 INT NEOT GRASS I, P123; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Panka D, 2013, ACTA SCI POL-HORTORU, V12, P67; Panka D, 2011, ACTA SCI POL-HORTORU, V10, P115; Pennell CGL, 2001, P 4 INT NEOT GRASS I, P465; Penrose CD, 2001, PROCEEDINGS OF THE XIX INTERNATIONAL GRASSLAND CONGRESS, P610; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Popay A.J., 1999, GRASSLAND RES PRACTI, V7, P113; Ravel C, 1997, AGRONOMIE, V17, P173, DOI 10.1051/agro:19970304; Rolston MP, 2002, NEW ZEAL J BOT, V40, P365; Rolston MP, 1995, P 3 INT HERB SEED C, P433; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Schardl CL, 2001, FUNGAL GENET BIOL, V33, P69, DOI 10.1006/fgbi.2001.1275; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Tadych M, 2007, MYCOL RES, V111, P466, DOI 10.1016/j.mycres.2007.02.002; Thorogood D, 2003, TURFGRASS BIOL GENET, P75; WHITE JF, 1987, PLANT DIS, V71, P340, DOI 10.1094/PD-71-0340; White JF, 1996, MYCOLOGIA, V88, P174, DOI 10.2307/3760920; WHITE JF, 1993, AGR ECOSYST ENVIRON, V44, P13, DOI 10.1016/0167-8809(93)90037-P; Wiewiora B., 2006, B IHAR, V242, P285; Wiewiora B., 2010, B IHAR, V256, P183; Wiewiora B., 2011, J LIFE SCI, V5, P831; Wiewiora B, 2011, MONOGRAFIE ROZPRAWY, V38, P1; Zabalgogeazcoa I, 2003, GRASS FORAGE SCI, V58, P94, DOI 10.1046/j.1365-2494.2003.00352.x; Zurek G, 2013, FUNGAL ECOL, V6, P554, DOI 10.1016/j.funeco.2013.09.001; Zurek M, 2012, FUNGAL ECOL, V5, P353, DOI 10.1016/j.funeco.2011.07.007	50	24	26	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117231	10.1371/journal.pone.0117231	http://dx.doi.org/10.1371/journal.pone.0117231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680199	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600055
J	Chajes, V; Biessy, C; Ferrari, P; Romieu, I; Freisling, H; Huybrechts, I; Scalbert, A; de Mesquita, BB; Romaguera, D; Gunter, MJ; Vineis, P; Hansen, CP; Jakobsen, MU; Clavel-Chapelon, F; Fagherazzi, G; Boutron-Ruault, MC; Katzke, V; Neamat-Allah, J; Boeing, H; Bachlechner, U; Trichopoulou, A; Naska, A; Orfanos, P; Pala, V; Masala, G; Mattiello, A; Skeie, G; Weiderpass, E; Agudo, A; Huerta, JM; Ardanaz, E; Sanchez, MJ; Dorronsoro, M; Quiros, JR; Johansson, I; Winkvist, A; Sonested, E; Key, T; Khaw, KT; Wareham, NJ; Peeters, PHM; Slimani, N				Chajes, Veronique; Biessy, Carine; Ferrari, Pietro; Romieu, Isabelle; Freisling, Heinz; Huybrechts, Inge; Scalbert, Augustin; de Mesquita, Bas Bueno; Romaguera, Dora; Gunter, Marc J.; Vineis, Paolo; Hansen, Camilla Plambeck; Jakobsen, Marianne Uhre; Clavel-Chapelon, Francoise; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Katzke, Verana; Neamat-Allah, Jasmine; Boeing, Heiner; Bachlechner, Ursula; Trichopoulou, Antonia; Naska, Androniki; Orfanos, Philippos; Pala, Valeria; Masala, Giovanna; Mattiello, Amalia; Skeie, Guri; Weiderpass, Elisabete; Agudo, Antonio; Maria Huerta, Jose; Ardanaz, Eva; Jose Sanchez, Maria; Dorronsoro, Miren; Ramon Quiros, Jose; Johansson, Ingegerd; Winkvist, Anna; Sonested, Emily; Key, Tim; Khaw, Kay-Tee; Wareham, Nicolas J.; Peeters, Petra H. M.; Slimani, Nadia			Plasma Elaidic Acid Level as Biomarker of Industrial Trans Fatty Acids and Risk of Weight Change: Report from the EPIC Study	PLOS ONE			English	Article							NUTRITION TRANSITION; PROCESSED FOODS; ADIPOSE-TISSUE; BODY-WEIGHT; OBESITY; CANCER; DIET; PARTICIPANTS; ASSOCIATIONS; RATIONALE	Background Few epidemiological studies have examined the association between dietary trans fatty acids and weight gain, and the evidence remains inconsistent. The main objective of the study was to investigate the prospective association between biomarker of industrial trans fatty acids and change in weight within the large study European Prospective Investigation into Cancer and Nutrition ( EPIC) cohort. Methods Baseline plasma fatty acid concentrations were determined in a representative EPIC sample from the 23 participating EPIC centers. A total of 1,945 individuals were followed for a median of 4.9 years to monitor weight change. The association between elaidic acid level and percent change of weight was investigated using a multinomial logistic regression model, adjusted by length of follow- up, age, energy, alcohol, smoking status, physical activity, and region. Results In women, doubling elaidic acid was associated with a decreased risk of weight loss ( odds ratio ( OR) = 0.69, 95% confidence interval ( CI) = 0.55- 0.88, p = 0.002) and a trend was observed with an increased risk of weight gain during the 5- year follow- up ( OR = 1.23, 95% CI = 0.97- 1.56, p = 0.082) ( p- trend<. 0001). In men, a trend was observed for doubling elaidic acid level and risk of weight loss ( OR = 0.82, 95% CI = 0.66- 1.01, p = 0.062) while no significant association was found with risk of weight gain during the 5- year follow- up ( OR = 1.08, 95% CI = 0.88- 1.33, p = 0.454). No association was found for saturated and cismonounsaturated fatty acids. Conclusions These data suggest that a high intake of industrial trans fatty acids may decrease the risk of weight loss, particularly in women. Prevention of obesity should consider limiting the consumption of highly processed foods, the main source of industrially- produced trans fatty acids.	[Chajes, Veronique; Biessy, Carine; Ferrari, Pietro; Romieu, Isabelle; Freisling, Heinz; Huybrechts, Inge; Scalbert, Augustin; Slimani, Nadia] Int Agcy Res Canc, Nutr & Metab Sect, F-69372 Lyon, France; [de Mesquita, Bas Bueno; Romaguera, Dora; Gunter, Marc J.; Vineis, Paolo; Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [de Mesquita, Bas Bueno] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands; [de Mesquita, Bas Bueno] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [de Mesquita, Bas Bueno] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Hansen, Camilla Plambeck; Jakobsen, Marianne Uhre] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Clavel-Chapelon, Francoise; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Nutr Hormones & Womens Hlth Team, Villejuif, France; [Clavel-Chapelon, Francoise; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine] Univ Paris 11, UMRS 1018, Villejuif, France; [Clavel-Chapelon, Francoise; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine] Inst Gustave Roussy, Villejuif, France; [Katzke, Verana; Neamat-Allah, Jasmine] German Canc Res Ctr, Heidelberg, Germany; [Boeing, Heiner; Bachlechner, Ursula] German Inst Human Nutr, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia; Naska, Androniki; Orfanos, Philippos] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia; Naska, Androniki; Orfanos, Philippos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Pala, Valeria] Natl Canc Inst, IRCCS, Epidemiol & Prevent Unit, I-20133 Milan, Italy; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Skeie, Guri; Weiderpass, Elisabete] Univ Tromso, Arctic Univ Norway, Dept Community Med, N-9001 Tromso, Norway; [Romaguera, Dora] Inst Invest Sanitaria Palma IdISPa, Barcelona, Spain; [Romaguera, Dora] CIBER Fisiopatol Obesidad Nutr CIBEROBN, Barcelona, Spain; [Agudo, Antonio] IDIBELL, Catalan Inst Oncol ICO, Unit Nutr Environm & Canc, Barcelona, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Maria Huerta, Jose; Ardanaz, Eva; Jose Sanchez, Maria] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Jose Sanchez, Maria] Andalusian Sch Publ Hlth, Granada, Spain; [Dorronsoro, Miren] Publ Hlth Direct & Biodonostia CIBERESP, Basque Reg Hlth Dept, San Sebastian, Spain; [Ramon Quiros, Jose] Publ Hlth Directorate, Asturias, Spain; [Johansson, Ingegerd] Umea Univ, Dept Odontol, S-90187 Umea, Sweden; [Winkvist, Anna] Gothenburg Univ, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, S-41124 Gothenburg, Sweden; [Sonested, Emily] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Key, Tim] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Clin Gerontol Unit, Cambridge CB2 1TN, England; [Wareham, Nicolas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Universiti Malaya; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; Fondazione IRCCS Istituto Nazionale Tumori Milan; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Naples Federico II; UiT The Arctic University of Tromso; Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Umea University; University of Gothenburg; Lund University; University of Oxford; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Utrecht University; Utrecht University Medical Center	Chajes, V (corresponding author), Int Agcy Res Canc, Nutr & Metab Sect, 150 Cours Albert Thomas, F-69372 Lyon, France.	chajesv@iarc.fr	Sánchez, Maria-José/D-1087-2011; Romaguera, Dora/ABE-7004-2020; Winkvist, Anna/AAC-6178-2021; Boutron-Ruault, Marie-Christine/H-3936-2014; Agudo, Antonio/J-1805-2016; Mattiello, Amalia AM/K-5112-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Jakobsen, Marianne Uhre/I-8550-2018; Weiderpass, Elisabete/AAP-2747-2021; Scalbert, Augustin/AAX-8160-2021; Khaw, Kay-Tee/AAZ-3209-2021; Romaguera, Dora/AAB-2852-2020; Pala, Valeria/K-4738-2016; Fagherazzi, Guy/ABB-2555-2020; Masala, Giovanna/AAC-5474-2022; Fagherazzi, Guy/P-3534-2017; Gunter, Marc/AAP-8621-2020; Orfanos, Philippos/AAL-2606-2021; Weiderpass, Elisabete/M-4029-2016; Huerta, José María/N-8654-2015	Sánchez, Maria-José/0000-0003-4817-0757; Romaguera, Dora/0000-0002-5762-8558; Winkvist, Anna/0000-0001-9122-7240; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Agudo, Antonio/0000-0001-9900-5677; Mattiello, Amalia AM/0000-0003-3676-7353; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Weiderpass, Elisabete/0000-0003-2237-0128; Scalbert, Augustin/0000-0001-6651-6710; Pala, Valeria/0000-0001-5438-970X; Fagherazzi, Guy/0000-0001-5033-5966; Masala, Giovanna/0000-0002-5758-9069; Fagherazzi, Guy/0000-0001-5033-5966; Weiderpass, Elisabete/0000-0003-2237-0128; Huerta, José María/0000-0002-9637-3869; Freisling, Heinz/0000-0001-8648-4998; Gunter, Marc/0000-0001-5472-6761; Orfanos, Philippos/0000-0002-9949-3137; Skeie, Guri/0000-0003-2476-4251; Chajes, Veronique/0000-0003-1297-3064; Naska, Androniki/0000-0002-1610-1813	Public Health Programme of the European Union [2005328]; MRC [MC_UU_12015/1] Funding Source: UKRI; Cancer Research UK [16491, 14136] Funding Source: researchfish; Medical Research Council [G0401527, MC_UU_12015/1, G1000143, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135, NF-SI-0512-10114] Funding Source: researchfish; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Public Health Programme of the European Union; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The EPIC-PANACEA ((European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project received funding from the Public Health Programme of the European Union (2005328). EPIC was financially supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005. Ligue contre le Cancer, Societe 3M, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Institute Carlos III (RTICC Rd06/0020/0091 and Rd12/0036/0018) from the Spanish Ministry of Health, the participating regional governments and institutions (Spain); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, the Wellcome Trust (United Kingdom); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer, National Research Council, Associazione Italiana per la Ricerca sul Cancro-AIRC (Italy); Dutch Ministry of Public Health, Welfare and Sports, Dutch Ministry of Health, Dutch Prevention Funds, LK Research Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society, Swedish Scientific Council, Regional Government of Skane (Sweden); Norwegian Cancer Society (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2008, OBES REV, V9, P48, DOI 10.1111/j.1467-789X.2007.00438.x; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Besson H, 2009, INT J OBESITY, V33, P497, DOI 10.1038/ijo.2009.25; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; Chajes V, 2011, NUTR CANCER, V63, P1235, DOI 10.1080/01635581.2011.617530; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Hansen CP, 2014, BRIT J NUTR, V111, P1283, DOI 10.1017/S0007114513003747; Jakobsen MU, 2011, OBESITY FACTS, V4, P312, DOI 10.1159/000330710; Kavanagh K, 2007, OBESITY, V15, P1675, DOI 10.1038/oby.2007.200; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Melanson EL, 2009, ANN NUTR METAB, V55, P229, DOI 10.1159/000229004; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2009, EUR J CLIN NUTR, V63, pS206, DOI 10.1038/ejcn.2009.82; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; Smit LA, 2010, LIPIDS, V45, P693, DOI 10.1007/s11745-010-3442-z; SOMMERFELD M, 1983, PROG LIPID RES, V22, P221, DOI 10.1016/0163-7827(83)90010-3; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Thompson AK, 2011, INT J OBESITY, V35, P315, DOI 10.1038/ijo.2010.141	25	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118206	10.1371/journal.pone.0118206	http://dx.doi.org/10.1371/journal.pone.0118206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675445	Green Published, gold			2022-12-27	WOS:000349914000043
J	Kunikata, H; Aizawa, N; Kudo, M; Mugikura, S; Nitta, F; Morimoto, R; Iwakura, Y; Ono, Y; Satoh, F; Takahashi, H; Ito, S; Takahashi, S; Nakazawa, T				Kunikata, Hiroshi; Aizawa, Naoko; Kudo, Masataka; Mugikura, Shunji; Nitta, Fumihiko; Morimoto, Ryo; Iwakura, Yoshitsugu; Ono, Yoshikiyo; Satoh, Fumitoshi; Takahashi, Hidetoshi; Ito, Sadayoshi; Takahashi, Shoki; Nakazawa, Toru			Relationship of Ocular Microcirculation, Measured by Laser Speckle Flowgraphy, and Silent Brain Infarction in Primary Aldosteronism	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; HEAD BLOOD-FLOW; PULSE-WAVE ANALYSIS; ATHEROSCLEROSIS RISK; FLUORESCEIN ANGIOGRAPHY; CEREBRAL INFARCTION; GLAUCOMA PATIENTS; CIRCULATION; STROKE; DIAGNOSIS	Purpose Recent studies have shown that the risk of cerebro- and cardiovascular events (CVEs) is higher in patients with primary aldosteronism (PA) than in those with essential hypertension (EH), and that silent brain infarction (SBI) is a risk factor and predictor of CVEs. Here, we evaluated the relationship between findings from laser speckle flowgraphy (LSFG), a recently introduced non-invasive means of measuring mean blur rate (MBR), an important biomarker of ocular blood flow, and the occurrence of SBI in patients with PA. Methods 87 PA patients without symptomatic cerebral events (mean 55.1 +/- 11.2 years old, 48 male and 39 female) were enrolled in this study. We measured MBR in the optic nerve head (ONH) with LSFG and checked the occurrence of SBI with magnetic resonance imaging. We examined three MBR waveform variables: skew, blowout score (BOS) and blowout time (BOT). We also recorded clinical findings, including age, blood pressure, and plasma aldosterone concentration. Results PA patients with SBI (15 of 87 patients; 17%) were significantly older and had significantly lower BOT in the capillary area of the ONH than the patients without SBI (P = 0.02 and P = 0.03, respectively). Multiple logistic regression analysis revealed that age and BOT were independent factors for the presence of SBI in PA patients (OR, 1.15, 95% CI 1.01-1.38; P = .03 and OR, 0.73, 95% CI 0.45-0.99; P = .04, respectively). Conclusion PA patients with SBI were older and had lower MBR BOT than those without SBI. Our analysis showed that age was a risk factor for SBI, and that BOT was a protective factor, in patients with PA. This suggests that BOT, a non-invasive and objective biomarker, may be a useful predictor of SBI and form part of future PA evaluations and clinical decision-making.	[Kunikata, Hiroshi; Aizawa, Naoko; Nitta, Fumihiko; Takahashi, Hidetoshi; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan; [Kudo, Masataka; Morimoto, Ryo; Iwakura, Yoshitsugu; Ono, Yoshikiyo; Satoh, Fumitoshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Dept Med, Sendai, Miyagi 980, Japan; [Mugikura, Shunji; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; [Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kunikata, H (corresponding author), Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan.	kunikata@oph.med.tohoku.ac.jp	Ito, Sadayoshi/A-3933-2015	Ito, Sadayoshi/0000-0002-5092-3626; MUGIKURA, SHUNJI/0000-0002-9138-610X	JST grant; JSPS KAKENHI [26293372, 26462629, 26670751]	JST grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper was supported in part by JST grant, JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (T.N. 26293372), for Scientific Research (C) (H.K. 26462629), and for Exploratory Research (T.N. 26670751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2013, CLIN EXPERIMENT OPHT, DOI [10.1111/ceo.12150, DOI 10.1111/CEO.12150]; Aizawa N, INVEST OPHTH VIS SCI, DOI [10.1167/iovs.14-15725, DOI 10.1167/IOVS.14-15725]; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Asumi M, 2010, ATHEROSCLEROSIS, V210, P674, DOI 10.1016/j.atherosclerosis.2010.01.008; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; CONN JW, 1955, T ASSOC AM PHYSICIAN, V68, P215; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Kawasaki R, 2010, STROKE, V41, P1826, DOI 10.1161/STROKEAHA.110.585042; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; Milan A, 2012, HIGH BLOOD PRESS CAR, V19, P11, DOI 10.2165/11593690-000000000-00000; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Miwa K, 2010, INTERNAL MED, V49, P817, DOI 10.2169/internalmedicine.49.3211; Mulatero P, 2013, J CLIN ENDOCR METAB, V98, P4826, DOI 10.1210/jc.2013-2805; Musa F, 2006, ACTA OPHTHALMOL SCAN, V84, P740, DOI 10.1111/j.1600-0420.2006.00728.x; Nishikawa T, 2011, ENDOCR J, V58, P711, DOI 10.1507/endocrj.EJ11-0133; Orth D, 1984, COLOR AND FLUORESCEI, P1; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; Satoh F, 2007, HYPERTENS RES, V30, P1083, DOI 10.1291/hypres.30.1083; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; Sharrett AR, 2007, OPHTHAL EPIDEMIOL, V14, P238, DOI 10.1080/09286580701396712; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tsuda S, 2014, CURR EYE RES, DOI [10.3109/02713683.2014.986333, DOI 10.3109/02713683.2014.986333]; Turchi F, 2014, NUTR METAB CARDIOVAS, V24, P476, DOI 10.1016/j.numecd.2013.09.009; VANBUCHEM FSP, 1956, LANCET, V271, P335; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2004, LANCET NEUROL, V3, P179, DOI 10.1016/S1474-4422(04)00682-9; Yatsuya H, 2010, STROKE, V41, P1349, DOI 10.1161/STROKEAHA.110.580837; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204; Yoshida Y, 2010, J OCUL PHARMACOL TH, V26, P187, DOI 10.1089/jop.2009.0117; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114	46	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117452	10.1371/journal.pone.0117452	http://dx.doi.org/10.1371/journal.pone.0117452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675373	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000023
J	Ocwieja, KE; Sherrill-Mix, S; Liu, CC; Song, JZ; Bau, H; Bushman, FD				Ocwieja, Karen E.; Sherrill-Mix, Scott; Liu, Changchun; Song, Jinzhao; Bau, Haim; Bushman, Frederic D.			A Reverse Transcription Loop-Mediated Isothermal Amplification Assay Optimized to Detect Multiple HIV Subtypes	PLOS ONE			English	Article							RAPID DETECTION	Diagnostic methods for detecting and quantifying HIV RNA have been improving, but efficient methods for point-of-care analysis are still needed, particularly for applications in resource-limited settings. Detection based on reverse-transcription loop-mediated isothermal amplification (RT-LAMP) is particularly useful for this, because when combined with fluorescence- based DNA detection, RT-LAMP can be implemented with minimal equipment and expense. Assays have been developed to detect HIV RNA with RT-LAMP, but existing methods detect only a limited subset of HIV subtypes. Here we report a bioinformatic study to develop optimized primers, followed by empirical testing of 44 new primer designs. One primer set (ACeIN-26), targeting the HIV integrase coding region, consistently detected subtypes A, B, C, D, and G. The assay was sensitive to at least 5000 copies per reaction for subtypes A, B, C, D, and G, with Z-factors of above 0.69 (detection of the minor subtype F was found to be unreliable). There are already rapid and efficient assays available for detecting HIV infection in a binary yes/no format, but the rapid RT-LAMP assay described here has additional uses, including 1) tracking response to medication by comparing longitudinal values for a subject, 2) detecting of infection in neonates unimpeded by the presence of maternal antibody, and 3) detecting infection prior to seroconversion.	[Ocwieja, Karen E.; Sherrill-Mix, Scott; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Changchun; Song, Jinzhao; Bau, Haim] Univ Penn, Dept Mech Engn & Appl Mech, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bushman, FD (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Bau, Haim H/D-1161-2009; Song, Jinzhao/Q-7866-2016	Sherrill-Mix, Scott/0000-0002-8955-8072; Ocwieja, Karen/0000-0002-1738-1634	National Institutes of Health [R01 AI052845, 1R41AI104418-01A1, K25AI099160, 5T32HG000046, T32 AI007324]; University of Pennsylvania Center for AIDS Research [P30 AI045008]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, P30AI045008, T32AI007632, R41AI104418, T32AI007324, K25AI099160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 AI052845 to F.D.B and the University of Pennsylvania Center for AIDS Research P30 AI045008. FDB, HHB and CK were supported, in part, by National Institutes of Health 1R41AI104418-01A1. CL was supported by National Institutes of Health K25AI099160. SS-M was supported in part by National Institutes of Health 5T32HG000046. K.E.O. was supported by National Institutes of Health T32 AI007324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2014, J CLIN MICROBIOL, V52, P2674, DOI 10.1128/JCM.00935-14; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Hosaka N, 2009, J VIROL METHODS, V157, P195, DOI 10.1016/j.jviromet.2009.01.004; Kuiken Carla, 2013, Methods Mol Biol, V939, P253, DOI 10.1007/978-1-62703-107-3_16; Liu CC, 2013, ANAL CHEM, V85, P10463, DOI 10.1021/ac402459h; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Murray CJ, 2014, LANCET, DOI [10.1016/S0140-6736(14)62428-4, DOI 10.1016/S0140-6736(14)62428-4]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; Zeng YL, 2014, GENE, V541, P123, DOI 10.1016/j.gene.2014.03.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	18	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117852	10.1371/journal.pone.0117852	http://dx.doi.org/10.1371/journal.pone.0117852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675344	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000035
J	Rohde, J; Pedersen, HR; Bjerring, PN; Larsen, FS				Rohde, Johan; Pedersen, Hans R.; Bjerring, Peter N.; Larsen, Fin Stolze			Effects of Dexamethasone and Cox Inhibitors on Intracranial Pressure and Cerebral Perfusion in the Lipopolysaccharide Treated Rats with Hyperammonemia	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; BLOOD-BRAIN-BARRIER; HEPATIC-ENCEPHALOPATHY; ENDOTHELIAL-CELLS; FLOW; INDOMETHACIN; RELEASE; EDEMA; AMMONIA; PERMEABILITY	Introduction Systemic inflammation may affect the brain by aggravating the stage of encephalopathy and increasing intracranial pressure (ICP) especially if liver insufficiency with hyperammonemia is present. The aim of this study was to determine if the influence of concomitant hyperammonemia and lipopolysaccharide (LPS) on the brain can be prevented by dexamethasone and cyclooxygenase (COX) inhibitors. Method Fifty-four male Wistar rats, 6 in each group, were divided into the following groups: Saline+saline; LPS (2mg/kg)+saline; LPS+indomethacin (10mg/kg); LPS+diclofenac (10mg/kg); LPS+dexamethasone (2mg/kg) in experiment A. Experiment-B included the following groups: LPS+NH3 (140 mu mol/kg/min)+saline; LPS+NH3+indomethacin; LPS+NH3+diclofenac and LPS+NH3+dexamethasone. ICP was monitored via a catheter placed in cisterna magna and changes in CBF were recorded by laser Doppler flowmetry. Results LPS with and without NH3 induced a similar increase in plasma 6-keto-prostaglandin-F-1 alpha (6-keto-PGF(1 alpha)) concentration together with a concomitant rise in CBF and ICP. Indomethacin and diclofenac prevented the increase in ICP by LPS alone, and with the addition of NH3 the increase in both CBF and ICP, which was associated with a decrease in 6-keto-PGF(1 alpha). Dexamethasone only reduced the LPS induced increase in ICP but not CBF, and partly the 6-keto-PGF(1 alpha) plasma concentration in the combined setup. Conclusion These data indicate that activation of cycloooxygenases is of central importance for development of cerebral hyperemia and high ICP during concomitant systemic inflammation and hyperammonemia.	[Rohde, Johan; Pedersen, Hans R.; Bjerring, Peter N.; Larsen, Fin Stolze] Univ Copenhagen, Dept Hepatol, Rigshosp A2121, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Rohde, J (corresponding author), Univ Copenhagen, Dept Hepatol, Rigshosp A2121, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	doktorrohde@gmail.com	Bjerring, Peter/AAB-7322-2020; Bjerring, Peter Nissen/Q-5089-2019	Larsen, Fin Stolze/0000-0003-2205-8265; Bjerring, Peter Nissen/0000-0001-8636-0709				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Godoy DA, 2014, NEUROCRIT CARE, V20, P230, DOI 10.1007/s12028-013-9924-0; Andresen J, 2006, J APPL PHYSIOL, V100, P318, DOI 10.1152/japplphysiol.00937.2005; Bemeur C, 2013, METAB BRAIN DIS, V28, P145, DOI 10.1007/s11011-012-9361-3; Blei AT, 2005, NEUROCHEM INT, V47, P71, DOI 10.1016/j.neuint.2005.04.009; Chastre A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049670; Chung CH, 2001, HEPATOLOGY, V34, P249, DOI 10.1053/jhep.2001.26383; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Farkas E, 2006, MICROVASC RES, V72, P113, DOI 10.1016/j.mvr.2006.05.007; Hribar M, 1999, EUR J IMMUNOL, V29, P3105; Jalan R, 2004, J HEPATOL, V41, P613, DOI 10.1016/j.jhep.2004.06.011; Jalan R, 2003, SEMIN LIVER DIS, V23, P271; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; MASFERRER JL, 1994, RECEPTOR, V4, P25; Mastronardi CA, 2001, NEUROIMMUNOMODULAT, V9, P148, DOI 10.1159/000049019; MOZES T, 1991, PROSTAG LEUKOTR ESS, V42, P209, DOI 10.1016/0952-3278(91)90085-J; Pedersen HR, 2007, J HEPATOL, V47, P245, DOI 10.1016/j.jhep.2007.03.026; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Possamai LA, 2014, J HEPATOL, V61, P439, DOI 10.1016/j.jhep.2014.03.031; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; SAIJA A, 1995, LIFE SCI, V56, P775, DOI 10.1016/0024-3205(95)00008-T; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028; Van Damme E, 2015, J GEN VIROL, V96, P131, DOI 10.1099/vir.0.069872-0; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; WANG Q, 1993, J CEREBR BLOOD F MET, V13, P724, DOI 10.1038/jcbfm.1993.92; Wright G, 2007, HEPATOLOGY, V45, P1517, DOI 10.1002/hep.21599; ZAKI AEO, 1983, EXPERIENTIA, V39, P988, DOI 10.1007/BF01989765	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117416	10.1371/journal.pone.0117416	http://dx.doi.org/10.1371/journal.pone.0117416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675251	gold, Green Submitted, Green Published			2022-12-27	WOS:000349914000022
J	Shin, HS; Han, DH; Shin, MS; Lee, HJ; Kim, MS; Kim, HD				Shin, Hye-Sun; Han, Dong-Hun; Shin, Myung-Seop; Lee, Hyun-Jin; Kim, Mi-Sun; Kim, Hyun-Duck			Korean Version of Child Perceptions Questionnaire and Dental Caries among Korean Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH IMPACT PROFILE; ORAL-HEALTH; VALIDATION; VALIDITY; RELIABILITY; ADOLESCENTS; TRANSLATION; CPQ(11-14)	Although dental caries has been a major oral health problem for children, the association between dental caries and oral health related quality of life has been still controversial. This study aims to evaluate the association between the Korean version of the Child Perceptions Questionnaire (K-CPQ) and dental caries among Korean children. Eight hundred one school children aged 8 to 14 years participated in this study. After the K-CPQ was validated we performed an association study. The K-CPQ was self-reported. Dental caries were evaluated by dentists using the World Health Organization Index. Correlation analyses (intraclass correlation coefficient, Cronbach's alpha and Pearson's correlation coefficient [r]) and linear regression models (partial r) including age, gender and type of school were applied. Untreated deciduous dental caries was associated with the K-CPQ8-10 overall score (partial r = 0.15, P < 0.05). The link was highlighted in the domains of functional limitation and emotional wellbeing. Filled teeth due to caries (FT) was associated with the K-CPQ11-14 overall domain (partial r = 0.14, P = 0.002) as well as with the oral symptoms domain (partial r = 0.16, P = 0.001). This association was highlighted among public school children. Our data indicate that K-CPQ was independently associated with dental caries. The K-CPQ could be a practical tool to evaluate the subjective oral health among Korean children aged 8 to 14.	[Shin, Hye-Sun; Han, Dong-Hun; Shin, Myung-Seop; Lee, Hyun-Jin; Kim, Mi-Sun; Kim, Hyun-Duck] Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea; [Han, Dong-Hun; Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HD (corresponding author), Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea.	hyundkim@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013-062881]; NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2013-070465]; Brain Korea 21 at Seoul National University School of Dentistry in Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea; Brain Korea 21 at Seoul National University School of Dentistry in Korea	This work was supported by the grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2013-062881) and the NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2013-070465) at Seoul National University in Korea. Ms. Shin was supported by grants from Brain Korea 21 at Seoul National University School of Dentistry in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz FD, 2011, MED ORAL PATOL ORAL, V16, pE430, DOI 10.4317/medoral.16.e430; Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301; Bae KH, 2007, COMMUNITY DENT ORAL, V35, P73, DOI 10.1111/j.1600-0528.2007.00331.x; Barbosa Tais S, 2009, BMC Oral Health, V9, P13, DOI 10.1186/1472-6831-9-13; Barbosa TS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-32; Bekes K, 2012, CLIN ORAL INVEST, V16, P165, DOI 10.1007/s00784-010-0496-5; Bendo CB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-114; Brown A, 2006, INT J PAEDIATR DENT, V16, P405, DOI 10.1111/j.1365-263X.2006.00775.x; Costa AA, 2011, J ORTHOD, V38, P275, DOI 10.1179/14653121141632; Do LG, 2008, COMMUNITY DENT HLTH, V25, P205, DOI 10.1922/CDH_2241Do06; Gherunpong Sudaduang, 2004, Community Dent Health, V21, P161; Goursand D, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-2; Gururatana O, 2011, COMMUNITY DENT HLTH, V28, P232, DOI 10.1922/CDH_2588Gururatana06; Jokovic A, 2004, PEDIATR DENT, V26, P512; Jokovic A, 2002, J DENT RES, V81, P459, DOI 10.1177/154405910208100705; Kolawole KA, 2011, EUR J PAEDIATR DENT, V12, P55; Kushnir D, 2004, J PUBLIC HEALTH DENT, V64, P71, DOI 10.1111/j.1752-7325.2004.tb02730.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larsson P, 2004, ACTA ODONTOL SCAND, V62, P147, DOI 10.1080/00016350410001496; Lawrence H P, 2001, Community Dent Health, V18, P207; Marshman Z, 2005, COMMUNITY DENT HLTH, V22, P151; McGrath C, 2008, INT J PAEDIATR DENT, V18, P267, DOI [10.1111/j.1365-263X.2007.00877.x, 10.1111/j.1365-263X.2007.00878.x]; Olivieri A, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-55; Oscarson N, 2007, CARIES RES, V41, P85, DOI 10.1159/000098040; Page LAF, 2005, J DENT RES, V84, P649, DOI 10.1177/154405910508400713; Page LAF, 2013, INT J PAEDIATR DENT, V23, P415, DOI 10.1111/ipd.12011; Page LAF, 2013, EUR J ORAL SCI, V121, P182, DOI 10.1111/eos.12034; Page LAF, 2012, J PUBLIC HEALTH DENT, V72, P287, DOI 10.1111/j.1752-7325.2012.00336.x; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Robinson PG, 2003, COMMUNITY DENT ORAL, V31, P90, DOI 10.1034/j.1600-0528.2003.00051.x; Sheiham A, 2005, B WORLD HEALTH ORGAN, V83, P644; Slade G D, 1994, Community Dent Health, V11, P3; Slade GD, 1998, COMMUNITY DENT ORAL, V26, P52; Torres CS, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-43; Vargas-Ferreira F, 2011, BRAZ ORAL RES, V25, P531, DOI 10.1590/S1806-83242011000600010; Wogelius P., 2009, BMC ORAL HEALTH, V9, P11, DOI DOI 10.1186/1472-6831-9-11; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116011	10.1371/journal.pone.0116011	http://dx.doi.org/10.1371/journal.pone.0116011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675410	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000006
J	Doldan-Martelli, V; Miguez, DG				Doldan-Martelli, Victoria; Miguez, David G.			Synergistic Interaction between Selective Drugs in Cell Populations Models	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-I TRIAL; FUSION PROTEIN; APOPTOSIS INDUCTION; MEDIATED APOPTOSIS; SPECIFICITY; LYMPHOMA; TARGET; LIGAND; CANCER	The design of selective drugs and combinatorial drug treatments are two of the main focuses in modern pharmacology. In this study we use a mathematical model of chimeric ligand-receptor interaction to show that the combination of selective drugs is synergistic in nature, providing a way to gain optimal selective potential at reduced doses compared to the same drugs when applied individually. We use a cell population model of proliferating cells expressing two different amounts of a target protein to show that both selectivity and synergism are robust against variability and heritability in the cell population. The reduction in the total drug administered due to the synergistic performance of the selective drugs can potentially result in reduced toxicity and off-target interactions, providing a mechanism to improve the treatment of cell-based diseases caused by aberrant gene overexpression, such as cancer and diabetes.	[Miguez, David G.] Univ Autonoma Madrid, Dept Fis Mat Condensada, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid	Miguez, DG (corresponding author), Univ Autonoma Madrid, Dept Fis Mat Condensada, Condensed Matter Phys Ctr IFIMAC, Cantoblanco, E-28049 Madrid, Spain.	david.gomez.miguez@uam.es	Míguez Gómez, David/K-4519-2014; Gómez, David Míguez/P-2889-2019	Míguez Gómez, David/0000-0001-8065-1142; Gómez, David Míguez/0000-0001-8065-1142; DOLDAN MARTELLI, Victoria Lucia/0000-0002-6895-8376	Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship [RYC-2010-07450]; Plan Nacional framework [BFU2011-30303]; Ministerio de Educacion y Ciencia of Spain	Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship; Plan Nacional framework; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	The authors thank the Instituto Nicolas Cabrera of the Universidad Autonoma de Madrid (Spain). This work has been supported by the Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship (Ref. RYC-2010-07450) and a Project from Plan Nacional framework (Ref. BFU2011-30303). VDM acknowledges financial support from the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Bremer E, 2005, J BIOL CHEM, V280, P10025, DOI 10.1074/jbc.M413673200; Bremer E, 2005, CANCER RES, V65, P3380, DOI 10.1158/0008-5472.CAN-04-2756; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cironi P, 2008, J BIOL CHEM, V283, P8469, DOI 10.1074/jbc.M708502200; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Doldan-Martelli V, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.2; Dowling MR, 2005, J R SOC INTERFACE, V2, P517, DOI 10.1098/rsif.2005.0069; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GEWERT DR, 1981, EUR J BIOCHEM, V116, P487, DOI 10.1111/j.1432-1033.1981.tb05362.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kioi M, 2006, TECHNOL CANCER RES T, V5, P239, DOI 10.1177/153303460600500307; KLEIN E, 1968, CANCER RES, V28, P1300; Kreitman RJ, 2000, J CLIN ONCOL, V18, P1622, DOI 10.1200/JCO.2000.18.8.1622; Kreitman RJ, 2005, J CLIN ONCOL, V23, P6719, DOI 10.1200/JCO.2005.11.437; Lauffenburger DA, 1993, RECEPTORS MODELS BIN, V365; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Miguez DG, 2010, BIOPHYS CHEM, V148, P74, DOI 10.1016/j.bpc.2010.02.012; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Ruiz-Herrero T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003274; SCHWARZ MA, 1995, CANCER RES, V55, P3692; Stieglmaier J, 2008, CANCER IMMUNOL IMMUN, V57, P233, DOI 10.1007/s00262-007-0370-8; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; Taylor ND, 2010, PROTEIN ENG DES SEL, V23, P251, DOI 10.1093/protein/gzp085; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Weddell JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097271; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zhang BL, 2011, REGUL TOXICOL PHARM, V60, P73, DOI 10.1016/j.yrtph.2011.02.007; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117558	10.1371/journal.pone.0117558	http://dx.doi.org/10.1371/journal.pone.0117558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671700	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300060
J	Naleway, AL; Weinmann, S; Krishnarajah, G; Arondekar, B; Fernandez, J; Swamy, G; Myers, E				Naleway, Allison L.; Weinmann, Sheila; Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle; Swamy, Geeta; Myers, Evan			Pregnancy after Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; FOLLOW-UP; FERTILITY; CONIZATION; EXCISION; OUTCOMES; WOMEN	Objective To determine whether treatments for precancerous cervical lesions were associated with lower pregnancy rates compared to rates in unexposed women and women who had a diagnostic cervical biopsy or colposcopy. Design Matched, retrospective cohort study. Setting Kaiser Permanente Northwest (KPNW), an integrated healthcare delivery system in Oregon and Washington. Patients Women 14 to 53 years old with KPNW enrollment during the period 1998 through 2009. Main Outcome Measure Pregnancy after exposure or index date. Pregnancy was defined using a validated algorithm and electronic medical records data. Results We observed 570 pregnancies following cervical treatment in 4,137 women, 1,533 pregnancies following a diagnostic procedure in 13,767 women, and 7,436 pregnancies in a frequency- matched sample of 81,435 women unexposed to treatment or diagnostic procedures. After adjusting for age and contraceptive use, we observed a higher rate of pregnancies in the treatment group compared to unexposed women (hazard ratio (HR) = 1.42, 95% confidence interval (CI): 1.30-1.55), but no difference in pregnancy rates between the treatment and diagnostic procedure groups (HR = 1.03, 95% CI: 0.93-1.13). Conclusions No adverse effects of cervical procedures on subsequent rates of pregnancy were observed in this cohort with up to twelve years of follow-up time.	[Naleway, Allison L.; Weinmann, Sheila] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97232 USA; [Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle] GlaxoSmithKline, North Amer Vaccine Dev, Philadelphia, PA USA; [Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle] GlaxoSmithKline, North Amer Vaccine Dev, King Of Prussia, PA USA; [Swamy, Geeta; Myers, Evan] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Kaiser Permanente; GlaxoSmithKline; GlaxoSmithKline; Duke University	Naleway, AL (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97232 USA.	allison.naleway@kpchr.org			GlaxoSmithKline Biologicals SA; GlaxoSmithKline	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA (www.gsk.com) funded this study and was involved in all stages of study conduct, including analysis and interpretation of the data and development of this manuscript. SW and AN received grants from GlaxoSmithKline to conduct the study.	Arybn M, 2008, BMJ-BRIT MED J, V337, pa1284, DOI [10.1136/bmj.a1284, DOI 10.1136/BMJ.A1284]; BIGRIGG A, 1994, LANCET, V343, P32, DOI 10.1016/S0140-6736(94)90881-8; Chew GK, 1999, INT J GYNECOL CANCER, V9, P487, DOI 10.1046/j.1525-1438.1999.99066.x; Coppleson M, 1992, GYNECOL ONCOL, P590; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; International Agency for Research on Cancer, 2005, IARC HDB CANC PREV, V10; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Luhn P, 2013, GYNECOL ONCOL, V128, P265, DOI 10.1016/j.ygyno.2012.11.003; Martin-Hirsch P, 2000, COCHRANE DB SYST REV, V2; McLaren J, 1967, J OBSTET GYNAECOL CO, V74, P487; Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; SPITZER M, 1995, OBSTET GYNECOL, V86, P504, DOI 10.1016/0029-7844(95)00237-L; Turlington WT, 1996, J REPROD MED, V41, P815; WEBER T, 1979, ACTA OBSTET GYN SCAN, V58, P347, DOI 10.3109/00016347909154594; WEED JC, 1978, OBSTET GYNECOL, V52, P245	18	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117525	10.1371/journal.pone.0117525	http://dx.doi.org/10.1371/journal.pone.0117525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671561	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300057
J	Rao, MS; Swathi, P; Rao, CAR; Rao, KV; Raju, BMK; Srinivas, K; Manimanjari, D; Maheswari, M				Rao, Mathukumalli Srinivasa; Swathi, Pettem; Rao, Chitiprolu Anantha Rama; Rao, K. V.; Raju, B. M. K.; Srinivas, Karlapudi; Manimanjari, Dammu; Maheswari, Mandapaka			Model and Scenario Variations in Predicted Number of Generations of Spodoptera litura Fab. on Peanut during Future Climate Change Scenario	PLOS ONE			English	Article							ELEVATED CO2; TEMPERATURE; LEPIDOPTERA; INDIA	The present study features the estimation of number of generations of tobacco caterpillar, Spodoptera litura. Fab. on peanut crop at six locations in India using MarkSim, which provides General Circulation Model (GCM) of future data on daily maximum (T.max), minimum (T.min) air temperatures from six models viz., BCCR-BCM2.0, CNRM-CM3, CSIRO-Mk3.5, ECHams5, INCM-CM3.0 and MIROC3.2 along with an ensemble of the six from three emission scenarios (A2, A1B and B1). This data was used to predict the future pest scenarios following the growing degree days approach in four different climate periods viz., Baseline-1975, Near future (NF) -2020, Distant future (DF)-2050 and Very Distant future (VDF)-2080. It is predicted that more generations would occur during the three future climate periods with significant variation among scenarios and models. Among the seven models, 1-2 additional generations were predicted during DF and VDF due to higher future temperatures in CNRM-CM3, ECHams5 & CSIRO-Mk3.5 models. The temperature projections of these models indicated that the generation time would decrease by 18-22% over baseline. Analysis of variance (ANOVA) was used to partition the variation in the predicted number of generations and generation time of S. litura on peanut during crop season. Geographical location explained 34% of the total variation in number of generations, followed by time period (26%), model (1.74%) and scenario (0.74%). The remaining 14% of the variation was explained by interactions. Increased number of generations and reduction of generation time across the six peanut growing locations of India suggest that the incidence of S. litura may increase due to projected increase in temperatures in future climate change periods.	[Rao, Mathukumalli Srinivasa; Swathi, Pettem; Rao, Chitiprolu Anantha Rama; Rao, K. V.; Raju, B. M. K.; Srinivas, Karlapudi; Manimanjari, Dammu; Maheswari, Mandapaka] Cent Res Inst Dryland Agr CRIDA, Hyderabad, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Research Institute of Dryland Agriculture	Rao, MS (corresponding author), Cent Res Inst Dryland Agr CRIDA, Hyderabad, Andhra Pradesh, India.	msrao909@gmail.com			Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA)	Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA)	The work was supported by grants from the Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA), http://nicra-icar.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal PK, 2008, INDIAN J AGR SCI, V78, P911; Arora M, 2005, HYDROLOG SCI J, V50, P81, DOI 10.1623/hysj.50.1.81.56330; Bannayan M, 2009, CLIMATIC CHANGE, V93, P389, DOI 10.1007/s10584-008-9510-1; Cline W., 2007, GLOBAL WARMING AGR I; Das DK., 2011, AGROPHYSICS, V11, P13; Elsaadany G.B., 2000, ANN AGR SCI, P1469; IPCC 2007 Climate Change, 2007, IMP AD VULN; IPCC Climate Change, 2013, PHYS SCI BAS SUMM PO, P3; Jones P. G., 2011, GENERATING CHARACTER; Jones PG, 2011, MARKSIMGCM WEATHER S; Krishna Kumar K., 2011, CURR SCI, V3, P312; Lastuka Z., 2008, PLANT PROTECT SCI, V45, pS53; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; POLLARD E, 1994, MONITORING BUTTERFLI; Rajib MA, 2011, P GLOB C GLOB WARM 2; RAO GVR, 1989, ENVIRON ENTOMOL, V18, P548, DOI 10.1093/ee/18.4.548; Rao M. Srinivasa, 2014, Scientific Research and Essays, V9, P195; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; Some L, 2012, W AFRICAN AGR CLIMAT; Srinivasa Rao M, 2012, S MAN STRESS DRYL CL, P12; Srinivasa Rao M, 2014, SOFTWARE ESTIMATING; Stern Nicholas, 2006, STERN REV EC CLIMATE; Wightman J. A., 1994, GROUNDNUT CROP SCI B, P395, DOI DOI 10.1007/978-94-011-0733-4_11; Zhai F., 2009, 131 ADBI; Ziter C, 2012, GLOBAL CHANGE BIOL, V18, P2771, DOI 10.1111/j.1365-2486.2012.02748.x	26	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116762	10.1371/journal.pone.0116762	http://dx.doi.org/10.1371/journal.pone.0116762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671564	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300025
J	Mitry, D; Peto, T; Hayat, S; Blows, P; Morgan, J; Khaw, T; Foster, PJ				Mitry, Danny; Peto, Tunde; Hayat, Shabina; Blows, Peter; Morgan, James; Khaw, Tee; Foster, Paul J.			Crowdsourcing as a Screening Tool to Detect Clinical Features of Glaucomatous Optic Neuropathy from Digital Photography	PLOS ONE			English	Article							DISC PHOTOGRAPHS; OPHTHALMOLOGISTS; OPHTHALMOSCOPY; CLASSIFICATION; AGREEMENT; WHITES	Aim Crowdsourcing is the process of simplifying and outsourcing numerous tasks to many untrained individuals. Our aim was to assess the performance and repeatability of crowdsourcing in the classification of normal and glaucomatous discs from optic disc images. Methods Optic disc images (N = 127) with pre-determined disease status were selected by consensus agreement from grading experts from a large cohort study. After reading brief illustrative instructions, we requested that knowledge workers (KWs) from a crowdsourcing platform (Amazon MTurk) classified each image as normal or abnormal. Each image was classified 20 times by different KWs. Two study designs were examined to assess the effect of varying KW experience and both study designs were conducted twice for consistency. Performance was assessed by comparing the sensitivity, specificity and area under the receiver operating characteristic curve (AUC). Results Overall, 2,540 classifications were received in under 24 hours at minimal cost. The sensitivity ranged between 83-88% across both trials and study designs, however the specificity was poor, ranging between 35-43%. In trial 1, the highest AUC (95% CI) was 0.64(0.62-0.66) and in trial 2 it was 0.63(0.61-0.65). There were no significant differences between study design or trials conducted. Conclusions Crowdsourcing represents a cost-effective method of image analysis which demonstrates good repeatability and a high sensitivity. Optimisation of variables such as reward schemes, mode of image presentation, expanded response options and incorporation of training modules should be examined to determine their effect on the accuracy and reliability of this technique in retinal image analysis.	[Mitry, Danny; Peto, Tunde; Blows, Peter; Foster, Paul J.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Mitry, Danny; Peto, Tunde; Blows, Peter; Foster, Paul J.] UCL Inst Ophthalmol, London, England; [Hayat, Shabina] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Morgan, James] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Khaw, Tee] Univ Cambridge, Addenbrookes Hosp, Dept Clin Gerontol, Cambridge CB2 2QQ, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Foster, PJ (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.	p.foster@ucl.ac.uk	Foster, Paul/V-7288-2019; Peto, Tunde/G-8812-2018; Morgan, James/GRO-2905-2022	Foster, Paul/0000-0002-4755-177X; Peto, Tunde/0000-0001-6265-0381; Morgan, James/0000-0002-8920-1065	Fight For Sight grant award [1471/2]; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; Fight for Sight [1471/72, 1507/08] Funding Source: researchfish	Fight For Sight grant award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	The authors would like to acknowledge the Special Trustees of Moorfields Eye Hospital and NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology. This study was funded by a Fight For Sight grant award (Ref: 1471/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara-Blanco A, 2003, AM J OPHTHALMOL, V136, P949, DOI 10.1016/S0002-9394(03)00480-X; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Bock R, 2010, MED IMAGE ANAL, V14, P471, DOI 10.1016/j.media.2009.12.006; Breusegem C, 2011, OPHTHALMOLOGY, V118, P742, DOI 10.1016/j.ophtha.2010.08.019; Bussel II, 2013, BR J OPHTHALMOL; Girkin CA, 2004, INVEST OPHTH VIS SCI, V45, P2272, DOI 10.1167/iovs.03-0996; Girkin CA, 2006, OPHTHALMOLOGY, V113, P2144, DOI 10.1016/j.ophtha.2006.06.035; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Mitry D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071154; Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501; Nguyen TB, 2012, RADIOLOGY, V262, P824, DOI 10.1148/radiol.11110938; Vessani RM, 2009, J GLAUCOMA, V18, P253, DOI 10.1097/IJG.0b013e31818153da; Wollstein G, 2000, OPHTHALMOLOGY, V107, P2272, DOI 10.1016/S0161-6420(00)00363-8	13	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117401	10.1371/journal.pone.0117401	http://dx.doi.org/10.1371/journal.pone.0117401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692287	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500054
J	Rahman, MS; Akter, S; Abe, SK; Islam, MR; Mondal, MNI; Rahman, JAMS; Rahman, MM				Rahman, Md. Shafiur; Akter, Shamima; Abe, Sarah Krull; Islam, Md. Rafiqul; Mondal, Md. Nazrul Islam; Rahman, J. A. M. Shoquilur; Rahman, Md. Mizanur			Awareness, Treatment, and Control of Diabetes in Bangladesh: A Nationwide Population-Based Study	PLOS ONE			English	Article							RISK-FACTORS; MULTIPLE IMPUTATION; SYSTEMATIC ANALYSIS; PREVALENCE; HYPERTENSION; MELLITUS; DISEASE; ADULTS	Objectives To examine awareness, treatment, and control of diabetes mellitus among the adult population in Bangladesh. Methods The study used data from the 2011 nationally representative Bangladesh Demographic and Health Survey (BDHS). The BDHS sample is comprised of 7,786 adults aged 35 years or older. The primary outcome variables were fasting blood glucose, diagnosis, treatment, and control of diabetes. Multilevel logistic regression models were used to identify the risk factors for diabetes awareness. Results Overall, age-standardized prevalence of diabetes was 9.2%. Among subjects with diabetes, 41.2% were aware of their condition, 36.9% were treated, and 14.2% controlled their condition. A significant inequality in diabetes management was found from poor to wealthy households: 18.2% to 63.2% (awareness), 15.8% to 56.6% (treatment), and 8.2% to 18.4% (control). Multilevel models suggested that participants who had a lower education and lower economic condition were less likely to be aware of their diabetes. Poor management was observed among non-educated, low-income groups, and those who lived in the northwestern region. Conclusions Diabetes has become a national health concern in Bangladesh; however, treatment and control are quite low. Improving detection, awareness, and treatment strategies is urgently needed to prevent the growing burden associated with diabetes.	[Rahman, Md. Shafiur] First Capital Univ Bangladesh, Dept Publ Hlth, Chuadanga, Bangladesh; [Akter, Shamima] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Abe, Sarah Krull; Rahman, Md. Mizanur] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Islam, Md. Rafiqul; Mondal, Md. Nazrul Islam; Rahman, J. A. M. Shoquilur; Rahman, Md. Mizanur] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Rajshahi	Rahman, MM (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	mizanur_rub@yahoo.com	Rahman, Shafiur/R-2964-2019; Abe, Sarah/ABF-2941-2020	Rahman, Shafiur/0000-0003-1911-6807; Abe, Sarah/0000-0003-3991-2739; Islam, Md. Rafiqul/0000-0001-6959-4554				ABUSAYEED M, 1995, DIABETES CARE, V18, P555, DOI 10.2337/diacare.18.4.555; Ahasan H. A. M. N., 2011, Journal of Medicine, V12, P125, DOI 10.3329/jom.v12i2.8419; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Bangladesh Bureau of Statistics (BBS), 2012, BANGL POP HOUS CENS; Bangladesh Bureau of Statistics (BBS), 2011, HOUS INC EXP SURV 20; BEGUM R, 1979, Bangladesh Medical Research Council Bulletin, V5, P1; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Cunningham-Myrie C, 2013, TROP MED INT HEALTH, V18, P1365, DOI 10.1111/tmi.12190; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Guariguata L, 2013, DIABETES RES CLIN PR; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; IDF, 2019, IDF DIABETES ATLAS; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Khambalia A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-719; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Li MZ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/753150; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lv SR, 2011, JIANGSU J PREVENTIVE, V22, P10; Mc Donald AJ, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-69; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mitra and Associates, 2013, BANGL DEM HLTH SURV; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Porapakkham Y, 2008, SINGAP MED J, V49, P868; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rahim M A, 2004, Bangladesh Med Res Counc Bull, V30, P60; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Singh Arvind Kumar, 2012, Indian J Community Med, V37, P236, DOI 10.4103/0970-0218.103472; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270	47	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118365	10.1371/journal.pone.0118365	http://dx.doi.org/10.1371/journal.pone.0118365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692767	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500118
J	Chen, R; Xu, M; Nagati, JS; Hogg, RT; Das, A; Gerard, RD; Garcia, JA				Chen, Rui; Xu, Min; Nagati, Jason S.; Hogg, Richard T.; Das, Alok; Gerard, Robert D.; Garcia, Joseph A.			The Acetate/ACSS2 Switch Regulates HIF-2 Stress Signaling in the Tumor Cell Microenvironment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ACETYL-COA SYNTHETASE; TRANSCRIPTIONAL ACTIVITY; GLUTAMINE-METABOLISM; HIF-1-ALPHA; OXYGEN; EXPRESSION; PROTEIN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; FACTOR-2-ALPHA	Optimal stress signaling by Hypoxia Inducible Factor 2 (HIF-2) during low oxygen states or hypoxia requires coupled actions of a specific coactivator/lysine acetyltransferase, Creb binding protein (CBP), and a specific deacetylase, Sirtuin 1 (SIRT1). We recently reported that acetylation of HIF-2 by CBP also requires a specific acetyl CoA generator, acetate-dependent acetyl CoA synthetase 2 (ACSS2). In this study, we demonstrate that ACSS2/HIF-2 signaling is active not only during hypoxia, but also during glucose deprivation. Acetate levels increase during stress and coincide with maximal HIF-2 alpha acetylation and CBP/HIF-2 alpha complex formation. Exogenous acetate induces HIF-2 alpha acetylation, CBP/HIF-2 alpha complex formation, and HIF-2 signaling. ACSS2 and HIF-2 are required for maximal colony formation, proliferation, migration, and invasion during stress. Acetate also stimulates flank tumor growth and metastasis in mice in an ACSS2 and HIF-2 dependent manner. Thus, ACSS2/CBP/SIRT1/HIF-2 signaling links nutrient sensing and stress signaling with cancer growth and progression in mammals.	[Chen, Rui; Xu, Min; Nagati, Jason S.; Hogg, Richard T.; Das, Alok; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Rui] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Garcia, Joseph A.] Vet Affairs North Texas Hlth Care Syst, Dept Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southeast University - China; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Chen, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	101011816@seu.edu.cn; joseph.garcia@utsouthwestern.edu		Nagati, Jason/0000-0002-4507-6581; Garcia, Joseph/0000-0002-5621-7538; Chen, Rui/0000-0002-7003-6602	United States Department of Veterans Affairs [I01BX000446]; United States National Institutes of Health [HL108104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by funds provided by the United States Department of Veterans Affairs (I01BX000446 - JG), and the United States National Institutes of Health (HL108104 - JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brusselmans K, 2001, J BIOL CHEM, V276, P39192, DOI 10.1074/jbc.C100428200; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mathew R, 2005, J PHARMACOL EXP THER, V315, P297, DOI 10.1124/jpet.105.087536; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Tokuda Y, 2000, J CELL PHYSIOL, V182, P414, DOI 10.1002/(SICI)1097-4652(200003)182:3<414::AID-JCP12>3.0.CO;2-5; Vordermark D, 2005, CANCER LETT, V230, P122, DOI 10.1016/j.canlet.2004.12.040; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	34	41	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116515	10.1371/journal.pone.0116515	http://dx.doi.org/10.1371/journal.pone.0116515			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689462	Green Published, gold			2022-12-27	WOS:000350322700012
J	de Araujo, AA; Varela, H; de Medeiros, CACX; Brito, GAD; de Lima, KC; de Moura, LM; de Araujo, RF				de Araujo, Aurigena Antunes; Varela, Hugo; Carvalho Xavier de Medeiros, Caroline Addison; de Castro Brito, Gerly Anne; de Lima, Kenio Costa; de Moura, Ligia Moreno; de Araujo Junior, Raimundo Fernandes			Azilsartan Reduced TNF-alpha and IL-1 beta Levels, Increased IL-10 Levels and Upregulated VEGF, FGF, KGF, and TGF-alpha in an Oral Mucositis Model	PLOS ONE			English	Article							GROWTH-FACTORS; WOUND MACROPHAGES; CELL-MIGRATION; PREVENTION; CYTOKINES; THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; PATHOGENESIS; TELMISARTAN	Oral mucositis (OM) is a common complication of treatments for head and neck cancer, particularly radiotherapy with or without chemotherapy. OM is characterised by oral erythema, ulceration, and pain. The aim of this study was to evaluate the effect of azilsartan (AZT), an angiotensin II receptor antagonist, on 5-fluorouracil (5-FU)-induced oral mucositis (OM) in Syrian hamsters. OM was induced by the intraperitoneal administration of 5-FU on experimental days 1 (60mg/Kg) and 2 (40mg/Kg). Animals were pretreated with oral AZT (1, 5, or 10 mg/kg) or vehicle 30 min before 5-FU injection and daily until day 10. Experimental treatment protocols were approved by the Animal Ethics Committee Use/CEUA (Number 28/2012) of the UFRN. Macroscopic analysis and cheek pouch samples were removed for histopathologic analysis. Myeloperoxidase (MPO), Malonyldialdehyde (MDA), interleukin-1 beta (IL-1 beta), interleukin-10 (IL-10), and tumour necrosis factor-alpha (TNF-alpha) were analysed by Enzyme Linked Immuno Sorbent Assay (ELISA). Vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), keratinocyte growth factor (KGF), and transforming growth factor (TGF)-alpha were measured by immunohistochemistry. Analysis of variance followed by Bonferroni's test was used to calculate the means of intergroup differences (p <= 0.05). Treatment with 1 mg/kg AZT reduced levels MPO (p<0.01), MDA (p<0.5) and histological inflammatory cell infiltration, and increased the presence of granulation tissue. AZT treatment at 1 mg/kg reduced the TNF-alpha (p<0.05) and IL-1 beta (p<0.05) levels, increased the cheek pouch levels of IL-10 (p<0.01), and upregulated VEGF, FGF, KGF, and TGF-alpha. Administration of AZT at higher doses (5 and 10 mg/kg) did not significantly reverse the OM. AZT at a dose of 1 mg/kg prevented the mucosal damage and inflammation associated with 5-FU-induced OM, increasing granulation and tissue repair.	[de Araujo, Aurigena Antunes] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil; [Varela, Hugo; de Moura, Ligia Moreno] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Natal, RN, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] State Univ Rio Grande Norte UERN, Postgrad Program Hlth & Soc, Natal, RN, Brazil; [de Castro Brito, Gerly Anne] Univ Fed Ceara, Postgrad Program Pharmacol & Morphol, Dept Morphol, Fortaleza, CE, Brazil; [de Lima, Kenio Costa] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Publ Hlth & Hlth Sci, Natal, RN, Brazil; [de Moura, Ligia Moreno] Univ Potiguar UnP, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol & Hlth Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Potiguar; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil.	aurigena@ufrnet.br	de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; de Araujo, Aurigena/ABI-8455-2020	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; 				Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Lopez TCC, 2013, BRAZ ORAL RES, V27, P342, DOI 10.1590/S1806-83242013005000019; Clancy P, 2014, ATHEROSCLEROSIS, V236, P108, DOI 10.1016/j.atherosclerosis.2014.06.011; de Araujo AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096750; de Castro JF, 2013, PHOTOMED LASER SURG; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; Donnelly JP, 2003, LANCET INFECT DIS, V3, P405, DOI 10.1016/S1473-3099(03)00668-6; Elad S, 2013, ALTERN THER HEALTH M, V19, P21; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Georgiou M, 2012, HIPPOKRATIA, V16, P215; HASENAU C, 1988, LARYNGO RHINO OTOL, V67, P576, DOI 10.1055/s-2007-998565; Kajiya T, 2011, J HYPERTENS, V29, P2476, DOI 10.1097/HJH.0b013e32834c46fd; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Li Y, 2006, J INVEST DERMATOL, V126, P2096, DOI 10.1038/sj.jid.5700350; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Nagib MM, 2013, TOXICOL APPL PHARM, V271, P106, DOI 10.1016/j.taap.2013.04.026; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; Nicolatou-Galitis O, 2013, SUPPORT CARE CANCER, V21, P3179, DOI 10.1007/s00520-013-1847-y; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Raja, 2007, FRONT BIOSCI-LANDMRK, V12, P2249; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Rimulo AL, 2011, EUR ARCH PAEDIATR DE, V12, P124, DOI 10.1007/BF03262792; Rodriguez-Caballero A, 2012, INT J ORAL MAX SURG, V41, P225, DOI 10.1016/j.ijom.2011.10.011; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Scully C, 2003, HEAD NECK-J SCI SPEC, V25, P1057, DOI 10.1002/hed.10318; Senger DR, 1996, AM J PATHOL, V149, P293; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Taguchi I, 2013, HYPERTENS RES, V36, P608, DOI 10.1038/hr.2013.3; Tanideh N, 2013, OR SURG OR MED OR PA, V115, P332, DOI 10.1016/j.oooo.2012.08.450; Tsuruoka S, 2013, INTERNAL MED, V52, P303, DOI 10.2169/internalmedicine.52.9066; von Bultzingslowen I, 2006, SUPPORT CARE CANCER, V14, P519, DOI 10.1007/s00520-006-0052-7; White WB, 2011, HYPERTENSION, V57, P413, DOI 10.1161/HYPERTENSIONAHA.110.163402	42	9	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116799	10.1371/journal.pone.0116799	http://dx.doi.org/10.1371/journal.pone.0116799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689279	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700023
J	Lewis, RS; Lopez, HO; Bowen, SW; Andres, KR; Steede, WT; Dewey, RE				Lewis, Ramsey S.; Lopez, Harry O.; Bowen, Steve W.; Andres, Karen R.; Steede, William T.; Dewey, Ralph E.			Transgenic and Mutation-Based Suppression of a Berberine Bridge Enzyme-Like (BBL) Gene Family Reduces Alkaloid Content in Field-Grown Tobacco	PLOS ONE			English	Article							NICOTIANA-TABACUM-L; PUTRESCINE N-METHYLTRANSFERASE; METHYLPUTRESCINE OXIDASE; RNA INTERFERENCE; B-LOCI; A-LOCI; BIOSYNTHESIS; NITROSAMINES; INHERITANCE; NORNICOTINE	Motivation exists to develop tobacco cultivars with reduced nicotine content for the purpose of facilitating compliance with expected tobacco product regulations that could mandate the lowering of nicotine levels per se, or the reduction of carcinogenic alkaloid-derived tobacco specific nitrosamines (TSNAs). A berberine bridge enzyme-like (BBL) gene family was recently characterized for N. tabacum and found to catalyze one of the final steps in pyridine alkaloid synthesis for this species. Because this gene family acts downstream in the nicotine biosynthetic pathway, it may represent an attractive target for genetic strategies with the objective of reducing alkaloid content in field-grown tobacco. In this research, we produced transgenic doubled haploid lines of tobacco cultivar K326 carrying an RNAi construct designed to reduce expression of the BBL gene family. Field-grown transgenic lines carrying functional RNAi constructs exhibited average cured leaf nicotine levels of 0.684%, in comparison to 2.454% for the untransformed control. Since numerous barriers would need to be overcome to commercialize transgenic tobacco cultivars, we subsequently pursued a mutation breeding approach to identify EMS-induced mutations in the three most highly expressed isoforms of the BBL gene family. Field evaluation of individuals possessing different homozygous combinations of truncation mutations in BBLa, BBLb, and BBLc indicated that a range of alkaloid phenotypes could be produced, with the triple homozygous knockout genotype exhibiting greater than a 13-fold reduction in percent total alkaloids. The novel source of genetic variability described here may be useful in future tobacco breeding for varied alkaloid levels.	[Lewis, Ramsey S.; Lopez, Harry O.; Bowen, Steve W.; Andres, Karen R.; Steede, William T.; Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lewis, RS (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	ramsey_lewis@ncsu.edu		Dewey, Ralph/0000-0003-1924-3777	Tobacco Education and Research Council/North Carolina Tobacco Foundation	Tobacco Education and Research Council/North Carolina Tobacco Foundation	This work was funded in part by a grant from the Tobacco Education and Research Council/North Carolina Tobacco Foundation. Any opinion, finding, conclusion or recommendation expressed in this publication are those of the authors and do not necessarily reflect the view and policies of the Tobacco Education and Research Council, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded in part by a grant from the Tobacco Education and Research Council/North Carolina Tobacco Foundation. Any opinion, finding, conclusion or recommendation expressed in this publication are those of the authors and do not necessarily reflect the view and policies of the Tobacco Education and Research Council, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN G, 1986, PLANT PHYSIOL, V81, P301, DOI 10.1104/pp.81.1.301; Atwood CL, 1991, EGGSARE9247 ID NAT E; Benowitz NL, 2007, CANCER EPIDEM BIOMAR, V16, P2479, DOI 10.1158/1055-9965.EPI-07-0393; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Bowman D.T., 1996, TOBACCO SCI, V40, P99; Burk L.G, 1983, CROP SCI, V75, P133; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; Burns DM, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.024158; Bush L., 1999, ANAL DETERMINATION N, P13; Bush LP, 2001, REC ADV TOB, V27, P23; Cane KA, 2005, FUNCT PLANT BIOL, V32, P305, DOI 10.1071/FP04008; CHAPLIN JF, 1976, CROP SCI, V16, P416, DOI 10.2135/cropsci1976.0011183X001600030026x; Chintapakorn Y, 2003, PLANT MOL BIOL, V53, P87, DOI 10.1023/B:PLAN.0000009268.45851.95; Davis R.E., 1976, TOBACCO SCI, V20, P139; DeBoer KD, 2011, PHYTOCHEMISTRY, V72, P344, DOI 10.1016/j.phytochem.2010.12.012; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P20; Donny EC, 2014, PREV MED, V68, P17, DOI 10.1016/j.ypmed.2014.06.020; Fisher, 2012, 2012 FLUE CURED TOBA, P23; Hatsukami DK, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.035584; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HECHT SS, 1989, CANCER SURV, V8, P273; Heim WG, 2007, PHYTOCHEMISTRY, V68, P454, DOI 10.1016/j.phytochem.2006.11.003; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Kajikawa M, 2009, PLANT MOL BIOL, V69, P287, DOI 10.1007/s11103-008-9424-3; KASPERBAUER MJ, 1972, CROP SCI, V12, P98, DOI 10.2135/cropsci1972.0011183X001200010034x; Katoh A, 2007, PLANT CELL PHYSIOL, V48, P550, DOI 10.1093/pcp/pcm018; Kerschen A, 2004, FEBS LETT, V566, P223, DOI 10.1016/j.febslet.2004.04.043; Kidd SK, 2006, PLANT MOL BIOL, V60, P699, DOI 10.1007/s11103-005-5546-z; LEGG PD, 1969, J HERED, V60, P213, DOI 10.1093/oxfordjournals.jhered.a107974; LEGG PD, 1971, CAN J GENET CYTOL, V13, P287, DOI 10.1139/g71-047; LEGG PD, 1970, CROP SCI, V10, P212, DOI 10.2135/cropsci1970.0011183X001000020041x; Lewis RS, 2007, THEOR APPL GENET, V115, P169, DOI 10.1007/s00122-007-0552-y; Lewis RS, 2008, PLANT BIOTECHNOL J, V6, P346, DOI 10.1111/j.1467-7652.2008.00324.x; Lewis RS, 2010, PHYTOCHEMISTRY, V71, P1988, DOI 10.1016/j.phytochem.2010.09.011; Reed DG, 2004, PLANT SCI, V167, P1123, DOI 10.1016/j.plantsci.2004.06.006; Riechers DE, 1999, PLANT MOL BIOL, V41, P387, DOI 10.1023/A:1006342018991; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; SAUNDERS JA, 1979, PLANT PHYSIOL, V64, P74, DOI 10.1104/pp.64.1.74; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1209, DOI 10.1093/pcp/pcn096; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Smith WD, 2003, REC ADV TOB SCI, V29, P5; Steel R., 1997, PRINCIPLES PROCEDURE; Wang P, 2008, J BIOSCIENCES, V33, P177, DOI 10.1007/s12038-008-0035-6; Wang P, 2009, MOL BIOL REP, V36, P2285, DOI 10.1007/s11033-009-9446-1; Xie J, 2004, REC ADV TOB SCI, P17	55	26	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117273	10.1371/journal.pone.0117273	http://dx.doi.org/10.1371/journal.pone.0117273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688975	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700033
J	Marangon, E; Posocco, B; Mazzega, E; Toffoli, G				Marangon, Elena; Posocco, Bianca; Mazzega, Elisa; Toffoli, Giuseppe			Development and Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Irinotecan and Its Main Metabolites in Human Plasma and Its Application in a Clinical Pharmacokinetic Study	PLOS ONE			English	Article							FLUORESCENCE	Irinotecan is currently used in several cancer regimens mainly in colorectal cancer (CRC). This drug has a narrow therapeutic range and treatment can lead to side effects, mainly neutropenia and diarrhea, frequently requiring discontinuing or lowering the drug dose. A wide inter-individual variability in irinotecan pharmacokinetic parameters and pharmacodynamics has been reported and associated to patients' genetic background. In particular, a polymorphism in the UGT1A1 gene (UGT1A1*28) has been linked to an impaired detoxification of SN-38 (irinotecan active metabolite) to SN-38 glucuronide (SN-38G) leading to increased toxicities. Therefore, therapeutic drug monitoring of irinotecan, SN-38 and SN-38G is recommended to personalize therapy. In order to quantify simultaneously irinotecan and its main metabolites in patients' plasma, we developed and validated a new, sensitive and specific HPLC-MS/MS method applicable to all irinotecan dosages used in clinic. This method required a small plasma volume, addition of camptothecin as internal standard and simple protein precipitation. Chromatographic separation was done on a Gemini C18 column (3 mu M, 100 mm x 2.0 mm) using 0.1% acetic acid/bidistilled water and 0.1% acetic acid/acetonitrile as mobile phases. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring. The standard curves were linear (R-2 >= 0.9962) over the concentration ranges (10-10000 ng/mL for irinotecan, 1-500 ng/mL for SN-38 and SN-38G and 1-5000 ng/mL for APC) and had good back-calculated accuracy and precision. The intra- and inter-day precision and accuracy, determined on three quality control levels for all the analytes, were always <12.3% and between 89.4% and 113.0%, respectively. Moreover, we evaluated this bioanalytical method by re-analysis of incurred samples as an additional measure of assay reproducibility. This method was successfully applied to a pharmacokinetic study in metastatic CRC patients enrolled in a genotype-guided phase Ib study of irinotecan administered in combination with 5-fluorouracil/leucovorin and bevacizumab.	[Marangon, Elena; Posocco, Bianca; Mazzega, Elisa; Toffoli, Giuseppe] NCI, CRO, Aviano, PN, Italy	IRCCS Aviano (CRO)	Marangon, E (corresponding author), NCI, CRO, Aviano, PN, Italy.	emarangon@cro.it	Posocco, Bianca/AAX-6323-2020; Toffoli, Giuseppe/F-6642-2018	Posocco, Bianca/0000-0002-3424-8827; Toffoli, Giuseppe/0000-0002-5323-4762	Italian Association for Cancer Research (AIRC) [IG 10325]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	For this work the authors were supported by the funding program of Italian Association for Cancer Research (AIRC) [project n. IG 10325]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corona G, 2010, THER DRUG MONIT, V32, P638, DOI 10.1097/FTD.0b013e3181ec3bf5; European Medicines Agency Committee for Medicinal Products for Human Use (CHMP), 2011, GUID BIOAN METH VAL; Fast Douglas M, 2009, AAPS J, V11, P238, DOI 10.1208/s12248-009-9100-9; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; KAYE B, 1992, BIOL MASS SPECTROM, V21, P585, DOI 10.1002/bms.1200211110; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058489; Newton KF, 2012, COLORECTAL DIS, V14, P3, DOI 10.1111/j.1463-1318.2010.02439.x; Owens TS, 2003, J CHROMATOGR B, V788, P65, DOI 10.1016/S1570-0232(02)01016-4; Sai K, 2002, BIOMED CHROMATOGR, V16, P209, DOI 10.1002/bmc.137; Sparreboom A, 1998, J CHROMATOGR B, V712, P225, DOI 10.1016/S0378-4347(98)00147-9; Toffoli G, 2006, J CLIN ONCOL, V24, P3061, DOI 10.1200/JCO.2005.05.5400; Toffoli G, 2010, J CLIN ONCOL, V28, P866, DOI 10.1200/JCO.2009.23.6125; U. S. Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2013, FDA GUID IND BIOAN M; U. S. Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2001, FDA GUID IND BIOAN M; Wu AHB, 2011, PHARMACOGENOMIC TEST, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]	15	33	34	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118194	10.1371/journal.pone.0118194	http://dx.doi.org/10.1371/journal.pone.0118194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689738	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700105
J	Wu, DH; Xu, L; Wen, CP; Xie, GQ; Ji, JJ; Pan, JL; Jiao, YF; Fan, YS				Wu, De-hong; Xu, Li; Wen, Cheng-ping; Xie, Guan-qun; Ji, Jin-jun; Pan, Jie-li; jiao, Yi-feng; Fan, Yong-sheng			The Effects of Jieduquyuzishen Prescription-Treated Rat Serum on the BAFF/BAFF-R Signal Pathway	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; GLUCOCORTICOID-INDUCED APOPTOSIS; DISEASE-ACTIVITY; TNF RECEPTOR; BAFF-R; CELLS; BLYS; PATHOGENESIS	Systemic lupus erythematosus (SLE) is a chronic inflammatory disease mainly characterized by B cell hyperactivity. Glucocorticoid (GC) is widely used in SLE for its potent anti-inflammatory and immunosuppressive effects. Despite its important clinical efficacy, highdose or long-term use of GC can cause severe side effects, such as osteoporosis, osteonecrosis, cataracts, hyperglycemia, coronary heart disease and cognitive impairment. Our early clinical studies have shown that Jieduquyuzishen prescription (JP) can effectively reduce the adverse effects and improve the curative effect of GC in the treatment of SLE. The BAFF/BAFF-R signaling pathway plays an important role in the development of SLE and has been regarded as a potential target for the therapy of SLE. In this study, we attempt to investigate the effect of JP on the BAFF/BAFF-R signaling pathway to explore the mechanism of JP in reducing the toxicity and enhancing the efficacy of GC. YAC-1 cells, isolated rat peripheral blood lymphocytes, polymorphonuclear neutrophils and spleen lymphocytes were treated with drug-containing serum. The results of RT-PCR, Western blot and dual-luciferase reporter gene assays indicate that either JP or GC can inhibit the mBAFF-induced up-regulation of BAFF, BAFF-R, Bcl-2, IL-10 and NF-kappa B in YAC-1 cells and WEHI-231 cells. Furthermore, MTS, flow cytometry and CFSE results reveal that the proliferation and survival of lymphocytes activated by mBAFF are suppressed by JP, GC and their combination. Contrary to GC, JP can reduce the apoptosis and raise the survival of polymorphonuclear neutrophils and can't increase the apoptosis of the peripheral blood lymphocytes and spleen lymphocytes. Therefore, it is possible that JP can down-regulate the BAFF/BAFF-R signaling pathway as effectively as GC, which may result in the dosage reduction of GC, thus decreasing the toxicity and improving the efficacy of GC-based treatment of SLE.	[Wu, De-hong; Fan, Yong-sheng] Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China; [Xu, Li; Wen, Cheng-ping; Xie, Guan-qun; Ji, Jin-jun; Pan, Jie-li; jiao, Yi-feng] Zhejiang Chinese Med Univ, Coll Basic Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Fan, YS (corresponding author), Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China.	applezjtcm@126.com		Wu, De-hong/0000-0001-6107-6154; Xu, Li/0000-0001-6883-6590; chengping, Wen/0000-0001-9254-6235	National Basic Research Program of China (973 Program) [2014CB543001]; National Natural Science Foundation of China [81202628, 81403289, 81373633]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program, No. 2014CB543001) and National Natural Science Foundation of China (No. 81202628, No. 81403289, No. 81373633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bosch X, 2011, NEW ENGL J MED, V365, P758, DOI 10.1056/NEJMcibr1107085; Chen J, 2014, J HUAZHONG U SCI-MED, V34, P125, DOI 10.1007/s11596-014-1243-y; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Davidson A, 2006, CURR OPIN RHEUMATOL, V18, P468; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Ding XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088223; [范永升 Fan Yongsheng], 2005, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V20, P667; Fan Yuan-xun, 2006, Journal of Nanjing University of Science and Technology, V30, P199; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lavie F, 2004, J PATHOL, V202, P496, DOI 10.1002/path.1533; Lentz VM, 1998, J IMMUNOL, V160, P3743; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; McConnell JR, 2002, CLIN EXP RHEUMATOL, V20, P653; MESSER J, 1983, NEW ENGL J MED, V309, P21, DOI 10.1056/NEJM198307073090105; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; MOTYKA B, 1995, EUR J IMMUNOL, V25, P1865, DOI 10.1002/eji.1830250711; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; Reyes LI, 2008, CYTOKINE, V42, P170, DOI 10.1016/j.cyto.2007.12.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Sionov RV, 2006, CELL CYCLE, V5, P1017, DOI 10.4161/cc.5.10.2738; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; WADMAN B, 1972, LANCET, V1, P907; Wen C., 2007, CHIN ARCH TRADITI CH, V25, P1599, DOI DOI 10.3969/j.issn.1673-7717.2007.08.027; Wen C., 2007, J ZHEJIANG U TRADITI, V31, P305, DOI [10.16466/j.issn1005-5509.2007.03.024, DOI 10.16466/J.ISSN1005-5509.2007.03.024]; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Zhu XJ, 2009, J CLIN IMMUNOL, V29, P603, DOI 10.1007/s10875-009-9303-y; Zilberman Y, 2004, CELL IMMUNOL, V227, P12, DOI 10.1016/j.cellimm.2004.01.005	47	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118462	10.1371/journal.pone.0118462	http://dx.doi.org/10.1371/journal.pone.0118462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689512	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700116
J	Ballard, ME; Weafer, J; Gallo, DA; de Wit, H				Ballard, Michael E.; Weafer, Jessica; Gallo, David A.; de Wit, Harriet			Effects of Acute Methamphetamine on Emotional Memory Formation in Humans: Encoding vs Consolidation	PLOS ONE			English	Article							D-AMPHETAMINE; ORAL METHAMPHETAMINE; RECOGNITION MEMORY; DRUG-ADDICTION; FALSE MEMORY; YOUNG MEN; ALCOHOL; STRESS; SLEEP; DEXTROAMPHETAMINE	Understanding how stimulant drugs affect memory is important for understanding their addictive potential. Here we examined the effects of acute d-methamphetamine (METH), administered either before (encoding phase) or immediately after (consolidation phase) study on memory for emotional and neutral images in healthy humans. Young adult volunteers (N = 60) were randomly assigned to either an encoding group (N = 29) or a consolidation group (N = 31). Across three experimental sessions, they received placebo and two doses of METH (10, 20 mg) either 45 min before (encoding) or immediately after (consolidation) viewing pictures of emotionally positive, neutral, and negative scenes. Memory for the pictures was tested two days later, under drug-free conditions. Half of the sample reported sleep disturbances following the high dose of METH, which affected their memory performance. Therefore, participants were classified as poor sleepers (less than 6 hours; n = 29) or adequate sleepers (6 or more hours; n = 31) prior to analyses. For adequate sleepers, METH (20 mg) administered before encoding significantly improved memory accuracy relative to placebo, especially for emotional (positive and negative), compared to neutral, stimuli. For poor sleepers in the encoding group, METH impaired memory. METH did not affect memory in the consolidation group regardless of sleep quality. These results extend previous findings showing that METH can enhance memory for salient emotional stimuli but only if it is present at the time of study, where it can affect both encoding and consolidation. METH does not appear to facilitate consolidation if administered after encoding. The study also demonstrates the important role of sleep in memory studies.	[Ballard, Michael E.; Weafer, Jessica; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Gallo, David A.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	de Wit, H (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave,MC3077, Chicago, IL 60637 USA.	hdew@uchicago.edu	Weafer, Jessica/GON-8302-2022; Ballard, Michael/F-9146-2013	Ballard, Michael/0000-0002-2651-6588	National Institute on Drug Abuse [DA002812, DA031796, DA033756];  [F31 DA030863]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002812, F32DA033756, F31DA030863, R21DA031796] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse grants DA002812 and DA031796 (HdW), and DA033756 (JW), and MEB was supported by F31 DA030863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A., 2002, EPISODIC MEMORY NEW; Ballard ME, 2013, PSYCHOPHARMACOLOGY, V226, P515, DOI 10.1007/s00213-012-2924-5; Ballard ME, 2012, PSYCHOPHARMACOLOGY, V219, P15, DOI 10.1007/s00213-011-2374-5; Ballard ME, 2014, J CLIN PSYCHOPHARM, V34, P85, DOI 10.1097/JCP.0000000000000039; Breitenstein C, 2004, NEUROPSYCHOPHARMACOL, V29, P1704, DOI 10.1038/sj.npp.1300464; Bruce KR, 1999, J STUD ALCOHOL, V60, P130, DOI 10.15288/jsa.1999.60.130; Bruce KR, 1997, EXP CLIN PSYCHOPHARM, V5, P242, DOI 10.1037/1064-1297.5.3.242; Bruce KR, 1999, ALCOHOL CLIN EXP RES, V23, P693, DOI 10.1111/j.1530-0277.1999.tb04171.x; Comer SD, 2001, PSYCHOPHARMACOLOGY, V155, P397, DOI 10.1007/s002130100727; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; FISCHMAN MW, 1991, BRIT J ADDICT, V86, P1563; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; Harris DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1677, DOI 10.1038/sj.npp.1300223; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JANAK PH, 1992, PHARMACOL BIOCHEM BE, V41, P837, DOI 10.1016/0091-3057(92)90235-8; Johnson BA, 2000, NEUROPSYCHOPHARMACOL, V22, P504, DOI 10.1016/S0893-133X(99)00116-5; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; Kensinger EA, 2009, EMOT REV, V1, P120, DOI 10.1177/1754073908100436; Kirkpatrick MG, 2012, PSYCHOPHARMACOLOGY, V219, P191, DOI 10.1007/s00213-011-2390-5; Knowles SKZ, 2004, BEHAV PHARMACOL, V15, P111, DOI 10.1097/00008877-200403000-00003; KRIVANEK J A, 1969, Agents and Actions, V1, P36, DOI 10.1007/BF01977664; Kuhlmann S, 2006, BEHAV NEUROSCI, V120, P217, DOI 10.1037/0735-7044.120.1.217; LAMB RJ, 1994, J EXP ANAL BEHAV, V61, P169, DOI 10.1901/jeab.1994.61-169; Lang P. J., 1999, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2009, COGNITION EMOTION, V23, P28; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; Mahoney JJ, 2014, PSYCHIAT RES, V219, P367, DOI 10.1016/j.psychres.2014.05.026; MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245; McNair D., 1971, MANUAL PROFILE MOOD; MEWALDT SP, 1979, PHARMACOL BIOCHEM BE, V10, P205, DOI 10.1016/0091-3057(79)90088-1; MOHS RC, 1980, DRUG ALCOHOL DEPEN, V5, P145, DOI 10.1016/0376-8716(80)90191-X; Nielson KA, 2009, NEUROBIOL LEARN MEM, V92, P70, DOI 10.1016/j.nlm.2009.03.002; Perez AY, 2008, DRUG ALCOHOL DEPEN, V94, P258, DOI 10.1016/j.drugalcdep.2007.10.011; Preuss D, 2009, NEUROBIOL LEARN MEM, V92, P318, DOI 10.1016/j.nlm.2009.03.009; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Roozendaal B, 2011, BEHAV NEUROSCI, V125, P797, DOI 10.1037/a0026187; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Simon NW, 2006, NEUROBIOL LEARN MEM, V86, P305, DOI 10.1016/j.nlm.2006.04.005; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Soderpalm A, 2003, PSYCHOPHARMACOLOGY, V170, P188, DOI 10.1007/s00213-003-1536-5; SOETENS E, 1993, NEUROSCI LETT, V161, P9, DOI 10.1016/0304-3940(93)90127-7; Thomson PDR, 2011, PHYS DESK REFERENCE; Torregrossa MM, 2011, NEUROBIOL LEARN MEM, V96, P609, DOI 10.1016/j.nlm.2011.02.014; Wachtel SR, 2002, DRUG ALCOHOL DEPEN, V68, P23, DOI 10.1016/S0376-8716(02)00104-7; Wardle MC, 2012, PSYCHOPHARMACOLOGY, V220, P143, DOI 10.1007/s00213-011-2498-7; White TL, 2006, PHARMACOL BIOCHEM BE, V85, P123, DOI 10.1016/j.pbb.2006.07.020; White TL, 2002, PHARMACOL BIOCHEM BE, V73, P729, DOI 10.1016/S0091-3057(02)00818-3; Yonelinas AP, 2011, STRESS, V14, P136, DOI 10.3109/10253890.2010.520376; Zeeuws I, 2007, HUM PSYCHOPHARM CLIN, V22, P279, DOI 10.1002/hup.848	54	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117062	10.1371/journal.pone.0117062	http://dx.doi.org/10.1371/journal.pone.0117062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679982	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600046
J	Christensen, B; Ludvigsen, M; Nellemann, B; Kopchick, JJ; Honore, B; Jorgensen, JOL				Christensen, Britt; Ludvigsen, Maja; Nellemann, Birgitte; Kopchick, John J.; Honore, Bent; Jorgensen, Jens Otto L.			Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers	PLOS ONE			English	Article							HUMANS; URINE; BLOOD; MASS	Introduction Despite implementation of the biological passport to detect erythropoietin abuse, a need for additional biomarkers remains. We used a proteomic approach to identify novel serum biomarkers of prolonged erythropoiesis-stimulating agent (ESA) exposure (Darbepoietin-alpha) and/or aerobic training. Trial Design Thirty-six healthy young males were randomly assigned to the following groups: Sedentary-placebo (n = 9), Sedentary-ESA (n = 9), Training-placebo (n = 10), or Training-ESA (n = 8). They were treated with placebo/Darbepoietin-alpha subcutaneously once/week for 10 weeks followed by a 3-week washout period. Training consisted of supervised biking 3/week for 13 weeks at the highest possible intensity. Serum was collected at baseline, week 3 (high dose Darbepoietin-alpha), week 10 (reduced dose Darbepoietin-a), and after a 3-week washout period. Methods Serum proteins were separated according to charge and molecular mass (2D-gel electrophoresis). The identity of proteins from spots exhibiting altered intensity was determined by mass spectrometry. Results Six protein spots changed in response to Darbepoietin-a treatment. Comparing all 4 experimental groups, two protein spots (serotransferrin and haptoglobin/haptoglobin related protein) showed a significant response to Darbepoietin-alpha treatment. The haptoglobin/haptoglobin related protein spot showed a significantly lower intensity in all subjects in the training-ESA group during the treatment period and increased during the washout period. Conclusion An isoform of haptoglobin/haptoglobin related protein could be a new anti-doping marker and merits further research.	[Christensen, Britt; Nellemann, Birgitte; Jorgensen, Jens Otto L.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Christensen, Britt; Nellemann, Birgitte] Aarhus Univ, Med Res Labs, Aarhus, Denmark; [Ludvigsen, Maja; Honore, Bent] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [Kopchick, John J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Christensen, Britt] Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Aarhus University	Christensen, B (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	britt.christensen@clin.au.dk	Jorgensen, Jens Otto Lunde/O-8003-2019; Honoré, Bent/ABF-3650-2021	Jorgensen, Jens Otto Lunde/0000-0001-7408-1526; Honore, Bent/0000-0002-3459-7429; Ludvigsen, Maja/0000-0001-5089-3271	World Anti-Doping Agency (WADA); Clinical Institute, Aarhus University, Denmark; Novo Nordisk Fonden [NNF13OC0007869] Funding Source: researchfish	World Anti-Doping Agency (WADA); Clinical Institute, Aarhus University, Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	The World Anti-Doping Agency (WADA) and Clinical Institute, Aarhus University, Denmark kindly supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanova A, 2007, BLOOD, V110, P762, DOI 10.1182/blood-2006-12-063602; Carnot P, 1906, CR HEBD ACAD SCI, V143, P384; Chang CC, 2009, J INVEST MED, V57, P650, DOI 10.2310/JIM.0b013e3181a3914e; Christensen B, 2015, MUSCLE NERVE, V51, P554, DOI 10.1002/mus.24355; Christensen B, 2013, AM J PHYSIOL-ENDOC M, V305, pE879, DOI 10.1152/ajpendo.00269.2013; Christensen B, 2011, J APPL PHYSIOL, V110, P149, DOI 10.1152/japplphysiol.00665.2010; Kamper P, 2011, BLOOD, V117, P6638, DOI 10.1182/blood-2010-12-327346; Kormoczi GF, 2006, EUR J CLIN INVEST, V36, P202, DOI 10.1111/j.1365-2362.2006.01617.x; Lamon S, 2007, CLIN CHIM ACTA, V379, P145, DOI 10.1016/j.cca.2007.01.014; Larsen MS, 2014, EXP PHYSIOL, V99, P1409, DOI 10.1113/expphysiol.2014.080606; Lasne F, 2000, NATURE, V405, P635, DOI 10.1038/35015164; Morkeberg J, 2007, MED SCI SPORT EXER, V39, P1742, DOI 10.1249/mss.0b013e31811e9d55; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Reichel C, 2011, FORENSIC SCI INT, V213, P20, DOI 10.1016/j.forsciint.2011.07.031; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Savourey G, 2004, EUR J APPL PHYSIOL, V93, P47, DOI 10.1007/s00421-004-1159-5; Schumacher YO, 2012, DRUG TEST ANAL, V4, P846, DOI 10.1002/dta.406; Sottas PE, 2011, CLIN CHEM, V57, P969, DOI 10.1373/clinchem.2011.162271; Viault F, 1891, CR HEBD ACAD SCI, V112, P295; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865	23	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117119	10.1371/journal.pone.0117119	http://dx.doi.org/10.1371/journal.pone.0117119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679398	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600050
J	Garcia-Grajales, JA; Rucabado, G; Garcia-Dopico, A; Pena, JM; Jerusalem, A				Garcia-Grajales, Julian A.; Rucabado, Gabriel; Garcia-Dopico, Antonio; Pena, Jose-Maria; Jerusalem, Antoine			Neurite, a Finite Difference Large Scale Parallel Program for the Simulation of Electrical Signal Propagation in Neurites under Mechanical Loading	PLOS ONE			English	Article							MESSAGE-PASSING INTERFACE; NERVE-FIBERS; QUANTITATIVE-ANALYSIS; COMPUTER-SIMULATION; IMPULSE CONDUCTION; MYELINATED FIBERS; ACTION-POTENTIALS; THEORETICAL BASIS; HIGH-PERFORMANCE; MODEL	With the growing body of research on traumatic brain injury and spinal cord injury, computational neuroscience has recently focused its modeling efforts on neuronal functional deficits following mechanical loading. However, in most of these efforts, cell damage is generally only characterized by purely mechanistic criteria, functions of quantities such as stress, strain or their corresponding rates. The modeling of functional deficits in neurites as a consequence of macroscopic mechanical insults has been rarely explored. In particular, a quantitative mechanically based model of electrophysiological impairment in neuronal cells, Neurite, has only very recently been proposed. In this paper, we present the implementation details of this model: a finite difference parallel program for simulating electrical signal propagation along neurites under mechanical loading. Following the application of a macroscopic strain at a given strain rate produced by a mechanical insult, Neurite is able to simulate the resulting neuronal electrical signal propagation, and thus the corresponding functional deficits. The simulation of the coupled mechanical and electrophysiological behaviors requires computational expensive calculations that increase in complexity as the network of the simulated cells grows. The solvers implemented in Neurite-explicit and implicit-were therefore parallelized using graphics processing units in order to reduce the burden of the simulation costs of large scale scenarios. Cable Theory and Hodgkin-Huxley models were implemented to account for the electrophysiological passive and active regions of a neurite, respectively, whereas a coupled mechanical model accounting for the neurite mechanical behavior within its surrounding medium was adopted as a link between electrophysiology and mechanics. This paper provides the details of the parallel implementation of Neurite, along with three different application examples: a long myelinated axon, a segmented dendritic tree, and a damaged axon. The capabilities of the program to deal with large scale scenarios, segmented neuronal structures, and functional deficits under mechanical loading are specifically highlighted.	[Garcia-Grajales, Julian A.] IMDEA Mat Inst, Madrid, Spain; [Garcia-Grajales, Julian A.; Garcia-Dopico, Antonio; Pena, Jose-Maria] Univ Politecn Madrid, DATSI Comp Sci, Madrid, Spain; [Rucabado, Gabriel] Univ Oxford, Madrid Supercomp & Visualizat Ctr, Oxford, England; [Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Garcia-Grajales, Julian A.; Jerusalem, Antoine] Univ Oxford, Math Inst, Oxford, England	IMDEA Materials Institute; Universidad Politecnica de Madrid; University of Oxford; University of Oxford; University of Oxford	Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Dopico, Antonio García/ABH-3119-2020	Dopico, Antonio García/0000-0001-7373-7853; Jerusalem, Antoine/0000-0001-5026-8038	European Union's Seventh Framework Programme (FP7) ERC Grant Agreement [306587]; Spanish Ministry of Science [TIN2010-21289-C02-02]; Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project	European Union's Seventh Framework Programme (FP7) ERC Grant Agreement; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project	Support was provided by the European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement no. 306587 [http://cordis.europa.eu/fp7/home_en.html], the Spanish Ministry of Science, (TIN2010-21289-C02-02) [http://www.idi.mineco.gob.es/portal/site/MICINN/], and the Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Belu R, 2007, ANNUAL ASEE CONFEREN; Ben-Shalom R, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00004; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bower JM, 1998, BOOK GENESIS EXPLORI; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Dalton S, 2013, CUSP C TEMPLATED SPA; de Camargo R, 2011, HIPC INT C, P1; de Camargo RY, 2011, CONCURR COMP-PRACT E, V23, P556, DOI 10.1002/cpe.1665; Fidjeland AK, 2013, NEUROINFORMATICS, V11, P267, DOI 10.1007/s12021-012-9174-x; FITZHUGH R, 1962, BIOPHYS J, V2, P11, DOI 10.1016/S0006-3495(62)86837-4; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; HAMORI J, 1981, J NEUROCYTOL, V10, P879, DOI 10.1007/BF01262659; Heinecke A, 2012, COMPUT SCI ENG, V14, P78, DOI 10.1109/MCSE.2012.23; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hines ML, 2008, J NEUROSCI METH, V169, P425, DOI 10.1016/j.jneumeth.2007.09.010; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Koch Christof, 1999, P1; KOLES ZJ, 1972, J PHYSIOL-LONDON, V227, P351, DOI 10.1113/jphysiol.1972.sp010036; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; LAX PD, 1956, COMMUN PUR APPL MATH, V9, P267, DOI 10.1002/cpa.3160090206; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; Meek J, 2001, J COMP NEUROL, V431, P255, DOI 10.1002/1096-9861(20010312)431:3<255::AID-CNE1069>3.0.CO;2-9; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Minkovich K, 2014, IEEE T NEUR NET LEAR, V25, P316, DOI 10.1109/TNNLS.2013.2276056; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; nVidia, 2012, CUBLAS LIB US GUID; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Richardson AG, 2000, MED BIOL ENG COMPUT, V38, P438, DOI 10.1007/BF02345014; SCHAUF CL, 1974, J NEUROL NEUROSUR PS, V37, P152, DOI 10.1136/jnnp.37.2.152; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; WALKER DW, 1994, PARALLEL COMPUT, V20, P657, DOI 10.1016/0167-8191(94)90033-7; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Wojcik GM, 2007, NEUROCOMPUTING, V70, P2593, DOI 10.1016/j.neucom.2006.12.015	59	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116532	10.1371/journal.pone.0116532	http://dx.doi.org/10.1371/journal.pone.0116532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680098	Green Published, Green Accepted, gold			2022-12-27	WOS:000350682600026
J	Ma, SK; Wang, YQ; Chen, JC; Zhang, MZ; Harris, RC; Chen, JK				Ma, Seong Kwon; Wang, Yinqiu; Chen, Jianchun; Zhang, Ming-Zhi; Harris, Raymond C.; Chen, Jian-Kang			Overexpression of G-Protein-Coupled Receptor 40 Enhances the Mitogenic Response to Epoxyeicosatrienoic Acids	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SODIUM-CHANNEL ACTIVITY; FREE FATTY-ACIDS; ARACHIDONIC-ACID; EPITHELIAL-CELLS; TYROSINE PHOSPHORYLATION; EPOXYGENASE METABOLITES; SRC KINASE; GPR40; CYTOCHROME-P450	The cytochrome P450 epoxygenase-dependent arachidonic acid metabolites, epoxyeicosatrienoic acids (EETs), are potent survival factors and mitogens for renal epithelial cells, but the molecular identity in the cells that initiates the mitogenic signaling of EETs has remained elusive. We screened kidney cell lines for the expression of G-protein-coupled receptor 40 (GPR40) and found that the porcine renal tubular epithelial cell line LLCPKcl4, which has been previously demonstrated to be sensitive to the mitogenic effect of EETs, expresses higher levels of GPR40 mRNA and protein than the human embryonic kidney cell line HEK293. EETs induced only a weak mitogenic EGFR signaling and mild cell proliferation in HEK293 cells. To determine whether GPR40 expression level is what mediates the mitogenic sensitivity of cells to EETs, we created a human GPR40 (hGPR40) cDNA construct and transfected it into HEK293 cells and picked up a number of stable transfectants. We found that GPR40 overexpression in HEK293 cells indeed significantly enhanced EETinduced cell proliferation and markedly augmented EGFR phosphorylation ERK activation, which were inhibited by the EGFR tyrosine kinase inhibitor, AG1478, or the HB-EGF inhibitor, CRM197. EETs significantly enhanced release of soluble HB-EGF, a natural ligand of EGFR, into the culture medium of hGPR40-transfected HEK293 cells, compared to empty vector-transfected cells. In mouse kidneys, markedly higher level of GPR40 protein was found in the cortex and outer stripe of outer medulla compared to the inner stripe of outer medulla and inner medulla. In situ hybridization confirmed that GPR40 mRNA was localized to a subset of renal tubules in the kidney, including the cortical collecting duct. Thus, this study provides the first demonstration that upregulation of GPR40 expression enhances the mitogenic response to EETs and a relatively high expression level of GPR40 is detected in a subset of tubules including cortical collecting ducts in the mammalian kidney.	[Ma, Seong Kwon; Wang, Yinqiu; Chen, Jianchun; Zhang, Ming-Zhi; Harris, Raymond C.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ma, Seong Kwon] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Chen, Jian-Kang] Georgia Regents Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA; [Chen, Jian-Kang] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA USA	Vanderbilt University; Chonnam National University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Harris, RC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	ray.harris@vanderbilt.edu			Department of Veterans Affairs; National Institutes of Health [DK38226, DK51265, DK62794, DK95785, DK83575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095785, P01DK038226, R01DK062794, R01DK051265, R01DK083575] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Department of Veterans Affairs (RCH) and National Institutes of Health Grant No. DK38226, DK51265, DK62794, and DK95785 (to R.C.H.) and funds from National Institutes of Health Grant No. DK83575 (to J.K.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; BURNS KD, 1995, AM J PHYSIOL-CELL PH, V269, pC831, DOI 10.1152/ajpcell.1995.269.4.C831; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Chen JR, 2000, J BIOL CHEM, V275, P13789, DOI 10.1074/jbc.275.18.13789; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; ENDOU H, 1983, JPN J PHARMACOL, V33, P423, DOI 10.1254/jjp.33.423; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; FITZPATRICK FA, 1986, J BIOL CHEM, V261, P5334; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Graber MN, 1997, J BIOL CHEM, V272, P29546, DOI 10.1074/jbc.272.47.29546; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Makita K, 1996, FASEB J, V10, P1456, DOI 10.1096/fasebj.10.13.8940291; Medhora M, 1998, INT J MOL MED, V2, P661; MORRISON AR, 1981, P NATL ACAD SCI-BIOL, V78, P7375, DOI 10.1073/pnas.78.12.7375; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Ou HY, 2013, AM J PHYSIOL-ENDOC M, V304, pE668, DOI 10.1152/ajpendo.00419.2012; Palop JJ, 2011, METHODS MOL BIOL, V670, P207, DOI 10.1007/978-1-60761-744-0_15; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Poitout V, 2013, DRUG DISCOV TODAY, V18, P1301, DOI 10.1016/j.drudis.2013.09.003; Rahman M, 1997, AM J HYPERTENS, V10, P356, DOI 10.1016/S0895-7061(96)00381-0; Roman RJ, 2000, CLIN EXP PHARMACOL P, V27, P855, DOI 10.1046/j.1440-1681.2000.03349.x; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140	40	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0113130	10.1371/journal.pone.0113130	http://dx.doi.org/10.1371/journal.pone.0113130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679385	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600001
J	Na, YR; Yoon, YN; Son, D; Jung, D; Gu, GJ; Seok, SH				Na, Yi Rang; Yoon, Yi Na; Son, Dain; Jung, Daun; Gu, Gyo Jeong; Seok, Seung Hyeok			Consistent Inhibition of Cyclooxygenase Drives Macrophages towards the Inflammatory Phenotype	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ZEBRAFISH LARVAE; GENE-EXPRESSION; ORAL ASPIRIN; ACTIVATION; MONOCYTE; CANCER; VIVO; POLARIZATION; INDUCTION	Macrophages play important roles in defense against infection, as well as in homeostasis maintenance. Thus alterations of macrophage function can have unexpected pathological results. Cyclooxygenase (COX) inhibitors are widely used to relieve pain, but the effects of long-term usage on macrophage function remain to be elucidated. Using bone marrow-derived macrophage culture and long-term COX inhibitor treatments in BALB/c mice and zebrafish, we showed that chronic COX inhibition drives macrophages into an inflammatory state. Macrophages differentiated in the presence of SC-560 (COX-1 inhibitor), NS-398 (COX-2 inhibitor) or indomethacin (COX-1/2 inhibitor) for 7 days produced more TNF alpha or IL-12p70 with enhanced p65/I kappa B phosphoylation. YmI and IRF4 expression was reduced significantly, indicative of a more inflammatory phenotype. We further observed that indomethacin or NS-398 delivery accelerated zebrafish death rates during LPS induced sepsis. When COX inhibitors were released over 30 days from an osmotic pump implant in mice, macrophages from peritoneal cavities and adipose tissue produced more TNFa in both the basal state and under LPS stimulation. Consequently, indomethacin-exposed mice showed accelerated systemic inflammation after LPS injection. Our findings suggest that macrophages exhibit a more inflammatory phenotype when COX activities are chronically inhibited.	[Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Macrophage Lab, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seok, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Macrophage Lab, 103 Daehak Ro, Seoul 110799, South Korea.	lamseok@snu.ac.kr	Seok, Seung Hyeok/J-3279-2012	Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Science, ICT and Future planning, Korea [2012R1A1A3013393, 2014R1A1A1008012]; Seoul National University Hospital	Ministry of Science, ICT and Future planning, Korea; Seoul National University Hospital	This work is supported by the Ministry of Science, ICT and Future planning, Korea (Grant number 2012R1A1A3013393, 2014R1A1A1008012). This study was also supported by a grant from Seoul National University Hospital (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Endres S, 1996, IMMUNOLOGY, V87, P264, DOI 10.1046/j.1365-2567.1996.472535.x; Feng Y, 2012, CURR BIOL, V22, P1253, DOI 10.1016/j.cub.2012.05.010; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Hussain M, 2012, PHARMACOL RES, V66, P7, DOI 10.1016/j.phrs.2012.02.003; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lang S, 2007, CANCER IMMUNOL IMMUN, V56, P1645, DOI 10.1007/s00262-007-0312-5; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Netea MG, 2000, EUR CYTOKINE NETW, V11, P379; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; PETRINI B, 1991, EUR J CANCER, V27, P591, DOI 10.1016/0277-5379(91)90225-3; Prechel MM, 2000, NEUROCHEM RES, V25, P357, DOI 10.1023/A:1007588903897; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; SAMUELSSON B, 1987, DRUGS, V33, P2, DOI 10.2165/00003495-198700331-00003; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shackelford RE, 1997, MOL PHARMACOL, V52, P421, DOI 10.1124/mol.52.3.421; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187	31	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118203	10.1371/journal.pone.0118203	http://dx.doi.org/10.1371/journal.pone.0118203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680189	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600111
J	Neuwirt, H; Wabnig, E; Feistritzer, C; Eder, IE; Salvador, C; Puhr, M; Culig, Z; Massoner, P; Tiefenthaler, M; Steurer, M; Konwalinka, G				Neuwirt, Hannes; Wabnig, Elisabeth; Feistritzer, Clemens; Eder, Iris E.; Salvador, Christina; Puhr, Martin; Culig, Zoran; Massoner, Petra; Tiefenthaler, Martin; Steurer, Michael; Konwalinka, Guenther			Akacid Medical Formulation Induces Apoptosis in Myeloid and Lymphatic Leukemic Cell Lines In Vitro and In Vivo	PLOS ONE			English	Article							CASPASE-INDEPENDENT APOPTOSIS; POLYMERIC GUANIDINE; CONVERTING-ENZYME; INHIBITOR; BCL-2; CYCLE; ACTIVATION; PHASE; SENSITIVITY; MUTATIONS	Akacid medical formulation (AMF) is an oligoguanidine that exerts biocidal activity against airborne and surface microorganisms including bacteria, viruses, fungi, and molds, while showing relatively low toxicity to humans. We have previously shown that AMF exerts antiproliferative effects on a variety of solid tumor cell lines. In this study we raised the question whether AMF could also substantially inhibit cell growth or induce apoptosis in cell lines derived from hematologic malignancies such as leukemia or lymphoma. We found that AMF has antiproliferative effects on various hematologic cell lines derived from human leukemia and lymphoma. Additionally, we show that AMF induces apoptosis in leukemia cell lines not only via the extrinsic and intrinsic pathway, but also in a caspase-independent manner. This effect was found also in G0-arrested cells. Finally, in our animal experiments utilizing male nu/nu Balb/c mice we found a significant growth retardation, which was immunohistochemically associated with a significantly lower number of KI67-positive cells and caspase-3 induction in AMF-treated mice.	[Neuwirt, Hannes; Wabnig, Elisabeth; Tiefenthaler, Martin] Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria; [Feistritzer, Clemens; Steurer, Michael] Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Austria; [Eder, Iris E.; Puhr, Martin; Culig, Zoran; Massoner, Petra] Med Univ Innsbruck, Dept Expt Urol, A-6020 Innsbruck, Austria; [Salvador, Christina] Med Univ Innsbruck, Dept Pediat, A-6020 Innsbruck, Austria; [Konwalinka, Guenther] Med Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Neuwirt, H (corresponding author), Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria.	Hannes.Neuwirt@i-med.ac.at	Salvador, Christina/AAQ-4798-2021; Neuwirt, Hannes/AAF-1090-2019	Tiefenthaler, Martin/0000-0002-5905-7955; Eder, Iris/0000-0003-3716-0027; Neuwirt, Hannes/0000-0003-1064-0098				Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180; Ashour AA, 2014, APOPTOSIS, V19, P241, DOI 10.1007/s10495-013-0927-2; Ashour ML, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-4; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Bellezza I, 2006, AM J PATHOL, V169, P2199, DOI 10.2353/ajpath.2006.060171; Boyd-Tressler A, 2014, J BIOL CHEM; Buxbaum A, 2006, J ANTIMICROB CHEMOTH, V58, P193, DOI 10.1093/jac/dkl206; Chen JC, 2014, NUTR CANCER, V66, P700, DOI 10.1080/01635581.2014.902974; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Davids MS, 2014, J CLIN ONCOL S, V32, p5s; Feiertag P, 2003, MACROMOL RAPID COMM, V24, P567, DOI 10.1002/marc.200390085; Fresquet V, 2014, BLOOD, V123, P4111, DOI 10.1182/blood-2014-03-560284; Geley S, 1997, FEBS LETT, V402, P36, DOI 10.1016/S0014-5793(96)01496-2; Geley S, 1997, FEBS LETT, V400, P15, DOI 10.1016/S0014-5793(96)01284-7; Groves MJ, 2013, BRIT J CANCER, V109, P2434, DOI 10.1038/bjc.2013.601; Hartmann BL, 1999, ONCOGENE, V18, P713, DOI 10.1038/sj.onc.1202339; Hsu MJ, 2005, BIOCHEM PHARMACOL, V70, P102, DOI 10.1016/j.bcp.2005.04.014; Iijima N, 1997, BLOOD, V90, P4901, DOI 10.1182/blood.V90.12.4901.4901_4901_4909; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kim EA, 2014, APOPTOSIS, V19, P1165, DOI 10.1007/s10495-014-0994-z; Kim JY, 2013, CARDIOVASC TOXICOL, V13, P148, DOI 10.1007/s12012-012-9193-8; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Kratzer C, 2006, J HOSP INFECT, V63, P316, DOI 10.1016/j.jhin.2006.01.024; Kratzer C, 2007, ANTIMICROB AGENTS CH, V51, P3437, DOI 10.1128/AAC.00130-07; Loffler M, 1999, ONCOGENE, V18, P4626, DOI 10.1038/sj.onc.1202820; Matsumoto T, 2014, BIOL PHARM BULL, V37, P633, DOI 10.1248/bpb.b13-00920; Neuwirt H, 2006, INT J ONCOL, V29, P503; Niu X, 2014, LEUKEMIA, V28, P1557, DOI 10.1038/leu.2014.72; Ohgidani M, 2012, J BIOSCI BIOENG, V114, P104, DOI 10.1016/j.jbiosc.2012.02.026; Park C, 2014, NUTR RES PRACT, V8, P132, DOI [10.4162/nrp.2014.8.2.132, 10.4162/nrp.2014.8.1.132]; Pasberg-Gauhl Cornelia, 2014, Drug Discov Today Technol, V11, P109, DOI 10.1016/j.ddtec.2014.04.001; Perri M, 2014, EXP CELL RES; Razzaghi-Abyaneh M, 2006, MYCOPATHOLOGIA, V161, P245, DOI 10.1007/s11046-006-0222-7; Saeed M, 2014, PHYTOMEDICINE, V21, P1525, DOI 10.1016/j.phymed.2014.07.011; Seymour JF DM, 2014, J CLIN ONCOL S, V32, p5s; Shorey LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034975; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Sun YS, 2014, BIOL PHARM BULL, V37, P608, DOI 10.1248/bpb.b13-00877; Wang J, 2014, CELL BIOCH BIOPHYS; Yang SJ, 2014, ONCOL REP, V31, P2286, DOI 10.3892/or.2014.3066; Ying TH, 2013, ANTICANCER RES, V33, P4411; Zeuner A, 2014, CELL DEATH DIFFER; Zhou YF, 2013, PHARMAZIE, V68, P755, DOI 10.1691/ph.2013.3520	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117806	10.1371/journal.pone.0117806	http://dx.doi.org/10.1371/journal.pone.0117806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680181	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600090
J	Volpetti, F; Garcia-Cordero, J; Maerkl, SJ				Volpetti, Francesca; Garcia-Cordero, Jose; Maerkl, Sebastian J.			A Microfluidic Platform for High-Throughput Multiplexed Protein Quantitation	PLOS ONE			English	Article							KINETICS	We present a high-throughput microfluidic platform capable of quantitating up to 384 biomarkers in 4 distinct samples by immunoassay. The microfluidic device contains 384 unit cells, which can be individually programmed with pairs of capture and detection antibody. Samples are quantitated in each unit cell by four independent MITOMI detection areas, allowing four samples to be analyzed in parallel for a total of 1,536 assays per device. We show that the device can be pre-assembled and stored for weeks at elevated temperature and we performed proof-of-concept experiments simultaneously quantitating IL-6, IL-1 beta, TNF-alpha, PSA, and GFP. Finally, we show that the platform can be used to identify functional antibody combinations by screening 64 antibody combinations requiring up to 384 unique assays per device.	[Volpetti, Francesca; Garcia-Cordero, Jose; Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Maerkl, SJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland.	sebastian.maerkl@epfl.ch	Garcia-Cordero, Jose L/D-1591-2009; Maerkl, Sebastian J. J/C-5438-2008	Garcia-Cordero, Jose L/0000-0002-3868-7405; Maerkl, Sebastian J. J/0000-0003-1917-5268	Swiss National Science Foundation [CR23I2_140697]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by a grant from the Swiss National Science Foundation (CR23I2_140697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bange A, 2005, BIOSENS BIOELECTRON, V20, P2488, DOI 10.1016/j.bios.2004.10.016; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Chou HP, 2001, BIOMED MICRODEVICES, V3, P323, DOI 10.1023/A:1012412916446; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Fidalgo LM, 2011, LAB CHIP, V11, P1612, DOI 10.1039/c0lc00537a; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Garcia-Cordero JL, 2014, LAB CHIP, V14, P2642, DOI [10.1039/C3LC51153G, 10.1039/c3lc51153g]; Garcia-Cordero JL, 2013, INTEGR BIOL-UK, V5, P650, DOI 10.1039/c3ib20263a; Garcia-Cordero JL, 2013, CHEM COMMUN, V49, P1264, DOI 10.1039/c2cc37740c; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Kim SH, 2011, ANGEW CHEM INT EDIT, V50, P1171, DOI 10.1002/anie.201004869; Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/nmat2815, 10.1038/NMAT2815]; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Limmer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089626; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Martin L, 2012, NAT METHODS, V9, P1192, DOI [10.1038/NMETH.2225, 10.1038/nmeth.2225]; Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8; Niederholtmeyer H, 2013, P NATL ACAD SCI USA, V110, P15985, DOI 10.1073/pnas.1311166110; Pla-Roca M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011460; Rockel S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1323; Rockel S, 2012, METHODS MOL BIOL, V786, P97, DOI 10.1007/978-1-61779-292-2_6; Singhal A, 2010, ANAL CHEM, V82, P8671, DOI 10.1021/ac101956e; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wilson R, 2006, ANGEW CHEM INT EDIT, V45, P6104, DOI 10.1002/anie.200600288; Zheng CH, 2012, LAB CHIP, V12, P2487, DOI [10.1039/c2lc40145b, 10.1039/c21c40145b]	30	30	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117744	10.1371/journal.pone.0117744	http://dx.doi.org/10.1371/journal.pone.0117744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680117	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600082
J	Wu, RY; Zhu, ZC; Cao, GH				Wu, Renyuan; Zhu, Zhencai; Cao, Guohua			Computational Fluid Dynamics Modeling of Rope-Guided Conveyances in Two Typical Kinds of Shaft Layouts	PLOS ONE			English	Article								The behavior of rope-guided conveyances is so complicated that the rope-guided hoisting system hasn't been understood thoroughly so far. In this paper, with user-defined functions loaded, ANSYS FLUENT 14.5 was employed to simulate lateral motion of rope-guided conveyances in two typical kinds of shaft layouts. With rope-guided mine elevator and mine cages taken into account, results show that the lateral aerodynamic buffeting force is much larger than the Coriolis force, and the side aerodynamic force have the same order of magnitude as the Coriolis force. The lateral aerodynamic buffeting forces should also be considered especially when the conveyance moves along the ventilation air direction. The simulation shows that the closer size of the conveyances can weaken the transverse aerodynamic buffeting effect.				zhuzhencai@cumt.edu.cn			Major State Basic Research Development Program of China (973 Program) [2014CB049404]; Changjiang Scholars and Innovative Research Team in University [IRT1292]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Major State Basic Research Development Program of China (973 Program) (Grant No. 2014CB049404), Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1292) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANSYS FLUENT US GUID; [Anonymous], 2011, SME MINING ENG HDB; Belyi VD, 1959, ROPE GUIDES SHAFT HO; Buchinski KW, 1993, 11 CIM UND OP C SASK; Chen X, 1985, COAL SCI TECHNOLOGY, V13, P23; Chen X, 1979, DESIGN COAL MINE, V26, P17; Greenway ME, 2000, SIAMM S SERIES S, V25, P89; Hamilton RS, 2000, SIAMM S SERIES S, V25, P83; Krige GJ, 2005, AUSTRALAS I MIN MET, V2005, P275; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Newmark N., 1959, J ENG MECH DIV, V85, P67, DOI [10.1061/JMCEA3.0000098, DOI 10.1061/JMCEA3.0000098]; Slonina W, 1980, RES REPORT; Wu RY, 2014, J VIBROENG, V16, P1555	13	1	1	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118268	10.1371/journal.pone.0118268	http://dx.doi.org/10.1371/journal.pone.0118268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679522	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600114
J	Rebello, MR; Kandukuru, P; Verhagen, JV				Rebello, Michelle R.; Kandukuru, Padma; Verhagen, Justus V.			Direct Behavioral and Neurophysiological Evidence for Retronasal Olfaction in Mice	PLOS ONE			English	Article							MULTIMODAL FOOD PERCEPTION; NEUROCOGNITIVE BASES; NEURAL ACTIVITY; ORTHONASAL; TASTE; STIMULI; FLAVOR; INPUT; BULB; REPRESENTATION	The neuroscience of flavor perception is hence becoming increasingly important to understand food flavor perception that guides food selection, ingestion and appreciation. We recently provided evidence that rats can use the retronasal mode of olfaction, an essential element of human flavor perception. We showed that in rats, like humans, odors can acquire a taste. We and others also defined how the input of the olfactory bulb (OB) -not functionally imageable in humans-codes retronasal smell in anesthetized rat. The powerful awake transgenic mouse, however, would be a valuable additional model in the study of flavor neuroscience. We used a go/no-go behavioral task to test the mouse's ability to detect and discriminate the retronasal odor amyl acetate. In this paradigm a tasteless aqueous odor solution was licked by water-restricted head-fixed mice from a lick spout. Orthonasal contamination was avoided. The retronasal odor was successfully discriminated by mice against pure distilled water in a concentration-dependent manner. Bulbectomy removed the mice's ability to discriminate the retronasal odor but not tastants. The OB showed robust optical calcium responses to retronasal odorants in these awake mice. These results suggest that mice, like rats, are capable of smelling retronasally. This direct neuro-behavioral evidence establishes the mouse as a useful additional animal model for flavor research.	[Verhagen, Justus V.] Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University	Verhagen, JV (corresponding author), Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA.	jverhagen@jbpierce.org			U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC009994, R01DC011286]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009994, R01DC011286] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders, Grants R01DC009994 and R01DC011286 to JVV. http://www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Croy I, 2014, EUR ARCH OTO-RHINO-L, V271, P1087, DOI 10.1007/s00405-013-2684-9; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Furudono Y, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-45; Gautam H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044781; Gautam SH, 2012, J NEUROSCI, V32, P7949, DOI 10.1523/JNEUROSCI.1413-12.2012; Gautam SH, 2010, CHEM SENSES, V35, P767, DOI 10.1093/chemse/bjq075; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Heilmann S, 2004, BEHAV NEUROSCI, V118, P412, DOI 10.1037/0735-7044.118.2.412; Hong Jae Hee, 2009, J Support Oncol, V7, P58; Hummel T, 2006, FLAVOUR FRAG J, V21, P42, DOI 10.1002/ffj.1700; Iannilli E, 2014, BRAIN RES; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; MURPHY C, 1977, SENS PROCESS, V1, P204; MURPHY C, 1980, PHYSIOL BEHAV, V24, P601, DOI 10.1016/0031-9384(80)90257-7; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Ramaekers MG, 2014, BRIT J NUTR, V111, P554, DOI 10.1017/S0007114513002729; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; ROBERTS DD, 1995, J AGR FOOD CHEM, V43, P2179, DOI 10.1021/jf00056a041; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Ruijschop RMAJ, 2008, BRIT J NUTR, V99, P1140, DOI 10.1017/S0007114507837482; Ruijschop RMAJ, 2009, J AGR FOOD CHEM, V57, P9888, DOI 10.1021/jf901445z; Shepherd GM, 2011, NEUROGASTRONOMY HOW, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Stein BE, 1993, MERGING OF THE SENSE; Veldhuizen MG, 2010, FRONTIERS IN HUMAN N, V4, DOI [10.3389/fnhum.2010.00228, DOI 10.3389/FNHUM.2010.00228]; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Verhagen JV, 2007, BRAIN RES REV, V53, P271, DOI 10.1016/j.brainresrev.2006.09.002; Verhagen JV, 2006, NEUROSCI BIOBEHAV R, V30, P613, DOI 10.1016/j.neubiorev.2005.11.003; Wachowiak M, 2013, J NEUROSCI, V33, P5285, DOI 10.1523/JNEUROSCI.4824-12.2013; Welge-Lussen A, 2009, NEUROSCI LETT, V454, P124, DOI 10.1016/j.neulet.2009.03.002; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zijlstra N, 2011, BRIT J NUTR, V106, P297, DOI 10.1017/S0007114511000146	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117218	10.1371/journal.pone.0117218	http://dx.doi.org/10.1371/journal.pone.0117218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675095	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000015
J	Tanaka, S; Tanaka, J; Miwa, Y; Horikawa, DD; Katayama, T; Arakawa, K; Toyoda, A; Kubo, T; Kunieda, T				Tanaka, Sae; Tanaka, Junko; Miwa, Yoshihiro; Horikawa, Daiki D.; Katayama, Toshiaki; Arakawa, Kazuharu; Toyoda, Atsushi; Kubo, Takeo; Kunieda, Takekazu			Novel Mitochondria-Targeted Heat-Soluble Proteins Identified in the Anhydrobiotic Tardigrade Improve Osmotic Tolerance of Human Cells	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; LOW-EARTH-ORBIT; LEA PROTEINS; WATER-STRESS; MODEL PEPTIDES; DESICCATION; DEHYDRATION; TREHALOSE; DEATH; LOCALIZATION	Tardigrades are able to tolerate almost complete dehydration through transition to a metabolically inactive state, called "anhydrobiosis". Late Embryogenesis Abundant (LEA) proteins are heat-soluble proteins involved in the desiccation tolerance of many anhydrobiotic organisms. Tardigrades, Ramazzottius varieornatus, however, express predominantly tardigrade- unique heat-soluble proteins: CAHS (Cytoplasmic Abundant Heat Soluble) and SAHS (Secretory Abundant Heat Soluble) proteins, which are secreted or localized in most intracellular compartments, except the mitochondria. Although mitochondrial integrity is crucial to ensure cellular survival, protective molecules for mitochondria have remained elusive. Here, we identified two novel mitochondrial heat-soluble proteins, RvLEAM and MAHS (Mitochondrial Abundant Heat Soluble), as potent mitochondrial protectants from Ramazzottius varieornatus. RvLEAM is a group3 LEA protein and immunohistochemistry confirmed its mitochondrial localization in tardigrade cells. MAHS-green fluorescent protein fusion protein localized in human mitochondria and was heat-soluble in vitro, though no sequence similarity with other known proteins was found, and one region was conserved among tardigrades. Furthermore, we demonstrated that RvLEAM protein as well as MAHS protein improved the hyperosmotic tolerance of human cells. The findings of the present study revealed that tardigrade mitochondria contain at least two types of heat-soluble proteins that might have protective roles in water-deficient environments.	[Tanaka, Sae; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Tanaka, Junko; Miwa, Yoshihiro] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Horikawa, Daiki D.; Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Katayama, Toshiaki] Database Ctr Life Sci, Kashiwa, Chiba, Japan; [Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Toyoda, Atsushi] Natl Inst Genet, Adv Genom Ctr, Mishima, Shizuoka 411, Japan	University of Tokyo; University of Tsukuba; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kunieda, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.	kunieda@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; Mondragon, Angel/F-3972-2017; KUBO, TAKEO/G-4951-2014	Mondragon, Angel/0000-0002-6721-2054; Arakawa, Kazuharu/0000-0002-2893-4919; Tanaka, Sae/0000-0002-3460-2777; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Japan Society for the Promotion of Science [26660288, 24657069, 25-10474]; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Exploratory Research (Nos. 26660288, 24657069) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research on Innovative Areas, Genome Science (No. 221S0002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. ST received a Grant-in-Aid for JSPS Fellows (No. 25-10474) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Contreras-Porcia L, 2011, J EXP BOT, V62, P1815, DOI 10.1093/jxb/erq364; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Carvalho RC, 2012, ANN BOT-LONDON, V110, P1007, DOI 10.1093/aob/mcs180; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Furuki T, 2014, BBA-BIOMEMBRANES, V1838, P2757, DOI 10.1016/j.bbamem.2014.07.009; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iturriaga Gabriel, 2008, Biochem J, V410, pe1, DOI 10.1042/BJ20071633; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; Marunde MR, 2013, J INSECT PHYSIOL, V59, P377, DOI 10.1016/j.jinsphys.2013.01.004; Mobjerg N, 2011, ACTA PHYSL OXFORD EN, V202, P1748; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Tanaka J, 1999, BIOCHEM BIOPH RES CO, V264, P938, DOI 10.1006/bbrc.1999.1617; Tripathi R, 2012, J EXP BIOL, V215, P2786, DOI 10.1242/jeb.071647; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	45	46	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118272	10.1371/journal.pone.0118272	http://dx.doi.org/10.1371/journal.pone.0118272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675104	gold, Green Submitted, Green Published			2022-12-27	WOS:000349914000045
J	Planas, ME; Garcia, PJ; Bustelo, M; Carcamo, CP; Martinez, S; Nopo, H; Rodriguez, J; Merino, MF; Morrison, A				Planas, Maria-Elena; Garcia, Patricia J.; Bustelo, Monserrat; Carcamo, Cesar P.; Martinez, Sebastian; Nopo, Hugo; Rodriguez, Julio; Merino, Maria-Fernanda; Morrison, Andrew			Effects of Ethnic Attributes on the Quality of Family Planning Services in Lima, Peru: A Randomized Crossover Trial	PLOS ONE			English	Article							HEALTH; CONTRACEPTION	Most studies reporting ethnic disparities in the quality of healthcare come from developed countries and rely on observational methods. We conducted the first experimental study to evaluate whether health providers in Peru provide differential quality of care for family planning services, based on the indigenous or mestizo (mixed ethnoracial ancestry) profile of the patient. In a crossover randomized controlled trial conducted in 2012, a sample of 351 out of the 408 public health establishments in Metropolitan Lima, Peru were randomly assigned to receive unannounced simulated patients enacting indigenous and mestizo profiles (sequence-1) or mestizo and then indigenous profiles (sequence-2), with a five week wash-out period. Both ethnic profiles used the same scripted scenario for seeking contraceptive advice but had distinctive cultural attributes such as clothing, styling of hair, make-up, accessories, posture and patterns of movement and speech. Our primary outcome measure of quality of care is the proportion of technical tasks performed by providers, as established by Peruvian family planning clinical guidelines. Providers and data analysts were kept blinded to the allocation. We found a non-significant mean difference of -0.7% (p = 0.23) between ethnic profiles in the percentage of technical tasks performed by providers. However we report large deficiencies in the compliance with quality standards of care for both profiles. Differential provider behaviour based on the patient's ethnic profiles compared in the study did not contribute to deficiencies in family planning outcomes observed. The study highlights the need to explore other determinants for poor compliance with quality standards, including demand and supply side factors, and calls for interventions to improve the quality of care for family planning services in Metropolitan Lima.	[Planas, Maria-Elena] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Intercultural & Gender Unit, Lima, Peru; [Planas, Maria-Elena] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Garcia, Patricia J.; Carcamo, Cesar P.] Univ Peruana Cayetano Heredia, Epidemiol STD & HIV Unit, Sch Publ Hlth & Adm, Lima, Peru; [Bustelo, Monserrat; Rodriguez, Julio; Morrison, Andrew] Interamer Dev Bank, Gender & Div Div, Washington, DC USA; [Martinez, Sebastian] Interamer Dev Bank, Off Strateg Planning & Dev Effectiveness, Washington, DC USA; [Nopo, Hugo] Interamer Dev Bank, Educ Div, Washington, DC USA; [Merino, Maria-Fernanda] Interamer Dev Bank, Execut Vice President Div, Washington, DC USA	Universidad Peruana Cayetano Heredia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidad Peruana Cayetano Heredia; Inter-American Development Bank; Inter-American Development Bank; Inter-American Development Bank; Inter-American Development Bank	Planas, ME (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Intercultural & Gender Unit, Lima, Peru.	mariaelena.planas@upch.pe	Planas, Maria Elena/H-1858-2013	Planas, Maria Elena/0000-0002-1094-7375; Nopo, Hugo/0000-0003-1769-2376	Inter-American Development Bank [RG-K1241]	Inter-American Development Bank	The Inter-American Development Bank (www.iadb.org) supported this work (Grant No RG-K1241). MB, SM, HN, JR, MFM and AM are affiliated to the institution that sponsored the study and had a role in the design, analysis, interpretation, and writing of the report. The corresponding author had full access to all the data in the study and all authors made the decision to submit for publication.	Aspinall PJ, 2011, PUBLIC HEALTH, V125, P680, DOI 10.1016/j.puhe.2011.05.001; Becker D, 2008, PERSPECT SEX REPRO H, V40, P202, DOI 10.1363/4020208; Benavides M, 2010, ESTADO DE LA NINEZ I; Bradby H, 2003, ETHNIC HEALTH, V8, P5, DOI 10.1080/13557850303555; Caceres C, 2008, Glob Public Health, V3 Suppl 2, P39, DOI 10.1080/17441690801981159; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Dehlendorf C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.009; Dehlendorf C, 2010, AM J OBSTET GYNECOL, V202, P214, DOI 10.1016/j.ajog.2009.08.022; Dela Cadena M., 2000, INDIGENOUS MESTIZOS; Heckman JJ, 1998, J ECON PERSPECT, V12, P101, DOI 10.1257/jep.12.2.101; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Instituto Nacional de Estadistica e Informatica, 2011, ENCUESTA DEMOGRAFICA; Leon FR, 2008, EVAL HEALTH PROF, V31, P3, DOI 10.1177/0163278707311868; List JA, 2011, HBK ECON, V4, P103, DOI 10.1016/S0169-7218(11)00408-4; Ministerio de Salud, 2004, GUIAS NACIONALES DE, DOI [10.1002/cii.238, DOI 10.1002/CII.238]; Ministerio de Salud, 2005, NORMA TECNICA DE PLA; Ministerio de Salud, 2007, MANUAL DE ORIENTACIO; National Research Council, 2004, MEASURING RACIAL DIS; Portocarrero G, 2007, RACISMO Y MESTIZAJE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Stepan N, 1991, THE HOUR OF EUGENICS; Valdivia M, 2011, PROTECCION SOCIAL EN, P121, DOI [10.1118/1.4898598, DOI 10.1118/1.4898598]; Valdivia N, 2012, DISCRIMINACION PERU, P85, DOI [10.1016/j.foodchem.2014.11.121, DOI 10.1016/J.FOODCHEM.2014.11.121]; Wade P, 1997, RACE AND ETHNICITY I; Yon C, 2005, HABLAN LAS MUJERES A	27	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115274	10.1371/journal.pone.0115274	http://dx.doi.org/10.1371/journal.pone.0115274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671664	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300005
J	Soria, A; Trabattoni, D; Squillace, N; Rainone, V; Gnudi, F; Clerici, M; Gori, A; Bandera, A				Soria, Alessandro; Trabattoni, Daria; Squillace, Nicola; Rainone, Veronica; Gnudi, Federica; Clerici, Mario; Gori, Andrea; Bandera, Alessandra			Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING MALIGNANCIES; TREATED HIV-INFECTION; ACTIVATION; RECOVERY; RISK; APOPTOSIS; IMPACT	Background Longitudinal characterization of immune recovery in the first-phase of antiretroviral therapy (ART) is poorly described. We compared immune kinetics in individuals who were diagnosed early or late with HIV-1 infection, (thus commencing ART with different CD4(+) T-cell counts), in order to investigate possible mechanisms involved in subsequent poor immune recovery. Methods Immunophenotyping, immune activation, proliferation, apoptosis, regulatory T-cells and intracellular cytokine production were compared at baseline and during 24-week follow-up in two groups of HIV-1-infected patients initiating the same ART (tenofovir/emtricitabine/efavirenz) and divided according to baseline CD4+ T-cell counts (late: <= 200/mu L; early: >200/mu L). Wilcoxon-rank sum test and analysis for repeated measures were used to evaluate differences between groups over time. Results Twenty-four out of 30 enrolled subjects were evaluable for the analysis, 13 late and 11 early presenters. Significantly lower CD4+ naive and memory T-cells, and higher plasma viral load, as well as augmented percentages of activated (CD4(+)/CD25(+) cells), apoptotic (CD4(+)/AnnexinV(+)/7AAD(-), CD4(+)/caspase 8(+) and CD4(+)/caspase 9(+)), and proliferating (CD8(+)/Ki67(+) cells) lymphocytes were present at baseline in late presenters; ART resulted in a reduction of apoptotic and proliferating lymphocytes within the follow-up period. Conclusions A skewing towards memory/activated/apoptotic phenotype is seen in HIV-1-infected subjects starting ART at low CD4(+) T-cell counts; ART results in early (24 weeks) trend towards normalization of these parameters. Antiretroviral therapy may play a role in rapidly limiting aberrant immune exhaustion even in late presenters, while requiring more time for repopulation of highly depleted naive T-cells.	[Soria, Alessandro; Squillace, Nicola; Gori, Andrea; Bandera, Alessandra] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Trabattoni, Daria; Rainone, Veronica; Gnudi, Federica] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplants, Milan, Italy; [Clerici, Mario] IRCCS, Don Carlo Gnocchi Fdn, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Soria, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.soria@hsgerardo.org	Gori, Andrea/AAC-6078-2022; Bandera, Alessandra/D-6255-2015; Trabattoni, Daria/G-7424-2012; Bandera, Alessandra/AAC-6081-2022; Gnudi, Federica/Y-3811-2019; Squillace, Nicola/AAA-1094-2021	Trabattoni, Daria/0000-0001-9535-3359; Gnudi, Federica/0000-0002-4591-5699; Squillace, Nicola/0000-0002-7608-6045; BANDERA, ALESSANDRA/0000-0001-9440-4601; SORIA, Alessandro/0000-0002-4447-2574; Bandera, Alessandra/0000-0003-1626-0328; Clerici, Mario/0000-0001-5920-6191	Bristol-Myers Squibb; ANLAIDS Sezione Lombardia	Bristol-Myers Squibb(Bristol-Myers Squibb); ANLAIDS Sezione Lombardia	The study was supported by a grant from Bristol-Myers Squibb and ANLAIDS Sezione Lombardia. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The drugs used in the study were standard of care, and were provided by the National Health System.	Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Hsu DC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-29; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lok JJ, 2013, AIDS, V27, P2101, DOI 10.1097/QAD.0b013e32836191b1; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Mudd JC, 2014, CURR OPIN HIV AIDS, V9, P500, DOI 10.1097/COH.0000000000000086; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Roger PM, 2002, J INFECT DIS, V185, P463, DOI 10.1086/338573; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	15	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117118	10.1371/journal.pone.0117118	http://dx.doi.org/10.1371/journal.pone.0117118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671649	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300036
J	Yun, J; Kim, PJ; Jeong, H				Yun, Jinhyuk; Kim, Pan-Jun; Jeong, Hawoong			Anatomy of Scientific Evolution	PLOS ONE			English	Article							HISTORY; NETWORKS; IMPACT; INDEX	The quest for historically impactful science and technology provides invaluable insight into the innovation dynamics of human society, yet many studies are limited to qualitative and small-scale approaches. Here, we investigate scientific evolution through systematic analysis of a massive corpus of digitized English texts between 1800 and 2008. Our analysis reveals great predictability for long-prevailing scientific concepts based on the levels of their prior usage. Interestingly, once a threshold of early adoption rates is passed even slightly, scientific concepts can exhibit sudden leaps in their eventual lifetimes. We developed a mechanistic model to account for such results, indicating that slowly-but-commonly adopted science and technology surprisingly tend to have higher innate strength than fast-and-commonly adopted ones. The model prediction for disciplines other than science was also well verified. Our approach sheds light on unbiased and quantitative analysis of scientific evolution in society, and may provide a useful basis for policy-making.	[Yun, Jinhyuk; Jeong, Hawoong] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, Pan-Jun; Jeong, Hawoong] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Kim, Pan-Jun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); Korea Advanced Institute of Science & Technology (KAIST)	Kim, PJ (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, South Korea.	pjkim@apctp.org; hjeong@kaist.edu	Jeong, Hawoong/C-1587-2011; Jeong, Hawoong/AAR-2524-2021	Jeong, Hawoong/0000-0002-2491-8620; Kim, Pan-Jun/0000-0002-9329-4997	National Research Foundation of Korea [2011-0028908, NRF-2012R1A1A2008925]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea through Grant No. 2011-0028908 (JY and HJ) and NRF-2012R1A1A2008925 (PJK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2014, EVOL HUM BEHAV, V35, P228, DOI 10.1016/j.evolhumbehav.2014.02.003; Arthur WB, 1996, HARVARD BUS REV, V74, P100; Bender D.A., 2009, DICT FOOD NUTR; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Blumm N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128701; Bornholdt S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058701; Chilvers Ian, 2004, OXFORD DICT ART; Dance Amber, 2013, Nature, V502, P397; Deschamps JY, 2005, XENOTRANSPLANTATION, V12, P91, DOI 10.1111/j.1399-3089.2004.00199.x; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Engelhardt H. T., 1996, FDN BIOETHICS; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; ERDOS P, 1960, B INT STATIST INST, V38, P343; Flowers N. T., 2008, Morbidity and Mortality Weekly Report, V57, P309; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hicks D, 2012, RES POLICY, V41, P251, DOI 10.1016/j.respol.2011.09.007; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Krieger K, 2014, NATURE, V508, P448, DOI 10.1038/508448a; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lin Y., 2012, P ACL 2012 SYSTEM DE, P169, DOI DOI 10.1007/978-1-4614-2311-9_8; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mehrotra C, 2005, PUBLIC HEALTH REP, V120, P278, DOI 10.1177/003335490512000310; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Polikarpov AA, 1991, P 1 INT C QUANT LING, P53; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Rocha LEC, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/28005; Rutherford-Johnson T, 2012, OXFORD DICT MUSIC, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Saito K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084265; SCHUYLER RL, 1959, POLIT SCI QUART, V74, P321, DOI 10.2307/2146272; Toffler A., 1984, 3 VAGA; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906	37	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117388	10.1371/journal.pone.0117388	http://dx.doi.org/10.1371/journal.pone.0117388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671617	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300051
J	Cuffe, JSM; Steane, S; Moritz, KM; Paravicini, TM				Cuffe, James S. M.; Steane, Sarah; Moritz, Karen M.; Paravicini, Tamara M.			Differential mRNA Expression and Glucocorticoid-Mediated Regulation of TRPM6 and TRPM7 in the Heart and Kidney throughout Murine Pregnancy and Development	PLOS ONE			English	Article							SERUM IONIZED MAGNESIUM; DEXAMETHASONE EXPOSURE; PLACENTAL GROWTH; MG2+ HOMEOSTASIS; DOWN-REGULATION; BLOOD-PRESSURE; HYPOMAGNESEMIA; KINASE; CA2+; SENSITIVITY	The transient receptor potential (TRP) channels TRPM6 and TRPM7 are critically involved in maintaining whole body and cellular Mg2+ homeostasis and ensuring the normal function of organs such as the heart and kidney. However, we do not know how the expression of TRPM6 and TPRM7 in these organs changes throughout fetal development and adult life, and whether this expression can be hormonally regulated. This study determined the ontogeny of TRPM6 and TRPM7 mRNA expression from mid-gestation through to adulthood in the mouse. In a second series of experiments, we examined how maternal administration of the glucocorticoids corticosterone and dexamethasone between embryonic days 12.5-15 affected TRPM6 and TRPM7 channel mRNA expression in the mother and fetus. Whilst renal TRPM7 expression was relatively constant throughout development, renal TRPM6 expression was markedly upregulated after birth. In contrast, cardiac TRPM7 expression was 2-4 fold higher in the fetus than in the adult. Surprisingly, TRPM6 expression was detected in the fetal heart (qPCR and in situ hybridization). Glucocorticoid administration during gestation increased fetal cardiac expression of both channels without affecting renal expression. In contrast, in the dam renal TRPM6 and TRPM7 expression was increased by glucocorticoids with no change in the cardiac channel expression. These data suggest that TRPM6 and TRPM7 channels are important in organogenesis, and that elevated maternal glucocorticoid levels can alter the expression of these channels. This suggests that perturbations in hormonal regulatory systems during pregnancy may adversely impact upon normal fetal development, at least in part by altering expression of TRPM channels.	[Cuffe, James S. M.; Steane, Sarah; Moritz, Karen M.; Paravicini, Tamara M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland	Paravicini, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	t.paravicini@uq.edu.au	Cuffe, James/H-1003-2016; Moritz, Karen/G-2508-2015	Cuffe, James/0000-0002-2675-8149; Moritz, Karen/0000-0002-8085-0034; steane, sarah/0000-0001-8594-3486				BARRI M, 1990, EXP PHYSIOL, V75, P681, DOI 10.1113/expphysiol.1990.sp003446; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Cuffe JSM, 2011, PLACENTA, V32, P981, DOI 10.1016/j.placenta.2011.09.009; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Dominguez LJ, 1998, J CLIN ENDOCR METAB, V83, P4402, DOI 10.1210/jc.83.12.4402; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Kisters K, 1998, GYNECOL OBSTET INVES, V46, P158, DOI 10.1159/000010024; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Meng Z, 2012, TRANSPL P, V44, P1206, DOI 10.1016/j.transproceed.2011.11.068; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Muneyyirci-Delale O, 1998, FERTIL STERIL, V69, P958, DOI 10.1016/S0015-0282(98)00053-3; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; O'Sullivan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069149; Rondon LJ, 2008, AM J PHYSIOL-REG I, V294, pR2001, DOI 10.1152/ajpregu.00153.2007; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Sah R, 2013, P NATL ACAD SCI USA, V110, pE3037, DOI 10.1073/pnas.1311865110; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Schlingmann KP, 2005, J AM SOC NEPHROL, V16, P3061, DOI 10.1681/ASN.2004110989; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Tabrizi FM, 2014, INDIAN J CLIN BIOCHE, V29, P174, DOI 10.1007/s12291-013-0336-x; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Woudenberg-Vrenken TE, 2011, NEPHRON PHYSIOL, V117, pP11, DOI 10.1159/000320580; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117978	10.1371/journal.pone.0117978	http://dx.doi.org/10.1371/journal.pone.0117978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692682	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500087
J	Husemann, M; Habel, JC; Namkung, S; Hochkirch, A; Otte, D; Danley, PD				Husemann, Martin; Habel, Jan Christian; Namkung, Suk; Hochkirch, Axel; Otte, Daniel; Danley, Patrick D.			Molecular Evidence for an Old World Origin of Galapagos and Caribbean Band-Winged Grasshoppers (Acrididae: Oedipodinae: Sphingonotus)	PLOS ONE			English	Article							POPULATION-STRUCTURE; TRANS-ATLANTIC; COLONIZATION; DIVERSIFICATION; ISLANDS; ORTHOPTERA; DISPERSAL; BIOGEOGRAPHY; VICARIANCE; LIZARDS	Patterns of colonization and diversification on islands provide valuable insights into evolutionary processes. Due to their unique geographic position and well known history, the Galapagos Islands are an important model system for evolutionary studies. Here we investigate the evolutionary history of a winged grasshopper genus to infer its origin and pattern of colonization in the Galapagos archipelago. The grasshopper genus Sphingonotus has radiated extensively in the Palaearctic and many species are endemic to islands. In the New World, the genus is largely replaced by the genus Trimerotropis. Oddly, in the Caribbean and on the Galapagos archipelago, two species of Sphingonotus are found, which has led to the suggestion that these might be the result of anthropogenic translocations from Europe. Here, we test this hypothesis using mitochondrial and nuclear DNA sequences from a broad sample of Sphingonotini and Trimerotropini species from the Old World and New World. The genetic data show two distinct genetic clusters representing the New World Trimerotropini and the Old World Sphingonotini. However, the Sphingonotus species from Galapagos and the Caribbean split basally within the Old World Sphingonotini lineage. The Galapagos and Caribbean species appear to be related to Old World taxa, but are not the result of recent anthropogenic translocations as revealed by divergence time estimates. Distinct genetic lineages occur on the four investigated Galapagos Islands, with deep splits among them compared to their relatives from the Palaearctic. A scenario of a past wider distribution of Sphingonotus in the New World with subsequent extinction on the mainland and replacement by Trimerotropis might explain the disjunct distribution.	[Husemann, Martin; Habel, Jan Christian] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Bavaria, Germany; [Husemann, Martin; Namkung, Suk; Danley, Patrick D.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Husemann, Martin] Univ Halle Wittenberg, Inst Biol, D-06108 Halle An Der Saale, Saxony Anhalt, Germany; [Hochkirch, Axel] Univ Trier, Dept Biogeog, Trier, Rhineland Palat, Germany; [Otte, Daniel] Drexel Univ, Acad Nat Sci, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Technical University of Munich; Baylor University; Martin Luther University Halle Wittenberg; Universitat Trier; Drexel University	Husemann, M (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Bavaria, Germany.	martinhusemann@yahoo.de	Husemann, Martin/C-4414-2015; Hochkirch, Axel/E-7891-2011; Hochkirch, Axel/A-4092-2008; Habel, Jan Christian/H-2112-2019	Husemann, Martin/0000-0001-5536-6681; Hochkirch, Axel/0000-0002-4475-0394; Danley, Patrick/0000-0001-8782-5045; Namkung, Suk/0000-0002-2220-6785; Habel, Jan Christian/0000-0003-1378-9381	Orthopterists' Society; URSA grant from Baylor University; German Research Foundation (DFG); Technische Universitat Munchen	Orthopterists' Society; URSA grant from Baylor University; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The analysed were financed by a small grant Orthopterists' Society to MH, and an URSA grant from Baylor University to PDD and SN. This work was supported by the German Research Foundation (DFG) and Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Blatchley WS., 1920, ORTHOPTERA NE AM; Bollmer JL, 2006, MOL PHYLOGENET EVOL, V39, P237, DOI 10.1016/j.ympev.2005.11.014; Buzzetti Filippo Maria, 2008, Memoirs on Biodiversity, V1, P39; Carranza S., 2003, Systematics and Biodiversity, V1, P275, DOI 10.1017/S1477200003001099; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Chapco William, 2011, Journal of Orthoptera Research, V20, P173, DOI 10.1665/034.020.0205; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Darwin C., 1859, NATURE; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Dirsh V. M., 1969, Bulletin of the British Museum (Natural History) Entomology, V23, P25; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; FINSTON TL, 1995, HEREDITY, V75, P390, DOI 10.1038/hdy.1995.151; Gentile G, 2009, P NATL ACAD SCI USA, V106, P507, DOI 10.1073/pnas.0806339106; GRANT PR, 1976, P NATL ACAD SCI USA, V73, P257, DOI 10.1073/pnas.73.1.257; Grant PR, 2011, WHY SPECIES MULTIPLY; Harpp KS, 2014, GEOPHYS MONOGR SER, V204, P1, DOI 10.1002/9781118852538; Hebard M., 1920, Proceedings of the California Academy of Science (4th Series), V2; Hochkirch A, 2008, ZOOL STUD, V47, P495; Hollier J, 2012, REV SUISSE ZOOL, V119, P215; Husemann M, 2014, MOL PHYLOGENET EVOL, V81, P174, DOI 10.1016/j.ympev.2014.09.017; Husemann M, 2013, ZOOL J LINN SOC-LOND, V168, P29, DOI 10.1111/zoj.12023; Husemann M, 2013, J BIOGEOGR, V40, P261, DOI 10.1111/jbi.12007; Husemann M, 2012, ZOOL SCR, V41, P515, DOI 10.1111/j.1463-6409.2012.00548.x; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kavar T, 2006, B ENTOMOL RES, V96, P117, DOI 10.1079/BER2005406; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lovejoy NR, 2006, P ROY SOC B-BIOL SCI, V273, P767, DOI 10.1098/rspb.2005.3381; MAC ARTHUR ROBERT H., 1967; Michalak I, 2010, J BIOGEOGR, V37, P1214, DOI 10.1111/j.1365-2699.2010.02306.x; Mists henko L., 1936, EOS REV ESPANOLA ENT, V12, P65; Otte D, 1984, ACRIDIDAE OEDIPODINA; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Pavlovcic P, 2008, B INSECTOL, V61, P191; Peck SB, 1996, CAN J ZOOL, V74, P1497, DOI 10.1139/z96-164; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2010, FIGTREE 1 3 1; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sequeira AS, 2000, HEREDITY, V85, P20, DOI 10.1046/j.1365-2540.2000.00690.x; Snodgrass R. E., 1902, P WASH ACAD SCI, V4, P411; Su ZH, 1998, MOL BIOL EVOL, V15, P1026, DOI 10.1093/oxfordjournals.molbev.a026001; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; WHITE MJD, 1949, GENETICS, V34, P537; WHITE MJD, 1951, GENETICS, V36, P31; WHITE WM, 1993, J GEOPHYS RES-SOL EA, V98, P19533, DOI 10.1029/93JB02018; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	53	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118208	10.1371/journal.pone.0118208	http://dx.doi.org/10.1371/journal.pone.0118208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692768	gold, Green Published			2022-12-27	WOS:000350061500108
J	Lee, J; Daniels, V; Sands, ZA; Lebon, F; Shi, JY; Biggin, PC				Lee, Joanna; Daniels, Veronique; Sands, Zara A.; Lebon, Florence; Shi, Jiye; Biggin, Philip C.			Exploring the Interaction of SV2A with Racetams Using Homology Modelling, Molecular Dynamics and Site-Directed Mutagenesis	PLOS ONE			English	Article							VESICLE PROTEIN 2A; SECONDARY STRUCTURE; BINDING-SITE; FORCE-FIELD; PREDICTION; EFFICIENT; LEVETIRACETAM; TRANSPORTER; LOCALIZATION; MECHANISM	The putative Major Facilitator Superfamily (MFS) transporter, SV2A, is the target for levetiracetam (LEV), which is a successful anti-epileptic drug. Furthermore, SV2A knock out mice display a severe seizure phenotype and die after a few weeks. Despite this, the mode of action of LEV is not known at the molecular level. It would be extremely desirable to understand this more fully in order to aid the design of improved anti-epileptic compounds. Since there is no structure for SV2A, homology modelling can provide insight into the ligand-binding site. However, it is not a trivial process to build such models, since SV2A has low sequence identity to those MFS transporters whose structures are known. A further level of complexity is added by the fact that it is not known which conformational state of the receptor LEV binds to, as multiple conformational states have been inferred by tomography and ligand binding assays or indeed, if binding is exclusive to a single state. Here, we explore models of both the inward and outward facing conformational states of SV2A (according to the alternating access mechanism for MFS transporters). We use a sequence conservation analysis to help guide the homology modelling process and generate the models, which we assess further with Molecular Dynamics (MD). By comparing the MD results in conjunction with docking and simulation of a LEV-analogue used in radioligand binding assays, we were able to suggest further residues that line the binding pocket. These were confirmed experimentally. In particular, mutation of D670 leads to a complete loss of binding. The results shed light on the way LEV analogues may interact with SV2A and may help with the ongoing design of improved anti-epileptic compounds.	[Lee, Joanna; Biggin, Philip C.] Univ Oxford, Oxford OX1 3QU, England; [Daniels, Veronique; Sands, Zara A.; Lebon, Florence; Shi, Jiye] UCB Pharma S, Chemin Foriest, B-1420 Braine l Alleud, Belgium	University of Oxford	Biggin, PC (corresponding author), Univ Oxford, S Parks Rd, Oxford OX1 3QU, England.	philip.biggin@bioch.ox.ac.uk		Daniels, Veronique/0000-0003-3403-8106; Biggin, Philip/0000-0001-5100-8836	BBSRC - UCB BioPharma SPRL; Walloon Region (Belgium) DGO6 [6536]; Biotechnology and Biological Sciences Research Council [1107134] Funding Source: researchfish	BBSRC - UCB BioPharma SPRL; Walloon Region (Belgium) DGO6; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Joanna Lee is a BBSRC-funded student in receipt of additional financial support from UCB BioPharma SPRL. Zara Sands, Florence Lebon and Jiye Shi are all employees of UCB BioPharma SPRL. During the course of the research reported herein, Veronique Daniels was an employee of UCB BioPharma SPRL and her research was supported by a grant from the Walloon Region (Belgium) DGO6 (Convention 6536). There are no patents or products in development or marketed products to nildeclare that arise from this work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crevecoeur J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-87; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Daniels V, 2013, BRIT J PHARMACOL, V169, P1091, DOI 10.1111/bph.12192; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fuks B, 2003, EUR J PHARMACOL, V478, P11, DOI 10.1016/j.ejphar.2003.08.033; Gambardella Antonio, 2008, Neuropsychiatr Dis Treat, V4, P33; GINGRICH JA, 1992, FEBS LETT, V312, P115, DOI 10.1016/0014-5793(92)80917-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Lynch BA, 2008, BIOCHEM BIOPH RES CO, V375, P491, DOI 10.1016/j.bbrc.2008.07.145; Madeo M, 2014, J BIOL CHEM; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2011, BIOCHEM SOC T, V39, P1341, DOI 10.1042/BST0391341; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	50	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116589	10.1371/journal.pone.0116589	http://dx.doi.org/10.1371/journal.pone.0116589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692762	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500018
J	Liu, HY; Li, QR; Cheng, XF; Wang, H; Wang, GJ; Hao, HP				Liu, Huiying; Li, Qingran; Cheng, Xuefang; Wang, Hong; Wang, Guangji; Hao, Haiping			UDP-Glucuronosyltransferase 1A Determinates Intracellular Accumulation and Anti-Cancer Effect of beta-Lapachone in Human Colon Cancer Cells	PLOS ONE			English	Article							INTRINSIC DRUG-RESISTANCE; GENE-EXPRESSION; DOWN-REGULATION; HUMAN LIVER; GLUCURONIDATION; DETOXIFICATION; ACTIVATION; MECHANISM; APOPTOSIS; DEATH	beta-lapachone (beta-lap), an NAD(P) H: quinone oxidoreductase 1 (NQO1) targeting antitumor drug candidate in phase II clinical trials, is metabolically eliminated via NQO1 mediated quinone reduction and subsequent UDP-glucuronosyltransferases (UGTs) catalyzed glucuronidation. This study intends to explore the inner link between the cellular glucuronidation and pharmacokinetics of beta-lap and its apoptotic effect in human colon cancer cells. HT29 cells S9 fractions exhibited high glucuronidation activity towards beta-lap, which can be inhibited by UGT1A9 competitive inhibitor propofol. UGT1A siRNA treated HT29 cells S9 fractions displayed an apparent low glucuronidation activity. Intracellular accumulation of beta-lap in HCT116 cells was much higher than that in HT29 cells, correlated with the absence of UGT1A in HCT116 cells. The cytotoxic and apoptotic effect of beta-lap in HT29 cells were much lower than that in HCT116 cells; moreover, beta-lap triggered activation of SIRT1-FOXO1 apoptotic pathway was observed in HCT116 cells but not in HT29 cells. Pretreatment of HT29 cells with UGT1A siRNA or propofol significantly decreased beta-lap's cytotoxic and apoptotic effects, due to the repression of glucuronidation and the resultant intracellular accumulation. In conclusion, UGT1A is an important determinant, via switching NQO1-triggered redox cycle to metabolic elimination, in the intracellular accumulation of beta-lap and thereafter its cytotoxicity in human colon cancer cells. Together with our previous works, we propose that UGTs determined cellular pharmacokinetics is an important determinant in the apoptotic effects of NQO1 targeting substrates serving as chemotherapeutic drugs.	[Liu, Huiying; Li, Qingran; Cheng, Xuefang; Wang, Hong; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Hao, Haiping/L-8265-2019	Hao, Haiping/0000-0003-2522-7546; Wang, Hong/0000-0002-6192-3082	National Natural Science Foundation of China [81430091, 81325025, 81273586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Nos. 81430091, 81325025 and 81273586, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html, National Natural Science Foundation of China (HH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2013, RADIAT ONCOL J, V31, P57, DOI 10.3857/roj.2013.31.2.57; Belanger AS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-9; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Blanco E, 2010, CANCER RES, V70, P3896, DOI 10.1158/0008-5472.CAN-09-3995; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cheng XF, 2012, MOL PHARMACEUT, V9, P3476, DOI 10.1021/mp300296m; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cummings J, 2004, BIOCHEM PHARMACOL, V67, P31, DOI 10.1016/j.bcp.2003.07.019; Cummings J, 2003, CANCER RES, V63, P8443; D'Anneo A, 2010, J CELL PHYSIOL, V222, P433, DOI 10.1002/jcp.21983; Dellinger RW, 2006, DRUG METAB DISPOS, V34, P943, DOI 10.1124/dmd.105.009100; Gauthier-Landry L, 2014, J STEROID BIOCH MOL; Greer AK, 2014, DRUG METAB DISPOS; Izumi K, 2012, MOL CARCINOGENESIS; Kim YH, 2012, FREE RADICAL BIO MED, V52, P880, DOI 10.1016/j.freeradbiomed.2011.12.007; Li YZ, 2000, MOL MED, V6, P1008, DOI 10.1007/BF03402052; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; Liu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079172; Menna-Barreto RFS, 2009, PARASITOLOGY, V136, P499, DOI 10.1017/S0031182009005745; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Park E, 2013, CELL DEATH DIS, V5, pe1230, DOI [10.1016/j.bcp.2014.12.018, DOI 10.1016/J.BCP.2014.12.018]; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; PLANCHON SM, 1995, CANCER RES, V55, P3706; Planchon SM, 2001, EXP CELL RES, V267, P95, DOI 10.1006/excr.2001.5234; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sentellas S, 2014, TOXICOL IN VITRO, V28, P1006, DOI 10.1016/j.tiv.2014.04.017; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Strassburg CP, 1997, CANCER RES, V57, P2979; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Suzuki M, 2006, RADIAT RES, V165, P525, DOI 10.1667/RR3554.1; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; Tang L, 2014, PHARM RES-DORDR, V31, P847, DOI 10.1007/s11095-013-1207-0; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang FJ, 2006, J PHARM SCI-US, V95, P2309, DOI 10.1002/jps.20721; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397	42	33	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117051	10.1371/journal.pone.0117051	http://dx.doi.org/10.1371/journal.pone.0117051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692465	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500035
J	Torode, TA; Marcus, SE; Jam, M; Tonon, T; Blackburn, RS; Herve, C; Knox, JP				Torode, Thomas A.; Marcus, Susan E.; Jam, Murielle; Tonon, Thierry; Blackburn, Richard S.; Herve, Cecile; Knox, J. Paul			Monoclonal Antibodies Directed to Fucoidan Preparations from Brown Algae	PLOS ONE			English	Article							PLANT-CELL WALLS; FUCUS-SERRATUS; SULFATED POLYSACCHARIDES; LAMPROTHAMNIUM-PAPULOSUM; PECTIC HOMOGALACTURONAN; ECTOCARPUS-SILICULOSUS; EXTRACELLULAR-MATRIX; EVOLUTION; HETEROGENEITY; PHAEOPHYCEAE	Cell walls of the brown algae contain a diverse range of polysaccharides with useful bioactivities. The precise structures of the sulfated fucan/fucoidan group of polysaccharides and their roles in generating cell wall architectures and cell properties are not known in detail. Four rat monoclonal antibodies, BAM1 to BAM4, directed to sulfated fucan preparations, have been generated and used to dissect the heterogeneity of brown algal cell wall polysaccharides. BAM1 and BAM4, respectively, bind to a non-sulfated epitope and a sulfated epitope present in the sulfated fucan preparations. BAM2 and BAM3 identified additional distinct epitopes present in the fucoidan preparations. All four epitopes, not yet fully characterised, occur widely within the major brown algal taxonomic groups and show divergent distribution patterns in tissues. The analysis of cell wall extractions and fluorescence imaging reveal differences in the occurrence of the BAM1 to BAM4 epitopes in various tissues of Fucus vesiculosus. In Ectocarpus subulatus, a species closely related to the brown algal model Ectocarpus siliculosus, the BAM4 sulfated epitope was modulated in relation to salinity levels. This new set of monoclonal antibodies will be useful for the dissection of the highly complex and yet poorly resolved sulfated polysaccharides in the brown algae in relation to their ecological and economic significance.	[Torode, Thomas A.; Marcus, Susan E.; Knox, J. Paul] Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Jam, Murielle; Tonon, Thierry; Herve, Cecile] Sorbonne Univ, Univ Paris 06, UMR 8227, Stn Biol Roscoff, F-90074 Roscoff, France; [Jam, Murielle; Tonon, Thierry; Herve, Cecile] CNRS, Stn Biol Roscoff, UMR 8227, Roscoff, France; [Blackburn, Richard S.] Univ Leeds, Ctr Tech Text, Sustainable Mat Res Grp, Leeds, W Yorkshire, England	University of Leeds; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Leeds	Knox, JP (corresponding author), Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds, W Yorkshire, England.	j.p.knox@leeds.ac.uk	Tonon, Thierry/A-3214-2009; Knox, Paul/H-4577-2012; Blackburn, Richard Simon/B-3210-2016	Tonon, Thierry/0000-0002-1454-6018; Knox, Paul/0000-0002-9231-6891; Blackburn, Richard Simon/0000-0001-6259-3807; Herve, Cecile/0000-0001-6649-8137; Torode, Thomas/0000-0001-9717-6923	UK Biotechnology and Biological Research Council; Assemble [227799]; European Union FP7 research network; Biotechnology and Biological Sciences Research Council [977478] Funding Source: researchfish	UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Assemble; European Union FP7 research network; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a UK Biotechnology and Biological Research Council (http://www.bbsrc.ac.uk) studentship to TAT. TAT also received two awards from Assemble (#227799), a European Union FP7 research network (http://www.assemblemarine.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Anastyuk SD, 2010, CARBOHYD RES, V345, P2206, DOI 10.1016/j.carres.2010.07.043; Aquino RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018862; Bilan MI, 2010, CARBOHYD RES, V345, P2038, DOI 10.1016/j.carres.2010.07.009; Brownlee C, 2001, SEMIN CELL DEV BIOL, V12, P345, DOI 10.1006/scdb.2001.0262; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Coelho SM, 2011, P NATL ACAD SCI USA, V108, P11518, DOI 10.1073/pnas.1102274108; Cornuault V, 2014, PLANT J, V78, P715, DOI 10.1111/tpj.12504; Deniaud-Bouet E, 2014, ANN BOT-LONDON, V114, P1203, DOI 10.1093/aob/mcu096; Descamps V, 2006, MAR BIOTECHNOL, V8, P27, DOI 10.1007/s10126-005-5107-0; Dittami SM, 2012, PLANT J, V71, P366, DOI 10.1111/j.1365-313X.2012.04982.x; Dittami SM, 2011, PLANT CELL ENVIRON, V34, P629, DOI 10.1111/j.1365-3040.2010.02268.x; Dittami SM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-2; EARDLEY DD, 1990, J PHYCOL, V26, P54, DOI 10.1111/j.0022-3646.1990.00054.x; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; GREEN JR, 1993, NEW PHYTOL, V124, P397, DOI 10.1111/j.1469-8137.1993.tb03830.x; Hahn T, 2012, PROCESS BIOCHEM, V47, P1691, DOI 10.1016/j.procbio.2012.06.016; JONES JL, 1988, PLANTA, V176, P298, DOI 10.1007/BF00395410; KLEIN MD, 1982, ANAL BIOCHEM, V124, P59, DOI 10.1016/0003-2697(82)90219-6; KLOAREG B, 1986, INT J BIOL MACROMOL, V8, P380, DOI 10.1016/0141-8130(86)90060-7; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kolender AA, 2004, CARBOHYD RES, V339, P1619, DOI 10.1016/j.carres.2004.03.029; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; LARSEN B, 1985, CARBOHYD RES, V143, P221, DOI 10.1016/S0008-6215(00)90710-9; LARSEN B, 1966, ACTA CHEM SCAND, V20, P219, DOI 10.3891/acta.chem.scand.20-0219; Le Bail A, 2011, PLANT CELL, V23, P1666, DOI 10.1105/tpc.110.081919; Lee KJD, 2013, PLANT J, V75, P1018, DOI 10.1111/tpj.12263; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; MABEAU S, 1987, J EXP BOT, V38, P1573, DOI 10.1093/jxb/38.9.1573; Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARIANI P, 1985, PROTOPLASMA, V128, P208, DOI 10.1007/BF01276343; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MCCULLY ME, 1968, PROTOPLASMA, V66, P205, DOI 10.1007/BF01252533; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; PARSONS TF, 1980, P NATL ACAD SCI-BIOL, V77, P7089, DOI 10.1073/pnas.77.12.7089; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peters AF, 2010, PHYCOL RES, V58, P157, DOI 10.1111/j.1440-1835.2010.00574.x; Pomin VH, 2008, GLYCOBIOLOGY, V18, P1016, DOI 10.1093/glycob/cwn085; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Seaweeds TD, 2002, NATURAL HIST MUSEUM; Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664; Shepherd VA, 1999, J MEMBRANE BIOL, V170, P229, DOI 10.1007/s002329900552; Shepherd VA, 1999, PLANT CELL ENVIRON, V22, P333, DOI 10.1046/j.1365-3040.1999.00414.x; VREELAND V, 1984, PLANTA, V162, P506, DOI 10.1007/BF00399916; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wei N, 2013, TRENDS BIOTECHNOL, V31, P70, DOI 10.1016/j.tibtech.2012.10.009; West John A., 1996, Muelleria, V9, P29; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Zhao D, 2012, MOL BIOSYST, V8, P753, DOI 10.1039/c1mb05337j	52	40	41	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118366	10.1371/journal.pone.0118366	http://dx.doi.org/10.1371/journal.pone.0118366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692870	Green Published, Green Accepted, gold			2022-12-27	WOS:000350061500119
J	Kayashima, Y; Makhanova, NA; Matsuki, K; Tomita, H; Bennett, BJ; Maeda, N				Kayashima, Yukako; Makhanova, Natalia A.; Matsuki, Kota; Tomita, Hirofumi; Bennett, Brian J.; Maeda, Nobuyo			Identification of Aortic Arch-Specific Quantitative Trait Loci for Atherosclerosis by an Intercross of DBA/2J and 129S6 Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INBRED MOUSE STRAINS; HYALURONAN RECEPTOR; HISTIDINE-DECARBOXYLASE; CORONARY-ARTERY; SUSCEPTIBILITY; STABILIN-2; CLEARANCE; HISTAMINE; PROMOTES	The genetic background of apolipoprotein E (apoE) deficient mice influences atherosclerotic plaque development. We previously reported three quantitative trait loci (QTL), Aath1-Aath3, that affect aortic arch atherosclerosis independently of those in the aortic root in a cross between C57BL6 apoEKO mice (B6-apoE) and 129S6 apoEKO mice (129-apoE). To gain further insight into genetic factors that influence atherosclerosis at different vascular locations, we analyzed 335 F2 mice from an intercross between 129-apoE and apoEKO mice on a DBA/2J genetic background (DBA-apoE). The extent of atherosclerosis in the aortic arch was very similar in the two parental strains. Nevertheless, a genome-wide scan identified two significant QTL for plaque size in the aortic arch: Aath4 on Chromosome (Chr) 2 at 137 Mb and Aath5 on Chr 10 at 51 Mb. The DBA alleles of Aath4 and Aath5 respectively confer susceptibility and resistance to aortic arch atherosclerosis over 129 alleles. Both QTL are also independent of those affecting plaque size at the aortic root. Genome analysis suggests that athero-susceptibility of Aath4 in DBA may be contributed by multiple genes, including Mertk and Cd93, that play roles in phagocytosis of apoptotic cells and modulate inflammation. A candidate gene for Aath5 is Stab2, the DBA allele of which is associated with 10 times higher plasma hyaluronan than the 129 allele. Overall, our identification of two new QTL that affect atherosclerosis in an aortic arch-specific manner further supports the involvement of distinct pathological processes at different vascular locations.	[Kayashima, Yukako; Makhanova, Natalia A.; Matsuki, Kota; Tomita, Hirofumi; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Bennett, Brian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA.	nobuyo@med.unc.edu		bennett, brian/0000-0002-0766-3195	National Institutes of Health (NIH) [HL042630]; American Heart Association [09POST2250823]; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, R37HL042630] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by a National Institutes of Health (NIH) grant HL042630 to NM (http://www.nih.gov/), an American Heart Association Fellowship Award 09POST2250823 to HT (http://www.heart.org/HEARTORG/), and an Uehara Memorial Foundation Fellowship (http://www.ueharazaidan.or.jp/) to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baetens M, 2011, HUM MUTAT, V32, P1053, DOI 10.1002/humu.21525; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bennett BJ, 2009, ARTERIOSCL THROM VAS, V29, P348, DOI 10.1161/ATVBAHA.108.176685; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Danese C, 2006, Clin Ter, V157, P9; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FERNS GAA, 1995, ATHEROSCLEROSIS, V114, P157, DOI 10.1016/0021-9150(94)05479-3; GILMOUR RS, 1994, J ENDOCRINOL, V140, P1, DOI 10.1677/joe.0.1400001; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kayashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088274; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Maeda N, 2007, MOUSE BIOMEDICAL RES, V3, P535; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; MARTIN SAM, 1984, BIOCHEM GENET, V22, P305, DOI 10.1007/BF00484230; MARTIN SAM, 1984, BIOCHEM GENET, V22, P645, DOI 10.1007/BF00485850; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Papakonstantinou E, 1998, GLYCOBIOLOGY, V8, P821, DOI 10.1093/glycob/8.8.821; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sadowitz B, 2012, J SURG RES, V173, pE63, DOI 10.1016/j.jss.2011.09.025; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smithies O, 2005, NAT REV GENET, V6, P419, DOI 10.1038/nrg1605; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zekavat G, 2010, IMMUNOGENETICS, V62, P397, DOI 10.1007/s00251-010-0442-3; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649	51	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117478	10.1371/journal.pone.0117478	http://dx.doi.org/10.1371/journal.pone.0117478			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689165	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700048
J	Ko, YL; Sun, CS; Chung, KM; Lin, YM; Feng, IC; Sheu, MJ; Koay, LB; Lin, CY; Ho, CH; Kuo, HT				Ko, Yen-Ling; Sun, Chi-Shu; Chung, Kun-Ming; Lin, Yu-Min; Feng, I-Che; Sheu, Ming-Jen; Koay, Lok-Beng; Lin, Ching-Yih; Ho, Chung-Han; Kuo, Hsing-Tao			Manifestations of Perihepatic Lymph Nodes in Acute Flare of Chronic Hepatitis B: Association with HBeAg Status and with HBeAg Seroconversion	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; VIRUS-INFECTION; ABDOMINAL LYMPHADENOPATHY; HEPATOCELLULAR-CARCINOMA; ANTIBODY SEROCONVERSION; ACUTE EXACERBATIONS; CHINESE PATIENTS; NATURAL-HISTORY; LIVER-DISEASE; CORE ANTIGEN	It has been observed that enlargement of perihepatic lymph nodes may be seen in patients with chronic hepatitis B, particularly during acute flares of CHB. We hypothesized that there may be a correlation between the nodal change patterns in CHB patients with acute flare and HBeAg status. Perihepatic lymph node sizes of 87 patients with acute flares of CHB were documented, with a median follow up of 43 months. Patients were separated into 3 groups, HBeAg-positive with HBe seroconversion (group 1), HBeAg-positive without HBe seroconversion (group 2), and HBeAg-negative (group 3). Group 1 has the highest incidence of enlarged lymph nodes (92.3%) compared with group 2 (75.8%) and group 3 (46.8%) (p = 0.003). And if nodal width at acute flare was >8mm and interval change of nodal width was >3mm, the incidence of HBeAg seroconversion will be 75% (p<0.001). Conclusion Larger perihepatic lymph nodes are seen in CHB acute flare patients with positive HBeAg and the magnitude of nodal width change may predict HBeAg seroconversion at recovery.	[Sun, Chi-Shu; Lin, Yu-Min; Feng, I-Che; Sheu, Ming-Jen; Koay, Lok-Beng; Lin, Ching-Yih; Kuo, Hsing-Tao] Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan; [Kuo, Hsing-Tao] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Tainan, Taiwan; [Ko, Yen-Ling; Chung, Kun-Ming] Chi Mei Med Ctr, Div Gen Internal Med, Dept Internal Med, Tainan, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Yongkang, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Kuo, HT (corresponding author), Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan.	kuohsu2003@yahoo.com.tw		Ho, Chung-Han/0000-0001-5925-8477				Barbier L, 2012, J HEPATOL, V57, P352, DOI 10.1016/j.jhep.2012.03.023; CASSANI F, 1990, J CLIN GASTROENTEROL, V12, P42, DOI 10.1097/00004836-199002000-00012; CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1002/hep.1840130303; Choi MS, 2001, J CLIN GASTROENTEROL, V32, P329, DOI 10.1097/00004836-200104000-00010; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chu CM, 1987, GASTROENTEROLOGY, V92, P220, DOI 10.1016/0016-5085(87)90863-8; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; CHU CM, 1985, HEPATOLOGY, V5, P431, DOI 10.1002/hep.1840050315; DUDLEY FJ, 1972, LANCET, V1, P723; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; He DM, 2013, HEPATOLOGY, V58, p416A; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hultkrantz S, 2005, IMMUNOLOGY, V116, P362, DOI 10.1111/j.1365-2567.2005.02236.x; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Kim HS, 2009, GASTROENTEROLOGY, V136, P505, DOI 10.1053/j.gastro.2008.10.089; Kuo HT, 2006, J CLIN ULTRASOUND, V34, P211, DOI 10.1002/jcu.20226; LIAW YF, 1983, GASTROENTEROLOGY, V84, P216; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lin YM, 2011, EUR J GASTROEN HEPAT, V23, P990, DOI 10.1097/MEG.0b013e32834ae825; LOK ASF, 1990, J HEPATOL, V10, P29, DOI 10.1016/0168-8278(90)90069-4; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; MATSUNO K, 1990, ARCH HISTOL CYTOL, V53, P179, DOI 10.1679/aohc.53.Suppl_179; Muller P, 2003, J HEPATOL, V39, P807, DOI 10.1016/S0168-8278(03)00357-X; Okada Y, 1996, CLIN RADIOL, V51, P160, DOI 10.1016/S0009-9260(96)80316-3; REALDI G, 1980, GASTROENTEROLOGY, V79, P195; SANCHEZTAPIAS JM, 1988, J HEPATOL, V6, P15, DOI 10.1016/S0168-8278(88)80458-6; Shu J, 2013, WORLD J RADIOL, V5, P208, DOI 10.4329/wjr.v5.i5.208; SJOGREN M, 1985, GASTROENTEROLOGY, V89, P252, DOI 10.1016/0016-5085(85)90323-3; Soresi M, 1998, J HEPATOL, V28, P544, DOI 10.1016/S0168-8278(98)80276-6; Soresi M, 1999, AM J GASTROENTEROL, V94, P497, DOI 10.1111/j.1572-0241.1999.00791.x; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; Tseng TC, 2012, J INFECT DIS, V206, P1521, DOI 10.1093/infdis/jis569; Vassilopoulos D, 2008, J VIRAL HEPATITIS, V15, P817, DOI 10.1111/j.1365-2893.2008.00996.x; Wu JF, 2010, GASTROENTEROLOGY, V138, P165, DOI 10.1053/j.gastro.2009.09.018; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yuen MF, 2004, J CLIN MICROBIOL, V42, P5036, DOI 10.1128/JCM.42.11.5036-5040.2004; Zheng MJ, 2013, CELL MOL IMMUNOL, V10, P143, DOI 10.1038/cmi.2012.59	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117590	10.1371/journal.pone.0117590	http://dx.doi.org/10.1371/journal.pone.0117590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689069	Green Submitted, gold, Green Published			2022-12-27	WOS:000350322700060
J	Dai, XY; Jin, X; Chen, XW; He, JY; Yin, Z				Dai, Xiangyan; Jin, Xia; Chen, Xiaowen; He, Jiangyan; Yin, Zhan			Sufficient Numbers of Early Germ Cells Are Essential for Female Sex Development in Zebrafish	PLOS ONE			English	Article							DEAD-END; GENE-EXPRESSION; LINE; DIFFERENTIATION; PROMOTER; DIMORPHISM; ABLATION; TOOL	The sex determination for zebrafish is controlled by a combination of genetic and environmental factors. The determination of sex in zebrafish has been suggested to rely on a mechanism that is affected by germ cell-derived signals. To begin our current study, a simplified and efficient germ cell-specific promoter of the dead end (dnd) gene was identified. Utilizing the metrodinazole (MTZ)/bacterial nitroreductase (NTR) system for inducible germ cell ablation, several stable Tg (dnd:NTR-EGFP(-3'UTR)) and Tg (dnd:NTR-EGFP(+3'UTR)) zebrafish lines were then generated with the identified promoter. A thorough comparison of the expression patterns and tissue distributions of endogenous dnd and ntr-egfp transcripts in vivo revealed that the identified 2032-bp zebrafish dnd promoter can recapitulate dnd expression faithfully in stable transgenic zebrafish. The correlation between the levels of the germ cell-derived signals and requirement for maintaining the female fate has been also explored with different durations of the MTZ treatments. Our results revealed the decreasing ratios of female presented in the treated transgenic group are fairly associated with the reducing levels of the early germ cell-derived signals. After the juvenile transgenic fish treated with 5 mM MTZ for 20 days, all MTZ-treated transgenic fish exclusively developed into males with subfertilities. Taken together, our results identified here a simplified and efficient dnd promoter, and provide clear evidence indicating that it was not the presence but the sufficiency of signals derived from germ cells that is essential for female sex development in zebrafish. Our model also provides a unique system for sex control in zebrafish studies.	[Dai, Xiangyan; Jin, Xia; Chen, Xiaowen; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Dai, Xiangyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yin, Z (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zyin@ihb.ac.cn		, Dai/0000-0003-0275-6840	National Basic Research Program of China (973 Program) [2014CB138602]; National Natural Science Foundation of China [31172390]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by funds obtained from the National Basic Research Program of China (973 Program, 2014CB138602) to ZY, and National Natural Science Foundation of China (No. 31172390) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya C, 2007, BIOCHEM BIOPH RES CO, V355, P194, DOI 10.1016/j.bbrc.2007.01.138; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Hsiao CD, 2003, DEV BIOL, V262, P313, DOI 10.1016/S0012-1606(03)00402-0; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Jiang N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099689; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Leu DH, 2010, DEV DYNAM, V239, P2714, DOI 10.1002/dvdy.22404; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Moss JB, 2009, DIABETES, V58, P1844, DOI 10.2337/db08-0628; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Sfakianakis DG, 2012, J BIOL RES-THESSALON, V17, P68; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wong TT, 2013, INT J DEV BIOL, V57, P767, DOI 10.1387/ijdb.120234tw; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427	32	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117824	10.1371/journal.pone.0117824	http://dx.doi.org/10.1371/journal.pone.0117824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679390	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600092
J	Moreira, PVL; Baraldi, LG; Moubarac, JC; Monteiro, CA; Newton, A; Capewell, S; O'Flaherty, M				Moreira, Patricia V. L.; Baraldi, Larissa Galastri; Moubarac, Jean-Claude; Monteiro, Carlos Augusto; Newton, Alex; Capewell, Simon; O'Flaherty, Martin			Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-KINGDOM; PRIMARY PREVENTION; RISK-FACTORS; DIETARY-FAT; POPULATION; CLASSIFICATION; REDUCTIONS; NUTRITION; PRODUCTS	Background The global burden of non-communicable diseases partly reflects growing exposure to ultra-processed food products (UPPs). These heavily marketed UPPs are cheap and convenient for consumers and profitable for manufacturers, but contain high levels of salt, fat and sugars. This study aimed to explore the potential mortality reduction associated with future policies for substantially reducing ultra-processed food intake in the UK. Methods and Findings We obtained data from the UK Living Cost and Food Survey and from the National Diet and Nutrition Survey. By the NOVA food typology, all food items were categorized into three groups according to the extent of food processing: Group 1 describes unprocessed/minimally processed foods. Group 2 comprises processed culinary ingredients. Group 3 includes all processed or ultra-processed products. Using UK nutrient conversion tables, we estimated the energy and nutrient profile of each food group. We then used the IMPACT Food Policy model to estimate reductions in cardiovascular mortality from improved nutrient intakes reflecting shifts from processed or ultra-processed to unprocessed/minimally processed foods. We then conducted probabilistic sensitivity analyses using Monte Carlo simulation. Results Approximately 175,000 cardiovascular disease (CVD) deaths might be expected in 2030 if current mortality patterns persist. However, halving the intake of Group 3 (processed) foods could result in approximately 22,055 fewer CVD related deaths in 2030 (minimum estimate 10,705, maximum estimate 34,625). An ideal scenario in which salt and fat intakes are reduced to the low levels observed in Group 1 and 2 could lead to approximately 14,235 (minimum estimate 6,680, maximum estimate 22,525) fewer coronary deaths and approximately 7,820 (minimum estimate 4,025, maximum estimate 12,100) fewer stroke deaths, comprising almost 13% mortality reduction. Conclusions This study shows a substantial potential for reducing the cardiovascular disease burden through a healthier food system. It highlights the crucial importance of implementing healthier UK food policies.	[Moreira, Patricia V. L.; Newton, Alex; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Baraldi, Larissa Galastri; Moubarac, Jean-Claude; Monteiro, Carlos Augusto] Univ Sao Paulo, Ctr Epidemiol Studies Hlth & Nutr, Sao Paulo, Brazil; [Monteiro, Carlos Augusto] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil	University of Liverpool; Universidade de Sao Paulo; Universidade de Sao Paulo	Moreira, PVL (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England.	patriciamoreira1111@hotmail.com	Moubarac, Jean-Claude/J-8235-2014; Baraldi, Larissa Galastri/K-9784-2019; Shao, Ruitai/AAU-7642-2021; Moubarac, Jean-Claude/ABE-6439-2020; Monteiro, Carlos Augusto/F-9892-2012	Baraldi, Larissa Galastri/0000-0002-6793-7899; Monteiro, Carlos Augusto/0000-0002-3777-1533; O'Flaherty, Martin/0000-0001-8944-4131	Brazilian higher education agency CNPq (National Council for Scientific and Technological Development), Science Without Borders Program; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	Brazilian higher education agency CNPq (National Council for Scientific and Technological Development), Science Without Borders Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Brazilian higher education agency CNPq (National Council for Scientific and Technological Development) as part of Science Without Borders Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agency DoHatFS, 2012, NAT DIET NUTR SURV; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Bromley H, 2014, IDENTIFYING MOST EFF; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Crovetto M, 2012, REV MED CHILE, V140, P305, DOI 10.4067/S0034-98872012000300004; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department for Environment FaRA, 2012, FAMILY FOOD, V2011, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; Fletcher JM, 2011, J POLICY ANAL MANAG, V30, P655, DOI 10.1002/pam.20582; Franco M, 2013, BMJ-BRIT MED J, V346, DOI [10.1136/ bmj. f4242, DOI 10.1136/BMJ.F4242]; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-007130, DOI 10.1136/BMJOPEN-2014-007130]; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Ji C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-007130, DOI 10.1136/BMJOPEN-2014-007130]; Kabir Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-117; Konfino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073824; Monteiro CA, 2013, OBESITY REV; Monteiro CA., 2012, WORLD NUTR, V3, P527; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Moubarac JC, 2013, GLOB PUBLIC HEALTH, V8, P845, DOI 10.1080/17441692.2013.796401; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Centre for Social Research, 2008, ASS DIET SOD LEV AD; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Pasquale S, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/ bmj. b5657, DOI 10.1136/BMJ.B5657]; Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rtveladze K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068785; Sadler K, 2012, NATL DIET NUTR SURVY; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Townsend N, 2012, CORONARY HEART DIS S; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Vandevijvere S, 2013, OBES REV, V14, P135, DOI 10.1111/obr.12082; Watts R, 2008, PROTECTING CHILDREN; Witold AZ, 2005, BMJ, V331; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Young F, 2010, AM J PREV MED, V39, P228, DOI 10.1016/j.amepre.2010.05.009	54	49	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118353	10.1371/journal.pone.0118353	http://dx.doi.org/10.1371/journal.pone.0118353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679527	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600121
J	Siriboon, C; Lin, YH; Kere, M; Chen, CD; Chen, LR; Chen, CH; Tu, CF; Lo, NW; Ju, JC				Siriboon, Chawalit; Lin, Yu-Hsuan; Kere, Michel; Chen, Chun-Da; Chen, Lih-Ren; Chen, Chien-Hong; Tu, Ching-Fu; Lo, Neng-Wen; Ju, Jyh-Cherng			Putative Porcine Embryonic Stem Cell Lines Derived from Aggregated Four-Celled Cloned Embryos Produced by Oocyte Bisection Cloning	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER; CULTURE-CONDITIONS; TRICHOSTATIN-A; SOMATIC-CELLS; PIG EMBRYOS; ESTABLISHMENT; BOVINE; DIFFERENTIATION; BLASTOCYSTS	We attempted to isolate ES cell lines using inner cellmasses fromhigh-quality cloned porcine blastocysts. After being seeded onto feeders, embryos had better (P < 0.05) attachment, outgrowth formation and primary colonization in both 2x and 3x aggregated cloned embryos (62.8, 42.6 and 12.8% vs. 76.2, 55.2 and 26.2%, respectively) compared to the non-aggregated group (41.6, 23.4 and 3.9%). Effects of feeder types (STO vs. MEF) and serumsources (FBS vs. KSR) on extraction of cloned embryo-derived porcine ES cells were examined. More (17.1%) ntES cell lines over Passage 3 were generated in the MEF/KSR group. However, ntES cells cultured in KSR-supplemented medium had a low proliferation rate with defective morphology, and eventually underwent differentiation or apoptosis subsequently. Approximately 26.1, 22.7 and 35.7% of primary colonies were formed after plating embryos in DMEM, DMEM/F12 and alpha-MEM media, respectively. Survival rates of ntES cells cultured in a-MEM, DMEM and DMEM/F12 were 16.7, 4.3 and 6.8%, respectively (P > 0.05). We further examined the beneficial effect of TSA treatment of 3x aggregated cloned embryos on establishment of ntES cell lines. Primary colony numbers and survival rates of ntES cells beyond passage 3 were higher (P < 0.05) in those derived from TSA-treated 3x blastocysts (36.7 and 26.7%) than from the non-treated aggregated group (23.1 and 11.5%). These cells, remaining undifferentiated over 25 passages, had alkaline phosphatase activity and expressed ES specific markers Oct4, Nanog, Sox2, and Rex01. Moreover, these ntES cells successfully differentiated into embryoid bodies (EBs) that expressed specific genes of all three germ layers after being cultured in LIF-free medium. In conclusion, we have successfully derived putative porcine ntES cells with high efficiency from quality cloned embryos produced by embryo aggregation, and optimized the ES cell culture system suitable for establishing and maintaining ntES cell lines in undifferentiated state.	[Siriboon, Chawalit; Ju, Jyh-Cherng] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siriboon, Chawalit; Lin, Yu-Hsuan; Kere, Michel; Chen, Chun-Da; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Chen, Lih-Ren] Execut Yuan, Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Chen, Chien-Hong; Tu, Ching-Fu] Agr Technol Res Inst 1, Hsinchu 300, Taiwan; [Lo, Neng-Wen] Tunghai Univ 181, Dept Anim Sci & Biotechnol, Taichung 407, Taiwan; [Ju, Jyh-Cherng] China Med Univ Hosp, Dept Med Res, Core Lab Stem Cell Res, Taichung, Taiwan; [Ju, Jyh-Cherng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Ju, Jyh-Cherng] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 40227, Taiwan; [Ju, Jyh-Cherng] Asia Univ, Coll Comp Sci, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; Taiwan Livestock Research Institute; Agricultural Technology Research Institute; Tunghai University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan	Ju, JC (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	jcju@mail.cmu.ed.tw	Chen, Chien-Hong/GOP-2714-2022	Chen, Chien-Hong/0000-0002-6352-3437	China Medical University Hospital [DMR-103-104]; National Science Council [96-2313-B-005-013, 98-2628-B005-019-MY3, 101-2313-B-005 -013 -MY3]; Ministry of Education, Taiwan, Republic of China, under the ATU plan; Executive Yuan	China Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China, under the ATU plan; Executive Yuan	This study was supported in part by grants from China Medical University Hospital (DMR-103-104), the National Science Council (NSC# 96-2313-B-005-013, NSC# 98-2628-B005-019-MY3, and NSC# 101-2313-B-005 -013 -MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; ANDERSON GB, 1994, THERIOGENOLOGY, V42, P204, DOI 10.1016/0093-691X(94)90676-A; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Brevini TAL, 2010, THERIOGENOLOGY, V74, P544, DOI 10.1016/j.theriogenology.2010.04.020; Brevini TAL, 2007, THERIOGENOLOGY, V67, P54, DOI 10.1016/j.theriogenology.2006.09.019; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chawalit S, 2012, REPROD SCI, V19, P976, DOI 10.1177/1933719112440049; Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Cibelli JB, 1998, NAT BIOTECHNOL, V16, P642, DOI 10.1038/nbt0798-642; EVANS MJ, 1990, THERIOGENOLOGY, V33, P125, DOI 10.1016/0093-691X(90)90603-Q; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; GILES JR, 1995, MOL REPROD DEV, V41, P204, DOI 10.1002/mrd.1080410211; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; HOCHEREAUDEREVIERS MT, 1993, REPROD NUTR DEV, V33, P475, DOI 10.1051/rnd:19930508; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; Kim HS, 2007, ZYGOTE, V15, P55, DOI 10.1017/S0967199406003972; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Koo DB, 2004, THERIOGENOLOGY, V62, P779, DOI 10.1016/j.theriogenology.2003.12.027; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Li M, 2004, J REPROD DEVELOP, V50, P237, DOI 10.1262/jrd.50.237; Li M, 2003, MOL REPROD DEV, V65, P429, DOI 10.1002/mrd.10301; Liao YJ, 2014, STEM CELL RES THERAP, V4, DOI [10.4172/2157-7633.1000208, DOI 10.4172/2157-7633.1000208]; Machaty Z, 1998, REPROD FERT DEVELOP, V10, P599, DOI 10.1071/RD98048; Miyoshi K, 2000, BIOL REPROD, V62, P1640, DOI 10.1095/biolreprod62.6.1640; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; Nguyen NT, 2009, REPROD FERT DEVELOP, V21, P805, DOI 10.1071/RD08277; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Pratt S L, 2006, Soc Reprod Fertil Suppl, V62, P303; RopeterScharfenstein M, 1996, J ANIM BREED GENET, V113, P427, DOI 10.1111/j.1439-0388.1996.tb00633.x; Shan ZY, 2012, DEV GROWTH DIFFER, V54, P481, DOI 10.1111/j.1440-169X.2012.01335.x; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; Sugimura S, 2009, THERIOGENOLOGY, V72, P549, DOI 10.1016/j.theriogenology.2009.04.011; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; Tang PC, 2000, ZYGOTE, V8, P235, DOI 10.1017/S0967199400001039; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Vassiliev I, 2011, CELL REPROGRAM, V13, P205, DOI 10.1089/cell.2010.0102; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wang WH, 1997, J REPROD FERTIL, V111, P101, DOI 10.1530/jrf.0.1110101; Wianny F, 1997, BIOL REPROD, V57, P756, DOI 10.1095/biolreprod57.4.756; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yang JR, 2009, CLONING STEM CELLS, V11, P235, DOI 10.1089/clo.2008.0050	59	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118165	10.1371/journal.pone.0118165	http://dx.doi.org/10.1371/journal.pone.0118165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680105	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600110
J	Zhu, D; Yang, DY; Guo, YY; Zheng, YF; Li, JL; Wang, B; Tao, Y; Jonas, JB				Zhu, Dan; Yang, Da-Yong; Guo, Yuan-Yuan; Zheng, Yan-Fei; Li, Jun-Lian; Wang, Bin; Tao, Yong; Jonas, Jost B.			Intracameral Interleukin 1 beta, 6, 8, 10, 12p, Tumor Necrosis Factor alpha and Vascular Endothelial Growth Factor and Axial Length in Patients with Cataract	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; AGE-RELATED MACULOPATHY; AQUEOUS-HUMOR LEVELS; DIABETIC-RETINOPATHY; MACULAR DEGENERATION; CYTOKINE CONCENTRATION; EYES; PHARMACOKINETICS; PATHOGENESIS; EXPRESSION	Objective To assess associations between the aqueous humour concentration of interleukin IL-1 beta, IL-6, IL-8, IL-10 and IL-12p, tumor necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) and axial length in eyes with cataract. Methods The hospital-based investigation included patients who underwent cataract surgery between March 2014 and April 2014. Using aqueous humour collected at the start of cataract surgery, the interleukins IL-1 beta, IL- 6, IL- 8, IL- 10 and IL- 12p, TNF-alpha and VEGF were examined using a cytometric bead array. Axial length was determined by partial coherence laser interferometry (IOL Master). Results The study included 33 patients with cataract (33 eyes) with a mean age of 69.2 +/- 10.8 years (range:50-87 years) and a mean axial length of 24.7 +/- 1.9 mm (range:22.6-31.5 mm). Lower aqueous concentration of VEGF was significantly associated with longer axial length (VEGF concentration (pg/mL) = -5.12 x Axial Length (mm) + 163; correlation coefficient r = -0.41; P<0.001) and more myopic refractive error (VEGF concentration (pg/mL) = 1.27xspherical equivalent (diopters)+44.8; r = 0.383; P = 0.002). The aqueous concentrations of all other substances were not significantly (all P>0.10) associated with axial length or refractive error. Conclusions Higher intravitreal concentrations of VEGF were measured in eyes with a longer axial length, while the intraocular concentrations of IL-1 beta, IL-6, IL-8, IL-10, IL-12p and TNF-alpha were not correlated with axial length. The lower concentration of VEGF in axially elongated eyes may be one of the reasons for the lower prevalence of age-related macular degeneration and diabetic retinopathy in myopic eyes.	[Zhu, Dan; Yang, Da-Yong; Guo, Yuan-Yuan; Zheng, Yan-Fei; Li, Jun-Lian] Inner Mongolia Med Univ, Affiliated Hosp, Dept Ophthalmol, Hohhot, Inner Mongolia, Peoples R China; [Wang, Bin; Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Inner Mongolia Medical University; Peking University; Ruprecht Karls University Heidelberg	Tao, Y (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drtaoyong@163.com		Tao, Yong/0000-0003-1443-2667	Program for New Century Excellent Talents in University [NCET-12-0010]; FOK YING TONG education foundation; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); FOK YING TONG education foundation(Fok Ying Tung Education Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	This study was supported by Program for New Century Excellent Talents in University (No: NCET-12-0010) and FOK YING TONG education foundation. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Carmi Y, 2013, J IMMUNOL, V190, P3500, DOI 10.4049/jimmunol.1202769; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Hu Q, 2014, RETINA; Ikram MK, 2003, INVEST OPHTH VIS SCI, V44, P3778, DOI 10.1167/iovs.03-0120; Jain I S, 1965, J All India Ophthalmol Soc, V13, P88; JAIN IS, 1967, ARCH OPHTHALMOL-CHIC, V77, P59; Jia Y, 2014, INVEST OPHTH VIS SCI, V55, P3922, DOI 10.1167/iovs.14-13983; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe381, DOI 10.1111/j.1755-3768.2012.02414.x; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Kon CH, 1999, INVEST OPHTH VIS SCI, V40, P705; Krohne TU, 2015, RETINA-J RET VIT DIS, V35, P69, DOI 10.1097/IAE.0000000000000265; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Limb GA, 1999, INVEST OPHTH VIS SCI, V40, P2453; Meyer CH, 2011, RETINA-J RET VIT DIS, V31, P1877, DOI 10.1097/IAE.0b013e318217373c; Miao H, 2012, MOL VIS, V18, P574; Missotten GSO, 2006, ARCH OPHTHALMOL-CHIC, V124, P1428, DOI 10.1001/archopht.124.10.1428; MOSS SE, 1994, OPHTHALMOLOGY, V101, P77; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005; Salom D, 2008, INVEST OPHTH VIS SCI, V49, P3499, DOI 10.1167/iovs.07-1168; Sawada O, 2011, JPN J OPHTHALMOL, V55, P401, DOI 10.1007/s10384-011-0027-1; Shin YJ, 2012, MOL VIS, V18, P2265; Tao Y, 2010, EYE, V24, P648, DOI 10.1038/eye.2009.160; Teichmann KD, 2002, J CATARACT REFR SURG, V28, P1886, DOI 10.1016/S0886-3350(02)01671-1; Tong JP, 2006, AM J OPHTHALMOL, V141, P456, DOI 10.1016/j.ajo.2005.10.012; Wakabayashi T, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/257381; Wang B, 2014, J OCUL PHARMACOL TH, V30, P587, DOI 10.1089/jop.2013.0241; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123	37	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117777	10.1371/journal.pone.0117777	http://dx.doi.org/10.1371/journal.pone.0117777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679504	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600086
J	Awad, AI; Aboud, EA				Awad, Abdelmoneim Ismail; Aboud, Esraa Abdulwahid			Knowledge, Attitude and Practice towards Antibiotic Use among the Public in Kuwait	PLOS ONE			English	Article							UPPER RESPIRATORY-INFECTIONS; SELF-MEDICATION; ANTIMICROBIAL RESISTANCE; GENERAL-PRACTITIONERS; COMMUNITY; CARE; EXPECTATIONS; PREVALENCE; BEHAVIOR	Background The emergence and spread of bacterial resistance to antibiotics is a growing problem worldwide, which presents a significant threat to public health globally in the 21st century. A substantial evidence has shown that the general community plays a role in the increase and spread of antibiotic resistance. The present study was designed to determine knowledge, attitude and practice towards antibiotic use. Methods A cross-sectional survey was performed using a pretested self-administered questionnaire on a sample of 770 randomly selected Kuwaiti individuals. Descriptive and multivariate logistic regression analysis were used in data analysis. Results The response rate was 88.3%. Nearly three-quarters (72.8%) of respondents had been prescribed antibiotics within 12 months prior to the study period, and 36% of them had not finished the course of treatment. Over one-quarter (27.5%) were self-medicated with antibiotics to treat mainly common cold, sore throat and cough. Self-medication was more prevalent among those who were prescribed antibiotics and those who had attitudes towards using and accessing antibiotic inappropriately. Almost 47% of participants had low knowledge regarding action, use, safety and resistance of antibiotics. Forty one percent of respondents had attitudes towards using and accessing antibiotic inappropriately. Better knowledge was found to be a predictor for positive attitude. Respondents level of agreement that doctors often prescribe antibiotics to meet the patient's expectation, and that doctors often take time to consider carefully the need for an antibiotic were 52.7% and 35.3%, respectively. Conclusions These findings will aid in the assessment of the adequacy of present public educational campaigns. Also, it will provide further insight in designing future multifaceted interventions to promote specific messages to rationalize antibiotic use, and compensate for knowledge and attitude gaps as an effort towards preventing development of antibiotic resistance.	[Awad, Abdelmoneim Ismail] Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait; [Aboud, Esraa Abdulwahid] Minist Hlth, Kuwait, Kuwait	Kuwait University	Awad, AI (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait.	amoneim@hsc.edu.kw	Awad, Abdelmoneim Ismail/AAU-1963-2020	Awad, Abdelmoneim Ismail/0000-0002-2266-3687				Abasaeed A, 2009, J INFECT DEV COUNTR, V3, P491, DOI 10.3855/jidc.466; Al-Mousa HH, 2011, MED PRIN PRACT, V21, P97, DOI 10.1159/000331903; Al-Ramahi R, 2013, INT J CLIN PHARM TH, V51, P562, DOI 10.5414/CP201814; Aly M, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-26; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; Awad A, 2010, EUR J CLIN PHARMACOL, V66, P1247, DOI 10.1007/s00228-010-0872-8; Barah F., 2010, Eastern Mediterranean Health Journal, V16, P516; Belongia EA, 2002, PREV MED, V34, P346, DOI 10.1006/pmed.2001.0992; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; European Commission, 2013, SPEC EURB 407 ANT RE; Franco Beatriz Espinosa, 2009, Infect Drug Resist, V2, P1; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hawkings NJ, 2008, PATIENT EDUC COUNS, V73, P146, DOI 10.1016/j.pec.2008.05.025; Hulscher MEJL, 2010, INT J MED MICROBIOL, V300, P351, DOI 10.1016/j.ijmm.2010.04.003; Jassim Abdul-Mohsin, 2010, Oman Med J, V25, P79, DOI 10.5001/omj.2010.25; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Kuwait Central Statistical Bureau, 2011, GEN POP CENS; Lim Ka Keat, 2012, South Med Rev, V5, P26; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Memish Z A, 2007, J Chemother, V19 Suppl 1, P17; Mohanna Mabrook, 2010, Oman Med J, V25, P41, DOI 10.5001/omj.2010.10; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Ong S, 2007, ANN EMERG MED, V50, P213, DOI 10.1016/j.annemergmed.2007.03.026; Raosoft Inc., 2004, RAOS SAMPL SIZ CALC; Sawair FA, 2009, MED PRIN PRACT, V18, P21, DOI 10.1159/000163041; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Vaandnen MH, 2006, HEALTH POLICY, V77, P166, DOI 10.1016/j.healthpol.2005.07.001; WHO, 2001, WHOCDSCSRDRS20012; Widayati Aris, 2011, BMC Res Notes, V4, P491, DOI 10.1186/1756-0500-4-491; World Health Organization, 2007, WORLD HLTH REP 2007; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	41	134	135	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117910	10.1371/journal.pone.0117910	http://dx.doi.org/10.1371/journal.pone.0117910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675405	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000036
J	Olusanya, BO; Osibanjo, FB; Slusher, TM				Olusanya, Bolajoko O.; Osibanjo, Folasade B.; Slusher, Tina M.			Risk Factors for Severe Neonatal Hyperbilirubinemia in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACUTE BILIRUBIN ENCEPHALOPATHY; JAUNDICE; TERM; KERNICTERUS; PREDICTION; STILL; NEED	Background Available evidence suggests that low- and middle-income countries (LMICs) bear the greatest burden of severe neonatal hyperbilirubinemia characterized by disproportionately high rates of morbidity, mortality and neurodevelopmental disorders compared to high-income countries. We set out to identify the risk factors that contribute to the burden of severe hyperbilirubinemia in the most developmentally disadvantaged LMICs to highlight areas for action and further research. Methods We systematically searched PubMed, Scopus, Ovid EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), WHO Library Database (WHOLIS), African Index Medicus (AIM), African Journals Online (AJOL), LILACS, and IndMed for reports published between January 1990 and June 2014. We included only studies that controlled for the effects of confounding variables in determining maternal and infant risk factors for severe hyperbilirubinemia. We conducted meta-analysis of the eligible studies and computed the summary risk estimates with random effects models. Results A total of 13 studies with 1,951 subjects and 32,208 controls from India, Nigeria, Pakistan, Nepal and Egypt were identified and analyzed. The pooled data showed that primiparity (OR, 1.59; 95% CI:1.26-2.00), delivery outside public hospitals (OR, 6.42; 95% CI:1.76-23.36), ABO incompatibility (OR, 4.01; 95% CI:2.44-6.61), Rhesus hemolytic disease (OR, 20.63; 95% CI:3.95-107.65), G6PD deficiency (OR, 8.01; 95% CI:2.09-30.69), UGT1A1 polymorphisms (OR, 4.92; 95% CI:1.30-18.62), low gestational age (OR, 1.71; 95% CI: 1.40-2.11), underweight/weight loss (OR, 6.26; 95% CI:1.23-31.86), sepsis (OR, 9.15; 95% CI:2.78-30.10) and high transcutaneous/total serum bilirubin levels (OR, 1.46; 95% CI:1.10-1.92) placed infants at increased risk of severe hyperbilirubinemia or bilirubin induced neurologic dysfunctions. Low social class was not associated with an increased risk of severe hyperbilirubinemia. Conclusions Infants at risk of severe hyperbilirubinemia in LMICs are associated with maternal and neonatal factors that can be effectively addressed by available interventions to curtail the disease burden prevailing in the affected countries.	[Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Osibanjo, Folasade B.] Ctr Hlth Start Initiat, Maternal & Child Hlth Unit, Lagos, Nigeria; [Slusher, Tina M.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Slusher, Tina M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center	Olusanya, BO (corresponding author), Ctr Hlth Start Initiat, Lagos, Nigeria.	boolusanya@aol.com	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				Adebami OJ, 2011, J PEDIATR NEUROL, V9, P347, DOI 10.3233/JPN-2011-0485; Agrawal SK, 2009, PEDIATR RES, V65, P675, DOI 10.1203/PDR.0b013e31819ed5de; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Arif K, 1999, Indian Pediatr, V36, P487; Berman Nancy G, 2002, BMC Med Res Methodol, V2, P10, DOI 10.1186/1471-2288-2-10; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G; Borenstein Michael, 2007, METAANALYSIS FIXED E; Burke BL, 2009, PEDIATRICS, V123, P524, DOI 10.1542/peds.2007-2915; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Chawla D, 2012, INDIAN J PEDIATR, V79, P198, DOI 10.1007/s12098-011-0409-x; De Niz M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-210; English M, 2003, ARCH DIS CHILD, V88, P438, DOI 10.1136/adc.88.5.438; Gamaleldin R, 2011, PEDIATRICS, V128, pE925, DOI 10.1542/peds.2011-0206; GBD Mortality and Causes of Death Collaborators, 2014, LANCET, DOI 10.1016/S0140-6736(14)62428-4; Hameed NN, 2011, NEONATOLOGY, V100, P57, DOI 10.1159/000321990; Hansen TWR, 2011, DEV MED CHILD NEUROL, V53, P24, DOI 10.1111/j.1469-8749.2011.04059.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu J, 2014, PEDIATR HEMAT ONCOL, V31, P68, DOI 10.3109/08880018.2013.860649; Kalakheti B K, 2009, Kathmandu Univ Med J (KUMJ), V7, P11; Kaplan M, 2009, J PERINATOL, V29, pS46, DOI 10.1038/jp.2008.216; Kaplan M, 2008, PEDIATR RES, V63, P109, DOI 10.1203/PDR.0b013e31815b8e7e; Kaplan M, 2011, NEONATOLOGY, V100, P354, DOI 10.1159/000330055; Kaur S, 2012, J PERINATOL, V32, P716, DOI 10.1038/jp.2011.170; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Maisels MJ, 2009, EARLY HUM DEV, V85, P727, DOI 10.1016/j.earlhumdev.2009.09.003; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moise KJ, 2002, OBSTET GYNECOL, V100, P600, DOI 10.1016/S0029-7844(02)02180-4; Murki S, 2001, Indian Pediatr, V38, P757; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nair H, 2009, INDIAN PEDIATR, V46, P1045; National Institute for Health and Clinical Excellence, 2010, NEONATAL JAUNDICE; Ogunlesi TA, 2011, J TROP PEDIATRICS, V57, P80, DOI 10.1093/tropej/fmq045; Olusanya BO, 2009, TROP MED INT HEALTH, V14, P301, DOI 10.1111/j.1365-3156.2009.02223.x; Olusanya BO, 2014, ACTA PAEDIATR, V103, P1102, DOI 10.1111/apa.12735; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Pao Mritunjay, 2005, Indian Journal of Pediatrics, V72, P835, DOI 10.1007/BF02731109; Scrafford CG, 2013, TROP MED INT HEALTH, V18, P1317, DOI 10.1111/tmi.12189; Shapiro SM, 2010, SEMIN FETAL NEONAT M, V15, P157, DOI 10.1016/j.siny.2009.12.004; Slusher TM, 2014, JAMA PEDIATRICS, DOI [10.1001/jamapediatrics.2014.2898, DOI 10.1001/JAMAPEDIATRICS.2014.2898]; SODEINDE O, 1995, ANN TROP PAEDIATR, V15, P107, DOI 10.1080/02724936.1995.11747757; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; The World Bank, NEW COUNTRY CLASSIFI; Tiwari PK, 2014, J PERINATOL, V34, P120, DOI 10.1038/jp.2013.140; WHO Working Group, 1981, B WORLD HEALTH ORGAN, V67, P61; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23	48	78	81	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117229	10.1371/journal.pone.0117229	http://dx.doi.org/10.1371/journal.pone.0117229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675342	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000017
J	Bocherens, H; Hofman-Kaminska, E; Drucker, DG; Schmolcke, U; Kowalczyk, R				Bocherens, Herve; Hofman-Kaminska, Emilia; Drucker, Dorothee G.; Schmoelcke, Ulrich; Kowalczyk, Rafal			European Bison as a Refugee Species? Evidence from Isotopic Data on Early Holocene Bison and Other Large Herbivores in Northern Europe	PLOS ONE			English	Article							BOS-PRIMIGENIUS BOJANUS; N-15 NATURAL-ABUNDANCE; MOOSE ALCES-ALCES; LATE PLEISTOCENE; STABLE-ISOTOPES; BONE-COLLAGEN; MYCORRHIZAL FUNGI; GLOBAL PATTERNS; NITROGEN ISOTOPES; FORAGING ECOLOGY	According to the refugee species concept, increasing replacement of open steppe by forest cover after the last glacial period and human pressure had together forced European bison (Bison bonasus)-the largest extant terrestrial mammal of Europe-into forests as a refuge habitat. The consequent decreased fitness and population density led to the gradual extinction of the species. Understanding the pre-refugee ecology of the species may help its conservation management and ensure its long time survival. In view of this, we investigated the abundance of stable isotopes (delta C-13 and delta N-15) in radiocarbon dated skeletal remains of European bison and other large herbivores-aurochs (Bos primigenius), moose (Alces alces), and reindeer (Rangifer tarandus)-from the Early Holocene of northern Europe to reconstruct their dietary habits and pattern of habitat use in conditions of low human influence. Carbon and nitrogen isotopic compositions in collagen of the ungulate species in northern central Europe during the Early Holocene showed significant differences in the habitat use and the diet of these herbivores. The values of the delta C-13 and delta N-15 isotopes reflected the use of open habitats by bison, with their diet intermediate between that of aurochs (grazer) and of moose (browser). Our results show that, despite the partial overlap in carbon and nitrogen isotopic values of some species, Early Holocene large ungulates avoided competition by selection of different habitats or different food sources within similar environments. Although Early Holocene bison and Late Pleistocene steppe bison utilized open habitats, their diets were significantly different, as reflected by their delta N-15 values. Additional isotopic analyses show that modern populations of European bison utilize much more forested habitats than Early Holocene bison, which supports the refugee status of the species.	[Bocherens, Herve; Drucker, Dorothee G.] Univ Tubingen, Fachbereich Geowissensch, Forsch Bereich Palaobiol, D-72074 Tubingen, Germany; [Bocherens, Herve] Univ Tubingen, Senckenberg Ctr Human Evolut & Palaeoecol HEP, D-72074 Tubingen, Germany; [Hofman-Kaminska, Emilia; Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, Gen Waszkiewicza 1c, PL-17230 Bialowieza, Poland; [Schmoelcke, Ulrich] Ctr Baltic & Scandinavian Archaeol ZBSA, D-24837 Schleswig, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Hofman-Kaminska, E (corresponding author), Polish Acad Sci, Mammal Res Inst, Gen Waszkiewicza 1c, PL-17230 Bialowieza, Poland.	ehofman@ibs.bialowieza.pl	BOCHERENS, Hervé/F-3580-2011; Drucker, Dorothée G./E-8900-2011	BOCHERENS, Hervé/0000-0002-0494-0126; Drucker, Dorothée G./0000-0003-0854-4371; Hofman-Kaminska, Emilia/0000-0001-7924-5307; Kowalczyk, Rafal/0000-0001-7264-2158; Schmolcke, Ulrich/0000-0002-8974-449X	Polish National Science Centre [N N304 301940]; budget of the Mammal Research Institute PAS in Bialowieza	Polish National Science Centre; budget of the Mammal Research Institute PAS in Bialowieza	This study was financed by the Polish National Science Centre grant no. N N304 301940 (to RK) and the budget of the Mammal Research Institute PAS in Bialowieza (to RK and EHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaris-Sorensen K, 2007, J ARCHAEOL SCI, V34, P914, DOI 10.1016/j.jas.2006.09.014; Aaris-Sorensen K, 2009, FOSS STRATA, P1; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Asada T, 2005, AQUAT BOT, V82, P297, DOI 10.1016/j.aquabot.2005.05.005; Barnett B, 1994, THESIS; Ben-David M, 2001, ALCES-N AM MOOSE CON, V37, P421; Benecke N, 2003, ARCHEOZOOLOGIA, V21, P19; Benecke Norbert, 2006, Munibe (Antropologia - Arkeologia), V57, P421; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; Bjorck J, 2002, QUATERNARY SCI REV, V21, P1489, DOI 10.1016/S0277-3791(01)00115-9; Bocherens H, 1997, QUATERNARY RES, V48, P370, DOI 10.1006/qres.1997.1927; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2011, QUATERN INT, V245, P249, DOI 10.1016/j.quaint.2011.02.023; BOERTJE RD, 1984, ARCTIC, V37, P161; Bonafini M, 2013, J ARCHAEOL SCI, V40, P3926, DOI 10.1016/j.jas.2013.03.028; BOROWSKI S, 1972, Acta Theriologica, V17, P151, DOI 10.4098/AT.arch.72-13; Bos JAA, 2001, REV PALAEOBOT PALYNO, V115, P177, DOI 10.1016/S0034-6667(01)00069-0; Bratlund Bodil, 1999, P39; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Brooks JR, 1997, OECOLOGIA, V110, P301, DOI 10.1007/s004420050163; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Crowley BE, 2012, P ROY SOC B-BIOL SCI, V279, P3597, DOI 10.1098/rspb.2012.0727; Deinet S, 2013, WILDLIFE COMEBACK IN, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; Drucker DG, 2012, QUATERN INT, V272, P322, DOI 10.1016/j.quaint.2012.05.040; Drucker DG, 2011, QUATERN INT, V245, P218, DOI 10.1016/j.quaint.2011.05.007; Drucker DG, 2011, QUATERN INT, V245, P268, DOI 10.1016/j.quaint.2011.07.019; Drucker DG, 2003, EARTH PLANET SC LETT, V216, P163, DOI 10.1016/S0012-821X(03)00514-4; Drucker DG, 2009, FOREST CANOPIES FORE, P103; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Drucker DG, 2010, ISOT ENVIRON HEALT S, V46, P107, DOI 10.1080/10256010903388410; Emmerton KS, 2001, NEW PHYTOL, V151, P513, DOI 10.1046/j.1469-8137.2001.00179.x; Eriksen BV, 2002, JUT ARCH SOC PUBL, V39, P25; Feng XH, 1998, OECOLOGIA, V117, P19, DOI 10.1007/s004420050626; Feranec RS, 2007, PALAEOGEOGR PALAEOCL, V252, P575, DOI 10.1016/j.palaeo.2007.05.012; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fischer L.A, 2002, THESIS; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; FRETWELL S D, 1972, P217; GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257; GEBCZYNSKA Z, 1991, ACTA THERIOL, V36, P307; GEE H, 1993, J QUATERNARY SCI, V8, P79, DOI 10.1002/jqs.3390080107; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gross M, 2013, CURR BIOL, V23, pR939, DOI 10.1016/j.cub.2013.10.039; Guthrie RD, 1990, FROZEN FAUNA OF THE; HEDGES REM, 1993, ARCHAEOMETRY, V35, P147, DOI 10.1111/j.1475-4754.1993.tb01030.x; Hobbie JE, 2009, CAN J MICROBIOL, V55, P84, DOI 10.1139/W08-127; Hofman-Kaminska E, 2012, ENVIRON MANAGE, V50, P530, DOI 10.1007/s00267-012-9913-7; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Jensen J, 2003, THE PREHISTORY OF DE; Jessen CA, 2014, QUATERNARY INTERNATI; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Kowalczyk R, 2013, ACTA THERIOL, V58, P391, DOI 10.1007/s13364-013-0136-y; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Krasinski, 2013, THE NATURE MONOGRAPH; Kristensen DK, 2011, CAN J ZOOL, V89, P892, DOI [10.1139/Z11-073, 10.1139/z11-073]; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; LARTER NC, 1991, CAN J ZOOL, V69, P2677, DOI 10.1139/z91-376; Martin MLSt, 2012, THESIS; Martin T, 1987, SENCKENBERGISCHE NAT, V96; McLeman C. I. A., 2006, THESIS; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Merceron G, 2014, FOREST ECOL MANAG, V328, P262, DOI 10.1016/j.foreco.2014.05.041; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; MOROW K, 1976, Acta Theriologica, V21, P101; NIEMINEN M, 1989, Rangifer, V9, P17; Noe-Nygaard N, 2005, J ARCHAEOL SCI, V32, P855, DOI 10.1016/j.jas.2005.01.004; Olech W., 2004, STATUS SURVEY CONSER; Pape R, 2012, AMBIO, V41, P421, DOI 10.1007/s13280-012-0257-6; Perzanowski KA, 2011, ROCZNIKI BIESZCZADZK, V19, P191; Perzanowski KA, 2008, ANN ZOOL FENN, V45, P347, DOI 10.5735/086.045.0417; Pushkina D, 2014, QUATERN INT, V339, P164, DOI 10.1016/j.quaint.2013.12.033; Pushkina D, 2010, NATURWISSENSCHAFTEN, V97, P299, DOI 10.1007/s00114-009-0642-6; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rivals F, 2010, PALAEOGEOGR PALAEOCL, V286, P42, DOI 10.1016/j.palaeo.2009.12.002; Sala MTN, 2010, ANTROPOLOGIA ARKEOLO, V61, P43; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmolcke U, 2005, MAMM BIOL, V70, P329, DOI 10.1016/j.mambio.2005.08.001; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schulz E, 2007, COUR FOR SEKENBG, V259, P155; SCHULZE ED, 1994, OECOLOGIA, V100, P406, DOI 10.1007/BF00317862; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; Stewart KM, 2003, ECOSCIENCE, V10, P297, DOI 10.1080/11956860.2003.11682777; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart Anthony John, 1999, P257; TEERI JA, 1979, OECOLOGIA, V39, P197, DOI 10.1007/BF00348068; Theuerkauf M, 2014, QUATERNARY SCI REV, V90, P183, DOI 10.1016/j.quascirev.2014.03.002; Turvey Samuel T., 2009, P17; Usinger H, 2005, INTERNATIONALE ARCHA, V5, P1, DOI [10.1016/j.acvd.2014.03.005, DOI 10.1016/J.ACVD.2014.03.005]; van Vuure C, 2005, RETRACING AUROCHS HI; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Wam HK, 2010, EUR J WILDLIFE RES, V56, P745, DOI 10.1007/s10344-010-0370-4; Weniger G, 1999, ARCHAOLOGIE UND BIOL	110	87	91	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115090	10.1371/journal.pone.0115090	http://dx.doi.org/10.1371/journal.pone.0115090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671634	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300004
J	Jha, AP; Morrison, AB; Dainer-Best, J; Parker, S; Rostrup, N; Stanley, EA				Jha, Amishi P.; Morrison, Alexandra B.; Dainer-Best, Justin; Parker, Suzanne; Rostrup, Nina; Stanley, Elizabeth A.			Minds "At Attention": Mindfulness Training Curbs Attentional Lapses in Military Cohorts	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; EXECUTIVE-CONTROL; STRESS REDUCTION; WANDERING MINDS; MOODS LEAD; SLEEP LOSS; PERFORMANCE; AWARENESS; IMPACT; EXPERIENCE	We investigated the impact of mindfulness training (MT) on attentional performance lapses associated with task-unrelated thought (i.e., mind wandering). Periods of persistent and intensive demands may compromise attention and increase off-task thinking. Here, we investigated if MT may mitigate these deleterious effects and promote cognitive resilience in military cohorts enduring a high-demand interval of predeployment training. To better understand which aspects of MT programs are most beneficial, three military cohorts were examined. Two of the three groups were provided MT. One group received an 8-hour, 8-week variant of Mindfulness-based Mind Fitness Training (MMFT) emphasizing engagement in training exercises (training-focused MT, n = 40), a second group received a didactic-focused variant emphasizing content regarding stress and resilience (didactic-focused MT, n = 40), and the third group served as a no-training control (NTC, n = 24). Sustained Attention to Response Task (SART) performance was indexed in all military groups and a no-training civilian group (CIV, n = 45) before (T1) and after (T2) the MT course period. Attentional performance (measured by A', a sensitivity index) was lower in NTC vs. CIV at T2, suggesting that performance suffers after enduring a high-demand predeployment interval relative to a similar time period of civilian life. Yet, there were significantly fewer performance lapses in the military cohorts receiving MT relative to NTC, with training-focused MT outperforming didactic-focused MT at T2. From T1 to T2, A' degraded in NTC and didactic-focused MT but remained stable in training-focused MT and CIV. In sum, while protracted periods of high-demand military training may increase attentional performance lapses, practice-focused MT programs akin to training-focused MT may bolster attentional performance more than didactic-focused programs. As such, training-focused MT programs should be further examined in cohorts experiencing protracted high-demand intervals.	[Jha, Amishi P.; Morrison, Alexandra B.; Dainer-Best, Justin; Parker, Suzanne; Rostrup, Nina] Univ Miami, Dept Psychol, Miami, FL 33133 USA; [Stanley, Elizabeth A.] Georgetown Univ, Walsh Sch Foreign Serv, Washington, DC USA; [Stanley, Elizabeth A.] Georgetown Univ, Dept Govt, Washington, DC 20057 USA; [Stanley, Elizabeth A.] Mind Fitness Training Inst, Alexandria, VA USA	University of Miami; Georgetown University; Georgetown University	Jha, AP (corresponding author), Univ Miami, Dept Psychol, Miami, FL 33133 USA.	a.jha@psy.miami.edu		Dainer-Best, Justin/0000-0002-1868-0337	Department of Army [W81XWH-09-C-0072, W81XWH-11-2-0124]	Department of Army	This research was supported by Department of Army (http://www.arl.army.mil/www/default.cfm) grants #W81XWH-09-C-0072 and W81XWH-11-2-0124 to APJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AB, 2008, J TRAUMA STRESS, V21, P253, DOI 10.1002/jts.20342; Baird B, 2013, CONSCIOUS COGN, V22, P1003, DOI 10.1016/j.concog.2013.06.009; Banks JB, 2014, COGNITION EMOTION, V28, P856, DOI 10.1080/02699931.2013.857643; Bastian M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00573; Bolton EE, 2001, J TRAUMA STRESS, V14, P249, DOI 10.1023/A:1007864305207; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; ENDSLEY MR, 1995, HUM FACTORS, V37, P65, DOI 10.1518/001872095779049499; Gallegos AM, 2013, J ALTERN COMPLEM MED, V19, P787, DOI 10.1089/acm.2012.0028; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kam JWY, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00725; Kam JWY, 2013, J COGNITIVE NEUROSCI, V25, P952, DOI 10.1162/jocn_a_00375; Kam JWY, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00329; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Leonard NR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00792; Levine P. A., 1997, WAKING TIGER HEALING; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; MacDonald C, 1998, MIL MED, V163, P477, DOI 10.1093/milmed/163.7.477; Maguen S, 2008, MIL MED, V173, P1; McVay JC, 2012, J EXP PSYCHOL LEARN, V38, P525, DOI 10.1037/a0025896; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Morgan CA, 2004, INT J LAW PSYCHIAT, V27, P265, DOI 10.1016/j.ijlp.2004.03.004; Morgan CA, 2006, BIOL PSYCHIAT, V60, P722, DOI 10.1016/j.biopsych.2006.04.021; Morrison AB, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00897; Mrazek MD, 2013, PSYCHOL SCI, V24, P776, DOI 10.1177/0956797612459659; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Murphy F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00888; Ogden P., 2006, TRAUMA BODY SENSORIM; Persson J, 2007, NEUROPSYCHOLOGIA, V45, P1571, DOI 10.1016/j.neuropsychologia.2006.12.007; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sayette MA, 2010, PSYCHOL SCI, V21, P26, DOI 10.1177/0956797609354059; Schooler J. W., 2014, PSYCHOL LEARNING MOT, V60; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Slagter HA, 2009, J COGNITIVE NEUROSCI, V21, P1536, DOI 10.1162/jocn.2009.21125; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stanley EA, 2014, WILEY BLACKWELL HANDBOOK OF MINDFULNESS, VOLS I AND II, P964; Stanley EA, 2011, COGN BEHAV PRACT, V18, P566, DOI 10.1016/j.cbpra.2010.08.002; Stanton NA, 2001, SAFETY SCI, V39, P189, DOI 10.1016/S0925-7535(01)00010-8; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Takarangi MKT, 2014, CONSCIOUS COGN, V27, P297, DOI 10.1016/j.concog.2014.06.002; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vinski MT, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00730; Zanesco AP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00566	60	116	122	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116889	10.1371/journal.pone.0116889	http://dx.doi.org/10.1371/journal.pone.0116889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671579	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300026
J	Symeon, GK; Goliomytis, M; Bizelis, I; Papadomichelakis, G; Pagonopoulou, O; Abas, Z; Deligeorgis, SG; Chadio, SE				Symeon, George K.; Goliomytis, Michael; Bizelis, Iosif; Papadomichelakis, George; Pagonopoulou, Olga; Abas, Zafeiris; Deligeorgis, Stelios G.; Chadio, Stella E.			Effects of Gestational Maternal Undernutrition on Growth, Carcass Composition and Meat Quality of Rabbit Offspring	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; FEED RESTRICTION; METABOLIC SYNDROME; BIRTH-WEIGHT; FETAL-GROWTH; MUSCLE; PREGNANCY; NUTRITION; ORGANOGENESIS; CONSEQUENCES	An experiment was conducted in order to evaluate the effects of gestational undernutrition of rabbit does on growth, carcass composition and meat quality of the offsprings. Thirty primiparous non lactating rabbit does were artificially inseminated and randomly divided in three treatment groups: Control (C; fed to 100% of maintenance requirements throughout gestation, n = 10), early undernourished (EU; fed to 50% of maintenance requirements during days 7-19 of gestation, n = 10) and late undernourished (LU; fed to 50% of maintenance requirements during days 20-27 of gestation, n = 10). During the 4th week of the gestation period, LU does significantly lost weight compared to C and EU groups (P<0.05). At kindling, C does produced litters with higher proportions of stillborn kits (P<0.05) while the total litter size (alive and stillborn kits) was not different among groups (10.7, 12.8 and 12.7 kits in C, EU and LU groups, respectively). Kit birth weight tended to be lower in the LU group. During fattening, body weight and feed intake were not different among offsprings of the three experimental groups. Moreover, the maternal undernutrition did not have any impact on carcass composition of the offsprings in terms of carcass parts and internal organs weights as well as meat quality of L. lumborum muscle (pH24, colour, water holding capacity and shear values) at slaughter (70 days of age). Therefore, it can be concluded that the gestational undernutrition of the mother does not have detrimental effects on the productive and quality traits of the offsprings.	[Symeon, George K.; Pagonopoulou, Olga] Democritus Univ Thrace, Sch Med, Dept Physiol, Alexandroupolis, Greece; [Abas, Zafeiris] Democritus Univ Thrace, Dept Agr Dev, Div Anim Prod, Nea Orestiada, Greece; [Goliomytis, Michael; Bizelis, Iosif; Deligeorgis, Stelios G.] Agr Univ Athens, Dept Anim Breeding & Husb, Fac Anim Sci & Aquaculture, GR-11855 Athens, Greece; [Chadio, Stella E.] Agr Univ Athens, Fac Anim Sci & Aquaculture, Dept Anat & Physiol Farm Anim, GR-11855 Athens, Greece; [Papadomichelakis, George] Agr Univ Athens, Dept Nutr Physiol & Feeding, Fac Anim Sci & Aquaculture, GR-11855 Athens, Greece	Democritus University of Thrace; Democritus University of Thrace; Agricultural University of Athens; Agricultural University of Athens; Agricultural University of Athens	Symeon, GK (corresponding author), Democritus Univ Thrace, Sch Med, Dept Physiol, Alexandroupolis, Greece.	gsymewn@yahoo.gr	Goliomytis, Michael/J-9625-2019; Papadomichelakis, George/AAM-5033-2021; Symeon, George/I-8567-2019; Pagonopoulou, Olga/AAH-9944-2021	Goliomytis, Michael/0000-0001-9606-9894; Symeon, George/0000-0002-3782-7031; Papadomichelakis, George/0000-0002-6774-2434; BIZELIS, IOSIF/0000-0002-9457-2696	European Social Fund (ESF); Greek State [LS9-1678]	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	This research project was implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and was co-financed by the European Social Fund (ESF) and the Greek State (grant number LS9-1678). Funder website: www.gsrt.gr. Authors who received the funding: GKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J., 1994, BIOL LAB RABBIT, P457; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bee G, 2004, J ANIM SCI, V82, P826; Blasco A., 1996, WORLD RABBIT SCI, V4, P93, DOI [DOI 10.4995/WRS.1996.278, DOI 10.4995/WRS.1993.189]; Cappon GD, 2005, BIRTH DEFECTS RES B, V74, P424, DOI 10.1002/bdrb.20058; Caton JS, 2009, J ANIM SCI, V87, P222, DOI 10.2527/jas.2008-1043; Chadio S, 2014, J DEV ORIG HLTH DIS, V5, P2, DOI 10.1017/S204017441300038X; CLARK RL, 1986, FUND APPL TOXICOL, V7, P272, DOI 10.1016/0272-0590(86)90157-0; Combes S, 2004, MEAT SCI, V66, P91, DOI 10.1016/S0309-1740(03)00019-6; COUDERT P, 1985, ANN ZOOTECH, V34, P31, DOI 10.1051/animres:19850104; Daniel ZCTR, 2007, J ANIM SCI, V85, P1565, DOI 10.2527/jas.2006-743; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORTUN L, 1994, ANN ZOOTECH, V43, P163, DOI 10.1051/animres:19940206; Fortun-Lamothe L, 2006, ANIM REPROD SCI, V93, P1, DOI 10.1016/j.anireprosci.2005.06.009; Fortun-Lamothe L, 1999, LIVEST PROD SCI, V60, P229, DOI 10.1016/S0301-6226(99)00096-2; Fortun-Lamothe L, 1999, ANIM REPROD SCI, V55, P289, DOI 10.1016/S0378-4320(99)00020-2; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gondret F., 2005, Archiv fur Tierzucht, V48, P68; Greenwood PL, 2000, J ANIM SCI, V78, P50; HASTINGSROBERTS MM, 1977, J NUTR, V107, P973, DOI 10.1093/jn/107.6.973; Hernandez P, 2004, J ANIM SCI, V82, P3138; Kind KL, 1999, AM J PHYSIOL-REG I, V277, pR1675, DOI 10.1152/ajpregu.1999.277.6.R1675; LEDIN I, 1984, ANN ZOOTECH, V33, P33, DOI 10.1051/animres:19840103; Manal AF, 2010, ANIM REPROD SCI, V120, P179, DOI 10.1016/j.anireprosci.2010.03.010; Martinez-Paredes E, 2012, ANIMAL, V6, P1086, DOI 10.1017/S1751731111002643; Matsuoka Tetsuya, 2006, Journal of Toxicological Sciences, V31, P169, DOI 10.2131/jts.31.169; MATSUZAWA T, 1981, TOXICOLOGY, V22, P255, DOI 10.1016/0300-483X(81)90088-3; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nafeaa Abeer, 2011, Vet Med Int, V2011, P839737, DOI 10.4061/2011/839737; Parigi-Bini R, 1990, P 5 JOURN RECH CUN F; PARIGIBINI R, 1992, ANIM PROD, V55, P153, DOI 10.1017/S0003356100037387; PETRERE JA, 1993, FUND APPL TOXICOL, V21, P517, DOI 10.1006/faat.1993.1128; Poigner J., 2000, World Rabbit Science, V8, P17; Ramirez JA, 2004, MEAT SCI, V67, P617, DOI 10.1016/j.meatsci.2003.12.012; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Robinson DL, 2013, J ANIM SCI, V91, P1428, DOI 10.2527/jas.2012-5799; Rommers JM, 2004, ANIM REPROD SCI, V81, P151, DOI 10.1016/j.anireprosci.2003.09.001; SAS Institute Inc., 2005, STAT AN SYST US GUID, DOI [10.4137/BBI.S19057, DOI 10.4137/BBI.S19057]; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Xiccato G, 2010, NUTRITION OF THE RABBIT, 2ND EDITION, P83, DOI 10.1079/9781845936693.0083	41	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118259	10.1371/journal.pone.0118259	http://dx.doi.org/10.1371/journal.pone.0118259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671602	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300091
J	Luo, S; Hipler, UC; Munzberg, C; Skerka, C; Zipfel, PF				Luo, Shanshan; Hipler, Uta-Christina; Muenzberg, Christin; Skerka, Christine; Zipfel, Peter F.			Sequence Variations and Protein Expression Levels of the Two Immune Evasion Proteins Gpm1 and Pra1 Influence Virulence of Clinical Candida albicans Isolates	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; BINDING SURFACE PROTEIN; PH-REGULATED ANTIGEN; IN-VITRO; BORRELIA-BURGDORFERI; PLASMINOGEN; GENE; MORTALITY; FAMILY; IDENTIFICATION	Candida albicans, the important human fungal pathogen uses multiple evasion strategies to control, modulate and inhibit host complement and innate immune attack. Clinical C. albicans strains vary in pathogenicity and in serum resistance, in this work we analyzed sequence polymorphisms and variations in the expression levels of two central fungal complement evasion proteins, Gpm1 (phosphoglycerate mutase 1) and Pra1 (pH-regulated antigen 1) in thirteen clinical C. albicans isolates. Four nucleotide (nt) exchanges, all representing synonymous exchanges, were identified within the 747-nt long GPM1 gene. For the 900-nt long PRA1 gene, sixteen nucleotide exchanges were identified, which represented synonymous, as well as non-synonymous exchanges. All thirteen clinical isolates had a homozygous exchange (A to G) at position 73 of the PRA1 gene. Surface levels of Gpm1 varied by 8.2, and Pra1 levels by 3.3 fold in thirteen tested isolates and these differences influenced fungal immune fitness. The high Gpm1/Pra1 expressing candida strains bound the three human immune regulators more efficiently, than the low expression strains. The difference was 44% for Factor H binding, 51% for C4BP binding and 23% for plasminogen binding. This higher Gpm1/Pra1 expressing strains result in enhanced survival upon challenge with complement active, Factor H depleted human serum (difference 40%). In addition adhesion to and infection of human endothelial cells was increased (difference 60%), and C3b surface deposition was less effective (difference 27%). Thus, variable expression levels of central immune evasion protein influences immune fitness of the human fungal pathogen C. albicans and thus contribute to fungal virulence.	[Luo, Shanshan; Muenzberg, Christin; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Hipler, Uta-Christina] Friedrich Schiller Univ Hosp, Clin Dermatol & Allergol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	Luo, Shanshan/D-6050-2015		Deutsche Forschungsgemeinschaft, DFG Priority Program [SPP 1161]; Funginet [Zi 432]	Deutsche Forschungsgemeinschaft, DFG Priority Program(German Research Foundation (DFG)); Funginet	This work was support by the Deutsche Forschungsgemeinschaft, DFG Priority Program SPP 1161 and Funginet (Zi 432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Alves SH, 2006, MYCOSES, V49, P220, DOI 10.1111/j.1439-0507.2006.01226.x; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Harriott MM, MICROBIOL-SGM 12, V156, P3635, DOI [10.1099/mic.0.039354-0, DOI 10.1099/MIC.0.039354-0]; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hunter JC, 1999, ENVIRON MANAGE, V24, P65; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Iannitti RG, TRENDS IMMUNOL; Johnsson E, 1998, J IMMUNOL, V161, P4894; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lesiak-Markowicz I, 2011, J INFECT DIS, V204, P802, DOI 10.1093/infdis/jir455; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Luo SS, 2013, J INFECT DIS, V207, P594, DOI 10.1093/infdis/jis718; Luo SS, 2011, J BIOL CHEM, V286, P8021, DOI 10.1074/jbc.M110.130138; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, J INFECT DIS, V185, P1786, DOI 10.1086/340649; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; MULLER HJ, 1991, P NATL ACAD SCI USA, V88, P10079, DOI 10.1073/pnas.88.22.10079; Olczak-Kowalczyk D, PEDIAT DENT, V32, P189; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SKERKA C, 1992, J IMMUNOL, V148, P3313; SKERKA C, 1993, J BIOL CHEM, V268, P2904; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; Tongchusak S, 2008, MICROBIOL IMMUNOL, V52, P231, DOI 10.1111/j.1348-0421.2008.00032.x; Yamamoto T, RINSHO BYORI, V58, P1027; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2007, ADV EXP MED BIOL, V598, P80; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6; ZIPFEL PF, 1991, BIOCHEM BIOPH RES CO, V181, P179, DOI 10.1016/S0006-291X(05)81398-1	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0113192	10.1371/journal.pone.0113192	http://dx.doi.org/10.1371/journal.pone.0113192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692293	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500004
J	Mennecart, B				Mennecart, Bastien			The European Ruminants during the "Microbunodon Event" (MP28, Latest Oligocene): Impact of Climate Changes and Faunal Event on the Ruminant Evolution	PLOS ONE			English	Article							SWISS MOLASSE BASIN; RHINE GRABEN URG; EARLY MIOCENE; LATE EOCENE; MAMMALIA; GENUS; ARTIODACTYLA; EXTINCTIONS; MORPHOLOGY; PHYLOGENY	The Earth already experienced numerous episodes of global warming and cooling. One of the latest impressive events of temperature rising was the Late Oligocene Warming that occurred around 25 Mya. An increase of the marine temperature of 2 to 4 degrees C has been observed in a short time interval. In Europe, this major climatic event can be correlated to the continental faunal turnover "Microbunodon Event". This event is marked by a huge faunal turnover (40% of the ungulate fauna during the first 500k years) and environmental changes. Drier conditions associated to the appearance of the seasonality lead to new environmental conditions dominated by wooded savannahs. This is correlated to a major arrival of Asiatic immigrants. Moreover, from a homogenous fauna during the main part of the Oligocene, local climatic variations between the European Western coast and the more central Europe could have provided faunal regionalism during the latest Oligocene and earliest Miocene. Considering the ruminants, this event is the major ever known for this group in Europe. A total renewal at the family level occurred. Thanks to a precise stratigraphic succession, major evolutionary elements are highlighted. Typical Oligocene species, mainly Tragulina, were adapted to wooded environments and were leaves/fruits eaters. They disappeared at the end of MP27 or the early MP28. This corresponds to the appearance of the Asiatic immigrants. The Tragulina (Lophiomerycidae, Bachitheriidae) and stem Pecora gave way to more derived stem and maybe crown Pecora (e.g. "Amphitragulus", Babameryx, Dremotherium). These newcomers were adapted to more open environments and mixed feeding. The disappearance of the Tragulina is probably linked to environmental and vegetation changes, and competition. They give way to more derived ruminants having a more efficient metabolism in drier conditions and a better assimilation of less energetic food.	[Mennecart, Bastien] UPMC, Univ Paris 04, CNRS,UMR 7207, MNHN,CR2P Ctr Rech Paleobiodiversi & Paleoenviron, F-75005 Paris, France; [Mennecart, Bastien] SNMB Bayer Staatssammlung Palaontol & Geol, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Mennecart, B (corresponding author), UPMC, Univ Paris 04, CNRS,UMR 7207, MNHN,CR2P Ctr Rech Paleobiodiversi & Paleoenviron, CP38,8 Rue Buffon, F-75005 Paris, France.	mennecartbastien@gmail.com	Mennecart, Bastien/W-4477-2017; Mennecart, B/AAO-8772-2020	Mennecart, Bastien/0000-0002-9669-2907; Mennecart, B/0000-0002-9669-2907	Swiss National Science Foundation [PBFRP2_145900]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study has been funded by the Swiss National Science Foundation project PBFRP2_145900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J-P., 1997, MEMOIRES TRAVAUX ECO, V21, P769; Aiglstorfer M, 2013, PALAEOBIO PALAEOENV, V94, P83; Antoine PO, 2011, CR PALEVOL, V10, P239, DOI 10.1016/j.crpv.2011.01.004; Barmann EV, 2011, MAMM BIOL, V76, P762, DOI 10.1016/j.mambio.2011.07.002; Ballmann P., 1970, Mitt. bayer. St. Palaont. Hist. Geol., V10, P271; Beamud E, 2003, EARTH PLANET SC LETT, V216, P501, DOI 10.1016/S0012-821X(03)00539-9; Becker D, 2003, GEOFOCUS, V9, P1; Becker D, 2009, NEUES JAHRB GEOL P-A, V254, P5, DOI 10.1127/0077-7749/2009/0002; Berger F. E., 1959, Palaeontographica, VA 112, P1; Berger J.-P., 2011, GEOCHRONIQUES MAGAZI, V117, P44; Berger JP, 2005, INT J EARTH SCI, V94, P711, DOI 10.1007/s00531-005-0479-y; Berger JP, 2005, INT J EARTH SCI, V94, P697, DOI 10.1007/s00531-005-0475-2; Berger JP, 1998, REV PALAEOBOT PALYNO, V101, P95, DOI 10.1016/S0034-6667(97)00071-7; BERGEROT JL, 1990, IEE CONF PUBL, V317, P189; Berthet Didier, 2003, Documents des Laboratoires de Geologie Lyon, V159, P1; Blondel C, 2005, ZOOL J LINN SOC-LOND, V144, P145, DOI 10.1111/j.1096-3642.2005.00166.x; Blondel C, 1997, GEOBIOS-LYON, V30, P573, DOI 10.1016/S0016-6995(97)80123-4; Blondel C, 1998, CR ACAD SCI II A, V326, P527, DOI 10.1016/S1251-8050(98)80081-5; BOUVRAIN G, 1986, CR ACAD SCI II, V302, P101; Bravard J.-P., 2002, TRAITEMENT VERSANTS, DOI [10.1120/jacmp.v15i6.4957, DOI 10.1120/JACMP.V15I6.4957]; Brunet M., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P225; Brunet M., 1987, MUNCHNER GEOWISSEN A, V10, P13, DOI DOI 10.1111/GCB.12846; Buechler W, 2003, OLIGOCENE MACROFLORA, DOI [10.1594/PANGAEA.106219, DOI 10.1594/PANGAEA.106219]; Costeur L, 2005, THESIS U C BERNARD L; Croizet JB, 1829, B SCI NATURELLES GEO, V16, P276; De Man E, 2004, NETH J GEOSCI, V83, P227, DOI 10.1017/S0016774600020291; Engesser Burkart, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P475; Engessert B., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P67; Estes R., 1976, B MUSEUM NATL DHISTO, V398, P297; Estes R., 1981, HDB PALAOHERPETOLO 2; Filhol H, 1887, B SOC PHILOMATIQUE P, V7, P12; Filhol H, 1877, RECHERCHES PHOSPHORI; Franzen Jens Lorenz, 2005, Annales de Paleontologie, V91, P329, DOI 10.1016/j.annpal.2005.04.002; Freudenberg H., 1941, Palaeontographica Stuttgart, V92A, P99; Gabunia L., 1964, OLIGOCENE MAMMALIAN; Gentry Alan W., 1999, P225; Geraads D., 1987, Palaeovertebrata (Montpellier), V17, P43; Gervais P., 1848, ZOOLOGIE PALEONTOLOG, V3; Giraud J, 1902, ETUDE GEOLOGIQUE LIM; Gradstein F.M., 2004, A; Groves C, 2011, UNGULATE TAXONOMY, DOI [10.1007/s13197-011-0356-6, DOI 10.1007/S13197-011-0356-6]; Habicht JKA, 1987, COMMISSION GEOLOGIQU, VI, P1; HARDENBOL J., 1998, SEPM SPECIAL PUBLICA, V160, P763, DOI DOI 10.2110/PEC.98.02.0003; Hartenberger JL, 1970, B SOC GEOLOGIQUE FRA, V7, P879; Heissig K., 1969, Abhandlungen der Bayerischen Akademie der Wissenschaften, V138, P1; Heissig K., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P101; Hugueney Marguerite, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P417; Janis C.M., 1987, Journal of Vertebrate Paleontology, V7, P200; JANIS CM, 1989, PALAEONTOLOGY, V32, P463; Janis CM., 1987, AM MUS NOVIT, V2893, P1; Jehenne Y., 1977, Geobios Lyon Memoire Special, VNo. 1, P233; Jehenne Y., 1992, Geobios Memoire Special (Villeurbanne), P201; JEHENNE Y, 1988, CR ACAD SCI II, V307, P1991; Jehenne Y., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P131; Kristkoiz, 1992, ABH BAYER AKAD WI MN, V167, P1; Lavocat R, 1951, REVISION FAUNE MAMMI, DOI [10.1038/ncomms?152, DOI 10.1038/NCOMMS?152]; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Lihoreau Fabrice, 2007, P89; Londeix Laurent, 2014, P294; Lyddeker R, 1885, CATALOGUE FOSSIL MAM; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MARTINEZ JN, 1995, LETHAIA, V28, P197, DOI 10.1111/j.1502-3931.1995.tb01423.x; Matthews W. D., 1925, American Museum Novitates, V196, P1; Mennecart B., 2012, GEOFOCUS, V32, P1; Mennecart B, 2012, RUMINANTS ANATOMY BE, P205; Mennecart B, 2015, J SYST PALAEONTOL, V13, P581, DOI 10.1080/14772019.2014.948505; Mennecart Bastien, 2012, Swiss Journal of Palaeontology, V131, P161, DOI 10.1007/s13358-011-0031-6; Mennecart B, 2011, SWISS J GEOSCI, V104, pS115, DOI 10.1007/s00015-010-0034-0; Metais Gregoire, 2007, P189; Miao D, 1982, ACTA PALAEONTOLOGICA, V21, P20; Modden C, 2000, ACTA PALAEONTOL POL, V45, P301; OETTINGEN-SPIELBERG THERESE ZU, 1952, NEUES JAHRB F GEOL U PALAONTOL ABHANDL, V94, P401; Picot L., 2002, GEOFOCUS, V5, P1; Popov SV., 2004, COUR FORSCH I SENCKE, V250, P1; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Rage JC, 2005, CR PALEVOL, V4, P428, DOI 10.1016/j.crpv.2005.04.001; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rossner Gertrud E., 2007, P213; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Scherler L, 2013, SWISS J GEOSCI, V106, P349, DOI 10.1007/s00015-013-0140-x; Scherler L, 2011, J VERTEBR PALEONTOL, V31, P479, DOI 10.1080/02724634.2011.550360; SCHLEICH H H, 1988, Palaeontologische Zeitschrift, V62, P95; Schlosser M, 1925, SOC SCI NATURELLES C, V38, P372, DOI [10.4196/kjpp.2014.18.6.509, DOI 10.4196/KJPP.2014.18.6.509]; Schlosser M., 1886, MORPHOLOGISCHES JB, V12, P1; Stehlin HG., 1909, B SOC GEOLOGIQUE FRA, V4 e surie, Tome IX:, P488; Stinton F.C., 1979, Eclogae Geologicae Helvetiae, V72, P851; Sudre J., 1984, Palaeovertebrata (Montpellier), V14, P1; SUDRE J, 1986, CR ACAD SCI II, V303, P749; Sudre Jean, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P205; Tobien H., 1974, Mainzer geowiss. Mitt., V3, P95; Trofimov B. A., 1957, Cursillos y Conferencias Instituto Lucas Mallada de Investigaciones Geologicas, V4, P137; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vianey-Liaud Monique, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P669; VIANEYLIAUD M, 1991, PALAEOGEOGR PALAEOCL, V85, P15, DOI 10.1016/0031-0182(91)90023-K; Viret J., 1929, ANN U LYON, V47, P1, DOI DOI 10.1016/J.BMCL.2008.01.089; Vislobokova Inesa, 2002, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V103A, P213; Vislobokova Inesa, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P215; Wehrli H, 1932, NOTIZBL VER ERDK, V5, P101; Weidmann Marc, 2014, Revue de Paleobiologie, V33, P463; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	102	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116830	10.1371/journal.pone.0116830	http://dx.doi.org/10.1371/journal.pone.0116830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692298	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500024
J	Lima, FED; Cibulski, SP; dos Santos, HF; Teixeira, TF; Varela, APM; Roehe, PM; Delwart, E; Franco, AC				de Sales Lima, Francisco Esmaile; Cibulski, Samuel Paulo; dos Santos, Helton Fernandes; Teixeira, Thais Fumaco; Muterle Varela, Ana Paula; Roehe, Paulo Michel; Delwart, Eric; Franco, Ana Claudia			Genomic Characterization of Novel Circular ssDNA Viruses from Insectivorous Bats in Southern Brazil	PLOS ONE			English	Article							PORCINE CIRCOVIRUS; GENETIC DIVERSITY; PATHOGENESIS; DIAGNOSIS; DISEASE; PIGS	Circoviruses are highly prevalent porcine and avian pathogens. In recent years, novel circular ssDNA genomes have recently been detected in a variety of fecal and environmental samples using deep sequencing approaches. In this study the identification of genomes of novel circoviruses and cycloviruses in feces of insectivorous bats is reported. Pan-reactive primers were used targeting the conserved rep region of circoviruses and cycloviruses to screen DNA bat fecal samples. Using this approach, partial rep sequences were detected which formed five phylogenetic groups distributed among the Circovirusand the recently proposed Cyclovirus genera of the Circoviridae. Further analysis using inverse PCR and Sanger sequencing led to the characterization of four new putative members of the family Circoviridae with genome size ranging from 1,608 to 1,790 nt, two inversely arranged ORFs, and canonical nonamer sequences atop a stem loop.	[de Sales Lima, Francisco Esmaile; Cibulski, Samuel Paulo; Roehe, Paulo Michel; Franco, Ana Claudia] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Virol Lab, Dept Microbiol Immunol & Parasitol, Porto Alegre, RS, Brazil; [Cibulski, Samuel Paulo; dos Santos, Helton Fernandes; Teixeira, Thais Fumaco; Muterle Varela, Ana Paula; Roehe, Paulo Michel] Inst Vet Res Desiderio Finamor IPVDF, FEPAGRO Anim Hlth, Eldorado Do Sul, RS, Brazil; [Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Universidade Federal do Rio Grande do Sul; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Lima, FED (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Virol Lab, Dept Microbiol Immunol & Parasitol, Porto Alegre, RS, Brazil.	esmaile.sales@gmail.com	ROEHE, PAULO MICHEL/K-1208-2012; Franco, Ana Cláudia AC/N-4373-2015; Cibulski, Samuel P/G-5190-2017	ROEHE, PAULO MICHEL/0000-0002-2370-7661; 	National Council for the Improvement of Higher Education (CAPES); National Council for Scientific and Technological Development (CNPq); Financiadora de Estudos e Projetos (FINEP)	National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by the National Council for the Improvement of Higher Education (CAPES), the National Council for Scientific and Technological Development (CNPq), and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe C, 2011, J RADIAT RES, V52, P208, DOI 10.1269/jrr.10122; Acosta-Leal R, 2010, PHYTOPATHOLOGY, V100, P1204, DOI 10.1094/PHYTO-04-10-0103; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Bassami MR, 1998, VIROLOGY, V249, P453, DOI 10.1006/viro.1998.9324; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Cheung AK, 2006, J VIROL, V80, P8686, DOI 10.1128/JVI.00655-06; Darwich L, 2004, ARCH VIROL, V149, P857, DOI 10.1007/s00705-003-0280-9; Dayaram A, 2013, J GEN VIROL, V94, P1827, DOI 10.1099/vir.0.052654-0; Lima FED, 2013, VIRUS GENES, V47, P164, DOI 10.1007/s11262-013-0899-x; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Ellis J, 1998, CAN VET J, V39, P44; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Grau-Roma L, 2011, VET J, V187, P23, DOI 10.1016/j.tvjl.2010.01.018; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hattermann K, 2003, ARCH VIROL, V148, P2471, DOI 10.1007/s00705-003-0181-y; King A.M.Q., 2012, VIRUS TAXONOMY, P343, DOI 10.1016/B978-0-12-384684-6.00034-3; King AMQ, 2012, VIRUS TAXONOMY CLASS, DOI [10.1016/j.mjafi.2012.08.017, DOI 10.1016/J.MJAFI.2012.08.017]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tan LV, 2013, MBIO, V4, DOI 10.1128/mBio.00231-13; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Padilla-Rodriguez M, 2013, ARCH VIROL, V158, P1389, DOI 10.1007/s00705-013-1606-x; Rijsewijk FAM, 2011, ARCH VIROL, V156, P1097, DOI 10.1007/s00705-011-0971-6; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Sambrook J., 2001, MOL CLONING LAB MANU; Segales J, 2005, VET MICROBIOL, V111, P223, DOI 10.1016/j.vetmic.2005.10.008; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Stewart ME, 2006, AVIAN PATHOL, V35, P86, DOI 10.1080/03079450600597345; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todd D, 2001, VIROLOGY, V286, P354, DOI 10.1006/viro.2001.0985; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Van Tan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03967; ZUKER M, 1995, NUCLEIC ACIDS RES, V23, P2791, DOI 10.1093/nar/23.14.2791	39	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118070	10.1371/journal.pone.0118070	http://dx.doi.org/10.1371/journal.pone.0118070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688970	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700098
J	De, W; Jing, K; Huan, Z; Qiong, ZH; Monagin, C; Min, ZJ; Ping, H; Wen, KC; Yan, LJ				De, Wu; Jing, Kou; Huan, Zhang; Qiong, Zhou Hui; Monagin, Corina; Min, Zhong Jian; Ping, Huang; Wen, Ke Chang; Yan, Lin Jin			Scrub Typhus, a Disease with Increasing Threat in Guangdong, China	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; RODENTS; OUTBREAK; PROVINCE; STRAINS	There has been a rapid increase in the number of scrub typhus cases in Guangdong Province, China. For this reason, an epidemiologic study was conducted to understand the characteristics of scrub typhus epidemics in Guangdong. From 2006 to 2013, the incidence of human cases increased from 0.4321 to 3.5917 per 100,000 with a bimodal peak in human cases typically occurring between May and November. To detect the prevalence of Orientia tsutsugamushi among suspected human cases and rodents, we performed ELISA tests of IgM/IgG and nested PCR tests on 59 whole blood samples from the suspected cases and 112 spleen samples from the rodents. Suspected cases tested positive for anti-O. tsutsugamushi IgM and IgG 66.1% (39/59) and 50.8% (30/59) of the time, respectively. Additionally, 20.3% (12/59) of blood samples and 13.4%(15/112) of spleen samples were positive for PCR. Phylogenetic analysis revealed that there were four definable clusters among the 27 nucleotide sequences of the 56-kDa antigen genes: 44.4% Karp (12/27), 25.9% Kato (7/27), 22.2% Gilliam (6/27) and 7.4% TA763 (2/27). We concluded many suspected cases may result in diagnostic errors; therefore, it is necessary to perform laboratory tests on suspected cases in hospitals. The high infection rate of O. tsutsugamushi among the limited rodents tested suggested that further rodent sampling throughout the province is necessary to further define high-risk areas. Furthermore, the multiple co-circulating genotypes of O. tsutsugamushi play a key role in the pervasiveness of scrub typhus in the Guangdong area.	[De, Wu; Jing, Kou; Huan, Zhang; Qiong, Zhou Hui; Ping, Huang; Wen, Ke Chang; Yan, Lin Jin] Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou, Guangdong, Peoples R China; [Monagin, Corina] Metabiota Inc, San Francisco, CA USA; [Min, Zhong Jian] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	De, W (corresponding author), Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou, Guangdong, Peoples R China.	wu_de68@cdcp.org.cn	ping, huang/GYD-3580-2022		Twelfth Five-Year Medical Research Key Project of PLA [AWS 11L 009]; Metabiota Inc. (formally known as Global Viral Forecasting)	Twelfth Five-Year Medical Research Key Project of PLA; Metabiota Inc. (formally known as Global Viral Forecasting)	Blood sample collection of suspected cases and surveillance data analysis were supported by the Twelfth Five-Year Medical Research Key Project of PLA (AWS 11L 009), samples collection of rodents and sequencing were supported by Metabiota Inc. (formally known as Global Viral Forecasting). Co-author Corina Monagin is employed by Metabiota, Inc. Metabiota, Inc. provided support in the form of salary for author CM, and helped in the preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, or decision to publish.	[储凯 Chu Kai], 2013, [中华传染病杂志, Chinese Journal of Infections Diseases], V31, P358; Coleman RE, 2002, AM J TROP MED HYG, V67, P497, DOI 10.4269/ajtmh.2002.67.497; Duong V, 2013, INFECT GENET EVOL, V15, P35, DOI 10.1016/j.meegid.2011.01.004; Fang YR, 2013, CHINESE RURAL HLTH S, V33, P426; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; Kim YJ, 2013, J KOREAN MED SCI, V28, P672, DOI 10.3346/jkms.2013.28.5.672; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Li J, 2005, PRACTICAL PREVENTIVE, V12, P1251; Lin PR, 2011, APPL ENVIRON MICROB, V77, P3398, DOI 10.1128/AEM.02796-10; [刘隽 Liu Jun], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P946; Meng Z, 2011, CHIN J EPIDEMIOL, V32, P419; Oaks SCJ, 1983, I MED RES MALAYS B, V21, P1; Ohashi N, 1996, MICROBIOL IMMUNOL, V40, P627, DOI 10.1111/j.1348-0421.1996.tb01120.x; Raina SK, 2013, J POSTGRAD MED, V59, DOI 10.4103/0022-3859.123191; Rodkvamtook W, 2011, AM J TROP MED HYG, V84, P599, DOI 10.4269/ajtmh.2011.09-0768; Ruang-areerate T, 2011, J CLIN MICROBIOL, V49, P2584, DOI 10.1128/JCM.00355-11; Shim SK, 2009, CLIN MICROBIOL INFEC, V15, P311, DOI 10.1111/j.1469-0691.2008.02254.x; Shouyin Z, 2009, FOREIGN MED SCI SECT, V30, P133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Wu G., 2007, INT J MED PARASIT DI, V34, P169, DOI [10.3760/cma.j.issn.1673-4122.2007.04.001, DOI 10.3760/CMA.J.ISSN.1673-4122.2007.04.001]; Yun Z, 2010, CHIN J PUBLIC HLTH, V26, P174; Zhang Lijuan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P482; Zhang M, 2012, AM J TROP MED HYG, V87, P1099, DOI 10.4269/ajtmh.2012.12-0306; Zhang WY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002493	26	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0113968	10.1371/journal.pone.0113968	http://dx.doi.org/10.1371/journal.pone.0113968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689778	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700003
J	Honda, T; Obara, Y; Yamauchi, A; Couvillon, AD; Mason, JJ; Ishii, K; Nakahata, N				Honda, Takuto; Obara, Yutaro; Yamauchi, Arata; Couvillon, Anthony D.; Mason, Justin J.; Ishii, Kuniaki; Nakahata, Norimichi			Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription	PLOS ONE			English	Article							TARGETED DELETION; SIGNALING PATHWAY; ACTIVATION; GROWTH; BMK1/ERK5; ERK5/BMK1; ERK1/2; PROLIFERATION; INHIBITION; PROMOTES	Extracellular signal-regulated kinases (ERKs) play critical roles in numerous cellular processes, including proliferation and differentiation. ERK5 contains a kinase domain at the N-terminal, and the unique extended C-terminal includes multiple autophosphorylation sites that enhance ERK5-dependent transcription. However, the impact of phosphorylation at the various sites remain unclear. In this study, we examined the role of phosphorylation at the ERK5 C-terminal. We found that a constitutively active MEK5 mutant phosphorylated ERK5 at the TEY motif, resulting in the sequential autophosphorylation of multiple C-terminal residues, including Thr732 and Ser769/773/775. However, when ERK1/2 was selectively activated by an oncogenic RAS mutant, ERK5 phosphorylation at Thr732 was induced without affecting the phosphorylation status at TEY or Ser769/773/775. The Thr732 phosphorylation was U0126-sensitive and was observed in a kinase-dead mutant of ERK5 as well, suggesting that ERK1/2 can phosphorylate ERK5 at Thr732. This phosphorylation was also promoted by epidermal growth factor and nerve growth factor in HEK293 and PC12 cells, respectively. The ERK5-T732A mutant was localized in the cytosol under basal conditions. In contrast, ERK5 phosphorylated at Thr732 via the RAS-ERK1/2 pathway and ERK5T732E, which mimics the phosphorylated form, were localized in both the nucleus and cytosol. Finally, ER-32A and U0126 blocked ERK5-dependent MEF2C transcriptional activity. Based on these findings, we propose a novel cross-talk mechanism in which ERK1/2, following activation by growth factor stimulation, phosphorylates ERK5 at Thr732. This phosphorylation event is responsible for ERK5 nuclear localization and ERK5-dependent transcription.	[Honda, Takuto; Obara, Yutaro; Yamauchi, Arata; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Ishii, Kuniaki] Yamagata Univ, Sch Med, Dept Pharmacol, Yamagata 9909585, Japan; [Couvillon, Anthony D.; Mason, Justin J.] Cell Signaling Technol, Danvers, MA 01923 USA	Tohoku University; Yamagata University	Obara, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	obaray@med.id.yamagata-u.ac.jp			Japan Society for the Promotion of Science [20790053, 24790063]; Exploratory Research Program for Young Scientists of Tohoku University; Sankyo Foundation of Life Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Nishinomiya Basic Research Fund; Grants-in-Aid for Scientific Research [26670118] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exploratory Research Program for Young Scientists of Tohoku University; Sankyo Foundation of Life Science; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Nishinomiya Basic Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 20790053 and 24790063 to Y.O.), The Exploratory Research Program for Young Scientists of Tohoku University (Y.O.), Sankyo Foundation of Life Science (Y.O.), The NOVARTIS Foundation (Japan) for the Promotion of Science (Y.O.), and Nishinomiya Basic Research Fund (Y.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kimura TE, 2010, CIRC RES, V106, P961, DOI 10.1161/CIRCRESAHA.109.209320; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Lennartsson J, 2010, CELL SIGNAL, V22, P955, DOI 10.1016/j.cellsig.2010.01.020; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Obara Y, 2011, CELL SIGNAL, V23, P666, DOI 10.1016/j.cellsig.2010.11.020; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050455; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Sharma G, 2007, BIOCHEM BIOPH RES CO, V354, P1078, DOI 10.1016/j.bbrc.2007.01.102; Su C, 2011, J NEUROSCI RES, V89, P1542, DOI 10.1002/jnr.22683; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	39	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117914	10.1371/journal.pone.0117914	http://dx.doi.org/10.1371/journal.pone.0117914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689862	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700082
J	Ozturk, H; Ozkirimli, E; Ozgur, A				Ozturk, Hakime; Ozkirimli, Elif; Ozgur, Arzucan			Classification of Beta-Lactamases and Penicillin Binding Proteins Using Ligand-Centric Network Models	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BACTERIAL-RESISTANCE; CLASS-A; STRUCTURAL INSIGHT; INTERACTIVE TREE; INHIBITION; EVOLUTION; PSEUDOMONAS; MEROPENEM; COMPLEX	beta-lactamase mediated antibiotic resistance is an important health issue and the discovery of new beta-lactam type antibiotics or beta-lactamase inhibitors is an area of intense research. Today, there are about a thousand beta-lactamases due to the evolutionary pressure exerted by these ligands. While beta-lactamases hydrolyse the beta-lactam ring of antibiotics, rendering them ineffective, Penicillin-Binding Proteins (PBPs), which share high structural similarity with beta-lactamases, also confer antibiotic resistance to their host organism by acquiring mutations that allow them to continue their participation in cell wall biosynthesis. In this paper, we propose a novel approach to include ligand sharing information for classifying and clustering beta-lactamases and PBPs in an effort to elucidate the ligand induced evolution of these beta-lactam binding proteins. We first present a detailed summary of the beta-lactamase and PBP families in the Protein Data Bank, as well as the compounds they bind to. Then, we build two different types of networks in which the proteins are represented as nodes, and two proteins are connected by an edge with a weight that depends on the number of shared identical or similar ligands. These models are analyzed under three different edge weight settings, namely unweighted, weighted, and normalized weighted. A detailed comparison of these six networks showed that the use of ligand sharing information to cluster proteins resulted in modules comprising proteins with not only sequence similarity but also functional similarity. Consideration of ligand similarity highlighted some interactions that were not detected in the identical ligand network. Analysing the beta-lactamases and PBPs using ligand-centric network models enabled the identification of novel relationships, suggesting that these models can be used to examine other protein families to obtain information on their ligand induced evolutionary paths.	[Ozturk, Hakime; Ozgur, Arzucan] Bogazici Univ, Dept Comp Engn, TR-80815 Bebek, Turkey; [Ozkirimli, Elif] Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey	Bogazici University; Bogazici University	Ozkirimli, E (corresponding author), Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey.	elif.ozkirimli@boun.edu.tr; arzucan.ozgur@boun.edu.tr	Öztürk, Hakime/J-6103-2018; Ozkirimli, Elif/Q-1586-2015; Ozgur, Arzucan/I-3147-2012	Ozkirimli, Elif/0000-0002-3206-8427; Ozgur, Arzucan/0000-0001-8376-1056; Ozturk, Hakime/0000-0002-2146-5638	Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme; TUBITAK BIDEB	Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme; TUBITAK BIDEB(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work has been supported by Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme and TUBITAK BIDEB 2210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM EP, 1988, REV INFECT DIS, V10, P677; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2013, CHEM BIOL, V20, P1107, DOI [10.1016/j.chembiol.2013.07.015, DOI 10.1016/J.CHEMBIOL.2013.07.015]; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Cheng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041064; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P3463, DOI 10.1128/AAC.00543-08; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016/j.ijantimicag.2008.01.017; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kalinina OV, 2012, NUCLEIC ACIDS RES, V40, pD549, DOI 10.1093/nar/gkr1049; Ke W, 2011, ANTIMICROB AGENTS CH, V55, P174, DOI 10.1128/AAC.00930-10; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; Lerner TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002524; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mitchell JBO, 2001, J CHEM INF COMP SCI, V41, P1617, DOI 10.1021/ci010364q; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Nobeli I, 2005, J MOL BIOL, V347, P415, DOI 10.1016/j.jmb.2005.01.061; Nukaga M, 2003, BIOCHEMISTRY-US, V42, P13152, DOI 10.1021/bi034986b; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; PRYKA RD, 1994, ANN PHARMACOTHER, V28, P1045, DOI 10.1177/106002809402800910; Pucci MJ, 2013, CLIN MICROBIOL REV, V26, P792, DOI 10.1128/CMR.00033-13; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sweden EET, 2013, EUROSURVEILLANCE, V18; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Urbach C, 2009, J MOL BIOL, V386, P109, DOI 10.1016/j.jmb.2008.12.001; Watkins RR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00392; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r; Xue L, 2001, J CHEM INF COMP SCI, V41, P394, DOI 10.1021/ci000305x; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	58	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117874	10.1371/journal.pone.0117874	http://dx.doi.org/10.1371/journal.pone.0117874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689853	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700081
J	Stevens, FR; Gaughan, AE; Linard, C; Tatem, AJ				Stevens, Forrest R.; Gaughan, Andrea E.; Linard, Catherine; Tatem, Andrew J.			Disaggregating Census Data for Population Mapping Using Random Forests with Remotely-Sensed and Ancillary Data	PLOS ONE			English	Article							LANDSCAN; SURFACES; KENYA; MAPS	High resolution, contemporary data on human population distributions are vital for measuring impacts of population growth, monitoring human-environment interactions and for planning and policy development. Many methods are used to disaggregate census data and predict population densities for finer scale, gridded population data sets. We present a new semi-automated dasymetric modeling approach that incorporates detailed census and ancillary data in a flexible, "Random Forest" estimation technique. We outline the combination of widely available, remotely-sensed and geospatial data that contribute to the modeled dasymetric weights and then use the Random Forest model to generate a gridded prediction of population density at similar to 100 m spatial resolution. This prediction layer is then used as the weighting surface to perform dasymetric redistribution of the census counts at a country level. As a case study we compare the new algorithm and its products for three countries (Vietnam, Cambodia, and Kenya) with other common gridded population data production methodologies. We discuss the advantages of the new method and increases over the accuracy and flexibility of those previous approaches. Finally, we outline how this algorithm will be extended to provide freely-available gridded population data sets for Africa, Asia and Latin America.	[Stevens, Forrest R.; Gaughan, Andrea E.] Univ Louisville, Dept Geog & Geosci, Louisville, KY 40292 USA; [Linard, Catherine] Fonds Natl Rech Sci FRS FNRS, B-1000 Brussels, Belgium; [Linard, Catherine] Univ Libre Bruxelles, Biol Control & Spatial Ecol, B-1050 Brussels, Belgium; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Louisville; Fonds de la Recherche Scientifique - FNRS; Universite Libre de Bruxelles; University of Southampton; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Stevens, FR (corresponding author), Univ Louisville, Dept Geog & Geosci, Louisville, KY 40292 USA.	forrest.stevens@louisville.edu	Linard, Catherine/AAF-1670-2021	Linard, Catherine/0000-0002-0819-7755; Stevens, Forrest/0000-0002-9328-3753; Tatem, Andrew/0000-0002-7270-941X	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Bill and Melinda Gates Foundation [49446, 1032350]	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	AJT acknowledges funding support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health, and is also supported by grants from the Bill and Melinda Gates Foundation (#49446 and #1032350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DE, 1973, PHOTOGRAMM ENG REM S, V39, P147; Azar D, 2013, REMOTE SENS ENVIRON, V130, P219, DOI 10.1016/j.rse.2012.11.022; Azar D, 2010, INT J REMOTE SENS, V31, P5635, DOI 10.1080/01431161.2010.496799; Balk D., 2005, INT SOC PHOTOGRAMMET, P1; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Balk DL, 2004, THE GLOBAL DISTRIBUT; Bhaduri B, 2007, GEOJOURNAL, V69, P103, DOI 10.1007/s10708-007-9105-9; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen K, 2002, INT J REMOTE SENS, V23, P37, DOI 10.1080/01431160010014297; CIAT, 2005, LATIN AMERICAN AND C; Deichmann U, 1996, REV SPATIAL POPULATI; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Gallego FJ, 2011, INT J GEOGR INF SCI, V25, P2051, DOI 10.1080/13658816.2011.583653; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Hastie T, 2009, SPRINGER SERIES IN S, DOI 10.1016/j.neunet.2009.04.005; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HR-COD. Humanitarian Response, 2013, HUMANITARIAN RESPONS; IUCN and UNEP, 2012, THE WORLD DATABASE O; Kenya Open Data, 2007, OPEN KENYA TRANSPARE; Lehner B., 2006, HYDROSHEDS TECHNICAL, P27; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7; Linard C, 2011, GEOJOURNAL, V76, P525, DOI 10.1007/s10708-010-9364-8; LO CP, 1995, INT J REMOTE SENS, V16, P17, DOI 10.1080/01431169508954369; Lung T, 2013, APPL GEOGR, V41, P36, DOI 10.1016/j.apgeog.2013.03.002; MDA Federal Inc, 2007, EARTHSAT GEOCOVER LC; Nelson A., 2004, AFRICAN POPULATION D; NOAA, 2012, VIIRS NIGHTTIME LIGH; Noor AM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-13; OSM, 2013, OPENSTREETMAP BASE D; R Core Team, 2021, R LANGUAGE ENV STAT; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Salvatore M., 2005, MAPPING GLOBAL URBAN; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Sikonja M. R., 2004, MACHINE LEARNING ECM; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tatem AJ, 2005, REMOTE SENS ENVIRON, V96, P87, DOI 10.1016/j.rse.2005.02.001; Tatem A, 2011, NATURE, V474, P36, DOI 10.1038/474036d; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tobler W, 1995, TECHNICAL REPORT TR; United Nations, 2012, WORLD URBANIZATION P, DOI [10.2149/tmh.2011-S05, DOI 10.2149/TMH.2011-S05]; Wu S, 2005, GISCIENCE REMOTE SEN, V42, P80	46	466	487	15	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0107042	10.1371/journal.pone.0107042	http://dx.doi.org/10.1371/journal.pone.0107042			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689585	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350322700001
J	Yuan, EC; Alderson, DL; Stromberg, S; Carlson, JM				Yuan, Edwin C.; Alderson, David L.; Stromberg, Sean; Carlson, Jean M.			Optimal Vaccination in a Stochastic Epidemic Model of Two Non-Interacting Populations	PLOS ONE			English	Article							STRATEGIES; DYNAMICS; FOOT; SIR	Developing robust, quantitative methods to optimize resource allocations in response to epidemics has the potential to save lives and minimize health care costs. In this paper, we develop and apply a computationally efficient algorithm that enables us to calculate the complete probability distribution for the final epidemic size in a stochastic Susceptible-Infected-Recovered (SIR) model. Based on these results, we determine the optimal allocations of a limited quantity of vaccine between two non-interacting populations. We compare the stochastic solution to results obtained for the traditional, deterministic SIR model. For intermediate quantities of vaccine, the deterministic model is a poor estimate of the optimal strategy for the more realistic, stochastic case.	[Yuan, Edwin C.; Stromberg, Sean; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Alderson, David L.] Naval Postgrad Sch, Dept Operat Res, Monterey, CA USA; [Yuan, Edwin C.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	University of California System; University of California Santa Barbara; United States Department of Defense; United States Navy; Naval Postgraduate School; Stanford University	Carlson, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	carlson@physics.ucsb.edu			Office of Naval Research MURI [DMR0606092]; David and Lucile Packard Foundation; Stansberry Fellowship through the CCS SURF foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-D-0001]; Office of Naval Research MURI [DMR0606092]; David and Lucile Packard Foundation; Stansberry Fellowship through the CCS SURF foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-D-0001]	Office of Naval Research MURI(MURIOffice of Naval Research); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Stansberry Fellowship through the CCS SURF foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office; Office of Naval Research MURI(MURIOffice of Naval Research); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Stansberry Fellowship through the CCS SURF foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office	This work was supported by an Office of Naval Research MURI Grant No. DMR0606092, the David and Lucile Packard Foundation, the Stansberry Fellowship through the CCS SURF foundation, and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Black AJ, 2015, J THEOR BIOL, V367, P159, DOI 10.1016/j.jtbi.2014.11.029; Black AJ, 2010, J R SOC INTERFACE, V7, P1219, DOI 10.1098/rsif.2009.0514; De Jong MCM, 2001, VACCINE, V19, P2722, DOI 10.1016/S0264-410X(00)00509-0; Gaff H, 2009, MATH BIOSCI ENG, V6, P469, DOI 10.3934/mbe.2009.6.469; Gordillo LF, 2008, B MATH BIOL, V70, P589, DOI 10.1007/s11538-007-9269-y; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jenkinson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036160; Keeling MJ, 2012, EPIDEMICS-NETH, V4, P78, DOI 10.1016/j.epidem.2012.03.001; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Knipl DH, 2011, MATH BIOSCI ENG, V8, P123, DOI 10.3934/mbe.2011.8.123; Lalley SP, 2014, ANN PROBAB, V42, P237, DOI 10.1214/13-AOP846; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Petrovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033285; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Wu JT, 2007, P ROY SOC B-BIOL SCI, V274, P2811, DOI 10.1098/rspb.2007.0893	21	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115826	10.1371/journal.pone.0115826	http://dx.doi.org/10.1371/journal.pone.0115826			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688857	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700006
J	Zakharova, NV; Artemenko, EO; Podoplelova, NA; Sveshnikova, AN; Demina, IA; Ataullakhanov, FI; Panteleev, MA				Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Demina, Irina A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.			Platelet Surface-Associated Activation and Secretion-Mediated Inhibition of Coagulation Factor XII	PLOS ONE			English	Article							ALPHA-GRANULE PROTEIN; THROMBUS FORMATION; CONTACT ACTIVATION; BLOOD-COAGULATION; IN-VIVO; PROCOAGULANT PLATELETS; C1 INHIBITOR; WHOLE-BLOOD; SUBPOPULATIONS; POLYPHOSPHATES	Coagulation factor XII (fXII) is important for arterial thrombosis, but its physiological activation mechanisms are unclear. In this study, we elucidated the role of platelets and platelet-derived material in fXII activation. FXII activation was only observed upon potent platelet stimulation (with thrombin, collagen-related peptide, or calcium ionophore, but not ADP) accompanied by phosphatidylserine exposure and was localised to the platelet surface. Platelets from three patients with grey platelet syndrome did not activate fXII, which suggests that platelet-associated fXII-activating material might be released from a-granules. FXII was preferentially bound by phosphotidylserine-positive platelets and annexin V abrogated platelet-dependent fXII activation; however, artificial phosphotidylserine/phosphatidylcholine microvesicles did not support fXII activation under the conditions herein. Confocal microscopy using DAPI as a poly-phosphate marker did not reveal poly-phosphates associated with an activated platelet surface. Experimental data for fXII activation indicates an auto-inhibition mechanism (k(i)/k(a) = 180 molecules/platelet). Unlike surface-associated fXII activation, platelet secretion inhibited activated fXII (fXIIa), particularly due to a released C1-inhibitor. Platelet surface-associated fXIIa formation triggered contact pathway-dependent clotting in recalcified plasma. Computer modelling suggests that fXIIa inactivation was greatly decreased in thrombi under high blood flow due to inhibitor washout. Combined, the surface-associated fXII activation and its inhibition in solution herein may be regarded as a flow-sensitive regulator that can shift the balance between surface-associated clotting and plasma-dependent inhibition, which may explain the role of fXII at high shear and why fXII is important for thrombosis but negligible in haemostasis.	[Zakharova, Natalia V.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Natl Res Ctr Hematol, Moscow, Russia; [Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Demina, Irina A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Sveshnikova, Anastasia N.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow, Russia; [Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.	mapanteleev@yandex.ru	Podoplelova, Nadezhda/AAT-3654-2020; Ataullakhanov, Fazoil/J-8076-2012; Panteleev, Mikhail A/H-5491-2012; Irina, Demina/A-7876-2014; Sveshnikova, Anastasia N/J-9945-2015; Podoplelova, Nadezhda/A-7482-2014; Zakharova, Natalia V/D-8644-2012	Podoplelova, Nadezhda/0000-0001-8013-1112; Panteleev, Mikhail A/0000-0002-8128-7757; Irina, Demina/0000-0002-4317-2094; Sveshnikova, Anastasia N/0000-0003-4720-7319; Podoplelova, Nadezhda/0000-0001-8013-1112; Zakharova, Natalia V/0000-0002-5267-0079	Russian Science Foundation [14-14-00195]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation grant 14-14-00195 (http://xn-m1afn.xn-p1ai/) (MAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaeva AA, 2013, J BIOL CHEM, V288, P29621, DOI 10.1074/jbc.M113.474163; Arnljots B, 1997, J VASC SURG, V25, P341, DOI 10.1016/S0741-5214(97)70356-2; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123; Boknas N, 2014, BLOOD, V124, P1692, DOI 10.1182/blood-2014-04-566067; CASTALDI PA, 1965, NATURE, V207, P422, DOI 10.1038/207422a0; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Faxalv L, 2013, BLOOD, V122, P3818, DOI 10.1182/blood-2013-05-499384; GRIEP MA, 1985, BIOCHEMISTRY-US, V24, P4124, DOI 10.1021/bi00336a047; GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kondratovich AY, 2002, BBA-GEN SUBJECTS, V1569, P86, DOI 10.1016/S0304-4165(01)00247-1; Kotova YN, 2008, J THROMB HAEMOST, V6, P1603, DOI 10.1111/j.1538-7836.2008.03052.x; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lipets EN, 2014, PLOS ONE IN PRESS; London FS, 2004, J BIOL CHEM, V279, P19854, DOI 10.1074/jbc.M310624200; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nickel KF, 2013, BLOOD, V122, P3847, DOI 10.1182/blood-2013-09-525840; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Ramjee MK, 2000, ANAL BIOCHEM, V277, P11, DOI 10.1006/abio.1999.4380; Ramstrom S, 2003, THROMB HAEMOSTASIS, V89, P132; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; SCHMAIER AH, 1993, BLOOD, V82, P465; SCHMAIER AH, 1985, J CLIN INVEST, V75, P242, DOI 10.1172/JCI111680; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; Topalov NN, 2012, ARTERIOSCL THROM VAS, V32, P2475, DOI 10.1161/ATVBAHA.112.253765; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Walsh P N, 1981, Ann N Y Acad Sci, V370, P241, DOI 10.1111/j.1749-6632.1981.tb29737.x; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019	39	29	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116665	10.1371/journal.pone.0116665	http://dx.doi.org/10.1371/journal.pone.0116665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688860	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700019
J	Ha, MA; Smith, GJ; Cichocki, JA; Fan, L; Liu, YS; Caceres, AI; Jordt, SE; Morris, JB				Ha, Michael A.; Smith, Gregory J.; Cichocki, Joseph A.; Fan, Lu; Liu, Yi-Shiuan; Caceres, Ana I.; Jordt, Sven Eric; Morris, John B.			Menthol Attenuates Respiratory Irritation and Elevates Blood Cotinine in Cigarette Smoke Exposed Mice	PLOS ONE			English	Article							NICOTINE METABOLISM; CAPSAICIN COUGH; COLD RECEPTOR; TRP CHANNELS; IN-VITRO; SENSITIVITY; IRRITANTS; RESPONSES; MOUSE; PAIN	Addition of menthol to cigarettes may be associated with increased initiation of smoking. The potential mechanisms underlying this association are not known. Menthol, likely due to its effects on cold-sensing peripheral sensory neurons, is known to inhibit the sensation of irritation elicited by respiratory irritants. However, it remains unclear whether menthol modulates cigarette smoke irritancy and nicotine absorption during initial exposures to cigarettes, thereby facilitating smoking initiation. Using plethysmography in a C57Bl/6J mouse model, we examined the effects of L-menthol, the menthol isomer added to cigarettes, on the respiratory sensory irritation response to primary smoke irritants (acrolein and cyclohexanone) and smoke of Kentucky reference 2R4 cigarettes. We also studied L-menthol's effect on blood levels of the nicotine metabolite, cotinine, immediately after exposure to cigarette smoke. L-menthol suppressed the irritation response to acrolein with an apparent IC50 of 4 ppm. Suppression was observed even at acrolein levels well above those necessary to produce a maximal response. Cigarette smoke, at exposure levels of 10 mg/m(3) or higher, caused an immediate and marked sensory irritation response in mice. This response was significantly suppressed by L-menthol even at smoke concentrations as high as 300 mg/m(3). Counterirritation by L-menthol was abolished by treatment with a selective inhibitor of Transient Receptor Potential Melastatin 8 (TRPM8), the neuronal cold/menthol receptor. Inclusion of menthol in the cigarette smoke resulted in roughly a 1.5-fold increase in plasma cotinine levels over those observed in mice exposed to smoke without added menthol. These findings document that, L-menthol, through TRPM8, is a strong suppressor of respiratory irritation responses, even during highly noxious exposures to cigarette smoke or smoke irritants, and increases blood cotinine. Therefore, L-menthol, as a cigarette additive, may promote smoking initiation and nicotine addiction.	[Ha, Michael A.; Smith, Gregory J.; Cichocki, Joseph A.; Morris, John B.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Toxicol Program, Storrs, CT USA; [Fan, Lu] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Liu, Yi-Shiuan] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Caceres, Ana I.; Jordt, Sven Eric] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA	University of Connecticut; Yale University; Yale University; Duke University	Jordt, SE (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA.	sven.jordt@yale.edu	Caceres, Ana I/E-5542-2012; Liu, Yi-Shiuan/AAI-3803-2020; Jordt, Sven-Eric/ABE-6517-2020	Caceres, Ana I/0000-0001-7219-8851; Liu, Yi-Shiuan/0000-0003-3205-8963; Jordt, Sven-Eric/0000-0001-6171-5622	National Institutes of Health of the United States; United States Food and Drug Administration [R01ES015056, R01HL105635, R01HL105635-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036151] Funding Source: NIH RePORTER	National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Food and Drug Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health of the United States and the United States Food and Drug Administration: R01ES015056 (to SEJ), R01HL105635 and R01HL105635-S1 (to SEJ and JBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARIE Y, 1981, FOOD COSMET TOXICOL, V19, P623, DOI 10.1016/0015-6264(81)90513-7; Alarie Y, 1973, CRC Crit Rev Toxicol, V2, P299, DOI 10.3109/10408447309082020; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Azagba S, 2014, CANC CAUSES CONTROL; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Bessac Bret F, 2010, Proc Am Thorac Soc, V7, P269, DOI 10.1513/pats.201001-004SM; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Buday Tomas, 2012, Cough, V8, P11, DOI 10.1186/1745-9974-8-11; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen C, 2011, NICOTINE TOB RES, V13, P741, DOI 10.1093/ntr/ntr031; de Oliveira C, 2014, J NEUROSCI, V34, P4445, DOI 10.1523/JNEUROSCI.5387-13.2014; Delnevo CD, 2011, AM J PREV MED, V41, P357, DOI 10.1016/j.amepre.2011.06.039; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FDA-TPSAC, 2011, MENTH CIG PUBL HLTH; Gavva NR, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-36; HARIHARAN M, 1991, CLIN CHEM, V37, P1276; Jones MR, 2013, CANCER EPIDEM BIOMAR, V22, P224, DOI 10.1158/1055-9965.EPI-12-0912; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kanezaki M, 2012, RESP MED, V106, P406, DOI 10.1016/j.rmed.2011.12.007; Klein AH, 2011, CHEM SENSES, V36, P649, DOI 10.1093/chemse/bjr029; Kong G, 2013, NICOTINE TOB RES, V15, P2094, DOI 10.1093/ntr/ntt102; Lanosa MJ, 2010, TOXICOL SCI, V115, P589, DOI 10.1093/toxsci/kfq057; Lee LY, 2010, LUNG, V188, pS23, DOI 10.1007/s00408-009-9191-1; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miguez-Burbano MJ, 2014, J ASS NURSES AIDS CA; Millqvist E, 2001, RESP MED, V95, P19, DOI 10.1053/rmed.2000.0965; Millqvist E, 2013, RESP MED, V107, P433, DOI 10.1016/j.rmed.2012.11.017; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P784, DOI 10.1001/jama.2013.276273; MORICE AH, 1994, THORAX, V49, P1024, DOI 10.1136/thx.49.10.1024; Morris JB, 2005, TOXICOL SCI, V83, P380, DOI 10.1093/toxsci/kfi038; NEURATH GB, 1987, INT ARCH OCC ENV HEA, V59, P199, DOI 10.1007/BF00378497; NSDUH, 2011, NSDUH REP REC TRENDS; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Raunio H, 2008, XENOBIOTICA, V38, P34, DOI 10.1080/00498250701708539; Rogers DF, 2002, CURR OPIN PHARMACOL, V2, P249, DOI 10.1016/S1471-4892(02)00146-7; Rojewski AM, 2014, NICOTINE TOB RES, V16, P115, DOI 10.1093/ntr/ntt137; Rosenbloom J, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-19; Saunders C J, 2013, F1000Res, V2, P74, DOI 10.12688/f1000research.2-74.v1; Shusterman D, 1997, ARCH ENVIRON HEALTH, V52, P334, DOI 10.1080/00039899709602208; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Smith SS, 2014, ADDICTION; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; VIJAYARAGHAVAN R, 1993, ARCH TOXICOL, V67, P478, DOI 10.1007/BF01969919; Vozoris NT, 2012, ARCH INTERN MED, V172, P590, DOI 10.1001/archinternmed.2012.320; Washam C, 2011, ENVIRON HEALTH PERSP, V119, pA286, DOI 10.1289/ehp.119-a286; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383	52	43	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117128	10.1371/journal.pone.0117128	http://dx.doi.org/10.1371/journal.pone.0117128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679525	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600051
J	Petterson, LJ; Dixson, BJ; Little, AC; Vasey, PL				Petterson, Lanna J.; Dixson, Barnaby J.; Little, Anthony C.; Vasey, Paul L.			Viewing Time Measures of Sexual Orientation in Samoan Cisgender Men Who Engage in Sexual Interactions with Fa'afafine	PLOS ONE			English	Article							AROUSAL; HOMOSEXUALITY; BISEXUALITY; SEARCH	Androphilia refers to attraction to adult males, whereas gynephilia refers to attraction to adult females. The current study employed self-report and viewing time (response time latency) measures of sexual attraction to determine the sexual orientation of Samoan cisgender men (i.e., males whose gender presentation and identity is concordant with their biological sex) who engage in sexual interactions with transgender male androphiles (known locally as fa'afafine) compared to: (1) Samoan cisgender men who only engage in sexual interactions with women, and (2) fa'afafine. As expected, both measures indicated that cisgender men who only engaged in sexual interactions with women exhibited a gynephilic pattern of sexual attraction, whereas fa'afafine exhibited an androphilic one. In contrast, both measures indicated that cisgender men who engaged in sexual interactions with fa'afafine demonstrated a bisexual pattern of sexual attraction. Most of the cisgender men who exhibited bisexual viewing times did not engage in sexual activity with both men and women indicating that the manner in which bisexual patterns of sexual attraction manifest behaviorally vary from one culture to the next.	[Petterson, Lanna J.; Vasey, Paul L.] Univ Lethbridge, Dept Psychol, Lab Comparat Sexual, Lethbridge, AB T1K 3M4, Canada; [Dixson, Barnaby J.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Little, Anthony C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling, Scotland	University of Lethbridge; University of New South Wales Sydney; University of Stirling	Petterson, LJ (corresponding author), Univ Lethbridge, Dept Psychol, Lab Comparat Sexual, Lethbridge, AB T1K 3M4, Canada.	l.petterson@uleth.ca	Little, Anthony/W-2732-2019	Little, Anthony/0000-0001-9100-1903; Dixson, Barnaby/0000-0003-0911-1244	University of Lethbridge; Victoria University of Wellington; Social Sciences and Humanities Research Council of Canada Grant; New Zealand International Doctoral Scholarship; American Institute of Bisexuality Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Alberta Innovates-Health Solutions Grant	University of Lethbridge; Victoria University of Wellington; Social Sciences and Humanities Research Council of Canada Grant; New Zealand International Doctoral Scholarship; American Institute of Bisexuality Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Health Solutions Grant	Various stages of this research were supported by the University of Lethbridge (www.uleth.ca) and Victoria University of Wellington (www.victoria.ac.nz); by a Social Sciences and Humanities Research Council of Canada Grant (www.sshrc.ca) to LJP; by a New Zealand International Doctoral Scholarship (http://www.enz.govt.nz/how-we-work/scholarships/nzidrs) to BJD; by an American Institute of Bisexuality Grant (www.americaninstituteofbisexuality.org), a Natural Sciences and Engineering Research Council of Canada Discovery Grant (www.nserc.ca), and an Alberta Innovates-Health Solutions Grant (www.aihealthsolutions.ca/) to PLV. The funders had no role in the study design, data, collection, and analysis, decision to publish, or preparation of the manuscript.	Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Bailey JM, 2011, ARCH SEX BEHAV, V40, P1293, DOI 10.1007/s10508-011-9778-5; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bailey JM, 2008, CONTEMPORARY PERSPEC, P43; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; BLANCHARD R, 1993, J NERV MENT DIS, V181, P570, DOI 10.1097/00005053-199309000-00008; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Cerny JA, 2011, ARCH SEX BEHAV, V40, P687, DOI 10.1007/s10508-011-9746-0; Chinas B, 1992, THE ISTHMUS ZAPOTECS; DIAMOND M, 1993, ARCH SEX BEHAV, V22, P291, DOI 10.1007/BF01542119; Ebsworth M, 2012, ARCH SEX BEHAV, V41, P161, DOI 10.1007/s10508-012-9923-9; Gangestad SW, 2000, J PERS SOC PSYCHOL, V78, P1109, DOI 10.1037//0022-3514.78.6.1109; Gaudio Rudi, 2009, ALLAH MADE US SEXUAL; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herdt G, 1996, THIRD SEX THIRD GEND; Imhoff R, 2012, ARCH SEX BEHAV, V41, P1389, DOI 10.1007/s10508-011-9879-1; Imhoff R, 2010, ARCH SEX BEHAV, V39, P1275, DOI 10.1007/s10508-009-9595-2; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Janssen E, 2011, ARCH SEX BEHAV, V40, P1297, DOI 10.1007/s10508-011-9826-1; Kottak Conrad, 2006, MIRROR FOR HUMANITY; Lauman EO, 1994, THE SOCIAL ORGANIZAT; Letourneau Elizabeth J, 2002, Sex Abuse, V14, P207, DOI 10.1177/107906320201400302; Lippa RA, 2013, ARCH SEX BEHAV, V42, P187, DOI 10.1007/s10508-012-9981-z; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Murray S. O., 2000, HOMOSEXUALITIES; Nanda S, 1999, NEITHER MAN NOR WOMA; Peletz M., 2009, GENDER PLURALISM SE; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Quinsey VL, 1996, ETHOL SOCIOBIOL, V17, P341, DOI 10.1016/S0162-3095(96)00060-X; Ramanathan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-827; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2015, BIOL PSYCHOL, V104, P56, DOI 10.1016/j.biopsycho.2014.11.009; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rosenthal AM, 2012, ARCH SEX BEHAV, V41, P135, DOI 10.1007/s10508-011-9881-7; Rullo JE, 2010, ARCH SEX BEHAV, V39, P874, DOI 10.1007/s10508-009-9497-3; SINGER B, 1984, J SEX RES, V20, P230, DOI 10.1080/00224498409551222; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; VanderLaan DP, 2013, HUM NATURE-INT BIOS, V24, P375, DOI 10.1007/s12110-013-9182-z; Vasey PL, 2014, NEUROSCI BIOBEHAV R, V46, P573, DOI 10.1016/j.neubiorev.2014.09.002; Vasey PL, 2014, THE EVOLUTION OF HUM, P185; Whitam F, 1986, MALE HOMOSEXUALITY I; WIKAN U, 1977, MAN, V12, P304, DOI 10.2307/2800801	43	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116529	10.1371/journal.pone.0116529	http://dx.doi.org/10.1371/journal.pone.0116529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679961	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600025
J	Boardman, AK; Campbell, J; Wirz, H; Sharon, A; Sauer-Budge, AF				Boardman, Anna K.; Campbell, Jennifer; Wirz, Holger; Sharon, Andre; Sauer-Budge, Alexis F.			Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device	PLOS ONE			English	Article							WHOLE-BLOOD; BACTEREMIA; PCR; IMPACT; TIME; CENTRIFUGATION; MORTALITY; DIAGNOSIS; THERAPY; CULTURE	Appropriate care for bacteremic patients is dictated by the amount of time needed for an accurate diagnosis. However, the concentration of microbes in the blood is extremely low in these patients (1-100 CFU/mL), traditionally requiring growth (blood culture) or amplification (e.g., PCR) for detection. Current culture-based methods can take a minimum of two days, while faster methods like PCR require a sample free of inhibitors (i.e., blood components). Though commercial kits exist for the removal of blood from these samples, they typically capture only DNA, thereby necessitating the use of blood culture for antimicrobial testing. Here, we report a novel, scaled-up sample preparation protocol carried out in a new microbial concentration device. The process can efficiently lyse 10 mL of bacteremic blood while maintaining the microorganisms' viability, giving a 30-mu L final output volume. A suite of six microorganisms (Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, and Candida albicans) at a range of clinically relevant concentrations was tested. All of the microorganisms had recoveries greater than 55% at the highest tested concentration of 100 CFU/mL, with three of them having over 70% recovery. At the lowest tested concentration of 3 CFU/mL, two microorganisms had recoveries of ca. 40-50% while the other four gave recoveries greater than 70%. Using a Taqman assay for methicillin-sensitive S. aureus (MSSA) to prove the feasibility of downstream analysis, we show that our microbial pellets are clean enough for PCR amplification. PCR testing of 56 spiked-positive and negative samples gave a specificity of 0.97 and a sensitivity of 0.96, showing that our sample preparation protocol holds great promise for the rapid diagnosis of bacteremia directly from a primary sample.	[Boardman, Anna K.; Campbell, Jennifer; Wirz, Holger; Sharon, Andre; Sauer-Budge, Alexis F.] Fraunhofer USA, Ctr Mfg Innovat, Brookline, MA 02446 USA; [Sharon, Andre] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Sauer-Budge, Alexis F.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Sauer-Budge, AF (corresponding author), Fraunhofer USA, Ctr Mfg Innovat, Brookline, MA 02446 USA.	asauerbudge@fraunhofer.org	Sauer-Budge, Alexis/L-2286-2019	Sauer-Budge, Alexis/0000-0001-5961-5286	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI090815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090815] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding from National Institute of Allergy and Infectious Diseases, National Institutes of Health R01AI090815, ( http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; BELDING ME, 1972, APPL MICROBIOL, V24, P691, DOI 10.1128/AEM.24.5.691-698.1972; BERNHARDT M, 1991, J CLIN MICROBIOL, V29, P422, DOI 10.1128/JCM.29.3.422-425.1991; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Boardman AK, 2013, ANAL METHODS-UK, V5, P273, DOI 10.1039/c2ay25662b; Bu Y, 2008, ANAL BIOCHEM, V375, P370, DOI 10.1016/j.ab.2008.01.010; BURCKHARDT J, 1994, PCR METH APPL, V3, P239; Cheah ALY, 2013, CLIN MICROBIOL INFEC, V19, pE181, DOI 10.1111/1469-0691.12132; Cheng IF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02365; Chu HY, 2007, OPT EXPRESS, V15, P12230, DOI 10.1364/OE.15.012230; de Vries JE, 2001, CLIN CHEM, V47, P1701; FARMER SG, 1972, APPL MICROBIOL, V23, P500, DOI 10.1128/AEM.23.3.500-504.1972; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; HERLICH MB, 1982, J CLIN MICROBIOL, V16, P99, DOI 10.1128/JCM.16.1.99-102.1982; Ho KM, 2009, ANAESTH INTENS CARE, V37, P457, DOI 10.1177/0310057X0903700320; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kim SH, 2013, J ANTIMICROB CHEMOTH, V68, P2890, DOI 10.1093/jac/dkt256; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAMBERG RE, 1983, J CLIN MICROBIOL, V17, P856, DOI 10.1128/JCM.17.5.856-859.1983; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; MARTIN E, 1992, J CLIN MICROBIOL, V30, P2246, DOI 10.1128/JCM.30.9.2246-2255.1992; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; Nejadnik MR, 2009, LANGMUIR, V25, P6245, DOI 10.1021/la9001169; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; PANACCIO M, 1993, BIOTECHNIQUES, V14, P238; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Pechorsky A, 2009, J MICROBIOL METH, V78, P325, DOI 10.1016/j.mimet.2009.07.008; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Rodriguez-Bano J, 2009, J INFECTION, V58, P131, DOI 10.1016/j.jinf.2008.11.003; Rothman RE, 2002, J INFECT DIS, V186, P1677, DOI 10.1086/345367; Ryding U, 2002, DIAGN MICR INFEC DIS, V42, P9, DOI 10.1016/S0732-8893(01)00311-X; Sharma R, 2012, GENE, V501, P85, DOI 10.1016/j.gene.2012.03.065; Shime N, 2010, EUR J CLIN MICROBIOL, V29, P1475, DOI 10.1007/s10096-010-1024-x; SULLIVAN NM, 1975, J CLIN MICROBIOL, V1, P30, DOI 10.1128/JCM.1.1.30-36.1975; Walter A, 2011, LAB CHIP, V11, P1013, DOI [10.1039/c0lc00536c, 10.1039/c01c00536c]; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wiesinger-Mayr H, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-78; Zhang JY, 2010, LAB CHIP, V10, P3265, DOI [10.1039/c0lc00051e, 10.1039/c0lcC0051e]; Zhang XY, 2005, J AM CHEM SOC, V127, P4484, DOI 10.1021/ja043623b	47	18	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116837	10.1371/journal.pone.0116837	http://dx.doi.org/10.1371/journal.pone.0116837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675242	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000010
J	Cleys, ER; Halleran, JL; Enriquez, VA; da Silveira, JC; West, RC; Winger, QA; Anthony, RV; Bruemmer, JE; Clay, CM; Bouma, GJ				Cleys, Ellane R.; Halleran, Jennifer L.; Enriquez, Vanessa A.; da Silveira, Juliano C.; West, Rachel C.; Winger, Quinton A.; Anthony, Russell V.; Bruemmer, Jason E.; Clay, Colin M.; Bouma, Gerrit J.			Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta	PLOS ONE			English	Article							GROWTH/PERMEABILITY FACTOR EXPRESSION; TROPHOBLAST INVASION; IMMUNOHISTOCHEMICAL LOCALIZATION; GROWTH-RETARDATION; DNA METHYLATION; GENE ACTIVATION; ESTROGEN; PREECLAMPSIA; PREGNANCY; DIFFERENTIATION	Sex steroid hormones regulate developmental programming in many tissues, including programming gene expression during prenatal development. While estradiol is known to regulate placentation, little is known about the role of testosterone and androgen signaling in placental development despite the fact that testosterone rises in maternal circulation during pregnancy and in placenta-induced pregnancy disorders. We investigated the role of testosterone in placental gene expression, and focused on androgen receptor (AR). Prenatal androgenization decreased global DNA methylation in gestational day 90 placentomes, and increased placental expression of AR as well as genes involved in epigenetic regulation, angiogenesis, and growth. As AR complexes with histone lysine demethylases (KDMs) to regulate AR target genes in human cancers, we also investigated if the same mechanism is present in the ovine placenta. AR co-immunoprecipitated with KDM1A and KDM4D in sheep placentomes, and AR-KDM1A complexes were recruited to a half-site for androgen response element (ARE) in the promoter region of VEGFA. Androgenized ewes also had increased cotyledonary VEGFA. Finally, in human first trimester placental samples KDM1A and KDM4D immunolocalized to the syncytiotrophoblast, with nuclear KDM1A and KDM4D immunostaining also present in the villous stroma. In conclusion, placental androgen signaling, possibly through AR-KDM complex recruitment to AREs, regulates placental VEGFA expression. AR and KDMs are also present in first trimester human placenta. Androgens appear to be an important regulator of trophoblast differentiation and placental development, and aberrant androgen signaling may contribute to the development of placental disorders.	[Cleys, Ellane R.; Halleran, Jennifer L.; Enriquez, Vanessa A.; da Silveira, Juliano C.; West, Rachel C.; Winger, Quinton A.; Anthony, Russell V.; Bruemmer, Jason E.; Clay, Colin M.; Bouma, Gerrit J.] Colorado State Univ, Anim Reprod & Biotechnol Lab, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Bruemmer, Jason E.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Bouma, GJ (corresponding author), Colorado State Univ, Anim Reprod & Biotechnol Lab, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Gerrit.Bouma@colostate.edu	Bouma, Gerrit/AAT-4644-2020; Da Silveira, Juliano/AAH-9784-2020; Silveira, Juliano C/B-3086-2013	Bouma, Gerrit/0000-0003-2433-5086; Da Silveira, Juliano/0000-0002-4796-6393; Silveira, Juliano C/0000-0002-4796-6393; Bruemmer, Jason/0000-0002-4236-756X	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture [2010-38420-20397]; Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture; Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council	This project was supported by Agriculture and Food Research Initiative competitive grant 2010-38420-20397 from the United States Department of Agriculture National Institute of Food and Agriculture, and by the Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acromite MT, 1999, AM J OBSTET GYNECOL, V180, P60, DOI 10.1016/S0002-9378(99)70150-X; Albrecht ED, 2006, PLACENTA, V27, P483, DOI 10.1016/j.placenta.2005.04.005; Albrecht ED, 2004, J CLIN ENDOCR METAB, V89, P5803, DOI 10.1210/jc.2004-0479; Albrecht ED, 1999, PLACENTA, V20, P129, DOI 10.1053/plac.1998.0359; Angiolini E, 2006, PLACENTA SA, V27; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Beckett EM, 2011, 44 ANN M SOC STUD RE, V85; BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728; BROSENS IA, 1988, TROPHOBLAST RES, V3, P61; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P36, DOI 10.1186/1477-7827-1-36; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P13, DOI 10.1186/1477-7827-1-13; Carlsen SM, 2005, ACTA OBSTET GYN SCAN, V84, P117, DOI 10.1111/j.0001-6349.2005.00493.x; Castracane VD, 1998, HUM REPROD, V13, P460, DOI 10.1093/humrep/13.2.460; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Comstock CES, 2008, CONTEMP ENDOCRINOL S, P83, DOI 10.1007/978-1-59745-309-7_5; Ford SP, 2004, BIOL REPROD S, V71; Ford SP, 2006, J SOC GYNECOL INVE S, V13; GAIANI R, 1984, J REPROD FERTIL, V70, P55, DOI 10.1530/jrf.0.0700055; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; HILL DJ, 1993, PLACENTA, V14, P1, DOI 10.1016/S0143-4004(05)80244-9; HORIE K, 1992, HUM REPROD, V7, P1461, DOI 10.1093/oxfordjournals.humrep.a137595; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Iavazzo C, 2010, ARCH GYNECOL OBSTET, V282, P235, DOI 10.1007/s00404-010-1495-0; IWAMURA M, 1994, J HISTOCHEM CYTOCHEM, V42, P783, DOI 10.1177/42.6.8189040; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Karjalainen MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051378; Karvela M, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.04.071; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Khatri P, 2013, PLACENTA, V34, P416, DOI 10.1016/j.placenta.2013.01.018; Lim JH, 2011, J ASSIST REPROD GEN, V28, P85, DOI 10.1007/s10815-010-9485-5; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milosevic M, 2007, CANCER RES, V67, P6022, DOI 10.1158/0008-5472.CAN-07-0561; MIZUNO M, 1968, J CLIN ENDOCR METAB, V28, P1133, DOI 10.1210/jcem-28-8-1133; Niklaus AL, 2003, BIOL REPROD, V68, P1997, DOI 10.1095/biolreprod.102.011288; Osgerby JC, 2004, J ENDOCRINOL, V182, P89, DOI 10.1677/joe.0.1820089; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rama S, 2004, MOL CELL ENDOCRINOL, V218, P79, DOI 10.1016/j.mce.2003.12.016; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Salamalekis E, 2006, EUR J OBSTET GYN R B, V126, P16, DOI 10.1016/j.ejogrb.2005.07.007; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shabisgh A, 1999, ENDOCRINOLOGY, V140, P1920, DOI 10.1210/en.140.4.1920; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Sun M, 2012, AM J PHYSIOL-ENDOC M, V303, pE1373, DOI 10.1152/ajpendo.00421.2012; van der Linden DS, 2013, J ANIM SCI, V91, P644, DOI 10.2527/jas.2012-5629; VATNICK I, 1991, J DEV PHYSIOL, V15, P351; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Verrier L, 2011, BIOL CELL, V103, P381, DOI 10.1042/BC20110028; Vonnahme KA, 2006, J ANIM SCI, V84, P3451, DOI 10.2527/jas.2006-132; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Wieciech I, 2013, ACTA HISTOCHEM, V115, P290, DOI 10.1016/j.acthis.2012.08.003; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9; ZHOU Y, 1993, AM J OBSTET GYNECOL, V169, P224, DOI 10.1016/0002-9378(93)90172-F	68	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117472	10.1371/journal.pone.0117472	http://dx.doi.org/10.1371/journal.pone.0117472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675430	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000024
J	Ericsson, AC; Davis, JW; Spollen, W; Bivens, N; Givan, S; Hagan, CE; McIntosh, M; Franklin, CL				Ericsson, Aaron C.; Davis, J. Wade; Spollen, William; Bivens, Nathan; Givan, Scott; Hagan, Catherine E.; McIntosh, Mark; Franklin, Craig L.			Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice	PLOS ONE			English	Article							T-CELL RESPONSES; GUT MICROBIOTA; INTESTINAL MICROBIOTA; MOUSE; STRAIN; DATABASE; DISEASE; HEALTH	The commensal gut microbiota has been implicated as a determinant in several human diseases and conditions. There is mounting evidence that the gut microbiota of laboratory mice (Mus musculus) similarly modulates the phenotype of mouse models used to study human disease and development. While differing model phenotypes have been reported using mice purchased from different vendors, the composition and uniformity of the fecal microbiota in mice of various genetic backgrounds from different vendors is unclear. Using culture-independent methods and robust statistical analysis, we demonstrate significant differences in the richness and diversity of fecal microbial populations in mice purchased from two large commercial vendors. Moreover, the abundance of many operational taxonomic units, often identified to the species level, as well as several higher taxa, differed in vendorand strain-dependent manners. Such differences were evident in the fecal microbiota of weanling mice and persisted throughout the study, to twenty-four weeks of age. These data provide the first in-depth analysis of the developmental trajectory of the fecal microbiota in mice from different vendors, and a starting point from which researchers may be able to refine animal models affected by differences in the gut microbiota and thus possibly reduce the number of animals required to perform studies with sufficient statistical power.	[Ericsson, Aaron C.; Hagan, Catherine E.; Franklin, Craig L.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Biostat, Columbia, MO USA; [Spollen, William; Givan, Scott] Univ Missouri, Informat Res Core Facil, Columbia, MO USA; [Bivens, Nathan; McIntosh, Mark] Univ Missouri, DNA Core Facil, Columbia, MO USA; [McIntosh, Mark] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269; Bivens, Nathan/0000-0002-6023-8729; Givan, Scott/0000-0002-0630-8589	National Institutes of Health [U42 OD010918-13]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Studies were funded by a grant from the National Institutes of Health (U42 OD010918-13) to the University of Missouri Mutant Mouse Resource and Research Center (www.mmrrc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ericsson AC, 2014, COMPARATIVE MEDICINE; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kuczynski J, 2011, USING QIIME TO ANALY, DOI [10.1002/0471250953.bi0801s36, DOI 10.1002/0471250953.BI0801S36]; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MOSCA A, 1995, ANAEROBE, V1, P21, DOI 10.1016/S1075-9964(95)80379-3; Paulson JN, METAGENOMESEQ STATIS, P160; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smyth G, 2005, LIMMA LINEAR MODELS; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	190	192	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116704	10.1371/journal.pone.0116704	http://dx.doi.org/10.1371/journal.pone.0116704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675094	Green Submitted, gold, Green Published			2022-12-27	WOS:000349914000009
J	Shimanoe, C; Hara, M; Nishida, Y; Nanri, H; Otsuka, Y; Nakamura, K; Higaki, Y; Imaizumi, T; Taguchi, N; Sakamoto, T; Horita, M; Shinchi, K; Tanaka, K				Shimanoe, Chisato; Hara, Megumi; Nishida, Yuichiro; Nanri, Hinako; Otsuka, Yasuko; Nakamura, Kazuyo; Higaki, Yasuki; Imaizumi, Takeshi; Taguchi, Naoto; Sakamoto, Tatsuhiko; Horita, Mikako; Shinchi, Koichi; Tanaka, Keitaro			Perceived Stress and Coping Strategies in Relation to Body Mass Index: Cross-Sectional Study of 12,045 Japanese Men and Women	PLOS ONE			English	Article							MULTIINSTITUTIONAL COLLABORATIVE COHORT; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL STRESS; LIFE-STYLE; RISK; ASSOCIATIONS; CORTISOL; METAANALYSIS; PREVALENCE	Background Accumulated evidence suggests a weak positive relationship between psychosocial stress and body mass index (BMI), but little is known about stress coping strategies and BMI. Objective We aimed to examine if perceived stress and coping strategies are related to BMI, with any of their mutual interactions on BMI. Methods This cross-sectional study included 5,063 men and 6,982 women aged 40-69 years. A self-administered questionnaire ascertained perceived stress and 5 items of coping strategies (emotion expression, emotional support seeking, positive reappraisal, problem solving, and disengagement). Analyses were performed by gender with adjustment for age, socioeconomic status, and lifestyle factors. Results No significant associations were detected between perceived stress and BMI in either men (P-trend = 0.09) or women (P-trend = 0.58). In men, however, 'disengagement' showed an inverse association with BMI (P-trend < 0.001), and 'positive reappraisal' and 'problem solving' revealed a positive association with BMI (P-trend = 0.04 and 0.007, respectively) even after controlling for perceived stress. A possible interaction between perceived stress and 'dis-engagement' on BMI was found in men (P-interaction = 0.027); the inverse association between 'disengagement' and BMI was more evident in higher levels of stress (beta = -0.13, P-trend = 0.21 in low; beta = -0.22, P-trend = 0.01 in medium; and beta = -0.24, P-trend = 0.06 in high). In men, 'disengagement' was inversely associated with overweight/obesity (odds ratio 0.79, 95% confidential interval 0.67-0.95), and "positive reappraisal" was positively associated with it (1.25, 1.02-1.54). Conclusions Coping strategies may have an important role in developing overweight/obesity, particularly in men.	[Shimanoe, Chisato; Hara, Megumi; Nishida, Yuichiro; Nanri, Hinako; Otsuka, Yasuko; Imaizumi, Takeshi; Taguchi, Naoto; Horita, Mikako; Tanaka, Keitaro] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Nanri, Hinako] Showa Univ, Sch Med, Dept Publ Hlth, Shinagawa Ku, Tokyo 142, Japan; [Nakamura, Kazuyo] St Marys Coll, Fac Nursing, Kurume, Fukuoka, Japan; [Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Exercise Physiol Lab, Fukuoka 81401, Japan; [Sakamoto, Tatsuhiko] Fukuoka Prefectural Govt, Chikushi Off Hlth Human Serv & Environm Issues, Onojo, Japan; [Shinchi, Koichi] Saga Univ, Fac Med, Div Int Hlth & Nursing, Saga 840, Japan	Saga University; Showa University; Fukuoka University; Saga University	Shimanoe, C (corresponding author), Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan.	chisatos@cc.saga-u.ac.jp	Nishida, Yuichiro/H-8791-2019; Hara, Masayuki/AAH-4361-2019	Nishida, Yuichiro/0000-0003-2320-7234; Hara, Megumi/0000-0002-8708-3237; Shimanoe, Chisato/0000-0002-3561-9538; Nanri, Hinako/0000-0001-7263-3550; Shinchi, Koichi/0000-0003-2367-7607	Ministry of Education, Culture, Sports, Science and Technology, Japan [17015018, 221S0001, 20249038, 18390182, 20689014, 18790380]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on the Special Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001); Scientific Research (A) (No. 20249038) and (B) (No. 18390182); and Young Scientists (A) (No. 20689014) and (B) (No. 18790380) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington WE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120001; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chen WQ, 2009, STRESS HEALTH, V25, P431, DOI 10.1002/smi.1263; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Eller NH, 2006, BIOL PSYCHOL, V73, P280, DOI 10.1016/j.biopsycho.2006.05.003; Fujimoto S, 1968, Nihon Eiseigaku Zasshi, V23, P443; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Hara M, 2010, J EPIDEMIOL, V20, P40, DOI 10.2188/jea.JE20090062; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Health Promortion and Nutrition Division Health Service Bureau Ministry of Health and Welfare of Japan, 1994, 5 REV REC DIET ALL J; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Jiang JY, 2013, PREV MED, V57, P60, DOI 10.1016/j.ypmed.2013.04.014; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kelly SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-765; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kouvonen A, 2005, PSYCHOSOM MED, V67, P577, DOI 10.1097/01.psy.0000170330.08704.62; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAZARUS RS, 1984, J BEHAV MED, V7, P375, DOI 10.1007/BF00845271; Martin LA, 2013, INT J BEHAV MED, V20, P97, DOI 10.1007/s12529-011-9204-3; Nakagawa A, 2011, RES DATABASE REPORT; Nanri H, 2011, J EPIDEMIOL, V21, P122, DOI 10.2188/jea.JE20100110; Nicdao EG, 2007, INT J EAT DISORDER, V40, pS22, DOI 10.1002/eat.20450; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; O'Donnell K, 2008, PSYCHONEUROENDOCRINO, V33, P601, DOI 10.1016/j.psyneuen.2008.01.015; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Rueggeberg R, 2012, PSYCHOSOM MED, V74, P937, DOI 10.1097/PSY.0b013e3182732dc6; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Sasaki Megumi, 2002, Nihon Koshu Eisei Zasshi, V49, P399; Science Japan and Agency Technology, 2000, STAND TABL FOOD COMP; Shimanoe C, 2014, INT J BEHAV MED, V21, P821, DOI 10.1007/s12529-013-9341-y; Steptoe A, 2004, PSYCHOSOM MED, V66, P323, DOI 10.1097/01.psy.0000126198.67070.72; Strickland OL, 2007, J CARDIOVASC NURS, V22, P272, DOI 10.1097/01.JCN.0000278964.05748.d8; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; Wardle J, 2000, J PSYCHOSOM RES, V48, P195, DOI 10.1016/S0022-3999(00)00076-3; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; Yang TC, 2014, INT J BEHAV MED, V21, P282, DOI 10.1007/s12529-013-9293-2	44	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118105	10.1371/journal.pone.0118105	http://dx.doi.org/10.1371/journal.pone.0118105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB8WX	25675249	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000040
J	Barnes, DE; Mehling, W; Wu, E; Beristianos, M; Yaffe, K; Skultety, K; Chesney, MA				Barnes, Deborah E.; Mehling, Wolf; Wu, Eveline; Beristianos, Matthew; Yaffe, Kristine; Skultety, Karyn; Chesney, Margaret A.			Preventing Loss of Independence through Exercise (PLIE): A Pilot Clinical Trial in Older Adults with Dementia	PLOS ONE			English	Article							MINI-MENTAL-STATE; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; TAI CHI; OUTCOMES; PERFORMANCE; REHABILITATION; MANAGEMENT; INVENTORY; MEMANTINE	Background Current dementia medications have small effect sizes, many adverse effects and do not change the disease course. Therefore, it is critically important to study alternative treatment strategies. The goal of this study was to pilot-test a novel, integrative group exercise program for individuals with mild-to-moderate dementia called Preventing Loss of Independence through Exercise (PLIE), which focuses on training procedural memory for basic functional movements (e.g., sit-to-stand) while increasing mindful body awareness and facilitating social connection. Methods We performed a 36-week cross-over pilot clinical trial to compare PLIE with usual care (UC) at an adult day program for individuals with dementia in San Francisco, CA. Assessments of physical performance, cognitive function, physical function, dementia-related behaviors, quality of life and caregiver burden were performed by blinded assessors at baseline, 18 weeks (cross-over) and 36 weeks. Our primary outcomes were effect sizes based on between-group comparisons of change from baseline to 18 weeks; secondary outcomes were within-group comparisons of change before and after cross-over. Results Twelve individuals enrolled (7 PLIE, 5 UC) and 2 withdrew (1 PLIE, 18 weeks; 1 UC, 36 weeks). Participants were 82% women (mean age, 84 +/- 4 years); caregivers were 82% daughters (mean age, 56 +/- 13 years). Effect sizes were not statistically significant but suggested potentially clinically meaningful (>= 0.25 SDs) improvement with PLIE versus UC for physical performance (Cohen's D: 0.34 SDs), cognitive function (0.76 SDs) and quality of life (0.83 SDs) as well as for caregiver measures of participant's quality of life (0.33 SDs) and caregiver burden (0.49 SDs). Results were similar when within-group comparisons were made before and after cross-over. Conclusions PLIE is a novel, integrative exercise program that shows promise for improving physical function, cognitive function, quality of life and caregiver burden in individuals with mild-to-moderate dementia. Larger randomized, controlled trials are warranted.	[Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Barnes, Deborah E.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Mehling, Wolf] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Mehling, Wolf; Wu, Eveline; Chesney, Margaret A.] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Wu, Eveline] Calif Inst Integral Studies, San Francisco, CA USA; [Beristianos, Matthew] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Beristianos, Matthew] Calif Sch Profess Psychol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Skultety, Karyn] Inst Aging, San Francisco, CA USA; [Chesney, Margaret A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barnes, DE (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Deborah.barnes@ucsf.edu			UCSF Osher Center for Integrative Medicine	UCSF Osher Center for Integrative Medicine	We thank Drew and Ellen Bradley for their generous support of the UCSF Osher Center for Integrative Medicine, which enabled the development and pilot-testing of the Preventing Loss of Independence through Exercise (PLIE) program.	Acosta D, 2009, WORLD ALZHEIMER REPO; American Dance Therapy Association, 2014, ABOUT DANCE MOVEMENT; American Occupational Therapy Association, 2014, ABOUT OCCUPATIONAL T; American Physical Therapy Association, 2011, TODAYS PHYSICAL THER; American Tai Chi and Qigong Association, 2014, THE OVERVIEW OF TAI; American Yoga Association, 2006, GENERAL YOGA INFORMA; Bezprozvanny I, 2010, DRUG NEWS PERSPECT, V23, P518, DOI 10.1358/dnp.2010.23.8.1500435; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Eldridge LL, 2002, BEHAV NEUROSCI, V116, P722, DOI 10.1037//0735-7044.116.4.722; Fagan T, 2012, CLINICAL TRIALS OF I; Fagan T, 2010, LILLY HALTS IDENTITY; Fleischman DA, 2005, BRAIN, V128, P2006, DOI 10.1093/brain/awh559; Fogel A, 2009, THE PSYCHOPHYSIOLOGY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Garcia-Rodriguez B, 2009, J ALZHEIMERS DIS, V18, P541, DOI 10.3233/JAD-2009-1161; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Guzman-Garcia A, 2013, INT J GERIATR PSYCH, V28, P914, DOI 10.1002/gps.3913; Hansen RA, 2007, DRUG AGING, V24, P155, DOI 10.2165/00002512-200724020-00007; Hazard RG, 2012, SPINE J, V12, P1132, DOI 10.1016/j.spinee.2012.09.003; Healing Yoga Foundation, 2014, HEALING THROUGH YOGA; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Heyn PC, 2008, J NUTR HEALTH AGING, V12, P401, DOI 10.1007/BF02982674; Hogan DB, 2008, CAN MED ASSOC J, V179, P1019, DOI 10.1503/cmaj.081103; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jeffrey S, 2013, IVIG FAILS IN PHASE; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Lam LCW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.008; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Lyttle T.S.K., 1997, J BODYW MOV THER, V1, P262, DOI [10.1016/S1360-8592(97)80061-7, DOI 10.1016/S1360-8592(97)80061-7]; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; Meekums B., 1996, PROFESSIONAL CARE FO, P119, DOI [10.1007/978-1-4899-3015-6_7, DOI 10.1007/978-1-4899-3015-6_7]; Mehling Wolf E, 2011, Philos Ethics Humanit Med, V6, P6, DOI 10.1186/1747-5341-6-6; Mendelson AD, 2011, HEALTH EDUC RES, V26, P167, DOI 10.1093/her/cyq077; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Oken BS, 2006, ALTERN THER HEALTH M, V12, P40; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Potter R, 2011, INT J GERIATR PSYCH, V26, P1000, DOI 10.1002/gps.2641; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Rockwood K, 2004, J NEUROL NEUROSUR PS, V75, P677, DOI 10.1136/jnnp.2003.029074; Rolland Y, 2007, J AM GERIATR SOC, V55, P158, DOI 10.1111/j.1532-5415.2007.01035.x; Rosen Method&REG;, 2014, ROSEN METHOD MOVEMEN; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandlund ES, 2000, INT J STRESS MANAGE, V7, P139, DOI 10.1023/A:1009536319034; Sherrington CS, 1906, THE INTEGRATIVE ACTI, P412; Smith M, 2006, ALZ DIS ASSOC DIS, V20, P133, DOI 10.1097/00002093-200607000-00002; Taylor-Piliae RE, 2010, J AGING PHYS ACTIV, V18, P261, DOI 10.1123/japa.18.3.261; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; The Feldenkrais&REG;Educational Foundation of North America and the FELDENKRAIS GUILD&REG;of North America, 2014, THE FELDENKRAIS METH; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Weyer G, 1997, Int Psychogeriatr, V9, P123, DOI 10.1017/S1041610297004298; Wu E, 2014, AGING MENT HEALTH, P1; Yao L, 2013, WESTERN J NURS RES, V35, P281, DOI 10.1177/0193945912443319	63	42	43	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0113367	10.1371/journal.pone.0113367	http://dx.doi.org/10.1371/journal.pone.0113367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671576	gold, Green Published			2022-12-27	WOS:000349545300002
J	Haigh, R; Ianson, D; Holt, CA; Neate, HE; Edwards, AM				Haigh, Rowan; Ianson, Debby; Holt, Carrie A.; Neate, Holly E.; Edwards, Andrew M.			Effects of Ocean Acidification on Temperate Coastal Marine Ecosystems and Fisheries in the Northeast Pacific	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; JUVENILE PINK SALMON; EARLY-LIFE STAGES; DISSOLVED INORGANIC CARBON; EGG-PRODUCTION RATE; SUB-ARCTIC PACIFIC; RED KING CRAB; HIGH CO2; PSEUDO-NITZSCHIA; BRITISH-COLUMBIA	As the oceans absorb anthropogenic CO2 they become more acidic, a problem termed ocean acidification (OA). Since this increase in CO2 is occurring rapidly, OA may have profound implications for marine ecosystems. In the temperate northeast Pacific, fisheries play key economic and cultural roles and provide significant employment, especially in rural areas. In British Columbia (BC), sport (recreational) fishing generates more income than commercial fishing (including the expanding aquaculture industry). Salmon (fished recreationally and farmed) and Pacific Halibut are responsible for the majority of fishery-related income. This region naturally has relatively acidic (low pH) waters due to ocean circulation, and so may be particularly vulnerable to OA. We have analyzed available data to provide a current description of the marine ecosystem, focusing on vertical distributions of commercially harvested groups in BC in the context of local carbon and pH conditions. We then evaluated the potential impact of OA on this temperate marine system using currently available studies. Our results highlight significant knowledge gaps. Above trophic levels 2-3 (where most local fishery-income is generated), little is known about the direct impact of OA, and more importantly about the combined impact of multi-stressors, like temperature, that are also changing as our climate changes. There is evidence that OA may have indirect negative impacts on finfish through changes at lower trophic levels and in habitats. In particular, OA may lead to increased fish-killing algal blooms that can affect the lucrative salmon aquaculture industry. On the other hand, some species of locally farmed shellfish have been well-studied and exhibit significant negative direct impacts associated with OA, especially at the larval stage. We summarize the direct and indirect impacts of OA on all groups of marine organisms in this region and provide conclusions, ordered by immediacy and certainty.	[Haigh, Rowan; Holt, Carrie A.; Neate, Holly E.; Edwards, Andrew M.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Ianson, Debby] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Neate, Holly E.; Edwards, Andrew M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada; University of Victoria	Ianson, D (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, 9860 West Saanich Rd, Sidney, BC V8L 4B2, Canada.	debby.ianson@dfo-mpo.gc.ca	/AAL-3738-2021	Holt, Carrie/0000-0002-4699-9978; Ianson, Debby/0000-0001-8317-5196	Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding	Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding	The authors were funded by Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; Allen SE, 2013, PROG OCEANOGR, V115, P6, DOI 10.1016/j.pocean.2013.05.026; [Anonymous], 2014, R LANG ENV STAT COMP; Arkhipkin AI, 2000, J ZOOL, V250, P31, DOI 10.1111/j.1469-7998.2000.tb00575.x; Armstrong JL, 2008, T AM FISH SOC, V137, P1299, DOI 10.1577/T07-196.1; Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Asnaghi V, 2014, MAR ENVIRON RES, V93, P78, DOI 10.1016/j.marenvres.2013.08.005; Asnaghi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061978; Aydin KY, 2005, DEEP-SEA RES PT II, V52, P757, DOI 10.1016/j.dsr2.2004.12.017; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Bacher C, 2003, AQUAT LIVING RESOUR, V16, P10, DOI 10.1016/S0990-7440(03)00003-2; Baker P, 1995, J SHELLFISH RES, V14, P501; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Baldwin A, 2011, E FAUNA BC ELECTRONI; Baldwin A, 2009, E FAUNA BC ELECTRONI; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bass C. L., 2006, SCIENTIFIC COMMITTEE; Bates C, 2004, E FLORA BC ATLAS OF; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bayer FM, 2001, P BIOL SOC WASH, V114, P309; BC Ministry of Agriculture, 2012, BRITISH COLUMBIA SEA; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; BEER S, 1989, AQUAT BOT, V34, P153, DOI 10.1016/0304-3770(89)90054-5; Bejarano AC, 2008, HUM ECOL RISK ASSESS, V14, P544, DOI 10.1080/10807030802074220; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Brewer PG, 2013, BIOGEOSCIENCES, V10, P7411, DOI 10.5194/bg-10-7411-2013; BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Bylhouwer B, 2013, J GEOPHYS RES-OCEANS, V118, P2565, DOI 10.1002/jgrc.20194; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; CAIRNS S D, 1992, Palaios, V7, P96, DOI 10.2307/3514799; Cairns SD, 2011, SMITHSON CONTRIB ZOO, V634, P55; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Conway K. W., 2007, GEOLOGICAL SURVEY CA; CONWAY KW, 1991, CONT SHELF RES, V11, P771, DOI 10.1016/0278-4343(91)90079-L; Conway KW, 2005, ERLANGEN EARTH CONF, P605, DOI 10.1007/3-540-27673-4_29; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Cosgrove J, 2009, E FAUNA BC ELECTRONI; Crim RN, 2011, J EXP MAR BIOL ECOL, V400, P272, DOI 10.1016/j.jembe.2011.02.002; CRIMS, 2013, SALTWATER FINFISH AN; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; CUSHING DH, 1969, J CONSEIL, V33, P81; Deeds JR, 2008, MAR DRUGS, V6, P308, DOI [10.3390/md6020308, 10.3390/md20080015]; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dineshram R, 2012, MAR POLLUT BULL, V64, P2160, DOI 10.1016/j.marpolbul.2012.07.043; Dixson D.L., 2014, GLOBAL CHANGE BIOL; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Druehl LD, 2000, PACIFIC SEAWEEDS A G; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; DUFFY JE, 1990, BIOSCIENCE, V40, P368, DOI 10.2307/1311214; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Egge JK, 2009, BIOGEOSCIENCES, V6, P877, DOI 10.5194/bg-6-877-2009; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Findlay HS, 2011, MAR BIOL RES, V7, P565, DOI 10.1080/17451000.2010.547200; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Finney JL, 2010, CAN SCI ADVIS SEC RE, V2010; Fisheries and Oceans Canada, 2014, PACIFIC REGION INTEG; Fisheries and Oceans Canada, 2013, PACIFIC REGION EXPLO; Fisheries and Oceans Canada, 2013, PACIFIC REGION INTEG; Ford JK, 2014, MARINE MAMMALS OF BR; Foreman MGG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006995; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Foster MS., 1985, US FISH WILDL SERV B, V85; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2010, BIOGEOSCIENCES, V7, P3915, DOI 10.5194/bg-7-3915-2010; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Fu FX, 2008, HARMFUL ALGAE, V7, P76, DOI 10.1016/j.hal.2007.05.006; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gardner G.A., 1982, Canadian Special Publication of Fisheries and Aquatic Sciences, V62, P1; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gillespie GE, 2012, CAN SCI ADVIS SEC RE; Gillespie GE, 1999, CAN STOCK ASSESS SEC, V99; Ginger KWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064147; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0448; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gower J, 2013, RESEARCH DOCUMENT 20, P60; Gravinese PM, 2014, OCEAN SCIENCES MEETI; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haigh N, 2013, WORKSHOP 6 ECONOMIC; HAIGH R, 1991, MAR BIOL, V110, P301, DOI 10.1007/BF01313717; HAIGH R, 1992, MAR ECOL PROG SER, V89, P117, DOI 10.3354/meps089117; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Harbo R, 1996, SHELLS AND SHELLFISH; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Harris SL, 2009, DEEP-SEA RES PT II, V56, P2487, DOI 10.1016/j.dsr2.2009.02.009; HARRISON PJ, 1983, CAN J FISH AQUAT SCI, V40, P1064, DOI 10.1139/f83-129; Hart J.L., 1973, Bulletin Fish Res Bd Canada, V180, P1; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hendriks IE, 2014, BIOGEOSCIENCES, V11, P333, DOI 10.5194/bg-11-333-2014; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Hettinger A, 2013, GLOBAL CHANGE BIOL, V19, P3317, DOI 10.1111/gcb.12307; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hickey BM, 2013, HARMFUL ALGAE, V25, P1, DOI 10.1016/j.hal.2013.01.006; Hickey BM, 2008, OCEANOGRAPHY, V21, P90, DOI 10.5670/oceanog.2008.07; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Hofmann AF, 2013, BIOGEOSCIENCES, V10, P2409, DOI 10.5194/bg-10-2409-2013; Hofmann LC, 2012, MAR ECOL PROG SER, V464, P89, DOI 10.3354/meps09892; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Hwang DF, 2000, TOXICON, V38, P1491, DOI 10.1016/S0041-0101(00)00080-5; Ianson D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001451; Ianson D, 2003, DEEP-SEA RES PT I, V50, P1023, DOI 10.1016/S0967-0637(03)00114-6; Ianson D., 2001, J OCEANOGR, V57, P723, DOI DOI 10.1023/A:1021288510407; Ianson D, 2010, CAN SCI ADVIS SEC RE, P56; Ianson D, 2013, CAN TECH REP FISH AQ, V3032; Ianson D, 2009, J OCEANOGR, V65, P677, DOI 10.1007/s10872-009-0059-z; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Intergovernmental Panel on Climate Change, 2011, WORKSHOP REPORT OF T; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; International Hydrographic Organization Data Centre, 2014, IHO IOC GEBCO GAZETT; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Ishimatsu A, 2004, J OCEANOGR, V60, P731, DOI 10.1007/s10872-004-5765-y; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Jamieson GS, 2006, CAN SCI ADVIS SEC RE; JOHNSON AM, 1982, TRANS N AM WILDL NAT, V47, P293; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Joseph JE, 2010, J ACOUST SOC AM, V128, pEL144, DOI 10.1121/1.3425738; Jutfelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065825; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; Kaplan MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063714; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Kikkawa T, 2004, MAR POLLUT BULL, V48, P108, DOI 10.1016/S0025-326X(03)00367-9; Kim D, 1999, J PLANKTON RES, V21, P1017, DOI 10.1093/plankt/21.6.1017; Kim H, 2013, HARMFUL ALGAE, V26, P1, DOI 10.1016/j.hal.2013.03.004; Kim JM, 2010, ENVIRON SCI TECHNOL, V44, P8140, DOI 10.1021/es102028k; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kunkel JG, 2012, J SHELLFISH RES, V31, P515, DOI 10.2983/035.031.0211; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; Lalli CM., 1989, PELAGIC SNAILS THE B; Lambert P., 2011, Canadian Technical Report of Fisheries and Aquatic Sciences, V2929, P1; Lambert P, 2007, E FAUNA BC ELECTRONI; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lassiter AM, 2006, DEEP-SEA RES PT II, V53, P3063, DOI 10.1016/j.dsr2.2006.07.013; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Leduc AOHC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0447; Lessard J, 2007, J SHELLFISH RES, V26, P677, DOI 10.2983/0730-8000(2007)26[677:DNAHKH]2.0.CO;2; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Lindahl O, 2005, AMBIO, V34, P131, DOI 10.1639/0044-7447(2005)034[0131:IMWQBM]2.0.CO;2; Lipsen MS, 2007, PROG OCEANOGR, V75, P304, DOI 10.1016/j.pocean.2007.08.004; Lischka S, 2012, GLOBAL CHANGE BIOL, V18, P3517, DOI 10.1111/gcb.12020; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; Loomis J.B., 1994, MAR RESOUR ECON, V9, P3, DOI [10.1086/mre.9.3.42629085, DOI 10.1086/MRE.9.3.42629085]; Love ML., 2011, CERTAINLY MORE YOU W; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Lucas BG, 2007, CANADIAN TECHNICAL R, V2667; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Mackas D, 2013, PROG OCEANOGR, V115, P129, DOI 10.1016/j.pocean.2013.05.019; Mackas DL, 2012, ICES J MAR SCI, V69, P448, DOI 10.1093/icesjms/fsr163; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mackas DL, 2001, CAN J FISH AQUAT SCI, V58, P685, DOI 10.1139/cjfas-58-4-685; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Maneja RH, 2013, MAR ECOL PROG SER, V477, P251, DOI 10.3354/meps10146; Maneja RH, 2013, MAR BIOL, V160, P1963, DOI 10.1007/s00227-012-2054-y; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MARTIN AJ, 1993, J EUKARYOT MICROBIOL, V40, P535, DOI 10.1111/j.1550-7408.1993.tb06105.x; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; McFarlane GA, 1997, OCEANOL ACTA, V20, P191; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Merryfield WJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005123; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; Moroney JV, 1999, PLANT PHYSIOL, V119, P9, DOI 10.1104/pp.119.1.9; MORSE ANC, 1991, AM SCI, V79, P154; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Muzzarelli R. A., 1977, CHITIN; Nagorsen D, 2009, E FAUNA BC ELEC TRON; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakagawa Yoshizumi, 2001, Plankton Biology and Ecology, V48, P68; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nemcek N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002879; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Nimer NA, 1997, J PHYCOL, V33, P625, DOI 10.1111/j.0022-3646.1997.00625.x; O'Donnell MJ, 2013, NAT CLIM CHANGE, V3, P587, DOI 10.1038/NCLIMATE1846; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Olson MB, 2006, MAR ECOL PROG SER, V326, P207, DOI 10.3354/meps326207; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Peden A, 2002, E FAUNA BC ELECTRONI; Pedersen SA, 2013, BIOGEOSCIENCES, V10, P7481, DOI 10.5194/bg-10-7481-2013; PERRY RI, 1983, CAN J FISH AQUAT SCI, V40, P871, DOI 10.1139/f83-114; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Peterson TD, 2007, J PLANKTON RES, V29, P219, DOI 10.1093/plankt/fbm010; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Preikshot DB, 2007, THESIS; Punt AE, 2014, ECOL MODEL, V285, P39, DOI 10.1016/j.ecolmodel.2014.04.017; Raven J., 2005, OCEAN ACIDIFICATION; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Rensel J.E, 2007, FISH KILLS HARMFUL A; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2011, GUIDE TO BEST PRACTI; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts R, 2001, J SHELLFISH RES, V20, P571; Roger LM, 2012, ICES J MAR SCI, V69, P465, DOI 10.1093/icesjms/fsr171; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Rooper CN, 2007, ESTUAR COAST SHELF S, V75, P371, DOI 10.1016/j.ecss.2007.05.006; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Ryer CH, 1997, MAR ECOL PROG SER, V147, P77, DOI 10.3354/meps147077; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saba GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052224; Sanders MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074118; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Sato-Okoshi W, 2010, POLAR SCI, V4, P257, DOI 10.1016/j.polar.2010.05.006; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Shaffer J, 2004, P 2003 GEORG BAS PUG, P1; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; SMITH KL, 1983, MAR BIOL, V76, P325, DOI 10.1007/BF00393036; STENZEL HB, 1963, SCIENCE, V142, P232, DOI 10.1126/science.142.3589.232; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Stone RP, 2013, NOAA TECH MEM NMFS A; Stone RP, 2007, STATE DEEP CORAL ECO, P65; Stroomer C., 2013, BRIT COLUMBIAS FISHE; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Swanson AK, 2007, GLOBAL CHANGE BIOL, V13, P1696, DOI 10.1111/j.1365-2486.2007.01384.x; Talmage SC, 2012, MAR ECOL PROG SER, V464, P121, DOI 10.3354/meps09867; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tatters AO, 2013, HARMFUL ALGAE, V30, P37, DOI 10.1016/j.hal.2013.08.007; Tatters AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032116; Taylor F. J. R., 2002, HARMFUL ALGAL BLOOMS, P77; TAYLOR FJR, 1993, DEV MAR BIO, V3, P705; Timmins-Schiffman E, 2013, MAR BIOL, V160, P1973, DOI 10.1007/s00227-012-2055-x; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P1485, DOI 10.4319/lo.2000.45.7.1485; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Tortell PD, 2012, CONT SHELF RES, V47, P119, DOI 10.1016/j.csr.2012.07.007; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P1461, DOI 10.4319/lo.2009.54.5.1461; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; Twiner MJ, 2000, J PLANKTON RES, V22, P1961, DOI 10.1093/plankt/22.10.1961; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; WILSON JG, 1994, ESTUARIES, V17, P94, DOI 10.2307/1352337; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zhai WD, 2012, CHINESE SCI BULL, V57, P1062, DOI 10.1007/s11434-011-4949-2; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9; Zhang ML, 2011, J SHELLFISH RES, V30, P267, DOI 10.2983/035.030.0211; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; [No title captured]	345	67	74	1	236	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117533	10.1371/journal.pone.0117533	http://dx.doi.org/10.1371/journal.pone.0117533			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671596	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300059
J	Ball, A; Sanchez-Azofeifa, A; Portillo-Quintero, C; Rivard, B; Castro-Contreras, S; Fernandes, G				Ball, Aaron; Sanchez-Azofeifa, Arturo; Portillo-Quintero, Carlos; Rivard, Benoit; Castro-Contreras, Saulo; Fernandes, Geraldo			Patterns of Leaf Biochemical and Structural Properties of Cerrado Life Forms: Implications for Remote Sensing	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; WATER-CONTENT; CHLOROPHYLL; BIODIVERSITY; TREES; VEGETATION; LIANAS; AREA; DISCRIMINATION; CONSERVATION	Aim The general goal of this study is to investigate and analyze patterns of ecophysiological leaf traits and spectral response among life forms (trees, shrubs and lianas) in the Cerrado ecosystem. In this study, we first tested whether life forms are discriminated through leaf level functional traits. We then explored the correlation between leaf-level plant functional traits and spectral reflectance. Location Serra do Cipo National Park, Minas Gerais, Brazil. Methods Six ecophysiological leaf traits were selected to best characterize differences between life forms in the woody plant community of the Cerrado. Results were compared to spectral vegetation indices to determine if plant groups provide means to separate leaf spectral responses. Results Values obtained from leaf traits were similar to results reported from other tropical dry sites. Trees and shrubs significantly differed from lianas in terms of the percentage of leaf water content and Specific Leaf Area. Spectral indices were insufficient to capture the differences of these key traits between groups, though indices were still adequately correlated to overall trait variation. Conclusion The importance of life forms as biochemical and structurally distinctive groups is a significant finding for future remote sensing studies of vegetation, especially in arid and semi-arid environments. The traits we found as indicative of these groups (SLA and water content) are good candidates for spectral characterization. Future studies need to use the full wavelength (400 nm-2500 nm) in order to capture the potential response of these traits. The ecological linkage to water balance and life strategies encourages these traits as starting points for modeling plant communities using hyperspectral remote sensing.	[Ball, Aaron; Sanchez-Azofeifa, Arturo; Portillo-Quintero, Carlos; Rivard, Benoit; Castro-Contreras, Saulo] Univ Alberta, Earth & Atmospher Sci Dept, Edmonton, AB T6G 2E3, Canada; [Fernandes, Geraldo] Univ Fed Minas Gerais, ICB, Ecol Evolut Herbivoros Tropicais DBG, BR-30161970 Belo Horizonte, MG, Brazil	University of Alberta; Universidade Federal de Minas Gerais	Sanchez-Azofeifa, A (corresponding author), Univ Alberta, Earth & Atmospher Sci Dept, Edmonton, AB T6G 2E3, Canada.	arturo.sanchez@ualberta.ca	Sánchez, Arturo/L-3622-2019; Fernandes, Geraldo/AAN-5602-2021; Sanchez-Azofeifa, Arturo/F-4700-2014	Sánchez, Arturo/0000-0002-4946-1559; Fernandes, Geraldo/0000-0003-1559-6049; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600	Inter-American Institute for Global Change Research (IAI) [CRN3 025]; US National Science Foundation [GEO-1128040]; University of Alberta; National Science and Engineering Research Council of Canada (NSERC-Discovery); Conselho Nacional de Pesquisa; Fundacao de Desenvolvimento da Pesquisa de Minas Gerais; CAPES; ICER [1128040] Funding Source: National Science Foundation	Inter-American Institute for Global Change Research (IAI); US National Science Foundation(National Science Foundation (NSF)); University of Alberta(University of Alberta); National Science and Engineering Research Council of Canada (NSERC-Discovery)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Pesquisa; Fundacao de Desenvolvimento da Pesquisa de Minas Gerais; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was carried out with the aid of a grant from the Inter-American Institute for Global Change Research (IAI) CRN3 025, which is supported by the US National Science Foundation (Grant GEO-1128040). We acknowledge the support provided by University of Alberta, the National Science and Engineering Research Council of Canada (NSERC-Discovery), Conselho Nacional de Pesquisa, Fundacao de Desenvolvimento da Pesquisa de Minas Gerais, and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Anorve Mariana, 2008, P27, DOI 10.1201/9781420053432.ch2; Alvarez-Anorve MY, 2012, AM J BOT, V99, P816, DOI 10.3732/ajb.1100200; Sanchez-Azofeifa GA, 2009, REMOTE SENS ENVIRON, V113, P2076, DOI 10.1016/j.rse.2009.05.013; Asner GP, 2009, FRONT ECOL ENVIRON, V7, P269, DOI 10.1890/070152; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Bucci SJ, 2006, PLANT CELL ENVIRON, V29, P2153, DOI 10.1111/j.1365-3040.2006.01591.x; Cartelat A, 2005, FIELD CROP RES, V91, P35, DOI 10.1016/j.fcr.2004.05.002; Castro-Esau KL, 2006, REMOTE SENS ENVIRON, V103, P276, DOI 10.1016/j.rse.2005.01.019; Castro-Esau KL, 2006, AM J BOT, V93, P517, DOI 10.3732/ajb.93.4.517; Castro-Esau KL, 2004, REMOTE SENS ENVIRON, V90, P353, DOI 10.1016/j.rse.2004.01.013; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Carvalho F, 2012, APPL SOIL ECOL, V52, P9, DOI 10.1016/j.apsoil.2011.10.001; De Souza AA, 2001, AN 14 S BRAS SENS RE, P3095; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Goulas Y, 2004, APPL OPTICS, V43, P4488, DOI 10.1364/AO.43.004488; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Holden M, 1976, CHEM BIOCH PLANT PIG, P1; Holdridge L. R., 1967, Life zone ecology.; Kalacska M, 2007, REMOTE SENS ENVIRON, V109, P406, DOI 10.1016/j.rse.2007.01.012; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Meyer S, 2006, PLANT CELL ENVIRON, V29, P1338, DOI 10.1111/j.1365-3040.2006.01514.x; Miura T, 2003, AN 11 SBSR BEL HOR B, P1077; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Pooter H, 1999, NEW PHYTOL, V143, P163; PRICE JC, 1994, REMOTE SENS ENVIRON, V49, P181, DOI 10.1016/0034-4257(94)90013-2; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ratter JA, 2006, SYST ASSOC SPEC VOL, P31; Sims DA, 2003, REMOTE SENS ENVIRON, V84, P526, DOI 10.1016/S0034-4257(02)00151-7; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	43	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117659	10.1371/journal.pone.0117659	http://dx.doi.org/10.1371/journal.pone.0117659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692675	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500067
J	Ouyang, Q; Zhu, LL; Chen, K; Su, FX				Ouyang, Qian; Zhu, Liling; Chen, Kai; Su, Fengxi			Effect of Implant vs. Tissue Reconstruction on Cancer Specific Survival Varies by Axillary Lymph Node Status in Breast Cancer Patients	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; POSTMASTECTOMY; CARCINOMA; DATABASE	Background To compare the breast cancer-specific survival (BCSS) between patients who underwent tissue or implant reconstruction after mastectomy. Method We used the database from Surveillance, Epidemiology, and End Results (SEER) registries and compared the BCSS between patients who underwent tissue and implant reconstruction after mastectomy. Cox-regression models were fitted, adjusting for known clinicopathological features. The interaction between the reconstruction types (tissue/implant) and nodal status (N-stage) was investigated. Results A total of 6,426 patients with a median age of 50 years were included. With a median follow up of 100 months, the 10-year cumulative BCSS and non-BCSS were 85.1% and 95.4%, respectively. Patients who underwent tissue reconstruction had tumors with a higher T-stage, N-stage, and tumor grade and tended to be ER/PR-negative compared to those who received implant reconstruction. In univariate analysis, implant-reconstruction was associated with a 2.4% increase (P = 0.003) in the BCSS compared with tissue-reconstruction. After adjusting for significant risk factors of the BCSS (suggested by univariate analysis) and stratifying based on the N-stage, there was only an association between the reconstruction type and the BCSS for the N2-3 patients (10-year BCSS of implant vs. tissue-reconstruction: 68.7% and 59.0%, P = 0.004). The 10-year BCSS rates of implant vs. tissue-reconstruction were 91.7% and 91.8% in N0 patients (P>0.05) and 84.5% and 84.4% in N1 patients (P>0.05), respectively. Conclusions The implant (vs. tissue) reconstruction after mastectomy was associated with an improved BCSS in N2-3 breast cancer patients but not in N0-1 patients. A well-designed, prospective study is needed to further confirm these findings.	[Ouyang, Qian; Zhu, Liling; Chen, Kai; Su, Fengxi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, K (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China.	ckaichen@126.com; fengxisu@vip.163.com			National Natural Science Foundation of China [81172524, 81372817]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant# 81172524 and 81372817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman AK, 2008, CANCER-AM CANCER SOC, V112, P489, DOI 10.1002/cncr.23214; Alderman AK, 2007, CANCER-AM CANCER SOC, V109, P1715, DOI 10.1002/cncr.22598; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Cordeiro PG, 2008, NEW ENGL J MED, V359, P1590, DOI 10.1056/NEJMct0802899; Downes KJ, 2005, CANCER-AM CANCER SOC, V103, P906, DOI 10.1002/cncr.20851; Dreyfuss DA, 1987, SURG FORUM, V38; Jiang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066815; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Medina-Franco H, 2002, ANN SURG, V235, P814, DOI 10.1097/00000658-200206000-00008; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Petit JY, 2013, ANN ONCOL, V24, P1479, DOI 10.1093/annonc/mds660; SU CW, 1995, PLAST RECONSTR SURG, V96, P513, DOI 10.1097/00006534-199509000-00001; Zakhireh J, 2010, J CLIN ONCOL, V28, P173, DOI 10.1200/JCO.2008.21.7588	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118161	10.1371/journal.pone.0118161	http://dx.doi.org/10.1371/journal.pone.0118161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692294	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500104
J	Yang, XJ; Yuan, YL; Pang, Y; Wang, B; Bai, YL; Wang, YH; Yu, BZ; Zhang, ZY; Fan, M; Zhao, YL				Yang, Xiujun; Yuan, Yanli; Pang, Yu; Wang, Bo; Bai, Yunlong; Wang, Yanhua; Yu, Baozhu; Zhang, Zhiying; Fan, Ming; Zhao, Yanlin			The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANCE; TREATMENT OUTCOMES; SURVEILLANCE; PREVALENCE	Background We conducted a first baseline survey in Jilin Province of China to determine the proportion of drug-resistant tuberculosis (TB), and to analyze risk factors associated with the emergence of drug-resistance. Methodology/Principal Findings Thirty counties in Jilin Province were randomly selected as survey sites using a stratified cluster sampling method. People enrolled in the survey were new and re-treated, smear-positive pulmonary TB patients newly enrolled in local TB control and prevention institutions during the survey period. Sputum samples were collected, and the susceptibility of bacterial strains to anti-TB drugs was analyzed by proportion method. Based on the survey results, we estimated the number of drug-resistant TB patients and analyzed the risk factors associated with the emergence of drug resistance. Of 1,174 new TB patients and 597 re-treated TB patients, 8.6% and 23.2% were multi-drug resistant (MDR)-TB patients, respectively. Approximately 12% of MDR-TB patients were extensively drug-resistant. We estimate that approximately 1,290 new MDR-TB cases develop in Jilin Province every year. Of these, 810 cases would be new patients, and 480 cases would involve re-treated patients. Risk factors associated with MDR-TB include employment status, educational background, and income level. Conclusions/Significance Jilin Province remains one of the highest-burden areas in China for drug-resistant TB. The higher number of MDR-TB among new cases suggested that the transmission of drug-resistant strains in Jilin is an urgent problem in the MDR-TB control and prevention system of Jilin Province. Improving the treatment compliance of TB patients and the quality of medical care in public health institutions is urgently needed.	[Yang, Xiujun; Yuan, Yanli; Wang, Bo; Bai, Yunlong; Wang, Yanhua; Yu, Baozhu; Fan, Ming] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Pang, Yu; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Zhiying] PATH Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Fan, M (corresponding author), Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China.	jk7977068@163.com; zhaoyanlin@chinatb.org	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022					[Anonymous], 2003, WHOCDCTB2003313; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Bashour H, 2003, East Mediterr Health J, V9, P757; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Huang Fei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1276; Javaid A, 2008, INT J TUBERC LUNG D, V12, P326; Kritski AL, 1997, CHEST, V111, P1162, DOI 10.1378/chest.111.5.1162; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang XM, 2012, EMERG INFECT DIS, V18, P496, DOI 10.3201/eid1803.110760; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2010, WHOHTMTB20103; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Yumo HA, 2011, INT J TUBERC LUNG D, V15, P352; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhao YD, 2012, INFECT GENET EVOL, V12, P718, DOI 10.1016/j.meegid.2011.09.022; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	28	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117361	10.1371/journal.pone.0117361	http://dx.doi.org/10.1371/journal.pone.0117361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689373	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700037
J	Ahnis, A; Figura, A; Hofmann, T; Stengel, A; Elbelt, U; Klapp, BF				Ahnis, Anne; Figura, Andrea; Hofmann, Tobias; Stengel, Andreas; Elbelt, Ulf; Klapp, Burghard F.			Surgically and Conservatively Treated Obese Patients Differ in Psychological Factors, Regardless of Body Mass Index or Obesity-Related Co-Morbidities: A Comparison between Groups and an Analysis of Predictors	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICD-10-SYMPTOM-RATING ISR; METABOLIC SYNDROME; BARIATRIC SURGERY; FOLLOW-UP; QUESTIONNAIRE; VALIDATION; DEPRESSION; IMPACT; RISK	Objective For the treatment of obesity, both conservative and surgical procedures are available. Psychological factors are likely to influence the choice of treatment; however, to date, systematic studies that investigate these factors are few in number. The aim of our study was to analyze whether patients who undergo a surgical treatment differ from those who require a conservative treatment in regard to psychological factors, regardless of their somatic conditions. Furthermore, predictors of treatment choice will be examined. Methods A total of 244 patients (189 women), with a mean body mass index of 45.1 kg/m(2), underwent a weight reduction treatment, with 126 patients undergoing bariatric surgery and 118 patients participating in a conservative, multimodal outpatient weight reduction program. Differences in the results of the psychological questionnaires between conservatively and surgically treated patients were evaluated through the use of t-tests, chi(2)-tests and an ANCOVA. For the analysis of the predictors, logistic regression models were calculated. Results Surgically and conservatively treated obese patients differ in psychological, somatic, and socio-demographic factors. The psychological differences between the groups are independent of obesity-related co-morbidities, such as body mass index (BMI), type 2 diabetes mellitus, hypertension and coronary heart disease. The following psychological and somatic factors equally predict the choice of bariatric surgery: apathy, delegated active coping, a sense of coherence, complaints, type 2 diabetes mellitus, BMI, and age. Conclusion Longitudinal studies are required to assess the predictive value of the psychological factors in regard to the postsurgical weight course to improve the pre-surgical screening and treatment selection process. The pre-surgical identification of psychological predictors should result in a more personalized medicine course and may ensure long term outcomes.	[Ahnis, Anne; Figura, Andrea; Hofmann, Tobias; Stengel, Andreas; Klapp, Burghard F.] Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany; [Elbelt, Ulf] Charite, Ctr Internal Med Gastroenterol & Nephrol, Div Endocrinol Diabet & Nutr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ahnis, A (corresponding author), Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany.	anne.ahnis@charite.de	Elbelt, Ulf/AAJ-6469-2020	Figura, Andrea/0000-0002-1240-1501; Hofmann, Tobias/0000-0002-4002-3552; Stengel, Andreas/0000-0003-3294-4340; Elbelt, Ulf/0000-0002-7510-9284				Ahnis A, 2010, DGPM DKPM K 2010 BER, V5, P210; Ahnis A, 2012, PATIENT PREFER ADHER, V6, P165, DOI 10.2147/PPA.S28022; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Brahler E, 2000, PSYCHOTHER PSYCH MED, V50, P14, DOI 10.1055/s-2000-13233; Brahler E., 2008, GBB 24 GIESSENER BES, V3rd; Buddeberg-Fischer B, 2006, OBES SURG, V16, P321, DOI 10.1381/096089206776116471; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie Deutsche Adipositas-Gesellschaft Deutsche Gesellschaft fur Psychosomatische Medizin und Psychotherapie Deutsche Gesellschaft fur Ernahrungsmedizin, 2010, S3 LEITL CHIR AD; Elbelt U, BIOPSYCHOSOCIA UNPUB; Ellert U, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1330, DOI 10.1007/s00103-005-1168-5; Fischer HF, 2010, PSYCHOTHER PSYCH MED, V60, P307, DOI 10.1055/s-0029-1214419; Fliege H, 2001, DIAGNOSTICA, V47, P510; Gradaschi R, 2013, J HUM NUTR DIET, V26, P34, DOI 10.1111/jhn.12080; HORHOLD M, 1993, Z MED PSYCHOL, V2, P27; Karlsson J, 1998, INT J OBESITY, V22, P113, DOI 10.1038/sj.ijo.0800553; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Keating CL, 2012, OBESITY, V20, P2412, DOI 10.1038/oby.2012.124; Knoll N, 2002, THESIS FREIE U BERLI; Lapidoth JD, 2008, OBES SURG, V18, P715, DOI 10.1007/s11695-007-9250-8; Lowe B, 2002, GESUNDHEITSFRAGEBOGE, DOI [10.1111/j.1439-0388.1994.tb00458.x.Implications, DOI 10.1111/J.1439-0388.1994.TB00458.X]; Paul T., 2004, EDI 2 EATING DISORDE; Pudel V, 1989, FEV FRAGEBOGEN ESSVE; Riedl A, 2010, ADIPOSITAS, V4, P2; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Ryden A, 2004, INT J OBESITY, V28, P1485, DOI 10.1038/sj.ijo.0802768; Ryden A, 2001, BRIT J CLIN PSYCHOL, V40, P177, DOI 10.1348/014466501163625; Sadhasivam S, 2007, SURG OBES RELAT DIS, V3, P531, DOI 10.1016/j.soard.2007.07.004; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Schowalter M, 2008, OBES SURG, V18, P314, DOI 10.1007/s11695-007-9316-7; Schulz U, 2003, DIAGNOSTICA, V49, P73, DOI 10.1026//0012-1924.49.2.73; Schumacher J, 2000, PSYCHOTHER PSYCH MED, V50, P472, DOI 10.1055/s-2000-9207; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tritt K., 2010, FRAGEBOGEN ICD 10 SY; Tritt K, 2008, Z PSYCHOSOM MED PSYC, V54, P409, DOI 10.13109/zptm.2008.54.4.409; Ware JE Jr, 2001, SCORE INTERPRET SING	36	9	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117460	10.1371/journal.pone.0117460	http://dx.doi.org/10.1371/journal.pone.0117460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679521	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600065
J	Bodewes, FAJA; Bijvelds, MJ; de Vries, W; Baller, JFW; Gouw, ASH; de Jonge, HR; Verkade, HJ				Bodewes, Frank A. J. A.; Bijvelds, Marcel J.; de Vries, Willemien; Baller, Juul F. W.; Gouw, Annette S. H.; de Jonge, Hugo R.; Verkade, Henkjan J.			Cholic Acid Induces a Cftr Dependent Biliary Secretion and Liver Growth Response in Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MOUSE; DUCT EPITHELIAL-CELLS; FARNESOID-X RECEPTOR; P-GLYCOPROTEIN GENE; BILE-SALTS; DISEASE; MODEL; MDR2; RAT	The cause of Cystic fibrosis liver disease (CFLD), is unknown. It is well recognized that hepatic exposure to hydrophobic bile salts is associated with the development of liver disease. For this reason, we hypothesize that, CFTR dependent variations, in the hepatic handling of hydrophobic bile salts, are related to the development CFLD. To test our hypothesis we studied, in Cftr(-/-) and control mice, bile production, bile composition and liver pathology, in normal feeding condition and during cholate exposure, either acute (intravenous) or chronic (three weeks via the diet). In Cftr(-/-) and control mice the basal bile production was comparable. Intravenous taurocholate increased bile production to the same extent in Cftr(-/-) and control mice. However, chronic cholate exposure increased the bile flow significantly less in Cftr(-/-) mice than in controls, together with significantly higher biliary bile salt concentration in Cftr(-/-) mice. Prolonged cholate exposure, however, did not induce CFLD like pathology in Cftr(-/-) mice. Chronic cholate exposure did induce a significant increase in liver mass in controls that was absent in Cftr(-/-) mice. Chronic cholate administration induces a cystic fibrosis-specific hepatobiliary phenotype, including changes in bile composition. These changes could not be associated with CFLD like pathological changes in CFmouse livers. However, chronic cholate administration induces liver growth in controls that is absent in Cftr(-/-) mice. Our findings point to an impaired adaptive homeotrophic liver response to prolonged hydrophobic bile salt exposure in CF conditions.	[Bodewes, Frank A. J. A.; de Vries, Willemien; Baller, Juul F. W.; Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9700 AB Groningen, Netherlands; [Bijvelds, Marcel J.; de Jonge, Hugo R.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Bodewes, FAJA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9700 AB Groningen, Netherlands.	f.a.j.a.bodewes@umcg.nl		Verkade, Henkjan J/0000-0002-7034-2861; Bijvelds, Marcel/0000-0003-0814-188X				Benedetti A, 1997, HEPATOLOGY, V26, P9; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodewes FAJA, 2012, AM J PHYSIOL-GASTR L, V302, pG1035, DOI 10.1152/ajpgi.00258.2011; BOTTCHER CJF, 1961, J ATHEROSCLER RES, V1, P36, DOI 10.1016/S0368-1319(61)80052-5; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Corbett K, 2004, J PEDIATR-US, V145, P327, DOI 10.1016/j.jpeds.2004.05.051; De Lisle RC, 2006, J PEDIATR GASTR NUTR, V42, P46, DOI 10.1097/01.mpg.0000189322.34582.3e; De Lisle RC, 2011, J PEDIATR GASTR NUTR, V53, P371, DOI 10.1097/MPG.0b013e318219c397; Debray D, 2012, GASTROENTEROLOGY, V142, P1581, DOI 10.1053/j.gastro.2012.02.033; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Fiorotto R, 2011, GASTROENTEROLOGY, V141, P1498, DOI 10.1053/j.gastro.2011.06.052; Fitz JG, 2002, SEMIN LIVER DIS, V22, P241, DOI 10.1055/s-2002-34502; FITZ JG, 1993, J CLIN INVEST, V91, P319, DOI 10.1172/JCI116188; Freudenberg F, 2010, AM J PHYSIOL-GASTR L, V299, pG205, DOI 10.1152/ajpgi.00341.2009; HEUMAN DM, 1989, J LIPID RES, V30, P1161; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Moyer K, 2009, CURR OPIN GASTROEN, V25, P272, DOI 10.1097/MOG.0b013e3283298865; Nash KL, 2008, J CYST FIBROS, V7, P252, DOI 10.1016/j.jcf.2007.10.004; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Rowland M, 2011, AM J GASTROENTEROL, V106, P104, DOI 10.1038/ajg.2010.316; Scholte Bob J, 2004, J Cyst Fibros, V3 Suppl 2, P183, DOI 10.1016/j.jcf.2004.05.039; SCOTTJUPP R, 1991, ARCH DIS CHILD, V66, P698, DOI 10.1136/adc.66.6.698; Sinaasappel M, 1988, ACTA PAEDIATR SCAND, V363, P50; SINAASAPPEL M, 1988, ACTA PAEDIATR SCAND, V363, P45; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; Tormos AM, 2013, FREE RADICAL RES, V47, P905, DOI 10.3109/10715762.2013.821200; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; vanNieuwerk CMJ, 1997, J HEPATOL, V26, P138, DOI 10.1016/S0168-8278(97)80020-7; vanNieuwkerk CMJ, 1996, GASTROENTEROLOGY, V111, P165, DOI 10.1053/gast.1996.v111.pm8698195; Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wouthuyzen-Bakker M, 2012, PEDIATR RES, V71, P4, DOI 10.1038/pr.2011.4; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Zhang LS, 2012, HEPATOLOGY, V56, P2336, DOI 10.1002/hep.25905	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117599	10.1371/journal.pone.0117599	http://dx.doi.org/10.1371/journal.pone.0117599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680200	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600076
J	Holst, PJ; Jensen, BAH; Ragonnaud, E; Thomsen, AR; Christensen, JP				Holst, Peter J.; Jensen, Benjamin A. H.; Ragonnaud, Emeline; Thomsen, Allan R.; Christensen, Jan P.			Targeting of Non-Dominant Antigens as a Vaccine Strategy to Broaden T-Cell Responses during Chronic Viral Infection	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; EXHAUSTED PHENOTYPE; IN-VIVO; MEMORY; ADENOVIRUS; IMMUNITY; EFFECTOR; EXPRESSION; CHALLENGE; SIV	In this study, we compared adenoviral vaccine vectors with the capacity to induce equally potent immune responses against non-dominant and immunodominant epitopes of murine lymphocytic choriomeningitis virus (LCMV). Our results demonstrate that vaccination targeting non-dominant epitopes facilitates potent virus-induced T-cell responses against immunodominant epitopes during subsequent challenge with highly invasive virus. In contrast, when an immunodominant epitope was included in the vaccine, the T-cell response associated with viral challenge remained focussed on that epitope. Early after challenge with live virus, the CD8+ T cells specific for vaccine-encoded epitopes, displayed a phenotype typically associated with prolonged/persistent antigenic stimulation marked by high levels of KLRG-1, as compared to T cells reacting to epitopes not included in the vaccine. Notably, this association was lost over time in T cells specific for the dominant T cell epitopes, and these cells were fully capable of expanding in response to a new viral challenge. Overall, our data suggests a potential for broadening of the antiviral CD8+ T-cell response by selecting non-dominant antigens to be targeted by vaccination. In addition, our findings suggest that prior adenoviral vaccination is not likely to negatively impact the long-term and protective immune response induced and maintained by a vaccine-attenuated chronic viral infection.	[Holst, Peter J.; Jensen, Benjamin A. H.; Thomsen, Allan R.; Christensen, Jan P.] Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Holst, Peter J.; Ragonnaud, Emeline] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Holst, PJ (corresponding author), Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark.	pholst@sund.ku.dk	Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; ragonnaud, emeline/0000-0001-5460-7789; Holst, Peter Johannes/0000-0002-1279-304X; Thomsen, Allan Randrup/0000-0002-2392-9803	Danish Research Council; Novo Nordisk Foundation; Aase and Einar Danielsens Fond; Hede Nielsen Family Foundation; Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden [NNF14OC0011875] Funding Source: researchfish	Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase and Einar Danielsens Fond; Hede Nielsen Family Foundation; Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank The Danish Research Council, The Novo Nordisk Foundation, Aase and Einar Danielsens Fond, The Hede Nielsen Family Foundation and the Foundation for the Advancement of Medical Sciences for funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bannard O, 2010, J IMMUNOL, V185, P7141, DOI 10.4049/jimmunol.1002537; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bartholdy C, 2004, J IMMUNOL, V173, P6284, DOI 10.4049/jimmunol.173.10.6284; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Christensen JP, 2003, J IMMUNOL, V171, P4733, DOI 10.4049/jimmunol.171.9.4733; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hoegh-Petersen M, 2009, VACCINE, V27, P6723, DOI 10.1016/j.vaccine.2009.08.104; Holst PJ, 2007, J GEN VIROL, V88, P1708, DOI 10.1099/vir.0.82727-0; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Holst PJ, 2011, J IMMUNOL, V186, P3997, DOI 10.4049/jimmunol.1001251; Holst PJ, 2010, J IMMUNOL, V184, P4431, DOI 10.4049/jimmunol.0900537; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Lecuroux C, 2009, AIDS, V23, P1649, DOI 10.1097/QAD.0b013e32832e6634; Leligdowicz A, 2010, EUR J IMMUNOL, V40, P1963, DOI 10.1002/eji.200940295; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MK, 2012, J CLIN INVEST, DOI [10.1172/JCI64993, DOI 10.1172/JCI64993]; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mikkelsen M, 2011, J IMMUNOL, V186, P2355, DOI 10.4049/jimmunol.1001877; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Roshorm Y, 2012, EUR J IMMUNOL, V42, P3243, DOI 10.1002/eji.201242624; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Steffensen MA, 2013, J VIROL, V87, P6283, DOI 10.1128/JVI.00465-13; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tan WG, 2013, J VIROL, V87, P1359, DOI 10.1128/JVI.02055-12; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wiesel M, 2009, APMIS, V117, P356, DOI 10.1111/j.1600-0463.2009.02459.x; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117242	10.1371/journal.pone.0117242	http://dx.doi.org/10.1371/journal.pone.0117242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679375	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600057
J	Sarna, M; Wojcik, KA; Hermanowicz, P; Wnuk, D; Burda, K; Sanak, M; Czyz, J; Michalik, M				Sarna, Michal; Wojcik, Katarzyna A.; Hermanowicz, Pawel; Wnuk, Dawid; Burda, Kvetoslava; Sanak, Marek; Czyz, Jaroslaw; Michalik, Marta			Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts	PLOS ONE			English	Article							TO-MYOFIBROBLAST TRANSITION; NANOMECHANICAL ANALYSIS; ACTIN CYTOSKELETON; STRESS FIBERS; GROWTH-FACTOR; CELLS; DIFFERENTIATION; EXPRESSION; STIFFNESS; MECHANICS	During asthma development, differentiation of epithelial cells and fibroblasts towards the contractile phenotype is associated with bronchial wall remodeling and airway constriction. Pathological fibroblast-to-myofibroblast transition (FMT) can be triggered by local inflammation of bronchial walls. Recently, we have demonstrated that human bronchial fibroblasts (HBFs) derived from asthmatic patients display some inherent features which facilitate their FMT in vitro. In spite of intensive research efforts, these properties remain unknown. Importantly, the role of undifferentiated HBFs in the asthmatic process was systematically omitted. Specifically, biomechanical properties of undifferentiated HBFs have not been considered in either FMT or airway remodeling in vivo. Here, we combine atomic force spectroscopy with fluorescence microscopy to compare mechanical properties and actin cytoskeleton architecture of HBFs derived from asthmatic patients and non-asthmatic donors. Our results demonstrate that asthmatic HBFs form thick and aligned 'ventral' stress fibers accompanied by enlarged focal adhesions. The differences in cytoskeleton architecture between asthmatic and non-asthmatic cells correlate with higher elastic modulus of asthmatic HBFs and their increased predilection to TGF-beta-induced FMT. Due to the obvious links between cytoskeleton architecture and mechanical equilibrium, our observations indicate that HBFs derived from asthmatic bronchi can develop considerably higher static tension than non-asthmatic HBFs. This previously unexplored property of asthmatic HBFs may be potentially important for their myofibroblastic differentiation and bronchial wall remodeling during asthma development.	[Sarna, Michal; Burda, Kvetoslava] AGH Univ Sci & Technol, Dept Med Phys & Biophys, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland; [Wojcik, Katarzyna A.; Wnuk, Dawid; Czyz, Jaroslaw; Michalik, Marta] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wojcik, Katarzyna A.] Jagiellonian Univ, Fac Pharm, Dept Pharmaceut Biochem, Coll Med, Krakow, Poland; [Hermanowicz, Pawel] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sanak, Marek] Jagiellonian Univ, Coll Med, Lab Mol Biol & Clin Genet, Krakow, Poland	AGH University of Science & Technology; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Sarna, M (corresponding author), AGH Univ Sci & Technol, Dept Med Phys & Biophys, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland.	michal.sarna@fis.agh.edu.pl; marta.michalik@uj.edu.pl	Burda, Kvetoslava/AAW-2621-2021; Wnuk, Dawid/X-1664-2018; Sanak, Marek/AAV-1628-2021	Burda, Kvetoslava/0000-0001-5049-6217; Wnuk, Dawid/0000-0002-5807-2440; Sanak, Marek/0000-0001-7635-8103; Hermanowicz, Pawel/0000-0002-4708-442X; Wojcik-Pszczola, Katarzyna/0000-0002-2477-5607; Czyz, Jaroslaw/0000-0001-6779-7630	Polish National Science Centre [2011/01/B/NZ3/00004]; European Union [UDA-POIG.01.03.01-14-036/09-00, POIG.02.01.00-12-064/08, POIG 01.02-00-109/99]	Polish National Science Centre; European Union(European Commission)	This work was supported by the Polish National Science Centre (grant 2011/01/B/NZ3/00004). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (Grants No: UDA-POIG.01.03.01-14-036/09-00-"Application of polyisoprenoid derivatives as drug carriers and metabolism regulators"; POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"; POIG 01.02-00-109/99 "Innovative methods of stem cell applications in medicine"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Daniel-Wojcik A, 2008, INT J ONCOL, V33, P309, DOI 10.3892/ijo_00000010; Desideria D, 2007, RECENT PATENTS INFLA, V1, P237, DOI 10.2174/187221307782418847; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dufrene YF, 2003, CURR OPIN MICROBIOL, V6, P317, DOI 10.1016/S1369-5274(03)00058-4; Evans ND, 2009, EUR CELLS MATER, V18, P1; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/NNANO.2012.163, 10.1038/nnano.2012.163]; Hermanowicz P, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4881683; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Kliche K, 2011, PFLUG ARCH EUR J PHY, V462, P209, DOI 10.1007/s00424-011-0929-2; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Michalik Marta, 2012, J Allergy (Cairo), V2012, P206109, DOI 10.1155/2012/206109; Michalik M, 2013, EUR J PHARMACOL, V704, P23, DOI 10.1016/j.ejphar.2013.02.023; Michalik M, 2011, RESP MED, V105, P1467, DOI 10.1016/j.rmed.2011.04.009; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sandbo N, 2011, TRANSL RES, V158, P181, DOI 10.1016/j.trsl.2011.05.004; Sarna M, 2013, PIGM CELL MELANOMA R, V26, P727, DOI 10.1111/pcmr.12113; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; West AR, 2013, PULM PHARMACOL THER, V26, P3, DOI 10.1016/j.pupt.2012.08.009; Westergren-Thorsson G, 2010, CLIN RESPIR J, V4, P1, DOI 10.1111/j.1752-699X.2010.00190.x; Wojcik KA, 2013, PHARMACOL REP, V65, P164, DOI 10.1016/S1734-1140(13)70974-5; Wojcik KA, 2012, POL ARCH MED WEWN, V122, P326, DOI 10.20452/pamw.1343	43	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116840	10.1371/journal.pone.0116840	http://dx.doi.org/10.1371/journal.pone.0116840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679502	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600037
J	Waldo, SW; Brenner, DA; McCabe, JM; Dela Cruz, M; Long, B; Narla, VA; Park, J; Kulkarni, A; Sinclair, E; Chan, SY; Schick, SF; Malik, N; Ganz, P; Hsue, PY				Waldo, Stephen W.; Brenner, Daniel A.; McCabe, James M.; Dela Cruz, Mark; Long, Brian; Narla, Venkata A.; Park, Joseph; Kulkarni, Ameya; Sinclair, Elizabeth; Chan, Stephen Y.; Schick, Suzaynn F.; Malik, Namita; Ganz, Peter; Hsue, Priscilla Y.			A Novel Minimally-Invasive Method to Sample Human Endothelial Cells for Molecular Profiling	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VASCULAR INFLAMMATION; PROGENITOR CELLS; RT-PCR; BIOPSY; EXPRESSION	Objective The endothelium is a key mediator of vascular homeostasis and cardiovascular health. Molecular research on the human endothelium may provide insight into the mechanisms underlying cardiovascular disease. Prior methodology used to isolate human endothelial cells has suffered from poor yields and contamination with other cell types. We thus sought to develop a minimally invasive technique to obtain endothelial cells derived from human subjects with higher yields and purity. Methods Nine healthy volunteers underwent endothelial cell harvesting from antecubital veins using guidewires. Fluorescence-activated cell sorting (FACS) was subsequently used to purify endothelial cells from contaminating cells using endothelial surface markers (CD34 / CD105 / CD146) with the concomitant absence of leukocyte and platelet specific markers (CD11b / CD45). Endothelial lineage in the purified cell population was confirmed by expression of endothelial specific genes and microRNA using quantitative polymerase chain reaction (PCR). Results A median of 4,212 (IQR: 2161 - 6583) endothelial cells were isolated from each subject. Quantitative PCR demonstrated higher expression of von Willebrand Factor (vWF, P<0.001), nitric oxide synthase 3 (NOS3, P<0.001) and vascular cell adhesion molecule 1 (VCAM-1, P<0.003) in the endothelial population compared to similarly isolated leukocytes. Similarly, the level of endothelial specific microRNA-126 was higher in the purified endothelial cells (P<0.001). Conclusion This state-of-the-art technique isolates human endothelial cells for molecular analysis in higher purity and greater numbers than previously possible. This approach will expedite research on the molecular mechanisms of human cardiovascular disease, elucidating its pathophysiology and potential therapeutic targets.	[Waldo, Stephen W.; Brenner, Daniel A.; McCabe, James M.; Dela Cruz, Mark; Narla, Venkata A.; Park, Joseph; Kulkarni, Ameya; Chan, Stephen Y.; Ganz, Peter; Hsue, Priscilla Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA USA; [Dela Cruz, Mark; Narla, Venkata A.; Ganz, Peter; Hsue, Priscilla Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Excellence Vasc Res, San Francisco, CA USA; [Long, Brian; Sinclair, Elizabeth] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Schick, Suzaynn F.; Malik, Namita] Univ Calif San Francisco, Div Occupat & Environm Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Waldo, SW (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA.	swaldo@mgh.harvard.edu		Park, Joseph/0000-0002-3313-641X; Ganz, Peter/0000-0002-0437-8882	Center for AIDS Research at the University of California, San Francisco; NIH [R01HL095130, K24AI112393]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095130, R01HL124021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI112393] Funding Source: NIH RePORTER	Center for AIDS Research at the University of California, San Francisco; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for AIDS Research at the University of California, San Francisco (DAB) and by the NIH (R01HL095130, K24AI112393 both to PYH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Barbier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019651; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Colombo PC, 2005, CIRCULATION, V111, P58, DOI 10.1161/01.CIR.0000151611.89232.3B; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8; Feng L, 2005, DIABETES CARE, V28, P379, DOI 10.2337/diacare.28.2.379; Feng L, 1999, RADIOLOGY, V212, P655, DOI 10.1148/radiology.212.3.r99au28655; Ganz P, 2013, EUR HEART J, V34, P2025, DOI 10.1093/eurheartj/eht199; Ganz P, 2009, J AM COLL CARDIOL, V53, P331, DOI 10.1016/j.jacc.2008.10.021; Giallongo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101848; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Kennedy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017625; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; MICHELSON AD, 1991, BLOOD, V77, P770; Onat D, 2007, J APPL PHYSIOL, V103, P1873, DOI 10.1152/japplphysiol.00367.2007; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Psaltis PJ, 2014, CIRC RES, V115, P364, DOI 10.1161/CIRCRESAHA.115.303299; Silver AE, 2010, J VASC RES, V47, P1, DOI 10.1159/000231715; Tabit CE, 2013, CIRCULATION, V127, P86, DOI 10.1161/CIRCULATIONAHA.112.127514; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118081	10.1371/journal.pone.0118081	http://dx.doi.org/10.1371/journal.pone.0118081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679506	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600107
J	Wu, QH; Chen, YX; Zhou, SH; Fu, L; Chen, JJ; Xiao, Y; Zhang, D; Ouyang, SH; Zhao, XJ; Cui, Y; Zhang, DY; Liang, Y; Wang, ZZ; Xie, JZ; Qin, JX; Wang, GX; Li, DL; Huang, YL; Yu, MH; Lu, P; Wang, LL; Wang, L; Wang, H; Dang, C; Li, J; Zhang, Y; Peng, HR; Yuan, CG; You, MS; Sun, QX; Wang, JR; Wang, LX; Luo, MC; Han, J; Liu, ZY				Wu, Qiu-Hong; Chen, Yong-Xing; Zhou, Sheng-Hui; Fu, Lin; Chen, Jiao-Jiao; Xiao, Yao; Zhang, Dong; Ouyang, Shu-Hong; Zhao, Xiao-Jie; Cui, Yu; Zhang, De-Yun; Liang, Yong; Wang, Zhen-Zhong; Xie, Jing-Zhong; Qin, Jin-Xia; Wang, Guo-Xin; Li, De-Lin; Huang, Yin-Lian; Yu, Mei-Hua; Lu, Ping; Wang, Li-Li; Wang, Ling; Wang, Hao; Dang, Chen; Li, Jie; Zhang, Yan; Peng, Hui-Ru; Yuan, Cheng-Guo; You, Ming-Shan; Sun, Qi-Xin; Wang, Ji-Rui; Wang, Li-Xin; Luo, Ming-Cheng; Han, Jun; Liu, Zhi-Yong			High-Density Genetic Linkage Map Construction and QTL Mapping of Grain Shape and Size in the Wheat Population Yanda1817 x Beinong6	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L.; D-GENOME; AEGILOPS-TAUSCHII; AGRONOMIC TRAITS; MOLECULAR MARKER; POLYPLOID WHEAT; KERNEL WEIGHT; BREAD WHEAT; SEED SIZE	High-density genetic linkage maps are necessary for precisely mapping quantitative trait loci (QTLs) controlling grain shape and size in wheat. By applying the Infinium iSelect 9K SNP assay, we have constructed a high-density genetic linkage map with 269 F-8 recombinant inbred lines (RILs) developed between a Chinese cornerstone wheat breeding parental line Yanda1817 and a high-yielding line Beinong6. The map contains 2431 SNPs and 128 SSR & EST-SSR markers in a total coverage of 3213.2 cM with an average interval of 1.26 cM per marker. Eighty-eight QTLs for thousand-grain weight (TGW), grain length (GL), grain width (GW) and grain thickness (GT) were detected in nine ecological environments (Beijing, Shijiazhuang and Kaifeng) during five years between 2010-2014 by inclusive composite interval mapping (ICIM) (LOD >= 2.5). Among which, 17 QTLs for TGW were mapped on chromosomes 1A, 1B, 2A, 2B, 3A, 3B, 3D, 4A, 4D, 5A, 5B and 6B with phenotypic variations ranging from 2.62% to 12.08%. Four stable QTLs for TGW could be detected in five and seven environments, respectively. Thirty-two QTLs for GL were mapped on chromosomes 1B, 1D, 2A, 2B, 2D, 3B, 3D, 4A, 4B, 4D, 5A, 5B, 6B, 7A and 7B, with phenotypic variations ranging from 2.62% to 44.39%. QGl. cau-2A. 2 can be detected in all the environments with the largest phenotypic variations, indicating that it is a major and stable QTL. For GW, 12 QTLs were identified with phenotypic variations range from 3.69% to 12.30%. We found 27 QTLs for GT with phenotypic variations ranged from 2.55% to 36.42%. In particular, QTL QGt. cau-5A. 1 with phenotypic variations of 6.82-23.59% was detected in all the nine environments. Moreover, pleiotropic effects were detected for several QTL loci responsible for grain shape and size that could serve as target regions for fine mapping and marker assisted selection in wheat breeding programs.	[Wu, Qiu-Hong; Chen, Yong-Xing; Zhou, Sheng-Hui; Fu, Lin; Chen, Jiao-Jiao; Xiao, Yao; Zhang, Dong; Ouyang, Shu-Hong; Zhao, Xiao-Jie; Cui, Yu; Zhang, De-Yun; Liang, Yong; Wang, Zhen-Zhong; Xie, Jing-Zhong; Qin, Jin-Xia; Wang, Guo-Xin; Li, De-Lin; Huang, Yin-Lian; Yu, Mei-Hua; Lu, Ping; Wang, Li-Li; Wang, Ling; Wang, Hao; Dang, Chen; Li, Jie; Zhang, Yan; Peng, Hui-Ru; Yuan, Cheng-Guo; You, Ming-Shan; Sun, Qi-Xin; Liu, Zhi-Yong] China Agr Univ, State Key Lab Agrobiotechnol, Dept Plant Genet & Breeding, Beijing 100193, Peoples R China; [Wang, Ji-Rui; Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Ji-Rui] Sichuan Agr Univ, Triticeae Res Inst, Chengdu 611130, Sichuan, Peoples R China; [Wang, Li-Xin] Beijing Acad Agr & Forestry Sci, Beijing 100197, Peoples R China; [Han, Jun] Beijing Univ Agr, Beijing 102206, Peoples R China	China Agricultural University; University of California System; University of California Davis; Sichuan Agricultural University; Beijing Academy of Agriculture & Forestry; Beijing University of Agriculture	Han, J (corresponding author), Beijing Univ Agr, Beijing 102206, Peoples R China.	hanjun4226@163.com; zhiyongliu@cau.edu.cn	chen, JJ/HGB-6029-2022; Li, Delin/AAO-2275-2021; CHEN, JIAO/GZA-5784-2022; Xie, Jingzhong/AAF-5899-2020	Li, Delin/0000-0002-3689-3790; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233	973 project [2011CB100104]; National Natural Science Foundation of China [31030056, 31271710]; Ministry of Education of China [111-2-03]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by 973 project 2011CB100104; National Natural Science Foundation of China 31030056, 31271710; Ministry of Education of China 111-2-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Berard A, 2009, PLANT BIOTECHNOL J, V7, P364, DOI 10.1111/j.1467-7652.2009.00404.x; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chang JZ, 2013, PLANTA, V237, P1495, DOI 10.1007/s00425-013-1860-x; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Cui F, 2013, MOL BREEDING, V31, P265, DOI 10.1007/s11032-012-9786-8; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Giura A, 1996, EUPHYTICA, V89, P77, DOI 10.1007/BF00015722; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo Y, 2013, FIELD CROP RES, V154, P119, DOI 10.1016/j.fcr.2013.07.012; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kang GZ, 2013, PLANT PHYSIOL BIOCH, V73, P93, DOI 10.1016/j.plaphy.2013.09.003; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar N, 2006, EUPHYTICA, V151, P135, DOI 10.1007/s10681-006-9133-4; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Lincoln L, 1993, CONSTRUCTING GENETIC, P1; Liu Ren-Hu, 2003, Yichuan, V25, P317; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Paux E, 2012, BIOTECHNOL ADV, V30, P1071, DOI 10.1016/j.biotechadv.2011.09.015; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Pozzi C, 2004, CEREAL GENOMICS, P165; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rasheed A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-128; Roder MS, 1998, GENETICS, V149, P2007; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Varshney RK, 2000, THEOR APPL GENET, V100, P1290, DOI 10.1007/s001220051437; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; Williams K, 2013, EUPHYTICA, V190, P99, DOI 10.1007/s10681-012-0783-0; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhuang QS., 2003, CHINESE WHEAT IMPROV	58	87	96	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118144	10.1371/journal.pone.0118144	http://dx.doi.org/10.1371/journal.pone.0118144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675376	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000041
J	Aleman, Y; Vinken, L; Kour, V; Perez, L; Alvarez, A; Abrahantes, Y; Fonseca, C; Perez, J; Correa, C; Soto, Y; Schrooten, Y; Vandamme, AM; Van Laethem, K				Aleman, Yoan; Vinken, Lore; Kour, Vivian; Perez, Lissette; Alvarez, Alina; Abrahantes, Yeissel; Fonseca, Carlos; Perez, Jorge; Correa, Consuelo; Soto, Yudira; Schrooten, Yoeri; Vandamme, Anne-Mieke; Van Laethem, Kristel			Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SEQUENCE-BASED ANALYSIS; BLOOD SPOT SPECIMENS; FIELD-EVALUATION; VIROSEQ(TM) 2.0; HIV-1; ASSAY; MUTATIONS; STRAINS	As commercial human immunodeficiency virus type 1 drug resistance assays are expensive, they are not commonly used in resource-limited settings. Hence, a more affordable inhouse procedure was set up taking into account the specific epidemiological and economic circumstances of Cuba. The performance characteristics of the in-house assay were evaluated using clinical samples with various subtypes and resistance patterns. The lower limit of amplification was determined on dilutions series of 20 clinical isolates and ranged from 84 to 529 RNA copies/mL. For the assessment of trueness, 14 clinical samples were analyzed and the ViroSeq HIV-1 Genotyping System v2.0 was used as the reference standard. The mean nucleotide sequence identity between the two assays was 98.7% +/- 1.0. Additionally, 99.0% of the amino acids at drug resistance positions were identical. The sensitivity and specificity in detecting drug resistance mutations was respectively 94.1% and 99.5%. Only few discordances in drug resistance interpretation patterns were observed. The repeatability and reproducibility were evaluated using 10 clinical samples with 3 replicates per sample. The in-house test was very precise as nucleotide sequence identity among paired nucleotide sequences ranged from 98.7% to 99.9%. The acceptance criteria were met by the inhouse test for all performance characteristics, demonstrating a high degree of accuracy. Subsequently, the applicability in routine clinical practice was evaluated on 380 plasma samples. The amplification success rate was 91% and good quality consensus sequences encoding the entire protease and the first 335 codons in reverse transcriptase could be obtained for 99% of the successful amplicons. The reagent cost per sample using the inhouse procedure was around (sic) 80 per genotyping attempt. Overall, the in-house assay provided good results, was feasible with equipment and reagents available in Cuba and was half as expensive as commercial assays.	[Aleman, Yoan; Kour, Vivian; Perez, Lissette; Alvarez, Alina; Correa, Consuelo; Soto, Yudira] Inst Trop Med Pedro Kouri, Dept Virol, Havana, Cuba; [Vinken, Lore; Schrooten, Yoeri; Vandamme, Anne-Mieke; Van Laethem, Kristel] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium; [Abrahantes, Yeissel; Fonseca, Carlos; Perez, Jorge] Hosp Inst Trop Med Pedro Kouri, Havana, Cuba; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, P-1200 Lisbon, Portugal	KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Van Laethem, K (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.	kristel.vanlaethem@uzleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Van Laethem, Kristel/R-6282-2016	Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Laethem, Kristel/0000-0001-6036-2271; Correa Sierra, Consuelo B/0000-0003-2897-8388	Vlaamse Interuniversitaire Raad (VLIR) [ZEIN2008PR358]; Global Fund To Fight AIDS, Tuberculosis and Malaria; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0692.14N]; AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs	Vlaamse Interuniversitaire Raad (VLIR); Global Fund To Fight AIDS, Tuberculosis and Malaria; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs	This work was supported by grants from the Vlaamse Interuniversitaire Raad (VLIR) (ZEIN2008PR358), the Global Fund To Fight AIDS, Tuberculosis and Malaria, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0692.14N) and by the AIDS Reference Laboratory of Leuven that receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Aitken SC, 2012, J CLIN VIROL, V54, P21, DOI 10.1016/j.jcv.2012.01.010; Beddows S, 2003, J MED VIROL, V70, P337, DOI 10.1002/jmv.10401; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2012, ANTIVIR THER, V17, P941, DOI 10.3851/IMP2320; Bile EC, 2005, J CLIN VIROL, V32, P60, DOI 10.1016/j.jcv.2004.07.008; Chaturbhuj DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087441; Chaturbhuj DN, 2013, J VIROL METHODS, V189, P87, DOI 10.1016/j.jviromet.2013.01.001; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Chen JHK, 2012, HONG KONG MED J, V18, P20; Clinical and Laboratory Standards Institute (CLSI), 2006, MM10A CLSI; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; HHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES USE ANTIR; Huang DD, 2003, J CLIN MICROBIOL, V41, P3265, DOI 10.1128/JCM.41.7.3265-3272.2003; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Jagodzinski LL, 2003, J CLIN MICROBIOL, V41, P998, DOI 10.1128/JCM.41.3.998-1003.2003; Jennings L, 2009, ARCH PATHOL LAB MED, V133, P743, DOI 10.1043/1543-2165-133.5.743; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maes B, 2004, J VIROL METHODS, V119, P45, DOI 10.1016/j.jviromet.2004.02.005; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Mracna M, 2001, J CLIN MICROBIOL, V39, P4323, DOI 10.1128/JCM.39.12.4323-4327.2001; Parkin N, 2012, CLIN INFECT DIS, V54, pS273, DOI 10.1093/cid/cir982; Perez J, 2004, PERSPECTIVES PRACTIC; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thew KK, 2012, ANN ACAD MED SINGAP, V41, P553; Thiam M, 2013, J VIROL METHODS, V188, P97, DOI 10.1016/j.jviromet.2012.11.044; Vandamme AM, 2011, AIDS REV, V13, P77; Vinken L, 2013, J VIROL METHODS, V193, P135, DOI 10.1016/j.jviromet.2013.05.017; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; World Health Organization, 2010, WHO HIVRESNET HIV DR; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	40	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117176	10.1371/journal.pone.0117176	http://dx.doi.org/10.1371/journal.pone.0117176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671421	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300039
J	Ammann, RA; Teuffel, O; Agyeman, P; Amport, N; Leibundgut, K				Ammann, Roland A.; Teuffel, Oliver; Agyeman, Philipp; Amport, Nadine; Leibundgut, Kurt			The Influence of Different Fever Definitions on the Rate of Fever in Neutropenia Diagnosed in Children with Cancer	PLOS ONE			English	Article							PEDIATRIC FEBRILE NEUTROPENIA; MANAGEMENT; RISK; ONCOLOGY; ANTIBIOTICS; OUTPATIENT; GUIDELINE; CENTERS; TRIALS	Background The temperature limit defining fever (TLDF) is based on scarce evidence. This study aimed to determine the rate of fever in neutropenia (FN) episodes additionally diagnosed by lower versus standard TLDF. Methods In a single center using a high TLDF (39.0 degrees C tympanic temperature, Limit(Standard)), pediatric patients treated with chemotherapy for cancer were observed prospectively. Results of all temperature measurements and CBCs were recorded. The application of lower TLDFs (Limit(Low); range, 37.5 degrees C to 38.9 degrees C) versus Limit(Standard) was simulated in silicon, resulting in three types of FN: simultaneous FN, diagnosed at both limits within 1 hour; earlier FN, diagnosed > 1hour earlier at Limit(Low); and additional FN, not diagnosed at Limit(Standard). Results In 39 patients, 8896 temperature measurements and 1873 CBCs were recorded during 289 months of chemotherapy. Virtually applying Limit(Standard) resulted in 34 FN diagnoses. The predefined relevantly (>= 15%) increased FN rate was reached at Limit(Low) 38.4 degrees C, with total 44 FN, 23 simultaneous, 11 earlier, and 10 additional (Poisson rate ratio(Additional/Standard), 0.29; 95% lower confidence bound, 0.16). Virtually applying 37.5 degrees C as Limit(Low) led to earlier FN diagnosis (median, 4.5 hours; 95% CI, 1.0 to 20.8), and to 53 additional FN diagnosed. In 51 (96%) of them, spontaneous defervescence without specific therapy was observed in reality. Conclusion Lower TLDFs led to many additional FN diagnoses, implying overtreatment because spontaneous defervescence was observed in the vast majority. Lower TLDFs led as well to relevantly earlier diagnosis in a minority of FN episodes. The question if the high TLDF is not only efficacious but as well safe remains open.	[Ammann, Roland A.; Teuffel, Oliver; Agyeman, Philipp; Amport, Nadine; Leibundgut, Kurt] Univ Bern, Dept Pediat, Bern, Switzerland; [Teuffel, Oliver] Med Serv Statutory Hlth Insurance Baden Wurttemb, Div Oncol, Tubingen, Germany; [Agyeman, Philipp] Univ Bern, Inst Infect Dis, Bern, Switzerland	University of Bern; University of Bern	Ammann, RA (corresponding author), Univ Bern, Dept Pediat, Bern, Switzerland.	roland.ammann@insel.ch	Agyeman, Philipp/AAG-3510-2019; Ammann, Roland A/I-4716-2019	Ammann, Roland A/0000-0002-1902-2352; Leibundgut, Kurt/0000-0003-2514-6041; Agyeman, Philipp Kwame Abayie/0000-0002-8339-5444	Swiss Cancer League [KLS-2933-02-2012]	Swiss Cancer League	This study was supported by an unrestricted research grant from the Swiss Cancer League (Grant No. KLS-2933-02-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Ammann RA, 2012, CURR OPIN INFECT DIS, V25, P258, DOI 10.1097/QCO.0b013e328351d199; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; Bate J, 2013, ARCH DIS CHILD, V98, P315, DOI 10.1136/archdischild-2013-303810; Binz P, 2013, PEDIATR BLOOD CANCER, V60, P799, DOI 10.1002/pbc.24380; Cheng S, 2011, BRIT J CANCER, V105, P606, DOI 10.1038/bjc.2011.213; Fletcher M, 2013, PEDIATR BLOOD CANCER, V60, P1299, DOI 10.1002/pbc.24485; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gibson F, 2013, SUPPORT CARE CANCER, V21, P1241, DOI 10.1007/s00520-012-1653-y; Ichikawa M, 2011, PEDIATR BLOOD CANCER, V57, P1159, DOI 10.1002/pbc.23106; Kaz Europe SA, 2011, BRAUN THERM IRT 4520, P3; Klaassen RJ, 2000, J CLIN ONCOL, V18, P1012, DOI 10.1200/JCO.2000.18.5.1012; Koh A, 2011, PRINCIPLES PRACTICE, P1190; Lehrnbecher T, 2012, J CLIN ONCOL, V30, P4427, DOI 10.1200/JCO.2012.42.7161; Manji A, 2012, SUPPORT CARE CANCER, V20, P1135, DOI 10.1007/s00520-012-1425-8; Nijhuis CO, 2005, J CLIN ONCOL, V23, P7437, DOI 10.1200/JCO.2004.00.5264; Nimah MM, 2006, PEDIATR CRIT CARE ME, V7, P48, DOI 10.1097/01.PCC.0000185476.35550.B2; Phillips B, 2007, ARCH DIS CHILD, V92, P495, DOI 10.1136/adc.2006.102699; Phillips RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038300; Schlapbach LJ, 2007, PEDIATR BLOOD CANCER, V49, P11, DOI 10.1002/pbc.21097; Schoot RA, 2012, SUPPORT CARE CANCER, V20, P3149, DOI 10.1007/s00520-012-1447-2; Sung L, 2004, J CLIN ONCOL, V22, P3922, DOI 10.1200/JCO.2004.01.077; Teuffel O, 2012, CURR OPIN PEDIATR, V24, P40, DOI 10.1097/MOP.0b013e32834c4b12; Teuffel O, 2011, PEDIATRICS, V127, pE279, DOI 10.1542/peds.2010-0734	24	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117528	10.1371/journal.pone.0117528	http://dx.doi.org/10.1371/journal.pone.0117528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671574	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300058
J	Kim, ES; Shin, JH; Park, SJ; Jo, YK; Kim, JS; Kang, IH; Nam, JB; Chung, DY; Cho, Y; Lee, EH; Chang, JW; Cho, DH				Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Kim, Jae-Sung; Kang, Il-Hwan; Nam, Jung-Bum; Chung, Doo-Young; Cho, Yoonchul; Lee, EunJoo H.; Chang, Jong Wook; Cho, Dong-Hyung			Inhibition of Autophagy Suppresses Sertraline-Mediated Primary Ciliogenesis in Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							PRIMARY CILIA; ANTIDEPRESSANT SERTRALINE; CALCIUM; INTRAFLAGELLAR; HEDGEHOG; DISEASE; LINES; SIZE	Primary cilia are conserved cellular organelles that regulate diverse signaling pathways. Autophagy is a complex process of cellular degradation and recycling of cytoplasmic proteins and organelles, and plays an important role in cellular homeostasis. Despite its potential importance, the role of autophagy in ciliogenesis is largely unknown. In this study, we identified sertraline as a regulator of autophagy and ciliogenesis. Sertraline, a known antidepressant, induced the growth of cilia and blocked the disassembly of cilia in htRPE cells. Following treatment of sertraline, there was an increase in the number of cells with autophagic puncta and LC3 protein conversion. In addition, both a decrease of ATG5 expression and the treatment of an autophagy inhibitor resulted in the suppression of the sertraline-induced activation of autophagy in htRPE cells. Interestingly, we found that genetic and chemical inhibition of autophagy attenuated the growth of primary cilia in htRPE cells. Taken together, our results suggest that the inhibition of autophagy suppresses sertralineinduced ciliogenesis.	[Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Kang, Il-Hwan; Nam, Jung-Bum; Chung, Doo-Young; Cho, Yoonchul; Lee, EunJoo H.; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea; [Kim, Jae-Sung] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Chang, Jong Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Res Inst Future Med Stem Cell & Regenerat Med, Seoul, South Korea	Kyung Hee University; Korea Institute of Radiological & Medical Sciences; Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Res Inst Future Med Stem Cell & Regenerat Med, Seoul, South Korea.	jongwook.chang@samsung.com; dhcho@khu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1058361]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1058361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chien JM, 2011, HUM EXP TOXICOL, V30, P1635, DOI 10.1177/0960327110396523; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Daniel WA, 2006, EUR NEUROPSYCHOPHARM, V16, P580, DOI 10.1016/j.euroneuro.2006.01.004; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Grohol J., 2012, PSYCH CENTRAL; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang CJ, 2009, J RECEPT SIG TRANSD, V29, P342, DOI 10.3109/10799890903295135; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jo YK, 2011, BIOCHEM BIOPH RES CO, V404, P1039, DOI 10.1016/j.bbrc.2010.12.106; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kim ES, 2014, EXP DERMATOL, V23, P204, DOI 10.1111/exd.12337; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ohno Y, 2007, BRAIN RES, V1178, P44, DOI 10.1016/j.brainres.2007.08.018; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Reddy KK, 2008, PIGM CELL MELANOMA R, V21, P451, DOI 10.1111/j.1755-148X.2008.00481.x; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tang ZM, 2014, AUTOPHAGY, V10, P379, DOI 10.4161/auto.27346; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Taylor D, 2012, MAUDSLEY PRESCRIBING, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Wang GK, 2008, J MEMBRANE BIOL, V222, P79, DOI 10.1007/s00232-008-9103-y; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yuan SAL, 2012, P NATL ACAD SCI USA, V109, P2021, DOI 10.1073/pnas.1112834109	44	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118190	10.1371/journal.pone.0118190	http://dx.doi.org/10.1371/journal.pone.0118190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671433	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300087
J	Verissimo, P; Timenetsky, KT; Casalaspo, TJA; Goncalves, LHR; Yang, ASY; Eid, RC				Verissimo, Pedro; Timenetsky, Karina T.; Andre Casalaspo, Thaisa Juliana; Rodrigues Goncalves, Louise Helena; Yun Yang, Angela Shu; Eid, Raquel Caserta			High Prevalence of Respiratory Muscle Weakness in Hospitalized Acute Heart Failure Elderly Patients	PLOS ONE			English	Article							TASK-FORCE; DYSFUNCTION; EXERCISE; PRESSURES; STRENGTH; SOCIETY	Introduction Respiratory Muscle Weakness (RMW) has been defined when the maximum inspiratory pressure (MIP) is lower than 70% of the predictive value. The prevalence of RMW in chronic heart failure patients is 30 to 50%. So far there are no studies on the prevalence of RMW in acute heart failure (AHF) patients. Objectives Evaluate the prevalence of RMW in patients admitted because of AHF and the condition of respiratory muscle strength on discharge from the hospital. Methods Sixty-three patients had their MIP measured on two occasions: at the beginning of the hospital stay, after they had reached respiratory, hemodynamic and clinical stability and before discharge from the hospital. The apparatus and technique to measure MIP were adapted because of age-related limitations of the patients. Data on cardiac ejection fraction, ECG, brain natriuretic peptide (BNP) levels and on the use of noninvasive ventilation (NIV) were collected. Results The mean age of the 63 patients under study was 75 years. On admission the mean ejection fraction was 33% (95% CI: 31-35) and the BNP hormone median value was 726.5 pg/ml (range: 217 to 2283 pg/ml); 65% of the patients used NIV. The median value of MIP measured after clinical stabilization was -52.7 cmH2O (range: -20 to -120 cmH(2)O); 76% of the patients had MIP values below 70% of the predictive value. On discharge, after a median hospital stay of 11 days, the median MIP was -53.5 cmH(2)O (range:-20 to -150 cmH(2)O); 71% of the patients maintained their MIP values below 70% of the predictive value. The differences found were not statistically significant. Conclusion Elderly patients admitted with AHF may present a high prevalence of RMW on admission; this condition may be maintained at similar levels on discharge in a large percentage of these patients, even after clinical stabilization of the heart condition.	[Verissimo, Pedro] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; Hosp Israelita Albert Einstein, Coronary Care Unit, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Verissimo, P (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.	pedropbusp@yahoo.com.br						Bosnak-Guclu M, 2011, RESP MED, V105, P1671, DOI 10.1016/j.rmed.2011.05.001; Brower Roy G, 2009, Crit Care Med, V37, pS422, DOI 10.1097/CCM.0b013e3181b6e30a; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Callegaro CC, 2010, RESP PHYSIOL NEUROBI, V171, P31, DOI 10.1016/j.resp.2010.01.009; Caruso P, 1999, CHEST, V115, P1096, DOI 10.1378/chest.115.4.1096; Chiappa GR, 2008, J AM COLL CARDIOL, V51, P1663, DOI 10.1016/j.jacc.2007.12.045; Chung CJ, 2011, PHYSICIAN SPORTSMED, V39, P37, DOI 10.3810/psm.2011.11.1937; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Frankenstein L, 2009, EUR J CARDIOV PREV R, V16, P424, DOI 10.1097/HJR.0b013e3283030a7e; Gosker HR, 2000, AM J CLIN NUTR, V71, P1033; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Jonghe B, 2009, CRIT CARE MED, V37, P309; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; MARINI J J, 1986, Journal of Critical Care, V1, P32, DOI 10.1016/S0883-9441(86)80114-9; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Meyer FJ, 2001, CIRCULATION, V103, P2153; Montera MW, 2012, ARQ BRAS CARDIOL, V98; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; NISHIMURA Y, 1994, CHEST, V105, P355, DOI 10.1378/chest.105.2.355; OMLAND T, 2008, CRIT CARE MED, V36, P17; Ribeiro Jorge P, 2009, Curr Heart Fail Rep, V6, P95; RIBEIRO JP, 2012, REV BRAS FISIOTER, V16, P261, DOI DOI 10.1590/S1413-35552012005000034; Smart NA, 2013, INT J CARDIOL, V167, P1502, DOI 10.1016/j.ijcard.2012.04.029; Tzanis G, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-14; Winkelmann ER, 2009, AM HEART J, V158, DOI 10.1016/j.ahj.2009.09.005; Wohlgemuth M, 2003, EUR RESPIR J, V22, P1001, DOI 10.1183/09031936.03.00028103; Wong E, 2011, HEART LUNG CIRC, V20, P289, DOI 10.1016/j.hlc.2011.01.009; Yosef-Brauner O, 2015, CLIN RESPIR J, V9, P1, DOI 10.1111/crj.12091	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118218	10.1371/journal.pone.0118218	http://dx.doi.org/10.1371/journal.pone.0118218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671566	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300089
J	McDowell, KS; Zahid, S; Vadakkumpadan, F; Blauer, J; MacLeod, RS; Trayanova, NA				McDowell, Kathleen S.; Zahid, Sohail; Vadakkumpadan, Fijoy; Blauer, Joshua; MacLeod, Rob S.; Trayanova, Natalia A.			Virtual Electrophysiological Study of Atrial Fibrillation in Fibrotic Remodeling	PLOS ONE			English	Article							CATHETER ABLATION; SINUS RHYTHM; COMPUTATIONAL TECHNIQUES; CONVENTIONAL ABLATION; IMPULSE CONDUCTION; ROTOR MODULATION; CARDIAC TISSUE; WAVE DYNAMICS; FOCAL IMPULSE; FIBROSIS	Research has indicated that atrial fibrillation (AF) ablation failure is related to the presence of atrial fibrosis. However it remains unclear whether this information can be successfully used in predicting the optimal ablation targets for AF termination. We aimed to provide a proof-of-concept that patient-specific virtual electrophysiological study that combines i) atrial structure and fibrosis distribution from clinical MRI and ii) modeling of atrial electrophysiology, could be used to predict: (1) how fibrosis distribution determines the locations from which paced beats degrade into AF; (2) the dynamic behavior of persistent AF rotors; and (3) the optimal ablation targets in each patient. Four MRI-based patient-specific models of fibrotic left atria were generated, ranging in fibrosis amount. Virtual electrophysiological studies were performed in these models, and where AF was inducible, the dynamics of AF were used to determine the ablation locations that render AF non-inducible. In 2 of the 4 models patient-specific models AF was induced; in these models the distance between a given pacing location and the closest fibrotic region determined whether AF was inducible from that particular location, with only the mid-range distances resulting in arrhythmia. Phase singularities of persistent rotors were found to move within restricted regions of tissue, which were independent of the pacing location from which AF was induced. Electrophysiological sensitivity analysis demonstrated that these regions changed little with variations in electrophysiological parameters. Patient-specific distribution of fibrosis was thus found to be a critical component of AF initiation and maintenance. When the restricted regions encompassing the meander of the persistent phase singularities were modeled as ablation lesions, AF could no longer be induced. The study demonstrates that a patient-specific modeling approach to identify non-invasively AF ablation targets prior to the clinical procedure is feasible.	[McDowell, Kathleen S.; Zahid, Sohail; Vadakkumpadan, Fijoy; Trayanova, Natalia A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21202 USA; [Blauer, Joshua; MacLeod, Rob S.] Univ Utah, Sch Med, Comprehens Arrhythmia Res & Management Ctr, Salt Lake City, UT USA	Johns Hopkins University; Utah System of Higher Education; University of Utah	Trayanova, NA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21202 USA.	ntrayanova@jhu.edu		Trayanova, Natalia/0000-0002-8661-063X	National Institutes of Health (NIH) [PD1 HL123271]; U.S. National Science Foundation [NSF-OCI-108849]; NIH [P41 GM103545-14]; Center for Integrative Biomedical Computing (CIBC) at the University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL123271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103545, T32GM007057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative Biomedical Computing (CIBC) at the University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Director's Pioneer Award to N.T. (PD1 HL123271, "Virtual Electrophysiology Laboratory" and by American Heart Association Predoctoral Fellowship to K.M. This work was also supported in part by the U.S. National Science Foundation, grant NSF-OCI-108849. The authors also acknowledge support for image processing and model generation software from the Center for Integrative Biomedical Computing (CIBC) at the University of Utah, sponsored by NIH Grant P41 GM103545-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum N, 2011, J CARDIOVASC ELECTR, V22, P16, DOI 10.1111/j.1540-8167.2010.01876.x; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Arevalo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068872; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Atienza F, 2009, HEART RHYTHM, V6, P33, DOI 10.1016/j.hrthm.2008.10.024; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kohl P, 2014, J MOL CELL CARDIOL, V70, P37, DOI 10.1016/j.yjmcc.2013.12.024; Krueger MW, 2014, J ELECTROCARDIOL, V47, P324, DOI 10.1016/j.jelectrocard.2013.11.003; Krummen DE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1149, DOI 10.1161/CIRCEP.111.969022; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; Lardo AC, 2000, CIRCULATION, V102, P698, DOI 10.1161/01.CIR.102.6.698; Larson C, 2003, ANN BIOMED ENG, V31, P768, DOI 10.1114/1.1581289; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Maleckar MM, 2008, PROG BIOPHYS MOL BIO, V98, P161, DOI 10.1016/j.pbiomolbio.2009.01.010; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; McDowell KS, 2012, J ELECTROCARDIOL, V45, P640, DOI 10.1016/j.jelectrocard.2012.08.005; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; McGann C, 2014, CIRC-ARRHYTHMIA ELEC, V7, P23, DOI 10.1161/CIRCEP.113.000689; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2013, J AM COLL CARDIOL, V62, P138, DOI 10.1016/j.jacc.2013.03.021; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Plank G, 2008, HEART RHYTHM; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; Prassl AJ, 2009, IEEE T BIO-MED ENG, V56, P1318, DOI 10.1109/TBME.2009.2014243; Quinn TA, 2014, CIRCULATION, V130; Sanchez JE, 2003, J INTERV CARD ELECTR, V8, P9, DOI 10.1023/A:1022315308803; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tanner H, 2005, J AM COLL CARDIOL, V46, P338, DOI 10.1016/j.jacc.2005.03.063; Trayanova NA, 2014, CIRC RES, V114, P1516, DOI 10.1161/CIRCRESAHA.114.302240; Vadakkumpadan F, 2012, IEEE ENG MED BIO, P4067, DOI 10.1109/EMBC.2012.6346860; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Vigmond EJ, 2002, IEEE T BIO-MED ENG, V49, P1260, DOI 10.1109/TBME.2002.804597; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	46	89	90	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117110	10.1371/journal.pone.0117110	http://dx.doi.org/10.1371/journal.pone.0117110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692857	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500039
J	Pakpour, AH; Yekaninejad, MS; Pallich, G; Burri, A				Pakpour, Amir H.; Yekaninejad, Mir Saeed; Pallich, Gianandrea; Burri, Andrea			Using Ecological Momentary Assessment to Investigate Short-Term Variations in Sexual Functioning in a Sample of Peri-Menopausal Women from Iran	PLOS ONE			English	Article							INDEX FSFI; DYSFUNCTION; SATISFACTION; VALIDATION; DISTRESS; DESIRE; LOVE	The investigation of short-term changes in female sexual functioning has received little attention so far. The aims of the study were to gain empirical knowledge on within-subject and within- and across-variable fluctuations in women's sexual functioning over time. More specifically, to investigate the stability of women's self-reported sexual functioning and the moderating effects of contextual and interpersonal factors. A convenience sample of 206 women, recruited across eight Health care Clinics in Rasht, Iran. Ecological momentary assessment was used to examine fluctuations of sexual functioning over a six week period. A shortened version of the Female Sexual Function Index (FSFI) was applied to assess sexual functioning. Self-constructed questions were included to assess relationship satisfaction, partner's sexual performance and stress levels. Mixed linear two-level model analyses revealed a link between orgasm and relationship satisfaction (Beta = 0.125, P = 0.074) with this link varying significantly between women. Analyses further revealed a significant negative association between stress and all six domains of women's sexual functioning. Women not only reported differing levels of stress over the course of the assessment period, but further differed from each other in how much stress they experienced and how much this influenced their sexual response. Orgasm and sexual satisfaction were both significantly associated with all other domains of sexual function (P < 0.001). And finally, a link between partner performance and all domains of women's sexual functioning (P < 0.001) could be detected. Except for lubrication (P = 0.717), relationship satisfaction had a significant effect on all domains of the sexual response (P < 0.001). Overall, our findings support the new group of criteria introduced in the DSM-5, called "associated features" such as partner factors and relationship factors. Consideration of these criteria is important and necessary for clinicians when diagnosing FSD.	[Pakpour, Amir H.] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran; [Yekaninejad, Mir Saeed] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Pallich, Gianandrea; Burri, Andrea] Univ Zurich, Dept Psychol, Zurich, Switzerland	Qazvin University of Medical Sciences (QUMS); Tehran University of Medical Sciences; University of Zurich	Burri, A (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.	a.burri@psychologie.uzh.ch	Pakpour, Amir H./C-6160-2014; Yekaninejad, Mir Saeed/L-6752-2016	Pakpour, Amir H./0000-0002-8798-5345; Yekaninejad, Mir Saeed/0000-0003-3648-5276; Burri, Andrea/0000-0002-4705-3551	Qazvin University of Medical Sciences	Qazvin University of Medical Sciences	This study was funded by the Qazvin University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bancroft J, 2005, J ENDOCRINOL, V186, P411, DOI 10.1677/joe.1.06233; Bandura A., 1992, SELF EFFICACY THOUGH, P3; Bandura A., 1995, SELF EFFICACY CHANGI, P1, DOI DOI 10.1017/CBO9780511527692; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Basson R, 2004, J SEX MED, V1, P24, DOI 10.1111/j.1743-6109.2004.10105.x; Bodenmann G., 2007, PERS RELATIONSHIP, V14, P407, DOI [DOI 10.1016/J.CPR.2008.10.004, 10.1016/j.cpr.2008.10.004]; Brezsnyak M, 2004, J SEX MARITAL THER, V30, P199, DOI 10.1080/00926230490262393; Brunswick E, 1949, SYSTEMATIC REPRESENT; Burri A, 2011, PSYCHOL MED, V41, P2435, DOI 10.1017/S0033291711000493; Burri A, 2014, J SEX MED, V11, P2243, DOI 10.1111/jsm.12551; Burri A, 2013, ARCH SEX BEHAV, V42, P961, DOI 10.1007/s10508-013-0089-x; Burri A, 2011, J SEX MED, V8, P2420, DOI 10.1111/j.1743-6109.2011.02341.x; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; Cayan S, 2004, J SEX MARITAL THER, V30, P333, DOI 10.1080/00926230490465091; Ciocca G, 2015, INT J IMPOT RES, V27, P81, DOI 10.1038/ijir.2014.33; Clayton AH, 2007, J SEX MED, V4, P260, DOI 10.1111/j.1743-6109.2007.00609.x; Dennerstein L, 2005, J SEX MED, V2, P118, DOI 10.1111/j.1743-6109.2005.00128.x; Dunne MP, 2000, ARCH SEX BEHAV, V29, P549, DOI 10.1023/A:1002002420159; Elkin A, 1999, STRESS DUMMIES; Fakhri A, 2012, J SEX MED, V9, P514, DOI 10.1111/j.1743-6109.2011.02553.x; Guo BR, 2005, J SEX MARITAL THER, V31, P21, DOI 10.1080/00926230590475224; Hamilton LD, J SEX MARIT IN PRESS; Hamilton LD, 2013, J SEX MED, V10, P2443, DOI 10.1111/jsm.12249; Hartmann U, 2004, MENOPAUSE, V11, P726, DOI 10.1097/01.GME.0000143705.42486.33; Hendrick SS, 2002, J SOC PERS RELAT, V19, P361, DOI 10.1177/0265407502193004; Ishak WW., 2013, REPROD SYSTEM SEXUAL, V2, P122, DOI [10.4172/2161-038X.1000122, DOI 10.4172/2161-038X.1000122]; Isidori AM, 2010, J SEX MED, V7, P1139, DOI 10.1111/j.1743-6109.2009.01635.x; Littel RC, 1996, SAS SYSTEM MIXED MOD; Metz ME, 2002, J SEX MARITAL THER, V28, P139, DOI 10.1080/00926230252851889; Moskowitz DS, 2006, J PSYCHIATR NEUROSCI, V31, P13; Neustifter B, 2012, J APPL STAT, V39, P883, DOI 10.1080/02664763.2011.626848; Pettinger R, 2002, STRESS MANAGEMENT, VCapstone; Puts DA, 2012, ARCH SEX BEHAV, V41, P1127, DOI 10.1007/s10508-012-9967-x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Schmaling K., 2000, PSYCHOL COUPLES ILLN; Schnarch D., 1997, PASSIONATE MARRIAGE; Shiffman S., 2007, SCI REAL TIME DATA C, V1, P27; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sprecher S, 2002, J SEX RES, V39, P190, DOI 10.1080/00224490209552141; Witting K, 2008, J SEX MED, V5, P2587, DOI 10.1111/j.1743-6109.2008.00984.x	41	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117299	10.1371/journal.pone.0117299	http://dx.doi.org/10.1371/journal.pone.0117299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692787	Green Accepted, gold, Green Published			2022-12-27	WOS:000350061500048
J	Aluisio, AR; Maroof, Z; Chandramohan, D; Bruce, J; Masher, MI; Manaseki-Holland, S; Ensink, JHJ				Aluisio, Adam R.; Maroof, Zabihullah; Chandramohan, Daniel; Bruce, Jane; Masher, Mohammad I.; Manaseki-Holland, Semira; Ensink, Jeroen H. J.			Risk Factors Associated with Recurrent Diarrheal Illnesses among Children in Kabul, Afghanistan: A Prospective Cohort Study	PLOS ONE			English	Article							GLOBAL BURDEN; HYGIENE INTERVENTIONS; CHILDHOOD DIARRHEA; REDUCE DIARRHEA; DISEASE; PNEUMONIA; WATER; SUPPLEMENTATION; MALNUTRITION; INFECTIONS	Introduction Childhood diarrheal illnesses are a major public health problem. In low-income settings data on disease burden and factors associated with diarrheal illnesses are poorly defined, precluding effective prevention programs. This study explores factors associated with recurrent diarrheal illnesses among children in Kabul, Afghanistan. Methods A cohort of 1-11 month old infants was followed for 18 months from 2007-2009. Data on diarrheal episodes were gathered through active and passive surveillance. Information on child health, socioeconomics, water and sanitation, and hygiene behaviors was collected. Factors associated with recurrent diarrheal illnesses were analyzed using random effects recurrent events regression models. Results 3,045 children were enrolled and 2,511 (82%) completed 18-month follow-up. There were 14,998 episodes of diarrheal disease over 4,200 child-years (3.51 episodes/child-year, 95% CI 3.40-3.62). Risk of diarrheal illness during the winter season was 63% lower than the summer season (HR = 0.37, 95% CI 0.35-0.39, P < 0.001). Soap for hand washing was available in 72% of households and 11.9% had toilets with septic/canalization. Half of all mothers reported using soap for hand washing. In multivariate analysis diarrheal illness was lower among children born to mothers with post-primary education (aHR = 0.79, 95% CI 0.69-0.91, p = 0.001), from households where maternal hand washing with soap was reported (aHR = 0.83, 95% CI 0.74-0.92, p < 0.001) and with improved sanitation facilities (aHR = 0.76, 95% CI 0.63-0.93, p = 0.006). Malnourished children from impoverished households had significantly increased risks for recurrent disease [(aHR = 1.15, 95% CI 1.03-1.29, p = 0.016) and (aHR = 1.20, 95% CI 1.05-1.37, p = 0.006) respectively]. Conclusions Maternal hand washing and improved sanitation facilities were protective, and represent important prevention points among public health endeavors. The discrepancy between soap availability and utilization suggests barriers to access and knowledge, and programs simultaneously addressing these aspects would likely be beneficial. Enhanced maternal education and economic status were protective in this population and these findings support multi-sector interventions to combat illness.	[Aluisio, Adam R.; Maroof, Zabihullah; Chandramohan, Daniel; Bruce, Jane; Ensink, Jeroen H. J.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Aluisio, Adam R.] Suny Downstate Med Ctr, Div Int Emergency Med, Dept Emergency Med, Brooklyn, NY 11203 USA; [Masher, Mohammad I.] Kabul Med Univ, Dept Paediat, Kabul, Afghanistan; [Masher, Mohammad I.] Royal Manchester Childrens Hosp, Afghanistan Dept Pediat Endocrinol, Manchester M27 1HA, Lancs, England; [Manaseki-Holland, Semira] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Royal Manchester Children's Hospital; University of Birmingham	Ensink, JHJ (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	jeroen.ensink@lshtm.ac.uk	Manaseki-Holland, Semira/AFX-1728-2022; Aluisio, Adam/AGU-9179-2022; Manaseki-Holland, Semira/I-7303-2017	Manaseki-Holland, Semira/0000-0001-5827-8855; Manaseki-Holland, Semira/0000-0001-5827-8855	Wellcome Trust [082476/Z/07/Z]; Development Partnership in higher education [53]	Wellcome Trust(Wellcome Trust); Development Partnership in higher education	This study was funded by the Wellcome Trust (Grant reference 082476/Z/07/Z, http://wellcome.ac.uk/funding/index/htm) and the Development Partnership in higher education (grant reference code 53, http://www.britishcouncil.org/delphe/htm). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acerra JR, 2009, INT J EMERG MED, V2, P77, DOI 10.1007/s12245-009-0106-y; ALAM N, 1989, INT J EPIDEMIOL, V18, P697, DOI 10.1093/ije/18.3.697; Aluisio AR, 2013, PEDIATRICS, V132, pE832, DOI 10.1542/peds.2012-3986; [Anonymous], 2009, WHO CHILD GROWTH STA; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, PEDIATRICS, V131, P634, DOI 10.1542/peds.2012-3737; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Clasen TF, 2009, INTERVENTIONS TO IMP; Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Ejemot RI, 2009, HAND WASHING FOR PRE; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fielding JE, 2006, HEALTH AFFAIR, V25, P969, DOI 10.1377/hlthaff.25.4.969; Fischer Walker Christa L, 2012, BMC Public Health, V12, P220, DOI 10.1186/1471-2458-12-220; Fosgate GT, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-7; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hashizume M, 2008, EPIDEMIOL INFECT, V136, P1281, DOI 10.1017/S0950268807009776; Hausman AJ, 2002, AM J COMMUN PSYCHOL, V30, P453, DOI 10.1023/A:1015345321658; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Jousilahti P, 1997, PUBLIC HEALTH, V111, P5, DOI 10.1038/sj.ph.1900318; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kotloff KL, 2013, LANCET; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Lee G, 2010, ANN EPIDEMIOL, V20, P151, DOI 10.1016/j.annepidem.2009.10.004; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; MAHMUD A, 1993, ACTA PAEDIATR, V82, P79, DOI 10.1111/j.1651-2227.1993.tb12908.x; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Mashal T, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-301; Meddings DR, 2004, B WORLD HEALTH ORGAN, V82, P281; MORRIS SS, 1994, INT J EPIDEMIOL, V23, P617, DOI 10.1093/ije/23.3.617; Opryszko MC, 2010, J WATER HEALTH, V8, P687, DOI 10.2166/wh.2010.121; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel MM, 2013, PEDIATR INFECT DIS J, V32, pE134, DOI 10.1097/INF.0b013e31827d3b68; Pinera JF, 2009, DISASTERS, V33, P574, DOI 10.1111/j.1467-7717.2008.01088.x; Ramakrishnan R, 1998, Indian J Public Health, V42, P3; Ravallion M, 2009, WORLD BANK ECON REV, V23, P163, DOI 10.1093/wber/lhp007; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Siziya S, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-8; Thomsen JL, 2006, FAM PRACT, V23, P407, DOI 10.1093/fampra/cml012; UNICEF, 2009, DIARRHOEA WHY CHILDR; UNICEF WHO, 2013, END PREVENTABLE DEAT; United Nations Genarel Assembly, 2010, PLENARY 108TH MEETIN; Vikram K, 2012, SOC SCI MED, V75, P331, DOI 10.1016/j.socscimed.2012.02.043; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO/UNICEF, JOINT MONITORING PRO	49	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116342	10.1371/journal.pone.0116342	http://dx.doi.org/10.1371/journal.pone.0116342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679979	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000350682600018
J	Koshoji, NH; Bussadori, SK; Bortoletto, CC; Prates, RA; Oliveira, MT; Deana, AM				Koshoji, Nelson H.; Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.; Deana, Alessandro M.			Laser Speckle Imaging: A Novel Method for Detecting Dental Erosion	PLOS ONE			English	Article							ENAMEL	Erosion is a highly prevalent condition known as a non-carious lesion that causes progressive tooth wear due to chemical processes that do not involve the action of bacteria. Speckle images proved sensitive to even minimal mineral loss from the enamel. The aim of the present study was to investigate the use of laser speckle imaging analysis in the spatial domain to quantify shifts in the microstructure of the tooth surface in an erosion model. 32 fragments of the vestibular surface of bovine incisors were divided in for groups (10 min, 20 min. 30 min and 40 min of acid etching) immersed in a cola-based beverage (pH approximately 2.5) twice a day during 7 days to create an artificial erosion. By analyzing the laser speckle contrast map (LASCA) in the eroded region compared to the sound it was observed that the LASCA map shifts, proportionally to the acid each duration, by: 18%; 23%; 39% and 44% for the 10 min; 20 min; 30 min and 40 min groups, respectively. To the best of our knowledge, this is the first study to demonstrate the correlation between speckle patterns and erosion progression.	[Koshoji, Nelson H.; Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.; Deana, Alessandro M.] Nove de Julho Univ UNINOVE, Dept Biophoton, Sao Paulo, Brazil; [Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.] Nove de Julho Univ UNINOVE, Sch Dent, Sao Paulo, Brazil; [Deana, Alessandro M.] Nove de Julho Univ UNINOVE, Sch Informat Technol, Sao Paulo, Brazil; [Koshoji, Nelson H.] Nove de Julho Univ UNINOVE, Sch Engn, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade Nove de Julho; Universidade Nove de Julho	Deana, AM (corresponding author), Nove de Julho Univ UNINOVE, Dept Biophoton, Sao Paulo, Brazil.	amdeana@uninove.br	Oliveira, Marcelo T/C-9236-2011; Prates, Renato A/F-8235-2014; Deana, Alessandro M/K-4787-2012; Bussadori, Sandra/J-5458-2014	Oliveira, Marcelo T/0000-0002-3859-6933; Prates, Renato A/0000-0002-8115-9237; Bussadori, Sandra/0000-0002-9853-1138; Deana, Alessandro Melo/0000-0002-0014-6953				Amaechi BT, 2005, J DENT, V33, P243, DOI 10.1016/j.jdent.2004.10.014; Barron Robert P, 2003, J Can Dent Assoc, V69, P84; Bartlett D, 2013, J AM DENT ASS S1, V138, p21S; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Cheng ZJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015020; Deana AM, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/7/075607; Goodman, 1984, STAT PROPERTIES LASE; Grenby TH, 1669, EUROPEAN J ORAL SCI, V104, P207; Grippo JO, 2004, J AM DENT ASSOC, V135, P1109, DOI 10.14219/jada.archive.2004.0369; Jager DHJ, 2012, J DENT, V40, P1103, DOI 10.1016/j.jdent.2012.09.004; Koshoji NH, 2015, P SPIE IN PRESS; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; Murakami C, 2011, CARIES RES, V45, P121, DOI 10.1159/000324807; O'driscoll P, 1998, INT ENDOD J, P376; Scheutzel P, 1996, EUR J ORAL SCI, V104, P178, DOI 10.1111/j.1600-0722.1996.tb00066.x; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Uchino M, 2004, KEY ENG MAT, V261-263, P1581, DOI 10.4028/www.scientific.net/KEM.261-263.1581; West NX, 2001, J ORAL REHABIL, V28, P860, DOI 10.1046/j.1365-2842.2001.00778.x; Young A, 2011, CARIES RES, V45, P33, DOI 10.1159/000325943; Zero DT, 2005, INT DENT J, V55, P285; Zhou SL, 2012, J DENT, V40, P255, DOI 10.1016/j.jdent.2011.12.016	22	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118429	10.1371/journal.pone.0118429	http://dx.doi.org/10.1371/journal.pone.0118429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679807	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600122
J	Lu, SQ; Chen, SB; Mao, DB; Zhang, Y; Long, M				Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian			Contribution of the CR Domain to P-Selectin Lectin Domain Allostery by Regulating the Orientation of the EGF Domain	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CATCH BONDS; GLYCOPROTEIN LIGAND-1; MOLECULAR-DYNAMICS; CELL-ADHESION; FORCE; DISSOCIATION; FLOW; BINDING; PSGL-1	The allostery of P-selectin has been studied extensively with a focus on the Lec and EGF domains, whereas the contribution of the CR domain remains unclear. Here, molecular dynamics simulations (MDS) combined with homology modeling were preformed to investigate the impact of the CR domain on P-selectin allostery. The results indicated that the CR domain plays a role in the allosteric dynamics of P-selectin in two ways. First, the CR1 domain tends to stabilize the low affinity of P-selectin during the equilibration processes with the transition inhibition from the S1 to S1' state by restraining the extension of the bent EGF orientation, or with the relaxation acceleration of the S2 state by promoting the bending of the extended EGF orientation. Second, the existence of CR domain increases intramolecular extension prior to complex separation, increasing the time available for the allosteric shift during forced dissociation with a prolonged bond duration. These findings further our understanding of the structure-function relationship of P-selectin with the enriched microstructural bases of the CR domain.	[Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Lu, SQ (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China.	lsq@imech.ac.cn; mlong@imech.ac.cn			National Natural Science Foundation of China [31230027, 11372332]; National Key Basic Research Foundation of China [2011CB710904]; CAS Knowledge Innovation Program [KJCX2-YW-L08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); CAS Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China grants 31230027 and 11372332 http://www.nsfc.gov.cn/publish/portal1/); National Key Basic Research Foundation of China grant 2011CB710904 http://www.most.gov.cn/eng/); CAS Knowledge Innovation Program grant KJCX2-YW-L08 http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MOL OP ENV MOE; Chou KC, 1997, J PROTEIN CHEM, V16, P765, DOI 10.1023/A:1026363816730; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lu SQ, 2006, POLYMER, V47, P2539, DOI 10.1016/j.polymer.2005.11.095; Lue Shouqin, 2005, Molecular & Cellular Biomechanics, V2, P161; Lu SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015417; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Sun GY, 2009, EUR BIOPHYS J BIOPHY, V38, P701, DOI 10.1007/s00249-009-0428-y; Tu LL, 1996, J IMMUNOL, V157, P3995; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zhang Y, 2008, BIOPHYS J, V95, P5439, DOI 10.1529/biophysj.108.137141; Zhang Y, 2011, SCI CHINA PHYS MECH, V54, P923, DOI 10.1007/s11433-011-4302-4; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5; Zhu Cheng, 2005, Molecular & Cellular Biomechanics, V2, P91; Zhu C, 2014, ANN BIOMED ENG, V42, P388, DOI 10.1007/s10439-013-0904-5	37	4	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118083	10.1371/journal.pone.0118083	http://dx.doi.org/10.1371/journal.pone.0118083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675100	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000039
J	Blanchard, TC; Hayden, BY				Blanchard, Tommy C.; Hayden, Benjamin Y.			Monkeys Are More Patient in a Foraging Task than in a Standard Intertemporal Choice Task	PLOS ONE			English	Article							CAPUCHIN MONKEYS; REWARDS; PREFERENCES; HUMANS	Studies of animal impulsivity generally find steep subjective devaluation, or discounting, of delayed rewards - often on the order of a 50% reduction in value in a few seconds. Because such steep discounting is highly disfavored in evolutionary models of time preference, we hypothesize that discounting tasks provide a poor measure of animals' true time preferences. One prediction of this hypothesis is that estimates of time preferences based on these tasks will lack external validity, i.e. fail to predict time preferences in other contexts. We examined choices made by four rhesus monkeys in a computerized patch-leaving foraging task interleaved with a standard intertemporal choice task. Monkeys were significantly more patient in the foraging task than in the intertemporal choice task. Patch-leaving behavior was well fit by parameter-free optimal foraging equations but poorly fit by the hyperbolic discount parameter obtained from the intertemporal choice task. Day-to-day variation in time preferences across the two tasks was uncorrelated with each other. These data are consistent with the conjecture that seemingly impulsive behavior in animals is an artifact of their difficulty understanding the structure of intertemporal choice tasks, and support the idea that animals are more efficient rate maximizers in the multi-second range than intertemporal choice tasks would suggest.	[Blanchard, Tommy C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Blanchard, TC (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	blanchard.tommy@gmail.com			National Institutes of Health [R01 038106]; National Science Foundation [1253576]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institutes of Health (http://www.nih.gov/) R01 038106 to BYH, and National Science Foundation (http://www.nsf.gov/) CAREER Award 1253576 to BYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2013, J COMP PSYCHOL WASH, V127; Addessi E, 2014, COGNITION, V130, P428, DOI 10.1016/j.cognition.2013.11.019; Blanchard TC, 2014, J NEUROSCI, V34, P646, DOI 10.1523/JNEUROSCI.3151-13.2014; Blanchard TC, 2013, P NATL ACAD SCI USA, V110, P15491, DOI 10.1073/pnas.1310446110; Bramlett JL, 2012, ANIM COGN, V15, P963, DOI 10.1007/s10071-012-0522-x; Genty E, 2012, ANIM COGN, V15, P1161, DOI 10.1007/s10071-012-0540-8; GREEN L, 1994, PSYCHON B REV, V1, P383, DOI 10.3758/BF03213979; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Kacelnik A, 2003, TIME DECISION EC PSY; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Pavlic TP, 2010, BEHAV ECOL SOCIOBIOL, V64, P1255, DOI 10.1007/s00265-010-0940-1; Pearson JM, 2010, FRONT PSYCHOL, V1, DOI [10.3389/fpsyg.2011.00062, DOI 10.3389/FPSYG.2011.00062]; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Stephens DW, 2009, BEHAV PROCESS, V80, P252, DOI 10.1016/j.beproc.2008.11.014; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Stephens DW, 2004, P ROY SOC B-BIOL SCI, V271, P2459, DOI 10.1098/rspb.2004.2871; Stephens DW, 2003, ANIM BEHAV, V66, P59, DOI 10.1006/anbe.2003.2177; Stephens DW, 1987, FORAGING THEORY; Stevens JR, 2008, CURR BIOL, V18, pR11, DOI 10.1016/j.cub.2007.11.021	23	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117057	10.1371/journal.pone.0117057	http://dx.doi.org/10.1371/journal.pone.0117057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671436	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300031
J	Breitburg, DL; Hondorp, D; Audemard, C; Carnegie, RB; Burrell, RB; Trice, M; Clark, V				Breitburg, Denise L.; Hondorp, Darryl; Audemard, Corinne; Carnegie, Ryan B.; Burrell, Rebecca B.; Trice, Mark; Clark, Virginia			Landscape-Level Variation in Disease Susceptibility Related to Shallow-Water Hypoxia	PLOS ONE			English	Article							REAL-TIME PCR; PARASITE PERKINSUS-MARINUS; HYPERCAPNIC HYPOXIA; OYSTER POPULATIONS; DISSOLVED-OXYGEN; IMMUNE-RESPONSE; CHESAPEAKE BAY; DYNAMICS; ECOLOGY; STRESS	Diel-cycling hypoxia is widespread in shallow portions of estuaries and lagoons, especially in systems with high nutrient loads resulting from human activities. Far less is known about the effects of this form of hypoxia than deeper-water seasonal or persistent low dissolved oxygen. We examined field patterns of diel-cycling hypoxia and used field and laboratory experiments to test its effects on acquisition and progression of Perkinsus marinus infections in the eastern oyster, Crassostrea virginica, as well as on oyster growth and filtration. P. marinus infections cause the disease known as Dermo, have been responsible for declines in oyster populations, and have limited success of oyster restoration efforts. The severity of diel-cycling hypoxia varied among shallow monitored sites in Chesapeake Bay, and average daily minimum dissolved oxygen was positively correlated with average daily minimum pH. In both field and laboratory experiments, diel-cycling hypoxia increased acquisition and progression of infections, with stronger results found for younger (1-year-old) than older (2-3-year-old) oysters, and more pronounced effects on both infections and growth found in the field than in the laboratory. Filtration by oysters was reduced during brief periods of exposure to severe hypoxia. This should have reduced exposure to waterborne P. marinus, and contributed to the negative relationship found between hypoxia frequency and oyster growth. Negative effects of hypoxia on the host immune response is, therefore, the likely mechanism leading to elevated infections in oysters exposed to hypoxia relative to control treatments. Because there is considerable spatial variation in the frequency and severity of hypoxia, diel-cycling hypoxia may contribute to landscape-level spatial variation in disease dynamics within and among estuarine systems.	[Breitburg, Denise L.; Hondorp, Darryl; Burrell, Rebecca B.; Clark, Virginia] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Hondorp, Darryl] USGS Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA; [Audemard, Corinne; Carnegie, Ryan B.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Trice, Mark] Maryland Dept Nat Resources, Annapolis, MD 21401 USA	Smithsonian Institution; Smithsonian Environmental Research Center; United States Department of the Interior; United States Geological Survey; William & Mary; Virginia Institute of Marine Science	Breitburg, DL (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	breitburgd@si.edu			MD Sea Grant [SA7528085-CC]; Smithsonian Institution Johnson Fund; Smithsonian Women's Committee	MD Sea Grant; Smithsonian Institution Johnson Fund; Smithsonian Women's Committee	Research was funded by Award # SA7528085-CC from MD Sea Grant to DLB and CA, Smithsonian Institution Johnson Fund to DH, and Smithsonian Women's Committee funding to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RS, 1998, J FISH DIS, V21, P371, DOI 10.1046/j.1365-2761.1998.00128.x; Andrews J.D., 1988, American Fisheries Society Special Publication, V18, P47; Audemard C, 2006, PARASITOLOGY, V132, P827, DOI 10.1017/S0031182006009851; Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004; Baumann H, 2014, ESTUAR COAST, P1; Boyd JN, 1999, J EXP BIOL, V202, P3135; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; BREITBURG DL, 1995, MAR ECOL PROG SER, V125, P45, DOI 10.3354/meps125045; Burge CA, 2013, MICROB ECOL, V65, P869, DOI 10.1007/s00248-013-0190-7; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BURRESON E M, 1991, Journal of Shellfish Research, V10, P417; Burreson EM, 1996, J SHELLFISH RES, V15, P17; Bushek David, 1994, Annual Review of Fish Diseases, V4, P201, DOI 10.1016/0959-8030(94)90029-9; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Carnegie RB., 2013, STATUS MAJOR OYSTER; Cheng W, 2004, AQUACULTURE, V232, P103, DOI 10.1016/S0044-8486(03)00488-5; Clark V, 2014, CRASSOSTREA VIRGINIC; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; DAVANZO C, 1994, ESTUARIES, V17, P131, DOI 10.2307/1352562; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliot P, 2000, SPATIAL EPIDEMIOLOGY; Ford SE, 2012, J MAR RES, V70, P253, DOI 10.1357/002224012802851850; Gauthier JD, 2006, J SHELLFISH RES, V25, P619, DOI 10.2983/0730-8000(2006)25[619:TMRPAT]2.0.CO;2; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Holman JD, 2004, BIOL BULL-US, V206, P188, DOI 10.2307/1543642; Johnson PTJ, 2010, ECOL APPL, V20, P16, DOI 10.1890/08-0633.1; Johnson Pieter T. J., 2008, P71; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Kennedy VS, 2011, J SHELLFISH RES, V30, P719, DOI 10.2983/035.030.0312; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Le Moullac G, 1998, FISH SHELLFISH IMMUN, V8, P621, DOI 10.1006/fsim.1998.0166; Macey BM, 2008, APPL ENVIRON MICROB, V74, P6077, DOI 10.1128/AEM.00317-08; MACKIN JOHN G., 1961, PUBL INST MAR SCI [PORT ARANSAS TEXAS], V7, P132; McCallum Hamish, 2008, P100; McKenzie VJ, 2007, ECOHEALTH, V4, P384, DOI 10.1007/s10393-007-0131-3; Mikulski CM, 2000, J SHELLFISH RES, V19, P301; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Newell RIE, 2007, MAR ECOL PROG SER, V341, P293, DOI 10.3354/meps341293; PAYNTER K T, 1991, Journal of Shellfish Research, V10, P425; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Qiu RJ, 2011, AQUACULT INT, V19, P283, DOI 10.1007/s10499-010-9390-z; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Ray S.M., 1966, P NATL SHELLFISH ASS, V54, P55, DOI DOI 10.2983/0730-8000(2006)25; Reiskind MH, 2004, J MED ENTOMOL, V41, P650, DOI 10.1603/0022-2585-41.4.650; Robohm RA, 2005, J SHELLFISH RES, V24, P773; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Sanford E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2681; Scholnick DA, 2012, BIOL BULL-US, V222, P56, DOI 10.1086/BBLv222n1p56; Soniat TM, 2006, J SHELLFISH RES, V25, P83, DOI 10.2983/0730-8000(2006)25[83:UTSAFO]2.0.CO;2; Tarnowski M, 2007, MARYLAND OYSTER POPU; Tyler RM, 2009, ESTUAR COAST, V32, P123, DOI 10.1007/s12237-008-9108-x; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wang YJ, 2012, AQUACULTURE, V356, P22, DOI 10.1016/j.aquaculture.2012.06.001; Wenner E, 2004, J COASTAL RES, P17, DOI 10.2112/SI45-017.1; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161; Yarnall HA, 2009, QUANTITATIVE COMPETI; Zhang J, 2010, BIOGEOSCIENCES, V7, DOI [10.5194/bg-7-1413-2010, DOI 10.5194/BG-7-1413-2010]	62	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116223	10.1371/journal.pone.0116223	http://dx.doi.org/10.1371/journal.pone.0116223			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671595	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300018
J	Kramer, R; Sauer-Heilborn, A; Welte, T; Jauregui, R; Brettar, I; Guzman, CA; Hofle, MG				Kramer, Rolf; Sauer-Heilborn, Annette; Welte, Tobias; Jauregui, Ruy; Brettar, Ingrid; Guzman, Carlos A.; Hoefle, Manfred G.			High Individuality of Respiratory Bacterial Communities in a Large Cohort of Adult Cystic Fibrosis Patients under Continuous Antibiotic Treatment	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ANAEROBIC-BACTERIA; DIVERSITY; LUNG; INFECTIONS; DNA; IDENTIFICATION; PATHOGENESIS; ADAPTATION; STANDARDS	Background Routine clinical diagnostics of CF patients focus only on a restricted set of well-known pathogenic species. Recent molecular studies suggest that infections could be polymicrobial with many bacteria not detected by culture-based diagnostics. Methodology and Principal Findings A large cohort of 56 adults with continuous antibiotic treatment was studied and different microbial diagnostic methods were compared, including culture-independent and culture-based bacterial diagnostics. A total of 72 sputum samples including longitudinal observations was analysed by 16S rRNA gene sequence comparison. Prevalence of known pathogens was highly similar among all methods but the vast spectrum of bacteria associated with CF was only revealed by culture-independent techniques. The sequence comparison enabled confident determination of the bacterial community composition and revealed a high diversity and individuality in the communities across the cohort. Results of microbiological analyses were further compared with individual host factors, such as age, lung function and CFTR genotype. No statistical relationship between these factors and the diversity of the entire community or single bacterial species could be identified. However, patients with non-Delta F508 mutations in the CFTR gene often had low abundances of Pseudomonas aeruginosa. Persistence of specific bacteria in some communities was demonstrated by longitudinal analyses of 13 patients indicating a potential clinical relevance of anaerobic bacteria, such as Fusobacterium nucleatum and Streptococcus millerii. Conclusions The high individuality in community composition and the lack of correlation to clinical host factors might be due to the continuous treatment with antibiotics. Since this is current practice for adult CF patients, the life-long history of the patient and the varying selection pressure on the related microbial communities should be a focus of future studies and its relation to disease progression. These studies should be substantially larger, providing more molecular information on the microbial communities complemented by detailed genetic assessment of the host.	[Kramer, Rolf; Brettar, Ingrid; Guzman, Carlos A.; Hoefle, Manfred G.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Sauer-Heilborn, Annette; Welte, Tobias] Hannover Med Sch, Dept Pneumol, Hannover, Germany; [Jauregui, Ruy] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Welte, Tobias] German Ctr Infect Res, Hannover, Germany; [Welte, Tobias] German Ctr Lung Res, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research	Hofle, MG (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	manfred.hoefle@helmholtz-hzi.de		Jauregui, Ruy/0000-0002-3484-8937; Kramer, Rolf/0000-0002-6095-4338				Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Castellani C, 2014, J CYST FIBROS, V13, pS1, DOI 10.1016/j.jcf.2014.03.008; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cystic Fibrosis Foundation Patient Registry, 2012, 2011 ANN DAT REP; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hogardt M, 2006, MIQ 24 AT MUK QUAL M; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Jones AM, 2011, THORAX, V66, P558, DOI 10.1136/thx.2010.157875; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meyer M, 2010, COLD SPRING HARB PRO, DOI [DOI 10.1101/PDB.PR0T5448, 10.1101/pdb.prot5448]; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	50	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117436	10.1371/journal.pone.0117436	http://dx.doi.org/10.1371/journal.pone.0117436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671713	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300053
J	Ligasova, A; Strunin, D; Friedecky, D; Adam, T; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Friedecky, David; Adam, Tomas; Koberna, Karel			A Fatal Combination: A Thymidylate Synthase Inhibitor with DNA Damaging Activity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; IN-VIVO; 5-FLUOROURACIL; CANCER; EDU; QUANTITATION; REPLICATION; SYNTHETASE	2'-deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 mu M EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.	[Ligasova, Anna; Strunin, Dmytro; Friedecky, David; Adam, Tomas; Koberna, Karel] Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77900, Czech Republic	Palacky University Olomouc	Ligasova, A (corresponding author), Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77900, Czech Republic.	anna.ligasova@upol.cz	KOBERNA, Karel/G-5551-2019; Ligasová, Anna/P-5460-2015; FRIEDECKÝ, David/AAR-5649-2021	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768; Adam, Tomas/0000-0003-4317-4708; Friedecky, David/0000-0002-3448-9073	Technology Agency of the Czech Republic [TA03010598, TA03010719, TE02000058]; Ministry of Education, Youth and Sports [LO1304]	Technology Agency of the Czech Republic; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010598, TA03010719 and TE02000058] and the Ministry of Education, Youth and Sports [LO1304]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bradford JA., 2011, CURR PROTOC CYTOM; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; de Groot T, 2014, J AM SOC NEPHROL, V25, P501, DOI 10.1681/ASN.2013090988; Debiak M, 2011, TOXICOLOGY, V280, P53, DOI 10.1016/j.tox.2010.11.007; DECLERCQ E, 1978, MOL PHARMACOL, V14, P422; DECLERCQ E, 1980, J INFECT DIS, V141, P563, DOI 10.1093/infdis/141.5.563; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dornfeld K, 2005, NUCLEIC ACIDS RES, V33, P6644, DOI 10.1093/nar/gki975; Freshney RI, 2005, CULTURE ANIMAL CELLS, P365; Hua H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr063; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; MILANESI G, 1984, MOL CELL BIOL, V4, P1551, DOI 10.1128/MCB.4.8.1551; Palmeira CA, 2008, ANTICANCER RES, V28, P443; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; van Laar JAM, 1998, EUR J CANCER, V34, P296, DOI 10.1016/S0959-8049(97)00366-3; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	36	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117459	10.1371/journal.pone.0117459	http://dx.doi.org/10.1371/journal.pone.0117459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671308	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300054
J	Nogueira, NP; Saraiva, FMS; Sultano, PE; Cunha, PRBB; Laranja, GAT; Justo, GA; Sabino, KCC; Coelho, MGP; Rossini, A; Atella, GC; Paes, MC				Nogueira, Natalia P.; Saraiva, Francis M. S.; Sultano, Pedro E.; Cunha, Paula R. B. B.; Laranja, Gustavo A. T.; Justo, Graca A.; Sabino, Katia C. C.; Coelho, Marsen G. P.; Rossini, Ana; Atella, Georgia C.; Paes, Marcia C.			Proliferation and Differentiation of Trypanosoma cruzi inside Its Vector Have a New Trigger: Redox Status	PLOS ONE			English	Article							METACYCLIC TRYPOMASTIGOTES; BLOODSUCKING INSECT; XANTHURENIC ACID; GROWTH; BLOOD; IDENTIFICATION; AZADIRACHTIN; MECHANISM; CYCLE; DNA	Trypanosoma cruzi proliferate and differentiate inside different compartments of triatomines gut that is the first environment encountered by T. cruzi. Due to its complex life cycle, the parasite is constantly exposed to reactive oxygen species (ROS). We tested the influence of the pro-oxidant molecules H2O2 and the superoxide generator, Paraquat, as well as, metabolism products of the vector, with distinct redox status, in the proliferation and metacyclogenesis. These molecules are heme, hemozoin and urate. We also tested the antioxidants NAC and GSH. Heme induced the proliferation of epimastigotes and impaired the metacyclogenesis. beta-hematin, did not affect epimastigote proliferation but decreased parasite differentiation. Conversely, we show that urate, GSH and NAC dramatically impaired epimastigote proliferation and during metacyclogenesis, NAC and urate induced a significant increment of trypomastigotes and decreased the percentage of epimastigotes. We also quantified the parasite loads in the anterior and posterior midguts and in the rectum of the vector by qPCR. The treatment with the antioxidants increased the parasite loads in all midgut sections analyzed. In vivo, the group of vectors fed with reduced molecules showed an increment of trypomastigotes and decreased epimastigotes when analyzed by differential counting. Heme stimulated proliferation by increasing the cell number in the S and G2/M phases, whereas NAC arrested epimastigotes in G1 phase. NAC greatly increased the percentage of trypomastigotes. Taken together, these data show a shift in the triatomine gut microenvironment caused by the redox status may also influence T. cruzi biology inside the vector. In this scenario, oxidants act to turn on epimastigote proliferation while antioxidants seem to switch the cycle towards metacyclogenesis. This is a new insight that defines a key role for redox metabolism in governing the parasitic life cycle.	[Nogueira, Natalia P.; Saraiva, Francis M. S.; Sultano, Pedro E.; Laranja, Gustavo A. T.; Paes, Marcia C.] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Interacao Tripanossomatideos & Vetores, Rio De Janeiro, Brazil; [Atella, Georgia C.; Paes, Marcia C.] INCT EM, Rio De Janeiro, Brazil; [Cunha, Paula R. B. B.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis IBqM, Lab Bioquim Lipideos & Lipoprot, Rio de Janeiro, Brazil; [Justo, Graca A.; Sabino, Katia C. C.; Coelho, Marsen G. P.] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Imunol Aplicada Bioquim Prot & Prod Nat, Rio De Janeiro, Brazil; [Rossini, Ana] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Toxicol & Biol Mol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Paes, MC (corresponding author), Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Interacao Tripanossomatideos & Vetores, Rio De Janeiro, Brazil.	mcpaes@uerj.br	Coelho, M.G.P./AAR-8546-2021; Atella, Georgia/AAK-7897-2020; PAES, MARCIA CRISTINA/AAL-9530-2021	Coelho, M.G.P./0000-0002-8945-7415; Saraiva, Francis/0000-0002-6744-3549; Bittencourt-Cunha, Paula/0000-0002-3913-1441; Pereira de Almeida Nogueira, Natalia/0000-0003-3258-607X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)	The funders, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROHER FJ, 1988, CELL DIFFER DEV, V22, P165, DOI 10.1016/0045-6039(88)90029-2; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Caldas S, 2012, ACTA TROP, V123, P170, DOI 10.1016/j.actatropica.2012.05.002; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cortez MR, 2012, EXP PARASITOL, V131, P363, DOI 10.1016/j.exppara.2012.05.005; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; Echevarria M, 2001, PFLUG ARCH EUR J PHY, V442, P27, DOI 10.1007/s004240000494; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Garcia E.S, 1975, ACAD BRAS CIENC, V47, P539; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GARCIA ES, 1982, AM J TROP MED HYG, V31, P259, DOI 10.4269/ajtmh.1982.31.259; GONZALEZ MS, 1992, J INVERTEBR PATHOL, V60, P201, DOI 10.1016/0022-2011(92)90098-O; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Kollien AH, 1997, PARASITOL RES, V83, P781, DOI 10.1007/s004360050339; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; KRASSNER SM, 1990, J PROTOZOOL, V37, P128, DOI 10.1111/j.1550-7408.1990.tb05882.x; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Martins C, 2008, MOL BIOCHEM PARASIT, V160, P60, DOI 10.1016/j.molbiopara.2008.03.004; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; OSUNA A, 1990, CELL DIFFER DEV, V30, P89, DOI 10.1016/0922-3371(90)90077-A; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SCHAUB GA, 1988, EXP PARASITOL, V65, P174, DOI 10.1016/0014-4894(88)90121-X; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Sekharam M, 1998, TOXICOL APPL PHARM, V149, P210, DOI 10.1006/taap.1997.8361; Souza CF, 2009, BIOCHEM BIOPH RES CO, V390, P541, DOI 10.1016/j.bbrc.2009.09.135; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; UCROS H, 1983, ACTA TROP, V40, P105; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907; Wigglesworth VB, 1931, J EXP BIOL, V8, P443	51	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116712	10.1371/journal.pone.0116712	http://dx.doi.org/10.1371/journal.pone.0116712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671543	Green Submitted, Green Published			2022-12-27	WOS:000349545300024
J	Shanmugam, M; Li, D; Gao, SM; Fefelova, N; Shah, V; Voit, A; Pachon, R; Yehia, G; Xie, LH; Babu, GJ				Shanmugam, Mayilvahanan; Li, Dan; Gao, Shumin; Fefelova, Nadezhda; Shah, Vikas; Voit, Antanina; Pachon, Ronald; Yehia, Ghassan; Xie, Lai-Hua; Babu, Gopal J.			Cardiac Specific Expression of Threonine 5 to Alanine Mutant Sarcolipin Results in Structural Remodeling and Diastolic Dysfunction	PLOS ONE			English	Article							RETICULUM CALCIUM-TRANSPORT; PROTEASOME INHIBITION; VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; PRESSURE-OVERLOAD; ATPASE SERCA; OVEREXPRESSION; PHOSPHOLAMBAN; CONTRACTILITY	The functional importance of threonine 5 (T5) in modulating the activity of sarcolipin (SLN), a key regulator of sarco/endoplasmic reticulum (SR) Ca2+ ATPase (SERCA) pump was studied using a transgenic mouse model with cardiac specific expression of threonine 5 to alanine mutant SLN (SLNT5A). In these transgenic mice, the SLNT5A protein replaces the endogenous SLN in atria, while maintaining the total SLN content. The cardiac specific expression of SLNT5A results in severe cardiac structural remodeling accompanied by bi-atrial enlargement. Biochemical analyses reveal a selective downregulation of SR Ca2+ handling proteins and a reduced SR Ca2+ uptake both in atria and in the ventricles. Optical mapping analysis shows slower action potential propagation in the transgenic mice atria. Doppler echocardiography and hemodynamic measurements demonstrate a reduced atrial contractility and an impaired diastolic function. Together, these findings suggest that threonine 5 plays an important role in modulating SLN function in the heart. Furthermore, our studies suggest that alteration in SLN function can cause abnormal Ca2+ handling and subsequent cardiac remodeling and dysfunction.	[Shanmugam, Mayilvahanan; Li, Dan; Gao, Shumin; Fefelova, Nadezhda; Shah, Vikas; Voit, Antanina; Pachon, Ronald; Yehia, Ghassan; Xie, Lai-Hua; Babu, Gopal J.] Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Babu, GJ (corresponding author), Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA.	babugo@njms.rutgers.edu	Babu, Gopal/AAB-7787-2021	Babu, Gopal/0000-0001-7833-5300	Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ	Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ	This work was supported by the funds from the Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ (to GJB).	Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Depre C, 2010, CARDIOVASC RES, V85, P251, DOI 10.1093/cvr/cvp362; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Gladden JD, 2013, AM J PHYSIOL-HEART C, V305, pH1440, DOI 10.1152/ajpheart.00007.2013; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; Hedhli N, 2010, CARDIOVASC RES, V85, P321, DOI 10.1093/cvr/cvp226; Hong CS, 2008, J MOL CELL CARDIOL, V44, P672, DOI 10.1016/j.yjmcc.2008.01.012; Huang SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1298, DOI 10.1152/ajpheart.00765.2007; Kadambi VJ, 1998, J MOL CELL CARDIOL, V30, P1275, DOI 10.1006/jmcc.1998.0688; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Stansfield WE, 2008, AM J PHYSIOL-HEART C, V294, pH645, DOI 10.1152/ajpheart.00196.2007; Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049; Uemura N, 2004, EUR J CLIN INVEST, V34, P723, DOI 10.1111/j.1365-2362.2004.01422.x; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Xie LH, 2012, AM J PHYSIOL-CELL PH, V302, pC1762, DOI 10.1152/ajpcell.00425.2011; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309; Yu XC, 2009, CURR OPIN PHARMACOL, V9, P167, DOI 10.1016/j.coph.2008.11.005; Zheng JY, 2014, CIRC-HEART FAIL, V7, P194, DOI 10.1161/CIRCHEARTFAILURE.113.000519; Zheng Q, 2010, PANMINERVA MED, V52, P9	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115822	10.1371/journal.pone.0115822	http://dx.doi.org/10.1371/journal.pone.0115822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671318	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300014
J	Tsukahara, K; Kubota, A; Hasegawa, Y; Takemura, H; Terada, T; Taguchi, T; Nagahara, K; Nakatani, H; Yoshino, K; Higaki, Y; Iwae, S; Beppu, T; Hanamure, Y; Tomita, K; Kohno, N; Kawabata, K; Fukushima, M; Teramukai, S; Fujii, M				Tsukahara, Kiyoaki; Kubota, Akira; Hasegawa, Yasuhisa; Takemura, Hideki; Terada, Tomonori; Taguchi, Takahide; Nagahara, Kunihiko; Nakatani, Hiroaki; Yoshino, Kunitoshi; Higaki, Yuichiro; Iwae, Shigemichi; Beppu, Takeshi; Hanamure, Yutaka; Tomita, Kichinobu; Kohno, Naoyuki; Kawabata, Kazuyoshi; Fukushima, Masanori; Teramukai, Satoshi; Fujii, Masato		ACTS-HNC Grp	Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC)	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; CONCURRENT CHEMORADIOTHERAPY; CONCOMITANT CHEMOTHERAPY; RADIATION-THERAPY; GASTRIC-CANCER; 5-FLUOROURACIL; RADIOTHERAPY; URACIL	Background We conducted a phase III study to evaluate S-1 as compared with UFT as control in patients after curative therapy for stage III, IVA, or IVB squamous-cell carcinoma of the head and neck (SCCHN). Patients and Methods Patients were randomly assigned to the UFT group (300 or 400 mg day(-1) for 1 year) or the S-1 group (80, 100, or 120 mg day(-1) for 1 year). The primary end point was disease-free survival (DFS). Secondary end points were relapse-free survival, overall survival (OS), and safety. Results A total of 526 patients were enrolled, and 505 were eligible for analysis. The 3-year DFS rate was 60.0% in the UFT group and 64.1% in the S-1 group (HR, 0.87; 95% CI, 0.66-1.16; p = 0.34). The 3-year OS rate was 75.8% and 82.9%, respectively (HR, 0.64; 95% CI, 0.44-0.94; p = 0.022). Among grade 3 or higher adverse events, the incidences of leukopenia (5.2%), neutropenia (3.6%), thrombocytopenia (2.0%), and mucositis/stomatitis (2.4%) were significantly higher in the S-1 group. Conclusions Although DFS did not differ significantly between the groups, OS was significantly better in the S-1 group than in the UFT group. S-1 is considered a treatment option after curative therapy for stage III, IVA, IVB SCCHN.	[Tsukahara, Kiyoaki] Tokyo Med Univ Hachioji Med Ctr, Dept Otolaryngol Head & Neck Surg, Hachioji, Tokyo, Japan; [Kubota, Akira] Kanagawa Canc Ctr, Dept Head & Neck Surg, Yokohama, Kanagawa 2410815, Japan; [Hasegawa, Yasuhisa] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Takemura, Hideki] Yokohama Rosai Hosp, Dept Otolaryngol, Yokohama, Kanagawa, Japan; [Terada, Tomonori] Hyogo Coll Med, Dept Otolaryngol, Nishinomiya, Hyogo 6638501, Japan; [Taguchi, Takahide] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Nagahara, Kunihiko] Kusatsu Gen Hosp, Dept Head & Neck Surg, Kusatsu, Japan; [Nakatani, Hiroaki] Natl Hosp Org Fukuyama Med Ctr, Dept Otolaryngol Head & Neck Surg, Fukuyama, Hiroshima, Japan; [Yoshino, Kunitoshi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Higaki, Yuichiro] Natl Hosp Org Kyushu Canc Ctr, Dept Head & Neck Surg, Fukuoka, Japan; [Iwae, Shigemichi] Hyogo Canc Ctr, Dept Head & Neck Surg, Akashi, Hyogo, Japan; [Beppu, Takeshi] Saitama Canc Ctr, Dept Head & Neck Surg, Saitama, Japan; [Hanamure, Yutaka] Kagoshima City Hosp, Dept Otolaryngol, Kagoshima, Japan; [Tomita, Kichinobu] Akasaka Surge Clin, Dept Otolaryngol, Fukuoka, Japan; [Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 181, Japan; [Kawabata, Kazuyoshi] Canc Inst Hosp, Div Head & Neck Surg, Tokyo, Japan; [Fukushima, Masanori] Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Teramukai, Satoshi] Kanazawa Univ Hosp, Innovat Clin Res Ctr, Kanazawa, Ishikawa, Japan; [Fujii, Masato] Natl Hosp Org Tokyo Med Ctr, Dept Otolaryngol, Tokyo, Japan	Tokyo Medical University; Kanagawa Prefectural Cancer Center; Aichi Cancer Center; Yokohama Rosai Hospital; Hyogo College of Medicine; Yokohama City University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kyushu Cancer Center; Hyogo Cancer Center; Kagoshima City Hospital; Kyorin University; Japanese Foundation for Cancer Research; Kanazawa University	Fujii, M (corresponding author), Natl Hosp Org Tokyo Med Ctr, Dept Otolaryngol, Tokyo, Japan.	fujiimasato@kankakuki.go.jp	Teramukai, Satoshi/I-2249-2019	Teramukai, Satoshi/0000-0003-2184-0597	Foundation for Biomedical Research and Innovation, Translational Research Informatics Center; Taiho Pharmaceutical Co., Ltd., Japan	Foundation for Biomedical Research and Innovation, Translational Research Informatics Center; Taiho Pharmaceutical Co., Ltd., Japan	This study was sponsored by the 'Foundation for Biomedical Research and Innovation, Translational Research Informatics Center,' with funding from Taiho Pharmaceutical Co., Ltd., Japan (http://www.taiho.co.jp/english/) under the study contract. The funding source of the study participated in study design, but had no role in data collection, data management, data analysis, and data interpretation. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Diasio RB, 1999, ONCOLOGY-NY, V13, P17; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; FUJII S, 1979, GANN, V70, P209; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Haddad R, 2013, LANCET ONCOL, V14, P257, DOI 10.1016/S1470-2045(13)70011-1; Hitt R, 2014, ANN ONCOL, V25, P216, DOI 10.1093/annonc/mdt461; Ho DH, 1998, CLIN CANCER RES, V4, P2085; Inuyama Y, 2001, Gan To Kagaku Ryoho, V28, P1381; Inuyama Y, 1998, Gan To Kagaku Ryoho, V25, P1151; Japan Society for Head and Neck Cancer, 2013, PRACT GUID HEAD NECK; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705, DOI 10.1016/0360-3016(92)90642-U; Leon X, 2005, CLIN ONCOL-UK, V17, P418, DOI 10.1016/j.clon.2005.02.014; National Comprehensive Cancer Network (NCCN), 2013, NCCN GUID HEAD NECK; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; TATSUMI K, 1987, JPN J CANCER RES, V78, P748; Tsukuda M, 2005, BRIT J CANCER, V93, P884, DOI 10.1038/sj.bjc.6602804; Tsukuda M, 2000, ONCOLOGY-NY, V14, P93; Uesaka K, 2013, J CLIN ONCOL S145, V31	27	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116965	10.1371/journal.pone.0116965	http://dx.doi.org/10.1371/journal.pone.0116965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671770	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300029
J	Machulska, A; Zlomuzica, A; Adolph, D; Rinck, M; Margraf, J				Machulska, Alla; Zlomuzica, Armin; Adolph, Dirk; Rinck, Mike; Margraf, Juergen			"A Cigarette a Day Keeps the Goodies Away": Smokers Show Automatic Approach Tendencies for Smoking-But Not for Food-Related Stimuli	PLOS ONE			English	Article							INCENTIVE-SENSITIZATION THEORY; APPROACH-BIAS; ADDICTION; CUES; ALCOHOL; DYSREGULATION; NONSMOKERS; DEPENDENCE; BEHAVIORS; RESPONSES	Smoking leads to the development of automatic tendencies that promote approach behavior toward smoking-related stimuli which in turn may maintain addictive behavior. The present study examined whether automatic approach tendencies toward smoking-related stimuli can be measured by using an adapted version of the Approach-Avoidance Task (AAT). Given that progression of addictive behavior has been associated with a decreased reactivity of the brain reward system for stimuli signaling natural rewards, we also used the AAT to measure approach behavior toward natural rewarding stimuli in smokers. During the AAT, 92 smokers and 51 non-smokers viewed smoking-related vs. non-smoking-related pictures and pictures of natural rewards (i.e. highly palatable food) vs. neutral pictures. They were instructed to ignore image content and to respond to picture orientation by either pulling or pushing a joystick. Within-group comparisons revealed that smokers showed an automatic approach bias exclusively for smoking-related pictures. Contrary to our expectations, there was no difference in smokers' and non-smokers' approach bias for nicotine-related stimuli, indicating that non-smokers also showed approach tendencies for this picture category. Yet, in contrast to non-smokers, smokers did not show an approach bias for food-related pictures. Moreover, self-reported smoking attitude could not predict approach-avoidance behavior toward nicotine-related pictures in smokers or non-smokers. Our findings indicate that the AAT is suited for measuring smoking-related approach tendencies in smokers. Furthermore, we provide evidence for a diminished approach tendency toward food-related stimuli in smokers, suggesting a decreased sensitivity to natural rewards in the course of nicotine addiction. Our results indicate that in contrast to similar studies conducted in alcohol, cannabis and heroin users, the AAT might only be partially suited for measuring smoking-related approach tendencies in smokers. Nevertheless, our findings are of special importance for current etiological models and smoking cessation programs aimed at modifying nicotine-related approach tendencies in the context of a nicotine addiction.	[Machulska, Alla; Zlomuzica, Armin; Adolph, Dirk; Rinck, Mike; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Univ Str 150, Bochum, Germany; [Rinck, Mike] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Ruhr University Bochum; Radboud University Nijmegen	Margraf, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Univ Str 150, Bochum, Germany.	juergen.margraf@rub.de	Margraf, Jürgen/A-6873-2008; Rinck, Mike/A-6944-2010	Margraf, Jürgen/0000-0001-5207-7016; Machulska, Alla/0000-0001-5968-429X	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This study was funded by a research grant to Jurgen Margraf by the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/web/start.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley BP, 2008, J PSYCHOPHARMACOL, V22, P737, DOI 10.1177/0269881107083844; Cousijn J, 2011, ADDICTION, V106, P1667, DOI 10.1111/j.1360-0443.2011.03475.x; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; De Houwer J, 2003, PSYCHOLOGY OF EVALUATION, P219; Deutsch R, 2006, PSYCHOL INQ, V17, P166, DOI 10.1207/s15327965pli1703_2; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; Ernst LH, 2014, ADDICT BIOL, V19, P497, DOI 10.1111/adb.12005; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HEINZ A, 1994, PHARMACOPSYCHIATRY, V27, P7, DOI 10.1055/s-2007-1014317; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kroemer NB, 2013, NEUROPSYCHOPHARMACOL, V38, P2307, DOI 10.1038/npp.2013.133; Lang PJ, 1995, INT AFFECTIVE PICTUR; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lubman DI, 2009, ARCH GEN PSYCHIAT, V66, P205, DOI 10.1001/archgenpsychiatry.2008.522; McCabe RE, 2004, J ANXIETY DISORD, V18, P7, DOI 10.1016/j.janxdis.2003.07.003; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rubinstein ML, 2011, NICOTINE TOB RES, V13, P751, DOI 10.1093/ntr/ntr046; Stippekohl B, 2012, PSYCHOPHARMACOLOGY, V222, P593, DOI 10.1007/s00213-012-2670-8; Stippekohl B, 2010, NEUROPSYCHOPHARMACOL, V35, P1209, DOI 10.1038/npp.2009.227; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Swanson JE, 2001, COGNITION EMOTION, V15, P207, DOI 10.1080/0269993004200060; Waters AJ, 2003, ADDICTION, V98, P1409, DOI 10.1046/j.1360-0443.2003.00465.x; Watson P, 2013, J EXP PSYCHOPATHOL, V4, P250, DOI 10.5127/jep.030512; Wiers CE, 2013, PSYCHOPHARMACOLOGY, V229, P187, DOI 10.1007/s00213-013-3098-5; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Zhou YY, 2012, PSYCHOPHARMACOLOGY, V221, P171, DOI 10.1007/s00213-011-2557-0	36	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116464	10.1371/journal.pone.0116464	http://dx.doi.org/10.1371/journal.pone.0116464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692468	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500015
J	Bussiere, FI; Brossier, F; Le Vern, Y; Niepceron, A; Silvestre, A; de Sablet, T; Lacroix-Lamande, S; Laurent, F				Bussiere, Francoise I.; Brossier, Fabien; Le Vern, Yves; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice			Reduced Parasite Motility and Micronemal Protein Secretion by a p38 MAPK Inhibitor Leads to a Severe Impairment of Cell Invasion by the Apicomplexan Parasite Eimeria tenella	PLOS ONE			English	Article							TOXOPLASMA-GONDII; HOST-CELL; KINASE INHIBITORS; MOLECULAR CHARACTERIZATION; ACTIN CYTOSKELETON; IDENTIFICATION; ANTIGEN; PHOSPHORYLATION; ANTIBODIES; INFECTION	E. tenella infection is associated with a severe intestinal disease leading to high economic losses in poultry industry. Mitogen activated protein kinases (MAPKs) are implicated in early response to infection and are divided in three pathways: p38, extracellular signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK). Our objective was to determine the importance of these kinases on cell invasion by E. tenella. We evaluated the effect of specific inhibitors (ERK: PD98059, JNKII: SP600125, p38 MAPK: SB203580) on the invasion of epithelial cells. Incubation of SP600125 and SB203580 with epithelial cells and parasites significantly inhibited cell invasion with the highest degree of inhibition (90%) for SB203580. Silencing of the host p38 alpha MAPK expression by siRNA led to only 20% decrease in cell invasion. In addition, when mammalian epithelial cells were pre-treated with SB203580, and washed prior infection, a 30% decrease in cell invasion was observed. This decrease was overcome when a p38 MAPK activator, anisomycin was added during infection. This suggests an active but limited role of the host p38 MAPK in this process. We next determined whether SB203580 has a direct effect on the parasite. Indeed, parasite motility and secretion of micronemal proteins (EtMIC1, 2, 3 and 5) that are involved in cell invasion were both decreased in the presence of the inhibitor. After chasing the inhibitor, parasite motility and secretion of micronemal proteins were restored and subsequently cell invasion. SB203580 inhibits cell invasion by acting partly on the host cell and mainly on the parasite.	[Bussiere, Francoise I.; Brossier, Fabien; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice] INRA, Apicomplexes & Immun Mucosale, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Bussiere, Francoise I.; Brossier, Fabien; Le Vern, Yves; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice] Univ Tours, UMR1282, Infectiol & Sante Publ, F-37000 Tours, France; [Le Vern, Yves] INRA, Plate Forme Anal Integrat Biomol, Lab Cytometrie & Fluorimetrie, UMR1282,Infectiol & Sante Publ, F-37380 Nouzilly, France	INRAE; Universite de Tours; INRAE	Bussiere, FI (corresponding author), INRA, Apicomplexes & Immun Mucosale, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	Francoise.Bussiere@tours.inra.fr	de Sablet, Thibaut/AAI-4513-2020; Laurent, fabrice/AAC-2266-2019; Silvestre, Anne/V-1165-2017	Laurent, fabrice/0000-0002-9687-7952; Silvestre, Anne/0000-0001-6824-7868; Bussiere, Francoise I/0000-0001-9365-6831; LAMANDE, Sonia/0000-0002-7865-4587	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	Funding from the Institut National de la Recherche Agronomique (INRA).	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Becker S, 1997, PARASITOL RES, V83, P273, DOI 10.1007/s004360050246; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Brossier F, 2003, J BIOL CHEM, V278, P6229, DOI 10.1074/jbc.M209837200; Brumlik M. J., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/971968, DOI 10.1155/2011/971968]; Brumlik MJ, 2011, EXP PARASITOL, V128, P170, DOI 10.1016/j.exppara.2011.02.016; Bumstead J, 2000, MOL BIOCHEM PARASIT, V110, P311, DOI 10.1016/S0166-6851(00)00280-2; Bumstead JM, 1998, PARASITOLOGY, V117, P39, DOI 10.1017/S0031182098002741; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Delorme-Walker V, 2012, J CELL SCI, V125, P4333, DOI 10.1242/jcs.103648; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; DVORAK JA, 1981, SCIENCE, V214, P1034, DOI 10.1126/science.7029713; ENTZEROTH R, 1989, PARASITOL RES, V76, P174, DOI 10.1007/BF00930842; ENTZEROTH R, 1992, EUR J CELL BIOL, V59, P405; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Gomez-Marin JE, 1998, PARASITE IMMUNOL, V20, P631, DOI 10.1046/j.1365-3024.1998.00194.x; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Grimwood J, 1996, INFECT IMMUN, V64, P4099, DOI 10.1128/IAI.64.10.4099-4104.1996; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; JENSEN JB, 1976, J PARASITOL, V62, P988, DOI 10.2307/3279196; Kipper M, 2013, VET PARASITOL, V196, P77, DOI 10.1016/j.vetpar.2013.01.013; LAURENT F, 1994, MOL BIOCHEM PARASIT, V63, P79, DOI 10.1016/0166-6851(94)90010-8; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MILLER LH, 1988, MOL BIOCHEM PARASIT, V31, P217, DOI 10.1016/0166-6851(88)90151-X; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Robert-Gangneux F, 2000, PARASITE, V7, P95, DOI 10.1051/parasite/2000072095; Santos JM, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI 10.1016/j.molbiopara.2011.11.010; Sharman PA, 2010, PARASITE IMMUNOL, V32, P590, DOI 10.1111/j.1365-3024.2010.01209.x; Shirley MW, 1995, BIOTECHNOLOGY GUIDEL, VXII, P1; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Singh AP, 2002, MOL BIOCHEM PARASIT, V121, P21, DOI 10.1016/S0166-6851(02)00017-8; Sukhumayasi W, 2010, EXP PARASITOL, V126, P415, DOI 10.1016/j.exppara.2010.01.019; Sweeney KR, 2010, EUKARYOT CELL, V9, P1680, DOI 10.1128/EC.00079-10; Talevich E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-321; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tomley FM, 1996, MOL BIOCHEM PARASIT, V79, P195, DOI 10.1016/0166-6851(96)02662-X; VIEIRA MCF, 1994, BIOCHEM BIOPH RES CO, V203, P967, DOI 10.1006/bbrc.1994.2276; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Wei F, 2013, PARASITOL RES, V112, P2121, DOI 10.1007/s00436-013-3451-y; Wei S, 2002, INT J PARASITOL, V32, P969, DOI 10.1016/S0020-7519(02)00061-9; Wei S, 2007, ANTIMICROB AGENTS CH, V51, P4324, DOI 10.1128/AAC.00680-07; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	61	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116509	10.1371/journal.pone.0116509	http://dx.doi.org/10.1371/journal.pone.0116509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689363	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700011
J	Chen, YY; Chu, DC; Chou, P				Chen, Yu-Yen; Chu, Dachen; Chou, Pesus			Enhancing the Early Differential Diagnosis of Plateau Iris and Pupillary Block Using A-Scan Ultrasonography	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; LASER PERIPHERAL IRIDOPLASTY; STATISTICAL POWER; ANTERIOR; CHINESE; EYES	Purpose To distinguish the frequently misdiagnosed plateau iris eyes from pupillary block group and normal group, we compared the ocular biometrical parameters of them by A-scan ultrasongraphy. Methods In total, we retrospectively reviewed general characteristics and ocular findings including ocular biometric measurements of 71 normal, 39 plateau iris, and 83 pupillary block eyes. Results The normal controls, plateau iris group and pupillary block group were significantly different in age, but not in gender. The anterior chamber depth tended to decrease and the lens thickness tended to increase from normal to plateau iris to pupillary block eyes. Compared to those of plateau iris group, the pupillary block group had significantly shallower anterior chamber depth (2.90mm vs. 2.33mm; p<0.001), thicker lens (4.77 mm vs. 5.11mm; p<0.001), shorter axial length (23.16mm vs. 22.63mm; p<0.001), smaller relative lens position (2.28 vs. 2.16; p<0.001) and larger lens/axial length factor (2.06 vs. 2.26; p<0.001). However, when comparing plateau iris and normal eyes, only axial length and lens/axial length factor were significantly different (23.16 vs. 23.54; p<0.05 and 2.06 vs. 1.96; p<0.05). Conclusions Measured by A-scan ultrasonography, the ocular biometrics of plateau iris were significantly different from those of pupillary block eyes. However, our A-scan ultrasongraphy generally found no significant biometric differences between plateau iris and normal eyes. These findings suggest that while A-scan ultrasonography might be used as a practical tool for differentiating plateau iris and papillary block eyes, a more meticulous gonioscopy and other assessments may be necessary to distinguish plateau iris from normal eyes.	[Chen, Yu-Yen; Chu, Dachen; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chen, Yu-Yen; Chu, Dachen; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Yu-Yen] Yang Ming Univ Hosp, Dept Ophthalmol, Yilan City, Ilan County, Taiwan; [Chu, Dachen] Taipei City Hosp, Zhongxing Branch, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	pschou@ym.edu.tw						COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen P., 2014, APPL MULTIPLE REGRES, DOI [10.4324/9781410606266, DOI 10.4324/9780203774441]; Diniz Filho Alberto, 2010, Arq. Bras. Oftalmol., V73, P155, DOI 10.1590/S0004-27492010000200011; Fox N, 1997, FAM PRACT, V14, P324, DOI 10.1093/fampra/14.4.324; Garudadri CS, 2002, J GLAUCOMA, V11, P502, DOI 10.1097/00061198-200212000-00009; He MG, 2007, OPHTHALMOLOGY, V114, P1513, DOI 10.1016/j.ophtha.2006.11.032; HUNG PT, 1979, ARCH OPHTHALMOL-CHIC, V97, P1862; Hung PT, 1996, ASIA PAC J OPHTHALMO, V2, P82; Johnson GJ, 2005, EYE LOND, V19; Klimek Katarzyna M, 2008, Wiad Lek, V61, P211; Kumar RS, 2008, OPHTHALMOLOGY, V115, P430, DOI 10.1016/j.ophtha.2007.07.026; Kumar RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1269, DOI 10.1001/archophthalmol.2009.241; Lan YW, 2007, OPHTHALMOLOGICA, V221, P388, DOI 10.1159/000107498; Mandell MA, 2003, AM J OPHTHALMOL, V136, P900, DOI 10.1016/S0002-9394(03)00578-6; MARKOWITZ SN, 1985, AM J OPHTHALMOL, V99, P400, DOI 10.1016/0002-9394(85)90005-4; Pavlin CJ, 1999, AM J OPHTHALMOL, V128, P288, DOI 10.1016/S0002-9394(99)00149-X; Ritch R, 2004, OPHTHALMOLOGY, V111, P104, DOI 10.1016/j.ophtha.2003.05.001; Ritch R, 2003, OPHTHALMOLOGY, V110, P1880, DOI 10.1016/S0161-6420(03)00563-3; Ritch R., 1992, J GLAUCOMA, V1, P23; Ritch R, 1989, GLAUCOMAS, V1; Ritch R, 2007, SURV OPHTHALMOL, V52, P279, DOI 10.1016/j.survophthal.2007.02.006; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Sihota R, 2000, J GLAUCOMA, V9, P208; Silver DM, 2004, J GLAUCOMA, V13, P100, DOI 10.1097/00061198-200404000-00004; Tran HV, 2003, AM J OPHTHALMOL, V135, P40; Wang NL, 2002, CHINESE MED J-PEKING, V115, P1706; Zhang Y, 2014, OPHTHAL EPIDEMIOL, V21, P268, DOI 10.3109/09286586.2014.929707	28	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118811	10.1371/journal.pone.0118811	http://dx.doi.org/10.1371/journal.pone.0118811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689856	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700120
J	Crespo, E; Lucia, M; Cruzado, JM; Luque, S; Melilli, E; Manonelles, A; Lloberas, N; Torras, J; Grinyo, JM; Bestard, O				Crespo, Elena; Lucia, Marc; Cruzado, Josep M.; Luque, Sergio; Melilli, Edoardo; Manonelles, Anna; Lloberas, Nuria; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol			Pre-Transplant Donor-Specific T-Cell Alloreactivity Is Strongly Associated with Early Acute Cellular Rejection in Kidney Transplant Recipients Not Receiving T-Cell Depleting Induction Therapy	PLOS ONE			English	Article							GRAFT FUNCTION; ELISPOT ASSAY; HETEROLOGOUS IMMUNITY; RENAL-FUNCTION; TOLERANCE; RESPONSES; PANEL; IMMUNOSUPPRESSION; SENSITIZATION; ALLOIMMUNITY	Preformed T-cell immune-sensitization should most likely impact allograft outcome during the initial period after kidney transplantation, since donor-specific memory T-cells may rapidly recognize alloantigens and activate the effector immune response, which leads to allograft rejection. However, the precise time-frame in which acute rejection is fundamentally triggered by preformed donor-specific memory T cells rather than by de novo activated naive T cells is still to be established. Here, preformed donor-specific alloreactive T-cell responses were evaluated using the IFN-gamma ELISPOT assay in a large consecutive cohort of kidney transplant patients (n = 90), to assess the main clinical variables associated with cellular sensitization and its predominant time-frame impact on allograft outcome, and was further validated in an independent new set of kidney transplant recipients (n = 67). We found that most highly T-cell sensitized patients were elderly patients with particularly poor HLA class-I matching, without any clinically recognizable sensitizing events. While one-year incidence of all types of biopsy-proven acute rejection did not differ between T-cell alloreactive and non-alloreactive patients, Receiver Operating Characteristic curve analysis indicated the first two months after transplantation as the highest risk time period for acute cellular rejection associated with baseline T-cell sensitization. This effect was particularly evident in young and highly alloreactive individuals that did not receive T-cell depletion immunosuppression. Multivariate analysis confirmed preformed T-cell sensitization as an independent predictor of early acute cellular rejection. In summary, monitoring anti-donor T-cell sensitization before transplantation may help to identify patients at increased risk of acute cellular rejection, particularly in the early phases after kidney transplantation, and thus guide decision-making regarding the use of induction therapy.	[Crespo, Elena; Lucia, Marc; Cruzado, Josep M.; Luque, Sergio; Manonelles, Anna; Lloberas, Nuria; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol] Bellvitge Biomed Res Inst IDIBELL, Expt Nephrol Lab, Barcelona, Spain; [Cruzado, Josep M.; Melilli, Edoardo; Manonelles, Anna; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol] Bellvitge Univ Hosp, Dept Nephrol, Renal Transplant Unit, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Bestard, O (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Expt Nephrol Lab, Barcelona, Spain.	obestard@bellvitgehospital.cat	Crespo, Elena/ABI-7633-2020; Torras, Joan/AAH-8131-2021; Lloberas, Nuria/U-7497-2019	Crespo, Elena/0000-0002-2121-5196; LUQUE, SONIA/0000-0002-3215-320X; Torras, Juan/0000-0002-1135-7588; Manonelles Montero, Anna/0000-0003-2456-388X; Melilli, Edoardo/0000-0001-6965-3745	European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim) [12CEE014]; Spanish Red de Investigacion Renal (REDinREN) [RD12/0021];  [FIS PI10/01786];  [PI13/01263]	European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim); Spanish Red de Investigacion Renal (REDinREN); ; 	We acknowledge the expert assistance of our lab technician Gema Cerezo for carefully managing all biological samples, and Yolanda Perez, our bio-bank coordinator at our center. We also thank all the renal transplant unit staff for their support and care of the patients. This work was supported in part by two national public grants (FIS PI10/01786 and PI13/01263), a European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim, 12CEE014), and the Spanish Red de Investigacion Renal (REDinREN, RD12/0021).	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Andree H, 2006, J AM SOC NEPHROL, V17, P573, DOI 10.1681/ASN.2005030299; Augustine JJ, 2005, AM J TRANSPLANT, V5, P1971, DOI 10.1111/j.1600-6143.2005.00958.x; Augustine JF, 2007, J AM SOC NEPHROL, V18, P1602, DOI 10.1681/ASN.2006101105; Augustine JJ, 2008, TRANSPLANTATION, V86, P529, DOI 10.1097/TP.0b013e31818046db; Baxter-Lowe LA, 2003, AM SOC HISTOCOMPAT I, V2; Bestard O, 2013, AM J TRANSPLANT, V13, P1880, DOI 10.1111/ajt.12285; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bestard O, 2007, J IMMUNOL, V179, P4901, DOI 10.4049/jimmunol.179.7.4901; Bestard O, 2013, KIDNEY INT, V84, P1226, DOI 10.1038/ki.2013.236; Bestard O, 2011, TRANSPL INT, V24, P451, DOI 10.1111/j.1432-2277.2011.01223.x; Brehm MA, 2003, J IMMUNOL, V170, P4077, DOI 10.4049/jimmunol.170.8.4077; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; Cherkassky L, 2011, AM J TRANSPLANT, V11, P1388, DOI 10.1111/j.1600-6143.2011.03540.x; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; Gebel HM, 2000, TRANSPLANTATION, V69, P1370, DOI 10.1097/00007890-200004150-00027; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Hricik DE, 2013, TRANSPLANTATION, V95, P1254, DOI 10.1097/TP.0b013e31828ad866; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Kim SH, 2007, TRANSPL P, V39, P3057, DOI 10.1016/j.transproceed.2007.06.080; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; Kohlmeier JE, 2010, J IMMUNOL, V185, P3456, DOI 10.4049/jimmunol.1001745; Martins PNA, 2014, INT REV IMMUNOL, V33, P162, DOI 10.3109/08830185.2013.829469; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Poggio ED, 2006, J AM SOC NEPHROL, V17, P564, DOI 10.1681/ASN.2005030293; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Valujskikh A, 2007, ADV EXP MED BIOL, V601, P247; Zeevi A, 2007, AM J TRANSPLANT, V7, P471, DOI 10.1111/j.1600-6143.2006.01641.x	32	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117618	10.1371/journal.pone.0117618	http://dx.doi.org/10.1371/journal.pone.0117618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689405	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700063
J	Long, Z; Chen, Z; Wang, CR; Huang, FZ; Peng, HR; Hou, X; Ding, DX; Ye, W; Wang, JL; Pan, Q; Li, JD; Xia, K; Tang, BS; Ashizawa, T; Jiang, H				Long, Zhe; Chen, Zhao; Wang, Chunrong; Huang, Fengzhen; Peng, Huirong; Hou, Xuan; Ding, Dongxue; Ye, Wei; Wang, Junling; Pan, Qian; Li, Jiada; Xia, Kun; Tang, Beisha; Ashizawa, Tetsuo; Jiang, Hong			Two Novel SNPs in ATXN3 3 ' UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients	PLOS ONE			English	Article								Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is an autosomal dominantly-inherited disease that produces progressive problems with movement. It is caused by the expansion of an area of CAG repeats in a coding region of ATXN3. The number of repeats is inversely associated with age at disease onset (AO) and is significantly associated with disease severity; however, the degree of CAG expansion only explains 50 to 70% of variance in AO. We tested two SNPs, rs709930 and rs910369, in the 3' UTR of ATXN3 gene for association with SCA3/MJD risk and with SCA3/MJD AO in an independent cohort of 170 patients with SCA3/MJD and 200 healthy controls from mainland China. rs709930 genotype frequencies were statistically significantly different between patients and controls (p = 0.001, alpha = 0.05). SCA3/MJD patients carrying the rs709930 A allele and rs910369 T allele experienced an earlier onset, with a decrease in AO of approximately 2 to 4 years. The two novel SNPs found in this study might be genetic modifiers for AO in SCA3/MJD.	[Long, Zhe; Chen, Zhao; Wang, Chunrong; Huang, Fengzhen; Peng, Huirong; Hou, Xuan; Ding, Dongxue; Ye, Wei; Wang, Junling; Tang, Beisha; Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Wang, Junling; Tang, Beisha; Jiang, Hong] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China; [Wang, Junling; Pan, Qian; Li, Jiada; Xia, Kun; Tang, Beisha; Jiang, Hong] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Ashizawa, Tetsuo] Univ Florida, Dept Neurol, Gainesville, FL USA; [Wang, Chunrong] Xiangtan Cent Hosp, Dept Neurol, Xiangtan 411100, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Dept Neurol, Chenzhou 423000, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Inst Translat Med, Chenzhou 423000, Hunan, Peoples R China	Central South University; Central South University; Central South University; State University System of Florida; University of Florida; University of South China; University of South China	Jiang, H (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	jianghong73868@126.com	XIA, KUN/AAO-3525-2020	Li, Jia-Da/0000-0002-4236-3518	National Basic Research Program (973 Program) [2012CB944601, 2012CB517902, 2011CB510002]; New Century Excellent Talents in University [NCET-10-0836]; National Natural Science Foundation of China [81410308019, 81471156, 81271260, 30971585]; Hunan Funds for Distinguished Young Scientists [14JJ1008]; Xinjiang Natural Science Foundation [201318101-4]; Undergraduate Innovation Project of Central South University [YB13028, 201410533324]; Graduate Innovation Project of Central South University [2014zzts078]; High-Level Medical Personnel of Hunan Province 225 Project	National Basic Research Program (973 Program)(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Funds for Distinguished Young Scientists; Xinjiang Natural Science Foundation; Undergraduate Innovation Project of Central South University; Graduate Innovation Project of Central South University; High-Level Medical Personnel of Hunan Province 225 Project	This study was supported by the National Basic Research Program (973 Program) (Nos. 2012CB944601, 2012CB517902 and 2011CB510002 to Hong Jiang), the New Century Excellent Talents in University (No. NCET-10-0836 to Hong Jiang), the National Natural Science Foundation of China (Nos. 81410308019, 81471156, 81271260, 30971585 to Hong Jiang), Hunan Funds for Distinguished Young Scientists (No. 14JJ1008 to Hong Jiang), Xinjiang Natural Science Foundation (No. 201318101-4 to Hong Jiang), the Undergraduate Innovation Project of Central South University (No. YB13028, 201410533324 to Hong Jiang), Graduate Innovation Project of Central South University (No. 2014zzts078 to Zhao Chen) and High-Level Medical Personnel of Hunan Province 225 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt C, 2012, CEREBELLUM, V11, P1045, DOI 10.1007/s12311-012-0373-7; Bettencourt C, 2011, ARCH NEUROL-CHICAGO, V68, P1580, DOI 10.1001/archneurol.2011.636; Carvalho DR, 2008, PEDIATR NEUROL, V38, P296, DOI 10.1016/j.pediatrneurol.2007.12.006; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; du Montcel ST, 2014, BRAIN, V137, P2444, DOI 10.1093/brain/awu174; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; MACIEL P, 1995, AM J HUM GENET, V57, P54; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Peng HR, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.020; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; Shi YT, 2014, INT J NEUROSCI, V124, P97, DOI 10.3109/00207454.2013.827679; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Warrenburg BPCV, 2005, ANN NEUROL, V57, P505, DOI 10.1002/ana.20424	13	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117488	10.1371/journal.pone.0117488	http://dx.doi.org/10.1371/journal.pone.0117488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689313	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700049
J	Monette, MM; Evans, DL; Krunkosky, T; Camus, A; Jaso-Friedmann, L				Monette, Margaret Mariscal; Evans, Donald Lee; Krunkosky, Thomas; Camus, Alvin; Jaso-Friedmann, Liliana			Nonspecific Cytotoxic Cell Antimicrobial Protein (NCAMP-1): A Novel Alarmin Ligand Identified in Zebrafish	PLOS ONE			English	Article							DENDRITIC CELLS; RECEPTOR; RELEASE; ATP; ACTIVATION; PEPTIDE; MODEL; LIPOPOLYSACCHARIDE; CATHELICIDIN; EXPRESSION	Cells from the coelomic cavity of adult zebrafish (zf) were used to study the alarmin-like activities of nonspecific cytotoxic cell antimicrobial protein-1 (NCAMP-1). Immunohistochemistry studies using polyclonal anti-NCAMP-1 identified constitutive NCAMP-1 in epithelial cells of the zf anterior kidney, in liver parenchyma and in the lamina propria of the intestine. NCAMP-1 was also located in the cytosol of mononuclear cells in these tissues. Cytosolic NCAMP-1 was detected in a diverse population of coelomic cells (CC) using confocal microscopy and polyclonal anti-NCAMP-1 staining. Large mononuclear and heterophil-like CC had intracellular NCAMP-1. These studies indicated that NCAMP-1 is constitutively found in epithelial cells and in ZFCC. To establish a relationship between NCAMP-1 and the alarmin functions of ATP, a stimulation-secretion model was initiated using zf coelomic cells (ZFCC). ZFCCs treated with the alarmin ATP secreted NCAMP-1 into culture supernatants. Treatment of ZFCC with either ATP or NCAMP-1 activated purinergic receptor induced pore formation detected by the ZFCC uptake of the dye YO-PRO-1. ATP induced YO-PRO-1 uptake was inhibited by antagonists oxidized-ATP, KN62, or CBB. These antagonists did not compete with NCAMP-1 induced YO-PRO-1 uptake. Binding of ZFCC by both ATP and NCAMP-1 produced an influx of Ca2+. Combined treatment of ZFCC with ATP and NCAMP-1 increased target cell cytotoxicity. Individually NCAMP-1 or ATP treatment did not produce target cell damage. Similar to ATP, NCAMP-1 activates cellular pore formation, calcium influx and cytotoxicity.	[Monette, Margaret Mariscal; Evans, Donald Lee; Jaso-Friedmann, Liliana] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Krunkosky, Thomas] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA USA; [Camus, Alvin] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Jaso-Friedmann, L (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ljaso@uga.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported while serving at the National Science Foundation. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Bao BL, 2006, MOL IMMUNOL, V43, P367, DOI 10.1016/j.molimm.2005.02.014; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Evans DL, 2005, DEV COMP IMMUNOL, V29, P1049, DOI 10.1016/j.dci.2005.03.011; Evans DL, 2009, J LEUKOCYTE BIOL, V86, P133, DOI [10.1189/JLB.1108682, 10.1189/jlb.1108682]; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Jaso-Friedmann L, 2014, J LEUKOCYTE BIOL, V95, P785, DOI 10.1189/jlb.0313171; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Kaur H, 2005, SCAND J IMMUNOL, V62, P361, DOI 10.1111/j.1365-3083.2005.01665.x; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lopez-Castejon G, 2007, MOL IMMUNOL, V44, P1286, DOI 10.1016/j.molimm.2006.05.015; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Michel AD, 2000, BRIT J PHARMACOL, V130, P513, DOI 10.1038/sj.bjp.0703368; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Moss LD, 2009, DEV COMP IMMUNOL, V33, P1077, DOI 10.1016/j.dci.2009.05.009; MURGIA M, 1993, J BIOL CHEM, V268, P8199; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pelegrin P, 2004, DEV COMP IMMUNOL, V28, P229, DOI 10.1016/j.dci.2003.08.002; Pelegrin P, 2001, CYTOKINE, V16, P67, DOI 10.1006/cyto.2001.0949; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Reimann J, 2004, IMMUNOL REV, V199, P54, DOI 10.1111/j.0105-2896.2004.00136.x; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Robinette D, 1998, CELL MOL LIFE SCI, V54, P467, DOI 10.1007/s000180050175; Rovere-Querini P, 2008, EMBO, V5, P825; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Traver D, 2003, ADV IMMUNOL, V81, P253; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vojtech LN, 2009, INFECT IMMUN, V77, P914, DOI 10.1128/IAI.01201-08; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang D, 2010, BBA-GENE REGUL MECH, V1799, P157, DOI 10.1016/j.bbagrm.2009.11.002; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116576	10.1371/journal.pone.0116576	http://dx.doi.org/10.1371/journal.pone.0116576			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689842	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700016
J	Steinhilber, J; Bonin, M; Walter, M; Fend, F; Bonzheim, I; Quintanilla-Martinez, L				Steinhilber, Julia; Bonin, Michael; Walter, Michael; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia			Next-Generation Sequencing Identifies Deregulation of MicroRNAs Involved in Both Innate and Adaptive Immune Response in ALK plus ALCL	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; BINDING-PROTEIN-BETA; LARGE-CELL LYMPHOMAS; C/EBP-BETA; CYCLIN D1; EXPRESSION; MIRNAS; SURVIVAL; DIFFERENTIATION; PROLIFERATION	Anaplastic large cell lymphoma (ALCL) is divided into two systemic diseases according to the expression of the anaplastic lymphoma kinase (ALK). We investigated the differential expression of miRNAs between ALK+ ALCL, ALK-ALCL cells and normal T-cells using next generation sequencing (NGS). In addition, a C/EBP beta-dependent miRNA profile was generated. The data were validated in primary ALCL cases. NGS identified 106 miRNAs significantly differentially expressed between ALK+ and ALK-ALCL and 228 between ALK+ ALCL and normal T-cells. We identified a signature of 56 miRNAs distinguishing ALK+ ALCL, ALK-ALCL and T-cells. The top candidates significant differentially expressed between ALK+ and ALK-ALCL included 5 upregulated miRNAs: miR-340, miR-203, miR-135b, miR-182, miR-183; and 7 downregulated: miR-196b, miR-155, miR-146a, miR-424, miR-503, miR-424*, miR-542-3p. The miR-17-92 cluster was also upregulated in ALK+ cells. Additionally, we identified a signature of 3 miRNAs significantly regulated by the transcription factor C/EBP beta, which is specifically overexpressed in ALK+ ALCL, including the miR-181 family. Of interest, miR-181a, which regulates T-cell differentiation and modulates TCR signalling strength, was significantly downregulated in ALK+ ALCL cases. In summary, our data reveal a miRNA signature linking ALK+ ALCL to a deregulated immune response and may reflect the abnormal TCR antigen expression known in ALK+ ALCL.	[Steinhilber, Julia; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia] Inst Pathol & Neuropathol, Tubingen, Germany; [Steinhilber, Julia; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia] Ctr Comprehens Canc, Tubingen, Germany; [Bonin, Michael; Walter, Michael] Univ Tubingen, Univ Hosp Tubingen, MFT Serv, Dept Med Genet & Appl Genom, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Quintanilla-Martinez, L (corresponding author), Inst Pathol & Neuropathol, Tubingen, Germany.	irina.bonzheim@med.uni-tuebingen.de; Leticia.Quintanilla-Fend@med.uni-tuebingen.de			University of Tubingen [SFB 685, TP B8]; IZKF fortune program, University of Tubingen [1924-0-0]	University of Tubingen; IZKF fortune program, University of Tubingen	This work was supported by the SFB 685 "Immunotherapy" of the University of Tubingen, TP B8 (LQM and FF, http://www.sfb685.de/) and by the IZKF fortune program (1924-0-0), University of Tubingen (IB, https://www.medizin.uni-tuebingen.de/Forschung/Forschungsf%C3%B6rderung/Interne+Forschungsf%C3%B6rderung/fort%C3% BCne.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Anastasov Natasa, 2009, J Hematop, V2, P9, DOI 10.1007/s12308-008-0020-x; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bonzheim I, 2004, BLOOD, V104, P3358, DOI 10.1182/blood-2004-03-1037; Bonzheim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064544; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Desjobert C, 2011, BLOOD, V117, P6627, DOI 10.1182/blood-2010-09-301994; Drexler HG, 2004, LEUKEMIA, V18, P1569, DOI 10.1038/sj.leu.2403465; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kinney MC, 2011, ARCH PATHOL LAB MED, V135, P19, DOI 10.1043/2010-0507-RAR.1; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kutty RK, 2010, MOL VIS, V16, P1475; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu CL, 2013, BLOOD, V122, P2083, DOI 10.1182/blood-2012-08-447375; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Mukherjee A, 2014, J VIROL, V88, P7929, DOI 10.1128/JVI.00787-14; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Quintanilla-Martinez L, 2006, BLOOD, V108, P2029, DOI 10.1182/blood-2005-10-014258; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; SHIMAKAGE M, 1993, INTERVIROLOGY, V36, P215, DOI 10.1159/000150340; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Specht K, 2002, CLIN CANCER RES, V8, P2902; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	60	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117780	10.1371/journal.pone.0117780	http://dx.doi.org/10.1371/journal.pone.0117780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688981	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700072
J	Zhao, WJ; Wang, YP; Liu, SY; Huang, JJ; Zhai, ZX; He, C; Ding, JM; Wang, J; Wang, HJ; Fan, WB; Zhao, JG; Meng, H				Zhao, Wenjing; Wang, Yapeng; Liu, Shuyun; Huang, Jiaojiao; Zhai, Zhengxiao; He, Chuan; Ding, Jinmei; Wang, Jun; Wang, Huijuan; Fan, Weibing; Zhao, Jianguo; Meng, He			The Dynamic Distribution of Porcine Microbiota across Different Ages and Gastrointestinal Tract Segments	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOTA; BACTERIAL COMMUNITY; DIVERSITY; STABILITY; OBESE; GENE; MICE	Metagenome of gut microbes has been implicated in metabolism, immunity, and health maintenance of its host. However, in most of previous studies, the microbiota was sampled from feces instead of gastrointestinal (GI) tract. In this study, we compared the microbial populations from feces at four different developmental stages and contents of four intestinal segments at maturity to examine the dynamic shift of microbiota in pigs and investigated whether adult porcine fecal samples could be used to represent samples of the GI tract. Analysis results revealed that the ratio of Firmicutes to Bacteroidetes from the feces of the older pigs (2-, 3-, 6-month) were 10 times higher compared to those from piglets (1-month). As the pigs matured, so did it seem that the composition of microbiome became more stable in feces. In adult pigs, there were significant differences in microbial profiles between the contents of the small intestine and large intestine. The dominant genera in the small intestine belonged to aerobe or facultative anaerobe categories, whereas the main genera in the large intestine were all anaerobes. Compared to the GI tract, the composition of microbiome was quite different in feces. The microbial profile in large intestine was more similar to feces than those in the small intestine, with the similarity of 0.75 and 0.38 on average, respectively. Microbial functions, predicted by metagenome profiles, showed the enrichment associated with metabolism pathway and metabolic disease in large intestine and feces while higher abundance of infectious disease, immune function disease, and cancer in small intestine. Fecal microbes also showed enriched function in metabolic pathways compared to microbes from pooled gut contents. Our study extended the understanding of dynamic shift of gut microbes during pig growth and also characterized the profiles of bacterial communities across GI tracts of mature pigs.	[Zhao, Wenjing; Liu, Shuyun; Zhai, Zhengxiao; He, Chuan; Ding, Jinmei; Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China; [Wang, Yapeng; Huang, Jiaojiao; Zhao, Jianguo] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [He, Chuan; Wang, Jun; Wang, Huijuan; Fan, Weibing] Shanghai Personal Biotechnol Ltd Co, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhao, JG (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	zhaojg@ioz.ac.cn; menghe@sjtu.edu.cn	ding, jin/GVT-5062-2022; He, Chuan/AAN-4356-2020; wang, hui/GRS-4730-2022	He, Chuan/0000-0002-8532-2898; 	National High Technology Research and Development Program of China [2011AA100901]; National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012, 2-3]; Shanghai Personal Biotechnology Limited Company	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai; Shanghai Personal Biotechnology Limited Company	This work was supported by (1) the National High Technology Research and Development Program of China (grant No. 2011AA100901), http://program.most.gov.cn/; (2) the National Science Foundation of China (grant No. 31272430), http://www.nsfc.gov.cn/; and (3) Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012,2-3), http://www.xmgl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Chuan He, Jun Wang, Huijuan Wang, and Weibing Fan are employed by Shanghai Personal Biotechnology Limited Company. Shanghai Personal Biotechnology Limited Company provided support in the form of salaries for authors Chuan He, Jun Wang, Huijuan Wang, and Weibing Fan but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi JH, 2014, POULTRY SCI, V93, P1942, DOI 10.3382/ps.2014-03974; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hopwood DE, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P199; Kohl KD, 2014, ENVIRON MICROBIOL, V16, P2869, DOI 10.1111/1462-2920.12376; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	42	219	233	10	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117441	10.1371/journal.pone.0117441	http://dx.doi.org/10.1371/journal.pone.0117441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688558	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700044
J	Ibrahim, SM; El-Denshary, ES; Abdallah, DM				Ibrahim, Sherehan M.; El-Denshary, Ezzedin S.; Abdallah, Dalaal M.			Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLYCATION END-PRODUCTS; INSULIN-RESISTANCE; PPAR-GAMMA; ADIPOSE-TISSUE; UP-REGULATION; NITRIC-OXIDE; URIC-ACID; RECEPTOR; ADIPONECTIN	Geraniol (GO) potent antitumor and chemopreventive effects are attributed to its antioxidant and anti-inflammatory properties. In the current study, the potential efficacy of GO (250 mg/kg) in ameliorating metabolic syndrome (MetS) induced by fructose in drinking water was elucidated. Moreover, the effect of pioglitazone (5 and 10 mg/kg; PIO) and the possible interaction of the co-treatment of GO with PIO5 were studied in the MetS model. After 4 weeks of treatment, GO and/or PIO reduced the fasting blood glucose and the glycemic excursion in the intraperitoneal glucose tolerance test. GO and PIO5/10 restrained visceral adiposity and partly the body weight gain. The decreased level of peroxisome proliferator activated receptor (PPAR)-gamma transcriptional activity in the visceral adipose tissue of MetS rats was increased by single treatment regimens. Though GO did not affect MetS-induced hyperinsulinemia, PIO5/10 lowered it. Additionally, GO and PIO5/10 suppressed glycated hemoglobin and the receptor for advanced glycated end products (RAGE). These single regimens also ameliorated hyperuricemia, the disrupted lipid profile, and the elevated systolic blood pressure evoked by MetS. The rise in serum transaminases, interleukin-1 beta, and tumor necrosis factor-alpha, as well as hepatic lipid peroxides and nitric oxide (NO) was lowered by the single treatments to different extents. Moreover, hepatic non-protein thiols, as well as serum NO and adiponectin were enhanced by single regimens. Similar effects were reached by the combination of GO with PIO5; however, a potentiative interaction was noted on fasting serum insulin level, while synergistic effects were reflected as improved insulin sensitivity, as well as reduced RAGE and triglycerides. Therefore, GO via the transcriptional activation of PPAR-gamma reduces inflammation and free radical injury produced by MetS. Thereby, these effects provide novel mechanistic insights on GO management of MetS associated critical risk factors. Moreover, the co-administration of GO to PIO5 exalted the antidiabetic drug anti-MetS efficacy.	[Ibrahim, Sherehan M.; El-Denshary, Ezzedin S.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Abdallah, DM (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	dalabdallah@staff.cu.edu.eg	Abdallah, Dalaal/GVT-0783-2022	, Sherehan/0000-0003-3495-3451				Abate N, 2000, J DIABETES COMPLICAT, V14, P154, DOI 10.1016/S1056-8727(00)00067-2; Abe S, 2003, MEDIAT INFLAMM, V12, P323, DOI 10.1080/09629350310001633342; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Albright A L, 1994, Obes Res, V2, P535; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Bartolome N, 2007, ANN NY ACAD SCI, V1096, P55, DOI 10.1196/annals.1397.070; Brunzell JD, 2003, AM J MED, V115, P24, DOI 10.1016/j.amjmed.2003.08.011; Carnesecchi S, 2002, J PHARMACOL EXP THER, V303, P711, DOI 10.1124/jpet.102.039263; CHADHA A, 1984, XENOBIOTICA, V14, P365, DOI 10.3109/00498258409151425; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Desai RV, 2010, AM J CARDIOL, V106, P1134, DOI 10.1016/j.amjcard.2010.06.023; Desiderio JG, 2005, 37 MIDDL ATL REG M; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; El-Abhar HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037757; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elmazar MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045638; Emanuelli B, 2004, DIABETES, V53, pS97, DOI 10.2337/diabetes.53.suppl_3.S97; Fried SK, 2003, AM J CLIN NUTR, V78, p873S, DOI 10.1093/ajcn/78.4.873S; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Grundy SM, 2006, AM J CLIN NUTR, V83, P1248, DOI 10.1093/ajcn/83.6.1248; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; HIRSCH J, 1995, AM J CLIN NUTR, V61, p996S, DOI 10.1093/ajcn/61.4.996S; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jack MM, 2012, EXP NEUROL, V234, P62, DOI 10.1016/j.expneurol.2011.12.015; Jayachandran M, 2015, MOL CELL BIOCHEM, V398, P39, DOI 10.1007/s11010-014-2203-3; Katsukawa M, 2011, BIOSCI BIOTECH BIOCH, V75, P1010, DOI 10.1271/bbb.110039; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Khan MA, 2002, DIABETES CARE, V25, P708, DOI 10.2337/diacare.25.4.708; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Liang HF, 2008, ENDOCRINOLOGY, V149, P2943, DOI 10.1210/en.2007-0978; Mahmoud AAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106993; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Marcuzzi A, 2011, IN VIVO, V25, P87; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Milan G, 2002, OBES RES, V10, P1095, DOI 10.1038/oby.2002.149; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; de Carvalho KIM, 2014, N-S ARCH PHARMACOL, V387, P355, DOI 10.1007/s00210-013-0947-z; Ong TP, 2006, CARCINOGENESIS, V27, P1194, DOI 10.1093/carcin/bgi291; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Psyrogiannis Agathoklis, 2003, Hormones (Athens), V2, P161; Qin BL, 2008, AM J PHYSIOL-GASTR L, V294, pG1120, DOI 10.1152/ajpgi.00407.2007; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Robins SJ, 2003, DIABETES CARE, V26, P1513, DOI 10.2337/diacare.26.5.1513; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Singh BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034200; Spruss A, 2011, ANTIOXID REDOX SIGN, V14, P2121, DOI 10.1089/ars.2010.3263; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Su YW, 2010, PLANTA MED, V76, P1666, DOI 10.1055/s-0030-1249947; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Tham DM, 2003, DRUG NEWS PERSPECT, V16, P109, DOI 10.1358/dnp.2003.16.2.740244; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Tjokroprawiro Askandar, 2006, Acta Med Indones, V38, P160; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vieira A, 2011, BRAZ J MED BIOL RES, V44, P538, DOI 10.1590/S0100-879X2011007500037; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang GZ, 2013, J THORAC DIS, V5, P706, DOI 10.3978/j.issn.2072-1439.2013.08.69; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yuan GJ, 2004, WORLD J GASTROENTERO, V10, P1047	75	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117516	10.1371/journal.pone.0117516	http://dx.doi.org/10.1371/journal.pone.0117516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679220	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600070
J	Singh, VK; Vaish, M; Johansson, TR; Baum, KR; Ring, RP; Singh, S; Shukla, SK; Moskovitz, J				Singh, Vineet K.; Vaish, Manisha; Johansson, Trintje R.; Baum, Kyle R.; Ring, Robert P.; Singh, Saumya; Shukla, Sanjay K.; Moskovitz, Jackob			Significance of Four Methionine Sulfoxide Reductases in Staphylococcus aureus	PLOS ONE			English	Article							OXIDATIVE STRESS; STREPTOCOCCUS-GORDONII; VIRULENCE DETERMINANT; ENTEROCOCCUS-FAECALIS; RESISTANCE; EXPRESSION; MSRA; GENE; IDENTIFICATION; MAINTENANCE	Staphylococcus aureus is a major human pathogen and emergence of antibiotic resistance in clinical staphylococcal isolates raises concerns about our ability to control these infections. Cell wall-active antibiotics cause elevated synthesis of methionine sulfoxide reductases (Msrs: MsrA1 and MsrB) in S. aureus. MsrA and MsrB enzymes reduce S-epimers and R-epimers of methionine sulfoxide, respectively, that are generated under oxidative stress. In the S. aureus chromosome, there are three msrA genes (msrA1, msrA2 and msrA3) and one msrB gene. To understand the precise physiological roles of Msr proteins in S. aureus, mutations in msrA1, msrA2 and msrA3 and msrB genes were created by site-directed mutagenesis. These mutants were combined to create a triple msrA (msrA1, msrA2 and msrA3) and a quadruple msrAB (msrA1, msrA2, msrA3, msrB) mutant. These mutants were used to determine the roles of Msr proteins in staphylococcal growth, antibiotic resistance, adherence to human lung epithelial cells, pigment production, and survival in mice relative to the wild-type strains. MsrA1-deficient strains were sensitive to oxidative stress conditions, less pigmented and less adherent to human lung epithelial cells, and showed reduced survival in mouse tissues. In contrast, MsrB-deficient strains were resistant to oxidants and were highly pigmented. Lack of MsrA2 and MsrA3 caused no apparent growth defect in S. aureus. In complementation experiments with the triple and quadruple mutants, it was MsrA1 and not MsrB that was determined to be critical for adherence and phagocytic resistance of S. aureus. Overall, the data suggests that MsrA1 may be an important virulence factor and MsrB probably plays a balancing act to counter the effect of MsrA1 in S. aureus.	[Singh, Vineet K.; Vaish, Manisha; Johansson, Trintje R.; Baum, Kyle R.; Ring, Robert P.; Singh, Saumya] AT Still Univ Hlth Sci, Dept Microbiol & Immunol, Kirksville, MO 63501 USA; [Shukla, Sanjay K.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Moskovitz, Jackob] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	A.T. Still University of Health Sciences; University of Kansas	Singh, VK (corresponding author), AT Still Univ Hlth Sci, Dept Microbiol & Immunol, Kirksville, MO 63501 USA.	vsingh@atsu.edu			Warner/Fermaturo grant Fund; A.T. Still University Board of Trustees Research Fund; National Institutes of Health [1R15AI090680-01]; Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI090680] Funding Source: NIH RePORTER	Warner/Fermaturo grant Fund; A.T. Still University Board of Trustees Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Warner/Fermaturo grant and A.T. Still University Board of Trustees Research Funds, by grant 1R15AI090680-01 from the National Institutes of Health to VKS, and grants from the Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program to TRJ and KRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d; Atack JM, 2008, MICROBIOL-SGM, V154, P2219, DOI 10.1099/mic.0.2008/019711-0; AUGUSTIN J, 1992, EUR J BIOCHEM, V204, P1149, DOI 10.1111/j.1432-1033.1992.tb16740.x; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Bong SM, 2010, J BIOL CHEM, V285, P25044, DOI 10.1074/jbc.M110.103119; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Kavanagh KT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-18; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Lan LF, 2010, J BACTERIOL, V192, P3068, DOI 10.1128/JB.00928-09; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lei Y, 2011, MOL MICROBIOL, V80, P726, DOI 10.1111/j.1365-2958.2011.07603.x; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Pang YY, 2014, J INNATE IMMUN, V6, P353, DOI 10.1159/000355915; Pierce D, 2012, AM FAM PHYSICIAN, V85, P981; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; RYFFEL C, 1991, J BACTERIOL, V173, P7416, DOI 10.1128/jb.173.23.7416-7422.1991; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788; Singh Kuldeep, 2012, Int J Microbiol, V2012, P719594, DOI 10.1155/2012/719594; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Singh VK, 2014, CAN J MICROBIOL, V60, P625, DOI 10.1139/cjm-2014-0360; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Singh VK, 2003, INT J ANTIMICROB AG, V21, P256, DOI 10.1016/S0924-8579(02)00359-X; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Singh VK, 2001, MICROBIOL-SGM, V147, P3037, DOI 10.1099/00221287-147-11-3037; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Vaish Manisha, 2013, Int J Microbiol, V2013, P312146, DOI 10.1155/2013/312146; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Zhao C, 2013, MICROBIOL-SGM, V159, P615, DOI 10.1099/mic.0.065037-0; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	54	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117594	10.1371/journal.pone.0117594	http://dx.doi.org/10.1371/journal.pone.0117594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680075	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600074
J	Sinreih, M; Zukunft, S; Sosic, I; Cesar, J; Gobec, S; Adamski, J; Rizner, TL				Sinreih, Masa; Zukunft, Sven; Sosic, Izidor; Cesar, Jozko; Gobec, Stanislav; Adamski, Jerzy; Rizner, Tea Lanisnik			Combined Liquid Chromatography-Tandem Mass Spectrometry Analysis of Progesterone Metabolites	PLOS ONE			English	Article							KETO REDUCTASE SUPERFAMILY; ENDOMETRIAL CANCER; NEUROACTIVE STEROIDS; RECEPTOR; AKR1C1-AKR1C4; EXPRESSION; PREGNANCY; PROTEINS; ESTROGEN; HORMONES	Progesterone has a number of important functions throughout the human body. While the roles of progesterone are well known, the possible actions and implications of progesterone metabolites in different tissues remain to be determined. There is a growing body of evidence that these metabolites are not inactive, but can have significant biological effects, as anesthetics, anxiolytics and anticonvulsants. Furthermore, they can facilitate synthesis of myelin components in the peripheral nervous system, have effects on human pregnancy and onset of labour, and have a neuroprotective role. For a better understanding of the functions of progesterone metabolites, improved analytical methods are essential. We have developed a combined liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for detection and quantification of progesterone and 16 progesterone metabolites that has femtomolar sensitivity and good reproducibility in a single chromatographic run. MS/MS analyses were performed in positive mode and under constant electrospray ionization conditions. To increase the sensitivity, all of the transitions were recorded using the Scheduled MRM algorithm. This LC-MS/MS method requires small sample volumes and minimal sample preparation, and there is no need for derivatization. Here, we show the application of this method for evaluation of progesterone metabolism in the HES endometrial cell line. In HES cells, the metabolism of progesterone proceeds mainly to (20S)-20-hydroxy- pregn-4-ene-3-one, (20S)-20-hydroxy-5 alpha-pregnane-3-one and (20S)-5 alpha-pregnane-3 alpha,20-diol. The investigation of possible biological effects of these metabolites on the endometrium is currently undergoing.	[Sinreih, Masa; Rizner, Tea Lanisnik] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Zukunft, Sven; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Munich, Germany; [Sosic, Izidor; Cesar, Jozko; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res, Neuherberg, Germany	University of Ljubljana; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Ljubljana; Technical University of Munich	Rizner, TL (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia.	Tea.Lanisnik-Rizner@mf.uni-lj.si		Gobec, Stanislav/0000-0002-9678-3083; Sosic, Izidor/0000-0002-3370-4587; Lanisnik Rizner, Tea/0000-0002-3453-4081; Adamski, Jerzy/0000-0001-9259-0199	Slovenian Research Agency [J3-5510]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by an ICGEB grant to T. L. R., a Young Researcher Grant to M.S. and a J3-5510 Grant to T. L. R., both from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P671, DOI 10.1111/j.1365-2982.2007.01080.x; Arici A, 1999, STEROIDS, V64, P530, DOI 10.1016/S0039-128X(99)00029-X; ATHERDEN LM, 1959, BIOCHEM J, V71, P411, DOI 10.1042/bj0710411; DESAI NN, 1994, FERTIL STERIL, V61, P760; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Hevir N, 2011, CHEM-BIOL INTERACT, V191, P217, DOI 10.1016/j.cbi.2011.01.003; Hill M, 2011, PHYSIOL RES, V60, P225, DOI 10.33549/physiolres.932077; Hill M, 2007, J STEROID BIOCHEM, V105, P166, DOI 10.1016/j.jsbmb.2006.10.010; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Jin Y, 2011, BIOCHEM J, V437, P53, DOI 10.1042/BJ20101804; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kim YS, 2000, ANAL BIOCHEM, V277, P187, DOI 10.1006/abio.1999.4384; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Leb CR, 1997, J CLIN ENDOCR METAB, V82, P4064, DOI 10.1210/jc.82.12.4064; Martini L, 2003, STEROIDS, V68, P825, DOI 10.1016/S0039-128X(03)00134-X; Murphy BEP, 2000, J STEROID BIOCHEM, V74, P137, DOI 10.1016/S0960-0760(00)00098-4; Murphy BEP, 2004, PSYCHONEUROENDOCRINO, V29, P245, DOI 10.1016/S0306-4530(03)00026-X; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2004, MOL CELL ENDOCRINOL, V215, P63, DOI 10.1016/j.mce.2003.11.006; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Quinkler M, 1999, J CLIN ENDOCR METAB, V84, P4165, DOI 10.1210/jc.84.11.4165; Quinkler M, 2002, EUR J ENDOCRINOL, V146, P789, DOI 10.1530/eje.0.1460789; SATYASWAROOP PG, 1980, STEROIDS, V35, P21, DOI 10.1016/0039-128X(80)90108-7; Schindler AE, 2009, MATURITAS, V62, P334, DOI 10.1016/j.maturitas.2008.12.018; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Sinreih M, 2013, CHEM-BIOL INTERACT, V202, P210, DOI 10.1016/j.cbi.2012.11.012; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P74, DOI 10.1016/j.mce.2008.09.019; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Wiebe JP, 2000, CANCER RES, V60, P936; Wiebe JP, 2005, J STEROID BIOCHEM, V93, P201, DOI 10.1016/j.jsbmb.2004.12.003; WIEBE JP, 1986, STEROIDS, V47, P249, DOI 10.1016/0039-128X(86)90095-4; WU L, 1993, J BIOL CHEM, V268, P12964; Zhang YH, 2009, MOL CELL ENDOCRINOL, V298, P76, DOI 10.1016/j.mce.2008.09.034	37	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117984	10.1371/journal.pone.0117984	http://dx.doi.org/10.1371/journal.pone.0117984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680188	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600097
J	Chettier, R; Nelson, L; Ogilvie, JW; Albertsen, HM; Ward, K				Chettier, Rakesh; Nelson, Lesa; Ogilvie, James W.; Albertsen, Hans M.; Ward, Kenneth			Haplotypes at LBX1 Have Distinct Inheritance Patterns with Opposite Effects in Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-FUNCTION; VARIANTS; GENES	Adolescent idiopathic scoliosis (AIS) is a clinically significant disorder with high heritability that affects 2-4% of the population. Genome-wide association studies have identified LBX1 as a strong susceptibility locus for AIS in Asian and Caucasian populations. Here we further dissect the genetic association with AIS in a Caucasian population. To identify genetic markers associated with AIS we employed a genome-wide association study (GWAS) design comparing 620 female Caucasian patients who developed idiopathic scoliosis during adolescence with 1,287 ethnically matched females who had normal spinal curves by skeletal maturity. The genomic region around LBX1 was imputed and haplotypes investigated for genetic signals under different inheritance models. The strongest signal was identified upstream of LBX1 (rs11190878, P-trend = 4.18x10(-9), OR = 0.63[0.54-0.74]). None of the remaining SNPs pass the genome-wide significance threshold. We found rs11190870, downstream of LBX1 and previously associated with AIS in Asian populations, to be in modest linkage disequilibrium (LD) with rs11190878 (r(2) = 0.40, D' = 0.81). Haplotype analysis shows that rs11190870 and rs11190878 track a single risk factor that resides on the ancestral haplotype and is shared across ethnic groups. We identify six haplotypes at the LBX1 locus including two strongly associated haplotypes; a recessive risk haplotype (TTA, Control(freq) = 0.52, P = 1.25x10(-9), OR = 1.56), and a co-dominant protective haplotype (CCG, Control(freq) = 0.28, P = 2.75x10(-7), OR = 0.65). Together the association signals from LBX1 explain 1.4% of phenotypic variance. Our results identify two clinically relevant haplotypes in the LBX1-region with opposite effects on AIS risk. The study demonstrates the utility of haplotypes over un-phased SNPs for individualized risk assessment by more strongly delineating individuals at risk for AIS without compromising the effect size.	[Chettier, Rakesh; Nelson, Lesa; Ward, Kenneth] Affiliated Genet Inc, Salt Lake City, UT 84109 USA; [Ogilvie, James W.] Lucina Fdn, Salt Lake City, UT 84109 USA; [Albertsen, Hans M.; Ward, Kenneth] Juneau Biosci LLC, Salt Lake City, UT 84109 USA		Ward, K (corresponding author), Affiliated Genet Inc, Salt Lake City, UT 84109 USA.	kward@affiliatedgenetics.com			Affiliated Genetics, Inc.	Affiliated Genetics, Inc.	This study was funded by Affiliated Genetics, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Juneau Biosciences, LLC provided support in the form of salaries for authors HMA and KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barois A, 1999, B ACAD NAT MED PARIS, V183, P721; BENGTSSON G, 1974, ACTA PSYCHIAT SCAND, V50, P50, DOI 10.1111/j.1600-0447.1974.tb07656.x; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053234; Grauers A, 2012, EUR SPINE J, V21, P1069, DOI 10.1007/s00586-011-2074-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Kotwicki T, 2008, STUD HEALTH TECHNOL, V140, P44, DOI 10.3233/978-1-58603-888-5-44; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Lenke Lawrence G, 2005, Instr Course Lect, V54, P537; Lenke LG, 2003, SPINE, V28, pS199, DOI 10.1097/01.BRS.0000092216.16155.33; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Londono D, 2014, J MED GENET, V51, P401, DOI 10.1136/jmedgenet-2013-102067; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Miller NH, 2007, CLIN ORTHOP RELAT R, P6, DOI 10.1097/BLO.0b013e318126c062; Miller NH, 1999, ORTHOP CLIN N AM, V30, P343, DOI 10.1016/S0030-5898(05)70091-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; PEHRSSON K, 1991, THORAX, V46, P474, DOI 10.1136/thx.46.7.474; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu XS, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-38; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; RENSHAW TS, 1988, CLIN ORTHOP RELAT R, P26; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Tang NLS, 2012, J ORTHOP RES, V30, P1464, DOI 10.1002/jor.22090; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117708	10.1371/journal.pone.0117708	http://dx.doi.org/10.1371/journal.pone.0117708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675428	Green Submitted, gold, Green Published			2022-12-27	WOS:000349914000030
J	Chu, CHG; Kee, CS				Chu, Chin Hung Geoffrey; Kee, Chea Su			Effects of Optically Imposed Astigmatism on Early Eye Growth in Chicks	PLOS ONE			English	Article							TILTED-DISC SYNDROME; GANGLION-CELL LAYER; REFRACTIVE ERROR; CORNEAL ASTIGMATISM; FORM DEPRIVATION; EXPERIMENTAL MYOPIA; PRESCHOOL-CHILDREN; INFANT ASTIGMATISM; SPECTACLE LENSES; HIGH PREVALENCE	Purpose To determine the effects of optically imposed astigmatism on early eye growth in chicks. Methods 5-day-old (P5) White Leghorn chicks were randomly assigned to either wear, monocularly, a "high magnitude" (H: +4.00DS/-8.00DC) crossed-cylindrical lens oriented at one of four axes (45, 90, 135, and 180; n = 20 in each group), or were left untreated (controls; n = 8). Two additional groups wore a "low magnitude" (L: +2.00DS/-4.00DC) cylindrical lens orientated at either axis 90 or 180 (n = 20 and n = 18, respectively). Refractions were measured at P5 and after 7 days of treatment for all chicks (P12), whereas videokeratography and ex-vivo eyeshape analysis were performed at P12 for a subset of chicks in each group (n = 8). Results Compared to controls, chicks in the treatment groups developed significant amounts of refractive astigmatism (controls: 0.03 +/- 0.22DC; treatment groups: 1.34 +/- 0.22DC to 5.51 +/- 0.26DC, one-way ANOVAs, p <= 0.05) with axes compensatory to those imposed by the cylindrical lenses. H cylindrical lenses induced more refractive astigmatism than L lenses (H90 vs. L90: 5.51 +/- 0.26D vs. 4.10 +/- 0.16D; H180 vs. L180: 2.84 +/- 0.44D vs. 1.34 +/- 0.22D, unpaired two-sample t-tests, both p <= 0.01); and imposing with-the-rule (H90 and L90) and against-the- rule astigmatisms (H180 and L180) resulted in, respectively, steeper and flatter corneal shape. Both corneal and internal astigmatisms were moderately to strongly correlated with refractive astigmatisms (Pearson's r: +0.61 to +0.94, all p <= 0.001). In addition, the characteristics of astigmatism were significantly correlated with multiple eyeshape parameters at the posterior segments (Pearson's r: -0.27 to +0.45, all p <= 0.05). Conclusions Chicks showed compensatory ocular changes in response to the astigmatic magnitudes imposed in this study. The correlations of changes in refractive, corneal, and posterior eyeshape indicate the involvement of anterior and posterior ocular segments during the development of astigmatism.	[Chu, Chin Hung Geoffrey; Kee, Chea Su] Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Chu, CHG (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China.	geopicasso@yahoo.com		Kee, Chea-Su/0000-0002-5177-129X	RGC General Research Fund [561209]; Internal Competitive Research Grant [G-YK90]; Centre of Myopia Research; Niches Areas-Myopia Research Fund from The Hong Kong Polytechnic University [J-BB7P]	RGC General Research Fund; Internal Competitive Research Grant; Centre of Myopia Research; Niches Areas-Myopia Research Fund from The Hong Kong Polytechnic University	Grant support was provided by RGC General Research Fund #561209; Internal Competitive Research Grant G-YK90, The Centre of Myopia Research and The Niches Areas-Myopia Research Fund (J-BB7P) from The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JE, 1972, J AM OPTOM ASSOC, V43, P1257; Abrahamsson M, 2003, ACTA OPHTHALMOL SCAN, V81, P33, DOI 10.1034/j.1600-0420.2003.00022.x; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; ALPINS NA, 1993, J CATARACT REFR SURG, V19, P524, DOI 10.1016/S0886-3350(13)80617-7; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Avila NV, 2010, J COMP PHYSIOL A, V196, P825, DOI 10.1007/s00359-010-0562-0; Barutchu A, 2002, CLIN EXP OPHTHALMOL, V30, P217, DOI 10.1046/j.1442-9071.2002.00514.x; Batschelet E, 1981, CIRCULAR STAT BIOL; Benavente-Perez A, 2012, INVEST OPHTH VIS SCI, V53, P6479, DOI 10.1167/iovs.12-9822; Beresford JA, 2001, OPTOMETRY VISION SCI, V78, P40, DOI 10.1097/00006324-200101010-00013; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; Boote C, 2009, J STRUCT BIOL, V166, P195, DOI 10.1016/j.jsb.2009.01.009; Bozkurt B, 2002, CORNEA, V21, P458, DOI 10.1097/00003226-200207000-00005; Campbell M. C. W., 2008, J VISION, V8, P48; Chen Y, 2004, ANAT HISTOL EMBRYOL, V33, P161, DOI 10.1111/j.1439-0264.2004.00528.x; Chen YX, 2000, J VET MED SCI, V62, P53, DOI 10.1292/jvms.62.53; Chu CH, 2012, VISION RES, V55, P24, DOI 10.1016/j.visres.2011.12.011; Chu CHG, 2014, VISION RES, V98, P26, DOI 10.1016/j.visres.2014.03.002; Clementi M, 1998, AM J HUM GENET, V63, P825, DOI 10.1086/302014; COULOMBRE ALFRED J., 1964, ADVANCE MORPHOGENESIS, V4, P81; Cowen L, 2003, INVEST OPHTH VIS SCI, V44, P4593, DOI 10.1167/iovs.02-0730; Cox MJ, 2010, ENCY EYE, P135; DEQUEIROZ K, 1988, AUK, V105, P29; Dobson V, 2003, VISION RES, V43, P1081, DOI 10.1016/S0042-6989(03)00014-2; Dobson V, 2008, INVEST OPHTH VIS SCI, V49, P4427, DOI 10.1167/iovs.08-1985; Dobson V, 2007, OPTOMETRY VISION SCI, V84, P124, DOI 10.1097/OPX.0b013e318031b6ac; Duke-Elder S, 1993, DUKE ELDERS PRACTICE; Duke-Elder S., 1970, OPHTHALMIC OPT REFRA; EHRLICH DL, 1995, VISION RES, V35, P1313, DOI 10.1016/0042-6989(94)00228-E; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fischer AJ, 2008, DEV BIOL, V317, P196, DOI 10.1016/j.ydbio.2008.02.023; FLEDELIUS HC, 1986, ACTA OPHTHALMOL, V64, P487; Flitcroft DI, 2005, BRIT J OPHTHALMOL, V89, P484, DOI 10.1136/bjo.2004.045328; FULTON AB, 1982, OPHTHALMOLOGY, V89, P298, DOI 10.1016/s0161-6420(82)34788-0; Furtado KS, 2013, OA ANAESTHETICS, V1, P20, DOI DOI 10.13172/2052-7853-1-2-1006; GLASSER A, 1994, VISION RES, V34, P1549, DOI 10.1016/0042-6989(94)90112-0; Goss DA, 1999, OPHTHAL PHYSL OPT, V19, P438, DOI 10.1046/j.1475-1313.1999.00455.x; Gunduz A, 2002, J CATARACT REFR SURG, V28, P1836, DOI 10.1016/S0886-3350(02)01424-4; GWIAZDA J, 1985, VISION RES, V25, P1269, DOI 10.1016/0042-6989(85)90042-2; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Harvey EM, 2006, OPTOMETRY VISION SCI, V83, P206, DOI 10.1097/01.opx.0000214333.84822.71; Harvey EM, 2011, INVEST OPHTH VIS SCI, V52, P4350, DOI 10.1167/iovs.10-6061; HOWLAND HC, 1978, SCIENCE, V202, P331, DOI 10.1126/science.694540; Huang J, 1997, INVEST OPHTHALMOL  S, V38, pS546; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; IRVING EL, 1992, OPHTHAL PHYSL OPT, V12, P448, DOI 10.1111/j.1475-1313.1992.tb00315.x; IRVING EL, 1991, OPTOMETRY VISION SCI, V68, P364, DOI 10.1097/00006324-199105000-00007; IRVING EL, 1995, VISION RES, V35, P1165, DOI 10.1016/0042-6989(94)00235-E; Irving EL, 1996, J COMP PHYSIOL A, V179, P185; Johnson CA, 2004, INVEST OPHTH VIS SCI, V45, pU416; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; Kaye SB, 1997, J CATARACT REFR SURG, V23, P1496, DOI 10.1016/S0886-3350(97)80020-X; Kee CS, 2008, INVEST OPHTH VIS SCI, V49, P858, DOI 10.1167/iovs.06-1370; Kee CS, 2013, EXP EYE RES, V114, P89, DOI 10.1016/j.exer.2013.04.020; Kee CS, 2004, INVEST OPHTH VIS SCI, V45, P1647, DOI 10.1167/iovs.03-0841; Kisilak ML, 2008, J MOD OPTIC, V55, P611, DOI 10.1080/09500340701470003; Lansche R K, 1966, Headache, V6, P147, DOI 10.1111/j.1526-4610.1966.hed0603147.x; Laskowski F. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS687; LORD REXFORD D., 1956, AMER MIDLAND NAT, V56, P325, DOI 10.2307/2422424; LYLE WM, 1972, AMER J OPT ARCH AM A, V49, P517; Mahan RP, 1991, CIRCULAR STAT METHOD, V16; Mandalos AT, 2002, EUR J OPHTHALMOL, V12, P1; MANDELMAN T, 1983, VISION RES, V23, P1555, DOI 10.1016/0042-6989(83)90169-4; MARSHTOOTLE WL, 1989, INVEST OPHTH VIS SCI, V30, P2245; McLean RC, 2003, INVEST OPHTH VIS SCI, V44, P449, DOI 10.1167/iovs.01-0670; Miller J M, 2000, Ophthalmic Epidemiol, V7, P187, DOI 10.1076/0928-6586(200009)7:3;1-V;FT187; MOHINDRA I, 1978, SCIENCE, V202, P329, DOI 10.1126/science.694539; Montes-Mico R, 2000, J PEDIAT OPHTH STRAB, V37, P349; MURPHY CJ, 1995, INVEST OPHTH VIS SCI, V36, P889; Nalbach HO, 1993, VISION BRAIN BEHAV B; Nickla DL, 2006, J COMP PHYSIOL A, V192, P399, DOI 10.1007/s00359-005-0077-2; Nickla DL, 2005, OPTOMETRY VISION SCI, V82, P318, DOI 10.1097/01.OPX.0000159368.31481.DE; Norton TT, 2006, INVEST OPHTH VIS SCI, V47, P4687, DOI 10.1167/iovs.05-1369; Oh IK, 2014, INVEST OPHTH VIS SCI, V55, P4313, DOI 10.1167/iovs.14-14277; Phillips J, 2000, P 8 INT C MYOP, P162; Pinero DP, 2014, CONTACT LENS ANTERIO, V37, P49, DOI 10.1016/j.clae.2013.07.006; RAASCH TW, 1995, OPTOMETRY VISION SCI, V72, P272, DOI 10.1097/00006324-199504000-00008; Read SA, 2007, CLIN EXPT OPTOMETRY, V90; SAUNDERS H, 1981, OPHTHAL PHYSL OPT, V1, P159, DOI 10.1111/j.1475-1313.1981.tb00388.x; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; Schmid KL, 1997, EXP EYE RES, V64, P837, DOI 10.1006/exer.1997.0282; Shen W, 2007, INVEST OPHTH VIS SCI, V48, P4829, DOI 10.1167/iovs.06-1273; Shih YF, 2004, OPTOMETRY VISION SCI, V81, P94, DOI 10.1097/00006324-200402000-00007; SIVAK JG, 1990, CIBA F SYMP, V155, P160; Smith EL, 1998, OPTOMETRY VISION SCI, V75, P388, DOI 10.1097/00006324-199806000-00023; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; Smith EL, 1998, MYOPIA UPDATES, P336; Sokol Jason A, 2005, Eye Contact Lens, V31, P111, DOI 10.1097/01.ICL.0000140921.39111.47; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Thibos LN, 2001, INVEST OPHTH VIS SCI, V42, pS58; Thomas S, 2000, VISION RES, V40, P3553, DOI 10.1016/S0042-6989(00)00209-1; TRELSTAD RL, 1971, J CELL BIOL, V50, P840, DOI 10.1083/jcb.50.3.840; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Votaw JR, 2004, ANESTHESIOLOGY, V101, P1128, DOI 10.1097/00000542-200411000-00012; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WALLMAN J, 1987, VISION RES, V27, P1139, DOI 10.1016/0042-6989(87)90027-7; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1988, CLIN VISION SCI, V3, P99; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38	102	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117729	10.1371/journal.pone.0117729	http://dx.doi.org/10.1371/journal.pone.0117729			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675443	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000031
J	Puschmann, C; Bastos, M				Puschmann, Cornelius; Bastos, Marco			How Digital Are the Digital Humanities? An Analysis of Two Scholarly Blogging Platforms	PLOS ONE			English	Article							SOCIAL MEDIA; SCIENCE	In this paper we compare two academic networking platforms, HASTAC and Hypotheses, to show the distinct ways in which they serve specific communities in the Digital Humanities (DH) in different national and disciplinary contexts. After providing background information on both platforms, we apply co-word analysis and topic modeling to show thematic similarities and differences between the two sites, focusing particularly on how they frame DH as a new paradigm in humanities research. We encounter a much higher ratio of posts using humanities-related terms compared to their digital counterparts, suggesting a one-way dependency of digital humanities-related terms on the corresponding unprefixed labels. The results also show that the terms digital archive, digital literacy, and digital pedagogy are relatively independent from the respective unprefixed terms, and that digital publishing, digital libraries, and digital media show considerable cross-pollination between the specialization and the general noun. The topic modeling reproduces these findings and reveals further differences between the two platforms. Our findings also indicate local differences in how the emerging field of DH is conceptualized and show dynamic topical shifts inside these respective contexts.	[Puschmann, Cornelius] Zeppelin Univ, Fac Social Sci, D-88045 Friedrichshafen, Germany; [Bastos, Marco] Duke Univ, Franklin Humanitites Inst, Durham, NC 27701 USA	Zeppelin University; Duke University	Puschmann, C (corresponding author), Zeppelin Univ, Fac Social Sci, Seemooser Horn 20D, D-88045 Friedrichshafen, Germany.	cornelius.puschmann@hiig.de	Yang, Wujian/B-3167-2019; Bastos, Marco/D-4616-2013	Yang, Wujian/0000-0001-7663-0912; Bastos, Marco/0000-0003-0480-1078; Puschmann, Cornelius/0000-0002-3189-0662	National Science Foundation [1243622]; German Research Foundation [PU 439/2-1]; Direct For Computer & Info Scie & Enginr [1243622] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation under grant number 1243622 and the German Research Foundation under grant number PU 439/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Ilan J., 2012, P 17 INT C SCI TECHN, V52900, P98; Berry D, 2012, UNDERSTANDING DIGITA, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Borgman CL, 2007, SCHOLARSHIP DIGITAL, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003; Cope WW, 2009, 1 MONDAY, V14; Davidson C.N., 2004, CHRON HIGHER EDUC, V50, pB7; Dutton WH, 2010, WORLD WIDE RES RESHA, DOI [10.7551/mitpress/9780262014397.001.0001, DOI 10.7551/MITPRESS/9780262014397.001.0001]; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Feinerer I, 2008, J STAT SOFTW, V25; Gold MK, 2012, DEBATES IN THE DIGITAL HUMANITIES, P1; Grun B, 2011, J STAT SOFTW, V40, P1; Gruzd A, 2012, COMPUT HUM BEHAV, V28, P2340, DOI 10.1016/j.chb.2012.07.004; HASTAC, 2014, AB HASTAC; Hypotheses.org, 2014, AB HYP; Juola P, 2008, LIT LINGUIST COMPUT, V23, P73, DOI 10.1093/llc/fqm042; Kirschenbaum Matthew G, 2010, ADE B, V150, P1, DOI DOI 10.1632/ADE.150.55; Kjellberg S., 2010, 1 MONDAY, V15; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Leydesdorff L, 2004, SCIENTOMETRICS, V60, P159, DOI 10.1023/B:SCIE.0000027678.31097.e0; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Lui Marco, 2012, P ACL 2012 SYST DEM; Mahrt M, 2014, TWITTER AND SOC, V89, P399; McPherson Tara, 2008, CINEMA J, V48.2, P119, DOI [10.1353/cj.0.0077, DOI 10.1353/CJ.0.0077]; Meyer ET, 2009, KNOWL MAN RES PRACT, V7, P218, DOI 10.1057/kmrp.2009.13; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Moody James, 2006, AM SOCIOL, V37, P67; Moretti F, 2007, GRAPHS MAPS TREES AB, DOI [10.1016/j.encep.2007.07.008, DOI 10.1016/J.ENCEP.2007.07.008]; Nentwich M, 2012, CYBERSCIENCE 2 0 RES, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; PINCH TJ, 1984, SOC STUD SCI, V14, P399, DOI 10.1177/030631284014003004; Priem J., 2010, 1 MONDAY, V15, DOI DOI 10.5210/FM.V15I7.2874; Puschmann C, 2011, P GEN ONL RES 2011; Puschmann C., 2014, OPENING SCI, P89, DOI [10.1007/978-3-319-00026-8_6, DOI 10.1007/978-3-319-00026-8_6]; Puschmann C, 2012, SCI INTERNET, P171; Ross C, 2011, J DOC, V67, P214, DOI 10.1108/00220411111109449; Rowlands I, 2011, LEARN PUBL, V24, P183, DOI 10.1087/20110306; Schreibman S., 2004, COMPANION DIGITAL HU; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Taddy M, 2013, J AM STAT ASSOC, V108, P755, DOI 10.1080/01621459.2012.734168; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yan E., 2012, P 17 INT C SCI TECHN, P917	41	15	15	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115035	10.1371/journal.pone.0115035	http://dx.doi.org/10.1371/journal.pone.0115035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CB8WX	25675441	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000349914000001
J	Schoormans, D; Li, JM; Darabi, H; Brandberg, Y; Sprangers, MAG; Eriksson, M; Zwinderman, KH; Hall, P				Schoormans, Dounya; Li, Jingmei; Darabi, Hatef; Brandberg, Yvonne; Sprangers, Mirjam A. G.; Eriksson, Mikael; Zwinderman, Koos H.; Hall, Per			The Genetic Basis of Quality of Life in Healthy Swedish Women: A Candidate Gene Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC HEART-FAILURE; BREAST-CANCER RISK; SELF-RATED HEALTH; BIOLOGICAL PATHWAYS; COGNITIVE-ABILITY; LUNG-CANCER; DEPRESSION; MORTALITY; FATIGUE	Background Quality of life (QoL) is an increasingly important parameter in clinical practice as it predicts mortality and poor health outcomes. It is hypothesized that one may have a genetic predisposition for QoL. We therefore related 139 candidate genes, selected through a literature search, to QoL in healthy females. Methods In 5,142 healthy females, background characteristics (i. e. demographic, clinical, lifestyle, and psychological factors) were assessed. QoL was measured by the EORTC QLQ-C30, which consists of 15 domains. For all women genotype information was available. For each candidate gene, single nucleotide polymorphisms (SNPs) were identified based on their functional (n = 2,663) and physical annotation (n = 10,649). SNPs were related to each QoL-domain, while controlling for background characteristics and population stratification. Finally, gene-based analyses were performed relating the combined effect of 10,649 SNPs (selected based on physical annotation) for each gene, to QoL using the statistical software package VEGAS. Results Overall, we found no relation between genetic variations (SNPs and genes) and 14 out of 15 QoL-domains. The strongest association was found between cognitive functioning and the top SNP rs1468951 (p = 1.21E-05) in the GSTZ1 gene. Furthermore, results of the gene-based test showed that the combined effect of 11 SNPs within the GSTZ1 gene is significantly associated with cognitive functioning (p = 2.60E-05). Conclusion If validated, the involvement of GSTZ1 in cognitive functioning underscores its heritability which is likely the result of differences in the dopamine pathway, as GSTZ1 contributes to the equilibrium between dopamine and its neurotoxic metabolites via the glutathione redox cycle.	[Schoormans, Dounya; Li, Jingmei; Darabi, Hatef; Sprangers, Mirjam A. G.; Eriksson, Mikael; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Schoormans, Dounya; Sprangers, Mirjam A. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Li, Jingmei] Genome Inst Singapore, Singapore, Singapore; [Brandberg, Yvonne] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Zwinderman, Koos H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam; Tilburg University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam	Schoormans, D (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	d.schoormans@uvt.nl	Li, Jingmei/I-2904-2012	Li, Jingmei/0000-0001-8587-7511; eriksson, mikael/0000-0001-8135-4270				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ask H, 2014, J ANXIETY DISORD, V28, P363, DOI 10.1016/j.janxdis.2014.04.003; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barsevick A, 2010, QUAL LIFE RES, V19, P1419, DOI 10.1007/s11136-010-9757-7; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blackburn AC, 1998, CYTOGENET CELL GENET, V83, P109, DOI 10.1159/000015145; Bower JE, 2013, J CLIN ONCOL, V31, P1656, DOI 10.1200/JCO.2012.46.2143; Buchanan CC, 2012, J AM MED INFORM ASSN, V19, P289, DOI 10.1136/amiajnl-2011-000652; Canderelli R, 2007, J AM ACAD NURSE PRAC, V19, P635, DOI 10.1111/j.1745-7599.2007.00269.x; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Coker TR, 2011, ARCH PEDIAT ADOL MED, V165, P354, DOI 10.1001/archpediatrics.2011.13; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Farkas J, 2009, EUR J HEART FAIL, V11, P518, DOI 10.1093/eurjhf/hfp038; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Harris SE, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-43; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Illi J, 2012, CYTOKINE, V58, P437, DOI 10.1016/j.cyto.2012.02.015; Jang KL, 2004, J AFFECT DISORDERS, V80, P125, DOI 10.1016/S0165-0327(03)00108-3; Kao CF, 2012, INT J NEUROPSYCHOPH, V15, P1401, DOI 10.1017/S1461145711001891; Kullowatz A, 2007, RESP MED, V101, P638, DOI 10.1016/j.rmed.2006.06.002; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mathews WC, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-5; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Michelson H, 2000, QUAL LIFE RES, V9, P1093, DOI 10.1023/A:1016654621784; Michelson H, 2000, ACTA ONCOL, V39, P477; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nes RB, 2006, PSYCHOL MED, V36, P1033, DOI 10.1017/S0033291706007409; Ordonana JR, 2013, QUAL LIFE RES, V22, P1189, DOI 10.1007/s11136-012-0277-5; Pelle AJ, 2009, QUAL LIFE RES, V18, P689, DOI 10.1007/s11136-009-9485-z; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rausch SM, 2010, CANCER-AM CANCER SOC, V116, P4103, DOI 10.1002/cncr.25255; RICKHAM PP, 1964, BRIT MED J, V2, P173; Schlarb Angelika A, 2012, Sleep Disord, V2012, P806913, DOI 10.1155/2012/806913; Schoormans D, 2014, EUR J CARDIOVASC NUR, V13, P86, DOI 10.1177/1474515113481908; Schoormans D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045126; Shi QL, 2010, QUAL LIFE RES, V19, P1407, DOI 10.1007/s11136-010-9738-x; Sloan JA, 2012, J CLIN ONCOL, V30, P1699, DOI 10.1200/JCO.2010.34.5629; Sprangers MAG, 2002, ACTA ONCOL, V41, P229, DOI 10.1080/02841860260088764; Sprangers MAG, 2014, QUAL LIFE RES, V23, P1997, DOI 10.1007/s11136-014-0656-1; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Sprangers MAG, 2009, TWIN RES HUM GENET, V12, P301, DOI 10.1375/twin.12.3.301; Starr JM, 2008, PSYCHIAT GENET, V18, P211, DOI 10.1097/YPG.0b013e328304dea8; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tanguay RM, 2013, ONLINE METABOLIC MOL; Wald A, 2011, BEST PRACT RES CL GA, V25, P19, DOI 10.1016/j.bpg.2010.12.004; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391	55	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118292	10.1371/journal.pone.0118292	http://dx.doi.org/10.1371/journal.pone.0118292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675377	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000047
J	Guan, XF; Fan, GX; Wu, XB; Gu, GF; Gu, X; Zhang, HL; He, SS				Guan, Xiaofei; Fan, Guoxin; Wu, Xinbo; Gu, Guangfei; Gu, Xin; Zhang, Hailong; He, Shisheng			Diffusion Tensor Imaging Studies of Cervical Spondylotic Myelopathy: A Systemic Review and Meta-Analysis	PLOS ONE			English	Article							SPINAL-CORD; SIGNAL INTENSITY; COMPRESSIVE MYELOPATHY; FIBER TRACTOGRAPHY; DISEASE SEVERITY; ANISOTROPY; COEFFICIENT; PREDICTION; PROGNOSIS; TRACKING	A meta-analysis was conducted to assess alterations in measures of diffusion tensor imaging (DTI) in the patients of cervical spondylotic myelopathy (CSM), exploring the potential role of DTI as a diagnosis biomarker. A systematic search of all related studies written in English was conducted using PubMed, Web of Science, EMBASE, CINAHL, and Cochrane comparing CSM patients with healthy controls. Key details for each study regarding participants, imaging techniques, and results were extracted. DTI measurements, such as fractional anisotropy (FA), apparent diffusion coefficient (ADC), and mean diffusivity (MD) were pooled to calculate the effect size (ES) by fixed or random effects meta-analysis. 14 studies involving 479 CSM patients and 278 controls were identified. Meta-analysis of the most compressed levels (MCL) of CSM patients demonstrated that FA was significantly reduced (ES -1.52, 95% CI -1.87 to -1.16, P < 0.001) and ADC was significantly increased (ES 1.09, 95% CI 0.89 to 1.28, P < 0.001). In addition, a notable ES was found for lowered FA at C2-C3 for CSM vs. controls (ES -0.83, 95% CI -1.09 to -0.570, P < 0.001). Meta-regression analysis revealed that male ratio of CSM patients had a significant effect on reduction of FA at MCL (P = 0.03). The meta-analysis of DTI studies of CSM patients clearly demonstrated a significant FA reduction and ADC increase compared with healthy subjects. This result supports the use of DTI parameters in differentiating CSM patients from health subjects. Future researches are required to investigate the diagnosis performance of DTI in cervical spondylotic myelopathy.	[Guan, Xiaofei; Fan, Guoxin; Wu, Xinbo; Gu, Guangfei; Gu, Xin; Zhang, Hailong; He, Shisheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China	Tongji University	He, SS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China.	tjspinecenter@163.com						Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aota Y, 2008, SPINE, V33, P814, DOI 10.1097/BRS.0b013e318169505e; Banaszek A, 2014, EUR SPINE J, V23, P1523, DOI 10.1007/s00586-014-3323-x; Baptiste Darryl C, 2006, Spine J, V6, p190S, DOI 10.1016/j.spinee.2006.04.024; Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Budzik JF, 2011, EUR RADIOL, V21, P426, DOI 10.1007/s00330-010-1927-z; Chen CJ, 2001, RADIOLOGY, V221, P789, DOI 10.1148/radiol.2213010365; Cheung MM, 2009, IEEE ENG MED BIO, P2715, DOI 10.1109/IEMBS.2009.5333389; CRANDALL PH, 1966, J NEUROSURG, V25, P57, DOI 10.3171/jns.1966.25.1.0057; Cui JL, 2014, EUR SPINE J; Demir A, 2003, RADIOLOGY, V229, P37, DOI 10.1148/radiol.2291020658; Facon D, 2005, AM J NEURORADIOL, V26, P1587; Fehlings MG, 2009, J NEUROSURG-SPINE, V11, P97, DOI 10.3171/2009.5.SPINE09210; Fernandez de Rota JJ, 2007, SPINE, V6, P17; Ford JC, 1998, JMRI-J MAGN RESON IM, V8, P775, DOI 10.1002/jmri.1880080405; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Hori M, 2006, J MAGN RESON IMAGING, V23, P183, DOI 10.1002/jmri.20488; Hori M, 2014, MAGN RESON IMAGING; Hori M, 2012, EUR RADIOL, V22, P1797, DOI 10.1007/s00330-012-2410-9; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Jones J, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10262; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Kara B, 2011, NEURORADIOLOGY, V53, P609, DOI 10.1007/s00234-011-0844-4; Kim TH, 2010, AM J NEURORADIOL, V31, P682, DOI 10.3174/ajnr.A1881; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JW, 2011, SKELETAL RADIOL, V40, P1543, DOI 10.1007/s00256-011-1161-z; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maier SE, 2005, ANN NY ACAD SCI, V1064, P50, DOI 10.1196/annals.1340.011; Mamata H, 2005, J MAGN RESON IMAGING, V22, P38, DOI 10.1002/jmri.20357; MATSUDA Y, 1991, J NEUROSURG, V74, P887, DOI 10.3171/jns.1991.74.6.0887; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Mkang EA, 2010, THE INTERNET JOURNAL, V5; MONTGOMERY DM, 1992, ORTHOP CLIN N AM, V23, P487; Rajasekaran S, 2014, SPINE, V39, P1183, DOI 10.1097/BRS.0000000000000369; Rajasekaran S, 2012, J BONE JOINT SURG BR, V94B, P1024, DOI 10.1302/0301-620X.94B8.29618; Song T, 2011, EUR SPINE J, V20, P422, DOI 10.1007/s00586-010-1587-3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Uda T, 2013, SPINE, V38, P407, DOI 10.1097/BRS.0b013e31826f25a3; Urakawa T, 2011, J NEUROSURG-SPINE, V15, P648, DOI 10.3171/2011.7.SPINE10843; Vedantam A, 2014, NEUROSURGERY, V74, P1, DOI 10.1227/NEU.0000000000000171; Vedantam A, 2011, J NEUROSURG-SPINE, V15, P660, DOI 10.3171/2011.8.SPINE11452; Wells G, 2000, THE NEWCASTLE OTTAWA; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Wen CY, 2013, SPINE J, V13, P697, DOI 10.1016/j.spinee.2013.02.061; Xiangshui M, 2010, CLIN RADIOL, V65, P465, DOI 10.1016/j.crad.2010.01.019	46	34	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117707	10.1371/journal.pone.0117707	http://dx.doi.org/10.1371/journal.pone.0117707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671624	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300068
J	Felappi, JF; Vieira, RC; Fagundes, NJR; Verrastro, LV				Felappi, Jessica F.; Vieira, Renata C.; Fagundes, Nelson J. R.; Verrastro, Laura V.			So Far Away, Yet So Close: Strong Genetic Structure in Homonota uruguayensis (Squamata, Phyllodactylidae), a Species with Restricted Geographic Distribution in the Brazilian and Uruguayan Pampas	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PHENOTYPIC EVOLUTION; HEMIDACTYLUS GECKOS; GUINEA ISLANDS; DNA; MITOCHONDRIAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; DIVERSIFICATION; GEKKONIDAE	The Pampas is a biologically rich South American biome, but is poorly represented in phylogeographic studies. While the Pleistocene glacial cycles may have affected the evolutionary history of species distributed in forested biomes, little is known about their effects on the habitats that remained stable through glacial cycles. The South American Pampas have been covered by grasslands during both glacial and interglacial periods and therefore represent an interesting system to test whether the genetic structure in such environments is less pronounced. In this study, we sampled Pampean populations of Homonota uruguayensis from Southern Brazil and Uruguay to assess the tempo and mode of population divergence, using both morphological measurements and molecular markers. Our results indicate that, in spite of its narrow geographic distribution, populations of H. uruguayensis show high levels of genetic structure. We found four major well-supported mtDNA clades with strong geographic associations. Estimates of their divergence times fell between 3.16 and 1.82 million years before the present. Populations from the central portion of the species distribution, on the border between Uruguay and Brazil, have high genetic diversity and may have undergone a population expansion approximately 250,000 years before the present. The high degree of genetic structure is reflected in the analyses of morphological characters, and most individuals could be correctly assigned to their parental population based on morphology alone. Finally, we discuss the biogeographic and conservation implications of these findings.	[Felappi, Jessica F.; Vieira, Renata C.; Verrastro, Laura V.] Univ Fed Rio Grande do Sul, Dept Zool, Porto Alegre, RS, Brazil; [Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	nelson.fagundes@ufrgs.br; lauraver@ufrgs.br	Verrastro, Laura/I-3243-2012; Fagundes, Nelson/F-7490-2014	Verrastro, Laura/0000-0002-3094-8906; Felappi, Jessica/0000-0003-3814-5646; Fagundes, Nelson/0000-0003-0456-0323	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [479412/2008-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors received funding for this study from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-http://www.cnpq.br/), grant # 479412/2008-1 to LVV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaval F, 2007, ANFIBIOS REPTILES UR; Arnold EN, 2008, ZOOL SCR, V37, P619, DOI 10.1111/j.1463-6409.2008.00351.x; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Behling H, 2005, REV PALAEOBOT PALYNO, V133, P235, DOI 10.1016/j.revpalbo.2004.10.004; BILENCA D, 2004, IDENTIFICACION AREAS; Boldrini I., 2009, CAMPOS SULINOS CONSE, P63; Brown RP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-271; Cabrera AL, 1980, BIOGEOGRAFIA AM LATI, DOI [10.1016/j.ympev.2015.01.003, DOI 10.1016/J.YMPEV.2015.01.003]; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carreira S., 2005, REPTILES URUGUAY; Clegg SM, 2002, EVOLUTION, V56, P2090; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Fernandes FA, 2009, GENETICA, V136, P449, DOI 10.1007/s10709-008-9345-8; Fontoura-Rodrigues ML, 2013, THESIS PONTIFICIA U; Freitas TRO, 2012, J MAMMAL, V93, P1355, DOI DOI 10.1644/12-MAMM-A-007.1; Fu YX, 1997, GENETICS, V147, P915; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Grela I.A., 2004, THESIS U REPUBLICA U; Gudynas E., 1981, ASRA Journal, V1, P13; Gudynas E., 1986, Contribuciones en Biologia Centro Educativo Don Orione, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2004, MOL PHYLOGENET EVOL, V30, P855, DOI 10.1016/S1055-7903(03)00260-4; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Jesus J, 2006, HERPETOL J, V16, P291; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Ljubisavljevic Katarina, 2007, Zootaxa, V1613, P1; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MANTEL N, 1967, CANCER RES, V27, P209; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Miller JR, 2008, GENETICS, V180, P1023, DOI 10.1534/genetics.108.092031; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Morando M, 2014, ZOOL SCR, V43, P249, DOI 10.1111/zsc.12052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nascimento FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061924; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Passoni JC, 2008, MOL PHYLOGENET EVOL, V46, P403, DOI 10.1016/j.ympev.2007.10.022; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Piantoni C, 2006, AMPHIBIA-REPTILIA, V27, P393, DOI 10.1163/156853806778190060; Polly P.D., 2004, PALAEONTOL ELECTRON, V7, p7A; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Siedchlag AC, 2010, MOL PHYLOGENET EVOL, V56, P622, DOI 10.1016/j.ympev.2010.04.027; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Speranza PR, 2007, J BIOGEOGR, V34, P427, DOI 10.1111/j.1365-2699.2006.01622.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres-Perez F, 2007, J ZOOL SYST EVOL RES, V45, P72, DOI 10.1111/j.1439-0469.2006.00392.x; Turchetto C, 2014, MOL ECOL, V23, P374, DOI 10.1111/mec.12632; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vaz-Ferreira R, 1973, B SOC ZOOLOGICA URUG, V2, P53, DOI [10.1016/j.anireprosci.2014.07.023, DOI 10.1016/J.ANIREPROSCI.2014.07.023]; Vaz-Ferreira R, 1965, REV FACULTAD HUMANID, V22, P239; Vieira RC, 2012, THESIS U FEDERAL RIO; Werneck FP, 2012, EVOLUTION, V66, P3014, DOI 10.1111/j.1558-5646.2012.01682.x; Wlasiuk G, 2003, EVOLUTION, V57, P913; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x	83	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118162	10.1371/journal.pone.0118162	http://dx.doi.org/10.1371/journal.pone.0118162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692471	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500105
J	Tao, ZC; Li, CL; Sun, S				Tao, Zhencheng; Li, Chaolun; Sun, Song			Grazing and Metabolism of Euphausia pacifica in the Yellow Sea	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; TROPHIC INTERACTIONS; POPULATION-STRUCTURE; NITROGEN BUDGETS; ANTARCTIC KRILL; CHLOROPHYLL-A; JAPAN SEA; CARBON; GROWTH; ZOOPLANKTON	Grazing and metabolism of Euphausia pacifica in the Yellow Sea were studied from September 2006 to August 2007. Euphausia pacifica is a selective-feeding omnivore and grazing rates among different months were monitored using a Coulter Counter and batch culture feeding experiments. Euphausia pacifica mainly grazed microzooplankton in August and September, which resulted in an increase in chlorophyll a concentration. Oxygen consumption rate of E. pacifica was 38.7-42.5 mu mol O-2 g(-1) DW h(-1) in March, which was four times higher than the oxygen consumption rates in September and December. The vigorous metabolism of E. pacifica in March consumed 3.1% of body carbon daily, which is likely related to its high reproduction and grazing rate. Respiration and metabolism of E. pacifica in September and December were similar and were lower. O:N ratio of E. pacifica was the highest (17.3-23.8) in March when spawning activity occurred and when food was abundant. The energetic source of E. pacifica during September and December was mostly protein from eating a carnivorous diet, including such items as microzooplankton. Euphausia pacifica was found in cold water at the bottom of the Yellow Sea in summer and autumn and maintained a low consumption status. O: N ratios of E. pacifica in March, September, and December were negatively correlated with SSTs and no significant correlation was found between O: N ratios and chlorophyll a concentration. Seawater temperature is clearly the most important parameter influencing the metabolism of E. pacifica.	[Tao, Zhencheng; Li, Chaolun; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Sun, Song] Chinese Acad Sci, Inst Oceanol, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Sun, S (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	sunsong@qdio.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chaolun/0000-0003-1890-0587; Zhencheng, TAO/0000-0002-5948-0171	National Natural Science Foundation of P. R. China [41306155, 41230963]; National Key Basic Research Program of China [2011CB403604]	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of P. R. China (No. 41306155 and 41230963), and National Key Basic Research Program of China (No. 2011CB403604).	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; [Anonymous], 1984, J OCEANOL SOC KOREA; BODEN BRIAN P., 1955, BULL SCRIPPS INST OCEANOGR TECH SER, V6, P287; Brinton E., 1962, B SCRIPPS I OCEANOGR, V8, P21; Bryan AK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Cai B, 1986, S CHINESE CRUSTACEAN, V1, P140; Calbet A, 1999, LIMNOL OCEANOGR, V44, P1370, DOI 10.4319/lo.1999.44.6.1370; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chang J, 2003, DEEP-SEA RES PT II, V50, P1237, DOI 10.1016/S0967-0645(03)00020-1; da Costa RM, 2012, HARMFUL ALGAE, V17, P75, DOI 10.1016/j.hal.2012.03.002; Dilling L, 1998, MAR ECOL PROG SER, V170, P189, DOI 10.3354/meps170189; Du XN, 2014, J PLANKTON RES, V36, P1031, DOI 10.1093/plankt/fbu027; Endo Y, 1981, ECOLOGICAL STUDIES E; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Guo DH, 2003, ACTA OCEANOL SIN, V22, P265; He C.B., 1959, OCEANOL LIMNOL SINIC, V2, P11; Iguchi N, 2004, PROG OCEANOGR, V61, P213, DOI 10.1016/j.pocean.2004.06.007; IGUCHI N, 1995, J PLANKTON RES, V17, P1757, DOI 10.1093/plankt/17.9.1757; IKEDA T, 1974, Memoirs of the Faculty of Fisheries Hokkaido University, V22, P1; IKEDA T, 1984, POLAR BIOL, V3, P1, DOI 10.1007/BF00265561; Kang YD, 1966, S 9 C W PAC FISH RES; Kim HS, 2010, DEEP-SEA RES PT II, V57, P1733, DOI 10.1016/j.dsr2.2010.03.017; Kim H, 2013, LIMNOL OCEANOGR-METH, V11, P382, DOI 10.4319/lom.2013.11.382; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LASKER R, 1966, J FISH RES BOARD CAN, V23, P1291, DOI 10.1139/f66-121; LIE HJ, 1986, PROG OCEANOGR, V17, P229, DOI 10.1016/0079-6611(86)90046-7; Lu SG, 2009, CHIN J OCEANOL LIMN, V27, P793, DOI 10.1007/s00343-009-9221-0; MACKAS D, 1976, J EXP MAR BIOL ECOL, V25, P77, DOI 10.1016/0022-0981(76)90077-0; Mauchline J, 1969, Adv. mar. Biol., V7, P1; MAYZAUD P, 1973, MAR BIOL, V21, P19, DOI 10.1007/BF00351188; MAYZAUD P, 1988, MAR ECOL PROG SER, V45, P289, DOI 10.3354/meps045289; [孟田湘 Meng Tianxiang], 2003, [海洋水产研究, Marine Fisheries Research], V24, P1; Nakagawa Y, 2004, MAR ECOL PROG SER, V271, P261, DOI 10.3354/meps271261; Nakagawa Yoshizumi, 2001, Plankton Biology and Ecology, V48, P68; OHMAN MD, 1984, MAR ECOL PROG SER, V19, P125, DOI 10.3354/meps019125; Pagano M, 2003, ESTUAR COAST SHELF S, V56, P433, DOI 10.1016/S0272-7714(02)00193-2; Pagano M, 1998, HYDROBIOLOGIA, V390, P83, DOI 10.1023/A:1003561821745; Pinchuk AI, 2007, MAR BIOL, V151, P257, DOI 10.1007/s00227-006-0483-1; Ponomareva LA, 1966, EUPHAUSIIDS N PACIFI; Pu XM, 2004, J PLANKTON RES, V26, P1049, DOI 10.1093/plankt/fbh097; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; ROSS RM, 1982, MAR BIOL, V68, P15, DOI 10.1007/BF00393136; ROSS RM, 1981, LIMNOL OCEANOGR, V26, P235, DOI 10.4319/lo.1981.26.2.0235; ROSS RM, 1982, MAR BIOL, V68, P1, DOI 10.1007/BF00393135; Saborowski R, 2002, MAR BIOL, V140, P547; Shaw CT, 2010, DEEP-SEA RES PT II, V57, P584, DOI 10.1016/j.dsr2.2009.10.008; Shaw T.L., 2006, PROTOCOLS MEASURING; SMALL LF, 1967, LIMNOL OCEANOGR, V12, P272, DOI 10.4319/lo.1967.12.2.0272; SUH HL, 1991, MAR BIOL, V111, P45, DOI 10.1007/BF01986344; Sun S, 2011, J PLANKTON RES, V33, P873, DOI 10.1093/plankt/fbq160; Sun S, 2010, DEEP-SEA RES PT II, V57, P1006, DOI 10.1016/j.dsr2.2010.02.002; Swadling KM, 2005, MAR BIOL, V146, P1169, DOI 10.1007/s00227-004-1519-z; Taki K, 2010, J PLANKTON RES, V32, P761, DOI 10.1093/plankt/fbq027; TORRES JJ, 1983, MAR BIOL, V74, P79, DOI 10.1007/BF00394278; Wang R, 2003, J FISH CHINA S, V27, P31; Wang Rong, 2004, Ocean Science Journal, V39, P1; Wang XJ, 2005, FISHERY MODERNIZATIO, V3, P37; WIDDOWS J, 1978, J MAR BIOL ASSOC UK, V58, P125, DOI 10.1017/S0025315400024450; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]; Xue Ying, 2004, Journal of Fishery Sciences of China, V11, P420; Yoon WD, 2000, J PLANKTON RES, V22, P939, DOI 10.1093/plankt/22.5.939; Yu Y, 2014, MAR BIOL RES, V10, P641, DOI 10.1080/17451000.2013.852683; Zhang WC, 2006, HYDROBIOLOGIA, V553, P357, DOI 10.1007/s10750-005-0857-2; Zhang WC, 2002, AQUAT MICROB ECOL, V27, P249, DOI 10.3354/ame027249	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115825	10.1371/journal.pone.0115825	http://dx.doi.org/10.1371/journal.pone.0115825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688560	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700005
J	Chakraborty, A; Mahapatra, T; Mahapatra, S; Ansari, S; Siddhanta, S; Banerjee, S; Banerjee, D; Sarkar, RN; Guha, SK; Chakraborty, N				Chakraborty, Avirup; Mahapatra, Tanmay; Mahapatra, Sanchita; Ansari, Sabbir; Siddhanta, Sattik; Banerjee, Siwalik; Banerjee, Dipanjan; Sarkar, Rathindra Nath; Guha, Subhashish Kamal; Chakraborty, Nilanjan			Distribution and Determinants of Cytomegalovirus Induced End Organ Disease/s among People Living with HIV/AIDS in a Poor Resource Setting: Observation from India	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; AIDS; MORTALITY; SURVIVAL; VIRUS; VIREMIA; PREDICTORS; AUTOPSY	Background In India, despite well-established anti-retroviral treatment programs, Cytomegalovirus (CMV) infection-related end-organ diseases (EODs) still remain a major concern resulting in exacerbation of morbidity and mortality among HIV/AIDS patients. A prospective study was designed to understand the distribution and prognosis of CMV associated EODs and to determine a standardized cut-off value for serum CMV viral load associated with the development of EODs amongst HIV/AIDS subjects. Methods In a cohort of 400 late-diagnosed HAART naive HIV/AIDS subjects attending anti-retroviral centers of Kolkata during 2008-2014, the median duration of follow-up was 560 days, and at least 3 visits subsequent to the baseline were mandatory for eligibility. HIV-1 and CMV viral load were estimated by performing Real-Time Polymerase Chain Reactions (PCR). Results Among subjects, 40.5% (162/400) had CMV EODs which were more common at lower CD4 counts. Poor prognosis and higher death rate were associated with a low CD4 count and increased HIV-1 and CMV viral loads. Subjects having higher CD4 count responded better to therapy [for CD4 = 60-100: Risk Ratio: RR = 1.48 (95% Confidence Interval: 95% CI = 1.181.82) and for CD4 = 30-59: RR = 1.64 (95% CI = 1.18-2.27)]. The cut off value of the serum CMV viral load (expressed as log10DNA/ml serum) associated with the development of EODs and disseminated CMV EODs was determined as 5.4 (p<0.0001) and 6.4 (p<0.0001) respectively. These cut offs were found to have satisfactorily high sensitivity, specificity, positive and negative predictive values. Conclusion Prognosis of CMV EOD was poor as indicated by higher death rates among subjects with lower CD4 count, and specific cut-off values were found to have useful potential for identification and treatment of CMV infected HIV/AIDS patients in due time to avoid CMV EODs among HIV/AIDS subjects. Targeted intervention programs seemed to be required urgently to make these cut-offs operational in order to minimize the burden of CMV EOD in this vulnerable population.	[Chakraborty, Avirup; Ansari, Sabbir; Chakraborty, Nilanjan] ID & BG Hosp, ICMR Virus Unit, Kolkata 700010, India; [Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Siddhanta, Sattik; Banerjee, Siwalik; Sarkar, Rathindra Nath] Calcutta Med Coll & Hosp, Dept Gen Med, Kolkata 700073, India; [Banerjee, Dipanjan] Calcutta Med Coll & Hosp, Apex Clin, Kolkata 700073, India; [Guha, Subhashish Kamal] Sch Trop Med, Dept Virol, Kolkata 700073, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; University of California System; University of California Los Angeles; Calcutta School of Tropical Medicine (CSTM)	Chakraborty, N (corresponding author), ID & BG Hosp, ICMR Virus Unit, GB4,57 Dr SC Banerjee Rd Beliaghata, Kolkata 700010, India.	nilanjan_19@yahoo.com			Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India	Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India	The current research (Principal Investigator: NC) was funded by the Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India (http://icmrvirusunit.org.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama V, 2014, J MED VIROL, V86, P1821, DOI 10.1002/jmv.24027; Brooks GF, 2007, JAWETZ MELNICK ADELB, P428; COLLIER AC, 1987, AM J MED, V82, P593, DOI 10.1016/0002-9343(87)90105-7; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; DREW WL, 1992, CLIN INFECT DIS, V14, P608, DOI 10.1093/clinids/14.2.608-a; Erice A, 2003, CLIN INFECT DIS, V37, P567, DOI 10.1086/375843; GERNA G, 1990, AIDS, V4, P1027, DOI 10.1097/00002030-199010000-00014; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; JACOBSON MA, 1988, ANN INTERN MED, V108, P585, DOI 10.7326/0003-4819-108-4-585; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; KALAYJIAN RC, 1993, MEDICINE, V72, P67, DOI 10.1097/00005792-199303000-00001; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Monforte AD, 1997, AIDS, V11, P517, DOI 10.1097/00002030-199704000-00016; MORGELLO S, 1987, HUM PATHOL, V18, P289, DOI 10.1016/S0046-8177(87)80012-6; RodriguezBarradas MC, 1996, CLIN INFECT DIS, V23, P76, DOI 10.1093/clinids/23.1.76; Shepp DH, 1996, J ACQ IMMUN DEF SYND, V11, P460, DOI 10.1097/00042560-199604150-00006; Spector SA, 1996, J INT ASS PHYS AIDS, V2, P15; Walmsley SL, 2001, ANTIVIR THER, V6, P47; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143; Wohl DA, 2005, JAIDS-J ACQ IMM DEF, V38, P538, DOI 10.1097/01.qai.0000155204.96973.c3	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117466	10.1371/journal.pone.0117466	http://dx.doi.org/10.1371/journal.pone.0117466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679798	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600066
J	Dorraki, M; Cambrell, GK; Abbott, D				Dorraki, Mohsen; Cambrell, Gregory K.; Abbott, Derek			Analysis of the Transient Response of a Dual-Fed RC Transmission Line	PLOS ONE			English	Article							DELAY ANALYSIS	The transient analysis of a uniform transmission line of finite length is considered in this paper. For the first time this paper provides an analytical expression for the time-domain response of an RC transmission line, which is stimulated by a step function that is fed into both ends of the transmission line. In particular, we find an analytical expression for the step response at the center of the transmission line, in order to determine the worst-case rise time. This is of interest, for example, in large charge-coupled device (CCD) arrays, where long polysilicon lines are dual-fed in order to mitigate degradation in rise time. The analytical expressions for the RC transmission line are supported by computer-simulated lumped RC models.	[Dorraki, Mohsen] Amirkabir Univ Technol, Dept Elect Engn, Tehran, Iran; [Cambrell, Gregory K.] Monash Univ, Fac Engn, Dept Elect & Comp Syst Engn, Clayton, Vic 3800, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia	Amirkabir University of Technology; Monash University; University of Adelaide	Dorraki, M (corresponding author), Amirkabir Univ Technol, Dept Elect Engn, Tehran, Iran.	dorraki@aut.ac.ir	Abbott, Derek/E-8352-2011; Dorraki, Mohsen/J-6393-2019	Abbott, Derek/0000-0002-0945-2674; Dorraki, Mohsen/0000-0002-6675-3393				Gupta S, 1999, TWELFTH INTERNATIONAL CONFERENCE ON VLSI DESIGN, PROCEEDINGS, P160, DOI 10.1109/ICVD.1999.745142; Kahng A. B., 1997, ACM Transactions on Design Automation of Electronic Systems, V2, P168, DOI 10.1145/253052.253137; KAHNG AB, 1994, ACM IEEE D, P563; KAMASZ SR, 1993, P SOC PHOTO-OPT INS, V1900, P147, DOI 10.1117/12.148593; Ng J, 2002, MICROELECTRON J, V33, P171, DOI 10.1016/S0026-2692(01)00116-1; PEIRSON RC, 1969, J APPL PHYS, V40, P118, DOI 10.1063/1.1657014; RAO VB, 1995, DES AUT CON, P370; SAKURAI T, 1983, IEEE J SOLID-ST CIRC, V18, P418, DOI 10.1109/JSSC.1983.1051966	8	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116993	10.1371/journal.pone.0116993	http://dx.doi.org/10.1371/journal.pone.0116993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679379	Green Published, gold			2022-12-27	WOS:000350682600043
J	Heskamp, S; Boerman, OC; Molkenboer-Kuenen, JDM; Wauters, CA; Strobbe, LJA; Mandigers, CMPW; Bult, P; Oyen, WJG; van der Graaf, WTA; van Laarhoven, HWM				Heskamp, Sandra; Boerman, Otto C.; Molkenboer-Kuenen, Janneke D. M.; Wauters, Carla A.; Strobbe, Luc J. A.; Mandigers, Caroline M. P. W.; Bult, Peter; Oyen, Wim J. G.; van der Graaf, Winette T. A.; van Laarhoven, Hanneke W. M.			Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients	PLOS ONE			English	Article							GROWTH-FACTOR-I; MONOCLONAL-ANTIBODY; FACTOR RECEPTOR; TRASTUZUMAB RESISTANCE; COLORECTAL-CANCER; EWING SARCOMA; PHASE-II; CELLS; PATHWAY; SENSITIVITY	Introduction The insulin-like growth factor 1 receptor (IGF-1R) may be involved in the development of resistance against conventional cancer treatment. The aim of this study was to assess whether IGF-1R expression of breast tumors changes during neoadjuvant therapy and to study whether these changes were associated with survival. Methods Paraffin embedded tumor tissue was collected from pretreatment biopsies and surgical resections of 62 breast cancer patients who were treated with neoadjuvant chemotherapy or endocrine therapy. IGF-1R expression was determined immunohistochemically and compared before and after treatment. Results High membranous IGF-1R expression at diagnosis correlated significantly with ER positivity, low tumor stage (stage I/II) and longer overall survival (p < 0.05). After neoadjuvant treatment, membranous IGF-1R expression remained the same in 41 (65%) tumors, was upregulated in 11 (18%) tumors and downregulated in 11 (18%) tumors. Changes in membranous IGF-1R expression were associated with overall survival (log-rank test: p = 0.013, multivariate cox-regression: p = 0.086). Mean overall survival time for upregulation, no change, and downregulation in IGF-1R expression was 3.0 +/- 0.5 years, 7.3 +/- 1.0 years and 15.0 +/- 1.8 years, respectively. Changes in other parameters were not significantly associated with survival. Conclusion Neoadjuvant therapy can induce changes in IGF-1R expression. Upregulation of IGF-1R expression after neoadjuvant treatment is a poor prognostic factor in breast cancer patients, providing a rationale for incorporating anti-IGF-1R drugs in the management of these patients.	[Heskamp, Sandra; Boerman, Otto C.; Molkenboer-Kuenen, Janneke D. M.; Oyen, Wim J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen, Netherlands; [Heskamp, Sandra; van der Graaf, Winette T. A.; van Laarhoven, Hanneke W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands; [Wauters, Carla A.] Canisius Wilhelmina Hosp, Dept Pathol, Nijmegen, Netherlands; [Strobbe, Luc J. A.] Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; [Mandigers, Caroline M. P. W.] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Heskamp, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen, Netherlands.	sandra.heskamp@radboudumc.nl	van Laarhoven, Hanneke/AAW-3464-2021; Boerman, Otto C/A-8112-2014; Strobbe, Luc JA/N-8760-2018; van der Graaf, Winette T/A-5006-2014; Heskamp, Sandra/O-8762-2015; Bult, Peter/L-4236-2015; Oyen, Wim J.G./D-4178-2009; Oyen, Wim J.G./AAD-3373-2020	Boerman, Otto C/0000-0001-6832-101X; van der Graaf, Winette T/0000-0001-7549-3338; Heskamp, Sandra/0000-0001-7250-0846; Bult, Peter/0000-0001-6427-9889; Oyen, Wim J.G./0000-0001-8235-7078; Oyen, Wim J.G./0000-0001-8235-7078; van Laarhoven, H.W.M./0000-0003-1274-5643	Dutch Research Council for Hanneke van Laarhoven [016.096.010]	Dutch Research Council for Hanneke van Laarhoven	This study was financially supported by a personal research grant of the Dutch Research Council for Hanneke van Laarhoven (016.096.010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedos M, 2009, ANN ONCOL, V20, P1948, DOI 10.1093/annonc/mdp234; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Dunn SE, 1997, CANCER RES, V57, P2687; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Feldser D, 1999, CANCER RES, V59, P3915; FOEKENS JA, 1989, CANCER, V63, P2139, DOI 10.1002/1097-0142(19890601)63:11<2139::AID-CNCR2820631112>3.0.CO;2-D; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167; Guo YS, 1998, J CELL PHYSIOL, V175, P141, DOI 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Harris LN, 2007, CLIN CANCER RES, V13, P1198, DOI 10.1158/1078-0432.CCR-06-1304; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Heskamp S, 2014, MOL IMAGING BIOL, V16, P529, DOI 10.1007/s11307-014-0723-6; Kaufman PA, 2010, CANCER RES, V70, DOI 10.1158/0008-5472.SABCS10-S1-4; Kim JH, 2010, ONCOL REP, V23, P989, DOI 10.3892/or_00000724; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Malempati S, 2012, J CLIN ONCOL, V30, P256, DOI 10.1200/JCO.2011.37.4355; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; PAPA V, 1993, CANCER RES, V53, P3736; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; PEYRAT JP, 1988, CANCER RES, V48, P6429; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; STEWART AJ, 1990, J BIOL CHEM, V265, P21172; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Tong LC, 2011, AM J SURG PATHOL, V35, P545, DOI 10.1097/PAS.0b013e31820e6237; Watkins D, 2011, J CLIN ONCOL S, V29; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	38	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117745	10.1371/journal.pone.0117745	http://dx.doi.org/10.1371/journal.pone.0117745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680198	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600083
J	Leong, SL; Hinds, MG; Connor, AR; Smith, DP; Illes-Toth, E; Pham, CLL; Barnham, KJ; Cappai, R				Leong, Su Ling; Hinds, Mark G.; Connor, Andrea R.; Smith, David P.; Illes-Toth, Eva; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto			The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated alpha-Synuclein Dimerisation	PLOS ONE			English	Article							SPECTROMETRY-MASS SPECTROMETRY; PARKINSONS-DISEASE; ELECTROSPRAY-IONIZATION; UNFOLDED PROTEINS; NMR-SPECTROSCOPY; AMYLOID FIBRILS; CONFORMATIONAL STATES; SECONDARY STRUCTURE; CHEMICAL-SHIFTS; BINDING	alpha-synuclein (alpha-syn) is a major component of the intracellular inclusions called Lewy bodies, which are a key pathological feature in the brains of Parkinson's disease patients. The neurotransmitter dopamine (DA) inhibits the fibrillisation of alpha-syn into amyloid, and promotes alpha-syn aggregation into SDS-stable soluble oligomers. While this inhibition of amyloid formation requires the oxidation of both DA and the methionines in alpha-syn, the molecular basis for these processes is still unclear. This study sought to define the protein sequences required for the generation of oligomers. We tested N-(alpha-syn residues 43-140) and C-terminally (1-95) truncated alpha-syn, and found that similar to full-length protein both truncated species formed soluble DA: alpha-syn oligomers, albeit 1-95 had a different profile. Using nuclear magnetic resonance (NMR), and the N- terminally truncated alpha-syn 43-140 protein, we analysed the structural characteristics of the DA: alpha-syn 43-140 dimer and alpha-syn 43-140 monomer and found the dimerisation interface encompassed residues 43 to 60. Narrowing the interface to this small region will help define the mechanism by which DA mediates the formation of SDS-stable soluble DA: alpha-syn oligomers.	[Leong, Su Ling; Connor, Andrea R.; Pham, Chi L. L.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Leong, Su Ling; Hinds, Mark G.; Connor, Andrea R.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hinds, Mark G.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Smith, David P.; Illes-Toth, Eva] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Barnham, Kevin J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Sheffield Hallam University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Cappai, R (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.	r.cappai@unimelb.edu.au	Hinds, Mark Gavin/AAD-3653-2020; Cappai, Roberto/B-3347-2010	Hinds, Mark Gavin/0000-0002-2856-5375; Wuthrich, Kurt/0000-0001-8739-6965; Illes-Toth, Eva/0000-0001-5232-8196; Smith, David/0000-0001-5177-8574; Cappai, Roberto/0000-0002-9505-8496	National Health and Medical Research Council of Australia [628946]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia, Program Grant 628946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Bae EJ, 2013, ANTIOXID REDOX SIGN, V18, P770, DOI 10.1089/ars.2011.4429; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hokenson MJ, 2004, BIOCHEMISTRY-US, V43, P4621, DOI 10.1021/bi049979h; Illes-Toth E, 2013, J AM SOC MASS SPECTR, V24, P1346, DOI 10.1007/s13361-013-0676-z; Ito S, 2010, NEUROSCI RES, V66, P124, DOI 10.1016/j.neures.2009.10.005; Jain MK, 2014, NEUROBIOL DIS, V63, P115, DOI 10.1016/j.nbd.2013.11.004; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kahle PJ, 2002, J NEUROCHEM, V82, P449, DOI 10.1046/j.1471-4159.2002.01020.x; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511+; Keller R., 2004, COMPUTER AIDED RESON, V1; Kjaergaard M, 2012, PROG NUCL MAG RES SP, V60, P42, DOI 10.1016/j.pnmrs.2011.10.001; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pham CLL, 2013, BIOSCIENCE REP, V33, P807, DOI 10.1042/BSR20130092; Pham CLL, 2014, PROTEINS, V82, P10, DOI 10.1002/prot.24332; Pham CLL, 2009, J MOL BIOL, V387, P771, DOI 10.1016/j.jmb.2009.02.007; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Planchard MS, 2014, PROTEIN SCI, V23, P1369, DOI 10.1002/pro.2521; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Yamaguchi Y, 2010, J MOL BIOL, V395, P445, DOI 10.1016/j.jmb.2009.10.068; Yamakawa K, 2010, BIOCHEM BIOPH RES CO, V391, P129, DOI 10.1016/j.bbrc.2009.11.015; Zijlstra N, 2014, BIOPHYS J, V106, P440, DOI 10.1016/j.bpj.2013.12.009	60	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116497	10.1371/journal.pone.0116497	http://dx.doi.org/10.1371/journal.pone.0116497			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679387	Green Published, gold, Green Accepted			2022-12-27	WOS:000350682600022
J	Sroga, GE; Siddula, A; Vashishth, D				Sroga, Grazyna E.; Siddula, Alankrita; Vashishth, Deepak			Glycation of Human Cortical and Cancellous Bone Captures Differences in the Formation of Maillard Reaction Products between Glucose and Ribose	PLOS ONE			English	Article							FRUCTOSE CORN SYRUP; INSULIN-RESISTANCE; NONENZYMATIC GLYCATION; SWEETENED BEVERAGES; CROSS-LINKS; BIOMECHANICAL PROPERTIES; MATRIX PROTEINS; TISSUE PROTEINS; END-PRODUCTS; COLLAGEN	To better understand some aspects of bone matrix glycation, we used an in vitro glycation approach. Within two weeks, our glycation procedures led to the formation of advanced glycation end products (AGEs) at the levels that corresponded to approx. 25-30 years of the natural in vivo glycation. Cortical and cancellous bones from human tibias were glycated in vitro using either glucose (glucosylation) or ribose (ribosylation). Both glucosylation and ribosylation led to the formation of higher levels of AGEs and pentosidine (PEN) in cancellous than cortical bone dissected from all tested donors (young, middle-age and elderly men and women). More efficient glycation of bone matrix proteins in cancellous bone most likely depended on the higher porosity of this tissue, which facilitated better accessibility of the sugars to the matrix proteins. Notably, glycation of cortical bone from older donors led to much higher AGEs levels as compared to young donors. Such efficient in vitro glycation of older cortical bone could result from aging-related increase in porosity caused by the loss of mineral content. In addition, more pronounced glycation in vivo would be driven by elevated oxidation processes. Interestingly, the levels of PEN formation differed pronouncedly between glucosylation and ribosylation. Ribosylation generated very high levels of PEN (approx. 6-vs. 2.5-fold higher PEN level than in glucosylated samples). Kinetic studies of AGEs and PEN formation in human cortical and cancellous bone matrix confirmed higher accumulation of fluorescent crosslinks for ribosylation. Our results suggest that in vitro glycation of bone using glucose leads to the formation of lower levels of AGEs including PEN, whereas ribosylation appears to support a pathway toward PEN formation. Our studies may help to understand differences in the progression of bone pathologies related to protein glycation by different sugars, and raise awareness for excessive sugar supplementation in food and drinks.	[Sroga, Grazyna E.; Siddula, Alankrita; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Vashishth, D (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	vashid@rpi.edu		Vashishth, Deepak/0000-0001-5712-0167	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [AG20618, AR49635]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020618, R56AG020618] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Numbers AG20618 and AR49635. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors acknowledge use of human bone tissues provided by the National Disease Research Interchange (NDRI) with support from NIH grant 5 U42 RR006042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTLE JP, 1983, NEW ENGL J MED, V309, P7, DOI 10.1056/NEJM198307073090102; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; BROOM AD, 1964, BIOCHEMISTRY-US, V3, P494, DOI 10.1021/bi00892a005; Cai WJ, 2014, P NATL ACAD SCI USA, V111, P4940, DOI 10.1073/pnas.1316013111; CHANG RS, 1960, J EXP MED, V111, P235, DOI 10.1084/jem.111.2.235; Clark PM, 2014, P NATL ACAD SCI USA, V111, pE2866, DOI 10.1073/pnas.1410326111; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Fayle S.E., 2002, MAILLARD REACTION, P1; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gross LS, 2004, AM J CLIN NUTR, V79, P774; GROSS M, 1991, KLIN WOCHENSCHR, V69, P31, DOI 10.1007/BF01649054; GUNDBERG CM, 1986, J BIOL CHEM, V261, P4557; Han CSA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024623; HANOVER LM, 1993, AM J CLIN NUTR, V58, P724, DOI 10.1093/ajcn/58.5.724S; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Jilka RL, 2014, J BONE MINER RES, V29, P103, DOI 10.1002/jbmr.2007; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; KATZ J., 1955, JOUR BIOL CHEM, V214, P853; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Laroque D, 2008, FOOD CHEM, V111, P1032, DOI 10.1016/j.foodchem.2008.05.033; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Lowndes J, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-55; MAHONEY JR, 1989, J SURG RES, V47, P530, DOI 10.1016/0022-4804(89)90131-5; Malerbi DA, 1996, DIABETES CARE, V19, P1249, DOI 10.2337/diacare.19.11.1249; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Nikel O, 2013, LANGMUIR, V29, P13873, DOI 10.1021/la403203w; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Nursten HE, 2005, MAILLARD REACTION: CHEMISTRY, BIOCHEMISTRY AND IMPLICATIONS, P1, DOI 10.1039/9781847552570; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223; RACKER E, 1961, ADV ENZYMOL REL S BI, V23, P323; RAHBAR S, 1969, BIOCHEM BIOPH RES CO, V36, P838, DOI 10.1016/0006-291X(69)90685-8; REITZER LJ, 1980, J BIOL CHEM, V255, P5616; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stanhope KL, 2008, AM J CLIN NUTR, V88, p1733S, DOI 10.3945/ajcn.2008.25825D; Su T, 2013, PROG BIOCHEM BIOPHYS, V40, P816, DOI 10.3724/SP.J.1206.2013.00341; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Teitelbaum JE, 2006, J ALTERN COMPLEM MED, V12, P857, DOI 10.1089/acm.2006.12.857; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viviani GL, 2008, METABOLISM, V57, P163, DOI 10.1016/j.metabol.2007.08.020; Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wei Y, 2012, BBA-GEN SUBJECTS, V1820, P488, DOI 10.1016/j.bbagen.2012.01.005; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7	63	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117240	10.1371/journal.pone.0117240	http://dx.doi.org/10.1371/journal.pone.0117240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679213	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600056
J	Caverly, LJ; Caceres, SM; Fratelli, C; Happoldt, C; Kidwell, KM; Malcolm, KC; Nick, JA; Nichols, DP				Caverly, Lindsay J.; Caceres, Silvia M.; Fratelli, Cori; Happoldt, Carrie; Kidwell, Kelley M.; Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.			Mycobacterium abscessus Morphotype Comparison in a Murine Model	PLOS ONE			English	Article							FIBROSIS LUNG-DISEASE; CYSTIC-FIBROSIS; NONTUBERCULOUS-MYCOBACTERIA; PSEUDOMONAS-AERUGINOSA; PULMONARY INFECTION; MICE; ROUGH; MASSILIENSE; PREVALENCE; INDUCTION	Pulmonary infections with Mycobacterium abscessus (M. abscessus) are increasingly prevalent in patients with lung diseases such as cystic fibrosis. M. abscessus exists in two morphotypes, smooth and rough, but the impact of morphotype on virulence is unclear. We developed an immune competent mouse model of pulmonary M. abscessus infection and tested the differences in host inflammatory response between the morphotypes of M. abscessus. Smooth and rough morphotypes of M. abscessus were isolated from the same American Type Culture Collection strain. Wild type and cystic fibrosis mice were intratracheally inoculated with known quantities of M. abscessus suspended in fibrin plugs. At the time of sacrifice lung and splenic tissues and bronchoalveolar lavage fluid were collected and cultured. Bronchoalveolar lavage fluid was analyzed for leukocyte count, differential and cytokine expression. Pulmonary infection with M. abscessus was present at both 3 days and 14 days post-inoculation in all groups at greater levels than systemic infection. Inoculation with M. abscessus rough morphotype resulted in more bronchoalveolar lavage fluid neutrophils compared to smooth morphotype at 14 days post-inoculation in both wild type (p = 0.01) and cystic fibrosis (p<0.01) mice. Spontaneous in vivo conversion from smooth to rough morphotype occurred in 12/57 (21%) of mice. These mice trended towards greater weight loss than mice in which morphotype conversion did not occur. In the described fibrin plug model of M. abscessus infection, pulmonary infection with minimal systemic dissemination is achieved with both smooth and rough morphotypes. In this model M. abscessus rough morphotype causes a greater host inflammatory response than the smooth based on bronchoalveolar lavage fluid neutrophil levels.	[Caverly, Lindsay J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Caceres, Silvia M.; Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Fratelli, Cori; Happoldt, Carrie; Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Kidwell, Kelley M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.] Univ Colorado Denver, Dept Med, Aurora, CO USA	University of Michigan System; University of Michigan; National Jewish Health; National Jewish Health; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Caverly, LJ (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	caverlyl@med.umich.edu		Kidwell, Kelley M/0000-0002-1717-4483; Nichols, David/0000-0001-8611-7960	Cystic fibrosis foundation [CAVERL13D0]; National Institute of Health [K12HD028820, T32HL007670, KL2 TR000156]; Charles Woodson Fund for Clinical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, KL2TR001080, KL2TR000156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007670] Funding Source: NIH RePORTER	Cystic fibrosis foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Woodson Fund for Clinical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by Cystic fibrosis foundation, www.cff.org: grant number CAVERL13D0 to author: LJC, National Institute of Health, www.nih.gov: grant numbers K12HD028820, T32HL007670 to author: LJC, grant number KL2 TR000156 to author: DPN and Charles Woodson Fund for Clinical Research, www.charleswoodsonfoundation.org to author: KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Ballarino GJ, 2009, RESP MED, V103, P1448, DOI 10.1016/j.rmed.2009.04.026; Bryant JM, 2013, LANCET, DOI [10.1016/S2214-109X(13)70180-3, DOI 10.1016/S2214-109X(13)70180-3]; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Cardona PJ, 1999, SCAND J IMMUNOL, V49, P362; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Caverly L F C, 2012, AJRCCM, P185; Chan ED, 2013, SEMIN RESP CRIT CARE, V34, P110, DOI 10.1055/s-0033-1333573; Chandler JD, 2013, BRIT J PHARMACOL, V169, P1166, DOI 10.1111/bph.12206; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Irvin Charles G, 2009, Proc Am Thorac Soc, V6, P306, DOI 10.1513/pats.200808-091RM; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; Jeon BY, 2009, J MICROBIOL, V47, P633, DOI 10.1007/s12275-009-0139-1; Jonsson B, 2013, APMIS, V121, P45, DOI 10.1111/j.1600-0463.2012.02932.x; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Leung JM, 2013, SEMIN RESP CRIT CARE, V34, P124, DOI 10.1055/s-0033-1333574; Madsen Priscilla, 2005, Paediatr Respir Rev, V6, P292; Malcolm KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057402; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Martiniano Stacey L, 2014, Ann Am Thorac Soc, V11, P36, DOI 10.1513/AnnalsATS.201309-310OC; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Pawlik A, 2013, MOL MICROBIOL, DOI [10.1111/mmi.12478, DOI 10.1111/MMI.12478]; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; POLLOCK HM, 1977, J CLIN MICROBIOL, V5, P329; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Ruger K, 2013, J CLIN MICROBIOL, DOI [10.1128/JCM.02925-13, DOI 10.1128/JCM.02925-13]; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Seear M, 1997, AM J RESP CRIT CARE, V155, P364, DOI 10.1164/ajrccm.155.1.9001337; SNOUWAERT JN, 1995, AM J RESP CRIT CARE, V151, pS59, DOI 10.1164/ajrccm/151.3_Pt_2.S59; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Tomashefski JF, 1996, AM J RESP CRIT CARE, V154, P523, DOI 10.1164/ajrccm.154.2.8756832; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9	44	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117657	10.1371/journal.pone.0117657	http://dx.doi.org/10.1371/journal.pone.0117657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675351	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000029
J	Ariani, A; Di Baccio, D; Romeo, S; Lombardi, L; Andreucci, A; Lux, A; Horner, DS; Sebastiani, L				Ariani, Andrea; Di Baccio, Daniela; Romeo, Stefania; Lombardi, Lara; Andreucci, Andrea; Lux, Alexander; Horner, David Stephen; Sebastiani, Luca			RNA Sequencing of Populus x canadensis Roots Identifies Key Molecular Mechanisms Underlying Physiological Adaption to Excess Zinc	PLOS ONE			English	Article							EURAMERICANA CLONE I-214; HEAVY-METAL ACCUMULATION; ARABIDOPSIS-THALIANA; NICOTIANAMINE-SYNTHASE; IRON HOMEOSTASIS; TRANSPORTER; POPLAR; RESPONSES; EXPRESSION; HALLERI	Populus x canadensis clone I-214 exhibits a general indicator phenotype in response to excess Zn, and a higher metal uptake in roots than in shoots with a reduced translocation to aerial parts under hydroponic conditions. This physiological adaptation seems mainly regulated by roots, although the molecular mechanisms that underlie these processes are still poorly understood. Here, differential expression analysis using RNA-sequencing technology was used to identify the molecular mechanisms involved in the response to excess Zn in root. In order to maximize specificity of detection of differentially expressed (DE) genes, we consider the intersection of genes identified by three distinct statistical approaches (61 up- and 19 down- regulated) and validate them by RT-qPCR, yielding an agreement of 93% between the two experimental techniques. Gene Ontology (GO) terms related to oxidationreduction processes, transport and cellular iron ion homeostasis were enriched among DE genes, highlighting the importance of metal homeostasis in adaptation to excess Zn by P. x canadensis clone I-214. We identified the up-regulation of two Populus metal transporters (ZIP2 and NRAMP1) probably involved in metal uptake, and the down-regulation of a NAS4 gene involved in metal translocation. We identified also four Fe-homeostasis transcription factors (two bHLH38 genes, FIT and BTS) that were differentially expressed, probably for reducing Zn-induced Fe-deficiency. In particular, we suggest that the down-regulation of FIT transcription factor could be a mechanism to cope with Zn-induced Fe-deficiency in Populus. These results provide insight into the molecular mechanisms involved in adaption to excess Zn in Populus spp., but could also constitute a starting point for the identification and characterization of molecular markers or biotechnological targets for possible improvement of phytoremediation performances of poplar trees.	[Ariani, Andrea; Di Baccio, Daniela; Romeo, Stefania; Sebastiani, Luca] Scuola Super Sant Anna, Inst Life Sci, BioLabs, I-56127 Pisa, Italy; [Lombardi, Lara; Andreucci, Andrea] Univ Pisa, Dept Biol, I-56126 Pisa, Italy; [Lux, Alexander] Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia; [Lux, Alexander] Slovak Acad Sci, Inst Chem, Bratislava, Slovakia; [Horner, David Stephen] Univ Milan, Dept Biosci, Milan, Italy	Scuola Superiore Sant'Anna; University of Pisa; Comenius University Bratislava; Slovak Academy of Sciences; University of Milan	Sebastiani, L (corresponding author), Scuola Super Sant Anna, Inst Life Sci, BioLabs, I-56127 Pisa, Italy.	sebastiani@sssup.it	Sebastiani, Luca/AAU-5989-2021; Sebastiani, Luca/B-1055-2008; Horner, David/AAC-2274-2022; Lux, Alexander/AAU-6675-2021; Di Baccio, Daniela/O-3452-2019	Sebastiani, Luca/0000-0002-8536-3569; Sebastiani, Luca/0000-0002-8536-3569; Lux, Alexander/0000-0001-8651-8166; Di Baccio, Daniela/0000-0001-6270-0270	Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale	Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was supported by the Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale (Significant bilateral project between Italy and Slovak) (http://www.esteri.it/MAE/IT/Politica_Estera/CooperScientificaTecnologica/Progetti_grande_rilevanza.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2011, J EXP BOT, V62, P3737, DOI 10.1093/jxb/err025; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; BAKER AJM, 1981, J PLANT NUTR, V3, P643, DOI 10.1080/01904168109362867; Berta M, 2010, PLANT BIOLOGY, V12, P341, DOI 10.1111/j.1438-8677.2009.00320.x; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Bluthgen Nils, 2005, Genome Inform, V16, P106; Brautigam A, 2010, PLANT BIOLOGY, V12, P831, DOI 10.1111/j.1438-8677.2010.00373.x; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craciun AR, 2012, J EXP BOT, V63, P4179, DOI 10.1093/jxb/ers104; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Deinlein U, 2012, PLANT CELL, V24, P708, DOI 10.1105/tpc.111.095000; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Di Baccio D, 2005, NEW PHYTOL, V167, P73, DOI 10.1111/j.1469-8137.2005.01462.x; Di Baccio D, 2003, NEW PHYTOL, V159, P443, DOI 10.1046/j.1469-8137.2003.00818.x; Di Baccio D, 2009, ENVIRON EXP BOT, V67, P153, DOI 10.1016/j.envexpbot.2009.05.014; Di Baccio D, 2011, TREE PHYSIOL, V31, P1293, DOI 10.1093/treephys/tpr106; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Erland S, 2002, ECOL STU AN, V157, P163; Frerot H, 2010, NEW PHYTOL, V187, P355, DOI 10.1111/j.1469-8137.2010.03295.x; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; He JL, 2013, PLANT PHYSIOL, V162, P424, DOI 10.1104/pp.113.215681; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kohler A, 2003, FEBS LETT, V542, P37, DOI 10.1016/S0014-5793(03)00334-X; Lado LR, 2008, GEODERMA, V148, P189, DOI 10.1016/j.geoderma.2008.09.020; Laureysens I, 2005, ENVIRON POLLUT, V133, P541, DOI 10.1016/j.envpol.2004.06.013; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; PULFORD ID, 2005, TRACE ELEMENTS ENV, P383; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sebastiani L, 2004, ENVIRON EXP BOT, V52, P79, DOI 10.1016/j.envexpbot.2004.01.003; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Shanmugam V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00281; Shanmugam V, 2011, NEW PHYTOL, V190, P125, DOI 10.1111/j.1469-8137.2010.03606.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Stolarikova M, 2012, BIOLOGIA, V67, P483, DOI 10.2478/s11756-012-0039-4; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vassilev Andon, 2004, ScientificWorldJournal, V4, P9; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wu HL, 2012, PLANT PHYSIOL, V158, P790, DOI 10.1104/pp.111.190983; Wu ZJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-564; Xiao HH, 2008, ANN BOT-LONDON, V102, P881, DOI 10.1093/aob/mcn178; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331	77	18	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117571	10.1371/journal.pone.0117571	http://dx.doi.org/10.1371/journal.pone.0117571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671786	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300061
J	Fuhr, MJ; Meyer, M; Fehr, E; Ponzio, G; Werner, S; Herrmann, HJ				Fuhr, Matthias Jorg; Meyer, Michael; Fehr, Eric; Ponzio, Gilles; Werner, Sabine; Herrmann, Hans Jurgen			A Modeling Approach to Study the Effect of Cell Polarization on Keratinocyte Migration	PLOS ONE			English	Article							WOUND REPAIR; RECEPTORS 1	The skin forms an efficient barrier against the environment, and rapid cutaneous wound healing after injury is therefore essential. Healing of the uppermost layer of the skin, the epidermis, involves collective migration of keratinocytes, which requires coordinated polarization of the cells. To study this process, we developed a model that allows analysis of live-cell images of migrating keratinocytes in culture based on a small number of parameters, including the radius of the cells, their mass and their polarization. This computational approach allowed the analysis of cell migration at the front of the wound and a reliable identification and quantification of the impaired polarization and migration of keratinocytes from mice lacking fibroblast growth factors 1 and 2 - an established model of impaired healing. Therefore, our modeling approach is suitable for large-scale analysis of migration phenotypes of cells with specific genetic defects or upon treatment with different pharmacological agents.	[Fuhr, Matthias Jorg; Fehr, Eric; Herrmann, Hans Jurgen] ETH, Inst Bldg Mat Computat Phys Engn Mat, Zurich, Switzerland; [Meyer, Michael; Werner, Sabine] ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Ponzio, Gilles] CNRS, UMR 7275, Valbonne, France; [Ponzio, Gilles] Univ Nice Sophia Antipolis, F-06189 Nice, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Werner, S (corresponding author), ETH, Inst Mol Hlth Sci, Zurich, Switzerland.	sabine.werner@biol.ethz.ch; hans@ifb.baug.ethz.ch	Ponzio, Gilles/Q-1256-2016	Ponzio, Gilles/0000-0003-2741-0248; Meyer, Michael/0000-0002-8238-0216; Werner, Sabine/0000-0001-7397-8710	Swiss National Foundation SNF [205321121701, 310030_132884]; European Research Council (ERC) [319968-FlowCCS]	Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC))	This work was supported by grants from the Swiss National Foundation SNF (No. 205321121701 to H.J.H. and 310030_132884 to S.W.) and the European Research Council (ERC) Advanced Grant 319968-FlowCCS (to H.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2011, BIOPHYS J, V100, P535, DOI 10.1016/j.bpj.2010.11.083; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Griebel M, 2007, NUMERICAL SIMULATION; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Iannaccone P, 1996, FRACTAL GEOMETRY BIO; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Losa GA, 2005, CELL TISSUE RES, V322, P257, DOI 10.1007/s00441-005-0030-2; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Muller AK, 2012, SEMIN CELL DEV BIOL, V23, P963, DOI 10.1016/j.semcdb.2012.09.015; Nuatro J, 2007, SUMM COMP SIM C 2007; Ouaknin GY, 2009, BIOPHYS J, V97, P1811, DOI 10.1016/j.bpj.2009.05.064; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Sullivan THR, 2008, WORLD ACAD SCI ENG T, V20, P1019; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Yuan CQ, 2003, WEAR, V255, P315, DOI 10.1016/S0043-1648(03)00206-0	30	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117676	10.1371/journal.pone.0117676	http://dx.doi.org/10.1371/journal.pone.0117676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671585	Green Published, gold			2022-12-27	WOS:000349545300066
J	Heblich, S; Lameli, A; Riener, G				Heblich, Stephan; Lameli, Alfred; Riener, Gerhard			The Effect of Perceived Regional Accents on Individual Economic Behavior: A Lab Experiment on Linguistic Performance, Cognitive Ratings and Economic Decisions	PLOS ONE			English	Article							JOB INTERVIEW; DISCRIMINATION; IDENTIFICATION; LANGUAGE; IDENTITY; DIALECT; MATTERS; BEAUTY	Does it matter if you speak with a regional accent? Speaking immediately reveals something of one's own social and cultural identity, be it consciously or unconsciously. Perceiving accents involves not only reconstructing such imprints but also augmenting them with particular attitudes and stereotypes. Even though we know much about attitudes and stereotypes that are transmitted by, e.g. skin color, names or physical attractiveness, we do not yet have satisfactory answers how accent perception affects human behavior. How do people act in economically relevant contexts when they are confronted with regional accents? This paper reports a laboratory experiment where we address this question. Participants in our experiment conduct cognitive tests where they can choose to either cooperate or compete with a randomly matched male opponent identified only via his rendering of a standardized text in either a regional accent or standard accent. We find a strong connection between the linguistic performance and the cognitive rating of the opponent. When matched with an opponent who speaks the accent of the participant's home region-the in-group opponent-, individuals tend to cooperate significantly more often. By contrast, they are more likely to compete when matched with an accent speaker from outside their home region, the out-group opponent. Our findings demonstrate, firstly, that the perception of an out-group accent leads not only to social discrimination but also influences economic decisions. Secondly, they suggest that this economic behavior is not necessarily attributable to the perception of a regional accent per se, but rather to the social rating of linguistic distance and the in-group/out-group perception it evokes.	[Heblich, Stephan] Univ Bristol, CESifo, IZA, Bristol, Avon, England; [Heblich, Stephan] Univ Bristol, SERC, Dept Econ, Bristol, Avon, England; [Lameli, Alfred] Res Ctr Deutsch Sprachatlas, Marburg, Germany; [Lameli, Alfred] ADW Mainz, Marburg, Germany; [Riener, Gerhard] Univ Mannheim, Dusseldorf Inst Competit Econ, D-68131 Mannheim, Germany; [Riener, Gerhard] Univ Gottingen, CRC PEG, Mannheim, Germany	University of Bristol; University of Bristol; University of Mannheim; University of Gottingen	Riener, G (corresponding author), Univ Mannheim, Dusseldorf Inst Competit Econ, D-68131 Mannheim, Germany.	riener@dice.hhu.de		Riener, Gerhard/0000-0003-1056-2034; Heblich, Stephan/0000-0001-6486-3727; Lameli, Alfred/0000-0003-1516-2224	Max Planck Society; Academy of Science and Literature Mainz [REDE 0404]; German Research Foundation (DFG) [RTG1411]; Research Center Deutscher Sprachatlas	Max Planck Society(Max Planck SocietyFoundation CELLEX); Academy of Science and Literature Mainz; German Research Foundation (DFG)(German Research Foundation (DFG)); Research Center Deutscher Sprachatlas	This research is supported by the Max Planck Society, the Academy of Science and Literature Mainz (grant REDE 0404), the German Research Foundation (DFG grant RTG1411) and the Research Center Deutscher Sprachatlas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer Peter, 2005, PERSPECTIVES VARIATI, P7, DOI DOI 10.1515/9783110909579.7; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; Chambers J. K., 1999, DIALECTOLOGY; Coupland N, 2007, J SOCIOLING, V11, P74, DOI 10.1111/j.1467-9841.2007.00311.x; De Fina A, 2007, LANG SOC, V36, P371, DOI 10.1017/S0047404507070182; Deprez-Sims AS, 2010, INT J PSYCHOL, V45, P417, DOI 10.1080/00207594.2010.499950; Dixon JA, 2002, J LANG SOC PSYCHOL, V21, P162, DOI 10.1177/02627X02021002004; Durante R, 2014, J EUROPEAN EC ASS; Eckert P, 2012, ANNU REV ANTHROPOL, V41, P87, DOI 10.1146/annurev-anthro-092611-145828; Falck O, 2012, J URBAN ECON, V72, P225, DOI 10.1016/j.jue.2012.05.007; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frumkin L, 2007, PSYCHOL CRIME LAW, V13, P317, DOI 10.1080/10683160600822246; Ginsburgh V., 2011, MANY LANGUAGES DO WE; Gluszek A, 2010, PERS SOC PSYCHOL REV, V14, P214, DOI 10.1177/1088868309359288; Greiner B., 2004, 13513 MPRA; Grosse N. D., 2010, EXPLAINING GENDER DI; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hanushek E. A., 2013, RETURNS SKILLS WORLD; Herrgen J, 1989, DIALEKTGEOGRAPHIE DI, P304; Holmes K, 2001, NEW ZEAL J PSYCHOL, V30, P79; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huesmann A, 1998, ZWISCHEN DIALEKT STA, pXV; Institut fur Demoskopie Allensbach, 2008, ALLENSBACH, DOI [10.1016/j.envpol.2015.01.010, DOI 10.1016/J.ENVPOL.2015.01.010]; Kehrein Roland., 2012, REGIONALSPRACHLICHE; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Krauss RM, 1997, HDB SOCIAL PSYCHOL, P41; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LAMBERT WE, 1960, J ABNORM SOC PSYCH, V60, P44, DOI 10.1037/h0044430; Lameli A, 2004, STANDARD SUBSTANDARD, DOI [10.1016/j.watres.2015.01.006, DOI 10.1016/J.WATRES.2015.01.006]; Lev-Ari S, 2010, J EXP SOC PSYCHOL, V46, P1093, DOI 10.1016/j.jesp.2010.05.025; Mai R, 2011, J SERV RES-US, V14, P460, DOI 10.1177/1094670511414551; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Preston D, 2010, LANGUAGE SPACE INT H; Purnell T, 1999, J LANG SOC PSYCHOL, V18, P10, DOI 10.1177/0261927X99018001002; Purschke C, 2011, REGIONALSPRACHE HORE, V347, pXVI; Rakic T, 2011, BRIT J PSYCHOL, V102, P868, DOI 10.1111/j.2044-8295.2011.02051.x; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; ROMAINE S, 1980, LANG SPEECH, V23, P213, DOI 10.1177/002383098002300301; Schmidt JE, TAAL TONGVAL, V63, P1, DOI [10.1002/acr.22531, DOI 10.1002/ACR.22531]; Schmitt EH, 1992, INTERDIALEKTALE VERS; Souza AL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00953; Thorne S., 2005, J QUANT LINGUIST, V12, P151; Tsalikis J., 1992, INT MARKET REV, V9, P57; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	48	13	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0113475	10.1371/journal.pone.0113475	http://dx.doi.org/10.1371/journal.pone.0113475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671607	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300003
J	Lindahl, E; Sattorov, N; Boqvist, S; Magnusson, U				Lindahl, Elisabeth; Sattorov, Nosirjon; Boqvist, Sofia; Magnusson, Ulf			A Study of Knowledge, Attitudes and Practices Relating to Brucellosis among Small-Scale Dairy Farmers in an Urban and Peri-Urban Area of Tajikistan	PLOS ONE			English	Article							RISK-FACTORS; RUMINANTS	Improvement of knowledge, attitudes and practices among urban livestock farmers could have a significant impact on the reduction of many zoonotic infections in urban farming. This study aimed to describe and evaluate weak areas in knowledge, attitudes and practices with regards to brucellosis among urban and peri-urban small-scale dairy farmers in a low income country to generate information essential for control programmes and public health interventions. The cross-sectional study was conducted during six weeks in 2011. The study subjects were small-scale dairy farmers living in the urban and peri-urban area of the capital Dushanbe in Tajikistan. In total, 441 farmers were interviewed using a questionnaire with questions about demographic characteristics, knowledge, attitudes and practices relating to brucellosis. Descriptive statistics were used and a logistic regression model applied to evaluate potential predictors to knowledge about brucellosis. The majority (85%) of the farmers had never heard of brucellosis. Low educational level was found to be associated with low awareness of brucellosis (P = < 0.001). Respondents who talked about animal health issues with family members or friends were less likely to have heard of brucellosis compared to those who often talked to veterinarians (P = 0.03). Sixty three per cent of the participants wanted more information about brucellosis. Seventeen per cent sold unpasteurized dairy products on a regular basis direct to consumers. Almost 30% of the households consumed unpasteurized dairy products on regular basis. A majority of the respondents did not use any protection when handling cows having an abortion or when dealing with aborted materials. Poor knowledge, high-risk behaviours and a willingness to learn more strengthens the logic for including health education as part of control programmes.	[Lindahl, Elisabeth; Magnusson, Ulf] Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, SE-75007 Uppsala, Sweden; [Sattorov, Nosirjon] Tajik Agrarian Univ, Dushanbe, Tajikistan; [Boqvist, Sofia] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Div Food Safety & Bacteriol, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Tajik Agrarian University Named Shirinsho Shotemur; Swedish University of Agricultural Sciences	Magnusson, U (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, POB 7054, SE-75007 Uppsala, Sweden.	ulf.magnusson@slu.se		Boqvist, Sofia/0000-0002-8072-7132; Magnusson, Ulf/0000-0002-7087-6820	Swedish Ministry of Foreign Affair's special investment in food security	Swedish Ministry of Foreign Affair's special investment in food security	This study was supported by the Swedish Ministry of Foreign Affair's special investment in food security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamahy HA, 2000, EPIDEMIOL INFECT, V125, P309, DOI 10.1017/S0950268899004458; Bonfoh B, 2012, ECOHEALTH, V9, P132, DOI 10.1007/s10393-011-0722-x; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Earhart K, 2009, INT J INFECT DIS, V13, P749, DOI 10.1016/j.ijid.2009.02.014; FAO, 2014, PATHW SUCC BRUC CONT; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Jackson R, 2007, VET REC, V161, P476, DOI 10.1136/vr.161.14.476; Kang'Ethe E.K., 2007, E AFR MED J, V84, P48, DOI [10.4314/eamj.v84i11.9576, DOI 10.4314/EAMJ.V84I11.9576]; Kangethe EK., 2007, E AFR MED J, V84, P45; Kangethe EK, 2007, E AFR MED J, V84, P96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; Kozukeev Turatbek B, 2006, MMWR Suppl, V55, P31; Lindahl E, 2014, TROP ANIM HEALTH PRO, V46, P563, DOI 10.1007/s11250-013-0534-9; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Smits HL, 2012, VET REC, V170, P97, DOI 10.1136/vr.e666; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; Solera J, 1999, CLIN INFECT DIS, V29, P1440, DOI 10.1086/313524; United Nations, 2012, SOC IND; Ward D, 2012, VET REC, V170, DOI 10.1136/vr.100012; WHO, 2014, NEGL ZOON DIS; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	22	60	64	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117318	10.1371/journal.pone.0117318	http://dx.doi.org/10.1371/journal.pone.0117318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668783	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000018
J	Ahn, SB; Chan, C; Dent, OF; Mohamedali, A; Kwun, SY; Clarke, C; Fletcher, J; Chapuis, PH; Nice, EC; Baker, MS				Ahn, Seong Beom; Chan, Charles; Dent, Owen F.; Mohamedali, Abidali; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie; Chapuis, Pierre H.; Nice, Edouard C.; Baker, Mark S.			Epithelial and Stromal Cell Urokinase Plasminogen Activator Receptor Expression Differentially Correlates with Survival in Rectal Cancer Stages B and C Patients	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; HUMAN COLON-CANCER; PROGNOSTIC VALUE; CRYSTAL-STRUCTURE; TUMOR FRONT; IN-VIVO; UPAR; CARCINOMA; METASTASIS; SYSTEM	Urokinase plasminogen activator receptor (uPAR) has been proposed as a potential prognostic factor for colorectal cancer (CRC) patient survival. However, CRC uPAR expression remains controversial, especially regarding cell types where uPAR is overexpressed (e.g., epithelium (uPAR(E)) or stroma-associated cells (uPAR(S))) and associated prognostic relevance. In this study, two epitope-specific anti-uPAR monoclonal antibodies (MAbs) could discriminate expression of uPAR(E) from uPAR(S) and were used to examine this association with survival of stages B and C rectal cancer (RC) patients. Using immunohistochemistry, MAbs #3937 and R4 were used to discriminate uPAR(E) from uPAR(S) respectively in the central and invasive frontal regions of 170 stage B and 179 stage C RC specimens. Kaplan-Meier and Cox regression analyses were used to determine association with survival. uPAR expression occurred in both epithelial and stromal compartments with differential expression observed in many cases, indicating uPAR(E) and uPAR(S) have different cellular roles. In the central and invasive frontal regions, uPAR(E) was adversely associated with overall stage B survival (HR = 1.9; p = 0.014 and HR = 1.5; p = 0.031, respectively) reproducing results from previous studies. uPARS at the invasive front was associated with longer stage C survival (HR = 0.6; p = 0.007), reflecting studies demonstrating that macrophage peritumoural accumulation is associated with longer survival. This study demonstrates that different uPAR epitopes should be considered as being expressed on different cell types during tumour progression and at different stages in RC. Understanding how uPAR(E) and uPAR(S) expression affects survival is anticipated to be a useful clinical prognostic marker of stages B and C RC.	[Ahn, Seong Beom; Mohamedali, Abidali; Baker, Mark S.] Macquarie Univ, Fac Human Sci, Australian Sch Adv Med, N Ryde, NSW 2109, Australia; [Chan, Charles; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie] Univ Sydney, Concord Hosp, Dept Anat Pathol, Concord, NSW 2139, Australia; [Chan, Charles; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie] Univ Sydney, Discipline Pathol, Concord, NSW 2139, Australia; [Dent, Owen F.; Chapuis, Pierre H.] Univ Sydney, Concord Hosp, Dept Colorectal Surg, Concord, NSW 2139, Australia; [Dent, Owen F.; Chapuis, Pierre H.] Univ Sydney, Discipline Surg, Concord, NSW 2139, Australia; [Nice, Edouard C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Macquarie University; Concord Repatriation General Hospital; University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; University of Sydney; Monash University	Baker, MS (corresponding author), Macquarie Univ, Fac Human Sci, Australian Sch Adv Med, N Ryde, NSW 2109, Australia.	mark.baker@mq.edu.au	Mohamedali, Abidali/AGZ-8179-2022	Baker, Mark/0000-0001-5858-4035; Ahn, Seong Beom/0000-0001-5907-3544; Mohamedali, Abidali/0000-0001-5627-4105	NHMRC [1010303]; Cancer Council NSW [RG10-04, RG08-16]; Macquarie University MQSN grant; Australian School of Advanced Medicine (ASAM), Macquarie University; Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Macquarie University MQSN grant; Australian School of Advanced Medicine (ASAM), Macquarie University; Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres	This study was supported with research project grant funding from the NHMRC (#1010303), Cancer Council NSW (RG10-04 & RG08-16), and a Macquarie University MQSN grant; and supported through the Australian School of Advanced Medicine (ASAM), Macquarie University, Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097248; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Bokey EL, 1999, BRIT J SURG, V86, P1164, DOI 10.1046/j.1365-2168.1999.01216.x; Boonstra MC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-269; Boonstra MC, 2011, CURR PHARM DESIGN, V17, P1890; DAVIS NC, 1983, AUST NZ J SURG, V53, P211, DOI 10.1111/j.1445-2197.1983.tb02430.x; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Duriseti S, 2010, J BIOL CHEM, V285, P26878, DOI 10.1074/jbc.M109.077677; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Ferlay J, 2012, IARC CANCERBASE, V11; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Funada Y, 2003, ONCOL REP, V10, P309; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Genua M, 2014, GUT; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; Hoyer-Hansen G, 2007, ADV CLIN CHEM, V44, P65, DOI 10.1016/S0065-2423(07)44003-3; Illemann M, 2014, CANC MED, V1002, P242; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Kaneko I, 2007, WORLD J GASTROENTERO, V13, P3829; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Kho PSS, 2012, INT J COLORECTAL DIS, V27, P1409, DOI 10.1007/s00384-012-1469-8; Khorana AA, 2003, CANCER, V97, P960, DOI 10.1002/cncr.11152; LeBeau AM, 2014, THERANOSTICS, V4, P267, DOI 10.7150/thno.7323; Li YD, 2007, J MOL BIOL, V365, P1117, DOI 10.1016/j.jmb.2006.10.059; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lomholt AF, 2010, ACTA ONCOL, V49, P805, DOI 10.3109/0284186X.2010.491086; Minoo P, 2010, HUM PATHOL, V41, P70, DOI 10.1016/j.humpath.2009.05.013; NEWLAND RC, 1981, CANCER, V47, P1424, DOI 10.1002/1097-0142(19810315)47:6<1424::AID-CNCR2820470630>3.0.CO;2-O; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; OHTANI H, 1995, INT J CANCER, V62, P691, DOI 10.1002/ijc.2910620608; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Saito K, 2000, INT J CANCER, V86, P24, DOI 10.1002/(SICI)1097-0215(20000401)86:1<24::AID-IJC4>3.0.CO;2-A; Saldanha RG, 2007, J PROTEOME RES, V6, P1016, DOI 10.1021/pr060518n; Seetoo DQ, 2003, J SURG ONCOL, V82, P184, DOI 10.1002/jso.10210; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sugita J, 2002, JPN J CANCER RES, V93, P320, DOI 10.1111/j.1349-7006.2002.tb02175.x; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Takeha S, 1997, JPN J CANCER RES, V88, P72, DOI 10.1111/j.1349-7006.1997.tb00304.x; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Xu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085349; Yang JL, 2000, INT J CANCER, V89, P431, DOI 10.1002/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V	50	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117786	10.1371/journal.pone.0117786	http://dx.doi.org/10.1371/journal.pone.0117786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692297	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500074
J	Avanzino, L; Bove, M; Pelosin, E; Ogliastro, C; Lagravinese, G; Martino, D				Avanzino, Laura; Bove, Marco; Pelosin, Elisa; Ogliastro, Carla; Lagravinese, Giovanna; Martino, Davide			The Cerebellum Predicts the Temporal Consequences of Observed Motor Acts	PLOS ONE			English	Article							MAGNETIC STIMULATION; TIME PERCEPTION; EXPECTATION; PRECISION; PATHWAYS; RTMS	It is increasingly clear that we extract patterns of temporal regularity between events to optimize information processing. The ability to extract temporal patterns and regularity of events is referred as temporal expectation. Temporal expectation activates the same cerebral network usually engaged in action selection, comprising cerebellum. However, it is unclear whether the cerebellum is directly involved in temporal expectation, when timing information is processed to make predictions on the outcome of a motor act. Healthy volunteers received one session of either active (inhibitory, 1Hz) or sham repetitive transcranial magnetic stimulation covering the right lateral cerebellum prior the execution of a temporal expectation task. Subjects were asked to predict the end of a visually perceived human body motion (right hand handwriting) and of an inanimate object motion (a moving circle reaching a target). Videos representing movements were shown in full; the actual tasks consisted of watching the same videos, but interrupted after a variable interval from its onset by a dark interval of variable duration. During the 'dark' interval, subjects were asked to indicate when the movement represented in the video reached its end by clicking on the spacebar of the keyboard. Performance on the timing task was analyzed measuring the absolute value of timing error, the coefficient of variability and the percentage of anticipation responses. The active group exhibited greater absolute timing error compared with the sham group only in the human body motion task. Our findings suggest that the cerebellum is engaged in cognitive and perceptual domains that are strictly connected to motor control.	[Avanzino, Laura; Bove, Marco; Lagravinese, Giovanna] Univ Genoa, Sect Human Physiol, Dept Expt Med, Genoa, Italy; [Pelosin, Elisa; Ogliastro, Carla] Univ Genoa, Dept Neurosci DiNOGMI, Genoa, Italy; [Martino, Davide] Kings Coll Hosp London, Dept Neurol, London, England; [Martino, Davide] Queen Elizabeth Hosp, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, London, England	University of Genoa; University of Genoa; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; Queen Mary University London	Avanzino, L (corresponding author), Univ Genoa, Sect Human Physiol, Dept Expt Med, Genoa, Italy.	lavanzino76@gmail.com	Lagravinese, Giovanna/AAB-1007-2021; Pelosin, Elisa/AAA-9637-2019; Avanzino, Laura/K-6623-2016	Lagravinese, Giovanna/0000-0002-6570-3626; AVANZINO, LAURA/0000-0001-6286-1509; Pelosin, Elisa/0000-0002-9880-2241				Assmus A, 2005, NEUROSCIENCE, V132, P923, DOI 10.1016/j.neuroscience.2005.01.047; Avanzino L, 2012, BASAL GANGLIA, V2, P231, DOI 10.1016/j.baga.2012.05.003; Avanzino L, 2013, BRAIN, V136, P444, DOI 10.1093/brain/aws328; Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x; Bangert AS, 2011, ACTA PSYCHOL, V136, P20, DOI 10.1016/j.actpsy.2010.09.006; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Broadway JM, 2011, ACTA PSYCHOL, V137, P115, DOI 10.1016/j.actpsy.2011.03.008; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Christensen A, 2014, J NEUROSCI, V34, P6707, DOI 10.1523/JNEUROSCI.3276-13.2014; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Craighero L, 2008, BRAIN RES BULL, V75, P770, DOI 10.1016/j.brainresbull.2008.01.014; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gooch CM, 2010, NEUROPSYCHOLOGIA, V48, P1022, DOI 10.1016/j.neuropsychologia.2009.11.028; Grondin S, 2012, J EXP PSYCHOL HUMAN, V38, P880, DOI 10.1037/a0027188; Ito M, 2005, PROG BRAIN RES, V148, P95, DOI 10.1016/S0079-6123(04)48009-1; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Lee KH, 2007, J COGNITIVE NEUROSCI, V19, P147, DOI 10.1162/jocn.2007.19.1.147; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Nowak DA, 2004, CEREBELLUM, V3, P227, DOI 10.1080/14734220410019057; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Roth MJ, 2013, CURR BIOL, V23, P930, DOI 10.1016/j.cub.2013.04.027; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Sokolov AA, 2010, CEREB CORTEX, V20, P486, DOI 10.1093/cercor/bhp117; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Torriero S, 2004, J COGNITIVE NEUROSCI, V16, P1605, DOI 10.1162/0898929042568488; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Vierordt K., 1868, ZEITSINN NACH VERSUC; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	49	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116607	10.1371/journal.pone.0116607	http://dx.doi.org/10.1371/journal.pone.0116607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689858	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700017
J	Capoccia, S; Maccarinelli, F; Buffoli, B; Rodella, LF; Cremona, O; Arosio, P; Cirulli, F				Capoccia, Sara; Maccarinelli, Federica; Buffoli, Barbara; Rodella, Luigi F.; Cremona, Ottavio; Arosio, Paolo; Cirulli, Francesca			Behavioral Characterization of Mouse Models of Neuroferritinopathy	PLOS ONE			English	Article							LIGHT-CHAIN GENE; BRAIN IRON ACCUMULATION; PARKINSONS-DISEASE; CLINICAL-FEATURES; FTL MUTATION; HEREDITARY FERRITINOPATHY; NATURAL-HISTORY; JAPANESE FAMILY; NEURODEGENERATION; MICE	Ferritin is the main intracellular protein of iron storage with a central role in the regulation of iron metabolism and detoxification. Nucleotide insertions in the last exon of the ferritin light chain cause a neurodegenerative disease known as Neuroferritinopathy, characterized by iron deposition in the brain, particularly in the cerebellum, basal ganglia and motor cortex. The disease progresses relentlessly, leading to dystonia, chorea, motor disability and neuropsychiatry features. The characterization of a good animal model is required to compare and contrast specific features with the human disease, in order to gain new insights on the consequences of chronic iron overload on brain function and behavior. To this aim we studied an animal model expressing the pathogenic human FTL mutant 498InsTC under the phosphoglycerate kinase (PGK) promoter. Transgenic (Tg) mice showed strong accumulation of the mutated protein in the brain, which increased with age, and this was accompanied by brain accumulation of ferritin/iron bodies, the main pathologic hallmark of human neuroferritinopathy. Tg-mice were tested throughout development and aging at 2-, 8- and 18-months for motor coordination and balance (Beam Walking and Footprint tests). The Tg-mice showed a significant decrease in motor coordination at 8 and 18 months of age, with a shorter latency to fall and abnormal gait. Furthermore, one group of aged naive subjects was challenged with two herbicides (Paraquat and Maneb) known to cause oxidative damage. The treatment led to a paradoxical increase in behavioral activation in the transgenic mice, suggestive of altered functioning of the dopaminergic system. Overall, data indicate that mice carrying the pathogenic FTL498InsTC mutation show motor deficits with a developmental profile suggestive of a progressive pathology, as in the human disease. These mice could be a powerful tool to study the neurodegenerative mechanisms leading to the disease and help developing specific therapeutic targets.	[Capoccia, Sara; Cirulli, Francesca] Ist Super Sanita, Dept Cell Biol, Sect Behav Neurosci, I-00161 Rome, Italy; [Maccarinelli, Federica; Arosio, Paolo] Univ Brescia, Dept Mol & Translat Med, Sect Biotechnol, Brescia, Italy; [Buffoli, Barbara; Rodella, Luigi F.] Univ Brescia, Sect Anat & Physiopathol, Dept Clin & Expt Sci, Brescia, Italy; [Cremona, Ottavio] Univ Vita Salute San Raffaele, Milan, Italy; [Cremona, Ottavio] Ist Sci San Raffaele, Ctr Imaging Sperimentale, Milan, Italy	Istituto Superiore di Sanita (ISS); University of Brescia; University of Brescia; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Arosio, P (corresponding author), Univ Brescia, Dept Mol & Translat Med, Sect Biotechnol, Brescia, Italy.	paolo.arosio@unibs.it	Maccarinelli, Federica/AAW-4212-2020; Cirulli, Francesca/B-1581-2013; arosio, paolo/E-6817-2010; Cremona, Ottavio/AAB-8793-2019; Buffoli, Barbara/E-9934-2010	Cirulli, Francesca/0000-0001-9440-1873; Cremona, Ottavio/0000-0001-9462-1040; Buffoli, Barbara/0000-0002-8531-7730; arosio, paolo/0000-0002-5343-8992; MACCARINELLI, Federica/0000-0002-0328-4673; Rodella, Luigi Fabrizio/0000-0002-9497-4708	Telethon project [GGP 10099]; MIUR-PRIN-11; AIRC; Ricerca Finalizzata	Telethon project(Fondazione Telethon); MIUR-PRIN-11; AIRC(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	The work was partially supported by Telethon project n. GGP 10099 grant to P.A. and O.C., by Grant MIUR-PRIN-11 to P.A., and by AIRC and Ricerca Finalizzata 2011-2012 to O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Ayton S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/581256; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Berry A, 2013, NEUROSCI BIOBEHAV R, V37, P790, DOI 10.1016/j.neubiorev.2013.03.005; Berry A, 2012, PSYCHONEUROENDOCRINO, V37, P762, DOI 10.1016/j.psyneuen.2011.09.007; Borchelt DR, 1996, CHEM BIOL, V3, P619, DOI 10.1016/S1074-5521(96)90128-3; Brunelin J, 2008, SCHIZOPHR RES, V100, P206, DOI 10.1016/j.schres.2007.11.009; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Crompton DE, 2002, BLOOD CELL MOL DIS, V29, P522, DOI 10.1006/bcmd.2002.0589; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Devos D, 2009, BRAIN, V132, DOI 10.1093/brain/awn274; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Faucheux BA, 1999, LANCET, V353, P981, DOI 10.1016/S0140-6736(99)00641-8; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Horowitz MP, 2010, J ALZHEIMERS DIS, V20, pS551, DOI 10.3233/JAD-2010-100354; Jin L, 2012, EUR J NEUROL, V19, P969, DOI 10.1111/j.1468-1331.2011.03658.x; Kaur D, 2007, BRAIN RES, V1140, P188, DOI 10.1016/j.brainres.2006.03.006; Keogh MJ, 2013, INT REV NEUROBIOL, V110, P91, DOI 10.1016/B978-0-12-410502-7.00006-5; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; Le Weidong, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS158, DOI 10.1016/S1353-8020(13)70038-5; Lewis MM, 2011, NEUROSCIENCE, V177, P230, DOI 10.1016/j.neuroscience.2010.12.060; Luscieti S, 2010, J BIOL CHEM, V285, P11948, DOI 10.1074/jbc.M109.096404; LUZZAGO A, 1986, BIOCHIM BIOPHYS ACTA, V872, P61, DOI 10.1016/0167-4838(86)90147-0; Maccarinelli F, 2015, NEUROBIOL DIS, V81, P119, DOI 10.1016/j.nbd.2014.10.023; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Matsunaga T, 2004, J BIOL CHEM, V279, P28614, DOI 10.1074/jbc.M400977200; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mineur YS, 2002, BRAIN RES BULL, V57, P41, DOI 10.1016/S0361-9230(01)00635-9; Moutton S, 2014, PARKINSONISM RELAT D, V20, P935, DOI 10.1016/j.parkreldis.2014.04.026; Muhoberac BB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00032; Murray-Kolb LE, 2003, AM J CLIN NUTR, V77, P180, DOI 10.1093/ajcn/77.1.180; Nishida K, 2014, J NEUROL SCI, V342, P173, DOI 10.1016/j.jns.2014.03.060; Norbury R, 2003, EXP GERONTOL, V38, P109, DOI 10.1016/S0531-5565(02)00166-3; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Ohta E, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/197438; Ory-Magne F, 2009, MOVEMENT DISORD, V24, P1676, DOI 10.1002/mds.22669; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Schneider SA, 2013, J NEURAL TRANSM, V120, P695, DOI 10.1007/s00702-012-0922-8; Storti E, 2013, MOVEMENT DISORD, V28, P252, DOI 10.1002/mds.25275; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x; Varga Gabor, 2011, Neuropsychopharmacol Hung, V13, P93; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118990	10.1371/journal.pone.0118990	http://dx.doi.org/10.1371/journal.pone.0118990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689865	Green Submitted, gold, Green Published			2022-12-27	WOS:000350322700121
J	Grimm, SK; Battles, MB; Ackerman, ME				Grimm, Sebastian K.; Battles, Michael B.; Ackerman, Margaret E.			Directed Evolution of a Yeast-Displayed HIV-1 SOSIP gp140 Spike Protein toward Improved Expression and Affinity for Conformational Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN COMPLEX; HUMAN MONOCLONAL-ANTIBODY; SURFACE DISPLAY; BINDING-SITE; NEUTRALIZING ANTIBODIES; EMERGING CONCEPTS; IMMUNOGEN DESIGN; EPITOPE; GP120	Design of an envelope-based immunogen capable of inducing a broadly neutralizing antibody response is thought to be key to the development of a protective HIV-1 vaccine. However, the broad diversity of viral variants and a limited ability to produce native envelope have hampered such design efforts. Here we describe adaptation of the yeast display system and use of a combinatorial protein engineering approach to permit directed evolution of HIV envelope variants. Because the intrinsic instability and complexity of this trimeric glycoprotein has greatly impeded the development of immunogens that properly represent the structure of native envelope, this platform addresses an essential need for methodologies with the capacity to rapidly engineer HIV spike proteins towards improved homogeneity, stability, and presentation of neutralizing epitopes. We report for the first time the display of a designed SOSIP gp140 on yeast, and the in vitro evolution of derivatives with greatly improved expression and binding to conformation-dependent antibodies. These efforts represent an initial and critical step toward the ability to rapidly engineer HIV-1 envelope immunogens via directed evolution.	[Grimm, Sebastian K.; Battles, Michael B.; Ackerman, Margaret E.] Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA	Dartmouth College	Ackerman, ME (corresponding author), Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA.	margaret.e.ackerman@dartmouth.edu		Battles, Michael/0000-0002-5321-7460	National Institute of Health, National Institute of Allergy and Infectious Disease [1R01AI102691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102691] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health, National Institute of Allergy and Infectious Disease 1R01AI102691 to MEA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2013, NEW ENGL J MED, V369, P389, DOI 10.1056/NEJMcibr1304437; Ackerman ME, 2012, ANNU REV MED, V63, P113, DOI 10.1146/annurev-med-050310-085221; Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Antipov E, 2008, P NATL ACAD SCI USA, V105, P17694, DOI 10.1073/pnas.0809851105; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Dai K, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P23; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Grimm SK, 2013, CURR OPIN BIOTECH, V24, P1078, DOI 10.1016/j.copbio.2013.02.015; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rakestraw JA, 2011, PROTEIN ENG DES SEL, V24, P525, DOI 10.1093/protein/gzr008; Rakestraw JA, 2006, BIOTECHNOL PROGR, V22, P1200, DOI 10.1021/bp0600233; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang XP, 2009, VIRAL IMMUNOL, V22, P407, DOI 10.1089/vim.2009.0046	83	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117227	10.1371/journal.pone.0117227	http://dx.doi.org/10.1371/journal.pone.0117227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688555	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700031
J	Jeong, CW; Park, GT; Yun, H; Hsieh, TF; Do Choi, Y; Choi, Y; Lee, JS				Jeong, Cheol Woong; Park, Guen Tae; Yun, Hyein; Hsieh, Tzung-Fu; Do Choi, Yang; Choi, Yeonhee; Lee, Jong Seob			Control of Paternally Expressed Imprinted UPWARD CURLY LEAF1, a Gene Encoding an F-Box Protein That Regulates CURLY LEAF Polycomb Protein, in the Arabidopsis Endosperm	PLOS ONE			English	Article							SEED DEVELOPMENT; DNA METHYLATION; LIFE-CYCLE; MEDEA; THALIANA; DEMETER; PHERES1; PLANT; METHYLTRANSFERASE; IDENTIFICATION	Genomic imprinting, an epigenetic process in mammals and flowering plants, refers to the differential expression of alleles of the same genes in a parent-of-origin-specific manner. In Arabidopsis, imprinting occurs primarily in the endosperm, which nourishes the developing embryo. Recent high-throughput sequencing analyses revealed that more than 200 loci are imprinted in Arabidopsis; however, only a few of these imprinted genes and their imprinting mechanisms have been examined in detail. Whereas most imprinted loci characterized to date are maternally expressed imprinted genes (MEGs), PHERES1 (PHE1) and ADMETOS (ADM) are paternally expressed imprinted genes (PEGs). Here, we report that UPWARD CURLY LEAF1 (UCL1), a gene encoding an E3 ligase that degrades the CURLY LEAF (CLF) polycomb protein, is a PEG. After fertilization, paternally inherited UCL1 is expressed in the endosperm, but not in the embryo. The expression pattern of a beta-glucuronidase (GUS) reporter gene driven by the UCL1 promoter suggests that the imprinting control region (ICR) of UCL1 is adjacent to a transposable element in the UCL1 5'-up-stream region. Polycomb Repressive Complex 2 (PRC2) silences the maternal UCL1 allele in the central cell prior to fertilization and in the endosperm after fertilization. The UCL1 imprinting pattern was not affected in paternal PRC2 mutants. We found unexpectedly that the maternal UCL1 allele is reactivated in the endosperm of Arabidopsis lines with mutations in cytosine DNA METHYLTRANSFERASE 1 (MET1) or the DNA glycosylase DEME-TER (DME), which antagonistically regulate CpG methylation of DNA. By contrast, maternal UCL1 silencing was not altered in mutants with defects in non-CpG methylation. Thus, silencing of the maternal UCL1 allele is regulated by both MET1 and DME as well as by PRC2, suggesting that divergent mechanisms for the regulation of PEGs evolved in Arabidopsis.	[Jeong, Cheol Woong; Park, Guen Tae; Yun, Hyein; Choi, Yeonhee; Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Hsieh, Tzung-Fu] N Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA; [Hsieh, Tzung-Fu] N Carolina State Univ, Dept Plant & Microbial Biol, Kannapolis, NC USA; [Do Choi, Yang] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Seoul National University (SNU)	Choi, Y (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	yhc@snu.ac.kr; 08jongs@snu.ac.kr	Choi, Yeonhee/AAF-5906-2020	Hsieh, Tzung-Fu/0000-0001-7584-3721	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2011-0022425]; Brain Korea 21 Program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2011-0022425 to JSL) and by the Brain Korea 21 Program (to GTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; Berger F, 2006, CURR OPIN PLANT BIOL, V9, P664, DOI 10.1016/j.pbi.2006.09.015; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Garnier O, 2008, EPIGENETICS-US, V3, P14, DOI 10.4161/epi.3.1.5554; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2013, ANNU REV GENET, V47, P187, DOI 10.1146/annurev-genet-110711-155527; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Haig D, 1997, P ROY SOC B-BIOL SCI, V264, P1657, DOI 10.1098/rspb.1997.0230; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Iwasa Y, 1998, CURR TOP DEV BIOL, V40, P255, DOI 10.1016/S0070-2153(08)60369-5; Jeong CW, 2011, P NATL ACAD SCI USA, V108, P8036, DOI 10.1073/pnas.1104232108; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kohler C, 2010, HEREDITY, V105, P57, DOI 10.1038/hdy.2009.176; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kradolfer D, 2013, DEV CELL, V26, P525, DOI 10.1016/j.devcel.2013.08.006; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; McKeown PC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-113; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sleutels F, 2002, ADV GENET, V46, P119; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Villar CBR, 2009, MOL PLANT, V2, P654, DOI 10.1093/mp/ssp014; Walbot V, 2003, NAT REV GENET, V4, P369, DOI 10.1038/nrg1064; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wohrmann HJP, 2012, GENE DEV, V26, P1837, DOI 10.1101/gad.195123.112; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	56	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117431	10.1371/journal.pone.0117431	http://dx.doi.org/10.1371/journal.pone.0117431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689861	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700043
J	Jin, JH; Qin, Q; Guo, HY; Liu, SL; Ge, SY; Zhang, HX; Cui, JY; Ren, FZ				Jin, Junhua; Qin, Qian; Guo, Huiyuan; Liu, Songling; Ge, Shaoyang; Zhang, Hongxing; Cui, Jianyun; Ren, Fazheng			Effect of Pre-Stressing on the Acid-Stress Response in Bifidobacterium Revealed Using Proteomic and Physiological Approaches	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; TOLERANCE RESPONSE; ESCHERICHIA-COLI; ADAPTATION; PATHWAYS; ARGININE; PH	Weak acid resistance limits the application of Bifidobacteria as a probiotic in food. The acid tolerance response (ATR), caused by pre-stressing cells at a sublethal pH, could improve the acid resistance of Bifidobacteria to subsequent acid stress. In this study, we used Bifidobacterium longum sub. longum BBMN68 to investigate the effect of the ATR on the acid stress response (ASR), and compared the difference between the ATR and the ASR by analyzing the two-dimensional-PAGE protein profiles and performing physiological tests. The results revealed that a greater abundance of proteins involved in carbohydrate metabolism and protein protection was present after the ASR than after the ATR in Bifidobacterium. Pre-stressing cells increased the abundance of proteins involved in energy production, amino acid metabolism, and peptidoglycan synthesis during the ASR of Bifidobacterium. Moreover, after the ASR, the content of ATP, NH3, thiols, and peptidoglycan, the activity of H+-ATPase, and the maintenance of the intracellular pH in the pre-stressed Bifidobacterium cells was significantly higher than in the uninduced cells. These results provide the first explanation as to why the resistance of Bifidobacterium to acid stress improved after pre-stressing.	[Jin, Junhua; Zhang, Hongxing] Beijing Univ Agr, Food Sci & Engn Coll, Beijing Lab Food Qual & Safety, Beijing 102206, Peoples R China; [Qin, Qian; Guo, Huiyuan; Liu, Songling; Ge, Shaoyang; Cui, Jianyun; Ren, Fazheng] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Guo, Huiyuan] Beijing Higher Inst Engn Res Ctr Anim Prod, Beijing 100083, Peoples R China; [Liu, Songling] China Agr Univ, Key Lab Funct Dairy, Beijing 100083, Peoples R China; [Ge, Shaoyang] Beijing Resources Yatai Feed Technol Co LTD, Beijing, Peoples R China	Beijing University of Agriculture; China Agricultural University; China Agricultural University	Ren, FZ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	renfazheng@263.net	Qin, Qin/GVT-5910-2022; qin, qin x/GXG-6164-2022		Ministry of Science and Technology of China [2011AA100903, 2012BAD12B08]; Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group [13ZK006]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [20140315]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by Ministry of Science and Technology of China (2011AA100903, 2012BAD12B08), (http://program.most.gov.cn/); Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group (13ZK006); The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (20140315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracey D, 1990, J MICROBIOL METH, V3, P113; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carlsson N, 2011, ANAL BIOCHEM, V411, P116, DOI 10.1016/j.ab.2010.12.026; Champagne CP, 2005, CRIT REV FOOD SCI, V45, P61, DOI 10.1080/10408690590900144; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Jin JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050777; Jin JH, 2011, CURR MICROBIOL, V62, P612, DOI 10.1007/s00284-010-9751-x; Kim EK, 2008, BIOCHEM BIOPH RES CO, V369, P1047, DOI 10.1016/j.bbrc.2008.02.139; KRAUSE I, 1995, J CHROMATOGR A, V715, P67, DOI 10.1016/0021-9673(95)00578-B; LAZDUNSKI AM, 1989, FEMS MICROBIOL LETT, V63, P265, DOI 10.1111/j.1574-6968.1989.tb03400.x; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Masco L, 2005, INT J FOOD MICROBIOL, V102, P221, DOI 10.1016/j.ijfoodmicro.2004.11.018; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI 10.2217/FMB.09.129; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Miao Y, 2005, BEIJING DA XUEXUEBAO, V2, P201; O'May GA, 2005, J CLIN MICROBIOL, V43, P3059, DOI 10.1128/JCM.43.7.3059-3065.2005; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Sanchez B, 2007, APPL ENVIRON MICROB, V73, P6450, DOI 10.1128/AEM.00886-07; Thi MHT, 2011, APPL ENVIRON MICROB, V77, P3327, DOI 10.1128/AEM.02518-10; Tonon T, 2000, J APPL MICROBIOL, V89, P526, DOI 10.1046/j.1365-2672.2000.01142.x; Waddington L, 2010, J APPL MICROBIOL, V108, P1408, DOI 10.1111/j.1365-2672.2009.04540.x; Wu CD, 2012, APPL MICROBIOL BIOT, V93, P707, DOI 10.1007/s00253-011-3757-6; Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003; Xiao M, 2011, MICROBIOL-SGM, V157, P1573, DOI 10.1099/mic.0.044297-0; Zhang J, 2007, APPL ENVIRON MICROB, V73, P5268, DOI 10.1128/AEM.02787-06; Zuniga M, 1998, J BACTERIOL, V180, P4154	28	23	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117702	10.1371/journal.pone.0117702	http://dx.doi.org/10.1371/journal.pone.0117702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689631	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700065
J	Majumder, N; Ram, F				Majumder, Nabanita; Ram, Faujdar			Explaining the Role of Proximate Determinants on Fertility Decline among Poor and Non-Poor in Asian Countries	PLOS ONE			English	Article							INDUCED-ABORTION; MARRIAGE; TRENDS; CONTRACEPTION; POSTPARTUM; AMENORRHEA; FRAMEWORK; NUTRITION; EDUCATION; INDIA	Objectives We examined the overall contributions of the poor and non-poor in fertility decline across the Asian countries. Further, we analyzed the direct and indirect factors that determine the reproductive behaviour of two distinct population sub-groups. Design Data from several new rounds of DHS surveys are available over the past few years. The DHS provides cross-nationally comparable and useful data on fertility, family planning, maternal and child health along with the other information. Six selected Asian countries namely: Bangladesh, India, Indonesia, Nepal, Philippines, and Vietnam are considered for the purpose of the study. Three rounds of DHS surveys for each country (except Vietnam) are considered in the present study. Methods Economic status is measured by computing a "wealth index", i.e. a composite indicator constructed by aggregating data on asset ownership and housing characteristics using principal components analysis (PCA). Computed household wealth index has been broken into three equal parts (33.3 percent each) and the lowest and the highest 33.3 percent is considered as poor and non-poor respectively. The Bongaarts model was employed to quantify the contribution of each of the proximate determinants of fertility among poor and non-poor women. Results Fertility reduction across all population subgroups is now an established fact despite the diversity in the level of socio-economic development in Asian countries. It is clear from the analysis that fertility has declined irrespective of economic status at varying degrees within and across the countries which can be attributed to the increasing level of contraceptive use especially among poor women. Over the period of time changing marriage pattern and induced abortion are playing an important role in reducing fertility among poor women. Conclusions Fertility decline among majority of the poor women across the Asian countries is accompanied by high prevalence of contraceptive use followed by changing marriage pattern and induced abortion.	[Majumder, Nabanita; Ram, Faujdar] Int Inst Populat Sci, Bombay, Maharashtra, India	International Institute for Population Sciences	Majumder, N (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	nabanitamajumder.iips@gmail.com						Adioetomo SM, 1983, MAJALAH DEMOGRAFI IN, V10, P49; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amin S, 2009, 18 POP COUNC; [Anonymous], [No title captured]; [Anonymous], 2006, DHS METHODOLOGICAL R; [Anonymous], 2003, REV INCOME WEALTH; Arnold F, 1990, IRD ASSESSMENT DHS 1; Arokiasamy P., 2009, Economic and Political Weekly, V44, P55; Bbaale E, 2011, J SUSTAINABLE DEV, V6, P20; Bernstein S, 2002, ASIA PACIFIC POPULAT, V17; Bhat PNM, 2002, WORLD DEV, V30, P1791, DOI 10.1016/S0305-750X(02)00065-7; BLACKER J, 1994, POPUL DEV REV, V20, P200, DOI 10.2307/2137639; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; BONGAARTS J, 1984, POPUL DEV REV, V10, P341, DOI 10.2307/1973086; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Bongaarts J, 2002, P EXP GROUP COMPL FE, V172, P288; Bongaarts J, 1993, WORKING PAPERS POPUL; Bracher M, 1992, Health Transit Rev, V2, P19; Bulatao RA., 1983, DETERMINANTS FERTILI, P1; Caldwell J. C., 1982, THEORY FERTILITY DEC; Caldwell JC, 1993, REVOLUTION ASIAN FER; Chen LC, 1974, POPULATION STUDIES, V28, P278; Cheng KW, 2011, J FAM ECON ISS, V32, P257, DOI 10.1007/s10834-011-9248-1; Chidambaram VC, 1980, WFS COMP STUDIES INT; Choi Y, 2010, 2010 PAA M DALL; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Cleland J, 1994, BANGLADESH FERTILITY; COALE AJ, 1974, POPUL INDEX, V40, P185, DOI 10.2307/2733910; Coale Ansley., 1986, DECLINE FERTILITY EU; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Dreze J, 2001, POPUL DEV REV, V27, P33, DOI 10.1111/j.1728-4457.2001.00033.x; Dwivedi Laxmi Kant, 2007, Genus, V63, P19; EASTERLIN RA, 1975, STUD FAMILY PLANN, V6, P54, DOI 10.2307/1964934; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P4; Feyisetan B, 2000, INT FAM PLAN PERSPEC, V26, P100, DOI 10.2307/2648298; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Freedman R, 1995, ASIAS RECENT FERTILI; Frejka T, 1985, INT FAMILY PLANNING, V11, P125; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Ginneken J. K. van, 1977, Journal of Biosocial Science, P41, DOI 10.1017/S0021932000023828; Goldman N, 1985, WFS COMP STUDIES INT; GOODKIND D, 1994, STUD FAMILY PLANN, V25, P342, DOI 10.2307/2137878; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hajnal J, 1953, POP STUD-J DEMOG, V7, P111, DOI 10.2307/2172028; Hajnal John, 1965, POPULATION HIST ESSA, P101, DOI DOI 10.4324/9781315127019-7; Haughton J, 1997, POP STUD-J DEMOG, V51, P203, DOI 10.1080/0032472031000149916; HUFFMAN SL, 1987, POP STUD-J DEMOG, V41, P447, DOI 10.1080/0032472031000142996; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P120; Hussein E, 1995, PERSPECTIVES FERTILI, P31; Johnston HB, 1996, INT FAM PLAN PERSPEC, V22, P108, DOI 10.2307/2950751; Jones G. W., 2007, ASIA PAC POPULAT J, V22, P13; Jones R. E., 1990, 9006; JONES RE, 1989, J BIOSOC SCI, V21, P83, DOI 10.1017/S0021932000017740; JONES RE, 1988, HUM BIOL, V60, P853; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Knodel J, 1978, NATURAL FERTILITY PA, P273; Leridon H., 1977, HUMAN FERTILITY BASI; LUNN PG, 1981, LANCET, V1, P1428; Magadi MA, 2003, STUD FAMILY PLANN, V34, P149, DOI 10.1111/j.1728-4465.2003.00149.x; Maitra P, 2001, DISCUSSION PAPERS MO; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; McNay K, 2003, POP STUD-J DEMOG, V57, P21, DOI 10.1080/0032472032000061703; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Notestein F. W., 1953, P 8 INT C AGR EC, P13; Pallikadavath S, 2006, INT FAM PLAN PERSPEC, V32, P120, DOI 10.1363/3212006; Rodriguez G, 1988, SEM BIOM DEM DET HUM; Ross J, 2001, INT FAM PLAN PERSPEC, V27, P119, DOI 10.2307/2673833; Ross J, 2002, INT FAMILY PLANNING, V28; Rutstein S. O., 2004, DHS COMP REPORTS; SANTOW G, 1987, POP STUD-J DEMOG, V41, P147, DOI 10.1080/0032472031000142576; Shah IH, 1994, PROGR SOCIAL SCI RES, P139; Singh G, 2006, INTERNET J PEDIAT NE, V7; Singh G, 2007, J OBSTET GYN INDIA, V57, P53; SINGH S, 1985, POP STUD-J DEMOG, V39, P113, DOI 10.1080/0032472031000141316; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Singh S, 1996, INT FAM PLAN PERSPEC, V22, P148, DOI 10.2307/2950812; Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606; SMITH PC, 1980, J FAM HIST, V5, P58, DOI 10.1177/036319908000500104; Sun T, 2001, PAA ANN M MARCH 28 3; Teerawichitchainan B, 2010, INT PERSPECT SEX R H, V36, P80, DOI 10.1363/ipsrh.36.080.10; TSUI AO, 1981, STUD FAMILY PLANN, V12, P381, DOI 10.2307/1965995; United Nations, 1990, PATT 1 MARR TIM PREV; United Nations, 1987, POP STUD DEP INT EC; Vaessen M, 2004, HOUSEHOLD SAMPLE SUR; Van De Walle E, 1973, IPPF Med Bull, V7, P1; Vidal-Zeballos D, 1994, DEMOGRAPHIC HLTH SUR; Vu L, 2009, AGE 1 MARRIAGE VIETN; Wood J W, 1985, J Biosoc Sci Suppl, V9, P159; Xenos PC, 1992, WORKING PAPERS PROGR	96	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115441	10.1371/journal.pone.0115441	http://dx.doi.org/10.1371/journal.pone.0115441			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689843	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700004
J	Ouellette-Kuntz, H; Coo, H; Cobigo, V; Wilton, AS				Ouellette-Kuntz, Helene; Coo, Helen; Cobigo, Virginie; Wilton, Andrew S.			Uptake of Colorectal Cancer Screening among Ontarians with Intellectual and Developmental Disabilities	PLOS ONE			English	Article							LIFE EXPECTANCY; DOWN-SYNDROME; PRIMARY-CARE; ADULTS; INDIVIDUALS; PROGRAMS; PEOPLE; TESTS; WOMEN	Under-screening for cancer may contribute to a greater disease burden in individuals with intellectual and developmental disabilities (IDD) as their life expectancy increases. In 2008, the province of Ontario launched Canada's first population-based colorectal cancer screening program. Our objectives were to compare the proportions of Ontarians with and without IDD who have undergone colorectal cancer screening and to examine factors associated with screening uptake among Ontarians with IDD. Records for Ontario residents 50-64 years of age were linked across various administrative health and social services datasets to identify individuals with IDD and to select a random sample of the age-equivalent Ontario population without IDD as a comparison group. Logistic regression models were fit to examine the odds of screening uptake among individuals with IDD while controlling for age, sex, urban or rural residence, neighbourhood income quintile, expected use of health care resources, and being enrolled with or seeing a physician in a patient enrolment model (any of several primary care practice models designed to improve patient access and quality of care in Ontario), and to examine the association between these variables and colorectal cancer screening in the IDD population. The odds of having had a fecal occult blood test in the previous two years and being up-to-date with colorectal tests were 32% and 46% lower, respectively, for Ontarians with IDD compared to those without IDD. Being older, female, having a greater expected use of health care resources, and being enrolled with or seeing a physician in a primary care patient enrolment model were all significantly associated with higher odds of having been screened for colorectal cancer in the IDD population. These findings underscore the need for targeted interventions aimed at making colorectal cancer screening more equitable.	[Ouellette-Kuntz, Helene; Coo, Helen] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Ouellette-Kuntz, Helene] Ongwanada Resource Ctr, Kingston, ON, Canada; [Ouellette-Kuntz, Helene; Cobigo, Virginie; Wilton, Andrew S.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cobigo, Virginie] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	Queens University - Canada; University of Toronto; University of Ottawa	Ouellette-Kuntz, H (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	helene.kuntz@queensu.ca			Canadian Institutes of Health Research (CIHR) [103973]; Ontario Ministry of Community and Social Services (MCSS); Surrey Place Centre; Health Care Access Research and Developmental Disabilities (H-CARDD) Program; Centre for Addiction and Mental Health (CAMH); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long Term Care (MOHLTC); Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Community and Social Services (MCSS); Surrey Place Centre; Health Care Access Research and Developmental Disabilities (H-CARDD) Program; Centre for Addiction and Mental Health (CAMH); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by a Canadian Institutes of Health Research (CIHR; www.cihr-irsc.gc.ca/) Partnerships in Health Systems Improvement grant (PHE#103973) in partnership with the Ontario Ministry of Community and Social Services (MCSS) and Surrey Place Centre, and is part of the Health Care Access Research and Developmental Disabilities (H-CARDD) Program. The work was also supported by the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES), which receive annual grants from the Ontario Ministry of Health and Long Term Care (MOHLTC), as well as by CAMH and Fonds de Recherche en Sante du Quebec postdoctoral support for R. Balogh and V. Cobigo, respectively. The opinions, results and conclusions reported in this paper are those of the authors and are not necessarily those of the funding sources. No endorsement by CIHR, CAMH, ICES, the Ontario MCSS, the Ontario MOHLTC, or the Fonds de Recherche en Sante du Quebec is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2011, DEV DISABIL RES REV, V17, P27, DOI 10.1002/ddrr.135; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Bonardi A., 2011, EXPANDING SURVEILLAN; Brouwers M, 2009, INTERVENTIONS INCREA; Burgess DJ, 2009, PREV MED, V48, P99, DOI 10.1016/j.ypmed.2008.11.014; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2013, CAN CANC STAT 2013; Cobigo V, 2013, J INTELL DISABIL RES, V57, P478, DOI 10.1111/jir.12035; dos Santos Silva I., 1999, CANC EPIDEMIOLOGY PR, P83; Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844; Fischer LS, 2012, INTELLECT DEV DISAB, V50, P383, DOI 10.1352/1934-9556-50.5.383; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Honein-AbouHaidar GN, 2013, CANCER EPIDEMIOL, V37, P946, DOI 10.1016/j.canep.2013.04.007; Jaakkimainen L., 2006, PRIMARY CARE ONTARIO; Javanparast S, 2010, PREV MED, V50, P165, DOI 10.1016/j.ypmed.2010.02.003; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Kralj B, 2012, ONTARIO MED REV, V79, P18; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lin E, 2013, J INTELL DISABIL RES, V57, P462, DOI 10.1111/jir.12002; Lofters AK, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-20; Lunsky Y, 2013, ATLAS PRIMARY CARE A; Ontario Cancer Care, 2012, COLONCANCERCHECK2010; Ontario Ministry of Health and Long-term Care, 2012, INF PROC CLAIM CUM P; Ontario Ministry of Health and Long-Term Care, 2008, B COLONCANCERCHECK P; OUELETTEKUNTZ H, 2010, J DEV DISABILITIES, V0015; Patja K, 2000, J INTELL DISABIL RES, V44, P591, DOI 10.1046/j.1365-2788.2000.00280.x; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Reynolds F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-30; Statistics Canada, 2014, TABL 051 0005 EST PO; Sullivan SG, 2004, CANCER CAUSE CONTROL, V15, P1021, DOI 10.1007/s10552-004-1256-0; Sullivan WF, 2011, CAN FAM PHYSICIAN, V57, P541; The Johns Hopkins University Bloomberg School of Public Health, 2005, J HOPK ACG CAS MIX S; Tinmouth J, 2012, CAN FAM PHYSICIAN, V58, pE570; Tyler CV, 2010, INTELLECT DEV DISAB, V48, P271, DOI 10.1352/1934-9556-48.4.271; Ward Paul R, 2009, Qual Prim Care, V17, P49; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wilkinson JE, 2007, J AM BOARD FAM MED, V20, P399, DOI 10.3122/jabfm.2007.04.060210; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118023	10.1371/journal.pone.0118023	http://dx.doi.org/10.1371/journal.pone.0118023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689849	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700094
J	Pohlkamp, T; Durakoglugil, M; Lane-Donovan, C; Xian, XD; Johnson, EB; Hammer, RE; Herz, J				Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Johnson, Eric B.; Hammer, Robert E.; Herz, Joachim			Lrp4 Domains Differentially Regulate Limb/Brain Development and Synaptic Plasticity	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-4; AMYLOID PRECURSOR PROTEIN; LIMB DEVELOPMENT; MICE LACKING; REELIN; AGRIN; MUTATIONS; DISEASE; COMPLEX; BRAIN	Apolipoprotein E (ApoE) genotype is the strongest predictor of Alzheimer's Disease (AD) risk. ApoE is a cholesterol transport protein that binds to members of the Low-Density Lipoprotein (LDL) Receptor family, which includes LDL Receptor Related Protein 4 (Lrp4). Lrp4, together with one of its ligands Agrin and its co-receptors Muscle Specific Kinase (MuSK) and Amyloid Precursor Protein (APP), regulates neuromuscular junction (NMJ) formation. All four proteins are also expressed in the adult brain, and APP, MuSK, and Agrin are required for normal synapse function in the CNS. Here, we show that Lrp4 is also required for normal hippocampal plasticity. In contrast to the closely related Lrp8/Apoer2, the intracellular domain of Lrp4 does not appear to be necessary for normal expression and maintenance of long-term potentiation at central synapses or for the formation and maintenance of peripheral NMJs. However, it does play a role in limb development.	[Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Johnson, Eric B.; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pohlkamp, T (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	Theresa@Herzlab.org; Joachim.Herz@UTSouthwestern.edu	Xian, Xunde/B-9490-2012; Pohlkamp, Theresa/H-2705-2019	Xian, Xunde/0000-0003-3059-1254; Pohlkamp, Theresa/0000-0003-3923-1917; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health (NIH) [R37 HL63762, F30 AG047799]; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, R01HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047799] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH), grant R37 HL63762 (to J.H.) and NIH grant F30 AG047799 (to C.L.D.). J.H. is further supported by the American Health Assistance Foundation, the Consortium for Frontotemporal Dementia Research, the Bright Focus Foundation, the Lupe Murchison Foundation, The Ted Nash Long Life Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Choi HY, 2013, ELIFE, V2, DOI 10.7554/eLife.00220; Daniels MP, 2012, NEUROCHEM INT, V61, P848, DOI 10.1016/j.neuint.2012.02.028; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Gomez AM, 2014, ELIFE, V3, DOI 10.7554/eLife.04287; Gomez AM, 2011, DEV DYNAM, V240, P2626, DOI 10.1002/dvdy.22772; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2007, ANAL FUNCTION MEGF7; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Karner CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010418; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Liu ZH, 2006, J ENDOCRINOL, V189, P409, DOI 10.1677/joe.1.06420; Pohlkamp T, 2013, CEREB CORTEX; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Qi Y, 2013, NEUROSCI LETT, V542, P53, DOI 10.1016/j.neulet.2013.03.012; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Tao YM, 2013, NAT NEUROSCI, V16, P290, DOI 10.1038/nn.3320; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weber H, 2014, EUR NEUROPSYCHOPHARM, V24, P65, DOI 10.1016/j.euroneuro.2013.09.005; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307	42	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116701	10.1371/journal.pone.0116701	http://dx.doi.org/10.1371/journal.pone.0116701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688974	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700020
J	Rycroft, D; Sosabowski, J; Coulstock, E; Davies, M; Morrey, J; Friel, S; Kelly, F; Hamatake, R; Ovecka, M; Prince, R; Goodall, L; Sepp, A; Walker, A				Rycroft, Daniel; Sosabowski, Jane; Coulstock, Edward; Davies, Marie; Morrey, John; Friel, Sarah; Kelly, Fiona; Hamatake, Robert; Ovecka, Milan; Prince, Rob; Goodall, Laura; Sepp, Armin; Walker, Adam			Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ASIALOGLYCOPROTEIN RECEPTOR; DOMAIN ANTIBODIES; CELLS; INHIBITION; THERAPY; GENE; MECHANISMS; LIPOSOMES; DELIVERY	Interferon alpha (IFN alpha) is used for the treatment of hepatitis B virus infection, and whilst efficacious, it is associated with multiple adverse events caused by systemic exposure to interferon. We therefore hypothesise that targeting IFN directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFNa therapy. Furthermore we investigated whether directing IFN to the reservoir of infection in the liver may improve antiviral efficacy by increasing local concentration in target organs and tissues. Our previous results show that the mIFN alpha 2 fused to an ASGPR specific liver targeting antibody, DOM26h-196-61, results in a fusion protein which retains the activity of both fusion partners when measured in vitro. In vivo targeting of the liver by mIFN alpha 2-DOM26h-196-61, hereafter referred to as targeted mIFN alpha 2, was observed in microSPECT imaging studies in mice. In this study we show by pharmacokinetic analysis that antibody mediated liver-targeting results in increased uptake and exposure of targeted mIFNa2 in target tissues, and correspondingly reduced uptake and exposure in systemic circulation, clearance organs and non-target tissues. We also show that cytokine activity and antiviral activity of liver-targeted IFN is observed in vivo, but that, contrary to expectations, liver-targeting of mIFN alpha 2 using ASGPR specific dAbs actually leads to a reduced pharmacodynamic effect in target organs and lower antiviral activity in vivo when compared to non-targeted mIFN alpha 2-dAb fusions.	[Rycroft, Daniel; Coulstock, Edward; Davies, Marie; Friel, Sarah; Ovecka, Milan; Goodall, Laura; Sepp, Armin; Walker, Adam] GlaxoSmithKline, Biopharm Innovat Unit, Biopharm Res & Dev, Cambridge, England; [Sosabowski, Jane] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Morrey, John] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Kelly, Fiona] GlaxoSmithKline, Biopharm R&D, Biopharm Translat Med, Stevenage, Herts, England; [Hamatake, Robert] GlaxoSmithKline, Res Triangle Pk, NC USA; [Prince, Rob] GlaxoSmithKline, Biopharm R&D, Biopharm Discovery, Stevenage, Herts, England	GlaxoSmithKline; University of London; Queen Mary University London; Utah System of Higher Education; Utah State University; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Walker, A (corresponding author), GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England.	adam.z.walker@gsk.com			National Institutes of Health (NIH) [HHSN272201000039I/HHSN27200001/A19]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work carried out by JM was funded by the National Institutes of Health (NIH). NIH contract number is HHSN272201000039I/HHSN27200001/A19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Coulstock E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057263; Deal KA, 1998, NUCL MED BIOL, V25, P379, DOI 10.1016/S0969-8051(97)00222-9; Dieperink E, 2003, PSYCHOSOMATICS, V44, P104, DOI 10.1176/appi.psy.44.2.104; DUNCAN R, 1986, BIOCHIM BIOPHYS ACTA, V880, P62, DOI 10.1016/0304-4165(86)90120-0; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Iorio R, 1997, PEDIATR INFECT DIS J, V16, P984, DOI 10.1097/00006454-199710000-00016; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jeong YI, 2005, INT J PHARMACEUT, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027; Morrey JD, 2008, ANTIVIR RES, V79, P71, DOI 10.1016/j.antiviral.2008.01.157; Pacifico F, 2003, MOL CELL ENDOCRINOL, V208, P51, DOI 10.1016/j.mce.2003.06.001; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Seow YYT, 2002, NEPHRON, V91, P431, DOI 10.1159/000064283; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; Treichel U, 1997, ARCH VIROL, V142, P493, DOI 10.1007/s007050050095; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117847	10.1371/journal.pone.0117847	http://dx.doi.org/10.1371/journal.pone.0117847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689509	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700077
J	Wade, D; Diaw, PA; Daneau, G; Diallo, AA; Mboup, S; Dieye, TN; Kestens, L				Wade, Djibril; Diaw, Papa Alassane; Daneau, Geraldine; Diallo, Abdoul Aziz; Mboup, Souleymane; Dieye, Tandakha Ndiaye; Kestens, Luc			Laboratory and Field Evaluation of the Partec CyFlow MiniPOC for Absolute and Relative CD4 T-Cell Enumeration	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; PERFORMANCE EVALUATION; FLOW CYTOMETER; SINGLE-PLATFORM; POINT; PIMA; SETTINGS; ANALYZER; COUNTS; SYSTEM	Background A new CD4 point-of-care instrument, the CyFlow miniPOC, which provides absolute and percentage CD4 T-cells, used for screening and monitoring of HIV-infected patients in resource-limited settings, was introduced recently. We assessed the performance of this novel instrument in a reference laboratory and in a field setting in Senegal. Methodology A total of 321 blood samples were obtained from 297 adults and 24 children, all HIV-patients attending university hospitals in Dakar, or health centers in Ziguinchor. Samples were analyzed in parallel on CyFlow miniPOC, FACSCount CD4 and FACSCalibur to assess CyFlow miniPOC precision and accuracy. Results At the reference lab, CyFlow miniPOC, compared to FACSCalibur, showed an absolute mean bias of -12.6 cells/mm(3) and a corresponding relative mean bias of -2.3% for absolute CD4 counts. For CD4 percentages, the absolute mean bias was -0.1%. Compared to FACSCount CD4, the absolute and relative mean biases were -31.2 cells/mm3 and -4.7%, respectively, for CD4 counts, whereas the absolute mean bias for CD4 percentages was 1.3%. The CyFlow miniPOC was able to classify HIV-patients eligible for ART with a sensitivity of >= 95% at the different ART-initiation thresholds (200, 350 and 500 CD4 cells/mm(3)). In the field lab, the room temperature ranged from 30 to 35 degrees C during the working hours. At those temperatures, the CyFlow miniPOC, compared to FACSCount CD4, had an absolute and relative mean bias of 7.6 cells/mm(3) and 2.8%, respectively, for absolute CD4 counts, and an absolute mean bias of 0.4% for CD4 percentages. The CyFlow miniPOC showed sensitivity equal or greater than 94%. Conclusion The CyFlow miniPOC showed high agreement with FACSCalibur and FACSCount CD4. The CyFlow miniPOC provides both reliable absolute CD4 counts and CD4 percentages even under the field conditions, and is suitable for monitoring HIV-infected patients in resource-limited settings.	[Wade, Djibril; Diaw, Papa Alassane; Diallo, Abdoul Aziz; Mboup, Souleymane; Dieye, Tandakha Ndiaye] Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal; [Wade, Djibril; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Immunol Lab, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Wade, Djibril; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Wade, D (corresponding author), Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal.	wadedjibril@yahoo.fr	Wade, Djibril/AAK-1418-2021	Wade, Djibril/0000-0002-1321-365X; Daneau, Geraldine/0000-0002-2570-0893	Belgian Directorate General of Development	Belgian Directorate General of Development	This study was funded by Belgian Directorate General of Development. The funder had no role in study design, data collection and analysis, decision too publish, or preparation of the manuscript.	Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BROUGHTON PM, 1974, ANN CLIN BIOCHEM, V11, P207, DOI 10.1177/000456327401100164; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68; Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005; Li X, 2010, CYTOM PART B-CLIN CY, V78B, P31, DOI 10.1002/cyto.b.20488; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Logan C, 2013, J IMMUNOL METHODS, V387, P107, DOI 10.1016/j.jim.2012.10.002; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mbopi-Keou FX, 2012, CLIN VACCINE IMMUNOL, V19, P609, DOI 10.1128/CVI.00023-12; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005; Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721; Pattanapanyasat K, 2008, CYTOM PART B-CLIN CY, V74B, pS98, DOI 10.1002/cyto.b.20415; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Renault Cybele A, 2010, Open AIDS J, V4, P171, DOI 10.2174/1874613601004010171; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Strauss K, 1996, CYTOMETRY, V26, P52; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Thakar Madhuri R, 2006, AIDS Res Ther, V3, P26, DOI 10.1186/1742-6405-3-26; UNITAID, 2013, HIV AIDS DIAGN TECHN; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; Wade D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075484; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116663	10.1371/journal.pone.0116663	http://dx.doi.org/10.1371/journal.pone.0116663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688553	gold, Green Published			2022-12-27	WOS:000350322700018
J	Zhao, GY; Li, H; Zhao, P; Cai, WZ				Zhao, Guangyu; Li, Hu; Zhao, Ping; Cai, Wanzhi			Comparative Mitogenomics of the Assassin Bug Genus Peirates (Hemiptera: Reduviidae: Peiratinae) Reveal Conserved Mitochondrial Genome Organization of P. atromaculatus, P. fulvescens and P. turpis	PLOS ONE			English	Article							CONTROL REGION; TOTAL DNA; EVOLUTION; SEQUENCE; REARRANGEMENTS; CHARACTERS; COLEOPTERA	In this study, we sequenced four new mitochondrial genomes and presented comparative mitogenomic analyses of five species in the genus Peirates (Hemiptera: Reduviidae). Mitochondrial genomes of these five assassin bugs had a typical set of 37 genes and retained the ancestral gene arrangement of insects. The A+T content, AT-and GC-skews were similar to the common base composition biases of insect mtDNA. Genomic size ranges from 15,702 bp to 16,314 bp and most of the size variation was due to length and copy number of the repeat unit in the putative control region. All of the control region sequences included large tandem repeats present in two or more copies. Our result revealed similarity in mitochondrial genomes of P. atromaculatus, P. fulvescens and P. turpis, as well as the highly conserved genomic-level characteristics of these three species, e.g., the same start and stop codons of protein-coding genes, conserved secondary structure of tRNAs, identical location and length of non-coding and overlapping regions, and conservation of structural elements and tandem repeat unit in control region. Phylogenetic analyses also supported a close relationship between P. atromaculatus, P. fulvescens and P. turpis, which might be recently diverged species. The present study indicates that mitochondrial genome has important implications on phylogenetics, population genetics and speciation in the genus Peirates.	[Zhao, Guangyu; Li, Hu; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhao, Guangyu] Daxing 1 Middle Sch, Beijing, Peoples R China; [Li, Hu] China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Zhao, Ping] Kaili Univ, Coll Environm & Life Sci, Kaili, Guizhou, Peoples R China	China Agricultural University; China Agricultural University; Kaili University	Cai, WZ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	tigerleecau@hotmail.com; caiwz@cau.edu.cn			National Basic Research Program of China [2013CB127600]; National Natural Science Foundation of China [31372229, 31401991, 31201737]; Beijing Natural Science Foundation [6152016, 6144027]; Special Fund for Agroscientific Research in the Public Interest [201103012, 201103022, 201303024]; National Key Technology R & D Program of the Ministry of Science and Technology [2012BAD19B00]; Special Fund for Scientific Research [2012FY111100]; China Postdoctoral Science Foundation [2013M540167, 2014T70145]; Chinese Universities Scientific Fund [2014BH021]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund for Agroscientific Research in the Public Interest; National Key Technology R & D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Special Fund for Scientific Research; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Universities Scientific Fund	This research is supported by grants from the National Basic Research Program of China (No. 2013CB127600), the National Natural Science Foundation of China (No. 31372229), the Beijing Natural Science Foundation (No. 6152016), the Special Fund for Agroscientific Research in the Public Interest (Nos. 201103012, 201103022, 201303024), the National Key Technology R & D Program of the Ministry of Science and Technology (No. 2012BAD19B00) and the Special Fund for Scientific Research (No. 2012FY111100) for Wanzhi Cai; and the National Natural Science Foundation of China (No. 31401991), the Beijing Natural Science Foundation (No. 6144027), the China Postdoctoral Science Foundation (Nos. 2013M540167, 2014T70145) and the Chinese Universities Scientific Fund (No. 2014BH021) for Hu Li; and the National Natural Science Foundation of China (No. 31201737) for Ping Zhao. All authors have read and approved the final manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Cai Wanzhi, 2006, Zootaxa, V1360, P51; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Coscaron MD, 1996, P ENTOMOL SOC WASH, V98, P500; COSCARON MDC, 1995, ENTOMOL SCAND, V26, P191; Coscaron MDC, 1997, ENTOMOL SCAND, V28, P39; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Gao JY, 2013, ZOOTAXA, V3669, P1; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hsiao TY, 1981, HDB DETERMINATION CH, V2; Kocher A, 2014, GENE, V552, P184, DOI 10.1016/j.gene.2014.09.033; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061685; Li H, 2015, MITOCHONDR DNA, V26, P674, DOI 10.3109/19401736.2013.840602; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055381; Liu Hai-yu, 2011, Entomotaxonomia, V33, P109; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Maldonado Capriles J, 1990, PUERTO RICO SPECIAL; Miller M.A., 2010, P GAT COMP ENV WORKS; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinstein ND, 2013, GENOME BIOL EVOL, V5, P1185, DOI 10.1093/gbe/evt081; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Sosa MX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002737; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Timmermans MJTN, 2012, MOL PHYLOGENET EVOL, V63, P299, DOI 10.1016/j.ympev.2011.12.021; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042056; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101375; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077511; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhao GY, 2016, MITOCHONDRIAL DNA A, V27, P16, DOI 10.3109/19401736.2013.867438; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	55	11	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117862	10.1371/journal.pone.0117862	http://dx.doi.org/10.1371/journal.pone.0117862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689825	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700080
J	Blom, MM; Zarit, SH; Zwaaftink, RBMG; Cuijpers, P; Pot, AM				Blom, Marco M.; Zarit, Steven H.; Zwaaftink, Rob B. M. Groot; Cuijpers, Pim; Pot, Anne Margriet			Effectiveness of an Internet Intervention for Family Caregivers of People with Dementia: Results of a Randomized Controlled Trial	PLOS ONE			English	Article							PSYCHOLOGICAL TREATMENTS; DISTRESS; ANXIETY; QUESTIONNAIRE; DEPRESSION; DISORDERS; PROGRAM	Background The World Health Organization stresses the importance of accessible and (cost) effective caregiver support, given the expected increase in the number of people with dementia and the detrimental impact on the mental health of family caregivers. Methods This study assessed the effectiveness of the Internet intervention 'Mastery over Dementia'. In a RCT, 251 caregivers, of whom six were lost at baseline, were randomly assigned to two groups. Caregivers in the experimental group (N = 149) were compared to caregivers who received a minimal intervention consisting of e-bulletins (N = 96). Outcomes were symptoms of depression (Center for Epidemiologic Studies Depression Scale: CES-D) and anxiety (Hospital Anxiety and Depression Scale: HADS-A). All data were collected via the Internet, and an intention-to-treat analysis was carried out. Results Almost all caregivers were spouses or children (in-law). They were predominantly female and lived with the care recipient in the same household. Age of the caregivers varied from 26 to 87 years. Level of education varied from primary school to university, with almost half of them holding a bachelor's degree or higher. Regression analyses showed that caregivers in the experimental group showed significantly lower symptoms of depression (p = .034) and anxiety (p = .007) post intervention after adjustment for baseline differences in the primary outcome scores and the functional status of the patients with dementia. Effect sizes were moderate for symptoms of anxiety (.48) and small for depressive symptoms (.26). Conclusions The Internet course 'Mastery over Dementia' offers an effective treatment for family caregivers of people with dementia reducing symptoms of depression and anxiety. The results of this study justify further development of Internet interventions for family caregivers of people with dementia and suggest that such interventions are promising for keeping support for family caregivers accessible and affordable. The findings are even more promising because future generations of family caregivers will be more familiar with the Internet.	[Blom, Marco M.; Zwaaftink, Rob B. M. Groot] Dutch Alzheimers Soc, Dept Sci Res, Amersfoort, Netherlands; [Zarit, Steven H.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Zarit, Steven H.] Univ Coll Hlth Sci, Inst Gerontol, Jonkoping, Sweden; [Cuijpers, Pim; Pot, Anne Margriet] Vrije Univ Amsterdam, Dept Clin Psychol, EMGO, Amsterdam, Netherlands; [Pot, Anne Margriet] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Program Aging, Utrecht, Netherlands; [Pot, Anne Margriet] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vrije Universiteit Amsterdam; Trimbos Institute; University of Queensland	Blom, MM (corresponding author), Dutch Alzheimers Soc, Dept Sci Res, Amersfoort, Netherlands.	m.blom@alzheimer-nederland.nl	Cuijpers, Pim/G-1703-2013; Janson, Patrick/AAC-7581-2022	Pot, Anne Margriet/0000-0003-2917-4322	Alzheimer Nederland (Dutch Alzheimer's Society); Geriant; VU University	Alzheimer Nederland (Dutch Alzheimer's Society); Geriant; VU University	This study was funded by Alzheimer Nederland (Dutch Alzheimer's Society), Geriant and the VU University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Beauchamp N, 2005, GERONTOLOGIST, V45, P793, DOI 10.1093/geront/45.6.793; Blom MM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-17; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Choi M, 2012, HEALTHC INFORM RES, V18, P191, DOI 10.4258/hir.2012.18.3.191; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Cooper C, 2007, INT J GERIATR PSYCH, V22, P181, DOI 10.1002/gps.1656; Cuijpers P, 2005, AGING MENT HEALTH, V9, P325, DOI 10.1080/13607860500090078; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Gallagher-Thompson D, 2007, PSYCHOL AGING, V22, P37, DOI 10.1037/0882-7974.22.1.37; Hedman E, 2013, PSYCHOL MED, V43, P363, DOI 10.1017/S0033291712001079; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kajiyama B, 2013, AGING MENT HEALTH, V17, P544, DOI 10.1080/13607863.2013.775641; Kelders SM, 2012, J MED INTERNET RES, V14, P17, DOI 10.2196/jmir.2104; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Pot AM, 1998, PATIENT EDUC COUNS, V34, P43, DOI 10.1016/S0738-3991(98)00048-2; Pot AM, 2007, INT PSYCHOGERIATR S, V19, P11; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Vernooij-Dassen MJFJ, 1999, J AM GERIATR SOC, V47, P256, DOI 10.1111/j.1532-5415.1999.tb04588.x; Vernooij-Dassen M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005318.pub2; Warmerdam L, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1436; World Health Organization Alzheimer's Disease International, 2012, DEMENTIA A PUBLIC HE, DOI [10.1186/alzrt143, DOI 10.1186/ALZRT143]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	117	119	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116622	10.1371/journal.pone.0116622	http://dx.doi.org/10.1371/journal.pone.0116622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679228	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600028
J	Ding, G; Zou, WJ; Zhang, H; Xue, YD; Cai, Y; Huang, GF; Chen, LF; Duan, SM; Kang, LJ				Ding, Gang; Zou, Wenjuan; Zhang, Hu; Xue, Yadan; Cai, Yang; Huang, Guifang; Chen, Lufeng; Duan, Shumin; Kang, Lijun			In Vivo Tactile Stimulation-Evoked Responses in Caenorhabditis elegans Amphid Sheath Glia	PLOS ONE			English	Article							C-ELEGANS; MECHANOTRANSDUCTION CHANNEL; DEG/ENAC CHANNEL; TOUCH SENSATION; SUBUNIT; NEURONS	Glial cells are important components of the nervous system. However, how they respond to physiological stimuli in vivo remains largely unknown. In this study, we investigated the electrophysiological activities and Ca2+ responses of the C. elegans amphid sheath glia (AMsh glia) to tactile stimulation in vivo. We recorded robust inward currents and Ca2+ elevation in the AMsh cell with the delivery of tactile stimuli of varying displacements to the nose tip of the worm. Compared to the adjacent mechanoreceptor ASH neuron, the AMsh cell showed greater sensitivity to tactile stimulation. Amiloride, an epithelial Na+ channel blocker, blocked the touch-induced currents and Ca2+ signaling in the ASH neuron, but not those in the AMsh cell. Taken together, our results revealed that AMsh glial cells actively respond to in vivo tactile stimulation and likely function cell-autonomously as mechanoreceptors.	[Ding, Gang; Zou, Wenjuan; Zhang, Hu; Xue, Yadan; Cai, Yang; Huang, Guifang; Duan, Shumin; Kang, Lijun] Zhejiang Univ, Sch Med, Minist Hlth China, Dept Neurobiol,Key Lab Med Neurobiol,Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Yang; Chen, Lufeng] Xinjiang Med Univ, Basic Med Coll, Dept Pharmacol, Urumqi, Peoples R China	Zhejiang University; Xinjiang Medical University	Duan, SM (corresponding author), Zhejiang Univ, Sch Med, Minist Hlth China, Dept Neurobiol,Key Lab Med Neurobiol,Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China.	duanshumin@zjuem.zju.edu.cn; kanglijun@zju.edu.cn		KANG, Lijun/0000-0001-9939-5134	Major National Scientific Research Projects of the Ministry of Science and Technology of China [2013CB945603]; National Foundation of Natural Science of China [31271180]; Zhejiang Natural Science Funds for Distinguished Young Scholars of China [LR14C090001]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Major National Scientific Research Projects of the Ministry of Science and Technology of China; National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scholars of China; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Major National Scientific Research Projects of the Ministry of Science and Technology of China (2013CB945603, to LJK). http://www.most.gov.cn/; the National Foundation of Natural Science of China (31271180, to LJK). http://www.nsfc.gov.cn/; Zhejiang Natural Science Funds for Distinguished Young Scholars of China (LR14C090001, to LJK). http://www.zjnsf.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Brophy P, 2009, CURR OPIN NEUROBIOL, V19, P459, DOI 10.1016/j.conb.2009.10.013; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Davila D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00272; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Doroquez DB, 2014, ELIFE, V3, DOI 10.7554/eLife.01948; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Han L, 2013, J NEUROSCI, V33, P936, DOI 10.1523/JNEUROSCI.2749-12.2013; Heiman MG, 2009, CELL, V137, P344, DOI 10.1016/j.cell.2009.01.057; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Li ZY, 2014, CELL, V159, P751, DOI 10.1016/j.cell.2014.09.056; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Oikonomou G, 2011, GLIA, V59, P1253, DOI 10.1002/glia.21084; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Richmond J, 2009, J VIS EXP; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Stiernagle Theresa, 2006, WormBook, P1; Stout RF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00067; Stout RF, 2011, CELL CALCIUM, V50, P98, DOI 10.1016/j.ceca.2011.05.016; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zou Wen-juan, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P222	30	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117114	10.1371/journal.pone.0117114	http://dx.doi.org/10.1371/journal.pone.0117114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671616	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300035
J	Venn-Watson, S; Garrison, L; Litz, J; Fougeres, E; Mase, B; Rappucci, G; Stratton, E; Carmichael, R; Odell, D; Shannon, D; Shippee, S; Smith, S; Staggs, L; Tumlin, M; Whitehead, H; Rowles, T				Venn-Watson, Stephanie; Garrison, Lance; Litz, Jenny; Fougeres, Erin; Mase, Blair; Rappucci, Gina; Stratton, Elizabeth; Carmichael, Ruth; Odell, Daniel; Shannon, Delphine; Shippee, Steve; Smith, Suzanne; Staggs, Lydia; Tumlin, Mandy; Whitehead, Heidi; Rowles, Teri			Demographic Clusters Identified within the Northern Gulf of Mexico Common Bottlenose Dolphin (Tursiops truncates) Unusual Mortality Event: January 2010-June 2013	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; INFECTION	1 National Marine Mammal Foundation, San Diego, California, United States of America, 2 National Marine Fisheries Service, Southeast Fisheries Science Center, Miami, Florida, United States of America, 3 National Marine Fisheries Service, Southeast Regional Office, St. Petersburg, Florida, United States of America, 4 NOAA Affiliate, Southeast Fisheries Science Center, Miami, Florida, United States of America, 5 Dauphin Island Sea Lab and University of South Alabama, Dauphin Island, Alabama, United States of America, 6 Hubbs- SeaWorld Research Institute, Melbourne Beach, Florida, United States of America, 7 Institute for Marine Mammal Studies, Gulfport, Mississippi, United States of America, 8 Emerald Coast Wildlife Refuge, Fort Walton Beach, Florida, United States of America, 9 Marine Wildlife Response, Esther, Florida, United States of America, 10 Audubon Aquarium of the Americas, New Orleans, Louisiana, United States of America, 11 Gulf World Marine Park, Panama City Beach, Florida, United States of America, 12 Louisiana Department of Wildlife and Fisheries, Baton Rouge, Louisiana, United States of America, 13 Texas Marine Mammal Stranding Network, Galveston, Texas, United States of America, 14 National Marine Fisheries Service, Office of Protected Resources, Silver Spring, Maryland, United States of America	[Venn-Watson, Stephanie] Natl Marine Mammal Fdn, San Diego, CA 92106 USA; [Garrison, Lance; Litz, Jenny; Mase, Blair] Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Fougeres, Erin] Southeast Reg Off, Natl Marine Fisheries Serv, St Petersburg, FL USA; [Rappucci, Gina; Stratton, Elizabeth] NOAA Affiliate, Southeast Fisheries Sci Ctr, Miami, FL USA; [Carmichael, Ruth] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Carmichael, Ruth] Univ S Alabama, Dauphin Isl, AL USA; [Odell, Daniel] Hubbs SeaWorld Res Inst, Melbourne Beach, FL USA; [Shannon, Delphine] Inst Marine Mammal Studies, Gulfport, MS USA; [Shippee, Steve] Emerald Coast Wildlife Refuge, Ft Walton Beach, FL USA; [Shippee, Steve] Marine Wildlife Response, Esther, FL USA; [Smith, Suzanne] Audubon Aquarium Amer, New Orleans, LA USA; [Staggs, Lydia] Gulf World Marine Pk, Panama City Beach, FL USA; [Tumlin, Mandy] Louisiana Dept Wildlife & Fisheries, Baton Rouge, LA USA; [Whitehead, Heidi] Texas Marine Mammal Stranding Network, Galveston, TX USA; [Rowles, Teri] Off Protected Resources, Natl Marine Fisheries Serv, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Dauphin Island Sea Lab; University of South Alabama; National Oceanic Atmospheric Admin (NOAA) - USA	Venn-Watson, S (corresponding author), Natl Marine Mammal Fdn, San Diego, CA 92106 USA.	stephanie.venn-watson@nmmf.org		Carmichael, Ruth/0000-0002-6033-3777	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by the National Oceanic and Atmospheric Administration, in which represented co-authors from the National Marine Fisheries Service participated in the study design, data collection and analysis, and preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Antonio FJ, 2011, AQUAT TOXICOL, V105, P177, DOI 10.1016/j.aquatox.2011.05.022; Barry KP, 2008, LAKE PONTCHARTRAIN L; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Fernandez S, 1998, FISH B-NOAA, V96, P357; Fire SE, 2011, HARMFUL ALGAE, V10, P330, DOI 10.1016/j.hal.2010.12.001; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; GARROTT RA, 1993, MAR MAMMAL SCI, V9, P343, DOI 10.1111/j.1748-7692.1993.tb00468.x; KRAFFT A, 1995, J WILDLIFE DIS, V31, P410, DOI 10.7589/0090-3558-31.3.410; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Lipscomb TP, 1996, J VET DIAGN INVEST, V8, P283, DOI 10.1177/104063879600800302; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Mattson MC, 2006, MAR MAMMAL SCI, V22, P654, DOI 10.1111/j.1748-7692.2006.00057.x; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20222, DOI 10.1073/pnas.1214389109; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; National Response Team, 2011, SCEN COORD REP UNPUB; NOAA Fisheries, 2010 2014 CET UN MOR; NOAA Fisheries, 2011 2012 BOTTL DOLP; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; Twiner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042974	23	12	12	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117248	10.1371/journal.pone.0117248	http://dx.doi.org/10.1371/journal.pone.0117248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671657	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300044
J	Paradis, AN; Gay, MS; Wilson, CG; Zhang, LB				Paradis, Alexandra N.; Gay, Maresha S.; Wilson, Christopher G.; Zhang, Lubo			Newborn Hypoxia/Anoxia Inhibits Cardiomyocyte Proliferation and Decreases Cardiomyocyte Endowment in the Developing Heart: Role of Endothelin-1	PLOS ONE			English	Article							CELL-CYCLE CONTROL; INDUCIBLE FACTOR-I; FETAL HYPOXIA; MYOCARDIAL-CELLS; PRETERM INFANTS; CARDIAC-MUSCLE; EXPRESSION; GROWTH; RAT; GENE	In the developing heart, cardiomyocytes undergo terminal differentiation during a critical window around birth. Hypoxia is a major stress to preterm infants, yet its effect on the development and maturation of the heart remains unknown. We tested the hypothesis in a rat model that newborn anoxia accelerates cardiomyocyte terminal differentiation and results in reduced cardiomyocyte endowment in the developing heart via an endothelin-1-dependent mechanism. Newborn rats were exposed to anoxia twice daily from postnatal day 1 to 3, and hearts were isolated and studied at postnatal day 4 (P4), 7 (P7), and 14 (P14). Anoxia significantly increased HIF-1 alpha protein expression and pre-proET-1 mRNA abundance in P4 neonatal hearts. Cardiomyocyte proliferation was significantly decreased by anoxia in P4 and P7, resulting in a significant reduction of cardiomyocyte number per heart weight in the P14 neonates. Furthermore, the expression of cyclin D2 was significantly decreased due to anoxia, while p27 expression was increased. Anoxia has no significant effect on cardiomyocyte binucleation or myocyte size. Consistently, prenatal hypoxia significantly decreased cardiomyocyte proliferation but had no effect on binucleation in the fetal heart. Newborn administration of PD156707, an ETA-receptor antagonist, significantly increased cardiomyocyte proliferation at P4 and cell size at P7, resulting in an increase in the heart to body weight ratio in P7 neonates. In addition, PD156707 abrogated the anoxia-mediated effects. The results suggest that hypoxia and anoxia via activation of endothelin-1 at the critical window of heart development inhibits cardiomyocyte proliferation and decreases myocyte endowment in the developing heart, which may negatively impact cardiac function later in life.	[Paradis, Alexandra N.; Gay, Maresha S.; Wilson, Christopher G.; Zhang, Lubo] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Dept Basic Sci,Div Pharmacol, Loma Linda, CA 92354 USA; [Wilson, Christopher G.] Loma Linda Univ, Sch Med, Div Neonatol, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Dept Basic Sci,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grant HL118861 (to L. Zhang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapitov AV, 2002, J RENIN-ANGIO-ALDO S, V3, P1, DOI 10.3317/jraas.2002.001; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; ANVERSA P, 1975, LAB INVEST, V33, P696; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BOLIVAR JM, 1995, J PEDIATR-US, V127, P767, DOI 10.1016/S0022-3476(95)70171-0; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; BUGAISKY L, 1979, TEX REP BIOL MED, V39, P123; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; CLUBB FJ, 1984, LAB INVEST, V50, P571; Coe Y, 2002, J PHARMACOL EXP THER, V302, P672, DOI 10.1124/jpet.302.2.672; Cooper AL, 1999, AM J PHYSIOL-HEART C, V277, pH1326, DOI 10.1152/ajpheart.1999.277.4.H1326; Dimaguila MAVT, 1997, J PEDIATR-US, V130, P577, DOI 10.1016/S0022-3476(97)70242-7; DRANSFIELD DA, 1983, AM J DIS CHILD, V137, P441, DOI 10.1001/archpedi.1983.02140310023005; Gardner LB, 2003, MOL CELL BIOL, V23, P9032, DOI 10.1128/MCB.23.24.9032-9045.2003; Goldie RG, 1999, CLIN EXP PHARMACOL P, V26, P145, DOI 10.1046/j.1440-1681.1999.03014.x; HARVEY PR, 1999, HEART DEV; HASHIGUCHI K, 1991, J CARDIOVASC PHARM, V17, pS509, DOI 10.1097/00005344-199100177-00145; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Kakinuma Y, 2001, CIRCULATION, V103, P2387; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Louey S, 2007, J PHYSIOL-LONDON, V580, P639, DOI 10.1113/jphysiol.2006.122200; MandarimdeLacerda CA, 1995, ACTA ANAT, V154, P261; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Minchenko A, 2000, MOL CELL BIOCHEM, V208, P53, DOI 10.1023/A:1007042729486; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; NAG AC, 1980, CYTOBIOS, V28, P41; Ostlund E, 2000, ACTA OBSTET GYN SCAN, V79, P276, DOI 10.1034/j.1600-0412.2000.079004276.x; Paradis A, 2014, INT J MED SCI, V11, P373, DOI 10.7150/ijms.7802; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; REYNOLDS EE, 1995, J PHARMACOL EXP THER, V273, P1410; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SMITH HE, 1977, DEV BIOL, V57, P109, DOI 10.1016/0012-1606(77)90358-X; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Tong W, 2013, AM J PHYSL REGULATOR; Tong WN, 2011, AM J PHYSIOL-HEART C, V301, pH2113, DOI 10.1152/ajpheart.00356.2011; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WILKES BM, 1993, J HISTOCHEM CYTOCHEM, V41, P535, DOI 10.1177/41.4.8450193; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yamada J, 2001, J Matern Fetal Med, V10, P409; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; YANAGISAWA M, 1994, CIRCULATION, V89, P1320, DOI 10.1161/01.CIR.89.3.1320; ZAK R, 1974, CIRC RES, V35, P17; Zhang FX, 2007, ACTA PHARMACOL SIN, V28, P44, DOI 10.1111/j.1745-7254.2007.00488.x	59	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116600	10.1371/journal.pone.0116600	http://dx.doi.org/10.1371/journal.pone.0116600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692855	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500019
J	Wu, Y; He, JC; Zhou, XT; Chu, RY				Wu, Ying; He, Ji C.; Zhou, Xing T.; Chu, Ren Y.			A Limitation of Hartmann-Shack System in Measuring Wavefront Aberrations for Patients Received Laser Refractive Surgery	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; IN-SITU KERATOMILEUSIS; PUPIL SIZE; SPHERICAL-ABERRATION; CONTACT-LENSES; HUMAN EYE; OFF-EYE; ON-EYE; LASIK; MYOPIA	Purpose To explore the relationship between ablation parameters of myopic laser surgery and measurement area of wavefront aberration (WA) with Hartmann-Shack wavefront sensor. Methods 58 subjects undergone myopic laser surgeries and 74 uncorrected myopic subjects were enrolled in this experiment. The laser ablation parameters were obtained from surgical records, which included spherical error (Rx), depth, and optical zone (OZ) of ablation. The measured area of WA was tested by the WASCA, and the real pupil size was tested by Pentacam. The corneal eccentricity (E value) and curvature was also measured with the Pentacam. All the measurements were performed under mydriatic condition. Results For uncorrected myopic eyes, the measured area of WA was similar with the real pupil size. But for the corrected eyes, the measured area of WA was smaller than the real pupil size with a mean difference of 0.66 +/- 0.54 mm for moderate myopia (t = 6.45, p < 0.0001) and 1.76 +/- 0.55 mm for high myopia (t = 18.92, p < 0.0001), but not for mild myopia. The Rx (t = -3.20, p = 0.0017), OZ (t = 64.4, p < 0.0001) and postoperative corneal E value (t = 2.52, p = 0.017) were the independent factors of measured area of WA. Measured area of WA = -0.81*Rx + 1.13*OZ + 0.49* postoperative corneal E value (r(2) = 0.997). Conclusions The WASCA has a limitation in measuring wavefront aberration over the whole pupil area when it's used for patients received myopic laser surgery. The measured area is smaller than the real pupil size and depends linearly on ablation depth, optical zone and corneal eccentricity.	[Wu, Ying; Zhou, Xing T.; Chu, Ren Y.] Fudan Univ, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [He, Ji C.] New England Coll Optometry, Boston, MA USA	Fudan University	Zhou, XT (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	xingtaozhou@163.com	zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [11074052]; Special Fund for Public Health Service Research of China [201302015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Public Health Service Research of China	YW received funding from the National Natural Science Foundation of China (No. 11074052) (www.nsfc.gov.cn) and the Special Fund for Public Health Service Research of China (No. 201302015) (www.moh.gov.cn) for data collection and analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon A, 2012, J REFRACT SURG, V28, P901, DOI 10.3928/1081597X-20121106-01; Bellucci R, 2007, CURR OPIN OPHTHALMOL, V18, P67, DOI 10.1097/ICU.0b013e3280121af1; Buzzonetti L, 2004, J CATARACT REFR SURG, V30, P1929, DOI 10.1016/j.jcrs.2004.01.036; Chalita MR, 2004, OPHTHALMOLOGY, V111, P447, DOI 10.1016/j.ophtha.2003.06.022; Charman W N, 2005, Cont Lens Anterior Eye, V28, P75, DOI 10.1016/j.clae.2005.02.003; Choi J, 2007, OPTOMETRY VISION SCI, V84, P42, DOI 10.1097/01.opx.0000254036.45989.65; Dietze HH, 2003, OPTOMETRY VISION SCI, V80, P126, DOI 10.1097/00006324-200302000-00008; Goes FJ, 2005, J REFRACT SURG, V21, P691; Helgesen A, 2004, ACTA OPHTHALMOL SCAN, V82, P454, DOI 10.1111/j.1395-3907.2004.00278.x; Kashani S, 2009, AM J OPHTHALMOL, V147, P417, DOI 10.1016/j.ajo.2008.09.017; Kosaki R, 2009, J REFRACT SURG, V25, P331, DOI 10.3928/1081597X-20090401-06; Kremer I, 2005, J CATARACT REFR SURG, V31, P1366, DOI 10.1016/j.jcrs.2004.12.055; LIANG JZ, 1994, J OPT SOC AM A, V11, P1949, DOI 10.1364/JOSAA.11.001949; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; MacRae S, 1999, J CATARACT REFR SURG, V25, P1191, DOI 10.1016/S0886-3350(99)00144-3; Marcos S, 2001, INVEST OPHTH VIS SCI, V42, P3349; Mello GR, 2012, J CATARACT REFR SURG, V38, P1671, DOI 10.1016/j.jcrs.2012.07.004; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Schallhorn SC, 2003, OPHTHALMOLOGY, V110, P1606, DOI 10.1016/S0161-6420(03)00494-9; Sharma M, 2007, J REFRACT SURG, V23, P252; Yamaguchi T, 2009, J CATARACT REFR SURG, V35, P57, DOI 10.1016/j.jcrs.2008.09.012	21	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117256	10.1371/journal.pone.0117256	http://dx.doi.org/10.1371/journal.pone.0117256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692489	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500045
J	Jin, PY; Zhu, JF; Zou, HD; Lu, LN; Zhao, HJ; Li, QQ; He, XG				Jin, Peiyao; Zhu, Jianfeng; Zou, Haidong; Lu, Lina; Zhao, Huijuan; Li, Qiangqiang; He, Xiangui			Screening for Significant Refractive Error Using a Combination of Distance Visual Acuity and Near Visual Acuity	PLOS ONE			English	Article							CHILDREN; ASTIGMATISM; PREVALENCE; MYOPIA	Purpose To explore the effectiveness of using a series of tests combining near visual acuity (NVA) and distance visual acuity (DVA) for large-scale screenings for significant refractive error (SRE) in primary school children. Method Each participant underwent DVA, NVA and cycloplegic autorefraction measurements. SREs, including high myopia, high hyperopia and high astigmatism were analyzed. Cycloplegic refraction results were considered to be the gold standard for the comparison of different screening measurements. Receiver-operating characteristic (ROC) curves were constructed to compare the area under the curve (AUC) and the Youden index among DVA, NVA and the series combined tests of DVA and NVA. The efficacies (including sensitivity, specificity, positive predictive value, and negative predictive value) of each test were evaluated. Only the right eye data of each participant were analysed for statistical purpose. Result A total of 4416 children aged 6 to 12 years completed the study, among which 486 students had right eye SRE (SRE prevalence rate = 11.01%). There was no difference in the prevalence of high hyperopia and high astigmatism among different age groups. However, the prevalence of high myopia significantly increased with the age (chi(2) = 381.81, p<0.01). High hyperopia was the biggest SRE factor associated with amblyopia p 0.01, OR = 167.40, 95% CI: 75.14 similar to 372.94). The DVA test was better than the NVA test for detecting high myopia (Z = 2.71, p<0.01), but the NVA test was better for detecting high hyperopia (Z = 2.35, p = 0.02) and high astigmatism (Z = 4.45, p<0.01). The series combined DVA and NVA test had the biggest AUC and the highest Youden Index for detecting high hyperopia, myopia, astigmatism, as well as all of the SREs (all p<0.01). Conclusion The series combined DVA and NVA test was more accurate for detecting SREs than either of the two tests alone. This new method could be applied to large-scale SRE screening of children, aged 6 to 12, in areas that are less developed.	[Jin, Peiyao; Zhu, Jianfeng; Zou, Haidong; Lu, Lina; He, Xiangui] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China; [Jin, Peiyao; Zou, Haidong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhao, Huijuan; Li, Qiangqiang] Baoshan Ctr Dis Prevent & Control, Dept Eye Dis Prevent & Control, Shanghai, Peoples R China	Shanghai Jiao Tong University	He, XG (corresponding author), Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China.	xianhezi@163.com		Zou, Haidong/0000-0002-6831-7560	National Natural Science Foundation of China for Young Staff [81402695]; Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [20112013, 2011-15]; Shanghai Municipal Health Bureau [20114127, 20134263]	National Natural Science Foundation of China for Young Staff; Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; Shanghai Municipal Health Bureau	The research was funded by: 1. National Natural Science Foundation of China for Young Staff (Grant no. 81402695); 2. Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (20112013)(Grant no. 2011-15); 3. Shanghai Municipal Health Bureau (Grant no. 20114127 and 20134263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford J, 1998, QUAL HEALTH CARE, V7, P240, DOI 10.1136/qshc.7.4.240; Colburn JD, 2010, J AAPOS, V14, P211, DOI 10.1016/j.jaapos.2010.02.006; Comm Practice Ambulatory Med Secti, 2003, OPHTHALMOLOGY, V110, P860, DOI 10.1016/S0161-6420(03)00414-7; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Fan DS, 2004, CLIN EXP OPHTHALMOL, V32, P462, DOI 10.1111/j.1442-9071.2004.00863.x; Goertz AD, 2014, ACTA OPHTHALMOL, V92, P497, DOI 10.1111/aos.12308; Hamasaki I, 2007, JPN J OPHTHALMOL, V51, P111, DOI 10.1007/s10384-006-0400-7; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Huang YQ, 2014, INT J OPHTHALMOL-CHI, V7, P457, DOI 10.3980/j.issn.2222-3959.2014.03.13; KOHLER L, 1978, ACTA PAEDIATR SCAND, V67, P373, DOI 10.1111/j.1651-2227.1978.tb16337.x; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; LOVASIK JV, 1986, AM J OPTOM PHYS OPT, V63, P787; Ma YY, 2013, OPTOMETRY VISION SCI, V90, P1479, DOI 10.1097/OPX.0000000000000095; O'Donoghue L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034441; Rajavi Zhale, 2012, J Ophthalmic Vis Res, V7, P3; Robaei D, 2006, OPHTHALMOLOGY, V113, P1567, DOI 10.1016/j.ophtha.2006.02.066; Weinstein S, 2005, AM J ROENTGENOL, V184, P14, DOI 10.2214/ajr.184.1.01840014; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Xiao X, 2014, OPTOMETRY VISION SCI, V91, P390, DOI 10.1097/OPX.0000000000000221; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	23	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117399	10.1371/journal.pone.0117399	http://dx.doi.org/10.1371/journal.pone.0117399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689600	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700039
J	Pourbadie, HG; Naderi, N; Mehranfard, N; Janahmadi, M; Khodagholi, F; Motamedi, F				Pourbadie, Hamid Gholami; Naderi, Nima; Mehranfard, Nasrin; Janahmadi, Mahyar; Khodagholi, Fariba; Motamedi, Fereshteh			Preventing Effect of L-Type Calcium Channel Blockade on Electrophysiological Alterations in Dentate Gyrus Granule Cells Induced by Entorhinal Amyloid Pathology	PLOS ONE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; DETERMINING INPUT RESISTANCE; RAT CEREBELLAR GRANULE; ALZHEIMERS-DISEASE; SYNAPTIC INPUTS; CORTEX LESIONS; BETA PEPTIDES; MEMORY; EXCITABILITY; CA1	The entorhinal cortex (EC) is one of the earliest affected brain regions in Alzheimer's disease (AD). EC-amyloid pathology induces synaptic failure in the dentate gyrus (DG) with resultant behavioral impairment, but there is little known about its impact on neuronal properties in the DG. It is believed that calcium dyshomeostasis plays a pivotal role in the etiology of AD. Here, the effect of the EC amyloid pathogenesis on cellular properties of DG granule cells and also possible neuroprotective role of L-type calcium channel blockers (CCBs), nimodipine and isradipine, were investigated. The amyloid beta (A beta) 1-42 was injected bilaterally into the EC of male rats and one week later, electrophysiological properties of DG granule cells were assessed. Voltage clamp recording revealed appearance of giant sIPSC in combination with a decrease in sEPSC frequency which was partially reversed by CCBs in granule cells from A beta treated rats. EC amyloid pathogenesis induced a significant reduction of input resistance (R-in) accompanied by a profound decreased excitability in the DG granule cells. However, daily administration of CCBs, isradipine or nimodipine (i.c.v. for 6 days), almost preserved the normal excitability against A beta. In conclusion, lower tendency to fire AP along with reduced Rin suggest that DG granule cells might undergo an alteration in the membrane ion channel activities which finally lead to the behavioral deficits observed in animal models and patients with early-stage Alzheimer's disease.	[Pourbadie, Hamid Gholami] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran; [Pourbadie, Hamid Gholami; Naderi, Nima; Mehranfard, Nasrin; Motamedi, Fereshteh] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Pourbadie, Hamid Gholami; Mehranfard, Nasrin] Shahid Beheshti Univ Med Sci, Dept Physiol, Fac Med, Tehran, Iran; [Naderi, Nima] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Tehran, Iran; [Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Fac Med, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Motamedi, F (corresponding author), Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.	motamedi@ams.ac.ir	Janahmadi, Mahyar/AAU-6425-2021; Naderi, Nima/U-5410-2018; Gholami Pourbadie, Hamid/K-9674-2017; Mehranfard, Nasrin/L-5766-2017; Khodagholi, Fariba/AAZ-4436-2020	Naderi, Nima/0000-0003-4591-8918; Gholami Pourbadie, Hamid/0000-0002-7634-7428; Mehranfard, Nasrin/0000-0002-7298-0189; Khodagholi, Fariba/0000-0002-4911-4530; Motamedi, Fereshteh/0000-0003-4030-8627	Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran	Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was supported by a grant from Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekonda TS, 2011, NEUROBIOL DIS, V41, P62, DOI 10.1016/j.nbd.2010.08.020; Antri M, 2009, J NEUROSCI, V29, P1140, DOI 10.1523/JNEUROSCI.3073-08.2009; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bott JB, 2013, NEUROBIOL AGING, V34, P2683, DOI 10.1016/j.neurobiolaging.2013.04.018; BRAAK E, 1991, CELL TISSUE RES, V264, P33, DOI 10.1007/BF00305720; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P35; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cameron WE, 2000, J NEUROPHYSIOL, V84, P2330, DOI 10.1152/jn.2000.84.5.2330; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Finkbeiner S, 1997, BIOESSAYS, V19, P657, DOI 10.1002/bies.950190803; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Funk GD, 2000, CLIN EXP PHARMACOL P, V27, P120, DOI 10.1046/j.1440-1681.2000.03202.x; Gholamipour-Badie H, 2013, BEHAV BRAIN RES, V237, P190, DOI 10.1016/j.bbr.2012.09.045; Glenner GG, 2012, BIOCHEM BIOPH RES CO, V425, P534, DOI 10.1016/j.bbrc.2012.08.020; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Green KN, 2009, J CELL MOL MED, V13, P2787, DOI 10.1111/j.1582-4934.2009.00861.x; Green KN, 2001, J NEUROCHEM, V77, P953, DOI 10.1046/j.1471-4159.2001.00338.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haghani M, 2012, CELL PHYSIOL BIOCHEM, V29, P391, DOI 10.1159/000338494; Hardman R, 1997, BRAIN RES, V758, P187, DOI 10.1016/S0006-8993(97)00223-0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Kerrigan TL, 2014, NEUROPHARMACOLOGY, V79, P515, DOI 10.1016/j.neuropharm.2013.09.004; Kim S, 2011, MOL CELLS, V32, P289, DOI 10.1007/s10059-011-0075-x; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; Lazarov O, 2002, J NEUROSCI, V22, P9785; Luo CX, 2005, J NEUROCHEM, V94, P1077, DOI 10.1111/j.1471-4159.2005.03262.x; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Mudher AK, 2001, NEUROSCI LETT, V301, P5, DOI 10.1016/S0304-3940(01)01593-2; NAGAHARA AH, 1995, BEHAV NEUROSCI, V109, P3, DOI 10.1037/0735-7044.109.1.3; Nunez-Abades PA, 2000, J NEUROPHYSIOL, V84, P2317, DOI 10.1152/jn.2000.84.5.2317; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G, 2005, RAT BRAIN STREOTAXIC; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Price SA, 1998, NEUROREPORT, V9, P539; Ramirez JJ, 2007, NEUROBIOL LEARN MEM, V87, P264, DOI 10.1016/j.nlm.2006.09.002; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Randall AD, 2010, NEUROPHARMACOLOGY, V59, P243, DOI 10.1016/j.neuropharm.2010.02.011; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Rocher AB, 2008, NEUROBIOL DIS, V32, P309, DOI 10.1016/j.nbd.2008.07.014; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Schulz DJ, 2006, J NEUROSCI, V26, P10362, DOI 10.1523/JNEUROSCI.3194-06.2006; Sipos E, 2007, NEUROSCIENCE, V147, P28, DOI 10.1016/j.neuroscience.2007.04.011; Small DH, 2009, NEUROCHEM RES, V34, P1824, DOI 10.1007/s11064-009-9960-5; Spencer JP, 2006, NEUROSCIENCE, V137, P795, DOI 10.1016/j.neuroscience.2005.10.007; Spowart-Manning L, 2005, BEHAV BRAIN RES, V156, P269, DOI 10.1016/j.bbr.2004.05.031; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; THOMPSON LT, 1990, BRAIN RES, V535, P119, DOI 10.1016/0006-8993(90)91830-A; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ueda K, 1997, J NEUROCHEM, V68, P265; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008366; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Wykes R, 2012, NEUROBIOL AGING, V33, P1609, DOI 10.1016/j.neurobiolaging.2011.05.001; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746	72	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117555	10.1371/journal.pone.0117555	http://dx.doi.org/10.1371/journal.pone.0117555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689857	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700055
J	Prandi, F; Piola, M; Soncini, M; Colussi, C; D'Alessandra, Y; Penza, E; Agrifoglio, M; Vinci, MC; Polvani, G; Gaetano, C; Fiore, GB; Pesce, M				Prandi, Francesca; Piola, Marco; Soncini, Monica; Colussi, Claudia; D'Alessandra, Yuri; Penza, Eleonora; Agrifoglio, Marco; Vinci, Maria Cristina; Polvani, Gianluca; Gaetano, Carlo; Fiore, Gianfranco Beniamino; Pesce, Maurizio			Adventitial Vessel Growth and Progenitor Cells Activation in an Ex Vivo Culture System Mimicking Human Saphenous Vein Wall Strain after Coronary Artery Bypass Grafting	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TO-MESENCHYMAL TRANSITION; STEM-CELLS; CYCLIC STRETCH; DIFFERENTIATION; NEOINTIMA; PROLIFERATION; FAILURE; ATHEROSCLEROSIS; CONTRIBUTES	Saphenous vein graft disease is a timely problem in coronary artery bypass grafting. Indeed, after exposure of the vein to arterial blood flow, a progressive modification in the wall begins, due to proliferation of smooth muscle cells in the intima. As a consequence, the graft progressively occludes and this leads to recurrent ischemia. In the present study we employed a novel ex vivo culture system to assess the biological effects of arterial-like pressure on the human saphenous vein structure and physiology, and to compare the results to those achieved in the presence of a constant low pressure and flow mimicking the physiologic vein perfusion. While under both conditions we found an activation of Matrix Metallo-Proteases 2/9 and of microRNAs-21/146a/221, a specific effect of the arterial-like pressure was observed. This consisted in a marked geometrical remodeling, in the suppression of Tissue Inhibitor of Metallo-Protease-1, in the enhanced expression of TGF-beta(1) and BMP-2 mRNAs and, finally, in the upregulation of microRNAs-138/200b/200c. In addition, the veins exposed to arterial-like pressure showed an increase in the density of the adventitial vasa vasorum and of cells co-expressing NG2, CD44 and SM22 alpha markers in the adventitia. Cells with nuclear expression of Sox-10, a transcription factor characterizing multipotent vascular stem cells, were finally found in adventitial vessels. Our findings suggest, for the first time, a role of arterial-like wall strain in the activation of pro-pathologic pathways resulting in adventitial vessels growth, activation of vasa vasorumcells, and upregulation of specific gene products associated to vascular remodeling and inflammation.	[Prandi, Francesca; Vinci, Maria Cristina; Pesce, Maurizio] IRCCS, Ctr Cardiol Monzino, Unita Ingn Tissutale, Milan, Italy; [Piola, Marco; Soncini, Monica; Fiore, Gianfranco Beniamino] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, Rome, Italy; [D'Alessandra, Yuri] IRCCS, Ctr Cardiol Monzino, Unita Immunol & Genom Funz, Milan, Italy; [Penza, Eleonora] IRCCS, Ctr Cardiol Monzino, Div Cardiochirurg 2, Milan, Italy; [Agrifoglio, Marco; Polvani, Gianluca] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Div Cardiovasc Epigenet, D-60054 Frankfurt, Germany	IRCCS Centro Cardiologico Monzino; Polytechnic University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; University of Milan; Goethe University Frankfurt	Pesce, M (corresponding author), IRCCS, Ctr Cardiol Monzino, Unita Ingn Tissutale, Milan, Italy.	maurizio.pesce@ccfm.it	POLVANI, GIANLUCA/I-4656-2018; Vinci, Maria Cristina/E-7401-2016; Agrifoglio, Marco/I-4555-2018; Gaetano, Carlo/P-9997-2019; Colussi, Claudia/H-8609-2019; D'Alessandra, Yuri/K-4098-2016; Pesce, Maurizio/AAA-4207-2019; Pesce, Maurizio/B-4260-2010; Piola, Marco/N-9298-2017; Soncini, Monica/E-9609-2018	POLVANI, GIANLUCA/0000-0003-1055-0965; Vinci, Maria Cristina/0000-0001-6323-147X; Agrifoglio, Marco/0000-0003-4453-295X; Gaetano, Carlo/0000-0002-5238-1832; D'Alessandra, Yuri/0000-0002-3440-2353; Pesce, Maurizio/0000-0002-3097-8961; Pesce, Maurizio/0000-0002-3097-8961; Colussi, Claudia/0000-0002-7727-8911; Piola, Marco/0000-0002-4501-2385; Soncini, Monica/0000-0001-8607-7196	Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS	Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS	The present research was granted by an Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderman JAF, 2012, JOURNAL OF THE AMERI, V1, DOI [10.1161/JAHA.112.006213, DOI 10.1161/JAHA.112.006213]; BATELLIER J, 1993, ARTERIOSCLER THROMB, V13, P379, DOI 10.1161/01.ATV.13.3.379; Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI 10.1089/ARS.2008.2390; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dangwal S, 2014, ANNUAL REVIEW OF PHA, V54, DOI [10.1146/annurev-pharmtox-011112-140338, DOI 10.1146/ANNUREV-PHARMTOX-011112-140338]; Daniel JM, 2010, ARTERIOSCL THROM VAS, V30, P1890, DOI 10.1161/ATVBAHA.110.209692; Dashwood MR, 2013, VASC PHARMACOL, V58, P240, DOI 10.1016/j.vph.2012.07.008; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Fogelstrand P, 2005, CARDIOVASC RES, V67, P326, DOI 10.1016/j.cardiores.2005.03.027; Gasper WJ, 2013, J VASC SURG, V57, P9, DOI 10.1016/j.jvs.2012.06.098; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grudzinska MK, 2013, ARTERIOSCL THROM VAS, V33, P1271, DOI 10.1161/ATVBAHA.112.300773; Hoglund VJ, 2010, ARTERIOSCL THROM VAS, V30, P1877, DOI 10.1161/ATVBAHA.110.211433; Hu YH, 2011, ARTERIOSCL THROM VAS, V31, P1523, DOI 10.1161/ATVBAHA.110.221176; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Hu YH, 2002, CIRC RES, V91, pE13, DOI 10.1161/01.RES.0000037090.34760.EE; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Konstantinov IE, 1997, ANN THORAC SURG, V64, P1522, DOI 10.1016/S0003-4975(97)00928-4; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Li FH, 2010, ARTERIOSCL THROM VAS, V30, P1787, DOI 10.1161/ATVBAHA.110.208520; Locker C, 2012, CIRCULATION, V126, P1023, DOI 10.1161/CIRCULATIONAHA.111.084624; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; McDonald RA, 2013, EUR HEART J, V34, P1636, DOI 10.1093/eurheartj/eht105; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; McGah PM, 2012, J VASC SURG, V56, P403, DOI 10.1016/j.jvs.2012.01.045; MCGEACHIE J, 1981, ANN SURG, V194, P100, DOI 10.1097/00000658-198107000-00018; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Newby AC, 2013, CARDIOVASC RES, V97, P193, DOI 10.1093/cvr/cvs351; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pesce M, 2003, CIRC RES, V93, pE51, DOI 10.1161/01.RES.0000090624.04507.45; Piola M, 2012, RECENT PAT CARDIOVAS; Piola M, 2013, J TISSUE ENG REGEN M, DOI [10.1002/term.1858, DOI 10.1002/TERM.1858]; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Reddy MA, 2012, ARTERIOSCL THROM VAS, V32, P721, DOI 10.1161/ATVBAHA.111.241109; Robertson KE, 2012, PHARMACOL THERAPEUT, V136, P23, DOI 10.1016/j.pharmthera.2012.07.002; Sankaran S, 2012, ANN BIOMED ENG, V40, P2228, DOI 10.1007/s10439-012-0579-3; Shukla N, 2012, CURR OPIN PHARMACOL, V12, P114, DOI 10.1016/j.coph.2012.01.001; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Thomas AC, 2012, CURR OPIN PHARMACOL, V12, P121, DOI 10.1016/j.coph.2012.01.002; Torsney E, 2005, TRENDS CARDIOVAS MED, V15, P64, DOI 10.1016/j.tcm.2005.02.003; Wallitt EJW, 2007, ANN THORAC SURG, V84, P317, DOI 10.1016/j.athoracsur.2007.02.035; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Wong AP, 2008, ATHEROSCLEROSIS, V196, P580, DOI 10.1016/j.atherosclerosis.2007.06.029	56	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117409	10.1371/journal.pone.0117409	http://dx.doi.org/10.1371/journal.pone.0117409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689822	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700041
J	Quintas, V; Prada-Lopez, I; Donos, N; Suarez-Quintanilla, D; Tomas, I				Quintas, Vctor; Prada-Lopez, Isabel; Donos, Nikolaos; Suarez-Quintanilla, David; Tomas, Inmaculada			Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an In Situ Model of Oral Biofilm Growth: A Randomised Clinical Trial	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; DENTAL PLAQUE; SUPRAGINGIVAL PLAQUE; FOOD PRESERVATIVES; MOUTHRINSE; GINGIVITIS; BACTERIAL; EFFICACY; VITALITY; MICROORGANISMS	Objective To evaluate the in situ antiplaque effect after 4 days of using of 2 commercial antimicrobial agents in short term on undisturbed plaque-like biofilm. Trial Design and Participants An observer-masked, crossover randomised clinical trial on 15 oral and systemically healthy volunteers between 20-30 years who were randomly and sequentially allocated in the same group which performed 3 interventions in different randomised sequences. Intervention The participants wore an appliance in 3 different rinsing periods doing mouthwashes twice a day (1/0/1) with essential oils, 0.2% chlorhexidine or sterile water (negative control). At the end of each 4-day mouthwash period, samples were removed from the appliance. Posteriorly, after bacterial vital staining, samples were analysed using a Confocal Laser Scanning Microscope. Main Outcome Measures Bacterial vitality, thickness and covering grade by the biofilm after 4 days of applying each of the mouthwashes. Results The essential oils and the 0.2% chlorhexidine were significantly more effective than the sterile water at reducing bacterial vitality, thickness and covering grade by the biofilm. No significant differences were found between the 0.2% chlorhexidine and the essential oils at reducing the bacterial vitality (13.2% vs. 14.7%). However, the 0.2% chlorhexidine showed more reduction than the essential oils in thickness (6.5 mu m vs. 10.0 mu m; p< 0.05) and covering grade by the biofilm (20.0% vs. 54.3%; p< 0.001). Conclusion The essential oils and 0.2% chlorhexidine showed a high antiplaque effect. Although the 0.2% chlorhexidine showed better results with regard to reducing the thickness and covering grade by the biofilm, both antiseptics showed a high and similar antibacterial activity.	[Quintas, Vctor; Prada-Lopez, Isabel; Suarez-Quintanilla, David; Tomas, Inmaculada] Univ Santiago de Compostela, Sch Med & Dent, Oral Sci Res Grp, Santiago De Compostela, Spain; [Donos, Nikolaos] UCL Eastman Dent Inst, Periodontol Unit, London, England	Universidade de Santiago de Compostela; University of London; University College London	Tomas, I (corresponding author), Univ Santiago de Compostela, Sch Med & Dent, Oral Sci Res Grp, Santiago De Compostela, Spain.	inmaculada.tomas@usc.es	TOMAS-CARMONA, INMACULADA/M-1135-2014	TOMAS-CARMONA, INMACULADA/0000-0002-3317-0853	Carlos III Institute of Health (General Division of Evaluation and Research Promotion, Madrid, Spain) [PI11/01383]; National Plan of Research, Development and Innovation [PN I+D+I 2008-2011]; European Regional Development Fund (ERDF)	Carlos III Institute of Health (General Division of Evaluation and Research Promotion, Madrid, Spain); National Plan of Research, Development and Innovation; European Regional Development Fund (ERDF)(European Commission)	This work was supported by project PI11/01383 from Carlos III Institute of Health (General Division of Evaluation and Research Promotion, Madrid, Spain), which is integrated in National Plan of Research, Development and Innovation (PN I+D+I 2008-2011). This project was cofinanced by European Regional Development Fund (ERDF 2007-2013). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Ahmad A, 2008, J BIOMED MATER RES A, V87A, P933, DOI 10.1002/jbm.a.31832; Al-Ahmad A, 2008, ARCH ORAL BIOL, V53, P765, DOI 10.1016/j.archoralbio.2008.02.014; Arweiler NB, 2006, J CLIN PERIODONTOL, V33, P334, DOI 10.1111/j.1600-051X.2006.00917.x; Arweiler NB, 2004, CARIES RES, V38, P442, DOI 10.1159/000079625; Arweiler NB, 2008, CLIN ORAL INVEST, V12, P203, DOI 10.1007/s00784-008-0188-6; Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x; Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Charles CH, 2004, J CLIN PERIODONTOL, V31, P878, DOI 10.1111/j.1600-051X.2004.00578.x; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Decker EM, 2001, LETT APPL MICROBIOL, V33, P188, DOI 10.1046/j.1472-765x.2001.00971.x; Demke R, 2012, DENT TODAY, V31, P101; Demke R, 2012, DENT TODAY, V31, P195; Demke Richard, 2012, Dent Today, V31, P96; Diaz J., 2010, MICROSCOPY SCI TECHN, P597; Dige I, 2007, EUR J ORAL SCI, V115, P459, DOI 10.1111/j.1600-0722.2007.00494.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fine DH, 2001, J CLIN PERIODONTOL, V28, P697, DOI 10.1034/j.1600-051x.2001.028007697.x; Gandini S, 2012, ANN AGR ENV MED, V19, P173; Garcia-Caballero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083522; Gu HJ, 2012, ARCH ORAL BIOL, V57, P369, DOI 10.1016/j.archoralbio.2011.10.001; Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7; Hannig C, 2010, J MED MICROBIOL, V59, P1, DOI 10.1099/jmm.0.015420-0; Hendry M.J., 1993, BIOFOULING, V7, P339, DOI 10.1080/08927019309386264; Hope CK, 2006, J MICROBIOL METH, V66, P390, DOI 10.1016/j.mimet.2006.01.003; Jentsch H, 2002, ULTRASTRUCT PATHOL, V26, P309, DOI 10.1080/01913120290104584; Jentsch H, 2013, ULTRASTRUCT PATHOL, V37, P233, DOI 10.3109/01913123.2013.763882; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; MORAN J, 1994, J PERIODONTOL, V65, P904, DOI 10.1902/jop.1994.65.10.904; Neely Anthony L, 2012, J Evid Based Dent Pract, V12, P69, DOI 10.1016/S1532-3382(12)70017-9; Netuschil L, 1998, ARCH ORAL BIOL, V43, P277, DOI 10.1016/S0003-9969(97)00121-0; Pan P, 2000, J CLIN PERIODONTOL, V27, P256, DOI 10.1034/j.1600-051x.2000.027004256.x; Pizzo G, 2008, J PERIODONTOL, V79, P1177, DOI [10.1902/jop.2008.070583, 10.1902/jop.2008.070583 ]; Pizzo G, 2013, AM J DENT, V26, P156; Pratten J, 1998, APPL ENVIRON MICROB, V64, P3515; Quintas V, 2014, CLIN ORAL INVESTIG I; Riep BG, 1999, J CLIN PERIODONTOL, V26, P164, DOI 10.1034/j.1600-051X.1999.260306.x; Roberts SK, 1999, DENT PLAQUE REVISITE, P1; Rodrigues J A, 2003, Int J Dent Hyg, V1, P227; Rosin M, 2002, J CLIN PERIODONTOL, V29, P392, DOI 10.1034/j.1600-051X.2002.290503.x; Sharma N, 2004, J AM DENT ASSOC, V135, P496, DOI 10.14219/jada.archive.2004.0217; Singh A, 2013, INT J DENT HYG, V11, P48, DOI 10.1111/j.1601-5037.2012.00556.x; Stoeken JE, 2007, J PERIODONTOL, V78, P1218, DOI 10.1902/jop.2007.060269; Strydonck DAC, 2012, J CLIN PERIODONTOL, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Tatakis DN, 2004, J CLIN PERIODONTOL, V31, P229, DOI 10.1111/j.1600-051X.2004.00477.x; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Tomas I, 2009, ORAL DIS, V15, P428, DOI 10.1111/j.1601-0825.2009.01570.x; Tomas I, 2013, J PERIODONTOL, V84, P1662, DOI 10.1902/jop.2013.120475; Ulkur Feyza, 2013, Eur J Dent, V7, P352, DOI 10.4103/1305-7456.115420; Van Leeuwen MPC, 2011, J PERIODONTOL, V82, P174, DOI 10.1902/jop.2010.100266; Wood SR, 2000, J DENT RES, V79, P21, DOI 10.1177/00220345000790010201; World Health Organization, 1997, ORAL HEALTH SURVEYS; Wu CD, 2002, PERIODONTOL 2000, V28, P91, DOI 10.1034/j.1600-0757.2002.280105.x	55	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117177	10.1371/journal.pone.0117177	http://dx.doi.org/10.1371/journal.pone.0117177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689859	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700030
J	Bao, PP; Zhao, ZG; Gao, YT; Zheng, Y; Zhang, B; Cai, H; Zheng, W; Shu, XO; Lu, W				Bao, Ping-Ping; Zhao, Zhi-Guo; Gao, Yu-Tang; Zheng, Ying; Zhang, Ben; Cai, Hui; Zheng, Wei; Shu, Xiao-Ou; Lu, Wei			Association of Type 2 Diabetes Genetic Variants with Breast Cancer Survival among Chinese Women	PLOS ONE			English	Article							COMORBIDITY; IMPACT; MORTALITY; MELLITUS; STAGE; MECHANISMS; RECEPTORS; METFORMIN; PROGNOSIS; OUTCOMES	Objective To evaluate whether the genetic susceptibility of T2D was associated with overall survival (OS) and disease-free survival (DFS) outcomes for breast cancer (BC). Methods Included in the study were 6346 BC patients who participated in three population-based epidemiological studies of BC and were genotyped with either GWAS or Exome-chip. We constructed a genetic risk score (GRS) for diabetes using risk variants identified from the GWAS catalog (http://genome.gov/gwastudies) that were associated with T2D risk at a minimum significance level of P <= 5.0E-8 among Asian population and evaluated its associations with BC outcomes with Cox proportional hazards models. Results During a median follow-up of 8.08 years (range, 0.01-16.95 years), 1208 deaths were documented in 6346 BC patients. Overall, the diabetes GRS was not associated with OS and DFS. Analyses stratified by estrogen receptor status (ER) showed that the diabetes GRS was inversely associated with OS among women with ER-but not in women with ER+ breast cancer; the multivariable adjusted HR was 1.38 (95% CI: 1.05-1.82) when comparing the highest to the lowest GRS quartiles. The association of diabetes GRS with OS varied by diabetes status (P for interaction < 0.01). In women with history of diabetes, higher diabetes GRS was significantly associated with worse OS, with HR of 2.22 (95% CI: 1.28-3.88) for the highest vs. lowest quartile, particularly among women with an ER-breast cancer, with corresponding HR being 4.59 (95% CI: 1.04-20.28). No significant association between the diabetes GRS and OS was observed across different BMI and PR groups. Conclusions Our study suggested that genetic susceptibility of T2D was positively associated with total mortality among women with ER-breast cancer, particularly among subjects with a history of diabetes. Additional studies are warranted to verify the associations and elucidate the underlying biological mechanism.	[Bao, Ping-Ping; Zheng, Ying; Lu, Wei] Shanghai Municipal Ctr Dis Prevent & Control, Shanghai, Peoples R China; [Zhao, Zhi-Guo; Zhang, Ben; Cai, Hui; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr,I, Nashville, TN 37235 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Vanderbilt University; Shanghai Jiao Tong University	Lu, W (corresponding author), Shanghai Municipal Ctr Dis Prevent & Control, 1380 Zhongshan Rd West, Shanghai, Peoples R China.	weiloo@msn.com	Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; gao, yi/HCI-8298-2022; Lu, Wei/AAE-2921-2022; Zhang, Ben/GQP-3420-2022; Gao, Yu/HGE-1937-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Lu, Wei/0000-0002-4150-8674; 	NATIONAL CANCER INSTITUTE [UM1CA182910] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen WW, 2012, ONCOLOGIST, V17, P485, DOI 10.1634/theoncologist.2011-0412; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hale PJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S16; Hindorff LA, CATALOG PUBLISHED GE; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Kaplan MA, 2012, MED ONCOL, V29, P1576, DOI 10.1007/s12032-011-0109-4; Land LH, 2012, CRIT REV ONCOL HEMAT, V81, P196, DOI 10.1016/j.critrevonc.2011.03.001; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nechuta S, 2013, BREAST CANCER RES TR, V139, P227, DOI 10.1007/s10549-013-2521-2; Papa V, 1996, J ENDOCRINOL INVEST, V19, P324, DOI 10.1007/BF03347871; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Sheppard AJ, 2011, CANCER EPIDEM BIOMAR, V20, P2160, DOI 10.1158/1055-9965.EPI-11-0459; Shu XO, 2009, JAMA-J AM MED ASSOC, V302, P2437, DOI 10.1001/jama.2009.1783; Singh SK, 2010, GROWTH HORM IGF RES, V20, P245, DOI 10.1016/j.ghir.2010.03.001; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang PP, 2013, CANCER EPIDEMIOL, V37, P207, DOI 10.1016/j.canep.2012.12.009; Zhang ZJ, 2014, DIABETES OBES METAB, V16, P707, DOI 10.1111/dom.12267; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	33	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117419	10.1371/journal.pone.0117419	http://dx.doi.org/10.1371/journal.pone.0117419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679392	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600064
J	Gonzalez-Escalona, N; Gavilan, RG; Brown, EW; Martinez-Urtaza, J				Gonzalez-Escalona, Narjol; Gavilan, Ronnie G.; Brown, Eric W.; Martinez-Urtaza, Jaime			Transoceanic Spreading of Pathogenic Strains of Vibrio parahaemolyticus with Distinctive Genetic Signatures in the recA Gene	PLOS ONE			English	Article							GENOME SEQUENCE DATA; O3-K6; EPIDEMIOLOGY; EMERGENCE; OUTBREAKS; CLUSTERS; DIARRHEA; SEROTYPE; OYSTERS; CLONE	Vibrio parahaemolyticus is an important human pathogen whose transmission is associated with the consumption of contaminated seafood. Consistent multilocus sequence typing for V. parahaemolyticus has shown difficulties in the amplification of the recA gene by PCR associated with a lack of amplification or a larger PCR product than expected. In one strain (090-96, Peru, 1996), the produced PCR product was determined to be composed of two recA fragments derived from different Vibrio species. To better understand this phenomenon, we sequenced the whole genome of this strain. The hybrid recA gene was found to be the result of a fragmentation of the original lineage-specific recA gene resulting from a DNA insertion of approximately 30 kb in length. This insert had a G+C content of 38.8%, lower than that of the average G+C content of V. parahaemolyticus (45.2%), and contained 19 ORFs, including a complete recA gene. This new acquired recA gene deviated 24% in sequence from the original recA and was distantly related to recA genes from bacteria of the Vibrionaceae family. The reconstruction of the original recA gene (recA3) identified the precursor as belonging to ST189, a sequence type reported previously only in Asian countries. The identification of this singular genetic feature in strains from Asia reveals new evidence for genetic connectivity between V. parahaemolyticus populations at both sides of the Pacific Ocean that, in addition to the previously described pandemic clone, supports the existence of a recurrent transoceanic spreading of pathogenic V. parahaemolyticus with the corresponding potential risk of pandemic expansion.	[Gonzalez-Escalona, Narjol; Brown, Eric W.] US FDA, Ctr Food & Appl Nutr, College Pk, MD 20740 USA; [Gavilan, Ronnie G.] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Martinez-Urtaza, Jaime] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	US Food & Drug Administration (FDA); Instituto Nacional de Salud - Peru; University of Bath	Gonzalez-Escalona, N (corresponding author), US FDA, Ctr Food & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov	Martinez-Urtaza, Jaime/ABG-5429-2020; Gonzalez-Escalona, Narjol/A-7598-2009; Gonzalez-Escalona, Narjol/H-6161-2019	Martinez-Urtaza, Jaime/0000-0001-6219-0418; Gonzalez-Escalona, Narjol/0000-0003-4568-0022; Gavilan, Ronnie/0000-0003-1437-5607	FDA Foods Program Intramural Funds	FDA Foods Program Intramural Funds	This project was supported by the FDA Foods Program Intramural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chao GX, 2011, INT J FOOD MICROBIOL, V145, P459, DOI 10.1016/j.ijfoodmicro.2011.01.022; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Gil AI, 2007, INT J INFECT DIS, V11, P324, DOI 10.1016/j.ijid.2006.08.003; Gonzalez-Escalona N, 2005, EMERG INFECT DIS, V11, P129, DOI 10.3201/eid1101.040762; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Haendiges J, 2014, EMERG INFECT DIS, V20, P718, DOI 10.3201/eid2004.130818; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; Johnson CN, 2009, MICROB ECOL, V57, P437, DOI 10.1007/s00248-008-9418-3; Jolley KA, 2013, EUROSURVEILLANCE, V18, P41; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li YH, 2014, EMERG INFECT DIS, V20, P685, DOI 10.3201/eid2004.130744; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Martinez-Urtaza J, 2008, EPIDEMIOLOGY, V19, P829, DOI 10.1097/EDE.0b013e3181883d43; Martinez-Urtaza J, 2013, NEW ENGL J MED, V369, P1573, DOI 10.1056/NEJMc1305535; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Stine OC, 2000, INFECT IMMUN, V68, P7180, DOI 10.1128/IAI.68.12.7180-7185.2000; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Thompson CC, 2004, INT J SYST EVOL MICR, V54, P919, DOI 10.1099/ijs.0.02963-0; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038	34	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117485	10.1371/journal.pone.0117485	http://dx.doi.org/10.1371/journal.pone.0117485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679989	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600067
J	Liu, X; Zhou, L; Pan, FQ; Gao, Y; Yuan, X; Fan, DL				Liu, Xing; Zhou, Liang; Pan, Fuqiang; Gao, Yang; Yuan, Xi; Fan, Dongli			Comparison of the Postoperative Incidence Rate of Capsular Contracture among Different Breast Implants: A Cumulative Meta-Analysis	PLOS ONE			English	Article							POVIDONE-IODINE IRRIGATION; SILICONE GEL; TEXTURED SURFACE; SMOOTH IMPLANTS; AUGMENTATION; RECONSTRUCTION; MYOFIBROBLASTS; COMPLICATIONS; INFECTION; HISTOLOGY	Background A large number of clinical studies have reported that the different materials used in breast implants were a possible cause of the different incidence rates of capsular contracture observed in patients after implantation. However, this theory lacks comprehensive support from evidence-based medicine, and considerable controversy remains. Objectives In this study, a cumulative systematic review examined breast augmentation that used implants with textured or smooth surfaces to analyze the effects of these two types of implants on the occurrence of postoperative capsular contracture. Methods We conducted a comprehensive search of literature databases, including PubMed and EMBASE, for clinical reports on the incidence of capsular contracture after the implantation of breast prostheses. We performed a cumulative meta-analysis on the incidence of capsular contracture in order from small to large sample sizes and conducted subgroup analyses according to the prosthetic material used, the implant pocket placement, the incision type and the duration of follow-up. Relative risks (RR) and 95% confidence intervals (CI) were used as the final pooled statistics. Results This meta-analysis included 16 randomized controlled trials (RCTs) and two retrospective studies. The cumulative comparison of textured and smooth breast implants showed statistical significance at 2.13 (95% CI, 1.18-3.86) when the fourth study was entered into the analysis. With the inclusion of more reports, the final results indicated that smooth breast implants were more likely to be associated with capsular contracture, with statistical significance at 3.10 (95% CI, 2.23-4.33). In the subgroup analyses, the subgroups based on implant materials included the silicone implant group and the saline implant group, with significant pooled statistical levels of 4.05 (95% CI, 1.97-8.31) and 3.12 (95% CI, 2.19-4.42), respectively. According to implant pocket placement, a subglandular group and a submuscular group were included in the analyses, and only the subglandular group had a statistically significant pooled result of 3.59 (95% CI, 2.43-5.30). Four subgroups were included in the analyses according to incision type: the inframammary incision group, the periareolar incision group, the transaxillary incision group and the mastectomy incision group. Among these groups, only the pooled results of the inframammary and mastectomy incision groups were statistically significant, at 2.82 (95% CI, 1.30-6.11) and 2.30 (95% CI, 1.17-4.50), respectively. Three follow-up duration subgroups were included in the analyses: the one-year group, the two-to three-year group and the >= five-year group. These subgroups had statistically significant results of 4.67 (95% CI, 2.35-9.28), 3.42 (95% CI, 2.26-5.16) and 2.71 (95% CI, 1.64-4.49), respectively. Conclusion In mammaplasty, the use of textured implants reduces the incidence of postoperative capsular contracture. Differences in implant pocket placement and incision type are also likely to affect the incidence of capsular contracture; however, this conclusion awaits further study.	[Liu, Xing; Fan, Dongli] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China; [Zhou, Liang] Third Mil Med Univ, Coll Prevent Med, Dept Hlth Stat, Chongqing 400038, Peoples R China; [Pan, Fuqiang; Yuan, Xi] Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing 400038, Peoples R China; [Gao, Yang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Plast & Cosmet Surg, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Fan, DL (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.	fdltmmu@sina.com			Natural Science Foundation of China [81071574, 81372075]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by two Natural Science Foundation of China grants (No. 81071574 and No. 81372075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WP, 2006, PLAST RECONSTR SURG, V117, P1214, DOI 10.1097/01.prs.0000208306.79104.18; Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1; ASPLUND O, 1984, PLAST RECONSTR SURG, V73, P270, DOI 10.1097/00006534-198402000-00022; BAKER JL, 1981, PLAST RECONSTR SURG, V68, P905, DOI 10.1097/00006534-198112000-00010; Baker JL, 1978, P S ED FDN AM SOC PL, P256; Barnsley GP, 2006, PLAST RECONSTR SURG, V117, P2182, DOI 10.1097/01.prs.0000218184.47372.d5; Barr S, 2010, Eplasty, V10, pe31; Bassetto F, 2010, AESTHET PLAST SURG, V34, P481, DOI 10.1007/s00266-010-9483-0; Berry MG, 2010, J PLAST RECONSTR AES, V63, P1761, DOI 10.1016/j.bjps.2009.07.047; BIGGS TM, 1990, PLAST RECONSTR SURG, V85, P368, DOI 10.1097/00006534-199003000-00005; Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5; BURKHARDT BR, 1995, PLAST RECONSTR SURG, V96, P1317, DOI 10.1097/00006534-199511000-00013; BURKHARDT BR, 1994, PLAST RECONSTR SURG, V93, P123, DOI 10.1097/00006534-199401000-00018; Chen Wen-li, 2005, Zhonghua Zheng Xing Wai Ke Za Zhi, V21, P172; Chen Y, 2005, FUJIAN MED J, V4, P49; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; COLEMAN DJ, 1991, BRIT J PLAST SURG, V44, P444, DOI 10.1016/0007-1226(91)90204-W; Collis N, 2000, PLAST RECONSTR SURG, V106, P786, DOI 10.1097/00006534-200009040-00005; COURTISS EH, 1979, PLAST RECONSTR SURG, V63, P812, DOI 10.1097/00006534-197963060-00006; Cunningham B, 2009, AESTHET PLAST SURG, V33, P440, DOI 10.1007/s00266-009-9364-6; Daniels AU, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13614; Danino AM, 2001, PLAST RECONSTR SURG, V108, P2047, DOI 10.1097/00006534-200112000-00032; Embrey M, 1999, AESTHET PLAST SURG, V23, P197, DOI 10.1007/s002669900268; ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P879, DOI 10.1097/00006534-199105000-00012; Ersek RA, 1997, PLAST RECONSTR SURG, V100, P1729, DOI 10.1097/00006534-199712000-00014; Fagrell D, 2001, PLAST RECONSTR SURG, V108, P2108, DOI 10.1097/00006534-200112000-00046; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Gagnon L., 2012, COSMETIC SURG TIMES, V15, P6; Gahm J, 2013, J PLAST RECONSTR AES, V66, P1521, DOI 10.1016/j.bjps.2013.06.054; Gurunluoglu R, 2013, ANN PLAS SURG, V70, P103, DOI 10.1097/SAP.0b013e31822ed5ce; Haddow LJ, 2008, J INFECTION, V57, P82, DOI 10.1016/j.jinf.2008.01.010; Hajdu SD, 2011, EUR J CLIN INVEST, V41, P203, DOI 10.1111/j.1365-2362.2010.02389.x; HAKELIUS L, 1992, PLAST RECONSTR SURG, V90, P247, DOI 10.1097/00006534-199290020-00012; Hammerstad M, 1996, SCAND J PLAST RECONS, V30, P33, DOI 10.3109/02844319609072402; Henriksen TF, 2005, ANN PLAS SURG, V54, P343, DOI 10.1097/01.sap.0000151459.07978.fa; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hill JL, 2012, ANN PLAS SURG, V68, P432, DOI 10.1097/SAP.0b013e31823b6ac6; Huemer GM, 2012, PLAST RECONSTR SURG, V130, P780, DOI 10.1097/PRS.0b013e318262f025; Kulmala I, 2004, ANN PLAS SURG, V53, P413, DOI 10.1097/01.sap.0000131275.62449.c8; Lesesne CP, 1997, AESTHET PLAST SURG, V21, P93, DOI 10.1007/s002669900091; LOSSING C, 1993, PLAST RECONSTR SURG, V91, P1277, DOI 10.1097/00006534-199306000-00014; Malata CM, 1997, BRIT J PLAST SURG, V50, P99, DOI 10.1016/S0007-1226(97)91320-5; MAY JW, 1994, ANN PLAS SURG, V32, P225, DOI 10.1097/00000637-199403000-00001; MOORE JR, 1979, PLAST RECONSTR SURG, V63, P9, DOI 10.1097/00006534-197901000-00002; Moreira M, 2010, WOUND REPAIR REGEN, V18, P417, DOI 10.1111/j.1524-475X.2010.00601.x; Moyer HR, 2012, PLAST RECONSTR SURG, V130, P793, DOI 10.1097/PRS.0b013e318262f174; Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44; Pittet B, 2005, LANCET INFECT DIS, V5, P94, DOI 10.1016/S1473-3099(05)01281-8; Plenk H, 2011, ARTIF ORGANS, V35, P237, DOI 10.1111/j.1525-1594.2011.01221.x; POLLOCK H, 1993, PLAST RECONSTR SURG, V91, P404, DOI 10.1097/00006534-199303000-00002; Prantl L, 2005, AESTHET PLAST SURG, V29, P510, DOI 10.1007/s00266-005-5049-y; Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a; Puskas JE, 2012, WIRES NANOMED NANOBI, V4, P153, DOI 10.1002/wnan.164; Rieger UM, 2013, BRIT J SURG, V100, P768, DOI 10.1002/bjs.9084; Rubino C, 2001, ANN PLAS SURG, V46, P95, DOI 10.1097/00000637-200102000-00001; Spear SL, 2007, PLAST RECONSTR SURG, V120, p8S, DOI 10.1097/01.prs.0000286580.93214.df; Spear SL, 1999, AESTHETIC SURG J, V19, P347; Spear SL, 2007, PLAST RECONSTR SURG, V120, p17S, DOI DOI 10.1097/01.PRS.0000286580.93214; Steiert A, 2012, J BIOMED MATER RES A, V100A, P1248, DOI 10.1002/jbm.a.34008; Stevens WG, 2013, PLAST RECONSTR SURG, V132, P1115, DOI 10.1097/01.prs.0000435317.76381.68; Tarpila E, 1997, PLAST RECONSTR SURG, V99, P1934, DOI 10.1097/00006534-199706000-00019; THUESEN B, 1995, SCAND J PLAST RECONS, V29, P9, DOI 10.3109/02844319509048417; VAZQUEZ B, 1987, AESTHET PLAST SURG, V11, P101, DOI 10.1007/BF01575494; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wong CH, 2006, PLAST RECONSTR SURG, V118, P1224, DOI 10.1097/01.prs.0000237013.50283.d2; Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017; Zhu Z, 2006, J HUBEI COLL CHINESE, V4, P91; Zuckerman DM, 2010, REPROD HEALTH MATTER, V18, P94, DOI 10.1016/S0968-8080(10)35520-0	68	55	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116071	10.1371/journal.pone.0116071	http://dx.doi.org/10.1371/journal.pone.0116071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680100	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600012
J	Massoudi, R; Van Wanrooij, MM; Versnel, H; Van Opstal, AJ				Massoudi, Roohollah; Van Wanrooij, Marc M.; Versnel, Huib; Van Opstal, A. John			Spectrotemporal Response Properties of Core Auditory Cortex Neurons in Awake Monkey	PLOS ONE			English	Article							RECEPTIVE-FIELDS; INFERIOR COLLICULUS; SOUND FEATURES; MODULATIONS; REPRESENTATION; FREQUENCY; SUBDIVISIONS; SELECTIVITY; LINEARITY; DYNAMICS	So far, most studies of core auditory cortex (AC) have characterized the spectral and temporal tuning properties of cells in non-awake, anesthetized preparations. As experiments in awake animals are scarce, we here used dynamic spectral-temporal broadband ripples to study the properties of the spectrotemporal receptive fields (STRFs) of AC cells in awake monkeys. We show that AC neurons were typically most sensitive to low ripple densities (spectral) and low velocities (temporal), and that most cells were not selective for a particular spectrotemporal sweep direction. A substantial proportion of neurons preferred amplitude-modulated sounds (at zero ripple density) to dynamic ripples (at non-zero densities). The vast majority (>93%) of modulation transfer functions were separable with respect to spectral and temporal modulations, indicating that time and spectrum are independently processed in AC neurons. We also analyzed the linear predictability of AC responses to natural vocalizations on the basis of the STRF. We discuss our findings in the light of results obtained from the monkey midbrain inferior colliculus by comparing the spectrotemporal tuning properties and linear predictability of these two important auditory stages.	[Massoudi, Roohollah; Van Wanrooij, Marc M.; Van Opstal, A. John] Radboud Univ Nijmegen, Dept Biophys, Donders Inst Brain Cognit & Behav, NL-6525 AJ Nijmegen, Netherlands; [Van Wanrooij, Marc M.] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 AJ Nijmegen, Netherlands; [Versnel, Huib] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Otorhinolaryngol Head & Neck Surg, NL-3508 GA Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Van Opstal, AJ (corresponding author), Radboud Univ Nijmegen, Dept Biophys, Donders Inst Brain Cognit & Behav, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	J.vanOpstal@donders.ru.nl	van Opstal, John/D-1907-2010; van Wanrooij, Marc/J-3385-2012	van Wanrooij, Marc/0000-0003-4180-1835; van Opstal, John/0000-0001-5957-5712; Massoudi, Roohollah/0000-0002-9011-783X	VICI and Open Competition grant of the Earth and Life Sciences of NWO [ALW 865.05.003, 821.02.009]; Radboud University Nijmegen	VICI and Open Competition grant of the Earth and Life Sciences of NWO; Radboud University Nijmegen	This research was supported by a VICI and Open Competition grant of the Earth and Life Sciences of NWO (ALW 865.05.003 and 821.02.009; AJVO; RM), and the Radboud University Nijmegen (AJVO, RM, MVW, HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Ahmed B, 2006, J PHYSIOL-LONDON, V572, P763, DOI 10.1113/jphysiol.2005.104380; ALLON N, 1985, BRAIN RES, V360, P75, DOI 10.1016/0006-8993(85)91222-3; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031537; Bendor D, 2012, J NEUROSCI, V32, P16149, DOI 10.1523/JNEUROSCI.2563-12.2012; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Britvina T, 2008, NEUROSCIENCE, V154, P1576, DOI 10.1016/j.neuroscience.2008.04.035; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Brosch M, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00005; Burkard RF, 2007, AUDITORY EVOKED POTE, P200; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Eggermont JJ, 2011, HEARING RES, V271, P123, DOI 10.1016/j.heares.2010.01.014; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Felsheim C, 1996, HEARING RES, V98, P137, DOI 10.1016/0378-5955(96)00078-0; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Klein DJ, 2006, J COMPUT NEUROSCI, V20, P111, DOI 10.1007/s10827-005-3589-4; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Langers DRM, 2003, NEUROIMAGE, V20, P265, DOI 10.1016/S1053-8119(03)00258-1; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Massoudi R, 2014, EUR J NEUROSCI, V39, P1538, DOI 10.1111/ejn.12532; Massoudi R, 2013, EUR J NEUROSCI, V37, P1830, DOI 10.1111/ejn.12180; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Niwa M, 2012, J NEUROSCI, V32, P3193, DOI 10.1523/JNEUROSCI.0767-11.2012; Paxinos G., 2000, RHESUS MONKEY BRAIN; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Recanzone GH, 2011, HEARING RES, V271, P115, DOI 10.1016/j.heares.2010.03.084; Recanzone GH, 2008, J NEUROSCI, V28, P13184, DOI 10.1523/JNEUROSCI.3619-08.2008; RYAN A, 1977, J NEUROPHYSIOL, V40, P943, DOI 10.1152/jn.1977.40.4.943; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sahani M, 2003, ADV NEURAL INFORM PR, P125; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Shamma SA, 1995, AUD NEUROSCI; Simon JZ, 2007, NEURAL COMPUT, V19, P583, DOI 10.1162/neco.2007.19.3.583; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tian BA, 2013, P NATL ACAD SCI USA, V110, P7892, DOI 10.1073/pnas.1221062110; Versnel H, 1998, J ACOUST SOC AM, V103, P2502, DOI 10.1121/1.422771; Versnel H., 1995, AUDIT NEUROSCI, V1, P271; Versnel H, 2009, J NEUROSCI, V29, P9725, DOI 10.1523/JNEUROSCI.5459-08.2009; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; YESHURUN Y, 1989, B MATH BIOL, V51, P337, DOI 10.1007/BF02460112; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010	62	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116118	10.1371/journal.pone.0116118	http://dx.doi.org/10.1371/journal.pone.0116118			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680187	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600013
J	Rampazo, EV; Amorim, KNS; Yamamoto, MM; Panatieri, RH; Rodrigues, MM; Boscardin, SB				Rampazo, Eline V.; Amorim, Kelly N. S.; Yamamoto, Marcio M.; Panatieri, Raquel Hoffmann; Rodrigues, Mauricio M.; Boscardin, Silvia B.			Antigen Targeting to Dendritic Cells Allows the Identification of a CD4 T-Cell Epitope within an Immunodominant Trypanosoma cruzi Antigen	PLOS ONE			English	Article							AMASTIGOTE SURFACE PROTEIN-2; SUSCEPTIBLE MOUSE STRAIN; LCRV VIRULENCE PROTEIN; PROTECTIVE IMMUNITY; TRANS-SIALIDASE; IN-VIVO; GENETIC IMMUNIZATION; STEADY-STATE; PLASMID DNA; INFECTION	Targeting antigens to dendritic cells (DCs) by using hybrid monoclonal antibodies (mAbs) directed against DC receptors is known to improve activation and support long-lasting T cell responses. In the present work, we used the mAb alpha DEC205 fused to the Trypanosoma cruzi amastigote surface protein 2 (ASP-2) to identify a region of this protein recognized by specific T cells. The hybrid alpha DEC-ASP2 mAb was successfully generated and preserved its ability to bind the DEC205 receptor. Immunization of BALB/c mice with the recombinant mAb in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)) specifically enhanced the number of IFN-gamma producing cells and CD4+ T cell proliferation when compared to mice immunized with a mAb without receptor affinity or with the non-targeted ASP-2 protein. The strong immune response induced in mice immunized with the hybrid alpha DEC-ASP2 mAb allowed us to identify an ASP-2-specific CD4+ T cell epitope recognized by the BALB/c MHCII haplotype. We conclude that targeting parasite antigens to DCs is a useful strategy to enhance T cell mediated immune responses facilitating the identification of new T-cell epitopes.	[Rampazo, Eline V.; Amorim, Kelly N. S.; Yamamoto, Marcio M.; Panatieri, Raquel Hoffmann; Boscardin, Silvia B.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Antigen Targeting Dendrit Cells, Sao Paulo, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, CTCMol, Sao Paulo, Brazil; [Rodrigues, Mauricio M.; Boscardin, Silvia B.] Natl Inst Sci & Technol Vaccines, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Boscardin, SB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Antigen Targeting Dendrit Cells, Sao Paulo, Brazil.	sbboscardin@usp.br	Boscardin, Silvia Beatriz/C-3397-2012	Boscardin, Silvia Beatriz/0000-0002-7845-7110	Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV) [15203*12]; Sao Paulo State Research Funding Agency (FAPESP) [2007/08648-9]; BNP-Paribas Bank; CNPq; commercial source BNP-Paribas Bank	Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); BNP-Paribas Bank; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); commercial source BNP-Paribas Bank	This research was supported by the Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV, 15203*12), Sao Paulo State Research Funding Agency (FAPESP, 2007/08648-9) and BNP-Paribas Bank. E.V. Rampazo, K.N.S. Amorim and R. H. Panatieri received fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that partial funding for this study was provided by the commercial source BNP-Paribas Bank. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Charalambous A, 2006, J IMMUNOL, V177, P8410, DOI 10.4049/jimmunol.177.12.8410; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; Costa F, 1998, VACCINE, V16, P768, DOI 10.1016/S0264-410X(97)00277-6; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fralish BH, 2003, VACCINE, V21, P3070, DOI 10.1016/S0264-410X(03)00121-X; Fujimura AE, 2001, INFECT IMMUN, V69, P5477, DOI 10.1128/IAI.69.9.5477-5486.2001; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henriques HR, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002330, 10.1371/journal.pntd.0002469]; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Matos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067453; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878; Wang B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3135; Wizel B, 1998, INFECT IMMUN, V66, P5073, DOI 10.1128/IAI.66.11.5073-5081.1998	31	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117778	10.1371/journal.pone.0117778	http://dx.doi.org/10.1371/journal.pone.0117778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679777	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600087
J	Skunca, N; Dessimoz, C				Skunca, Nives; Dessimoz, Christophe			Phylogenetic Profiling: How Much Input Data Is Enough?	PLOS ONE			English	Article							GENE ONTOLOGY; PROTEIN; IDENTIFICATION; PREDICTION	Phylogenetic profiling is a well-established approach for predicting gene function based on patterns of gene presence and absence across species. Much of the recent developments have focused on methodological improvements, but relatively little is known about the effect of input data size on the quality of predictions. In this work, we ask: how many genomes and functional annotations need to be considered for phylogenetic profiling to be effective? Phylogenetic profiling generally benefits from an increased amount of input data. However, by decomposing this improvement in predictive accuracy in terms of the contribution of additional genomes and of additional annotations, we observed diminishing returns in adding more than similar to 100 genomes, whereas increasing the number of annotations remained strongly beneficial throughout. We also observed that maximising phylogenetic diversity within a clade of interest improves predictive accuracy, but the effect is small compared to changes in the number of genomes under comparison. Finally, we show that these findings are supported in light of the Open World Assumption, which posits that functional annotation databases are inherently incomplete. All the tools and data used in this work are available for reuse from http://lab.dessimoz.org/14_phylprof. Scripts used to analyse the data are available on request from the authors.	[Skunca, Nives] ETH, Dept Comp Sci, CH-8092 Zurich, Switzerland; [Skunca, Nives; Dessimoz, Christophe] Swiss Inst Bioinformat, CH-8092 Zurich, Switzerland; [Skunca, Nives; Dessimoz, Christophe] UCL, London WC1E 6BT, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of London; University College London	Skunca, N (corresponding author), ETH, Dept Comp Sci, Univ Str 19, CH-8092 Zurich, Switzerland.	skuncan@inf.ethz.ch; c.dessimoz@ucl.ac.uk	Dessimoz, Christophe/D-3678-2011	Dessimoz, Christophe/0000-0002-2170-853X	Biotechnology and Biological Sciences Research Council [BB/L018241/1]; Department of Computer Science at ETH Zurich; BBSRC [BB/L018241/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Computer Science at ETH Zurich; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a Biotechnology and Biological Sciences Research Council grant (BB/L018241/1) to CD and by funds from the Department of Computer Science at ETH Zurich to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Gutierrez RA, 2004, PLANT PHYSIOL, V135, P1888, DOI 10.1104/pp.104.043687; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Ruano-Rubio V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-383; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schneider A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003124; Simonsen M, 2012, BIOINFORMATICS, V28, P851, DOI 10.1093/bioinformatics/btr720; Skunca N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002852; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Sun JC, 2007, BIOCHEM BIOPH RES CO, V353, P985, DOI 10.1016/j.bbrc.2006.12.146; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Vens C, 2008, MACH LEARN, V73, P185, DOI 10.1007/s10994-008-5077-3; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	28	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0114701	10.1371/journal.pone.0114701	http://dx.doi.org/10.1371/journal.pone.0114701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679783	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600003
J	Zhao, J; Wang, J; Du, JF; Xu, HL; Zhang, W; Ni, QX; Yu, H; Risch, HA; Gao, YT; Gao, Y				Zhao, Jing; Wang, Jing; Du, Jinfeng; Xu, Hongli; Zhang, Wei; Ni, Quan-Xing; Yu, Herbert; Risch, Harvey A.; Gao, Yu-Tang; Gao, Ying			Urinary Prostaglandin E-2 Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUG-USE; CYCLOOXYGENASE-2 EXPRESSION; INTRAEPITHELIAL NEOPLASIA; PGE-M; ASSOCIATION; INFLAMMATION; EICOSANOIDS; BIOMARKER; ASPIRIN; GROWTH	Pancreatic cancer has been increasing in importance in Shanghai over the last four decades. The etiology of the disease is still unclear. Evidence suggests that the COX-2 pathway, an important component of inflammation, may be involved in the disease. We aimed to evaluate the association between urinary prostaglandin E-2 metabolite (PGE-M) level and risk of pancreatic cancer. From a recent population-based case-control study in Shanghai, 200 pancreatic ductal adenocarcinoma cases and 200 gender-and age-frequency matched controls were selected for the present analysis. Urinary PGE-M was measured with a liquid chromatography/mass spectrometric assay. Adjusted unconditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). A positive association was observed between PGE-M leve and pancreatic cancer risk: OR = 1.63 (95% CI 1.01-2.63) for the third tertile compared to the first. Though the interactions were not statistically significant, the associations tended to be stronger among subjects with diabetes history (OR = 3.32; 95% CI 1.20-9.19) and higher meat intake (OR = 2.12; 95% CI 1.10-4.06). The result suggests that higher urinary PGE-M level may be associated with increased risk of pancreatic ductal adenocarcinoma.	[Zhao, Jing; Du, Jinfeng; Gao, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Jing; Xu, Hongli; Zhang, Wei; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Ni, Quan-Xing] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China; [Yu, Herbert] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Risch, Harvey A.] Yale Canc Ctr, New Haven, CT USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Cancer Research Center of Hawaii; University of Hawaii System; Yale University; Yale University	Gao, YT (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200030, Peoples R China.	ytgao@vip.sina.com; yinggao@sibs.ac.cn	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022	Zhao, Jing/0000-0001-8698-2436	U.S. National Cancer Institute [5R01CA114421]; Science and Technology Commission of Shanghai Municipality [08411954100]; 100 talented plan of Chinese Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA114421] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); 100 talented plan of Chinese Academy of Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the U.S. National Cancer Institute (5R01CA114421, HAR), the Science and Technology Commission of Shanghai Municipality (08411954100, YTG) and the 100 talented plan of Chinese Academy of Sciences (YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM O, 1992, CLIN INVESTIGATOR, V70, P721; Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168; Bradley MC, 2010, BRIT J CANCER, V102, P1415, DOI 10.1038/sj.bjc.6605636; Cai QY, 2006, J CLIN ONCOL, V24, P5010, DOI 10.1200/JCO.2006.06.4931; Cui Y, 2014, CANCER EPIDEM BIOMAR, V23, P2866, DOI 10.1158/1055-9965.EPI-14-0685; Ding Xian-Zhong, 2003, Mol Cancer, V2, P10, DOI 10.1186/1476-4598-2-10; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P3075, DOI 10.1158/1055-9965.EPI-09-0680; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Gao Y-T, 2007, CANC INCIDENCE MORTA, P69, DOI [10.1016/j.fsigen.2007.08.013, DOI 10.1016/J.FSIGEN.2007.08.013]; Gong ZH, 2011, AM J EPIDEMIOL, V174, P1373, DOI 10.1093/aje/kwr267; Gross ND, 2005, CLIN CANCER RES, V11, P6087, DOI 10.1158/1078-0432.CCR-05-0733; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson JC, 2006, CLIN GASTROENTEROL H, V4, P1358, DOI 10.1016/j.cgh.2006.07.015; Kelley DS, 1998, LIPIDS, V33, P125, DOI 10.1007/s11745-998-0187-9; Kim S, 2013, CANCER PREV RES, V6, P511, DOI 10.1158/1940-6207.CAPR-13-0040; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P2561, DOI 10.1158/1055-9965.EPI-06-0574; Li D, 1998, LIPIDS, V33, P437, DOI 10.1007/s11745-998-0225-7; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Maitra A, 2002, AM J CLIN PATHOL, V118, P194, DOI 10.1309/TPG4-CK1C-9V8V-8AWC; Mckay CJ, 2008, BEST PRACT RES CL GA, V22, P65, DOI 10.1016/j.bpg.2007.11.007; Molina MA, 1999, CANCER RES, V59, P4356; Morris PG, 2013, CANCER PREV RES, V6, P428, DOI 10.1158/1940-6207.CAPR-12-0431; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Okami J, 1999, CLIN CANCER RES, V5, P2018; Risch HA, 2014, CANCER EPIDEM BIOMAR, V23, P172, DOI 10.1158/1055-9965.EPI-13-0447; Risch HA, 2013, AM J EPIDEMIOL, V177, P1326, DOI 10.1093/aje/kws458; Shrubsole MJ, 2012, CANCER PREV RES, V5, P336, DOI 10.1158/1940-6207.CAPR-11-0426; Tucker ON, 1999, CANCER RES, V59, P987; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang J, 2012, CANCER EPIDEMIOL, V36, pE354, DOI 10.1016/j.canep.2012.08.004; Wenger FA, 2002, CLIN EXP METASTAS, V19, P681, DOI 10.1023/A:1021387826867; Wu XY, 2010, CANCER EPIDEM BIOMAR, V19, P947, DOI 10.1158/1055-9965.EPI-10-0046; Zhou H, 2009, CANCER LETT, V273, P292, DOI 10.1016/j.canlet.2008.08.006; 李连弟, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P520	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118004	10.1371/journal.pone.0118004	http://dx.doi.org/10.1371/journal.pone.0118004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679523	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600100
J	Durivage, N; Keyes, K; Leray, E; Pez, O; Bitfoi, A; Koc, C; Goelitz, D; Kuijpers, R; Lesinskiene, S; Mihova, Z; Otten, R; Fermanian, C; Kovess-Masfety, V				duRivage, Nathalie; Keyes, Katherine; Leray, Emmanuelle; Pez, Ondine; Bitfoi, Adina; Koc, Ceren; Goelitz, Dietmar; Kuijpers, Rowella; Lesinskiene, Sigita; Mihova, Zlatka; Otten, Roy; Fermanian, Christophe; Kovess-Masfety, Viviane			Parental Use of Corporal Punishment in Europe: Intersection between Public Health and Policy	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; AFRICAN-AMERICAN; MENTAL-HEALTH; CHILD; DISCIPLINE; STRENGTHS	Studies have linked the use of corporal punishment of children to the development of mental health disorders. Despite the recommendation of international governing bodies for a complete ban of the practice, there is little European data available on the effects of corporal punishment on mental health and the influence of laws banning corporal punishment. Using data from the School Children Mental Health Europe survey, the objective of this cross-sectional study was to examine the prevalence and legal status of corporal punishment across six European countries and to evaluate the association between parental use of corporal punishment and children's mental health. The study found that odds of having parents who reported using occasional to frequent corporal punishment were 1.7 times higher in countries where its use is legal, controlling for socio-demographic factors. Children with parents who reported using corporal punishment had higher rates of both externalized and internalized mental health disorders.	[duRivage, Nathalie; Keyes, Katherine] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [duRivage, Nathalie; Leray, Emmanuelle; Pez, Ondine; Fermanian, Christophe; Kovess-Masfety, Viviane] Paris Descartes Univ, Ecole Hautes Etud Sante Publ, EA4057, Paris, France; [Bitfoi, Adina] Romanian League Mental Hlth, Bucharest, Romania; [Koc, Ceren] Yeniden Hlth & Educ Soc, Istanbul, Turkey; [Goelitz, Dietmar] Univ Koblenz, Inst Psychol, Koblenz, Germany; [Lesinskiene, Sigita] Univ Vilnius, Fac Med, Psychiat Clin, Vilnius, Lithuania; [Mihova, Zlatka] New Bulgarian Univ, Sofia, Bulgaria; [Kuijpers, Rowella] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Columbia University; UDICE-French Research Universities; Universite Paris Cite; University of Koblenz & Landau; Vilnius University; New Bulgarian University; Radboud University Nijmegen	Kovess-Masfety, V (corresponding author), Paris Descartes Univ, Ecole Hautes Etud Sante Publ, EA4057, Paris, France.	Viviane.Kovess@ehesp.fr	Leray, Emmanuelle/ABH-4374-2020	Leray, Emmanuelle/0000-0001-8424-4499; kovess-masfety, viviane/0000-0001-7045-6175; Goelitz, Dietmar/0000-0002-1329-4023	European Union [2006336]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021511] Funding Source: NIH RePORTER	European Union(European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project had been financed by the European Union, grant number 2006336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EUROPE AND CENTRAL A; Aucoin KJ, 2006, J APPL DEV PSYCHOL, V27, P527, DOI 10.1016/j.appdev.2006.08.001; Berlin LJ, 2009, CHILD DEV, V80, P1403, DOI 10.1111/j.1467-8624.2009.01341.x; Bidaut-Russell M, 1998, CHILD PSYCHIAT HUM D, V28, P249, DOI 10.1023/A:1022636115485; Bornstein MH, 2013, WORLD PSYCHIATRY, V12, P258, DOI 10.1002/wps.20071; Dietz TL, 2000, CHILD ABUSE NEGLECT, V24, P1529, DOI 10.1016/S0145-2134(00)00213-1; Frick PJ, 1999, BEHAV MODIF, V23, P106, DOI 10.1177/0145445599231005; General UNS, 2013, EU MEMBER STATES FOL; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Kuijpers RCWM, 2013, CHILD YOUTH CARE FOR, V42, P35, DOI 10.1007/s10566-012-9185-7; Lansford JE, 2004, J CHILD PSYCHOL PSYC, V45, P801, DOI 10.1111/j.1469-7610.2004.00273.x; Lansford JE, 2014, DEV PSYCHOPATHOL, V26, P561, DOI 10.1017/S0954579414000236; Mahoney A, 2000, J CLIN CHILD PSYCHOL, V29, P266, DOI 10.1207/S15374424jccp2902_12; No GC, 2013, PROGRESS REPORT 2013, P1; Osterman K, 2014, AGGRESSIVE BEHAV, V40, P568, DOI 10.1002/ab.21537; Pez O, 2011, EUROPEAN REPORT THE; Rodriguez CM, 2003, J MARRIAGE FAM, V65, P809, DOI 10.1111/j.1741-3737.2003.00809.x; Shojaei T, 2009, CAN J PSYCHIAT, V54, P767, DOI 10.1177/070674370905401107; Straus MA., 2010, LAW CONTEMP PROBL, V73, P1; Turner HA, 2004, J FAM ISSUES, V25, P761, DOI 10.1177/0192513X03258313; Valla JP, 2000, J AM ACAD CHILD PSY, V39, P85, DOI 10.1097/00004583-200001000-00020; Wolraich ML, 1998, PEDIATRICS, V101, P723; Wu CI, 2007, CURR SOCIOL, V55, P579, DOI 10.1177/0011392107077640; Zolotor AJ, 2010, CHILD ABUSE REV, V19, P229, DOI 10.1002/car.1131	26	33	33	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118059	10.1371/journal.pone.0118059	http://dx.doi.org/10.1371/journal.pone.0118059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB8WX	25674788	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000038
J	Astarita, G; Avanesian, A; Grimaldi, B; Realini, N; Justinova, Z; Panlilio, LV; Basit, A; Goldberg, SR; Piomelli, D				Astarita, Giuseppe; Avanesian, Agnesa; Grimaldi, Benedetto; Realini, Natalia; Justinova, Zuzana; Panlilio, Leight V.; Basit, Abdul; Goldberg, Steven R.; Piomelli, Daniele			Methamphetamine Accelerates Cellular Senescence through Stimulation of De Novo Ceramide Biosynthesis	PLOS ONE			English	Article							KAPPA-B; SPHINGOLIPID METABOLISM; BETA-GALACTOSIDASE; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; MOUSE-BRAIN; DNA-BINDING; TNF-ALPHA; RAT; APOPTOSIS	Methamphetamine is a highly addictive psychostimulant that causes profound damage to the brain and other body organs. Post mortem studies of human tissues have linked the use of this drug to diseases associated with aging, such as coronary atherosclerosis and pulmonary fibrosis, but the molecular mechanism underlying these findings remains unknown. Here we used functional lipidomics and transcriptomics experiments to study abnormalities in lipid metabolism in select regions of the brain and, to a greater extent, peripheral organs and tissues of rats that self-administered methamphetamine. Experiments in various cellular models (primary mouse fibroblasts and myotubes) allowed us to investigate the molecular mechanisms of systemic inflammation and cellular aging related to methamphetamine abuse. We report now that methamphetamine accelerates cellular senescence and activates transcription of genes involved in cell-cycle control and inflammation by stimulating production of the sphingolipid messenger ceramide. This pathogenic cascade is triggered by reactive oxygen species, likely generated through methamphetamine metabolism via cytochrome P-450, and involves the recruitment of nuclear factor-kappa B (NF-kappa B) to induce expression of enzymes in the de novo pathway of ceramide biosynthesis. Inhibitors of NF-kappa B signaling and ceramide formation prevent methamphetamine-induced senescence and systemic inflammation in rats self-administering the drug, attenuating their health deterioration. The results suggest new therapeutic strategies to reduce the adverse consequences of methamphetamine abuse and improve effectiveness of abstinence treatments.	[Astarita, Giuseppe; Avanesian, Agnesa] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Grimaldi, Benedetto; Realini, Natalia; Basit, Abdul; Piomelli, Daniele] Italian Inst Technol, Genoa, Italy; [Justinova, Zuzana; Panlilio, Leight V.; Goldberg, Steven R.] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, Baltimore, MD USA; [Justinova, Zuzana] Univ Maryland, Sch Med, MPRC, Dept Psychiat, Baltimore, MD 21201 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University of California System; University of California Irvine	Piomelli, D (corresponding author), Italian Inst Technol, Genoa, Italy.	piomelli@uci.edu	Basit, Abdul/H-9903-2019; Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014; Justinova, Zuzana/A-9109-2011	Basit, Abdul/0000-0002-1164-5520; Grimaldi, Benedetto/0000-0002-2589-9302; Astarita, Giuseppe/0000-0001-6700-301X; Justinova, Zuzana/0000-0001-5793-7484	National Institute on Drug Abuse [RC2 DA028902]; National Institute on Drug Abuse, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000003, RC2DA028902] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Drug Abuse, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by the National Institute on Drug Abuse (RC2 DA028902 to D. P.) and by the Intramural Research Program of the National Institute on Drug Abuse, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz O, 1998, BRAIN RES, V813, P200, DOI 10.1016/S0006-8993(98)01020-8; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; ASTARITA G, 2009, METH MOL B 1, V579, P201, DOI DOI 10.1007/978-1-60761-322-0_; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carvalho F, 2009, ADICCIONES, V21, P99, DOI 10.20882/adicciones.236; Cherner M, 2010, J INT NEUROPSYCH SOC, V16, P890, DOI 10.1017/S1355617710000779; Conner DA, 2001, CURR PROTOC MOL BIOL; Curtis Eric K, 2006, Gen Dent, V54, P125; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gluck MR, 2001, J NEUROCHEM, V79, P152, DOI 10.1046/j.1471-4159.2001.00549.x; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Karch SB, 1999, J FORENSIC SCI, V44, P359; Kaye S, 2008, ADDICTION, V103, P1353, DOI 10.1111/j.1360-0443.2008.02231.x; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kuczenski R, 2007, EXP NEUROL, V207, P42, DOI 10.1016/j.expneurol.2007.05.023; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee YW, 2002, J NEUROSCI RES, V70, P82, DOI 10.1002/jnr.10370; Lee YW, 2001, J NEUROSCI RES, V66, P583, DOI 10.1002/jnr.1248; Lin LY, 1997, DRUG METAB DISPOS, V25, P1059; Melo P, 2012, NEUROTOXICOLOGY, V33, P491, DOI 10.1016/j.neuro.2012.03.002; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Miller CJ, 2001, J GERONTOL A-BIOL, V56, pB8, DOI 10.1093/gerona/56.1.B8; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Modrak DE, 2009, MOL CANCER RES, V7, P890, DOI 10.1158/1541-7786.MCR-08-0457; Mouton RE, 2000, MECH AGEING DEV, V113, P169, DOI 10.1016/S0047-6374(99)00105-0; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; PALESTINI P, 1993, J NEUROCHEM, V61, P955, DOI 10.1111/j.1471-4159.1993.tb03608.x; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; SUNDARAM KS, 1989, NEUROCHEM RES, V14, P245, DOI 10.1007/BF00971318; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wu DF, 1997, BIOCHEM PHARMACOL, V53, P1605, DOI 10.1016/S0006-2952(97)00014-2; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	52	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116961	10.1371/journal.pone.0116961	http://dx.doi.org/10.1371/journal.pone.0116961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671639	Green Published, gold			2022-12-27	WOS:000349545300028
J	Balcells, ME; Garcia, P; Meza, P; Pena, C; Cifuentes, M; Couvin, D; Rastogi, N				Elvira Balcells, Maria; Garcia, Patricia; Meza, Paulina; Pena, Carlos; Cifuentes, Marcela; Couvin, David; Rastogi, Nalin			A First Insight on the Population Structure of Mycobacterium tuberculosis Complex as Studied by Spoligotyping and MIRU-VNTRs in Santiago, Chile	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; DRUG-RESISTANCE; STRAINS; DIFFERENTIATION; GENOTYPE; LINEAGE; RISK; LIMA	Tuberculosis (TB) remains a significant public health problem worldwide, but the ecology of the prevalent mycobacterial strains, and their transmission, can vary depending on country and region. Chile is a country with low incidence of TB, that has a geographically isolated location in relation to the rest of South American countries due to the Andes Mountains, but recent migration from neighboring countries has changed this situation. We aimed to assess the genotypic diversity of Mycobacterium tuberculosis complex (MTBC) strains in Santiago, Chile, and compare with reports from other Latin-American countries. We analyzed MTBC isolates from pulmonary tuberculosis cases collected between years 2008 and 2013 in Central Santiago, using two genotyping methods: spoligotyping and 12-loci mycobacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTRs). Data obtained were analyzed and compared to the SITVIT2 database. Mean age of the patients was 47.5 years and 61% were male; 11.6% were migrants. Of 103 strains (1 isolate/patient) included, there were 56 distinct spoligotype patterns. Of these, 16 strains (15.5%) corresponded to orphan strains in the SITVIT2 database, not previously reported. Latin American and Mediterranean (LAM) (34%) and T (33%) lineages were the most prevalent strains, followed by Haarlem lineage (16.5%). Beijing family was scarcely represented with only two cases (1.9%), one of them isolated from a Peruvian migrant. The most frequent clustered spoligotypes were SIT33/LAM3 (10.7%), SIT53/T1 (8.7%), SIT50/H3 (7.8%), and SIT37/T3 (6.8%). We conclude that LAM and T genotypes are the most prevalent genotypes of MTBC in Santiago, Chile, and together correspond to almost two thirds of analyzed strains, which is similar to strain distribution reported from other countries of Latin America. Nevertheless, the high proportion of SIT37/T3, which was rarely found in other Latin American countries, may underline a specific history or demographics of Chile related to probable human migrations and evolutions.	[Elvira Balcells, Maria] Pontificia Univ Catolica Chile, Sch Med, Dept Infect Dis, Alameda 340, Santiago, Chile; [Garcia, Patricia; Meza, Paulina] Pontificia Univ Catolica Chile, Sch Med, Microbiol Lab, Clin Lab Dept, Santiago, Chile; [Pena, Carlos; Cifuentes, Marcela] Hosp San Borja Arriaran, Div Resp, Santiago, Chile; [Pena, Carlos; Cifuentes, Marcela] Hosp San Borja Arriaran, Microbiol Lab, Santiago, Chile; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile	Balcells, ME (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Infect Dis, Alameda 340, Santiago, Chile.	balcells@med.puc.cl	Balcells, Maria Elvira/GRR-9067-2022; RASTOGI, NALIN/AAP-1958-2020	Balcells, Maria Elvira/0000-0002-7223-9665; RASTOGI, NALIN/0000-0002-7199-7747	Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT [1130600]; Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT [1130600]	Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by funding by Chilean National Funding Agency CONICYT, FONDECYT GRANT No 1130600 (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Barbosa CD, 2012, INT J TUBERC LUNG D, V16, P1377, DOI 10.5588/ijtld.11.0709; Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Cohen T, 2011, EMERG INFECT DIS, V17, P969, DOI [10.3201/eid1706.101471, 10.3201/eid/1706.101471]; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Couvin D, 2014, EUROREFERENCE J REFE, V12, P36, DOI [10.1186/1471-2407-14-960, DOI 10.1186/1471-2407-14-960]; Cowan LS, 2002, J CLIN MICROBIOL, V40, P1592, DOI 10.1128/JCM.40.5.1592-1602.2002; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Garzelli C, 2012, INFECT GENET EVOL, V12, P610, DOI 10.1016/j.meegid.2011.10.015; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Jagielski T, 2010, J CLIN MICROBIOL, V48, P3899, DOI 10.1128/JCM.00572-10; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kasai H, 2000, J CLIN MICROBIOL, V38, P301; Kato-Maeda M, 2010, INT J TUBERC LUNG D, V14, P538; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Mancilla E Marcos, 2006, Rev. chil. infectol., V23, P220; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Meza P, 2014, REV CHIL INFECTOL, V31, P21, DOI 10.4067/S0716-10182014000100003; MILLET J, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/689852; Monteserin J, 2013, INFECT GENET EVOL, V17, P195, DOI 10.1016/j.meegid.2013.04.010; Morcillo N., 2005, Rev. argent. microbiol., V37, P92; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Ritacco V, 2012, INFECT GENET EVOL, V12, P711, DOI 10.1016/j.meegid.2011.06.006; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tuberculosis Informe De Situacion Chile, 2012, PROGR NAC TUB; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, WHO REPORT	52	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118007	10.1371/journal.pone.0118007	http://dx.doi.org/10.1371/journal.pone.0118007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671320	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300078
J	Olsen, IH; Holt, N; Langer, SW; Hasselby, JP; Gronbaek, H; Hillingso, J; Mahmoud, M; Ladekarl, M; Iversen, LH; Kjaer, A; Federspiel, BH; Knigge, U				Olsen, Ingrid Holst; Holt, Nanna; Langer, Seppo W.; Hasselby, Jane P.; Gronbaek, Henning; Hillingso, Jens; Mahmoud, Masti; Ladekarl, Morten; Iversen, Lene H.; Kjaer, Andreas; Federspiel, Birgitte H.; Knigge, Ulrich			Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients	PLOS ONE			English	Article							APPENDIX; TUMORS; SURVIVIN; CHEMOTHERAPY; GUIDELINES; MANAGEMENT; DIAGNOSIS; NEOPLASMS; BEHAVIOR; MARKER	Background Appendiceal goblet cell carcinoids (GCCs) exhibit neuroendocrine and adenocarcinoma features. Patients and Methods Analysis of demography, pathology, prognostic markers, treatment and survival in 83 GCC patients (f/m: 56/27) diagnosed 1992-2013. Results Median age for f/m was 59/58 years, respectively, and similar for localized and disseminated disease. At diagnosis 54 patients had localized appendiceal disease (f/m: 29/25). According to TNM 24% had Stage I, 70% had Stage II and 6% had Stage III. Twenty-nine patients had disseminated disease (f/m: 27/2). Chromogranin A, synaptophysin and p53 were positive in >90%. Serotonin was positive in 70%. Median Ki67 index was 32% (6-75%) and higher in Tang group C (50%) compared to group A (30%; p< 0.0001), and group B (30%; p< 0.004). All patients had surgery. Sixty-three (76%) had radical resections including all patients with localized disease. Median OS was 83 months. The 1-, 5-and 10-year survival rates were 90%, 58%, and 38%, respectively. For localized disease OS was 164 months and 1-, 5-and 10-year survival rates were 100%, 80%, and 55%, respectively. For disseminated disease OS was 19 months and 1-, 5-and 10-year survival rates were 73%, 18% and 6%, respectively. The 1-, 5- and 10 year-survival rates for f/m were 87%/96%, 49%/76% and 31%/57%, respectively (p = 0.02). According to the Tang classification group A, B, and C OS was 118, 83 and 20 months, respectively (p = 0.0002). Conclusion The Tang classification was found to be a significant prognostic factor, while the Ki67 index was not. Localized GCCs occurred equally in males and females, while disseminated GCCs were mostly seen in females. Median age of patients with localized disease and disseminated disease was identical. Cox regression analysis found Stage IV, focally positive synaptophysin and non-radical surgery as strongest negative prognostic factors.	[Olsen, Ingrid Holst; Hillingso, Jens; Mahmoud, Masti; Knigge, Ulrich] Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol, European NET Ctr Excellence,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Langer, Seppo W.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Oncol, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Hasselby, Jane P.; Federspiel, Birgitte H.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Pathol, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Knigge, Ulrich] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Endocrinol, Copenhagen, Denmark; [Olsen, Ingrid Holst; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Olsen, Ingrid Holst; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence, Copenhagen, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, European NET Ctr Excellence, Dept Oncol, DK-8000 Aarhus, Denmark; [Iversen, Lene H.] Aarhus Univ Hosp, European NET Ctr Excellence, Dept Surg, DK-8000 Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University	Olsen, IH (corresponding author), Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol, European NET Ctr Excellence,Fac Hlth Sci, DK-2100 Copenhagen, Denmark.	ingridho@sund.ku.dk	Gronbaek, Henning/AAJ-3202-2020; Ladekarl, Morten/AAQ-1702-2020; Kjaer, Andreas/E-8932-2015	Gronbaek, Henning/0000-0001-8998-7910; Iversen, Lene Hjerrild/0000-0002-2336-2923; Ladekarl, Morten/0000-0002-0182-1228; Hillingsoe, Jens G./0000-0002-2381-7836; /0000-0001-9732-9192; Holt Jessen, Nanna/0000-0002-2032-1691; Kjaer, Andreas/0000-0002-2706-5547	Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation; Research Foundation of the Capital Region; Arvid Nilssons Foundation; Internalization Foundation; Lundbeck Foundation; Svend Andersen Foundation; National Advanced Technology Foundation; NOVO Nordisk Foundation; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish; The Danish Cancer Society [R72-A4569] Funding Source: researchfish	Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation; Research Foundation of the Capital Region; Arvid Nilssons Foundation; Internalization Foundation; Lundbeck Foundation(Lundbeckfonden); Svend Andersen Foundation; National Advanced Technology Foundation; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by The Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation, The Research Foundation of the Capital Region, Arvid Nilssons Foundation, Internalization Foundation, The Lundbeck Foundation, Svend Andersen Foundation, National Advanced Technology Foundation and The NOVO Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binderup T, 2010, J NUCL MED, V51, P704, DOI 10.2967/jnumed.109.069765; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Boudreaux JP, 2010, PANCREAS, V39, P753, DOI 10.1097/MPA.0b013e3181ebb2a5; Bucher P, 2005, WORLD J SURG, V29, P1436, DOI 10.1007/s00268-005-7958-y; BUTLER JA, 1994, AM J SURG, V168, P685, DOI 10.1016/S0002-9610(05)80145-X; Grabowski P, 2005, NEUROENDOCRINOLOGY, V81, P1, DOI 10.1159/000084892; Greene FL, 2002, AJCC CANC STAGING HD; Holt N, 2013, SCI WORLD J, DOI 10.1155/2013/543696; Hristov AC, 2007, AM J SURG PATHOL, V31, P1502, DOI 10.1097/PAS.0b013e31804f7aa1; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Kanthan R, 2001, ARCH PATHOL LAB MED, V125, P386; Koch CA, 2002, EUR J ENDOCRINOL, V146, P381, DOI 10.1530/eje.0.1460381; Landry CS, 2008, ARCH SURG-CHICAGO, V143, P664, DOI 10.1001/archsurg.143.7.664; Lee KS, 2013, EUR J RADIOL, V82, P85, DOI 10.1016/j.ejrad.2012.05.038; Liu E, 2011, AM J SURG, V202, P400, DOI 10.1016/j.amjsurg.2010.08.036; Mandai M, 2001, EUR J OBSTET GYN R B, V97, P90, DOI 10.1016/S0301-2115(00)00503-0; McConnell YJ, 2014, ANN SURG ONCOL, V21, P1975, DOI 10.1245/s10434-013-3469-5; McCusker ME, 2002, CANCER, V94, P3307, DOI 10.1002/cncr.10589; Pahlavan Payam S, 2005, World J Surg Oncol, V3, P36, DOI 10.1186/1477-7819-3-36; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; Pham TH, 2006, ANN SURG ONCOL, V13, P370, DOI 10.1245/ASO.2006.02.016; Plockinger U, 2008, NEUROENDOCRINOLOGY, V87, P20, DOI 10.1159/000109876; Ramnani DM, 2000, CANCER; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Roy P, 2010, WORLD J GASTRO ONCOL, V2, P251, DOI 10.4251/wjgo.v2.i6.251; Sobin LH, 2011, TNM CLASSIFICATION M; SUBBUSWAMY SG, 1974, CANCER-AM CANCER SOC, V34, P338, DOI 10.1002/1097-0142(197408)34:2<338::AID-CNCR2820340218>3.0.CO;2-W; Sukpan K, 2011, INT J GYNECOL CANCER, V21, P911, DOI 10.1097/IGC.0b013e31821a2567; Tang LH, 2008, AM J SURG PATHOL, V32, P1429, DOI 10.1097/PAS.0b013e31817f1816; Toumpanakis C, 2007, DIS COLON RECTUM, V50, P315, DOI 10.1007/s10350-006-0762-4; van Eeden S, 2007, HISTOPATHOLOGY, V51, P763, DOI 10.1111/j.1365-2559.2007.02883.x; Varisco B, 2004, AM SURGEON, V70, P593	32	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117627	10.1371/journal.pone.0117627	http://dx.doi.org/10.1371/journal.pone.0117627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671432	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300063
J	Salces-Ortiz, J; Ramon, M; Gonzalez, C; Perez-Guzman, MD; Garde, JJ; Garcia-Alvarez, O; Maroto-Morales, A; Calvo, JH; Serrano, MM				Salces-Ortiz, Judit; Ramon, Manuel; Gonzalez, Carmen; Perez-Guzman, M. Dolores; Garde, J. Julian; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Calvo, Jorge H.; Serrano, M. Magdalena			Differences in the Ovine HSP90AA1 Gene Expression Rates Caused by Two Linked Polymorphisms at Its Promoter Affect Rams Sperm DNA Fragmentation under Environmental Heat Stress Conditions	PLOS ONE			English	Article							SHOCK RESPONSE; CHAPERONE; CELLS; SHEEP; TRANSCRIPTION; MECHANISMS; FERTILITY; INTEGRITY; IMPACT; REPAIR	Heat shock (HS) is one of the best-studied exogenous cellular stresses. Almost all tissues, cell types, metabolic pathways and biochemical reactions are affected in greater or lesser extent by HS. However, there are some especially thermo sensible cellular types such as the mammalian male germ cells. The present study examined the role of three INDELs in conjunction with the -660G/C polymorphism located at the HSP90AA1 promoter region over the gene expression rate under HS. Specially, the -668insC INDEL, which is very close to the -660G/C transversion, is a good candidate to be implied in the transcriptional regulation of the gene by itself or in a cooperative way with this SNP. Animals carrying the genotype Il-668 showed higher transcription rates than those with ID-668 (FC = 3.07) and DD-668 (FC = 3.40) genotypes for samples collected under HS. A linkage between gene expression and sperm DNA fragmentation was also found. When HS conditions were present along or in some stages of the spermatogenesis, alternative genotypes of the -668insC and -660G/C mutations are involved in the effect of HS over sperm DNA fragmentation. Thus, unfavorable genotypes in terms of gene expression induction (ID(-668)GC(-660) and DD(-668)GG(-660)) do not produce enough mRNA (stored as messenger ribonucleoprotein particles) and Hsp90 alpha protein to cope with future thermal stress which might occur in posterior stages when transcriptional activity is reduced and cell types and molecular processes are more sensible to heat (spermatocytes in pachytene and spermatids protamination). This would result in the impairment of DNA packaging and the consequent commitment of the events occurring shortly after fertilization and during embryonic development. In the short-term, the assessment of the relationship between sperm DNA fragmentation sensitivity and ram's fertility will be of interest to a better understanding of the mechanisms of response to HS and its consequences on animal production and reproduction performance.	[Salces-Ortiz, Judit; Gonzalez, Carmen; Serrano, M. Magdalena] INIA, Madrid 28040, Spain; [Ramon, Manuel; Perez-Guzman, M. Dolores] CERSYRA, Valdepenas 13300, Spain; [Garde, J. Julian; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro] CSIC UCLM JCCM, SaBio IREC, Albacete, Spain; [Calvo, Jorge H.] CITA, Unidad Tecnol Prod Anim, Zaragoza 59059, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Ramon, M (corresponding author), CERSYRA, Av Vino 10, Valdepenas 13300, Spain.	m.ramon.fernandez@gmail.com	garcia-alvarez, olga/AAM-5128-2020; garcia-alvarez, olga/L-4424-2014; Fernandez, Manuel Ramon/B-5755-2014; Serrano, Malena/GXH-8219-2022; Serrano, Magdalena M/R-5716-2017; Calvo, Jorge H/E-5240-2016; López-Brea, José Julián Garde/AAE-5894-2019; Garde, Julian J/O-5607-2015	garcia-alvarez, olga/0000-0003-4310-0557; garcia-alvarez, olga/0000-0003-4310-0557; Fernandez, Manuel Ramon/0000-0003-4179-9894; Serrano, Magdalena M/0000-0002-1621-3102; Calvo, Jorge H/0000-0001-9513-0219; López-Brea, José Julián Garde/0000-0002-3667-6518; Garde, Julian J/0000-0002-3667-6518; Gonzalez Verdejo, Carmen/0000-0001-8757-9147; Salces-Ortiz, Judit/0000-0002-3572-4020	INIA projects [RTA2009-00098-00-00, RTA2012-00041-00-00]; INIA doctoral grant	INIA projects; INIA doctoral grant	This work was supported by RTA2009-00098-00-00 and RTA2012-00041-00-00 INIA projects. Judit Salces-Ortiz was supported by an INIA doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mahecha A, 2001, BIOL REPROD, V65, P119, DOI 10.1095/biolreprod65.1.119; Banks S, 2005, REPRODUCTION, V129, P505, DOI 10.1530/rep.1.00531; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de la Fuente M, 2012, FEBS LETT, V586, P4061, DOI 10.1016/j.febslet.2012.10.018; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; Dominguez K, 2011, SPERM CHROMATIN: BIOLOGICAL AND CLINICAL APPLICATIONS IN MALE INFERTILITY AND ASSISTED REPRODUCTION, P61, DOI 10.1007/978-1-4419-6857-9_4; Erlejman AG, 2014, BBA-GENE REGUL MECH, V1839, P71, DOI 10.1016/j.bbagrm.2013.12.006; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fleming JS, 2004, MOL REPROD DEV, V68, P103, DOI 10.1002/mrd.20049; Freeman BC, 2000, METH MOL B, V99, P393; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Hales Barbara F, 2005, Toxicol Appl Pharmacol, V207, P514, DOI 10.1016/j.taap.2004.12.021; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marcos-Carcavilla A, 2008, CELL STRESS CHAPERON, V13, P19, DOI 10.1007/s12192-007-0004-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P343, DOI 10.1007/s12192-009-0149-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Oner Y, 2013, TROP ANIM HEALTH PRO, V45, P947, DOI 10.1007/s11250-012-0313-z; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Paul C, 2008, MOL HUM REPROD, V14, P1, DOI 10.1093/molehr/gam089; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086107; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Sailer BL, 1997, J ANDROL, V18, P294; Salces-Ortiz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066641; Setchell B. P., 2006, Animal Reproduction, V3, P81; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; [Team RC Computing RFfS], 2013, COMPUTING RFFS; Ulberg LC, 1958, J HERED, V49; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	48	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116360	10.1371/journal.pone.0116360	http://dx.doi.org/10.1371/journal.pone.0116360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671615	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300019
J	Whalan, S; Abdul Wahab, MA; Sprungala, S; Poole, AJ; de Nys, R				Whalan, Steve; Abdul Wahab, Muhammad A.; Sprungala, Susanne; Poole, Andrew J.; de Nys, Rocky			Larval Settlement: The Role of Surface Topography for Sessile Coral Reef Invertebrates	PLOS ONE			English	Article							ATTACHMENT STRENGTH; METAMORPHOSIS; INDUCTION; SELECTION; ECOLOGY; SPONGES; CUES; RECRUITMENT; PATTERNS; BIOFILMS	For sessile marine invertebrates with complex life cycles, habitat choice is directed by the larval phase. Defining which habitat-linked cues are implicated in sessile invertebrate larval settlement has largely concentrated on chemical cues which are thought to signal optimal habitat. There has been less effort establishing physical settlement cues, including the role of surface microtopography. This laboratory based study tested whether surface microtopography alone (without chemical cues) plays an important contributing role in the settlement of larvae of coral reef sessile invertebrates. We measured settlement to tiles, engineered with surface microtopography (holes) that closely matched the sizes (width) of larvae of a range of corals and sponges, in addition to surfaces with holes that were markedly larger than larvae. Larvae from two species of scleractinian corals (Acropora millepora and Ctenactis crassa) and three species of coral reef sponges (Luffariella variabilis, Carteriospongia foliascens and Ircinia sp.,) were used in experiments. L. variabilis, A. millepora and C. crassa showed markedly higher settlement to surface microtopography that closely matched their larval width. C. foliascens and Ircinia sp., showed no specificity to surface microtopography, settling just as often to microtopography as to flat surfaces. The findings of this study question the sole reliance on chemical based larval settlement cues, previously established for some coral and sponge species, and demonstrate that specific physical cues (surface complexity) can also play an important role in larval settlement of coral reef sessile invertebrates.	[Whalan, Steve] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, POB 157, Lismore, NSW 2480, Australia; [Abdul Wahab, Muhammad A.; de Nys, Rocky] James Cook Univ, MACRO, Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Abdul Wahab, Muhammad A.] James Cook Univ, AIMS JCL, Townsville, Qld 4811, Australia; [Sprungala, Susanne] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Sprungala, Susanne] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Dept Mol Sci, Townsville, Qld 4811, Australia; [Poole, Andrew J.] CSIRO Mfg Flagship, Victoria 3216, Australia	Southern Cross University; James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Whalan, S (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, POB 157, Lismore, NSW 2480, Australia.	stephen.whalan@scu.edu.au	de Nys, Rocky/D-6741-2012	de Nys, Rocky/0000-0003-3869-4928; Abdul Wahab, Muhammad Azmi/0000-0003-4088-9652; Poole, Andrew/0000-0001-9584-6452; Whalan, Steve/0000-0001-6786-8945	Great Barrier Reef Foundation [G13/36138.1]	Great Barrier Reef Foundation	This work was undertaken with funding to SW through the Great Barrier Reef Foundation and under permit G13/36138.1, issued by the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2014, CORAL REEFS, V33, P381, DOI 10.1007/s00338-013-1119-9; Abdul Wahab MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098181; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Aldred N, 2010, BIOFOULING, V26, P287, DOI 10.1080/08927010903511626; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bishop CD, 2006, INTEGR COMP BIOL, V46, P662, DOI 10.1093/icb/icl043; Callow ME, 2002, BIOFOULING, V18, P237, DOI 10.1080/08927010290014917; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CRISP DJ, 1960, NATURE, V185, P119, DOI 10.1038/185119a0; CRISP DJ, 1954, J ANIM ECOL, V23, P142, DOI 10.2307/1664; Dixson DL, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.53; Duckworth AR, 2008, CONT SHELF RES, V28, P2168, DOI 10.1016/j.csr.2008.03.024; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hills JM, 1999, FUNCT ECOL, V13, P868, DOI 10.1046/j.1365-2435.1999.00377.x; Hodson J, 2010, OECOLOGIA, V164, P73, DOI 10.1007/s00442-010-1691-4; Hollander AF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Howdeshell KL, 2003, ENVIRON HEALTH PERSP, V111, P1180, DOI 10.1289/ehp.5993; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Keough MJ, 1996, J EXP MAR BIOL ECOL, V207, P59, DOI 10.1016/S0022-0981(96)02632-9; Kingsford MJ, 2002, B MAR SCI, V70, P309; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lau SCK, 2005, AQUAT MICROB ECOL, V38, P41, DOI 10.3354/ame038041; LETOURNEUX F, 1988, MAR BIOL, V97, P57, DOI 10.1007/BF00391245; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Myan FWY, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-30; Nozawa Y, 2012, J EXP MAR BIOL ECOL, V413, P145, DOI 10.1016/j.jembe.2011.12.008; Nozawa Y, 2011, ZOOL STUD, V50, P53; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Petersen D, 2005, MAR BIOL, V146, P937, DOI 10.1007/s00227-004-1503-7; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Resetarits WJ, 2005, ECOL LETT, V8, P480, DOI 10.1111/j.1461-0248.2005.00747.x; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scardino AJ, 2011, BIOFOULING, V27, P73, DOI 10.1080/08927014.2010.536837; SEBENS KP, 1983, BIOL BULL, V165, P286, DOI 10.2307/1541370; Siboni N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037774; SOLER M, 1994, BEHAV ECOL SOCIOBIOL, V35, P295, DOI 10.1007/s002650050100; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Tebben J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087545; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Toonen RJ, 2001, MAR ECOL PROG SER, V224, P115, DOI 10.3354/meps224115; Vucko MJ, 2014, BIOFOULING, V30, P1, DOI 10.1080/08927014.2013.836507; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; Whalan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030386	60	62	63	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117675	10.1371/journal.pone.0117675	http://dx.doi.org/10.1371/journal.pone.0117675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671562	Green Accepted, Green Published, gold			2022-12-27	WOS:000349545300065
J	Halcox, JP; Tubach, F; Lopez-Garcia, E; De Backer, G; Borghi, C; Dallongeville, J; Guallar, E; Medina, J; Perk, J; Sazova, O; Sweet, S; Roy, C; Banegas, JR; Rodriguez-Artalejo, F				Halcox, Julian P.; Tubach, Florence; Lopez-Garcia, Esther; De Backer, Guy; Borghi, Claudio; Dallongeville, Jean; Guallar, Eliseo; Medina, Jesus; Perk, Joep; Sazova, Oguen; Sweet, Stephen; Roy, Carine; Banegas, Jose R.; Rodriguez-Artalejo, Fernando			Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe	PLOS ONE			English	Article							ADULT-POPULATION; PREVALENCE; MANAGEMENT; METAANALYSIS; PREVENTION; SPAIN	Aims To analyse the treatment and control of dyslipidaemia in patients at high and very high cardiovascular risk being treated for the primary prevention of cardiovascular disease (CVD) in Europe. Methods and Results Data were assessed from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA, ClinicalTrials.gov identifier: NCT00882336), which included a randomly sampled population of primary CVD prevention patients from 12 European countries (n = 7641). Patients' 10-year risk of CVD-related mortality was calculated using the Systematic Coronary Risk Evaluation (SCORE) algorithm, identifying 5019 patients at high cardiovascular risk (SCORE >= 5% and/or receiving lipid-lowering therapy), and 2970 patients at very high cardiovascular risk (SCORE >= 10% or with diabetes mellitus). Among high-risk individuals, 65.3% were receiving lipid-lowering therapy, and 61.3% of treated patients had uncontrolled low-density lipoprotein cholesterol (LDL-C) levels (>= 2.5 mmol/L). For very-high-risk patients (uncontrolled LDL-C levels defined as >= 1.8 mmol/L) these figures were 49.5% and 82.9%, respectively. Excess 10-year risk of CVD-related mortality (according to SCORE) attributable to lack of control of dyslipidaemia was estimated to be 0.72% and 1.61% among high-risk and very-high-risk patients, respectively. Among high-risk individuals with uncontrolled LDL-C levels, only 8.7% were receiving a high-intensity statin (atorvastatin >= 40 mg/day or rosuvastatin >= 20 mg/day). Among very-high-risk patients, this figure was 8.4%. Conclusions There is a considerable opportunity for improvement in rates of lipid-lowering therapy use and achievement of lipid-level targets in high-risk and very-high-risk patients being treated for primary CVD prevention in Europe.	[Halcox, Julian P.] Swansea Univ, Coll Med, Inst Life Sci 2, Swansea, W Glam, Wales; [Tubach, Florence; Roy, Carine] Hop Bichat Claude Bernard, AP HP, INSERM, CIC EC 1425, F-75877 Paris, France; [Tubach, Florence; Roy, Carine] Hop Bichat Claude Bernard, AP HP, Epidemiol & Clin Res Dept, F-75877 Paris, France; [Tubach, Florence] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1123, Paris, France; [Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, IdiPaz, Dept Preventat Med & Publ Hlth, Madrid, Spain; [Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando] CIBERESP, Madrid, Spain; [De Backer, Guy] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Borghi, Claudio] Univ Bologna, Dept Internal Med, Bologna, Italy; [Dallongeville, Jean] Univ Lille Nord France, Inst Pasteur Lille, INSERM, U 744, Lille, France; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Medina, Jesus] AstraZeneca Farmaceut Spain, Global Med Affairs, Observat Res Ctr, Madrid, Spain; [Perk, Joep] Linnaeus Univ, Sch Hlth & Caring Sci, Kalmar, Sweden; [Sazova, Oguen] AstraZeneca Global Med Affairs, London, England; [Sweet, Stephen] Oxford PharmaGenesis Ltd, Res Evaluat Unit, Oxford, England	Swansea University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Ghent University; University of Bologna; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centro Nacional de Investigaciones Cardiovasculares (CNIC); AstraZeneca; Linnaeus University; AstraZeneca	Halcox, JP (corresponding author), Swansea Univ, Coll Med, Inst Life Sci 2, Swansea, W Glam, Wales.	J.P.J.Halcox@swansea.ac.uk	De Backer, Guy/AAI-4607-2021; Lopez-Garcia, Esther/A-8894-2019	Halcox, Julian/0000-0001-6926-2947	AstraZeneca	AstraZeneca(AstraZeneca)	The EURIKA study was funded by AstraZeneca. The study was run by an independent academic steering committee, which worked under rules agreed a priori that allowed intellectual input of the funder (i.e. the funder contributed ideas to the study design, data analysis and preparation of the manuscript) while granting the executive and decision making role to the committee. The authors had full access to all data and had final responsibility for the contents of the manuscript and the decision to submit it for publication. Writing support was provided by Oxford PharmaGenesis Ltd, Oxford, UK, and was funded by AstraZeneca.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P304, DOI 10.1097/HJR.0b013e3283213140; Dallongeville J, 2012, EUR J PREV CARDIOL, V19, P541, DOI 10.1177/1741826711407705; Degli Esposti Luca, 2011, Monaldi Arch Chest Dis, V76, P160; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; EAS, 2013, NEW GUID US 2013 ACC; Firmann M, 2010, EUR J CARDIOV PREV R, V17, P682, DOI 10.1097/HJR.0b013e32833a09ab; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel R, 2008, REV ESP CARDIOL, V61, P1030, DOI 10.1016/S1885-5857(09)60006-2; Genuth S, 2012, J CLIN ENDOCR METAB, V97, P41, DOI 10.1210/jc.2011-1679; Germano G, 2012, EUR HEART J, V33, P137; Gomez-Huelgas R, 2011, INT J CLIN PRACT, V65, P35, DOI 10.1111/j.1742-1241.2010.02543.x; Grassi G, 2009, ACTA CARDIOL, V64, P771, DOI 10.2143/AC.64.6.2044742; Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3; Guallar-Castillon P, 2012, REV ESP CARDIOL, V65, P551, DOI [10.1016/j.recesp.2012.02.005, 10.1016/j.rec.2012.03.001]; Huffman JC, 2003, PSYCHOSOMATICS, V44, P222, DOI 10.1176/appi.psy.44.3.222; Laccetti R, 2013, PUBLIC HEALTH NUTR, V16, P305, DOI 10.1017/S1368980012002716; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; NICE, 2010, NICE CLIN GUID 67 CA; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rodriguez-Artalejo F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-382; Schwandt Peter, 2004, Expert Rev Cardiovasc Ther, V2, P431, DOI 10.1586/14779072.2.3.431; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tattersall MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059309	27	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115270	10.1371/journal.pone.0115270	http://dx.doi.org/10.1371/journal.pone.0115270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692692	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500007
J	Lee, EH; Lee, K; Hwang, KY; Kim, HY				Lee, Eun Hye; Lee, Kitaik; Hwang, Kwang Yeon; Kim, Hwa-Young			Essential Role of the C-Terminal Helical Domain in Active Site Formation of Selenoprotein MsrA from Clostridium oremlandii	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; CATALYTIC MECHANISM; KINETIC CHARACTERIZATION; EXPRESSION; SYSTEM	We previously determined the crystal structures of 1-Cys type selenoprotein MsrA from Clostridium oremlandii (CoMsrA). The overall structure of CoMsrA is unusual, consisting of two domains, the N-terminal catalytic domain and the C-terminal distinct helical domain which is absent from other known MsrA structures. Deletion of the helical domain almost completely abolishes the catalytic activity of CoMsrA. In this study, we determined the crystal structure of the helical domain-deleted (Delta H-domain) form of CoMsrA at a resolution of 1.76 angstrom. The monomer structure is composed of the central rolled mixed beta-sheet surrounded by a-helices. However, there are significant conformational changes in the N- and C-termini and loop regions of the Delta H-domain protein relative to the catalytic domain structure of full-length CoMsrA. The active site structure in the Delta H-domain protein completely collapses, thereby causing loss of catalytic activity of the protein. Interestingly, dimer structures are observed in the crystal formed by N-terminus swapping between two molecules. The Delta H-domain protein primarily exists as a dimer in solution, whereas the full-length CoMsrA exists as a monomer. Collectively, this study provides insight into the structural basis of the essential role of the helical domain of CoMsrA in its catalysis.	[Lee, Eun Hye; Lee, Kitaik; Hwang, Kwang Yeon] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu, South Korea	Korea University; Yeungnam University	Hwang, KY (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea.	chahong@korea.ac.kr; hykim@ynu.ac.kr		Lee, Kitaik/0000-0002-7761-5586	Yeungnam University Research Grant	Yeungnam University Research Grant	This work was supported by the 2014 Yeungnam University Research Grant (HYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kim HY, 2013, ANTIOXID REDOX SIGN, V19, P958, DOI 10.1089/ars.2012.5081; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Kim HY, 2009, PROTEINS, V74, P1008, DOI 10.1002/prot.22212; Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee EH, 2014, ARCH BIOCHEM BIOPHYS, V545, P1, DOI 10.1016/j.abb.2013.12.024; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117836	10.1371/journal.pone.0117836	http://dx.doi.org/10.1371/journal.pone.0117836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692691	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500077
J	Pokrovsky, I; Ehrich, D; Ims, RA; Kondratyev, AV; Kruckenberg, H; Kulikova, O; Mihnevich, J; Pokrovskaya, L; Shienok, A				Pokrovsky, Ivan; Ehrich, Dorothee; Ims, Rolf A.; Kondratyev, Alexander V.; Kruckenberg, Helmut; Kulikova, Olga; Mihnevich, Julia; Pokrovskaya, Liya; Shienok, Alexander			Rough-Legged Buzzards, Arctic Foxes and Red Foxes in a Tundra Ecosystem without Rodents	PLOS ONE			English	Article							CLIMATE-CHANGE; ALOPEX-LAGOPUS; CONFIDENCE-INTERVALS; POPULATION-DYNAMICS; BREEDING SUCCESS; LEMMING CYCLES; PREY; DIET; FLUCTUATIONS; HYPOTHESIS	Small rodents with multi-annual population cycles strongly influence the dynamics of food webs, and in particular predator-prey interactions, across most of the tundra biome. Rodents are however absent from some arctic islands, and studies on performance of arctic predators under such circumstances may be very instructive since rodent cycles have been predicted to collapse in a warming Arctic. Here we document for the first time how three normally rodent-dependent predator species-rough-legged buzzard, arctic fox and red fox-perform in a low-arctic ecosystem with no rodents. During six years (in 2006-2008 and 2011-2013) we studied diet and breeding performance of these predators in the rodent-free Kolguev Island in Arctic Russia. The rough-legged buzzards, previously known to be a small rodent specialist, have only during the last two decades become established on Kolguev Island. The buzzards successfully breed on the island at stable low density, but with high productivity based on goslings and willow ptarmigan as their main prey -altogether representing a novel ecological situation for this species. Breeding density of arctic fox varied from year to year, but with stable productivity based on mainly geese as prey. The density dynamic of the arctic fox appeared to be correlated with the date of spring arrival of the geese. Red foxes breed regularly on the island but in very low numbers that appear to have been unchanged over a long period - a situation that resemble what has been recently documented from Arctic America. Our study suggests that the three predators found breeding on Kolguev Island possess capacities for shifting to changing circumstances in low-arctic ecosystem as long as other small -medium sized terrestrial herbivores are present in good numbers.	[Pokrovsky, Ivan] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Ehrich, Dorothee; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, NO-9037 Tromso, Norway; [Kondratyev, Alexander V.] Russian Acad Sci, Far East Branch, Inst Biol Problems North, Magadan 685000, Russia; [Kruckenberg, Helmut] Inst Waterbird & Wetlands Res IWWR eV, D-27283 Verden, Aller, Germany; [Kulikova, Olga] Moscow MV Lomonosov State Univ, Fac Geog, RU-119991 Moscow, Russia; [Mihnevich, Julia; Pokrovskaya, Liya; Shienok, Alexander] Moscow MV Lomonosov State Univ, Fac Biol, RU-119991 Moscow, Russia	Max Planck Society; UiT The Arctic University of Tromso; Institute of Biological Problems of the North; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Pokrovsky, I (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.	ivanpok@mail.ru	Kondratyev, Alexander AV/J-8301-2012; Kulikova, Olga/AAO-2204-2020; Pokrovsky, Ivan/B-5144-2010; Ehrich, Dorothee/F-6492-2015	Kondratyev, Alexander AV/0000-0002-4657-3336; Kulikova, Olga/0000-0002-4029-9452; Pokrovsky, Ivan/0000-0002-6533-674X; Ehrich, Dorothee/0000-0002-3028-9488; Pokrovskaya, Liya/0000-0003-1751-7260	Institute for Waterbird and Wetlands Research (IWWR) e.V.; UiT - Arctic University of Norway; Norwegian Environment Agency; Conservation Arctic Flora and Fauna (CAFF); Max-Planck Institute for Ornithology; ECORA GEF Project; Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [FKZ 3510 860 1000]; NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK	Institute for Waterbird and Wetlands Research (IWWR) e.V.; UiT - Arctic University of Norway; Norwegian Environment Agency; Conservation Arctic Flora and Fauna (CAFF); Max-Planck Institute for Ornithology; ECORA GEF Project; Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK	This study was funded by Institute for Waterbird and Wetlands Research (IWWR) e.V., UiT - Arctic University of Norway, The Norwegian Environment Agency, Conservation Arctic Flora and Fauna (CAFF) and Max-Planck Institute for Ornithology. The authors would also like to thank the German Committee for Bird Protection (VsK, Hamburg) and the ECORA GEF Project for financial support of their expeditions 2006-2012. In 2011 and 2012 this study was part of a project of the Institute of Avian Research, the Department of Biology and Environmental Science, University of Oldenburg, IWWR e.V. and the Wadden Sea National Park Administration of Lower Saxony, which was funded by the Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (FKZ 3510 860 1000), the NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerbjorn A, 2013, J APPL ECOL, V50, P59, DOI 10.1111/1365-2664.12033; [Anonymous], 2011, GOOSE B; [Anonymous], [No title captured]; BATZLI GO, 1980, US IBP SYNTHESIS SER, P335; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Ehrich D, 2015, ECOSYSTEMS, V18, P404, DOI 10.1007/s10021-014-9834-9; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; Elton CS, 1924, BR J EXP BIOL, V2, P119; Fuglei E, 2003, POLAR BIOL, V26, P93, DOI 10.1007/s00300-002-0458-8; Fuglei Eva, 2008, Science Progress, V91, P175, DOI 10.3184/003685008X327468; Gallant D, 2012, POLAR BIOL, V35, P1421, DOI 10.1007/s00300-012-1181-8; GALUSHIN VM, 1974, IBIS, V116, P127, DOI 10.1111/j.1474-919X.1974.tb00232.x; Ganter B, 2013, ARCTIC BIODIVERSITY; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Glazov MV, 1997, ARCTIC BIRDS INT BRE; Goltsman ME, 2011, BIOL BULL+, V38, P709, DOI 10.1134/S1062359010151014; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2013, ARCTIC BIODIVERSITY; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Jefferies RL, 2006, ECOL STUD-ANAL SYNTH, V190, P293; Kalyakin V. N., 1989, BIRDS COMMUNITIES TU, P51; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; Kondratyev A., 2013, IMPORTANCE BARENTS S; KORPIMAKI E, 1994, OIKOS, V69, P504, DOI 10.2307/3545862; Krasnov Yu. V., 2008, Ornitologiya, V35, P83; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Kruckenberg H, 2006, ANGEW FELDBIOLOGIE, V2, P1; Kruckenberg Helmut, 2012, Wader Study Group Bulletin, V119, P102; Marti Carl D., 2007, P129; McCann K.S., 2011, FOOD WEBS; Mechnikova SA, 2009, RAPTORS SO YAMAL BRE; Morozov V.V., 2004, Ornitologiya, V31, P9; Pasanen S, 1971, Aquilo (Ser Zool), V12, P53; Pokrovsky I, 2014, POLAR BIOL, V37, P447, DOI 10.1007/s00300-013-1441-2; POOLE A, 2002, BIRDS N AM ONLINE; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; Reid DG, 2012, ARCTIC REPORT CARD; Reif V, 2001, ECOGRAPHY, V24, P267, DOI 10.1034/j.1600-0587.2001.240304.x; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; SIMMONS R E, 1991, Journal of Raptor Research, V25, P63; Sokolov A. A., 2002, FUNCTIONAL LINKS ROU; Steenhof K., 2007, RAPTOR RES MANAGEMEN, P181; Sundell J, 2004, J ANIM ECOL, V73, P167, DOI 10.1111/j.1365-2656.2004.00795.x; Syroechkovski EE, 1995, BREEDING CONDITIONS; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; Tarroux A, 2010, POLAR BIOL, V33, P1021, DOI 10.1007/s00300-010-0780-5; Tast J, 2010, KILPISJARVI NOTES, V22, P10; Tast J., 2010, KILPISJ RVI NOTES, V22, P1; Tomkovich P.S., 1998, INT WADER STUDIES, V10, P132; Tornberg R, 2007, ORNIS FENNICA, V84, P21; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiklund CG, 1999, AMBIO, V28, P281; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Yurlov AK, 1998, INT WADER STUDIES, V10, P105	63	12	12	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118740	10.1371/journal.pone.0118740	http://dx.doi.org/10.1371/journal.pone.0118740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692786	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500128
J	Snijders, L; van der Eijk, J; van Rooij, EP; de Goede, P; van Oers, K; Naguib, M				Snijders, Lysanne; van der Eijk, Jerine; van Rooij, Erica P.; de Goede, Piet; van Oers, Kees; Naguib, Marc			Song Trait Similarity in Great Tits Varies with Social Structure	PLOS ONE			English	Article							PARUS-MAJOR; DAWN CHORUS; BIRD SONG; HONEST ADVERTISEMENT; EXTRAPAIR PATERNITY; TERRITORY DEFENSE; NEIGHBORS; BEHAVIOR; COMMUNICATION; HERITABILITY	For many animals, long-range signalling is essential to maintain contact with conspecifics. In territorial species, individuals often have to balance signalling towards unfamiliar potential competitors (to solely broadcast territory ownership) with signalling towards familiar immediate neighbours (to also maintain so-called "dear enemy" relations). Hence, to understand how signals evolve due to these multilevel relationships, it is important to understand how general signal traits vary in relation to the overall social environment. For many territorial songbirds dawn is a key signalling period, with several neighbouring individuals singing simultaneously without immediate conflict. In this study we tested whether sharing a territory boundary, rather than spatial proximity, is related to similarity in dawn song traits between territorial great tits (Parus major) in a wild personality-typed population. We collected a large dataset of automatized dawn song recordings from 72 unique male great tits, during the fertile period of their mate, and compared specific song traits between neighbours and non-neighbours. We show here that both song rate and start time of dawn song were repeatable song traits. Moreover, neighbours were significantly more dissimilar in song rate compared to non-neighbours, while there was no effect of proximity on song rate similarity. Additionally, similarity in start time of dawn song was unrelated to sharing a territory boundary, but birds were significantly more similar in start time of dawn song when they were breeding in close proximity of each other. We suggest that the dissimilarity in dawn song rate between neighbours is either the result of neighbouring great tits actively avoiding similar song rates to possibly prevent interference, or a passive consequence of territory settlement preferences relative to the types of neighbours. Neighbourhood structuring is therefore likely to be a relevant selection pressure shaping variation in territorial birdsong.	[Snijders, Lysanne; van der Eijk, Jerine; van Rooij, Erica P.; Naguib, Marc] Wageningen Univ, Behav Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Snijders, Lysanne; de Goede, Piet; van Oers, Kees] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Snijders, L (corresponding author), Wageningen Univ, Behav Ecol Grp, NL-6700 AP Wageningen, Netherlands.	lysanne.snijders@wur.nl	van Oers, Kees/B-2562-2009; Snijders, Lysanne/I-1384-2019; Naguib, Marc/C-2650-2009; KNAW, NIOO-KNAW/A-4320-2012	van Oers, Kees/0000-0001-6984-906X; Snijders, Lysanne/0000-0003-0911-3418; KNAW, NIOO-KNAW/0000-0002-3835-159X; Naguib, Marc/0000-0003-0494-4888	Netherlands Organisation for Scientific Research (NWO) [821.01.01]; Dobberke Stichting [UPS/BP/5215]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dobberke Stichting	The Netherlands Organisation for Scientific Research (NWO) funded this project with an ALW open competition grant 821.01.01 to MN. A grant from the Dobberke Stichting was awarded to MN (UPS/BP/5215) which allowed the authors to acquire a number of the automatic song recorders used in this study. (https://www.knaw.nl/nl/prijzen/subsidies/dobberke-stichting-voor-vergelijkende-psychologie) (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2004, P ROY SOC B-BIOL SCI, V271, pS167, DOI 10.1098/rsbl.2003.0133; Amrhein V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1633, DOI 10.1007/s00265-008-0592-6; Amy M, 2010, P ROY SOC B-BIOL SCI, V277, P3685, DOI 10.1098/rspb.2010.0598; Arroyo-Solis A, 2013, J AVIAN BIOL, V44, P288, DOI 10.1111/j.1600-048X.2012.05796.x; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; BIRKHEAD TR, 1992, BIOL J LINN SOC, V45, P363, DOI 10.1111/j.1095-8312.1992.tb00649.x; Boncoraglio G, 2007, FUNCT ECOL, V21, P134, DOI 10.1111/j.1365-2435.2006.01207.x; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; CUTHILL IC, 1990, BEHAV ECOL SOCIOBIOL, V26, P209; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Foote JR, 2011, ANIM BEHAV, V81, P871, DOI 10.1016/j.anbehav.2011.01.028; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; Godfrey JD, 2000, J ANIM ECOL, V69, P301, DOI 10.1046/j.1365-2656.2000.00393.x; Goodwin SE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1083; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grabowska-Zhang AM, 2012, BIOL LETTERS, V8, P544, DOI 10.1098/rsbl.2012.0183; Halupka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102801; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; KACELNIK A, 1983, BEHAVIOUR, V83, P287, DOI 10.1163/156853983X00200; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Krebs J.R., 1977, P47; KREBS JR, 1982, BEHAV ECOL SOCIOBIOL, V11, P185, DOI 10.1007/BF00300061; Kunc HP, 2005, ANIM BEHAV, V70, P1265, DOI 10.1016/j.anbehav.2005.02.010; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MACE R, 1986, ANIM BEHAV, V34, P621, DOI 10.1016/S0003-3472(86)80139-7; Maynard DF, 2012, ANIM BEHAV, V84, P563, DOI 10.1016/j.anbehav.2012.06.008; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; MCGREGOR PK, 1982, BEHAVIOUR, V79, P126, DOI 10.1163/156853982X00210; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MYRBERG AA, 1985, ANIM BEHAV, V33, P411, DOI 10.1016/S0003-3472(85)80065-8; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Nowicki S, 1998, BEHAVIOUR, V135, P615, DOI 10.1163/156853998792897888; Otter K, 1997, BEHAV ECOL, V8, P167, DOI 10.1093/beheco/8.2.167; Peake TM, 2005, ANIM BEHAV, V69, P1063, DOI 10.1016/j.anbehav.2004.08.009; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Smith TB, 2013, EVOL APPL, V6, P865, DOI 10.1111/eva.12072; Snijders L, 2014, ANIM BEHAV, V98, P95, DOI 10.1016/j.anbehav.2014.09.029; Sprau P, 2010, BEHAV ECOL, V21, P1011, DOI 10.1093/beheco/arq097; Staicer CA, 1996, ANIM BEHAV, V51, P375, DOI 10.1006/anbe.1996.0036; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Todt D, 2000, ADV STUD BEHAV, V29, P247, DOI 10.1016/S0065-3454(08)60107-2; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; Verhulst S, 2003, ANIM BIOL, V53, P159, DOI 10.1163/157075603769700359; Videan EN, 2005, AM J PRIMATOL, V66, P131, DOI 10.1002/ajp.20133; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051; York JE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0970	57	16	16	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116881	10.1371/journal.pone.0116881	http://dx.doi.org/10.1371/journal.pone.0116881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692873	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500029
J	Wu, XN; Lu, HF; Huang, K; Wu, SJ; Qiao, WB				Wu, Xiaonan; Lu, Hongfang; Huang, Kun; Wu, Shijuan; Qiao, Weibiao			Frequency Spectrum Method-Based Stress Analysis for Oil Pipelines in Earthquake Disaster Areas	PLOS ONE			English	Article							NONCLASSICALLY DAMPED STRUCTURES; TIME HISTORY ANALYSIS; SOIL MECHANICS MODEL; RESPONSE SPECTRA; TECTONIC STRESS; GROUND MOTIONS; SRSS; SIMULATION; EXCITATION; CALIFORNIA	When a long distance oil pipeline crosses an earthquake disaster area, inertial force and strong ground motion can cause the pipeline stress to exceed the failure limit, resulting in bending and deformation failure. To date, researchers have performed limited safety analyses of oil pipelines in earthquake disaster areas that include stress analysis. Therefore, using the spectrum method and theory of one-dimensional beam units, CAESAR II is used to perform a dynamic earthquake analysis for an oil pipeline in the XX earthquake disaster area. This software is used to determine if the displacement and stress of the pipeline meet the standards when subjected to a strong earthquake. After performing the numerical analysis, the primary seismic action axial, longitudinal and horizontal displacement directions and the critical section of the pipeline can be located. Feasible project enhancement suggestions based on the analysis results are proposed. The designer is able to utilize this stress analysis method to perform an ultimate design for an oil pipeline in earthquake disaster areas; therefore, improving the safe operation of the pipeline.	[Wu, Xiaonan; Lu, Hongfang; Huang, Kun; Wu, Shijuan] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China; [Wu, Xiaonan] Southwest Petr Univ, Sch Civil Engn & Architecture, Chengdu, Sichuan, Peoples R China; [Lu, Hongfang; Huang, Kun; Wu, Shijuan] Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China; [Qiao, Weibiao] China Petr Univ, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China; [Qiao, Weibiao] Liaoning Shihua Univ, Coll Petr Engn, Fushun, Liaoning, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; Southwest Petroleum University; China University of Petroleum; Liaoning Petrochemical University	Lu, HF (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China.	luhongfang_sci@126.com; swpuhk@126.com	Qiao, Weibiao/V-1376-2019; Lu, Hongfang/T-1016-2019	Lu, Hongfang/0000-0002-5172-9008	Sichuan Provincial Key Disciplinary Development Project Fund [SZD0416]	Sichuan Provincial Key Disciplinary Development Project Fund	This research is supported by Sichuan Provincial Key Disciplinary Development Project Fund (SZD0416). And special acknowledgement should be given to the Project-Research on stress analysis of oil pipeline from Southwest Petroleum University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI K, 1984, J GEOPHYS RES, V89, P5867, DOI 10.1029/JB089iB07p05867; AKI K, 1969, J GEOPHYS RES, V74, P615, DOI 10.1029/JB074i002p00615; [Anonymous], 1995, EARTHQ SPECTRA, DOI DOI 10.1193/1.1585831; ASCE, 2005, 705 ASCE, DOI [10.1016/j.febslet.2014.10.035, DOI 10.1016/J.FEBSLET.2014.10.035]; ASME, 2013, B3142012 ASME, DOI [10.1115/1.4028414, DOI 10.1115/1.4028414]; Atkinson GM, 1997, B SEISMOL SOC AM, V87, P97; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; Chen LQ, 2014, OPEN CIVIL ENG J, V8, P239; CHENG M, 1994, EARTHQ ENG STRUCT D, V23, P303, DOI 10.1002/eqe.4290230306; China National Petroleum Corporation, 2009, 504702008 GB CHIN NA; CNPC, 2007, 502532006 CNPC GB; FRANKEL A, 1991, J GEOPHYS RES-SOLID, V96, P6291, DOI 10.1029/91JB00237; George M., 1998, PIPE STRESS ANAL THE; GUPTA AK, 1976, NUCL ENG DES, V36, P96, DOI 10.1016/0029-5493(76)90146-1; Gysi M, 2001, SOIL TILL RES, V61, P133, DOI 10.1016/S0167-1987(01)00161-1; HANKS TC, 1979, J GEOPHYS RES, V84, P2235, DOI 10.1029/JB084iB05p02235; Hao JB, 2009, OIL GAS STORAGE TRAN, V28, P27; HETTIARATCHI DRP, 1987, SOIL USE MANAGE, V3, P94, DOI 10.1111/j.1475-2743.1987.tb00718.x; Huang K., 2013, DEVELOPMENT, V5, P1249; Huang K., 2012, NATURE GAS OIL, V30, P1; Huang K., 2013, ADV J FOOD SCI TECHN, V5, P1249; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; Jiang X, 2013, NATURAL GAS OIL, V31, P26; Kim S., 1999, EARTHQ SPECTRA, V15, P417, DOI [10.1193/1.1586051, DOI 10.1193/1.1586051]; Li J., 2011, ELECT MEASUREMENT IN, V4, P25; Lopez OA, 2000, EARTHQUAKE ENG STRUC, V29, P1759, DOI 10.1002/1096-9845(200012)29:12<1759::AID-EQE984>3.3.CO;2-B; Menun C., 1998, EARTHQ SPECTRA, P153, DOI DOI 10.1193/1.1585993; Metropolo PL, 2004, PROCESS SAF PROG, V23, P307, DOI 10.1002/prs.10054; Ministry of Housing and Urban-Rural Development of the People's Republic of China, 2009, GB 50011 2010 COD SE, DOI [10.1016/j.vetimm.2014.02.004, DOI 10.1016/J.VETIMM.2014.02.004]; Naeim F., 1995, EARTHQ SPECTRA, V11, P111, DOI DOI 10.1193/1.1585805; Peng L.C., 1978, PIPE LINE IND, V47, P65; Penzien J, 1997, EARTHQUAKE ENG STRUC, V26, P849; PYKE R, 1979, J GEOTECH ENG-ASCE, V105, P715; RAJANI BB, 1995, CAN GEOTECH J, V32, P309, DOI 10.1139/t95-032; RAUTIAN TG, 1978, B SEISMOL SOC AM, V68, P923; ROSCOE KH, 1970, GEOTECHNIQUE, V20, P129, DOI 10.1680/geot.1970.20.2.129; Sabetta F, 1996, B SEISMOL SOC AM, V86, P337; SCANLAN RH, 1974, J ENG MECH DIV-ASCE, V100, P635; SINGH MP, 1986, EARTHQUAKE ENG STRUC, V14, P133, DOI 10.1002/eqe.4290140110; SINGH MP, 1980, J ENG MECH DIV-ASCE, V106, P1405; SINHA R, 1995, EARTHQUAKE ENG STRUC, V24, P615, DOI 10.1002/eqe.4290240410; SMEBY W, 1985, EARTHQUAKE ENG STRUC, V13, P1, DOI 10.1002/eqe.4290130103; Spanos P.D., 1985, INT J SOIL DYN EARTH, V4, P2; Sreejith B, 2004, NUCL ENG DES, V227, P313, DOI 10.1016/j.nucengdes.2003.11.005; TING JM, 1989, J GEOTECH ENG-ASCE, V115, P379, DOI 10.1061/(ASCE)0733-9410(1989)115:3(379); Wang W. S., 2012, THESIS; Watkins R.K., 1999, STRUCTURAL MECH BURI; WILSON EL, 1981, EARTHQUAKE ENG STRUC, V9, P187, DOI 10.1002/eqe.4290090207; Wu X. N., 2012, OIL GAS STORAGE TRAN, V31, P927; Wu XG, 2014, PIPELINE TECHNIQUE E, V2, P16; [吴晓南 Wu Xiaonan], 2014, [天然气工业, Natural Gas Industry], V34, P152; Wu XN, 2014, APPL MECH MATER, V501-504, P2331, DOI 10.4028/www.scientific.net/AMM.501-504.2331; [吴晓南 Wu Xiaonan], 2013, [天然气工业, Natural Gas Industry], V33, P73; WYSS M, 1973, GEOPHYS J ROY ASTR S, V31, P341, DOI 10.1111/j.1365-246X.1973.tb06506.x; Yu G. Q., 2008, GAS HEAT, V28, P20; Zeng J, 2007, GAS HEAT, V5, P55, DOI [10.1016/ j. ijscr. 2014.10.038, DOI 10.1016/J.IJSCR.2014.10.038]; Zhang DH, 1999, OIL GAS STORAGE TRAN, V18, P13; Zhang HB, 2010, OIL GAS STORAGE TRAN, V29, P15, DOI DOI 10.13595/J; Zhang P, 1998, NATURAL GAS IND, V18, P72	60	10	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115299	10.1371/journal.pone.0115299	http://dx.doi.org/10.1371/journal.pone.0115299			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692790	gold, Green Published			2022-12-27	WOS:000350061500008
J	Arends, F; Nowald, C; Pflieger, K; Boettcher, K; Zahler, S; Lieleg, O				Arends, Fabienna; Nowald, Constantin; Pflieger, Kerstin; Boettcher, Kathrin; Zahler, Stefan; Lieleg, Oliver			The Biophysical Properties of Basal Lamina Gels Depend on the Biochemical Composition of the Gel	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HYDROGELS; GROWTH; MORPHOGENESIS; DIFFUSION; CELLS	The migration of cells within a three-dimensional extracellular matrix (ECM) depends sensitively on the biochemical and biophysical properties of the matrix. An example for a biological ECM is given by reconstituted basal lamina gels purified from the Engelbreth-HolmSwarm sarcoma of mice. Here, we compare four different commercial variants of this ECM, which have all been purified according to the same protocol. Nevertheless, in those gels, we detect strong differences in the migration behavior of leukocyte cells as well as in the Brownian motion of nanoparticles. We show that these differences correlate with the mechanical properties and the microarchitecture of the gels which in turn arise from small variations in their biochemical composition.	[Arends, Fabienna; Nowald, Constantin; Boettcher, Kathrin; Lieleg, Oliver] Tech Univ Munich, Inst Med Engn IMETUM, D-85748 Garching, Germany; [Arends, Fabienna; Nowald, Constantin; Boettcher, Kathrin; Lieleg, Oliver] Tech Univ Munich, Dept Mech Engn, D-85748 Garching, Germany; [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Ctr Drug Res, D-81377 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Lieleg, O (corresponding author), Tech Univ Munich, Inst Med Engn IMETUM, Boltzmannstr 11, D-85748 Garching, Germany.	oliver.lieleg@tum.de		Lieleg, Oliver/0000-0002-6874-7456; Zahler, Stefan/0000-0002-5140-7287	Deutsche Forschungsgemeinschaft [SFB 1032]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through project B7 "Nanoagents in 3-dimensional biopolymer hydrogels" and project B8 "Controlling Cellular Function by Structured Surfaces: Artificial Angiogenesis" in the framework of SFB 1032 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Arends F, 2013, LANGMUIR, V29, P15965, DOI 10.1021/la404016y; AUMAILLEY M, 1991, EXP CELL RES, V196, P177, DOI 10.1016/0014-4827(91)90248-S; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Bruce A., 2002, MOL BIOL CELL, V4th ed.; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Desban N, 2006, J CELL SCI, V119, P3206, DOI 10.1242/jcs.03057; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lieleg O, 2007, PHYS REV LETT, V99; Lieleg O, 2010, SOFT MATTER, V6, P218, DOI 10.1039/b912163n; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Lodish H, 2008, MOL CELL BIOL; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Schuster BS, 2013, BIOMATERIALS, V34, P3439, DOI 10.1016/j.biomaterials.2013.01.064; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118090	10.1371/journal.pone.0118090	http://dx.doi.org/10.1371/journal.pone.0118090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689062	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700099
J	Bigdeli, S; Dettloff, RO; Frank, CW; Davis, RW; Crosby, LD				Bigdeli, Saharnaz; Dettloff, Roger O.; Frank, Curtis W.; Davis, Ronald W.; Crosby, Laurel D.			A Simple Method for Encapsulating Single Cells in Alginate Microspheres Allows for Direct PCR and Whole Genome Amplification	PLOS ONE			English	Article								Microdroplets are an effective platform for segregating individual cells and amplifying DNA. However, a key challenge is to recover the contents of individual droplets for downstream analysis. This paper offers a method for embedding cells in alginate microspheres and performing multiple serial operations on the isolated cells. Rhodobacter sphaeroides cells were diluted in alginate polymer and sprayed into microdroplets using a fingertip aerosol sprayer. The encapsulated cells were lysed and subjected either to conventional PCR, or whole genome amplification using either multiple displacement amplification (MDA) or a two-step PCR protocol. Microscopic examination after PCR showed that the lumen of the occupied microspheres contained fluorescently stained DNA product, but multiple displacement amplification with phi29 produced only a small number of polymerase colonies. The 2-step WGA protocol was successful in generating fluorescent material, and quantitative PCR from DNA extracted from aliquots of microspheres suggested that the copy number inside the microspheres was amplified up to 3 orders of magnitude. Microspheres containing fluorescent material were sorted by a dilution series and screened with a fluorescent plate reader to identify single microspheres. The DNA was extracted from individual isolates, re-amplified with full-length sequencing adapters, and then a single isolate was sequenced using the Illumina MiSeq platform. After filtering the reads, the only sequences that collectively matched a genome in the NCBI nucleotide database belonged to Rhodobacter sphaeroides. This demonstrated that sequencing-ready DNA could be generated from the contents of a single microsphere without culturing. However, the 2-step WGA strategy showed limitations in terms of low genome coverage and an uneven frequency distribution of reads across the genome. This paper offers a simple method for embedding cells in alginate microspheres and performing PCR on isolated cells in common bulk reactions, although further work must be done to improve the amplification coverage of single genomes.	[Bigdeli, Saharnaz; Dettloff, Roger O.; Davis, Ronald W.; Crosby, Laurel D.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Bigdeli, Saharnaz; Frank, Curtis W.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Dettloff, Roger O.] Caerus Mol Diagnost, Mountain View, CA USA	Stanford University; Stanford University	Crosby, LD (corresponding author), Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, 3165 Porter Dr, Palo Alto, CA 94304 USA.	laurel@stanford.edu	t, lf/AAJ-4924-2020		Human Microbiome Project, NIH [1R21HG005820]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005820] Funding Source: NIH RePORTER	Human Microbiome Project, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded by a grant from the Human Microbiome Project, NIH 1R21HG005820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Breguet V, 2007, BIOTECHNOL PROGR, V23, P1223, DOI 10.1021/bp070150e; Camacho C, 2008, BLAST COMMAND LINE A; Haight F. A., 1967, HDB POISSON DISTRIBU; Ho J, 2001, STP PHARMA SCI, V11, P109; Kurihara T, 2011, J BIOMOL TECH S, V22, pS51; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F; WADOWSKY RM, 1994, J CLIN MICROBIOL, V32, P1054, DOI 10.1128/JCM.32.4.1054-1057.1994; Walser M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp160; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	13	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117738	10.1371/journal.pone.0117738	http://dx.doi.org/10.1371/journal.pone.0117738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689864	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700069
J	Gilmartin, JFM; Vaatainen, S; Tormalehto, S; Bell, JS; Lonnroos, E; Salo, L; Hallikainen, I; Martikainen, J; Koivisto, AM				Gilmartin, Julia Fiona-Maree; Vaatainen, Saku; Tormalehto, Soili; Bell, J. Simon; Lonnroos, Eija; Salo, Lotta; Hallikainen, Ilona; Martikainen, Janne; Koivisto, Anne M.		ALSOVA Study Grp	Depressive Symptoms Are Associated with Analgesic Use in People with Alzheimer's Disease: Kuopio ALSOVA Study	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; NURSING-HOME PATIENTS; QUALITY-OF-LIFE; INCREASED RISK; DEMENTIA; PAIN; DIAGNOSIS; MILD; INVENTORY	Neuropsychiatric symptoms of Alzheimer's disease (AD) such as depression may be associated with pain, which according to the literature may be inadequately recognized and managed in this population. This study aimed to identify the factors associated with analgesic use in persons with AD; in particular, how AD severity, functional status, neuropsychiatric symptoms of AD, co-morbidities and somatic symptoms are associated with analgesic use. 236 community-dwelling persons with very mild or mild AD at baseline, and their caregivers, were interviewed over five years as part of the prospective ALSOVA study. Generalized Estimating Equations (GEEs) were used to estimate unadjusted and adjusted odds ratios (ORs) for the factors associated with analgesic use over a five year follow-up. The proportion of persons with AD using any analgesic was low (13.6%) at baseline and remained relatively constant during the follow-up (15.3% at Year 5). Over time, the most prevalent analgesic changed from non-steroidal anti-inflammatories (8.1% of persons with AD at Year 1) to acetaminophen (11.1% at Year 5). Depressive symptoms (measured by the Beck Depression Inventory, BDI) were independently associated with analgesic use, after effects of age, gender, education, AD severity, co-morbidities and somatic symptoms were taken into account. For every one unit increase in BDI, the odds of analgesic use increased by 4% (OR = 1.04, 95% confidence interval CI = 1.02-1.07). Caregiver depressive symptoms were not statistically significantly associated with analgesic use of the person with AD. Depressive symptoms were significantly associated with analgesic use during the five year follow-up period. Possible explanations warranting investigation are that persons with AD may express depressive symptoms as painful somatic complaints, or untreated pain may cause depressive symptoms. Greater awareness of the association between depressive symptoms and analgesic use may lead to safer and more effective prescribing for these conditions.	[Gilmartin, Julia Fiona-Maree; Salo, Lotta; Hallikainen, Ilona; Koivisto, Anne M.] Univ Eastern Finland, Sch Med, Inst Clin Med, Neurol, Kuopio, Finland; [Gilmartin, Julia Fiona-Maree; Bell, J. Simon] Monash Univ, Ctr Med Use & Safety, Parkville, Vic, Australia; [Gilmartin, Julia Fiona-Maree] UCL, Sch Pharm, London, England; [Vaatainen, Saku; Tormalehto, Soili; Martikainen, Janne] Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland; [Bell, J. Simon] Univ Eastern Finland, Sch Pharm, Kuopio Res Ctr Geriatr Care, Fac Hlth Sci, Kuopio, Finland; [Bell, J. Simon; Lonnroos, Eija] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Geriatr, Kuopio, Finland; [Hallikainen, Ilona] Univ Eastern Finland, Sch Educ Sci & Psychol, Kuopio, Finland; [Koivisto, Anne M.] Kuopio Univ Hosp, Neurol NeuroCtr, SF-70210 Kuopio, Finland	University of Eastern Finland; Monash University; University of London; University College London; University of London School of Pharmacy; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Gilmartin, JFM (corresponding author), Univ Eastern Finland, Sch Med, Inst Clin Med, Neurol, Kuopio, Finland.	j.gilmartin@ucl.ac.uk		Tormalehto, Soili/0000-0003-0138-2285; Valimaki, Tarja/0000-0001-6178-5671; von und zu Fraunberg, Mikael/0000-0002-8457-4639; Gilmartin-Thomas, Julia/0000-0002-1783-0161	Jahnsson Foundation; Kuopio University Hospital EVO/VTR-grant [5220/5772728]; Alzheimer's Australia Dementia Research Foundation	Jahnsson Foundation; Kuopio University Hospital EVO/VTR-grant; Alzheimer's Australia Dementia Research Foundation	The ALSOVA project is supported by grants from the Jahnsson Foundation and Kuopio University Hospital EVO/VTR-grant (5220/5772728). The authors are grateful for funding provided for this study by the Alzheimer's Australia Dementia Research Foundation (http:// dementiaresearchfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Andreasen P, 2014, EUR J PUBLIC HEALTH, V24, P40, DOI 10.1093/eurpub/ckt014; [Anonymous], 2014, WHO COLL CTR DRUG ST; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck IR, 2014, INT J GERIATR PSYCH, V29, P624, DOI 10.1002/gps.4045; Bell JS, 2011, PAIN, V152, P543, DOI 10.1016/j.pain.2010.11.003; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Byrne GJ, 2005, AUST PRESCR, V28, P67, DOI 10.18773/austprescr.2005.052; Cole LJ, 2006, BRAIN, V129, P2957, DOI 10.1093/brain/awl228; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dillon C, 2013, NEUROPSYCH DIS TREAT, V9, P1443, DOI 10.2147/NDT.S47133; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Engedal K, 2011, INT J GERIATR PSYCH, V26, P944, DOI 10.1002/gps.2631; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Gallini A, 2013, DRUG AGING, V30, P439, DOI 10.1007/s40266-013-0070-3; Gruber-Baldini AL, 2005, GERONTOLOGIST, V45, P50, DOI 10.1093/geront/45.suppl_1.50; Haasum Y, 2011, DRUG AGING, V28, P283, DOI 10.2165/11587040-000000000-00000; Hadjistavropoulos T, 2008, PAIN MANAG NURS, V9, P48, DOI 10.1016/j.pmn.2007.12.004; Hallikainen I, 2013, INT PSYCHOGERIATR, V25, P1335, DOI 10.1017/S1041610213000653; Hallikainen I, 2012, DEMENT GER COGN D EX, V2, P209, DOI 10.1159/000338231; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hjelm C, 2014, J CARDIOVASC NURS, V29, P82, DOI 10.1097/JCN.0b013e318275543d; Hoffmann F, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-20; Holtzer R, 2005, J AM GERIATR SOC, V53, P2083, DOI 10.1111/j.1532-5415.2005.00535.x; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Husebo BS, 2008, J AM MED DIR ASSOC, V9, P427, DOI 10.1016/j.jamda.2008.03.001; Jensen-Dahm C, 2014, PAIN, V155, P1439, DOI 10.1016/j.pain.2013.12.031; Jensen-Dahm C, 2012, J AM GERIATR SOC, V60, P1274, DOI 10.1111/j.1532-5415.2012.04036.x; Karttunen K, 2011, INT J GERIATR PSYCH, V26, P473, DOI 10.1002/gps.2550; Laiho K, 2001, RHEUMATOL INT, V20, P85, DOI 10.1007/s002960000087; Lovheim H, 2008, PHARMACOEPIDEM DR S, V17, P912, DOI 10.1002/pds.1600; Lyketsos CG, 2004, DEMENT GERIATR COGN, V17, P55, DOI 10.1159/000074277; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Nygaard HA, 2005, INT J GERIATR PSYCH, V20, P730, DOI 10.1002/gps.1350; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Onder G, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.03.014; Perneczky R, 2006, AM J GERIAT PSYCHIAT, V14, P139, DOI 10.1097/01.JGP.0000192478.82189.a8; Phung KTT, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003584; ROVNER BW, 1989, AM J PSYCHIAT, V146, P350; Scherder EJA, 2000, PSYCHIATRY, V63, P1; Scherder EJA, 1997, ALZ DIS ASSOC DIS, V11, P171, DOI 10.1097/00002093-199709000-00010; Schmader KE, 1998, AGE AGEING, V27, P493, DOI 10.1093/ageing/27.4.493; SCHUG SA, 1992, DRUG SAFETY, V7, P200, DOI 10.2165/00002018-199207030-00005; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Tamura BK, 2012, CLIN GERIATR MED, V28, P199, DOI 10.1016/j.cger.2012.01.004; Tan ECK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005757; TERI L, 1992, J CONSULT CLIN PSYCH, V60, P379, DOI 10.1037/0022-006X.60.3.379; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Tune L E, 1998, Depress Anxiety, V8 Suppl 1, P91, DOI 10.1002/(SICI)1520-6394(1998)8:1+<91::AID-DA14>3.0.CO;2-M; Valimaki T, 2012, THESIS U E FINLAND; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Xavier AJ, 2014, J GERONTOL A-BIOL, V69, P1117, DOI 10.1093/gerona/glu105; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	56	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117926	10.1371/journal.pone.0117926	http://dx.doi.org/10.1371/journal.pone.0117926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688858	Green Accepted, Green Published, gold			2022-12-27	WOS:000350322700084
J	Lim, D; Condon, P; DeSteno, D				Lim, Daniel; Condon, Paul; DeSteno, David			Mindfulness and Compassion: An Examination of Mechanism and Scalability	PLOS ONE			English	Article							MEDITATION; EMOTION; ATTENTION; INCREASES; RESPONSES; GRATITUDE	Emerging evidence suggests that meditation engenders prosocial behaviors meant to benefit others. However, the robustness, underlying mechanisms, and potential scalability of such effects remain open to question. The current experiment employed an ecologically valid situation that exposed participants to a person in visible pain. Following three-week, mobile-app based training courses in mindfulness meditation or cognitive skills (i.e., an active control condition), participants arrived at a lab individually to complete purported measures of cognitive ability. Upon entering a public waiting area outside the lab that contained three chairs, participants seated themselves in the last remaining unoccupied chair; confederates occupied the other two. As the participant sat and waited, a third confederate using crutches and a large walking boot entered the waiting area while displaying discomfort. Compassionate responding was assessed by whether participants gave up their seat to allow the uncomfortable confederate to sit, thereby relieving her pain. Participants' levels of empathic accuracy was also assessed. As predicted, participants assigned to the mindfulness meditation condition gave up their seats more frequently than did those assigned to the active control group. In addition, empathic accuracy was not increased by mindfulness practice, suggesting that mindfulness-enhanced compassionate behavior does not stem from associated increases in the ability to decode the emotional experiences of others.	[Lim, Daniel; Condon, Paul; DeSteno, David] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Northeastern University	DeSteno, D (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	d.desteno@gmail.com	Lim, Daniel/Y-3206-2019		Headspace, Inc.	Headspace, Inc.	Headspace, Inc. provided the authors with free subscription accounts for participants so that participants would have free access to the web-based meditation sessions.	Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Davidson RJ, 2010, EMOTION, V10, P8, DOI 10.1037/a0018480; DeSteno D, 2010, EMOTION, V10, P289, DOI 10.1037/a0017883; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Gethin Rupert., 1998, FDN BUDDHISM; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; Leiberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017798; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Mascaro JS, 2013, SOC COGN AFFECT NEUR, V8, P48, DOI 10.1093/scan/nss095; Scherer KR, 2011, J NONVERBAL BEHAV, V35, P305, DOI 10.1007/s10919-011-0115-4; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Weng HY, 2013, PSYCHOL SCI, V24, P1171, DOI 10.1177/0956797612469537	25	122	122	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118221	10.1371/journal.pone.0118221	http://dx.doi.org/10.1371/journal.pone.0118221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689827	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700106
J	Liu, LY; Xu, XF; Jing, LL; Zhou, GY; Cao, Z; Han, YC; Zhou, RL				Liu, Luying; Xu, Xuefang; Jing, Lili; Zhou, Gengyin; Cao, Zhang; Han, Yanchun; Zhou, Rouli			Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma	PLOS ONE			English	Article							LAPTM4B GENE POLYMORPHISM; TETRATRANSMEMBRANE PROTEIN; POOR-PROGNOSIS; CANCER; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; POPULATION; RESISTANCE; TOLERANCE	Objective The purpose of this work was to analyze the relationships between the expression status of Lysosomal-associated protein transmembrane-4 beta 35 (LAPTM4B-35) in cancerous tissues and clinicopathological characteristics and prognosis of the patients with gastric carcinoma (GC). Methods The GC samples from 157 patients in a discovery cohort and 148 patients in a testing cohort with follow-up data were used to validate the feasibility of expression of LAPTM4B-35 protein in predicting GC prognosis. Immunohistochemical staining was used to determine the expression of LAPTM4B-35 protein in precancerous gastric lesions and gastric carcinomas. The correlation between the expression of LAPTM4B-35 and clinicopathologic characteristics of patients with gastric carcinoma was analyzed using chi-square test. Univariate and multivariate analyses were performed to determine the association between LAPTM4B-35 expression and prognosis. Results LAPTM4B-35 expression was increased steadily in sequential stages of precancerous gastric lesions. Positive LAPTM4B-35 expression was more frequently detected in patients with distant metastasis (P = 0.023) and III+ IV TNM stages (P = 0.042) in the discovery cohort. Kaplan-Meier survival curves and univariate analysis showed that expression of LAPTM4B-35 had a significant impact on overall survival of patients with gastric carcinoma in discovery cohort (P < 0.001) and testing cohort (P = 0.001). LAPTM4B-35 expression was an independent prognostic indicator for the overall survival of patients with gastric carcinoma in both cohorts. Conclusions The present research demonstrated that LAPTM4B-35 over-expression was an independent factor in gastric carcinoma prognosis. LAPTM4B gene may be a useful target of interventions slowing the progression of precancerous gastric lesions and a new therapy method to improve the prognosis of gastric carcinoma.	[Liu, Luying; Xu, Xuefang; Cao, Zhang; Han, Yanchun] Binzhou Med Univ, Dept Pathol, Yantai, Shandong, Peoples R China; [Liu, Luying; Zhou, Gengyin] Shandong Univ, Sch Med, Dept Pathol & Pathophysiol, Jinan 250100, Shandong, Peoples R China; [Jing, Lili] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Pathol, Yantai, Shandong, Peoples R China; [Zhou, Rouli] Peking Univ, Dept Cell Biol & Genet, Sch Basic Med Sci, Beijing 100871, Peoples R China	Binzhou Medical University; Shandong University; Binzhou Medical University; Peking University	Liu, LY (corresponding author), Binzhou Med Univ, Dept Pathol, Yantai, Shandong, Peoples R China.	llixq@126.com; rlzhou@bjmu.edu.cn			Natural Science Foundation of Shandong Province [ZR2011HM073, ZR2011HQ025]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the Natural Science Foundation of Shandong Province (No. ZR2011HM073 and No. ZR2011HQ025, http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2014, HEPATO-GASTROENTEROL, V61, P518, DOI 10.5754/hge12954; Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; CORREA P, 1992, CANCER RES, V52, P6735; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang Y, 2012, AM J SURG, V204, P677, DOI 10.1016/j.amjsurg.2012.02.003; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2012, AUTOPHAGY, V8, P273, DOI 10.4161/auto.8.2.18941; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2010, INT J GYNECOL PATHOL, V29, P587, DOI 10.1097/PGP.0b013e3181e0898e; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Sun Y, 2012, CHINESE J CANCER RES, V24, P18, DOI 10.1007/s11670-012-0018-x; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034984; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; Zhang G, 2012, J INT MED RES, V40, P1275, DOI 10.1177/147323001204000406; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, HEPATO-GASTROENTEROL, V57, P207; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	37	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118026	10.1371/journal.pone.0118026	http://dx.doi.org/10.1371/journal.pone.0118026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689860	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700095
J	Johnson, MD; De Leon, YL				Johnson, Matthew D.; De Leon, Yesenia L.			Effect of an Invasive Plant and Moonlight on Rodent Foraging Behavior in a Coastal Dune Ecosystem	PLOS ONE			English	Article							PREDATION RISK; BUSH LUPINE; PATCH USE; APPARENT COMPETITION; TIME ALLOCATION; SEED PREDATION; SELECTION; SIZE; MANAGEMENT; VIGILANCE	Understanding how invasive plants may alter predator avoidance behaviors is important for granivorous rodents because their foraging can trigger ripple effects in trophic webs. Previous research has shown that European beach grass Ammophila arenaria, an invasive species in coastal California, affects the predation of other seeds by the rodents Microtus californicus, Peromyscus maniculatus, and Reithrodontomys megalotis. This may be due to lower perceived predation risk by rodents foraging in close proximity to the cover provided by Ammophila, but this mechanism has not yet been tested. We examined the perceived predation risk of rodents by measuring the 'giving up density' of food left behind in experimental patches of food in areas with and without abundant cover from Ammophila and under varying amount of moonlight. We found strong evidence that giving up density was lower in the thick uniform vegetation on Ammophila-dominated habitat than it was in the more sparsely and diversely vegetated restored habitat. There was also evidence that moonlight affected giving up density and that it mediated the effects of habitat, although with our design we were unable to distinguish the effects of lunar illumination and moon phase. Our findings illustrate that foraging rodents, well known to be risk-averse during moonlit nights, are also affected by the presence of an invasive plant. This result has implications for granivory and perhaps plant demography in invaded and restored coastal habitats. Future research in this system should work to unravel the complex trophic links formed by a non-native invasive plant (i.e., Ammophila) providing cover favored by native rodents, which likely forage on and potentially limit the recruitment of native and non-native plants, some of which have ecosystem consequences of their own.	[Johnson, Matthew D.; De Leon, Yesenia L.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Johnson, MD (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	matt.johnson@humboldt.edu			National Science Foundation [0934022]; Direct For Biological Sciences [0934022] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was made possible by funding from National Science Foundation (Undergraduate Research and Mentoring award #0934022) to Dr. Bruce O'Gara (PI) and Johnson (co-PI) at Humboldt State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATZLI G O, 1970, Ecology (Washington D C), V51, P1027, DOI 10.2307/1933629; BATZLI GO, 1971, J MAMMAL, V52, P141, DOI 10.2307/1378438; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Buell AC, 1995, CONSERV BIOL, V9, P1587, DOI 10.1046/j.1523-1739.1995.09061587.x; Bureau of Land Management, 2011, OV COAST DUN NAT PLA; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Dangremond EM, 2010, ECOLOGY, V91, P2261, DOI 10.1890/09-0418.1; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Falcy MR, 2013, ECOLOGY, V94, P2632, DOI 10.1890/13-0426.1; Gordon DR, 1998, ECOL APPL, V8, P975, DOI 10.1890/1051-0761(1998)008[0975:EOINIP]2.0.CO;2; Gutman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023446; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Johnson MD, 2008, WEST N AM NATURALIST, V68, P444, DOI 10.3398/1527-0904-68.4.444; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; KOTLER BP, 1988, OIKOS, V53, P145, DOI 10.2307/3566056; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; LONGLAND WS, 1994, AM MIDL NAT, V132, P82, DOI 10.2307/2426203; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Maron JL, 1997, OECOLOGIA, V111, P76, DOI 10.1007/s004420050210; Maron JL, 2001, J ECOL, V89, P578, DOI 10.1046/j.1365-2745.2001.00560.x; Mattos KJ, 2010, BEHAV ECOL, V21, P556, DOI 10.1093/beheco/arq020; Mooney H.A., 2000, INVASIVE SPECIES CHA; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; MURRAY BR, 1994, WILDLIFE RES, V21, P647, DOI 10.1071/WR9940647; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pickart AJ, 1998, RESTOR ECOL, V6, P59, DOI 10.1046/j.1526-100x.1998.00618.x; PRICE MV, 1984, J MAMMAL, V65, P353, DOI 10.2307/1381183; PRICE MV, 1983, OECOLOGIA, V60, P259, DOI 10.1007/BF00379529; Prugh LR, 2014, J ANIM ECOL, V83, P504, DOI 10.1111/1365-2656.12148; R Core Team, 2018, R LANG ENV STAT COMP; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; U.S. Naval Observatory, 2014, COMPL SUN MOON DAT O; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1986, ECOLOGY BIOL INVASIO, V58; Wiedemann AM, 1996, LANDSCAPE URBAN PLAN, V34, P287, DOI 10.1016/0169-2046(95)00240-5; Zimecki Michal, 2006, Postepy Hig Med Dosw (Online), V60, P1	43	9	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117903	10.1371/journal.pone.0117903	http://dx.doi.org/10.1371/journal.pone.0117903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679785	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600094
J	Laverty, AA; Elkin, SL; Watt, HC; Millett, C; Restrick, LJ; Williams, S; Bell, D; Hopkinson, NS				Laverty, Anthony A.; Elkin, Sarah L.; Watt, Hilary C.; Millett, Christopher; Restrick, Louise J.; Williams, Sian; Bell, Derek; Hopkinson, Nicholas S.			Impact of a COPD Discharge Care Bundle on Readmissions following Admission with Acute Exacerbation: Interrupted Time Series Analysis	PLOS ONE			English	Article							PULMONARY REHABILITATION; POPULATION; PREVALENCE	Objectives We evaluated the impact of a COPD discharge care bundle on readmission rates following hospitalisation with an acute exacerbation. Design Interrupted time series analysis, comparing readmission rates for COPD exacerbations at nine trusts that introduced the bundle, to two comparison groups; (1) other NHS trusts in London and (2) all other NHS trusts in England. Care bundles were implemented at different times for different NHS trusts, ranging from October 2009 to April 2011. Setting Nine NHS acute trusts in the London, England. Participants Patients aged 45 years and older admitted to an NHS acute hospital in England for acute exacerbation of COPD. Data come from Hospital Episode Statistics, April 2002 to March 2012. Main Outcome Measures Annual trend readmission rates (and in total bed days) within 7, 28 and 90 days, before and after implementation. Results In hospitals introducing the bundle readmission rates were rising before implementation and falling afterwards (e.g. readmissions within 28 days + 2.13% per annum (pa) pre and -5.32% pa post (p for difference in trends = 0.012)). Following implementation, readmission rates within 7 and 28 day were falling faster than among other trusts in London, although this was not statistically significant (e.g. readmissions within 28 days -4.6% pa vs. -3.2% pa, p = 0.44). Comparisons with a national control group were similar. Conclusions The COPD discharge care bundle appeared to be associated with a reduction in readmission rate among hospitals using it. The significance of this is unclear because of changes to background trends in London and nationally.	[Laverty, Anthony A.; Watt, Hilary C.; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Elkin, Sarah L.] Imperial Coll London NHS Trust, London, England; [Restrick, Louise J.; Williams, Sian] London Resp Team NHS London, London, England; [Bell, Derek] NIHR CLAHRC Northwest London, London, England; [Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	Laverty, AA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	a.laverty@imperial.ac.uk		Laverty, Anthony/0000-0003-1318-8439; Williams, Sian/0000-0002-0527-2254; Millett, Christopher/0000-0002-0793-9884	National Institute for Health Research (NIHR); Imperial Centre for Patient Safety and Service Quality	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the Collaborations for Leadership in Applied Health Research and Care (CLAHRC) programme for North West London. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Additional support was received from Imperial Centre for Patient Safety and Service Quality and the NIHR Biomedical Research Centre scheme. The funders had no role in the study design, interpretation, or the decision to publish.	[Anonymous], AN INTERNATIONAL COM; [Anonymous], 2014, ALL PARTY PARLIAMENT; Audit Commission, 2012, PAYMENT BY RESULTS D; Bolton CE, 2013, THORAX, V68, P887, DOI 10.1136/thoraxjnl-2013-203809; BTS Care Bundles for CAP and COPD, BTS CARE BUNDLES FOR; Buckingham RJ, 2008, REPORT NATL CHRONIC; Department of Health, CONSULTATION ON A ST; Falzon C, 2013, PRIM CARE RESP J, V22, P59, DOI 10.4104/pcrj.2013.00008; Falzon C, 2011, THORAX, V66, P630, DOI 10.1136/thx.2010.140913; Health and Social Care Information Centre, HOSPITAL EPISODE STA; Hopkinson NS, 2012, THORAX, V67, P90, DOI 10.1136/thoraxjnl-2011-200233; Jones SE, 2013, THORAX; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lennox L, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000035; London Respiratory Team, ANNUAL REPORT 2011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nacul L, 2011, J PUBLIC HEALTH-UK, V33, P108, DOI 10.1093/pubmed/fdq031; National Institute for Clinical Excellence, 2010, MANAGEMENT OF CHRONI; Pronovost P, 2014, NEW ENGL J MED, V371, P691, DOI 10.1056/NEJMp1405800; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Purdy S, 2011, J HEALTH SERV RES PO, V16, P133, DOI 10.1258/jhsrp.2010.010013; Robb E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1234; Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916; Royal College of Physicians (London) and British Lung Foundation, 2008, THE NATIONAL CHRONIC; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walker PP, 2013, THORAX, V68, P968, DOI 10.1136/thoraxjnl-2012-202365; Williams S, 2011, THE CASE FOR A COPD; Yohannes AM, 2011, CHRON RESP DIS, V8, P193, DOI 10.1177/1479972311413400; Zoumot Z, 2014, THORAX, V69, P973, DOI 10.1136/thoraxjnl-2014-205667	29	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116187	10.1371/journal.pone.0116187	http://dx.doi.org/10.1371/journal.pone.0116187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679218	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600014
J	Liu, LB; Li, M; Zhuo, WY; Zhang, YS; Xu, AD				Liu, Li-Bin; Li, Mu; Zhuo, Wen-Yan; Zhang, Yu-Sheng; Xu, An-Ding			The Role of Hs-CRP, D-Dimer and Fibrinogen in Differentiating Etiological Subtypes of Ischemic Stroke	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEVERITY; ASSOCIATION; INFARCTION; DIAGNOSIS; RISK	The aim of this study was to evaluate the diagnostic value of the serum biochemical markers high-sensitivity C-reactive protein (hs-CRP), D-dimer (DD) and fibrinogen (Fg) in differentiating etiological subtypes of ischemic stroke. This study was a retrospective case-only study, consecutively including patients with acute ischemic stroke. All patients were classified into subtypes using the TOAST classification system. A total of 317 patients were evaluated. Hs-CRP and DD levels were significantly different among the subtypes and were the highest in CE, followed by LAA and SAA; no significant difference between the subtypes was found for Fg. Hs-CRP > 6.96 mg/L was classified as the CE subtype, with a sensitivity of 41% and a specificity of 74%; DD > 791.30 ng/mL was classified as CE, with a sensitivity of 58% and a specificity of 78%. The combination of hs-CRP and DD classification as CE yielded a sensitivity of 65% and a specificity of 91%. DD > 791.30 ng/mL was considered an independent predictive factor of CE. Hs-CRP and DD could be useful for identifying the etiological subtypes of acute ischemic stroke, especially for predicting CE. The diagnostic value of DD was higher than that of hs-CRP.	[Liu, Li-Bin; Li, Mu; Zhang, Yu-Sheng; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Liu, Li-Bin; Zhuo, Wen-Yan] Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China	Jinan University; Jinan University	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	ADX63@sohu.com		Xu, An-Ding/0000-0003-3154-0985				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Anderson JL, 2004, AM J CARDIOL, V94, P1255, DOI 10.1016/j.amjcard.2004.07.108; Beer C, 2011, MED SCI MONITOR, V17, pCR467, DOI 10.12659/MSM.881931; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Eidelman RS, 2003, EUR HEART J, V24, P501, DOI 10.1016/S0195-668X(02)00810-2; Eikelboom John W, 2003, J Stroke Cerebrovasc Dis, V12, P74, DOI 10.1053/jscd.2003.16; Giannopoulos S, 2008, NEUROL RES, V30, P727, DOI 10.1179/174313208X297904; Habib SS, 2013, PAK J MED SCI, V29, P1425; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Kara H, 2014, NEUROPSYCH DIS TREAT, V10, P1451, DOI 10.2147/NDT.S67665; Koch Horst J, 2005, J Stroke Cerebrovasc Dis, V14, P75, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.002; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Luo Y, 2012, CAN J NEUROL SCI, V39, P69, DOI 10.1017/S0317167100012713; MARDER VJ, 1983, ANN NY ACAD SCI, V408, P397, DOI 10.1111/j.1749-6632.1983.tb23260.x; Matsumoto M, 2013, CEREBROVASC DIS, V35, P64, DOI 10.1159/000345336; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Pandey A, 2014, NEUROCHEM RES, V39, P1426, DOI 10.1007/s11064-014-1328-9; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Terruzzi A, 2008, NEUROL SCI, V29, P245, DOI 10.1007/s10072-008-0975-5; Tombul T, 2005, J CLIN NEUROSCI, V12, P429, DOI 10.1016/j.jocn.2004.06.013; Turaj Wojciech, 2006, Neurol Neurochir Pol, V40, P297; Vibo R, 2007, FREE RADICAL RES, V41, P282, DOI 10.1080/10715760601083235; Zi WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086465	28	23	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118301	10.1371/journal.pone.0118301	http://dx.doi.org/10.1371/journal.pone.0118301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680111	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600117
J	Menze, ET; Esmat, A; Tadros, MG; Abdel-Naim, AB; Khalifa, AE				Menze, Esther T.; Esmat, Ahmed; Tadros, Mariane G.; Abdel-Naim, Ashraf B.; Khalifa, Amani E.			Genistein Improves 3-NPA-Induced Memory Impairment in Ovariectomized Rats: Impact of Its Antioxidant, Anti-Inflammatory and Acetylcholinesterase Modulatory Properties	PLOS ONE			English	Article							KAPPA-B ACTIVATION; 3-NITROPROPIONIC ACID; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; ANIMAL-MODEL; SUCCINATE-DEHYDROGENASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; BCL-2 EXPRESSION; ESTROGEN	Huntington's disease (HD) is a progressive neurodegenerative disorder. The pre-motor symptomatic stages of the disease are commonly characterized by cognitive problems including memory loss. 3-Nitropropionic acid (3-NPA) is a mitochondrial toxin that produces selective lesions in the brain similar to that of HD and was proven to cause memory impairment in rodents. Phytoestrogens have well-established neuroprotective and memory enhancing effects with fewer side effects in comparison to estrogens. This study investigated the potential neuroprotective and memory enhancing effect of genistein (5, 10 and 20 mg/kg), a phytoestrogen, in ovariectomized rats challenged with 3-NPA (20 mg/kg). These potential effects were compared to those of 17 beta-estradiol (2.5 mg/kg). Systemic administration of 3-NPA for 4 consecutive days impaired locomotor activity, decreased retention latencies in the passive avoidance task, decreased striatal, cortical and hippocampal ATP levels, increased oxidative stress, acetylcholinesterase (AChE) activity, cycloxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expressions. Pretreatment with genistein and 17 beta-estradiol attenuated locomotor hypoactivity, increased retention latencies in the passive avoidance task, increased ATP levels, improved the oxidative stress profile, attenuated the increase in AChE activity and decreased the expression of COX-2 and iNOS. Overall, the higher genistein dose (20 mg/kg) was the most effective. In conclusion, this study suggests neuroprotective and memory enhancing effects for genistein in a rat model of HD. These effects might be attributed to its antioxidant, anti-inflammatory and cholinesterase inhibitory activities.	[Menze, Esther T.; Esmat, Ahmed; Tadros, Mariane G.; Abdel-Naim, Ashraf B.; Khalifa, Amani E.] Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	Tadros, MG (corresponding author), Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	mirogeogo@yahoo.com	Esmat, Ahmed/R-4805-2016; Abdel-Naim, Ashraf B/J-3199-2012	Esmat, Ahmed/0000-0002-1937-9300; Abdel-Naim, Ashraf B/0000-0002-0400-9075; Menze, Esther/0000-0002-1819-9113; Khalifa, Amani/0000-0002-1627-7800				ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahuja M, 2008, TOXICOLOGY, V244, P111, DOI 10.1016/j.tox.2007.11.003; Al Mutairy A, 2010, NEUROTOXICOL TERATOL, V32, P226, DOI 10.1016/j.ntt.2009.09.003; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; Arce C, 2010, NEUROSCI MED, V1, P50, DOI [10.1155/2015/598496, DOI 10.1155/2015/598496]; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Banchroft J.D., 1996, THEORY PRACTICE HIST; Bang OY, 2004, NEUROBIOL DIS, V16, P21, DOI 10.1016/j.nbd.2003.12.017; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Barnes S, 2000, J NUTR, V130, p656S, DOI 10.1093/jn/130.3.656S; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1993, J NEUROSCI, V13, P4181; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; Bonelli RM, 2004, EXPERT OPIN PHARMACO, V5, P767, DOI 10.1517/14656566.5.4.767; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Brouillet E, 1998, J NEUROCHEM, V70, P794; Browne SE, 1999, BRAIN PATHOL, V9, P147; Castello-Ruiz M, 2011, PHYTOMEDICINE, V18, P513, DOI 10.1016/j.phymed.2011.02.001; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Curzon P, 2009, BEHAV ASSESSMENT SEN; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Diaz A, 2011, PHARMACOL BIOCHEM BE, V98, P67, DOI 10.1016/j.pbb.2010.12.005; Duan WZ, 2000, EXP NEUROL, V165, P1, DOI 10.1006/exnr.2000.7434; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; File SE, 2001, PSYCHOPHARMACOLOGY, V157, P430, DOI 10.1007/s002130100845; Folstein S.E., 1989, HUNTINGTONS DIS DISO; Gomez-Zubeldia MA, 2001, MENOPAUSE, V8, P274; Hahn-Barma V, 1998, J NEUROL NEUROSUR PS, V64, P172, DOI 10.1136/jnnp.64.2.172; Ho AK, 2003, NEUROLOGY, V61, P1702, DOI 10.1212/01.WNL.0000098878.47789.BD; Huang YH, 2010, BRIT J NUTR, V104, P1297, DOI 10.1017/S0007114510002291; JAMES LF, 1980, AM J VET RES, V41, P377; Jang M, 2014, BRAIN BEHAV IMMUN, V38, P151, DOI 10.1016/j.bbi.2014.01.015; Johansson AC, 2002, J NEUROIMMUNOL, V123, P135, DOI 10.1016/S0165-5728(01)00468-4; JONES DNC, 1995, J NEUROSCI, V15, P7282; Kalpana S, 2013, INT J SCI ENG RES, V4, P296; Kumar P, 2009, NEUROSCI RES, V63, P302, DOI 10.1016/j.neures.2009.01.005; Kyuhou SI, 2008, NEUROSCI LETT, V448, P10, DOI 10.1016/j.neulet.2008.10.045; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; Mandy HM, 2011, NEUROCHEM INT, V59, P770, DOI 10.1016/j.neuint.2011.07.012; Martins DB, 2012, LIFE SCI, V90, P351, DOI 10.1016/j.lfs.2011.12.006; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Miller PJ, 1997, EXP NEUROL, V146, P212, DOI 10.1006/exnr.1997.6522; MING L, 1995, J TOXICOL-CLIN TOXIC, V33, P363, DOI 10.3109/15563659509028924; Montoya A, 2006, J PSYCHIATR NEUROSCI, V31, P21; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Phillips W, 2008, MOVEMENT DISORD, V23, P1491, DOI 10.1002/mds.21971; Poumeau-Delille G, 1953, TECHNIQUES BIOL ENDO; Prokai L, 2005, DRUG DEVELOP RES, V66, P118, DOI 10.1002/ddr.20050; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Sato T, 2004, PHARMACOL RES, V49, P151, DOI 10.1016/j.phrs.2003.09.006; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Seaman RL, 2000, NEUROSCI LETT, V280, P183, DOI 10.1016/S0304-3940(00)00790-4; Sharma M, 2012, IOSR J PHARM, V2, P61; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silva RH, 2007, PROG NEURO-PSYCHOPH, V31, P65, DOI 10.1016/j.pnpbp.2006.06.019; SMETS LA, 1994, BLOOD, V84, P1613; SPOKES EGS, 1980, BRAIN, V103, P179, DOI 10.1093/brain/103.1.179; Tadros MG, 2005, PHARMACOL BIOCHEM BE, V82, P574, DOI 10.1016/j.pbb.2005.10.018; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; VILLA P, 1994, J NEUROCHEM, V62, P1468; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Xu J, 2007, J MOL NEUROSCI, V31, P101, DOI 10.1007/s12031-007-0010-y; Xu SZ, 2009, FREE RADICAL BIO MED, V47, P167, DOI 10.1016/j.freeradbiomed.2009.04.021; Yuan GJ, 2006, WORLD J GASTROENTERO, V12, P2375, DOI 10.3748/wjg.v12.i15.2375; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066	82	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117223	10.1371/journal.pone.0117223	http://dx.doi.org/10.1371/journal.pone.0117223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675218	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000016
J	Focaccetti, C; Bruno, A; Magnani, E; Bartolini, D; Principi, E; Dallaglio, K; Bucci, EO; Finzi, G; Sessa, F; Noonan, DM; Albini, A				Focaccetti, Chiara; Bruno, Antonino; Magnani, Elena; Bartolini, Desiree; Principi, Elisa; Dallaglio, Katiuscia; Bucci, Eraldo O.; Finzi, Giovanna; Sessa, Fausto; Noonan, Douglas M.; Albini, Adriana			Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes	PLOS ONE			English	Article							CANCER-PATIENTS; BREAST-CANCER; IN-VITRO; MOLECULAR-MECHANISMS; GROWTH-FACTOR; ANTICANCER DRUGS; CARDIO-ONCOLOGY; FOLINIC ACID; HUMAN LIVER; CARDIOTOXICITY	Antimetabolites are a class of effective anticancer drugs interfering in essential biochemical processes. 5-Fluorouracil (5-FU) and its prodrug Capecitabine are widely used in the treatment of several solid tumors (gastro-intestinal, gynecological, head and neck, breast carcinomas). Therapy with fluoropyrimidines is associated with a wide range of adverse effects, including diarrhea, dehydration, abdominal pain, nausea, stomatitis, and hand-foot syndrome. Among the 5-FU side effects, increasing attention is given to cardiovascular toxicities induced at different levels and intensities. Since the mechanisms related to 5-FU-induced cardiotoxicity are still unclear, we examined the effects of 5-FU on primary cell cultures of human cardiomyocytes and endothelial cells, which represent two key components of the cardiovascular system. We analyzed at the cellular and molecular level 5-FU effects on cell proliferation, cell cycle, survival and induction of apoptosis, in an experimental cardioncology approach. We observed autophagic features at the ultrastructural and molecular levels, in particular in 5-FU exposed cardiomyocytes. Reactive oxygen species (ROS) elevation characterized the endothelial response. These responses were prevented by a ROS scavenger. We found induction of a senescent phenotype on both cell types treated with 5-FU. In vivo, in a xenograft model of colon cancer, we showed that 5-FU treatment induced ultrastructural changes in the endothelium of various organs. Taken together, our data suggest that 5-FU can affect, both at the cellular and molecular levels, two key cell types of the cardiovascular system, potentially explaining some manifestations of 5-FU-induced cardiovascular toxicity.	[Focaccetti, Chiara; Bruno, Antonino; Bartolini, Desiree; Principi, Elisa; Noonan, Douglas M.] IRCCS MultiMed, Ctr Sci & Technol, Milan, Italy; [Magnani, Elena; Dallaglio, Katiuscia; Albini, Adriana] IRCCS Arcispedale Santa Maria Nuova, Dept Res & Stat, Reggio Emilia, Italy; [Bucci, Eraldo O.] IRCCS MultiMed, Oncol Unit, Castellanza, VA, Italy; [Finzi, Giovanna; Sessa, Fausto] Osped Circolo Varese, Dept Pathol, Varese, Italy; [Sessa, Fausto] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Noonan, Douglas M.] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	IRCCS Multimedica; IRCCS Arcispedale S. Maria Nuova; IRCCS Multimedica; University of Insubria; University of Insubria	Albini, A (corresponding author), IRCCS Arcispedale Santa Maria Nuova, Dept Res & Stat, Reggio Emilia, Italy.	albini.adriana@gmail.com	Noonan, Douglas M/A-8620-2010; Bruno, Antonino/J-7066-2016; Principi, Elisa/O-2424-2015; Bartolini, Desirée/K-5319-2016; Focaccetti, Chiara/AAD-9378-2019	Noonan, Douglas M/0000-0001-8058-0719; Bruno, Antonino/0000-0002-4790-0861; Bartolini, Desirée/0000-0003-3849-757X; Focaccetti, Chiara/0000-0002-7334-3966; Principi, Elisa/0000-0003-3747-1167; Albini, Adriana/0000-0002-9624-5103	Ministero Italiano della Salute, Grande Progetto Strategico (GPS); Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [2010NECHBX 003]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG10228]	Ministero Italiano della Salute, Grande Progetto Strategico (GPS); Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	These studies were supported by the Ministero Italiano della Salute, Grande Progetto Strategico (GPS), by the Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) 2010NECHBX 003, AIRC (Associazione Italiana per la Ricerca sul Cancro) (IG10228). AB is a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellow. KD is a Fondazione Veronesi fellow. The authors thank Paola Corradino for assistance and bibliography and Alessandra Panvini Rosati for secretarial help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2012, INTERN EMERG MED, V7, P399, DOI 10.1007/s11739-012-0845-2; Albini A, 2011, FUTUR CARDIOL, V7, P693, DOI [10.2217/fca.11.54, 10.2217/FCA.11.54]; Albini A, 2011, JNCI-J NATL CANCER I, V103, P608, DOI 10.1093/jnci/djr034; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Alili L, 2014, DRUG INDUCED ACCELER; Amstutz U, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-54; Becker K, 1999, DRUGS, V57, P475, DOI 10.2165/00003495-199957040-00003; Bijnsdorp IV, 2010, INT J CANCER, V126, P2457, DOI 10.1002/ijc.24943; Boisen L, 2010, EXP GERONTOL, V45, P779, DOI 10.1016/j.exger.2010.06.003; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Brower V, 2013, JNCI-J NATL CANCER I, V105, P835, DOI 10.1093/jnci/djt161; Bu XX, 2008, CANCER BIOL THER, V7, P392, DOI 10.4161/cbt.7.3.5366; Buchel B, 2013, BIOMED CHROMATOGR, V27, P7, DOI 10.1002/bmc.2741; Cardinale D, 2013, SEMIN ONCOL, V40, P186, DOI 10.1053/j.seminoncol.2013.01.008; Casale F, 2004, PHARMACOL RES, V50, P173, DOI 10.1016/j.phrs.2004.01.006; Coleman PR, 2013, AGING-US, V5, P913, DOI 10.18632/aging.100622; CORONEL B, 1988, INTENS CARE MED, V14, P429, DOI 10.1007/BF00262901; Cwikiel M, 1996, ANN ONCOL, V7, P731; CWIKIEL M, 1995, ACTA ONCOL, V34, P83, DOI 10.3109/02841869509093643; CWIKIEL M, 1995, SCANNING MICROSCOPY, V9, P561; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Durak I, 2000, J TOXICOL ENV HEAL A, V59, P585; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Eskandari MR, 2014, XENOBIOTICA, P1; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Filgueiras MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063177; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; FOX SB, 1995, J PATHOL, V176, P183, DOI 10.1002/path.1711760212; FRAILE RJ, 1980, CANCER RES, V40, P2223; Gajalakshmi P, 2013, TOXICOL APPL PHARM, V269, P121, DOI 10.1016/j.taap.2013.03.011; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Gemma C., 2007, OXIDATIVE STRESS AGI; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grem JL, 1997, SEMIN RADIAT ONCOL, V7, P249, DOI 10.1016/S1053-4296(97)80023-9; Gressett Sarah M, 2006, J Oncol Pharm Pract, V12, P131, DOI 10.1177/1078155206069242; Grover S, 2013, INT J CARDIOL, V168, P5465, DOI 10.1016/j.ijcard.2013.07.246; Hemalatha T, 2010, BIOCHEM CELL BIOL, V88, P491, DOI [10.1139/O09-165, 10.1139/o09-165]; Ignatescu MC, 1999, ARTERIOSCL THROM VAS, V19, P2340, DOI 10.1161/01.ATV.19.10.2340; Ijichi K, 2014, ANTICANCER RES, V34, P2907; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Jensen SA, 2006, CANCER CHEMOTH PHARM, V58, P487, DOI 10.1007/s00280-005-0178-1; Kleiman N S, 1987, Am J Med, V82, P566, DOI 10.1016/0002-9343(87)90465-7; Kosmas C, 2008, J CANCER RES CLIN, V134, P75, DOI 10.1007/s00432-007-0250-9; L'Ecuyer T, 2001, MOL GENET METAB, V74, P370, DOI 10.1006/mgme.2001.3243; Lamberti M, 2014, TOXICOL LETT, V227, P151, DOI 10.1016/j.toxlet.2014.03.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Maseri A, 2001, AM J MED, V111, P326, DOI 10.1016/S0002-9343(01)00930-5; Menna P, 2008, CHEM RES TOXICOL, V21, P978, DOI 10.1021/tx800002r; METZKURSCHEL U, 1990, RENAL FAILURE, V12, P93, DOI 10.3109/08860229009087124; Meyer CC, 1997, PHARMACOTHERAPY, V17, P729; MISSET B, 1990, INTENS CARE MED, V16, P210, DOI 10.1007/BF01724805; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Molteni LP, 2010, BREAST J, V16, pS45, DOI 10.1111/j.1524-4741.2010.01004.x; MOSSERI M, 1993, CANCER RES, V53, P3028; Muneoka Katsuki, 2005, Int J Clin Oncol, V10, P441, DOI 10.1007/s10147-005-0516-7; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Polk A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-47; Polk A, 2013, CANCER TREAT REV, V39, P974, DOI 10.1016/j.ctrv.2013.03.005; Russo G, 2012, INTERN EMERG MED, V7, P439, DOI 10.1007/s11739-012-0794-9; Saif MW, 2009, EXPERT OPIN DRUG SAF, V8, P191, DOI [10.1517/14740330902733961 , 10.1517/14740330902733961]; SCHOBER C, 1993, CANCER, V72, P2242, DOI 10.1002/1097-0142(19931001)72:7<2242::AID-CNCR2820720730>3.0.CO;2-E; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Sereno M, 2008, CLIN TRANSL ONCOL, V10, P35, DOI 10.1007/s12094-008-0150-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sikora E, 2013, CURR VASC PHARM; Sorrentino MF, 2012, CARDIOL J, V19, P453, DOI 10.5603/CJ.2012.0084; Spasojevic I, 2009, MOLECULES, V14, P53, DOI 10.3390/molecules14010053; Swystun LL, 2009, J THROMB HAEMOST, V7, P619, DOI 10.1111/j.1538-7836.2009.03300.x; Tabata T, 2004, DRUG METAB DISPOS, V32, P762, DOI 10.1124/dmd.32.7.762; te Poele RH, 2002, CANCER RES, V62, P1876; Tokalov SV, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-57; Tsibiribi P, 2006, HUM EXP TOXICOL, V25, P305, DOI 10.1191/0960327106ht628oa; Tsibiribi Panayota, 2006, Bull Cancer, V93, pE27; VANGROENINGEN CJ, 1988, CANCER RES, V48, P6956; Vene R, 2007, MOL CANCER THER, V6, P286, DOI 10.1158/1535-7163.MCT-06-0346; Wada H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-361; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; WEIDMANN B, 1994, CANCER, V73, P2001, DOI 10.1002/1097-0142(19940401)73:7<2001::AID-CNCR2820730736>3.0.CO;2-S; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	85	174	176	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115686	10.1371/journal.pone.0115686	http://dx.doi.org/10.1371/journal.pone.0115686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671635	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300012
J	Uchiya, KI; Takahashi, H; Nakagawa, T; Yagi, T; Moriyama, M; Inagaki, T; Ichikawa, K; Nikai, T; Ogawa, K				Uchiya, Kei-ichi; Takahashi, Hiroyasu; Nakagawa, Taku; Yagi, Tetsuya; Moriyama, Makoto; Inagaki, Takayuki; Ichikawa, Kazuya; Nikai, Toshiaki; Ogawa, Kenji			Characterization of a Novel Plasmid, pMAH135, from Mycobacterium avium Subsp hominissuis	PLOS ONE			English	Article							NUMBER TANDEM-REPEAT; SECRETION SYSTEM; VII SECRETION; NONTUBERCULOUS MYCOBACTERIA; EFFLUX TRANSPORTERS; INSERTION SEQUENCES; REPLICATION REGION; PULMONARY-DISEASE; GENOME SEQUENCE; MATE FAMILY	Mycobacterium avium complex (MAC) causes mainly two types of disease. The first is disseminated disease in immunocompromised hosts, such as individuals infected by human immunodeficiency virus (HIV). The second is pulmonary disease in individuals without systemic immunosuppression, and the incidence of this type is increasing worldwide. M. avium subsp. hominissuis, a component of MAC, causes infection in pigs as well as in humans. Many aspects of the different modes of M. avium infection and its host specificity remain unclear. Here, we report the characteristics and complete sequence of a novel plasmid, designated pMAH135, derived from M. avium strain TH135 in an HIV-negative patient with pulmonary MAC disease. The pMAH135 plasmid consists of 194,711 nucleotides with an average G + C content of 66.5% and encodes 164 coding sequences (CDSs). This plasmid was unique in terms of its homology to other mycobacterial plasmids. Interestingly, it contains CDSs with sequence homology to mycobactin biosynthesis proteins and type VII secretion system-related proteins, which are involved in the pathogenicity of mycobacteria. It also contains putative conserved domains of the multidrug efflux transporter. Screening of isolates from humans and pigs for genes located on pMAH135 revealed that the detection rate of these genes was higher in clinical isolates from pulmonary MAC disease patients than in those from HIV-positive patients, whereas the genes were almost entirely absent in isolates from pigs. Moreover, variable number tandem repeats typing analysis showed that isolates carrying pMAH135 genes are grouped in a specific cluster. Collectively, the pMAH135 plasmid contains genes associated with M. avium's pathogenicity and resistance to antimicrobial agents. The results of this study suggest that pMAH135 influence not only the pathological manifestations of MAC disease, but also the host specificity of MAC infection.	[Uchiya, Kei-ichi; Moriyama, Makoto; Inagaki, Takayuki; Nikai, Toshiaki] Meijo Univ, Fac Pharm, Dept Microbiol, Nagoya, Aichi 468, Japan; [Takahashi, Hiroyasu] Kainan Hosp Aichi Prefectural Welf Federat Agr Co, Dept Pharm, Yatomi, Japan; [Nakagawa, Taku; Ogawa, Kenji] Natl Hosp Org, Higashi Nagoya Natl Hosp, Dept Clin Res, Nagoya, Aichi, Japan; [Nakagawa, Taku; Ogawa, Kenji] Natl Hosp Org, Higashi Nagoya Natl Hosp, Dept Pulm Med, Nagoya, Aichi, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Ctr Natl Univ Hosp Infect Control, Dept Infect Dis, Nagoya, Aichi, Japan; [Moriyama, Makoto] Natl Hosp Org, Toyohashi Med Ctr, Dept Pharm, Toyohashi, Aichi, Japan; [Inagaki, Takayuki; Ichikawa, Kazuya] Nagoya Univ Hosp, Dept Pharm, Nagoya, Aichi, Japan	Meijo University; Nagoya University; Nagoya University	Uchiya, KI (corresponding author), Meijo Univ, Fac Pharm, Dept Microbiol, Nagoya, Aichi 468, Japan.	kuchiya@meijo-u.ac.jp	Yagi, Tetsuya/J-3303-2012		JSPS KAKENHI Grant [24590164]; Grants-in-Aid for Scientific Research [24590164] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24590164 (to KU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BEGGS ML, 1995, J BACTERIOL, V177, P4836, DOI 10.1128/jb.177.17.4836-4840.1995; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Gavigan JA, 1997, J BACTERIOL, V179, P4115, DOI 10.1128/jb.179.13.4115-4122.1997; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hughes VM, 2001, J MICROBIOL METH, V44, P209, DOI 10.1016/S0167-7012(00)00246-3; Ichikawa K, 2009, J MED MICROBIOL, V58, P945, DOI 10.1099/jmm.0.008623-0; ICHIYAMA S, 1988, MICROBIOL IMMUNOL, V32, P733, DOI 10.1111/j.1348-0421.1988.tb01434.x; Inagaki T, 2009, J CLIN MICROBIOL, V47, P2156, DOI 10.1128/JCM.02373-08; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Iwamoto T, 2012, INFECT GENET EVOL, V12, P846, DOI 10.1016/j.meegid.2011.06.018; JUCKER MT, 1990, AM REV RESPIR DIS, V142, P858, DOI 10.1164/ajrccm/142.4.858; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; LABIDI A, 1985, ANN INST PASTEUR MIC, V136B, P209, DOI 10.1016/S0769-2609(85)80045-4; Maekawa K, 2011, CHEST, V140, P723, DOI 10.1378/chest.10-2315; Mahillon J, 1999, RES MICROBIOL, V150, P675, DOI 10.1016/S0923-2508(99)00124-2; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Mishra MN, 2013, J BACTERIOL, V195, P1610, DOI 10.1128/JB.01724-12; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; QIN MH, 1994, J BACTERIOL, V176, P419, DOI 10.1128/JB.176.2.419-425.1994; Radomski N, 2010, J CLIN MICROBIOL, V48, P1026, DOI 10.1128/JCM.01869-09; Ramasoota P, 2001, VET MICROBIOL, V78, P251, DOI 10.1016/S0378-1135(00)00302-3; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Sakatani Mitsunori, 2005, Kekkaku, V80, P25; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Sugawara H, 2009, 20 INT C GEN INF KAN; Tanaka E, 1997, AM J RESP CRIT CARE, V155, P2041, DOI 10.1164/ajrccm.155.6.9196113; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Tsuyuguchi K, 2001, CLIN EXP IMMUNOL, V123, P428, DOI 10.1046/j.1365-2249.2001.01474.x; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; VONREYN CF, 1994, LANCET, V343, P1137, DOI 10.1016/S0140-6736(94)90239-9; Weiss CH, 2012, EXPERT REV RESP MED, V6, P597, DOI [10.1586/ERS.12.58, 10.1586/ers.12.58]; Yu XW, 2012, CELL SIGNAL, V24, P1841, DOI 10.1016/j.cellsig.2012.05.014	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117797	10.1371/journal.pone.0117797	http://dx.doi.org/10.1371/journal.pone.0117797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671431	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300071
J	Kanao, R; Masuda, Y; Deguchi, S; Yumoto-Sugimoto, M; Hanaoka, F; Masutani, C				Kanao, Rie; Masuda, Yuji; Deguchi, Saori; Yumoto-Sugimoto, Mayumi; Hanaoka, Fumio; Masutani, Chikahide			Relevance of Simultaneous Mono-Ubiquitinations of Multiple Units of PCNA Homo-Trimers in DNA Damage Tolerance	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; POLYMERASE-ETA; TRANSLESION SYNTHESIS; MONOUBIQUITINATED PCNA; XERODERMA-PIGMENTOSUM; FAMILY MODIFICATIONS; STALLED REPLICATION; BINDING DOMAINS; DVC1 C1ORF124; POL-ETA	DNA damage tolerance (DDT) pathways, including translesion synthesis (TLS) and additional unknown mechanisms, enable recovery from replication arrest at DNA lesions. DDT pathways are regulated by post-translational modifications of proliferating cell nuclear antigen (PCNA) at its K164 residue. In particular, mono-ubiquitination by the ubiquitin ligase RAD18 is crucial for Pol eta-mediated TLS. Although the importance of modifications of PCNA to DDT pathways is well known, the relevance of its homo-trimer form, in which three K164 residues are present in a single ring, remains to be elucidated. Here, we show that multiple units of a PCNA homo-trimer are simultaneously mono-ubiquitinated in vitro and in vivo. RAD18 catalyzed sequential mono-ubiquitinations of multiple units of a PCNA homo-trimer in a reconstituted system. Exogenous PCNA formed hetero-trimers with endogenous PCNA in WI38VA13 cell transformants. When K164R-mutated PCNA was expressed in these cells at levels that depleted endogenous PCNA homo-trimers, multiple modifications of PCNA complexes were reduced and the cells showed defects in DDT after UV irradiation. Notably, ectopic expression of mutant PCNA increased the UV sensitivities of Pol eta-proficient, Pol eta-deficient, and REV1-depleted cells, suggesting the disruption of a DDT pathway distinct from the Pol eta-and REV1-mediated pathways. These results suggest that simultaneous modifications of multiple units of a PCNA homo-trimer are required for a certain DDT pathway in human cells.	[Kanao, Rie; Masuda, Yuji; Masutani, Chikahide] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan; [Kanao, Rie; Deguchi, Saori; Yumoto-Sugimoto, Mayumi; Hanaoka, Fumio; Masutani, Chikahide] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Masuda, Yuji] Nagoya Univ, Grad Sch Med, Dept Toxicogen, Nagoya, Aichi 4648601, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 171, Japan	Nagoya University; Osaka University; Nagoya University; Gakushuin University	Masutani, C (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan.	masutani@riem.nagoya-u.ac.jp	Masuda, Yuji/I-6315-2014; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Masutani, Chikahide/0000-0002-8600-8227	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26740017, 24310040, 26550024, 22131008, 25241011]; Mitsubishi Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI [26740017 to RK, 24310040 and 26550024 to YM, 22131008 to FH, and 25241011 to CM] from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Mitsubishi Foundation, the Takeda Science Foundation, and the Uehara Memorial Foundation [to CM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; GIRARDI AJ, 1966, ANN MED EXP BIOL FEN, V44, P242; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Lehmann AR, 2011, FEBS LETT, V585, P2772, DOI 10.1016/j.febslet.2011.06.005; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Pastushok L, 2010, NUCLEIC ACIDS RES, V38, P5047, DOI 10.1093/nar/gkq239; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Qin ZS, 2013, NUCLEIC ACIDS RES, V41, P7356, DOI 10.1093/nar/gkt542; Ramasubramanyan S, 2010, DNA REPAIR, V9, P777, DOI 10.1016/j.dnarep.2010.03.015; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Yanagihara H, 2011, MOL CELL, V43, P788, DOI 10.1016/j.molcel.2011.07.026; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118775	10.1371/journal.pone.0118775	http://dx.doi.org/10.1371/journal.pone.0118775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692884	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500129
J	Lin, YC; Kao, CH; Chen, CC; Ke, CJ; Yao, CH; Chen, YS				Lin, Yu-Ching; Kao, Chia-Hong; Chen, Chung-Chia; Ke, Cherng-Jyh; Yao, Chun-Hsu; Chen, Yueh-Sheng			Time-Course Effect of Electrical Stimulation on Nerve Regeneration of Diabetic Rats	PLOS ONE			English	Article							PERIPHERAL-NERVES; INJURY; IMPROVES; NEUROPATHY; REINNERVATION; DEGENERATION; RECOVERY; DEFICIT; MUSCLE; CELLS	Background Electrical stimulation (ES) has been shown to promote nerve regeneration in rats with experimental diabetes induced using streptozotocin (STZ). However, the time-course effect of ES on nerve regeneration of diabetic animals has not been reported in previous studies. The present study attempted to examine the effect of different timing of ES after peripheral nerve transection in diabetic rats. Methodology/Findings Fifty Sprague-Dawley rats were used in the study. They were classified into five groups. STZ-induced diabetes was created in groups A to D. Normal animals in group E were used as the non-diabetic controls. The sciatic nerve was transected and repaired using a silicone rubber conduit across a 10-mm gap in all groups. Groups A to C received ES for 15 minutes every other day for 2 weeks. Stimulation was initiated on day 1 following the nerve repair for group A, day 8 for group B, and day 15 for group C. The diabetic control group D and the normal control group E received no ES. At 30 days after surgery in group A, histological evaluations showed a higher success percentage of regeneration across the 10-mm nerve gap, and the electrophysiological results showed significantly larger mean values of evoked muscle action potential area and amplitude of the reinnervated gastrocnemius muscle compared with group D. Conclusions/Significance It is concluded that an immediate onset of ES may improve the functional recovery of large nerve defect in diabetic animals.	[Lin, Yu-Ching; Kao, Chia-Hong; Chen, Chung-Chia; Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan; [Kao, Chia-Hong] Taipei Med Univ Hosp, Dept Chinese Med, Taipei, Taiwan; [Chen, Chung-Chia] Taipei City Hosp, Linsen Chinese Med Branch, Taipei, Taiwan; [Ke, Cherng-Jyh] Natl Taiwan Univ, Dept Orthoped, Coll Med, Taipei 10764, Taiwan; [Chen, Yueh-Sheng] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Yueh-Sheng] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan	China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei City Hospital; National Taiwan University; Asia University Taiwan; China Medical University Taiwan	Chen, YS (corresponding author), China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan.	yuehsc@mail.cmu.edu.tw			China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan; National Science Council of the Republic of China, Taiwan [NSC102-2221-E-039-007-MY3]; China Medical University [CMU102-S-24]; Linsen (Chinese Medicine) Branch, Taipei City Hospital [TPH103-67]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]	China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan; National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Linsen (Chinese Medicine) Branch, Taipei City Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan. The authors would also like to thank National Science Council of the Republic of China, Taiwan (NSC102-2221-E-039-007-MY3), China Medical University (CMU102-S-24), Linsen (Chinese Medicine) Branch, Taipei City Hospital (TPH103-67), and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168; Biscetti F, 2013, MOL CELL ENDOCRINOL, V381, P80, DOI 10.1016/j.mce.2013.07.011; Brenner MJ, 2008, MICROSURG, V28, P265, DOI 10.1002/micr.20483; Chen YS, 2010, J NEUROPATH EXP NEUR, V69, P294, DOI 10.1097/NEN.0b013e3181d26487; Cull G, 2003, J GLAUCOMA, V12, P301, DOI 10.1097/00061198-200308000-00003; DEMEDINACELI L, 1995, J NEUROSCI METH, V58, P29, DOI 10.1016/0165-0270(94)00156-B; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Federici T, 2009, NEUROSURGERY, V65, pA87, DOI 10.1227/01.NEU.0000335653.52938.F2; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Ghayemi N, 2014, INT J SURG, V12, P457, DOI 10.1016/j.ijsu.2014.03.018; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064; Haastert-Talini K, 2013, INT REV NEUROBIOL, V109, P111, DOI 10.1016/B978-0-12-420045-6.00005-5; Hashikawa-Hobara N, 2012, J PHARMACOL SCI, V119, P117, DOI 10.1254/jphs.12R02CP; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Hundepool CA, 2014, J NEUROSURG, V121, P195, DOI 10.3171/2014.4.JNS131260; Jolivalt CG, 2008, J NEUROPATH EXP NEUR, V67, P702, DOI 10.1097/NEN.0b013e31817e23f4; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Kao CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079078; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002; Kosacka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032881; Lin YC, 2014, RESTOR NEUROL NEUROS, V32, P437, DOI 10.3233/RNN-130381; Lu MC, 2009, J TRAUMA, V67, P1066, DOI 10.1097/TA.0b013e318182351a; Ma WY, 1999, EXP NEUROL, V159, P459, DOI 10.1006/exnr.1999.7149; McLoughlin TJ, 2003, J APPL PHYSIOL, V94, P876, DOI 10.1152/japplphysiol.00766.2002; Nakamura H, 2009, NEUROREPORT, V20, P1481, DOI 10.1097/WNR.0b013e32833283e6; Nishida N, 2013, J DIABETES INVEST, V4, P533, DOI 10.1111/jdi.12115; Pabari A, 2014, PLAST RECONSTR SURG, V133, P1420, DOI 10.1097/PRS.0000000000000226; Piao YL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/191632; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Serafin A, 2010, MUSCLE NERVE, V41, P630, DOI 10.1002/mus.21564; Singh B, 2014, BRAIN, V137, P1051, DOI 10.1093/brain/awu031; Tarabal O, 1996, EUR J NEUROSCI, V8, P829, DOI 10.1111/j.1460-9568.1996.tb01269.x; Teodori RM, 2011, BRAZ J PHYS THER, V15, P325, DOI 10.1590/S1413-35552011005000008; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TESFAYE S, 1994, DIABETOLOGIA, V37, P847, DOI 10.1007/BF00400938; VanBuren T, 1996, EUR J PHARMACOL, V296, P277, DOI 10.1016/0014-2999(95)00718-0; Vivo M, 2008, EXP NEUROL, V211, P180, DOI 10.1016/j.expneurol.2008.01.020; Xu CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105045; Yao CH, 2012, J TRAUMA ACUTE CARE, V72, P199, DOI 10.1097/TA.0b013e31822d233c; YASUDA H, 1993, J NEUROL SCI, V120, P64, DOI 10.1016/0022-510X(93)90026-U; Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758; Yin Q, 1998, J HAND SURG-BRIT EUR, V23B, P433, DOI 10.1016/S0266-7681(98)80117-4; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	48	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116711	10.1371/journal.pone.0116711	http://dx.doi.org/10.1371/journal.pone.0116711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689049	Green Submitted, gold, Green Published			2022-12-27	WOS:000350322700021
J	Vermeersch, KA; Wang, LJ; Mezencev, R; McDonald, JF; Styczynski, MP				Vermeersch, Kathleen A.; Wang, Lijuan; Mezencev, Roman; McDonald, John F.; Styczynski, Mark P.			OVCAR-3 Spheroid-Derived Cells Display Distinct Metabolic Profiles	PLOS ONE			English	Article							CANCER STEM-CELLS; OVARIAN-CANCER; SIDE POPULATION; 3T3-L1 FIBROBLASTS; GAS-CHROMATOGRAPHY; DIFFERENTIATION; PROLINE; POLYAMINES; IDENTIFICATION; PATHOGENESIS	Introduction Recently, multicellular spheroids were isolated from a well-established epithelial ovarian cancer cell line, OVCAR-3, and were propagated in vitro. These spheroid-derived cells displayed numerous hallmarks of cancer stem cells, which are chemo- and radioresistant cells thought to be a significant cause of cancer recurrence and resultant mortality. Gene set enrichment analysis of expression data from the OVCAR-3 cells and the spheroid-derived putative cancer stem cells identified several metabolic pathways enriched in differentially expressed genes. Before this, there had been little previous knowledge or investigation of systems-scale metabolic differences between cancer cells and cancer stem cells, and no knowledge of such differences in ovarian cancer stem cells. Methods To determine if there were substantial metabolic changes corresponding with these transcriptional differences, we used two-dimensional gas chromatography coupled to mass spectrometry to measure the metabolite profiles of the two cell lines. Results These two cell lines exhibited significant metabolic differences in both intracellular and extracellular metabolite measurements. Principal components analysis, an unsupervised dimensional reduction technique, showed complete separation between the two cell types based on their metabolite profiles. Pathway analysis of intracellular metabolomics data revealed close overlap with metabolic pathways identified from gene expression data, with four out of six pathways found enriched in gene-level analysis also enriched in metabolitelevel analysis. Some of those pathways contained multiple metabolites that were individually statistically significantly different between the two cell lines, with one of the most broadly and consistently different pathways, arginine and proline metabolism, suggesting an interesting hypothesis about cancerous and stem-like metabolic phenotypes in this pair of cell lines. Conclusions Overall, we demonstrate for the first time that metabolism in an ovarian cancer stem cell line is distinct from that of more differentiated isogenic cancer cells, supporting the potential importance of metabolism in the differences between cancer cells and cancer stem cells.	[Vermeersch, Kathleen A.; Styczynski, Mark P.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Wang, Lijuan; Mezencev, Roman; McDonald, John F.] Georgia Inst Technol, Ovarian Canc Inst, Atlanta, GA 30332 USA; [Wang, Lijuan; Mezencev, Roman; McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Styczynski, MP (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	Mark.Styczynski@chbe.gatech.edu	Mezencev, Roman/O-8489-2019; Mezencev, Roman/A-8573-2009	Mezencev, Roman/0000-0003-4361-7628; 	Integrative BioSystems Institute; Defense Advanced Research Projects Agency Young Faculty Award [DARPA YFA N66001-11-1-4128]; Ovarian Cycle; Deborah Nash Endowment Fund; Josephine Robinson Family Fund; J.D. Rhodes Trust	Integrative BioSystems Institute; Defense Advanced Research Projects Agency Young Faculty Award; Ovarian Cycle; Deborah Nash Endowment Fund; Josephine Robinson Family Fund; J.D. Rhodes Trust	KAV and MPS were supported by the Integrative BioSystems Institute (http://www.ibsi.gatech.edu/) and Defense Advanced Research Projects Agency Young Faculty Award (DARPA YFA N66001-11-1-4128) (http://www.darpa.mil/default.aspx). RM, LW, and JFM were supported by Ovarian Cycle, Deborah Nash Endowment Fund, Josephine Robinson Family Fund, and the J.D. Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Anderson AS, 2014, EXP CELL RES, V328, P44, DOI 10.1016/j.yexcr.2014.08.028; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; Casalino L, 2011, J MOL CELL BIOL, V3, P108, DOI 10.1093/jmcb/mjr001; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Cipolleschi MG, 2014, CELL CYCLE, V13, P268, DOI 10.4161/cc.27031; Comes S, 2013, STEM CELL REP, V1, P307, DOI 10.1016/j.stemcr.2013.09.001; D'Aguanno S, 2014, J PROTEOME RES, V13, P2120, DOI 10.1021/pr4012574; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; ERWIN BG, 1984, AM J PHYSIOL, V246, pC293, DOI 10.1152/ajpcell.1984.246.3.C293; EWTON DZ, 1984, J CELL PHYSIOL, V120, P263, DOI 10.1002/jcp.1041200302; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Fong MY, 2010, HISTOL HISTOPATHOL, V25, P113, DOI 10.14670/HH-25.113; Gammon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062493; Gao QL, 2009, ULTRASTRUCT PATHOL, V33, P175, DOI 10.1080/01913120903086072; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kim TH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/132702; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee MJ, 2013, J CELL BIOCHEM, V114, P2718, DOI 10.1002/jcb.24620; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lim D, 2013, PATHOLOGY, V45, P229, DOI 10.1097/PAT.0b013e32835f2264; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Meissen JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046770; Menendez JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00262; Mlynarik V, 2012, NMR BIOMED, V25, P506, DOI 10.1002/nbm.1763; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2013, EPIGENETICS-US, V8, P231, DOI 10.4161/epi.24042; Phang JM, 2012, FRONT BIOSCI-LANDMRK, V17, P1835, DOI 10.2741/4022; Sebastian Carlos, 2014, Critical Reviews in Oncogenesis, V19, P363; Shen YA, 2015, CELL CYCLE, V14, P86, DOI 10.4161/15384101.2014.974419; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sudarshan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021037; SUGIURA M, 1984, CANCER RES, V44, P1440; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Teja-Isavadharm P, 2010, MOLECULES, V15, P8747, DOI 10.3390/molecules15128747; Vincent Zangiacomi, 2014, Genes Cancer, V5, P250; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vlashi E, 2015, FREE RADICAL BIO MED, V79, P264, DOI 10.1016/j.freeradbiomed.2014.10.732; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wei XL, 2013, BIOINFORMATICS, V29, P1786, DOI 10.1093/bioinformatics/btt275; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572; Zhou MS, 2010, CANCER EPIDEM BIOMAR, V19, P2262, DOI 10.1158/1055-9965.EPI-10-0126	65	25	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118262	10.1371/journal.pone.0118262	http://dx.doi.org/10.1371/journal.pone.0118262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688563	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700109
J	Wang, L; Chopp, M; Szalad, A; Jia, LF; Lu, XR; Lu, M; Zhang, L; Zhang, Y; Zhang, RL; Zhang, ZG				Wang, Lei; Chopp, Michael; Szalad, Alexandra; Jia, LongFei; Lu, XueRong; Lu, Mei; Zhang, Li; Zhang, Yi; Zhang, RuiLan; Zhang, Zheng Gang			Sildenafil Ameliorates Long Term Peripheral Neuropathy in Type II Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE; ENDOTHELIAL-CELLS; VASA NERVORUM; ANGIOGENESIS; RATS; NEUROGENESIS; STROKE; ACTIVATION; PROMOTES; MOUSE	Diabetic peripheral neuropathy is a common complication of long-standing diabetes mellitus. To mimic clinical trials in which patients with diabetes enrolled have advanced peripheral neuropathy, we investigated the effect of sildenafil, a specific inhibitor of phosphodiesterase type 5 enzyme, on long term peripheral neuropathy in middle aged male mice with type II diabetes. Treatment of diabetic mice (BKS. Cg-m+/+Lepr(db)/J, db/db) at age 36 weeks with sildenafil significantly increased functional blood vessels and regional blood flow in the sciatic nerve, concurrently with augmentation of intra-epidermal nerve fiber density in the skin and myelinated axons in the sciatic nerve. Functional analysis showed that the sildenafil treatment considerably improved motor and sensory conduction velocities in the sciatic nerve and peripheral thermal stimulus sensitivity compared with the saline treatment. In vitro studies showed that mouse dermal endothelial cells (MDE) cultured under high glucose levels exhibited significant down regulation of angiopoietin 1 (Ang1) expression and reduction of capillary-like tube formation, which were completely reversed by sildenafil. In addition, incubation of dorsal root ganglia (DRG) neurons with conditioned medium harvested from MDE under high glucose levels suppressed neurite outgrowth, where as conditional medium harvested from MDE treated with sildenafil under high glucose levels did not inhibit neurite outgrowth of DRG neurons. Moreover, blockage of the Ang1 receptor, Tie2, with a neutralized antibody against Tie2 abolished the beneficial effect of sildenafil on tube formation and neurite outgrowth. Collectively, our data indicate that sildenafil has a therapeutic effect on long term peripheral neuropathy of middle aged diabetic mice and that improvement of neurovascular dysfunction by sildenafil likely contributes to the amelioration of nerve function. The Ang1/Tie2 signaling pathway may play an important role in these restorative processes.	[Wang, Lei; Chopp, Michael; Szalad, Alexandra; Jia, LongFei; Lu, XueRong; Lu, Mei; Zhang, Li; Zhang, Yi; Zhang, RuiLan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Wang, L (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	leiwang@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	ZHANG, YI/0000-0001-8373-017X	Dykstra Foundation; United States National Institutes of Health [RO1 NS075084, RO1 AG037506, RO1 NS075156, RO1 DK097519]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079612, R01NS075156, R01NS075084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	Dykstra Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Dykstra Foundation, and the United States National Institutes of Health (RO1 NS075084, RO1 AG037506, RO1 NS075156 and RO1 DK097519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N., 2007, FASEB J, V21, pA747, DOI [10.1096/FASEBJ.21.6.A747-A, DOI 10.1096/FASEBJ.21.6.A747-A]; Boucek Petr, 2006, Review of Diabetic Studies, V3, P143, DOI 10.1900/RDS.2006.3.143; Cameron NE, 2005, ANN NY ACAD SCI, V1043, P784, DOI 10.1196/annals.1333.091; Cameron NE, 1999, DIABETES RES CLIN PR, V45, P137, DOI 10.1016/S0168-8227(99)00043-1; Charnogursky Gerald, 2014, Handb Clin Neurol, V120, P773, DOI 10.1016/B978-0-7020-4087-0.00051-6; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Di Wu Q, 1999, AM J PHYSIOL-CELL PH, V277, pC1229, DOI 10.1152/ajpcell.1999.277.6.C1229; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Griffin JW, 2001, CURR OPIN NEUROL, V14, P655, DOI 10.1097/00019052-200110000-00016; Hackett G, 2006, INT J CLIN PRACT, V60, P1123, DOI 10.1111/j.1742-1241.2006.01087.x; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; Ii M, 2005, CIRCULATION, V112, P93, DOI 10.1161/CIRCULATIONAHA.104.511964; Kim HK, 2008, STEM CELLS DEV, V17, P669, DOI 10.1089/scd.2008.0141; Koneru S, 2008, J CELL MOL MED, V12, P2651, DOI 10.1111/j.1582-4934.2008.00319.x; Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Neeraj Arora DK, 2007, FASEB J, V21, P7066; NORIDO F, 1984, EXP NEUROL, V83, P221, DOI 10.1016/S0014-4886(84)90094-3; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patil CS, 2004, PHARMACOLOGY, V72, P190, DOI 10.1159/000080104; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Sameni H R, 2008, Pak J Biol Sci, V11, P1994, DOI 10.3923/pjbs.2008.1994.2000; SHIRASAKI N, 1991, J NEUROCYTOL, V20, P573, DOI 10.1007/BF01215265; SIMA AAF, 1978, ACTA NEUROPATHOL, V41, P85, DOI 10.1007/BF00689757; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang L, 2012, NEUROBIOL DIS, V48, P546, DOI 10.1016/j.nbd.2012.08.002; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang ZG, 1999, J CEREBR BLOOD F MET, V19, P68, DOI 10.1097/00004647-199901000-00008; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	44	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118134	10.1371/journal.pone.0118134	http://dx.doi.org/10.1371/journal.pone.0118134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689401	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700102
J	Ding, J; Zhao, L; Chang, YQ; Zhao, WM; Du, ZL; Hao, ZL				Ding, Jun; Zhao, Le; Chang, Yaqing; Zhao, Wenming; Du, Zhenlin; Hao, Zhenlin			Transcriptome Sequencing and Characterization of Japanese Scallop Patinopecten yessoensis from Different Shell Color Lines	PLOS ONE			English	Article							GENERATION; EXPRESSION; PROTEINS; REVEALS; TOOL	Shell color is an important trait that is used in breeding the Japanese scallop Patinopecten yessoensis, the most economically important scallop species in China. We constructed four transcriptome libraries from different shell color lines of P. yessoensis: the left and right shell mantles of ordinary strains of P. yessoensis and the left shell mantles of the 'Ivory' and 'Maple' strains. These four libraries were paired-end sequenced using the Illumina HiSeq 2000 platform and contained 54,802,692 sequences, 40,798,962 sequences, 74,019,262 sequences, and 44,466,166 sequences, respectively. A total of 214,087,082 expressed sequence tags were assembled into 73,522 unigenes with an average size of 1,163 bp. When the data were compared against the public Nr and Swiss-Prot databases using BlastX, nearly 30.55% (22,458) of the unigenes were significantly matched to known unique proteins. Gene Ontology annotation and pathway mapping analysis using the Kyoto Encyclopedia of Genes and Genomes categorized unigenes according to their diverse biological functions and processes and identified candidate genes that were potentially involved in growth, pigmentation, metal transcription, and immunity. Expression profile analysis was performed on all four libraries and many differentially expressed genes were identified. In addition, 5,772 simple sequence repeats were obtained from the P. yessoensis transcriptomes, and 464,197, 395,646, and 310,649 single nucleotide polymorphisms were revealed in the ordinary strains, the 'Ivory' strain, and the 'Maple' strain, respectively. These results provide valuable information for future genomic studies on P. yessoensis and improve our understanding of the molecular mechanisms involved in the growth, immunity, shell coloring, and shell biomineralization of this species. These resources also may be used in a variety of applications, such as trait mapping, marker-assisted breeding, studies of population genetics and genomics, and work on functional genomics.	[Ding, Jun; Zhao, Le; Chang, Yaqing; Hao, Zhenlin] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhao, Wenming; Du, Zhenlin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Chang, YQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	yaqingchang@hotmail.com		Zhao, Le/0000-0003-0505-9936	National High-Tech Research and Development Program of China [2012AA10A410]; Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project) [2011-G12]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project)	This research was supported by the National High-Tech Research and Development Program of China (No 2012AA10A410) and the Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project: 2011-G12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Anderson Robert S., 1988, American Fisheries Society Special Publication, V18, P238; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Chang Ya-Qing, 2007, Acta Ecologica Sinica, V27, P1145; Charles GH., 1966, PHYSIOL MOLLUSCA, V2, P455; Chen S, 2007, J ZHEJIANG OCEAN U, V26, P160; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; [丁君 DING Jun], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P121; Duan CH, 2005, J JILIN U INFORM SCI, V19, P32; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO SW, 2010, BMC GENOMICS S2, V11, DOI DOI 10.1186/1471-; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ke JY, 2009, J NINGDE TEACHERS CO, V21, P113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J.Z., 2001, J JIANGSU OCEAN U, V1, P22; Li N, 2009, THESIS OCEAN U CHINA; [刘美剑 Liu Meijian], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YZ, 2012, THESIS GUANGDONG OCE; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morse M. Patricia, 1997, P7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044621; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; SKILLMAN AG, 1992, J AM CHEM SOC, V114, P9538, DOI 10.1021/ja00050a037; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang LL, 2007, AQUACULTURE, V271, P252, DOI 10.1016/j.aquaculture.2007.06.020; Wang QC, 1984, FISHERIES SCI, V3, P24; Wang T, 2009, J YANTAI U NATURAL S, V22, P35; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang HF, 2005, J CHEM EDUC, V26, P3; [张婧 Zhang Jing], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P83; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z	53	54	56	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116406	10.1371/journal.pone.0116406	http://dx.doi.org/10.1371/journal.pone.0116406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680107	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600019
J	Fawley, WN; Knetsch, CW; MacCannell, DR; Harmanus, C; Du, T; Mulvey, MR; Paulick, A; Anderson, L; Kuijper, EJ; Wilcox, MH				Fawley, Warren N.; Knetsch, C. W.; MacCannell, Duncan R.; Harmanus, Celine; Du, Tim; Mulvey, Michael R.; Paulick, Ashley; Anderson, Lydia; Kuijper, E. J.; Wilcox, Mark H.			Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile	PLOS ONE			English	Article							CHANGING EPIDEMIOLOGY; TYPING METHODS; INFECTION; STRAINS; SCHEME	PCR-ribotyping has been adopted in many laboratories as the method of choice for C. difficile typing and surveillance. However, issues with the conventional agarose gel-based technique, including inter-laboratory variation and interpretation of banding patterns have impeded progress. The method has recently been adapted to incorporate high-resolution capillary gel-based electrophoresis (CE-ribotyping), so improving discrimination, accuracy and reproducibility. However, reports to date have all represented single-centre studies and inter-laboratory variability has not been formally measured or assessed. Here, we achieved in a multi-centre setting a high level of reproducibility, accuracy and portability associated with a consensus CE-ribotyping protocol. Local databases were built at four participating laboratories using a distributed set of 70 known PCR-ribotypes. A panel of 50 isolates and 60 electronic profiles (blinded and randomized) were distributed to each testing centre for PCR-ribotype identification based on local databases generated using the standard set of 70 PCR-ribotypes, and the performance of the consensus protocol assessed. A maximum standard deviation of only +/- 3.8bp was recorded in individual fragment sizes, and PCR-ribotypes from 98.2% of anonymised strains were successfully discriminated across four ribotyping centres spanning Europe and North America (98.8% after analysing discrepancies). Consensus CE-ribotyping increases comparability of typing data between centres and thereby facilitates the rapid and accurate transfer of standardized typing data to support future national and international C. difficile surveillance programs.	[Fawley, Warren N.; Wilcox, Mark H.] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England; [MacCannell, Duncan R.; Paulick, Ashley; Anderson, Lydia] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Knetsch, C. W.; Harmanus, Celine; Kuijper, E. J.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, Leiden, Netherlands; [Du, Tim; Mulvey, Michael R.] PHAC, Winnipeg, MB, Canada; [Wilcox, Mark H.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Leeds; Centers for Disease Control & Prevention - USA; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Public Health Agency of Canada; University of Leeds	Wilcox, MH (corresponding author), Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England.	mark.wilcox@leedsth.nhs.uk	Kuijper, ed/AAB-7853-2022	Kuijper, ed/0000-0001-5726-2405; Paulick, Ashley/0000-0001-6796-4355; Knetsch, Wilco/0000-0001-8569-3456; Harmanus, Celine/0000-0002-5328-3273				Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Behroozian AA, 2013, INFECT CONT HOSP EP, V34, P961, DOI 10.1086/671728; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; CHACHATY E, 1994, FEMS MICROBIOL LETT, V122, P61, DOI 10.1111/j.1574-6968.1994.tb07144.x; Eckert C, 2011, J CLIN MICROBIOL, V49, P3352, DOI 10.1128/JCM.00324-11; European Clostridium difficile infection study network (ECDIS-NET), EUR SUPP CAP BUILD S; Fawley WN, 2005, J CLIN MICROBIOL, V43, P2685, DOI 10.1128/JCM.43.6.2685-2696.2005; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hensgens MP, 2009, EUROSURVEILLANCE, V14, P7; Huber CA, 2013, J CLIN MICROBIOL, V51, P2810, DOI 10.1128/JCM.00143-13; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Kurka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086535; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Sadeghifard N, 2006, APPL ENVIRON MICROB, V72, P7311, DOI 10.1128/AEM.01179-06; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; Tenover FC, 2011, J CLIN MICROBIOL, V49, P1831, DOI 10.1128/JCM.02446-10; Valiente E, 2012, J MED MICROBIOL, V61, P49, DOI 10.1099/jmm.0.036194-0; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12	29	143	145	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118150	10.1371/journal.pone.0118150	http://dx.doi.org/10.1371/journal.pone.0118150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679978	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600109
J	Wu, HW; Zhu, L; Zhang, H; Shi, XH; Zhang, L; Wang, WZ; Xue, HD; Liang, ZY				Wu, Huanwen; Zhu, Liang; Zhang, Hui; Shi, Xiaohua; Zhang, Li; Wang, Wenze; Xue, Huadan; Liang, Zhiyong			Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; FACTOR RECEPTOR; SIGNALING PATHWAY; TUMOR-CELLS; EXPRESSION; METASTASIS; SURVIVAL; ACTIVATION; AXIS	Background Epidermal growth factor receptor (EGFR) is highly expressed in pancreatic ductal adenocarcinoma (PDAC) and is involved in tumorigenesis and development. However, EGFR expression alone has limited clinical and prognostic significance. Recently, the cross-talk between EGFR and G-protein-coupled chemokine receptor CXCR4 has become increasingly recognized. Methods In the present study, immunohistochemical staining of EGFR and CXCR4 was performed on paraffin-embedded specimens from 131 patients with surgically resected PDAC. Subsequently, the associations between EGFR expression, CXCR4 expression, EGFR/CXCR4 coexpression and clinicopathologic factors were assessed, and survival analyses were performed. Results In total, 64 (48.9%) patients expressed EGFR, 68 (51.9%) expressed CXCR4, and 33 (25.2%) coexpressed EGFR and CXCR4. No significant association between EGFR and CXCR4 expression was observed (P = 0.938). EGFR expression significantly correlated with tumor differentiation (P = 0.031), whereas CXCR4 expression significantly correlated with lymph node metastasis (P = 0.001). EGFR/CXCR4 coexpression was significantly associated with lymph node metastasis (P = 0.026), TNM stage (P = 0.048), and poor tumor differentiation (P = 0.004). By univariate survival analysis, both CXCR4 expression and EGFR/CXCR4 coexpression were significant prognostic factors for poor disease-free survival (DFS) and overall survival (OS). Moreover, EGFR/CXCR4 coexpression significantly increased the hazard ratio for both recurrence and death compared with EGFR or CXCR4 protein expression alone. Multivariate survival analysis demonstrated that EGFR/CXCR4 coexpression was an independent prognostic factor for DFS (HR = 2.33, P<0.001) and OS (HR = 2.48, P = 0.001). Conclusions In conclusion, our data indicate that although EGFR expression alone has limited clinical and prognostic significance, EGFR/CXCR4 coexpression identified a subset of PDAC patients with more aggressive tumor characteristics and a significantly worse prognosis. Our results suggest a potentially important "cross-talk" between CXCR4 and EGFR intracellular pathways and indicate that the simultaneous inhibition of these pathways might be an attractive therapeutic strategy for PDAC.	[Wu, Huanwen; Zhang, Hui; Shi, Xiaohua; Zhang, Li; Wang, Wenze; Liang, Zhiyong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhu, Liang; Xue, Huadan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xue, HD (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China.	bjdanna95@hotmail.com; liangzhiyong1220@yahoo.com		Wu, Huanwen/0000-0002-3996-3176	National Natural Science Foundation of China [81150027]; Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China [201402001]; Peking Union Medical College Hospital Youth Science Foundation [Pumch10700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China; Peking Union Medical College Hospital Youth Science Foundation	This research is supported by the National Natural Science Foundation of China (Project No. 81150027), the Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China (Project No. 201402001) and the Peking Union Medical College Hospital Youth Science Foundation (Project No. Pumch10700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zobair AA, 2013, ONCOL REP, V29, P1524, DOI 10.3892/or.2013.2254; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bachet JB, 2012, ANN ONCOL, V23, P2327, DOI 10.1093/annonc/mdr617; Billadeau DD, 2006, J GASTROINTEST CANC, V37, P110, DOI 10.1007/s12029-007-0011-7; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Funel N, 2011, ANN ONCOL, V22, P482, DOI 10.1093/annonc/mdq686; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Guo JH, 2013, ONCOL LETT, V5, P1572, DOI 10.3892/ol.2013.1261; Guo ZG, 2007, COLLOID SURFACE B, V60, P1, DOI 10.1016/j.colsurfb.2007.05.013; Handra-Luca A, 2013, J CLIN PATHOL; Jacobson O, 2013, THERANOSTICS, V3, P1, DOI 10.7150/thno.5760; Katsumoto K, 2013, THERANOSTICS, V3, P11, DOI 10.7150/thno.4806; Luo GP, 2011, PANCREATOLOGY, V11, P595, DOI 10.1159/000334465; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mori T, 2004, MOL CANCER THER, V3, P29; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Pryczynicz A, 2008, ANTICANCER RES, V28, P1399; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Valsecchi ME, 2012, CANCER-AM CANCER SOC, V118, P3484, DOI 10.1002/cncr.26661; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Zhong WX, 2012, EXP THER MED, V4, P363, DOI 10.3892/etm.2012.631	35	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116803	10.1371/journal.pone.0116803	http://dx.doi.org/10.1371/journal.pone.0116803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679210	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600035
J	Ng, R; Allore, HG; Trentalange, M; Monin, JK; Levy, BR				Ng, Reuben; Allore, Heather G.; Trentalange, Mark; Monin, Joan K.; Levy, Becca R.			Increasing Negativity of Age Stereotypes across 200 Years: Evidence from a Database of 400 Million Words	PLOS ONE			English	Article							MEDICALIZATION; PERCEPTIONS	Scholars argue about whether age stereotypes (beliefs about old people) are becoming more negative or positive over time. No previous study has systematically tested the trend of age stereotypes over more than 20 years, due to lack of suitable data. Our aim was to fill this gap by investigating whether age stereotypes have changed over the last two centuries and, if so, what may be associated with this change. We hypothesized that age stereotypes have increased in negativity due, in part, to the increasing medicalization of aging. This study applied computational linguistics to the recently compiled Corpus of Historical American English (COHA), a database of 400 million words that includes a range of printed sources from 1810 to 2009. After generating a comprehensive list of synonyms for the term elderly for these years from two historical thesauri, we identified 100 collocates (words that co-occurred most frequently with these synonyms) for each of the 20 decades. Inclusion criteria for the collocates were: (1) appeared within four words of the elderly synonym, (2) referred to an old person, and (3) had a stronger association with the elderly synonym than other words appearing in the database for that decade. This yielded 13,100 collocates that were rated for negativity and medicalization. We found that age stereotypes have become more negative in a linear way over 200 years. In 1880, age stereotypes switched from being positive to being negative. In addition, support was found for two potential explanations. Medicalization of aging and the growing proportion of the population over the age of 65 were both significantly associated with the increase in negative age stereotypes. The upward trajectory of age-stereotype negativity makes a case for remedial action on a societal level.	[Ng, Reuben; Allore, Heather G.; Monin, Joan K.; Levy, Becca R.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Allore, Heather G.; Trentalange, Mark] Yale Univ, Sch Med, New Haven, CT USA	Yale University; Yale University	Levy, BR (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Becca.Levy@Yale.edu	Ng, Reuben/A-2931-2009	Ng, Reuben/0000-0002-1186-0570; Allore, Heather/0000-0001-7685-8175	International Fulbright Science and Technology Award; National Institute on Aging grant [K01 AG042450-01, R01AG032284]; National Heart, Lung, and Blood Institute [R01HL089314]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG042450, R01AG032284, P30AG021342] Funding Source: NIH RePORTER	International Fulbright Science and Technology Award; National Institute on Aging grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yale Claude D. Pepper Older Americans Independence Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by an International Fulbright Science and Technology Award to Dr. Ng; a National Institute on Aging grant (K01 AG042450-01) to Dr. Monin; and a National Institute of Aging grant (R01AG032284) and a National Heart, Lung, and Blood Institute grant (R01HL089314) to Dr. Levy. In addition, this study was supported in part by the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINNEY EA, 1990, SOC SCI MED, V30, P761, DOI 10.1016/0277-9536(90)90199-3; Binstock RH, 2012, GERONTOLOGIST, V52, P408, DOI 10.1093/geront/gnr118; Bowling A, 2007, BRIT J GEN PRACT, V57, P347; Butler R., 2008, LONGEVITY REVOLUTION; Chudacoff Howard P., 1989, OLD ARE YOU AGE CONS; Church K. W., 1990, Computational Linguistics, V16, P22; Estes CL., 2001, PRODUCTIVE AGING CON, P197; GERBNER G, 1994, MEDIA EFFECTS ADV TH, P17, DOI DOI 10.1037/0022-3514.74.5.1164; Glover JJ, 2000, J CLIN ETHIC, V11, P318; Hunston S., 2002, CORPORA APPL LINGUIS; Kay Christian, 2009, HIST THESAURUS OXFOR; LEVY B, 1994, J PERS SOC PSYCHOL, V66, P989, DOI 10.1037/0022-3514.66.6.989; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Lockenhoff CE, 2009, PSYCHOL AGING, V24, P941, DOI 10.1037/a0016901; McEnery T., 2001, CORPUS LINGUISTICS I, V2nd; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Ng R, 2012, CHILD YOUTH CARE FOR, V41, P529, DOI 10.1007/s10566-012-9182-x; North MS, 2012, PSYCHOL BULL, V138, P982, DOI 10.1037/a0027843; Robinson T, 2006, INT J AGING HUM DEV, V62, P159, DOI 10.2190/2CXV-0LTM-2MJJ-NPEU; U.S.Census Bureau, 2011, STAT ABSTR US; U.S. Census Bureau, 1949, HIST STAT US 1789 19; Waite M, 2012, OXFORD THESAURUS	22	108	108	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117086	10.1371/journal.pone.0117086	http://dx.doi.org/10.1371/journal.pone.0117086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB8WX	25675438	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000013
J	Wilkinson, AD; Collier, CJ; Flores, F; Mercurio, P; O'Brien, J; Ralph, PJ; Negri, AP				Wilkinson, Adam D.; Collier, Catherine J.; Flores, Florita; Mercurio, Phil; O'Brien, Jake; Ralph, Peter J.; Negri, Andrew P.			A Miniature Bioassay for Testing the Acute Phytotoxicity of Photosystem II Herbicides on Seagrass	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TROPICAL BENTHIC MICROALGAE; CHLOROPHYLL-A FLUORESCENCE; HALOPHILA-OVALIS; PHOTOSYNTHETIC TOLERANCES; TOXICITY; TEMPERATURE; ECOSYSTEMS; PESTICIDE; AUSTRALIA	Photosystem II (PSII) herbicides have been detected in nearshore tropical waters such as those of the Great Barrier Reef and may add to the pressure posed by runoff containing sediments and nutrients to threatened seagrass habitats. There is a growing number of studies into the potential effects of herbicides on seagrass, generally using large experimental setups with potted plants. Here we describe the successful development of an acute 12-well plate phytotoxicity assay for the PSII herbicide Diuron using isolated Halophila ovalis leaves. Fluorescence images demonstrated Diuron affected the entire leaf surface evenly and responses were not influenced by isolating leaves from the plant. The optimum exposure duration was 24 h, by which time the inhibition of effective quantum yield of PSII (Delta F/F-m') was highest and no deterioration of photosystems was evident in control leaves. The inhibition of Delta F/F-m' by Diuron in isolated H. ovalis leaves was identical to both potted and hydroponically grown plants (with leaves remaining attached to rhizomes), indicating similar reductions in photosynthetic activity in these acute well-plate assays. The sensitivity of the assay was not influenced by irradiance (range tested 40 to 400 mu mol photons m(-2) s(-1)). High irradiance, however, caused photo-oxidative stress in H. ovalis and this generally impacted in an additive or sub-additive way with Diuron to damage PSII. The bioassay using isolated leaves is more rapid, uses far less biological material and does not rely on specialised aquarium facilities in comparison with assays using potted plants. The development and validation of this sensitive bioassay will be useful to reliably screen and monitor the phytotoxicity of existing and emerging PSII herbicides and contribute to risk assessments and water quality guideline development in the future.	[Wilkinson, Adam D.; Collier, Catherine J.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Wilkinson, Adam D.; Flores, Florita; Mercurio, Phil; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Collier, Catherine J.] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res TropWATER, Cairns, Qld, Australia; [Mercurio, Phil; O'Brien, Jake] Univ Queensland, Sch Med, Coopers Plains, Qld, Australia; [Mercurio, Phil; O'Brien, Jake] Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia; [Ralph, Peter J.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW 2007, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; University of Queensland; University of Technology Sydney	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Ralph, Peter/L-1527-2019; Negri, Andrew P/G-9909-2017; Flores, Florita/I-3033-2017; O'Brien, Jake William/C-4749-2015; O'Brien, Jake William/AAD-9103-2019; Ralph, Peter J/C-5029-2009; Collier, Catherine/M-6308-2014	Ralph, Peter/0000-0002-3103-7346; Negri, Andrew P/0000-0003-1388-7395; Flores, Florita/0000-0003-4637-1379; O'Brien, Jake William/0000-0001-9336-9656; Ralph, Peter J/0000-0002-3103-7346; Collier, Catherine/0000-0001-9494-6582	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project [4.2]	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project(Australian Government)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer S, 2006, AQUAT BOT, V84, P367, DOI 10.1016/j.aquabot.2005.11.007; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094014; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Davis AM, 2013, AGR ECOSYST ENVIRON, V180, P123, DOI 10.1016/j.agee.2011.06.019; Durako MJ, 2003, MAR BIOL, V142, P1219, DOI 10.1007/s00227-003-1038-3; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Flores F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075798; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; GBRMPA, 2010, WAT QUAL GUID GREAT; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; Inglis Graeme J., 2000, Pacific Conservation Biology, V5, P251; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; Kahn AE, 2009, AQUAT BOT, V90, P195, DOI 10.1016/j.aquabot.2008.07.003; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kirkman H., 1997, SEAGRASSES AUSTR; Kuster A, 2007, CHEMOSPHERE, V67, P194, DOI 10.1016/j.chemosphere.2006.08.023; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Magnusson M, 2013, WATER RES, V47, P5211, DOI 10.1016/j.watres.2013.06.003; Magnusson M, 2012, MAR POLLUT BULL, V65, P363, DOI 10.1016/j.marpolbul.2011.09.029; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; Marba N, 2006, SEAGRASSES BIOL ECOL; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Negri AP, 2011, LIMNOL OCEANOGR, V56, P471, DOI 10.4319/lo.2011.56.2.0471; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osmond CB, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P1; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 2005, AQUAT BOT, V81, P69, DOI 10.1016/j.aquabot.2004.11.003; Ralph PJ, 2000, AQUAT BOT, V66, P141, DOI 10.1016/S0304-3770(99)00024-8; Ralph PJ, 1998, MAR ECOL PROG SER, V171, P123, DOI 10.3354/meps171123; RALPH PJ, 1995, AQUAT BOT, V51, P55, DOI 10.1016/0304-3770(95)00456-A; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; SCHWARZSCHILD AC, 1994, J EXP MAR BIOL ECOL, V183, P77, DOI 10.1016/0022-0981(94)90158-9; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; van Dam JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033900; Wahedally S.F., 2012, TANZ J NAT APPL SCI, V3, P458; WAYCOTT M, 2004, GUIDE TROPICAL SEAGR; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	49	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117541	10.1371/journal.pone.0117541	http://dx.doi.org/10.1371/journal.pone.0117541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674791	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000026
J	Coelho, A; Fraichard, S; Le Goff, G; Faure, P; Artur, Y; Ferveur, JF; Heydel, JM				Coelho, Alexandra; Fraichard, Stephane; Le Goff, Gaelle; Faure, Philippe; Artur, Yves; Ferveur, Jean-Francois; Heydel, Jean-Marie			Cytochrome P450-Dependent Metabolism of Caffeine in Drosophila melanogaster	PLOS ONE			English	Article							REAL-TIME PCR; GLUTATHIONE-S-TRANSFERASE; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; RELATIVE CONTRIBUTION; PHEROMONE; DETOXIFICATION; RESPONSES; METHYLXANTHINES; THEOPHYLLINE	Caffeine (1, 3, 7-trimethylxanthine), an alkaloid produced by plants, has antioxidant and insecticide properties that can affect metabolism and cognition. In vertebrates, the metabolites derived from caffeine have been identified, and their functions have been characterized. However, the metabolites of caffeine in insects remain unknown. Thus, using radiolabelled caffeine, we have identified some of the primary caffeine metabolites produced in the body of Drosophila melanogaster males, including theobromine, paraxanthine and theophylline. In contrast to mammals, theobromine was the predominant metabolite (paraxanthine in humans; theophylline in monkeys; 1, 3, 7-trimethyluric acid in rodents). A transcriptomic screen of Drosophila flies exposed to caffeine revealed the coordinated variation of a large set of genes that encode xenobiotic-metabolizing proteins, including several cytochromes P450s (CYPs) that were highly overexpressed. Flies treated with metyrapone-an inhibitor of CYP enzymes-showed dramatically decreased caffeine metabolism, indicating that CYPs are involved in this process. Using interference RNA genetic silencing, we measured the metabolic and transcriptomic effect of three candidate CYPs. Silencing of CYP6d5 completely abolished theobromine synthesis, whereas CYP6a8 and CYP12d1 silencing induced different consequences on metabolism and gene expression. Therefore, we characterized several metabolic products and some enzymes potentially involved in the degradation of caffeine. In conclusion, this pioneer approach to caffeine metabolism in insects opens novel perspectives for the investigation of the physiological effects of caffeine metabolites. It also indicates that caffeine could be used as a bio-marker to evaluate CYP phenotypes in Drosophila and other insects.	[Coelho, Alexandra; Fraichard, Stephane; Faure, Philippe; Artur, Yves; Ferveur, Jean-Francois; Heydel, Jean-Marie] Univ Bourgogne, CNRS 6265, INRA 1324, Ctr Sci Gout & Alimentat, F-21000 Dijon, France; [Le Goff, Gaelle] UNSA, INRA, CNRS, UMR 1355,Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Ferveur, JF (corresponding author), Univ Bourgogne, CNRS 6265, INRA 1324, Ctr Sci Gout & Alimentat, F-21000 Dijon, France.	jean-francois.ferveur@u-bourgogne.fr; jean-marie.heydel@u-bourgogne.fr	Legoff, Gaelle/B-7501-2015; Heydel, jean-Marie/E-5379-2017; Fraichard, Stephane/R-1930-2019; ARTUR, Yves E/A-8504-2019	Legoff, Gaelle/0000-0003-1973-7136; Heydel, jean-Marie/0000-0002-6089-9922; 	Regional Council of Burgundy France (PARI); European Funding for Regional Economical Development (FEDER); Centre National de la Recherche Scientifique (CNRS); Institut National de la Recherche Agronomique (INRA); French Ministry of Research and Higher Education	Regional Council of Burgundy France (PARI)(Region Bourgogne-Franche-Comte); European Funding for Regional Economical Development (FEDER); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA); French Ministry of Research and Higher Education	This work was funded in part by the Regional Council of Burgundy France (PARI), the European Funding for Regional Economical Development (FEDER) the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Recherche Agronomique (INRA) and the French Ministry of Research and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshuaib WB, 2006, INT J DEV NEUROSCI, V24, P249, DOI 10.1016/j.ijdevneu.2006.03.002; Ashihara H, 2004, FRONT BIOSCI-LANDMRK, V9, P1864, DOI 10.2741/1367; Bannenberg G, 2003, CHEM-BIOL INTERACT, V143, P449, DOI 10.1016/S0009-2797(02)00183-7; Benchekroun Y, 1997, J CHROMATOGR B, V688, P245, DOI 10.1016/S0378-4347(96)00323-4; BERTHOU F, 1992, XENOBIOTICA, V22, P671, DOI 10.3109/00498259209053129; BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carrillo JA, 2000, THER DRUG MONIT, V22, P409, DOI 10.1097/00007691-200008000-00008; CHOU TM, 1994, COMP BIOCHEM PHYS C, V109, P173, DOI 10.1016/0742-8413(94)00048-F; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Franco R, 2013, NUTRIENTS, V5, P4159, DOI 10.3390/nu5104159; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44; Hollingsworth RG, 2002, NATURE, V417, P915, DOI 10.1038/417915a; ITOYAMA MM, 1992, REV BRAS GENET, V15, P303; Itoyama MM, 1997, BRAZILIAN JOURNAL OF, V20; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jensen HR, 2006, J AGR FOOD CHEM, V54, P1289, DOI 10.1021/jf052046n; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kot M, 2008, BIOCHEM PHARMACOL, V76, P543, DOI 10.1016/j.bcp.2008.05.025; Kot M, 2008, BIOCHEM PHARMACOL, V75, P1538, DOI 10.1016/j.bcp.2007.12.017; Kucharski R, 2005, J MOL NEUROSCI, V27, P269, DOI 10.1385/JMN:27:3:269; KUHLMANN W, 1968, CANCER RES, V28, P2375; KULKARNI AP, 1978, B ENVIRON CONTAM TOX, V20, P227, DOI 10.1007/BF01683513; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Laranja AT, 2006, REV SAUDE PUBL, V40, P1112, DOI 10.1590/S0034-89102006000700022; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Mahapatra CT, 2010, TOXICOL SCI, V116, P225, DOI 10.1093/toxsci/kfq097; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; MATHAVAN S, 1985, EXP BIOL, V44, P133; Matsagas K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006578; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Mitchell ES, 2011, PHYSIOL BEHAV, V104, P816, DOI 10.1016/j.physbeh.2011.07.027; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Morozova TV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r95; Morra R, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00954.x; Nakayama S, 2012, J INSECT PHYSIOL, V58, P750, DOI 10.1016/j.jinsphys.2012.02.011; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Raj MA, 2013, ANAL CHIM ACTA, V771, P14, DOI 10.1016/j.aca.2013.02.017; Sellier MJ, 2011, CHEM SENSES, V36, P323, DOI 10.1093/chemse/bjq133; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Sharma A, 2011, CHEMOSPHERE, V82, P370, DOI 10.1016/j.chemosphere.2010.10.002; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Si A, 2005, PHARMACOL BIOCHEM BE, V82, P664, DOI 10.1016/j.pbb.2005.11.009; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; TANG BK, 1994, PHARMACOGENETICS, V4, P117, DOI 10.1097/00008571-199406000-00002; Thimgan MS, 2011, J CLIN SLEEP MED, V7, pS26, DOI 10.5664/JCSM.1352; Trinh K, 2010, J NEUROSCI, V30, P5525, DOI 10.1523/JNEUROSCI.4777-09.2010; Visetson S., 1991, THESIS; Welsh EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001112.pub2; Willoughby L, 2007, PEST MANAG SCI, V63, P803, DOI 10.1002/ps.1391; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Zornik E, 1999, PEPTIDES, V20, P45, DOI 10.1016/S0196-9781(98)00151-X	60	30	31	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117328	10.1371/journal.pone.0117328	http://dx.doi.org/10.1371/journal.pone.0117328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671424	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300047
J	Takeda, K; Uchihashi, T; Watanabe, H; Ishida, T; Igarashi, K; Nakamura, N; Ohno, H				Takeda, Kouta; Uchihashi, Takayuki; Watanabe, Hiroki; Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi; Ohno, Hiroyuki			Real-Time Dynamic Adsorption Processes of Cytochrome c on an Electrode Observed through Electrochemical High-Speed Atomic Force Microscopy	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; QUARTZ-CRYSTAL MICROBALANCE; INFRARED-ABSORPTION SPECTROSCOPY; SURFACE-PLASMON RESONANCE; REDOX POTENTIALS; ENZYME-ACTIVITY; GOLD ELECTRODE; TAPPING-MODE; PROTEINS; AFM	An understanding of dynamic processes of proteins on the electrode surface could enhance the efficiency of bioelectronics development and therefore it is crucial to gain information regarding both physical adsorption of proteins onto the electrode and its electrochemical property in real-time. We combined high-speed atomic force microscopy (HS-AFM) with electrochemical device for simultaneous observation of the surface topography and electron transfer of redox proteins on an electrode. Direct electron transfer of cytochrome c (cyt c) adsorbed on a self-assembled monolayers (SAMs) formed electrode is very attractive subject in bioelectrochemistry. This paper reports a real-time visualization of cyt c adsorption processes on an 11-mercaptoundecanoic acid-modified Au electrode together with simultaneous electrochemical measurements. Adsorbing cyt c molecules were observed on a subsecond time resolution simultaneously with increasing redox currents from cyt c using EC-HS-AFM. The root mean square roughness (R-RMS) from the AFM images and the number of the electrochemically active cyt c molecules adsorbed onto the electrode (Gamma) simultaneously increased in positive cooperativity. Cyt c molecules were fully adsorbed on the electrode in the AFM images when the peak currents were steady. This use of electrochemical HS-AFM significantly facilitates understanding of dynamic behavior of biomolecules on the electrode interface and contributes to the further development of bioelectronics.	[Takeda, Kouta; Nakamura, Nobuhumi; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Uchihashi, Takayuki; Watanabe, Hiroki] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 920, Japan; [Ishida, Takuya; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan; [Uchihashi, Takayuki; Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi] Japan Sci & Technol Agcy JST, Adv Low Carbon Technol Res & Dev Program ALCA, Tokyo, Japan	Tokyo University of Agriculture & Technology; Kanazawa University; University of Tokyo; Japan Science & Technology Agency (JST)	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp; nobu1@cc.tuat.ac.jp	Uchihashi, Takayuki/D-5209-2011; Ohno, Hiroyuki/F-6459-2012; Nakamura, Nobuhumi/C-1972-2013; Igarashi, Kiyohiko/E-6799-2016; Takeda, Kouta/G-6554-2016	Uchihashi, Takayuki/0000-0002-0263-5312; Ohno, Hiroyuki/0000-0001-9716-3495; Nakamura, Nobuhumi/0000-0002-5373-2972; Igarashi, Kiyohiko/0000-0001-5152-7177; Watanabe, Hiroki/0000-0001-8547-1247; Takeda, Kouta/0000-0001-5227-4132	Japan Society for the Promotion of Science [2125007, 268641]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [14J08641, 24114008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Japan Society for the Promotion of Science (No. 2125007) to H.O., by a Grant-in-Aid for JSPS Fellows (No. 268641) to K.T., and by a grant from the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) to T.U., K.I., and N.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Ataka K, 2004, J AM CHEM SOC, V126, P9445, DOI 10.1021/ja048346n; Ataka K, 2007, ANAL BIOANAL CHEM, V388, P47, DOI 10.1007/s00216-006-1071-4; Avila A, 2000, J PHYS CHEM B, V104, P2759, DOI 10.1021/jp992591p; Boussaad S, 1999, J AM CHEM SOC, V121, P4510, DOI 10.1021/ja990117r; COTTON TM, 1980, J AM CHEM SOC, V102, P7960, DOI 10.1021/ja00547a036; Deng J, 2013, NANOSCALE, V5, P8130, DOI 10.1039/c3nr02327c; Fedurco M, 2000, COORDIN CHEM REV, V209, P263, DOI 10.1016/S0010-8545(00)00292-7; Feng ZQ, 1997, J CHEM SOC FARADAY T, V93, P1367; Fleming BD, 2008, LANGMUIR, V24, P323, DOI 10.1021/la702511w; Fujita K, 2003, ELECTROCHEM COMMUN, V5, P47, DOI 10.1016/S1388-2481(02)00531-3; Furusawa H, 2009, ANAL CHEM, V81, P2268, DOI 10.1021/ac802412t; Goda T, 2012, LANGMUIR, V28, P14730, DOI 10.1021/la302977s; Hiasa T, 2012, PHYS CHEM CHEM PHYS, V14, P8419, DOI 10.1039/c2cp40252a; Hobara D, 2002, NANO LETT, V2, P1021, DOI 10.1021/nl0256863; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jin B, 2012, J PHYS CHEM C, V116, P13038, DOI 10.1021/jp303740e; KASSNER RJ, 1973, J AM CHEM SOC, V95, P2674, DOI 10.1021/ja00789a044; Kranz C, 2004, ULTRAMICROSCOPY, V100, P127, DOI 10.1016/j.ultramic.2003.10.004; Kueng A, 2003, ANGEW CHEM INT EDIT, V42, P3238, DOI 10.1002/anie.200351111; Luo QL, 1998, J COLLOID INTERF SCI, V200, P104, DOI 10.1006/jcis.1997.5364; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MOORE GR, 1983, FEBS LETT, V161, P171, DOI 10.1016/0014-5793(83)81001-1; Murata K, 2009, ELECTROCHEM COMMUN, V11, P1623, DOI 10.1016/j.elecom.2009.06.012; Murgida DH, 2008, CHEM SOC REV, V37, P937, DOI 10.1039/b705976k; Murgida DH, 2004, ACCOUNTS CHEM RES, V37, P854, DOI 10.1021/ar0400443; Murgida DH, 2001, ANGEW CHEM INT EDIT, V40, P728; Nakano K, 2007, LANGMUIR, V23, P6270, DOI 10.1021/la063697w; Niki K, 2003, J PHYS CHEM B, V107, P9947, DOI 10.1021/jp035392l; Paulo TD, 2013, J PHYS CHEM B, V117, P8673, DOI 10.1021/jp400694k; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; SONG S, 1993, J PHYS CHEM-US, V97, P6564, DOI 10.1021/j100126a037; STELLWAGEN E, 1978, NATURE, V275, P73, DOI 10.1038/275073a0; TARLOV MJ, 1991, J AM CHEM SOC, V113, P1847, DOI 10.1021/ja00005a068; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Wei JJ, 2002, ANGEW CHEM INT EDIT, V41, P4700, DOI 10.1002/anie.200290021; Wisitruangsakul N, 2008, PHYS CHEM CHEM PHYS, V10, P5276, DOI 10.1039/b806528d; Zhang L, 2005, BIOSENS BIOELECTRON, V21, P337, DOI 10.1016/j.bios.2004.10.021	42	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116685	10.1371/journal.pone.0116685	http://dx.doi.org/10.1371/journal.pone.0116685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671430	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300023
J	Ashraf, JM; Ahmad, S; Rabbani, G; Hasan, Q; Jan, AT; Lee, EJ; Khan, RH; Alam, K; Choi, I				Ashraf, Jalaluddin M.; Ahmad, Saheem; Rabbani, Gulam; Hasan, Qambar; Jan, Arif Tasleem; Lee, Eun Ju; Khan, Rizwan Hasan; Alam, Khursheed; Choi, Inho			3-Deoxyglucosone: A Potential Glycating Agent Accountable for Structural Alteration in H3 Histone Protein through Generation of Different AGEs	PLOS ONE			English	Article							END-PRODUCTS; PHYSICOCHEMICAL ANALYSIS; ASSAY; METHYLGLYOXAL; ENDPRODUCTS; PENTOSIDINE; FRUCTOSE; SERUM; STATE	Advanced glycation end-products (AGEs) are heterogeneous group of compounds, known to be implicated in diabetic complications. One of the consequences of the Maillard reaction is attributed to the production of reactive intermediate products such as a-oxoaldehydes. 3deoxyglucosone (3-DG), an alpha-oxoaldehyde has been found to be involved in accelerating vascular damage during diabetes. In the present study, calf thymus histone H3 was treated with 3-deoxyglucosone to investigate the generation of AGEs (N-epsilon-carboxymethyllysine, pentosidine), by examining the degree of side chain modifications and formation of different intermediates and employing various physicochemical techniques. The results clearly indicate the formation of AGEs and structural changes upon glycation of H3 by 3-deoxyglucosone, which may hamper the normal functioning of H3 histone, that may compromise the veracity of chromatin structures and function in secondary complications of diabetes.	[Ashraf, Jalaluddin M.; Hasan, Qambar; Jan, Arif Tasleem; Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Ahmad, Saheem] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Rabbani, Gulam; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Alam, Khursheed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India	Yeungnam University; Integral University; Aligarh Muslim University; Aligarh Muslim University	Ashraf, JM (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	jmashraf@gmail.com; inhochoi@ynu.ac.kr	Khan, Rizwan/GXZ-5789-2022; Ahmad, Saheem/R-7016-2017; Khan, Rizwan Hasan/F-8276-2014; Rabbani, Gulam/AAE-5629-2022; Jan, Arif Tasleem/AAX-6531-2020; Ashraf, Jalauddin M/P-5391-2014; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Khan, Rizwan Hasan/0000-0002-9965-8982; Rabbani, Gulam/0000-0002-5293-8231; Jan, Arif Tasleem/0000-0002-3607-543X; Ashraf, Jalauddin M/0000-0001-7885-2551; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	National Research Foundation of Korea grant - Korea government (MSIP) [2014R1A2A2A01006324]	National Research Foundation of Korea grant - Korea government (MSIP)	This work was supported by National Research Foundation of Korea grant funded by the Korea government (MSIP) (No. 2014R1A2A2A01006324).	Afrin S, 2014, J LUMIN, V151, P219, DOI 10.1016/j.jlumin.2014.02.028; Ahmad S, 2012, IUBMB LIFE, V64, P151, DOI 10.1002/iub.582; Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; Amiri Majd A. M., 2013, J BASIC APPL SCI RES, V3, P878; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Ashraf JM, 2014, IUBMB LIFE, V66, P686, DOI 10.1002/iub.1318; Ashraf JM, 2012, INT J BIOL MACROMOL, V51, P604, DOI 10.1016/j.ijbiomac.2012.06.013; Corbin J, 1998, J BIOL CHEM, V273, P771, DOI 10.1074/jbc.273.2.771; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FOJO AT, 1983, ARCH BIOCHEM BIOPHYS, V224, P636, DOI 10.1016/0003-9861(83)90251-5; Garay-Sevilla ME, 2005, J ENDOCRINOL INVEST, V28, P223, DOI 10.1007/BF03345377; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Jairajpuri DS, 2007, CLIN CHIM ACTA, V378, P86, DOI 10.1016/j.cca.2006.10.020; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kessel L, 2002, PHOTOCHEM PHOTOBIOL, V76, P549, DOI 10.1562/0031-8655(2002)076<0549:TRASSF>2.0.CO;2; Khalifah RG, 1999, BIOCHEM BIOPH RES CO, V257, P251, DOI 10.1006/bbrc.1999.0371; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Misselwitz J, 2002, PEDIATR NEPHROL, V17, P316, DOI 10.1007/s00467-001-0815-9; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rahim M, 2014, COLLOID SURFACE B, V117, P473, DOI 10.1016/j.colsurfb.2013.12.008; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Schmitt A, 2005, ANAL BIOCHEM, V346, P101, DOI 10.1016/j.ab.2005.07.035; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Sima AAF, 1999, DIABETOLOGIA, V42, P773, DOI 10.1007/s001250051227; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SMITH RE, 1978, ANAL BIOCHEM, V90, P246, DOI 10.1016/0003-2697(78)90029-5; Stefek M, 1999, REDOX REP, V4, P43, DOI 10.1179/135100099101534738; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Talasz H, 2002, J CELL BIOCHEM, V85, P24, DOI 10.1002/jcb.10103; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Wolffe A., 1998, CHROMATIN STRUCTURE; Zheng N, 2010, J HUAZHONG U SCI-MED, V30, P546, DOI 10.1007/s11596-010-0466-9	42	47	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116804	10.1371/journal.pone.0116804	http://dx.doi.org/10.1371/journal.pone.0116804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689368	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700024
J	Demitto, FD; do Amaral, RCR; Maltempe, FG; Siqueira, VLD; Scodro, RBD; Lopes, MA; Caleffi-Ferracioli, KR; Canezin, PH; Cardoso, RF				Demitto, Fernanda de Oliveira; Ribeiro do Amaral, Renata Claro; Maltempe, Flaviane Granero; Dias Siqueira, Vera Lucia; de Lima Scodro, Regiane Bertin; Lopes, Mariana Aparecida; Caleffi-Ferracioli, Katiany R.; Canezin, Pedro Henrique; Cardoso, Rosilene Fressatti			In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							EFFLUX PUMP; DRUG-RESISTANCE; P-GLYCOPROTEIN; INHIBITOR; SUSCEPTIBILITY; OFLOXACIN; ISOLATE; GENE	The aim of the present study was to evaluate the effect of the combination of rifampicin (RIF) and verapamil (VP) against the Mycobacterium tuberculosis H(37)Rv reference strain and six multidrug-resistant (MDR) M. tuberculosis clinical isolates by determining Time-Kill Curves and the ability to efflux drug by fluorometry. The RIF+VP combination showed synergism in one MDR clinical isolate. For the other five MDR clinical isolates, the drug combination showed no interaction. The MDR clinical isolate had lower ethidium bromide (EtBr) accumulation when exposed to the RIF+VP combination, compared with RIF and VP exposure alone. The other MDR clinical isolates showed no significant difference in EtBr accumulation. These results suggest greater efflux action in one of the MDR clinical isolates compared with the M. tuberculosis H37Rv reference strain. The other five MDR isolates may have additional mechanisms of drug resistance to RIF. The use of the RIF+VP combination made one MDR bacillus more susceptible to RIF probably by inhibiting efflux pumps, and this combination therapy, in some cases, may contribute to a reduction of resistance to RIF in M. tuberculosis.	[Demitto, Fernanda de Oliveira; Canezin, Pedro Henrique] Univ Estadual Maringa, Hlth Sci, BR-87020900 Maringa, Parana, Brazil; [Ribeiro do Amaral, Renata Claro; Maltempe, Flaviane Granero; Lopes, Mariana Aparecida] Univ Estadual Maringa, Biosci & Pathophysiol, BR-87020900 Maringa, Parana, Brazil; [Dias Siqueira, Vera Lucia; de Lima Scodro, Regiane Bertin; Caleffi-Ferracioli, Katiany R.; Cardoso, Rosilene Fressatti] Univ Estadual Maringa, Lab Med Bacteriol, Dept Clin Anal & Biomed, BR-87020900 Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Cardoso, RF (corresponding author), Univ Estadual Maringa, Lab Med Bacteriol, Dept Clin Anal & Biomed, Ave Colombo 5790, BR-87020900 Maringa, Parana, Brazil.	rfressatticardoso@gmail.com	de Lima Scodro, Regiane Bertin/Y-9234-2019; Caleffi Ferracioli, Katiany Rizzieri/AAX-9056-2021; Cardoso, Rosilene F/J-4796-2015; Cardoso, Rosilene Fressatti/AAX-9166-2021	de Lima Scodro, Regiane Bertin/0000-0002-9129-2445; Caleffi Ferracioli, Katiany Rizzieri/0000-0003-0345-1600; Cardoso, Rosilene F/0000-0001-6228-4780; Cardoso, Rosilene Fressatti/0000-0001-6228-4780; de Oliveira Demitto Tamogami, Fernanda/0000-0002-0939-9615				Caleffi-Ferracioli KR, 2013, TUBERCULOSIS, V93, P660, DOI 10.1016/j.tube.2013.09.001; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; CHAN EL, 1987, DIAGN MICR INFEC DIS, V6, P157, DOI 10.1016/0732-8893(87)90101-5; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; de Knegt GJ, 2013, TUBERCULOSIS, V93, P96, DOI 10.1016/j.tube.2012.10.013; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Jin J, 2010, MOLECULES, V15, P7750, DOI 10.3390/molecules15117750; Jones K, 2001, AIDS, V15, P1353, DOI 10.1097/00002030-200107270-00004; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; LUNAHERRERA J, 1995, ANTIMICROB AGENTS CH, V39, P440, DOI 10.1128/AAC.39.2.440; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Machado L, 2011, IN VIVO, V25, P769; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rodrigues L, 2013, ANTIMICROB AGENTS CH, V57, P751, DOI 10.1128/AAC.01482-12; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Rodrigues L, 2009, INT J ANTIMICROB AG, V34, P529, DOI 10.1016/j.ijantimicag.2009.07.010; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Shi R, 2007, MINI-REV MED CHEM, V7, P1177, DOI 10.2174/138955707782331740; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Singh M, 2011, INDIAN J MED RES, V133, P535; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	36	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116545	10.1371/journal.pone.0116545	http://dx.doi.org/10.1371/journal.pone.0116545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689777	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700015
J	Hu, H; Duan, ZH; Long, XR; Hertzanu, Y; Tong, XQ; Xu, XQ; Shi, HB; Liu, S; Yang, ZQ				Hu, Hao; Duan, Zhenhua; Long, Xiaoran; Hertzanu, Yancu; Tong, Xiaoqiang; Xu, Xiaoquan; Shi, Haibin; Liu, Sheng; Yang, Zhengqiang			Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study	PLOS ONE			English	Article							TRANS-ARTERIAL CHEMOEMBOLIZATION; PHASE-II; MANAGEMENT; PROGNOSIS; OUTCOMES	Aims This retrospective study was carried out to compare the outcomes between elderly (>= 70 years of age) and nonelderly patients (< 70 years of age) with advanced hepatocellular carcinoma (HCC) who received sorafenib combined with transarterial chemoembolization (TACE). Methods 88 patients with a confirmed diagnosis of advanced HCC were enrolled in this study. Of these, 24 elderly patients were matched with 48 nonelderly patients at a 1:2 ratio using propensity score matching to minimize selection bias. The related adverse events and survival benefits were compared between the two groups. Results Sorafenib combined with TACE was equally well tolerated in both age groups, and grade 3 or 4 adverse events were similarly observed in 54.2% of elderly and 50.0% of nonelderly patients (P = 0.739). There were no significant differences in survival time between the elderly and nonelderly patients (P = 0.876). Significant prognostic factors for overall survival as identified by multivariate analysis were the Child-Pugh score and portal vein invasion. Conclusions Sorafenib combined with TACE may be well tolerated and effective in elderly patients with advanced HCC. Age alone is not a parameter for the treatment of advanced HCC patients.	[Hu, Hao; Shi, Haibin; Liu, Sheng; Yang, Zhengqiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing, Jiangsu, Peoples R China; [Duan, Zhenhua] Chengdu Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Long, Xiaoran] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China; [Hertzanu, Yancu] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Tong, Xiaoqiang] Peking Univ, Hosp 1, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China; [Xu, Xiaoquan] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Anhui Medical University; Ben Gurion University; Peking University; Nanjing Medical University	Yang, ZQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing, Jiangsu, Peoples R China.	olivialong@sina.cn	Duan, Zhenhua/GRJ-2294-2022					Abou-Alfa GK, 2011, J CLIN ONCOL, V29, P3949, DOI 10.1200/JCO.2011.37.9651; Bai W, 2013, J DIGEST DIS, V14, P181, DOI 10.1111/1751-2980.12038; Bendik E, 2014, EUR RADIOL, V24, P250, DOI 10.1007/s00330-013-3006-8; Biselli M, 1997, J GERONTOL A-BIOL, V52, pM305, DOI 10.1093/gerona/52A.5.M305; Boehm S, 2010, GERONTOLOGY, V56, P303, DOI 10.1159/000262450; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Cohen MJ, 2014, LIVER INT, V34, P1109, DOI 10.1111/liv.12486; Cohen MJ, 2013, WORLD J GASTROENTERO, V19, P2521, DOI 10.3748/wjg.v19.i16.2521; Costanzo GGD, 2013, MED ONCOL, V30, P446, DOI [10.1007/s12032-012-0446-y, DOI 10.1007/S12032-012-0446-Y]; Hoshida Y, 1999, J HEPATOL, V31, P860, DOI 10.1016/S0168-8278(99)80287-6; Hu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096620; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077240; Lencioni R, 2012, Int J Clin Pract, V66, P675, DOI 10.1111/j.1742-1241.2012.02940.x; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068453; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217; MONDAZZI L, 1994, HEPATOLOGY, V19, P1115, DOI 10.1002/hep.1840190508; Montella L, 2013, ONCOLOGY-BASEL, V84, P265, DOI 10.1159/000345558; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Nanashima A, 2011, J SURG ONCOL, V104, P284, DOI 10.1002/jso.21932; Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279; Ozenne V, 2011, DIGEST LIVER DIS, V43, P1001, DOI 10.1016/j.dld.2011.06.019; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460; Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tan WF, 2010, ACTA PHARMACOL SIN, V31, P1643, DOI 10.1038/aps.2010.124; Teratani T, 2002, CANCER-AM CANCER SOC, V95, P816, DOI 10.1002/cncr.10735; Wong H, 2011, ONCOLOGIST, V16, P1721, DOI 10.1634/theoncologist.2011-0192; Yau T, 2009, CANCER-AM CANCER SOC, V115, P5507, DOI 10.1002/cncr.24636	34	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117168	10.1371/journal.pone.0117168	http://dx.doi.org/10.1371/journal.pone.0117168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689846	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700029
J	Lauria, V; Power, AM; Lordan, C; Weetman, A; Johnson, MP				Lauria, Valentina; Power, Anne Marie; Lordan, Colm; Weetman, Adrian; Johnson, Mark P.			Spatial Transferability of Habitat Suitability Models of Nephrops norvegicus among Fished Areas in the Northeast Atlantic: Sufficiently Stable for Marine Resource Conservation?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EASTERN ENGLISH-CHANNEL; NORWAY LOBSTER; DISTRIBUTIONS; VALIDATION; GENERALITY; ABUNDANCE; CRITERIA; BAY	Knowledge of the spatial distribution and habitat associations of species in relation to the environment is essential for their management and conservation. Habitat suitability models are useful in quantifying species- environment relationships and predicting species distribution patterns. Little is known, however, about the stability and performance of habitat suitability models when projected into new areas (spatial transferability) and how this can inform resource management. The aims of this study were to model habitat suitability of Norway lobster (Nephrops norvegicus) in five fished areas of the Northeast Atlantic (Aran ground, Irish Sea, Celtic Sea, Scotland Inshore and Fladen ground), and to test for spatial transferability of habitat models among multiple regions. Nephrops burrow density was modelled using generalised additive models (GAMs) with predictors selected from four environmental variables (depth, slope, sediment and rugosity). Models were evaluated and tested for spatial transferability among areas. The optimum models (lowest AICc) for different areas always included depth and sediment as predictors. Burrow densities were generally greater at depth and in finer sediments, but relationships for individual areas were sometimes more complex. Aside from an inclusion of depth and sediment, the optimum models differed between fished areas. When it came to tests of spatial transferability, however, most of the models were able to predict Nephrops density in other areas. Furthermore, transferability was not dependent on use of the optimum models since competing models were also able to achieve a similar level of transferability to new areas. A degree of decoupling between model 'fitting' performance and spatial transferability supports the use of simpler models when extrapolating habitat suitability maps to different areas. Differences in the form and performance of models from different areas may supply further information on the processes shaping species' distributions. Spatial transferability of habitat models can be used to support fishery management when the information is scarce but caution needs to be applied when making inference and a multi-area transferability analysis is preferable to bilateral comparisons between areas.	[Lauria, Valentina; Johnson, Mark P.] Natl Univ Ireland, Sch Nat Sci, Ryan Inst, Galway, Ireland; [Power, Anne Marie] Natl Univ Ireland, Sch Nat Sci, Ryan Inst, Dept Zool, Galway, Ireland; [Lordan, Colm] Inst Marine, Oranmore, Co Galway, Ireland; [Weetman, Adrian] Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Marine Institute Ireland; Marine Scotland Science (MSS)	Lauria, V (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	valentina.lauria@plymouth.ac.uk	Lauria, Valentina/AAG-4906-2021; Lordan, Colm/AAU-4539-2020; Johnson, Mark/W-4226-2019; Lauria, Valentina/R-9053-2018; Johnson, Mark P/B-5017-2009	Lordan, Colm/0000-0001-8929-3513; Johnson, Mark/0000-0002-5078-1410; Lauria, Valentina/0000-0002-4179-9133; Johnson, Mark P/0000-0002-5078-1410; Power, Anne Marie/0000-0001-7351-2451	European Union through the FP7 Framework Programme FP7-SME-286903	European Union through the FP7 Framework Programme FP7-SME-286903	This work was funded by the European Union through the FP7 Framework Programme FP7-SME-2011-286903 (NEPHROPS project). VL AMP MPJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Dias M, 1998, THESIS U ABERDEEN; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Bailey M. C., 2012, SUSTAINABLE FISHING; Bell MC, 2005, NEW ZEAL J MAR FRESH, V39, P1023, DOI 10.1080/00288330.2005.9517373; Bivand R, 2013, R PACKAGE RGDAL DATA; Bulluck L, 2006, GLOBAL ECOL BIOGEOGR, V15, P27, DOI 10.1111/j.1466-822x.2006.00170.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell N, 2009, ICES J MAR SCI, V66, P646, DOI 10.1093/icesjms/fsp046; Campbell N, 2009, ICES J MAR SCI, V66, P2052, DOI 10.1093/icesjms/fsp176; dos Santos A, 2005, J MAR BIOL ASSOC UK, V85, P937, DOI 10.1017/S0025315405011914; Dueri S, 2014, GLOBAL CHANGE BIOL, V20, P742, DOI 10.1111/gcb.12460; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Fleishman E, 2003, CONSERV BIOL, V17, P806, DOI 10.1046/j.1523-1739.2003.02113.x; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Guay JC, 2003, CAN J FISH AQUAT SCI, V60, P1398, DOI 10.1139/F03-120; Guinan J, 2011, MODELLING HABITAT SU, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Heinanen S, 2008, ECOGRAPHY, V31, P601, DOI 10.1111/j.0906-7590.2008.05410.x; Hijmans R. J., 2013, INTRO RASTER PACKAGE, P1; ICES Advisory Commitee on Fishery Management, 2004, 2004ACFM19 ICES CM; ICES Advisory Commitee on Fishery Management, 2012, STUD GROUP NEPHR SUR; Jensen OP, 2005, MAR ECOL PROG SER, V299, P239, DOI 10.3354/meps299239; Johnson MP, 2013, ADV MAR BIOL, V64, P27, DOI 10.1016/B978-0-12-410466-2.00002-9; Lauria V, 2011, ICES J MAR SCI, V68, P1500, DOI 10.1093/icesjms/fsr081; Leftwich KN, 1997, T AM FISH SOC, P37, DOI [10.1577/1548-8659(1997)126&LT;0725, DOI 10.1577/1548-8659(1997)126<0725]; Maki-Petays A, 2002, CAN J FISH AQUAT SCI, V59, P218, DOI 10.1139/F01-209; Martin CS, 2012, J EXP MAR BIOL ECOL, V418, P91, DOI 10.1016/j.jembe.2012.03.010; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Planque B, 2011, FISH OCEANOGR, V20, P1, DOI 10.1111/j.1365-2419.2010.00546.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Schaub M, 2011, ECOGRAPHY, V34, P693, DOI 10.1111/j.1600-0587.2010.06584.x; Sikder S, 2013, INT J ADV ENG SCI AP, V5, P104, DOI 10.1007/s12572-013-0090-6; Strakosh TR, 2003, ECOL FRESHW FISH, V12, P265, DOI 10.1046/j.1600-0633.2003.00022.x; Strauss B, 2007, ECOL MODEL, V204, P104, DOI 10.1016/j.ecolmodel.2006.12.027; Sundblad G, 2009, ESTUAR COAST SHELF S, V83, P90, DOI 10.1016/j.ecss.2009.03.025; THOMAS JA, 1993, REGUL RIVER, V8, P285, DOI 10.1002/rrr.3450080307; Thompson IS, 1998, 1998CC12 ICES CM; Tuck ID, 1997, ICES J MAR SCI, V54, P125, DOI 10.1006/jmsc.1996.0179; Ungfors A, 2013, ADV MAR BIOL, V64, P247, DOI 10.1016/B978-0-12-410466-2.00007-8; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x; Zhu GP, 2014, BIOL INVASIONS, V16, P1069, DOI 10.1007/s10530-013-0559-z; Zuur AF, 2007, ANAL ECOLOGICAL DATA, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]	58	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117006	10.1371/journal.pone.0117006	http://dx.doi.org/10.1371/journal.pone.0117006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679507	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600044
J	Zheng, GH; Li, SZ; Huang, MM; Liu, FW; Tao, J; Chen, LD				Zheng, Guohua; Li, Shuzhen; Huang, Maomao; Liu, Feiwen; Tao, Jing; Chen, Lidian			The Effect of Tai Chi Training on Cardiorespiratory Fitness in Healthy Adults: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; IMPROVING AEROBIC CAPACITY; TIME PHYSICAL-ACTIVITY; OLDER-ADULTS; CHUAN PRACTITIONERS; EXERCISE INTENSITY; BLOOD-PRESSURE; RISK-FACTORS; WOMEN; MORTALITY	Background Tai Chi may be efficient for healthy adults to improve the cardiorespiratory fitness, but there is no systematic evaluation for its effectiveness. Objective To systematically assess the effectiveness of Tai Chi on cardiorespiratory fitness in healthy adults. Methods Seven electronic databases were searched from their inception to October 2013. The controlled trails including randomized controlled trial (RCT), non-randomized controlled trial (NRCT), self-controlled trial (SCT), and cohort study (CS) testing Tai Chi exercise against non-intervention control conditions in healthy adults that assessed any type cardiorespiratory fitness outcome measures were considered. Two reviewers independently performed the selection of the studies according to predefined criteria. The risk of bias was assessed using Cochrane criteria. RevMan 5.2 software was applied for data analysis. Results Twenty studies (2 RCTs, 8 NRCTs, 3 SCTs, and 7 CSs) with 1868 participants were included, but most of them belonged to low methodological quality. The results of systematic review showed that Tai Chi exercise had positive effect on majority outcomes of cardio function (Blood pressure: n = 536, SPB SMD = -0.93, 95% CI -1.30 to -0.56, P < 0.00001; DBP SMD = -0.54, 95% CI -0.90 to -0.18, P < 0.00001; heart rate at quiet condition: n = 986, SMD = -0.72, 95% CI -1.27 to -0.18, P = 0.010; stroke volume: n = 583, SMD = 0.44, 95% CI 0.28 to 0.61, P < 0.00001; cardio output: n = 583, MD = 0.32 L/ min, 95% CI 0.08 to 0.56, P = 0.009), lung capacity (FVC at quiet condition: n = 1272, MD = 359.16 mL, 95% CI 19.57 to 698.75, P = 0.04 for less than one year intervention, and MD = 442.46 mL, 95% CI 271.24 to 613.68, P<0.0001 for more than one year intervention; V.O(2)peak: n = 246, SMD = 1.33, 95% CI 0.97 to 1.70, P < 0.00001), and cardiorespiratory endurance (O-2 pulse at quiet condition: n = 146, SMD = 1.04; 95% CI 0.69 to 1.39; P < 0.00001; stair test index at quiet condition: n = 679, SMD = 1.34, 95% CI 0.27 to 2.40, p = 0.01). No adverse events were reported. Conclusions The results are encouraging and suggest that Tai Chi may be effective in improving cardiorespiratory fitness in healthy adults. However, concerning the low methodological quality in the included studies, more larger-scale well-designed trails are needed till the specific and accurate conclusions can be perorated.	[Zheng, Guohua; Li, Shuzhen; Huang, Maomao; Liu, Feiwen; Tao, Jing] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou, Peoples R China; [Chen, Lidian] Fujian Univ Tradit Chinese Med, Fuzhou, Peoples R China	Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine	Chen, LD (corresponding author), Fujian Univ Tradit Chinese Med, Fuzhou, Peoples R China.	lidianchen87@163.com		Li, shuzhen/0000-0002-8336-092X; Tao, Jing/0000-0001-9751-5294; Chen, Lidian/0000-0002-6454-7932	Collaboration Innovation Center for Rehabilitation Technology (number 1 Collaboration Center); Rehabilitation Research Center for Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China	Collaboration Innovation Center for Rehabilitation Technology (number 1 Collaboration Center); Rehabilitation Research Center for Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China	This study is supported by the Collaboration Innovation Center for Rehabilitation Technology (number 1 Collaboration Center (2012)) and Rehabilitation Research Center for Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmaidi S, 1998, EUR J APPL PHYSIOL O, V78, P170, DOI 10.1007/s004210050403; Barlow CE, 2006, AM J EPIDEMIOL, V163, P142, DOI 10.1093/aje/kwj019; Birdee GS, 2013, J ALTERN COMPLEM MED, V19, P550, DOI 10.1089/acm.2012.0223; Bu Bin, 2010, J Evid Based Med, V3, P205, DOI 10.1111/j.1756-5391.2010.01107.x; Chan AWK, 2013, COMPLEMENT THER MED, V21, P585, DOI 10.1016/j.ctim.2013.09.008; Chang MY, 2013, AM J HEALTH PROMOT, V28, P16, DOI 10.4278/ajhp.120720-QUAN-356; Chen S. Y., 2013, EVID-BASED COMPL ALT, V2013, DOI [DOI 10.1155/2013/983208, 10.1155/2013/983208]; Cheon SM, 2013, J CLIN NEUROL, V9, P237, DOI 10.3988/jcn.2013.9.4.237; Fu X, 2009, J GANSU NORMAL COLL, V14, P73; Fujie S, 2013, PHYSIOL GENOMICS, V45, P237, DOI 10.1152/physiolgenomics.00089.2012; Gatts Strawberry, 2008, Curr Aging Sci, V1, P68; GOVINDASAMY D, 1992, EUR J APPL PHYSIOL, V65, P203, DOI 10.1007/BF00705082; Han YZ, 2010, STUDY PHASED EVALUAT; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho Rainbow T H, 2012, Evid Based Complement Alternat Med, V2012, P923925, DOI 10.1155/2012/923925; Hong YL, 2000, BRIT J SPORT MED, V34, P29, DOI 10.1136/bjsm.34.1.29; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; LAI JS, 1995, J AM GERIATR SOC, V43, P1222, DOI 10.1111/j.1532-5415.1995.tb07397.x; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Lan C, 2004, AM J CHINESE MED, V32, P151, DOI 10.1142/S0192415X04001746; Lan C, 2004, AM J CHINESE MED, V32, P141, DOI 10.1142/S0192415X04001734; Lan C, 1999, MED SCI SPORT EXER, V31, P634, DOI 10.1097/00005768-199905000-00002; Lan C, 2001, MED SCI SPORTS EXERC, V5, P12, DOI [10.1002/bmc.3406, DOI 10.1002/BMC.3406]; Lan C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/502131; Lan C, 2008, AM J CHINESE MED, V36, P1041, DOI 10.1142/S0192415X08006442; Lan Ching, 2008, V52, P12, DOI 10.1159/000134225; Lang CC, 2007, J CARD FAIL, V13, P672, DOI 10.1016/j.cardfail.2007.05.004; Laukkanen Jari A, 2002, Curr Atheroscler Rep, V4, P468, DOI 10.1007/s11883-002-0052-0; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lee LYK, 2013, STRESS HEALTH, V29, P117, DOI 10.1002/smi.2435; Lee MS, 2009, BRIT J SPORT MED, V43, P569, DOI 10.1136/bjsm.2008.053272; Lei XS, 2001, MODERN REKABITLTALIO, V5, P64; Leung RWM, 2013, EXPERT REV RESP MED, V7, P587, DOI 10.1586/17476348.2013.839244; Li JX, 2001, BRIT J SPORT MED, V35, P148, DOI 10.1136/bjsm.35.3.148; [李兴海 LI Xinghai], 2008, [河南师范大学学报. 自然科学版, Journal of Henan Normal University. Natural Science], V36, P123; Liang YW, 2001, J PHYS ED, V8, P64; Liu X., 2010, CHINA PRACTICAL MED, V5, P34; Lo HM, 2012, INT J NURS PRACT, V18, P545, DOI 10.1111/ijn.12006; Lu WA, 2003, MED SCI SPORT EXER, V35, P1972, DOI 10.1249/01.MSS.0000099242.10669.F7; Lu WA, 2012, INT J GERONTOL, V6, P267, DOI 10.1016/j.ijge.2012.01.025; Malagrino PA, 2013, ARQ BRAS ENDOCRINOL, V57, P33, DOI 10.1590/S0004-27302013000100005; Manson J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-114; Minton O, 2008, JNCI-J NATL CANCER I, V100, P1155, DOI 10.1093/jnci/djn250; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Motivala SJ, 2006, J GERONTOL A-BIOL, V61, P1177, DOI 10.1093/gerona/61.11.1177; Nabkasorn C, 2006, EUR J PUBLIC HEALTH, V16, P179, DOI 10.1093/eurpub/cki159; Ng SM, 2012, ALTERN THER HEALTH M, V18, P16; Nguyen MH, 2012, OPEN ACCESS J SPORTS, V3, P7, DOI 10.2147/OAJSM.S27329; Niu RC, 2014, HEART LUNG CIRC, V23, P347, DOI 10.1016/j.hlc.2013.10.057; Peng CZ, 2006, FIGHTING MARTIAL SCI, V6, P32; Prentis JM, 2013, BJU INT, V112, pE13, DOI 10.1111/bju.12219; [荣湘江 RONG Xiangjiang], 2009, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V24, P345; Savovic J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-37; Singhal N, 2014, J PHYS ACT HEALTH, V11, P296, DOI 10.1123/jpah.2012-0029; Sloan RA, 2013, SINGAP MED J, V54, P576; Snowden CP, 2013, ANN SURG, V257, P999, DOI 10.1097/SLA.0b013e31828dbac2; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Taylor-Piliae Ruth E, 2004, J Cardiovasc Nurs, V19, P48; Taylor-Piliae RE, 2014, ARCH PHYS MED REHAB, V95, P816, DOI 10.1016/j.apmr.2014.01.001; Taylor-Piliae Ruth E., 2008, V52, P40, DOI 10.1159/000134283; Thornton EW, 2004, HEALTH PROMOT INT, V19, P33, DOI 10.1093/heapro/dah105; Tousignant M, 2013, DISABIL REHABIL, V35, P1429, DOI 10.3109/09638288.2012.737084; Tsimaras V, 2003, PERCEPT MOTOR SKILL, V96, P1239, DOI 10.2466/PMS.96.4.1239-1251; Tu HL, 2005, J WUHAN I PHYS ED, V39, P70; Verhagen AP, 2004, FAM PRACT, V21, P107, DOI 10.1093/fampra/cmh122; Wang GJ, 2010, CHINESE J GERONTOLOG, V12, P3802; Xiong KY, 2013, EUR J SPORT SCI, V13, P386, DOI 10.1080/17461391.2011.635706; Xu M, 1997, J CHENGDU PHYS ED I, V3, P79; Yan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061672; Yan Y., 2013, J LIAONING NORMAL U, V36, P124; Yan Y, 2010, SCI INFORM, V28, P271; Yeh Gloria Y, 2008, Prev Cardiol, V11, P82; Yeh GY, 2008, EXPLORE-NY, V4, P275, DOI 10.1016/j.explore.2008.04.011; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; Yu R, 2013, J SPORT MED PHYS FIT, V53, P680	76	41	45	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117360	10.1371/journal.pone.0117360	http://dx.doi.org/10.1371/journal.pone.0117360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680184	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600062
J	Sasatani, M; Xu, YB; Kawai, H; Cao, LL; Tateishi, S; Shimura, T; Li, JX; Iizuka, D; Noda, A; Hamasaki, K; Kusunoki, Y; Kamiya, K				Sasatani, Megumi; Xu, Yanbin; Kawai, Hidehiko; Cao, Lili; Tateishi, Satoshi; Shimura, Tsutomu; Li, Jianxiang; Iizuka, Daisuke; Noda, Asao; Hamasaki, Kanya; Kusunoki, Yoichiro; Kamiya, Kenji			RAD18 Activates the G2/M Checkpoint through DNA Damage Signaling to Maintain Genome Integrity after Ionizing Radiation Exposure	PLOS ONE			English	Article							STRAND BREAK REPAIR; PCNA MONOUBIQUITINATION; MAMMALIAN-CELLS; UBIQUITIN; 53BP1; SITES; MDC1; RECOMBINATION; RETENTION; MECHANISM	The ubiquitin ligase RAD18 is involved in post replication repair pathways via its recruitment to stalled replication forks, and its role in the ubiquitylation of proliferating cell nuclear antigen (PCNA). Recently, it has been reported that RAD18 is also recruited to DNA double strand break (DSB) sites, where it plays novel functions in the DNA damage response induced by ionizing radiation (IR). This new role is independent of PCNA ubiquitylation, but little is known about how RAD18 functions after IR exposure. Here, we describe a role for RAD18 in the IR-induced DNA damage signaling pathway at G2/M phase in the cell cycle. Depleting cells of RAD18 reduced the recruitment of the DNA damage signaling factors ATM, gamma H2AX, and 53BP1 to foci in cells at the G2/M phase after IR exposure, and attenuated activation of the G2/M checkpoint. Furthermore, depletion of RAD18 increased micronuclei formation and cell death following IR exposure, both in vitro and in vivo. Our data suggest that RAD18 can function as a mediator for DNA damage response signals to activate the G2/M checkpoint in order to maintain genome integrity and cell survival after IR exposure.	[Sasatani, Megumi; Xu, Yanbin; Cao, Lili; Li, Jianxiang; Iizuka, Daisuke; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, Hiroshima 7348553, Japan; [Kawai, Hidehiko] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Minami Ku, Hiroshima 7348553, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Shimura, Tsutomu] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Noda, Asao; Hamasaki, Kanya] Radiat Effects Res Fdn, Dept Genet, Minami Ku, Hiroshima 7320815, Japan; [Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Minami Ku, Hiroshima 7320815, Japan	Hiroshima University; Hiroshima University; Kumamoto University; National Institute of Public Health - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	Kamiya, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	kkamiya@hiroshima-u.ac.jp		IIZUKA, Daisuke/0000-0003-3990-4800; Noda, Asao/0000-0002-9029-9813; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare; NIFS Collaborative Research Program [NIFS10KOBS015, NIFS13KOBA028]; Grants-in-Aid for Scientific Research [26340024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare; NIFS Collaborative Research Program(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Fusion Science (NIFS) - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funding was provided by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare (to KK and MS). The funding was also provided in part by NIFS Collaborative Research Program (NIFS10KOBS015) (NIFS13KOBA028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Liu T, 2012, DNA REPAIR, V11, P131, DOI 10.1016/j.dnarep.2011.10.012; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang B, 2014, METHODS MOL BIOL, V1170, P313, DOI 10.1007/978-1-4939-0888-2_15; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xie C, 2014, BIOCHEM BIOPH RES CO, V445, P263, DOI 10.1016/j.bbrc.2014.02.003; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yoshimura A, 2006, DNA REPAIR, V5, P1307, DOI 10.1016/j.dnarep.2006.05.045; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	34	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117845	10.1371/journal.pone.0117845	http://dx.doi.org/10.1371/journal.pone.0117845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675240	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000034
J	Cermeno, P; Quilez-Badia, G; Ospina-Alvarez, A; Sainz-Trapaga, S; Boustany, AM; Seitz, AC; Tudela, S; Block, BA				Cermeno, Pablo; Quilez-Badia, Gemma; Ospina-Alvarez, Andres; Sainz-Trapaga, Susana; Boustany, Andre M.; Seitz, Andy C.; Tudela, Sergi; Block, Barbara A.			Electronic Tagging of Atlantic Bluefin Tuna (Thunnus thynnus, L.) Reveals Habitat Use and Behaviors in the Mediterranean Sea	PLOS ONE			English	Article							STATE-SPACE MODEL; POPULATION-STRUCTURE; DIVING BEHAVIOR; REPRODUCTIVE-BIOLOGY; MITOCHONDRIAL-DNA; THERMAL BIOLOGY; SEXUAL-MATURITY; YELLOWFIN TUNA; HOME-RANGE; WESTERN	We analyzed the movements of Atlantic tuna (Thunnus thynnus L.) in the Mediterranean Sea using data from 2 archival tags and 37 pop-up satellite archival tags (PAT). Bluefin tuna ranging in size from 12 to 248 kg were tagged on board recreational boats in the western Mediterranean and the Adriatic Sea between May and September during two different periods (2000 to 2001 and 2008 to 2012). Although tuna migrations between the Mediterranean Sea and the Atlantic Ocean have been well reported, our results indicate that part of the bluefin tuna population remains in the Mediterranean basin for much of the year, revealing a more complex population structure. In this study we demonstrate links between the western Mediterranean, the Adriatic and the Gulf of Sidra (Libya) using over 4336 recorded days of location and behavior data from tagged bluefin tuna with a maximum track length of 394 days. We described the oceanographic preferences and horizontal behaviors during the spawning season for 4 adult bluefin tuna. We also analyzed the time series data that reveals the vertical behavior of one pop-up satellite tag recovered, which was attached to a 43.9 kg tuna. This fish displayed a unique diving pattern within 16 days of the spawning season, suggesting a use of the thermocline as a thermoregulatory mechanism compatible with spawning. The results obtained hereby confirm that the Mediterranean is clearly an important habitat for this species, not only as spawning ground, but also as an overwintering foraging ground.	[Cermeno, Pablo; Boustany, Andre M.; Block, Barbara A.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Cermeno, Pablo; Quilez-Badia, Gemma; Ospina-Alvarez, Andres; Sainz-Trapaga, Susana; Tudela, Sergi] WWF Mediterranean Programme, Barcelona 08002, Spain; [Ospina-Alvarez, Andres] Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Marine Conservat, Santiago 6513677, Chile; [Ospina-Alvarez, Andres] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Ecol, Santiago 6513677, Chile; [Boustany, Andre M.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Seitz, Andy C.] Monterey Bay Aquarium, Tuna Res & Conservat Ctr, Monterey, CA 93940 USA; [Seitz, Andy C.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA	Stanford University; World Wildlife Fund; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Duke University; Monterey Bay Aquarium Research Institute; University of Alaska System; University of Alaska Fairbanks	Cermeno, P (corresponding author), Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	pcerme@gmail.com	Ospina-Alvarez, Andres/M-2556-2014	Ospina-Alvarez, Andres/0000-0003-2454-7169	Prince Albert II of Monaco Foundation; Project Oceans United Postcode Lotteries; Tag A Giant Foundation (TAG); Stanford University	Prince Albert II of Monaco Foundation; Project Oceans United Postcode Lotteries; Tag A Giant Foundation (TAG); Stanford University(Stanford University)	The project was supported by the Prince Albert II of Monaco Foundation, the Project Oceans United Postcode Lotteries, Tag A Giant Foundation (TAG) and Stanford University. PC was funded by a Young Researcher Award from the Prince Albert II of Monaco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2004, FISH B-NOAA, V102, P407; Abdelhadi B, 2011, MEDITERRANEA SERIE E; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Alvarado Bremer J.R., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P127; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Arena P, 1988, MMM CNR ATT SEM UU O, P273; Arena P., 2006, LENGTH WEIGHT RELATI; Arena P, 1981, QUAD LAB TECN PESC S, V3, P77; Arena P, 1982, ATT CONV UU OO SOTT, P361; Arena P, 1963, FAO P GEN FISH COUN, V7, P395; Arregui I., 2006, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V59, P769; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Bahurel P, 2009, OCEANOBS 09 OC SOC S; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Broughton RE, 1997, MOL MAR BIOL BIOTECH, V6, P308; Buljan M, 1964, ACTA ADRIAT, V11, P35; Bunag DM, 1956, PHILIPP J FISH, V26, P877; Cannas R, 2012, COL VOL SCI PAP ICCA, V67, P351; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cermeno P, 2012, COL VOL SCI PAP ICCA, V68, P151; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Cort JL, 2013, REV FISH SCI, V21, P181, DOI 10.1080/10641262.2013.793284; de la Serna J.D., 2004, COL VOL SCI PAP ICCA, V56, P1196; De la Serna JM, 1992, COL VOL SCI PAP ICCA, V39, P692; De la Serna JM, 2011, COL VOL SCI PAP ICCA, V66, P984; De la Serna JM, 1993, COL VOL SCI PAP ICCA, V40, P116; De Metrio G., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1163; de Metrio G., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1337; De Metrio G, 2005, P 5 C FISH TEL HELD; Di Natale A, 2005, COL VOL SCI PAP ICCA, V58, P1296; Di Natale A, 2005, COL VOL SCI PAP ICCA, V58, P1285; Di Natale A, 2006, COL VOL SCI PAP ICCA, V59, P829; DiNatale A., 2010, COLLECTIVE VOLUMES S, V65, P1004; Druon JN, 2011, MAR ECOL PROG SER, V439, P223, DOI 10.3354/meps09321; EDMUNDS PH, 1973, J FISH RES BOARD CAN, V30, P1031, DOI 10.1139/f73-172; Ely B, 2002, MAR BIOTECHNOL, V4, P583, DOI 10.1007/s10126-002-0040-y; FAO, 2013, 15 SESS SCI ADV COMM; FAO, 2013, CWP HDB FISH STAT H, V1; FAO, 2006, 8 SESS SCI ADV COMM; Farley JH, 1998, FISH B-NOAA, V96, P223; Fromentin JM, 2014, ICES J MAR SCI, V71, P510, DOI 10.1093/icesjms/fst157; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2009, COL VOL SCI PAP ICCA, V65, P812; Fromentin JM, 2004, COL VOL SCI PAP ICCA, V56, P1182; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P535; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Hattour A, 2003, COLLECTIVE VOLUME SC, V55, P204; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hunter J.R., 1985, NOAA TECH REP NMFS, V36, P67; ICCAT, 2007, COL VOL SCI PAP ICCA, V60, P652; ICCAT, 2009, COLLECT VOL SCI PAP, V64, P1; Idrissi M., 2010, ICCAT COLLECT VOL SC, V65, P968; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; June F. C., 1954, Fishery Bulletin United States, V54, P47; Karakulak F.S., 2009, COLLECTIVE VOLUME SC, V63, P153; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Lloret J, 2000, ICES J MAR SCI, V57, P171, DOI 10.1006/jmsc.2000.0570; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Mather FJ, 1995, NMFSSEFSC370 NOAA; McGowan M. F., 1986, INT COMM CONSERV ATL, V24, P182; MCPHERSON GR, 1991, AUST J MAR FRESH RES, V42, P465, DOI 10.1071/MF9910465; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Morovic Mira, 2004, Gayana (Concepc.), V68, P405; Muhling BA, 2010, FISH OCEANOGR, V19, P526, DOI 10.1111/j.1365-2419.2010.00562.x; Natale AD, 2011, COL VOL SCI PAP ICCA, V66, P995; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Oray I, 1997, COL VOL SCI PAP ICCA, V46; Oray I.K., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1341; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Parrack M., 1979, COL VOL SCI PAP ICCA, V8, P356; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Piccinetti C, 2012, COL VOL SCI PAP ICCA, V69, P891; Platonenko S., 1997, COL VOL SCI PAP ICCA, V46, P496; Pujolar JM, 2003, MAR BIOL, V143, P613, DOI 10.1007/s00227-003-1080-1; Quilez-Badia G, 2013, COL VOL SCI PAP ICCA, V69, P435; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Relini M, 1995, COLL VOL SCI PAP, V44, P378; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RODRIGUEZRODA J, 1969, INVEST PESQ, V33, P87; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; Salat J, 2011, 13 PLIN C MED STORMS, V13, P13; Sara R., 1964, Proceedings of the General Fisheries Council for the Mediterranean FAO, VNo. 7, P371; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Sarasquete C, 2002, HISTOL HISTOPATHOL, V17, P775, DOI 10.14670/HH-17.775; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer Kurt M., 1998, Inter-American Tropical Tuna Commission Bulletin, V21, P205; Serna J. M. de la, 2012, COL VOL SCI PAP ICCA, V68, P115; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sournia A., 1973, B ETUDE COMMUN MEDIT, V5, P1; SPENCER SR, 1990, ECOLOGY, V71, P1817, DOI 10.2307/1937590; STEQUERT B, 1995, AQUAT LIVING RESOUR, V8, P79, DOI 10.1051/alr:1995006; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Takagi M, 1999, FISHERIES SCI, V65, P571, DOI 10.2331/fishsci.65.571; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Thompson Jr HC, 1980, COL VOL SCI PAP ICCA, V9, P499; Tudela S, 2011, COL VOL SCI PAP ICCA, V66, P1157; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vlaming V. de, 1983, Control processes in fish physiology., P176; WALLACE RA, 1981, AM ZOOL, V21, P325; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wurtz M., 2010, MEDITERRANEAN PELAGI; Yamashita H, 2001, COL VOL SCI PAP ICCA, V52, P809; Yuen H. S. H., 1955, 150 US FISH WILDL SE	128	41	42	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116638	10.1371/journal.pone.0116638	http://dx.doi.org/10.1371/journal.pone.0116638			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671316	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300022
J	Goldmacher, VS; Audette, CA; Guan, YH; Sidhom, EH; Shah, JV; Whiteman, KR; Kovtun, YV				Goldmacher, Victor S.; Audette, Charlene A.; Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.; Whiteman, Kathleen R.; Kovtun, Yelena V.			High-Affinity Accumulation of a Maytansinoid in Cells via Weak Tubulin Interaction	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; CALF BRAIN TUBULIN; SOLUTION VARIABLES; VINCA ALKALOIDS; BINDING; CANCER; VINBLASTINE; DRUGS; NUCLEOTIDES; VINCRISTINE	The microtubule-targeting maytansinoids accumulate in cells and induce mitotic arrest at 250-to 1000-fold lower concentrations than those required for their association with tubulin or microtubules. To identify the mechanisms of this intracellular accumulation and exceptional cytotoxicity of maytansinoids we studied interaction of a highly cytotoxic maytansinoid, S-methyl DM1 and several other maytansinoids with cells. S-methyl DM1 accumulated inside the cells with a markedly higher apparent affinity than to tubulin or microtubules. The apparent affinities of maytansinoids correlated with their cytotoxicities. The number of intracellular binding sites for S-methyl DM1 in MCF7 cells was comparable to the number of tubulin molecules per cell (similar to 4-6 x 10(7) copies). Efflux of (3) [H]-S-methyl DM1 from cells was enhanced in the presence of an excess of non-labeled S-methyl DM1, indicating that re-binding of (3) [H]-S-methyl DM1 to intracellular binding sites contributed to its intracellular retention. Liposomes loaded with non-polymerized tubulin recapitulated the apparent high-affinity association of S-methyl DM1 to cells. We propose a model for the intracellular accumulation of maytansinoids in which molecules of the compounds diffuse into a cell and associate with tubulin. Affinities of maytansinoids for individual tubulin molecules are weak, but the high intracellular concentration of tubulin favors, after dissociation of a compound-tubulin complex, their re-binding to a tubulin molecule, or to a tip of a microtubule in the same cell, over their efflux. As a result, a significant fraction of microtubule tips is occupied with a maytansinoid when added to cells at sub-nanomolar concentrations, inducing mitotic arrest and cell death.	[Goldmacher, Victor S.; Audette, Charlene A.; Whiteman, Kathleen R.; Kovtun, Yelena V.] ImmunoGen Inc, Dept Cell Biol, Waltham, MA 02451 USA; [Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	ImmunoGen, Inc.; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Goldmacher, VS (corresponding author), ImmunoGen Inc, Dept Cell Biol, Waltham, MA 02451 USA.	victor.goldmacher@immunogen.com		Goldmakher, Viktor/0000-0001-6130-4436; Sidhom, Eriene-Heidi/0000-0002-2658-9672	Beckman Laser Institute SPARK program	Beckman Laser Institute SPARK program	Support for FCS work in the Shah Lab was provided by the Beckman Laser Institute SPARK program (YG and JVS): www.beckmanlaserinstitutefoundation.com/programs/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANC DISCOVERY, V3, P366; Barlow SB, 2002, J CELL SCI, V115, P3469; BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; Correia John J., 2008, P21, DOI 10.1007/978-1-59745-336-3_2; CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Flygare JA, 2013, CHEM BIOL DRUG DES, V81, P113, DOI 10.1111/cbdd.12085; Goldmacher VS, 2012, ANNU REP MED CHEM, V47, P349, DOI 10.1016/B978-0-12-396492-2.00023-0; HERZOG W, 1977, P NATL ACAD SCI USA, V74, P1860, DOI 10.1073/pnas.74.5.1860; JORDAN MA, 1991, CANCER RES, V51, P2212; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lobert S, 1996, BIOCHEMISTRY-US, V35, P6806, DOI 10.1021/bi953037i; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; MANDELBAUMSHAVIT F, 1976, BIOCHEM BIOPH RES CO, V72, P47, DOI 10.1016/0006-291X(76)90958-X; NA GC, 1986, BIOCHEMISTRY-US, V25, P6222, DOI 10.1021/bi00368a058; OHTA S, 1993, BRIT J CANCER, V68, P74, DOI 10.1038/bjc.1993.289; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; OSTLUND RE, 1980, J CELL BIOL, V85, P386, DOI 10.1083/jcb.85.2.386; PRAKASH V, 1985, BIOCHEMISTRY-US, V24, P5004, DOI 10.1021/bi00340a007; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; Putnam AJ, 1998, J CELL SCI, V111, P3379; SANDOVAL IV, 1978, P NATL ACAD SCI USA, V75, P3178, DOI 10.1073/pnas.75.7.3178; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SINGER WD, 1988, BIOCHEM PHARMACOL, V37, P2691, DOI 10.1016/0006-2952(88)90264-X; Sontag CA, 2004, BIOPHYS CHEM, V108, P215, DOI 10.1016/j.bpc.2003.10.029; THROWER D, 1991, J IMMUNOL METHODS, V136, P45, DOI 10.1016/0022-1759(91)90248-E; Thrower DA, 1996, CELL MOTIL CYTOSKEL, V35, P121, DOI 10.1002/(SICI)1097-0169(1996)35:2<121::AID-CM5>3.0.CO;2-D; Verdier-Pinard P, 2000, MOL PHARMACOL, V57, P180; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; YORK J, 1981, BIOCHEM PHARMACOL, V30, P3239, DOI 10.1016/0006-2952(81)90524-4	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117523	10.1371/journal.pone.0117523	http://dx.doi.org/10.1371/journal.pone.0117523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671541	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300056
J	Tadee, P; Boonkhot, P; Pornruangwong, S; Patchanee, P				Tadee, Pakpoom; Boonkhot, Phacharaporn; Pornruangwong, Srirat; Patchanee, Prapas			Comparative Phenotypic and Genotypic Characterization of Salmonella spp. in Pig Farms and Slaughterhouses in Two Provinces in Northern Thailand	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; PLASMID ANALYSIS; FOOD ANIMALS; PHAGE TYPES; PORK; ENTERITIDIS; PREVALENCE; HUMANS; RISK	Salmonella spp. are an important group of bacterial zoonotic pathogens which can cause acute food-borne diseases in humans. Pork products are the main source of salmonellosis, but the origins and transmission routes of the disease have not been clearly determined. The purpose of this study was to characterize Salmonella spp. isolated in pig production lines both from pig farms and from slaughterhouses in Chiang Mai and Lamphun provinces in northern Thailand. The study focuses on the association among serotypes, antimicrobial resistance patterns and Pulse Field Gel Electrophoresis (PFGE) patterns to investigate possible sources of infection and to provide information which could help strengthen salmonellosis control programs in the region. A total of 86 strains of Salmonella comprising five majority serotypes were identified. Antibiotic resistance to tetracycline was found to be the most prevalent (82.56%) followed by ampicillin (81.40%) and streptomycin (63.95%). Seven clusters and 28 fingerprint-patterns generated by PFGE were identified among strains recovered from various locations and at different times, providing information on associations among the strains as well as evidence of the existence of persistent strains in some areas. Study results suggest that Salmonella control programs should be implemented at slaughterhouse production lines, including surveillance to insure good hygiene practices, in addition to regular monitoring of large populations of farm animals.	[Tadee, Pakpoom; Boonkhot, Phacharaporn; Patchanee, Prapas] Chiang Mai Univ, Fac Vet Med, Dept Food Anim Clin, Chiang Mai 50000, Thailand; [Pornruangwong, Srirat] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand	Chiang Mai University; Ministry of Public Health - Thailand	Patchanee, P (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Food Anim Clin, Chiang Mai 50000, Thailand.	patprapas@gmail.com	Tadee, Phacharaporn/S-1269-2019	Patchanee, Prapas/0000-0001-7690-0046	National Science and Technology Development Agency (NSTDA) [P-10-10409, P-11-00729]	National Science and Technology Development Agency (NSTDA)	This study has been carried out with financial support from the National Science and Technology Development Agency (NSTDA) Project ID: P-10-10409 and P-11-00729. Laboratory analysis was provided by WHO National Salmonella and Shigella Center Laboratory (NSSC), Nonthaburi, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas Z, 2007, INT J ANTIMICROB AG, V30, P541, DOI 10.1016/j.ijantimicag.2007.06.034; Boonmar S, 1998, J CLIN MICROBIOL, V36, P971, DOI 10.1128/JCM.36.4.971-974.1998; Campioni F, 2012, FOOD MICROBIOL, V32, P254, DOI 10.1016/j.fm.2012.06.008; Clinical and Laboratory Standards Institute (CLSI), 2011, M02A10 CLSI; Dorn-In S, 2009, PREV VET MED, V88, P15, DOI 10.1016/j.prevetmed.2008.06.022; Farzan A, 2006, PREV VET MED, V73, P241, DOI 10.1016/j.prevetmed.2005.09.003; Giovannini A, 2004, FOOD CONTROL, V15, P139, DOI 10.1016/S0956-7135(03)00025-2; Gonzales-Barron UA, 2012, FOOD RES INT, V45, P1184, DOI 10.1016/j.foodres.2010.04.036; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kuo HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095772; Liu WB, 2011, FOOD MICROBIOL, V28, P1182, DOI 10.1016/j.fm.2011.04.001; Lu Y, 2012, PLOS ONE, V9; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; Mc Mahon MAS, 2007, J APPL MICROBIOL, V103, P1883, DOI 10.1111/j.1365-2672.2007.03412.x; Murmann L, 2009, FOOD CONTROL, V20, P191, DOI 10.1016/j.foodcont.2008.04.007; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Patrick AD, 2007, ANTIGENIC FORMULAS S, P111; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Prendergast DM, 2009, INT J FOOD MICROBIOL, V131, P233, DOI 10.1016/j.ijfoodmicro.2009.03.003; Pulsrikarn C, 2012, THAI J VET MED, V42, P21; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Ridley AM, 1998, J CLIN MICROBIOL, V36, P2314, DOI 10.1128/JCM.36.8.2314-2321.1998; Rostagno MH, 2012, FOOD RES INT, V45, P634, DOI 10.1016/j.foodres.2011.04.041; Schwaiger K, 2012, INT J FOOD MICROBIOL, V154, P206, DOI 10.1016/j.ijfoodmicro.2011.12.014; Sirichote P, 2010, SE ASIAN J TROP MED, V41, P1405; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Swanenburg M, 2001, INT J FOOD MICROBIOL, V70, P231, DOI 10.1016/S0168-1605(01)00546-3; Tadee P, 2014, J VET SCI, V15, P327, DOI 10.4142/jvs.2014.15.2.327; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Van Boxstael S, 2012, FOOD RES INT, V45, P913, DOI 10.1016/j.foodres.2011.05.025; van Hoek AHAM, 2012, INT J FOOD MICROBIOL, V153, P45, DOI 10.1016/j.ijfoodmicro.2011.10.013; Visscher CF, 2011, INT J FOOD MICROBIOL, V146, P44, DOI 10.1016/j.ijfoodmicro.2011.01.038; Wong DMALF, 2002, LIVEST PROD SCI, V76, P215	34	23	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116581	10.1371/journal.pone.0116581	http://dx.doi.org/10.1371/journal.pone.0116581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692670	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500017
J	Borghese, B; Sibiude, J; Santulli, P; Pillet, MCL; Marcellin, L; Brosens, I; Chapron, C				Borghese, Bruno; Sibiude, Jeanne; Santulli, Pietro; Pillet, Marie-Christine Lafay; Marcellin, Louis; Brosens, Ivo; Chapron, Charles			Low Birth Weight Is Strongly Associated with the Risk of Deep Infiltrating Endometriosis: Results of a 743 Case-Control Study	PLOS ONE			English	Article							IN-UTERO EXPOSURES; ANATOMICAL DISTRIBUTION; BLADDER ENDOMETRIOSIS; DISEASE; WOMEN; EXPRESSION; STENOSIS; OVARY	The influence of intrauterine environment on the risk of endometriosis is still controversial. Whether birth weight modifies the risk of endometriosis in adulthood remains an open question. For this purpose, we designed a case-control study involving 743 women operated on for benign gynecological indications from January 2004 to December 2011. Study group included 368 patients with histologically proven endometriosis: 54 superficial endometriosis (SUP), 79 endometriomas (OMA) and 235 deep infiltrating endometriosis (DIE). Control group included 375 patients without endometriosis as surgically checked. Mean birth weights were compared between patients and controls, according to endometriosis groups and rAFS stages. Mean birth weight was significantly lower for patients with endometriosis as compared to controls (3,119g +/- 614 and 3,251g +/- 557 respectively; p = 0.002). When compared to controls, patients with DIE had the lowest birth weight with a highly significant difference (3,103g +/- 620, p = 0.002). In univariate analysis, patients with low birth weight (LBW), defined as a BW<2,500g, had a higher risk of endometriosis, especially DIE, as compared to the reference group (OR = 1.5, 95% CI: 1.0-2.3 and OR = 1.7, 95% CI: 1.0-2.7, respectively). Multivariate analysis, adjusted on ethnicity and smoking status, showed the persistence of a significant association between endometriosis and LBW with a slight increase in the magnitude of the association (aOR = 1.7, 95% CI: 1.0-2.6 for endometriosis, aOR = 1.8; 95% CI: 1.1-2.9 for DIE). In conclusion, LBW is independently associated with the risk of endometriosis in our population. Among patients with LBW, the risk is almost two-times higher to develop DIE. This association could reflect common signaling pathways between endometriosis and fetal growth regulation. There is also the possibility of a role played by placental insufficiency on the development of the neonate's pelvis and the occurrence of neonatal uterine bleeding that could have consequences on the risk of severe endometriosis.	[Borghese, Bruno; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS UMR 8104, Paris, France; [Borghese, Bruno; Marcellin, Louis; Chapron, Charles] INSERM, U1016, Paris, France; [Borghese, Bruno; Sibiude, Jeanne; Santulli, Pietro; Pillet, Marie-Christine Lafay; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Sorbonne Paris Cite, Grp Hosp Cochin, AP HP,Serv Gynecol Obstet & Med Reprod 2, Paris, France; [Santulli, Pietro] Univ Paris 05, Grp Hosp Cochin, AP HP, Sorbonne Paris Cite,Fac Med,EA 1833,ERTi, Paris, France; [Brosens, Ivo] Katholieke Univ Leuven, Leuven, Belgium; [Brosens, Ivo] Leuven Inst Fertil & Embryol, Leuven, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; KU Leuven	Borghese, B (corresponding author), Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS UMR 8104, Paris, France.	bruno.borghese@cch.aphp.fr	Santulli, Pi/O-8756-2017; Chapron, Charles/O-8567-2017; Sibiude, Jeanne/GRS-5411-2022; Marcellin, Louis/O-8787-2017; louis, marcellin/V-4728-2019; Santulli, Pietro/T-5201-2019	louis, marcellin/0000-0003-4482-9710; Borghese, Bruno/0000-0002-6385-5829				*AFS, 1985, FERTIL STERIL, V43, P351; Barbieri RL, 1998, FERTIL STERIL, V70, P571, DOI 10.1016/S0015-0282(98)00189-7; Benagiano G, 2014, J MATERN-FETAL NEO M, V27, P303, DOI 10.3109/14767058.2013.814630; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Brosens I, 2013, HUM REPROD, V28, P2026, DOI 10.1093/humrep/det243; Brosens I, 2013, HUM REPROD, V28, P2893, DOI 10.1093/humrep/det359; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2003, HUM REPROD, V18, P157, DOI 10.1093/humrep/deg009; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Chapron C, 2011, J PEDIATR ADOL GYNEC, V24, pS7, DOI 10.1016/j.jpag.2011.07.006; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Chapron C, 2010, FERTIL STERIL, V94, P2353, DOI 10.1016/j.fertnstert.2010.04.020; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; FRASER IS, 1986, OBSTET GYNECOL, V68, P630; Gargett CE, 2014, MOL HUM REPROD, DOI [10.1093/molehr/gau085, DOI 10.1093/MOLEHR/GAU085]; Gondret F, 2013, GEN COMP ENDOCR, V194, P208, DOI 10.1016/j.ygcen.2013.09.018; Holt VL, 2000, EPIDEMIOLOGY, V11, P654, DOI 10.1097/00001648-200011000-00007; Liede A, 2000, J MED GENET, V37, P794, DOI 10.1136/jmg.37.10.794; Mazzuca MQ, 2010, J PHYSIOL-LONDON, V588, P1997, DOI 10.1113/jphysiol.2010.187849; Meola J, 2010, FERTIL STERIL, V93, P1750, DOI 10.1016/j.fertnstert.2008.12.058; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; OBER WB, 1955, PEDIATRICS, V16, P445; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; Pillet MCL, 2012, HUM REPROD, V27, P265, DOI 10.1093/humrep/der346; Somigliana E, 2007, FERTIL STERIL, V87, P1287, DOI 10.1016/j.fertnstert.2006.11.090; Somigliana E, 2011, GYNECOL OBSTET INVES, V72, P135, DOI 10.1159/000323531; Turan N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-10; Wolff EF, 2013, FERTIL STERIL, V99, P790, DOI 10.1016/j.fertnstert.2012.11.013	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117387	10.1371/journal.pone.0117387	http://dx.doi.org/10.1371/journal.pone.0117387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679207	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600063
J	Cristofari, R; Trucchi, E; Whittington, JD; Vigetta, S; Gachot-Neveu, H; Stenseth, NC; Le Maho, Y; Le Bohec, C				Cristofari, Robin; Trucchi, Emiliano; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Stenseth, Nils Christian; Le Maho, Yvon; Le Bohec, Celine			Spatial Heterogeneity as a Genetic Mixing Mechanism in Highly Philopatric Colonial Seabirds	PLOS ONE			English	Article							PENGUIN APTENODYTES-PATAGONICUS; POPULATION-STRUCTURE; KING PENGUIN; NATAL DISPERSAL; SITE FIDELITY; R-PACKAGE; RELATEDNESS; DYNAMICS; CROZET; DIFFERENTIATION	How genetic diversity ismaintained in philopatric colonial systems remains unclear, and under-standing the dynamic balance of philopatry and dispersal at all spatial scales is essential to the study of the evolution of coloniality. In the King penguin, Aptenodytes patagonicus, return rates of post-fledging chicks to their natal sub-colony are remarkably high. Empirical studies have shown that adults return year after year to their previous breeding territories within a radius of a few meters. Yet, little reliable data are available on intra-and inter-colonial dispersal in this species. Here, we present the first fine-scale study of the genetic structure in a king penguin colony in the Crozet Archipelago. Samples were collected from individual chicks and analysed at 8 microsatellite loci. Precise geolocation data of hatching sites and selective pressures associated with habitat features were recorded for all sampling locations. We found that despite strong natal and breeding site fidelity, king penguins retain a high degree of panmixia and genetic diversity. Yet, genetic structure appears markedly heterogeneous across the colony, with higher-than-expected inbreeding levels, and local inbreeding and relatedness hotspots that overlap predicted higher-quality nesting locations. This points towards heterogeneous population structure at the sub-colony level, in which fine-scale environmental features drive local philopatric behaviour, while lower-quality patches may act as genetic mixing mechanisms at the colony level. These findings show how a lack of global genetic structuring can emerge from small-scale heterogeneity in ecological parameters, as opposed to the classical model of homogeneous dispersal. Our results also emphasize the importance of sampling design for estimation of population parameters in colonial seabirds, as at high spatial resolution, basic genetic features are shown to be location-dependent. Finally, this study stresses the importance of understanding intra-colonial dispersal and genetic mixing mechanisms in order to better estimate species-wide gene flows and population dynamics.	[Cristofari, Robin; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Le Maho, Yvon] Univ Strasbourg UdS, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib CSM CNRS UdS 647, Strasbourg 02, France; [Cristofari, Robin; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Le Maho, Yvon] CNRS, UMR 7178, LIA BioSensib 647, Strasbourg 02, France; [Cristofari, Robin; Whittington, Jason D.; Le Maho, Yvon; Le Bohec, Celine] CSM, LIA BioSensib 647, Monaco, Monaco; [Cristofari, Robin; Trucchi, Emiliano; Whittington, Jason D.; Stenseth, Nils Christian; Le Bohec, Celine] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, Oslo, Norway	Centre National de la Recherche Scientifique (CNRS); University of Oslo	Cristofari, R (corresponding author), Univ Strasbourg UdS, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib CSM CNRS UdS 647, Strasbourg 02, France.	robin.cristofari@iphc.cnrs.fr	Stenseth, Nils Chr./G-5212-2016; LE BOHEC, CELINE/AAD-3589-2022; Cristofari, Robin/AAO-8097-2021	Stenseth, Nils Chr./0000-0002-1591-5399; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais Paul-Emile Victor (Programme 137); Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Fondation de France / Fondation Ars Cuttoli; Marie Curie Intra European Fellowships (European Commission) [235962, 252252]	Institut Polaire Francais Paul-Emile Victor (Programme 137); Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Fondation de France / Fondation Ars Cuttoli; Marie Curie Intra European Fellowships (European Commission)	This study was supported by the Institut Polaire Francais Paul-Emile Victor (Programme 137), the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), the Fondation de France / Fondation Ars Cuttoli (to JDW), and Marie Curie Intra European Fellowships (FP7-PEOPLE-IEF-2008, European Commission, project No 235962 to CLB, and FP7-PEOPLE-IEF-2010, European Commission, project No 252252 to ET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, MOL ECOL RESOUR, V9, P1530, DOI 10.1111/j.1755-0998.2009.02710.x; Akst EP, 2002, CONSERV GENET, V3, P375, DOI 10.1023/A:1020555303124; Arnaud CM, 2012, MOL ECOL, V21, P493, DOI 10.1111/j.1365-294X.2011.05219.x; Ballou JD, 1997, J HERED, V88, P169, DOI 10.1093/oxfordjournals.jhered.a023085; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Barlow EJ, 2013, IBIS, V155, P762, DOI 10.1111/ibi.12060; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bicknell AWJ, 2012, MOL ECOL, V21, P2863, DOI 10.1111/j.1365-294X.2012.05558.x; Billing TM, 2007, MOL ECOL NOTES, V7, P425, DOI 10.1111/j.1471-8286.2006.01607.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bouzat JL, 2009, AUK, V126, P326, DOI 10.1525/auk.2009.07122; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bried J, 2007, J ZOOL, V272, P20, DOI 10.1111/j.1469-7998.2006.00242.x; Bried J, 2001, IBIS, V143, P670, DOI 10.1111/j.1474-919X.2001.tb04895.x; Brodin A, 1998, AUK, V115, P767, DOI 10.2307/4089426; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Cote SD, 2000, ANIM BEHAV, V59, P813, DOI 10.1006/anbe.1999.1384; Coulson John C., 2002, P87; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Delord K, 2004, POLAR BIOL, V27, P793, DOI 10.1007/s00300-004-0651-z; Descamps S, 2005, POLAR BIOL, V28, P303, DOI 10.1007/s00300-004-0684-3; Descamps Sebastien, 2002, Avian Science, V2, P87; Descamps S, 2009, CONDOR, V111, P81, DOI 10.1525/cond.2009.080066; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; DUNFORD C, 1977, AM NAT, V111, P782, DOI 10.1086/283206; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; Falla RA, 1937, BIRDS BRIT AUSTR NZ, DOI [10.4997/JRCPE.2011.319., DOI 10.4997/JRCPE.2011.319]; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Chacon A, 2013, ECOGRAPHY, V26, P1; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frederiksen M, 1999, WATERBIRDS, V22, P274, DOI 10.2307/1522215; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; GALES R, 1988, AUST WILDLIFE RES, V15, P579; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; HUNTER S, 1991, IBIS, V133, P343, DOI 10.1111/j.1474-919X.1991.tb04581.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2012, ECOL EVOL, V2, P1048, DOI 10.1002/ece3.237; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Le Bohec C, 2007, J ANIM ECOL, V76, P1149, DOI 10.1111/j.1365-2656.2007.01268.x; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lecomte N, 2006, ANIM BEHAV, V71, P457, DOI 10.1016/j.anbehav.2005.07.007; Mangin S, 2003, J AVIAN BIOL, V34, P30, DOI 10.1034/j.1600-048X.2003.02916.x; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Miller JA, 2012, PROGR PHYS GEOGRAPHY, V37, P161; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Osborne PE, 2007, DIVERS DISTRIB, V13, P313, DOI 10.1111/j.1472-4642.2007.00344.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearce JM, 2005, CONSERV GENET, V6, P743, DOI 10.1007/s10592-005-9034-4; Pearce JM, 2008, AUK, V125, P711, DOI 10.1525/auk.2008.07154; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; ROUNSEVELL DE, 1982, AUST WILDLIFE RES, V9, P519; Ruzzante DE, 2001, MOL ECOL, V10, P2107, DOI 10.1046/j.1365-294X.2001.01352.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Shepherd LD, 2005, J HERED, V96, P566, DOI 10.1093/jhered/esi070; Steiner UK, 2005, BEHAV ECOL, V16, P634, DOI 10.1093/beheco/ari035; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Stonehouse B., 1960, KING PENGUIN APTENOD; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Viblanc VA, 2014, OECOLOGIA, P1, DOI [10.1007/s00442-014-3116-2, DOI 10.1007/S00442-014-3116-2]; Vogl C, 2002, J EVOLUTION BIOL, V15, P433, DOI 10.1046/j.1420-9101.2002.00404.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Weir B.S., 1990, GENETIC DATA ANAL ME; Wheelwright NT, 1998, ECOLOGY, V79, P755, DOI 10.1890/0012-9658(1998)079[0755:PNDAIA]2.0.CO;2; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Winters JB, 2003, MOL ECOL, V12, P2251, DOI 10.1046/j.1365-294X.2003.01896.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	88	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117981	10.1371/journal.pone.0117981	http://dx.doi.org/10.1371/journal.pone.0117981			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680103	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600096
J	Dhakal, R; Park, E; Lee, SW; Baek, KH				Dhakal, Radhika; Park, Euiho; Lee, Se-Weon; Baek, Kwang-Hyun			Soybean (Glycine max L. Merr.) Sprouts Germinated under Red Light Irradiation Induce Disease Resistance against Bacterial Rotting Disease	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; GENE-EXPRESSION; JASMONIC ACID; SIGNALING PATHWAYS; DEFENSE RESPONSES; BOTRYTIS-CINEREA; FUSARIUM-WILT; SEED SPROUTS; RICE LEAVES	Specific wavelengths of light can exert various physiological changes in plants, including effects on responses to disease incidence. To determine whether specific light wavelength had effects on rotting disease caused by Pseudomonas putida 229, soybean sprouts were germinated under a narrow range of wavelengths from light emitting diodes (LEDs), including red (650-660), far red (720-730) and blue (440-450 nm) or broad range of wavelength from daylight fluorescence bulbs. The controls were composed of soybean sprouts germinated in darkness. After germination under different conditions for 5 days, the soybean sprouts were inoculated with P. putida 229 and the disease incidence was observed for 5 days. The sprouts exposed to red light showed increased resistance against P. putida 229 relative to those grown under other conditions. Soybean sprouts germinated under red light accumulated high levels of salicylic acid (SA) accompanied with up-regulation of the biosynthetic gene ICS and the pathogenesis-related (PR) gene PR-1, indicating that the resistance was induced by the action of SA via de novo synthesis of SA in the soybean sprouts by red light irradiation. Taken together, these data suggest that only the narrow range of red light can induce disease resistance in soybean sprouts, regulated by the SA-dependent pathway via the de novo synthesis of SA and up-regulation of PR genes.	[Dhakal, Radhika; Park, Euiho; Baek, Kwang-Hyun] Yeungnam Univ, Sch Biotechnol, Gyongsan, Gyeongbuk, South Korea; [Lee, Se-Weon] Rural Dev Adm, Int Technol Cooperat Ctr, Jeonju, South Korea	Yeungnam University; Rural Development Administration (RDA)	Baek, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, Gyeongbuk, South Korea.	khbaek@ynu.ac.kr			Yeungnam University	Yeungnam University	This research was conducted under a research fund provided by Yeungnam University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim Montaser Fawzy, 2011, Mycobiology, V39, P290, DOI 10.5941/MYCO.2011.39.4.290; Achuo EA, 2004, PLANT PATHOL, V53, P65, DOI 10.1111/j.1365-3059.2004.00947.x; Ahn SY, 2013, J PLANT PATHOL, V95, P477; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; BRIDGE MA, 1973, PHYTOPATHOLOGY, V63, P606, DOI 10.1094/Phyto-63-606; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Carviel JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088608; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; DOUPNIK B, 1993, PLANT DIS, V77, P1170; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; GUO A, 1993, PHYSIOL MOL PLANT P, V42, P413, DOI 10.1006/pmpp.1993.1031; Harmon S, 1987, J FOOD PROTECT; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Holt S, 1997, J KOR SOYBEAN DIG, V14, P77; Islam SZ, 2008, J PHYTOPATHOL, V156, P708, DOI 10.1111/j.1439-0434.2008.01435.x; Islam SZ, 2002, HORTSCIENCE, V37, P678, DOI 10.21273/HORTSCI.37.4.678; Islam SZ, 1998, J PHYTOPATHOL, V146, P479, DOI 10.1111/j.1439-0434.1998.tb04609.x; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kang SG, 2009, PLANT PATHOLOGY J, V25, P381, DOI 10.5423/PPJ.2009.25.4.381; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; Khanam NN, 2005, PHYSIOL MOL PLANT P, V66, P20, DOI 10.1016/j.pmpp.2005.03.006; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; LEEMAN M, 1995, EUR J PLANT PATHOL, V101, P655, DOI 10.1007/BF01874869; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu K., 1997, SOYBEANS CHEM TECHNO, P137, DOI DOI 10.1079/BJN/2002529; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Marek G, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-21; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; Noda S, 2009, NAT PHOTONICS, V3, P129, DOI 10.1038/nphoton.2009.15; PENACORTES H, 1993, PLANTA, V191, P123, DOI 10.1007/BF00240903; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; Rahman MZ, 2003, J PHYTOPATHOL, V151, P86, DOI 10.1046/j.1439-0434.2003.00685.x; Robertson LJ, 2002, INT J FOOD MICROBIOL, V75, P119, DOI 10.1016/S0168-1605(01)00738-3; Sanchez L, 2012, PLANT PHYSIOL, V160, P1630, DOI 10.1104/pp.112.201913; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Sano H, 1996, PLANT CELL PHYSIOL, V37, P762, DOI 10.1093/oxfordjournals.pcp.a029011; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; TU JC, 1978, PHYSIOL PLANT PATHOL, V12, P233, DOI 10.1016/0048-4059(78)90065-6; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Wang H, 2010, EUR J PLANT PATHOL, V127, P125, DOI 10.1007/s10658-009-9577-1; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xiao CW, 2008, J NUTR, V138, p1244S, DOI 10.1093/jn/138.6.1244S; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zeier J, 2004, PLANTA, V219, P673, DOI 10.1007/s00425-004-1272-z	53	8	9	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117712	10.1371/journal.pone.0117712	http://dx.doi.org/10.1371/journal.pone.0117712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679808	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600080
J	Jia, LN; Ma, XT; Gui, BS; Ge, H; Wang, L; Ou, Y; Tian, LF; Chen, Z; Duan, ZY; Han, J; Fu, RG				Jia, Lining; Ma, Xiaotao; Gui, Baosong; Ge, Heng; Wang, Li; Ou, Yan; Tian, Lifang; Chen, Zhao; Duan, Zhaoyang; Han, Jin; Fu, Rongguo			Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-beta-Induced Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Objective This study was to investigate whether sorafenib can inhibit the progression of renal fibrosis and to study the possible mechanisms of this effect. Methods Eight-week-old rats were subjected to unilateral ureteral obstruction (UUO) and were intragastrically administered sorafenib, while control and sham groups were administered vehicle for 14 or 21 days. NRK-52E cells were treated with TGF-beta 1 and sorafenib for 24 or 48 hours. HE and Masson staining were used to visualize fibrosis of the renal tissue in each group. The expression of alpha-SMA and E-cadherin in kidney tissue and NRK-52E cells were performed using immunohistochemistry and immunofluorescence. The apoptosis rate of NRK-52E cells was determined by flow cytometry analysis. The protein levels of Smad3 and p-Smad3 in kidney tissue and NRK-52E cells were detected by western blot analysis. Results HE staining demonstrated that kidney interstitial fibrosis, tubular atrophy, and inflammatory cell infiltration in the sorafenib-treated-UUO groups were significantly decreased compared with the vehicle-treated-UUO group (p<0.05). Masson staining showed that the area of fibrosis was significantly decreased in the sorafenib-treated-UUO groups compared with vehicle-treated-UUO group (p<0.01). The size of the kidney did not significantly increase; the cortex of the kidney was thicker and had a richer blood supply in the middle-dose sorafenib group compared with the vehicle-treated-UUO group (p<0.05). Compared with the vehicle-treated-UUO and TGF-beta-stimulated NRK-52E groups, the expression of a-SMA and E-cadherin decreased and increased, respectively, in the UUO kidneys and NRK-52E cells of the sorafenib-treated groups (p<0.05). The apoptotic rate of NRK-52E cells treated with sorafenib decreased for 24 hours in a dose-dependent manner (p<0.05). Compared with the vehicle-treated UUO and TGF-beta-stimulated NRK-52E groups, the ratio of p-Smad3 to Smad3 decreased in the sorafenib-treated groups (p<0.05). Conclusion Our results suggest that sorafenib may useful for the treatment of renal fibrosis through the suppression of TGF-beta/Smad3-induced EMT signaling.	[Jia, Lining; Ma, Xiaotao; Gui, Baosong; Ge, Heng; Wang, Li; Ou, Yan; Tian, Lifang; Chen, Zhao; Duan, Zhaoyang; Han, Jin; Fu, Rongguo] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nephropathy, Xian, Peoples R China	Xi'an Jiaotong University	Fu, RG (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nephropathy, Xian, Peoples R China.	jldoctor@126.com						Bae E, 2012, BIOCHEM BIOPH RES CO, V427, P593, DOI 10.1016/j.bbrc.2012.09.103; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Boffa Jean-Jacques, 2012, Rev Prat, V62, P72; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; D'Amico M, 2012, AM J PHYSIOL-GASTR L, V302, pG1191, DOI 10.1152/ajpgi.00252.2011; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Martinelli E, 2010, CLIN CANCER RES, V16, P4990, DOI 10.1158/1078-0432.CCR-10-0923; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Morinaga J, 2013, AM J PHYSIOL-RENAL, V305, pF173, DOI 10.1152/ajprenal.00586.2012; Peer CJ, 2012, CLIN CANCER RES, V18, P2099, DOI 10.1158/1078-0432.CCR-11-2484; Piera-Velazquez S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S7; Reiberger T, 2009, J HEPATOL, V51, P865, DOI 10.1016/j.jhep.2009.06.024; Rosenbloom J, 2013, BBA-MOL BASIS DIS, V1832, P1088, DOI 10.1016/j.bbadis.2012.12.007; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Thabut D, 2011, HEPATOLOGY, V54, P573, DOI 10.1002/hep.24427; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yuanmeng J, 2012, NAT MED, V18, P580, DOI [10.1038/nm.2685, DOI 10.1038/NM.2685]; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang J, 2013, IEEE T INF FOREN SEC, V8, P5, DOI 10.1109/TIFS.2012.2223675	22	20	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117757	10.1371/journal.pone.0117757	http://dx.doi.org/10.1371/journal.pone.0117757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679376	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600085
J	Kelc, R; Trapecar, M; Gradisnik, L; Rupnik, MS; Vogrin, M				Kelc, Robi; Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak; Vogrin, Matjaz			Platelet-Rich Plasma, Especially When Combined with a TGF-beta Inhibitor Promotes Proliferation, Viability and Myogenic Differentiation of Myoblasts In Vitro	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; IMPROVE MUSCLE RECOVERY; SKELETAL-MUSCLE; ANTIFIBROTIC AGENT; CELL-PROLIFERATION; MYOSTATIN; DECORIN; DESMIN; EXPRESSION; INJURIES	Regeneration of skeletal muscle after injury is limited by scar formation, slow healing time and a high recurrence rate. A therapy based on platelet-rich plasma (PRP) has become a promising lead for tendon and ligament injuries in recent years, however concerns have been raised that PRP-derived TGF-beta could contribute to fibrotic remodelling in skeletal muscle after injury. Due to the lack of scientific grounds for a PRP -based muscle regeneration therapy, we have designed a study using human myogenic progenitors and evaluated the potential of PRP alone and in combination with decorin (a TGF-beta inhibitor), to alter myoblast proliferation, metabolic activity, cytokine profile and expression of myogenic regulatory factors (MRFs). Advanced imaging multicolor single-cell analysis enabled us to create a valuable picture on the ratio of quiescent, activated and terminally committed myoblasts in treated versus control cell populations. Finally high-resolution confocal microscopy validated the potential of PRP and decorin to stimulate the formation of polynucleated myotubules. PRP was shown to down-regulate fibrotic cytokines, increase cell viability and proliferation, enhance the expression of MRFs, and contribute to a significant myogenic shift during differentiation. When combined with decorin further synergistc effects were identified. These results suggest that PRP could not only prevent fibrosis but could also stimulate muscle commitment, especially when combined with a TGF-beta inhibitor.	[Kelc, Robi; Vogrin, Matjaz] Univ Med Ctr Maribor, Dept Orthopaed Surg, Maribor, Slovenia; [Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor	Kelc, R (corresponding author), Univ Med Ctr Maribor, Dept Orthopaed Surg, Maribor, Slovenia.	robi.kelc@gmail.com	Slak Rupnik, Marjan/E-6246-2015; Trapecar, Martin/AAL-5800-2020; Rupnik, Marjan Slak/R-4738-2019	Slak Rupnik, Marjan/0000-0002-3744-4882; Trapecar, Martin/0000-0002-0860-8948; Rupnik, Marjan Slak/0000-0002-3744-4882				ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227; BERGAMINI A, 1992, J VIROL METHODS, V40, P275, DOI 10.1016/0166-0934(92)90086-S; Borrione P, 2012, 32 WORLD C SPORTS ME, P301; Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Cencic J, 2012, CURRENT MED CHEM, P135; Cencic J, 2009, ANN C INT DRUG DISC; Chan YS, 2005, AM J SPORT MED, V33, P43, DOI 10.1177/0363546504265190; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Fakhfakh R, 2011, MOL THER, V19, P204, DOI 10.1038/mt.2010.171; FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085; Fukushima K, 2001, AM J SPORT MED, V29, P394, DOI 10.1177/03635465010290040201; Furutani Y, 2011, J CELL BIOCHEM, V112, P614, DOI 10.1002/jcb.22953; Hamid MSA, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-138; Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004; Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; Li HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064923; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li Y, 2007, MOL THER, V15, P1616, DOI 10.1038/sj.mt.6300250; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Meligy FY, 2012, IN VITRO CELL DEV-AN, V48, P203, DOI 10.1007/s11626-012-9488-x; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Sanchez M, 2009, SPORTS MED, V39, P345, DOI 10.2165/00007256-200939050-00002; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Schallmoser K, 2009, JOVE-J VIS EXP, DOI [10.3791/1656, DOI 10.3791/1656]; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Terada S, 2013, J BONE JOINT SURG AM, V95A, P980, DOI 10.2106/JBJS.L.00266; Tripathi AK, 2011, J MUSCLE RES CELL M, DOI [10.1007/s10974-011-9281-6, DOI 10.1007/S10974-011-9281-6]; UNGEFROREN H, 1995, BIOL REPROD, V52, P1095, DOI 10.1095/biolreprod52.5.1095; Wright-Carpenter T, 2004, INT J SPORTS MED, V25, P588, DOI 10.1055/s-2004-821304; Yamane A, 1998, ARCH ORAL BIOL, V43, P407, DOI 10.1016/S0003-9969(98)00018-1; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	51	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117302	10.1371/journal.pone.0117302	http://dx.doi.org/10.1371/journal.pone.0117302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679956	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600060
J	McMahon, MM; Deepak, A; Fernandez-Baca, D; Boss, D; Sanderson, MJ				McMahon, Michelle M.; Deepak, Akshay; Fernandez-Baca, David; Boss, Darren; Sanderson, Michael J.			STBase: One Million Species Trees for Comparative Biology	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DATA SETS; GENE; TIME; CHALLENGES; COALESCENT; BOOTSTRAP; HISTORY; EXAMPLE; RESOLVE	Comprehensively sampled phylogenetic trees provide the most compelling foundations for strong inferences in comparative evolutionary biology. Mismatches are common, however, between the taxa for which comparative data are available and the taxa sampled by published phylogenetic analyses. Moreover, many published phylogenies are gene trees, which cannot always be adapted immediately for species level comparisons because of discordance, gene duplication, and other confounding biological processes. A new database, STBase, lets comparative biologists quickly retrieve species level phylogenetic hypotheses in response to a query list of species names. The database consists of 1 million single-and multi-locus data sets, each with a confidence set of 1000 putative species trees, computed from GenBank sequence data for 413,000 eukaryotic taxa. Two bodies of theoretical work are leveraged to aid in the assembly of multi-locus concatenated data sets for species tree construction. First, multiply labeled gene trees are pruned to conflict-free singly-labeled species-level trees that can be combined between loci. Second, impacts of missing data inmulti-locus data sets are ameliorated by assembling only decisive data sets. Data sets overlapping with the user's query are ranked using a scheme that depends on user-provided weights for tree quality and for taxonomic overlap of the tree with the query. Retrieval times are independent of the size of the database, typically a few seconds. Tree quality is assessed by a real-time evaluation of boot-strap support on just the overlapping subtree. Associated sequence alignments, tree files and metadata can be downloaded for subsequent analysis. STBase provides a tool for comparative biologists interested in exploiting the most relevant sequence data available for the taxa of interest. It may also serve as a prototype for future species tree oriented databases and as a resource for assembly of larger species phylogenies from precomputed trees.	[McMahon, Michelle M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Deepak, Akshay; Fernandez-Baca, David] Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; [Boss, Darren; Sanderson, Michael J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; Iowa State University; University of Arizona	McMahon, MM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	mcmahonm@email.arizona.edu	Deepak, Akshay/AAA-7369-2019	Deepak, Akshay/0000-0001-6854-8599; Boss, Darren/0000-0001-7588-9500	US National Science Foundation, Division of Environmental Biology [DEB-0829674]; Division of Computing and Communication Foundations [1422134] Funding Source: National Science Foundation	US National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the US National Science Foundation, Division of Environmental Biology, grant DEB-0829674, to MJS, MMM, and DFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenta N, 2003, LECT N BIOINFORMAT, V2812, P216; Anderson CNK, 2012, METHODS MOL BIOL, V856, P3, DOI 10.1007/978-1-61779-585-5_1; Ane C, 2005, SYST BIOL, V54, P146, DOI 10.1080/10635150590905984; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bader DA, 2006, ADV COMPUT, V68, P127, DOI 10.1016/S0065-2458(06)68004-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baum D, 2012, TREE THINKING INTRO; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cormen Thomas H., 2009, INTRO ALGORITHMS; Deepak A, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-18; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flynn S, 2006, SEED INFORM DATABASE; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Goldman N, 2008, PHILOS T R SOC B, V363, P3889, DOI 10.1098/rstb.2008.0182; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hinchliff CE, 2013, SYST BIOL, V62, P205, DOI 10.1093/sysbio/sys088; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Huber KT, 2006, J MATH BIOL, V52, P613, DOI 10.1007/s00285-005-0365-z; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Izquierdo-Carrasco F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-470; Jenkins B, 1997, DR DOBBS J, V22, P107; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Lanfear R, 2011, MOL PHYLOGENET EVOL, V61, P958, DOI 10.1016/j.ympev.2011.07.018; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Manning CD, 2008, INTRO INFORM RETRIEV; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Motwani R., 1995, RANDOMIZED ALGORITHM; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Olavsrud T, 2012, IMPLEMENT NEXT GENER; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Piel William H., 2002, Research Report from the National Institute for Environmental Studies Japan, V171, P41; Pringle EG, 2007, PLANT ECOL, V193, P211, DOI 10.1007/s11258-006-9259-4; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Sanderson MJ, 2003, MOL BIOL EVOL, V20, P1036, DOI 10.1093/molbev/msg115; Saslis-Lagoudakis CH, 2012, P NATL ACAD SCI USA, V109, P15835, DOI 10.1073/pnas.1202242109; Scornavacca C, 2011, INFORM COMPUT, V209, P590, DOI 10.1016/j.ic.2010.11.022; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2010, APPL MATH LETT, V23, P82, DOI 10.1016/j.aml.2009.08.009; Stockham Cara, 2002, Bioinformatics, V18 Suppl 1, pS285; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Zobel J, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1132956.1132959	67	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117987	10.1371/journal.pone.0117987	http://dx.doi.org/10.1371/journal.pone.0117987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679219	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600098
J	Diaz-Martinez, I; Pereda-Suberbiola, X; Perez-Lorente, F; Canudo, JI				Diaz-Martinez, Ignacio; Pereda-Suberbiola, Xabier; Perez-Lorente, Felix; Canudo, Jose Ignacio			Ichnotaxonomic Review of Large Ornithopod Dinosaur Tracks: Temporal and Geographic Implications	PLOS ONE			English	Article							CRETACEOUS JIAGUAN FORMATION; SOUTH-KOREA; ORNITHISCHIAN DINOSAURS; VERTEBRATE FOOTPRINTS; JINDONG FORMATION; THEROPOD TRACKS; NATIONAL-PARK; DAKOTA GROUP; SAUROPOD; COUNTY	Background Large ornithopod tracks are known from the Upper Jurassic to the uppermost Cretaceous rocks of all continents but Antarctica. They include the tracks historically called Iguanodon footprints, iguanodontid footprints, hadrosaur/hadrosaurid footprints, and other large ornithopod tracks that have been used to define ichnotaxa. More than 40 ichnospecies based on large ornithopod tracks have been defined, but the validity of many of them is questionable. Methodology/Principal Findings 34 ichnogenera and 44 ichnospecies have been analysed in this work. Many of them are considered to be invalid because they have been defined on the basis of poorly preserved tracks without diagnostic features, have an inadequate diagnosis, or are based on temporal and/or geographical criteria. Only eight ichnospecies belonging to the ichnogenera Caririchnium, lguanodontipus and Hadrosauropodus are here regarded as valid. Conclusions/Significance The monospecific ichnogenus lguanodontipus (I. burrep) is characterized by a small, rounded heel and elongate, narrow digit impressions. Its distribution is limited to the Berriasian-Valanginian of Europe. Caririchnium consists of four ichnospecies (C. magnificum [type ichnospecies], C. kortmeyeri, C. billsarjeanti and C. lotus) with a large, rounded heel and short, wide digit impressions. This ichnogenus ranges from the Berriasian-Hauterivian to the Aptian-Albian of South America, North America, Asia and Europe. Finally, Hadrosauropodus (three ichnospecies: H. langstoni [type ichnospecies], H. leonardii and H. kyoungsookimi) shows a large, bibbed heel and short, wide digit impressions. It is known from the Aptian-Albian to the Maastrichtian of North America, Asia and Europe. The ichnofamily lguanodontipodidae includes large iguanodontian tracks characterized mainly by mesaxonic, tridactyl and subsymmetrical pes tracks that are as wide as (or wider than) long and have one pad impression in each digit and one in the heel. Its distribution is confidently limited to the Cretaceous of Europe, Asia, North America and South America.					PEREDA SUBERBIOLA, Xabier/J-4306-2012; Suberbiola, Xabier Pereda/M-2804-2019; Martínez, Ignacio Díaz/I-2766-2015	PEREDA SUBERBIOLA, Xabier/0000-0002-7336-7167; Martínez, Ignacio Díaz/0000-0001-5301-8384; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Gobierno Vasco/Eusko Jaurlaritza [IT834-13]; Spanish Ministerio de Economia y Competitividad (MINECO) [CGL2010-16447]; European Regional Development Fund; Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"); MINECO [CGL2010-18851/BTE, CGL2013-47521-P]; Gobierno de Argentina (CONICET)	Gobierno Vasco/Eusko Jaurlaritza(Basque Government); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural")(Gobierno de Aragon); MINECO(Spanish Government); Gobierno de Argentina (CONICET)	This paper is a contribution to the projects: IT834-13 of the Gobierno Vasco/Eusko Jaurlaritza; CGL2010-16447 subsidized by the Spanish Ministerio de Economia y Competitividad (MINECO), the European Regional Development Fund, and the Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"); the project CGL2010-18851/BTE (MINECO); and the project CGL2013-47521-P (MINECO). IDM is the beneficiary of a Postdoctoral grant from the Gobierno de Argentina (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRREZABALA L M, 1983, Munibe, V35, P1; Aguirrezabala L.M., 1980, Munibe, V32, P257; Alonso R.N., 1980, Acta Geologica Lilloana, V15, P55; Alonso RN, 1986, ACT 4 C ARG PAL BIOE, V2, P33, DOI [10.1016/j.acuro.2014.11.005, DOI 10.1016/J.ACURO.2014.11.005]; Alvarez Bermejo JM, 2013, ZUBIA, V31, P199; Apesteguia S, 2011, AN ACAD BRAS CIENC, V83, P267, DOI 10.1590/S0001-37652011000100015; Azuma Y, 1991, B FUKUI PREFECTURAL, V4, P33; Ballerstedt M., 1914, Zentralblatt fuer Mineralogie Stuttgart, V1914; Ballerstedt M, 1921, Z DTSCH GEOLOGISCHEN, V72, P231; Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Beckles S.H., 1862, Q J GEOLOGICAL SOC, V18, P443, DOI DOI 10.1144/GSL.JGS.1862.018.01-02.60; Beckles SH, 1854, Q J GEOL SOC LOND, V10, P456, DOI [DOI 10.1144/GSLIGS.1854.010.01-02.52, 10.1144/gsl.jgs.1854.010.01-02.52]; Beckles SH, 1852, Q J GEOL SOC LOND, V8, P396, DOI [10.1144/gsl.jgs.1852.008.01-02.42, DOI 10.1144/GSL.JGS.1852.008.01-02.42]; Bellerstedt M., 1905, NATURWISSENSCHAFTLIC, V4, P481; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; Bertling M, 2006, LETHAIA, V39, P265, DOI 10.1080/00241160600787890; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2012, COMPLETE DINOSAUR, P551; CALVO J O, 1991, Ameghiniana, V28, P241; Calvo JO, 1999, NAT SCI MUS MONOGRAP, V15, P13; Calvo Jorge O., 2007, P314; Carpenter K, 1992, U WYOMING CONTRIBUTI, V29, P81; Casanovas Cladellas M.L., 1993, Zubia Monografico, V5, P9; Casanovas Cladellas Maria Lourdes, 1994, Revue de Paleobiologie Volume Special, V7, P29; Casanovas Cladelles M.L., 1989, Ciencias de la Tierra Instituto de Estudios Riojanos, V12, P1; Casanovas M.L., 1997, Zubia, V15, P229; Casanovas M.L., 1995, ZUBIA, V13, P55, DOI [10.1093/jisesa, DOI 10.1093/JISESA]; Casanovas M.L., 1995, CIENCIAS TIERRA, V18, P27; CASANOVAS ML, 1971, ACTA GEOL HISP, V6, P139, DOI DOI 10.1073/PNAS.1324002111; Casanovas-Cladellas M.L., 1987, Paleontologia i Evolucio, V19, P3; Casier E, 1960, IGUANODONS BERNISSAR; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Chen PJ, 2006, CRETACEOUS RES, V27, P22, DOI 10.1016/j.cretres.2005.10.008; Cobos Alberto, 2012, Geogaceta, V52, P185; Coria Rodolfo A., 2007, P167; Currie P.J., 1989, P293; CURRIE P J, 1983, Acta Palaeontologica Polonica, V28, P63; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; Currie Philip J., 1995, P431; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; CURRIE PJ, 1979, PALAEOGEOGR PALAEOCL, V28, P103, DOI 10.1016/0031-0182(79)90114-7; Dalla Vecchia F.M., 2009, ACT 4 JORN INT PAL D, P45; Delair J.B., 1973, Proceedings Dorset nat Hist Archaeol Soc, V94, P17; Delair JB, 1985, HIST BIBLIOGRAPHY S; Demathieu G, 2009, ICHNOS, V16, P268, DOI 10.1080/10420940802686053; Diaz-Martinez I, 2009, TRIBUTE C DARWIN BER, P34; Diaz-Martinez I, 2012, FUNDAMENTAL, V20, P63; Diaz-Martinez I, 2013, THESIS U LA RIOJA LO; Diaz-Martinez I, 2011, ZUBIA, V29, P61; Diedrich Cajus, 2011, Palaeobiodiversity Palaeoenvironments, V91, P129, DOI 10.1007/s12549-010-0044-y; Diedrich Cajus, 2004, Ichnos, V11, P215, DOI 10.1080/10420940490444924; Dietrich, 1927, Z DTSCH GEOLOGISCHEN, V78, P614; Dollo L, 1905, B SCI FRANCE BELGIQU, V40, P1; Dong Zhi-Ming, 2003, Vertebrata Palasiatica, V41, P324; dos Santos AD, 2013, CRETACEOUS RES, V46, P151, DOI 10.1016/j.cretres.2013.09.005; Doublet S, 2004, THESIS U BOURGOGNE B; Dzhalilov MR, 1993, TRACE FOSSILS DYNAMI, P47; Farlow James O., 2001, P408; Fiorillo AR, 2014, GEOLOGY, V42, P719, DOI 10.1130/G35740.1; FUENTES VIDARTE C., 2005, CELTIBERIA, V99, P367; Fuentes Vidarte C, 2002, HUELLAS DINOSAURIOS, P360; Gabunia LK, 1988, T 30 SESS UN PAL SOC; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; Gangloff Roland A., 2004, Ichnos, V11, P299, DOI 10.1080/10420940490442269; Gierlinski Gerard D., 2008, Oryctos, V8, P107; Gierlinski Gerard D., 2008, Oryctos, V8, P29; Godefroit P., 2012, BERNISSART DINOSAURS, P175; Godefroit Pascal, 2012, P334; Goldring R, 2005, CRETACEOUS RES, V26, P665, DOI 10.1016/j.cretres.2005.03.001; Grabbe H, 1881, VERHANDLUNGEN NATURH, V38, P161; Harris Jerald D., 1998, Modern Geology, V23, P291; Haubold H., 1990, Historical Biology, V4, P75; Haubold H., 1971, ICHNIA AMPHIBIORUM R; HernuYndez Medrano N., 2008, ZUBIA, V23-24, P79, DOI DOI 10.1093/JISESA/IEU138; Hitchcock E, 1844, AM J SCI, V47, P492; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hornung JJ, 2012, PALAEONTOL Z, V86, P231, DOI 10.1007/s12542-012-0131-7; Huh M, 2006, CRETACEOUS RES, V27, P123, DOI 10.1016/j.cretres.2005.10.003; Huh M, 2003, ISL ARC, V12, P132, DOI 10.1046/j.1440-1738.2003.00386.x; Hunt AP, 1998, NEW MEXICO MUSEUM NA, V14, P163; Hunt AP, 2006, NEW MEXICO MUSEUM NA, V35, P62; Ibrahim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090751; Jacobs L.L., 1989, P349; JAILLARD E, 1993, CRETACEOUS RES, V14, P623, DOI 10.1006/cres.1993.1044; Jimenez-Vela A, 2006, ZUBIA, V18-19, P115; Kappus EJ, 2011, NEW MEXICO MUSEUM NA, V53, P272; Kappus Eric, 2003, Palaeontologia Electronica, V6, P1; Kim HM, 1986, 1 INT S DIN TRACKS T, P17; Kim HM, 1993, J NATURAL HIST ENV, V1, P39; Kim JY, 2009, CRETACEOUS RES, V30, P1387, DOI 10.1016/j.cretres.2009.08.003; Kuhn O., 1958, FAHRTEN VORZEITLICHE; Langston W, 1997, DINOSAUR TRACKS CRET, P5; Langston W.J., 1960, NATURAL HIST PA S NA, V4, P1; Lee YN, 1997, CRETACEOUS RES, V18, P849, DOI 10.1006/cres.1997.0091; LEONARDI G, 1979, AN ACAD BRAS CIENC, V51, P501; Leonardi G, 2007, 20 C BRAS PAL, P355; Leonardi G., 1994, ANNOTATED ATLAS S AM; Lim JD, 2012, ICHNOS, V19, P101, DOI 10.1080/10420940.2012.664059; Llompart C., 1984, Acta Geologica Hispanica, V19, P143; Lockley M, 2000, DINOSAUR TRACKS OTHE, DOI [10.2108/jsz.17.323, DOI 10.2108/JSZ.17.323]; Lockley M.G., 1987, Mountain Geologist, V24, P107; Lockley Martin, 2007, Ichnos, V14, P39, DOI 10.1080/10420940601006818; Lockley Martin, 2008, Oryctos, V8, P53; Lockley Martin, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P83; Lockley Martin G., 2001, P428; Lockley Martin G., 2000, Ichnos, V7, P217; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley Martin G., 1994, Gaia, V10, P135; Lockley MG, 2014, BIOL J LINN SOC, V113, P721, DOI 10.1111/bij.12294; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley MG, 2012, ICHNOS, V19, P93, DOI 10.1080/10420940.2011.625726; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 2000, Gaia (Lisboa), V15, P339; Lockley MG, 2006, CRETACEOUS RES, V27, P70, DOI 10.1016/j.cretres.2005.10.010; Lockley MG, 2000, GAIA, V15, P312; Lockley MG, 1995, DINOSAUR TRACKS OTHE, DOI [10.1007/BF02479948, DOI 10.1007/BF02479948]; Lockley MG, 1992, ASPECTS NONMARINE CR, P269; Lockley MG, 1991, TRACKING DINOSAURS N, DOI [10.1007/BF00226257, DOI 10.1007/BF00226257]; Lockley MG, 1988, PROFESSIONAL CONTRIB, V12, P288; Lockley MG, 2004, ICHNOS, V11, P262, DOI [DOI 10.1080/10420940490428805, 10.1080/10420940490428805]; Lockley MG, 1989, DINOSAUR TRACKS TRAC, P441; LOCKLEY MG, 1998, NEW MEXICO MUSEUM NA, V14, P135; Lockley MG, 1987, PALEONTOLOGY GEOLOGY, P85; Lockwood JAF, 2014, BIOL J LINN SOC, V113, P707, DOI 10.1111/bij.12349; Lucas SG, 2001, LETHAIA, V34, P30, DOI 10.1080/002411601300068198; Lucas SG., 2011, NEW MEXICO MUSEUM NA, V53, P357; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MARTY D., 2008, GEOFOCUS, V21, P1; Mateus Octavio, 2008, Oryctos, V8, P47; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; Matsukawa M, 1999, PALAEOGEOGR PALAEOCL, V147, P39, DOI 10.1016/S0031-0182(98)00154-0; MATSUKAWA M, 1995, PALAIOS, V10, P3, DOI 10.2307/3515004; MATSUKAWA M, 1994, CRETACEOUS RES, V15, P101, DOI 10.1006/cres.1994.1005; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; McCrea RT, 2000, THESIS U SASKATCHEWA; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; MEYER C, 2000, 5 EUR WORKSH VERT PA, V39, P52; Meyer Christian A., 2003, Ichnos, V10, P221, DOI 10.1080/10420940390256186; MORATALLA GARCIA J.J., 1993, THESIS U COMPLUTENSE; Moratalla JJ, 2008, ESTUD GEOL-MADRID, V64, P161, DOI 10.3989/egeol.08642.043; Moreno K, 2005, J S AM EARTH SCI, V20, P253, DOI 10.1016/j.jsames.2005.05.012; Moreno K, 2002, REV GEOL CHILE, V29, P191; Moreno K, 1997, 8 C IB BIOD ZOOL VER, P64; Moreno K, 2012, ACTA PALAEONTOL POL, V57, P73, DOI 10.4202/app.2010.0119; Nadon G.C., 2001, P395; Nicosia Umberto, 1999, Geologica Romana, V35, P237; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; Norman David B., 2011, Palaeontological Association Field Guides to Fossils, V14, P407; Norman DB, 2010, ZOOTAXA, P47; Norman David B., 2013, Revue de Paleobiologie, V32, P385; Norman DB, 2002, SPEC PAP PALAEONTOL, P161; Novas FE, 2009, AGE OF DINOSAURS S A, DOI [10.1007/s11940-009-0049-x, DOI 10.1007/S11940-009-0049-X]; Pascual-Arribas C, 2000, ESTUD GEOL, V56, P41, DOI [10.3989/egeol.00561-2155, DOI 10.3989/EGE01.00561-2155]; Pascual-Arribas Carlos, 2009, Studia Geologica Salmanticensia, V45, P105; Pereda-Suberbiola X, 2009, ACT 4 JORN INT PAL D, P207; Perez-Lorente F., 1993, Zubia Monografico, V5, P189; Perez-Lorente F, 2006, ZUBIA, V18-19, P9; Perez-Lorente F, 2003, DINOSAURIOS OTROS RE, P161; Petti FM, 2010, CRETACEOUS RES, V31, P546, DOI 10.1016/j.cretres.2010.07.004; Pinuela L, 2000, THESIS U OVIEDO SPAI; Pittman J.G., 1989, P135; Psihoyos L, 1994, HUNTING DINOSAURS, DOI [10.1007/BF01412372, DOI 10.1007/BF01412372]; Romero Molina M.M., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P13; Romilio A, 2011, CRETACEOUS RES, V32, P135, DOI 10.1016/j.cretres.2010.11.003; Rozhdestvensky AK, 1964, P TASHK GOV U, P227; Ruiz-Omenaca Jose Ignacio, 2007, P3; Sampson SD, 2011, LIFE STONE NATURAL H, P143; Sarjeant W.A.S., 1989, P369; SARJEANT WA, 1974, PALAEOGEOGR PALAEOCL, V16, P265, DOI 10.1016/0031-0182(74)90024-8; Sarjeant William A.S., 1998, Ichnos, V6, P183; Schulp AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002243; Schumacher B.A., 2003, Ichnos, V10, P255, DOI 10.1080/10420940390256302; STERNBERG C.H., 1932, NATL MUSEUM CANADA B, P59; Strevell, 1932, DINOSAUROPODES; Struckmann C, 1880, NEUES JB MINERALOGIE, V1, P125; Suner Maite, 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P397; Tagart E, 1846, Q J GEOL SOC LOND, V2, P267, DOI [DOI 10.1144/GSL.JGS.1846.002.01-02.45, 10.1144/gsl.jgs.1846.002.01-02.45]; Taquet, 1984, ORME DINOSAURI, P165; Teilhard de Chardin P., 1929, GEOL SOC CHINA B, V8, P131, DOI [10.1111/j.1755-6724.1929.mp8002005.x, DOI 10.1111/J.1755-6724.1929.MP8002005.X]; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn T, 1990, DINOSAUR TRACKS, DOI [10.1007/BF00232411, DOI 10.1007/BF00232411]; Torcida F., 2003, DINOSAURIOS OTROS RE, V26, P109; Tylor A, 1862, Q J GEOL SOC LOND, V18, P247, DOI [10.1144/gsl.jgs.1862.018.01-02.37, DOI 10.1144/GSL.JGS.1862.018.01-02.37]; Viera LI, 1984, MUNIBE, V36, P3; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072579; Vyalov O.S., 1988, Ezhegodnik Vsesoyuznogo Paleontologicheskogo Obshchestva, V31, P322; Weems RE, 2004, GEOLOGICAL SOC AM AB, P116; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wings O, 2005, 53 S VERT PAL COMP A, P24; Wu W.H., 2012, BERNISSART DINOSAURS, P293; Xing Li-da, 2009, Dizhi Tongbao, V28, P829; Xing LD, 2013, PALAEOGEOGR PALAEOCL, V392, P177, DOI 10.1016/j.palaeo.2013.09.003; Xing LD, 2012, ACTA GEOL SIN-ENGL, V86, P304, DOI 10.1111/j.1755-6724.2012.00660.x; Xing Lida, 2007, Dizhi Xuebao, V81, P1591; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; Young C.C., 1943, B GEOLOGICAL SOC CHI, V23, P151, DOI DOI 10.1111/J.1755-6724.1943.MP233-4006.X; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhen S., 1989, P187; Zhen S, 1996, STUDY DINOSAUR FOOTP; Zhen Shuonan, 1995, Memoirs of Beijing Natural History Museum, V54, P105	203	56	56	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115477	10.1371/journal.pone.0115477	http://dx.doi.org/10.1371/journal.pone.0115477			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674787	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000349914000002
J	Strauss, WM; Hetem, RS; Mitchell, D; Maloney, SK; Meyer, LCR; Fuller, A				Strauss, W. Maartin; Hetem, Robyn S.; Mitchell, Duncan; Maloney, Shane K.; Meyer, Leith C. R.; Fuller, Andrea			Selective Brain Cooling Reduces Water Turnover in Dehydrated Sheep	PLOS ONE			English	Article							CAROTID RETE; ARTERIAL BLOOD; HEAT-STRESS; TEMPERATURE; REHYDRATION; ENVIRONMENT; THERMOREGULATION; MAGNITUDE; RUMINANTS; SIGNALS	In artiodactyls, arterial blood destined for the brain can be cooled through counter-current heat exchange within the cavernous sinus via a process called selective brain cooling. We test the hypothesis that selective brain cooling, which results in lowered hypothalamic temperature, contributes to water conservation in sheep. Nine Dorper sheep, instrumented to provide measurements of carotid blood and brain temperature, were dosed with deuterium oxide (D2O), exposed to heat for 8 days (40 degrees C for 6-h per day) and deprived of water for the last five days (days 3 to 8). Plasma osmolality increased and the body water fraction decreased over the five days of water deprivation, with the sheep losing 16.7% of their body mass. Following water deprivation, both the mean 24h carotid blood temperature and the mean 24h brain temperature increased, but carotid blood temperature increased more than did brain temperature resulting in increased selective brain cooling. There was considerable inter-individual variation in the degree to which individual sheep used selective brain cooling. In general, sheep spent more time using selective brain cooling, and it was of greater magnitude, when dehydrated compared to when they were euhydrated. We found a significant positive correlation between selective brain cooling magnitude and osmolality (an index of hydration state). Both the magnitude of selective brain cooling and the proportion of time that sheep spent selective brain cooling were negatively correlated with water turnover. Sheep that used selective brain cooling more frequently, and with greater magnitude, lost less water than did conspecifics using selective brain cooling less efficiently. Our results show that a 50kg sheep can save 2.6L of water per day (similar to 60% of daily water intake) when it employs selective brain cooling for 50% of the day during heat exposure. We conclude that selective brain cooling has a water conservation function in artiodactyls.	[Strauss, W. Maartin; Hetem, Robyn S.; Mitchell, Duncan; Maloney, Shane K.; Meyer, Leith C. R.; Fuller, Andrea] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa; [Strauss, W. Maartin] Univ S Africa, Coll Agr & Environm Sci, Dept Environm Sci, Johannesburg, South Africa; [Meyer, Leith C. R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA 6009, Australia	University of Witwatersrand; University of South Africa; University of Western Australia	Strauss, WM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa.	strauwm@unisa.ac.za	Meyer, Leith/AAN-4930-2020; Fuller, Andrea/P-3133-2016; maloney, shane k/AAU-5811-2021; Strauss, W. Maartin/F-8579-2014; Hetem, Robyn Sheila/A-1438-2015	Fuller, Andrea/0000-0001-6370-8151; maloney, shane k/0000-0002-5878-2266; Strauss, W. Maartin/0000-0002-3087-1937; Hetem, Robyn Sheila/0000-0003-1953-3520; Meyer, Leith/0000-0002-5122-2469	National Research Foundation (NRF) Thuthuka grant [76248]; University of the Witwatersrand Medical Faculty Research Endowment Fund [0014108521201BFRU000]	National Research Foundation (NRF) Thuthuka grant; University of the Witwatersrand Medical Faculty Research Endowment Fund	This study was funded through a National Research Foundation (NRF) Thuthuka grant, awarded to WMS (grant code: 76248), and the University of the Witwatersrand Medical Faculty Research Endowment Fund, awarded to WMS (grant number: 0014108521201BFRU000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MA, 1972, J PHYSIOL-LONDON, V220, P711, DOI 10.1113/jphysiol.1972.sp009731; BAKER MA, 1989, J PHYSIOL-LONDON, V417, P421, DOI 10.1113/jphysiol.1989.sp017810; DAWES JDK, 1953, J ANAT, V87, P311; DEGEN AA, 1992, J AGR SCI, V119, P419, DOI 10.1017/S0021859600012260; DORIS PA, 1983, PFLUG ARCH EUR J PHY, V398, P337, DOI 10.1007/BF00657244; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Ehleringer JR., 1989, STABLE ISOTOPES ECOL, V68, P525, DOI [10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-23]; FINCH VA, 1979, AM J PHYSIOL, V237, pR192, DOI 10.1152/ajpregu.1979.237.3.R192; Fuller A, 1999, J COMP PHYSIOL B, V169, P605, DOI 10.1007/s003600050261; Fuller A, 2007, AM J PHYSIOL-REG I, V293, pR438, DOI 10.1152/ajpregu.00074.2007; Fuller A, 2011, AM J PHYSIOL-REG I, V300, pR1409, DOI 10.1152/ajpregu.00731.2010; HALES JRS, 1973, PFLUG ARCH EUR J PHY, V345, P123, DOI 10.1007/BF00585835; HAYWARD JN, 1966, P SOC EXP BIOL MED, V121, P547; HECKER JF, 1964, AUST J AGR RES, V15, P961, DOI 10.1071/AR9640961; Hetem RS, 2008, AM J PHYSIOL-REG I, V294, pR246, DOI 10.1152/ajpregu.00570.2007; Hetem RS, 2012, J EXP BIOL, V215, P3917, DOI 10.1242/jeb.074666; JESSEN C, 1994, AM J PHYSIOL-REG I, V267, pR1528, DOI 10.1152/ajpregu.1994.267.6.R1528; Jessen C, 1998, PFLUG ARCH EUR J PHY, V436, P659, DOI 10.1007/s004240050686; JOHNSEN HK, 1987, AM J PHYSIOL, V253, pR848, DOI 10.1152/ajpregu.1987.253.6.R848; JOHNSON JA, 1970, AM J PHYSIOL, V218, P1273, DOI 10.1152/ajplegacy.1970.218.5.1273; Kuhnen G, 1997, COMP BIOCHEM PHYS A, V118, P891, DOI 10.1016/S0300-9629(97)00235-1; KUHNEN G, 1994, AM J PHYSIOL, V267, pR355, DOI 10.1152/ajpregu.1994.267.2.R355; Magilton JH, 1968, IEEE CONFERENCE RECO; Maloney SK, 2007, AM J PHYSIOL-REG I, V292, pR1298, DOI 10.1152/ajpregu.00275.2006; Maloney SK, 2002, PFLUG ARCH EUR J PHY, V443, P437, DOI 10.1007/s004240100704; Maloney SK, 2001, AM J PHYSIOL-REG I, V281, pR108, DOI 10.1152/ajpregu.2001.281.1.R108; McKinley M, 2008, CLIN EXP PHARMACOL P, V35, P701, DOI 10.1111/j.1440-1681.2007.04833.x; MCKINLEY MJ, 1983, AM J PHYSIOL, V245, pR287, DOI 10.1152/ajpregu.1983.245.2.R287; Mitchell D, 2002, COMP BIOCHEM PHYS B, V131, P571, DOI 10.1016/S1096-4959(02)00012-X; Mitchell D, 1997, J COMP PHYSIOL B, V167, P335, DOI 10.1007/s003600050082; Mitchell G, 2008, BIOL LETTERS, V4, P415, DOI 10.1098/rsbl.2008.0138; PLESCHKA K, 1979, PFLUG ARCH EUR J PHY, V382, P255, DOI 10.1007/BF00583710; PUROHIT GR, 1972, AUST J AGR RES, V23, P685, DOI 10.1071/AR9720685; Schoeman SJ, 1995, S AFR J ANIM SCI, V25, P75; Shkoinik A., 1972, Symposia Zool Soc Lond, VNo. 31, P229; SIEBERT BD, 1975, PHYSIOL ZOOL, V48, P36, DOI 10.1086/physzool.48.1.30155636; SILANIKOVE N, 1992, LIVEST PROD SCI, V30, P175, DOI 10.1016/S0301-6226(06)80009-6; SILANIKOVE N, 1994, EXP PHYSIOL, V79, P281, DOI 10.1113/expphysiol.1994.sp003764; Speakman J.R., 1997, DOUBLY LABELLED WATE; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1136, DOI 10.1152/ajplegacy.1970.219.4.1136; Vesterdorf K, 2011, J COMP PHYSIOL B, V181, P277, DOI 10.1007/s00360-010-0513-7	41	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115514	10.1371/journal.pone.0115514	http://dx.doi.org/10.1371/journal.pone.0115514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675092	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000003
J	Zhan, LB; Zheng, LP; Hosoi, T; Okuma, Y; Nomura, Y				Zhan, Libin; Zheng, Luping; Hosoi, Toru; Okuma, Yasunobu; Nomura, Yasuyuki			Stress-Induced Neuroprotective Effects of Epiregulin and Amphiregulin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-ALPHA; IN-VITRO; ISCHEMIA; EXPRESSION; GENE; STEM; PROTECTS; PROMOTES; SURVIVAL	Members of the epidermal growth factor family play important roles in the regulation of cell growth, proliferation, and survival. However, the specific roles of each epidermal growth factor family member with respect to brain injury are not well understood. Gene chip assay screens have revealed drastic increases in the expression of the epidermal growth factor family members amphiregulin and epiregulin following lipopolysaccharide stimulation, which activates an immune response. Both immune activity and endoplasmic reticulum stress are activated during cerebral ischemia. We found that the expression levels of amphiregulin and epiregulin were significantly increased under conditions of cerebral ischemia. Because endoplasmic reticulum stress increased the expression of amphiregulin and epiregulin in glial cells, endoplasmic reticulum stress may be a key mediatory factor of pathophysiological activity. Recombinant epiregulin and amphiregulin proteins effectively inhibited endoplasmic reticulum stress and the subsequent induction of neuronal cell death. Therefore, the upregulation of the epidermal growth factor family members epiregulin and amphiregulin may play a critical role in preventing endoplasmic reticulum stress- induced cell death, thus providing a potential therapy for brain injury.	[Zhan, Libin] Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Peoples R China; [Zhan, Libin; Hosoi, Toru; Okuma, Yasunobu; Nomura, Yasuyuki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Zhan, Libin; Zheng, Luping] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Peoples R China; [Hosoi, Toru] Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan	Dalian Medical University; Hokkaido University; Dalian Medical University; Hiroshima University; Kurume University	Nomura, Y (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan.	nomura_yasuyuki@kurume-u.ac.jp	Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X	Ministry of Education, Science and Culture of Japan; Japan-China Sasakawa Medical Fellowship	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-China Sasakawa Medical Fellowship	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture of Japan and was also supported in part by the Japan-China Sasakawa Medical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2005, J BIOL CHEM, V280, P19012, DOI 10.1074/jbc.M413344200; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kawahara N, 1999, J CEREBR BLOOD F MET, V19, P307, DOI 10.1097/00004647-199903000-00009; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Moskowitz MA, 2003, STROKE, V34, P324, DOI 10.1161/01.STR.0000054047.14853.AD; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Nilsson A, 2005, NEUROREPORT, V16, P213, DOI 10.1097/00001756-200502280-00002; Nishimura T, 2008, ONCOL REP, V19, P105; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; PUTTABYATAPPA M, 2013, BIOL REPROD, V88, DOI DOI 10.1095/BOLREPROD.112.103002; Qi X, 2004, J PHARMACOL EXP THER, V311, P388, DOI 10.1124/jpet.104.069088; Rizzi M, 2013, GROWTH FACTORS, V31, P90, DOI 10.3109/08977194.2013.795958; Shirasawa S, 2004, P NATL ACAD SCI USA, V101, P13921, DOI 10.1073/pnas.0404217101; Sisto M, 2010, HISTOCHEM CELL BIOL, V134, P345, DOI 10.1007/s00418-010-0735-5; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Tsuda N, 2008, BRAIN DEV-JPN, V30, P533, DOI 10.1016/j.braindev.2008.01.006; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076157; Xian CJ, 2001, EXP NEUROL, V172, P182, DOI 10.1006/exnr.2001.7771; Zhang JG, 2014, BIOMED REP, V2, P233, DOI 10.3892/br.2014.225	35	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118280	10.1371/journal.pone.0118280	http://dx.doi.org/10.1371/journal.pone.0118280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675253	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000046
J	Bishop, BM; Juba, ML; Devine, MC; Barksdale, SM; Rodriguez, CA; Chung, MC; Russo, PS; Vliet, KA; Schnur, JM; van Hoek, ML				Bishop, Barney M.; Juba, Melanie L.; Devine, Megan C.; Barksdale, Stephanie M.; Rodriguez, Carlos Alberto; Chung, Myung C.; Russo, Paul S.; Vliet, Kent A.; Schnur, Joel M.; van Hoek, Monique L.			Bioprospecting the American Alligator (Alligator mississippiensis) Host Defense Peptidome	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MASS-SPECTROMETRY; HYDROGEL PARTICLES; ANTIBACTERIAL; CATHELICIDIN; ASSAY; SURVIVAL	Cationic antimicrobial peptides and their therapeutic potential have garnered growing interest because of the proliferation of bacterial resistance. However, the discovery of new antimicrobial peptides from animals has proven challenging due to the limitations associated with conventional biochemical purification and difficulties in predicting active peptides from genomic sequences, if known. As an example, no antimicrobial peptides have been identified from the American alligator, Alligator mississippiensis, although their serum is antimicrobial. We have developed a novel approach for the discovery of new antimicrobial peptides from these animals, one that capitalizes on their fundamental and conserved physico-chemical properties. This sample-agnostic process employs custom-made functionalized hydrogel microparticles to harvest cationic peptides from biological samples, followed by de novo sequencing of captured peptides, eliminating the need to isolate individual peptides. After evaluation of the peptide sequences using a combination of rational and web-based bioinformatic analyses, forty-five potential antimicrobial peptides were identified, and eight of these peptides were selected to be chemically synthesized and evaluated. The successful identification of multiple novel peptides, exhibiting antibacterial properties, from Alligator mississippiensis plasma demonstrates the potential of this innovative discovery process in identifying potential new host defense peptides.	[Bishop, Barney M.; Juba, Melanie L.; Devine, Megan C.; Rodriguez, Carlos Alberto] George Mason Univ, Dept Chem & Biochem, Fairfax, VA 22030 USA; [Barksdale, Stephanie M.; Chung, Myung C.; van Hoek, Monique L.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Russo, Paul S.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Vliet, Kent A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Schnur, Joel M.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [van Hoek, Monique L.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA	George Mason University; George Mason University; George Mason University; State University System of Florida; University of Florida; George Mason University; George Mason University	Bishop, BM (corresponding author), George Mason Univ, Dept Chem & Biochem, Fairfax, VA 22030 USA.	bbishop1@gmu.edu	van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899	Defense Threat Reduction Agency [HDTRA1-12-C-0039]; George Mason University College of Science	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); George Mason University College of Science	The authors gratefully acknowledge the Defense Threat Reduction Agency (http://www.dtra.mil/) HDTRA1-12-C-0039 and the George Mason University College of Science (http://www.gmu.edu) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; Darville LNF, 2010, COMP BIOCHEM PHYS D, V5, P308, DOI 10.1016/j.cbd.2010.09.001; Dean SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00128; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Lata S, 2007, BMC BIOINFORMATICS, V10, P1; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Mak PA, 2011, CLIN VACCINE IMMUNOL, V18, P1252, DOI 10.1128/CVI.05028-11; Mariscal A, 2009, APPL MICROBIOL BIOT, V82, P773, DOI 10.1007/s00253-009-1879-x; Merchant ME, 2006, VET IMMUNOL IMMUNOP, V110, P221, DOI 10.1016/j.vetimm.2005.10.001; Merchant ME, 2003, COMP BIOCHEM PHYS B, V136, P505, DOI 10.1016/S1096-4959(03)00256-2; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Nagaoka I, 2005, INFLAMM RES, V54, P66, DOI 10.1007/s00011-004-1323-8; Nakajima Y, 1997, FEBS LETT, V415, P64, DOI 10.1016/S0014-5793(97)01101-0; Okuda D, 2006, ANTIMICROB AGENTS CH, V50, P2602, DOI 10.1128/AAC.00331-06; Olsson B, 2010, METABOLISM, V59, P1736, DOI 10.1016/j.metabol.2010.04.017; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Pata S, 2011, DEV COMP IMMUNOL, V35, P545, DOI 10.1016/j.dci.2010.12.011; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Sorensen O, 1997, BLOOD, V90, P2796; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tratnyek PG, 2001, CHEM ED, V6, P172, DOI [10.1007/s00897010471a, DOI 10.1007/S00897010471A]; van Hoek ML, 2014, PHARMACEUTICALS, V7, P723, DOI 10.3390/ph7060723; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	31	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117394	10.1371/journal.pone.0117394	http://dx.doi.org/10.1371/journal.pone.0117394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671663	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300052
J	Janssen, A; Kaiser, S; Meissner, K; Brenke, N; Menot, L; Arbizu, PM				Janssen, Annika; Kaiser, Stefanie; Meissner, Karin; Brenke, Nils; Menot, Lenaick; Arbizu, Pedro Martinez			A Reverse Taxonomic Approach to Assess Macrofaunal Distribution Patterns in Abyssal Pacific Polymetallic Nodule Fields	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BENTHIC DISTURBANCE; POPULATION-SIZE; RANGE SIZE; DEEP; SEA; DIVERSITY; DISPERSAL; COMMUNITIES; CRUSTACEA	Heightened interest in the exploitation of deep seafloor minerals is raising questions on the consequences for the resident fauna. Assessing species ranges and determination of processes underlying current species distributions are prerequisites to conservation planning and predicting faunal responses to changing environmental conditions. The abyssal central Pacific nodule belt, located between the Clarion and Clipperton Fracture Zones (CCZ), is an area prospected for mining of polymetallic nodules. We examined variations in genetic diversity and broad-scale connectivity of isopods and polychaetes across the CCZ. Faunal assemblages were studied from two mining claims (the eastern German and French license areas) located 1300 km apart and influenced by different productivity regimes. Using a reverse taxonomy approach based on DNA barcoding, we tested to what extent distance and large-scale changes in environmental parameters lead to differentiation in two macrofaunal taxa exhibiting different functions and life-history patterns. A fragment of the mitochondrial gene Cytochrome Oxidase Subunit 1 (COI) was analyzed. At a 97% threshold the molecular operational taxonomic units (MOTUs) corresponded well to morphological species. Molecular analyses indicated high local and regional diversity mostly because of large numbers of singletons in the samples. Consequently, variation in composition of genotypic clusters between sites was exceedingly large partly due to paucity of deep-sea sampling and faunal patchiness. A higher proportion of wide-ranging species in polychaetes was contrasted with mostly restricted distributions in isopods. Remarkably, several cryptic lineages appeared to be sympatric and occurred in taxa with putatively good dispersal abilities, whereas some brooding lineages revealed broad distributions across the CCZ. Geographic distance could explain variation in faunal connectivity between regions and sites to some extent, while assumed dispersal capabilities were not as important.	[Janssen, Annika; Kaiser, Stefanie; Brenke, Nils; Arbizu, Pedro Martinez] Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, D-26382 Wilhelmshaven, Germany; [Meissner, Karin] Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, Biozentrum Grindel, D-20146 Hamburg, Germany; [Menot, Lenaick] IFREMER, Ctr Brest, F-29280 Plouzane, France	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Hamburg; Ifremer	Janssen, A (corresponding author), Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, Sudstrand 44, D-26382 Wilhelmshaven, Germany.	ajanssen@senckenberg.de	MENOT, LENAICK/N-6899-2016	MENOT, LENAICK/0000-0002-8117-1607; Kaiser, Stefanie/0000-0003-2026-4663; Martinez-Arbizu, Pedro/0000-0002-0891-1154	Federal Ministry of Education and Research (BMBF, Germany) [03G0205D]; Federal Institute of Geoscience and Natural Resources (BGR, Germany); French Research Institute for Exploitation of the Sea (IFREMER, France); European Union [603418]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Federal Institute of Geoscience and Natural Resources (BGR, Germany); French Research Institute for Exploitation of the Sea (IFREMER, France); European Union(European Commission)	AJ and PMA received financial support from the Federal Ministry of Education and Research (BMBF, Germany, grant 03G0205D), the Federal Institute of Geoscience and Natural Resources (BGR, Germany) and the French Research Institute for Exploitation of the Sea (IFREMER, France) for the financial support of the investigation. SK, LM and PMA acknowledge funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS project, grant agreement no 603418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Basualdo Carola V., 2011, Rev. Soc. Entomol. Argent., V70, P27; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhaud M, 1998, HYDROBIOLOGIA, V375-76, P35, DOI 10.1023/A:1017073409259; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Blake JA, 2004, DEEP-SEA RES PT II, V51, P1797, DOI 10.1016/j.dsr2.2004.07.014; Blake James A., 2006, P565; Blank M, 2009, ZOOL SCR, V38, P313, DOI 10.1111/j.1463-6409.2008.00370.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Boggemann M, 2005, NEUE FOLGEN, V39, P1; Borowski C, 1998, DEEP-SEA RES PT II, V45, P55, DOI 10.1016/S0967-0645(97)00073-8; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A, 2005, ORG DIVERS EVOL, V5, P105, DOI 10.1016/j.ode.2004.10.007; Brenke N, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787444015; Brix S, 2011, ZOOTAXA, P79; Brix S, 2015, MAR BIODIVERS, V45, P7, DOI 10.1007/s12526-014-0218-3; Brokeland W, 2010, MAR BIOL, V157, P177, DOI 10.1007/s00227-009-1308-9; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clark AL, 2013, DEV REGULATORY FRAMC, V11; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cohen D, 1990, FAO SPECIEES CTALOGU, V10; Cronan DS, 1980, UNDERWATER MINERALS; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Ebbe Brigitte, 2010, P139, DOI 10.1002/9781444325508.ch8; Elsner NO, 2013, DEEP-SEA RES PT II, V86-87, P103, DOI 10.1016/j.dsr2.2012.07.043; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukushima T, 1995, OVERVIEW JAPAN DEEP; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Glover A, 2001, DEEP-SEA RES PT I, V48, P217, DOI 10.1016/S0967-0637(00)00053-4; Glover AG, 2002, MAR ECOL PROG SER, V240, P157, DOI 10.3354/meps240157; Gudmundsson G, 2000, DEEP-SEA RES PT I, V47, P2093, DOI 10.1016/S0967-0637(00)00013-3; Guerrero-Kommritz J, 2004, NEW SPECIES TANAELLA; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; HALBACH P, 1975, MINER DEPOSITA, V10, P397; Halbach P., 1980, GEOJOURNAL, V4, P407, DOI 10.1007/BF01795925; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannides A, 2003, BIOGEOCHEMISTERY MAR, P29; Hartman O, 1971, DEEP WATER BENTHIC P; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Havermans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HESSLER RR, 1974, DEEP-SEA RES, V21, P185, DOI 10.1016/0011-7471(74)90058-8; HESSLER RR, 1979, SARSIA, V64, P67, DOI 10.1080/00364827.1979.10411365; Horst R., 1923, Zoologische Mededeelingen Leiden, V7, P221; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; International Seabed Authority, 2013, CONT; International Seabed Authority, 2010, ISA TECHN STUD; Jennings RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077594; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Kaiser S, 2007, DEEP-SEA RES PT II, V54, P1776, DOI 10.1016/j.dsr2.2007.07.006; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Khodami S, 2014, POLISH POLAR RES, V35; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Letunic I, 2006, BIOINFORMATICS, V23, P172; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Mahon AR, 2009, MAR BIOL RES, V5, P172, DOI 10.1080/17451000802317683; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; MANTEL N, 1967, CANCER RES, V27, P209; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Meissner K, 2009, ZOOTAXA, V2278, P25; Menzel L, 2011, DEEP-SEA RES PT I, V58, P839, DOI 10.1016/j.dsr.2011.05.008; Mewes K, 2014, DEEP-SEA RES PT I, V91, P125, DOI 10.1016/j.dsr.2014.06.001; Miljutin DM, 2011, DEEP-SEA RES PT I, V58, P885, DOI 10.1016/j.dsr.2011.06.003; Miljutina Maria A., 2010, Marine Biodiversity, V40, P1, DOI 10.1007/s12526-009-0029-0; Osborn KJ, 2009, ZOOL SCR, V38, P617, DOI 10.1111/j.1463-6409.2009.00394.x; Paterson GLJ, 1998, DEEP-SEA RES PT II, V45, P225, DOI 10.1016/S0967-0645(97)00084-2; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Puillandre N, 2012, MOL ECOL, V21, P13; Radziejewska T, 2002, INT REV HYDROBIOL, V87, P457, DOI 10.1002/1522-2632(200207)87:4<457::AID-IROH457>3.0.CO;2-3; Raghukumar C, 2001, DEEP-SEA RES PT II, V48, P3381, DOI 10.1016/S0967-0645(01)00047-9; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Randrianiaina RD, 2011, CONTRIB ZOOL, V80, P17, DOI 10.1163/18759866-08001002; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Riehl T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049354; Rizzo Alexandra Elaine, 2004, Rev. Bras. Zool., V21, P937, DOI 10.1590/S0101-81752004000400031; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Roskop F, 1977, DEEP-SEA RES, V24, P10; ROUSE G.W., 2001, POLYCHAETES; Salton G, 1983, INTRO MODERN INFORM; Schuller M, 2012, ZOOTAXA, P1; Sharma R, 2001, DEEP-SEA RES PT II, V48, P3363, DOI 10.1016/S0967-0645(01)00046-7; Sharma R, 2000, MAR GEORESSOUR GEOTE, V23, P174; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Smith CR, 2008, ISA TECHNICAL STUDY; Smith CR, 2006, INT SEABED AUTHORITY; Smith CR, 2003, ECOLOGY DEEP PACIFIC; SSNER K, 2014, ZOOTAXA, V3786, P201; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thiel H, 2001, DEEP-SEA RES PT II, V48, P3869, DOI 10.1016/S0967-0645(01)00071-6; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Veillette J, 2007, DEEP-SEA RES PT I, V54, P1912, DOI 10.1016/j.dsr.2007.06.011; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wedding L, 2013, P R SOC B, V280; Wiedicke M, 2012, MARINE MINERALISCHE; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WILSON WH, 1991, B MAR SCI, V48, P500; Wolff T., 1962, Galathea Report, V6, P1; Zhou H, 2010, CHIN J OCEANOL LIMN, V28, P899, DOI 10.1007/s00343-010-9131-1	124	59	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117790	10.1371/journal.pone.0117790	http://dx.doi.org/10.1371/journal.pone.0117790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671322	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300070
J	Hu, YM; Liu, A; Vaudrey, J; Vaiciunaite, B; Moigboi, C; McTavish, SM; Kearns, A; Coates, A				Hu, Yanmin; Liu, Alexander; Vaudrey, James; Vaiciunaite, Brigita; Moigboi, Christiana; McTavish, Sharla M.; Kearns, Angela; Coates, Anthony			Combinations of beta-Lactam or Aminoglycoside Antibiotics with Plectasin Are Synergistic against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; BACTERICIDAL ACTIVITY; INFECTIOUS-DISEASES; STATIONARY-PHASE; POLYMYXIN-B; GENTAMICIN; NZ2114; VANCOMYCIN; DAPTOMYCIN; MEMBRANE	Bacterial infections remain the leading killer worldwide which is worsened by the continuous emergence of antibiotic resistance. In particular, methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and the latter can be difficult to treat. The traditional strategy of novel therapeutic drug development inevitably leads to emergence of resistant strains, rendering the new drugs ineffective. Therefore, rejuvenating the therapeutic potentials of existing antibiotics offers an attractive novel strategy. Plectasin, a defensin antimicrobial peptide, potentiates the activities of other antibiotics such as beta-lactams, aminoglycosides and glycopeptides against MSSA and MRSA. We performed in vitro and in vivo investigations to test against genetically diverse clinical isolates of MSSA (n = 101) and MRSA (n = 115). Minimum inhibitory concentrations (MIC) were determined by the broth microdilution method. The effects of combining plectasin with beta-lactams, aminoglycosides and glycopeptides were examined using the chequerboard method and time kill curves. A murine neutropenic thigh model and a murine peritoneal infection model were used to test the effect of combination in vivo. Determined by factional inhibitory concentration index (FICI), plectasin in combination with aminoglycosides (gentamicin, neomycin or amikacin) displayed synergistic effects in 76-78% of MSSA and MRSA. A similar synergistic response was observed when plectasin was combined with beta-lactams (penicillin, amoxicillin or flucloxacillin) in 87-89% of MSSA and MRSA. Interestingly, no such interaction was observed when plectasin was paired with vancomycin. Time kill analysis also demonstrated significant synergistic activities when plectasin was combined with amoxicillin, gentamicin or neomycin. In the murine models, plectasin at doses as low as 8 mg/kg augmented the activities of amoxicillin and gentamicin in successful treatment of MSSA and MRSA infections. We demonstrated that plectasin strongly rejuvenates the therapeutic potencies of existing antibiotics in vitro and in vivo. This is a novel strategy that can have major clinical implications in our fight against bacterial infections.	[Hu, Yanmin; Vaudrey, James; Vaiciunaite, Brigita; Coates, Anthony] St Georges Univ London, Inst Infect & Immun, London, England; [Liu, Alexander] Univ Oxford, Ctr Clin Magnet Resonance Res, Oxford, England; [Moigboi, Christiana; McTavish, Sharla M.; Kearns, Angela] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England	St Georges University London; University of Oxford; Public Health England	Hu, YM (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	ymhu@sgul.ac.uk		Coates, Anthony/0000-0001-8052-3175; McTavish, Sharla/0000-0002-8794-4981; Hu, Yanmin/0000-0003-0630-5342	European Commission under BacAttack [278998]; Helperby Therapeutics Group Ltd.	European Commission under BacAttack; Helperby Therapeutics Group Ltd.	This work was funded with support from the European Commission under grant agreement no: 278998, BacAttack. This communication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. The authors are also grateful for financial support from Helperby Therapeutics Group Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 1999, ANTIMICROB AGENTS CH, V43, P335, DOI 10.1128/AAC.43.2.335; ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Aligholi M, 2011, ACTA MICROBIOL IMM H, V58, P219, DOI 10.1556/AMicr.58.2011.3.5; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Barry AL, 1999, METHODS DETERMINING; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brinch KS, 2010, J ANTIMICROB CHEMOTH, V65, P1720, DOI 10.1093/jac/dkq159; CHAN EL, 1987, DIAGN MICR INFEC DIS, V6, P157, DOI 10.1016/0732-8893(87)90101-5; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Elemam A, 2010, J CLIN MICROBIOL, V48, P3558, DOI 10.1128/JCM.01106-10; Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068; Giacometti A, 2000, ANTIMICROB AGENTS CH, V44, P1716, DOI 10.1128/AAC.44.6.1716-1719.2000; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hill RLR, 2010, J ANTIMICROB CHEMOTH, V65, P442, DOI 10.1093/jac/dkp494; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hu Y, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks475, DOI 10.1093/JAC/DKS475]; Hu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011818; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mazurek B, 2012, NEUROSCI LETT, V506, P107, DOI 10.1016/j.neulet.2011.10.060; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostergaard C, 2009, ANTIMICROB AGENTS CH, V53, P1581, DOI 10.1128/AAC.01202-08; Pages JM, 2010, CURR TOP MED CHEM, V10, P1848, DOI 10.2174/156802610793176620; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Toone Eric J, 2011, Adv Enzymol Relat Areas Mol Biol, V77, pxi; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Xiong YQ, 2011, ANTIMICROB AGENTS CH, V55, P5325, DOI 10.1128/AAC.00453-11; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004; Yuan WC, 2013, J ANTIMICROB CHEMOTH, V68, P1089, DOI 10.1093/jac/dks522; Zechini Barbara, 2009, Recent Pat Antiinfect Drug Discov, V4, P37; Zhang Y, 2014, APPL MICROBIOL BIOT, V98, P681, DOI 10.1007/s00253-013-4881-2; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	45	31	31	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117664	10.1371/journal.pone.0117664	http://dx.doi.org/10.1371/journal.pone.0117664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692771	Green Published, Green Accepted, gold			2022-12-27	WOS:000350061500068
J	Keren, IN; Menalled, FD; Weaver, DK; Robison-Cox, JF				Keren, Ilai N.; Menalled, Fabian D.; Weaver, David K.; Robison-Cox, James F.			Interacting Agricultural Pests and Their Effect on Crop Yield: Application of a Bayesian Decision Theory Approach to the Joint Management of Bromus tectorum and Cephus cinctus	PLOS ONE			English	Article							STEM SAWFLY HYMENOPTERA; OVIPOSITION BEHAVIOR; STALK INSECTS; SPRING WHEATS; CEPHIDAE; WEEDS; COMPETITIVENESS; PERSPECTIVE; RESISTANCE; INFERENCE	Worldwide, the landscape homogeneity of extensive monocultures that characterizes conventional agriculture has resulted in the development of specialized and interacting multitrophic pest complexes. While integrated pest management emphasizes the need to consider the ecological context where multiple species coexist, management recommendations are often based on single-species tactics. This approach may not provide satisfactory solutions when confronted with the complex interactions occurring between organisms at the same or different trophic levels. Replacement of the single-species management model with more sophisticated, multi-species programs requires an understanding of the direct and indirect interactions occurring between the crop and all categories of pests. We evaluated a modeling framework to make multi-pest management decisions taking into account direct and indirect interactions among species belonging to different trophic levels. We adopted a Bayesian decision theory approach in combination with path analysis to evaluate interactions between Bromus tectorum (downy brome, cheatgrass) and Cephus cinctus (wheat stem sawfly) in wheat (Triticum aestivum) systems. We assessed their joint responses to weed management tactics, seeding rates, and cultivar tolerance to insect stem boring or competition. Our results indicated that C. cinctus oviposition behavior varied as a function of B. tectorum pressure. Crop responses were more readily explained by the joint effects of management tactics on both categories of pests and their interactions than just by the direct impact of any particular management scheme on yield. In accordance, a C. cinctus tolerant variety should be planted at a low seeding rate under high insect pressure. However as B. tectorum levels increase, the C. cinctus tolerant variety should be replaced by a competitive and drought tolerant cultivar at high seeding rates despite C. cinctus infestation. This study exemplifies the necessity of accounting for direct and indirect biological interactions occurring within agroecosystems and propagating this information from the statistical analysis stage to the management stage.	[Keren, Ilai N.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Menalled, Fabian D.; Weaver, David K.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Robison-Cox, James F.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Washington Department of Fish & Wildlife (WDFW); Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Menalled, FD (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	menalled@montana.edu			USDA NIFA [0210928]; Montana Wheat and Barley Committee	USDA NIFA(United States Department of Agriculture (USDA)); Montana Wheat and Barley Committee	This work was supported by USDA NIFA grant 0210928 and the Montana Wheat and Barley Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie CN, 1929, USDA TECHNICAL B, V157; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Beres BL, 2012, CROP SCI, V52, P1316, DOI 10.2135/cropsci2011.05.0239; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bhimasankaram P, 1997, LINEAR ALGEBRA APPL, V264, P329, DOI 10.1016/S0024-3795(97)00011-6; BLACKSHAW RE, 1991, WEED TECHNOL, V5, P557, DOI 10.1017/S0890037X00027329; Buteler M, 2010, CAN ENTOMOL, V142, P222, DOI 10.4039/n09-072; Buteler M, 2009, ENVIRON ENTOMOL, V38, P1707, DOI 10.1603/022.038.0624; Capinera JL, 2005, WEED SCI, V53, P892, DOI 10.1614/WS-04-049R.1; Delaney KJ, 2010, J ECON ENTOMOL, V103, P516, DOI 10.1603/EC09229; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grant WE, 1998, ECOL MODEL, V108, P67, DOI 10.1016/S0304-3800(98)00019-2; HOLMES N. D., 1962, CANADIAN ENTOMOL, V94, P348; HOLMES ND, 1984, CAN ENTOMOL, V116, P677, DOI 10.4039/Ent116677-5; HOLMES ND, 1977, CAN ENTOMOL, V109, P1591, DOI 10.4039/Ent1091591-12; HULBERT LC, 1955, ECOL MONOGR, V25, P181, DOI 10.2307/1943550; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Keren IN, 2012, DEV TOTAL SYSTEMS AP; Knodel JJ, 2009, J AGR URBAN ENTOMOL, V26, P183, DOI 10.3954/1523-5475-26.4.183; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Larocque GR, 2011, ENVIRON MODELL SOFTW, V26, P280, DOI 10.1016/j.envsoft.2010.03.009; Lehnhoff EA, 2013, PLOS ONE, P8; Lemerle D, 2004, J AGR SCI-CAMBRIDGE, V142, P395, DOI 10.1017/S002185960400454X; Lemerle D, 2001, AUST J AGR RES, V52, P527, DOI 10.1071/AR00056; Lewis WJ, 1997, P NATL ACAD SCI USA, V94, P12243, DOI 10.1073/pnas.94.23.12243; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; LUGINBILL P, 1958, J ECON ENTOMOL, V51, P804, DOI 10.1093/jee/51.6.804; Mack RN, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P253; Michaud JP, 2009, J ECON ENTOMOL, V102, P1044, DOI 10.1603/029.102.0324; Miller ZJ, 2013, WEED RES, V53, P102, DOI 10.1111/wre.12007; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Orloff N, 2013, WEED RES, V53, P192, DOI 10.1111/wre.12016; Pearl J, 2010, SOCIOL METHODOL, V40, P75, DOI 10.1111/j.1467-9531.2010.01228.x; Perez-Mendoza J, 2006, ENVIRON ENTOMOL, V35, P1279, DOI 10.1603/0046-225X(2006)35[1279:IOWADB]2.0.CO;2; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Plummer M, 2010, JAGS VERSION 2 2 0 U; Qureshi JA, 2007, INSECT SCI, V14, P425, DOI 10.1111/j.1744-7917.2007.00170.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reganold JP, 2011, SCIENCE, V332, P670, DOI 10.1126/science.1202462; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Shennan C, 2008, PHILOS T R SOC B, V363, P717, DOI 10.1098/rstb.2007.2180; Shiple B, 2000, CAUSE CORRELATION BI; STAHLMAN PW, 1990, WEED SCI, V38, P224, DOI 10.1017/S0043174500056447; USDA-NASS, 2010, CHEM US DAT WHEAT; Weaver DH, 2009, J ECON ENTOMOL, V102, P1009, DOI 10.1603/029.102.0320; Weaver DK, 2004, J AGR URBAN ENTOMOL, V21, P271; Zimdahl R.L., 2004, WEED CROP COMPETITIO, V2nd	49	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118111	10.1371/journal.pone.0118111	http://dx.doi.org/10.1371/journal.pone.0118111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692673	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500097
J	Lee, JS; Kang, CH; Park, SQ; Choi, HA; Sim, KB				Lee, Jung Seok; Kang, Chul-hoo; Park, Sukh Que; Choi, H. Alex; Sim, Ki-Bum			Clinical Significance of Cerebral Microbleeds Locations in CADASIL with R544C NOTCH3 Mutation	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; STROKE; HEMORRHAGES; ONSET	Background and Purpose Although cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopath (CADASIL) is the most common single-gene disorder of cerebral small blood vessels caused by NOTCH3 mutations, little has been described about the variation in the clinical findings between its underlying types of mutations. In particular, the presence of cerebral microbleeds (CMBs) has been an increasingly recognized magnetic resonance imaging finding in CADASIL, but their clinical significance is not clear. The purpose of this study is to assess whether CMBs are associated with symptomatic stroke in the CADASIL patients with R544C mutation and to compare the cerebral distribution of CMBs between CADASIL patients with and without symptomatic stroke. Methods This is a cohort study of patients who were diagnosed with genotype-confirmed R544C-mutation CADASIL. Primary neurologic symptoms were recorded. Symptomatic strokes were defined as transient ischemic attack, ischemic strokes and hemorrhagic strokes. CMBs were defined as focal areas of round signal loss on T2*-weighted gradient echo planar images with a diameter of less than 10 mm. The locations of CMBs were divided into lobar, basal ganglia, thalamus, brain stem and cerebellum. Multiple logistic regressions were performed to identify the epidemiologic or vascular risk factors associated with symptomatic stroke in patients with CADASIL. Results Among total of 51 subjects in this cohort, CMBs were present in 20 of 32 patients (64.5%) in the symptomatic stroke-group and in 8 of 19 patients (42.1%) in the non-stroke group (p = 0.16). CMBs were observed more frequently in the basal ganglia (p<0.001) and the cerebellum (p<0.018) in the symptomatic stoke group compared to the non-stroke group. The mean number of CMBs was significantly higher in the symptomatic stroke group (15.4 +/- 18.0 lesions per patients with CMBs) versus those without symptomatic stroke (3.3 +/- 3.0 lesions per patients with CMBs) (p = 0.003). Hypertension was an independent risk factor for symptomatic stroke in CADASIL (p = 0.014). It was independently associated with CMBs locations as basal ganglia (p = 0.016), thalamus (p = 0.010), brainstem (p = 0.044), and cerebellum (p = 0.049). However, It was not independently associated with CMBs on lobar lesion (p = 0.152). Conclusions In this study hypertension was an independent predictor of CMBs presence in specific brain locations, as well as symptomatic stroke in the CADASIL patients. The distribution and burden of CMBs might be a clinically useful marker for the risk of symptomatic stroke. However, further prospective studies on the relationship between CMBs distribution and syThis study was supported by a grant of the Jeju National University Hospital Research Fund (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript mptomatic stroke are required in order to support these preliminary findings.	[Lee, Jung Seok; Kang, Chul-hoo] Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurol, Cheju, South Korea; [Park, Sukh Que] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Seoul Hosp, Dept Neurosurg, Seoul, South Korea; [Choi, H. Alex] Univ Texas Med Sch Houston, Dept Neurol & Neurosurg, Houston, TX USA; [Sim, Ki-Bum] Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurosurg, Cheju, South Korea	Jeju National University; Soonchunhyang University; University of Texas System; University of Texas Health Science Center Houston; Jeju National University	Sim, KB (corresponding author), Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurosurg, Cheju, South Korea.	kibumsim@gmail.com			Jeju National University Hospital Research Fund	Jeju National University Hospital Research Fund	This study was supported by a grant of the Jeju National University Hospital Research Fund (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda-Velasquez JF, 2002, NEUROLOGY, V59, P277, DOI 10.1212/WNL.59.2.277; Boulanger JM, 2006, STROKE, V37, P911, DOI 10.1161/01.STR.0000204237.66466.5f; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JC, 2013, J STROKE CEREBROVASC, V22, P126, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.002; Choi JC, 2010, J CLIN NEUROL, V6, P1, DOI 10.3988/jcn.2010.6.1.1; Choi JC, 2006, NEUROLOGY, V67, P2042, DOI 10.1212/01.wnl.0000246601.70918.06; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Lee JS, 2011, J CLIN NEUROL, V7, P210, DOI 10.3988/jcn.2011.7.4.210; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SH, 2005, HYPERTENS RES, V28, P895, DOI 10.1291/hypres.28.895; Lee SH, 2004, J NEUROL, V251, P1183, DOI 10.1007/s00415-004-0500-6; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Rinnoci V, 2013, J NEUROL SCI, V330, P45, DOI 10.1016/j.jns.2013.04.002; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Viswanathan A, 2006, BRAIN, V129, P2375, DOI 10.1093/brain/awl177	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118163	10.1371/journal.pone.0118163	http://dx.doi.org/10.1371/journal.pone.0118163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692567	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500106
J	Nadol, P; O'connor, S; Duong, H; Le, LVN; Thang, PH; Tram, TH; Ha, HTT; Mcconnell, MS; Partridge, J; Kaldor, J; Law, M; Nguyen, TA				Nadol, Patrick; O'connor, Siobhan; Duong, Hao; Le, Linh-Vi N.; Pham Hong Thang; Tran Hong Tram; Hoang Thi Thanh Ha; Mcconnell, Michelle S.; Partridge, Jeff; Kaldor, John; Law, Matthew; Tuan Anh Nguyen			Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) - Vietnam, 2009-2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus	PLOS ONE			English	Article							GLOBAL EPIDEMIOLOGY; INFECTION; COINFECTION; PEOPLE; USERS; RISK	Introduction Given the overlapping modes of transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV), understanding the burden and relationship of these infections is critical for an effective response. Representative data on these infections among males who inject drugs (MWID), the key high-risk population for HIV in Vietnam, are currently lacking. Methods Data and stored specimens from Vietnam's 2009-2010 Integrated Biologic and Behavioral Survey, a cross-sectional study among high-risk populations, were used for this analysis. Plasma samples were tested for HIV, HBV, and HCV using commercial assays. A questionnaire was administered to provide demographic, behavior, and service-uptake information. Provincial-level analyses were conducted to profile MWID enrollees and to provide estimates on the prevalence of HIV, HBV, and HCV infection. Results Among 3010 MWID sampled across 10 provinces, the median (range) HIV prevalence was 28.1% (1.0%-55.5%). Median prevalence for current HBV infection (HBsAg+) was 14.1% (11.7%-28.0%), for previous exposure to HBV (total anti-HBc+) was 71.4% (49.9%-83.1%), and for current or past HCV infection (HCV Ag/Ab+) was 53.8%(10.9%-80.8%). In adjusted analysis, HBsAg+ (aOR: 2.09, 1.01-4.34) and HCV Ag/Ab+ (aOR: 19.58, 13.07-29.33) status were significantly associated with HIV infection; the association with total anti-HBc+ approached significance (aOR: 1.29, 0.99-1.68). Conclusion The prevalence and association between HIV, HBV, and HCV are high among MWID in Vietnam. These findings indicate the need for integrated policies and practice that for the surveillance, prevention, screening, and treatment of both HIV and viral hepatitis among MWID in Vietnam.	[Nadol, Patrick; Duong, Hao; Le, Linh-Vi N.; Mcconnell, Michelle S.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam; [Nadol, Patrick; Kaldor, John; Law, Matthew] Univ New S Wales, Kirby Inst Infect & Immun, Sydney, NSW, Australia; [O'connor, Siobhan] US Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Pham Hong Thang; Tran Hong Tram; Hoang Thi Thanh Ha; Tuan Anh Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Partridge, Jeff] US Ctr Dis Control & Prevent, Div Influenza Control, Atlanta, GA USA	University of New South Wales Sydney; Kirby Institute; Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE); Centers for Disease Control & Prevention - USA	Nadol, P (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam.	pen5@cdc.gov		Law, Matthew/0000-0002-3540-8837	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) [5U2GGH000116]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	The research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) under the terms of 5U2GGH000116. CDC staff were directly engaged in the study design, analysis, decision to publish, and preparation of the manuscript.	Ameringer S, 2009, NURS RES, V58, P123, DOI 10.1097/NNR.0b013e318199b517; Anderson JP, 2014, CLIN INFECT DIS, V58, P719, DOI 10.1093/cid/cit779; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47; [Anonymous], 2014, FEW ADD GET METH REL; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Sy BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078094; Centers for Disease Control and Prevention, MMWR MORB MORTAL W S, V38, P3; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Department of Health and Human Services, 2013, GUID US ANT AG HIV I; DiaSorin S.p.A, 2013, TECHN ASS DET PERF S, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Mark S., 2012, DEDUCER RDSANALYST G; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; Nguyen VTT, 2012, ASIA-PAC J PUBLIC HE, V24, P361, DOI 10.1177/1010539510385220; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Sereno Leandro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P311, DOI 10.1177/1545109712453939; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Sulkowski Mark S, 2003, Clin Liver Dis, V7, P179, DOI 10.1016/S1089-3261(02)00074-0; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Vietnam General Statistics Office, POP EMPL STAT; Vietnam Ministry of Health, 2012, VIET NAM HIV AIDS ES; Vietnam Ministry of Health, 2010, NAT STRAT HIV AIDS P; Vietnam Ministry of Health, 2011, EV EP IMP HARM RED P; Vietnam Ministry of Health (MOH), 2012, VIETN HIV AIDS EST P; Vietnam Ministry of Health NI of H and E, 2011, INT BIOL BEH SURV IB; Volz E., 2012, RESPONDENT DRIVEN SA; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization, 2012, GUID PREV VIR HEP B; World Health Organization, 2012, WHO UNODC UNAIDS TEC, DOI [10.1016/j.drugpo.2007.12.002, DOI 10.1016/J.DRUGPO.2007.12.002]; World Health Organization, 2013, GLOB POL REP PREV CO, DOI [10.1016/j.jhep.2013.06.029, DOI 10.1016/J.JHEP.2013.06.029]; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	44	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118304	10.1371/journal.pone.0118304	http://dx.doi.org/10.1371/journal.pone.0118304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692469	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500115
J	Cheng, H; Zheng, H; Wu, JX; Xu, W; Zhou, LH; Leong, KC; Fitzgerald, E; Rajagopalan, R; Too, HP; Choi, WK				Cheng, He; Zheng, Han; Wu, Jia Xin; Xu, Wei; Zhou, Lihan; Leong, Kam Chew; Fitzgerald, Eugene; Rajagopalan, Raj; Too, Heng Phon; Choi, Wee Kiong			Photo-Attachment of Biomolecules for Miniaturization on Wicking Si-Nanowire Platform	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; ENHANCED-PERFORMANCE; THIN-FILMS; DNA; SURFACE; MICROARRAY; ACID; HYBRIDIZATION; IMMOBILIZATION; DESIGN	We demonstrated the surface functionalization of a highly three-dimensional, superhydrophilic wicking substrate using light to immobilize functional biomolecules for sensor or microarray applications. We showed here that the three-dimensional substrate was compatible with photo-attachment and the performance of functionalization was greatly improved due to both increased surface capacity and reduced substrate reflectivity. In addition, photo-attachment circumvents the problems induced by wicking effect that was typically encountered on superhydrophilic three-dimensional substrates, thus reducing the difficulty of producing miniaturized sites on such substrate. We have investigated various aspects of photo-attachment process on the nanowire substrate, including the role of different buffers, the effect of wavelength as well as how changing probe structure may affect the functionalization process. We demonstrated that substrate fabrication and functionalization can be achieved with processes compatible with microelectronics processes, hence reducing the cost of array fabrication. Such functionalization method coupled with the high capacity surface makes the substrate an ideal candidate for sensor or microarray for sensitive detection of target analytes.	[Cheng, He; Fitzgerald, Eugene; Choi, Wee Kiong] Singapore MIT Alliance, Adv Mat Micro & Nano Syst, Singapore, Singapore; [Zheng, Han; Xu, Wei; Choi, Wee Kiong] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Wu, Jia Xin; Choi, Wee Kiong] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhou, Lihan; Too, Heng Phon] Bioproc Technol Inst, Singapore, Singapore; [Leong, Kam Chew] GLOBALFOUNDRIES Singapore Private Ltd, Singapore, Singapore; [Fitzgerald, Eugene] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Rajagopalan, Raj] Skolkovo Inst Sci & Technol, Moscow, Russia; [Too, Heng Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); GlobalFoundries; Massachusetts Institute of Technology (MIT); Skolkovo Institute of Science & Technology; National University of Singapore	Choi, WK (corresponding author), Singapore MIT Alliance, Adv Mat Micro & Nano Syst, Singapore, Singapore.	elechoi@nus.edu.sg	Wu, Jiaxin/GVT-3486-2022		National Research Foundation (Singapore)-POC [R-263-000-A11-281]	National Research Foundation (Singapore)-POC	This study was supported by the National Research Foundation (Singapore)-POC R-263-000-A11-281, www.nrf.gov.sg (RR, HPT and WKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, BIOCHIP J, V6, P174, DOI 10.1007/s13206-012-6210-8; Bodla KK, 2013, J HEAT TRANSFER, V135, P1; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; Dankbar DM, 2006, ANAL BIOANAL CHEM, V386, P1967, DOI 10.1007/s00216-006-0871-x; Dawood MK, 2012, LAB CHIP, V12, P5016, DOI 10.1039/c2lc40673j; Dawood MK, 2011, LANGMUIR, V27, P4126, DOI 10.1021/la1050783; Dolan PL, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e107; Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003; Eischeid AC, 2011, APPL ENVIRON MICROB, V77, P1145, DOI 10.1128/AEM.00403-10; Elaissari A, 1998, J COLLOID INTERF SCI, V202, P251, DOI 10.1006/jcis.1998.5517; Extrand CW, 2007, LANGMUIR, V23, P8882, DOI 10.1021/la700816n; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Forman JE, 2003, METHOD ENZYMOL, V361, P530; Fuchs J, 2010, ANAL BIOCHEM, V397, P132, DOI 10.1016/j.ab.2009.09.044; Gardner SN, 2013, J MICROBIOL METH, V94, P303, DOI 10.1016/j.mimet.2013.07.006; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Han KS, 2011, SOL ENERG MAT SOL C, V95, P288, DOI 10.1016/j.solmat.2010.04.064; Higashi N, 1999, LANGMUIR, V15, P111, DOI 10.1021/la9803427; Kim H, 2006, LANGMUIR, V22, P8121, DOI 10.1021/la0610708; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Kusnezow W, 2006, MOL CELL PROTEOMICS, V5, P1681, DOI 10.1074/mcp.T500035-MCP200; Lai CQ, 2013, J PHYS CHEM C, V117, P20802, DOI 10.1021/jp407561k; Le Goff GC, 2013, MACROMOL BIOSCI, V13, P227, DOI 10.1002/mabi.201200370; Li B, 2009, ACS APPL MATER INTER, V1, P1013, DOI 10.1021/am900001h; Li YC, 2007, ANAL CHEM, V79, P426, DOI 10.1021/ac061134j; Lianto P, 2012, NANOSCALE, V4, P7532, DOI 10.1039/c2nr32350h; Lundberg AJ, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P225, DOI 10.1109/ICCV.2001.937522; Miyachi H, 2004, BIOSENS BIOELECTRON, V20, P184, DOI 10.1016/j.bios.2004.02.022; Mocanu D, 2008, ANAL BIOCHEM, V380, P84, DOI 10.1016/j.ab.2008.05.034; Nakano K, 2006, ANAL CHIM ACTA, V578, P93, DOI 10.1016/j.aca.2006.04.085; Oh SJ, 2002, LANGMUIR, V18, P1764, DOI 10.1021/la0113522; Pan N, 2006, TEXT PROG, V38, P1, DOI 10.1533/tepr.2006.0002; Ranjan R, 2011, NANOSC MICROSC THERM, V15, P179, DOI 10.1080/15567265.2011.597492; Ressine A, 2007, BIOTECHNOL ANN REV, V13, P149, DOI 10.1016/S1387-2656(07)13007-6; Roy S, 2011, LAB CHIP, V11, P1886, DOI 10.1039/c0lc00638f; Sefiane K, 2004, J COLLOID INTERF SCI, V272, P411, DOI 10.1016/j.jcis.2003.10.039; Shigdel UK, 2008, ANGEW CHEM INT EDIT, V47, P90, DOI 10.1002/anie.200703625; Sim AYL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021901; Srivastava SK, 2009, SILICON NANOWIRE ARR; Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q; Sun YL, 2003, P SOC PHOTO-OPT INS, V5016, P91, DOI 10.1117/12.477358; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; USSERY DW, 1992, METHOD ENZYMOL, V212, P242; Vamvakaki V, 2008, ELECTROANAL, V20, P1845, DOI 10.1002/elan.200804268; Wong IY, 2010, BIOPHYS J, V98, P2954, DOI 10.1016/j.bpj.2010.03.017; Wu JX, 2014, LANGMUIR, V30, P2206, DOI 10.1021/la404419h; Wu X, 2011, APPL SURF SCI, V257, P7415, DOI 10.1016/j.apsusc.2011.02.106; Xu BJ, 2007, SENSOR ACTUAT A-PHYS, V135, P292, DOI 10.1016/j.sna.2006.07.003; Yang P, 2013, CHEM REV, V113, P5547, DOI 10.1021/cr300246p; Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779; Zhu Y, 2014, J MATER CHEM B, V2, P3582, DOI 10.1039/c4tb00281d	52	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116539	10.1371/journal.pone.0116539	http://dx.doi.org/10.1371/journal.pone.0116539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689680	Green Published, gold			2022-12-27	WOS:000350322700014
J	Hsieh, YT; Chen, KC; Cheng, CM; Cheng, TL; Tao, MH; Roffler, SR				Hsieh, Yuan-Ting; Chen, Kai-Chuan; Cheng, Chiu-Min; Cheng, Tian-Lu; Tao, Mi-Hua; Roffler, Steve R.			Impediments to Enhancement of CPT-11 Anticancer Activity by E. coli Directed Beta-Glucuronidase Therapy	PLOS ONE			English	Article							ENZYME PRODRUG THERAPY; INHIBIT TUMOR-GROWTH; ESCHERICHIA-COLI; CANCER-THERAPY; IRINOTECAN CPT-11; SALMONELLA-TYPHIMURIUM; SELECTIVE LOCALIZATION; ANTITUMOR-ACTIVITY; TARGETED DELIVERY; GENE-THERAPY	CPT-11 is a camptothecin analog used for the clinical treatment of colorectal adenocarcinoma. CPT-11 is converted into the therapeutic anti-cancer agent SN-38 by liver enzymes and can be further metabolized to a non-toxic glucuronide SN-38G, resulting in low SN-38 but high SN-38G concentrations in the circulation. We previously demonstrated that adenoviral expression of membrane-anchored beta-glucuronidase could promote conversion of SN-38G to SN-38 in tumors and increase the anticancer activity of CPT-11. Here, we identified impediments to effective tumor therapy with E. coli that were engineered to constitutively express highly active E. coli beta-glucuronidase intracellularly to enhance the anticancer activity of CPT-11. The engineered bacteria, E. coli (lux/beta G), could hydrolyze SN-38G to SN-38, increased the sensitivity of cultured tumor cells to SN-38G by about 100 fold and selectively accumulated in tumors. However, E. coli (lux/beta G) did not more effectively increase CPT-11 anticancer activity in human tumor xenografts as compared to non-engineered E. coli. SN-38G conversion to SN-38 by E. coli (lux/beta G) appeared to be limited by slow uptake into bacteria as well as by segregation of E. coli in necrotic regions of tumors that may be relatively inaccessible to systemically-administered drug molecules. Studies using a fluorescent glucuronide probe showed that significantly greater glucuronide hydrolysis could be achieved in mice pretreated with E. coli (lux/beta G) by direct intratumoral injection of the glucuronide probe or by intratumoral lysis of bacteria to release intracellular beta-glucuronidase. Our study suggests that the distribution of beta-glucuronidase, and possibly other therapeutic proteins, in the tumor microenvironment might be an important barrier for effective bacterial- based tumor therapy. Expression of secreted therapeutic proteins or induction of therapeutic protein release from bacteria might therefore be a promising strategy to enhance anti-tumor activity.	[Hsieh, Yuan-Ting] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsieh, Yuan-Ting; Chen, Kai-Chuan; Tao, Mi-Hua; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Kaohsiung University of Science & Technology; Kaohsiung Medical University	Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	sroff@ibms.sinica.edu.tw	Tao, Mi-Hua/S-7020-2018; Roffler, Steve R/N-7791-2018	Roffler, Steve R/0000-0003-2543-7295; Cheng, Tian-Lu/0000-0002-7263-2766; Tao, Mi-Hua/0000-0002-4307-5729	National Science Council, Taipei, Taiwan [NSC102-2320-B-001-013-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grant from the National Science Council, Taipei, Taiwan (NSC102-2320-B-001-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basili S, 2009, EXPERT OPIN THER PAT, V19, P555, DOI 10.1517/13543770902773437; BOUCHER Y, 1990, CANCER RES, V50, P4478; Chang DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083239; Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x; Chen CP, 2012, PROTEIN ENG DES SEL, V25, P367, DOI 10.1093/protein/gzs033; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Chen KC, 2011, BIOCONJUGATE CHEM, V22, P938, DOI 10.1021/bc1005784; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Cheng CM, 2013, CANCER GENE THER, V20, P276, DOI 10.1038/cgt.2013.17; Cheng TL, 1997, CANCER IMMUNOL IMMUN, V44, P305, DOI 10.1007/s002620050387; Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chung-Faye G, 2001, CLIN CANCER RES, V7, P2662; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Cronin M, 2014, MOL THER, V22, P1188, DOI 10.1038/mt.2014.23; Fonseca MJ, 2003, PHARMACEUT RES, V20, P423, DOI 10.1023/A:1022608321861; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Friedlos F, 2008, CLIN CANCER RES, V14, P4259, DOI 10.1158/1078-0432.CCR-07-4800; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hess C, 2014, PROTEIN ENG DES SEL, V27, P207, DOI 10.1093/protein/gzu013; Huang PT, 2011, CANCER GENE THER, V18, P381, DOI 10.1038/cgt.2011.3; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jang JK, 2013, MOL CANCER THER, V12, P2827, DOI 10.1158/1535-7163.MCT-13-0383; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; Jiang SN, MOL THER, V18, P635; KAWATO Y, 1991, CANCER RES, V51, P4187; KIMURA NT, 1980, CANCER RES, V40, P2061; Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005; Liang WJ, 2005, J BACTERIOL, V187, P2377, DOI 10.1128/JB.187.7.2377-2385.2005; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Liu M, 2014, MOL PHARMACEUT, V11, P2305, DOI 10.1021/mp400759d; Liu SC, 2008, CANCER RES, V68, P7995, DOI 10.1158/0008-5472.CAN-08-1698; Loeffler M, 2007, P NATL ACAD SCI USA, V104, P12879, DOI 10.1073/pnas.0701959104; Loeffler M, 2009, CANCER IMMUNOL IMMUN, V58, P769, DOI 10.1007/s00262-008-0555-9; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; MALMGREN RA, 1955, CANCER RES, V15, P473; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; NOVEL G, 1974, J BACTERIOL, V120, P89, DOI 10.1128/JB.120.1.89-95.1974; Pawelek JM, 1997, CANCER RES, V57, P4537; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; Prijovich ZM, 2009, MOL CANCER THER, V8, P940, DOI 10.1158/1535-7163.MCT-08-0812; Qhattal HSS, 2014, ACS NANO, V8, P5423, DOI 10.1021/nn405839n; Reddy S, 2011, CLIN CANCER RES, V17, P1509, DOI 10.1158/1078-0432.CCR-10-1654; Rivory LP, 1997, CLIN CANCER RES, V3, P1261; Rivory LP, 1996, BIOCHEM PHARMACOL, V52, P1103, DOI 10.1016/0006-2952(96)00457-1; Roffler SR, 2006, GENE THER, V13, P412, DOI 10.1038/sj.gt.3302671; Simonsen TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040006; Springer C. J., 1997, ADV DRUG DELIV REV, V26, P151; Sreeramoju P, 2010, ADV GENET, V69, P135, DOI 10.1016/S0065-2660(10)69015-3; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Wu CH, 2004, BIOTECHNOL APPL BIOC, V40, P167, DOI 10.1042/BA20030184; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhang HY, 2010, CANCER GENE THER, V17, P334, DOI 10.1038/cgt.2009.76; Zhang L, 2014, J CONTROL RELEASE, V183, P114, DOI 10.1016/j.jconrel.2014.03.043	63	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118028	10.1371/journal.pone.0118028	http://dx.doi.org/10.1371/journal.pone.0118028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688562	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700096
J	Ito, T; Tsubahara, A; Shinkoda, K; Yoshimura, Y; Kobara, K; Osaka, H				Ito, Tomotaka; Tsubahara, Akio; Shinkoda, Koichi; Yoshimura, Yosuke; Kobara, Kenichi; Osaka, Hiroshi			Excitability Changes in Intracortical Neural Circuits Induced by Differentially Controlled Walking Patterns	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX; CORTICOMOTOR EXCITABILITY; ELECTRICAL-STIMULATION; INHIBITION; MUSCLE; GAIT; PLASTICITY; MODULATION; EXERCISE	Our previous single-pulse transcranial magnetic stimulation (TMS) study revealed that excitability in the motor cortex can be altered by conscious control of walking relative to less conscious normal walking. However, substantial elements and underlying mechanisms for inducing walking-related cortical plasticity are still unknown. Hence, in this study we aimed to examine the characteristics of electromyographic (EMG) recordings obtained during different walking conditions, namely, symmetrical walking (SW), asymmetrical walking 1 (AW1), and asymmetrical walking 2 (AW2), with left to right stance duration ratios of 1: 1, 1: 2, and 2: 1, respectively. Furthermore, we investigated the influence of three types of walking control on subsequent changes in the intracortical neural circuits. Prior to each type of 7-min walking task, EMG analyses of the left tibialis anterior (TA) and soleus (SOL) muscles during walking were performed following approximately 3 min of preparative walking. Paired-pulse TMS was used to measure short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) in the left TA and SOL at baseline, immediately after the 7-min walking task, and 30 min post-task. EMG activity in the TA was significantly increased during AW1 and AW2 compared to during SW, whereas a significant difference in EMG activity of the SOL was observed only between AW1 and AW2. As for intracortical excitability, there was a significant alteration in SICI in the TA between SWand AW1, but not between SW and AW2. For the same amount of walking exercise, we found that the different methods used to control walking patterns induced different excitability changes in SICI. Our research shows that activation patterns associated with controlled leg muscles can alter post-exercise excitability in intracortical circuits. Therefore, how leg muscles are activated in a clinical setting could influence the outcome of walking in patients with stroke.	[Ito, Tomotaka; Tsubahara, Akio; Yoshimura, Yosuke; Kobara, Kenichi; Osaka, Hiroshi] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Okayama, Japan; [Shinkoda, Koichi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomech, Hiroshima, Japan	Hiroshima University	Ito, T (corresponding author), Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Okayama, Japan.	s-ito@mw.kawasaki-m.ac.jp		Ito, Tomotaka/0000-0002-2833-3945				Blicher JU, 2009, NEUROREHAB NEURAL RE, V23, P143, DOI 10.1177/1545968308317973; Capaday C, 1999, J NEUROPHYSIOL, V81, P129, DOI 10.1152/jn.1999.81.1.129; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; EIDELBERG E, 1981, PROG NEUROBIOL, V17, P185, DOI 10.1016/0301-0082(81)90013-7; Fedirchuk B, 1998, EXP BRAIN RES, V122, P351, DOI 10.1007/s002210050523; Forrester LW, 2006, ARCH PHYS MED REHAB, V87, P229, DOI 10.1016/j.apmr.2005.10.016; Fujiwara T, 2005, CRIT REV PHYS REHABI, V17, P163, DOI [DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.10, 10.1615/CritRevPhysRehabilMed.v17.i3.10]; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gallasch E, 2009, EUR J APPL PHYSIOL, V105, P47, DOI 10.1007/s00421-008-0871-y; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Ito T, 2014, NEUROREPORT, V25, P44, DOI 10.1097/WNR.0000000000000041; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; Kamibayashi K, 2009, EUR J NEUROSCI, V30, P100, DOI 10.1111/j.1460-9568.2009.06795.x; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1998, EXP BRAIN RES, V118, P421, DOI 10.1007/s002210050296; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Nielsen JB, 2003, NEUROSCIENTIST, V9, P195, DOI 10.1177/1073858403009003012; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P51; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515, DOI 10.1152/jn.1999.82.2.515; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Stinear JW, 2005, J PHYSIOL-LONDON, V567, P701, DOI 10.1113/jphysiol.2005.090654; Thompson AK, 2004, EXP BRAIN RES, V159, P491, DOI 10.1007/s00221-004-1972-4; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Yamaguchi T, 2012, EXP BRAIN RES, V218, P401, DOI 10.1007/s00221-012-3026-7; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151; Yen CL, 2008, NEUROREHAB NEURAL RE, V22, P22, DOI 10.1177/1545968307301875; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171; Zoghi M, 2003, J PHYSIOL-LONDON, V550, P933, DOI 10.1113/jphysiol.2003.042606	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117931	10.1371/journal.pone.0117931	http://dx.doi.org/10.1371/journal.pone.0117931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688972	Green Published, gold			2022-12-27	WOS:000350322700085
J	Ao, HS; Xu, F; Wang, XQ; Tang, XR; Zheng, Z; Hu, SS				Ao, Hushan; Xu, Fei; Wang, Xianqiang; Tang, Xinran; Zheng, Zhe; Hu, Shengshou			Effects of Metabolic Syndrome with or without Obesity on Outcomes after Coronary Artery Bypass Graft. A Cohort and 5-Year Study	PLOS ONE			English	Article							LONG-TERM OUTCOMES; BODY-MASS INDEX; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEART-DISEASE; FOLLOW-UP; RISK; MORTALITY; SURGERY	Background Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular disease, however, it remains unclear about effects of MetS with or without obesity on perioperative and long-term morbidity and mortality after coronary artery bypass graft (CABG). Methods An observational cohort study was performed on 4,916 consecutive patients receiving isolated primary CABG in Fuwai hospital. Of all patients, 1238 patients met the inclusion criteria and were divided into three groups: control, MetS with obesity and MetS without obesity (n = 868, 76 and 294 respectively). The patient's 5-year survival and major adverse cerebral and cardiovascular events (MACCE) were studied. Results Among all three groups, there were no significant differences in in-hospital postoperative complications, epinephrine use, stroke, ICU stay, ventilation time, atrial fibrillation, renal failure, coma, myocardial infarction, repeated revascularization, and long-term stroke. The patients in MetS without obesity group were not associated with increased perioperative or long-term morbidities and mortality. In contrast, the patients in MetS with obesity group were associated with significant increased perioperative complications including MACCE (30.26% vs. 20.75%, 16.7%, p = 0.0074) and mortality (11.84% vs. 3.74%, 3.11%, p = 0.0007) respectively. Patients in MetS with obesity group was associated with significantly increased long-term of MACCE (adjusted OR: 2.040; 95%CI:1.196-3.481; P < 0.05) and 5-years of mortality (adjusted HR:4.659; 95%CI:1.966-11.042; P < 0.05). Conclusions Patients with metabolic syndrome and obesity are associated with significant increased perioperative and long-term complications and mortality, while metabolic syndrome without obesity do not worsen outcomes after CABG.	[Ao, Hushan] Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Translat Cardiovasc Med, Dept Anesthesiol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Ao, HS (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Translat Cardiovasc Med, Dept Anesthesiol, Beijing 100730, Peoples R China.	aohushan@sina.com		Xu, Fei/0000-0003-0569-661X				Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Ao HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095223; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304; Echahidi N, 2007, J AM COLL CARDIOL, V50, P843, DOI 10.1016/j.jacc.2007.04.075; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Habib RH, 2005, ANN THORAC SURG, V79, P1976, DOI 10.1016/j.athoracsur.2004.11.029; HERLITZ J, 1988, ACTA MED SCAND, V224, P31; Ivanovic B, 2014, THORAC CARDIOV SURG, V62, P561, DOI 10.1055/s-0034-1372349; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kajimoto K, 2009, J THORAC CARDIOV SUR, V137, P658, DOI 10.1016/j.jtcvs.2008.11.043; Kasai T, 2009, J HYPERTENS, V27, P1017, DOI 10.1097/HJH.0b013e32832961cf; Kasai T, 2008, HYPERTENS RES, V31, P235, DOI 10.1291/hypres.31.235; Krauss Ronald M., 1998, Circulation, V98, P1472; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; Nigam A, 2006, AM HEART J, V151, P514, DOI 10.1016/j.ahj.2005.03.050; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REED GL, 1988, NEW ENGL J MED, V319, P1246, DOI 10.1056/NEJM198811103191903; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1; Yatskar L, 2008, ATHEROSCLEROSIS, V198, P389, DOI 10.1016/j.atherosclerosis.2007.09.046; Zacharias A, 2005, CIRCULATION, V112, P3247, DOI 10.1161/CIRCULATIONAHA.105.553743; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	30	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117671	10.1371/journal.pone.0117671	http://dx.doi.org/10.1371/journal.pone.0117671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679397	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600078
J	Maninchedda, U; Lepage, OM; Gangl, M; Hilairet, S; Remandet, B; Meot, F; Penarier, G; Segard, E; Cortez, P; Jorgensen, C; Steinberg, R				Maninchedda, Ugo; Lepage, Olivier M.; Gangl, Monika; Hilairet, Sandrine; Remandet, Bernard; Meot, Francoise; Penarier, Geraldine; Segard, Emilie; Cortez, Pierre; Jorgensen, Christian; Steinberg, Regis			Development of an Equine Groove Model to Induce Metacarpophalangeal Osteoarthritis: A Pilot Study on 6 Horses	PLOS ONE			English	Article							SUBCHONDRAL BONE FAILURE; INERTIAL SENSOR SYSTEM; POSTTRAUMATIC OSTEOARTHRITIS; ARTICULAR-CARTILAGE; OVERLOAD ARTHROSIS; SYNOVIAL-FLUID; JOINT; EXERCISE; INJURY; IMMOBILIZATION	The aim of this work was to develop an equine metacarpophalangeal joint model that induces osteoarthritis that is not primarily mediated by instability or inflammation. The study involved six Standardbred horses. Standardized cartilage surface damage or "grooves" were created arthroscopically on the distal dorsal aspect of the lateral and medial metacarpal condyles of a randomly chosen limb. The contralateral limb was sham operated. After 2 weeks of stall rest, horses were trotted 30 minutes every other day for 8 weeks, then evaluated for lameness and radiographed. Synovial fluid was analyzed for cytology and biomarkers. At 10 weeks post-surgery, horses were euthanized for macroscopic and histologic joint evaluation. Arthroscopic grooving allowed precise and identical damage to the cartilage of all animals. Under the controlled exercise regime, this osteoarthritis groove model displayed significant radiographic, macroscopic, and microscopic degenerative and reactive changes. Histology demonstrated consistent surgically induced grooves limited to non-calcified cartilage and accompanied by secondary adjacent cartilage lesions, chondrocyte necrosis, chondrocyte clusters, cartilage matrix softening, fissuring, mild subchondral bone inflammation, edema, and osteoblastic margination. Synovial fluid biochemistry and cytology demonstrated significantly elevated total protein without an increase in prostaglandin E2, neutrophils, or chondrocytes. This equine metacarpophalangeal groove model demonstrated that standardized non-calcified cartilage damage accompanied by exercise triggered altered osteochondral morphology and cartilage degeneration with minimal or inefficient repair and little inflammatory response. This model, if validated, would allow for assessment of disease processes and the effects of therapy.	[Maninchedda, Ugo; Lepage, Olivier M.; Gangl, Monika; Segard, Emilie] Univ Lyon, Equine Res Ctr, VetAgro Sup, GREMERES ICE, Marcy Letoile, France; [Hilairet, Sandrine; Remandet, Bernard; Meot, Francoise; Penarier, Geraldine; Cortez, Pierre; Steinberg, Regis] Sanofi Aventis Rech, Exploratory Unit, Montpellier, France; [Jorgensen, Christian] CHU Lapeyronie Univ Hosp, Clin Unit Osteoarticular Dis, Montpellier, France	VetAgro Sup; Sanofi-Aventis; Sanofi France; Universite de Montpellier; CHU de Montpellier	Maninchedda, U (corresponding author), Univ Lyon, Equine Res Ctr, VetAgro Sup, GREMERES ICE, Vet Campus Lyon, Marcy Letoile, France.	u.maninchedda@gmail.com		jorgensen, christian/0000-0001-6947-8094	GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport); Veterinary Campus of Lyon (VetAgro Sup); Exploratory unit at Sanofi-Aventis contract service; Sanofi-Aventis	GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport); Veterinary Campus of Lyon (VetAgro Sup); Exploratory unit at Sanofi-Aventis contract service; Sanofi-Aventis(Sanofi-Aventis)	The research was supported by GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport), Veterinary Campus of Lyon (VetAgro Sup) and the Exploratory unit at Sanofi-Aventis contract service. SH, BR, FM, GP, PC, RS received funding from Sanofi-Aventis in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAEP Horse Show Committee, 1999, GUID VET SERV HORS S, V7; Boyce MK, 2013, OSTEOARTHR CARTILAGE, V21, P746, DOI 10.1016/j.joca.2013.02.653; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022; Callender GR, 1938, AM J PATHOL, V14, P253; CHANDNANI VP, 1991, RADIOLOGY, V178, P557, DOI 10.1148/radiology.178.2.1987624; Cleary OB, 2010, AM J VET RES, V71, P33, DOI 10.2460/ajvr.71.1.33; FOLAND JW, 1994, VET SURG, V23, P369, DOI 10.1111/j.1532-950X.1994.tb00497.x; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; Frisbie DD, 1997, EQUINE VET J, V29, P349, DOI 10.1111/j.2042-3306.1997.tb03138.x; Frisbie DD, 2003, CLIN ORTHOP RELAT R, P215, DOI 10.1097/01.blo.0000030514.43495.f3; Frisbie DD, 2002, GENE THER, V9, P12, DOI 10.1038/sj.gt.3301608; Gossec L, 2008, OSTEOARTHR CARTILAGE, V16, P742, DOI 10.1016/j.joca.2008.02.021; Kawcak CE, 2008, OSTEOARTHR CARTILAGE, V16, P1519, DOI 10.1016/j.joca.2008.04.015; Kawcak CE, 2001, EQUINE VET J, V33, P120, DOI 10.1111/j.2042-3306.2001.tb00589.x; Keegan KG, 2012, AM J VET RES, V73, P368, DOI 10.2460/ajvr.73.3.368; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P145, DOI 10.1053/joca.2001.0491; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P282, DOI 10.1053/joca.2001.0507; Mastbergen SC, 2008, OSTEOARTHR CARTILAGE, V16, P919, DOI 10.1016/j.joca.2007.11.010; Mastbergen SC, 2006, OSTEOARTHR CARTILAGE, V14, P39, DOI 10.1016/j.joca.2004.07.009; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; Mcllwraith CW, 1988, EQUINE VET J S, VS6, P3; Neundorf RH, 2010, AM J VET RES, V71, P1284, DOI 10.2460/ajvr.71.11.1284; Norrdin R. W., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P251; Norrdin R. W., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P357; Norrdin RW, 1998, BONE, V22, P133, DOI 10.1016/S8756-3282(97)00253-6; RICHARDSON DW, 1993, AM J VET RES, V54, P449; Rickey EJ, 2012, AM J VET RES, V73, P1540, DOI 10.2460/ajvr.73.10.1540; Simmons EJ, 1999, AM J VET RES, V60, P7; van Harreveld PD, 2002, AM J VET RES, V63, P276, DOI 10.2460/ajvr.2002.63.276	30	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115089	10.1371/journal.pone.0115089	http://dx.doi.org/10.1371/journal.pone.0115089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680102	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600005
J	Morris, CE; Prikryl, EA; Joos, B				Morris, Catherine E.; Prikryl, Emil A.; Joos, Bela			Mechanosensitive Gating of Kv Channels	PLOS ONE			English	Article							SHAKER POTASSIUM CHANNELS; VOLTAGE-DEPENDENT K+; MEMBRANE-PROTEIN FUNCTION; SLOW INACTIVATION; STRUCTURAL BASIS; SODIUM-CHANNEL; ION CHANNELS; S3-S4 LINKER; OPEN STATE; ACTIVATION	K-selective voltage-gated channels (Kv) are multi-conformation bilayer-embedded proteins whose mechanosensitive (MS) P-open(V) implies that at least one conformational transition requires the restructuring of the channel-bilayer interface. Unlike Morris and colleagues, who attributed MS-Kv responses to a cooperative V-dependent closed-closed expansion <-> compaction transition near the open state, Mackinnon and colleagues invoke expansion during a V-independent closed <-> open transition. With increasing membrane tension, they suggest, the closed <-> open equilibrium constant, L, can increase > 100-fold, thereby taking steady-state P-open from 0 -> 1; "exquisite sensitivity to small...mechanical perturbations", they state, makes a Kv "as much a mechanosensitive...as...a voltage-dependent channel". Devised to explain successive g(K)(V) curves in excised patches where tension spontaneously increased until lysis, their L-based model falters in part because of an overlooked IK feature; with recovery from slow inactivation factored in, their g(V) datasets are fully explained by the earlier model (a MS V-dependent closed-closed transition, invariant L >= 4). An L-based MS-Kv predicts neither known Kv time courses nor the distinctive MS responses of Kv-ILT. It predicts Kv densities (hence gating charge per V-sensor) several-fold different from established values. If opening depended on elevated tension (L-based model), standard g(K)(V) operation would be compromised by animal cells' membrane flaccidity. A MS V-dependent transition is, by contrast, unproblematic on all counts. Since these issues bear directly on recent findings that mechanically-modulated Kv channels subtly tune pain-related excitability in peripheral mechanoreceptor neurons we undertook excitability modeling (evoked action potentials). Kvs with MS V-dependent closed-closed transitions produce nuanced mechanically-modulated excitability whereas an L-based MS-Kv yields extreme, possibly excessive (physiologically-speaking) inhibition.				bjoos@uottawa.ca		Joos, Bela/0000-0001-8576-5579; Morris, Catherine/0000-0002-7401-6545	Natural Sciences and Engineering Research Council (Canada); Ottawa Hospital Research Institute	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ottawa Hospital Research Institute	This work was supported by Natural Sciences and Engineering Research Council (Canada) (BJ, Discovery grant and EAP, undergraduate student research award) and Ottawa Hospital Research Institute (CEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Banderali U, 2010, CHANNELS, V4, P12, DOI 10.4161/chan.4.1.10260; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Boucher PA, 2009, BIOPHYS J, V97, P2761, DOI 10.1016/j.bpj.2009.08.054; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; CONTI F, 1982, J MEMBRANE BIOL, V69, P35, DOI 10.1007/BF01871239; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; DOPICO AM, 1994, AM J HYPERTENS, V7, P82, DOI 10.1093/ajh/7.1.82; Faure E, 2014, J BIOL CHEM, V289, P16452, DOI 10.1074/jbc.M113.537134; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Gil Z, 1999, P NATL ACAD SCI USA, V96, P14594; Gonzalez C, 2000, J GEN PHYSIOL, V115, P193, DOI 10.1085/jgp.115.2.193; Gu CX, 2001, BIOPHYS J, V80, P2678, DOI 10.1016/S0006-3495(01)76237-6; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2009, J GEN PHYSIOL, V133, P463, DOI 10.1085/jgp.200910236; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Kalstrup T, 2013, P NATL ACAD SCI USA, V110, P8272, DOI 10.1073/pnas.1220398110; Krepkiy D, 2012, J MOL BIOL, V423, P632, DOI 10.1016/j.jmb.2012.07.015; Labro AJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00168; Lacroix JJ, 2014, P NATL ACAD SCI USA, V111, pE1950, DOI 10.1073/pnas.1406161111; Laitko U, 2004, J GEN PHYSIOL, V123, P135, DOI 10.1085/jgp.200308965; Laitko U, 2006, J GEN PHYSIOL, V127, P687, DOI 10.1085/jgp.200509394; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; Lecar H, 1993, MECHANORECEPTION VAS, P1; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P160, DOI 10.1038/nsmb.2747; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Markin VS, 2004, PHYS BIOL, V1, P110, DOI 10.1088/1478-3967/1/2/007; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris Catherine E., 2006, V322, P315; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; Morris CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00019; Morris CE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00025; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; MORRIS CE, 1991, SCIENCE, V251, P1246, DOI 10.1126/science.1706535; Morris CE, 2011, MECHANOELECTRIC COUP, P43; MORRIS CE, 2011, CELL PHYSL SOURCE BO, P493; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Otway R, 2007, J AM COLL CARDIOL, V49, P578, DOI 10.1016/j.jacc.2006.09.044; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sezgin E, 2012, MOL MEMBR BIOL, V29, P144, DOI 10.3109/09687688.2012.700490; Shaikh S, 2014, CHANNELS, V8, P321, DOI 10.4161/chan.28366; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Soubias O, 2010, BIOPHYS J, V99, P817, DOI 10.1016/j.bpj.2010.04.068; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Sukharev SI, 2001, BIOL MEMBRANY, V18, P440; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Tabarean IV, 2002, BIOPHYS J, V82, P2982, DOI 10.1016/S0006-3495(02)75639-7; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Xu YP, 2013, NAT STRUCT MOL BIOL, V20, P574, DOI 10.1038/nsmb.2535; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zheng J, 2001, J GEN PHYSIOL, V118, P547, DOI 10.1085/jgp.118.5.547; Zhuang XH, 2014, BBA-BIOMEMBRANES, V1838, P2520, DOI 10.1016/j.bbamem.2014.06.010	80	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118335	10.1371/journal.pone.0118335	http://dx.doi.org/10.1371/journal.pone.0118335			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680191	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600118
J	Murgatroyd, DF; Casey, PP; Cameron, ID; Harris, IA				Murgatroyd, Darnel F.; Casey, Petrina P.; Cameron, Ian D.; Harris, Ian A.			The Effect of Financial Compensation on Health Outcomes following Musculoskeletal Injury: Systematic Review	PLOS ONE			English	Article							WHIPLASH-ASSOCIATED DISORDERS; LOW-BACK-PAIN; LUMBAR DISC HERNIATION; PROGNOSTIC-FACTORS; WORKERS-COMPENSATION; NECK PAIN; GENERAL HEALTH; DISABILITY; PREDICTORS; QUALITY	The effect of financial compensation on health outcomes following musculoskeletal injury requires further exploration because results to date are varied and controversial. This systematic review identifies compensation related factors associated with poorer health outcomes following musculoskeletal injury. Searches were conducted using electronic medical journal databases (Medline, CINAHL, Embase, Informit, Web of Science) for prospective studies published up to October 2012. Selection criteria included: prognostic factors associated with validated health outcomes; six or more months follow up; and multivariate statistical analysis. Studies solely measuring return to work outcomes were excluded. Twenty nine articles were synthesised and then assessed using GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology to determine evidence levels. The results were mixed. There was strong evidence of an association between compensation status and poorer psychological function; and legal representation and poorer physical function. There was moderate evidence of an association between compensation status and poorer physical function; and legal representation and poorer psychological function. There was limited evidence of an association between compensation status and increased pain. In seven studies the association depended on the outcome measured. No studies reported an association between compensation related factors and improved health outcomes. Further research is needed to find plausible reasons why compensation related factors are associated with poorer health following musculoskeletal injury.	[Murgatroyd, Darnel F.; Casey, Petrina P.; Cameron, Ian D.] Univ Sydney, Kolling Inst, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia; [Harris, Ian A.] UNSW, South Western Sydney Clin Sch, Ingham Inst Appl Med Res, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Ingham Institute for Applied Medical Research; University of New South Wales Sydney	Murgatroyd, DF (corresponding author), Univ Sydney, Kolling Inst, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia.	dmur0062@uni.sydney.edu.au		Sterling, Michele/0000-0003-1772-2248				Akkermans A.J., 2009, REFORMING PERSONAL I; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Ameratunga S, 2010, INTERN MED J, V40, P704, DOI 10.1111/j.1445-5994.2009.02101.x; Anderson PA, 2006, SPINE, V31, P2510, DOI 10.1097/01.brs.0000239180.14933.b7; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2007, TECHN REP GUID MAN A; Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034; Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a; Atlas SJ, 2010, SPINE, V35, P89, DOI 10.1097/BRS.0b013e3181c68047; Australian and New Zealand Consensus Statement on the Use of Research Evidence in Compensation Policy and Practice, 2012, AUSTR NZ CONS STAT U; Balyk R, 2008, CLIN ORTHOP RELAT R, V466, P3025, DOI 10.1007/s11999-008-0475-1; Bendix AF, 1998, SPINE, V23, P1775, DOI 10.1097/00007632-199808150-00010; Berglund A, 2006, PAIN, V125, P244, DOI 10.1016/j.pain.2006.05.026; Bhandari M, 2008, CAN J SURG, V51, P15; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001; Cameron ID, 2008, SPINE, V33, P250, DOI 10.1097/BRS.0b013e31816244ed; Carroll LJ, 2008, SPINE, V33, pS83, DOI 10.1097/BRS.0b013e3181643eb8; Carroll LJ, 2011, SPINE, V36, pS316, DOI 10.1097/BRS.0b013e3182388739; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cassidy JD, 2003, SPINE, V28, P1002, DOI 10.1097/00007632-200305150-00008; Clay FJ, 2014, J OCCUP REHABIL, V24, P111, DOI 10.1007/s10926-013-9435-z; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Clay FJ, 2010, J PAIN, V11, P420, DOI 10.1016/j.jpain.2009.12.002; Cote P, 2001, Spine (Phila Pa 1976), V26, pE445, DOI 10.1097/00007632-200110010-00020; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Elbers NA, 2013, INJURY, V44, P674, DOI 10.1016/j.injury.2011.11.025; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Grant G, 2009, MELB UNIV LAW REV, V33, P865; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Gun RT, 2005, SPINE, V30, P386, DOI 10.1097/01.brs.0000153399.24457.ee; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hadler NM, 1995, SPINE, V20, P2710, DOI 10.1097/00007632-199512150-00012; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Harris IA, 2008, J ORTHOP TRAUMA, V22, P216, DOI 10.1097/BOT.0b013e31815c11dc; Harris Ian A, 2011, J Orthop Surg (Hong Kong), V19, P317; Harris IA, 2009, MED J AUSTRALIA, V190, P619, DOI 10.5694/j.1326-5377.2009.tb02589.x; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hendriks EJM, 2005, PAIN, V114, P408, DOI 10.1016/j.pain.2005.01.006; Henschke Nicholas, 2008, BMJ, V337, pa171, DOI 10.1136/bmj.a171; Iles RA, 2008, OCCUP ENVIRON MED, V65, P507, DOI 10.1136/oem.2007.036046; Jensen OK, 2010, SPINE J, V10, P659, DOI 10.1016/j.spinee.2010.03.026; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kadzielski JJ, 2012, J HAND SURG-AM, V37A, P1812, DOI 10.1016/j.jhsa.2012.05.023; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Lakke SE, 2009, PAIN, V147, P153, DOI 10.1016/j.pain.2009.08.032; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Littleton SM, 2011, INJURY, V42, P927, DOI 10.1016/j.injury.2010.02.011; Littleton SM, 2011, INJURY; MacDermid JC, 2002, J CLIN EPIDEMIOL, V55, P849, DOI 10.1016/S0895-4356(02)00445-6; Mayou R, 2002, BRIT J PSYCHIAT, V180, P441, DOI 10.1192/bjp.180.5.441; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mock C, 2000, J TRAUMA, V49, P1002, DOI 10.1097/00005373-200012000-00005; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Health and Medical Research Council, 2009, NHMRC LEV EV GRAD RE; National Health and Medical Research Council Australian Government., 2000, REV EV SYST ID REV S; Phillips B, 2009, OXFORD CTR EVIDENCE; Pobereskin LH, 2005, J NEUROL NEUROSUR PS, V76, P1146, DOI 10.1136/jnnp.2004.049189; Rasmussen C, 2008, SCAND J RHEUMATOL, V37, P462, DOI 10.1080/03009740802241709; Rebbeck T, 2006, INJURY PREV, V12, P93, DOI 10.1136/ip.2005.010421; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Sharma R, 2009, J MANIP PHYSIOL THER, V32, P252, DOI 10.1016/j.jmpt.2009.03.010; Spearing NM, 2012, PAIN, V153, P1274, DOI 10.1016/j.pain.2012.03.007; Spearing NM, 2011, INJURY, V42, P15, DOI 10.1016/j.injury.2009.12.009; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Sterling M, 2006, PAIN, V122, P102, DOI 10.1016/j.pain.2006.01.014; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29; Yang Z, 2010, INJURY, V41, P226, DOI 10.1016/j.injury.2009.10.019	79	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117597	10.1371/journal.pone.0117597	http://dx.doi.org/10.1371/journal.pone.0117597			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25680118	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600075
J	Palacios-Garcia, I; Lara-Vasquez, A; Montiel, JF; Diaz-Veliz, GF; Sepulveda, H; Utreras, E; Montecino, M; Gonzalez-Billault, C; Aboitiz, F				Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Montiel, Juan F.; Diaz-Veliz, Gabriela F.; Sepulveda, Hugo; Utreras, Elias; Montecino, Martin; Gonzalez-Billault, Christian; Aboitiz, Francisco			Prenatal Stress Down-Regulates Reelin Expression by Methylation of Its Promoter and Induces Adult Behavioral Impairments in Rats	PLOS ONE			English	Article							PUTATIVE VULNERABILITY FACTOR; ELEVATED PLUS-MAZE; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; LEARNING-DEFICITS; BRAIN-DEVELOPMENT; BIPOLAR DISORDER; CAJAL-RETZIUS; EXPLORATORY-BEHAVIOR; GESTATIONAL STRESS	Prenatal stress causes predisposition to cognitive and emotional disturbances and is a risk factor towards the development of neuropsychiatric conditions like depression, bipolar disorders and schizophrenia. The extracellular protein Reelin, expressed by Cajal-Retzius cells during cortical development, plays critical roles on cortical lamination and synaptic maturation, and its deregulation has been associated with maladaptive conditions. In the present study, we address the effect of prenatal restraint stress (PNS) upon Reelin expression and signaling in pregnant rats during the last 10 days of pregnancy. Animals from one group, including control and PNS exposed fetuses, were sacrificed and analyzed using immunohistochemical, biochemical, cell biology and molecular biology approaches. We scored changes in the expression of Reelin, its signaling pathway and in the methylation of its promoter. A second group included control and PNS exposed animals maintained until young adulthood for behavioral studies. Using the optical dissector, we show decreased numbers of Reelin-positive neurons in cortical layer I of PNS exposed animals. In addition, neurons from PNS exposed animals display decreased Reelin expression that is paralleled by changes in components of the Reelin-signaling cascade, both in vivo and in vitro. Furthermore, PNS induced changes in the DNA methylation levels of the Reelin promoter in culture and in histological samples. PNS adult rats display excessive spontaneous locomotor activity, high anxiety levels and problems of learning and memory consolidation. No significant visuo-spatial memory impairment was detected on the Morris water maze. These results highlight the effects of prenatal stress on the Cajal-Retzius neuronal population, and the persistence of behavioral consequences using this treatment in adults, thereby supporting a relevant role of PNS in the genesis of neuropsychiatric diseases. We also propose an in vitro model that can yield new insights on the molecular mechanisms behind the effects of prenatal stress.	[Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Escuela Med, Dept Psiquiatria, Santiago, Chile; [Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile; [Montiel, Juan F.] Univ Diego Portales, Fac Med, Ctr Invest Biomed, Santiago, Chile; [Diaz-Veliz, Gabriela F.] Univ Chile, Inst Ciencias Biomed, Programa Farmacol Mol & Clin, Santiago, Chile; [Palacios-Garcia, Ismael; Utreras, Elias; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Lab Cell & Neuronal Dynam Cenedyn, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fac Med, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fondo Areas Prioritarias FONDAP, Ctr Genome Regulat, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University Diego Portales; Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Dept Biol, Lab Cell & Neuronal Dynam Cenedyn, Santiago, Chile.	chrgonza@uchile.cl; faboitiz@puc.cl	Gonzalez-Billault, Christian/P-2393-2019; Utreras, Elias/I-1038-2013; Gonzalez-Billault, Christian/K-9622-2013	Utreras, Elias/0000-0002-1004-0466; Diaz-Veliz, Gabriela/0000-0001-9549-4485; Gonzalez-Billault, Christian/0000-0003-0335-1482; Montiel, Juan F/0000-0001-8919-4662	Millennium Center for the Neuroscience of Memory, Chile [NC10-001-F]; program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile; FONDAP [15090007]; Becas Chile postdoctoral fellowship;  [ACT114]	Millennium Center for the Neuroscience of Memory, Chile; program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile; FONDAP; Becas Chile postdoctoral fellowship; 	This work has been supported by the Millennium Center for the Neuroscience of Memory, Chile, (NC10-001-F), developed with funds from the program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile (to FA). Also supported by ACT114 (to CG-B) and FONDAP 15090007 (to MM). JFM is a recipient of Becas Chile postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Aboitiz F, 1999, CEREB CORTEX, V9, P655, DOI 10.1093/cercor/9.7.655; Aboitiz F, 2011, BRAIN RES BULL, V84, P125, DOI 10.1016/j.brainresbull.2010.12.003; Alcantara S, 2006, CEREB CORTEX, V16, P487, DOI 10.1093/cercor/bhi128; Alcantara S, 1998, J NEUROSCI, V18, P7779; Andrus BM, 2010, MOL PSYCHIAT; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Badea A, 2007, NEUROIMAGE, V34, P1363, DOI 10.1016/j.neuroimage.2006.09.053; Baker S, 2009, BRAIN RES, V1302, P194, DOI 10.1016/j.brainres.2009.09.023; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Baquedano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027549; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Bland ST, 2005, BRAIN RES, V1051, P90, DOI 10.1016/j.brainres.2005.05.065; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Charles Paxinos GaW, 2007, RAT BRAIN STEREOTAXI; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148, DOI 10.1152/ajplung.1990.258.4.L148; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; Dagnino-Subiabre A, 2006, BRAIN RES, V1086, P27, DOI 10.1016/j.brainres.2006.02.118; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Diaz-Veliz G, 2004, NEUROTOX RES, V5, P629; DIAZVELIZ G, 1989, PHYSIOL BEHAV, V46, P397, DOI 10.1016/0031-9384(89)90010-3; Emack J, 2008, HORM BEHAV, V54, P514, DOI 10.1016/j.yhbeh.2008.02.025; Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001; Fatemi SH, 2011, NEUROPSYCHOPHARMACOL, V36, P2371, DOI 10.1038/npp.2011.169; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Gray TS, 1996, CRIT REV NEUROBIOL, V10, P155, DOI 10.1615/CritRevNeurobiol.v10.i2.10; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Gue M, 2004, BEHAV BRAIN RES, V150, P149, DOI 10.1016/S0166-4328(03)00250-X; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hosseini-Sharifabad M, 2007, ANAT SCI INT, V82, P211, DOI 10.1111/j.1447-073x.2007.00186.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Kupferman JV, 2014, CELL, V158, P1335, DOI 10.1016/j.cell.2014.07.035; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; Lordi B, 1997, PHYSIOL BEHAV, V62, P1087, DOI 10.1016/S0031-9384(97)00261-8; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Lussier AL, 2011, NEUROPHARMACOLOGY, V60, P1064, DOI 10.1016/j.neuropharm.2010.09.007; Lussier AL, 2009, NEUROSCI LETT, V460, P170, DOI 10.1016/j.neulet.2009.05.050; Marrone MC, 2006, EUR J NEUROSCI, V24, P2061, DOI 10.1111/j.1460-9568.2006.05083.x; Matrisciano F, 2012, NEUROPHARMACOLOGY; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mychasiuk R, 2011, NEUROSCIENCE, V180, P105, DOI 10.1016/j.neuroscience.2011.02.026; Negron-Oyarzo I, 2014, CEREB CORTEX; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Ognibene E, 2007, BRAIN RES, V1131, P173, DOI 10.1016/j.brainres.2006.11.007; Ohmiya M, 2002, NEUROSCI LETT, V317, P21, DOI 10.1016/S0304-3940(01)02412-0; Ordyan N E, 2003, Neurosci Behav Physiol, V33, P899, DOI 10.1023/A:1025952906715; Pappas GD, 2001, J NEUROCYTOL, V30, P413; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PETERS DAV, 1986, PHARMACOL BIOCHEM BE, V25, P873, DOI 10.1016/0091-3057(86)90400-4; Podhorna J, 2004, BEHAV BRAIN RES, V153, P43, DOI 10.1016/j.bbr.2003.10.033; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; Qin LN, 2011, BEHAV BRAIN RES, V217, P142, DOI 10.1016/j.bbr.2010.10.018; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; ROUTTENBERG A, 1978, DEV PSYCHOBIOL, V11, P469, DOI 10.1002/dev.420110510; Salm AK, 2004, DEV BRAIN RES, V148, P159, DOI 10.1016/j.devbrainres.2003.11.005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Sharaf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071091; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Stranahan AM, 2013, AGEING RES REV, V12, P815, DOI 10.1016/j.arr.2013.01.005; Stranahan AM, 2011, NEUROBIOL LEARN MEM, V96, P150, DOI 10.1016/j.nlm.2011.03.009; Szymanska M, 2009, PHARMACOL REP, V61, P612, DOI 10.1016/S1734-1140(09)70113-6; Tamura M, 2011, J NEUROSCI, V31, P11505, DOI 10.1523/JNEUROSCI.3447-10.2011; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tueting P, 1999, NEUROREPORT, V10, P1329, DOI 10.1097/00001756-199904260-00032; Tueting P, 2006, NEUROSCI BIOBEHAV R, V30, P1065, DOI 10.1016/j.neubiorev.2006.04.001; Ulupinar E, 2011, NEUROTOXICOL TERATOL, V33, P548, DOI 10.1016/j.ntt.2011.07.009; Utreras E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-24; Utreras E, 2013, NEUROCHEM INT, V62, P848, DOI 10.1016/j.neuint.2013.02.011; Vallee M, 1997, J NEUROSCI, V17, P2626; Ventruti A, 2011, NEUROSCIENCE, V189, P32, DOI 10.1016/j.neuroscience.2011.05.050; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Vyas A, 2002, J NEUROSCI, V22, P6810; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; WILLIAMS DI, 1979, PERCEPT MOTOR SKILL, V49, P46, DOI 10.2466/pms.1979.49.1.46; Wu J, 2007, BRAIN RES, V1141, P205, DOI 10.1016/j.brainres.2007.01.024; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003	104	43	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117680	10.1371/journal.pone.0117680	http://dx.doi.org/10.1371/journal.pone.0117680			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679528	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600079
J	Xie, QH; Hao, CM; Ji, LN; Hu, DY; Zhu, TY; Li, XH; Qin, DD; Zhang, DY				Xie, Qionghong; Hao, Chuan-Ming; Ji, Linong; Hu, Dayi; Zhu, Tongying; Li, Xuehai; Qin, Dandan; Zhang, Danyi			ACEI/ARB Underused in Patients with Type 2 Diabetes in Chinese Population (CCMR-3B Study)	PLOS ONE			English	Article							RENAL-DISEASE; RECEPTOR BLOCKERS; ACE-INHIBITORS; NEPHROPATHY; IRBESARTAN; COMPLICATIONS; HYPERTENSION; PREVALENCE; MELLITUS	Objective In patients with diabetic kidney disease, it is well documented that RAS blockade is associated with an improved outcome. This observational, multicenter study examined the "real-world" use of ACEI/ARB in patients with type 2 diabetes (T2DM) in China. Method Data from the China Cardiometabolic Registries on blood pressure, blood lipid and blood glucose in Chinese T2DM patients (CCMR-3B) were used for the present study. Consecutive outpatients with T2DM for more than 6 months were recruited to this non-interventional, observational, cross-sectional study. Albuminuria was defined as urine albumin creatinine ratio (ACR) >= 30mg/g. Results A total of 25,454 outpatients with T2DM from 6 regions in China were enrolled, 47.0% were male, and 59.8% had hypertension. ACR was measured in 6,383 of these patients and 3,231 of them >= 30mg/L. Among patients with hypertension, 73.0% were on antihypertensives, and 39.7% used ACEI/ARB. Of the 2,157 patients with hypertension and albuminuria, only 48.3% used ACEI/ARB. Among the non-hypertensive patients with albuminuria, ACEI/ARB usage was <1%. Multivariate analysis revealed that comorbidities, region, hospital tier, physician specialty and patient's educational level were associated with ACEI/ARB use. Conclusion In T2DM with hypertension and albuminuria in China, more than half of them were not treated with ACEI/ARB. This real world evidence suggests that the current treatment for patients with diabetes coexisting with hypertension and albuminuria in China is sub-optimal.	[Xie, Qionghong; Hao, Chuan-Ming; Zhu, Tongying] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China; [Hu, Dayi] Peking Univ, Dept Cardiol, Peoples Hosp, Beijing 100871, Peoples R China; [Li, Xuehai; Qin, Dandan; Zhang, Danyi] VitalStrateg Res Inst, Berwyn, PA USA	Fudan University; Peking University; Peking University	Hao, CM (corresponding author), Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China.	chuanminghao@fudan.edu.cn	Linong, Ji/AAB-6543-2020		Merck Sharp Dohme (China); Health Industry Special Scientific Research Projects, Ministry of Health [201002010]; National Science and Technology Ministry [2011BAI10B05]; Natural Science Foundation of China [NSFC: 81300569]	Merck Sharp Dohme (China); Health Industry Special Scientific Research Projects, Ministry of Health; National Science and Technology Ministry; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by an unrestricted grant offered by Merck Sharp & Dohme (China) and by grants from the Health Industry Special Scientific Research Projects, Ministry of Health (ID: 201002010) and the National Science and Technology Ministry (ID: 2011BAI10B05). QX was supported by Natural Science Foundation of China (NSFC: 81300569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Chan JCN, 2004, DIABETES CARE, V27, P874, DOI 10.2337/diacare.27.4.874; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chinese Diabetes Society, 2011, CHIN GUID TYP 2 DIAB; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coyle D, 2007, CLIN THER, V29, P1508, DOI 10.1016/j.clinthera.2007.07.029; Gerstein HC, 2000, LANCET, V355, P253; Ji LN, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.035; Juutilainen A, 2005, DIABETES CARE, V28, P2901, DOI 10.2337/diacare.28.12.2901; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Palmer AJ, 2008, NEPHROL DIAL TRANSPL, V23, P1216, DOI 10.1093/ndt/gfn082; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Rosen AB, 2006, J GEN INTERN MED, V21, P315, DOI 10.1111/j.1525-1497.2006.00351.x; Rosen AB, 2004, J GEN INTERN MED, V19, P669, DOI 10.1111/j.1525-1497.2004.30264.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Wheeler DC, 2013, KIDNEY INT, V83, P377, DOI 10.1038/ki.2012.425; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 1998, AM J KIDNEY DIS, V32, pS89, DOI 10.1053/ajkd.1998.v32.pm9820468; Winkelmayer WC, 2005, AM J KIDNEY DIS, V46, P1080, DOI 10.1053/j.ajkd.2005.08.018; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang SH, 2010, NEW ENGL J MED, V362, P2425; Yang Y, 2010, J GEN INTERN MED, V25, P298, DOI 10.1007/s11606-009-1242-z; Yeh HL, 2011, HEALTH POLICY, V100, P196, DOI 10.1016/j.healthpol.2010.11.010	31	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116970	10.1371/journal.pone.0116970	http://dx.doi.org/10.1371/journal.pone.0116970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675409	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000012
J	Yang, Y; Li, ZJ; Chen, Y; Zhang, XM; Wang, SZ				Yang, Yang; Li, Zhoujun; Chen, Yan; Zhang, Xiaoming; Wang, Senzhang			Improving the Robustness of Complex Networks with Preserving Community Structure	PLOS ONE			English	Article							CENTRALITY; UNIQUE	Complex networks are everywhere, such as the power grid network, the airline network, the protein-protein interaction network, and the road network. The networks are ` robust yet fragile', which means that the networks are robust against random failures but fragile under malicious attacks. The cascading failures, system-wide disasters and intentional attacks on these networks are deserving of in-depth study. Researchers have proposed many solutions to improve the robustness of these networks. However whilst many solutions preserve the degree distribution of the networks, little attention is paid to the community structure of these networks. We argue that the community structure of a network is a defining characteristic of a network which identifies its functionality and thus should be preserved. In this paper, we discuss the relationship between robustness and the community structure. Then we propose a 3-step strategy to improve the robustness of a network, while retaining its community structure, and also its degree distribution. With extensive experimentation on representative real-world networks, we demonstrate that our method is effective and can greatly improve the robustness of networks, while preserving community structure and degree distribution. Finally, we give a description of a robust network, which is useful not only for improving robustness, but also for designing robust networks and integrating networks.	[Yang, Yang; Li, Zhoujun; Chen, Yan; Zhang, Xiaoming; Wang, Senzhang] Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China	Beihang University	Li, ZJ (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China.	lizj@buaa.edu.cn			National Natural Science Foundation of China [61170189, 61202239, 61370126]; Research Fund for the Doctoral Program of Higher Education [20111102130003]; Fund of the State Key Laboratory of Software Development Environment [SKLSDE2013ZX-19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Fund of the State Key Laboratory of Software Development Environment	This work was funded by 1. National Natural Science Foundation of China: 61170189, 61202239 and 61370126 (http://www.nsfc.gov.cn/); 2. The Research Fund for the Doctoral Program of Higher Education: 20111102130003 (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm); 3. The Fund of the State Key Laboratory of Software Development Environment: SKLSDE2013ZX-19 (http://www.nlsde.buaa.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Beygelzimer A, 2005, PHYSICA A, V357, P593, DOI 10.1016/j.physa.2005.03.040; Borgatti SP, 2006, SOC NETWORKS, V28, P124, DOI 10.1016/j.socnet.2005.05.001; Burt R.S., 1995, STRUCTURAL HOLES SOC, V1st; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chen Y., 2012, SUPERVISED BAYESIAN, V1, P576; Cheng XQ, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10011; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Fernandes N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050854; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRIEDKIN NE, 1991, AM J SOCIOL, V96, P1478, DOI 10.1086/229694; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Herrmann HJ, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01027; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang ZY, 2012, ADV MATER RES-SWITZ, V433-440, P5147, DOI 10.4028/www.scientific.net/AMR.433-440.5147; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Klau GW, 2005, LECT NOTES COMPUT SC, V3418, P417; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Penton CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093893; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Shen HW, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10020; Sun PG, 2013, PHYSICA A, V392, P1977, DOI 10.1016/j.physa.2012.12.024; Sun PG, 2013, INFORM SCIENCES, V236, P83, DOI 10.1016/j.ins.2013.02.032; Ugander J., 2013, P 22 INT C WORLD WID, P1307, DOI DOI 10.1145/2488388.2488502; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Wang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026101; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Yang Y, 2014, PHYSICA A, V397, P129, DOI 10.1016/j.physa.2013.11.034	45	20	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116551	10.1371/journal.pone.0116551	http://dx.doi.org/10.1371/journal.pone.0116551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674786	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000008
J	Li, TC; Iwasaki, K; Katano, H; Kataoka, M; Nagata, N; Kobayashi, K; Mizutani, T; Takeda, N; Wakita, T; Suzuki, T				Li, Tian-Cheng; Iwasaki, Kenji; Katano, Harutaka; Kataoka, Michiyo; Nagata, Noriyo; Kobayashi, Kazumi; Mizutani, Tetsuya; Takeda, Naokazu; Wakita, Takaji; Suzuki, Tetsuro			Characterization of Self-Assembled Virus-Like Particles of Merkel Cell Polyomavirus	PLOS ONE			English	Article							CAPSID PROTEIN VP1; HEPATITIS-E-VIRUS; DNA; SIMIAN-VIRUS-40; RESOLUTION; CARCINOMA; ANTIBODIES; SYSTEM	In our recombinant baculovirus system, VP1 protein of merkel cell polyomavirus (MCPyV), which is implicated as a causative agent in Merkel cell carcinoma, was self-assembled into MCPyV-like particles (MCPyV-LP) with two different sizes in insect cells, followed by being released into the culture medium. DNA molecules of 1.5- to 5-kb, which were derived from host insect cells, were packaged in large, similar to 50-nm spherical particles but not in small, similar to 25-nm particles. Structure reconstruction using cryo-electron microscopy showed that large MCPyV-LPs are composed of 72 pentameric capsomeres arranged in a T = 7 icosahedral surface lattice and are 48 nm in diameter. The MCPyV-LPs did not share antigenic determinants with BK- and JC viruses (BKPyV and JCPyV). The VLP-based enzyme immunoassay was applied to investigate age-specific prevalence of MCPyV infection in the general Japanese population aged 1-70 years. While seroprevalence of MCPyV increased with age in children and young individuals, its seropositivity in each age group was lower compared with BKPyV and JCPyV.	[Li, Tian-Cheng; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Iwasaki, Kenji] Osaka Univ, Inst Prot Res, Osaka, Japan; [Katano, Harutaka; Kataoka, Michiyo; Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kobayashi, Kazumi] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi 4648601, Japan; [Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Tokyo, Japan; [Takeda, Naokazu] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Suzuki, Tetsuro] Hamamatsu Univ, Sch Med, Dept Infect Dis, Shizuoka, Japan	National Institute of Infectious Diseases (NIID); Osaka University; National Institute of Infectious Diseases (NIID); Nagoya University; Tokyo University of Agriculture & Technology; Osaka University; Hamamatsu University School of Medicine	Li, TC (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	litc@nih.go.jp; tesuzuki@hama-med.ac.jp	MIZUTANI, Tetsuya/G-1086-2013	MIZUTANI, Tetsuya/0000-0003-2570-0452; Katano, Harutaka/0000-0002-5332-4434	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labour, and Welfare of Japan (to TL and TS), and by the Platform for drug discovery, informatics and structural life science (to KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; Faust H, 2011, J INFECT DIS, V203, P1096, DOI 10.1093/infdis/jiq173; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Gillock ET, 1997, J VIROL, V71, P2857, DOI 10.1128/JVI.71.4.2857-2865.1997; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; Kanesashi SN, 2003, J GEN VIROL, V84, P1899, DOI 10.1099/vir.0.19067-0; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Li PP, 2001, J VIROL, V75, P7321, DOI 10.1128/JVI.75.16.7321-7329.2001; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2003, VIROLOGY, V311, P115, DOI 10.1016/S0042-6822(03)00141-7; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Matsuura Y, 2007, ARCH VIROL, V152, P1375, DOI 10.1007/s00705-007-0965-6; Mizutani T, 2007, EMERG INFECT DIS, V13, P322, DOI 10.3201/eid1302.061032; Neu U, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002738; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Nilsson J, 2005, J VIROL, V79, P5337, DOI 10.1128/JVI.79.9.5337-5345.2005; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Pawlita M, 1996, J VIROL, V70, P7517, DOI 10.1128/JVI.70.11.7517-7526.1996; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAYMENT I, 1982, NATURE, V295, P110, DOI 10.1038/295110a0; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schmidt U, 2000, J VIROL, V74, P1658, DOI 10.1128/JVI.74.4.1658-1662.2000; Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SOUSSI T, 1986, J VIROL, V59, P740, DOI 10.1128/JVI.59.3.740-742.1986; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Zhang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106430	38	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115646	10.1371/journal.pone.0115646	http://dx.doi.org/10.1371/journal.pone.0115646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671590	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300010
J	Liang, JY; Kang, DD; Wang, YG; Yu, Y; Fan, JL; Takashi, E				Liang, Jingyan; Kang, Dedong; Wang, Yingge; Yu, Ying; Fan, Jianglin; Takashi, En			Carbonate Ion-Enriched Hot Spring Water Promotes Skin Wound Healing in Nude Rats	PLOS ONE			English	Article							ARTERIAL-DISEASE; SPA THERAPY; CO2; METALLOPROTEINASES; ANGIOGENESIS; EXPRESSION; TIBERIAS; REPAIR; FOOT	Hot spring or hot spa bathing (Onsen) is a traditional therapy for the treatment of certain ailments. There is a common belief that hot spring bathing has therapeutic effects for wound healing, yet the underlying molecular mechanisms remain unclear. To examine this hypothesis, we investigated the effects of Nagano hot spring water (rich in carbonate ion, 42 degrees C) on the healing process of the skin using a nude rat skin wound model. We found that hot spring bathing led to an enhanced healing speed compared to both the unbathed and hot-water (42 degrees C) control groups. Histologically, the hot spring water group showed increased vessel density and reduced inflammatory cells in the granulation tissue of the wound area. Real-time RT-PCR analysis along with zymography revealed that the wound area of the hot spring water group exhibited a higher expression of matrix metalloproteinases-2 and -9 compared to the two other control groups. Furthermore, we found that the enhanced wound healing process induced by the carbonate ion-enriched hot spring water was mediated by thermal insulation and moisture maintenance. Our results provide the evidence that carbonate ion-enriched hot spring water is beneficial for the treatment of skin wounds.	[Liang, Jingyan; Wang, Yingge] Yangzhou Univ, Sch Med, Yangzhou 225009, Jiangsu, Peoples R China; [Liang, Jingyan; Wang, Yingge; Takashi, En] Nagano Coll Nursing, Komagane, Japan; [Kang, Dedong; Yu, Ying; Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan	Yangzhou University; University of Yamanashi	Fan, JL (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan.	jianglin@yamanashi.ac.jp; takashi@nagano-nurs.ac.jp		Fan, Jianglin/0000-0002-1737-6130; Liang, Jingyan/0000-0002-9674-0235	Ministry of Education, Culture, Sports and Technology, Japan	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports and Technology, Japan (JL, JF), http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, J DERMATOL SCI, V24, P112, DOI 10.1016/S0923-1811(00)00091-8; Andreassi L, 1996, CLIN DERMATOL, V14, P627, DOI 10.1016/S0738-081X(96)00095-8; Farina S, 2011, J DERMATOL TREAT, V22, P366, DOI 10.3109/09546634.2010.512950; Fioravanti A, 2011, RHEUMATOL INT, V31, P1, DOI 10.1007/s00296-010-1628-6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Hashimoto M, 2004, J APPL PHYSIOL, V96, P226, DOI 10.1152/japplphysiol.00812.2003; Hashkes PJ, 2002, SCAND J RHEUMATOL, V31, P172; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; ITO T, 1989, J INVEST DERMATOL, V93, P259, DOI 10.1111/1523-1747.ep12277584; Jiang HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4838; Kim DH, 2013, INT J PEDIATR OTORHI, V77, P117, DOI 10.1016/j.ijporl.2012.10.008; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Millikan LE, 2000, CLIN DERMATOL, V18, P125, DOI 10.1016/S0738-081X(99)00102-9; Oyama J, 2013, HEART VESSELS, V28, P173, DOI 10.1007/s00380-011-0220-7; SALO T, 1994, LAB INVEST, V70, P176; SAVIN E, 1995, ANGIOLOGY, V46, P785, DOI 10.1177/000331979504600904; Shirakura T, 1994, NYUYOKUKENKOUJUTSU, P14; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; TANIZAKI Y, 1986, ACTA MED OKAYAMA, V40, P55; TISHLER M, 1995, CLIN RHEUMATOL, V14, P21, DOI 10.1007/BF02208080; Toriyama I, 2002, INT ANGIOL, V21, P367; Yu Y, 2008, HISTOL HISTOPATHOL, V23, P1503, DOI 10.14670/HH-23.1503	26	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117106	10.1371/journal.pone.0117106	http://dx.doi.org/10.1371/journal.pone.0117106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671581	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300034
J	Murtagh, EM; Murphy, MH; Murphy, NM; Woods, C; Nevill, AM; Lane, A				Murtagh, Elaine M.; Murphy, Marie H.; Murphy, Niamh M.; Woods, Catherine; Nevill, Alan M.; Lane, Aoife			Prevalence and Correlates of Physical Inactivity in Community-Dwelling Older Adults in Ireland	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; PEOPLE; HEALTH; PARTICIPATION; INTERVENTIONS; PREDICTORS; WOMEN; MODEL; LIFE; IPAQ	The public health challenges associated with rapid population ageing are likely to be exacerbated by poor physical activity levels. The purpose of this study was to identify correlates of physical inactivity in a population-representative sample of older adults in Ireland. This paper reports a secondary analysis of data from 4892 adults aged 60+ from the Irish Longitudinal Study on Ageing (TILDA). TILDA includes an assessment of the mental and physical health, and social and financial circumstances of participants assessed in a home interview and self-completion questionnaire. Chi squared statistics and forced entry logistic regression were used to identify factors associated with physical inactivity. Females were over twice as likely to be inactive as their male counterparts (Odds Ratio 2.2). Increasing old age was associated with inactivity among males and females. Those who reported above secondary level education, no reported falls in the last year and no fear of falling were less likely to be physically inactive. While older adults who noted poor/fair self-reported health, that they did not look after grandchildren, did not own a car or did not attend a course were also more likely to be inactive than those who reported positively for these items. Gender displayed a strong but often contrasting influence on factors that affect physical activity among older adults. Among females, living alone or in a rural area, retirement, fair/poor emotional health and activity being limited by illness were all significantly associated with inactivity. While cohabiting, being employed and residing in an urban area were related to low levels of activity in males. Our findings identify specific groups of the older Irish population who may be at particular risk of physical inactivity and thereby the associated physiological and psychological hazards. These results can support the development of tailored interventions to promote healthy ageing.	[Murtagh, Elaine M.] Univ Limerick, Dept Arts Educ & Phys Educ, Mary Immaculate Coll, Limerick, Ireland; [Murphy, Marie H.] Univ Ulster, Sport & Exercise Sci Res Inst, Newtownabbey, Antrim, North Ireland; [Murphy, Niamh M.; Lane, Aoife] Waterford Inst Technol, Ctr Hlth Behav Res, Waterford, Ireland; [Woods, Catherine] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Nevill, Alan M.] Wolverhampton Univ, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England	University of Limerick; Mary Immaculate College - University Limerick; Ulster University; South East Technological University (SETU); Dublin City University; University of Wolverhampton	Murtagh, EM (corresponding author), Univ Limerick, Dept Arts Educ & Phys Educ, Mary Immaculate Coll, Limerick, Ireland.	elaine.murtagh@mic.ul.ie	Nevill, Alan/Q-1010-2019; Murtagh, Elaine M/AAF-4146-2022; Murtagh, Elaine M/AEO-8704-2022; Murtagh, Elaine M/AEU-2463-2022	Nevill, Alan/0000-0003-0506-3652; Murtagh, Elaine M/0000-0003-4232-1403; Murtagh, Elaine M/0000-0003-4232-1403; Murphy, Niamh/0000-0002-0176-2897; Woods, Catherine/0000-0002-0892-6591; Lane, Aoife/0000-0001-9991-554X	Centre for Ageing Research and Development in Ireland through a Data Mining grant	Centre for Ageing Research and Development in Ireland through a Data Mining grant	This project was funded by the Centre for Ageing Research and Development in Ireland through a Data Mining 2013 grant (www.cardi.ie) to EM, MHM, NMM, CW, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banister D., 2004, TRANSPORT POLICY, V11, P105, DOI [10.1016/S0967-070X(03)00052-0, DOI 10.1016/S0967-070X(03)00052-0]; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Benyamini Y, 2000, PSYCHOSOM MED, V62, P354, DOI 10.1097/00006842-200005000-00009; Bergman P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-367; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Burke KE, 2012, AGING MENT HEALTH, V16, P288, DOI 10.1080/13607863.2011.628976; Central Statistics Office, 2013, POP LAB FORC PROJ 20; Cerin E, 2010, J PHYS ACT HEALTH, V7, P451, DOI 10.1123/jpah.7.4.451; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crombie IK, 2004, AGE AGEING, V33, P287, DOI 10.1093/ageing/afh089; Department of Health, 2011, START ACT STAY ACT R; Department of Health and Children Health Service Executive, 2009, NAT GUID PHYS ACT IR; DiPietro L, 2007, PHYS ACTIVITY HLTH, P271; Donorfio LKM, 2009, J SAFETY RES, V40, P221, DOI 10.1016/j.jsr.2009.04.002; Eyler AA, 1998, HEALTH EDUC BEHAV, V25, P640, DOI 10.1177/109019819802500510; Finch H., 1997, PHYS ACTIVITY OUR AG; Fleury J, 2006, AM J COMMUN PSYCHOL, V37, P129, DOI 10.1007/s10464-005-9002-7; Gebel K, 2014, PREV MED, V60, P131, DOI 10.1016/j.ypmed.2013.12.030; Giuli C, 2012, ARCH GERONTOL GERIAT, V54, P50, DOI 10.1016/j.archger.2011.02.017; Hahs-Vaughn DL, 2005, J EXP EDUC, V73, P221, DOI 10.3200/JEXE.73.3.221-248; Haley C, 2010, J AGING PHYS ACTIV, V18, P375, DOI 10.1123/japa.18.4.375; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hansen BH, 2013, INTERNATIONAL JOURNA, P1, DOI [10.1007/s00038-012-0436-z, DOI 10.1007/S00038-012-0436-Z]; Heesch Kristiann C, 2010, Int J Behav Nutr Phys Act, V7, P35, DOI 10.1186/1479-5868-7-35; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; International Physical Activity Questionnaire, 2005, IPAQ SCOR PROT; Katzmarzyk P., 2007, PHYS ACTIVITY FITNES, P37; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Kohl HW, 2012, LANCET, DOI [10.1016/S2213-2600(12)70053-X, DOI 10.1016/S2213-2600(12)70053-X]; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Moschny A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-559; Murphy R, 2009, PHYS ACT HLTH PROM E, P3; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Noone J, 2010, RES AGING, V32, P715, DOI 10.1177/0164027510383531; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Plonczynski Donna J, 2003, Medsurg Nurs, V12, P213; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Sattelmair JR, 2009, CLIN GERIATR MED, V25, P677, DOI 10.1016/j.cger.2009.07.004; Savva GM, 2013, J AM GERIATR SOC, V61, pS291, DOI 10.1111/jgs.12196; Shaw BA, 2008, J AGING HEALTH, V20, P767, DOI 10.1177/0898264308321081; Stubbs B, 2014, ARCH GERONTOL GERIAT, V59, P195, DOI 10.1016/j.archger.2014.06.006; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; The Irish Longitudinal Study on Ageing, 2009, MAIN QUEST; Thurston M, 2004, HEALTH PROMOT INT, V19, P379, DOI 10.1093/heapro/dah311; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vagetti GC, 2013, ARCH GERONTOL GERIAT, V56, P492, DOI 10.1016/j.archger.2012.12.003; Walsh JME, 2001, J GEN INTERN MED, V16, P721, DOI 10.1111/j.1525-1497.2001.00506.x; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x	54	54	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118293	10.1371/journal.pone.0118293	http://dx.doi.org/10.1371/journal.pone.0118293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671621	Green Published, gold			2022-12-27	WOS:000349545300092
J	van Logtestijn, MDA; Dominguez-Huttinger, E; Stamatas, GN; Tanaka, RJ				van Logtestijn, Mark D. A.; Dominguez-Huettinger, Elisa; Stamatas, Georgios N.; Tanaka, Reiko J.			Resistance to Water Diffusion in the Stratum Corneum Is Depth-Dependent	PLOS ONE			English	Article							SKIN BARRIER FUNCTION; IN-VIVO; ANATOMIC SITE; TRANSPORT; ADULT; PROTEASES; OILS; AGE	The stratum corneum (SC) provides a permeability barrier that limits the inflow and outflow of water. The permeability barrier is continuously and dynamically formed, maintained, and degraded along the depth, from the bottom to the top, of the SC. Naturally, its functioning and structure also change dynamically in a depth-dependent manner. While transepidermal water loss is typically used to assess the function of the SC barrier, it fails to provide any information about the dynamic mechanisms that are responsible for the depth-dependent characteristics of the permeability barrier. This paper aims to quantitatively characterize the depth-dependency of the permeability barrier using in vivo non-invasive measurement data for understanding the underlying mechanisms for barrier formation, maintenance, and degradation. As a framework to combine existing experimental data, we propose a mathematical model of the SC, consisting of multiple compartments, to explicitly address and investigate the depth-dependency of the SC permeability barrier. Using this mathematical model, we derive a measure of the water permeability barrier, i.e. resistance to water diffusion in the SC, from the measurement data on transepidermal water loss and water concentration profiles measured non-invasively by Raman spectroscopy. The derived resistance profiles effectively characterize the depth-dependency of the permeability barrier, with three distinct regions corresponding to formation, maintenance, and degradation of the barrier. Quantitative characterization of the obtained resistance profiles allows us to compare and evaluate the permeability barrier of skin with different morphology and physiology ( infants vs adults, different skin sites, before and after application of oils) and elucidates differences in underlying mechanisms of processing barriers. The resistance profiles were further used to predict the spatial-temporal effects of skin treatments by in silico experiments, in terms of spatial-temporal dynamics of percutaneous water penetration.	[van Logtestijn, Mark D. A.; Dominguez-Huettinger, Elisa; Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Stamatas, Georgios N.] Johnson & Johnson Sante Beaute France, Issy Les Moulineaux, France	Imperial College London; Johnson & Johnson	Tanaka, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	r.tanaka@imperial.ac.uk		Tanaka, Reiko/0000-0002-0769-9382; Dominguez Huttinger, Elisa/0000-0002-9086-099X	Johnson & Johnson Consumer Companies; Mexican Council for Science and Technology (CONACyT); Engineering and Physical Sciences Research Council through Career Acceleration Fellowship [EP/G007446/1]; EPSRC [EP/G007446/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	Johnson & Johnson Consumer Companies; Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Engineering and Physical Sciences Research Council through Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported by a research grant from Johnson & Johnson Consumer Companies. EDH is supported by a PhD scholarship from the Mexican Council for Science and Technology (CONACyT; www.conacyt.mx). RJT received funding from Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) through Career Acceleration Fellowship (EP/G007446/1). The funder provided support in the form of salaries for one of the authors, GNS, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Please note that the authors did not collect any new data in this work, but carried out the meta-analysis of the data already presented in other papers (References 17, 18, and 19).	Anissimov YG, 2008, MATH MODELS DIFFEREN, P271; Anissimov YG, 2013, ADV DRUG DELIVER REV, V65, P169, DOI 10.1016/j.addr.2012.04.009; Bielfeldt S, 2009, IFSCC MAGAZINE, V12, P9; Bohling A, 2014, SKIN RES TECHNOL, V20, P50, DOI 10.1111/srt.12082; Boireau- Adamezyk E, 2014, SKIN RES TECHNOL, DOI [10.1111/srt.12198, DOI 10.1111/SRT.12198]; Bouwstra JA, 2003, J INVEST DERMATOL, V120, P750, DOI 10.1046/j.1523-1747.2003.12128.x; Caspers PJ, 2000, J RAMAN SPECTROSC, V31, P813, DOI 10.1002/1097-4555(200008/09)31:8/9<813::AID-JRS573>3.0.CO;2-7; Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Damien F, 2010, J INVEST DERMATOL, V130, P611, DOI 10.1038/jid.2009.272; Elias P, 2004, SKIN PHARMACOL PHYS, V14, P28; ELIAS PM, 1991, J CONTROL RELEASE, V15, P199, DOI 10.1016/0168-3659(91)90111-P; Elias PM, 2013, BIOCHIM BIOPHYS ACTA, P9, DOI [10.1016/ j. bbagrm. 2012.09.002, DOI 10.1016/J.BBAGRM.2012.09.002]; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Ishida-Yamamoto A, 2011, J DERMATOL, V38, P645, DOI 10.1111/j.1346-8138.2011.01227.x; Kalia YN, 1998, J INVEST DERMATOL, V111, P320, DOI 10.1046/j.1523-1747.1998.00289.x; Kalia YN, 1996, BIOPHYS J, V71, P2692, DOI 10.1016/S0006-3495(96)79460-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kikuchi K, 2006, PEDIATR DERMATOL, V23, P109, DOI 10.1111/j.1525-1470.2006.00191.x; Kubo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01731; Loden M, 2003, AM J CLIN DERMATOL, V4, P771; Lu N, 2014, INT J COSMETIC SCI, V36, P167, DOI 10.1111/ics.12112; Machado M., 2010, International Journal of Cosmetic Science, V32, P397, DOI 10.1111/j.1468-2494.2010.00587.x; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; McCarley KD, 2001, J PHARM SCI-US, V90, P1699, DOI 10.1002/jps.1120; Mohammed D, 2011, BRIT J DERMATOL, V164, P957, DOI 10.1111/j.1365-2133.2011.10211.x; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V126, P574, DOI 10.1016/j.jaci.2010.04.038; Patzelt A, 2012, SKIN RES TECHNOL, V18, P364, DOI 10.1111/j.1600-0846.2011.00578.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rawlings AV, 2013, CELL TISSUE RES, V351, P217, DOI 10.1007/s00441-012-1501-x; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Rogiers V, 2001, SKIN PHARMACOL APPL, V14, P117, DOI 10.1159/000056341; ROUGIER A, 1988, J SOC COSMET CHEM, V39, P15; SCHEUPLEIN RJ, 1971, PHYSIOL REV, V51, P702, DOI 10.1152/physrev.1971.51.4.702; Schwindt DA, 1998, J INVEST DERMATOL, V111, P385, DOI 10.1046/j.1523-1747.1998.00321.x; Stamatas GN, 2011, INT J COSMETIC SCI, V33, P17, DOI 10.1111/j.1468-2494.2010.00611.x; Stamatas GN, 2008, J DERMATOL SCI, V50, P135, DOI 10.1016/j.jdermsci.2007.11.006; Stamatas GN, 2010, PEDIATR DERMATOL, V27, P125, DOI 10.1111/j.1525-1470.2009.00973.x; Stamatas GN, 2006, BRIT J DERMATOL, V154, P125, DOI 10.1111/j.1365-2133.2005.06949.x; Tanaka RJ, 2013, J INVEST DERMATOL, V133, P1472, DOI 10.1038/jid.2013.69; Wurm EMT, 2012, BRIT J DERMATOL, V167, P270, DOI 10.1111/j.1365-2133.2012.10943.x; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; ZATZ JL, 1992, J SOC COSMET CHEM, V43, P37	44	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117292	10.1371/journal.pone.0117292	http://dx.doi.org/10.1371/journal.pone.0117292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671323	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300046
J	Veblen, KE; Nehring, KC; McGlone, CM; Ritchie, ME				Veblen, Kari E.; Nehring, Kyle C.; McGlone, Christopher M.; Ritchie, Mark E.			Contrasting Effects of Different Mammalian Herbivores on Sagebrush Plant Communities	PLOS ONE			English	Article							WESTERN NORTH-AMERICA; BROMUS-TECTORUM L; GREAT-BASIN; TREE ESTABLISHMENT; POPULATION-GROWTH; CATTLE; VEGETATION; COMPETITION; GRASSLAND; UNGULATE	Herbivory by both grazing and browsing ungulates shapes the structure and functioning of terrestrial ecosystems worldwide, and both types of herbivory have been implicated in major ecosystem state changes. Despite the ecological consequences of differences in diets and feeding habits among herbivores, studies that experimentally distinguish effects of grazing from spatially co-occurring, but temporally segregated browsing are extremely rare. Here we use a set of long-term exclosures in northern Utah, USA, to determine how domestic grazers vs. wild ungulate herbivores (including browsers and mixed feeders) affect sagebrush-dominated plant communities that historically covered similar to 62 million ha in North America. We sampled plant community properties and found that after 22 years grazing and browsing elicited perceptible changes in overall plant community composition and distinct responses by individual plant species. In the woody layer of the plant community, release from winter and spring wild ungulate herbivory increased densities of larger Wyoming big sagebrush (Artemisia tridentata, ssp. wyomingensis) at the expense of small sagebrush, while disturbance associated with either cattle or wild ungulate activity alone was sufficient to increase bare ground and reduce cover of biological soil crusts. The perennial bunchgrass, bottlebrush squirretail (Elymus elymoides), responded positively to release from summer cattle grazing, and in turn appeared to competitively suppress another more grazing tolerant perennial grass, Sandberg's blue grass (Poa secunda). Grazing by domestic cattle also was associated with increased non-native species biomass. Together, these results illustrate that ungulate herbivory has not caused sagebrush plant communities to undergo dramatic state shifts; however clear, herbivore-driven shifts are evident. In a dry, perennial- dominated system where plant community changes can occur very slowly, our results provide insights into potential long-term trajectories of these plant communities under different large herbivore regimes. Our results can be used to guide long-term management strategies for sagebrush systems and improve habitat for endemic wildlife species such as sage-grouse (Centrocercus spp.).	[Veblen, Kari E.; Nehring, Kyle C.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Veblen, Kari E.; Nehring, Kyle C.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [McGlone, Christopher M.] Utah State Univ, USDA ARS, Pollinating Insect Res Unit, Logan, UT 84322 USA; [Ritchie, Mark E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Syracuse University	Veblen, KE (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.	kari.veblen@usu.edu	Veblen, Kari E./D-1439-2012	Veblen, Kari E./0000-0001-7523-3368	Deseret Land and Livestock; Utah Agricultural Experiment Station; Utah Agricultural Experiment Station Mineral Lease Funds; USDA-ARS Pollinating Insect Research Unit; National Science Foundation DEB [0087201, 0244247]	Deseret Land and Livestock; Utah Agricultural Experiment Station; Utah Agricultural Experiment Station Mineral Lease Funds; USDA-ARS Pollinating Insect Research Unit; National Science Foundation DEB(National Science Foundation (NSF))	This work was supported by the Deseret Land and Livestock http://www.deseretlandandlivestock.com/(MER); Utah Agricultural Experiment Station http://uaes.usu.edu/(KEV); Utah Agricultural Experiment Station Mineral Lease Funds (MER); USDA-ARS Pollinating Insect Research Unit http://www.ars.usda.gov/main/site_main.htm?modecode=20-80-05-00(CMM); and the National Science Foundation DEB grants 0087201 and 0244247 (MER). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. With the exception of Deseret Land and Livestock, the funders had no role in study design. Deseret Land and Livestock identified general locations for the exclosures so we could focus the study on known winter ungulate range. However, the specific locations of different treatments were chosen by the authors.	Adler PB, 2005, ECOL APPL, V15, P774, DOI 10.1890/04-0231; Allen PS, 2014, INVAS PLANT SCI MANA, V7, P1, DOI 10.1614/IPSM-D-13-00021.1; Anderson TM, 2007, ECOLOGY, V88, P1191, DOI 10.1890/06-0399; Archer S.R., 2010, WILD RANGELANDS CONS, P53, DOI DOI 10.1002/9781444317091.CH4; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2001, ECOLOGY, V82, P3149, DOI 10.1890/0012-9658(2001)082[3149:EOMGOS]2.0.CO;2; Bagchi S, 2010, OECOLOGIA, V164, P1075, DOI 10.1007/s00442-010-1690-5; BAKER DL, 1982, J WILDLIFE MANAGE, V46, P694, DOI 10.2307/3808561; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bakker JD, 2010, WEST N AM NATURALIST, V70, P334, DOI 10.3398/064.070.0306; Beck JL, 2005, RANGELAND ECOL MANAG, V58, P135, DOI 10.2111/03-13.1; Beever EA, 2000, WEST N AM NATURALIST, V60, P236; Bowker MA, 2007, RESTOR ECOL, V15, P13, DOI 10.1111/j.1526-100X.2006.00185.x; Boyd CS, 2011, J ARID ENVIRON, V75, P734, DOI 10.1016/j.jaridenv.2011.03.008; Briske D. D., 1995, WILDLAND PLANTS PHYS, P635; Brookshire ENJ, 2002, OECOLOGIA, V132, P559, DOI 10.1007/s00442-002-1007-4; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Camp MJ, 2014, RANGELAND J, V36, P151, DOI 10.1071/RJ13065; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; Chambers JC, 2014, ECOSYSTEMS, V17, P360, DOI 10.1007/s10021-013-9725-5; Chambers JC, 2009, RESTOR ECOL, V17, P707, DOI 10.1111/j.1526-100X.2009.00588.x; Christianson DA, 2007, J WILDLIFE MANAGE, V71, P164, DOI 10.2193/2005-575; Cipriotti PA, 2012, APPL VEG SCI, V15, P35, DOI 10.1111/j.1654-109X.2011.01138.x; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Connelly JW, 2004, REPORT; Cook John G., 2002, P259; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Crawford JA, 2004, J RANGE MANAGE, V57, P2, DOI 10.2307/4003949; Davies KW, 2009, ECOL APPL, V19, P1536, DOI 10.1890/09-0111.1; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; FRANK DA, 1993, OECOLOGIA, V96, P157, DOI 10.1007/BF00317727; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Hedges LV, 1981, JOURNAL OF EDUCATION, V6; Herrick JE, 2005, MONITORING MANUAL FO, VII; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; HOBBS NT, 1981, J WILDLIFE MANAGE, V45, P156, DOI 10.2307/3807884; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; Humphrey LD, 2004, J ARID ENVIRON, V58, P405, DOI 10.1016/j.jaridenv.2003.11.008; JONES WEBSTER B., 1965, J RANGE MANAGE, V18, P218, DOI 10.2307/3895602; Kalisz S, 2014, P NATL ACAD SCI USA, V111, P4501, DOI 10.1073/pnas.1310121111; Kay CE, 2000, J RANGE MANAGE, V53, P145, DOI 10.2307/4003274; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Kraaij T, 2006, J ARID ENVIRON, V64, P174, DOI 10.1016/j.jaridenv.2005.04.009; Leger EA, 2008, ECOL APPL, V18, P1226, DOI 10.1890/07-1598.1; Leger EA, 2014, J ARID ENVIRON, V102, P9, DOI 10.1016/j.jaridenv.2013.10.015; Loeser MR, 2005, RANGELAND ECOL MANAG, V58, P234, DOI 10.2111/1551-5028(2005)58[234:VCAFRT]2.0.CO;2; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Manier DJ, 2007, OECOLOGIA, V152, P739, DOI 10.1007/s00442-007-0689-z; McCune B, 2002, ANALYIS OF ECOLOGICA; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; Miller RF, 2011, CH 11 CHARACTERISTIC; Moe SR, 2014, CONSERV SCI PRACT, V14, P154; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Newbold TAS, 2008, WEST N AM NATURALIST, V68, P291, DOI 10.3398/1527-0904(2008)68[291:COCIIA]2.0.CO;2; Noss RF, 1995, NATIONAL BIOLOGICAL; NRCS, 2013, THE PLANTS DATABASE, DOI [10.1016/j.mgene.2013.11.003, DOI 10.1016/J.MGENE.2013.11.003]; Odadi WO, 2013, ECOL APPL, V23, P455, DOI 10.1890/12-0878.1; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Okin GS, 2009, BIOSCIENCE, V59, P237, DOI 10.1525/bio.2009.59.3.8; Pajunen A, 2012, OIKOS, V121, P1544, DOI 10.1111/j.1600-0706.2011.20115.x; Parsons EWR, 2013, J ANIM ECOL, V82, P459, DOI 10.1111/1365-2656.12009; Pekin BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086288; Petersen CA, 2014, RANGELAND ECOL MANAG, V67, P78, DOI 10.2111/REM-D-13-00038.1; Pinheiro J, 2013, NLME LINEAR AND NONL; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Ponzetti JM, 2007, BRYOLOGIST, V110, P706, DOI 10.1639/0007-2745(2007)110[706:BSCIRT]2.0.CO;2; Porensky LM, 2013, OECOLOGIA, V173, P591, DOI 10.1007/s00442-013-2637-4; Porensky LM, 2013, J ARID ENVIRON, V96, P55, DOI 10.1016/j.jaridenv.2013.04.003; Poulos JM, 2014, PLANT ECOL, V215, P417, DOI 10.1007/s11258-014-0312-4; Prevey JS, 2010, ECOL APPL, V20, P1890, DOI 10.1890/09-0750.1; Read CF, 2014, J APPL ECOL EARLY VI; REINER RJ, 1982, J RANGE MANAGE, V35, P567, DOI 10.2307/3898639; Reisner MD, 2013, J APPL ECOL, V50, P1039, DOI 10.1111/1365-2664.12097; Rexroad EA, 2007, WEST N AM NATURALIST, V67, P16, DOI 10.3398/1527-0904(2007)67[16:VRTAYO]2.0.CO;2; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Riginos C, 2009, ECOLOGY, V90, P335, DOI 10.1890/08-0462.1; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Schlaepfer DR, 2014, RANGELAND ECOL MANAG, V67, P344, DOI 10.2111/REM-D-13-00079.1; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Staver AC, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00029.1; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; Stewart KM, 2009, OECOLOGIA, V161, P303, DOI 10.1007/s00442-009-1376-z; Stohlgren TJ, 1999, ECOL APPL, V9, P45, DOI 10.1890/1051-0761(1999)009[0045:HGASQA]2.0.CO;2; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Vavra M, 2007, FOREST ECOL MANAG, V246, P66, DOI 10.1016/j.foreco.2007.03.051; Veblen KE, 2010, J ECOL, V98, P993, DOI 10.1111/j.1365-2745.2010.01705.x; Wagoner SJ, 2013, J WILDLIFE MANAGE, V77, P897, DOI 10.1002/jwmg.545; Watson IW, 2007, RANGELAND J, V29, P25, DOI 10.1071/RJ07018; Wilkerson ML, 2013, ECOL EVOL, V3, P3672, DOI 10.1002/ece3.744; Yeo JJ, 2005, WEST N AM NATURALIST, V65, P91; Young T. P., 1997, African Journal of Range & Forage Science, V14, P94, DOI 10.1080/10220119.1997.9647929; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	104	16	16	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118016	10.1371/journal.pone.0118016	http://dx.doi.org/10.1371/journal.pone.0118016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671428	Green Published, gold			2022-12-27	WOS:000349545300079
J	Wu, CH; Huang, TY; Chen, BS; Chiou, LL; Lee, HS				Wu, Cheng-Han; Huang, Ting-Yu; Chen, Bo-Sung; Chiou, Ling-Ling; Lee, Hsuan-Shu			Long-Duration Muscle Dedifferentiation during Limb Regeneration in Axolotls	PLOS ONE			English	Article							DIFFERENTIATED CELLS; PAX7; PLASTICITY; ORIGIN; TAIL; EXPRESSION; MYOGENESIS; MODEL	Although still debated, limb regeneration in salamanders is thought to depend on the dedifferentiation of remnant tissue occurring early after amputation and generating the progenitor cells that initiate regeneration. This dedifferentiation has been demonstrated previously by showing the fragmentation of muscle fibers into mononucleated cells and by revealing the contribution of mature muscle fibers to the regenerates by using lineage-tracing studies. Here, we provide additional evidence of dedifferentiation by showing that Pax7 (paired-box protein-7) transcripts are expressed at the ends of remnant muscle fibers in axolotls by using in situ hybridization and by demonstrating the presence of Pax7(+) muscle-fiber nuclei in the early bud and mid-bud stages by means of immunohistochemical staining. During the course of regeneration, the remnant muscles did not progress; instead, muscle progenitors migrated out from the remnants and proliferated and differentiated in the new tissues at an early stage of differentiation. The regenerating muscles and remnant muscles were largely disconnected, and this left a gap between them until extremely late in the late stage of differentiation, at which point the new and old muscles connected together. Notably, Pax7 transcripts were detected in the regions of muscles that faced these gaps; thus, Pax7 expression might indicate dedifferentiation in the remnant-muscle ends and partial differentiation in the regenerating muscles. The roles of this long-duration dedifferentiation in the remnants remain unknown. However, the results presented here could support the hypothesis that long-duration muscle dedifferentiation facilitates the connection and fusion between the new and old muscles that are both in an immature state; this is because immature Pax7(+) myoblasts readily fuse during developmental myogenesis.	[Wu, Cheng-Han; Huang, Ting-Yu; Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan; [Chen, Bo-Sung; Lee, Hsuan-Shu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Bo-Sung; Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Lee, HS (corresponding author), Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan.	benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434	Ministry of Science and Technology, Taiwan [MOST 102-2314-B-002 -127 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant to HSL from Ministry of Science and Technology (MOST 102-2314-B-002 -127 -MY3), Taiwan (http://www.most.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; CAMERON JA, 1986, NATURE, V321, P607, DOI 10.1038/321607a0; CARLSON BM, 1970, ANAT REC, V166, P423, DOI 10.1002/ar.1091660302; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Enwere EK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00034; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Horst D, 2006, INT J DEV BIOL, V50, P47, DOI 10.1387/ijdb.052111dh; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; LENTZ TL, 1969, AM J ANAT, V124, P447, DOI 10.1002/aja.1001240404; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Sambasivan R, 2007, SEMIN CELL DEV BIOL, V18, P870, DOI 10.1016/j.semcdb.2007.09.013; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Straube WL, 2004, CLONING STEM CELLS, V6, P333, DOI 10.1089/clo.2004.6.333; TASSAVA RA, 1975, DIFFERENTIATION, V4, P23, DOI 10.1111/j.1432-0436.1975.tb01439.x; Thornton CS, 1983, J MORPHOL, V62, P17; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	37	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116068	10.1371/journal.pone.0116068	http://dx.doi.org/10.1371/journal.pone.0116068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671422	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300015
J	Zhao, YQ; Wang, YJ; Gao, YD; Li, GH; Huang, JF				Zhao, Yuqi; Wang, Yanjie; Gao, Yuedong; Li, Gonghua; Huang, Jingfei			Integrated Analysis of Residue Coevolution and Protein Structures Capture Key Protein Sectors in HIV-1 Proteins	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; T-CELL RESPONSES; REVERSE-TRANSCRIPTASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; COUPLING ANALYSIS; PHAGE DISPLAY; DOMAIN; INHIBITORS; COMPLEX	HIV type 1 (HIV-1) is characterized by its rapid genetic evolution, leading to challenges in anti-HIV therapy. However, the sequence variations in HIV-1 proteins are not randomly distributed due to a combination of functional constraints and genetic drift. In this study, we examined patterns of sequence variability for evidence of linked sequence changes (termed as coevolution or covariation) in 15 HIV-1 proteins. It shows that the percentage of charged residues in the coevolving residues is significantly higher than that in all the HIV-1 proteins. Most of the coevolving residues are spatially proximal in the protein structures and tend to form relatively compact and independent units in the tertiary structures, termed as "protein sectors". These protein sectors are closely associated with anti-HIV drug resistance, T cell epitopes, and antibody binding sites. Finally, we explored candidate peptide inhibitors based on the protein sectors. Our results can establish an association between the coevolving residues and molecular functions of HIV-1 proteins, and then provide us with valuable knowledge of pathology of HIV-1 and therapeutics development.	[Zhao, Yuqi; Li, Gonghua; Huang, Jingfei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 650223, Yunnan, Peoples R China; [Zhao, Yuqi] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Wang, Yanjie] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Wang, Yanjie] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Gao, Yuedong] Chinese Acad Sci, Kunming Inst Zool, Kunming Biol Divers Reg Ctr Instruments, Kunming 650223, Peoples R China; [Huang, Jingfei] Collaborat Innovat Ctr Nat Prod & Biol Drugs Yunn, Kunming 650223, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhao, YQ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang Donglu Kunming, Beijing 650223, Yunnan, Peoples R China.	zhaoyq@mail.kiz.ac.cn; huangjf@mail.kiz.ac.cn	Zhao, Yuqi/L-5639-2016	Zhao, Yuqi/0000-0003-0730-5854; Zhao, Yuqi/0000-0002-4256-4512; Li, Gong-Hua/0000-0002-9311-6613	National Natural Science Foundation of China [31123005]; West Light Foundation of The Chinese Academy of Sciences [Y302401081, Y302401082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grant No. 31123005), and West Light Foundation of The Chinese Academy of Sciences (awarded to Yuqi Zhao; Grant Nos. Y302401081 and Y302401082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar AA, 2012, N AM J MED SCI, V4, P120, DOI 10.4103/1947-2714.93882; Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Brackenridge S, 2011, J VIROL, V85, P5415, DOI 10.1128/JVI.00238-11; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Castel G, 2011, MOLECULES, V16, P3499, DOI 10.3390/molecules16053499; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Desjobert C, 2004, BIOCHEMISTRY-US, V43, P13097, DOI 10.1021/bi049385e; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Echegoyen L, 2011, J PHYS ORG CHEM, V24, P743, DOI 10.1002/poc.1909; Esposito F, 2011, FEBS J, V278, P1444, DOI 10.1111/j.1742-4658.2011.08057.x; Forssmann WG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001697; Fossen T, 2005, J BIOL CHEM, V280, P42515, DOI 10.1074/jbc.M507375200; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Nyamweya S, 2013, REV MED VIROL, V23, P221, DOI 10.1002/rmv.1739; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Okazaki T, 2006, J IMMUNOL, V176, P3753, DOI 10.4049/jimmunol.176.6.3753; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Poveda E, 2006, ANTIRETROVIRAL RESIS; Qureshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054908; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; SWAIN AL, 1990, P NATL ACAD SCI USA, V87, P8805, DOI 10.1073/pnas.87.22.8805; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wang JW, 2013, FEBS LETT, V587, P136, DOI 10.1016/j.febslet.2012.11.001; Wecker K, 2002, EUR J BIOCHEM, V269, P3779, DOI 10.1046/j.1432-1033.2002.03067.x; Willbold D, 1997, EUR J BIOCHEM, V245, P581, DOI 10.1111/j.1432-1033.1997.t01-1-00581.x; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11	75	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117506	10.1371/journal.pone.0117506	http://dx.doi.org/10.1371/journal.pone.0117506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671429	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300055
J	Cao, C; Hu, JX; Dong, YF; Zhan, R; Li, P; Su, H; Peng, Q; Wu, T; Lei, L; Huang, X; Wu, QH; Cheng, XS				Cao, Cheng; Hu, Jianxin; Dong, Yifei; Zhan, Rui; Li, Ping; Su, Hai; Peng, Qiang; Wu, Tao; Lei, Liang; Huang, Xiao; Wu, Qinghua; Cheng, Xiaoshu			Gender Differences in the Risk Factors for Endothelial Dysfunction in Chinese Hypertensive Patients: Homocysteine Is an Independent Risk Factor in Females	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PLASMA HOMOCYSTEINE; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; SEX-DIFFERENCES; LIFE-STYLE; FOLIC-ACID; MENOPAUSE; WOMEN; AGE	Objectives Endothelial dysfunction plays a key role in the pathogenesis of cardiovascular disease. However, the gender-related differences in risk factors for endothelial dysfunction are controversial. We investigated the gender differences in the risk factor profiles for endothelial dysfunction in Chinese hypertensive patients. Methods Vascular endothelial functions in 213 hypertensive patients were measured by digital reactive hyperemia peripheral arterial tonometry (RH-PAT). Peripheral blood samples were collected, and the self-reported smoking and alcohol consumption status, age, body mass index, heart rate, blood pressure and drug administrations were recorded. Results RH-PAT indexes were attenuated in both male and female hypertensive patients [1.60 (1.38-2.02) vs. 1.63 (1.44-1.98)]. Multivariate logistic regression analysis identified plasma creatinine (p < 0.001), total cholesterol (p = 0.001), homocysteine (p = 0.002) and smoking (p < 0.001) as the independent factors correlated with gender (male). Multivariate linear regression analysis further identified homocysteine as the factor that is significantly and independently correlated with the decrease in the RH-PAT indexes in female patients (odds ratio: -0.166, 95% confidence interval: -0.292 to -0.040, p = 0.01). However, none of these four factors were correlated with the RH-PAT indexes in male patients. Conclusions There are gender-related differences in the risk factors for endothelial dysfunction in Chinese hypertensive patients. Homocysteine is an independent factor for endothelial dysfunction in female hypertensive patients.	[Cao, Cheng; Hu, Jianxin; Dong, Yifei; Zhan, Rui; Li, Ping; Su, Hai; Peng, Qiang; Wu, Tao; Lei, Liang; Huang, Xiao; Wu, Qinghua; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang City, Jiangxi, Peoples R China; [Dong, Yifei] Key Lab Mol Biol Jiangxi Prov, Nanchang City, Jiangxi, Peoples R China	Nanchang University	Dong, YF (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang City, Jiangxi, Peoples R China.	yf_dong66@126.com	Huang, Xiao/ABB-9211-2020		National Natural Science Foundation of China [81200187]; Natural Science Foundation in Jiangxi Province [20122BAB21504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation in Jiangxi Province	This work was supported by a grant from National Natural Science Foundation of China (Grant NO. 81200187) and a grant from Natural Science Foundation in Jiangxi Province (Grant NO. 20122BAB21504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Billups KL, 2011, INT J CLIN PRACT, V65, P134, DOI 10.1111/j.1742-1241.2010.02564.x; Bittner V, 2009, J AM COLL CARDIOL, V54, P2374, DOI 10.1016/j.jacc.2009.10.008; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Centers for Disease Control and Prevention. National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; Ervin RB, 2009, 17 NAT HLTH STAT; Fukagawa NK, 2000, AM J CLIN NUTR, V72, P22; Ganji V, 2009, J NUTR, V139, P345, DOI 10.3945/jn.108.092726; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Hung MY, 2013, INT J MED SCI, V10, P255, DOI 10.7150/ijms.5383; Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Kuvin JT, 2003, AM J CARDIOL, V92, P275, DOI 10.1016/S0002-9149(03)00623-4; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Madsen JS, 2002, AM J OBSTET GYNECOL, V187, P33, DOI 10.1067/mob.2002.123030; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Naik S, 2011, INT J VITAM NUTR RES, V81, P306, DOI 10.1024/0300-9831/a000078; Patel Pawan D, 2008, Ther Adv Cardiovasc Dis, V2, P89, DOI 10.1177/1753944707088904; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094; Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wang CY, 2014, EUR J INTERN MED, V25, P538, DOI 10.1016/j.ejim.2014.04.011; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yao FJ, 2014, J ULTRAS MED, V33, P281, DOI 10.7863/ultra.33.2.281; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	23	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118686	10.1371/journal.pone.0118686	http://dx.doi.org/10.1371/journal.pone.0118686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692574	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500126
J	Krenz, WDC; Rodgers, EW; Baro, DJ				Krenz, Wulf-Dieter C.; Rodgers, Edmund W.; Baro, Deborah J.			Tonic 5nM DA Stabilizes Neuronal Output by Enabling Bidirectional Activity-Dependent Regulation of the Hyperpolarization Activated Current via PKA and Calcineurin	PLOS ONE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; TRANSIENT POTASSIUM CURRENT; PATTERN GENERATOR NETWORK; AKAP SIGNALING COMPLEXES; LOW-FREQUENCY DEPRESSION; CHANNEL MESSENGER-RNA; LONG-TERM DEPRESSION; SMALL NEURAL-NETWORK; I-H; DOPAMINE MODULATION	Volume transmission results in phasic and tonic modulatory signals. The actions of tonic dopamine (DA) at type 1 DA receptors (D1Rs) are largely undefined. Here we show that tonic 5nM DA acts at D1Rs to stabilize neuronal output over minutes by enabling activity-dependent regulation of the hyperpolarization activated current (I-h). In the presence but not absence of 5nM DA, I-h maximal conductance (G(max)) was adjusted according to changes in slow wave activity in order to maintain spike timing. Our study on the lateral pyloric neuron (LP), which undergoes rhythmic oscillations in membrane potential with depolarized plateaus, demonstrated that incremental, bi-directional changes in plateau duration produced corresponding alterations in LP I-h G(max) when preparations were superfused with saline containing 5nM DA. However, when preparations were superfused with saline alone there was no linear correlation between LP I-h G(max) and duty cycle. Thus, tonic nM DA modulated the capacity for activity to modulate LP I-h G(max); this exemplifies metamodulation (modulation of modulation). Pretreatment with the Ca2+-chelator, BAPTA, or the specific PKA inhibitor, PKI, prevented all changes in LP I-h in 5nM DA. Calcineurin inhibitors blocked activity-dependent changes enabled by DA and revealed a PKA-mediated, activity-independent enhancement of LP I-h G(max). These data suggested that tonic 5nM DA produced two simultaneous, PKA-dependent effects: a direct increase in LP I-h G(max) and a priming event that permitted calcineurin regulation of LP I-h. The latter produced graded reductions in LP I-h G(max) with increasing duty cycles. We also demonstrated that this metamodulation preserved the timing of LP's first spike when network output was perturbed with bath-applied 4AP. In sum, 5nM DA permits slow wave activity to provide feedback that maintains spike timing, suggesting that one function of low-level, tonic modulation is to stabilize specific features of a dynamic output.	[Krenz, Wulf-Dieter C.; Rodgers, Edmund W.; Baro, Deborah J.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Baro, DJ (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	dbaro@gsu.edu			National Institutes of Health [RO1, DA024039]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Institutes of Health RO1, DA024039, to DJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ayali A, 1998, BRAIN RES, V794, P155, DOI 10.1016/S0006-8993(98)00258-3; Ayali A, 1998, J NEUROPHYSIOL, V79, P2063, DOI 10.1152/jn.1998.79.4.2063; Ayali A, 1999, J NEUROSCI, V19, P6712; Ballo AW, 2012, J NEUROSCI, V32, P5106, DOI 10.1523/JNEUROSCI.6320-11.2012; Ballo AW, 2010, J NEUROSCI, V30, P8425, DOI 10.1523/JNEUROSCI.0405-10.2010; Baro DJ, 1997, J NEUROSCI, V17, P6597; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Bonin RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058679; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brager DH, 2012, CELL REP, V1, P225, DOI 10.1016/j.celrep.2012.02.002; Breton JD, 2009, J PHYSIOL-LONDON, V587, P5107, DOI 10.1113/jphysiol.2009.180943; Bucher D, 2003, J NEUROSCI, V23, P6866; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Burdakov D, 2005, NEURAL COMPUT, V17, P991, DOI 10.1162/0899766053491841; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Clark MC, 2006, COMP BIOCHEM PHYS B, V143, P294, DOI 10.1016/j.cbpb.2005.11.017; Clark MC, 2008, J NEUROCHEM, V104, P1006, DOI 10.1111/j.1471-4159.2007.05029.x; Clark MC, 2007, COMP BIOCHEM PHYS B, V146, P9, DOI 10.1016/j.cbpb.2006.08.018; Cleland TA, 1997, J NEUROPHYSIOL, V78, P3450, DOI 10.1152/jn.1997.78.6.3450; Dacher M, 2013, J NEUROSCI, V33, P2650, DOI 10.1523/JNEUROSCI.2037-12.2013; Devinney MJ, 2013, ANN NY ACAD SCI, V1279, P143, DOI 10.1111/nyas.12085; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Few WP, 2007, P NATL ACAD SCI USA, V104, P5187, DOI 10.1073/pnas.0611619104; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P866, DOI 10.1152/jn.1986.55.5.866; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P847, DOI 10.1152/jn.1986.55.5.847; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gruhn M, 2005, J NEUROPHYSIOL, V94, P2888, DOI 10.1152/jn.00434.2005; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; Hassfurth B, 2009, EUR J NEUROSCI, V30, P1227, DOI 10.1111/j.1460-9568.2009.06925.x; Hedrich UBS, 2011, J NEUROPHYSIOL, V105, P1671, DOI 10.1152/jn.01105.2010; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Johnson BR, 2005, J NEUROPHYSIOL, V94, P3101, DOI 10.1152/jn.00440.2005; Johnson BR, 2003, J NEUROPHYSIOL, V90, P631, DOI 10.1152/jn.00037.2003; JOHNSON BR, 1990, J NEUROSCI, V10, P2066; Johnson BR, 1997, J NEUROPHYSIOL, V78, P3210, DOI 10.1152/jn.1997.78.6.3210; Johnson BR, 2011, J NEUROPHYSIOL, V105, P293, DOI 10.1152/jn.00809.2010; Kadiri LR, 2011, J NEUROPHYSIOL, V106, P1288, DOI 10.1152/jn.00456.2011; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; Kirby MS, 2007, J NEUROPHYSIOL, V98, P3206, DOI 10.1152/jn.00795.2006; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; Kloppenburg P, 2000, J NEUROSCI, V20, P2523; Kloppenburg P, 2007, J NEUROPHYSIOL, V98, P2910, DOI 10.1152/jn.00660.2007; Krenz WDC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00039; Krenz WDC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00169; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin L, 2010, MOL CELL NEUROSCI, V43, P315, DOI 10.1016/j.mcn.2009.12.005; Ma YN, 2013, MOL CELL BIOL, V33, P3994, DOI 10.1128/MCB.00623-13; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Marder E, 2011, P NATL ACAD SCI US; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; McLean DL, 2004, J NEUROSCI, V24, P9561, DOI 10.1523/JNEUROSCI.1817-04.2004; Mesce KA, 2002, BRAIN BEHAV EVOLUT, V60, P339, DOI 10.1159/000067793; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Narayanan R, 2010, NEURON, V68, P921, DOI 10.1016/j.neuron.2010.11.033; Narayanan R, 2010, J NEUROPHYSIOL, V104, P1020, DOI 10.1152/jn.01129.2009; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Noam Y, 2014, J BIOL CHEM, V289, P5889, DOI 10.1074/jbc.M113.522060; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; O'Leary T, 2011, J PHYSIOL-LONDON, V589, P4811, DOI 10.1113/jphysiol.2011.210179; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Peck JH, 2006, J NEUROPHYSIOL, V96, P2931, DOI 10.1152/jn.00423.2005; Peck JH, 2001, J NEUROPHYSIOL, V86, P2957, DOI 10.1152/jn.2001.86.6.2957; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Pulver SR, 2003, J COMP NEUROL, V462, P400, DOI 10.1002/cne.10767; Ransdell JL, 2013, J NEUROPHYSIOL, V110, P42, DOI 10.1152/jn.00009.2013; Ransdell JL, 2012, J NEUROSCI, V32, P9649, DOI 10.1523/JNEUROSCI.1945-12.2012; Ribeiro JA, 2010, ACTA PHYSIOL, V199, P161, DOI 10.1111/j.1748-1716.2010.02115.x; Rodgers EW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-143; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; Rodgers EW, 2011, J NEUROSCI, V31, P13046, DOI 10.1523/JNEUROSCI.2194-11.2011; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Shah MM, 2014, J PHYSIOL-LONDON, V592, P2711, DOI 10.1113/jphysiol.2013.270058; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Silverman-Gavrila LB, 2005, J NEUROSCI, V25, P3168, DOI 10.1523/JNEUROSCI.4908-04.2005; Silverman-Gavrila LB, 2009, J NEUROCHEM, V109, P716, DOI 10.1111/j.1471-4159.2009.05973.x; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Stegen M, 2012, CEREB CORTEX, V22, P2087, DOI 10.1093/cercor/bhr294; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083067; Svensson E, 2001, J NEUROSCI, V21, P5984, DOI 10.1523/JNEUROSCI.21-16-05984.2001; Szucs A, 2006, J NEUROBIOL, V66, P1584, DOI 10.1002/neu.20325; Temporal S, 2014, CURR BIOL, V24, P1899, DOI 10.1016/j.cub.2014.06.067; Temporal S, 2012, J NEUROPHYSIOL, V107, P718, DOI 10.1152/jn.00622.2011; Thirumalai V, 2006, J NEUROPHYSIOL, V95, P1762, DOI 10.1152/jn.00764.2005; Thoby-Brisson M, 1998, J NEUROSCI, V18, P2212; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Weaver AL, 2003, J NEUROPHYSIOL, V89, P1327, DOI 10.1152/jn.00704.2002; Xiang M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004497; Ying SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042756; Zhang HM, 2010, J NEUROPHYSIOL, V104, P873, DOI 10.1152/jn.00195.2010; Zhao SB, 2012, J NEUROSCI, V32, P13380, DOI 10.1523/JNEUROSCI.6500-11.2012; Zoli M, 1998, BRAIN RES REV, V26, P136, DOI 10.1016/S0165-0173(97)00048-9	124	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117965	10.1371/journal.pone.0117965	http://dx.doi.org/10.1371/journal.pone.0117965			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692473	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500085
J	Castro, M; Deane, SM; Ruiz, L; Rawlings, DE; Guiliani, N				Castro, Matias; Deane, Shelly M.; Ruiz, Lina; Rawlings, Douglas E.; Guiliani, Nicolas			Diguanylate Cyclase Null Mutant Reveals That C-Di-GMP Pathway Regulates the Motility and Adherence of the Extremophile Bacterium Acidithiobacillus caldus	PLOS ONE			English	Article							LONG-TERM SURVIVAL; PSEUDOMONAS-AERUGINOSA; THIOBACILLUS-CALDUS; RESPONSE REGULATOR; CYCLIC DIGUANYLATE; VIBRIO-CHOLERAE; ALLOSTERIC CONTROL; BIOFILM FORMATION; RDAR MORPHOTYPE; DOMAIN PROTEINS	An understanding of biofilm formation is relevant to the design of biological strategies to improve the efficiency of the bioleaching process and to prevent environmental damages caused by acid mine/rock drainage. For this reason, our laboratory is focused on the characterization of the molecular mechanisms involved in biofilm formation in different biomining bacteria. In many bacteria, the intracellular levels of c-di-GMP molecules regulate the transition from the motile planktonic state to sessile community-based behaviors, such as biofilm development, through different kinds of effectors. Thus, we recently started a study of the c-di-GMP pathway in several biomining bacteria including Acidithiobacillus caldus. C-di-GMP molecules are synthesized by diguanylate cyclases (DGCs) and degraded by phosphodiesterases (PDEs). We previously reported the existence of intermediates involved in c-di-GMP pathway from different Acidithiobacillus species. Here, we report our work related to At. caldus ATCC 51756. We identified several putative-ORFs encoding DGC and PDE and effector proteins. By using total RNA extracted from At. caldus cells and RT-PCR, we demonstrated that these genes are expressed. We also demonstrated the presence of c-di-GMP by mass spectrometry and showed that genes for several of the DGC enzymes were functional by heterologous genetic complementation in Salmonella enterica serovar Typhimurium mutants. Moreover, we developed a DGC defective mutant strain (Delta c1319) that strongly indicated that the c-di-GMP pathway regulates the swarming motility and adherence to sulfur surfaces by At. caldus. Together, our results revealed that At. caldus possesses a functional c-di-GMP pathway which could be significant for ores colonization during the bioleaching process.	[Castro, Matias; Ruiz, Lina; Guiliani, Nicolas] Univ Chile, Fac Ciencias, Dept Biol, Lab Comunicac Bacteriana, Santiago, Chile; [Deane, Shelly M.; Rawlings, Douglas E.] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, South Africa	Universidad de Chile; Stellenbosch University	Guiliani, N (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Lab Comunicac Bacteriana, Santiago, Chile.	nguilian@uchile.cl	Hincapié, Lina María Ruiz/H-9593-2019; Guiliani, Nicolas/F-6536-2015	Hincapié, Lina María Ruiz/0000-0002-9363-2730; Rawlings, Douglas/0000-0002-2521-8167; Castro, Matias/0000-0002-2013-3041; Guiliani, Nicolas/0000-0002-9950-7316	FONDECYT [1080441, 1120295]; MECESUP [UCH0407, UCH-0604]; VID-Universidad de Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MECESUP; VID-Universidad de Chile	This work was supported by FONDECYT grants 1080441 and 1120295, MECESUP UCH0407, UCH-0604 and VID-Universidad de Chile. NG: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) (http://www.conicyt.cl/fondecyt/); MC: Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) (http://www.mecesup.cl/), Universidad de Chile, UCH-0604 and VID-Universidad de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Berne C, 2013, J PHYS CHEM B, V117, P10492, DOI 10.1021/jp405802e; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Chen LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039470; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Dopson M, 2004, MICROB ECOL, V48, P19, DOI 10.1007/s00248-003-2028-1; Draper J, 2011, J BACTERIOL, V193, P4338, DOI 10.1128/JB.05140-11; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Farah C, 2005, APPL ENVIRON MICROB, V71, P7033, DOI 10.1128/AEM.71.11.7033-7040.2005; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Foucher S, 2003, HYDROMETALLURGY, V71, P5, DOI 10.1016/S0304-386X(03)00142-7; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gonzalez A, 2013, APPL MICROBIOL BIOT, V97, P3729, DOI 10.1007/s00253-012-4229-3; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Koestler BJ, 2013, APPL ENVIRON MICROB, V79, P5233, DOI 10.1128/AEM.01596-13; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Okibe N, 2003, APPL ENVIRON MICROB, V69, P1936, DOI 10.1128/AEM.69.4.1936-1943.2003; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Rawlings DE, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-13; Rawlings DE, 1999, PROCESS MET, V9, P777; Rivas M, 2005, BIOL RES, V38, P283, DOI 10.4067/S0716-97602005000200018; Rohwerder T, 2003, APPL MICROBIOL BIOT, V63, P239, DOI 10.1007/s00253-003-1448-7; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Ruiz LM, 2008, HYDROMETALLURGY, V94, P133, DOI 10.1016/j.hydromet.2008.05.028; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sand W, 2006, RES MICROBIOL, V157, P49, DOI 10.1016/j.resmic.2005.07.012; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Semenza M, 2002, LAT AM APPL RES, V32, P303; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	67	16	16	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116399	10.1371/journal.pone.0116399	http://dx.doi.org/10.1371/journal.pone.0116399			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689133	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700009
J	Costanzo, JP; Reynolds, AM; do Amaral, MCF; Rosendale, AJ; Lee, RE				Costanzo, Jon P.; Reynolds, Alice M.; do Amaral, M. Clara F.; Rosendale, Andrew J.; Lee, Richard E., Jr.			Cryoprotectants and Extreme Freeze Tolerance in a Subarctic Population of the Wood Frog	PLOS ONE			English	Article							RANA-SYLVATICA; SEASONAL-VARIATION; UREA SYNTHESIS; METABOLIC CONSEQUENCES; SCAPHIOPUS-COUCHI; SPADEFOOT TOADS; XENOPUS-LAEVIS; BUFO-VIRIDIS; DEHYDRATION; ACCLIMATION	Wood frogs (Rana sylvatica) exhibit marked geographic variation in freeze tolerance, with subarctic populations tolerating experimental freezing to temperatures at least 10-13 degrees Celsius below the lethal limits for conspecifics from more temperate locales. We determined how seasonal responses enhance the cryoprotectant system in these northern frogs, and also investigated their physiological responses to somatic freezing at extreme temperatures. Alaskan frogs collected in late summer had plasma urea levels near 10 mu mol ml(-1), but this level rose during preparation for winter to 85.5 +/- 2.9 mu mol ml(-1) (mean +/- SEM) in frogs that remained fully hydrated, and to 186.9 +/- 12.4 mu mol ml(-1) in frogs held under a restricted moisture regime. An osmolality gap indicated that the plasma of winter-conditioned frogs contained an as yet unidentified osmolyte(s) that contributed about 75 mOsmol kg(-1) to total osmotic pressure. Experimental freezing to -8 degrees C, either directly or following three cycles of freezing/thawing between -4 and 0 degrees C, or -16 degrees C increased the liver's synthesis of glucose and, to a lesser extent, urea. Concomitantly, organs shed up to one-half (skeletal muscle) or two-thirds (liver) of their water, with cryoprotectant in the remaining fluid reaching concentrations as high as 0.2 and 2.1 M, respectively. Freeze/thaw cycling, which was readily survived by winter-conditioned frogs, greatly increased hepatic glycogenolysis and delivery of glucose (but not urea) to skeletal muscle. We conclude that cryoprotectant accrual in anticipation of and in response to freezing have been greatly enhanced and contribute to extreme freeze tolerance in northern R. sylvatica.	[Costanzo, Jon P.; Reynolds, Alice M.; do Amaral, M. Clara F.; Rosendale, Andrew J.; Lee, Richard E., Jr.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Costanzo, JP (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	costanjp@miamioh.edu			National Science Foundation Grant IOS [1022788]; Portuguese Science and Technology Foundation (Fundaeao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) Grant [SFRH/BD/63151/2009]	National Science Foundation Grant IOS(National Science Foundation (NSF)); Portuguese Science and Technology Foundation (Fundaeao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) Grant	This work was funded by the National Science Foundation Grant IOS 1022788 to JPC and the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educaeao e Ciencia, Portugal) Grant SFRH/BD/63151/2009 to MCFDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALINSKY JB, 1967, COMP BIOCHEM PHYSIOL, V22, P59, DOI 10.1016/0010-406X(67)90166-1; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CHURCHILL TA, 1993, AM J PHYSIOL, V265, pR1324, DOI 10.1152/ajpregu.1993.265.6.R1324; CHURCHILL TA, 1989, J INSECT PHYSIOL, V35, P579, DOI 10.1016/0022-1910(89)90147-9; Costanzo JP, 2008, J EXP BIOL, V211, P2969, DOI 10.1242/jeb.019695; Costanzo JP, 2013, J EXP BIOL, V216, P3461, DOI 10.1242/jeb.089342; Costanzo JP, 2013, J EXP BIOL, V216, P1961, DOI 10.1242/jeb.070268; Costanzo JP, 1997, PHYSIOL ZOOL, V70, P158, DOI 10.1086/639568; Costanzo JP, 2005, J EXP BIOL, V208, P4079, DOI 10.1242/jeb.01859; COSTANZO JP, 1991, J COMP PHYSIOL B, V161, P225, DOI 10.1007/BF00262302; Cowan KJ, 2000, EXP BIOL ONLINE, V5, P61; do Amaral MCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079169; do Amaral MC, 2014, GEOGRAPHIC VARIATION, P85; Doelling ARW, 2014, J INSECT PHYSIOL, V67, P20, DOI 10.1016/j.jinsphys.2014.05.024; Fincel EA, 2006, UREA A NATURAL CRYOP, P65; Goller K, 1999, J MOL CATAL B-ENZYM, V7, P37, DOI 10.1016/S1381-1177(99)00043-0; GRABLY S, 1981, COMP BIOCHEM PHYS A, V69, P683, DOI 10.1016/0300-9629(81)90156-0; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Higgins SA, 2013, COMP BIOCHEM PHYS A, V164, P344, DOI 10.1016/j.cbpa.2012.11.002; Hochachka P., 2002, BIOCH ADAPTATION MEC; HOFFMAN J, 1990, COMP BIOCHEM PHYS A, V97, P423; Hoffman J, 1998, PHYSIOL ZOOL, V71, P85, DOI 10.1086/515886; Hudson NJ, 2002, J EXP BIOL, V205, P2297; Irwin JT, 2003, J EXP BIOL, V206, P2859, DOI 10.1242/jeb.00500; JONES RM, 1980, J EXP ZOOL, V212, P255, DOI 10.1002/jez.1402120212; Jorgensen CB, 1997, COMP BIOCHEM PHYS A, V117, P161, DOI 10.1016/S0300-9629(96)00356-8; JUNGREIS AM, 1970, COMP BIOCHEM PHYSIOL, V32, P417, DOI 10.1016/0010-406X(70)90459-7; Kirton MP, 1974, FALL MOVEMENTS AND H, P57; Kiss AJ, 2011, INT J MOL SCI, V12, P8406, DOI 10.3390/ijms12128406; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; KRUUV J, 1992, CRYOBIOLOGY, V29, P291, DOI 10.1016/0011-2240(92)90028-Z; LAGERSPETZ KYH, 1977, J THERM BIOL, V2, P223, DOI 10.1016/0306-4565(77)90035-3; Larson DJ, 2014, J EXP BIOL, V217, P2193, DOI 10.1242/jeb.101931; LAYNE JR, 1987, CAN J ZOOL, V65, P2062, DOI 10.1139/z87-315; Layne JR, 2003, CAN J ZOOL, V81, P2061, DOI 10.1139/Z03-202; Layne JR, 1999, J EXP ZOOL, V283, P221, DOI 10.1002/(SICI)1097-010X(19990215)283:3<221::AID-JEZ1>3.0.CO;2-Q; LeBoucher J, 1997, CLIN CHEM, V43, P1421; LEE AR, 1982, J EXP ZOOL, V221, P169, DOI 10.1002/jez.1402210207; Lee RE, 1998, ANNU REV PHYSIOL, V60, P55, DOI 10.1146/annurev.physiol.60.1.55; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Marshall KE, 2011, J EXP BIOL, V214, P1205, DOI 10.1242/jeb.054569; MCCLANAHAN L, 1967, COMP BIOCHEM PHYSIOL, V20, P73, DOI 10.1016/0010-406X(67)90726-8; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; MORTON ML, 1981, COPEIA, P234, DOI 10.2307/1444067; Muir TJ, 2008, J EXP ZOOL PART A, V309A, P111, DOI 10.1002/jez.436; Muir TJ, 2007, J COMP PHYSIOL B, V177, P917, DOI 10.1007/s00360-007-0190-3; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Rosendale AJ, 2014, BBA-GEN SUBJECTS, V1840, P1701, DOI 10.1016/j.bbagen.2013.12.011; Rosendale AJ, 2012, J EXP ZOOL PART A, V317A, P401, DOI 10.1002/jez.1733; SCAPIN S, 1992, GEN COMP ENDOCR, V86, P128, DOI 10.1016/0016-6480(92)90134-6; Schiller TM, 2008, J EXP ZOOL PART A, V309A, P484, DOI 10.1002/jez.479; SCHLAGHECKE R, 1981, GEN COMP ENDOCR, V43, P479, DOI 10.1016/0016-6480(81)90232-X; SCHMID WD, 1968, ECOLOGY, V49, P180, DOI 10.2307/1933581; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; SCHMID WD, 1965, ECOLOGY, V46, P261, DOI 10.2307/1936329; SEYMOUR RS, 1973, COPEIA, P435; SHPUN S, 1992, COMP BIOCHEM PHYS A, V103, P473, DOI 10.1016/0300-9629(92)90274-T; SINSCH U, 1991, COMP BIOCHEM PHYS A, V98, P469, DOI 10.1016/0300-9629(91)90433-D; SOMASEKHAR T, 1987, INDIAN J EXP BIOL, V25, P173; SRIDHARA S, 1979, Proceedings of the Indian Academy of Sciences Section B, V88, P137; STOREY KB, 1987, AM J PHYSIOL, V253, pR292, DOI 10.1152/ajpregu.1987.253.2.R292; STOREY KB, 1986, CAN J ZOOL, V64, P49, DOI 10.1139/z86-008; STOREY KB, 1984, J COMP PHYSIOL B, V155, P29, DOI 10.1007/BF00688788; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; SUGDEN PH, 1991, BIOCHEM J, V273, P21, DOI 10.1042/bj2730021; Sunny NE, 2011, J ANIM SCI, V89, P3945, DOI 10.2527/jas.2011-3985; Teets NM, 2011, J EXP BIOL, V214, P806, DOI 10.1242/jeb.051912; Voituron Y, 2004, J EXP ZOOL PART A, V301A, P367, DOI 10.1002/jez.a.20042; West TG, 2006, J EXP BIOL, V209, P1159, DOI 10.1242/jeb.02101; Withers PC, 1996, J EXP BIOL, V199, P1809; WRAY S, 1995, J EXP BIOL, V198, P373	72	39	39	18	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117234	10.1371/journal.pone.0117234	http://dx.doi.org/10.1371/journal.pone.0117234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688861	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700032
J	Ferrette, BLD; Mendonca, FF; Coelho, R; de Oliveira, PGV; Hazin, FHV; Romanov, EV; Oliveira, C; Santos, MN; Foresti, F				da Silva Ferrette, Bruno Lopes; Mendonca, Fernando Fernandes; Coelho, Rui; Vasconcelos de Oliveira, Paulo Guilherme; Vieira Hazin, Fabio Hissa; Romanov, Evgeny V.; Oliveira, Claudio; Santos, Miguel Neves; Foresti, Fausto			High Connectivity of the Crocodile Shark between the Atlantic and Southwest Indian Oceans: Highlights for Conservation	PLOS ONE			English	Article							GULF-OF-MEXICO; MITOCHONDRIAL-DNA; RHIZOPRIONODON-LALANDII; POPULATION-GENETICS; NORTHWEST ATLANTIC; STATISTICAL TESTS; WESTERN ATLANTIC; RHINCODON-TYPUS; WHALE SHARK; PHYLOGEOGRAPHY	Among the various shark species that are captured as bycatch in commercial fishing operations, the group of pelagic sharks is still one of the least studied and known. Within those, the crocodile shark, Pseudocarcharias kamoharai, a small-sized lamnid shark, is occasionally caught by longline vessels in certain regions of the tropical oceans worldwide. However, the population dynamics of this species, as well as the impact of fishing mortality on its stocks, are still unknown, with the crocodile shark currently one of the least studied of all pelagic sharks. Given this, the present study aimed to assess the population structure of P. kamoharai in several regions of the Atlantic and Indian Oceans using genetic molecular markers. The nucleotide composition of the mitochondrial DNA control region of 255 individuals was analyzed, and 31 haplotypes were found, with an estimated diversity Hd = 0.627, and a nucleotide diversity pi = 0.00167. An analysis of molecular variance (AMOVA) revealed a fixation index phi(ST) = -0.01118, representing an absence of population structure among the sampled regions of the Atlantic Ocean, and between the Atlantic and Indian Oceans. These results show a high degree of gene flow between the studied areas, with a single genetic stock and reduced population variability. In panmictic populations, conservation efforts can be concentrated in more restricted areas, being these representative of the total biodiversity of the species. When necessary, this strategy could be applied to the genetic maintenance of P. kamoharai.	[da Silva Ferrette, Bruno Lopes; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista, UNESP, Inst Biociencias Botucatu, Lab Biol & Genet Peixes, Sao Paulo, Brazil; [Mendonca, Fernando Fernandes] Univ Fed Sao Paulo, UNIFESP, Inst Mar, Dept Ciencias Mar, Santos, Brazil; [Coelho, Rui; Santos, Miguel Neves] IPMA, IP, Olhao, Portugal; [Coelho, Rui] Univ Algarve, Ctr Ciencias Mar, CCMAR, Faro, Portugal; [Vasconcelos de Oliveira, Paulo Guilherme; Vieira Hazin, Fabio Hissa] Univ Fed Rural Pernambuco, UFRPE, Dept Pesca & Aquicultura, Pernambuco, Recife, Brazil; [Romanov, Evgeny V.] ARDA, Ctr Tech Appui Peche ReUNionnaise CAP RUN, Le Port, Reunion, France	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Instituto Portugues do Mar e da Atmosfera; Universidade do Algarve; Universidade Federal Rural de Pernambuco (UFRPE)	Mendonca, FF (corresponding author), Univ Fed Sao Paulo, UNIFESP, Inst Mar, Dept Ciencias Mar, Santos, Brazil.	fernando.mendonca@unifesp.br	Coelho, Rui/C-1163-2008; MENDONCA, FERNANDO FERNANDES/AAG-7078-2019; Mendonça, Fernando/ABC-7750-2021; Fapesp, Biota/F-8655-2017; Oliveira, Claudio/D-7713-2012	Coelho, Rui/0000-0003-3813-5157; Fapesp, Biota/0000-0002-9887-8449; Oliveira, Claudio/0000-0002-7010-8880; Hazin, Fabio/0000-0003-3755-5379; Mendonca, Fernando/0000-0002-4806-9897; Ferrette, Bruno/0000-0002-3108-9867	Foundation for Research Support of the Sao Paulo State - FAPESP [2011/23787-0, 2010/51903-2]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/93936/2013]; Foundation for Research Support of the Sao Paulo State - FAPESP [2011/23787-0, 2010/51903-2]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/93936/2013]	Foundation for Research Support of the Sao Paulo State - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Foundation for Research Support of the Sao Paulo State - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Foundation for Research Support of the Sao Paulo State - FAPESP (Ref: 2011/23787-0 and 2010/51903-2). Rui Coelho was supported by a Post-Doc grant from the Portuguese Foundation for Science and Technology (FCT, Ref: SFRH/BPD/93936/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baum JK, 2005, FISHERIES, V30, P27; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Coelho R, 2012, AQUAT LIVING RESOUR, V25, P311, DOI 10.1051/alr/2012030; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HAZIN F H V, 1990, Journal of the Tokyo University of Fisheries, V77, P51; Karl SA, 2012, MAR BIOL, V159, P489, DOI 10.1007/s00227-011-1828-y; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Lack M., 2009, TRENDS GLOBAL SHARK; Mendonca FF, 2013, AQUAT CONSERV, V23, P850, DOI 10.1002/aqc.2342; Mendonca FF, 2009, NEOTROP ICHTHYOL, V7, P213, DOI 10.1590/S1679-62252009000200012; Oliveira P, 2010, J FISH BIOL, V76, P1655, DOI 10.1111/j.1095-8649.2010.02606.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	28	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117549	10.1371/journal.pone.0117549	http://dx.doi.org/10.1371/journal.pone.0117549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689742	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700053
J	Gong, AD; Li, HP; Yuan, QS; Song, XS; Yao, W; He, WJ; Zhang, JB; Liao, YC				Gong, An-Dong; Li, He-Ping; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; He, Wei-Jie; Zhang, Jing-Bo; Liao, Yu-Cai			Antagonistic Mechanism of Iturin A and Plipastatin A from Bacillus amyloliquefaciens S76-3 from Wheat Spikes against Fusarium graminearum	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; HEAD BLIGHT; BIOLOGICAL-CONTROL; GENETIC DIVERSITY; GIBBERELLA-ZEAE; PLANT-PATHOGENS; SUBTILIS; LIPOPEPTIDES; FENGYCIN; IDENTIFICATION	Controlling toxigenic Fusarium graminearum (FG) is challenging. A bacterial strain (S76- 3, identified as Bacillus amyloliquefaciens) that was isolated from diseased wheat spikes in the field displayed strong antifungal activity against FG. Reverse-phase high performance liquid chromatography and electrospray ionization mass spectrometry analyses revealed that S76- 3 produced three classes of cyclic lipopeptides including iturin, plipastatin and surfactin. Each class consisted of several different molecules. The iturin and plipastatin fractions strongly inhibited FG; the surfactin fractions did not. The most abundant compound that had antagonistic activity from the iturin fraction was iturin A (m/z 1043.35); the most abundant active compound from the plipastatin fraction was plipastatin A (m/z 1463.90). These compounds were analyzed with collision-induced dissociation mass spectrometry. The two purified compounds displayed strong fungicidal activity, completely killing conidial spores at the minimal inhibitory concentration range of 50 mu g/ml (iturin A) and 100 mu g/ml (plipastatin A). Optical and fluorescence microscopy analyses revealed severe morphological changes in conidia and substantial distortions in FG hyphae treated with iturin A or plipastatin A. Iturin A caused leakage and/or inactivation of FG cellular contents and plipastatin A caused vacuolation. Time- lapse imaging of dynamic antagonistic processes illustrated that iturin A caused distortion and conglobation along hyphae and inhibited branch formation and growth, while plipastatin A caused conglobation in young hyphae and branch tips. Transmission electron microscopy analyses demonstrated that the cell walls of conidia and hyphae of iturin A and plipastatin A treated FG had large gaps and that their plasma membranes were severely damaged and separated from cell walls.	[Gong, An-Dong; Li, He-Ping; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; He, Wei-Jie; Zhang, Jing-Bo; Liao, Yu-Cai] Huazhong Agr Univ, Mol Biotechnol Lab Triticeae Crops, Wuhan 430070, Peoples R China; [Gong, An-Dong; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; Zhang, Jing-Bo; Liao, Yu-Cai] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Li, He-Ping; He, Wei-Jie] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Liao, YC (corresponding author), Huazhong Agr Univ, Mol Biotechnol Lab Triticeae Crops, Wuhan 430070, Peoples R China.	yucailiao@mail.hzau.edu.cn	Zhang, Jing/GWZ-7332-2022; yuan, qingsong/GXV-9897-2022		National Basic Research Program of China [2013CB127801]; National Natural Science Foundation of China [31201475, 31271718, 31272004]; Ministry of Agriculture of China [2014ZX0800202B-001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Basic Research Program of China (2013CB127801), the National Natural Science Foundation of China (31201475, 31271718, 31272004), and the Ministry of Agriculture of China (2014ZX0800202B-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguelles-Arias A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-63; Bie XM, 2009, J MICROBIOL METH, V79, P272, DOI 10.1016/j.mimet.2009.09.013; Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Connor N, 2010, APPL ENVIRON MICROB, V76, P1349, DOI 10.1128/AEM.01988-09; Crane JM, 2013, PHYTOPATHOLOGY, V103, P146, DOI 10.1094/PHYTO-07-12-0154-R; de Silva S, 1998, SYST APPL MICROBIOL, V21, P398, DOI 10.1016/S0723-2020(98)80049-0; Deacon JW, 2006, FUNGAL BIOL-UK; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Fickers P, 2009, APPL ENVIRON MICROB, V75, P4636, DOI 10.1128/AEM.00548-09; Gong M, 2006, ACTA BIOCH BIOPH SIN, V38, P233, DOI 10.1111/j.1745-7270.2006.00157.x; Honma M, 2012, BIOORGAN MED CHEM, V20, P3793, DOI 10.1016/j.bmc.2012.04.040; Horn JN, 2013, BIOPHYS J, V105, P1612, DOI 10.1016/j.bpj.2013.08.034; Huang XQ, 2008, CURR MICROBIOL, V56, P376, DOI 10.1007/s00284-007-9066-8; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; MAGETDANA R, 1985, BIOCHIM BIOPHYS ACTA, V815, P405, DOI 10.1016/0005-2736(85)90367-0; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; Nasir MN, 2010, COLLOID SURFACE B, V78, P17, DOI 10.1016/j.colsurfb.2010.01.034; Nasir MN, 2011, LANGMUIR, V27, P10785, DOI 10.1021/la200767e; Ndoye M, 2012, J PHYTOPATHOL, V160, P519, DOI 10.1111/j.1439-0434.2012.01944.x; Nganje W. E., 2002, 2002 NAT FUS HEAD BL, P275; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Patel H, 2011, BBA-BIOMEMBRANES, V1808, P2000, DOI 10.1016/j.bbamem.2011.04.008; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Qu B, 2008, PLANT PATHOL, V57, P15, DOI 10.1111/j.1365-3059.2007.01711.x; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Song B, 2013, APPL MICROBIOL BIOT, V97, P7141, DOI 10.1007/s00253-013-5000-0; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Tao Y, 2011, J MICROBIOL, V49, P146, DOI 10.1007/s12275-011-0171-9; Tendulkar SR, 2007, J APPL MICROBIOL, V103, P2331, DOI 10.1111/j.1365-2672.2007.03501.x; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Wang J, 2007, APPL MICROBIOL BIOT, V76, P889, DOI 10.1007/s00253-007-1054-1; Wang JH, 2011, TOXINS, V3, P1020, DOI 10.3390/toxins3081020; Windels CE, 2000, PHYTOPATHOLOGY, V90, P17, DOI 10.1094/PHYTO.2000.90.1.17; Wise C, 2014, PHYTOPATHOLOGY; Xu HM, 2014, APPL MICROBIOL BIOT, V98, P127, DOI 10.1007/s00253-013-5291-1; Xu YB, 2010, FUNGAL GENET BIOL, V47, P205, DOI 10.1016/j.fgb.2009.11.003; Yuan SK, 2005, CAN J PLANT PATHOL, V27, P58; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162; Zhang JB, 2013, PLANT PATHOL, V62, P92, DOI 10.1111/j.1365-3059.2012.02639.x; Zhang XY, 2013, APPL MICROBIOL BIOT, V97, P9525, DOI 10.1007/s00253-013-5198-x; Zhang YJ, 2009, MOL PLANT MICROBE IN, V22, P1143, DOI 10.1094/MPMI-22-9-1143; Zhao PC, 2013, J BASIC MICROB, V00, P1; Zhao YJ, 2014, PLOS ONE, DOI [10.1371/journal.pone.0092486, DOI 10.1371/J0URNAL.P0NE.0092486]; Zhou WW, 2008, J APPL MICROBIOL, V105, P912, DOI 10.1111/j.1365-2672.2008.03822.x	50	121	141	6	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116871	10.1371/journal.pone.0116871	http://dx.doi.org/10.1371/journal.pone.0116871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689464	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700025
J	Hu, ZY; Zhou, ZG; Hu, YH; Wu, JH; Li, YM; Huang, WL				Hu, Zheyi; Zhou, Zaigang; Hu, Yahui; Wu, Jinhui; Li, Yunman; Huang, Wenlong			HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo	PLOS ONE			English	Article							CHEMOTHERAPEUTIC DRUG-RESISTANCE; ABC-TRANSPORTERS; INHIBITORS; SUBSTRATE; MEMBRANE; MECHANISMS; CANCER; ASSAYS; GP; IDENTIFICATION	Background Multidrug efflux transporter P-glycoprotein ( P-gp) is highly expressed on membrane of tumor cells and is implicated in resistance to tumor chemotherapy. HZ08 is synthesized and studied in order to find a novel P-gp inhibitor. Methods MDCK-MDR1 monolayer transport, calcein-AM P-gp inhibition and P-gp ATPase assays were used to confirm the P-gp inhibition capability of HZ08. Furthermore, KB-WT and KBVCR cells were used to evaluate the P-gp inhibitory activity of HZ08 both in vitro and in vivo. Results Results showed that HZ08 was more potent than verapamil in MDCK-MDR1 monolayer transportation model. Meanwhile, P-gp ATPase assay and calcein-AM P-gp inhibition assay confirmed that HZ08 inhibited P-gp ATPase with a calcein-AM IC50 of 2.44 +/- 0.31 mu M. In addition, significantly greater in vitro multidrug resistance reversing effects were observed when vincristine or paclitaxel was used in combination with 10 mu M HZ08 compared with 10 mu M verapamil. Moreover, HZ08 could significantly enhance the sensitivity of vincristine with a similar effect like verapamil in both KB-WT and KB-VCR tumor xenograft models. Conclusions The novel structure HZ08 could be a potent P-gp inhibitor.	[Hu, Zheyi; Hu, Yahui; Li, Yunman] China Pharmaceut Univ, Dept Physiol, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Zaigang; Wu, Jinhui] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Huang, Wenlong] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University; China Pharmaceutical University	Wu, JH (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	wuj@nju.edu.cn; yunmanlicpu@hotmail.com	Wu, Jinhui/N-8386-2019; Wu, Jinhui/J-9476-2012	Wu, Jinhui/0000-0001-8809-1290; Wu, Jinhui/0000-0001-8809-1290; Zhou, Zaigang/0000-0002-5853-1395	National Nature Science Foundation of P.R. China [81173088]; National Science and Technology Major Project [2002AA233071]; Scientific Research and Innovation Project of College Students of Jiangsu Province [CXLX13 317]	National Nature Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Scientific Research and Innovation Project of College Students of Jiangsu Province	This work was supported by the National Nature Science Foundation of P.R. China (No. 81173088), National Science and Technology Major Project (No. 2002AA233071), Scientific Research and Innovation Project of College Students of Jiangsu Province (No. CXLX13 317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526; Akan I, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-22; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bartels AL, 2009, NEUROBIOL AGING, V30, P1818, DOI 10.1016/j.neurobiolaging.2008.02.002; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Ceckova-Novotna M, 2006, REPROD TOXICOL, V22, P400, DOI 10.1016/j.reprotox.2006.01.007; Cen JA, 2010, EUR J PHARMACOL, V647, P21, DOI 10.1016/j.ejphar.2010.08.013; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Colabufo NA, 2008, BIOORGAN MED CHEM, V16, P362, DOI [10.1016/j.bmc.2008.01.055, 10.1016/j.bmc.2007.09.039]; Constantinides PP, 2007, J PHARM SCI-US, V96, P235, DOI 10.1002/jps.20780; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; dos Santos SM, 2007, BIOCHEM BIOPH RES CO, V354, P216, DOI 10.1016/j.bbrc.2006.12.202; Ecker G, 1999, MOL PHARMACOL, V56, P791; Ekins S, 2002, MOL PHARMACOL, V61, P974, DOI 10.1124/mol.61.5.974; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Fang W, 2007, J PHARM PHARMACOL, V59, P1649, DOI 10.1211/jpp.59.12.0006; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Feng YD, 2013, EUR J PHARMACOL, V712, P53, DOI 10.1016/j.ejphar.2013.04.028; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Globisch C, 2006, BIOORGAN MED CHEM, V14, P1588, DOI 10.1016/j.bmc.2005.10.058; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Grellier P, 2008, PARASITE, V15, P219, DOI 10.1051/parasite/2008153219; Hiessbock R, 1999, J MED CHEM, V42, P1921, DOI 10.1021/jm980517+; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Lage H, 2003, INT J ANTIMICROB AG, V22, P188, DOI 10.1016/S0924-8579(03)00203-6; Liu FS, 2009, TAIWAN J OBSTET GYNE, V48, P239, DOI 10.1016/S1028-4559(09)60296-5; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Nozinic D, 2010, CROAT CHEM ACTA, V83, P323; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Polli JW, 1999, PHARM RES-DORDR, V16, P1206, DOI 10.1023/A:1018941328702; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Tran TT, 2004, J PHARM SCI-US, V93, P2108, DOI 10.1002/jps.20105; UCHIDA M, 1989, CHEM PHARM BULL, V37, P2109; Umsumarng S, 2013, INHIBITION OF P GLYC; vanAsperen J, 1997, J PHARM SCI, V86, P881, DOI 10.1021/js9701364; Varma MVS, 2006, CURR OPIN CHEM BIOL, V10, P367, DOI 10.1016/j.cbpa.2006.06.015; Varma MVS, 2003, PHARMACOL RES, V48, P347, DOI 10.1016/S1043-6618(03)00158-0; Wang EJ, 2001, PHARM RES-DORDR, V18, P800, DOI 10.1023/A:1011036428972; Wartenberg M, 2010, J CELL BIOCHEM, V109, P434, DOI 10.1002/jcb.22422; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhang YY, 2014, TOXICOL APPL PHARM, V274, P232, DOI 10.1016/j.taap.2013.11.019; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299	51	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116886	10.1371/journal.pone.0116886	http://dx.doi.org/10.1371/journal.pone.0116886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689592	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700026
J	Xu, F; Wang, Q; Zhang, H; Chen, SP; Ao, HS				Xu, Fei; Wang, Qian; Zhang, Heng; Chen, Sipeng; Ao, Hushan			Use of Pulmonary Artery Catheter in Coronary Artery Bypass Graft. Costs and Long-Term Outcomes	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CONTROLLED TRIAL; CARE	Background Pulmonary artery catheters (PAC) are used widely to monitor hemodynamics in patients undergoing coronary bypass graft (CABG) surgery. However, recent studies have raised concerns regarding both the effectiveness and safety of PAC. Therefore, our aim was to determine the effects of the use of PAC on the short- and long-term health and economic outcomes of patients undergoing CABG. Methods 1361 Chinese patients who consecutively underwent isolated, primary CABG at the Cardiovascular Institute of Fuwai Hospital from June 1, 2012 to December 31, 2012 were included in this study. Of all the patients, 453 received PAC during operation (PAC group) and 908 received no PAC therapy (control group). Short-term and long-term mortality and major complications were analyzed with multivariate regression analysis and propensity score matched-pair analysis was used to yield two well-matched groups for further comparison. Results The patients who were managed with PAC more often received intraoperative vasoactive drugs dopamine (70.9% vs. 45.5%; P<0.001) and epinephrine (7.7% vs. 2.6%; P<0.001). In addition, costs for initial hospitalization were higher for PAC patients ($14,535 vs. $13,873, respectively, p = 0.004). PAC use was neither associated with the perioperative mortality or major complications, nor was it associated with long-term mortality and major adverse cardiac and cerebrovascular events. In addition, comparison between two well-matched groups showed no significant differences either in baseline characteristics or in short- term and long-term outcomes. Conclusions There is no clear indication of any benefit or harm in managing CABG patients with PAC. However, use of PAC in CABG is more expensive. That is, PAC use increased costs without benefit and thus appears unjustified for routine use in CABG surgery.	[Xu, Fei; Ao, Hushan] Chinese Acad Med Sci, Dept Anesthesiol, Cardiovasc Inst, Beijing 100730, Peoples R China; [Xu, Fei; Zhang, Heng; Ao, Hushan] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Wang, Qian] Inner Mongolia Med Univ, Dept Anesthesiol, Huhhot Inner Mongolia, Peoples R China; [Zhang, Heng] Chinese Acad Med Sci, Dept Cardiothorac Surg, Cardiovasc Inst, Beijing 100730, Peoples R China; [Chen, Sipeng] Capital Med Univ, Dept Biostat Unit, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Inner Mongolia Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Ao, HS (corresponding author), Chinese Acad Med Sci, Dept Anesthesiol, Cardiovasc Inst, Beijing 100730, Peoples R China.	aohushan@sina.com		Xu, Fei/0000-0003-0569-661X				Am Soc Anesthesiologists Task Forc, 2003, ANESTHESIOLOGY, V99, P988; [Anonymous], 1997, CRIT CARE MED; BROHET CR, 1989, J ELECTROCARDIOL, V22, P158; Chernow B, 1997, CHEST, V111, P261, DOI 10.1378/chest.111.2.261; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; DAVIES MJ, 1982, ANAESTH INTENS CARE, V10, P9, DOI 10.1177/0310057X8201000103; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Iantorno Micaela, 2012, Acute Card Care, V14, P125, DOI 10.3109/17482941.2012.741245; Jacka MJ, 2002, CAN J ANAESTH, V49, P276, DOI 10.1007/BF03020527; Judge O, 2015, J CARDIOTHOR VASC AN, V29, P69, DOI 10.1053/j.jvca.2014.07.016; MIMOZ O, 1994, CRIT CARE MED, V22, P573, DOI 10.1097/00003246-199404000-00011; PEARSON KS, 1989, ANESTH ANALG, V69, P336; Ramsey SD, 2000, J CARDIOTHOR VASC AN, V14, P113, DOI 10.1016/S1053-0770(00)90001-6; Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Schwann NM, 2011, ANESTH ANALG, V113, P994, DOI 10.1213/ANE.0b013e31822c94a8; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	25	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117610	10.1371/journal.pone.0117610	http://dx.doi.org/10.1371/journal.pone.0117610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689312	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700062
J	Huang, TC; Wu, YY; Chen, YG; Lai, SW; Wu, SC; Ye, RH; Lu, CS; Chen, JH				Huang, Tzu-Chuan; Wu, Yi-Ying; Chen, Yu-Guang; Lai, Shiue-Wei; Wu, Sheng-Cheng; Ye, Ren-Hua; Lu, Chieh-Sheng; Chen, Jia-Hong			Discrimination Index of Microcytic Anemia in Young Soldiers: A Single Institutional Analysis	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BETA-THALASSEMIA TRAIT; BLOOD-CELL INDEXES; DIFFERENTIAL-DIAGNOSIS; POPULATION; FORMULAS; ALPHA; RELIABILITY; PREVALENCE; CHILDREN	Background The common differential diagnosis of microcytic anemia in young Asian men includes iron deficiency anemia (IDA), alpha-thalassemia (alpha T) and beta-thalassemia (beta T). In this study, we aimed to distinguish between these diseases in a distinct population of young men using a specific index. Patients and Methods We retrospectively reviewed the laboratory data of young men with microcytic anemia. The clinical, characteristic and laboratory data, including complete blood cell counts, serum ferritin and hemoglobin electrophoresis results, were collected; genomic DNA mutations were also evaluated. Based on these data, ten discrimination indices were used to differentiate thalassemia from IDA. The sensitivity, specificity, positive and negative predictive values, Youden's index and receiver operating characteristic (ROC) curves were also calculated. Results A total of 877 patients (92 patients with IDA, 332 with aT and 453 with beta T) were enrolled; the Shine and Lal (S&L) formula was the best method with which to discriminate IDA from thalassemia (100% sensitivity, 91% specificity). The new cut-off values were evaluated, and the approaches used in our study cohort, particularly the Green & King (G&K) formula, significantly increased the accuracies of red cell distribution width-containing indices (cut-off value: 58.66; 89.62% sensitivity and 96.2% specificity; AUC: 0.9716). In addition, when applied properly, these indices could differentiate IDA patients from aT patients, especially Huber-Herklotz index (HH). Conclusions The sensitivity and specificity differed among ethnic and age groups. We concluded that when using the original cut-off value, the S&L formula was the best discriminating index for differentiating between IDA and thalassemia in young Asian men. However, when using the formula, the newly obtained cut-off value must be applied to increase accuracy based on the results from our cohort.	[Huang, Tzu-Chuan; Wu, Yi-Ying; Chen, Yu-Guang; Lai, Shiue-Wei; Wu, Sheng-Cheng; Ye, Ren-Hua; Lu, Chieh-Sheng; Chen, Jia-Hong] Triserv Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Wu, Yi-Ying] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University	Chen, JH (corresponding author), Triserv Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan.	ndmc_tw.tw@yahoo.com.tw		Lu, Chieh-Sheng/0000-0002-9056-3135; Wu, Yi-Ying/0000-0003-0411-6265				AlFadhli SM, 2007, J TROP PEDIATRICS, V53, P93, DOI 10.1093/tropej/fml070; Batebi A, 2012, TURK J MED SCI, V42, P275, DOI 10.3906/sag-0909-294; Beyan C, 2007, EUR J HAEMATOL, V78, P524, DOI 10.1111/j.1600-0609.2007.00853.x; Chern JPS, 2006, PEDIATR BLOOD CANCER, V46, P72, DOI 10.1002/pbc.20343; Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.x; Ehsani M A, 2009, Pak J Biol Sci, V12, P473, DOI 10.3923/pjbs.2009.473.475; Ferrara M, 2010, HEMATOLOGY, V15, P112, DOI 10.1179/102453310X12583347010098; Gorakshakar Ajit C, 2011, Indian J Hum Genet, V17, P115, DOI 10.4103/0971-6866.92079; GREEN R, 1989, BLOOD CELLS, V15, P481; HAMBLIN TJ, 1973, LANCET, V1, P676; Huber AR, 2004, SCHWEIZ MED FORUM, V4, P947; Janel A, 2011, HEMATOLOGY, V16, P123, DOI 10.1179/102453311X12940641877849; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Lima C S, 1996, Sao Paulo Med J, V114, P1265; LIN CK, 1991, J LAB CLIN MED, V118, P599; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Martin A, 2013, PEDIATR CLIN N AM, V60, P1383, DOI 10.1016/j.pcl.2013.08.008; Matos JF, 2013, HEMATOLOGY, V18, P169, DOI 10.1179/1607845412Y.0000000054; Mehdi Syed Riaz, 2011, Indian J Hum Genet, V17, P207, DOI 10.4103/0971-6866.92106; MENTZER WC, 1973, LANCET, V1, P882; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Nalbantoglu B, 2012, PEDIATR HEMAT ONCOL, V29, P472, DOI 10.3109/08880018.2012.705230; Nesa A, 2011, Mymensingh Med J, V20, P110; Niazi M, 2010, GOMAL J MED SCI, V8, P125; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-x; Okan V, 2009, J INT MED RES, V37, P25, DOI 10.1177/147323000903700103; Pranpanus Savitree, 2009, Journal of the Medical Association of Thailand, V92, P739; Rahim Fakher, 2009, Indian J Med Sci, V63, P101; Rathod DA, 2007, AM J CLIN PATHOL, V128, P585, DOI 10.1309/R1YL4B4BT2WCQDGV; RICERCA BM, 1987, HAEMATOLOGICA, V72, P409; Shen CA, 2010, J PEDIAT HEMATOL ONC, V32, pE218, DOI 10.1097/MPH.0b013e3181e5e26e; SHINE I, 1977, LANCET, V1, P692; Sirdah M, 2008, INT J LAB HEMATOL, V30, P324, DOI 10.1111/j.1751-553X.2007.00966.x; SRIVASTAVA PC, 1973, LANCET, V1, P832; Urrechaga E, 2009, INT J LAB HEMATOL, V31, P528, DOI 10.1111/j.1751-553X.2008.01073.x	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0114061	10.1371/journal.pone.0114061	http://dx.doi.org/10.1371/journal.pone.0114061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679510	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600002
J	Nedergaard, MK; Michaelsen, SR; Urup, T; Broholm, H; El Ali, H; Poulsen, HS; Stockhausen, MT; Kjaer, A; Lassen, U				Nedergaard, Mette Kjoelhede; Michaelsen, Signe Regner; Urup, Thomas; Broholm, Helle; El Ali, Henrik; Poulsen, Hans Skovgaard; Stockhausen, Marie-Therese; Kjaer, Andreas; Lassen, Ulrik			F-18-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma	PLOS ONE			English	Article							TUMOR-GROWTH; ANGIOGENESIS; PET; INHIBITION; EXPRESSION; ANTIBODIES; ANTITUMOR; EFFICACY; RECEPTOR; CANCER	Background Conflicting data exist for anti-cancer effects of anti-placental growth factor (anti-PlGF) in combination with anti-VEGF. Still, this treatment combination has not been evaluated in intracranial glioblastoma (GBM) xenografts. In clinical studies, position emission tomography (PET) using the radiolabeled amino acid O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) and magnetic resonance imaging (MRI) add complementary but distinct information about glioma growth; however, the value of F-18-FET MicroPET combined with MicroMRI has not been investigated preclinically. Here we examined the use of F-18-FET MicroPET and MicroMRI for evaluation of anti-VEGF and anti-PlGF treatment response in GBM xenografts. Methods Mice with intracranial GBM were treated with anti-VEGF, anti-PlGF + anti-VEGF or saline. Bioluminescence imaging (BLI), F-18-FET MicroPET and T2-weighted (T2w)-MRI were used to follow tumour development. Primary end-point was survival, and tumours were subsequently analysed for Ki67 proliferation index and micro-vessel density (MVD). Further, PlGF and VEGFR-1 expression were examined in a subset of the xenograft tumours and in 13 GBM patient tumours. Results Anti-VEGF monotherapy increased survival and decreased F-18-FET uptake, BLI and MVD, while no additive effect of anti-PlGF was observed. F-18-FET SUVmax tumour-to-brain (T/B) ratio was significantly lower after one week (114 +/- 6%, n = 11 vs. 143 +/- 8%, n = 13; p = 0.02) and two weeks of treatment (116 +/- 12%, n = 8 vs. 190 +/- 24%, n = 5; p = 0.02) in the anti-VEGF group as compared with the control group. In contrast, T2w-MRI volume was unaffected by anti-VEGF. Gene expression of PlGF and VEGFR-1 in xenografts was significantly lower than in patient tumours. Conclusion F-18-FET PET was feasible for anti-angiogenic response evaluation and superior to T2w-MRI; however, no additive anti-cancer effect of anti-PlGF and anti-VEGF was observed. Thus, this study supports use of 18F-FET PET for response evaluation in future studies.	[Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Rigshosp, Nucl Med & PET, Dept Clin Physiol, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Michaelsen, Signe Regner; Urup, Thomas; Poulsen, Hans Skovgaard; Stockhausen, Marie-Therese] Rigshosp, Finsen Ctr, Dept Radiat Biol, DK-2100 Copenhagen, Denmark; [Broholm, Helle] Rigshosp, Ctr Diagnost Invest, Dept Neuropathol, DK-2100 Copenhagen, Denmark; [Lassen, Ulrik] Rigshosp, Dept Oncol, Phase Unit 1, Finsen Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nedergaard, MK (corresponding author), Rigshosp, Nucl Med & PET, Dept Clin Physiol, DK-2100 Copenhagen, Denmark.	Mette.Kjoelhede.Nedergaard@regionh.dk	Michaelsen, Signe/ABB-1451-2020; Urup, Thomas/AAC-9953-2020; ALI, Henrik El/C-6164-2017; Lassen, Ulrik/AAH-2799-2021; Kjaer, Andreas/E-8932-2015	Michaelsen, Signe/0000-0001-9047-6384; ALI, Henrik El/0000-0001-8226-3055; Kjaer, Andreas/0000-0002-2706-5547; Lassen, Ulrik/0000-0002-3865-4574	Danish Cancer Research Foundation; Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; John and Birgitte Meyer Foundation; Danish Research Council; Rigshospitalets Research Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish; The Danish Cancer Society [R90-A6057] Funding Source: researchfish	Danish Cancer Research Foundation; Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svend Andersen Foundation; John and Birgitte Meyer Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Rigshospitalets Research Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	Danish Cancer Research Foundation; The Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; The Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; The John and Birgitte Meyer Foundation; Danish Research Council; Rigshospitalets Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2011, CLIN CANCER RES, V17, P976, DOI 10.1158/1078-0432.CCR-10-2687; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Hedlund EME, 2013, P NATL ACAD SCI USA, V110, P654, DOI 10.1073/pnas.1209310110; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jalali S, 2014, NEURO-ONCOLOGY, V16, P868, DOI 10.1093/neuonc/nou040; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Lassen UN, 2013, J CLIN ONCOL, V31; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Munnink THO, 2013, J NUCL MED, V54, P929, DOI 10.2967/jnumed.112.112086; Nedergaard MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100009; Nomura M, 1998, J NEURO-ONCOL, V40, P123, DOI 10.1023/A:1006198422718; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Popperl G, 2006, EUR J NUCL MED MOL I, V33, P792, DOI 10.1007/s00259-005-0053-7; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Popperl G, 2005, EUR J NUCL MED MOL I, V32, P1018, DOI 10.1007/s00259-005-1819-7; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Zins K, 2013, INT J MOL SCI, V14, P17958, DOI 10.3390/ijms140917958	36	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115315	10.1371/journal.pone.0115315	http://dx.doi.org/10.1371/journal.pone.0115315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680186	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600006
J	Trombetta, DM; Cardoso, SC; Alves, VGL; Facure, A; Batista, DVS; da Silva, AX				Trombetta, Debora M.; Cardoso, Simone C.; Alves, Victor G. L.; Facure, Alessandro; Batista, Delano V. S.; da Silva, Ademir X.			Evaluation of the Radiotherapy Treatment Planning in the Presence of a Magnetic Valve Tissue Expander	PLOS ONE			English	Article							DOSE CALCULATION ALGORITHMS; POSTOPERATIVE RADIOTHERAPY; BREAST-CANCER; INTERFACES; PHANTOMS; PERTURBATION; DOSIMETRY; IMPLANTS; METAL	The combination of radiotherapy treatments and breast reconstruction, using temporary tissue expanders, generates several concerns due to the presence of a magnetic valve inside the radiation field. The objective of this work is to evaluate a radiotherapy treatment planning for a patient using a tissue expander. Isodose curve maps, obtained using radiochromic films, were compared to the ones calculated with two different dose calculation algorithms of the Eclipse radiotherapy Treatment Planning System (TPS), considering the presence or absence of the heterogeneity. The TPS calculation considering the presence of the heterogeneity shows changes around 5% in the isodose curves when they were compared with the calculation without heterogeneity correction. This calculation did not take in account the real density value of the heterogeneity. This limitation was quantified to be around 10% in comparison with the TPS calculation and experimental measurements using the radiochromic film. These results show that the magnetic valve should be taken in account in dose calculations of the TPS. With respect to the AAA and Pencil Beam Convolution algorithms, when the calculation is compared with the real distribution, AAA presents a distribution more similar to experimental dose distribution.	[Trombetta, Debora M.; Alves, Victor G. L.; da Silva, Ademir X.] Univ Fed Rio de Janeiro, Nucl Engn Program, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Rio De Janeiro, Brazil; [Trombetta, Debora M.; Cardoso, Simone C.] Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radiacao Gama, Rio De Janeiro, Brazil; [Alves, Victor G. L.] Inst Nacl Canc, Serv Qualidade Radiacoes Ionizantes, Rio De Janeiro, Brazil; [Facure, Alessandro] Comissao Nacl Energia Nucl, Rio De Janeiro, Brazil; [Batista, Delano V. S.] Inst Nacl Canc, Secao Fis Med, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Comissao Nacional de Energia Nuclear (CNEN); National Cancer Institute (Inca)	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radiacao Gama, Rio De Janeiro, Brazil.	simone@if.ufrj.br	Cardoso, Simone/V-2514-2019; Alves, Victor Gabriel Leandro/AAO-5748-2021; Cardoso, Simone/AAH-4274-2021	Alves, Victor Gabriel Leandro/0000-0001-7982-2039; Montano Trombetta, Debora/0000-0002-3473-3750; cardoso, simone/0000-0001-6216-202X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves VGL, 2013, COMPUT PHYS COMMUN, V184, P1708, DOI 10.1016/j.cpc.2013.02.023; [Anonymous], 1993, 50 ICRU; Balfour E, 1871, CYCLOPAEDIA INDIA E, V5; Bevilacqua V, 2007, LECT NOTES COMPUT SC, V4681, P1355; Bragg CM, 2008, RADIOTHER ONCOL, V86, P276, DOI 10.1016/j.radonc.2008.01.011; Carolan M, 2000, Australas Radiol, V44, P290, DOI 10.1046/j.1440-1673.2000.00816.x; Carrasco P, 2007, MED PHYS, V34, P3323, DOI 10.1118/1.2750972; Chatzigiannis C, 2011, J APPL CLIN MED PHYS, V12, P58, DOI 10.1120/jacmp.v12i2.3295; Chin DWH, 2009, J APPL CLIN MED PHYS, V10, P80, DOI 10.1120/jacmp.v10i1.2853; Damast S, 2006, INT J RADIAT ONCOL, V66, P305, DOI 10.1016/j.ijrobp.2006.05.017; Dang J, 2009, IEEE NUCL SCI CONF R, P3088, DOI 10.1109/NSSMIC.2009.5401670; DAS IJ, 1989, MED PHYS, V16, P367, DOI 10.1118/1.596345; FARAHANI M, 1990, PHYS MED BIOL, V35, P369, DOI 10.1088/0031-9155/35/3/006; Feeman T. G, 2010, SPRINGER UNDERGRADUA; Fogliata A, 2007, PHYS MED BIOL, V52, P1363, DOI 10.1088/0031-9155/52/5/011; Lewis D, 2012, RADIOTHER ONCOL; Mesbahi A, 2007, RADIAT MED, V25, P259; Moni Janaki, 2004, Med Dosim, V29, P49, DOI 10.1016/j.meddos.2003.10.005; Morehouse H, 2007, J ULTRAS MED, V26, P1123, DOI 10.7863/jum.2007.26.8.1123; Nava MB, 2004, PLASTIC RECONSTRUCTI, V128, P353; Niroomand-Rad A, 1998, MED PHYS, V25, P2093, DOI 10.1118/1.598407; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Paelinck L, 2007, RADIOTHER ONCOL, V84, pS194; Papanikolau N., 2004, 85 AAPM; Reft C, 2003, MED PHYS, V30, P1162, DOI 10.1118/1.1565113; Robinson D, 2008, J APPL CLIN MED PHYS, V9, P112, DOI 10.1120/jacmp.v9i2.2786; Roche A., 1996, HUMAN BODY COMPOSITI, P167; Ronde HS, 2009, ACTA ONCOL, V48, P209, DOI 10.1080/02841860802287108; SAUER OA, 1995, MED PHYS, V22, P1685, DOI 10.1118/1.597433; Sheikh-Bagheri D, 2002, MED PHYS, V29, P391, DOI 10.1118/1.1445413; Sievinen J, AAA PHOTON DOSE CALC; Spadea MF, 2013, J APPL CLIN MED PHYS, V14, P299, DOI 10.1120/jacmp.v14i1.4027; Spear SL, 2001, PLAST RECONSTR SURG, V107, P177, DOI 10.1097/00006534-200101000-00029; Su A, 2005, MED DOSIM, V30, P169, DOI 10.1016/j.meddos.2005.06.001; Thilmann C, 1996, Med Dosim, V21, P149, DOI 10.1016/0958-3947(96)00025-8; Thompson RCA, 2005, MED PHYS, V32, P1640, DOI 10.1118/1.1914545; Trombetta DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055430; Veit R, 1992, Z MED PHYS, V2, P123; Weinstein SP, 2002, RADIOLOGY, V224, P265, DOI 10.1148/radiol.2241010511; Wieslander E, 2003, PHYS MED BIOL, V48, P3295, DOI 10.1088/0031-9155/48/20/003; Williams PA, 2000, HDB HYDROCOLLOIDS; [No title captured]	43	10	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117548	10.1371/journal.pone.0117548	http://dx.doi.org/10.1371/journal.pone.0117548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679529	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600072
J	Abdelmagid, SA; Clarke, SE; Nielsen, DE; Badawi, A; El-Sohemy, A; Mutch, DM; Ma, DWL				Abdelmagid, Salma A.; Clarke, Shannon E.; Nielsen, Daiva E.; Badawi, Alaa; El-Sohemy, Ahmed; Mutch, David M.; Ma, David W. L.			Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults	PLOS ONE			English	Article							SERUM PHOSPHOLIPIDS; FISH-OIL; OMEGA-3-FATTY-ACID LEVELS; DESATURASE ACTIVITIES; INSULIN-RESISTANCE; METABOLIC SYNDROME; REFERENCE RANGES; LINOLENIC ACID; GENE VARIANTS; ASSOCIATION	Circulating fatty acids (FA) are associated with a multitude of chronic diseases. However, a major gap in establishing such relationships is the lack of accepted fatty acid reference ranges representing healthy individuals. Data on validated FA reference ranges would provide a better understanding of study baseline measures and aid in the evaluation and interpretation of pharmaceutical or dietary interventions. Reference ranges for plasma FA levels have been reported in a few small studies and on a limited number of FA. Therefore, we determined the average and percentiles of a broad set of 61 FA (C14 - C24:1) from plasma total lipids from an ethnically diverse population of healthy young Canadian males and females (Total n = 826). Plasma concentrations of some of the major FA ranged from 0.3 to 4.1 mmol/L for palmitic acid, 0.1 to 1.0 mmol/L for stearic acid, 0.03 to 3.2 mmol/L for oleic acid, 0.2 to 5.0 mmol/L for linoleic acid (LA), 12.0 to 186.9 mu mol/L for alpha-linolenic acid, and 7.2 to 237.5 mu mol/L for docosahexaenoic acid (DHA). Males had significantly higher plasma concentrations of.-linolenic acid (GLA) and n-3 docosapentaenoic acid and lower concentrations of palmitoleic acid, LA and DHA than females. Comparison of FA concentrations between Caucasians, East Asians and South Asians revealed that South Asians had significantly lower levels of palmitoleic acid (p < 0.01) and oleic acid (p = 0.01) while East Asians had lower levels of GLA (p = 0.02) and dihomo-gamma-linolenic acid (p = 0.03). Overall, these data provide a comprehensive set of quantitative values that profiles a small cohort of Canadians which highlights the utility of establishing validated FA reference ranges thatmay be used to understand how deficient, suboptimal, or excess amounts of a given FA may be associated with chronic disease.	[Abdelmagid, Salma A.; Clarke, Shannon E.; Mutch, David M.; Ma, David W. L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Nielsen, Daiva E.; El-Sohemy, Ahmed] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Badawi, Alaa] Publ Hlth Agcy Canada, Off Biotechnol Genom & Populat Hlth, Toronto, ON, Canada	University of Guelph; University of Toronto; Public Health Agency of Canada	Ma, DWL (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	davidma@uoguelph.ca	Nielsen, Daiva/AAT-5028-2020; Badawi, Alaa/ABC-1300-2021; Nielsen, Daiva/ACI-1414-2022	Nielsen, Daiva/0000-0002-4265-5748; Mutch, David/0000-0002-0908-7259; Ma, David/0000-0002-1165-5972; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Food and Materials Network; Public Health Agency of Canada; Canada Foundation for Innovation; Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada	Advanced Food and Materials Network; Public Health Agency of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by grants from the Advanced Food and Materials Network (AES), the Public Health Agency of Canada (DMM and AB), and the Canada Foundation for Innovation with matching funds from the Ontario Research Fund (DWLM and DMM) and Natural Sciences and Engineering Research Council of Canada (DWLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum SJ, 2013, PROSTAG LEUKOTR ESS, V88, P3, DOI 10.1016/j.plefa.2012.05.001; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Bradbury KE, 2011, NUTRIENTS, V3, P152, DOI 10.3390/nu3010152; Buydens-Branchey L, 2011, PSYCHIAT RES, V188, P422, DOI 10.1016/j.psychres.2011.05.027; Cantwell MM, 2000, P NUTR SOC, V59, P187, DOI 10.1017/S0029665100000203; Chien KL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-33; Chorell E, 2012, MOL BIOSYST, V8, P1187, DOI 10.1039/c2mb05428k; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; DAYTON S, 1966, J LIPID RES, V7, P103; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-62; Evans SJ, 2012, J PSYCHIATR RES, V46, P1435, DOI 10.1016/j.jpsychires.2012.07.016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontaine-Bisson B, 2009, ATHEROSCLEROSIS, V204, P465, DOI 10.1016/j.atherosclerosis.2008.10.037; Gallo S, 2010, J CLIN ENDOCR METAB, V95, P2410, DOI 10.1210/jc.2009-1975; Garneau V, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-46; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Glaser C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012045; Glew RH, 2010, J HEALTH POPUL NUTR, V28, P159; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Holub BJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-58; Kawashima A, 2009, J NUTR SCI VITAMINOL, V55, P400, DOI 10.3177/jnsv.55.400; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Klein CJ, 2013, NUTR CLIN PRACT, V28, P87, DOI 10.1177/0884533612469989; Kris-Etherton PM, 1999, CIRCULATION, V100, P1253, DOI 10.1161/01.CIR.100.11.1253; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee S, 2012, BRIT J NUTR, V107, P567, DOI 10.1017/S0007114511003199; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; MATTHEWS D R, 1985, Netherlands Journal of Medicine, V28, P20; Meldrum SJ, 2012, PROSTAG LEUKOTR ESS, V86, P233, DOI 10.1016/j.plefa.2012.03.006; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Miller MR, 2010, MATERN CHILD NUTR, V6, P338, DOI 10.1111/j.1740-8709.2009.00230.x; Monteiro J, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-60; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Neggers YH, 2009, ASIA PAC J CLIN NUTR, V18, P22; Ottestad I, 2012, BRIT J NUTR, V108, P315, DOI 10.1017/S0007114511005484; Park Y, 2009, NUTR RES, V29, P825, DOI 10.1016/j.nutres.2009.10.018; Park Y, 2009, J MED FOOD, V12, P803, DOI 10.1089/jmf.2008.1250; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pawlosky R, 2003, BRIT J NUTR, V90, P993, DOI 10.1079/BJN2003985; Pawlosky RJ, 2003, AM J CLIN NUTR, V77, P565, DOI 10.1093/ajcn/77.3.565; Perez-Martinez P, 2012, MOL NUTR FOOD RES, V56, P309, DOI 10.1002/mnfr.201100504; Rasic-Milutinovic Z, 2012, ARCH MED RES, V43, P75, DOI 10.1016/j.arcmed.2011.12.008; REEVES V B, 1984, American Journal of Clinical Nutrition, V40, P1345, DOI 10.1093/ajcn/40.6.1345; Roke K, 2013, PROSTAGLANDINS LEUKO, DOI [10.1016/j.plefa.2013.12.006, DOI 10.1016/J.PLEFA.2013.12.006]; Sabel KG, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-20; Sauerwald UC, 2012, J PEDIATR GASTR NUTR, V54, P353, DOI 10.1097/MPG.0b013e31823c3bfd; Schuchardt JP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-145; SCHWERTNER HA, 1993, CLIN CHEM, V39, P659; SERA RK, 1994, J CLIN LAB ANAL, V8, P81, DOI 10.1002/jcla.1860080205; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Steffen BT, 2012, EUR J CLIN NUTR, V66, P600, DOI 10.1038/ejcn.2011.215; Sun Q, 2007, AM J CLIN NUTR, V86, P74, DOI 10.1093/ajcn/86.1.74; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Telle-Hansen VH, 2012, LIPIDS, V47, P151, DOI 10.1007/s11745-011-3637-y; Wheeler SJ, 2011, BRIT J NUTR, V105, P601, DOI 10.1017/S0007114510004083; Wilk JB, 2012, AM J CLIN NUTR, V96, P882, DOI 10.3945/ajcn.112.042671; Woods MN, 2009, AM J CLIN NUTR, V89, P1180, DOI 10.3945/ajcn.2009.27444; Yaemsiri S, 2013, STROKE, V44, P2710, DOI 10.1161/STROKEAHA.111.000834; Yamagishi K, 2013, CEREBROVASC DIS, V36, P38, DOI [10.1159/000351205, 10.1159/000351151]; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008; Zulyniak MA, 2012, APPL PHYSIOL NUTR ME, V37, P1003, DOI [10.1139/h2012-081, 10.1139/H2012-081]	73	179	180	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116195	10.1371/journal.pone.0116195	http://dx.doi.org/10.1371/journal.pone.0116195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675440	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000007
J	Marcil, V; Amre, D; Seidman, EG; Boudreau, F; Gendron, FP; Menard, D; Beaulieu, JF; Sinnett, D; Lambert, M; Levy, E				Marcil, Valerie; Amre, Devendra; Seidman, Ernest G.; Boudreau, Francois; Gendron, Fernand P.; Menard, Daniel; Beaulieu, Jean Francois; Sinnett, Daniel; Lambert, Marie; Levy, Emile			Hepatocyte Nuclear Factor 4 Alpha Polymorphisms and the Metabolic Syndrome in French-Canadian Youth	PLOS ONE			English	Article							P2 PROMOTER VARIANTS; TYPE-2 DIABETES SUSCEPTIBILITY; FACTOR 4-ALPHA; GENETIC-VARIANTS; FACTOR-4-ALPHA GENE; COMMON VARIANTS; FATTY-ACID; TRANSCRIPTIONAL REGULATION; REPRESENTATIVE SAMPLE; INSULIN-RESISTANCE	Objectives Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a transcription factor involved in the regulation of serum glucose and lipid levels. Several HNF4A gene variants have been associated with the risk of developing type 2 diabetes mellitus. However, no study has yet explored its association with insulin resistance and the cardiometabolic risk in children. We aimed to investigate the relationship between HNF4A genetic variants and the presence of metabolic syndrome (MetS) and metabolic parameters in a pediatric population. Design and Methods Our study included 1,749 French-Canadians aged 9, 13 and 16 years and evaluated 24 HNF4A polymorphisms that were previously identified by sequencing. Results Analyses revealed that, after correction for multiple testing, one SNP (rs736824; P< 0.022) and two haplotypes (P1 promoter haplotype rs6130608-rs2425637; P< 0.032 and intronic haplotype rs736824-rs745975-rs3212183; P< 0.025) were associated with the risk of MetS. Additionally, a significant association was found between rs3212172 and apolipoprotein B levels (coefficient: -0.14 +/- 0.05; P<0.022). These polymorphisms are located in HNF4A P1 promoter or in intronic regions. Conclusions Our study demonstrates that HNF4 alpha genetic variants are associated with the MetS and metabolic parameters in French Canadian children and adolescents. This study, the first exploring the relation between HNF4A genetic variants and MetS and metabolic variables in a pediatric cohort, suggests that HNF4 alpha could represent an early marker for the risk of developing type 2 diabetes mellitus.	[Marcil, Valerie; Seidman, Ernest G.] McGill Univ, Res Inst, Montreal, PQ H3G 1A4, Canada; [Amre, Devendra; Sinnett, Daniel; Lambert, Marie] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Seidman, Ernest G.; Boudreau, Francois; Gendron, Fernand P.; Menard, Daniel; Beaulieu, Jean Francois; Levy, Emile] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Levy, Emile] Univ Montreal, CHU St Justine, Dept Nutr, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Levy, E (corresponding author), Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.	emile.levy@recherche-ste-Justine.qc.ca	AMRE, DEVENDRA K/D-4988-2015; Menard, Daniel/AAL-7821-2021; sinnett, daniel/S-4589-2017; Gendron, Fernand-Pierre/AAN-2965-2021	sinnett, daniel/0000-0003-3625-6676; 	Canadian Institutes of Health Research Team Grant [CTP-82942]; J.A. DeSeve Research Chair in Nutrition; Canada Research Chair in Immune Mediated Gastrointestinal Disorders; Canadian Institutes of Health Research Fellowship Award; Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR)); J.A. DeSeve Research Chair in Nutrition; Canada Research Chair in Immune Mediated Gastrointestinal Disorders; Canadian Institutes of Health Research Fellowship Award(Canadian Institutes of Health Research (CIHR)); Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University	This study was supported by the Canadian Institutes of Health Research Team Grant (CTP-82942), the J.A. DeSeve Research Chair in Nutrition (EL), the Canada Research Chair in Immune Mediated Gastrointestinal Disorders (ES), the Canadian Institutes of Health Research Fellowship Award and The Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University (VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Allard P, 2003, CLIN CHEM, V49, P644, DOI 10.1373/49.4.644; Andrulionye L, 2006, J MOL MED-JMM, V84, P701, DOI 10.1007/s00109-006-0063-3; Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Bourgey M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019368; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Chavali S, 2011, J HUM GENET, V56, P695, DOI 10.1038/jhg.2011.83; Cook S, 2008, J PEDIATR, V152, P165, DOI 10.1016/j.jpeds.2007.06.004; D'Adamo E, 2013, CURR PROB PEDIATR AD, V43, P114, DOI 10.1016/j.cppeds.2013.02.004; Damcott CM, 2004, DIABETES, V53, P3337, DOI 10.2337/diabetes.53.12.3337; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ek J, 2006, DIABETES, V55, P1869, DOI 10.2337/db05-1684; Eppens MC, 2006, CURR MED RES OPIN, V22, P1013, DOI 10.1185/030079906X104795; Ettinger LM, 2005, J PEDIATR-US, V147, P67, DOI 10.1016/j.jpeds.2005.02.003; Flegal KM, 2011, ADV NUTR, V2, p159S, DOI 10.3945/an.111.000307; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hansen SK, 2005, DIABETOLOGIA, V48, P452, DOI 10.1007/s00125-005-1671-0; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Hara K, 2006, DIABETES, V55, P1260, DOI 10.2337/db05-0620; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Huang WH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S68; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koo SH, 2007, BIOL PROCED ONLINE, V9, P27, DOI 10.1251/bpo131; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Lehman DM, 2007, DIABETES, V56, P513, DOI 10.2337/db06-0881; Leng SY, 2007, AM J PHYSIOL-GASTR L, V293, pG475, DOI 10.1152/ajpgi.00072.2007; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; Malecki MT, 1998, DIABETES, V47, P970, DOI 10.2337/diabetes.47.6.970; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; METZGER S, 1993, J BIOL CHEM, V268, P16831; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Muller YHL, 2005, DIABETES, V54, P3035, DOI 10.2337/diabetes.54.10.3035; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Paradis G, 2003, CAN J CARDIOL, V19, P523; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Pramfalk C, 2009, ARTERIOSCL THROM VAS, V29, P1235, DOI 10.1161/ATVBAHA.109.188581; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Saif-Ali R, 2011, ACTA BIOCHIM POL, V58, P179; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sookoian S, 2010, MOL GENET METAB, V99, P80, DOI 10.1016/j.ymgme.2009.08.004; Stan S, 2005, CLIN CHEM, V51, P1192, DOI 10.1373/clinchem.2004.046771; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Tanahashi T, 2006, HUM GENET, V120, P527, DOI 10.1007/s00439-006-0231-0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Vaxillaire M, 2005, DIABETOLOGIA, V48, P440, DOI 10.1007/s00125-004-1665-3; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wanic K, 2006, DIABETES METAB, V32, P86, DOI 10.1016/S1262-3636(07)70252-5; Weedon MN, 2004, DIABETES, V53, P3002, DOI 10.2337/diabetes.53.11.3002; Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902; Weissglas-Volkov D, 2006, DIABETES, V55, P1970, DOI 10.2337/db06-0035; Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	78	21	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117238	10.1371/journal.pone.0117238	http://dx.doi.org/10.1371/journal.pone.0117238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671620	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300043
J	Maroon, JC; Winkelman, R; Bost, J; Amos, A; Mathyssek, C; Miele, V				Maroon, Joseph C.; Winkelman, Robert; Bost, Jeffrey; Amos, Austin; Mathyssek, Christina; Miele, Vincent			Chronic Traumatic Encephalopathy in Contact Sports: A Systematic Review of All Reported Pathological Cases	PLOS ONE			English	Review							APOLIPOPROTEIN-E EPSILON-4; AMYLOID BETA-PROTEIN; DEMENTIA-PUGILISTICA; NEUROFIBRILLARY TANGLES; BRAIN-INJURY; DISEASE; TDP-43; NEUROPATHOLOGY; ASSOCIATION; COMORBIDITY	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with head trauma. Although initially believed to affect only boxers, the at-risk population has expanded to encompass a much wider demographic, including American football players, hockey players, wrestlers, and military veterans. This expansion has garnered considerable media attention and public concern for the potential neurodegenerative effects of head trauma. The main aim of this systematic review is to give a complete overview of the common findings and risk factors for CTE as well as the status quo regarding the incidence and prevalence of CTE. This systematic review was performed using PubMed and MEDLINE and includes all neuropathologically confirmed cases of CTE in the medical literature to date, from the first published case in 1954 to August 1, 2013 (n = 153). The demographics, including the primary source of mTBI (mild Traumatic Brain Injury), age and cause of death, ApoE genotype, and history of substance abuse, when listed, were obtained from each case report. The demographics of American football players found to have CTE are also presented separately in order to highlight the most prevalent group of CTE cases reported in recent years. These 153 case reports of CTE represent the largest collection to date. We found that a history of mTBI was the only risk factor consistently associated with CTE. In addition, we found no relationships between CTE and age of death or abnormal ApoE allele. Suicide and the presence of premorbid dementia was not strongly associated with CTE. We conclude that the incidence of CTE remains unknown due to the lack of large, longitudinal studies. Furthermore, the neuropathological and clinical findings related to CTE overlap with many common neurodegenerative diseases. Our review reveals significant limitations of the current CTE case reporting and questions the widespread existence of CTE in contact sports.	[Maroon, Joseph C.; Winkelman, Robert; Bost, Jeffrey; Amos, Austin; Mathyssek, Christina; Miele, Vincent] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bost, J (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15260 USA.	bostj@upmc.edu			Heindl Neuroscience Foundation; Nelson Peltz Foundation; Lewis Topper Foundation; Cameron Foundation; Mylan Laboratory Foundation; John and Cathie Garcia Foundation	Heindl Neuroscience Foundation; Nelson Peltz Foundation; Lewis Topper Foundation; Cameron Foundation; Mylan Laboratory Foundation; John and Cathie Garcia Foundation	Financial support for this study was provided by the Heindl Neuroscience Foundation, Nelson Peltz Foundation, Lewis Topper Foundation, Cameron Foundation, Mylan Laboratory Foundation, and John and Cathie Garcia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOP D, 1990, AM J PATHOL, V136, P255; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Beydoun MA, 2013, J AM GERIATR SOC, V61, P525, DOI 10.1111/jgs.12156; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Drachman DA, 1999, NEW ENGL J MED, V340, P1269, DOI 10.1056/NEJM199904223401609; Ersche KD, 2006, NEUROPSYCHOPHARMACOL, V31, P1036, DOI 10.1038/sj.npp.1300889; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; MANN DMA, 1983, CLIN NEUROPATHOL, V2, P1; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Pilon M, 2013, NY TIMES, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Reynolds E, 2014, PROG NEUROL SURG, V28, P128, DOI [10.1159/000358770, DOI 10.1159/000358770]; Robbins S, 2010, STARS STRIPES   0123; Roberts G, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schwarz A., 2010, NY TIMES; Schwarz A, 2007, NY TIMES, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Sher L, 2004, QJM-INT J MED, V97, P237, DOI 10.1093/qjmed/hch045; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tepper Stewart J, 2012, Continuum (Minneap Minn), V18, P807, DOI 10.1212/01.CON.0000418644.32032.7b; Thal Dietmar Rudolf, 2004, Sci Aging Knowledge Environ, V2004, ppe26; Tierney M, 2012, NY TIMES, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Volkow ND, 2004, BIOL PSYCHIAT, V56, P714, DOI 10.1016/j.biopsych.2004.07.007; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	82	102	102	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117338	10.1371/journal.pone.0117338	http://dx.doi.org/10.1371/journal.pone.0117338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671598	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000349545300050
J	Mukesh; Kumar, VP; Sharma, LK; Shukla, M; Sathyakumar, S				Mukesh; Kumar, Ved P.; Sharma, Lalit K.; Shukla, Malay; Sathyakumar, Sambandam			Pragmatic Perspective on Conservation Genetics and Demographic History of the Last Surviving Population of Kashmir Red Deer (Cervus elaphus hanglu) in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; VIABILITY ANALYSIS; STATISTICAL TESTS; PHYLOGEOGRAPHY; GROWTH; NEUTRALITY; PHYLOGENY; DIVERSITY; SOFTWARE; NUMBER	The hangul (Cervus elaphus hanglu) is of great conservation concern because it represents the easternmost and only hope for an Asiatic survivor of the red deer species in the Indian subcontinent. Despite the rigorous conservation efforts of the Department of Wildlife Protection in Jammu & Kashmir, the hangul population has experienced a severe decline in numbers and range contraction in the past few decades. The hangul population once abundant in the past has largely become confined to the Dachigam landscape, with a recent population estimate of 218 individuals. We investigated the genetic variability and demographic history of the hangul population and found that it has shown a relatively low diversity estimates when compared to other red deer populations of the world. Neutrality tests, which are used to evaluate demographic effects, did not support population expansion, and the multi-modal pattern of mismatch distribution indicated that the hangul population is under demographic equilibrium. Furthermore, the hangul population did not exhibit any signature of bottleneck footprints in the past, and Coalescent Bayesian Skyline plot analysis revealed that the population had not experienced any dramatic changes in the effective population size over the last several thousand years. We observed a strong evidence of sub-structuring in the population, wherein the majority of individuals were assigned to different clusters in Bayesian cluster analysis. Population viability analysis demonstrated insignificant changes in the mean population size, with a positive growth rate projected for the next hundred years. We discuss the phylogenetic status of hangul for the first time among the other red deer subspecies of the world and strongly recommend to upgrade hangul conservation status under IUCN that should be discrete from the other red deer subspecies of the world to draw more conservation attention from national and international bodies.	[Mukesh; Kumar, Ved P.; Sharma, Lalit K.; Sathyakumar, Sambandam] Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India; [Shukla, Malay] Gujarat Forens Sci Univ, Gandhinagar 382007, Gujarat, India	Wildlife Institute of India; National Forensic Sciences University	Mukesh (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India.	thamukesh@gmail.com		SHUKLA, MALAY/0000-0002-7239-5537; Sharma, Lalit Kumar/0000-0003-1214-7416				Ahmad Khursheed, 2009, Journal of the Bombay Natural History Society, V106, P245; [Anonymous], 2014, TRACER V1 6; Balakrishnan CN, 2003, MOL ECOL, V12, P1, DOI 10.1046/j.1365-294X.2003.01751.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Bennett A. F, 2003, LINKAGES LANDSCAPE R, DOI DOI 10.2305/IUCN.CH.2004.FR.1.EN; BENTON TG, 1995, EVOL ECOL, V9, P559, DOI 10.1007/BF01237655; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brown LM, 2004, CONSERV GENET, V5, P743, DOI 10.1007/s10592-004-1865-x; Charoo SA, 2010, SPAN J WILDL GALEMYS, V22, P171; Charoo SA, 2011, MONITORING HANGUL DA; Cornuet JM, 1996, GENETICS, V144, P2001; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feulner PGD, 2004, HEREDITY, V93, P299, DOI 10.1038/sj.hdy.6800504; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gaur A, 2003, MOL ECOL NOTES, V3, P607, DOI 10.1046/j.1471-8286.2003.00528.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Huang HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091570; IUCN, 1987, IUCN POL STAT CAPT B; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Lacy RC, 2014, VORTEX 10 USERS MANU, DOI [10.1097/OPX.0000000000000387, DOI 10.1097/0PX.0000000000000387]; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mahmut H, 2002, ZOOL SCI, V19, P485, DOI 10.2108/zsj.19.485; McDevitt AD, 2009, MAMM BIOL, V74, P263, DOI 10.1016/j.mambio.2009.03.015; Meffe G. K., 1994, PRINCIPLES CONSERVAT; Mukesh, 2013, BMC Res Notes, V6, P326, DOI 10.1186/1756-0500-6-326; Mukesh, 2013, ZOO BIOL, V32, P476, DOI 10.1002/zoo.21081; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Perez-Espona S, 2009, HEREDITY, V102, P199, DOI 10.1038/hdy.2008.111; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Pritchard JK, 2000, GENETICS, V155, P945; Pudovkin AI, 1996, GENETICS, V144, P383; Qureshi Qamar, 2009, Journal of the Bombay Natural History Society, V106, P63; Randi E, 1998, P ROY SOC B-BIOL SCI, V265, P793, DOI 10.1098/rspb.1998.0362; Randi E, 2001, ANIM CONSERV, V4, P1, DOI 10.1017/S1367943001001019; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; SCHALLER G B, 1969, Journal of the Bombay Natural History Society, V66, P1; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stoneking M, 1992, PHIL T ROY B, V337, P34; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1995, GENETICS, V140, P767; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Zachos FE, 2011, MAMMAL REV, V41, P138, DOI 10.1111/j.1365-2907.2010.00177.x; Zachos FE, 2009, WILDLIFE BIOL, V15, P175, DOI 10.2981/07-075	61	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117069	10.1371/journal.pone.0117069	http://dx.doi.org/10.1371/journal.pone.0117069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671567	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300033
J	Pacheco, AG; Grinsztejn, B; da Fonseca, MDM; Moreira, RI; Veloso, VG; Friedman, RK; Santini-Oliveira, M; Cardoso, SW; Falcao, M; Mill, JG; Bensenor, I; Lotufo, P; Chor, D				Pacheco, Antonio G.; Grinsztejn, Beatriz; da Fonseca, Maria de Jesus M.; Moreira, Ronaldo I.; Veloso, Valdilea G.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.; Falcao, Melissa; Mill, Jose G.; Bensenor, Isabela; Lotufo, Paulo; Chor, Dora			Traditional Risk Factors Are More Relevant than HIV-Specific Ones for Carotid Intima-Media Thickness (cIMT) in a Brazilian Cohort of HIV-Infected Patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK; HAART ERA; ATHEROSCLEROSIS; PROGRESSION; MORTALITY; DISEASE; EVENTS; DEATH; EQUATION	Background Combination antiretroviral therapy (cART) had a dramatic impact on the mortality profile in human immunodeficiency virus (HIV) infected individuals and increased their life-expectancy. Conditions associated with the aging process have been diagnosed more frequently among HIV-infected patients, particularly, cardiovascular diseases. Methods Patients followed in the Instituto de Pesquisa Clinica Evandro Chagas (IPEC) prospective cohort in Rio de Janeiro were submitted to the general procedures from the Brazilian Longitudinal Study of Adult Health, comprising several anthropometric, laboratory and imaging data. Carotid intima-media thickness (cIMT) was measured by ultrasonography, following the Mannheim protocol. Linear regression and proportional odds models were used to compare groups and covariables in respect to cIMT. The best model was chosen with the adaptive lasso procedure. Results A valid cIMT exam was available for 591 patients. Median cIMT was significantly larger for men than women (0.56mm vs. 0.53mm; p = 0.002; overall = 0.54mm). In univariable linear regression analysis, both traditional risk factors for cardiovascular diseases (CVD) and HIV-specific characteristics were significantly associated with cIMT values, but the best multivariable model chosen included only traditional characteristics. Hypertension presented the strongest association with higher cIMT terciles (OR = 2.51; 95% CI = 1.69-3.73), followed by current smoking (OR = 1,82; 95% CI = 1.19-2.79), family history of acute myocardial infarction or stroke (OR = 1.60; 95% CI = 1.10-2.32) and age (OR per year = 1.12; 95% CI = 1.10-1.14). Conclusions Our results show that traditional cardiovascular disease (CVD) risk factors are the major players in determining increased cIMT among HIV infected patients in Brazil. This finding reinforces the need for thorough assessment of those risk factors in these patients to guarantee the incidence of CVD events remain under control.	[Pacheco, Antonio G.; Falcao, Melissa] Fiocruz MS, Programa Comp Cientif, BR-21045900 Rio De Janeiro, Brazil; [Grinsztejn, Beatriz; Moreira, Ronaldo I.; Veloso, Valdilea G.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [da Fonseca, Maria de Jesus M.] Fiocruz MS, Dept Epidemiol & Metodos Quantitati Saude, BR-21045900 Rio De Janeiro, Brazil; [Mill, Jose G.] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil; [Bensenor, Isabela; Lotufo, Paulo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Pacheco, AG (corresponding author), Fiocruz MS, Programa Comp Cientif, BR-21045900 Rio De Janeiro, Brazil.	antgui@gmail.com	Cardoso, Sandra W/D-7965-2015; Lotufo, Paulo/A-9843-2008; Pacheco, Antonio Guilherme/E-6378-2013; Bensenor, Isabela Judith Martins/L-3306-2017	Cardoso, Sandra W/0000-0001-5230-0003; Lotufo, Paulo/0000-0002-4856-8450; Pacheco, Antonio Guilherme/0000-0003-3095-1774; 	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476, U01AI069476] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Falcao MDBD, 2012, ARQ BRAS CARDIOL, V99, P971; Calza L, 2008, J INFECTION, V57, P16, DOI 10.1016/j.jinf.2008.02.006; Ceccarelli G, 2013, INT J CLIN PRACT, V67, P1, DOI 10.1111/ijcp.12066; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fitch KV, 2013, AIDS, V27, P49, DOI 10.1097/QAD.0b013e328358b29c; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Fuchs SC, 2013, SCI WORLD J, DOI 10.1155/2013/163418; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Justice Amy C, 2012, AIDS, V26 Suppl 1, pS11; Kelesidis T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-23; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mangili A, 2011, JAIDS-J ACQ IMM DEF, V58, P148, DOI [10.1097/QAI.0B013E31822D4993, 10.1097/QAI.0b013e31822d4993]; Masia M, 2012, ENFERM INFEC MICR CL, V30, P517, DOI 10.1016/j.eimc.2012.02.014; Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; R Development Core Team, 2014, R LANG ENV STAT COMP; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Stein JH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001396; Stein James H, 2012, Top Antivir Med, V20, P129; Stein JH, 2012, TOP ANTIVIR MED, V20, P123; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Volpe GE, 2013, JAIDS-J ACQ IMM DEF, V64, P51, DOI 10.1097/QAI.0b013e31829ed726; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117461	10.1371/journal.pone.0117461	http://dx.doi.org/10.1371/journal.pone.0117461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692764	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500058
J	Fei, XF; Wu, JP; Kong, Z; Christakos, G				Fei, Xufeng; Wu, Jiaping; Kong, Zhe; Christakos, George			Urban-Rural Disparity of Breast Cancer and Socioeconomic Risk Factors in China	PLOS ONE			English	Article							ENVIRONMENTAL-POLLUTANTS; MORTALITY; CONTRACEPTIVES; DETERMINANTS; DIAGNOSIS; MODELS; LEVEL; WOMEN; STAGE; AGE	Breast cancer is one of the most commonly diagnosed cancers worldwide. The primary aim of this work is the study of breast cancer disparity among Chinese women in urban vs. rural regions and its associations with socioeconomic factors. Data on breast cancer incidence were obtained from the Chinese cancer registry annual report (2005-2009). The ten socio-economic factors considered in this study were obtained from the national population 2000 census and the Chinese city/county statistical yearbooks. Student's T test was used to assess disparities of female breast cancer and socioeconomic factors in urban vs. rural regions. Pearson correlation and ordinary least squares (OLS) models were employed to analyze the relationships between socioeconomic factors and cancer incidence. It was found that the breast cancer incidence was significantly higher in urban than in rural regions. Moreover, in urban regions, breast cancer incidence remained relatively stable, whereas in rural regions it displayed an annual percentage change (APC) of 8.55. Among the various socioeconomic factors considered, breast cancer incidence exhibited higher positive correlations with population density, percentage of non-agriculture population, and second industry output. On the other hand, the incidence was negatively correlated with the percentage of population employed in primary industry. Overall, it was observed that higher socioeconomic status would lead to a higher breast cancer incidence in China. When studying breast cancer etiology, special attention should be paid to environmental pollutants, especially endocrine disruptors produced during industrial activities. Lastly, the present work's findings strongly recommend giving high priority to the development of a systematic nationwide breast cancer screening program for women in China; with sufficient participation, mammography screening can considerably reduce mortality among women.	[Fei, Xufeng; Kong, Zhe] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jiaping; Christakos, George] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022	Christakos, George/0000-0002-1865-5764	Ministry of Education, China [20120101110131]; Department of Science and Technology, Zhejiang Province [2013C03045]	Ministry of Education, China(Ministry of Education, China); Department of Science and Technology, Zhejiang Province(Department of Science & Technology (India))	This work was supported partially by the Ministry of Education, China (20120101110131) and the Department of Science and Technology, Zhejiang Province (2013C03045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; [Anonymous], 2000, CHINESE 5 CENSUS DAT; Bliss JM, 2003, LANCET, V362, P1328, DOI 10.1016/S0140-6736(03)14591-6; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Bryere J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-87; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chen WQ, 2013, THORAC CANCER, V4, P59, DOI 10.1111/j.1759-7714.2012.00165.x; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Christakos G, 1997, SOC SCI MED, V45, P1503, DOI 10.1016/S0277-9536(97)00080-4; Clarke CA, 2010, CANCER EPIDEM BIOMAR, V19, P2727, DOI 10.1158/1055-9965.EPI-10-0692; COLDITZ GA, 1995, CANCER EPIDEM BIOMAR, V4, P567; Couto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055374; Curado M., 2007, IARC SCI PUB, VIX; Dey S, 2010, BREAST, V19, P417, DOI 10.1016/j.breast.2010.04.005; Fei XF, 2014, STOCH ENV RES RISK A, V28, P1075, DOI 10.1007/s00477-014-0876-5; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gentil J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-351; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P1641, DOI 10.1001/jama.300.14.1641; Hao J, 2008, CHINESE CANC REGISTR; Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679; Heitz F, 2013, ONKOLOGIE, V36, P477, DOI 10.1159/000354624; HENDERSON BE, 1988, CANCER RES, V48, P246; Hongyuan S., 2004, EC RES J, V11, P4; KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118; Larson SL, 2003, MED CARE, V41, P65, DOI 10.1097/01.MLR.0000076053.28108.F2; LewisMichl EL, 1996, ARCH ENVIRON HEALTH, V51, P255, DOI 10.1080/00039896.1996.9936024; Li Ni, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P703; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Merletti F, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S7; Morrell S, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.011127; National Statistics Bureau, 2005, CHIN COUNT STAT YB; National Statistics Bureau, 2005, CHIN CIT STAT YB; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Portier CJ, 2000, STOCH ENV RES RISK A, V14, P173, DOI 10.1007/PL00009780; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; Wang B, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130183, DOI 10.5888/PCD10.130183]; Wang JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-52; White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Yu HL, 2007, STOCH ENV RES RISK A, V21, P555, DOI 10.1007/s00477-007-0135-0; Zeng HM, 2013, THORAC CANCER, V4, P400, DOI 10.1111/1759-7714.12037; Zhang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0387-5	49	29	30	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117572	10.1371/journal.pone.0117572	http://dx.doi.org/10.1371/journal.pone.0117572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25688556	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700057
J	Jena, J; Kumar, R; Dixit, A; Pandey, S; Das, T				Jena, Jyotsnarani; Kumar, Ravindra; Dixit, Anshuman; Pandey, Sony; Das, Trupti			Evaluation of Simultaneous Nutrient and COD Removal with Polyhydroxybutyrate (PHB) Accumulation Using Mixed Microbial Consortia under Anoxic Condition and Their Bioinformatics Analysis	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; WASTE-WATER TREATMENT; ACTIVATED-SLUDGE; PHOSPHATE REMOVAL; POLYHYDROXYALKANOATES PHA; SIMULTANEOUS NITROGEN; OPERATING PARAMETERS; TREATMENT PLANTS; ORGANISMS PAOS; STORAGE	Simultaneous nitrate-N, phosphate and COD removal was evaluated from synthetic waste water using mixed microbial consortia in an anoxic environment under various initial carbon load (ICL) in a batch scale reactor system. Within 6 hours of incubation, enriched DNPAOs (Denitrifying Polyphosphate Accumulating Microorganisms) were able to remove maximum COD (87%) at 2g/L of ICL whereas maximum nitrate-N (97%) and phosphate (87%) removal along with PHB accumulation (49 mg/L) was achieved at 8 g/L of ICL. Exhaustion of nitrate-N, beyond 6 hours of incubation, had a detrimental effect on COD and phosphate removal rate. Fresh supply of nitrate-N to the reaction medium, beyond 6 hours, helped revive the removal rates of both COD and phosphate. Therefore, it was apparent that in spite of a high carbon load, maximum COD and nutrient removal can be maintained, with adequate nitrate-N availability. Denitrifying condition in the medium was evident from an increasing pH trend. PHB accumulation by the mixed culture was directly proportional to ICL; however the time taken for accumulation at higher ICL was more. Unlike conventional EBPR, PHB depletion did not support phosphate accumulation in this case. The unique aspect of all the batch studies were PHB accumulation was observed along with phosphate uptake and nitrate reduction under anoxic conditions. Bioinformatics analysis followed by pyrosequencing of the mixed culture DNA from the seed sludge revealed the dominance of denitrifying population, such as Corynebacterium, Rhodocyclus and Paraccocus (Alphaproteobacteria and Betaproteobacteria). Rarefaction curve indicated complete bacterial population and corresponding number of OTUs through sequence analysis. Chao1 and Shannon index (H') was used to study the diversity of sampling. "UCI95" and "LCI95" indicated 95% confidence level of upper and lower values of Chao1 for each distance. Values of Chao1 index supported the results of rarefaction curve.	[Jena, Jyotsnarani; Pandey, Sony; Das, Trupti] CSIR Inst Minerals & Mat Technol, Bhubaneswar, Odisha, India; [Kumar, Ravindra; Dixit, Anshuman] Inst Life Sci, Bhubaneswar, Odisha, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Minerals & Materials Technology (IMMT); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Das, T (corresponding author), CSIR Inst Minerals & Mat Technol, Bhubaneswar, Odisha, India.	trupti.sreyas@gmail.com	Jena, Jyotsnarani/N-8431-2017; Kumar, Ravindra/GQP-2547-2022; Pandey, Sony/D-6965-2013	Jena, Jyotsnarani/0000-0002-8593-6021; Kumar, Ravindra/0000-0001-5577-9048; Pandey, Sony/0000-0001-7584-6447	Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries) [CSC-0113]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries)	JJ is thankful to the Council of Scientific and Industrial Research (http://www.csirhrdg.res.in/), Government of India, for her fellowship. RK is thankful to the Department of Biotechnology (http://www.dbtindia.nic.in/index.asp), Government of India, for his fellowship. The authors are thankful to Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries: CSC-0113) for funding that aided the study design, data collection and analysis.	Ahn J, 2002, BIOTECHNOL BIOENG, V79, P83, DOI 10.1002/bit.10292; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; ARUN V, 1989, WATER SCI TECHNOL, V21, P363, DOI 10.2166/wst.1989.0238; Barak Y, 2000, APPL ENVIRON MICROB, V66, P1209, DOI 10.1128/AEM.66.3.1209-1212.2000; Bassin JP, 2012, WATER RES, V46, P3805, DOI 10.1016/j.watres.2012.04.015; Bengtsson S, 2008, BIORESOURCE TECHNOL, V99, P509, DOI 10.1016/j.biortech.2007.01.020; Beun JJ, 2000, BIOTECHNOL BIOENG, V68, P496, DOI 10.1002/(SICI)1097-0290(20000605)68:5<496::AID-BIT3>3.0.CO;2-S; Bucci V, 2012, ENVIRON SCI TECHNOL, V46, P3244, DOI 10.1021/es204052p; Chua ASM, 2003, WATER RES, V37, P3602, DOI 10.1016/S0043-1354(03)00252-5; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Dionisi D, 2001, WATER RES, V35, P2661, DOI 10.1016/S0043-1354(00)00562-5; Ferguson SJ, 1979, BIOCHEM SOC T, V7, P176, DOI 10.1042/bst0070176; Fernandez-Nava Y, 2010, J HAZARD MATER, V173, P682, DOI 10.1016/j.jhazmat.2009.08.140; Fogler L, 2004, BIORESOURCE TECHNOL, P1; Freitas F, 2009, BIORESOURCE TECHNOL, V100, P1969, DOI 10.1016/j.biortech.2008.10.031; Gebremariam SY, 2011, WATER ENVIRON RES, V83, P195, DOI 10.2175/106143010X12780288628534; Harper WF, 2003, WATER ENVIRON RES, V75, P216, DOI 10.2175/106143003X140999; Hu JY, 2003, WATER RES, V37, P3463, DOI 10.1016/S0043-1354(03)00205-7; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Hu ZR, 2002, WATER RES, V36, P4927, DOI 10.1016/S0043-1354(02)00186-0; Jena J, 2013, J SCI IND RES INDIA, V72, P127; Johnson K, 2010, WATER RES, V44, P2141, DOI 10.1016/j.watres.2009.12.031; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Kapagiannidis AG, 2012, BIOPROC BIOSYST ENG, V35, P371, DOI 10.1007/s00449-011-0575-2; Kasemsap C, 2007, BIORESOURCE TECHNOL, V98, P1020, DOI 10.1016/j.biortech.2006.04.035; Kathiraser Y, 2007, J CHEM TECHNOL BIOT, V82, P847, DOI 10.1002/jctb.1751; Kong Y, 2007, MICROBIOLOGY, V153, P124061, DOI [10.1099/mic.0.2007/007245-, DOI 10.1099/MIC.0.2007/007245-]; Kragelund C, 2006, MICROBIOL-SGM, V152, P3003, DOI 10.1099/mic.0.29249-0; KUBA T, 1993, WATER SCI TECHNOL, V27, P241, DOI 10.2166/wst.1993.0504; KUBA T, 1994, WATER SCI TECHNOL, V30, P263, DOI 10.2166/wst.1994.0277; Kumar MS, 2004, BIORESOURCE TECHNOL, V95, P327, DOI 10.1016/j.biortech.2004.02.019; Lemos PC, 2006, J BIOTECHNOL, V122, P226, DOI 10.1016/j.jbiotec.2005.09.006; Liao RH, 2013, BIORESOURCE TECHNOL, V134, P190, DOI 10.1016/j.biortech.2012.12.057; Meinhold J, 1999, WATER RES, V33, P1871, DOI 10.1016/S0043-1354(98)00411-4; Merzouki M, 2001, ENVIRON TECHNOL, V22, P397, DOI 10.1080/09593332208618269; MINO T, 1995, WATER SCI TECHNOL, V31, P25, DOI 10.1016/0273-1223(95)00177-O; Mulkerrins D, 2004, ENVIRON INT, V30, P249, DOI 10.1016/S0160-4120(03)00177-6; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Perez-Feito R, 2006, WATER ENVIRON RES, V78, P770, DOI 10.2175/106143006X99803; Qingjuan MENG, 2008, Journal of Environmental Sciences, V20, P933; Reddy MV, 2012, BIORESOURCE TECHNOL, V103, P313, DOI 10.1016/j.biortech.2011.09.040; Rene ER, 2007, BIRESOUR TECHNOL, V4, P839; Salehizadeh H, 2004, BIOTECHNOL ADV, V22, P261, DOI 10.1016/j.biotechadv.2003.09.003; Samantaray S, 2011, APPL ENVIRON MICROB, V77, P8735, DOI 10.1128/AEM.05275-11; Schuler AJ, 2003, WATER ENVIRON RES, V75, P485, DOI 10.2175/106143003X141286; Serafim LS, 2008, APPL MICROBIOL BIOT, V81, P615, DOI 10.1007/s00253-008-1757-y; Seviour RJ, 2003, FEMS MICROBIOL REV, V27, P99, DOI 10.1016/S0168-6445(03)00021-4; Shi HP, 2006, INT BIODETER BIODEGR, V57, P121, DOI 10.1016/j.ibiod.2006.01.001; Shi J, 2014, SAUDI J BIOL SCI, V21, P71, DOI 10.1016/j.sjbs.2013.06.003; SMOLDERS GJF, 1994, BIOTECHNOL BIOENG, V44, P837, DOI 10.1002/bit.260440709; Takabatake H, 2000, WATER SCI TECHNOL, V42, P351, DOI 10.2166/wst.2000.0402; Tsuneda S, 2006, BIOCHEM ENG J, V27, P191, DOI 10.1016/j.bej.2005.07.004; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; WALLEN LL, 1974, ENVIRON SCI TECHNOL, V8, P576, DOI 10.1021/es60091a007; Wang Y, 2012, J CHROMATOGR A, V1228, P99, DOI 10.1016/j.chroma.2011.08.085; Watanabe T, 2001, WATER RES, V35, P4102, DOI 10.1016/S0043-1354(01)00158-0; WENTZEL MC, 1989, WATER SA, V15, P71; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Zeng RJ, 2003, BIOTECHNOL BIOENG, V81, P397, DOI 10.1002/bit.10484; Zhang SH, 2010, BIORESOURCE TECHNOL, V101, P3870, DOI 10.1016/j.biortech.2009.12.134; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhou SF, 2013, BIOTECHNOL BIOENG, V110, P3177, DOI 10.1002/bit.24980; Zhou Y, 2008, WATER RES, V42, P2361, DOI 10.1016/j.watres.2008.01.003; Zou H, 2006, WORLD J MICROB BIOT, V22, P701, DOI 10.1007/s11274-005-9093-1	69	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116230	10.1371/journal.pone.0116230	http://dx.doi.org/10.1371/journal.pone.0116230			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689047	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700008
J	Mendes, TK; Novakovic, S; Raymant, G; Bertram, SE; Esmaillie, R; Nadarajan, S; Breugelmans, B; Hofmann, A; Gasser, RB; Colaiacovo, MP; Boag, PR				Mendes, Tasha K.; Novakovic, Stevan; Raymant, Greta; Bertram, Sonja E.; Esmaillie, Reza; Nadarajan, Saravanapriah; Breugelmans, Bert; Hofmann, Andreas; Gasser, Robin B.; Colaiacovo, Monica P.; Boag, Peter R.			Investigating the Role of RIO Protein Kinases in Caenorhabditis elegans	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; FAMILY; MATURATION; SKN-1	RIO protein kinases (RIOKs) are a relatively conserved family of enzymes implicated in cell cycle control and ribosomal RNA processing. Despite their functional importance, they remain a poorly understood group of kinases in multicellular organisms. Here, we show that the C. elegans genome contains one member of each of the three RIOK sub-families and that each of the genes coding for them has a unique tissue expression pattern. Our analysis showed that the gene encoding RIOK-1 (riok-1) was broadly and strongly expressed. Interestingly, the intestinal expression of riok-1 was dependent upon two putative binding sites for the oxidative and xenobiotic stress response transcription factor SKN-1. RNA interference (RNAi)-mediated knock down of riok-1 resulted in germline defects, including defects in germ line stem cell proliferation, oocyte maturation and the production of endomitotic oocytes. Taken together, our findings indicate new functions for RIOK-1 in post mitotic tissues and in reproduction.	[Mendes, Tasha K.; Novakovic, Stevan; Raymant, Greta; Boag, Peter R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bertram, Sonja E.; Esmaillie, Reza] Univ Cologne, Inst Genet, Cologne, Germany; [Nadarajan, Saravanapriah; Colaiacovo, Monica P.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Breugelmans, Bert; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Drug Discovery, Brisbane, Qld 4111, Australia	Monash University; University of Cologne; Harvard University; Harvard Medical School; University of Melbourne; Griffith University	Boag, PR (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	peter.boag@monash.edu	Hofmann, Andreas/M-9870-2019; Gasser, Robin/ABH-6185-2020; Hofmann, Andreas/B-9515-2008	Hofmann, Andreas/0000-0003-4408-5467; Gasser, Robin/0000-0002-4423-1690; Hofmann, Andreas/0000-0003-4408-5467; Novakovic, Stevan/0000-0002-9823-6411; Boag, Peter/0000-0002-0889-0859	National Health and Medical Research Council [APP1044022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105853, R01GM072551] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Health and Medical Research Council grant, APP1044022 (RBG, PRB & AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Angermayr M, 2003, BIOL CHEM, V384, P1287, DOI 10.1515/BC.2003.143; Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Baumas K, 2012, RNA BIOL, V9, DOI [10.4161/rna.9.2.18810, 10.4161/rna.18810]; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Breugelmans B, 2014, INT J PARASITOL, V44, P827, DOI 10.1016/j.ijpara.2014.06.005; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kelly WG, 1997, GENETICS, V146, P227; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2005, GENOMIC OVERVIEW PRO, P1; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Mello C, 1995, METHOD CELL BIOL, V48, P451; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shan JX, 2009, MOL CELL BIOCHEM, V332, P113, DOI 10.1007/s11010-009-0180-8; Stiernagle T, 2006, MAINTENANCE OF C ELE; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tariki M, 2013, CELL SIGNAL, V25, P2668, DOI 10.1016/j.cellsig.2013.08.037; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1	38	10	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117444	10.1371/journal.pone.0117444	http://dx.doi.org/10.1371/journal.pone.0117444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688864	Green Published, gold			2022-12-27	WOS:000350322700045
J	Saha, MK; Mahapatra, T; Biswas, S; Ghosh, P; Kire, M				Saha, Malay Kumar; Mahapatra, Tanmay; Biswas, Subrata; Ghosh, Piyali; Kire, Medo			Burden and Correlates of HIV Risk among Men Who Have Sex with Men in Nagaland, India: Analysis of Sentinel Surveillance Data	PLOS ONE			English	Article							BEHAVIOR; CHENNAI; INFECTION; MSM; PREVENTION; PREVALENCE; WOMEN; INCOME; MUMBAI	Background Dynamics of HIV epidemic are largely understudied among men having sex with men (MSM) in India, while their potentially critical role in HIV spread is often stressed. Unfortunately, the epidemic has probably concentrated in this hard-to-reach population in the north-eastern high HIV-prevalent areas, especially in the bordering state of Nagaland, where HIV prevalence among MSM was found to be 2nd highest in the whole country. Dearth of information regarding the socio-behavioral correlates of HIV acquisition among MSM in this remote hilly region thus called for detailed analyses of the HIV Sentinel Surveillance (HSS) data. Methods During the first ever conducted HSS among MSM in Nagaland, between March and May, 2011, as per the operational guideline of Indian National AIDS Control Program, 243 MSM were recruited, interviewed and tested for HIV. Anonymous data on socio-demographics, sexual behavior and laboratory results were analyzed using SAS version-9.2 to conduct descriptive and logistic regression analyses. Results Among the recruited MSM, mean age was 28.30 years, 46.09% were illiterate, 27.16% were unemployed, 57.02% identified them as Kothi (predominantly receptive anal sex partner), 14.81% were bisexual, 19.75% exchanged money for sex (within last 1 year) with men and 13.58% were HIV sero-positive. Increasing age (for 25-34yrs, adjusted odds ratio: AOR = 3.89, p = 0.046; reference = <25yrs), middle school (AOR = 3.44, p = 0.046) or higher (AOR = 4.47, p = 0.034) education (reference = illiterate), being Kothi [AOR = 3.60, p = 0.026; reference = double-decker: (involved in both insertive and receptive roles)] and having paid and received money for sex with a man (AOR = 7.32, p = 0.026; reference = didn't exchange money) were strongly associated with higher risk of HIV in both bivariate and multivariate analyses. Conclusion HIV burden was found to be alarmingly high among MSM in Nagaland. Targeted interventions for high-risk MSM, especially those who were older, educated, self-identified as kothis and involved in paid sex, seemed to be the need of the hour.	[Saha, Malay Kumar; Biswas, Subrata; Ghosh, Piyali] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India; [Mahapatra, Tanmay] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, W Bengal, India; [Kire, Medo] Nagaland State AIDS Control Soc, Monitoring & Evaluat Div, Kohima, Nagaland, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Saha, MK (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	sahamk@yahoo.com			National AIDS Control Organization, New Delhi, Regional Institute for HIV Sentinel Surveillance	National AIDS Control Organization, New Delhi, Regional Institute for HIV Sentinel Surveillance	National AIDS Control Organization, New Delhi, funded the study as a part of Regional Institute for HIV Sentinel Surveillance. MKS received the funding. The funder designed the HIV sentinel surveillance and its implementation but had no role in this study design, data compilation and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MAN QUAL STAND HIV T, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; [Anonymous], 2011, NAGALAND POPULATION; [Anonymous], 2009, ANN REP 2008 09 GOV; [Anonymous], 2012, ANN REP 2011 2012 GO; [Anonymous], 2012, TAL 2 STAT EV HIV EP, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; [Anonymous], 2011, NAG POP CENS DAT, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; [Anonymous], 2011, ANN REP 2010 2011 NA; [Anonymous], 2013, ANN REP 2012 2013 GO; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Bai X, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18848; Banik S, 2009, J LGBT HLTH RES, V4, P45; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bechani D, 2009, SAARC J TUBERCULOSIS, V6, P1; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Das A, 2014, INT J STD AIDS; Deb Soumya, 2009, Indian J Community Med, V34, P206, DOI 10.4103/0970-0218.55285; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Gupta A, 2006, JAIDS-J ACQ IMM DEF, V43, P483; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; KUMAR B, 1991, INT J STD AIDS, V2, P442, DOI 10.1177/095646249100200611; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; National AIDS Control Organisation, 2013, HIV SENT SURV 2012 1; National AIDS Control Organisation, 2012, HIV SENT SURV 2010 1; National AIDS Control Organization, 2010, HIV SENT SURV 2010 O; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Pappas G, 2001, AIDS PUBLIC POLICY J, V16, P4; Perez-Brumer AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059072; Safren SA, 2006, AIDS EDUC PREV, V18, P323, DOI 10.1521/aeap.2006.18.4.323; Setia Maninder Singh, 2006, Indian J Dermatol Venereol Leprol, V72, P425; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Thomas B, 2012, AIDS EDUC PREV, V24, P483, DOI 10.1521/aeap.2012.24.6.483; Thomas B, 2011, INDIAN J MED RES, V134, P920, DOI 10.4103/0971-5916.92637; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014	43	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117385	10.1371/journal.pone.0117385	http://dx.doi.org/10.1371/journal.pone.0117385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689469	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700038
J	Berglund, AMM; Rainio, MJ; Eeva, T				Berglund, Asa M. M.; Rainio, Miia J.; Eeva, Tapio			Temporal Trends in Metal Pollution: Using Bird Excrement as Indicator	PLOS ONE			English	Article							FLYCATCHERS FICEDULA-HYPOLEUCA; PLASMA-MASS SPECTROMETRY; TITS PARUS-MAJOR; CU-NI SMELTER; HEAVY-METAL; BREEDING SUCCESS; COPPER SMELTER; FOREST SOIL; WILD BIRDS; SW FINLAND	Past mining and smelting activities have resulted in metal polluted environments all over the world, but long-term monitoring data is often scarce, especially in higher trophic levels. In this study we used bird (Parus major and Ficedula hypoleuca) excrement to monitor metal pollution in the terrestrial environment following 16 years of continuously reduced emissions from a copper/nickel smelter in Finland. In the early 1990s, lead and cadmium concentrations dropped significantly in excrement, but the reduction did not directly reflect the changes in atmospheric emission from the smelter. This is likely due to a continuous contribution of metals also from the soil pool. We conclude that bird excrement can be used to assess changes in the environment as a whole but not specifically changes in atmospheric emission. Inter-annual variation in excrement concentration of especially copper and nickel demonstrates the importance of long-term monitoring to discern significant trends.	[Berglund, Asa M. M.; Rainio, Miia J.; Eeva, Tapio] Univ Turku, Sect Ecol, Turku, Finland	University of Turku	Berglund, AMM (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	asa.berglund@emg.umu.se	Rainio, Miia Johanna/H-9450-2019; Eeva, Tapio/V-8922-2018	Rainio, Miia Johanna/0000-0003-0420-9314; Eeva, Tapio/0000-0002-0395-1536	Academy of Finland [265859]	Academy of Finland(Academy of Finland)	This study was financed by the Academy of Finland (project 265859, http://www.aka.fi/en-GB/A/) by a grant to TE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backor M, 2004, ENVIRON EXP BOT, V52, P149, DOI 10.1016/j.envexpbot.2004.01.014; Barcan V, 2002, ENVIRON INT, V28, P63, DOI 10.1016/S0160-4120(02)00005-3; BELSKII EA, 1995, RUSS J ECOL+, V26, P38; Belskii E, 2013, ECOTOX ENVIRON SAFE, V97, P67, DOI 10.1016/j.ecoenv.2013.07.014; BERGKVIST B, 1989, WATER AIR SOIL POLL, V47, P217, DOI 10.1007/BF00279328; Berglund AMM, 2011, ENVIRON POLLUT, V159, P2368, DOI 10.1016/j.envpol.2011.07.001; Berglund AMM, 2011, SCI TOTAL ENVIRON, V409, P4326, DOI 10.1016/j.scitotenv.2011.07.004; Berglund AMM, 2012, ENVIRON TOXICOL CHEM, V31, P1317, DOI 10.1002/etc.1814; Berglund AMM, 2009, ENVIRON SCI TECHNOL, V43, P208, DOI 10.1021/es801723q; Beyer WN, 2004, ARCH ENVIRON CON TOX, V48, P108, DOI 10.1007/s00244-004-0010-7; Costa RA, 2013, ENVIRON MONIT ASSESS, V185, P5339, DOI 10.1007/s10661-012-2949-6; Cramp S, 1993, FLYCATCHERS SHRIEKS, VVII; Dauwe T, 2000, ARCH ENVIRON CON TOX, V39, P541, DOI 10.1007/s002440010138; Dauwe T, 2004, ENVIRON POLLUT, V131, P373, DOI 10.1016/j.envpol.2004.03.009; Derome J, 1998, CHEMOSPHERE, V36, P1131, DOI 10.1016/S0045-6535(97)10184-9; Derome J, 1998, ENVIRON POLLUT, V99, P225, DOI 10.1016/S0269-7491(97)00185-1; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Eeva T, 1997, ECOLOGY, V78, P1120, DOI 10.1890/0012-9658(1997)078[1120:PRVIFS]2.0.CO;2; Eeva T, 1996, OECOLOGIA, V108, P631, DOI 10.1007/BF00329036; Eeva T, 2000, NATURE, V403, P851, DOI 10.1038/35002672; Eeva T, 2009, ENVIRON POLLUT, V157, P3126, DOI 10.1016/j.envpol.2009.05.040; Eeva T, 2009, ENVIRON POLLUT, V157, P1857, DOI 10.1016/j.envpol.2009.01.015; Eeva T, 2012, BIOL CONSERV, V150, P33, DOI 10.1016/j.biocon.2012.03.004; EFSA (Europaen Food Safety Authority), 2010, MAN LEFT CENS DAT DI; FITZNER RE, 1995, B ENVIRON CONTAM TOX, V55, P398; Furness R.W., 1993, P86; Gunn J, 1995, WATER AIR SOIL POLL, V85, P1783, DOI 10.1007/BF00477238; Harmens H, 2010, ENVIRON POLLUT, V158, P3144, DOI 10.1016/j.envpol.2010.06.039; Heikens A, 2001, ENVIRON POLLUT, V113, P385, DOI 10.1016/S0269-7491(00)00179-2; Helsel DR, 1990, ENVIRON SCI TECHNOL, V24, P1776; Johns C, 2012, ENVIRON MONIT ASSESS, V184, P5371, DOI 10.1007/s10661-011-2346-6; Kiikkila O, 2003, SILVA FENN, V37, P399, DOI 10.14214/sf.497; Koptsik S, 2003, J ENVIRON MONITOR, V5, P441, DOI 10.1039/b210397b; Kozlov MV, 2009, ENVIRON POLLUT SER, V15, P1, DOI 10.1007/978-90-481-2467-1; Kozlov MV, 2005, ENVIRON POLLUT, V135, P91, DOI 10.1016/j.envpol.2004.10.005; Kubin E, 2000, FOR SCI, V65, P60; Kumar G, 2012, FOOD ADDIT CONTAM B, V5, P140, DOI 10.1080/19393210.2012.680612; Lange B, 2008, MICROCHIM ACTA, V160, P97, DOI 10.1007/s00604-007-0849-1; Malkonen E, 1999, NUTR CYCL AGROECOSYS, V55, P239, DOI 10.1023/A:1009851326584; Miksa IR, 2005, J VET DIAGN INVEST, V17, P331, DOI 10.1177/104063870501700405; Morrissey CA, 2005, ENVIRON TOXICOL CHEM, V24, P836, DOI 10.1897/04-110R.1; Mukhacheva SV, 2010, RUSS J ECOL+, V41, P513, DOI 10.1134/S1067413610060081; Nieminen T, 2009, SOILS CHANG WORLD 5, P89; Nieminen TM, 2005, THESIS U HELSINKI HE; Nriagu JO, 1984, ENV IMPACTS SMELTERS, P1; Palmer CD, 2006, SPECTROCHIM ACTA B, V61, P980, DOI 10.1016/j.sab.2006.09.001; Poikolainen J, 2004, SCI TOTAL ENVIRON, V318, P171, DOI 10.1016/S0048-9697(03)00396-6; Sardans J, 2010, SPECTROCHIM ACTA B, V65, P97, DOI 10.1016/j.sab.2009.11.009; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Swiergosz R, 1998, ENVIRON POLLUT, V102, P213, DOI 10.1016/S0269-7491(98)00093-1; Vidic T, 2006, ENVIRON SCI TECHNOL, V40, P4119, DOI 10.1021/es052339x; von Haartman L, 1956, IBIS, V98, P460, DOI DOI 10.1111/J.1474-919X.1956.TB01431.X; Wilkin TA, 2009, OECOLOGIA, V159, P463, DOI 10.1007/s00442-008-1222-8	53	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117071	10.1371/journal.pone.0117071	http://dx.doi.org/10.1371/journal.pone.0117071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680108	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600047
J	Cai, Q; Wu, J; Cai, Q; Chen, EZ; Jiang, ZY				Cai, Qiang; Wu, Jian; Cai, Qu; Chen, Er-Zhen; Jiang, Zhao-Yan			Association between Glu504Lys Polymorphism of ALDH2 Gene and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALDEHYDE DEHYDROGENASE 2; ALCOHOL-METABOLIZING ENZYMES; ESOPHAGEAL CANCER; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; JAPANESE POPULATION; CHINESE MALES; ENVIRONMENT INTERACTIONS; GLU487LYS POLYMORPHISM	Background The association of the aldehyde dehydrogenases-2 (ALDH2) Glu504Lys polymorphism (also named Glu487Lys, or rs671) and cancers has been investigated. This meta-analysis aims to comprehensively assess the influence of this polymorphism on the overall cancer risk. Methods Eligible publications were retrieved according to inclusion/exclusion criteria and the data were analyzed using the Review Manager software (V5.2). Results A meta-analysis based on 51 case-control studies consisting of 16774 cases and 32060 controls was performed to evaluate the association between the ALDH2 Glu504Lys polymorphism and cancer risk. The comparison of genotypes Lys+ (Lys/Lys and Lys/Glu) with Glu/Glu yielded a significant 20% increased cancer risk (OR = 1.20, 95%CI: 1.03-1.39, P = 0.02, I-2 = 92%). Subgroup analysis by cancer type indicated a significantly increased UADT cancer risk (OR = 1.39, 95%CI: 1.11-1.73, P = 0.004, I-2 = 94%) in individuals with the Lys+ genotypes. Subgroup analysis by country indicated that individuals from Japan with the Lys+ genotypes had a significant 38% increased cancer risk (OR = 1.38, 95%CI: 1.12-1.71, P = 0.003, I-2 = 93%). Conclusions Our results indicated that the ALDH2 Glu504Lys polymorphism is a susceptible loci associated with overall cancers, especially esophageal cancer and among Japanese population.	[Cai, Qiang; Wu, Jian; Cai, Qu; Jiang, Zhao-Yan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg,Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Chen, Er-Zhen] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jiang, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg,Shanghai Inst Digest Surg, Shanghai, Peoples R China.	zhaoyanjiang@gmail.com			National Natural Science Foundation [81070367, 81270537]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (No. 81070367 and No. 81270537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Boonyaphiphat P, 2002, CANCER LETT, V186, P193, DOI 10.1016/S0304-3835(02)00354-3; Cai L, 2006, CANCER-AM CANCER SOC, V106, P2345, DOI 10.1002/cncr.21881; Cao HX, 2010, ASIAN PAC J CANCER P, V11, P1073; Chao YC, 2000, AM J GASTROENTEROL, V95, P2958, DOI 10.1111/j.1572-0241.2000.02328.x; Chen YJ, 2006, INT J CANCER, V119, P2827, DOI 10.1002/ijc.22199; Chiang CP, 2012, ALCOHOL, V46, P37, DOI 10.1016/j.alcohol.2011.08.004; Choi JY, 2003, PHARMACOGENETICS, V13, P67, DOI 10.1097/00008571-200302000-00002; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Deng HW, 2001, GENETICS, V157, P885; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding JH, 2009, WORLD J GASTROENTERO, V15, P2395, DOI 10.3748/wjg.15.2395; Ding JH, 2008, ASIAN PAC J CANCER P, V9, P31; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eng MY, 2007, ALCOHOL RES HEALTH, V30, P22; Eom SY, 2009, CANCER CAUSE CONTROL, V20, P137, DOI 10.1007/s10552-008-9225-7; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Gao Y, 2013, HUM GENET, V132, P649, DOI 10.1007/s00439-013-1276-5; GOEDDE HW, 1992, HUM GENET, V88, P344; Gu HY, 2012, EXP THER MED, V4, P135, DOI 10.3892/etm.2012.547; Gu JY, 2014, ARCH MED RES, V45, P76, DOI 10.1016/j.arcmed.2013.10.002; Guo YM, 2008, WORLD J GASTROENTERO, V14, P1444, DOI 10.3748/wjg.14.1444; Hashimoto T, 2006, TUMOR BIOL, V27, P334, DOI 10.1159/000096126; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hiraki A, 2007, CANCER SCI, V98, P1087, DOI 10.1111/j.1349-7006.2007.00505.x; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hiyama T, 2008, INT J ONCOL, V32, P945; Hori H, 1997, J CLIN GASTROENTEROL, V25, P568, DOI 10.1097/00004836-199712000-00003; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Ji YB, 2011, ORAL ONCOL, V47, P583, DOI 10.1016/j.oraloncology.2011.04.007; Jo SA, 2007, CLIN CHIM ACTA, V382, P43, DOI 10.1016/j.cca.2007.03.016; Kanda J, 2009, CANCER SCI, V100, P296, DOI 10.1111/j.1349-7006.2008.01044.x; Katoh T, 1999, INT J CANCER, V83, P606, DOI 10.1002/(SICI)1097-0215(19991126)83:5<606::AID-IJC6>3.3.CO;2-G; Kawase T, 2009, J EPIDEMIOL, V19, P244, DOI 10.2188/jea.JE20081035; Kuriki Kiyonori, 2005, Asian Pac J Cancer Prev, V6, P62; Li DP, 2008, CLIN CHEM LAB MED, V46, P323, DOI 10.1515/CCLM.2008.073; Li QD, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-74; Liu P, 2012, GENET MOL RES, V11, P3497, DOI 10.4238/2012.September.26.5; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matsuo K, 2006, CARCINOGENESIS, V27, P1018, DOI 10.1093/carcin/bgi282; Matsuo K, 2001, CARCINOGENESIS, V22, P913, DOI 10.1093/carcin/22.6.913; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Matsuo K, 2012, EUR J CANCER PREV, V21, P193, DOI 10.1097/CEJ.0b013e32834c9be5; Matsuo Keitaro, 2002, J Epidemiol, V12, P70; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Miyasaka K, 2010, GERIATR GERONTOL INT, V10, pS120, DOI 10.1111/j.1447-0594.2010.00616.x; Munaka M, 2003, J CANCER RES CLIN, V129, P355, DOI 10.1007/s00432-003-0439-5; Oikawa T, 2010, SCAND J GASTROENTERO, V45, P1338, DOI 10.3109/00365521.2010.495419; Otani T, 2005, NUTR CANCER, V53, P42, DOI 10.1207/s15327914nc5301_5; Oze I, 2011, JPN J CLIN ONCOL, V41, P677, DOI 10.1093/jjco/hyr026; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Park JY, 2010, CARCINOGENESIS, V31, P660, DOI 10.1093/carcin/bgq021; Sakamoto T, 2006, INT J CANCER, V118, P1501, DOI 10.1002/ijc.21505; Sangrajrang S, 2010, BREAST CANCER RES TR, V123, P885, DOI 10.1007/s10549-010-0804-4; Scoccianti C, 2013, FUTURE ONCOL, V9, P1315, DOI 10.2217/fon.13.94; Seitz HK, 2007, TRANSL RES, V149, P293, DOI 10.1016/j.trsl.2006.12.002; Shin CM, 2011, INT J EPIDEMIOL, V40, P1047, DOI 10.1093/ije/dyr067; Takeshita T, 2000, CANCER LETT, V149, P69, DOI 10.1016/S0304-3835(99)00343-2; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Terry MB, 2007, CANCER CAUSE CONTROL, V18, P1039, DOI 10.1007/s10552-007-9046-0; Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25; Wang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088779; Wang YL, 2011, ASIAN PAC J CANCER P, V12, P2065; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu CF, 2005, WORLD J GASTROENTERO, V11, P5103, DOI 10.3748/wjg.v11.i33.5103; Wu M, 2013, INT J CANCER, V132, P1868, DOI 10.1002/ijc.27803; Xue P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045849; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Yang SJ, 2007, WORLD J GASTROENTERO, V13, P5760, DOI 10.3748/wjg.v13.i43.5760; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yin G, 2007, CANCER SCI, V98, P1248, DOI 10.1111/j.1349-7006.2007.00519.x; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yu SZ, 2002, JPN J CANCER RES, V93, P1287, DOI 10.1111/j.1349-7006.2002.tb01236.x; Zhang GH, 2010, WORLD J GASTROENTERO, V16, P6020, DOI 10.3748/wjg.v16.i47.6020; Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088656	77	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117173	10.1371/journal.pone.0117173	http://dx.doi.org/10.1371/journal.pone.0117173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680115	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600054
J	Camerini, AL; Schulz, PJ				Camerini, Anne-Linda; Schulz, Peter J.			Health Literacy and Patient Empowerment: Separating Con-joined Twins in the Context of Chronic Low Back Pain	PLOS ONE			English	Article							CULTURAL-ADAPTATION; COMMUNICATION; CARE; VALIDATION; OUTCOMES; MODEL	Objectives While health literacy has been widely considered key to patient empowerment, an alternative approach separates both concepts and distinguishes between dif-ferent types of patients according to their levels of health literacy and empowerment. These types are deemed to vary in their health-related actions and outcomes. In this study, we exam-ine the relationship between health literacy and patient empowerment and compare socio-demographic characteristics, health-related activities, and health outcomes in four types of patients suffering from chronic low back pain (cLBP). Methods In a cross-sectional study, 273 cLBP patients from four Swiss can-tons (Vaud, Geneva, Fribourg, Ticino) and Lombardy (Italy) were invited by their healthcare providers to complete a self-administered paper-and-pencil questionnaire which assessed pa-tients' health literacy, empowerment, involvement in the medical encounter, medication non-adherence, and perceived pain and functionality as a measure of health outcomes. Results Health literacy and patient empowerment were not significantly correlated with each other, r(271) = .09, p > .05, allowing to differentiate be-tween four types of patients based on their levels of health literacy and patient empowerment. Subsequent chi-square tests and analyses of variances revealed significant differences among patients that could, however, only be attributed to health literacy, as in the case of age and ed-ucational attainment, or patient empowerment, as in the case of patients' involvement in the medical encounter. No significant differences were evident for gender, medication non-adherence, and health outcomes. Conclusion The study provides empirical evidence for the need to consider health literacy and patient empowerment as independent concepts in the context of cLBP but calls for further studies to be able to conclude on how the two concepts interact and determine health-related activities and outcomes.	[Camerini, Anne-Linda; Schulz, Peter J.] Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Camerini, AL (corresponding author), Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland.	anne.linda.camerini@usi.ch	Schulz, Peter/GQQ-1290-2022; Schulz, Peter/AAM-9816-2020	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X; Camerini, Anne-Linda/0000-0002-2316-6228	Swiss National Science Foundation [FN 130030]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (Grant number: FN 130030). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LL, 2004, J PAIN SYMPTOM MANAG, V27, P440, DOI 10.1016/j.jpainsymman.2003.10.009; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; Diviani N, 2014, J PUBLIC HEALTH RES, V3, P92, DOI 10.4081/jphr.2014.295; Dubowicz A, 2013, PATIENT EDUC COUNS, V93, P224, DOI 10.1016/j.pec.2013.06.024; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Frisch AL, 2012, HEALTH PROMOT INT, V27, P117, DOI 10.1093/heapro/dar043; Ishikawa H, 2008, HEALTH EXPECT, V11, P113, DOI 10.1111/j.1369-7625.2008.00497.x; Londono AMM, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-12; Maciel SC, 2009, CLINICS, V64, P1167, DOI 10.1590/S1807-59322009001200006; Maetzel A, 2002, BEST PRACT RES CL RH, V16, P23, DOI 10.1053/berh.2001.0204; Menon ST, 2002, NURS EDUC TODAY, V22, P28, DOI 10.1054/nedt.2001.0721; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; Nunez M, 2006, QUAL LIFE RES, V15, P93, DOI 10.1007/s11136-005-0448-8; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Roter D, 2006, DOCTORS TALKING PATI, DOI [10.1016/j.jalz.2006.06.001, DOI 10.1016/J.JALZ.2006.06.001]; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Schulz PJ, 2012, SCI ENV HLTH RENEWED, P69, DOI [10.1002/pmh.1213, DOI 10.1002/PMH.1213]; SCHWARTZ L, 1991, PAIN, V44, P61, DOI 10.1016/0304-3959(91)90148-Q; Sidani S, 2010, RES NURS HEALTH, V33, P133, DOI 10.1002/nur.20364; Smith MY, 2006, J PAIN SYMPTOM MANAG, V32, P71, DOI 10.1016/j.jpainsymman.2006.01.007; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; THOMAS KW, 1990, ACAD MANAGE REV, V15, P666, DOI 10.2307/258687; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; World Health Organization, 1998, HLTH PROM GLOSS	41	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118032	10.1371/journal.pone.0118032	http://dx.doi.org/10.1371/journal.pone.0118032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25680195	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600104
J	Feng, J; Li, SS; Chen, HW				Feng, Jun; Li, Shusheng; Chen, Huawen			Impacts of Stress, Self-Efficacy, and Optimism on Suicide Ideation among Rehabilitation Patients with Acute Pesticide Poisoning	PLOS ONE			English	Article							DISPOSITIONAL OPTIMISM; EXPLANATORY STYLE; LIFE STRESS; SYMPTOMS; HEALTH; FIT; HOPELESSNESS; DEPRESSION; DISTRESS; MEDIATOR	Background The high incidence of pesticide ingestion as a means to commit suicide is a critical public health problem. An important predictor of suicidal behavior is suicide ideation, which is related to stress. However, studies on how to defend against stress-induced suicidal thoughts are limited. Objective This study explores the impact of stress on suicidal ideation by investigating the mediating effect of self-efficacy and dispositional optimism. Methods Direct and indirect (via self-efficacy and dispositional optimism) effects of stress on suicidal ideation were investigated among 296 patients with acute pesticide poisoning from four general hospitals. For this purpose, structural equation modeling (SEM) and bootstrap method were used. Results Results obtained using SEM and bootstrap method show that stress has a direct effect on suicide ideation. Furthermore, self-efficacy and dispositional optimism partially weakened the relationship between stress and suicidal ideation. Conclusion The final model shows a significant relationship between stress and suicidal ideation through self-efficacy or dispositional optimism. The findings extended prior studies and provide enlightenment on how self-efficacy and optimism prevents stress-induced suicidal thoughts.	[Feng, Jun; Li, Shusheng; Chen, Huawen] Huazhong Univ Sci & Technol, Dept Emergency Med, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Chen, HW (corresponding author), Huazhong Univ Sci & Technol, Dept Emergency Med, Tongji Hosp, Wuhan 430074, Peoples R China.	elleuzh434@163.com						ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; AUSBROOKS EP, 1995, HEALTH VAL, V19, P46; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1; Benight CC, 2002, J TRAUMA STRESS, V15, P177, DOI 10.1023/A:1015295025950; Bryan CJ, 2013, COGNITIVE THER RES, V37, P996, DOI 10.1007/s10608-013-9536-1; Carver CS, 2014, TRENDS COGN SCI, V18, P293, DOI 10.1016/j.tics.2014.02.003; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Cauberghe V, 2009, ACCIDENT ANAL PREV, V41, P276, DOI 10.1016/j.aap.2008.11.006; Cohen S., 1983, ENCY BEHAV MED, V24, P386, DOI 10.1007/978-1-4419-1005-9_773; Conversano Ciro, 2010, Clin Pract Epidemiol Ment Health, V6, P25, DOI 10.2174/1745017901006010025; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; FONTAINE KR, 1993, EUR J PERSONALITY, V7, P267, DOI 10.1002/per.2410070407; Freire C, 2013, INT J HYG ENVIR HEAL, V216, P445, DOI 10.1016/j.ijheh.2012.12.003; FRIEDMAN LC, 1992, J BEHAV MED, V15, P127, DOI 10.1007/BF00848321; Hassanian-Moghaddam H, 2011, BRIT J PSYCHIAT, V198, P309, DOI 10.1192/bjp.bp.109.067199; He F, 2014, SOC INDIC RES, V119, P897, DOI 10.1007/s11205-013-0519-0; He Fei, 2013, PLoS One, V8, pe82939, DOI 10.1371/journal.pone.0082939; Hirsch JK, 2006, SUICIDE LIFE-THREAT, V36, P661, DOI 10.1521/suli.2006.36.6.661; Hirsch JK, 2009, CRISIS, V30, P48, DOI 10.1027/0227-5910.30.1.48; Horwitz Adam G, 2011, J Adolesc, V34, P1077, DOI 10.1016/j.adolescence.2010.10.004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jex SM, 2001, J APPL PSYCHOL, V86, P401, DOI 10.1037//0021-9010.86.3.401; Jobin J, 2013, HEALTH PSYCHOL; Kim HJ, 2012, HUM EXP TOXICOL, V31, P751, DOI 10.1177/0960327111431709; King KA, 2011, J SCHOOL HEALTH, V81, P581, DOI 10.1111/j.1746-1561.2011.00630.x; LEWIS JW, 1980, SCIENCE, V208, P623, DOI 10.1126/science.7367889; Lian PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087152; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Magaletta PR, 1999, J CLIN PSYCHOL, V55, P539, DOI 10.1002/(SICI)1097-4679(199905)55:5<539::AID-JCLP2>3.3.CO;2-7; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Alhija FNA, 2006, STRUCT EQU MODELING, V13, P204, DOI 10.1207/s15328007sem1302_3; Peng JX, 2016, J HEALTH PSYCHOL, V21, P50, DOI 10.1177/1359105314521478; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Rogers WM, 2004, MULTIVAR BEHAV RES, V39, P379, DOI 10.1207/S15327906MBR3903_1; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Thomas JL, 2011, J CLIN PSYCHOL, V67, P866, DOI 10.1002/jclp.20809; Till B, 2011, J MEDIA PSYCHOL-GER, V23, P149, DOI 10.1027/1864-1105/a000048; Tucker RP, 2013, PERS INDIV DIFFER, V55, P606, DOI 10.1016/j.paid.2013.05.013; Valois RF, 2015, J CHILD FAM STUD, V24, P237, DOI 10.1007/s10826-013-9829-8; van Hoving DJ, 2011, AFR J EMERG MED, V1, P69, DOI 10.1016/j.afjem.2011.07.006; Wenzel A, 2011, J AFFECT DISORDERS, V132, P375, DOI 10.1016/j.jad.2011.03.006; Wesseling C, 2010, OCCUP ENVIRON MED, V67, P778, DOI 10.1136/oem.2009.047266; Xiao W, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-8; YANG B, 1994, SUICIDE LIFE-THREAT, V24, P127; Zhang JL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1555-8; Zhang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096451; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174	52	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118011	10.1371/journal.pone.0118011	http://dx.doi.org/10.1371/journal.pone.0118011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679994	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600102
J	Fujita, M; Watanabe, S; Yoshizawa, M; Yamamoto, J; Iwai, S				Fujita, Masashi; Watanabe, Shun; Yoshizawa, Mariko; Yamamoto, Junpei; Iwai, Shigenori			Analysis of Structural Flexibility of Damaged DNA Using Thiol-Tethered Oligonucleotide Duplexes	PLOS ONE			English	Article							INTRASTRAND CROSS-LINK; ANTICANCER DRUG CISPLATIN; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; ABASIC SITE; DODECAMER DUPLEX; 6-4 PHOTOPRODUCT; MAJOR ADDUCT; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTION	Bent structures are formed in DNA by the binding of small molecules or proteins. We developed a chemical method to detect bent DNA structures. Oligonucleotide duplexes in which two mercaptoalkyl groups were attached to the positions facing each other across the major groove were prepared. When the duplex contained the cisplatin adduct, which was proved to induce static helix bending, interstrand disulfide bond formation under an oxygen atmosphere was detected by HPLC analyses, but not in the non-adducted duplex, when the two thiol-tethered nucleosides were separated by six base pairs. When the insert was five and seven base pairs, the disulfide bond was formed and was not formed, respectively, regardless of the cisplatin adduct formation. The same reaction was observed in the duplexes containing an abasic site analog and the (6-4) photoproduct. Compared with the cisplatin case, the disulfide bond formation was slower in these duplexes, but the reaction rate was nearly independent of the linker length. These results indicate that dynamic structural changes of the abasic site- and (6-4) photoproduct-containing duplexes could be detected by our method. It is strongly suggested that the UV-damaged DNA-binding protein, which specifically binds these duplexes and functions at the first step of global-genome nucleotide excision repair, recognizes the easily bendable nature of damaged DNA.	[Fujita, Masashi; Watanabe, Shun; Yoshizawa, Mariko; Yamamoto, Junpei; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Div Chem, Toyonaka, Osaka 5608531, Japan	Osaka University	Iwai, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Chem, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	iwai@chem.es.osaka-u.ac.jp			Japan Society for the Promotion of Science [24310158]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research (24310158) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to SI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi L, 2000, J BIOMOL STRUCT DYN, V17, P645, DOI 10.1080/07391102.2000.10506555; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Beger RD, 1998, J BIOL CHEM, V273, P15565, DOI 10.1074/jbc.273.25.15565; BELLON SF, 1990, BIOPHYS CHEM, V35, P179, DOI 10.1016/0301-4622(90)80007-T; Blair RH, 2012, BIOCHEMISTRY-US, V51, P7444, DOI 10.1021/bi300491j; BORER PN, 1975, HDB BIOCH MOL BIOL N, V1, P589; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chen JY, 2007, BIOCHEMISTRY-US, V46, P3096, DOI 10.1021/bi6024269; Chiba J, 2014, CHEM COMMUN, V50, P11126, DOI 10.1039/c4cc04513k; Cline SD, 1999, BIOCHEMISTRY-US, V38, P15500, DOI 10.1021/bi991750s; Coppel Y, 1997, BIOCHEMISTRY-US, V36, P4817, DOI 10.1021/bi962677y; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Curuksu J, 2008, NUCLEIC ACIDS RES, V36, P2268, DOI 10.1093/nar/gkm1135; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; GOLJER I, 1995, J BIOL CHEM, V270, P22980, DOI 10.1074/jbc.270.39.22980; Hoehn ST, 2001, NUCLEIC ACIDS RES, V29, P3413, DOI 10.1093/nar/29.16.3413; Iwai S, 1999, NUCLEIC ACIDS RES, V27, P2299, DOI 10.1093/nar/27.11.2299; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; KAHN JD, 1994, NATURE, V368, P163, DOI 10.1038/368163a0; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; MANOHARAN M, 1994, GENE, V149, P147, DOI 10.1016/0378-1119(94)90423-5; MANOHARAN M, 1993, BIOORG MED CHEM LETT, V3, P2765, DOI 10.1016/S0960-894X(01)80760-5; Marathias VM, 1999, NUCLEIC ACIDS RES, V27, P1854, DOI 10.1093/nar/27.8.1854; Mizukoshi T, 2001, NUCLEIC ACIDS RES, V29, P4948, DOI 10.1093/nar/29.24.4948; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Park S, 2012, BIOCHEMISTRY-US, V51, P6728, DOI 10.1021/bi300649v; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shi XS, 2014, P NATL ACAD SCI USA, V111, pE1473, DOI 10.1073/pnas.1317032111; Spector TI, 1997, J AM CHEM SOC, V119, P7095, DOI 10.1021/ja964372c; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Todd RC, 2010, J INORG BIOCHEM, V104, P902, DOI 10.1016/j.jinorgbio.2010.04.005; Tsutakawa SE, 2012, MECH AGEING DEV, V133, P195, DOI 10.1016/j.mad.2011.11.009; Tubbs JL, 2010, CELL MOL LIFE SCI, V67, P3749, DOI 10.1007/s00018-010-0405-8; Wang KY, 1997, BIOCHEMISTRY-US, V36, P11629, DOI 10.1021/bi971464l; Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Wu YB, 2007, BIOCHEMISTRY-US, V46, P6477, DOI 10.1021/bi062291f; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	50	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117798	10.1371/journal.pone.0117798	http://dx.doi.org/10.1371/journal.pone.0117798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679955	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600088
J	Kepten, E; Weron, A; Sikora, G; Burnecki, K; Garini, Y				Kepten, Eldad; Weron, Aleksander; Sikora, Grzegorz; Burnecki, Krzysztof; Garini, Yuval			Guidelines for the Fitting of Anomalous Diffusion Mean Square Displacement Graphs from Single Particle Tracking Experiments	PLOS ONE			English	Article							BROWNIAN-MOTION; SUBDIFFUSION; MEMBRANE; DYNAMICS; MODELS	Single particle tracking is an essential tool in the study of complex systems and biophysics and it is commonly analyzed by the time-averaged mean square displacement (MSD) of the diffusive trajectories. However, past work has shown that MSDs are susceptible to significant errors and biases, preventing the comparison and assessment of experimental studies. Here, we attempt to extract practical guidelines for the estimation of anomalous time averaged MSDs through the simulation of multiple scenarios with fractional Brownian motion as a representative of a large class of fractional ergodic processes. We extract the precision and accuracy of the fitted MSD for various anomalous exponents and measurement errors with respect to measurement length and maximum time lags. Based on the calculated precision maps, we present guidelines to improve accuracy in single particle studies. Importantly, we find that in some experimental conditions, the time averaged MSD should not be used as an estimator.	[Kepten, Eldad; Garini, Yuval] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Kepten, Eldad; Garini, Yuval] Bar Ilan Univ, Inst Nanotechnol, Ramat Gan, Israel; [Weron, Aleksander; Sikora, Grzegorz; Burnecki, Krzysztof] Wroclaw Univ Technol, Inst Math & Comp Sci, Hugo Steinhaus Ctr, PL-50370 Wroclaw, Poland	Bar Ilan University; Bar Ilan University; Wroclaw University of Science & Technology	Kepten, E (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	eldad.kepten@biu.ac.il		Burnecki, Krzysztof/0000-0002-1754-4472; Garini, Yuval/0000-0002-8783-2015; kepten, eldad/0000-0002-0341-5290; Sikora, Grzegorz/0000-0002-7951-2660; Weron, Aleksander/0000-0002-8584-9876	Israel Centers of Research Excellence (ICORE) [1902/12]; Israel Science Foundation [51/12]; NCN Maestro [2012/06/A/ST1/00258]	Israel Centers of Research Excellence (ICORE); Israel Science Foundation(Israel Science Foundation); NCN Maestro	E. Kepten and Y. Garini were supported in part by the Israel Centers of Research Excellence (ICORE) No. 1902/12, and Israel Science Foundation No. 51/12. K. Burnecki, G. Sikora and A. Weron were supported by the NCN Maestro Grant No. 2012/06/A/ST1/00258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abry P, 1996, APPL COMPUT HARMON A, V3, P377, DOI 10.1006/acha.1996.0030; Albert B, 2013, J CELL BIOL, V202, P201, DOI 10.1083/jcb.201208186; Andreanov A, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/07/P07001; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Berglund AJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011917; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Burnecki K, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/10/P10036; Burnecki K, 2012, BIOPHYS J, V103, P1839, DOI 10.1016/j.bpj.2012.09.040; Burnecki K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021130; Burov S, 2011, PHYS CHEM CHEM PHYS, V13, P1800, DOI 10.1039/c0cp01879a; Cherstvy AG, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083039; Condamin S, 2008, P NATL ACAD SCI USA, V105, P5675, DOI 10.1073/pnas.0712158105; Courtland RE, 2003, J PHYS-CONDENS MAT, V15, pS359, DOI 10.1088/0953-8984/15/1/349; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Grebenkov DS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031124; Jeon JH, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816635; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jeon JH, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/25/252001; Kepten E, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041919; Kepten E, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052713; Klafter J, 1996, PHYS TODAY, V49, P33, DOI 10.1063/1.881487; Lin BH, 2000, PHYS REV E, V62, P3909, DOI 10.1103/PhysRevE.62.3909; Magdziarz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.180602; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; Michalet X, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061916; Nicolau DV, 2007, BIOPHYS J, V92, P1975, DOI 10.1529/biophysj.105.076869; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Sako Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100100; Saxton M, 2009, FUNDAMENTAL CONCEPTS, P1; SAXTON MJ, 1990, BIOPHYS J, V58, P1303, DOI 10.1016/S0006-3495(90)82470-X; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Shav-Tal Y, 2004, NAT REV MOL CELL BIO, V5, P855, DOI 10.1038/nrm1494; Sokolov IM, 2012, SOFT MATTER, V8, P9043, DOI 10.1039/c2sm25701g; Tejedor V, 2010, BIOPHYS J, V98, P1364, DOI 10.1016/j.bpj.2009.12.4282; Vestergaard CL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022726; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; Xu JY, 1998, RHEOL ACTA, V37, P387, DOI 10.1007/s003970050125	46	88	89	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117722	10.1371/journal.pone.0117722	http://dx.doi.org/10.1371/journal.pone.0117722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680069	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600081
J	Kessinger, CW; Kim, JW; Henke, PK; Thompson, B; McCarthy, JR; Hara, T; Sillesen, M; Margey, RJP; Libby, P; Weissleder, R; Lin, CP; Jaffer, FA				Kessinger, Chase W.; Kim, Jin Won; Henke, Peter K.; Thompson, Brian; McCarthy, Jason R.; Hara, Tetsuya; Sillesen, Martin; Margey, Ronan J. P.; Libby, Peter; Weissleder, Ralph; Lin, Charles P.; Jaffer, Farouc A.			Statins Improve the Resolution of Established Murine Venous Thrombosis: Reductions in Thrombus Burden and Vein Wall Scarring	PLOS ONE			English	Article							INFERIOR VENA-CAVA; IN-VIVO; POSTTHROMBOTIC SYNDROME; ENDOTHELIAL-CELLS; MOUSE MODELS; EXPRESSION; MICE; INFLAMMATION; INHIBITION; ROSUVASTATIN	Despite anticoagulation therapy, up to one-half of patients with deep vein thrombosis (DVT) will develop the post-thrombotic syndrome (PTS). Improving the long-term outcome of DVT patients at risk for PTS will therefore require new approaches. Here we investigate the effects of statins-lipid-lowering agents with anti-thrombotic and anti-inflammatory properties -in decreasing thrombus burden and decreasing vein wall injury, mediators of PTS, in established murine stasis and non-stasis chemical-induced venous thrombosis (N = 282 mice). Treatment of mice with daily atorvastatin or rosuvastatin significantly reduced stasis venous thrombus burden by 25% without affecting lipid levels, blood coagulation parameters, or blood cell counts. Statin-driven reductions in VT burden (thrombus mass for stasis thrombi, intravital microscopy thrombus area for non-stasis thrombi) compared similarly to the therapeutic anticoagulant effects of low molecular weight heparin. Blood from statin-treated mice showed significant reductions in platelet aggregation and clot stability. Statins additionally reduced thrombus plasminogen activator inhibitor-1 (PAI-1), tissue factor, neutrophils, myeloperoxidase, neutrophil extracellular traps (NETs), and macrophages, and these effects were most notable in the earlier timepoints after DVT formation. In addition, statins reduced DVT-induced vein wall scarring by 50% durably up to day 21 in stasis VT, as shown by polarized light microscopy of picrosirius red-stained vein wall collagen. The overall results demonstrate that statins improve VT resolution via profibrinolytic, anticoagulant, antiplatelet, and anti-vein wall scarring effects. Statins may therefore offer a new pharmacotherapeutic approach to improve DVT resolution and to reduce the post-thrombotic syndrome, particularly in subjects who are ineligible for anticoagulation therapy.	[Kessinger, Chase W.; Kim, Jin Won; Hara, Tetsuya; Margey, Ronan J. P.; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Cardiovasc Res Ctr, Boston, MA 02163 USA; [Kim, Jin Won] Korea Univ, Guro Hosp, Multimodal Imaging & Theranost Lab, Ctr Cardiovasc, Seoul, South Korea; [Henke, Peter K.] Univ Michigan, Dept Surg, Vasc Surg Sect, Ann Arbor, MI 48109 USA; [Thompson, Brian; Lin, Charles P.; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [McCarthy, Jason R.; Weissleder, Ralph; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA USA; [McCarthy, Jason R.; Weissleder, Ralph; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Sillesen, Martin] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Korea University; Korea University Medicine (KU Medicine); University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Jaffer, FA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Cardiovasc Res Ctr, Boston, MA 02163 USA.	fjaffer@mgh.harvard.edu	Jaffer, Farouc/AAK-8803-2020; Libby, Peter/AAY-6404-2021; Margey, Ronan/AAE-3746-2022	Jaffer, Farouc/0000-0001-7980-384X; Libby, Peter/0000-0002-1502-502X; Sillesen, Martin/0000-0001-9494-5475; /0000-0003-0828-4143	Merck, Ltd.; Kowa, Ltd.; U.S. National Institutes of Health (NIH) [R01 HL108229, T32 HL076136, UO1-HL080731]; American Heart Association Scientist Development Grant [0830352N, 13GRNT17060040]; Howard Hughes Medical Institute Early Career Award; Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122208, R01HL108229, U01HL080731, T32HL076136, R01HL122388] Funding Source: NIH RePORTER	Merck, Ltd.; Kowa, Ltd.; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); Howard Hughes Medical Institute Early Career Award(Howard Hughes Medical Institute); Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	F. Jaffer, Research Support, Merck and Kowa, Ltd. This research was supported in part by grants from the U.S. National Institutes of Health (NIH R01 HL108229, F.A.J.); T32 HL076136 (C.W.K).; and UO1-HL080731, (R.W., J.R.M., and P.L.); by an American Heart Association Scientist Development Grant (#0830352N, F.A.J.) and Grant-In-Aid (#13GRNT17060040, F.A.J.), by a Howard Hughes Medical Institute Early Career Award (F.A.J.), and by the Cardiovascular Research Foundation (J.W.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2006, J VASC SURG, V43, P601, DOI 10.1016/j.jvs.2005.10.073; Baldwin MJ, 2013, J THROMB HAEMOST, V11, P795, DOI 10.1111/jth.12180; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bourcier T, 2000, ARTERIOSCL THROM VAS, V20, P556, DOI 10.1161/01.ATV.20.2.556; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Chang K, 2010, ARTERIOSCL THROM VAS, V30, P1933, DOI 10.1161/ATVBAHA.110.206342; Chitsike RS, 2012, J THROMB HAEMOST, V10, P2039, DOI 10.1111/j.1538-7836.2012.04872.x; Deroo S, 2010, THROMB HAEMOSTASIS, V104, DOI [10.1160/TH10-05-0328, DOI 10.1160/TH10-05-0328]; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Diaz JA, 2010, THROMB HAEMOSTASIS, V104, P366, DOI 10.1160/TH09-09-0672; Duszak R, 2011, J AM COLL RADIOL, V8, P483, DOI 10.1016/j.jacr.2010.12.021; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Gertz K, 2003, STROKE, V34, P551, DOI 10.1161/01.STR.0000054055.28435.BF; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Guenther F, 2013, J THROMB HAEMOST, V11, P1154, DOI 10.1111/jth.12206; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Henke PK, 2011, J VASC SURG, V53, P500, DOI 10.1016/j.jvs.2010.08.050; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Hull RD, 2013, THROMB HAEMOSTASIS, V110, DOI [10.1160/TH13-10-0886, DOI 10.1160/TH13-10-0886]; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jaffer FA, 2002, ARTERIOSCL THROM VAS, V22, P1929, DOI 10.1161/01.ATV.0000033089.56970.2D; Jaffer FA, 2004, CIRCULATION, V110, P170, DOI 10.1161/01.CIR.0000134484.11052.44; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2011, THROMB RES, V127, pS89, DOI 10.1016/S0049-3848(11)70024-X; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Koopman K, 2009, THROMB RES, V124, P185, DOI 10.1016/j.thromres.2008.12.032; Mackman N, 2004, THROMB HAEMOSTASIS, V92, P440, DOI 10.1160/TH04-07-0414; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; Matsuno H, 2002, THROMB HAEMOSTASIS, V87, P98; Ni R, 2012, ARTERIOSCL THROM VAS, V32, P2609, DOI 10.1161/ATVBAHA.112.300090; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Obi AT, JOURNAL OF VASCULAR, V2; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Patterson KA, 2013, THROMB RES, V131, P268, DOI 10.1016/j.thromres.2012.12.006; Pignatelli P, 2012, CIRCULATION, V126, P92, DOI 10.1161/CIRCULATIONAHA.112.095554; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quartermain D, 2007, NEUROL RES, V29, P469, DOI 10.1179/016164107X164102; Rahimi K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001310; Ripplinger CM, 2012, ARTERIOSCL THROM VAS, V32, P2616, DOI 10.1161/ATVBAHA.112.251983; Rodriguez AL, 2012, J THROMB THROMBOLYS, V33, P371, DOI 10.1007/s11239-012-0687-9; Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sood V, 2010, THROMB HAEMOSTASIS, V104, P1174, DOI 10.1160/TH10-03-0184; Spiezia L, 2008, BLOOD COAGUL FIBRIN, V19, P355, DOI 10.1097/MBC.0b013e328309044b; Taqueti VR, 2013, INTEGR BIOL-UK, V5, P278, DOI 10.1039/c2ib20194a; Thorson CM, 2012, CRIT CARE MED, V40, P2967, DOI 10.1097/CCM.0b013e31825bcb60; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; Varma MR, 2003, J VASC SURG, V38, P1090, DOI 10.1016/S0741-5214(03)00431-2; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Violi F, 2013, CIRCULATION, V127, P251, DOI 10.1161/CIRCULATIONAHA.112.145334; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322	62	40	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116621	10.1371/journal.pone.0116621	http://dx.doi.org/10.1371/journal.pone.0116621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680183	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600027
J	Seok, J				Seok, Junhee			Evidence-Based Translation for the Genomic Responses of Murine Models for the Study of Human Immunity	PLOS ONE			English	Article							GENE-EXPRESSION; ANIMAL-MODELS; HUMAN-DISEASE; MOUSE MODELS	Murine models are an essential tool to study human immune responses and related diseases. However, the use of traditional murine models has been challenged by recent systemic surveys that show discordance between human and model immune responses in their gene expression. This is a significant problem in translational biomedical research for human immunity. Here, we describe evidence-based translation (EBT) to improve the analysis of genomic responses of murine models in the translation to human immune responses. Based on evidences from prior experiments, EBT introduces pseudo variances, penalizes gene expression changes in a model experiment, and finally detects false positive translations of model genomic responses that poorly correlate with human responses. Demonstrated over multiple data sets, EBT significantly improves the agreement of overall responses (up to 56%), experiment-specific responses (up to 143%), and enriched biological contexts (up to 100%) between human and model systems. In addition, we provide the category of genes specifically benefiting from EBT and the factors affecting the performance of EBT. The overall result indicates the usefulness of the proposed computational translation in biomedical research for human immunity using murine models.	Korea Univ, Sch Elect Engn, Seoul, South Korea	Korea University	Seok, J (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	jseok14@korea.ac.kr			National Research Foundation of Korea(NRF) - Korea government(MEST) [NRF-2014R1A1A2A16050527]	National Research Foundation of Korea(NRF) - Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	his work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST) (No. NRF-2014R1A1A2A16050527). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048979; Anvar SY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002258; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bushberg JT, 2012, ESSENTIAL PHYS MED I; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gelman A., 2004, BAYESIAN DATA ANAL; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nabhan AR, 2014, J BIOMED INFORM, V47, P178, DOI 10.1016/j.jbi.2013.10.011; Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Takao K, 2014, P NATL ACAD SCI US; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Winslow RL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003528; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118017	10.1371/journal.pone.0118017	http://dx.doi.org/10.1371/journal.pone.0118017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680113	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600103
J	Yoshimatsu, G; Sakata, N; Tsuchiya, H; Minowa, T; Takemura, T; Morita, H; Hata, T; Fukase, M; Aoki, T; Ishida, M; Motoi, F; Naitoh, T; Katayose, Y; Egawa, S; Unno, M				Yoshimatsu, Gumpei; Sakata, Naoaki; Tsuchiya, Haruyuki; Minowa, Takashi; Takemura, Taro; Morita, Hiromi; Hata, Tatsuo; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Egawa, Shinichi; Unno, Michiaki			The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation	PLOS ONE			English	Article							SEVERE ACUTE-PANCREATITIS; GRAFT-SURVIVAL; PORTAL-VEIN; RAT ISLETS; LIVER; MODEL; LIPOTOXICITY	Aims/Hypothesis Although the muscle is one of the preferable transplant sites in islet transplantation, its transplant efficacy is poor. Here we attempted to determine whether an intramuscular co-transplantation of mesenchymal stem cells (MSCs) could improve the outcome. Methods We co-cultured murine islets with MSCs and then analyzed the morphological changes, viability, insulin-releasing function (represented by the stimulation index), and gene expression of the islets. We also transplanted 500 islets intramuscularly with or without 5 x 10(5) MSCs to diabetic mice and measured their blood glucose level, the glucose changes in an intraperitoneal glucose tolerance test, and the plasma IL-6 level. Inflammation, apoptosis, and neovascularization in the transplantation site were evaluated histologically. Results The destruction of islets tended to be prevented by co-culture with MSCs. The stimulation index was significantly higher in islets co-cultured with MSCs (1.78 +/- 0.59 vs. 7.08 +/- 2.53; p = 0.0025). In terms of gene expression, Sult1c2, Gstm1, and Rab37 were significantly upregulated in islets co-cultured with MSCs. Although MSCs were effective in the in vitro assays, they were only partially effective in facilitating intramuscular islet transplantation. Co-transplanted MSCs prevented an early inflammatory reaction from the islets (plasma IL-6; p = 0.0002, neutrophil infiltration; p = 0.016 inflammatory area; p = 0.021), but could not promote neovascularization in the muscle, resulting in the failure of many intramuscular transplanted islets to engraft. Conclusions In conclusion, co-culturing and co-transplanting MSCs is potentially useful in islet transplantation, especially in terms of anti-inflammation, but further augmentation for an anti-apoptosis effect and neovascularization is necessary.	[Yoshimatsu, Gumpei; Sakata, Naoaki; Tsuchiya, Haruyuki; Hata, Tatsuo; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan; [Minowa, Takashi; Takemura, Taro; Morita, Hiromi] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki, Japan; [Katayose, Yu] Tohoku Univ Hosp, Div Integrated Surg & Oncol, Sendai, Miyagi, Japan; [Egawa, Shinichi] Tohoku Univ, Div Int Cooperat Disaster Med, Sendai, Miyagi 980, Japan	Tohoku University; National Institute for Materials Science; Tohoku University; Tohoku University	Sakata, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan.	n-sakata@surg1.med.tohoku.ac.jp	Naitoh, Takeshi/K-1693-2014; Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020; Sakata, Naoaki/H-4738-2019; Egawa, Shinichi/S-4055-2019	Naitoh, Takeshi/0000-0003-4169-6334; Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416; Sakata, Naoaki/0000-0002-3495-4270; Egawa, Shinichi/0000-0002-1115-4932; Minowa, Takashi/0000-0003-0046-5230	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390253, 22390252]; Challenging Exploratory Research [24659582]; Gonryo Medical Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gonryo Medical Foundation; Suzuken Memorial Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (B: 22390253 (SE); B: 22390252 to YK); Challenging Exploratory Research: 24659582 (to NS), the Gonryo Medical Foundation, and the Suzuken Memorial Foundation (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Beattie GM, 2000, CELL TRANSPLANT, V9, P431, DOI 10.1177/096368970000900314; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Brunt Keith R., 2007, V139, P197; Dadbinpour A, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-48; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Florina P, 2007, ENDOCRIN METAB CLIN, V36, P999, DOI 10.1016/j.ecl.2007.07.004; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Griscelli F, 2012, AM J PATHOL, V180, P2084, DOI 10.1016/j.ajpath.2012.01.011; Hematti P, 2013, TRANSPLANT REV-ORLAN, V27, P21, DOI 10.1016/j.trre.2012.11.003; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Kawahara T, 2011, AM J TRANSPLANT, V11, P2700, DOI 10.1111/j.1600-6143.2011.03717.x; KEMP CB, 1973, NATURE, V244, P447, DOI 10.1038/244447a0; Kim HI, 2010, J KOREAN MED SCI, V25, P203, DOI 10.3346/jkms.2010.25.2.203; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; Lee Y, 2007, DIABETES, V56, P2295, DOI 10.2337/db07-0460; Leitao CB, 2010, DIABETES CARE, V33, P658, DOI 10.2337/dc09-1387; Ljubicic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068255; Lund T, 2010, J SURG RES, V160, P145, DOI 10.1016/j.jss.2008.11.009; Maffi P, 2013, DIABETES, V62, P3523, DOI 10.2337/db13-0465; Meng HB, 2013, INT J CLIN EXP PATHO, V6, P2703; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mojibian M, 2013, DIABETOLOGIA, V56, P2213, DOI 10.1007/s00125-013-3004-z; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Paul P, 2012, ANAL BIOANAL CHEM, V403, P1491, DOI 10.1007/s00216-012-5944-4; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Sakata N, 2009, TRANSPL P, V41, P346, DOI 10.1016/j.transproceed.2008.08.155; Sakata N, 2008, PANCREAS, V36, P417, DOI 10.1097/MPA.0b013e31815ccad2; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Sakata N, 2013, TRANSPLANTATION, V96, pE38, DOI 10.1097/TP.0b013e3182a01333; Sakata N, 2011, WORLD J GASTROENTERO, V17, P5150, DOI 10.3748/wjg.v17.i47.5150; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Sakata N, 2009, ISLETS, V1, P26, DOI 10.4161/isl.1.1.8563; Stagner JI, 2007, J PANCREAS, V8, P628; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; Tu XH, 2012, WORLD J GASTROENTERO, V18, P2270, DOI 10.3748/wjg.v18.i18.2270; Yoshimatsu G, 2013, TRANSPL P, V45, P1875, DOI 10.1016/j.transproceed.2013.01.043	44	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117561	10.1371/journal.pone.0117561	http://dx.doi.org/10.1371/journal.pone.0117561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679812	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600073
J	Zhang, J; Fan, SK; Du, XM; Yang, JC; Wang, WY; Hou, H				Zhang, Juan; Fan, Shukai; Du, Xiaoming; Yang, Juncheng; Wang, Wenyan; Hou, Hong			Accumulation, Allocation, and Risk Assessment of Polycyclic Aromatic Hydrocarbons (PAHs) in Soil-Brassica chinensis System	PLOS ONE			English	Article							FRASER-RIVER BASIN; SEDIMENTS; VEGETABLES; CHROMATOGRAPHY; VEGETATION; STRAIT; CROPS; CHINA; COAL	Farmland soil and leafy vegetables accumulate more polycyclic aromatic hydrocarbons (PAHs) in suburban sites. In this study, 13 sampling areas were selected from vegetable fields in the outskirts of Xi'an, the largest city in northwestern China. The similarity of PAH composition in soil and vegetation was investigated through principal components analysis and redundancy analysis (RDA), rather than discrimination of PAH congeners from various sources. The toxic equivalent quantity of PAHs in soil ranged from 7 to 202 mu g/kg d.w., with an average of 41 mu g/kg d.w., which exceeded the agricultural/horticultural soil acceptance criteria for New Zealand. However, the cancer risk level posed by combined direct ingestion, dermal contact, inhalation of soil particles, and inhalation of surface soil vapor met the rigorous international criteria (1x10(-6)). The concentration of total PAHs was (1052 +/- 73) mu g/kg d.w. in vegetation (mean +/- standard error). The cancer risks posed by ingestion of vegetation ranged from 2x10(-5) to 2x10(-4) with an average of 1.66x10(-4), which was higher than international excess lifetime risk limits for carcinogens (1x10(-4)). The geochemical indices indicated that the PAHs in soil and vegetables were mainly from vehicle and crude oil combustion. Both the total PAHs in vegetation and bioconcentration factor for total PAHs (the ratio of total PAHs in vegetation to total PAHs in soil) increased with increasing pH as well as decreasing sand in soil. The total variation in distribution of PAHs in vegetation explained by those in soil reached 98% in RDA, which was statistically significant based on Monte Carlo permutation. Common pollution source and notable effects of soil contamination on vegetation would result in highly similar distribution of PAHs in soil and vegetation.	[Zhang, Juan; Du, Xiaoming; Wang, Wenyan; Hou, Hong] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Zhang, Juan] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Fan, Shukai] Beijing Gen Res Inst Min & Met, Inst Environm Engn, Beijing, Peoples R China; [Yang, Juncheng] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Chinese Research Academy of Environmental Sciences; University of Science & Technology Beijing; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Hou, H (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	houhong@craes.org.cn	Zhang, Juan/E-5475-2016	Zhang, Juan/0000-0002-9405-9024	Postdoctoral Science Foundation of China [2013M530686]; National Basic Research Program of China [2013CB127406]; Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment [SKLECRA2013OFP04]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment	This work was sponsored by the Postdoctoral Science Foundation of China (No. 2013M530686), the National Basic Research Program of China (2013CB127406), and the Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment (No. SKLECRA2013OFP04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai C, 2012, J ENVIRON MONITOR, V14, P3111, DOI 10.1039/c2em30554b; Carlon C., 2007, 22805EN EUR JOINT RE; Cavanagh JA, 2006, COMP SOIL GUIDELINE, P1; CCME, CAN SOIL QUAL GUID C, P235; Chin C.R., 2014, GUIDELINES RISK ASSE, P1; Connor J.A., 2007, SOFTWARE GUIDANCE MA, P1; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Dionex, 2007, ENVIRON CHEM, V27, P721; Doong RA, 2004, WATER RES, V38, P1733, DOI 10.1016/j.watres.2003.12.042; Grimalt JO, 2004, ENVIRON POLLUT, V131, P13, DOI 10.1016/j.envpol.2004.02.024; [郭伟 GUO Wei], 2007, [环境科学学报, Acta Scientiae Circumstantiae], V27, P824; He FP, 2009, J ENVIRON SCI-CHINA, V21, P675, DOI 10.1016/S1001-0742(08)62323-2; He LL, 2008, ENVIRON POLLUT, V156, P769, DOI 10.1016/j.envpol.2008.06.003; Khan S, 2012, J SOIL SEDIMENT, V12, P178, DOI 10.1007/s11368-011-0427-3; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Leps J, 2003, MULTIVARIATE ANAL EC; Ling WT, 2009, SOIL BIOL BIOCHEM, V41, P2187, DOI 10.1016/j.soilbio.2009.08.003; Liu JJ, 2012, J ENVIRON MONITOR, V14, P2634, DOI 10.1039/c2em30433c; Liu Y, 2008, ENVIRON POLLUT, V154, P298, DOI 10.1016/j.envpol.2007.10.020; Lu R, 2000, ANAL METHODS AGROCHE; [梅凡民 MEI Fanmin], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P223; Nadal M, 2004, ENVIRON POLLUT, V132, P1, DOI 10.1016/j.envpol.2004.04.003; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Northcott GL, 2001, ENVIRON SCI TECHNOL, V35, P1103, DOI 10.1021/es000071y; Okuda T, 2010, SCI TOTAL ENVIRON, V408, P1909, DOI 10.1016/j.scitotenv.2010.01.040; Orecchio S, 2009, J HAZARD MATER, V164, P876, DOI 10.1016/j.jhazmat.2008.08.083; Oyo-Ita OE, 2013, ENVIRON GEOCHEM HLTH, V35, P185, DOI 10.1007/s10653-012-9475-x; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Richter BE, 2000, J CHROMATOGR A, V874, P217, DOI 10.1016/S0021-9673(00)00073-X; Rocher V, 2004, SCI TOTAL ENVIRON, V323, P107, DOI 10.1016/j.scitotenv.2003.10.010; Sany SBT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094907; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; US EPA, 2007, 3051A USEPA, V3, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; USEPA, 2010, REG NEW ACT INGR AM, P1; USEPA (United States Environmental Protection Agency), 2007, TECHNICAL RESOURCE D, P1; Vacha R, 2010, PLANT SOIL ENVIRON, V56, P434, DOI 10.17221/7/2010-PSE; Van de Weghe H, 2006, J CHROMATOGR A, V1137, P91, DOI 10.1016/j.chroma.2006.10.014; Voutsa D, 1998, SCI TOTAL ENVIRON, V218, P203, DOI 10.1016/S0048-9697(98)00206-X; Wagrowski DM, 1997, ENVIRON SCI TECHNOL, V31, P279, DOI 10.1021/es960419i; Wang XC, 2006, MAR POLLUT BULL, V52, P129, DOI 10.1016/j.marpolbul.2005.08.010; Wang Y, 2012, SCI TOTAL ENVIRON, V439, P187, DOI 10.1016/j.scitotenv.2012.08.018; WILD SR, 1992, ENVIRON POLLUT, V76, P25, DOI 10.1016/0269-7491(92)90113-O; WILD SR, 1994, WASTE MANAGE RES, V12, P49, DOI 10.1177/0734242X9401200106; You SJ, 1999, SCI TOTAL ENVIRON, V227, P155, DOI 10.1016/S0048-9697(99)00024-8; Yunker MB, 1999, SCI TOTAL ENVIRON, V225, P181, DOI 10.1016/S0048-9697(98)00362-3; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0; Zhai F. Y., 2008, LONGITUDINAL STUDY C; Zhang J, 2013, SCI TOTAL ENVIRON, V463, P1, DOI 10.1016/j.scitotenv.2013.05.066	50	20	23	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115863	10.1371/journal.pone.0115863	http://dx.doi.org/10.1371/journal.pone.0115863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679782	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600010
J	Lee, IT; Liu, SW; Chi, PL; Lin, CC; Hsiao, LD; Yang, CM				Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Lin, Chih-Chung; Hsiao, Li-Der; Yang, Chuen-Mao			TNF-alpha Mediates PKC delta/JNK1/2/c-Jun-Dependent Monocyte Adhesion via ICAM-1 Induction in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; SIGNALING PATHWAYS; EXPRESSION; INFLAMMATION; MOLECULE-1; ACTIVATION; MOTILITY; DISEASES; STRESS	Retinal inflammatory diseases induced by cytokines, such as tumor necrosis factor-alpha (TNF-alpha) are associated with an up-regulation of intercellular adhesion molecule-1 (ICAM-1) in the retinal pigment epithelial cells (RPECs). Retinal pigment epithelium (RPE) is a monolayer of epithelial cells that forms the outer blood-retinal barrier in the posterior segment of the eye, and is also implicated in the pathology of, such as neovascularization in age-related macular degeneration (AMD). However, the detailed mechanisms of TNF-alpha-induced ICAM-1 expression are largely unclear in human RPECs. We demonstrated that in RPECs, TNF-alpha could induce ICAM-1 protein and mRNA expression and promoter activity, and monocyte adhesion. TNF-alpha-mediated responses were attenuated by pretreatment with the inhibitor of PKCs (Ro318220), PKC delta (Rottlerin), MEK1/2 (U0126), JNK1/2 (SP600125), or AP-1 (Tanshinone IIA) and transfection with siRNA of TNFR1, TRAF2, JNK2, p42, or c-Jun. We showed that TNF-alpha could stimulate the TNFR1 and TRAF2 complex formation. TNF-alpha stimulated JNK1/2 was also reduced by Rottlerin or SP600125. However, Rottlerin had no effect on TNF-alpha-induced p42/p44 MAPK phosphorylation. We observed that TNF-alpha induced c-Jun phosphorylation which was inhibited by Rottlerin or SP600125. On the other hand, TNF-alpha-stimulated ICAM-1 promoter activity was prominently lost in RPECs transfected with the point-mutated AP-1 ICAM-1 promoter plasmid. These results suggest that TNF-alpha-induced ICAM-1 expression and monocyte adhesion is mediated through a TNFR1/TRAF2/PKC delta/JNK1/2/c-Jun pathway in RPECs. These findings concerning TNF-alpha induced ICAM-1 expression in RPECs imply that TNF-alpha might play an important role in ocular inflammation and diseases.	[Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Ageing Res Ctr, Taoyuan, Taiwan; [Lin, Chih-Chung] Chang Gung Univ, Chang Gung Mem Hosp Lin Kou, Dept Anesthet, Taoyuan, Taiwan; [Lin, Chih-Chung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.	chuenmao@mail.cgu.edu.tw		Chi, Belinda/0000-0003-0332-6682; Yang, Chuen-Mao/0000-0002-3208-5438; Lee, I-Te/0000-0003-2665-3635	National Science Council, Taiwan [NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, NSC101-2314-B-182-182A-112]; Ministry of Education, Taiwan [EMRPD1C0261, EMRPD1C0271]; Chang Gung Medical Research Foundation, Taiwan [CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPG3B1092, CMRPG3C1301]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, and NSC101-2314-B-182-182A-112 from National Science Council, Taiwan; EMRPD1C0261 and EMRPD1C0271 from Ministry of Education, Taiwan; and CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPG3B1092 and CMRPG3C1301 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2011, CLIN EXP ALLERGY, V41, P149, DOI 10.1111/j.1365-2222.2010.03658.x; bdala-Valencia H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041054, DOI 10.1371/JOURNAL.PONE.0041054]; Ding RQ, 2011, J CARDIOVASC PHARM T, V16, P160, DOI 10.1177/1074248410382106; Giansanti V, 2013, J CELL MOL MED, V17, P103, DOI 10.1111/j.1582-4934.2012.01652.x; Huang XB, 2012, PHARM BIOL, V50, P1111, DOI 10.3109/13880209.2012.658476; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee CW, 2011, J CELL PHYSIOL, V226, P2103, DOI 10.1002/jcp.22537; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee IT, 2010, J CELL PHYSIOL, V224, P454, DOI 10.1002/jcp.22142; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Mullins RF, 2006, MOL VIS, V12, P224; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	20	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117911	10.1371/journal.pone.0117911	http://dx.doi.org/10.1371/journal.pone.0117911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675437	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000037
J	Oathes, DJ; Hilt, LM; Nitschke, JB				Oathes, Desmond J.; Hilt, Lori M.; Nitschke, Jack B.			Affective Neural Responses Modulated by Serotonin Transporter Genotype in Clinical Anxiety and Depression	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ANTERIOR CINGULATE; AMYGDALA ACTIVITY; GENETIC-VARIATION; PROMOTER REGION; ACTIVATION; DISORDER; BRAIN; POLYMORPHISM; UNCERTAINTY	Serotonin transporter gene variants are known to interact with stressful life experiences to increase chances of developing affective symptoms, and these same variants have been shown to influence amygdala reactivity to affective stimuli in non-psychiatric populations. The impact of these gene variants on affective neurocircuitry in anxiety and mood disorders has been studied less extensively. Utilizing a triallelic assay (5-HTTLPR and rs25531) to assess genetic variation linked with altered serotonin signaling, this fMRI study investigated genetic influences on amygdala and anterior insula activity in 50 generalized anxiety disorder patients, 26 of whom also met DSM-IV criteria for social anxiety disorder and/or major depressive disorder, and 39 healthy comparison subjects. A Group x Genotype interaction was observed for both the amygdala and anterior insula in a paradigm designed to elicit responses in these brain areas during the anticipation of and response to aversive pictures. Patients who are S/L-G carriers showed less activity than their L-A/L-A counterparts in both regions and less activity than S/L-G healthy comparison subjects in the amygdala. Moreover, patients with greater insula responses reported higher levels of intolerance of uncertainty, an association that was particularly pronounced for patients with two L-A alleles. A genotype effect was not established in healthy controls. These findings link the serotonin transporter gene to affective circuitry findings in anxiety and depression psychopathology and further suggest that its impact on patients may be different from effects typically observed in healthy populations.	[Oathes, Desmond J.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Hilt, Lori M.] Lawrence Univ, Dept Psychol, Appleton, WI 54912 USA; [Nitschke, Jack B.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Nitschke, Jack B.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Stanford University; Lawrence University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Oathes, DJ (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	desmond.oathes@gmail.com	Oathes, Desmond/X-4088-2019; Oathes, Desmond/AAW-3048-2021	Oathes, Desmond/0000-0001-7346-2669; 	National Institute of Mental Health [F32-MH081667, R01-MH74847, K02-MH082130, K08-MH63984]; National Institute of Child Health and Human Development [P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074847, K08MH063984, K02MH082130, T32MH018931] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health [F32-MH081667 to DJO and R01-MH74847, K02-MH082130, and K08-MH63984 to JBN]; and by a core grant to the Waisman Center from the National Institute of Child Health and Human Development [P30-HD03352]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Barlow D., 2001, ANXIETY ITS DISORDER, V2; Bauernfeind AL, 2013, J HUM EVOL, V64, P263, DOI 10.1016/j.jhevol.2012.12.003; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Caspi Avshalom, 2010, Am J Psychiatry, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Debiec J, 2014, P NATL ACAD SCI USA, V111, P12222, DOI 10.1073/pnas.1316740111; Domschke K, 2006, INT J NEUROPSYCHOPH, V9, P349, DOI 10.1017/S1461145705005869; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Friedel E, 2009, PSYCHOPHARMACOLOGY, V205, P261, DOI 10.1007/s00213-009-1536-1; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Goldstein AN, 2013, J NEUROSCI, V33, P10607, DOI 10.1523/JNEUROSCI.5578-12.2013; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Grupe DW, 2013, CEREB CORTEX, V23, P1874, DOI 10.1093/cercor/bhs175; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kalin NH, 2008, MOL PSYCHIATR, V13, P1021, DOI 10.1038/mp.2008.37; Keedwell PA, 2010, J AFFECT DISORDERS, V120, P120, DOI 10.1016/j.jad.2009.04.031; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Lau JYF, 2009, BIOL PSYCHIAT, V65, P349, DOI 10.1016/j.biopsych.2008.08.037; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lim JE, 2006, MOL PSYCHIATR, V11, P649, DOI 10.1038/sj.mp.4001797; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917; Mueller A, 2011, NEUROPSYCHOPHARMACOL, V36, P1332, DOI 10.1038/npp.2011.11; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Nemeroff CB, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-202, 10.1186/1741-7015-11-132]; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Nitschke JB, 2001, COGNITIVE THER RES, V25, P1, DOI 10.1023/A:1026485530405; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Somerville LH, 2013, CEREB CORTEX, V23, P49, DOI 10.1093/cercor/bhr373; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Whalen PJ, 2008, BIOL PSYCHIAT, V63, P858, DOI 10.1016/j.biopsych.2007.08.019; Williams LM, 2009, NEUROIMAGE, V47, P804, DOI 10.1016/j.neuroimage.2009.05.009	67	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115820	10.1371/journal.pone.0115820	http://dx.doi.org/10.1371/journal.pone.0115820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675343	Green Published, Green Submitted, gold			2022-12-27	WOS:000349914000005
J	Hsu, CT; Jacobs, AM; Altmann, U; Conrad, M				Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike; Conrad, Markus			The Magical Activation of Left Amygdala when Reading Harry Potter: An fMRI Study on How Descriptions of Supra-Natural Events Entertain and Enchant	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN MECHANISMS; METAANALYSIS; EMOTION; NETWORK; FICTION; SYSTEM; COMPREHENSION; SIMULATION; HEMISPHERE	Literature containing supra-natural, or magical events has enchanted generations of readers. When reading narratives describing such events, readers mentally simulate a text world different from the real one. The corresponding violation of world-knowledge during this simulation likely increases cognitive processing demands for ongoing discourse integration, catches readers' attention, and might thus contribute to the pleasure and deep emotional experience associated with ludic immersive reading. In the present study, we presented participants in an MR scanner with passages selected from the Harry Potter book series, half of which described magical events, while the other half served as control condition. Passages in both conditions were closely matched for relevant psycholinguistic variables including, e.g., emotional valence and arousal, passage-wise mean word imageability and frequency, and syntactic complexity. Post-hoc ratings showed that readers considered supra-natural contents more surprising and more strongly associated with reading pleasure than control passages. In the fMRI data, we found stronger neural activation for the supra-natural than the control condition in bilateral inferior frontal gyri, bilateral inferior parietal lobules, left fusiform gyrus, and left amygdala. The increased activation in the amygdala (part of the salience and emotion processing network) appears to be associated with feelings of surprise and the reading pleasure, which supra-natural events, full of novelty and unexpectedness, brought about. The involvement of bilateral inferior frontal gyri likely reflects higher cognitive processing demand due to world knowledge violations, whereas increased attention to supra-natural events is reflected in inferior frontal gyri and inferior parietal lobules that are part of the fronto-parietal attention network.	[Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike] Free Univ Berlin, Dept Educ & Psychol, D-14195 Berlin, Germany; [Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike; Conrad, Markus] Free Univ Berlin, Languages Emot, D-14195 Berlin, Germany; [Jacobs, Arthur M.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, D-14195 Berlin, Germany; [Conrad, Markus] Univ La Laguna, Dept Cognit Social & Org Psychol, San Cristobal De La Lagu 38205, Spain	Free University of Berlin; Free University of Berlin; Free University of Berlin; Universidad de la Laguna	Hsu, CT (corresponding author), Free Univ Berlin, Dept Educ & Psychol, D-14195 Berlin, Germany.	hsuchunting@gmail.com	Hsu, Chun-Ting/J-8874-2019; Conrad, Markus/N-3184-2014	Hsu, Chun-Ting/0000-0002-1829-6642; Conrad, Markus/0000-0003-1335-437X; Jacobs, Arthur/0000-0002-7910-3955	Deutsche Forschungsgemeinschaft (DFG); Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin [Project 201, Project 410]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin	This research was supported by two grants from Deutsche Forschungsgemeinschaft (DFG) to MC: "Bilingualism and Affectivity in Reading", Project 201 and "Sound-physiognomy in Language Organization, Processing and Production", Project 410 from the Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Altmann U, 2014, SOC COGN AFFECT NEUR, V9, P22, DOI 10.1093/scan/nss098; Altmann U, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00192; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bohrn IC, 2013, BRAIN LANG, V124, P1, DOI 10.1016/j.bandl.2012.10.003; Bohrn IC, 2012, NEUROPSYCHOLOGIA, V50, P2669, DOI 10.1016/j.neuropsychologia.2012.07.021; Bohrn IC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00204; Briesemeister BB, 2014, COGN AFFECT BEHAV NE; Briesemeister BB, 2014, BRAIN RES, V1564, P62, DOI 10.1016/j.brainres.2014.03.045; Briesemeister BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023743; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Citron FMM, 2014, J COGNITIVE NEUROSCI, V26, P2585, DOI 10.1162/jocn_a_00654; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Ewbank MP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00056; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Forgacs B, 2012, NEUROIMAGE, V63, P1432, DOI 10.1016/j.neuroimage.2012.07.029; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Graesser AC, 1997, ANNU REV PSYCHOL, V48, P163, DOI 10.1146/annurev.psych.48.1.163; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Harel A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00885; Herbert C, 2009, SOC COGN AFFECT NEUR, V4, P35, DOI 10.1093/scan/nsn027; Hsu CT, 2015, CORTEX, V63, P282, DOI 10.1016/j.cortex.2014.09.002; Hsu CT, 2014, NEUROREPORT, V25, P1356, DOI 10.1097/WNR.0000000000000272; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jacobs A. M., 2011, GEHIRN GEDICHT WIE W, P492; Jacobs AM, 2013, STIMMUNG METHODE; Jacobs AM, 2015, COGNITIVE NEUROSCIENCE OF NATURAL LANGUAGE USE, P135; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Kringelbach ML, 2008, INTERDISCIPL SCI REV, V33, P321, DOI 10.1179/174327908X392889; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leiner DJ, 2014, SOSCI SURVEY 2 4 00; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Menenti L, 2009, J COGNITIVE NEUROSCI, V21, P2358, DOI 10.1162/jocn.2008.21163; MIALL DS, 1994, POETICS, V22, P389, DOI 10.1016/0304-422X(94)00011-5; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nell V., 1988, LOST BOOK PSYCHOL RE; OATLEY K, 1995, POETICS, V23, P53, DOI 10.1016/0304-422X(94)P4296-S; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Raposo A, 2011, SOC COGN AFFECT NEUR, V6, P260, DOI 10.1093/scan/nsq033; Rowling, 2010, HARRY POTTER HALF BL; Rowling J. K., 2003, HARRY POTTER ORDER P; Rowling J. K., 1998, HARRY POTTER CHAMBER; Rowling J.K., 1997, HARRY POTTER PHILOSO, Vfirst; Rowling JK, 2007, HARRY POTTER DEATHLY, DOI [10.1093/jxb/erm028 PMID: 25506957, DOI 10.1093/JXB/ERM028]; Rowling JK, 2000, HARRY POTTER GOBLET; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; SCHMALHOFER F, 1986, J MEM LANG, V25, P279, DOI 10.1016/0749-596X(86)90002-1; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Schrott R, 2011, GEHIRN GEDICHT WIE W, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sharon T, 2004, BRIT J DEV PSYCHOL, V22, P293, DOI 10.1348/026151004323044627; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Subbotsky E, 2012, OPEN BEHAV SCI J, V6, P23; Subbotsky E, 2010, PERCEPT MOTOR SKILL, V111, P261, DOI 10.2466/04.09.11.PMS.111.4.261-277; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van Dijk T., 1983, STRATEGIES DISCOURSE; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viviani R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00746; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	89	23	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118179	10.1371/journal.pone.0118179	http://dx.doi.org/10.1371/journal.pone.0118179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671315	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300086
J	Carlsson, T; Bergman, G; Marttala, UM; Wadensten, B; Mattsson, E				Carlsson, Tommy; Bergman, Gunnar; Marttala, Ulla Melander; Wadensten, Barbro; Mattsson, Elisabet			Information following a Diagnosis of Congenital Heart Defect: Experiences among Parents to Prenatally Diagnosed Children	PLOS ONE			English	Article							DECISION-MAKING; HEALTH LITERACY; ULTRASOUND; PREGNANCY; INTERNET	Background Prenatal screening of pregnant women in Sweden has improved the detection of major congenital heart defects (CHD). The aim was to explore parental experiences and need for information following a prenatal diagnosis of CHD. Methods Semi-structured interviews conducted with six fathers and five mothers to seven prenatally diagnosed children. Data were analyzed through content analysis. Results Three themes and 9 categories emerged. Theme 1, Grasping the facts today while reflecting on the future, containing five categories: Difficulties sorting out information when in emotional chaos; Respectful information regarding termination of pregnancy; Early information is crucial; Understanding the facts regarding the anomaly; Preparing for the future. Theme 2, Personal contact with medical specialists who give honest and trustworthy information is valued, containing two categories: Trust in information received from medical specialists and Truth and honesty is valued. Theme 3, An overwhelming amount of information on the Internet, containing two categories: Difficulties in finding relevant information and Easy to focus on cases with a poor outcome when searching the Internet. Conclusion Early and honest information in line with individual preferences is crucial to support the decisional process regarding whether to continue or terminate the pregnancy. The use of illustrations is recommended, as a complement to oral information, as it increases comprehension and satisfaction with obtained information. Furthermore, the overwhelming amount of information on the Internet calls for compilation of easily accessible and reliable information sources via the Internet.	[Carlsson, Tommy; Wadensten, Barbro; Mattsson, Elisabet] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Bergman, Gunnar] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Marttala, Ulla Melander] Uppsala Univ, Dept Scandinavian Languages, Uppsala, Sweden; [Mattsson, Elisabet] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University; Uppsala University	Carlsson, T (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	tommy.carlsson@pubcare.uu.se		Carlsson, Tommy/0000-0003-4141-8692	foundation Riksbankens Jubileumsfond (RJ)	foundation Riksbankens Jubileumsfond (RJ)	Dr. Bergman was supported by the foundation Riksbankens Jubileumsfond (RJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman A, 2012, MIDWIFERY, V28, pE667, DOI 10.1016/j.midw.2011.07.008; [Anonymous], 2007, AUSTRAL ASIAN J CANC; Askelsdottir Bjork, 2008, Adv Neonatal Care, V8, P348, DOI 10.1097/01.ANC.0000342768.94734.23; Asplin N, 2012, SEX REPROD HEALTHC, V3, P73, DOI 10.1016/j.srhc.2011.12.002; Bergman Gunnar, 2008, Lakartidningen, V105, P899; Brosig CL, 2007, J PERINATOL, V27, P687, DOI 10.1038/sj.jp.7211807; Caldera K, 2013, FETAL DIAGN THER, V33, P61, DOI 10.1159/000339655; Cho RN, 2007, PRENATAL DIAG, V27, P463, DOI 10.1002/pd.1712; Erlen Judith A, 2004, Orthop Nurs, V23, P150, DOI 10.1097/00006416-200403000-00015; Fox Susannah, 2013, INFORM TRIAGE; Garcia J, 2002, BIRTH-ISS PERINAT C, V29, P225, DOI 10.1046/j.1523-536X.2002.00198.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Hedrick J, 2005, JOGNN-J OBST GYN NEO, V34, P732, DOI 10.1177/0884217505282020; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Ikemba CM, 2002, PEDIATRICS, V109, P419, DOI 10.1542/peds.109.3.419; Johnson A., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003716; Karlsson AM, 2014, SVENSKANS BESKRIVNIN, V33, P193; Lalor JG, 2007, BIRTH-ISS PERINAT C, V34, P80, DOI 10.1111/j.1523-536X.2006.00148.x; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lindau ST, 2002, AM J OBSTET GYNECOL, V186, P938, DOI 10.1067/mob.2002.122091; Massin MM, 2006, ACTA CARDIOL, V61, P406, DOI 10.2143/AC.61.4.2017300; Menahem Samuel, 2004, Heart Lung Circ, V13, P261, DOI 10.1016/j.hlc.2004.06.009; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Ohman SG, 2006, BIRTH-ISS PERINAT C, V33, P64; Patton M, 2002, QUALITATIVE RES EVAL, DOI [10.1111/zph.12179, DOI 10.1111/ZPH.12179]; Polkinghorne DE, 2005, J COUNS PSYCHOL, V52, P137, DOI 10.1037/0022-0167.52.2.137; Rempel GR, 2004, JOGNN, V33, P64, DOI 10.1177/0884217503261092; Sharland G, 2010, ARCH DIS CHILD-FETAL, V95, pF64, DOI 10.1136/adc.2008.151225; Swallow V, 2012, HEALTH EXPECT, V15, P157, DOI 10.1111/j.1369-7625.2011.00674.x; The Swedish Council for Technology Assessment, 1998, ROUT ULTR SCREEN PRE; Thomson G, 2013, MIDWIFERY, V29, P211, DOI 10.1016/j.midw.2012.01.002; Vandvik IH, 2000, ACTA PAEDIATR, V89, P1129, DOI 10.1080/713794571; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2	35	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117995	10.1371/journal.pone.0117995	http://dx.doi.org/10.1371/journal.pone.0117995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692879	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500089
J	Portilho, DM; Alves, MR; Kratassiouk, G; Roche, S; Magdinier, F; de Santana, EC; Polesskaya, A; Harel-Bellan, A; Mouly, V; Savino, W; Butler-Browne, G; Dumonceaux, J				Portilho, Debora Morueco; Alves, Marcelo Ribeiro; Kratassiouk, Gueorgui; Roche, Stephane; Magdinier, Frederique; de Santana, Eliane Correa; Polesskaya, Anna; Harel-Bellan, Annick; Mouly, Vincent; Savino, Wilson; Butler-Browne, Gillian; Dumonceaux, Julie			miRNA Expression in Control and FSHD Fetal Human Muscle Biopsies	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; TARGET GENES; MICRORNAS; D4Z4; HYPERTROPHY; MYOBLASTS; LOCATION; DISEASE; FAMILY	Background Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disorder and is one of the most common forms of muscular dystrophy. We have recently shown that some hallmarks of FSHD are already expressed in fetal FSHD biopsies, thus opening a new field of investigation for mechanisms leading to FSHD. As microRNAs (miRNAs) play an important role in myogenesis and muscle disorders, in this study we compared miRNAs expression levels during normal and FSHD muscle development. Methods Muscle biopsies were obtained from quadriceps of both healthy control and FSHD1 fetuses with ages ranging from 14 to 33 weeks of development. miRNA expression profiles were analyzed using TaqMan Human MicroRNA Arrays. Results During human skeletal muscle development, in control muscle biopsies we observed changes for 4 miRNAs potentially involved in secondary muscle fiber formation and 5 miRNAs potentially involved in fiber maturation. When we compared the miRNA profiles obtained from control and FSHD biopsies, we did not observe any differences in the muscle specific miRNAs. However, we identified 8 miRNAs exclusively expressed in FSHD1 samples (miR-330, miR-331-5p, miR-34a, miR-380-3p, miR-516b, miR-582-5p, miR-517* and miR-625) which could represent new biomarkers for this disease. Their putative targets are mainly involved in muscle development and morphogenesis. Interestingly, these FSHD1 specific miRNAs do not target the genes previously described to be involved in FSHD. Conclusions This work provides new candidate mechanisms potentially involved in the onset of FSHD pathology. Whether these FSHD specific miRNAs cause deregulations during fetal development, or protect against the appearance of the FSHD phenotype until the second decade of life still needs to be investigated.	[Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] Univ Paris 06, Sorbonne Univ, Ctr Res Myol, UM76, Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] INSERM, UMRS974, Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] CNRS, FRE 3617, F-75013 Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] Inst Myol, F-75013 Paris, France; [Portilho, Debora Morueco; Alves, Marcelo Ribeiro; de Santana, Eliane Correa; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, RJ, Brazil; [Alves, Marcelo Ribeiro] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST AIDS, Rio De Janeiro, RJ, Brazil; [Kratassiouk, Gueorgui] Univ Paris 11, CEA Saclay, CNRS, FRE 3377, Gif Sur Yvette, France; [Roche, Stephane; Magdinier, Frederique] Aix Marseille Univ, Fac Med Timone, INSERM, Lab Genet Med & Genom Fonctionnelle,UMRS 910, Marseille, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Dumonceaux, J (corresponding author), Univ Paris 06, Sorbonne Univ, Ctr Res Myol, UM76, Paris, France.	julie.dumonceaux@upmc.fr	Harel-Bellan, Annick/M-9795-2015; Roche, Stephane/B-6974-2009; Magdinier, Frederique/I-4735-2016; Mouly, Gillian/G-6595-2017	Roche, Stephane/0000-0001-6660-1317; Magdinier, Frederique/0000-0002-0159-9559; butler-browne, gillian/0000-0002-3431-242X; Ribeiro-Alves, Marcelo/0000-0002-8663-3364; Mouly, Vincent/0000-0003-3809-4033; Kratassiouk, Gueorgui/0000-0003-1174-004X; Harel-Bellan, Annick/0000-0002-2339-153X	FSH Society Delta Railroad Construction Company [FSHS-DRRC-2008]; Association Francaise contre les Myopathies (AFM-Telethon, France); Agence Nationale de la Recherche (FSHDecrypt) [ANR-09-GENO-038, ANR-13-BSV1-0004]; CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy [490272/2008-8]	FSH Society Delta Railroad Construction Company; Association Francaise contre les Myopathies (AFM-Telethon, France); Agence Nationale de la Recherche (FSHDecrypt)(French National Research Agency (ANR)); CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy	Research reported in this publication was supported by FSH Society Delta Railroad Construction Company Fellowship Grant to JD (FSHS-DRRC-2008; https://www.fshsociety.org), Association Francaise contre les Myopathies to JD and FM (AFM-Telethon, France; www.afm-telethon.fr), the Agence Nationale de la Recherche to SR, FM and JD(FSHDecrypt, ANR-09-GENO-038 and FSHDecipher, ANR-13-BSV1-0004; www.agencenationale-recherche.fr) and CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy to DMP, MRA, WS, VM and GBB (490272/2008-8; www.inserm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2013, ORPH REP SER 2013, V2013; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Attarian S, 2012, REV NEUROL-FRANCE, V168, P910, DOI 10.1016/j.neurol.2011.11.008; Barbet J. Patrick, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P585; BARBET JP, 1991, MECH DEVELOP, V35, P3, DOI 10.1016/0925-4773(91)90036-6; Basso D, 2009, STATISTICS, V194, P1; Brock M, 2014, EUR HEART J, V35, P3203, DOI 10.1093/eurheartj/ehs060; Broucqsault N, 2013, HUM MOL GENET, V22, P4206, DOI 10.1093/hmg/ddt272; BUTLERBROWNE GS, 1990, ANAT EMBRYOL, V181, P513; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Dmitriev P, 2013, J BIOL CHEM, V288, P34989, DOI 10.1074/jbc.M113.504522; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Ferreboeuf M, 2014, HUM MOL GENET, V23, P171, DOI 10.1093/hmg/ddt409; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Greco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039732; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Harafuji N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-55; He J, 2013, J INVEST MED, V61, P604, DOI [10.2310/JIM.0b013e3182819ac6, 10.231/JIM.0b013e3182819ac6]; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; KILMER DD, 1995, AM J PHYS MED REHAB, V74, pS131, DOI 10.1097/00002060-199509001-00007; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; LUNT PW, 1988, J NEUROL SCI, V88, P287, DOI 10.1016/0022-510X(88)90225-0; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reed PW, 2007, EXP NEUROL, V205, P583, DOI 10.1016/j.expneurol.2007.03.009; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Tang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028730; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; van der Maarel SM, 2012, CURR OPIN NEUROL, V25, P614, DOI 10.1097/WCO.0b013e328357f22d; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winston J, 2015, EUR J HUM GENET, V23, P67, DOI 10.1038/ejhg.2014.58	64	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116853	10.1371/journal.pone.0116853	http://dx.doi.org/10.1371/journal.pone.0116853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692472	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500025
J	Voda, R; Dapporto, L; Dinca, V; Vila, R				Voda, Raluca; Dapporto, Leonardo; Dinca, Vlad; Vila, Roger			Why Do Cryptic Species Tend Not to Co-Occur? A Case Study on Two Cryptic Pairs of Butterflies	PLOS ONE			English	Article							BIOTIC INTERACTIONS; REPRODUCTIVE INTERFERENCE; DISTRIBUTIONS; PATTERNS; BIOGEOGRAPHY; LEPIDOPTERA; MIGRATION; CLIMATE; PREDICTIONS; NESTEDNESS	As cryptic diversity is being discovered, mostly thanks to advances in molecular techniques, it is becoming evident that many of these taxa display parapatric distributions in mainland and that they rarely coexist on islands. Genetic landscapes, haplotype networks and ecological niche modeling analyses were performed for two pairs of non-sister cryptic butterfly species, Aricia agestis-A. cramera and Polyommatus icarus-P. celina (Lycaenidae), to specifically assess non-coexistence on western Mediterranean islands, and to test potential causes producing such chequered distribution patterns. We show that the morphologically and ecologically equivalent pairs of species do not coexist on any of the studied islands, although nearly all islands are colonized by one of them. According to our models, the cryptic pairs displayed marked climatic preferences and 'precipitation during the driest quarter' was recovered as the most important climatic determinant. However, neither dispersal capacity, nor climatic or ecological factors fully explain the observed distributions across particular sea straits, and the existence of species interactions resulting in mutual exclusion is suggested as a necessary hypothesis. Given that the studied species are habitat generalists, feeding on virtually unlimited resources, we propose that reproductive interference, together with climatic preferences, sustain density-dependent mechanisms like "founder takes all" and impede coexistence on islands. Chequered distributions among cryptic taxa, both sister and non-sister, are common in butterflies, suggesting that the phenomenon revealed here could be important in determining biodiversity patterns.	[Voda, Raluca; Dinca, Vlad; Vila, Roger] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Butterfly Divers & Evolut Lab, Barcelona, Spain; [Voda, Raluca] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Dapporto, Leonardo] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Dinca, Vlad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Autonomous University of Barcelona; Oxford Brookes University; University of Guelph	Vila, R (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Butterfly Divers & Evolut Lab, Barcelona, Spain.	roger.vila@csic.es	Vila, Roger/A-1817-2012; Dinca, Vlad Eugen/O-3879-2014; Voda, Raluca/E-6817-2015; Dapporto, Leonardo/E-5752-2010	Vila, Roger/0000-0002-2447-4388; Dinca, Vlad Eugen/0000-0003-1791-2148; Voda, Raluca/0000-0003-1970-5628; Dapporto, Leonardo/0000-0001-7129-4526	Spanish Ministerio de Economia y Competitividad [CGL2010-21226/BOS, CGL201348277-P]; Spanish Ministerio de Economia y Competitividad (predoctoral fellowship) [AP-2010-5409]; European Commission through Marie Curie International Outgoing Fellowship for Career Development [625997]; project "Barcoding Italian Butterflies"; project "Barcoding Butterflies of the Tuscan Archipelago National Park"	Spanish Ministerio de Economia y Competitividad(Spanish Government); Spanish Ministerio de Economia y Competitividad (predoctoral fellowship); European Commission through Marie Curie International Outgoing Fellowship for Career Development; project "Barcoding Italian Butterflies"; project "Barcoding Butterflies of the Tuscan Archipelago National Park"	Funding for this research was provided by the Spanish Ministerio de Economia y Competitividad (Projects CGL2010-21226/BOS and CGL201348277-P and a predoctoral fellowship to R. Voda, AP-2010-5409), by the European Commission through a Marie Curie International Outgoing Fellowship for Career Development to V. Dinca (project no. 625997), and by the projects "Barcoding Italian Butterflies" and "Barcoding Butterflies of the Tuscan Archipelago National Park." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biermann Heinrich, 1996, Atalanta (Marktleuthen), V27, P253; Blach-Overgaard A, 2010, ECOGRAPHY, V33, P380, DOI 10.1111/j.1600-0587.2010.06273.x; Boillat Harry, 2002, Alexanor, V22, P243; Borcard D, 2011, NUMERICAL ECOLOGY R, Vxi; Dapporto L, 2013, BIOL CONSERV, V157, P229, DOI 10.1016/j.biocon.2012.09.016; Dapporto L, 2012, DIVERS DISTRIB, V18, P1066, DOI 10.1111/j.1472-4642.2012.00903.x; Dapporto L, 2012, ORG DIVERS EVOL, V12, P39, DOI 10.1007/s13127-011-0065-z; Dapporto L, 2010, J ZOOL SYST EVOL RES, V48, P229, DOI 10.1111/j.1439-0469.2009.00550.x; Dasmahapatra KK, 2010, MOL ECOL, V19, P4283, DOI 10.1111/j.1365-294X.2010.04802.x; Dennis RLH, 2010, RESOURCE BASED HABIT, Vxii; Dennis RLH, 2012, J BIOGEOGR, V39, P1412, DOI 10.1111/j.1365-2699.2012.02698.x; Descimon Henri, 2009, P219; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2013, J EVOLUTION BIOL, V26, P2095, DOI 10.1111/jeb.12211; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Friberg M, 2013, J EVOLUTION BIOL, V26, P971, DOI 10.1111/jeb.12106; Friberg M, 2008, BEHAV ECOL SOCIOBIOL, V62, P873, DOI 10.1007/s00265-007-0511-2; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Grill A, 2013, CONTRIB ZOOL, V82, P27, DOI 10.1163/18759866-08201002; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KEDDY PA, 1992, FUNCT ECOL, V6, P621, DOI 10.2307/2389954; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kishi S, 2009, J ANIM ECOL, V78, P1043, DOI 10.1111/j.1365-2656.2009.01560.x; Kudrna Otakar, 2011, P1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Mallet J, 2010, ECOL ENTOMOL, V35, P90, DOI 10.1111/j.1365-2311.2009.01137.x; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nazari V, 2010, SYST ENTOMOL, V35, P132, DOI 10.1111/j.1365-3113.2009.00493.x; Ord TJ, 2011, EVOLUTION, V65, P2572, DOI 10.1111/j.1558-5646.2011.01319.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pianka E.R., 1979, P67; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Porter Adam H., 2009, P296; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Sammut P, 1984, NEUE ENTOMOLOGISCHE, V13, P1; Santos H, 2014, BIOL J LINN SOC, V112, P150, DOI 10.1111/bij.12247; Sanudo-Restrepo CP, 2013, MOL PHYLOGENET EVOL, V66, P369, DOI 10.1016/j.ympev.2012.10.010; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Talavera G, 2013, MOL PHYLOGENET EVOL, V69, P469, DOI 10.1016/j.ympev.2013.08.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrier MR, 2008, PAPILLONS JOUR MOROC; TENNENT WJ, 1996, BUTTERFLIES MOROCCO; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tobias JA, 2014, NATURE, V506, P359, DOI 10.1038/nature12874; Toews DPL, 2014, EVOLUTION, V68, P241, DOI 10.1111/evo.12260; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Vandergast AG, 2011, MOL ECOL RESOUR, V11, P158, DOI 10.1111/j.1755-0998.2010.02904.x; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wardle DA, 1998, J ECOL, V86, P405, DOI 10.1046/j.1365-2745.1998.00268.x; Wickman Per-Olof, 2009, P17; Wiemers M, 2010, EUR J ENTOMOL, V107, P325, DOI 10.14411/eje.2010.041; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zhou ZS, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1001	69	51	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117802	10.1371/journal.pone.0117802	http://dx.doi.org/10.1371/journal.pone.0117802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692577	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500076
J	Yamashita, M; Konishi, T; Sato, T				Yamashita, Momo; Konishi, Takuya; Sato, Tamaki			Sclerotic Rings in Mosasaurs (Squamata: Mosasauridae): Structures and Taxonomic Diversity	PLOS ONE			English	Article							CRETACEOUS BEARPAW FORMATION; PRESERVED SPECIMEN; SOUTHERN ALBERTA; NIOBRARA-CHALK; FEATURES; CANADA; PHYLOGENY; REPTILES; GENUS; EYE	Mosasaurs (Squamata: Mosasauridae) were a highly diverse, globally distributed group of aquatic lizards in the Late Cretaceous (98-66 million years ago) that exhibited a high degree of adaptation to life in water. To date, despite their rich fossil record, the anatomy of complete mosasaur sclerotic rings, embedded in the sclera of the eyeball, has not been thoroughly investigated. We here describe and compare sclerotic rings of four mosasaur genera, Tylosaurus, Platecarpus, Clidastes, and Mosasaurus, for the first time. Two specimens of Tylosaurus and Platecarpus share an exact scleral ossicle arrangement, excepting the missing portion in the specimen of Platecarpus. Furthermore, the exact arrangement and the total count of 14 ossicles per ring are shared between Tylosaurus and numerous living terrestrial lizard taxa, pertaining to both Iguania and Scleroglossa. In contrast, two species of Mosasaurus share the identical count of 12 ossicles and the arrangement with each other, while no living lizard taxa share exactly the same arrangement. Such a mosaic distribution of these traits both among squamates globally and among obligatorily aquatic mosasaurs specifically suggests that neither the ossicle count nor their arrangement played major roles in the aquatic adaptation in mosasaur eyes. All the mosasaur sclerotic rings examined consistently exhibit aperture eccentricity and the scleral ossicles with gently convex outer side. Hitherto unknown to any squamate taxa, one specimen of Platecarpus unexpectedly shows a raised, concentric band of roughened surface on the inner surface of the sclerotic ring. It is possible that one or both of these latter features may have related to adaptation towards aquatic vision in mosasaurs, but further quantitative study of extant reptilian clades containing both terrestrial and aquatic taxa is critical and necessary in order to understand possible adaptive significances of such osteological features.	[Yamashita, Momo; Sato, Tamaki] Tokyo Gakugei Univ, Dept Astron & Earth Sci, Koganei, Tokyo, Japan; [Konishi, Takuya] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada	Tokyo Gakugei University	Yamashita, M (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo, Japan.	myamashita@eps.s.u-tokyo.ac.jp						[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Brudenall DK, 2008, VET OPHTHALMOL, V11, P99, DOI 10.1111/j.1463-5224.2008.00607.x; Caldwell MW, 1996, ZOOL J LINN SOC-LOND, V116, P407, DOI 10.1006/zjls.1996.0027; Caldwell MW, 2002, AM J MED GENET, V112, P236, DOI 10.1002/ajmg.10773; Carroll Robert L., 1997, P467, DOI 10.1016/B978-012155210-7/50025-9; COULOMBRE AJ, 1973, DEV BIOL, V33, P257, DOI 10.1016/0012-1606(73)90136-X; Dollo L., 1889, B SOC BELG GEOL, V3, P271; EDINGER TILLY, 1929, ZOOL JAHRB ABT ANAT U ONTOGEN TIERE, V51, P163; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Everhart MJ, 2005, NETH J GEOSCI, V84, P231, DOI 10.1017/S0016774600021016; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Goldfuss A., 1845, NOVA ACTA ACAD CEASA, V21, P1; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Hattin DE, 1996, CRETACEOUS RES, V17, P443, DOI 10.1006/cres.1996.0027; Humphries S, 2002, J EXP BIOL, V205, P439; Jacobs LL, 2005, NETH J GEOSCI, V84, P257, DOI 10.1017/S0016774600021041; Kauffman E.G., 1977, Mountain Geologist, V14, P75; Konishi T, 2014, J VERTEBR PALEONTOL, V34, P802, DOI 10.1080/02724634.2014.838573; Konishi T, 2012, J VERTEBR PALEONTOL, V32, P1313, DOI 10.1080/02724634.2012.699811; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P1026, DOI 10.1080/02724634.2011.601714; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P754, DOI 10.1080/02724634.2011.579023; Konishi T, 2010, J VERTEBR PALEONTOL, V30, P1410, DOI 10.1080/02724634.2010.501464; Konishi T, 2009, J VERTEBR PALEONTOL, V29, P417, DOI 10.1671/039.029.0225; Land MF, 2002, ANIMAL EYES; LEMMRICH WERNER, 1931, JENAISCHE ZEITSCHR NATURWISS, V65, P513; Lima F.C., 2009, Brazilian Journal of Morphological Sciences, V26, P165; Lindgren J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3423; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Longrich N, 2010, ROYAL TYRR MUS CER S, P308; Marsh O.C., 1872, AM J SCI, V16, P290; Marsh O. C., 1880, AM J SCI, V109, P83; Martin G.R., 1994, P5; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; MCNEIL DH, 1984, CANADIAN SOC PETROLE, V9, P145; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; NATTIN D., 1982, BULLETIN, V225; NICHOLLS EL, 1988, THESIS U CALGARY CAL; Obradovich JD, 1993, EVOLUTION W INTERIOR, V39, P379; Ott M, 2006, J COMP PHYSIOL A, V192, P97, DOI 10.1007/s00359-005-0049-6; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Plisnier-Ladame F, 1969, Bull. Soc. belge Geol. Paleont. Hydrol., V78, P253; Romer A.S, 1956, OSTEOLOGY REPTILES; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; SIVAK J, 1987, PROC R SOC SER B-BIO, V229, P467, DOI 10.1098/rspb.1987.0005; Sivak J.G., 1975, P289; Sivak JG, 2004, INVEST OPHTH VIS SCI, V45, P740, DOI 10.1167/iovs.03-0466; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Torres-Carvajal O, 2003, J MORPHOL, V255, P94, DOI 10.1002/jmor.10051; Tsujita CJ, 1998, PALAEOGEOGR PALAEOCL, V144, P135, DOI 10.1016/S0031-0182(98)00090-X; TSUJITA CJ, 1995, PALAIOS, V10, P408, DOI 10.2307/3515044; UNDERWOOD G, 1970, BIOLOGY REPTILIA, V2, P1; Vikaryous MV, 2006, REV CRANIOFACIAL DEV, V235, P1244; Williston S. W., 1914, WATER REPTILES PRESE; WILLISTON SW, 1898, PALAEONTOLOGY, V4, P81	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117079	10.1371/journal.pone.0117079	http://dx.doi.org/10.1371/journal.pone.0117079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692667	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500037
J	Arnal, ME; Zhang, J; Erridge, C; Smidt, H; Lalles, JP				Arnal, Marie-Edith; Zhang, Jing; Erridge, Clett; Smidt, Hauke; Lalles, Jean-Paul			Maternal Antibiotic-Induced Early Changes in Microbial Colonization Selectively Modulate Colonic Permeability and Inducible Heat Shock Proteins, and Digesta Concentrations of Alkaline Phosphatase and TLR-Stimulants in Swine Offspring	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PHYSIOLOGICAL EXPRESSION; INTESTINAL PERMEABILITY; GASTROINTESTINAL-TRACT; LINKING INFLAMMATION; DIFFERENT REGIONS; BARRIER FUNCTION; GENE-EXPRESSION; GUT MICROBIOTA; HEAT-SHOCK-PROTEIN-25	Elevated intake of high energy diets is a risk factor for the development of metabolic diseases and obesity. High fat diets cause alterations in colonic microbiota composition and increase gut permeability to bacterial lipopolysaccharide, and subsequent low-grade chronic inflammation in mice. Chronic inflammatory bowel diseases are increasing worldwide and may involve alterations in microbiota-host dialog. Metabolic disorders appearing in later life are also suspected to reflect changes in early programming. However, how the latter affects the colon remains poorly studied. Here, we hypothesized that various components of colonic physiology, including permeability, ion exchange and protective inducible heat shock proteins (HSP) are influenced in the short-and long-terms by early disturbances in microbial colonization. The hypothesis was tested in a swine model. Offspring were born to control mothers (n = 12) or mothers treated with the antibiotic (ATB) amoxicillin around parturition (n = 11). Offspring were slaughtered between 14 and 42 days of age to study short-term effects. For long-term effects, young adult offspring from the same litters consumed a normal or a palm oil-enriched diet for 4 weeks between 140 and 169 days of age. ATB treatment transiently modified maternal fecal microbiota although the minor differences observed for offspring colonic microbiota were nonsignificant. In the short-term, consistently higher HSP27 and HSP70 levels and transiently increased horseradish peroxidase permeability in ATB offspring colon were observed. Importantly, long-term consequences included reduced colonic horseradish peroxidase permeability, and increased colonic digesta alkaline phosphatase (AP) and TLR2-and TLR4-stimulant concentrations in rectal digesta in adult ATB offspring. Inducible HSP27 and HSP70 did not change. Interactions between early ATB treatment and later diet were noted for paracellular permeability and concentrations of colonic digesta AP. In conclusion, our data suggest that early ATB-induced changes in bacterial colonization modulate important aspects of colonic physiology in the short- and longterms.	[Arnal, Marie-Edith; Lalles, Jean-Paul] INRA, Food & Digest, Cent & Behav Adaptat Dept, St Gilles, France; [Zhang, Jing; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Erridge, Clett] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England	INRAE; Wageningen University & Research; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Lalles, JP (corresponding author), INRA, Food & Digest, Cent & Behav Adaptat Dept, St Gilles, France.	jean-paul.lalles@rennes.inra.fr	Smidt, Hauke/D-7054-2014	Smidt, Hauke/0000-0002-6138-5026; Erridge, Clett/0000-0003-2978-346X; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]; INRA Human Nutrition Division; Region Bretagne, France; China Scholarship Council (CSC)	European Union(European Commission); INRA Human Nutrition Division; Region Bretagne, France(Region Bretagne); China Scholarship Council (CSC)(China Scholarship Council)	This work was financially supported by the European Union (contract No. 227549) through the Interplay project. The authors are solely responsible for the work described in this paper, and their opinions are not necessarily those of the European Union. MEA was the recipient of a PhD thesis grant from INRA Human Nutrition Division and the Region Bretagne, France which are acknowledged. JZ was supported by a PhD fellowship of the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; David JC, 2002, J NUTR, V132, P2551, DOI 10.1093/jn/132.9.2551; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; Fanca-Berthon P, 2010, J PEDIATR GASTR NUTR, V51, P402, DOI 10.1097/MPG.0b013e3181d75d52; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Heegaard PMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068110; Hu SE, 2010, AM J PHYSIOL-GASTR L, V299, pG1266, DOI 10.1152/ajpgi.00357.2010; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Keely S, 2012, GUT MICROBES, V3, P250, DOI [10.4161/gutmic.20529, 10.4161/gmic.20529]; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kojima K, 2004, AM J PHYSIOL-GASTR L, V286, pG645, DOI 10.1152/ajpgi.00080.2003; Kojima K, 2003, GASTROENTEROLOGY, V124, P1395, DOI 10.1016/S0016-5085(03)00215-4; Lalles JP, 2012, J ANIM SCI, V90, P421, DOI 10.2527/jas.53904; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lalles JP, 2012, J NUTR BIOCHEM, V23, P1490, DOI 10.1016/j.jnutbio.2011.10.001; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lalles JP, 2006, BRIT J NUTR, V95, P488, DOI 10.1079/BJN20051673; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Liu HY, 2014, AM J PHYSIOL-GASTR L, V306, pC1033, DOI 10.1152/ajpgi.00299.2013; Lopez-Posadas R, 2011, INFLAMM BOWEL DIS, V17, P543, DOI 10.1002/ibd.21381; Mani V, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-6; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Musch MW, 1999, GASTROENTEROLOGY, V117, P115, DOI 10.1016/S0016-5085(99)70557-3; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Perez Gutierrez O, 2010, THESIS WAGENINGEN U; Petrof EO, 2008, AM J PHYSIOL-GASTR L, V294, pG808, DOI 10.1152/ajpgi.00362.2007; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ren HY, 2001, GASTROENTEROLOGY, V121, P631, DOI 10.1053/gast.2001.27028; Reyns T, 2007, J VET PHARMACOL THER, V30, P550, DOI 10.1111/j.1365-2885.2007.00910.x; Ruel J, 2014, NAT REV GASTRO HEPAT, V11, P88, DOI 10.1038/nrgastro.2013.240; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Van Driessche W, 2007, AM J PHYSIOL-LUNG C, V293, pL520, DOI 10.1152/ajplung.00218.2007; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wallon C, 2009, ANN NY ACAD SCI, V1165, P206, DOI 10.1111/j.1749-6632.2009.04030.x; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581	52	22	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118092	10.1371/journal.pone.0118092	http://dx.doi.org/10.1371/journal.pone.0118092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689154	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700100
J	Borst, C; Xia, SQ; Bistrup, C; Tepel, M				Borst, Christoffer; Xia, Shengqiang; Bistrup, Claus; Tepel, Martin			Interleukin-8 Transcripts in Mononuclear Cells Determine Impaired Graft Function after Kidney Transplantation	PLOS ONE			English	Article							RENAL-ALLOGRAFTS; REPERFUSION; EXPRESSION; BIOMARKERS; INJURY; INHIBITION; CYTOKINES; MARKERS	Objective Interleukin-8 (IL-8) has been associated with ischemia reperfusion injury after renal allograft transplantation. Impaired allograft function may cause major impact on patient morbidity and health care costs. We investigated whether transcript levels in mononuclear cells including IL-8 on the first postoperative day may be involved in immediate allograft dysfunction as defined by reduced relative change in plasma creatinine at the first postoperative day. Methods We performed a single center, prospective-cohort study of 113 patients receiving kidney transplants. Peripheral blood mononuclear cells were harvested within 24 hours after transplantation. Transcripts were measured using quantitative RT-PCR. Results Transcript levels of IL-8 and S100A8 were significantly lower in patients with relative change in plasma creatinine less than 10% at the first postoperative day. Receiver-operator characteristic curves showed that IL-8 predicted the relative change in plasma creatinine less than 10% (area under curve (AUC), 0.80; P = 0.0007). Multivariate analyses showed that lower IL-8 transcripts, longer time on dialysis, higher recipient body mass index and deceased donor type were associated with relative change in plasma creatinine at the first postoperative day less than 10%. Conclusion Reduced levels of IL-8 transcripts in peripheral mononuclear cells predict immediate graft dysfunction and delayed graft function.	[Borst, Christoffer; Xia, Shengqiang; Bistrup, Claus; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Borst, Christoffer; Xia, Shengqiang; Tepel, Martin] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Inst Clin Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark.	mtepel@health.sdu.dk	Bistrup, Claus/F-3960-2019; Tepel, Martin/GRS-9581-2022	Bistrup, Claus/0000-0002-9280-916X; Tepel, Martin/0000-0002-0086-0997	European Union [62-1.2-10]	European Union(European Commission)	This study was supported by the European Union (Interreg 4A, grant number 62-1.2-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND PS, 1991, TRANSPLANT P, V23, P1304; Araki M, 2006, TRANSPLANTATION, V81, P783, DOI 10.1097/01.tp.0000198736.69527.32; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; Balato A, 2014, MYCOSES, V57, P176, DOI 10.1111/myc.12140; Boom H, 2000, KIDNEY INT, V58, P859, DOI 10.1046/j.1523-1755.2000.00235.x; Budde K, 1997, AM J KIDNEY DIS, V29, P871, DOI 10.1016/S0272-6386(97)90461-3; Burkhardt K, 2001, J AM SOC NEPHROL, V12, P1947, DOI 10.1681/ASN.V1291947; Cheadle C, 2011, CLIN TRANSPLANT, V25, P766, DOI 10.1111/j.1399-0012.2010.01365.x; Cugini D, 2005, KIDNEY INT, V67, P1753, DOI 10.1111/j.1523-1755.2005.00272.x; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Eikmans M, 2005, J AM SOC NEPHROL, V16, P3771, DOI 10.1681/ASN.2005040412; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jung DY, 2008, TRANSPL IMMUNOL, V18, P338, DOI 10.1016/j.trim.2007.10.004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu DZ, 2014, BIOMARKERS, V19, P424, DOI 10.3109/1354750X.2014.924997; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Mota APL, 2013, CYTOKINE, V62, P302, DOI 10.1016/j.cyto.2013.03.001; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Rammes A, 1997, J BIOL CHEM, V272, P9496; ROSENTHAL JT, 1991, TRANSPLANTATION, V51, P1115; Shaffi K, 2014, AM J KIDNEY DIS, V63, P1007, DOI 10.1053/j.ajkd.2014.01.436; Vilar E, 2010, TRANSPLANTATION, V89, P97, DOI 10.1097/TP.0b013e3181be3dd1; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117315	10.1371/journal.pone.0117315	http://dx.doi.org/10.1371/journal.pone.0117315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689147	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700035
J	Garcia-Torres, L; Caballero-Novella, JJ; Gomez-Candon, D; Pena, JM				Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Manuel Pena, Jose			Census Parcels Cropping System Classification from Multitemporal Remote Imagery: A Proposed Universal Methodology	PLOS ONE			English	Article							DECISION TREE CLASSIFICATION; LAND-COVER; TIME-SERIES; AGRICULTURE; NDVI; AREA; TM	A procedure named CROPCLASS was developed to semi-automate census parcel crop assessment in any agricultural area using multitemporal remote images. For each area, CROPCLASS consists of a) a definition of census parcels through vector files in all of the images; b) the extraction of spectral bands (SB) and key vegetation index (VI) average values for each parcel and image; c) the conformation of a matrix data (MD) of the extracted information; d) the classification of MD decision trees (DT) and Structured Query Language (SQL) crop predictive model definition also based on preliminary land-use ground-truth work in a reduced number of parcels; and e) the implementation of predictive models to classify unidentified parcels land uses. The software named CROPCLASS-2.0 was developed to semi-automatically perform the described procedure in an economically feasible manner. The CROPCLASS methodology was validated using seven GeoEye-1 satellite images that were taken over the LaVentilla area (Southern Spain) from April to October 2010 at 3- to 4-week intervals. The studied region was visited every 3 weeks, identifying 12 crops and others land uses in 311 parcels. The DT training models for each cropping system were assessed at a 95% to 100% overall accuracy (OA) for each crop within its corresponding cropping systems. The DT training models that were used to directly identify the individual crops were assessed with 80.7% OA, with a user accuracy of approximately 80% or higher for most crops. Generally, the DT model accuracy was similar using the seven images that were taken at approximately one-month intervals or a set of three images that were taken during early spring, summer and autumn, or set of two images that were taken at about 2 to 3 months interval. The classification of the unidentified parcels for the individual crops was achieved with an OA of 79.5%.	[Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Manuel Pena, Jose] Spanish Council Sci Res CSIC, Inst Sustainable Agr, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Garcia-Torres, L (corresponding author), Spanish Council Sci Res CSIC, Inst Sustainable Agr, Cordoba, Spain.	lgarciatorres@ias.csic.es	Peña, Jose M/K-4201-2014	Peña, Jose M/0000-0003-4592-3792; Gomez-Candon, David/0000-0002-4216-6709	Ministry of Economy and Competitivity [AGL-2010-15506]; Spanish Council for Scientific Research (CSIC)	Ministry of Economy and Competitivity; Spanish Council for Scientific Research (CSIC)	Funded by Spanish Council for Scientific Research (CSIC)(https:/www.csic.es), Ministry of Economy and Competitivity (https://sede.micinn.gob.es/) through the project AGL-2010-15506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Golden M, 1998, 1998 AVIRIS GEOSC WO; Bernstein LS, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.11.111719; Breiman L., 1984, CLASSIFICATION REGRE; de Colstoun ECB, 2003, REMOTE SENS ENVIRON, V85, P316, DOI 10.1016/S0034-4257(03)00010-5; EU-LPIS, 2014, LAND PARC INF SYST I; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Garcia-Torres L, 2014, CROPCLASS 2 O SOFTWA; Garcia-Torres L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091275; Ghose MK, 2010, INT J ADV COMPUT SC, V1, P93; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gomez-Candon D, 2011, PRECIS AGRIC, V12, P876, DOI 10.1007/s11119-011-9228-3; Inoue Y, 2003, PLANT PROD SCI, V6, P3, DOI 10.1626/pps.6.3; Jiang ZY, 2006, REMOTE SENS ENVIRON, V101, P366, DOI 10.1016/j.rse.2006.01.003; Lobell DB, 2004, REMOTE SENS ENVIRON, V93, P412, DOI 10.1016/j.rse.2004.08.002; Lunetta RS, 2010, INT J APPL EARTH OBS, V12, P81, DOI 10.1016/j.jag.2009.11.005; Maxwell SK, 2008, AGR ECOSYST ENVIRON, V127, P141, DOI 10.1016/j.agee.2008.03.012; ODENWELLER JB, 1984, REMOTE SENS ENVIRON, V14, P39, DOI 10.1016/0034-4257(84)90006-3; Ozdogan M, 2010, REMOTE SENS ENVIRON, V114, P1190, DOI 10.1016/j.rse.2010.01.006; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Serra P, 2008, INT J REMOTE SENS, V29, P2293, DOI 10.1080/01431160701408444; Sesnie SE, 2008, REMOTE SENS ENVIRON, V112, P2145, DOI 10.1016/j.rse.2007.08.025; Simonneaux V, 2008, INT J REMOTE SENS, V29, P95, DOI 10.1080/01431160701250390; South S, 2004, REMOTE SENS ENVIRON, V91, P90, DOI 10.1016/j.rse.2004.03.001; Thenkabail PS, 2012, PHOTOGRAMM ENG REM S, V78, P773; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zambon M, 2006, PHOTOGRAMM ENG REM S, V72, P25, DOI 10.14358/PERS.72.1.25; Zhong LH, 2014, REMOTE SENS ENVIRON, V140, P1, DOI 10.1016/j.rse.2013.08.023	33	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117551	10.1371/journal.pone.0117551	http://dx.doi.org/10.1371/journal.pone.0117551			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689830	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700054
J	Han, D; Walsh, MC; Kim, KS; Hong, SW; Lee, J; Yi, J; Rivas, G; Surh, CD; Choi, Y				Han, Daehee; Walsh, Matthew C.; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Rivas, Gloriany; Surh, Charles D.; Choi, Yongwon			Microbiota-Independent Ameliorative Effects of Antibiotics on Spontaneous Th2-Associated Pathology of the Small Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; T-CELLS; HOMEOSTASIS; PROBIOTICS; INDUCTION; MICE	We have previously generated a mouse model of spontaneous Th2-associated disease of the small intestine called TRAF6 Delta DC, in which dendritic cell (DC)-intrinsic expression of the signaling mediator TRAF6 is ablated. Interestingly, broad-spectrum antibiotic treatment ameliorates TRAF6 Delta DC disease, implying a role for commensal microbiota in disease development. However, the relationship between the drug effects and commensal microbiota status remains to be formally demonstrated. To directly assess this relationship, we have now generated TRAF6 Delta DC bone marrow chimera mice under germ-free (GF) conditions lacking commensal microbiota, and found, unexpectedly, that Th2-associated disease is actually exacerbated in GF TRAF6 Delta DC mice compared to specific pathogen-free (SPF) TRAF6 Delta DC mice. At the same time, broad-spectrum antibiotic treatment of GF TRAF6 Delta DC mice has an ameliorative effect similar to that observed in antibiotics-treated SPF TRAF6 Delta DC mice, implying a commensal microbiota-independent effect of broad-spectrum antibiotic treatment. We further found that treatment of GF TRAF6 Delta DC mice with broadspectrum antibiotics increases Foxp3(+) Treg populations in lymphoid organs and the small intestine, pointing to a possible mechanism by which treatment may directly exert an immunomodulatory effect. To investigate links between the exacerbated phenotype of the small intestines of GF TRAF6 Delta DC mice and local microbiota, we performed microbiotic profiling of the luminal contents specifically within the small intestines of diseased TRAF6 Delta DC mice, and, when compared to co-housed control mice, found significantly increased total bacterial content characterized by specific increases in Firmicutes Lactobacillus species. These data suggest a protective effect of Firmicutes Lactobacillus against the spontaneous Th2-related inflammation of the small intestine of the TRAF6 Delta DC model, and may represent a potential mechanism for related disease phenotypes.	[Han, Daehee; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Surh, Charles D.] Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang 790784, South Korea; [Han, Daehee; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Walsh, Matthew C.; Rivas, Gloriany; Choi, Yongwon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); University of Pennsylvania; Pennsylvania Medicine; La Jolla Institute for Immunology	Surh, CD (corresponding author), Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang 790784, South Korea.	csurh@ibs.re.kr; ychoi3@mail.med.upenn.edu			Institute for Basic Science [IBS-R005-D1-2014-a00]; Korea Institute of Oriental Medicine (KIOM); Ministry of Education, Science and Technology (MEST), Korea [K13050]; National Institutes of Health [AI064909, AI108627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108627, R01AI064909] Funding Source: NIH RePORTER	Institute for Basic Science; Korea Institute of Oriental Medicine (KIOM); Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Institute for Basic Science (IBS-R005-D1-2014-a00 to DH, KSK, SH, JL, JY, CDS), the Korea Institute of Oriental Medicine (KIOM), Ministry of Education, Science and Technology (MEST), Korea (K13050 to YC), and the National Institutes of Health (AI064909, AI108627 to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bamias G, 2002, J IMMUNOL, V169, P5308, DOI 10.4049/jimmunol.169.9.5308; Bindels LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037971; Han D, 2013, IMMUNITY, V38, P1211, DOI 10.1016/j.immuni.2013.05.012; HAUSER WE, 1982, AM J MED, V72, P711, DOI 10.1016/0002-9343(82)90534-4; Kim BS, 2014, J ETHNOPHARMACOL, V152, P532, DOI 10.1016/j.jep.2014.01.038; Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; MORIKAWA K, 1994, ANTIMICROB AGENTS CH, V38, P2643, DOI 10.1128/AAC.38.11.2643; MORRISSEY PJ, 1994, RES IMMUNOL, V145, P357, DOI 10.1016/S0923-2494(94)80200-9; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Quigley EMM, 2006, GASTROENTEROLOGY, V130, pS78, DOI 10.1053/j.gastro.2005.11.046; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; ROSZKOWSKI W, 1985, MED MICROBIOL IMMUN, V173, P279, DOI 10.1007/BF02124944; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; VanVlem B, 1996, INFECTION, V24, P275, DOI 10.1007/BF01743360; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118795	10.1371/journal.pone.0118795	http://dx.doi.org/10.1371/journal.pone.0118795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689829	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700119
J	Jury, NJ; McCormick, BA; Horseman, ND; Benoit, SC; Gregerson, KA				Jury, Nicholas J.; McCormick, Betsy A.; Horseman, Nelson D.; Benoit, Stephen C.; Gregerson, Karen A.			Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation	PLOS ONE			English	Article							NEUROENDOCRINE STRESS RESPONSES; DORSAL RAPHE NUCLEUS; FORCED SWIMMING TEST; POSTPARTUM DEPRESSION; MATERNAL-BEHAVIOR; MAJOR DEPRESSION; POSTNATAL DEPRESSION; PLASMA TRYPTOPHAN; CONTAINING FIBERS; BODY-TEMPERATURE	The physiology of mood regulation in the postpartum is poorly understood despite the fact that postpartum depression (PPD) is a common pathology. Serotonergic mechanisms and their dysfunction are widely presumed to be involved, which has led us to investigate whether lactation induces changes in central or peripheral serotonin (5-HT) systems and related affective behaviors. Brain sections from lactating (day 10 postpartum) and age-matched nulliparous (non-pregnant) C57BL/6J mice were processed for 5-HT immunohistochemistry. The total number of 5-HT immunostained cells and optical density were measured. Lactating mice exhibited lower immunoreactive 5-HT and intensity in the dorsal raphe nucleus when compared with nulliparous controls. Serum 5-HT was quantified from lactating and nulliparous mice using radioimmunoassay. Serum 5-HT concentrations were higher in lactating mice than in nulliparous controls. Affective behavior was assessed in lactating and non-lactating females ten days postpartum, as well as in nulliparous controls using the forced swim test (FST) and marble burying task (MBT). Animals were treated for the preceding five days with a selective serotonin reuptake inhibitor (SSRI, citalopram, 5mg/kg/day) or vehicle. Lactating mice exhibited a lower baseline immobility time during the FST and buried fewer marbles during the MBT as compared to nulliparous controls. Citalopram treatment changed these behaviors in lactating mice with further reductions in immobility during the FST and decreased marble burying. In contrast, the same regimen of citalopram treatment had no effect on these behaviors in either non-lactating postpartum or nulliparous females. Our findings demonstrate changes in both central and peripheral 5-HT systems associated with lactation, independent of pregnancy. They also demonstrate a significant interaction of lactation and responsiveness to SSRI treatment, which has important implications in the treatment of PPD. Although recent evidence has cast doubt on the effectiveness of SSRIs, these results support their therapeutic use in the treatment of PPD.	[Jury, Nicholas J.; Horseman, Nelson D.; Gregerson, Karen A.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA; [Gregerson, Karen A.] Univ Cincinnati, Div Pharmaceut Sci, James L Winkle Coll Pharm, Cincinnati, OH 45267 USA; [Horseman, Nelson D.; Gregerson, Karen A.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [McCormick, Betsy A.] Univ Cincinnati, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Cincinnati, OH 45267 USA; [Benoit, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jury, NJ (corresponding author), NIAAA, Lab Behav & Genom Neurosci, NIH, 5625 Fishers Lane,Room 2N09, Rockville, MD 20852 USA.	Nick.Jury@nih.gov		Jury, Nicholas/0000-0002-4233-117X	National Institutes of Health [DK-54966]; United States Department of Agriculture NRI grant [2007-35206-17898]; National Institutes of Health training grant [DK-059803]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054966, T32DK059803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture NRI grant; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KAG received National Institutes of Health grant DK-54966. NDH received United States Department of Agriculture NRI grant #2007-35206-17898. NJJ received a predoctoral fellowship on National Institutes of Health training grant DK-059803. The funders had a significant role in study design, data collection, analysis, decision to publish, and preparation of the manuscript.	AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8; ALDER E, 1988, PSYCHOL MED, V18, P389, DOI 10.1017/S0033291700007935; ALDER EM, 1983, J PSYCHOSOM RES, V27, P139, DOI 10.1016/0022-3999(83)90090-9; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1002/cpp.1875, DOI 10.1002/CPP.1875]; ARLETTI R, 1987, LIFE SCI, V41, P1725, DOI 10.1016/0024-3205(87)90600-X; Axelson DA, 2005, AM J PSYCHIAT, V162, P802, DOI 10.1176/appi.ajp.162.4.802; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BARTER R, 1955, J PATHOL BACTERIOL, V69, P25, DOI 10.1002/path.1700690106; BAUMANN P, 1995, INT CLIN PSYCHOPHARM, V10, P15, DOI 10.1097/00004850-199503001-00004; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Brummelte S, 2010, HORM BEHAV, V58, P769, DOI 10.1016/j.yhbeh.2010.07.012; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; Chenu F, 2006, BEHAV BRAIN RES, V172, P256, DOI 10.1016/j.bbr.2006.05.011; Christensen HR, 2013, ENDOCRINOLOGY, V154, P4777, DOI 10.1210/en.2013-1476; Cooke HJ, 2000, ANN NY ACAD SCI, V915, P77; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Craft RM, 2010, PHARMACOL BIOCHEM BE, V96, P402, DOI 10.1016/j.pbb.2010.06.012; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; Dawson PA, 2004, BEHAV BRAIN RES, V154, P457, DOI 10.1016/j.bbr.2004.03.013; DELGADO PL, 1991, PSYCHOPHARMACOL BULL, V27, P321; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Doornbos B, 2008, PROG NEURO-PSYCHOPH, V32, P1320, DOI 10.1016/j.pnpbp.2008.04.010; Dossett EC, 2008, OBSTET GYN CLIN N AM, V35, P419, DOI 10.1016/j.ogc.2008.04.004; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Epperson N, 2001, AM J PSYCHIAT, V158, P1631, DOI 10.1176/appi.ajp.158.10.1631; EYNARD N, 1993, CLIN CHEM, V39, P2337; Fergerson SS, 2002, AM J OBSTET GYNECOL, V186, P899, DOI 10.1067/mob.2002.123404; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; FLIERS E, 1986, BRAIN RES, V375, P363, DOI 10.1016/0006-8993(86)90759-6; Foldi CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018152; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Green AD, 2009, PHYSIOL BEHAV, V97, P259, DOI 10.1016/j.physbeh.2009.02.020; Grider JR, 1996, AM J PHYSIOL-GASTR L, V270, pG778, DOI 10.1152/ajpgi.1996.270.5.G778; Halligan SL, 2007, J AFFECT DISORDERS, V97, P145, DOI 10.1016/j.jad.2006.06.010; Hammond KA, 1997, J MAMMARY GLAND BIOL, V2, P243, DOI 10.1023/A:1026332304435; HANNAH P, 1992, BRIT J PSYCHIAT, V160, P777, DOI 10.1192/bjp.160.6.777; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Hebert MF, 2013, J POPUL THER CLIN PH, V20, pE350; Horder J, 2011, J PSYCHOPHARMACOL, V25, P1277, DOI 10.1177/0269881110372544; Huot RL, 2004, PSYCHONEUROENDOCRINO, V29, P279, DOI 10.1016/S0306-4530(03)00028-3; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Johnson MS, 2001, J EXP BIOL, V204, P1925; JORGENSEN H, 1992, NEUROENDOCRINOLOGY, V56, P371, DOI 10.1159/000126251; Kendall-Tackett K, 2010, J HUM LACT, V26, P187, DOI 10.1177/0890334409342071; KENDELL RE, 1981, J AFFECT DISORDERS, V3, P317, DOI 10.1016/0165-0327(81)90001-X; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KITTRELL EMW, 1988, PHYSIOL BEHAV, V42, P477; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; KOHLER C, 1982, J COMP NEUROL, V209, P91, DOI 10.1002/cne.902090109; KORDON C, 1973, NEUROENDOCRINOLOGY, V13, P213, DOI 10.1159/000122206; Kosten TA, 2010, INT J DEV NEUROSCI, V28, P53, DOI 10.1016/j.ijdevneu.2009.09.005; Lambert R, 2007, BREEDING STRATEGIES, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Leng G, 2005, VITAM HORM, V71, P27, DOI 10.1016/S0083-6729(05)71002-5; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; LI YQ, 1993, BRAIN RES, V623, P267, DOI 10.1016/0006-8993(93)91437-W; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Marazziti D, 2012, EUR NEUROPSYCHOPHARM, V22, P578, DOI 10.1016/j.euroneuro.2011.12.010; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Maurer-Spurej E, 2007, J PSYCHIATR NEUROSCI, V32, P23; McCoy SJB, 2006, J AM OSTEOPATH ASSOC, V106, P193; MERCHENTHALER I, 1993, ENDOCRINOLOGY, V133, P2645, DOI 10.1210/en.133.6.2645; Michaels CC, 2006, PHYSIOL BEHAV, V89, P735, DOI 10.1016/j.physbeh.2006.08.015; Misri S, 1997, CAN J PSYCHIAT, V42, P1061, DOI 10.1177/070674379704201007; MOOS F, 1983, NEUROENDOCRINOLOGY, V36, P300, DOI 10.1159/000123471; Navarre BM, 2010, PHYSIOL BEHAV, V99, P59, DOI 10.1016/j.physbeh.2009.10.011; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Newport DJ, 2004, J PSYCHIATR RES, V38, P467, DOI 10.1016/j.jpsychires.2004.01.011; Ng RC, 2010, PHARMACOTHERAPY, V30, P928, DOI 10.1592/phco.30.9.928; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; NORDSTROM P, 1992, INT CLIN PSYCHOPHARM, V6, P12, DOI 10.1097/00004850-199206006-00003; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; OWENS MJ, 1994, CLIN CHEM, V40, P288; Pawluski JL, 2012, BEHAV BRAIN RES, V228, P159, DOI 10.1016/j.bbr.2011.11.043; Pawuski JL, 2009, BEHAV BRAIN RES, V197, P55, DOI 10.1016/j.bbr.2008.08.001; Paxinos G, 2001, MOUSE BRAIN STEREOTA, P71, DOI [10.1023/A:1014088919546, DOI 10.1023/A:1014088919546]; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Schrader JA, 2009, PHYSIOL BEHAV, V98, P547, DOI 10.1016/j.physbeh.2009.08.012; SCRIBNER SJ, 1994, PHYSIOL BEHAV, V55, P361, DOI 10.1016/0031-9384(94)90147-3; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; SOFRONIEW MV, 1980, J HISTOCHEM CYTOCHEM, V28, P475, DOI 10.1177/28.5.7381192; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; VANPRAAG HM, 1984, NEUROBIOLOGY MOOD DI, P601; Yonkers KA, 2003, J CLIN PSYCHIAT, V64, P8; Yonkers KA, 2001, AM J PSYCHIAT, V158, P1856, DOI 10.1176/appi.ajp.158.11.1856	97	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117339	10.1371/journal.pone.0117339	http://dx.doi.org/10.1371/journal.pone.0117339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689282	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700036
J	Ito, T; Taniguchi, H; Fukagai, K; Okamuro, S; Kobayashi, A				Ito, Takao; Taniguchi, Hiroaki; Fukagai, Kousuke; Okamuro, Shota; Kobayashi, Akira			Inhibitory Mechanism of FAT4 Gene Expression in Response to Actin Dynamics during Src-Induced Carcinogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO SIGNALING PATHWAY; DNA METHYLATION; CELL-ADHESION; SIZE CONTROL; KINASE; CANCER; GROWTH; PHOSPHORYLATION; CYTOSKELETON	Oncogenic transformation is characterized by morphological changes resulting from alterations in actin dynamics and adhesive activities. Emerging evidence suggests that the protocadherin FAT4 acts as a tumor suppressor in humans, and reduced FAT4 gene expression has been reported in breast and lung cancers and melanoma. However, the mechanism controlling FAT4 gene expression is poorly understood. In this study, we show that transient activation of the Src oncoprotein represses FAT4 mRNA expression through actin depolymerization in the immortalized normal human mammary epithelial cell line MCF-10A. Src activation causes actin depolymerization via the MEK/Erk/Cofilin cascade. The MEK inhibitor U0126 blocks the inhibitory effect of Src on FAT4 mRNA expression and Src-induced actin depolymerization. To determine whether actin dynamics act on the regulation of FAT4 mRNA expression, we treated MCF-10A cells with the ROCK inhibitor Y-27632. Y-27632 treatment decreased FAT4 mRNA expression. This suppressive effect was blocked by siRNA-mediated knockdown of Cofilin1. Furthermore, simultaneous administration of Latrunculin A (an actin depolymerizing agent), Y-27632, and Cofilin1 siRNA to the cells resulted in a marked reduction of FAT4 mRNA expression. Intriguingly, we also found that FAT4 mRNA expression was reduced under both low cell density and low stiffness conditions, which suggests that mechanotransduction affects FAT4 mRNA expression. Additionally, we show that siRNA-mediated FAT4 knockdown induced the activity of the Hippo effector YAP/TAZ in MCF-10A cells. Taken together, our results reveal a novel inhibitory mechanism of FAT4 gene expression through actin depolymerization during Src-induced carcinogenesis in human breast cells.	[Ito, Takao; Taniguchi, Hiroaki; Fukagai, Kousuke; Okamuro, Shota; Kobayashi, Akira] Doshisha Univ, Grad Sch Life & Med Sci, Lab Genet Code, Kyoto 602, Japan	Doshisha University	Kobayashi, A (corresponding author), Doshisha Univ, Grad Sch Life & Med Sci, Lab Genet Code, Kyoto 602, Japan.	akobayas@mail.doshisha.ac.jp	Taniguchi, Hiroaki/H-6329-2016; Kobayashi, Akira/AAN-8003-2020	Ito, Takao/0000-0003-2224-034X; Taniguchi, Hiroaki/0000-0001-7270-390X; Kobayashi, Akira/0000-0001-9727-1218	Ministry of Education, Sports, Science and Technology; Strategic Research Foundation at Private Universities from the Ministry of Education, Sports, Science and Technology; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [26116725] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation at Private Universities from the Ministry of Education, Sports, Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding from Grants-in-aid from the Ministry of Education, Sports, Science and Technology (http://www.mext.go.jp/english/), AK, HT; The Strategic Research Foundation at Private Universities (2012-2016) from the Ministry of Education, Sports, Science and Technology (http://www.mext.go.jp/english/), AK; The Takeda Science Foundation (http://www.takeda-sci.or.jp/), HT; and The Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai/), HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cappello S, 2013, NAT GENET, V45, P1300, DOI 10.1038/ng.2765; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Edme N, 2002, J CELL SCI, V115, P2591; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Lund P, 2006, ONCOGENE, V25, P4890, DOI 10.1038/sj.onc.1209502; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Murphy AJ, 2014, PEDIATR BLOOD CANCER, V61, P198, DOI 10.1002/pbc.24788; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; SOULE HD, 1990, CANCER RES, V50, P6075; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sung J, 2005, CARCINOGENESIS, V26, P487, DOI 10.1093/carcin/bgh318; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	56	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118336	10.1371/journal.pone.0118336	http://dx.doi.org/10.1371/journal.pone.0118336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679223	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600119
J	Nyberg, G; Sundblom, E; Norman, A; Bohman, B; Hagberg, J; Elinder, LS				Nyberg, Gisela; Sundblom, Elinor; Norman, Asa; Bohman, Benjamin; Hagberg, Jan; Elinder, Liselotte Schafer			Effectiveness of a Universal Parental Support Programme to Promote Healthy Dietary Habits and Physical Activity and to Prevent Overweight and Obesity in 6-Year-Old Children: The Healthy School Start Study, a Cluster-Randomised Controlled Trial	PLOS ONE			English	Article							CHILDHOOD OBESITY; VEGETABLE CONSUMPTION; ACTIVITY PATTERNS; INTERVENTIONS; BEHAVIORS; FRUIT; ASSOCIATIONS; ADOLESCENTS; ADULTHOOD; TRACKING	Objective To develop and evaluate the effectiveness of a parental support programme to promote healthy dietary and physical activity habits and to prevent overweight and obesity in Swedish children. Methods A cluster-randomised controlled trial was carried out in areas with low to medium socio-economic status. Participants were six-year-old children (n = 243) and their parents. Fourteen pre-school classes were randomly assigned to intervention (n = 7) and control groups (n = 7). The intervention lasted for 6 months and included: 1) Health information for parents, 2) Motivational Interviewing with parents and 3) Teacher-led classroom activities with children. Physical activity was measured by accelerometry, dietary and physical activity habits and parental self-efficacy through a questionnaire. Body weight and height were measured and BMI standard deviation score was calculated. Measurements were conducted at baseline, post-intervention and at 6-months follow-up. Group differences were examined using analysis of covariance and Poisson regression, adjusted for gender and baseline values. Results There was no significant intervention effect in the primary outcome physical activity. Subgroup analyses showed a significant gender-group interaction in total physical activity (TPA), with girls in the intervention group demonstrating higher TPA during weekends (p = 0.04), as well as in sedentary time, with boys showing more sedentary time in the intervention group (p = 0.03). There was a significantly higher vegetable intake (0.26 servings) in the intervention group compared to the control group (p = 0.003). At follow-up, sub-group analyses showed a sustained effect for boys. The intervention did not affect the prevalence of overweight or obesity. Conclusions It is possible to influence vegetable intake in children and girls' physical activity through a parental support programme. The programme needs to be intensified in order to increase effectiveness and sustain the effects long-term. These findings are an important contribution to the further development of evidence-based parental support programmes to prevent overweight and obesity in children.	[Nyberg, Gisela; Sundblom, Elinor; Norman, Asa; Elinder, Liselotte Schafer] Karolinska Inst, Dept Publ Hlth Sci, S-17165 Solna, Sweden; [Nyberg, Gisela; Sundblom, Elinor; Elinder, Liselotte Schafer] Stockholm Cty Council, Ctr Epidemiol & Community Med, S-17129 Solna, Sweden; [Bohman, Benjamin] Karolinska Inst, Dept Clin Neurosci, S-17165 Solna, Sweden; [Hagberg, Jan] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska Institutet	Nyberg, G (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Tomtebodavagen 18 A, S-17165 Solna, Sweden.	gisela.nyberg@ki.se	Elinder, Liselotte S/J-4677-2012; Norman, Åsa/AAX-3246-2020	Elinder, Liselotte S/0000-0001-7270-1162; Norman, Åsa/0000-0002-0313-3066; Bohman, Benjamin/0000-0002-3415-7511	Public Health Fund, Stockholm County Council; Signhild Engkvist Foundation; Martin Rind Foundation; Lars Hierta Memorial Foundation	Public Health Fund, Stockholm County Council; Signhild Engkvist Foundation; Martin Rind Foundation; Lars Hierta Memorial Foundation	ES and LSE received funding for this study from the Public Health Fund, Stockholm County Council. GN received funding from the Signhild Engkvist Foundation, the Martin Rind Foundation and the Lars Hierta Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2004, OBES RES, V12, p38S, DOI 10.1038/oby.2004.267; Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1986, SOCIAL FOUNDATIONS O; Bandura A, 1997, SELF EFFICACY THE EX; Baranowski T, 2002, HEALTH BEHAVIOUR AND; Bayer O, 2009, CLIN NUTR, V28, P122, DOI 10.1016/j.clnu.2009.01.001; Bennett CA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-71; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Bloomfield L, 2007, J ADV NURS, V60, P487, DOI 10.1111/j.1365-2648.2007.04420.x; Bohman B, 2014, HEALTH EDUC BEHAV, V41, P392, DOI 10.1177/1090198113515243; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Burrows T, 2011, J PEDIATR GASTR NUTR, V53, P543, DOI 10.1097/MPG.0b013e3182274829; Campbell K, 2010, INT J PEDIATR OBES, V5, P501, DOI 10.3109/17477161003777425; Campbell MK, 2004, COMPUT BIOL MED, V34, P113, DOI 10.1016/S0010-4825(03)00039-8; Centis E, 2012, PEDIATR OBES, V7, P436, DOI 10.1111/j.2047-6310.2012.00079.x; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Collins C, 2014, J HUM NUTR DIET, V27, P557, DOI 10.1111/jhn.12192; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Cullen KW, 2000, PUBLIC HEALTH NUTR, V3, P345, DOI 10.1017/S1368980000000392; Davison KK, 2003, MED SCI SPORT EXER, V35, P1589, DOI 10.1249/01.MSS.0000084524.19408.0C; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Forsberg Lars, 2007, Cognitive Behaviour Therapy, V36, P162, DOI 10.1080/16506070701339887; Forsberg L, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-8; Fraser M, 2009, INTERVENTION RES DEV; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Golley RK, 2011, OBES REV, V12, P114, DOI 10.1111/j.1467-789X.2010.00745.x; Goran MI, 2005, OBES RES, V13, P762, DOI 10.1038/oby.2005.86; GORELY T, 2009, INT J BEHAV NUTR PHY, V6, DOI DOI 10.1186/1479-; Haynos AF, 2012, CLIN PSYCHOL REV, V32, P383, DOI 10.1016/j.cpr.2011.09.006; Hendrie GA, 2012, HEALTH EDUC BEHAV, V39, P159, DOI 10.1177/1090198111420286; Hingle MD, 2010, PREV MED, V51, P103, DOI 10.1016/j.ypmed.2010.04.014; JOHNSON CC, 1994, HEALTH EDUC QUART, pS91; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Kitzman-Ulrich H, 2010, CLIN CHILD FAM PSYCH, V13, P231, DOI 10.1007/s10567-010-0073-0; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Lai SK, 2014, SPORTS MED, V44, P67, DOI 10.1007/s40279-013-0099-9; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Magnusson MB, 2005, J HUM NUTR DIET, V18, P187, DOI 10.1111/j.1365-277X.2005.00604.x; Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Miller WR, 2013, MOTIVATIONAL INTERVI, DOI [10.3390/jpm3040288, DOI 10.3390/JPM3040288]; Mo-suwan L, 1998, AM J CLIN NUTR, V68, P1006, DOI 10.1093/ajcn/68.5.1006; Nyberg G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-185; Nyberg GA, 2009, MED SCI SPORT EXER, V41, P1842, DOI 10.1249/MSS.0b013e3181a48ee6; O'Connor TM, 2009, AM J PREV MED, V37, P141, DOI 10.1016/j.amepre.2009.04.020; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Schwartz RP, 2007, ARCH PEDIAT ADOL MED, V161, P495, DOI 10.1001/archpedi.161.5.495; Seabra AC, 2013, EUR J PUBLIC HEALTH, V23, P794, DOI 10.1093/eurpub/cks149; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sobol-Goldberg S, 2013, OBESITY, V21, P2422, DOI 10.1002/oby.20515; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Vereecken C, 2010, APPETITE, V55, P589, DOI 10.1016/j.appet.2010.09.009; Vereecken C, 2010, APPETITE, V54, P44, DOI 10.1016/j.appet.2009.09.005; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Vollmer RL, 2013, APPETITE, V71, P232, DOI 10.1016/j.appet.2013.08.015; Von Haartman F, 2009, PARENTAL SUPPORT FOR; Wabitsch M, 2000, EUR J PEDIATR, V159, pS8, DOI 10.1007/PL00014368	68	52	53	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116876	10.1371/journal.pone.0116876	http://dx.doi.org/10.1371/journal.pone.0116876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25680096	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600040
J	Qin, QL; Li, Y; Sun, ML; Rong, JC; Liu, SB; Chen, XL; Su, HN; Zhou, BC; Xie, BB; Zhang, YZ; Zhang, XY				Qin, Qi-Long; Li, Yi; Sun, Mei-Ling; Rong, Jin-Cheng; Liu, Sheng-Bo; Chen, Xiu-Lan; Su, Hai-Nan; Zhou, Bai-Cheng; Xie, Bin-Bin; Zhang, Yu-Zhong; Zhang, Xi-Ying			Comparative Transcriptome Analysis Reveals That Lactose Acts as an Inducer and Provides Proper Carbon Sources for Enhancing Exopolysaccharide Yield in the Deep-Sea Bacterium Zunongwangia profunda SM-A87	PLOS ONE			English	Article							SOUTHERN OKINAWA TROUGH; CAPSULAR POLYSACCHARIDES; EXTRACELLULAR POLYSACCHARIDES; ESCHERICHIA-COLI; ECOLOGICAL ROLES; ORGANIC-CARBON; BIOSYNTHESIS; MECHANISMS; GENERATION; EXPORT	Many marine bacteria secrete exopolysaccharides (EPSs) that have important ecological and physiological functions. Numerous nutritional and environmental factors influence bacterial EPS production. However, the regulatory mechanisms of EPS production are poorly understood. The deep-sea Bacteroidetes bacterium Zunongwangia profunda SM-A87 can produce high quantities of EPS, and its EPS production is enhanced significantly by lactose. Here, we studied the reasons behind the significant advantage that lactose has over other carbon sources in EPS production in SM-A87. RNA-seq technologies were used to study lactose-regulated genes in SM-A87. The expression level of genes within the EPS gene cluster was up-regulated when lactose was added. Supplement of lactose also influenced the expression of genes located outside the EPS gene cluster that are also involved in EPS biosynthesis. The major glycosyl components of SM-A87 EPS are mannose, glucose and galactose. Genomic metabolic pathway analyses showed that the EPS precursor GDPmannose can be synthesized from glucose, while the precursor UDP-glucose must be synthesized from galactose. Lactose can provide glucose and galactose simultaneously and prevent glucose inhibition. Lactose can also greatly stimulate the growth of SM-A87. Taken together, lactose acts not only as an inducer but also as a carbohydrate source for EPS production. This research broadens our knowledge of the regulation of EPS production in marine bacteria.	[Qin, Qi-Long; Li, Yi; Sun, Mei-Ling; Rong, Jin-Cheng; Liu, Sheng-Bo; Chen, Xiu-Lan; Su, Hai-Nan; Xie, Bin-Bin; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Qin, Qi-Long; Li, Yi; Sun, Mei-Ling; Rong, Jin-Cheng; Liu, Sheng-Bo; Chen, Xiu-Lan; Su, Hai-Nan; Zhou, Bai-Cheng; Xie, Bin-Bin; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Zhang, XY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangxiying@sdu.edu.cn			National Natural Science Foundation of China [31025001, 31290230, 31290231, 91228210, 31070061, 31170055, 41106161, 41176130, 81271896, 41276149, 31370056]; Hi-Tech Research and Development program of China [2011AA090703, 2012AA092103, 2012AA092105]; China Ocean Mineral Resources R & D Association (COMRA) Program [DY125-15-T-05, DY125-13-E-01]; Special Fund of China for Marine-scientific Research in the Public Interest [201005032-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R & D Association (COMRA) Program; Special Fund of China for Marine-scientific Research in the Public Interest	The work was supported by National Natural Science Foundation of China (31025001, 31290230, 31290231, 91228210, 31070061, 31170055, 41106161, 41176130, 81271896, 41276149, 31370056), Hi-Tech Research and Development program of China (2011AA090703, 2012AA092103, 2012AA092105), China Ocean Mineral Resources R & D Association (COMRA) Program (DY125-15-T-05, DY125-13-E-01), Special Fund of China for Marine-scientific Research in the Public Interest (201005032-6).	Adhya SL, 1998, ESSENTIALS MOL BIOL, P251; Aikawa C, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00118; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Audy J, 2010, MICROBIOL-SGM, V156, P653, DOI 10.1099/mic.0.033720-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Campanaro S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-567; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Degeest B, 2001, J APPL MICROBIOL, V91, P470, DOI 10.1046/j.1365-2672.2001.01404.x; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DILLS SS, 1980, MICROBIOL REV, V44, P385, DOI 10.1128/MMBR.44.3.385-418.1980; Domenech M, 2013, ENVIRON MICROBIOL, V15, P502, DOI 10.1111/j.1462-2920.2012.02853.x; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao SJ, 2003, DEEP-SEA RES PT II, V50, P1203, DOI 10.1016/S0967-0645(03)00018-3; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Levander F, 2002, APPL ENVIRON MICROB, V68, P784, DOI 10.1128/AEM.68.2.784-790.2002; Li HP, 2011, CARBOHYD POLYM, V84, P1117, DOI 10.1016/j.carbpol.2010.12.072; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu SB, 2013, APPL ENVIRON MICROB, V79, P224, DOI 10.1128/AEM.01801-12; Liu SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026825; Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Nwodo UU, 2012, INT J MOL SCI, V13, P14002, DOI 10.3390/ijms131114002; Okura M, 2013, APPL ENVIRON MICROB, V79, P2796, DOI 10.1128/AEM.03742-12; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; Qin QL, 2007, FEMS MICROBIOL LETT, V271, P53, DOI 10.1111/j.1574-6968.2007.00694.x; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Staudt AK, 2012, ARCH MICROBIOL, V194, P197, DOI 10.1007/s00203-011-0742-5; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhou WZ, 2009, COLLOID SURFACE B, V72, P295, DOI 10.1016/j.colsurfb.2009.04.018	42	3	4	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115998	10.1371/journal.pone.0115998	http://dx.doi.org/10.1371/journal.pone.0115998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679965	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600011
J	Satzer, D; DiBartolomeo, C; Ritchie, MM; Storino, C; Liimatainen, T; Hakkarainen, H; Idiyatullin, D; Mangia, S; Michaeli, S; Parr, AM; Low, WC				Satzer, David; DiBartolomeo, Christina; Ritchie, Michael M.; Storino, Christine; Liimatainen, Timo; Hakkarainen, Hanne; Idiyatullin, Djaudat; Mangia, Silvia; Michaeli, Shalom; Parr, Ann M.; Low, Walter C.			Assessment of Dysmyelination with RAFFn MRI: Application to Murine MPS I	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-I; STORAGE DISORDER; MOUSE MODEL; BRAIN MRI; RELAXATION; MYELIN; PULSES; CONTRAST; MUTANT; CELL	Type I mucopolysaccharidosis (MPS I) is an autosomal recessive lysosomal storage disorder with neurological features. Humans and laboratory animals with MPS I exhibit various white matter abnormalities involving the corpus callosum and other regions. In this study, we first validated a novel MRI technique, entitled Relaxation Along a Fictitious Field in the rotating frame of rank n (RAFFn), as a measure of myelination and dysmyelination in mice. We then examined differences between MPS I mice and heterozygotes using RAFF5 and histology. RAFF5 (i.e., RAFFn with n = 5) relaxation time constants were highly correlated with histological myelin density (R2 = 0.68, P<0.001), and RAFF5 clearly distinguished between the hypomyelinated and dysmyelinated shiverer mouse and the wild-type mouse. Bloch-McConnell theoretical analysis revealed slower exchange correlation times and smaller exchange-induced relaxation rate constants for RAFF4 and RAFF5 compared to RAFF1-3, T-1 rho, and T-2 rho. These data suggest that RAFF5 may assess methylene protons in myelin lipids and proteins, though other mechanisms (e.g. detection of myelin-bound water) may also explain the sensitivity of RAFF5 to myelin. In MPS I mice, mean RAFF5 relaxation time constants were significantly larger for the striatum (P = 0.004) and internal capsule (P = 0.039), and marginally larger for the fornix (P = 0.15). Histological assessment revealed no differences between MPS I mice and heterozygotes in myelin density or corpus callosum thickness. Taken together, these findings support subtle dysmyelination in the brains of mice with MPS I. Dysmyelination may result from myelin lipid abnormalities caused by the absence of alpha-L-iduronidase. Our findings may help to explain locomotor and cognitive deficits seen in mice with MPS I.	[Satzer, David; DiBartolomeo, Christina; Ritchie, Michael M.; Parr, Ann M.; Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Storino, Christine; Idiyatullin, Djaudat; Mangia, Silvia; Michaeli, Shalom] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Liimatainen, Timo; Hakkarainen, Hanne] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Eastern Finland	Low, WC (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	lowwalt@umn.edu	Mangia, Silvia/I-7348-2013; Liimatainen, Timo/F-9235-2019	Mangia, Silvia/0000-0001-6341-4516; Liimatainen, Timo/0000-0001-7472-9900; Satzer, David/0000-0001-8573-1555	University of Minnesota Foundation; National Institutes of Health (NIH) [P01HD032652, KL2 RR033182, UL1TR000114]; Academy of Finland; Sigrid Juselius Foundation; Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science; NIH [P41 EB015894, P30 NS057091, R01 NS061866, S10 RR023730, S10 RR027290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114, KL2TR000113] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027290, KL2RR033182, S10RR023730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061866, P30NS076408, P30NS057091] Funding Source: NIH RePORTER	University of Minnesota Foundation(University of Minnesota System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by the University of Minnesota Foundation as well as National Institutes of Health (NIH) grants P01HD032652, KL2 RR033182, and UL1TR000114. Additional assistance came from the Academy of Finland, Sigrid Juselius Foundation, and Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science. Research at the Center for Magnetic Resonance Research (CMRR) is funded by NIH grants P41 EB015894, P30 NS057091, R01 NS061866, S10 RR023730, and S10 RR027290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHUVANESWARAN C, 1982, AM J PATHOL, V108, P160; BIRD TD, 1978, J NEUROCHEM, V31, P387, DOI 10.1111/j.1471-4159.1978.tb12479.x; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Clarke Lorne A., 2007, P389, DOI 10.1007/978-0-387-70909-3_24; Gabrielli O, 2004, AM J MED GENET A, V125A, P224, DOI 10.1002/ajmg.a.20515; Garcia-Rivera MF, 2007, BRAIN RES BULL, V74, P429, DOI 10.1016/j.brainresbull.2007.07.018; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Heinecke KA, 2011, NEUROCHEM RES, V36, P1669, DOI 10.1007/s11064-011-0400-y; Horch RA, 2011, MAGN RESON MED, V66, P24, DOI 10.1002/mrm.22980; Idiyatullin D, 2008, J MAGN RESON, V193, P267, DOI 10.1016/j.jmr.2008.05.009; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Jones MZ, 1998, J NEUROPATH EXP NEUR, V57, P148, DOI 10.1097/00005072-199802000-00006; KOLODNY EH, 1993, CURR OPIN NEUROL NEU, V6, P379; Koshimori Y, 2014, BRAIN STRUCT FUNCT; Kumar M, 2014, J NEUROPATH EXP NEUR, V73, P39, DOI 10.1097/NEN.0000000000000023; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; LEE C, 1993, AM J NEURORADIOL, V14, P1285; Liimatainen T, 2014, MAGN RESON MED; Liimatainen T, 2011, J MAGN RESON, V209, P269, DOI 10.1016/j.jmr.2011.01.022; Liimatainen T, 2010, MAGN RESON MED, V64, P983, DOI 10.1002/mrm.22372; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Mangia S, 2011, MAGN RESON IMAGING, V29, P1346, DOI 10.1016/j.mri.2011.04.002; Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1; Michaeli S, 2004, J MAGN RESON, V169, P293, DOI 10.1016/j.jmr.2004.05.010; Michaeli S, 2006, J MAGN RESON, V181, P135, DOI 10.1016/j.jmr.2006.04.002; Nolte J, 2009, THE HUMAN BRAIN AN I; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ou L, 2014, MOL GENET METAB, V111, P116, DOI 10.1016/j.ymgme.2013.09.008; Patay Z, 2005, EUR RADIOL, V15, P2284, DOI 10.1007/s00330-005-2846-2; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; Savaskan NE, 2009, CELL TISSUE RES, V337, P213, DOI 10.1007/s00441-009-0815-9; Sener RN, 2004, ACTA RADIOL, V45, P561, DOI 10.1080/02841850410006128; SERESS L, 1995, HIPPOCAMPUS, V5, P217, DOI 10.1002/hipo.450050308; SEYFRIED TN, 1985, MOL CELL BIOCHEM, V68, P3; Shapiro E, 2012, MOL GENET METAB, V107, P116, DOI 10.1016/j.ymgme.2012.07.016; STEWART WA, 1993, MAGNET RESON MED, V29, P767, DOI 10.1002/mrm.1910290608; Tannus A, 1996, J MAGN RESON SER A, V120, P133, DOI 10.1006/jmra.1996.0110; Vite CH, 2013, COMPARATIVE MED, V63, P163; Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001; WATANABE I, 1972, J NEUROPATH EXP NEUR, V3, P352, DOI 10.1097/00005072-197204000-00010; WATTS RWE, 1986, J INHERIT METAB DIS, V9, P261, DOI 10.1007/BF01799658; WEINTRAUB H, 1987, ACTA NEUROPATHOL, V74, P374, DOI 10.1007/BF00687215; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wolf DA, 2011, NEUROBIOL DIS, V43, P123, DOI 10.1016/j.nbd.2011.02.015; YU RK, 1975, J NEUROCHEM, V25, P229, DOI 10.1111/j.1471-4159.1975.tb06957.x; Zhang J, 2013, PROC INTL SOC MAG RE, P764; Zheng Y, 2003, MOL GENET METAB, V79, P233, DOI 10.1016/S1096-7192(03)00116-1	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116788	10.1371/journal.pone.0116788	http://dx.doi.org/10.1371/journal.pone.0116788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680196	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600034
J	Mehta, SD; Donovan, B; Weber, KM; Cohen, M; Ravel, J; Gajer, P; Gilbert, D; Burgad, D; Spear, GT				Mehta, Supriya D.; Donovan, Brock; Weber, Kathleen M.; Cohen, Mardge; Ravel, Jacques; Gajer, Pawel; Gilbert, Douglas; Burgad, Derick; Spear, Greg T.			The Vaginal Microbiota over an 8-to 10-Year Period in a Cohort of HIV-Infected and HIV-Uninfected Women	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIAL VAGINOSIS; GENITAL-TRACT; GARDNERELLA-VAGINALIS; PRETERM DELIVERY; RISK-FACTORS; ACQUISITION; PREVALENCE; ASSOCIATION; MICROFLORA; MODEL	Background We identified predominant vaginal microbiota communities, changes over time, and how this varied by HIV status and other factors in a cohort of 64 women. Methods Bacterial DNA was extracted from reposited cervicovaginal lavage samples collected annually over an 8-10 year period from Chicago Women's Interagency HIV Study participants: 22 HIV-negative, 22 HIV-positive with stable infection, 20 HIV-positive with progressive infection. The vaginal microbiota was defined by pyrosequencing of the V1/V2 region of the 16S rRNA gene. Scheduled visits included Bacterial vaginsosis (BV) screening; clinically detected cases were referred for treatment. Hierarchical clustering identified bacterial community state types (CST). Multinomial mixed effects modeling determined trends over time in CST, by HIV status and other factors. Results The median follow-up time was 8.1 years (range 5.5-15.3). Six CSTs were identified. The mean relative abundance (RA) of Lactobacillus spp. by CST (with median number of bacterial taxa) was: CST-1-25.7% (10), CST-2-27.1% (11), CST-3-34.6%(9), CST-4-46.8% (9), CST-5-57.9% (4), CST-6-69.4%(2). The two CSTs representing the highest RA of Lactobacillus and lowest diversity increased with each additional year of follow-up (CST-5, adjusted odds ratio (aOR) = 1.62 [95% CI: 1.34-1.94]; CST-6, aOR = 1.57 [95 CI: 1.31-1.89]), while the two CSTs representing lowest RA of Lactobacillus and higher diversity decreased with each additional year (CST-1, aOR = 0.89 [95% CI: 0.80-1.00]; CST-2, aOR = 0.86 [95% CI: 0.75-0.99]). There was no association between HIV status and CST at baseline or over time. CSTs representing lower RA of Lactobacillus were associated with current cigarette smoking. Conclusions The vaginal microbial community significantly improved over time in this cohort of women with HIV and at high risk for HIV who had regular detection and treatment referral for BV.	[Mehta, Supriya D.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Donovan, Brock] Univ Illinois, Coll Med, Dept Bioengn, Chicago, IL USA; [Weber, Kathleen M.; Cohen, Mardge] Cook Cty Hlth & Hosp Syst, Core Ctr, Chicago, IL USA; [Ravel, Jacques; Gajer, Pawel] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Ravel, Jacques; Gajer, Pawel] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Gilbert, Douglas; Burgad, Derick; Spear, Greg T.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; John H Stroger Junior Hospital Cook County; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Rush University	Mehta, SD (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	Supriyad@uic.edu	Ravel, Jacques/D-2530-2009	Mehta, Supriya/0000-0002-7926-2489; Ravel, Jacques/0000-0002-0851-2233	National Institute of Allergy and Infectious Diseases [UO1-AI-34994]; National Cancer Institute; National Institute on Drug Abuse; American Recovery and Reinvestment Act (ARRA) NIAID supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Recovery and Reinvestment Act (ARRA) NIAID supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Chicago WIHS-I-IV was funded by the National Institute of Allergy and Infectious Diseases, UO1-AI-34994 (PI: Mardge H. Cohen MD) and co-funded by the National Cancer Institute and the National Institute on Drug Abuse. This WIHS substudy was funded by an American Recovery and Reinvestment Act (ARRA) NIAID supplement to the Chicago WIHS (ARRA PI: G. Spear). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bradshaw CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034540; Brotman RM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-471; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2011, ANAEROBE, V17, P191, DOI 10.1016/j.anaerobe.2011.01.001; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hemalatha R, 2012, AM J MED SCI, V344, P35, DOI 10.1097/MAJ.0b013e318235597b; Hessol NA, 2009, J WOMENS HEALTH, V18, P1627, DOI 10.1089/jwh.2008.1337; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Langstrom N, 2006, ARCH SEX BEHAV, V35, P37, DOI 10.1007/s10508-006-8993-y; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mirmonsef P, 2012, AM J REPROD IMMUNOL, V67, P391, DOI 10.1111/j.1600-0897.2011.01089.x; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Pavlova SI, 2000, MUTAT RES-GEN TOX EN, V466, P57, DOI 10.1016/S1383-5718(00)00003-6; R Core Team, 2012, R LANG ENV STAT COMP; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg JJ, 2012, AIDS, V26, P387, DOI 10.1097/QAD.0b013e32834ed7f0; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schwebke JR, 2007, SEX TRANSM DIS, V34, P876, DOI 10.1097/OLQ.0b013e318073bd82; Schwebke JR, 2007, AM J OBSTET GYNECOL, V196, P517, DOI 10.1016/j.ajog.2007.02.048; Schwebke JR, 2014, SEX TRANSM INFECT, V90, P61, DOI 10.1136/sextrans-2013-051232; Simhan HN, 2005, AM J OBSTET GYNECOL, V193, P1999, DOI 10.1016/j.ajog.2005.04.054; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; TOTTEN PA, 1982, J CLIN MICROBIOL, V15, P141, DOI 10.1128/JCM.15.1.141-147.1982; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watts DH, 2006, JAIDS-J ACQ IMM DEF, V43, P161, DOI 10.1097/01.qai.0000242448.90026.13; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X	55	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116894	10.1371/journal.pone.0116894	http://dx.doi.org/10.1371/journal.pone.0116894			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675346	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000011
J	Casas-Agustench, P; Fernandes, FS; do Carmo, MGT; Visioli, F; Herrera, E; Davalos, A				Casas-Agustench, Patricia; Fernandes, Flavia S.; Tavares do Carmo, Maria G.; Visioli, Francesco; Herrera, Emilio; Davalos, Alberto			Consumption of Distinct Dietary Lipids during Early Pregnancy Differentially Modulates the Expression of microRNAs in Mothers and Offspring	PLOS ONE			English	Article							FATTY-ACIDS; GENE-EXPRESSION; HIGH GLUCOSE; THERAPEUTICS; NUTRITION; DISEASE; FEMALE; MIR-21; GROWTH; CELLS	Diet during pregnancy and lactation influences the offspring's health in the long-term. Indeed, human epidemiological studies and animal experiments suggest that different type of fatty acids consumption during pregnancy affect offspring development and susceptibility to metabolic disorders. Epigenetic changes are thought to be elicited by dietary factors during critical timing of development. microRNAs (miRNAs) are versatile regulators of gene expression. Thus, we aimed to determine the influence of different fatty acids on miRNA expression in offspring when given during early pregnancy. We fed pregnant either soybean (SO), olive (OO), fish (FO), linseed (LO), or palm-oil (PO) diets from conception to day 12 of gestation; and standard diet thereafter. miRNA expression was assessed in liver an adipose tissue of pregnant rats and their virgin counterparts. While liver concentrations of fatty acids in pregnant or virgin rats replicated those of the diets consumed during early pregnancy, their pups' liver tissue marginally reflected those of the respective experimental feeds. By contrast, the liver fatty acid profile of adult offsprings was similar, regardless of the diet fed during gestation. Different parental miRNAs were modulated by the different type of fatty acid: in adult offspring, miR-215, miR-10b, miR-26, miR-377-3p, miR-21, and miR-192 among others, were differentially modulated by the different fatty acids fed during early pregnancy. Overall, our results show that maternal consumption of different types of fatty acids during early pregnancy influences miRNA expression in both maternal and offspring tissues, which may epigenetically explain the long-term phenotypic changes of the offspring.	[Casas-Agustench, Patricia; Visioli, Francesco; Davalos, Alberto] CEI UAM CSIC, Madrid Inst Adv Studies IMDEA Food, Lab Disorders Lipid Metab & Mol Nutr, Madrid, Spain; [Fernandes, Flavia S.; Tavares do Carmo, Maria G.] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Herrera, Emilio] Univ San Pablo CEU, Fac Pharm, Dept Biochem & Chem, Madrid, Spain; [Herrera, Emilio] Univ San Pablo CEU, Fac Med, Dept Biochem & Chem, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidade Federal do Rio de Janeiro; San Pablo CEU University; San Pablo CEU University	Herrera, E (corresponding author), Univ San Pablo CEU, Fac Pharm, Dept Biochem & Chem, Madrid, Spain.	eherrera@ceu.es; alberto.davalos@imdea.org	Visioli, Francesco/AAE-8510-2020; Herrera-Castillon, Emilio/D-9143-2012; Visioli, Francesco/J-9356-2013; Davalos, Alberto/AAA-9949-2021; , Patricia Casas-Agustench/M-7762-2014	Herrera-Castillon, Emilio/0000-0002-8152-787X; Visioli, Francesco/0000-0002-1756-1723; , Patricia Casas-Agustench/0000-0003-4424-1087; Davalos, Alberto/0000-0001-5709-6443	Instituto de Salud Carlos III (FIS) [PI11/00315]; European FEDER Funds; Sociedad Espanola de Arteriosclerosis; Ministerio de Economia y Competitividad [AGL2011-28995]; European Union [PIOF-GA-2010-272581]; Fundacion Ramon Areces [CIVP16A1835]	Instituto de Salud Carlos III (FIS)(Instituto de Salud Carlos IIIEuropean Commission); European FEDER Funds(European Commission); Sociedad Espanola de Arteriosclerosis; Ministerio de Economia y Competitividad(Spanish Government); European Union(European Commission); Fundacion Ramon Areces	This work was supported in part by the Instituto de Salud Carlos III (FIS, PI11/00315), European FEDER Funds and the Sociedad Espanola de Arteriosclerosis to A. D.; by the Ministerio de Economia y Competitividad to F. V. (AGL2011-28995); by the European Union Seventh Framework Programme (grant agreement no. PIOF-GA-2010-272581) to P. C-A. and by the Fundacion Ramon Areces to E. H (CIVP16A1835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Ayed R, 2014, BR J NUTR, P1; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Burdge GC, 2014, CURR OPIN CLIN NUTR, V17, P156, DOI 10.1097/MCO.0000000000000023; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Fernandes FS, 2012, PROSTAG LEUKOTR ESS, V86, P167, DOI 10.1016/j.plefa.2012.03.001; Fernandes FS, 2012, LIPIDS, V47, P505, DOI 10.1007/s11745-012-3660-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Karbiener M, 2013, STEM CELLS, DOI [10.1002/stem.1574, DOI 10.1002/STEM.1574]; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lamaziere A, 2013, PROSTAG LEUKOTR ESS, V88, P149, DOI 10.1016/j.plefa.2012.12.001; Lauritzen L, 2011, MATERN CHILD NUTR, V7, P41, DOI 10.1111/j.1740-8709.2011.00303.x; Leon DA, 1998, EUR J CLIN NUTR, V52, pS72; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCAS A, 1991, CIBA F SYMP, V156, P38; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058622; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rodriguez-Bernal CL, 2010, AM J CLIN NUTR, V91, P1659, DOI 10.3945/ajcn.2009.28866; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Sardinha FLC, 2013, AM J PHYSIOL-REG I, V304, pR313, DOI 10.1152/ajpregu.00392.2012; Shi Y, 2014, INT J INF TECH DECIS, V13, P1, DOI 10.1142/S0219622014010019; Simmons R, 2011, P NUTR SOC, V70, P73, DOI 10.1017/S0029665110003988; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song GX, 2014, GENE, V533, P481, DOI 10.1016/j.gene.2013.10.011; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Visioli F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00042; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Xu GF, 2014, MOL MED REP, V10, P223, DOI 10.3892/mmr.2014.2204; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62; Zhu LL, 2013, MOL BIOL REP, V40, P5669, DOI 10.1007/s11033-013-2668-2	53	31	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117858	10.1371/journal.pone.0117858	http://dx.doi.org/10.1371/journal.pone.0117858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671565	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300073
J	Ferreira, LC; Thums, M; Meeuwig, JJ; Vianna, GMS; Stevens, J; McAuley, R; Meekan, MG				Ferreira, Luciana C.; Thums, Michele; Meeuwig, Jessica J.; Vianna, Gabriel M. S.; Stevens, John; McAuley, Rory; Meekan, Mark G.			Crossing Latitudes-Long-Distance Tracking of an Apex Predator	PLOS ONE			English	Article							SHARKS CARCHARODON-CARCHARIAS; NEW-SOUTH-WALES; MARINE PROTECTED AREA; GULF-OF-MEXICO; GALEOCERDO-CUVIER; TIGER SHARK; MOVEMENT PATTERNS; GUADALUPE ISLAND; MESHING PROGRAM; HABITAT USE	Tiger sharks (Galeocerdo cuvier) are apex predators occurring in most tropical and warm temperate marine ecosystems, but we know relatively little of their patterns of residency and movement over large spatial and temporal scales. We deployed satellite tags on eleven tiger sharks off the north-western coast of Western Australia and used the Brownian Bridge kernel method to calculate home ranges and analyse movement behaviour. One individual recorded one of the largest geographical ranges of movement ever reported for the species, travelling over 4000 km during 517 days of monitoring. Tags on the remainder of the sharks reported for shorter periods (7-191 days). Most of these sharks had restricted movements and long-term (30-188 days) residency in coastal waters in the vicinity of the area where they were tagged. Core home range areas of sharks varied greatly from 1166.9 to 634,944 km(2). Tiger sharks spent most of their time in water temperatures between 23 degrees-26 degrees C but experienced temperatures ranging from 6 degrees C to 33 degrees C. One shark displayed seasonal movements among three distinct home range cores spread along most of the coast of Western Australia and generalized linear models showed that this individual had different patterns of temperature and depth occupancy in each region of the coast, with the highest probability of residency occurring in the shallowest areas of the coast with water temperatures above 23 degrees C. These results suggest that tiger sharks can migrate over very large distances and across latitudes ranging from tropical to the cool temperate waters. Such extensive long-term movements may be a key element influencing the connectivity of populations within and among ocean basins.	[Ferreira, Luciana C.; Vianna, Gabriel M. S.] Univ Western Australia, Sch Anim Biol, UWA Oceans Inst, Crawley, WA, Australia; [Ferreira, Luciana C.; Thums, Michele; Vianna, Gabriel M. S.; Meekan, Mark G.] Australian Inst Marine Sci, Perth, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Crawley, WA, Australia; [Stevens, John] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [McAuley, Rory] Govt Western Australia, WA Fisheries & Marine Res Labs, Dept Fisheries, Perth, WA, Australia	University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ferreira, LC (corresponding author), Univ Western Australia, Sch Anim Biol, UWA Oceans Inst, Crawley, WA, Australia.	luciana.ferreira@research.uwa.edu.au	Thums, Michele/A-3850-2013	Thums, Michele/0000-0002-8669-8440; Meekan, Mark/0000-0002-3067-9427; Meeuwig, Jessica/0000-0003-1169-8785	Australian Institute of Marine Science; CSIRO Marine and Atmospheric Research; Department of Fisheries, Government of Western Australia	Australian Institute of Marine Science; CSIRO Marine and Atmospheric Research(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of Fisheries, Government of Western Australia	Funding was provided by the Australian Institute of Marine Science, CSIRO Marine and Atmospheric Research and the Department of Fisheries, Government of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 1997, FISH RES, V29, P101, DOI 10.1016/S0165-7836(96)00536-X; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Bullard F., 1991, THESIS U N CAROLINA; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calange C, 2011, HOME RANGE ESTIMATIO; Carlstein E, 1998, BERNOULLI, V4, P305, DOI 10.2307/3318719; Castillo-Geniz JL, 1998, MAR FRESHWATER RES, V49, P611, DOI 10.1071/MF97120; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Compagno L. J. V., 1984, SHARKS WORLD ANNOTAT, V4; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; CRESSWELL G, 2000, PAP P R SOC TASMANIA, V133, P21, DOI DOI 10.26749/RSTPP.133.3.21; Dicken ML, 2009, AFR J MAR SCI, V31, P227, DOI 10.2989/AJMS.2009.31.2.10.882; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Drymon JM, 2013, FISH B-NOAA, V111, P370, DOI 10.7755/FB.111.4.6; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Estes J., 2001, ENCY BIODIVERSITY, P857, DOI [DOI 10.1006/RWBD.1999.0280, 10.1016/B0-12-226865-2/00358-8]; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Farmer BM, 2011, ENVIRON BIOL FISH, V91, P71, DOI 10.1007/s10641-010-9761-3; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Green M, 2009, REPORT NSW SHARK MES; GUDGER EW, 1949, COPEIA, P39; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Handley AJ, 2010, FISHERY REPORTS 2009; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Hazin FHV, 2008, B MAR SCI, V82, P199; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heithaus MR, 2010, CRC MAR BIOL SER, P611; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hooker SK, 1999, CONSERV BIOL, V13, P592, DOI 10.1046/j.1523-1739.1999.98099.x; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Kerstetter DW, 2004, FISH B-NOAA, V102, P750; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; KROGH M, 1994, AUST J MAR FRESH RES, V45, P1087; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Matsumoto T, 2005, COLLECT VOL SCI PAP, V58, P1694; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; PATERSON RA, 1990, BIOL CONSERV, V52, P147, DOI 10.1016/0006-3207(90)90123-7; Patton A, 2009, ECONOMET REV, V28, P372, DOI 10.1080/07474930802459016; PEPPERELL JG, 1992, AUST J MAR FRESH RES, V43, P213, DOI 10.1071/MF9920213; Politis D. N., 2004, ECON REV, V23, P53, DOI [DOI 10.1081/ETC-120028836, 10.1081/ETC-120028836]; Polovina JJ, 1993, MAR FISH REV, V55, P1; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; REID JL, 1994, PROG OCEANOGR, V33, P1, DOI 10.1016/0079-6611(94)90014-0; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rousseaux CSG, 2012, CONT SHELF RES, V32, P22, DOI 10.1016/j.csr.2011.10.010; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer C. A., 2009, IUCN RED LIST THREAT; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Sims DW, 2010, CRC MAR BIOL SER, P351; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; SMITH RL, 1991, J PHYS OCEANOGR, V21, P323, DOI 10.1175/1520-0485(1991)021<0323:TLCOWA>2.0.CO;2; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Team RDC, 2013, R LANG ENV STAT COMP; Vaudo JJ, 2014, ECOL EVOL, P1; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x	101	42	42	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116916	10.1371/journal.pone.0116916	http://dx.doi.org/10.1371/journal.pone.0116916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671609	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300027
J	Marquez, N; Martinez-Harms, J; Vasquez, RA; Mpodozis, J				Marquez, Natalia; Martinez-Harms, Jaime; Vasquez, Rodrigo A.; Mpodozis, Jorge			Early Olfactory Environment Influences Social Behaviour in Adult Octodon degus	PLOS ONE			English	Article							KIN RECOGNITION; GROUND-SQUIRRELS; ODOR; RAT; EXPERIENCE	We evaluated the extent to which manipulation of early olfactory environment can influence social behaviours in the South American Hystricognath rodent Octodon degus. The early olfactory environment of newborn degus was manipulated by scenting all litter members with eucalyptol during the first month of life. The social behaviour of sexually mature animals (5-7 months old) towards conspecifics was then assessed using a y-maze to compare the response of control (naive) and treated animals to two different olfactory configurations (experiment 1): (i) a non-familiarized conspecific impregnated with eucalyptol (eucalyptol arm) presented against (ii) a non-familiarized unscented conspecific (control arm). In addition, in dyadic encounters, we assessed the behaviour of control and eucalyptol treated animals towards a non-familiarized conspecific scented with eucalyptol (experiment 2). We found that control subjects explored and spent significantly less time in the eucalyptol arm, indicating neophobic behaviours towards the artificially scented conspecific. Treated subjects explored and spent similar time in both arms of the maze, showing the same interest for both olfactory stimuli presented. During dyadic encounters in experiment 2, an interaction effect between early experience and sex was observed. Control males escaped and avoided their scented partnermore frequently than eucalyptol treatedmale subjects and than females. Both groups did not differ in the exploration of their scented partners, suggesting that avoidance within agonistic context does not relate to neophobic behaviours. Our results suggest that the exposure to eucalyptol during early ontogeny decreases evasive behaviours within an agonistic context as a result of olfactory learning. Altogether, these results indicate that olfactory cues learned in early ontogeny can influence olfactory-guided behaviours in adult degus.	[Marquez, Natalia; Martinez-Harms, Jaime; Vasquez, Rodrigo A.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Inst Ecol & Biodiversidad, Santiago, Chile; [Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Universidad de Chile; Universidad de Chile	Marquez, N (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	nmarquez@zedat.fu-berlin.de	Márquez, Natalia/GPW-8415-2022	Marquez, Natalia/0000-0002-4200-6211	Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP [UCO-0214]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT [AT-24050185]; Iniciativa Cientifica Milenio [ICM-P05-002]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile [PFB-23-CONICYT]; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1140548, 1120124]	Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Iniciativa Cientifica Milenio; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	NM was founded by Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP UCO-0214, and by Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT AT-24050185; RAV was founded by Iniciativa Cientifica Milenio ICM-P05-002, Comision Nacional de Investigacion Cientifica y Tecnologica de Chile PFB-23-CONICYT, and Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1140548; JM was founded by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1120124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APFELBACH R, 1986, BEHAV PROCESS, V12, P363, DOI 10.1016/0376-6357(86)90005-7; BAUDOIN C, 1991, BEHAV PROCESS, V24, P49, DOI 10.1016/0376-6357(91)90086-F; CARTER CS, 1970, ANIM BEHAV, V18, P238, DOI 10.1016/S0003-3472(70)80033-1; DAVIS TM, 1975, BEHAV BIOL, V14, P511, DOI 10.1016/S0091-6773(75)90696-3; Dawkins Richard, 1976, SELFISH GENE; DUVEAU A, 1988, PHYSIOL BEHAV, V42, P265, DOI 10.1016/0031-9384(88)90080-7; Ebensperger LA, 2004, NATURWISSENSCHAFTEN, V91, P391, DOI 10.1007/s00114-004-0545-5; Ebensperger LA, 2012, BEHAV ECOL SOCIOBIOL, V66, P261, DOI 10.1007/s00265-011-1274-3; FILLION TJ, 1986, SCIENCE, V231, P729, DOI 10.1126/science.3945807; FULK GW, 1976, J MAMMAL, V57, P495, DOI 10.2307/1379298; GOTTLIEB G, 1991, DEV PSYCHOL, V27, P35, DOI 10.1037/0012-1649.27.1.35; GOTTLIEB GILBERT, 1961, BEHAVIOUR, V18, P205, DOI 10.1163/156853961X00132; Haplin Z.T., 1991, P220; Hepper P.G., 1991, P259, DOI 10.1017/CBO9780511525414.011; HOLMES WG, 1986, ANIM BEHAV, V34, P38, DOI 10.1016/0003-3472(86)90004-7; HOLMES WG, 1984, BEHAV ECOL SOCIOBIOL, V14, P225, DOI 10.1007/BF00299622; HOLMES WG, 1982, AM ZOOL, V22, P491; Jesseau SA, 2004, KIN DISCRIMINATION S; Jesseau SA, 2008, ANIM BEHAV, V75, P573, DOI 10.1016/j.anbehav.2007.06.015; KLEIMAN DG, 1975, BEHAV BIOL, V14, P519, DOI 10.1016/S0091-6773(75)90708-7; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lorenz K. Z., 1937, Auk, V1937, P245; MARR JN, 1969, BEHAVIOUR, V33, P277, DOI 10.1163/156853969X00116; MARR JN, 1965, J GENET PSYCHOL, V107, P167, DOI 10.1080/00221325.1965.10532774; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; Maturana-Romesin H, 2000, REV CHIL HIST NAT, V73, P261; MESERVE PL, 1993, OECOLOGIA, V94, P153, DOI 10.1007/BF00341311; Mino GPY, 1999, CAN J ZOOL, V77, P118; Mino GPY, 1999, CAN J ZOOL, V77, P1631, DOI 10.1139/cjz-77-10-1631; Oyama S, 1985, ONTOGENY INFORM DEV; RUSINIAK KW, 1979, BEHAV NEURAL BIOL, V25, P1, DOI 10.1016/S0163-1047(79)90688-5; Sevelinges Y, 2009, BEHAV BRAIN RES, V198, P313, DOI 10.1016/j.bbr.2008.11.003; Sokal RR, 2012, BIOMETRY PRINCIPLES, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Soto-Gamboa M, 2005, HORM BEHAV, V47, P311, DOI 10.1016/j.yhbeh.2004.11.010; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; Tang-Martinez Z, 2001, BEHAV PROCESS, V53, P21, DOI 10.1016/S0376-6357(00)00148-0; Vasquez RA, 2002, BEHAV ECOL, V13, P182, DOI 10.1093/beheco/13.2.182; Vasquez RA, 1997, REV CHIL HIST NAT, V70, P557; Villavicencio CP, 2009, ANIM BEHAV, V78, P377, DOI 10.1016/j.anbehav.2009.04.026; WILSON SC, 1974, AM ZOOL, V14, P341; WOO CC, 1987, DEV BRAIN RES, V36, P309, DOI 10.1016/0165-3806(87)90038-1	42	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118018	10.1371/journal.pone.0118018	http://dx.doi.org/10.1371/journal.pone.0118018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671542	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300080
J	Sanders, KL; Schroeder, T; Guinea, ML; Rasmussen, AR				Sanders, Kate L.; Schroeder, Tina; Guinea, Michael L.; Rasmussen, Arne R.			Molecules and Morphology Reveal Overlooked Populations of Two Presumed Extinct Australian Sea Snakes (Aipysurus: Hydrophiinae)	PLOS ONE			English	Article							CONSERVATION STATUS; PHYLOGENY	The critically endangered leaf-scaled (Aipysurus foliosquamaI) and short-nosed (A. aprae-frontalis) sea snakes are currently recognised only from Ashmore and Hibernia reefs similar to 600km off the northwest Australian coast. Steep population declines in both species were documented over 15 years and neither has been sighted on dedicated surveys of Ashmore and Hibernia since 2001. We examine specimens of these species that were collected from coastal northwest Australian habitats up until 2010 (A. foliosquama) and 2012 (A. apraefrontalis) and were either overlooked or treated as vagrants in conservation assessments. Morphological variation and mitochondrial sequence data confirm the assignment of these coastal specimens to A. foliosquama (Barrow Island, and offshore from Port Hedland) and A. apraefrontalis (Exmouth Gulf, and offshore from Roebourne and Broome). Collection dates, and molecular and morphological variation between coastal and offshore specimens, suggest that the coastal specimens are not vagrants as previously suspected, but instead represent separate breeding populations. The newly recognised populations present another chance for leaf-scaled and short-nosed sea snakes, but coastal habitats in northwest Australia are widely threatened by infrastructure developments and sea snakes are presently omitted from environmental impact assessments for industry. Further studies are urgently needed to assess these species' remaining distributions, population structure, and extent of occurrence in protected areas.	[Sanders, Kate L.; Schroeder, Tina] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5000, Australia; [Guinea, Michael L.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Rasmussen, Arne R.] Royal Danish Acad Fine Arts, Sch Architecture Design & Conservat, DK-1263 Copenhagen, Denmark	University of Adelaide; Charles Darwin University	Sanders, KL (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5000, Australia.	kate.sanders@adelaide.edu.au	Sanders, Kate L/D-1507-2019	Sanders, Kate L/0000-0002-9581-268X; Parkhurst, Tina/0000-0002-8481-9069; Rasmussen, Arne Redsted/0000-0001-5454-4423	Australian Research Council [FT130101965]; Australian Biological Resources Study grant [RF214-34]; PTTEP (Exploration and Production Public Company Limited) Australasia; School of Conservation, Copenhagen	Australian Research Council(Australian Research Council); Australian Biological Resources Study grant; PTTEP (Exploration and Production Public Company Limited) Australasia; School of Conservation, Copenhagen	This work was funded by an Australian Research Council Future Fellowship (FT130101965 Sanders) to KLS, an Australian Biological Resources Study grant (ID: RF214-34) to KLS, Timor Sea survey grants from PTTEP (Exploration and Production Public Company Limited) Australasia to MLG, and a School of Conservation, Copenhagen, Research Fund 2012-13 grant to ARR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094844; Armstrong Graham, 1992, Herpetofauna (Sydney), V22, P3; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Cogger H.G., 1975, P1; Cogger H.G., 1975, BIOL SEA SNAKES, P59; Cogger H.G., 1983, ZOOLOGICAL CATALOGUE, P241; Cogger HG, 2014, REPTILES AMPHIBIANS, DOI [10.1682/JRRD.2014.01.0007, DOI 10.1682/JRRD.2014.01.0007]; David P., 1999, DUMERILIA, V3, P3; Director of National Parks, 2013, DRAFT N W COMM MAR R; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GENEIOUS V5 0 4; Elfes CT, 2013, HERPETOL CONSERV BIO, V8, P37; Golay P., 1993, ENDOGLYPHS OTHER MAJ; Greer A.E., 1997, BIOL EVOLUTION AUSTR; Guinea Michael L., 2005, Beagle, P199; Guinea ML, 2012, SURVEYS SEA SNAKES S; Guinea ML, 2007, CONSULTANTS REPORT D; Guinea ML, 1995, REPORT AUSTR NATURE; Heatwole Harold, 1994, P167; Hibbard E., 1975, BIOL SEA SNAKES, P355; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kharin V.E., 2005, IZV TINRO, V140, P71; KHARIN VE, 1981, ZOOL ZH, V60, P257; Kharin VE, 2006, RUSS J MAR BIOL, V32, P194; LEVITON AE, 1985, COPEIA, P802; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Masini R, 2011, NODE 1 DREDGING SCI, P23; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McCosker J., 1975, BIOL SEA SNAKES, V75, P217; Minton S. A., 1975, BIOL SEA SNAKES, P141; Minton S.A., 1975, BIOL SEA SNAKES, P21; Miras JAM, 2009, IUCN RED LIST THREAT; Moore GI, 2015, MAR BIODIVERS, V45, P595, DOI 10.1007/s12526-014-0267-7; Nijman V, 2012, HERPETOL J, V22, P83; Rambaut A., 2007, TRACER V1 4; Rasmussen A.R., 1989, AMPHIBIA-REPTILIA, V10, P397, DOI DOI 10.1163/156853889X00043; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Rasmussen Arne Redsted, 2002, Steenstrupia, V27, P47; Rasmussen Arne Redsted, 1993, Bulletin of the British Museum (Natural History) Zoology, V59, P97; Sadlier RA, 2010, IUCN RED LIST THREAT; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2013, MOL PHYLOGENET EVOL, V66, P575, DOI 10.1016/j.ympev.2012.09.021; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Shuntov V.P., 1971, EKOLOGIYA, V4, P65; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith L.A., 1974, REC W AUSTR MUS, V3, P93; Smith M. A., 1926, MONOGRAPH SEA SNAKES; Storr G. M., 2002, SNAKES W AUSTR; Sutherland S, 2001, AUSTR ANIMAL TOXINS; THOMAS RA, 1976, COPEIA, P839; TSSC (Threatened Species Scientific Committee), 2010, LIST ADV AIP APR SHO; TSSC (Threatened Species Scientific Committee), 2010, LIST ADV AIP FOL LEA; Voris H., 1972, J MAR BIOL ASSOC IND, V14, P429; VORIS H K, 1977, Fieldiana Zoology, V70, P79; Wallach V, 2014, SNAKES WORLD CATALOG, DOI [10.1682/JRRD.2014.01.0007, DOI 10.1682/JRRD.2014.01.0007]; Wells R.W, 2007, AUSTRAL BIODIV REC, V8, P1	59	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115679	10.1371/journal.pone.0115679	http://dx.doi.org/10.1371/journal.pone.0115679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671608	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300011
J	Fuso, A; Ferraguti, G; Scarpa, S; Ferrer, I; Lucarelli, M				Fuso, Andrea; Ferraguti, Giampiero; Scarpa, Sigfrido; Ferrer, Isidre; Lucarelli, Marco			Disclosing Bias in Bisulfite Assay: MethPrimers Underestimate High DNA Methylation	PLOS ONE			English	Article							NON-CPG METHYLATION; EMBRYONIC STEM-CELLS; MAMMALIAN-CELLS; GENOME; DIFFERENTIATION; GENE; DEMETHYLATION; EXPRESSION; TISSUES; REGION	Discordant results obtained in bisulfite assays using MethPrimers (PCR primers designed using MethPrimer software or assuming that non-CpGs cytosines are non methylated) versus primers insensitive to cytosine methylation lead us to hypothesize a technical bias. We therefore used the two kinds of primers to study different experimental models and methylation statuses. We demonstrated that MethPrimers negatively select hypermethylated DNA sequences in the PCR step of the bisulfite assay, resulting in CpG methylation underestimation and non-CpG methylation masking, failing to evidence differential methylation statuses. We also describe the characteristics of "Methylation-Insensitive Primers" (MIPs), having degenerated bases (G/A) to cope with the uncertain C/U conversion. As CpG and non-CpG DNA methylation patterns are largely variable depending on the species, developmental stage, tissue and cell type, a variable extent of the bias is expected. The more the methylome is methylated, the greater is the extent of the bias, with a prevalent effect of non-CpG methylation. These findings suggest a revision of several DNA methylation patterns so far documented and also point out the necessity of applying unbiased analyses to the increasing number of epigenomic studies.	[Fuso, Andrea] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Fuso, Andrea] Santa Lucia Fdn, IRCCS, European Ctr Brain Res CERC, Rome, Italy; [Ferraguti, Giampiero; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Scarpa, Sigfrido] Univ Roma La Sapienza, Dept Surg P Valdoni, I-00185 Rome, Italy; [Ferrer, Isidre] Bellvitge Univ Hosp, Inst Neuropathol, IDIBELL, Lhospitalet De Llobregat, Spain; [Ferrer, Isidre] Univ Barcelona, CIBERNED, Lhospitalet De Llobregat, Spain; [Lucarelli, Marco] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; CIBERNED; University of Barcelona; Fondazione Cenci Bolognetti; Sapienza University Rome	Fuso, A (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	andrea.fuso@uniroma1.it	Lucarelli, Marco/AAC-1667-2019	Fuso, Andrea/0000-0001-9467-5671; FERRAGUTI, Giampiero/0000-0001-6129-4071; Lucarelli, Marco/0000-0002-5538-2494	European Community [278486 "DEVELAGE"]; Sapienza Universita di Roma	European Community(European Commission); Sapienza Universita di Roma	This research is supported by funding from: European Community 7th Framework program (FP7/2007-2013) grant no 278486 "DEVELAGE" to AF and SS; Sapienza Universita di Roma, Scientific Research Programs 2012 and 2013 to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuso A, 2006, ANAL BIOCHEM, V350, P24, DOI 10.1016/j.ab.2005.12.008; Fuso A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.013; Fuso A, 2011, NEUROBIOL AGING, V32, P187, DOI 10.1016/j.neurobiolaging.2009.02.013; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo WL, 2014, NUCLEIC ACIDS RES, V42, P3009, DOI 10.1093/nar/gkt1306; Gupta R, 2010, BIOTECHNIQUES, V49, pIII, DOI 10.2144/000113493; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Lucarelli M, 2001, J BIOL CHEM, V276, P7500, DOI 10.1074/jbc.M008234200; Nishino K, 2011, J REPROD DEVELOP, V57, P586, DOI 10.1262/jrd.11-033A; Patil V, 2014, EPIGENETICS-US, V9, P823, DOI 10.4161/epi.28741; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yan J, 2011, EXP CELL RES, V317, P2555, DOI 10.1016/j.yexcr.2011.08.019; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	31	36	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118318	10.1371/journal.pone.0118318	http://dx.doi.org/10.1371/journal.pone.0118318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692551	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500116
J	Ohnishi, A; Asayama, R; Mogi, M; Nakaoka, H; Kan-No, H; Tsukuda, K; Chisaka, T; Wang, XL; Bai, HY; Shan, BS; Kukida, M; Iwanami, J; Horiuchi, M				Ohnishi, Arika; Asayama, Rie; Mogi, Masaki; Nakaoka, Hirotomo; Kan-no, Harumi; Tsukuda, Kana; Chisaka, Toshiyuki; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Iwanami, Jun; Horiuchi, Masatsugu			Drinking Citrus Fruit Juice Inhibits Vascular Remodeling in Cuff-Induced Vascular Injury Mouse Model	PLOS ONE			English	Article							BLOOD-PRESSURE; ORANGE JUICE; UNSHIU; RISK; CELLS; MARKERS; DIETS	Citrus fruits are thought to have inhibitory effects on oxidative stress, thereby attenuating the onset and progression of cancer and cardiovascular disease; however, there are few reports assessing their effect on vascular remodeling. Here, we investigated the effect of drinking the juice of two different citrus fruits on vascular neointima formation using a cuff-induced vascular injury mouse model. Male C57BL6 mice were divided into five groups as follows: 1) Control (water) (C), 2) 10% Citrus unshiu (CU) juice (CU10), 3) 40% CU juice (CU40), 4) 10% Citrus iyo (CI) juice (CI10), and 5) 40% CI juice (CI40). After drinking them for 2 weeks from 8 weeks of age, cuff injury was induced by polyethylene cuff placement around the femoral artery. Neointima formation was significantly attenuated in CU40, CI10 and CI40 compared with C; however, no remarkable preventive effect was observed in CU10. The increases in levels of various inflammatory markers including cytokines such as monocyte chemotactic protein-1, interleukin-6 (IL-6), IL-1 beta, and tumor necrosis factor-alpha in response to vascular injury did not differ significantly between C, CU10 and CI10. The increases in cell proliferation and superoxide anion production were markedly attenuated in CI10, but not in CU10 compared with C. The increase in phosphorylated ERK expression was markedly attenuated both in CU10 and CI10 without significant difference between CU10 and CI10. Accumulation of immune cells did not differ between CU10 and CI10. These results indicate that drinking citrus fruit juice attenuates vascular remodeling partly via a reduction of oxidative stress. Interestingly, the preventive efficacy on neointima formation was stronger in CI than in CU at least in part due to more prominent inhibitory effects on oxidative stress by CI.	[Ohnishi, Arika; Asayama, Rie; Mogi, Masaki; Nakaoka, Hirotomo; Kan-no, Harumi; Tsukuda, Kana; Chisaka, Toshiyuki; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Iwanami, Jun; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Chisaka, Toshiyuki] Ehime Univ, Grad Sch Med, Dept Pediat, Tohon, Ehime, Japan; [Kukida, Masayoshi] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Mogi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp			JSPS KAKENHI [25293310, 25462220]; pharmaceutical company: Astellas Pharma Inc.; pharmaceutical company: Bayer Yakuhin, Ltd.; pharmaceutical company: Daiichi-Sankyo Pharmaceutical Co. Ltd.; pharmaceutical company: Nippon Boehringer Ingelheim Co. Ltd.; pharmaceutical company: Novartis Pharma K.K.; pharmaceutical company: Shionogi Co., Ltd.; pharmaceutical company: Takeda Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); pharmaceutical company: Astellas Pharma Inc.; pharmaceutical company: Bayer Yakuhin, Ltd.; pharmaceutical company: Daiichi-Sankyo Pharmaceutical Co. Ltd.; pharmaceutical company: Nippon Boehringer Ingelheim Co. Ltd.; pharmaceutical company: Novartis Pharma K.K.; pharmaceutical company: Shionogi Co., Ltd.; pharmaceutical company: Takeda Pharmaceutical Co. Ltd.	This study was supported by JSPS KAKENHI Grant Numbers 25293310 (MH) and 25462220 (MM), and research grants from pharmaceutical companies: Astellas Pharma Inc., Bayer Yakuhin, Ltd., Daiichi-Sankyo Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Shionogi & Co., Ltd., and Takeda Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Codoner-Franch P, 2008, J PEDIATR GASTR NUTR, V47, P349, DOI 10.1097/MPG.0b013e31816a8cdb; Codoner-Franch P, 2013, INT J FOOD SCI NUTR, V64, P815, DOI 10.3109/09637486.2013.798267; Codoner-Franch P, 2010, ACTA PAEDIATR, V99, P1841, DOI 10.1111/j.1651-2227.2010.01903.x; Devaraj S, 2011, CLIN NUTR, V30, P668, DOI 10.1016/j.clnu.2011.03.009; Foschi R, 2010, CANCER CAUSE CONTROL, V21, P237, DOI 10.1007/s10552-009-9454-4; Fujita T, 2009, HYPERTENSION, V53, P688, DOI 10.1161/HYPERTENSIONAHA.108.128140; Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G; Ghanim H, 2010, AM J CLIN NUTR, V91, P940, DOI 10.3945/ajcn.2009.28584; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; Jaganathan SK, 2014, WORLD J GASTROENTERO, V20, P4618, DOI 10.3748/wjg.v20.i16.4618; Jin H, 2013, ONCOL REP, V30, P2336, DOI 10.3892/or.2013.2711; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lee S, 2011, J ETHNOPHARMACOL, V133, P973, DOI 10.1016/j.jep.2010.07.018; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manners GD, 2007, J AGR FOOD CHEM, V55, P8285, DOI 10.1021/jf071797h; Matsumoto Ryoji, 2008, Horticultural Research (Japan), V7, P481, DOI 10.2503/hrj.7.481; Ministry of Education Culture Sports Science and Technology Japan, 2010, STAND TABL FOOD COMP; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Nogata Y, 2006, BIOSCI BIOTECH BIOCH, V70, P178, DOI 10.1271/bbb.70.178; Nunez-Cordoba JM, 2009, EUR J CLIN NUTR, V63, P605, DOI 10.1038/ejcn.2008.22; Oude Griep LM, 2011, EUR J CLIN NUTR, V65, P791, DOI 10.1038/ejcn.2011.36; Oude Griep LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013609; Steevens J, 2011, INT J CANCER, V129, P2681, DOI 10.1002/ijc.25928; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Suzuki R, 2007, INT J CANCER, V120, P252, DOI 10.1002/ijc.22240; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P2852, DOI 10.1271/bbb.70397; Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Xu CW, 2013, BIOL PHARM BULL, V36, P1549, DOI 10.1248/bpb.b13-00247; Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084	36	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117616	10.1371/journal.pone.0117616	http://dx.doi.org/10.1371/journal.pone.0117616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692290	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500064
J	Katzen, JB; Raparia, K; Agrawal, R; Patel, JD; Rademaker, A; Varga, J; Dematte, JE				Katzen, Jeremy B.; Raparia, Kirtee; Agrawal, Rishi; Patel, Jyoti D.; Rademaker, Alfred; Varga, John; Dematte, Jane E.			Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; SCLERODERMA; ASSOCIATION; DISEASE; METAANALYSIS; KRAS	Background Systemic Sclerosis (SSc) is a rare connective tissue disorder associated with an increased risk of malignancy including lung cancer. Methods A single center review of all cases of lung cancer in patients with SSc was conducted. Clinical, radiographic, and detailed pathologic data was collected. Risk factors were compared with our center's SSc Registry. Cancer characteristics were compared with the National Cancer Institute SEER Cancer Statistics (NCI SEER) data. Results 17 cases were identified; the majority were females (82%) with the lung cancers diagnosed after the onset of SSc (88%). Tobacco use was identified in 65% of cases. Serologic testing showed 50% of cases were Scl-70 positive. Twelve cases had radiographic evidence of SSc lung involvement, however only 6 had restrictive physiology on pulmonary function testing. Thirteen cases had pulmonary nodules preceding lung cancer. Thirteen of the cancers were adenocarcinoma. Ten underwent molecular mutational profiling: 2/8 had KRAS mutation and 1/10 had EGFR mutation. More of the non-small cell lung cancers were diagnosed at localized disease (56%) than in the NCI SEER database. However, 5 years survival among the stage I cases was 25% versus an expected survival of 54%. Conclusions The high proportion of adenocarcinomas seen in our study is different from that reported in the literature. Lung cancers were diagnosed at an early stage, likely due to our center's practice of radiographic screening for SSc associated lung involvement, however this did not confer a survival advantage. A high proportion of patients who developed lung cancer had interstitial lung disease.	[Katzen, Jeremy B.; Dematte, Jane E.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Raparia, Kirtee] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Agrawal, Rishi] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Patel, Jyoti D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Rademaker, Alfred] Northwestern Univ, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA; [Varga, John] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Varga, John] Northwestern Univ, Feinberg Sch Med, Northwestern Scleroderma Program, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Katzen, JB (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	Jeremy-Katzen@northwestern.edu	Varga, John/AAK-6472-2021		U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute [P30CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from the U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute (P30CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 2004, HLTH CONS SMOK REP S; Aubry MC, 2002, MAYO CLIN PROC, V77, P763, DOI 10.4065/77.8.763; Bonifazi M, 2013, RHEUMATOLOGY, V52, P143, DOI 10.1093/rheumatology/kes303; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Colaci M, 2013, AUTOIMMUN REV, V12, P374, DOI 10.1016/j.autrev.2012.06.003; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Derk CT, 2006, J RHEUMATOL, V33, P1113; Dufort S, 2009, ANAL BIOCHEM, V391, P166, DOI 10.1016/j.ab.2009.05.027; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Howlader N, 2011, SURVEILLANCE EPIDEMI, DOI [10.1016/j.healun.2014.01.862, DOI 10.1016/J.HEALUN.2014.01.862]; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Kuo CF, 2012, SCAND J RHEUMATOL, V41, P44, DOI 10.3109/03009742.2011.618145; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moinzadeh P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4486; Olesen AB, 2010, BRIT J DERMATOL, V163, P800, DOI 10.1111/j.1365-2133.2010.09861.x; Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PETERSGOLDEN M, 1985, J RHEUMATOL, V12, P1136; Pontifex EK, 2007, ANN RHEUM DIS, V66, P551, DOI 10.1136/ard.2006.056424; Raparia K, 2014, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2013-0301-RS, DOI 10.5858/ARPA.2013-0301-RS]; Reveille JD, 2003, ARTHRIT RHEUM-ARTHR, V49, P399, DOI 10.1002/art.11113; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; TRAVIS WD, 2011, J THORAC ONCOL, V6, P244, DOI DOI 10.1097/JT0.0B013E318206A221; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Villa C, 2014, ARCH PATHOL LAB MED, DOI [10.5858/1543-2165-139.1.140, DOI 10.5858/1543-2165-139.1.140]; Zhang JQ, 2013, CANCER EPIDEMIOL, V37, P523, DOI 10.1016/j.canep.2013.04.014	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117829	10.1371/journal.pone.0117829	http://dx.doi.org/10.1371/journal.pone.0117829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689302	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700075
J	Lu, XX; Fan, QL; Xu, L; Li, L; Yue, Y; Xu, YY; Su, Y; Zhang, DC; Wang, LN				Lu, Xinxing; Fan, Qiuling; xu, Li; Li, Lin; Yue, Yuan; Xu, Yanyan; Su, Yan; Zhang, Dongcheng; Wang, Lining			Ursolic Acid Attenuates Diabetic Mesangial Cell Injury through the Up-Regulation of Autophagy via miRNA-21/PTEN/Akt/mTOR Suppression	PLOS ONE			English	Article							INDUCED APOPTOSIS; I COLLAGEN; KIDNEY; 3-KINASE-AKT; NEPHROPATHY; EXPRESSION; EFFECTORS; TARGET; GROWTH; MODEL	Objective To investigate the effect of ursolic acid on autophagy mediated through the miRNA-21-targeted phosphoinositide 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway in rat mesangial cells cultured under high glucose (HG) conditions. Methods Rat glomerular mesangial cells were cultured under normal glucose, HG, HG with the PI3K inhibitor LY294002 or HG with ursolic acid conditions. Cell proliferation and hypertrophy were assayed using an MTT assay and the ratio of total protein to cell number, respectively. The miRNA-21 expression was detected using RT-qPCR. The expression of phosphatase and tensin homolog (PTEN)/AKT/mTOR signaling signatures, autophagy-associated protein and collagen I was detected by western blotting and RT-qPCR. Autophagosomes were observed using electron microscopy. Results Compared with mesangial cells cultured under normal glucose conditions, the cells exposed to HG showed up-regulated miRNA-21 expression, down-regulated PTEN protein and mRNA expression, up-regulated p85PI3K, pAkt, pmTOR, p62/SQSTMI, and collagen I expression and down-regulated LC3II expression. Ursolic acid and LY294002 inhibited HG-induced mesangial cell hypertrophy and proliferation, down-regulated p85PI3K, pAkt, pmTOR, p62/SQSTMI, and collagen I expression and up-regulated LC3II expression. However, LY294002 did not affect the expression of miRNA-21 and PTEN. Ursolic acid down-regulated miRNA-21 expression and up-regulated PTEN protein and mRNA expression. Conclusions Ursolic acid inhibits the glucose-induced up-regulation of mesangial cell miRNA-21 expression, up-regulates PTEN expression, inhibits the activation of PI3K/Akt/mTOR signaling pathway, and enhances autophagy to reduce the accumulation of the extracellular matrix and ameliorate cell hypertrophy and proliferation.	[Lu, Xinxing; Fan, Qiuling; xu, Li; Li, Lin; Yue, Yuan; Xu, Yanyan; Wang, Lining] China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Peoples R China; [Lu, Xinxing; Su, Yan; Zhang, Dongcheng] Peoples Hosp Liaoning Prov, Dept Nephrol, Shenyang 110001, Peoples R China	China Medical University	Fan, QL (corresponding author), China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Peoples R China.	cmufql@163.com			National Natural Science Foundation of China [81270808]; Science and technology plan of Liaoning Provincial technology Department [2012225019]; Science and technology plan project of Shenyang Cityi1/4 [F11-264-1-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology plan of Liaoning Provincial technology Department; Science and technology plan project of Shenyang Cityi1/4	This work is supported by National Natural Science Foundation of China (No. 81270808), Science and technology plan of Liaoning Provincial technology Department (2012225019), and Science and technology plan project of Shenyang Cityi1/4 F11-264-1-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa Y, 2007, BIOSCI BIOTECH BIOCH, V71, P31, DOI 10.1271/bbb.60288; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Estacio R O, 2001, Adv Intern Med, V46, P359; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Hafizi S, 2004, AM J PHYSIOL-HEART C, V287, pH1232, DOI 10.1152/ajpheart.00040.2004; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kasinath BS, 2011, KIDNEY INT, V80, P334, DOI 10.1038/ki.2011.165; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kitada M, 2011, EXP DIABETES RES, DOI 10.1155/2011/908185; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Leng SL, 2013, INT J CANCER, V133, P2781, DOI 10.1002/ijc.28301; Li Jin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P467; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Mavroeidi V, 2013, J HISTOCHEM CYTOCHEM, V61, P433, DOI 10.1369/0022155413482925; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Pai Preethi G, 2012, ISRN Pharmacol, V2012, P410902, DOI 10.5402/2012/410902; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sekulic A, 2000, CANCER RES, V60, P3504; Shin SW, 2012, BBA-MOL CELL RES, V1823, P451, DOI 10.1016/j.bbamcr.2011.10.014; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang J, 2012, BASIC CLIN PHARMACOL, V111, P106, DOI 10.1111/j.1742-7843.2012.00870.x; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Wang Yuan-Yuan, 2011, Shengli Xuebao, V63, P325; Wu B, 2012, ARCH PHARM RES, V35, P543, DOI 10.1007/s12272-012-0318-1; YOSHIOKA K, 1990, J PATHOL, V162, P141, DOI 10.1002/path.1711620207; Zhou Y, 2010, INT J MOL MED, V26, P565, DOI 10.3892/ijmm_00000500	44	48	57	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117400	10.1371/journal.pone.0117400	http://dx.doi.org/10.1371/journal.pone.0117400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689721	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700040
J	Voordouw, MJ; Lachish, S; Dolan, MC				Voordouw, Maarten J.; Lachish, Shelly; Dolan, Marc C.			The Lyme Disease Pathogen Has No Effect on the Survival of Its Rodent Reservoir Host	PLOS ONE			English	Article							WHITE-FOOTED MICE; IXODES-SCAPULARIS ACARI; BORRELIA-BURGDORFERI INFECTION; POLYMERASE-CHAIN-REACTION; SENSU-STRICTO STRAINS; WILD BIRD POPULATION; PEROMYSCUS-LEUCOPUS; ENDEMIC MALARIA; DAMMINI ACARI; HUMAN RISK	Zoonotic pathogens that cause devastating morbidity and mortality in humans may be relatively harmless in their natural reservoir hosts. The tick-borne bacterium Borrelia burgdorferi causes Lyme disease in humans but few studies have investigated whether this pathogen reduces the fitness of its reservoir hosts under natural conditions. We analyzed four years of capture-mark-recapture (CMR) data on a population of white-footed mice, Peromyscus leucopus, to test whether B. burgdorferi and its tick vector affect the survival of this important reservoir host. We used a multi-state CMR approach to model mouse survival and mouse infection rates as a function of a variety of ecologically relevant explanatory factors. We found no effect of B. burgdorferi infection or tick burden on the survival of P. leucopus. Our estimates of the probability of infection varied by an order of magnitude (0.051 to 0.535) and were consistent with our understanding of Lyme disease in the Northeastern United States. B. burgdorferi establishes a chronic avirulent infection in their rodent reservoir hosts because this pathogen depends on rodent mobility to achieve transmission to its sedentary tick vector. The estimates of B. burgdorferi infection risk will facilitate future theoretical studies on the epidemiology of Lyme disease.	[Voordouw, Maarten J.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachish, Shelly] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England; [Dolan, Marc C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Enter & Zoonot Infect Dis, Ft Collins, CO USA	University of Pennsylvania; University of Oxford; Centers for Disease Control & Prevention - USA	Voordouw, MJ (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	maarten.voordouw@unine.ch	Voordouw, Maarten J./G-3686-2013	Voordouw, Maarten J./0000-0001-9384-0436	Centers for Diseases Control and Prevention [CK000170]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID) [AI076342]; Swiss National Science Foundation [FN 31003A_141153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER	Centers for Diseases Control and Prevention; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grant CK000170 from the Centers for Diseases Control and Prevention and AI076342 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID). This work was also supported by a grant from the Swiss National Science Foundation to Maarten Voordouw (FN 31003A_141153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1988, ANN NY ACAD SCI, V539, P180, DOI 10.1111/j.1749-6632.1988.tb31852.x; ANDERSON JF, 1985, J CLIN MICROBIOL, V22, P36, DOI 10.1128/JCM.22.1.36-38.1985; ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; ANDERSON JF, 1987, APPL ENVIRON MICROB, V53, P892, DOI 10.1128/AEM.53.4.892-894.1987; Bergstrom S, 1999, INT J PARASITOL, V29, P1359, DOI 10.1016/S0020-7519(99)00088-0; Boulinier T, 1996, IBIS, V138, P326, DOI 10.1111/j.1474-919X.1996.tb04345.x; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burns CE, 2005, ECOLOGY, V86, P753, DOI 10.1890/03-0735; Chambert T, 2012, J ANIM ECOL, V81, P986, DOI 10.1111/j.1365-2656.2012.01979.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2012, PARASITOLOGY, V139, P915, DOI 10.1017/S003118201200008X; Devevey G, 2009, PARASITOLOGY, V136, P1351, DOI 10.1017/S0031182009990746; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Faustino CR, 2004, J ANIM ECOL, V73, P651, DOI 10.1111/j.0021-8790.2004.00840.x; Fokidis HB, 2006, WILDLIFE SOC B, V34, P764, DOI 10.2193/0091-7648(2006)34[764:KTARMS]2.0.CO;2; GERN L, 1994, EUR J EPIDEMIOL, V10, P75, DOI 10.1007/BF01717456; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hawlena H, 2006, OECOLOGIA, V148, P30, DOI 10.1007/s00442-005-0345-4; Hofmeister EK, 1999, AM J TROP MED HYG, V60, P598, DOI 10.4269/ajtmh.1999.60.598; HOFMEISTER EK, 1992, J CLIN MICROBIOL, V30, P2625, DOI 10.1128/JCM.30.10.2625-2631.1992; Hudson P., 2002, ECOLOGY WILDLIFE DIS; JACQUOT JJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P407, DOI 10.1007/BF00170588; Jaffe G, 2005, J MAMMAL, V86, P39, DOI 10.1644/1545-1542(2005)086&lt;0039:LPOBPI&gt;2.0.CO;2; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Lebl K, 2010, ECOL RES, V25, P251, DOI 10.1007/s11284-009-0629-y; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Lindsay LR, 1997, J WILDLIFE DIS, V33, P766, DOI 10.7589/0090-3558-33.4.766; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; LOYE J, 1995, TRENDS ECOL EVOL, V10, P232, DOI 10.1016/S0169-5347(00)89072-2; MAGNARELLI LA, 1987, J INFECT DIS, V156, P234, DOI 10.1093/infdis/156.1.234; MAIN AJ, 1982, J MED ENTOMOL, V19, P655, DOI 10.1093/jmedent/19.6.655; MANNELLI A, 1994, J PARASITOL, V80, P1038, DOI 10.2307/3283457; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; MOODY KD, 1994, J WILDLIFE DIS, V30, P155, DOI 10.7589/0090-3558-30.2.155; Moore J., 2002, PARASITES BEHAV ANIM; Neuhaus P, 2003, P ROY SOC B-BIOL SCI, V270, pS213, DOI 10.1098/rsbl.2003.0073; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2006, BIOSCIENCE, V56, P383, DOI 10.1641/0006-3568(2006)056[0383:CTATZW]2.0.CO;2; Ostfeld RS, 1996, J MAMMAL, V77, P266, DOI 10.2307/1382727; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Phelps KL, 2010, SOUTHWEST NAT, V55, P363, DOI 10.1894/MLK-08.1; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; RANDOLPH SE, 1975, J ANIM ECOL, V44, P451, DOI 10.2307/3606; Randolph SE, 1998, PARASITOL TODAY, V14, P186, DOI 10.1016/S0169-4758(98)01224-1; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Schmidt KA, 1999, J MED ENTOMOL, V36, P749, DOI 10.1093/jmedent/36.6.749; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; Scott MC, 2012, J MED ENTOMOL, V49, P697, DOI 10.1603/ME11162; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; SHIH CM, 1995, J CLIN MICROBIOL, V33, P3164, DOI 10.1128/JCM.33.12.3164-3168.1995; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Stearns S.C., 1992, pi; Telfer S, 2002, J ANIM ECOL, V71, P558, DOI 10.1046/j.1365-2656.2002.00623.x; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Tschirren B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0364; Tschirren B, 2012, EVOLUTION, V66, P720, DOI 10.1111/j.1558-5646.2011.01473.x; Vandegrift KJ, 2008, ECOLOGY, V89, P2251, DOI 10.1890/07-1935.1; Vessey SH, 2007, INTEGR ZOOL, V2, P123, DOI 10.1111/j.1749-4877.2007.00053.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM	86	33	34	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118265	10.1371/journal.pone.0118265	http://dx.doi.org/10.1371/journal.pone.0118265			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688863	Green Published, gold			2022-12-27	WOS:000350322700110
J	Al-Amery, SM; Nambiar, P; Jamaludin, M; John, J; Ngeow, WC				Al-Amery, Samah M.; Nambiar, Phrabhakaran; Jamaludin, Marhazlinda; John, Jacob; Ngeow, Wei Cheong			Cone Beam Computed Tomography Assessment of the Maxillary Incisive Canal and Foramen: Considerations of Anatomical Variations When Placing Immediate Implants	PLOS ONE			English	Article							NASOPALATINE DUCT; JAW; MORPHOLOGY; PLACEMENT; LOCATION; BONES; NERVE	Introduction The maxillary incisive canal connects the roof of the oral cavity with the floor of nasal cavity and has the incisive and nasal foramina respectively at its two opposite ends. Its close proximity with the anterior incisors affects one's ability to place immediate implants in ideal position. Objective To avoid causing complication, variations in their dimensions were studied. Material and Methods Images of ninety Mongoloids patients examined with i-CAT Cone Beam Computed Tomography were included. The sizes of the nasopalatine foramen, the incisive canal and foramen, and anterior maxillary bone thickness were measured. The direction and course of the canals were assessed. Results The mean labiopalatal and mesiodistal measurements of the incisive foramen were 2.80mm and 3.49 mm respectively, while the labiopalatal width of the nasal foramen was 6.06mm. The incisive canal was 16.33mm long and 3.85 mm wide. The anterior maxillary bone has an average thickness of 7.63 mm. The dimensions of the incisive foramen and incisive canal, and anterior maxillary bone thickness demonstrated gender differences with males showing greater values. The anterior maxillary bone thickness was affected by age but this difference was not observed in canal dimensions. The majority of subjects have a funnel shape-like incisive canal with the broader opening located at its superior. They seem to have a longer slanted-curve canal with one channel at its middle portion and a narrower incisive foramen opening than those reported elsewhere. Conclusions This study found that gender is an important factor that affected the characteristics of the IC and the amount of bone anterior to it. Male generally had bigger IC and thicker anterior bone. In addition, the anterior maxillary bone thickness was affected by aging, where it becomes thinner with increased age even though the subjects were fully dentate.	[Al-Amery, Samah M.; Nambiar, Phrabhakaran; John, Jacob] Univ Malaya, Fac Dent, Dept Diagnost & Integrated Dent Practice, Kuala Lumpur, Malaysia; [Jamaludin, Marhazlinda] Univ Malaya, Fac Dent, Dept Community Oral Hlth & Clin Prevent, Kuala Lumpur, Malaysia; [Ngeow, Wei Cheong] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ngeow, WC (corresponding author), Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia.	ngeowy@um.edu.my	NAMBIAR, PHRABHAKARAN K N/B-9495-2010; JOHN, JACOB/AAU-1464-2021; Jamaludin, Marhazlinda/B-8936-2010; Cheong, Ngeow Wei/A-2530-2009; JOHN, JACOB/B-8683-2010; John, Jacob/ABD-7448-2020	JOHN, JACOB/0000-0001-8452-0676; Jamaludin, Marhazlinda/0000-0003-1177-1508; Cheong, Ngeow Wei/0000-0003-4354-3518; JOHN, JACOB/0000-0001-8452-0676; 	Ministry of Education, Malaysia [UM.C/HIR/MOHE/DENT/19]	Ministry of Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by the Ministry of Education, Malaysia Grant (UM.C/HIR/MOHE/DENT/19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artzi Z, 2000, CLIN ORAL IMPLAN RES, V11, P505, DOI 10.1034/j.1600-0501.2000.011005505.x; Asaumi R, 2010, ORAL RADIOL, V26, P20, DOI 10.1007/s11282-010-0039-4; Bornstein MM, 2011, CLIN ORAL IMPLAN RES, V22, P295, DOI 10.1111/j.1600-0501.2010.02010.x; Casado PL, 2008, IMPLANT DENT, V17, P169, DOI 10.1097/ID.0b013e3181776c52; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; Chandler Nicholas P., 1996, New Zealand Dental Journal, V92, P80; Chatriyanuyoke P, 2012, J ORAL IMPLANTOL, V38, P713, DOI 10.1563/AAID-JOI-D-10-00106; Cheng S, 1997, Zhonghua Kou Qiang Yi Xue Za Zhi, V32, P149; DALEY TD, 1994, ORAL SURG ORAL MED O, V77, P276, DOI 10.1016/0030-4220(94)90299-2; Drake R., 2009, GRAYS ANATOMY STUDEN; Ennis LM, 1967, DENT ROENTGENOLOGY, P334; Filippi A, 1999, BRIT J ORAL MAX SURG, V37, P134, DOI 10.1054/bjom.1997.0092; Ghom AG, 2008, TXB ORAL RADIOLOGY, P191; Glickman GN, 2002, PATHWAY PF THE PULP, P77; Guler AU, 2005, J ORAL REHABIL, V32, P741, DOI 10.1111/j.1365-2842.2005.01499.x; Guncu GN, 2013, CLIN ORAL IMPLAN RES, V24, P1023, DOI 10.1111/j.1600-0501.2012.02493.x; Iordanishvili A, 1990, STOMATOLOGIIA MOSK, P25; Jacob S, 2000, ARCH OTOLARYNGOL, V126, P741, DOI 10.1001/archotol.126.6.741; Jacobs R, 2007, ORAL SURG ORAL MED O, V103, P683, DOI 10.1016/j.tripleo.2006.11.014; KREIDLER JF, 1993, J CRANIO MAXILL SURG, V21, P339, DOI 10.1016/S1010-5182(05)80494-9; Liang X, 2009, J CLIN PERIODONTOL, V36, P598, DOI 10.1111/j.1600-051X.2009.01429.x; Mardinger O, 2008, J PERIODONTOL, V79, P1659, DOI 10.1902/jop.2008.080043 ; Mecall R A, 1991, Int J Periodontics Restorative Dent, V11, P8; Moss HD, 2000, J ENDODONT, V26, P107, DOI 10.1097/00004770-200002000-00012; Mraiwa N, 2004, DENTOMAXILLOFAC RAD, V33, P396, DOI 10.1259/dmfr/53801969; Penarrocha M, 2009, INT J ORAL MAX IMPL, V24, P936; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1130; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1125; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1146; ROSENQUIST JB, 1992, INT J ORAL MAX SURG, V21, P210, DOI 10.1016/S0901-5027(05)80220-6; Sarandha DL, 2008, TXB COMPLETE DENTURE; Scheid RC, 2007, WOELFELS DENT ANATOM, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Scher E L, 1994, Implant Dent, V3, P38, DOI 10.1097/00008505-199404000-00007; Scortecci GM, 2001, IMPLANTS RESTORATIVE, P265; Song WC, 2009, ORAL SURG ORAL MED O, V108, P583, DOI 10.1016/j.tripleo.2009.06.036; Standring S, 2005, GRAYS ANATOMY ANATOM, P538; SWANSON KS, 1991, J ORAL MAXIL SURG, V49, P268, DOI 10.1016/0278-2391(91)90217-A; Tozum TF, 2012, J PERIODONTOL, V83, P337, DOI 10.1902/jop.2011.110326; 김규태, 2004, Imaging Science in Dentistry, V34, P7	39	40	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117251	10.1371/journal.pone.0117251	http://dx.doi.org/10.1371/journal.pone.0117251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679505	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000350682600058
J	Shen, LB; Liu, GB; Zou, YY; Zhou, Z; Su, ZX; Gu, X				Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun			The Evolutionary Panorama of Organ-Specifically Expressed or Repressed Orthologous Genes in Nine Vertebrate Species	PLOS ONE			English	Article							DUPLICATE GENES; PROTEIN EVOLUTION; RNA-SEQ; GENOME; FAMILIES; TREES; LISTS; REST	RNA sequencing (RNA-Seq) technology provides the detailed transcriptomic information for a biological sample. Using the RNA-Seq data of six organs from nine vertebrate species, we identified a number of organ-specifically expressed or repressed orthologous genes whose expression patterns are mostly conserved across nine species. Our analyses show the following results: (i) About 80% of these genes have a chordate or more ancient origin and more than half of them are the legacy of one or multiple rounds of large-scale gene duplication events. (ii) Their evolutionary rates are shaped by the organ in which they are expressed or repressed, e.g. the genes specially expressed in testis and liver generally evolve more than twice as fast as the ones specially expressed in brain and cerebellum. The organ-specific transcription factors were discriminated from these genes. The ChIP-seq data from the ENCODE project also revealed the transcription-related factors that might be involved in regulating human organ-specifically expressed or repressed genes. Some of them are shared by all six human organs. The comparison of ENCODE data with mouse/chicken ChIP-seq data proposes that organ-specifically expressed or repressed orthologous genes are regulated in various combinatorial fashions in different species, although their expression features are conserved among these species. We found that the duplication events in some gene families might help explain the quick organ/tissue divergence in vertebrate lineage. The phylogenetic analysis of testis-specifically expressed genes suggests that some of them are prone to develop new functions for other organs/tissues.	[Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Fudan University; Fudan University; Iowa State University	Gu, X (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	xungufudan@gmail.com	Su, Zhixi/B-6487-2012; Zhou, Zhan/I-2372-2013	Zhou, Zhan/0000-0002-2730-5483	Ministry of Science and Technology China [2012CB910101]; National Science Foundation of China [31272299]; Fudan University; Iowa State University; Shanghai Pujiang Program [13PJD005]; National Natural Science Foundation of China [31301034]; China Postdoctoral Science Foundation [2013M531117]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University; Iowa State University; Shanghai Pujiang Program(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was partly supported by a grant from the Ministry of Science and Technology China (2012CB910101) and a grant from the National Science Foundation of China (31272299). XG was supported by grants from Fudan University and Iowa State University. ZS was supported by the Shanghai Pujiang Program (13PJD005). YZ was supported by the National Natural Science Foundation of China (31301034). ZZ was supported by a General Financial Grant from the China Postdoctoral Science Foundation (2013M531117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dong D, 2011, NUCLEIC ACIDS RES, V39, P837, DOI 10.1093/nar/gkq874; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Force A, 1999, GENETICS, V151, P1531; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Halfon MS, 2002, PHYSIOL GENOMICS, V10, P131, DOI 10.1152/physiolgenomics.00072.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Ohno S., 1970, EVOLUTION GENE DUPLI; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rama SS, 2012, RAPIDLY EVOLVING GEN, DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116872	10.1371/journal.pone.0116872	http://dx.doi.org/10.1371/journal.pone.0116872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679776	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600038
J	Vortman, Y; Safran, RJ; Brodetzki, TR; Dor, R; Lotem, A				Vortman, Yoni; Safran, Rebecca J.; Brodetzki, Tali Reiner; Dor, Roi; Lotem, Arnon			Expression of Multiple Sexual Signals by Fathers and Sons in the East-Mediterranean Barn Swallow: Are Advertising Strategies Heritable?	PLOS ONE			English	Article							BODY-MASS INDEX; HIRUNDO-RUSTICA; TAIL ORNAMENTS; TRADE-OFF; SELECTION; COLOR; PATERNITY; TRAITS; FERTILIZATION; REPEATABILITY	The level of expression of sexually selected traits is generally determined by genes, environment and their interaction. In species that use multiple sexual signals which may be costly to produce, investing in the expression of one sexual signal may limit the expression of the other, favoring the evolution of a strategy for resource allocation among signals. As a result, even when the expression of sexual signals is condition dependent, the relative level of expression of each signal may be heritable. We tested this hypothesis in the East-Mediterranean barn swallow (Hirundo rustica transitiva), in which males have been shown to express two uncorrelated sexual signals: red-brown ventral coloration, and long tail streamers. We show that variation in both signals may partially be explained by age, as well as by paternal origin (genetic father-son regressions), but that the strongest similarity between fathers and sons is the relative allocation towards one trait or the other (relative expression index), rather than the expression of the traits themselves. These results suggest that the expression of one signal is not independent of the other, and that genetic strategies for resource allocation among sexual signals may be selected for during the evolution of multiple sexual signals.	[Vortman, Yoni] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Vortman, Yoni; Brodetzki, Tali Reiner; Dor, Roi; Lotem, Arnon] Tel Aviv Univ, Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Safran, Rebecca J.; Dor, Roi] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Dor, Roi] Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY USA	University of Haifa; Tel Aviv University; University of Colorado System; University of Colorado Boulder; Cornell University	Vortman, Y (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	vortmanyo@gmail.com	Brodetzki, Tali Reiner/W-8137-2019	Brodetzki, Tali Reiner/0000-0002-1705-2056; Dor, Roi/0000-0002-8743-9387	Israel Science Foundation (ISF) [1181/07]; National Science Foundation [NSF IOS 07071421]; Dan David Prize scholarship; University of Haifa Post-doctoral fellowship	Israel Science Foundation (ISF)(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); Dan David Prize scholarship; University of Haifa Post-doctoral fellowship	This work was funded by the Israel Science Foundation (ISF grant number 1181/07 to AL) and the National Science Foundation, (NSF IOS 07071421 to RJS). YV was supported by the Dan David Prize scholarship and by the University of Haifa Post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Badyaev AV, 2002, EVOLUTION, V56, P412; Balbontin J, 2011, J EVOLUTION BIOL, V24, P440, DOI 10.1111/j.1420-9101.2010.02183.x; Becker WA, 1992, MANUAL QUANTITATIVE, V5th; Bro-Jorgensen J, 2007, CURR BIOL, V17, P850, DOI 10.1016/j.cub.2007.03.042; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cotton S, 2004, J EVOLUTION BIOL, V17, P1310, DOI 10.1111/j.1420-9101.2004.00754.x; Dohm MR, 2002, FUNCT ECOL, V16, P273; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dor R, 2010, MOL PHYLOGENET EVOL, V56, P409, DOI 10.1016/j.ympev.2010.02.008; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Evans MR, 1998, NATURE, V394, P233, DOI 10.1038/28297; Falconer D. S., 1996, INTRO QUANTITATIVE G; Galvan I, 2011, J EVOLUTION BIOL, V24, P999, DOI 10.1111/j.1420-9101.2011.02232.x; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hering E., 1878, LEHRE LICHTSINNE; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Lifjeld JT, 2011, BEHAV ECOL SOCIOBIOL, V65, P1687, DOI 10.1007/s00265-011-1176-4; Maguire SE, 2010, J AVIAN BIOL, V41, P74, DOI 10.1111/j.1600-048X.2009.04806.x; MOLLER AP, 1991, EVOLUTION, V45, P1823, DOI 10.1111/j.1558-5646.1991.tb02690.x; MOLLER AP, 1988, NATURE, V332, P640, DOI 10.1038/332640a0; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moller AP., 1994, SEXUAL SELECTION BAR; Murai M, 2009, EVOLUTION, V63, P2363, DOI 10.1111/j.1558-5646.2009.00726.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; RATHBUN GB, 1981, J MAMMAL, V62, P635, DOI 10.2307/1380414; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Saino N, 2003, BEHAV ECOL SOCIOBIOL, V54, P465, DOI 10.1007/s00265-003-0642-z; Saino N, 2003, ITAL J ZOOL, V70, P167, DOI 10.1080/11250000309356511; Saino N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Saino N, 2014, ANIM BEHAV, V87, P137, DOI 10.1016/j.anbehav.2013.10.022; Scandolara C, 2014, ANIM BEHAV, V87, P187, DOI 10.1016/j.anbehav.2013.10.030; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Shutler D, 2011, BIOL LETTERS, V7, P101, DOI 10.1098/rsbl.2010.0531; Smith HG, 1991, BEHAV ECOL, V2, P90, DOI 10.1093/beheco/2.1.90; Sokal RR, 1995, BIOMETRY; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Vortman Y, 2013, AM NAT, V182, P514, DOI 10.1086/671908; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Wagner WE, 2012, P ROY SOC B-BIOL SCI, V279, P2899, DOI 10.1098/rspb.2012.0275; White P.S., 1992, MOL GENETIC ANAL POP, P50; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; [No title captured]	61	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118054	10.1371/journal.pone.0118054	http://dx.doi.org/10.1371/journal.pone.0118054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679206	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600105
J	Yin, L; Xie, YY; Yin, SY; Lv, XL; Zhang, J; Gu, ZZ; Sun, HD; Liu, SQ				Yin, Liang; Xie, Yingying; Yin, Songyue; Lv, Xiaolei; Zhang, Jia; Gu, Zezong; Sun, Haidan; Liu, Siqi			The S-Nitrosylation Status of PCNA Localized in Cytosol Impacts the Apoptotic Pathway in a Parkinson's Disease Paradigm	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; NITRIC-OXIDE; CYSTEINE RESIDUES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SH-SY5Y CELLS; CYTOCHROME-C; CASPASE-9; DEATH; ACTIVATION	It is generally accepted that nitric oxide (NO) or its derivatives, reactive nitrogen species (RNS), are involved in the development of Parkinson's disease (PD). Recently, emerging evidence in the study of PD has indicated that protein S-nitrosylation triggers the signaling changes in neurons. In this study, SH-SY5Y cells treated with rotenone were used as a model of neuronal death in PD. The treated cells underwent significant apoptosis, which was accompanied by an increase in intracellular NO in a rotenone dose-dependent manner. The CyDye switch approach was employed to screen for changes in S-nitrosylated (SNO) proteins in response to the rotenone treatment. Seven proteins with increased S-nitrosylation were identified in the treated SH-SY5Y cells, which included proliferating cell nuclear antigen (PCNA). Although PCNA is generally located in the nucleus and participates in DNA replication and repair, significant PCNA was identified in the SH-SY5Y cytosol. Using immunoprecipitation and pull-down approaches, PCNA was found to interact with caspase-9; using mass spectrometry, the two cysteine residues PCNA-Cys81 and -Cys162 were identified as candidate S-nitrosylated residues. In addition, the evidence obtained from in vitro and the cell model studies indicated that the S-nitrosylation of PCNA-Cys81 affected the interaction between PCNA and caspase-9. Furthermore, the interaction of PCNA and caspase-9 partially blocked caspase-9 activation, indicating that the S-nitrosylation of cytosolic PCNA may be a mediator of the apoptotic pathway.	[Yin, Liang; Xie, Yingying; Yin, Songyue; Sun, Haidan; Liu, Siqi] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Yin, Liang; Liu, Siqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lv, Xiaolei; Zhang, Jia; Liu, Siqi] Beijing Prot Innovat, Beijing, Peoples R China; [Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Sun, HD (corresponding author), Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	sunhd@genomics.org.cn; siqiliu@genomics.org.cn			National Key Basic Research Program of China [2010CB912703]; National High Technology Research and Development Program of China [2012AA020205]; Nature Science Foundation of China [91131009]	National Key Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Key Basic Research Program of China: 2010CB912703; National High Technology Research and Development Program of China: 2012AA020205; Nature Science Foundation of China: 91131009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthwal MK, 2001, REDOX REP, V6, P297, DOI 10.1179/135100001101536436; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Casey DP, 2013, J APPL PHYSIOL, V115, P446, DOI 10.1152/japplphysiol.00446.2013; Chen JS, 2010, FEBS J, V277, P3028, DOI 10.1111/j.1742-4658.2010.07712.x; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gatto EM, 1996, MOVEMENT DISORD, V11, P261, DOI 10.1002/mds.870110308; Gatto EM, 2000, NITRIC OXIDE-BIOL CH, V4, P534, DOI 10.1006/niox.2000.0288; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jiang ZL, 2009, WOUND REPAIR REGEN, V17, P224, DOI 10.1111/j.1524-475X.2009.00459.x; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Lam YW, 2010, PLOS ONE, DOI [10.1371/journal.pone.0014462, DOI 10.1371/JOURNAL.PONE.0014462]; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Martin MC, 2008, J BIOL CHEM, V283, P3854, DOI 10.1074/jbc.M705647200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; MICHEL PP, 2006, SCIENCE STKE, V332, pPE19, DOI DOI 10.1126/STKE.3322006PE19; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Ortiz-Ortiz MA, 2009, NEUROTOX RES, V16, P160, DOI 10.1007/s12640-009-9065-6; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Petit C, 1999, BRAZ J MED BIOL RES, V32, P1407, DOI 10.1590/S0100-879X1999001100011; Phattanarudee S, 2013, CAN J PHYSIOL PHARM, V91, P510, DOI 10.1139/cjpp-2013-0066; Qu Z, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-17; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Shaikh SB, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-55; Shi Q, 2008, BIOL PHARM BULL, V31, P1536, DOI 10.1248/bpb.31.1536; Singh S, 2005, REDOX REP, V10, P103, DOI 10.1179/135100005X38842; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sumbayev VV, 2003, ARCH BIOCHEM BIOPHYS, V415, P133, DOI 10.1016/S0003-9861(03)00199-1; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Torta F, 2008, PROTEOMICS, V8, P4484, DOI 10.1002/pmic.200800089; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang LC, 1998, J NEUROSCI, V18, P8145; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yu Y, 2009, J BIOL CHEM, V284, P19310, DOI 10.1074/jbc.M109.015289; Zhang HH, 2011, BIOL REPROD, V84, P966, DOI 10.1095/biolreprod.110.090688; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang JL, 2005, AM J PHYSIOL-CELL PH, V288, pC840, DOI 10.1152/ajpcell.00325.2004; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang XL, 2014, ONCOL LETT, V7, P411, DOI 10.3892/ol.2013.1703; Zhang ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106669; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	65	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117546	10.1371/journal.pone.0117546	http://dx.doi.org/10.1371/journal.pone.0117546			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675097	Green Submitted, gold, Green Published			2022-12-27	WOS:000349914000027
J	Barbosa-Resende, W; Rangel, VD; Frontarolli, AC; Araujo, RRH; da Silva, CHM; Pinto, RDC; Morales, NDO				Barbosa-Resende, Wener; Rangel, Viviane de Oliveira; Frontarolli, Ana Claudia; Hoffman Araujo, Renata R.; Martins da Silva, Carlos Henrique; Costa Pinto, Rogerio de Melo; Oliveira Morales, Nivea de Macedo			Psychometric Properties of the Autoquestionnaire Qualite De Vie Enfant Image (AUQEI) Applied to Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; OF-LIFE; HEALTH QUESTIONNAIRE; BRAZILIAN VERSION; RELIABILITY; ADOLESCENTS; VALIDITY; INSTRUMENTS; AGREEMENT	Background Quality of life (QL) assessments of children with incapacitating diseases, such as cerebral palsy (CP), have often been conducted with the help of the representatives of a child, making QL assessment more subjective. TheAutoquestionnaireQualite de Vie Enfant Image (AUQEI) is a QL assessment designed for children to self-report-it uses images to facilitate the reporting process. Objective evaluate the psychometric properties of AUQEI when responses are given by children with CP. Findings Children aged 4 to 12 years (45 with CP and 45 healthy children) gave responses to the questionnaire. The data quality, reliability and validity were assessed. The data loss rate ranged from 8.8% to 46.7%, and was highest for the "autonomy" factor. No floor or ceiling effect was detected. The success rate for reliability of the internal consistency of the items was less than 80% for the "autonomy" factor. Cronbach's alpha coefficient was 0.71 for the instrument and less than 0.5 for the factors. All the factors had a success rate of greater than 80% for the discriminating validity of the items. The factors did not have correlations between each other, thus indicating adequate discriminating validity. Convergent validity was tested and a significant correlation was demonstrated only between the AUQEI "functioning" factor and the Child Health Questionnaire-50-Item (CHQ-PF50) physical summary score (r = 0.31, p = 0.042). The AUQEI scores did not have correlations with the gross motor function scores (p>0.05) as expected for divergent validity. Regarding construct validity, the total AUQEI score obtained by the CP group was lower (median: 47.3) than that of the healthy group (median: 51.0) (p<0.01). Conclusion The AUQEI was shown to be a reliable and valid instrument for assessing children with CP when the total score was used. Convergent validity should continue to be tested in future studies.	[Barbosa-Resende, Wener; Costa Pinto, Rogerio de Melo] Univ Fed Uberlandia, Grad Program Hlth Sci, Fac Med, BR-38400 Uberlandia, MG, Brazil; [Rangel, Viviane de Oliveira] Univ Fed Uberlandia, Fac Med, BR-38400 Uberlandia, MG, Brazil; [Frontarolli, Ana Claudia] Phys Therapy & Specialty Ctr Unimed, Uberlandia, MG, Brazil; [Hoffman Araujo, Renata R.] Assoc Assistance Disabled Children, Uberlandia, MG, Brazil; [Martins da Silva, Carlos Henrique; Oliveira Morales, Nivea de Macedo] Univ Fed Uberlandia, Fac Med, Grad Program Hlth Sci, Dept Pediat, BR-38400 Uberlandia, MG, Brazil; [Costa Pinto, Rogerio de Melo] Fac Math, Ctr Exact Sci & Technol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Barbosa-Resende, W (corresponding author), Univ Fed Uberlandia, Grad Program Hlth Sci, Fac Med, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	wener_educa@hotmail.com						Akodu A K, 2012, Nig Q J Hosp Med, V22, P99; Assumpcao FB, 2000, ARQ NEURO-PSIQUIAT, V58, P119, DOI 10.1590/S0004-282X2000000100018; Barbosa APM, 2012, REV NEUROCIENC, V20, P367; Barreire Simone G., 2003, J. Pediatr. (Rio J.), V79, P55, DOI 10.1590/S0021-75572003000100010; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Brasil: Ministerio da Saude, 2013, DIR AT PESS COM PAR; Carlon S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-81; Centro de Estudos Pesquisas e Projetos Economico-Sociais (CEPES), 2003, UB PAIN INF MUN PAIN; Dalvand H, 2012, ARCH PHYS MED REHAB, V93, P480, DOI 10.1016/j.apmr.2011.10.019; Davis E, 2010, DEV MED CHILD NEUROL, V52, P174, DOI 10.1111/j.1469-8749.2009.03382.x; Dey M, 2012, QUAL LIFE RES, V21, P1797, DOI 10.1007/s11136-012-0109-7; Dickinson H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-273; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Elias AV, 2006, ARQ NEURO-PSIQUIAT, V64, P295, DOI 10.1590/S0004-282X2006000200022; Ferreira PRA, 2008, HOR CI, V2, P47; Gates P, 2010, DEV MED CHILD NEUROL, V52, P843, DOI 10.1111/j.1469-8749.2010.03666.x; Green Liza B, 2007, Phys Med Rehabil Clin N Am, V18, P859, DOI 10.1016/j.pmr.2007.07.005; Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232; Health outcomes methodology symposium, 2000, MED CARE S2, V38, P7; Himmelmann K, 2014, ACTA PAEDIATR, V103, P618, DOI 10.1111/apa.12614; Hodgkinson I., 2002, Annales de Readaptation et de Medecine Physique, V45, P154, DOI 10.1016/S0168-6054(02)00195-2; Kucynski E, 2003, AN PEDIATR, V58, P550; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Machado CSM, 2001, CLIN EXP RHEUMATOL, V19, pS25; Manificat S, 1997, ARCH PEDIATRIE, V4, P1238, DOI 10.1016/S0929-693X(97)82616-4; Manificat S, 1997, NEUROPSYCHIAT ENFAN, V45, P106; McCarthy ML, 2002, DEV MED CHILD NEUROL, V44, P468; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Morales NDO, 2007, QUAL LIFE RES, V16, P437, DOI 10.1007/s11136-006-9136-6; Morales NMO, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-109; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Sankar Chitra, 2005, Indian Journal of Pediatrics, V72, P865, DOI 10.1007/BF02731117; Scholtes VAB, 2006, DEV MED CHILD NEUROL, V48, P64; Shikako-Thomas K, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/387280; Borges MBS, 2011, ARQ NEURO-PSIQUIAT, V69, P799, DOI 10.1590/S0004-282X2011000600014; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2005, DEV MED CHILD NEUROL, V47, P592, DOI 10.1017/S0012162205001179; Vilibor RHH, 2010, REV NEUROCIENC, V18, P380; Waters E, 2007, DEV MED CHILD NEUROL, V49, P49, DOI 10.1017/S0012162207000126; Wechsler D, 2002, WISC 3 ESCALA INTELI, DOI [10.1016/j.ophtha.2014.10.028, DOI 10.1016/J.OPHTHA.2014.10.028]; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; WHOQOL, 1997, MEAS QUAL LIF	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115643	10.1371/journal.pone.0115643	http://dx.doi.org/10.1371/journal.pone.0115643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671523	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300008
J	Crenshaw, DG; Asin, K; Gottschalk, WK; Liang, ZF; Zhang, NY; Roses, AD				Crenshaw, Donna G.; Asin, Karen; Gottschalk, William K.; Liang, Zhifeng; Zhang, Nanyin; Roses, Allen D.			Effects of Low Doses of Pioglitazone on Resting-State Functional Connectivity in Conscious Rat Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ACTIVATED-RECEPTOR-GAMMA; ALZHEIMERS ASSOCIATION WORKGROUPS; MITOCHONDRIAL BIOGENESIS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ROSIGLITAZONE; DISEASE; EXPRESSION; NETWORKS	Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-gamma (PPAR.) agonist in clinical use for treatment of type 2 diabetes (T2DM). Accumulating evidence suggests PPAR gamma agonists may be useful for treating or delaying the onset of Alzheimer's disease (AD), possibly via actions on mitochondria, and that dose strengths lower than those clinically used for T2DM may be efficacious. Our major objective was to determine if low doses of pioglitazone, administered orally, impacted brain activity. We measured blood-oxygenation-level dependent (BOLD) low-frequency fluctuations in conscious rats to map changes in brain resting-state functional connectivity due to daily, oral dosing with low-dose PIO. The connectivity in two neural circuits exhibited significant changes compared with vehicle after two days of treatment with PIO at 0.08 mg/kg/day. After 7 days of treatment with a range of PIO dose-strengths, connections between 17 pairs of brain regions were significantly affected. Functional connectivity with the CA1 region of the hippocampus, a region that is involved in memory and is affected early in the progression of AD, was specifically investigated in a seed-based analysis. This approach revealed that the spatial pattern of CA1 connectivity was consistent among all dose groups at baseline, prior to treatment with PIO, and in the control group imaged on day 7. Compared to baseline and controls, increased connectivity to CA1 was observed regionally in the hypothalamus and ventral thalamus in all PIO-treated groups, but was least pronounced in the group treated with the highest dose of PIO. These data support our hypothesis that PIO modulates neuronal and/or cerebrovascular function at dose strengths significantly lower than those used to treat T2DM and therefore may be a useful therapy for neurodegenerative diseases including AD.	[Crenshaw, Donna G.; Gottschalk, William K.; Roses, Allen D.] Zinfandel Pharmaceut Inc, Chapel Hill, NC 27517 USA; [Asin, Karen] Takeda Dev Ctr Amer Inc, Deerfield, IL USA; [Liang, Zhifeng; Zhang, Nanyin] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Crenshaw, DG (corresponding author), Zinfandel Pharmaceut Inc, Chapel Hill, NC 27517 USA.	dcrenshaw@zinfandelpharma.com; roses@zinfandelpharma.com	Liang, Zhfieng/A-4914-2016; Zhang, Nanyin/N-3457-2014	Liang, Zhfieng/0000-0001-7940-3467; Gottschalk, William/0000-0001-6760-2338; Zhang, Nanyin/0000-0002-5824-9058	Takeda Development Center Americas, Inc.; National Institute of Mental Health [R01MH098003]; National Institute of Neurological Disorders and Stroke [R01NS085200]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085200] Funding Source: NIH RePORTER	Takeda Development Center Americas, Inc.(Takeda Pharmaceutical Company Ltd); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by Takeda Development Center Americas, Inc. An employee of the funder and employees of, or consultants to, Zinfandel Pharmaceuticals, Inc, which is in a business alliance with the funder, participated in study design and data analysis, the decision to publish, and preparation of the manuscript. Data was collected and analyzed by individuals according to a sponsored research contract with the funder. These individuals also participated in manuscript preparation and the decision to publish. The work was also supported by grants to NZ from the National Institute of Mental Health (R01MH098003) and the National Institute of Neurological Disorders and Stroke (R01NS085200).	Abbatecola AM, 2010, DIABETES CARE, V33, P1706, DOI 10.2337/dc09-2030; Akram Afia, 2010, Mol Neurodegener, V5, P36, DOI 10.1186/1750-1326-5-36; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, 2010, CHANGING THE TRAJECT; Beason-Held LL, 2013, J NEUROSCI, V33, P18008, DOI 10.1523/JNEUROSCI.1402-13.2013; Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Elbrecht A, 1996, BIOCHEM BIOPH RES CO, V224, P431, DOI 10.1006/bbrc.1996.1044; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Geldmacher DS, 2011, ARCH NEUROL-CHICAGO, V68, P45, DOI 10.1001/archneurol.2010.229; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; Grossman S L, 1997, Expert Opin Investig Drugs, V6, P1025, DOI 10.1517/13543784.6.8.1025; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Kummer MP, 2008, PPAR RESEARCH, P8; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Liang ZF, 2015, NEUROIMAGE, V104, P89, DOI 10.1016/j.neuroimage.2014.10.013; Liang ZF, 2014, NEUROIMAGE, V103, P485, DOI 10.1016/j.neuroimage.2014.08.050; Liang ZF, 2013, NEUROIMAGE, V83, P237, DOI 10.1016/j.neuroimage.2013.06.029; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Lorenzi M, 2011, DRUG AGING, V28, P205, DOI 10.2165/11586440-000000000-00000; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Moon JH, 2012, INT J NEUROPSYCHOPH, V15, P135, DOI 10.1017/S1461145711001611; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Nicolakakis N, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00021; Papadopoulos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068612; Pflanzner T, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.025; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Sanabria-Diaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068860; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Vasudevan Abu R, 2004, Diabetes Technol Ther, V6, P850, DOI 10.1089/dia.2004.6.850; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	58	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117973	10.1371/journal.pone.0117973	http://dx.doi.org/10.1371/journal.pone.0117973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671601	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300075
J	Neupane, D; Panthi, B; McLachlan, CS; Mishra, SR; Kohrt, BA; Kallestrup, P				Neupane, Dinesh; Panthi, Bindu; McLachlan, Craig S.; Mishra, Shiva Raj; Kohrt, Brandon A.; Kallestrup, Per			Prevalence of Undiagnosed Depression among Persons with Hypertension and Associated Risk Factors: A Cross-Sectional Study in Urban Nepal	PLOS ONE			English	Article							MENTAL-HEALTH; SYMPTOMS; COMORBIDITY; DISEASE; ANXIETY; IMPACT; TWIN	Background Despite an increasing number of studies exploring prevalence of depression among hypertensive patients in high income countries, limited data is available from low and middle income countries, particularly Nepal. Our aim was to investigate the prevalence of undiagnosed (sub clinical) depression and associated risk factors among hypertensive patients attending a tertiary health care clinic in Nepal. Methods The study was based on a cross-sectional study design, with 321 hypertensive patients attending the Out-Patient Department of a central hospital in Nepal. Blood measure was recorded via a mercury column sphygmomanometer. Depression levels were assessed using the Beck Depression Inventory-Ia (BDI) scale. Demographics and risk factors were assessed. Result The proportion of participants with undiagnosed depression was 15%. Multivariable analyses demonstrated an increase in BDI scores with increased aging. Approximately a 1 point increase in the BDI score was observed for each additional decade of aging in hypertensive patients. Additional factors associated with increased risk of depression included being female (4.28 point BDI score increase), smoking (5.61 point BDI score increase), being hypertensive with no hypertensive medication (4.46 point BDI score increase) and being illiterate (4.46 point BDI score increase). Conclusions Among persons with hypertension in outpatient settings in Nepal, demographic (age, sex, education), behavioural (smoking,) and adherence factors (anti-hypertensive medication) were associated with undiagnosed depression. Screening programs in Nepal may assist early intervention in hypertensive patients with sub clinical depression.	[Neupane, Dinesh; Kallestrup, Per] Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark; [Panthi, Bindu] Fac Sci & Technol, Nobel Coll, Kathmandu, Nepal; [McLachlan, Craig S.] Univ New S Wales, Rural Clin Sch, Sydney, NSW, Australia; [Mishra, Shiva Raj] Nepal Dev Soc, Kathmandu, Nepal; [Kohrt, Brandon A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Aarhus University; University of New South Wales Sydney; Duke University	Neupane, D (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark.	neupane.dinesh@gmail.com	Neupane, Dinesh/C-3631-2014; Mishra, Shiva Raj/C-4172-2014; Kallestrup, Per/AAA-8313-2022	Neupane, Dinesh/0000-0002-1501-2990; Mishra, Shiva Raj/0000-0002-2993-3504; Kallestrup, Per/0000-0001-6041-4510; McLachlan, Craig/0000-0001-9843-8980				Agrawal SK, 2012, 17 WORLD C HEART DIS; Aryal KK, 2014, NONCOMMUNICABLE DIS; Beck AT., 1996, MANUAL BECK DEPRESSI; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bogner HR, 2005, AM J GERIAT PSYCHIAT, V13, P861, DOI 10.1176/appi.ajgp.13.10.861; BRIGHT RA, 1992, JAMA-J AM MED ASSOC, V267, P1783; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Das R, 2010, CELL CYCLE, V9, P638, DOI 10.4161/cc.9.4.11016; Gea A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-192; Health Management Information System (HMIS), 2010, ETHN GROUP; Joshi M, 2006, KATHMANDU U J SCI EN, V2, P1; Kataoka C, 2004, AM J PHYSIOL-HEART C, V286, pH768, DOI 10.1152/ajpheart.00937.2002; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kim MT, 2003, ANN BEHAV MED, V26, P24, DOI 10.1207/S15324796ABM2601_04; Kohrt B.A., 2002, NEPAL J PSYCHIAT, V2, P123; Kohrt BA, 2008, CULT MED PSYCHIAT, V32, P462, DOI 10.1007/s11013-008-9110-6; Kohrt BA, 2012, BRIT J PSYCHIAT, V201, P268, DOI 10.1192/bjp.bp.111.096222; Kohrt BA, 2009, ANN HUM BIOL, V36, P261, DOI 10.1080/03014460902839194; Lokshin M, 2009, WORLD BANK ECON REV, V23, P481, DOI 10.1093/wber/lhp011; Luitel NP, 2013, SOC PSYCH PSYCH EPID, V48, P183, DOI 10.1007/s00127-012-0539-0; Luitel NP, 2013, SOC PSCYCHIATRY PSYC, V48, P182; Marazziti D, 2014, CNS SPECTRUMS, V19, P293, DOI 10.1017/S1092852913000667; Mehta KD, 2011, SE ASIAN J TROP MED, V42, P197; Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Niraula K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-309; Patten SB, 2004, PSYCHOTHER PSYCHOSOM, V73, P207, DOI 10.1159/000077739; Patten SB, 2001, COMPR PSYCHIAT, V42, P124, DOI 10.1053/comp.2001.21218; PATTEN SB, 1995, CAN J PSYCHIAT, V40, P264; Ried L. Douglas, 2000, Journal of Pharmacoepidemiology, V8, P1, DOI 10.1300/J055v08n01_01; Saboya PMHP, 2010, INT J PSYCHIAT MED, V40, P307, DOI 10.2190/PM.40.3.f; Scherrer JF, 2003, PSYCHOSOM MED, V65, P548, DOI 10.1097/01.PSY.0000077507.29863.CB; Sharma SK, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/821971; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Shrestha UK, 2006, DIABETIC MED, V23, P1130, DOI 10.1111/j.1464-5491.2006.01953.x; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Weaver LJ, 2011, ETHOS, V39, P211, DOI 10.1111/j.1548-1352.2011.01185.x; WHO, 2012, REP FORM M MEMB STAT; WHO, 2012, DEPRESSION, DOI [10.1002/da.22048, DOI 10.1002/DA.22048]; WHO, 2013, GLOB BRIEF HYP, DOI [10.1016/S0140-6736(13)60772-2, DOI 10.1016/S0140-6736(13)60772-2]; World Health Organization, 1995, PHYS STAT US INT ANT; Zhao J, 2009, PSYCHOSOM MED, V71, P691, DOI 10.1097/PSY.0b013e3181b05c57	43	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117329	10.1371/journal.pone.0117329	http://dx.doi.org/10.1371/journal.pone.0117329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671522	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300048
J	Stafford, MR; Mayo-Wilson, E; Loucas, CE; James, A; Hollis, C; Birchwood, M; Kendall, T				Stafford, Megan R.; Mayo-Wilson, Evan; Loucas, Christina E.; James, Anthony; Hollis, Chris; Birchwood, Max; Kendall, Tim			Efficacy and Safety of Pharmacological and Psychological Interventions for the Treatment of Psychosis and Schizophrenia in Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; EARLY-ONSET SCHIZOPHRENIA; DOUBLE-BLIND; 1ST-EPISODE PSYCHOSIS; 2ND-GENERATION ANTIPSYCHOTICS; SCHIZOAFFECTIVE DISORDER; 1ST EPISODE; RISPERIDONE; OLANZAPINE; THERAPY	Background Studies report contrasting results regarding the efficacy and safety of pharmacological, psychological, and combined interventions in psychosis and schizophrenia in children, adolescents and young adults. Methods Systematic review and meta-analysis. Embase, Medline, PreMedline, PsycINFO, and CENTRAL were searched to July 2013 without restriction to publication status. Randomised trials comparing any pharmacological, psychological, or combined intervention for psychosis and schizophrenia in children, adolescents and young adults were included. Studies were assessed for bias, and GRADE criteria were used to describe the quality of the results. Results Twenty-seven trials including 3067 participants were identified. Meta-analyses were performed for 12 comparisons: symptoms, relapse, global state, psychosocial functioning, depression, weight and discontinuation. Low quality evidence demonstrated that antipsychotics have small beneficial effects on psychotic symptoms (SMD = -0.42, 95% CI -0.58 to -0.26), and a medium adverse effect on weight gain (WMD = 1.61, 95% CI 0.61 to 2.60) and discontinuation due to side effects (RR = 2.44, 95% CI, 1.12 to 5.31). There were no trials of psychological treatments in under-18 year olds. There was no evidence of an effect of psychological interventions on psychotic symptoms in an acute episode, or relapse rate, but low quality evidence of a large effect for family plus individual CBT on the number of days to relapse (WMD = 32.25, 95% CI -36.52 to -27.98). Conclusions For children, adolescents and young adults, the balance of risk and benefit of antipsychotics appears less favourable than in adults. Research is needed to establish the potential for psychological treatments, alone and in combination with antipsychotics, in this population.	[Stafford, Megan R.; Loucas, Christina E.; Kendall, Tim] Royal Coll Psychiatrists, NCCMH, London SW1X 8PG, England; [Mayo-Wilson, Evan] UCL, CORE, London, England; [James, Anthony] Warneford Hosp, Highfield Adolescent Unit, Oxford OX3 7JX, England; [Hollis, Chris] Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Birchwood, Max] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Nottingham; University of Warwick	Kendall, T (corresponding author), Royal Coll Psychiatrists, NCCMH, London SW1X 8PG, England.	tim2.kendall@virgin.net	Mayo-Wilson, Evan/J-6289-2019; Birchwood, Max/E-3474-2017	Mayo-Wilson, Evan/0000-0001-6126-2459; Birchwood, Max/0000-0002-7476-0171; Hollis, Chris/0000-0003-1083-6744	National Collaborating Centre for Mental Health; National Institute for Health Research [NF-SI-0514-10119] Funding Source: researchfish	National Collaborating Centre for Mental Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Collaborating Centre for Mental Health and conducted as part of a guideline about psychosis in children, adolescents and young adults. The full review protocol is available from the authors. TK receives 1.4 pound million per year for the National Collaborating Centre for Mental Health from the National Institute for Health and Clinical Excellence to develop guidelines for the treatment of mental health problems (https://www.nice.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; Alvarez-Jimenez M, 2008, CNS DRUGS, V22, P547, DOI 10.2165/00023210-200822070-00002; [Anonymous], 2012, COMPUTER PROGRAM VER; APTER A, 1978, BRIT J MED PSYCHOL, V51, P155, DOI 10.1111/j.2044-8341.1978.tb02460.x; Arango C, 2009, EUR CHILD ADOLES PSY, V18, P418, DOI 10.1007/s00787-009-0749-5; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bird V, 2010, BRIT J PSYCHIAT, V197, P350, DOI 10.1192/bjp.bp.109.074526; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; BURD L, 1987, J AM ACAD CHILD PSY, V26, P347, DOI 10.1097/00004583-198705000-00012; Calarge CA, 2013, THER ADV PSYCHOPHARM, V3, P278, DOI 10.1177/2045125313487548; Correll Christoph U, 2010, J Clin Psychiatry, V71, pe29, DOI 10.4088/JCP.9101tx4c; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Findling RL, 2008, AM J PSYCHIAT, V165, P1432, DOI 10.1176/appi.ajp.2008.07061035; Findling RL, 2012, J CHILD ADOL PSYCHOP, V22, P327, DOI 10.1089/cap.2011.0092; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Fraguas D, 2011, EUR NEUROPSYCHOPHARM, V21, P621, DOI 10.1016/j.euroneuro.2010.07.002; GILLBERG C, 1984, J CHILD PSYCHOL PSYC, V25, P35, DOI 10.1111/j.1469-7610.1984.tb01717.x; Gillberg C, 2001, EPIDEMIOLOGY OF EARL; Gleeson JFM, 2009, J CLIN PSYCHIAT, V70, P477, DOI 10.4088/JCP.08m04407; Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Haas M, 2009, J CHILD ADOL PSYCHOP, V19, P611, DOI 10.1089/cap.2008.0144; Haddock G, 2006, BRIT J PSYCHIAT, V188, P250, DOI 10.1192/bjp.188.3.250; Hedges L. V., 1994, HDB RES SYNTHESIS, P29; HELLGREN L, 1987, J AM ACAD CHILD PSY, V26, P351, DOI 10.1097/00004583-198705000-00013; Hermes EDA, 2012, J CLIN PSYCHIAT, V73, P526, DOI 10.4088/JCP.11m07162; Higgins JP., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/14651858.ED000142, DOI 10.1002/14651858.ED000142]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollis C, 2000, AM J PSYCHIAT, V157, P1652, DOI 10.1176/appi.ajp.157.10.1652; Hollis C, 2011, SCHIZOPHRENIA, P22; Jackson C, 2009, BEHAV RES THER, V47, P454, DOI 10.1016/j.brat.2009.02.009; Jackson HJ, 2008, PSYCHOL MED, V38, P725, DOI 10.1017/S0033291707002061; Jensen JB, 2008, J CHILD ADOL PSYCHOP, V18, P317, DOI 10.1089/cap.2007.0123; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kennedy E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004027.pub2; Kryzhanovskaya L, 2009, J AM ACAD CHILD PSY, V48, P60, DOI 10.1097/CHI.0b013e3181900404; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Lieberman JA, 2003, AM J PSYCHIAT, V160, P1396, DOI 10.1176/appi.ajp.160.8.1396; Linszen D, 1996, PSYCHOL MED, V26, P333, DOI 10.1017/S0033291700034723; Mak GKL, 2007, HONG KONG J PSYCHIAT, V17, P17, DOI DOI 10.1002/JCLP.20336; Mangalore R, 2007, J MENT HEALTH POLICY, V10, P23; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martens L, 2009, PROMOTING RECOVERY F; Mattai AK, 2010, CURR OPIN PSYCHIATR, V23, P304, DOI 10.1097/YCO.0b013e32833b027e; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; Meunch J, 2010, AM FAM PHYSICIAN, V81, P617; Mozes T, 2006, J CHILD ADOL PSYCHOP, V16, P393, DOI 10.1089/cap.2006.16.393; NHS, 2013, CHILDREN AND YOUNG P; NICE, 2013, PSYCHOSIS AND SCHIZO, DOI [10.1136/bmj.f150, DOI 10.1136/BMJ.F150]; NICE, 2009, CORE INTERVENTIONS I; PAILLEREMARTINOT ML, 1995, AM J PSYCHIAT, V152, P130; Parks J, 2006, 13TH TECHNICAL REPOR; Perkins DO, 2008, J CLIN PSYCHIAT, V69, P106, DOI 10.4088/JCP.v69n0114; POMH- UK, 2012, POMH UK TOPIC 10B RE; POOL D, 1976, CURR THER RES CLIN E, V19, P99; Power PJR, 2003, AUST NZ J PSYCHIAT, V37, P414, DOI 10.1046/j.1440-1614.2003.01209.x; Robinson DG, 2006, AM J PSYCHIAT, V163, P2096, DOI 10.1176/ajp.2006.163.12.2096; Sikich L, 2004, NEUROPSYCHOPHARMACOL, V29, P133, DOI 10.1038/sj.npp.1300327; Sikich L, 2008, AM J PSYCHIAT, V165, P1420, DOI 10.1176/appi.ajp.2008.08050756; Sikich L, 2008, J CLIN PSYCHIAT, V69, P21; Singh J, 2011, BIOL PSYCHIAT, V70, P1179, DOI 10.1016/j.biopsych.2011.06.021; STAFFORD MR, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F185; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Swadi HS, 2010, INT CLIN PSYCHOPHARM, V25, P1, DOI 10.1097/YIC.0b013e3283320511; van Bruggen J, 2003, INT CLIN PSYCHOPHARM, V18, P341, DOI 10.1097/00004850-200311000-00005; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P9, DOI 10.1177/1359786810382149; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Xiong Y, 2004, GUIZHOU MED J, V28, P697; Yao H, 2003, J CLIN PSYCHOL MED S, V7468, P801; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	72	59	64	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117166	10.1371/journal.pone.0117166	http://dx.doi.org/10.1371/journal.pone.0117166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671707	Green Published, gold			2022-12-27	WOS:000349545300037
J	Ssematimba, A; Jores, J; Mariner, JC				Ssematimba, Amos; Jores, Joerg; Mariner, Jeffrey C.			Mathematical Modelling of the Transmission Dynamics of Contagious Bovine Pleuropneumonia Reveals Minimal Target Profiles for Improved Vaccines and Diagnostic Assays	PLOS ONE			English	Article							SPREAD; VACCINATION; PERSISTENCE; POPULATION; CHALLENGES; SIMULATION; EFFICACY; CATTLE; IMPACT; TESTS	Contagious bovine pleuropneumonia (CBPP) is a cattle disease that has hampered the development of the livestock sector in sub-Saharan Africa. Currently, vaccination with a live vaccine strain is its recommended control measure although unofficial antimicrobial use is widely practiced. Here, modelling techniques are used to assess the potential impact of early elimination of infected cattle via accurate diagnosis on CBPP dynamics. A herd-level stochastic epidemiological model explicitly incorporating test sensitivity and specificity is developed. Interventions by annual vaccination, annual testing and elimination and a combination of both are implemented in a stepwise manner and their effectiveness compared by running 1000 simulations per intervention over ten years. The model predicts that among the simulated interventions, the ones likely to eliminate the disease from an isolated herd all involved annual vaccination of more than 75% of the animals with a vaccine that protects for at least 18 months combined with annual testing (and elimination of positive reactors) of 75% of the animals every six months after vaccination. The highest probability of disease elimination was 97.5% and this could occur within a median of 2.3 years. Generally, our model predicts that regular testing and elimination of positive reactors using improved tests will play a significant role in minimizing CBPP burden especially in the current situation where improved vaccines are yet to be developed.	[Ssematimba, Amos; Jores, Joerg; Mariner, Jeffrey C.] Int Livestock Res Inst, Nairobi 00100, Kenya; [Jores, Joerg] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland; [Mariner, Jeffrey C.] Tufts Cummings Sch Vet Med, North Grafton, MA USA	CGIAR; International Livestock Research Institute (ILRI); University of Bern	Ssematimba, A (corresponding author), Int Livestock Res Inst, Old Naivasha Rd,POB 30709, Nairobi 00100, Kenya.	a.ssematimba@cgiar.org	Ssematimba, Amos/S-3217-2019	Ssematimba, Amos/0000-0002-5407-2478; Jores, Joerg/0000-0003-3790-5746	CGIAR research program on "Livestock and Fish"; BBSRC-CIDLID project; German Federal Ministry for Economic Cooperation and Development [09.7860.1-001.00, 81121408]	CGIAR research program on "Livestock and Fish"; BBSRC-CIDLID project; German Federal Ministry for Economic Cooperation and Development	This work was financed by the CGIAR research program on "Livestock and Fish" and supported via a BBSRC-CIDLID project. It was also supported from the German Federal Ministry for Economic Cooperation and Development (project No 09.7860.1-001.00, contract No: 81121408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanfu W, 2009, ONDERSTEPOORT J VET, V76, P13; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Bellini S, 1998, REV SCI TECH OIE, V17, P654, DOI 10.20506/rst.17.3.1124; FAO, 2004, SUST CBPP CONTR PROG; Jores J, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-122; Kairu-Wanyoike SW, 2013, PREV VET MED, V110, P356, DOI 10.1016/j.prevetmed.2013.02.013; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lu Z, 2013, PREV VET MED, V108, P148, DOI 10.1016/j.prevetmed.2012.08.001; Mariam SH, 2010, WIPING TEARS AFRICAN; Mariner JC, 2006, PREV VET MED, V73, P55, DOI 10.1016/j.prevetmed.2005.09.001; Mariner JC, 2006, PREV VET MED, V73, P75, DOI 10.1016/j.prevetmed.2005.09.002; Masiga WN, 1996, REV SCI TECH OIE, V15, P1283, DOI 10.20506/rst.15.4.980; Matthews L, 2005, NAT REV MICROBIOL, V3, P529, DOI 10.1038/nrmicro1178; Muuka G, 2012, TROP ANIM HEALTH PRO, V45, P9, DOI 10.1007/s11250-012-0235-9; Muuka G, 2011, TROP ANIM HEALTH PRO, V43, P1057, DOI 10.1007/s11250-011-9805-5; Ngotho A, 2014, STANGE DIS KILLS LIV; Nkando I, 2012, RES VET SCI, V93, P568, DOI 10.1016/j.rvsc.2011.08.020; Ochola F, 2013, VACCINATION CONTAGIO; Rich KM, 2012, NAT RES MANAG POLICY, P305, DOI 10.1007/978-1-4419-7077-0_16; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Sidibe CAK, 2012, TROP ANIM HEALTH PRO, V44, P1233, DOI 10.1007/s11250-011-0063-3; Swai Emmanuel, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P303, DOI 10.1016/S2221-1691(13)60067-2; Tambi NE, 2006, REV SCI TECH OIE, V25, P999, DOI 10.20506/rst.25.3.1710; Teshale Sori, 2005, International Journal of Applied Research in Veterinary Medicine, V3, P344; Thiaucourt F., 2004, Infectious diseases of livestock. Volume Three, P2045; Thiaucourt F., 2003, VVolume 114, P147; Thiaucourt F, 2000, ANN NY ACAD SCI, V916, P71, DOI 10.1111/j.1749-6632.2000.tb05276.x; Wanyoike SW, 2009, THESIS U READING UK; Webb CR, 2011, VET REC, V168, P14; WINDSOR RS, 1977, RES VET SCI, V23, P224, DOI 10.1016/S0034-5288(18)33158-8; Woolhouse MEJ, 2003, J APPL MICROBIOL, V94, p126S	34	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116730	10.1371/journal.pone.0116730	http://dx.doi.org/10.1371/journal.pone.0116730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668725	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000009
J	Molnar, J; Frank, E; Minorics, R; Kadar, Z; Ocsovszki, I; Schonecker, B; Wolfling, J; Zupko, I				Molnar, Judit; Frank, Eva; Minorics, Renata; Kadar, Zalan; Ocsovszki, Imre; Schoenecker, Bruno; Woelfling, Janos; Zupko, Istvan			A Click Approach to Novel D-Ring-Substituted 16 alpha-Triazolylestrone Derivatives and Characterization of Their Antiproliferative Properties	PLOS ONE			English	Article							AZIDE-ALKYNE CYCLOADDITION; STEREOSELECTIVE-SYNTHESIS; PRESUMED INHIBITORS; SOLANIDINE ANALOGS; CYTOTOXIC ACTIVITY; CANCER-CELLS; ANTICANCER; STEROIDS; CDC25B; 1,2,3-TRIAZOLES	A simple and efficient synthesis of novel, D-ring substituted estrone derivatives containing a 16 alpha-triazolyl moiety is described. Two epimeric azido alcohols (16 alpha-azido-17 alpha-hydroxy and 16 alpha-azido-17 beta-hydroxy) of estra-1,3,5(10)-triene-3-methyl ether were prepared, followed by copper(I)-catalyzed azide-alkyne cycloaddition with various terminal alkynes. The steroidal triazoles were obtained in high yields and their activities against three human cancer cell lines (HeLa, MCF7 and A431) were screened. The most effective analogs were submitted to additional experiments in order to characterize their antiproliferative properties. As evidenced by flow cytometry, the selected steroids induced a disturbance in the HeLa cell cycle in a concentration- and exposure-dependent manner, through an increase of the hypodiploid population (subG1) and a cell cycle arrest in the G2/M phase. A noncancerous human fibroblast cell line (MRC5) was used to determine the selectivities of these compounds. Fluorescent microscopy after Hoechst 33258 - propidium iodide (HOPI) double staining revealed nuclear condensation and disturbed cell membrane integrity. The enhanced activities of caspase-3 and caspase-9 without activation of caspase-8 in the treated cells indicated the activation of the intrinsic pathway of apoptosis. The levels of cell cycle regulators (CDK1, cyclin B1/B2 and cdc25B) were decreased and the ratio Bax/Bcl-2 was increased 24 h after the treatment of HeLa cells (determined at an mRNA level by means of an RT-PCR technique). Under the same conditions, two agents elicited substantially increased degrees of phosphorylation of stathmin, as evidenced by Western blotting. The presented results demonstrate that these steroids can be regarded as appropriate structural scaffolds for the design and synthesis of further steroid analogs as innovative drug candidates with good efficacy.	[Molnar, Judit; Minorics, Renata; Zupko, Istvan] Univ Szeged, Dept Pharmacodynam & Biopharm, Szeged, Hungary; [Frank, Eva; Kadar, Zalan; Woelfling, Janos] Univ Szeged, Dept Organ Chem, Szeged, Hungary; [Ocsovszki, Imre] Univ Szeged, Dept Biochem, Szeged, Hungary; [Schoenecker, Bruno] Univ Jena, Inst Organ Chem & Macromol Chem, Jena, Germany	Szeged University; Szeged University; Szeged University; Friedrich Schiller University of Jena	Wolfling, J (corresponding author), Univ Szeged, Dept Organ Chem, Szeged, Hungary.	wolfling@chem.u-szeged.hu; zupko@pharm.u-szeged.hu	Frank, Eva/C-7870-2013; Zupkó, István/E-3687-2013; Minorics, Renata/AAC-7677-2020; Wolfling, Janos/A-3922-2008	Frank, Eva/0000-0002-1332-0551; Minorics, Renata/0000-0001-9685-813X; Wolfling, Janos/0000-0002-3037-309X	Hungarian Scientific Research Fund [OTKA K-109293, K-101659]; European Union; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0035]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF))	Financial support from the Hungarian Scientific Research Fund (http://www.otka.hu/en) is gratefully acknowledged. Grant numbers: OTKA K-109293 (IZ) and K-101659 (JW). This study was supported by the European Union and co-financed by the European Social Fund (JM, RM, IZ); project number: TAMOP-4.2.2.A-11/1/KONV-2012-0035 (http://www.u-szeged.hu/tamop422a0035-index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ R, 1994, J MED CHEM, V37, P4185, DOI 10.1021/jm00050a015; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Banday AH, 2010, STEROIDS, V75, P801, DOI 10.1016/j.steroids.2010.02.015; Berenyi A, 2013, STEROIDS, V78, P69, DOI 10.1016/j.steroids.2012.10.009; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brinkmann K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.61; Brodie A, 1999, United States Patent, Patent No. [5,994,335, 5994335]; BUCKLE DR, 1986, J MED CHEM, V29, P2262, DOI 10.1021/jm00161a022; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Frank E, 2013, J STEROID BIOCHEM, V137, P301, DOI 10.1016/j.jsbmb.2013.02.018; Frank E, 2011, STEROIDS, V76, P1141, DOI 10.1016/j.steroids.2011.05.002; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Genin MJ, 2000, J MED CHEM, V43, P953, DOI 10.1021/jm990373e; Gupta A, 2013, J STEROID BIOCHEM, V137, P242, DOI 10.1016/j.jsbmb.2013.05.011; Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1; Hofmeister H, 1992, United States Patent, Patent No. [5,389,624, 5389624]; Kadar Z, 2012, BIOORGAN MED CHEM, V20, P1396, DOI 10.1016/j.bmc.2012.01.008; Kadar Z, 2011, ORG BIOMOL CHEM, V9, P8051, DOI 10.1039/c1ob06086d; Kadar Z, 2011, MOLECULES, V16, P4786, DOI 10.3390/molecules16064786; Kamal A, 2011, BIOORGAN MED CHEM, V19, P2565, DOI 10.1016/j.bmc.2011.03.015; Kambhampati S, 2013, MOL CANCER THER, V12, P255, DOI 10.1158/1535-7163.MCT-12-0777; Krivopalov V.P., 2005, RUSS CHEM REV, V74, P339, DOI DOI 10.1070/RC2005V074N04ABEH000893; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lee CH, 2007, CANCER SCI, V98, P795, DOI 10.1111/j.1349-7006.2007.00473.x; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu JF, 2013, EUR J MED CHEM, V64, P621, DOI 10.1016/j.ejmech.2013.03.068; Majeed R, 2013, EUR J MED CHEM, V63, P782, DOI 10.1016/j.ejmech.2013.03.028; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Minorics R, 2011, STEROIDS, V76, P156, DOI 10.1016/j.steroids.2010.10.006; Molnar J, 2013, CURR SIGNAL TRANSD T, V8, P148, DOI 10.2174/15743624113086660006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Peyrat JF, 2012, CURR MED CHEM, V19, P4142, DOI 10.2174/092986712802430072; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salvador JAR, 2013, J STEROID BIOCHEM, V137, P199, DOI 10.1016/j.jsbmb.2013.04.006; SCHONECKER B, 1975, TETRAHEDRON, V31, P1113, DOI 10.1016/0040-4020(75)80134-7; Stenkvist B, 1999, ONCOL REP, V6, P493; Tolomeo M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P387, DOI 10.2174/1568011024606361; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Wolfling J, 2006, STEROIDS, V71, P809, DOI 10.1016/j.steroids.2006.05.011; Wolfting J, 2004, STEROIDS, V69, P451, DOI 10.1016/j.steroids.2004.04.003; Wu P, 2007, ALDRICHIM ACTA, V40, P7; Xu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105768; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zupko I, 2014, MOLECULES, V19, P2061, DOI 10.3390/molecules19022061	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118104	10.1371/journal.pone.0118104	http://dx.doi.org/10.1371/journal.pone.0118104			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692552	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000350061500096
J	Kurnosov, AA; Ustyugova, SV; Nazarov, VI; Minervina, AA; Komkov, AY; Shugay, M; Pogorelyy, MV; Khodosevich, KV; Mamedov, IZ; Lebedev, YB				Kurnosov, Alexey A.; Ustyugova, Svetlana V.; Nazarov, Vadim I.; Minervina, Anastasia A.; Komkov, Alexander Yu.; Shugay, Mikhail; Pogorelyy, Mikhail V.; Khodosevich, Konstantin V.; Mamedov, Ilgar Z.; Lebedev, Yuri B.			The Evidence for Increased L1 Activity in the Site of Human Adult Brain Neurogenesis	PLOS ONE			English	Article							SOMATIC RETROTRANSPOSITION; HIPPOCAMPAL NEUROGENESIS; INTERSPERSED REPEATS; ALU ELEMENTS; GENOME; LINE-1; CELLS; IDENTIFICATION; NEUROBLASTS; LANDSCAPE	Retroelement activity is a common source of polymorphisms in human genome. The mechanism whereby retroelements contribute to the intraindividual genetic heterogeneity by inserting into the DNA of somatic cells is gaining increasing attention. Brain tissues are suspected to accumulate genetic heterogeneity as a result of the retroelements somatic activity. This study aims to expand our understanding of the role retroelements play in generating somatic mosaicism of neural tissues. Whole-genome Alu and L1 profiling of genomic DNA extracted from the cerebellum, frontal cortex, subventricular zone, dentate gyrus, and the myocardium revealed hundreds of somatic insertions in each of the analyzed tissues. Interestingly, the highest concentration of such insertions was detected in the dentate gyrus-the hotspot of adult neurogenesis. Insertions of retroelements and their activity could produce genetically diverse neuronal subsets, which can be involved in hippocampal-dependent learning and memory.	[Kurnosov, Alexey A.; Ustyugova, Svetlana V.; Nazarov, Vadim I.; Minervina, Anastasia A.; Komkov, Alexander Yu.; Shugay, Mikhail; Pogorelyy, Mikhail V.; Mamedov, Ilgar Z.; Lebedev, Yuri B.] Russ Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Comparat & Funct Genom, Moscow, Russia; [Ustyugova, Svetlana V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Nazarov, Vadim I.] Natl Res Univ, Higher Sch Econ, Dept Informat Technol & Automated Syst, Moscow, Russia; [Khodosevich, Konstantin V.] Univ Heidelberg Hosp, German Canc Res Ctr DKFZ, Dept Clin Neurobiol, Heidelberg, Germany	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; California Institute of Technology; HSE University (National Research University Higher School of Economics); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Mamedov, IZ (corresponding author), Russ Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Comparat & Funct Genom, Moscow, Russia.	khodosevich@urz.uni-hd.de; Imamedov@mx.ibch.ru	Pogorelyy, Mikhail V/H-9610-2014; Lebedev, Yury B/G-6738-2012; Minervina, Anastasia A/P-7067-2016; Mamedov, Ilgar Z/H-9559-2014; Komkov, Alexander Y/L-4643-2016; Shugay, Mikhail/O-1073-2016; Komkov, Alexander/AAX-4816-2021; Nazarov, Vadim/K-8762-2015	Pogorelyy, Mikhail V/0000-0003-0773-1204; Lebedev, Yury B/0000-0003-4554-4733; Minervina, Anastasia A/0000-0001-9884-6351; Mamedov, Ilgar Z/0000-0002-3992-9285; Shugay, Mikhail/0000-0001-7826-7942; Komkov, Alexander/0000-0001-9113-698X; Nazarov, Vadim/0000-0003-3659-2709; Khodosevich, Konstantin/0000-0001-7232-5558	Russian Foundation for Basic Research [RFBR-12-04-33065, RFBR-11-04-01159];  [14.604.21.0118]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 	Funding provided by RFBR-12-04-33065 Russian Foundation for Basic Research http://www.rfbr.ru/rffi/eng to IZM, RFBR-11-04-01159 Russian Foundation for Basic Research http://www.rfbr.ru/rffi/eng to YBL and state contract 14.604.21.0118 https://sstp.ru to YBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amosova A L, 2009, Bioorg Khim, V35, P779; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arokium H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108682; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Khatua AK, 2010, VIROLOGY, V400, P68, DOI 10.1016/j.virol.2010.01.021; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedev YB, 2007, GENE, V390, P122, DOI 10.1016/j.gene.2006.09.031; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Mamedov I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf071; Mamedov IZ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni018; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jcis.2014.12.029, DOI 10.1016/J.JCIS.2014.12.029]; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Scrucca L, 2004, R NEWS, V4, P22; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	52	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117854	10.1371/journal.pone.0117854	http://dx.doi.org/10.1371/journal.pone.0117854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689626	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000350322700078
J	Oshida, K; Vasani, N; Thomas, RS; Applegate, D; Rosen, M; Abbott, B; Lau, C; Guo, G; Aleksunes, LM; Klaassen, C; Corton, JC				Oshida, Keiyu; Vasani, Naresh; Thomas, Russell S.; Applegate, Dawn; Rosen, Mitch; Abbott, Barbara; Lau, Christopher; Guo, Grace; Aleksunes, Lauren M.; Klaassen, Curtis; Corton, J. Christopher			Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha) in a Mouse Liver Gene Expression Compendium	PLOS ONE			English	Article							FATTY-ACID OXIDATION; NONGENOTOXIC CARCINOGEN; MICE; EXPOSURE; STEATOHEPATITIS; ACCUMULATION; SIGNATURES; PATHWAYS; KNOCKOUT; PROTECTS	The nuclear receptor family member peroxisome proliferator-activated receptor alpha (PPAR alpha) is activated by therapeutic hypolipidemic drugs and environmentally-relevant chemicals to regulate genes involved in lipid transport and catabolism. Chronic activation of PPAR alpha in rodents increases liver cancer incidence, whereas suppression of PPAR alpha activity leads to hepatocellular steatosis. Analytical approaches were developed to identify biosets (i.e., gene expression differences between two conditions) in a genomic database in which PPAR alpha activity was altered. A gene expression signature of 131 PPAR alpha-dependent genes was built using microarray profiles from the livers of wild-type and PPAR alpha-null mice after exposure to three structurally diverse PPAR alpha activators (WY-14,643, fenofibrate and perfluorohexane sulfonate). A fold-change rank-based test (Running Fisher's test (p-value <= 10(-4))) was used to evaluate the similarity between the PPAR alpha signature and a test set of 48 and 31 biosets positive or negative, respectively for PPAR alpha activation; the test resulted in a balanced accuracy of 98%. The signature was then used to identify factors that activate or suppress PPAR alpha in an annotated mouse liver/primary hepatocyte gene expression compendium of similar to 1850 biosets. In addition to the expected activation of PPAR alpha by fibrate drugs, di(2-ethylhexyl) phthalate, and perfluorinated compounds, PPAR alpha was activated by benzofuran, galactosamine, and TCDD and suppressed by hepatotoxins acetaminophen, lipopolysaccharide, silicon dioxide nanoparticles, and trovafloxacin. Additional factors that activate (fasting, caloric restriction) or suppress (infections) PPAR alpha were also identified. This study 1) developed methods useful for future screening of environmental chemicals, 2) identified chemicals that activate or suppress PPAR alpha, and 3) identified factors including diets and infections that modulate PPAR alpha activity and would be hypothesized to affect chemical-induced PPAR alpha activity.	[Oshida, Keiyu; Vasani, Naresh; Rosen, Mitch; Abbott, Barbara; Lau, Christopher; Corton, J. Christopher] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Thomas, Russell S.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA; [Applegate, Dawn] RegeneMed, San Diego, CA USA; [Guo, Grace; Aleksunes, Lauren M.] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Klaassen, Curtis] Univ Washington, Seattle, WA 98195 USA	United States Environmental Protection Agency; The Hamner Institutes for Health Sciences; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle	Corton, JC (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov	Vasani, Naresh B/K-9082-2019	Thomas, Russell/0000-0002-2340-0301; Aleksunes, Lauren/0000-0002-0032-1037; Vasani, Naresh/0000-0003-4814-3310; Abbott, Barbara/0000-0001-8996-5842				Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; BICHET N, 1990, TOXICOL APPL PHARM, V106, P509, DOI 10.1016/0041-008X(90)90345-U; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen C, 2009, CHEM RES TOXICOL, V22, P699, DOI 10.1021/tx800464q; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Currie RA, 2005, TOXICOL SCI, V86, P453, DOI 10.1093/toxsci/kfi207; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Diani-Moore S, 2014, DRUG METAB DISPOS, V42, P294, DOI 10.1124/dmd.113.055368; Fisher P, 2007, NUCLEIC ACIDS RES, V35, P5625, DOI 10.1093/nar/gkm623; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Lu XY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055101; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Mohapatra SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-10; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pery ARR, 2013, SCI TOTAL ENVIRON, V456, P307, DOI 10.1016/j.scitotenv.2013.03.099; Peters JM, 1998, CARCINOGENESIS, V19, P1989, DOI 10.1093/carcin/19.11.1989; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ren HZ, 2009, REPROD TOXICOL, V27, P266, DOI 10.1016/j.reprotox.2008.12.011; Rosen MB, 2010, PPAR RES, V2010, DOI 10.1155/2010/794739; Rosen MB, 2009, REPROD TOXICOL, V27, P278, DOI 10.1016/j.reprotox.2009.01.007; Ross PK, 2009, TOXICOL APPL PHARM, V235, P199, DOI 10.1016/j.taap.2008.12.011; SAKAI M, 1995, CANCER RES, V55, P5370; Sanderson LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001681; Schaap MM, 2012, ARCH TOXICOL, V86, P1717, DOI 10.1007/s00204-012-0883-6; Shaw PJ, 2009, TOXICOL SCI, V107, P270, DOI 10.1093/toxsci/kfn205; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Simon R, 2007, CANCER INFORM, V3, P11; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai ES, 2003, FEBS LETT, V546, P237, DOI 10.1016/S0014-5793(03)00578-7; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wu Q, 2008, J APPL TOXICOL, V28, P724, DOI 10.1002/jat.1331; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100	65	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0112655	10.1371/journal.pone.0112655	http://dx.doi.org/10.1371/journal.pone.0112655			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689681	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700002
J	Shi, JJ; Jiang, Q; Ding, XW; Xu, WH; Wang, DW; Chen, ML				Shi, Jiaojiao; Jiang, Qi; Ding, Xiangwei; Xu, Wenhua; Wang, Dao W.; Chen, Minglong			The ER Stress-Mediated Mitochondrial Apoptotic Pathway and MAPKs Modulate Tachypacing-Induced Apoptosis in HL-1 Atrial Myocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; DOWN-REGULATION; FIBRILLATION; KINASE; INHIBITION; HEART; PHOSPHORYLATION; DYSFUNCTION	Background and Object Cell apoptosis is a contributing factor in the initiation, progression and relapse of atrial fibrillation (AF), a life-threatening illness accompanied with stroke and heart failure. However, the regulatory cascade of apoptosis is intricate and remains unidentified, especially in the setting of AF. The aim of this study was to explore the roles of endoplasmic reticulum (ER) stress, mitochondrial apoptotic pathway (MAP), mitogen-activated protein kinases (MAPKs), and their cross-talking in tachypacing-induced apoptosis. Methods and Results HL-1 cells were cultured in the presence of tachypacing for 24 h to simulate atrial tachycardia remodeling. Results showed that tachypacing reduced cell viability measured by the cell counting kit-8, dissipated mitochondrial membrane potential detected by JC-1 staining and resulted in approximately 50% apoptosis examined by Hoechst staining and annexin V/propidium iodide staining. In addition, the proteins involved in ER stress, MAP and MAPKs were universally up-regulated or activated via phosphorylation, as confirmed by western blotting; and reversely silencing of ER stress, caspase-3 (the ultimate executor of MAP) and MAPKs with specific inhibitors prior to pacing partially alleviated apoptosis. An inhibitor of ER stress was applied to further investigate the responses of mitochondria and MAPKs to ER stress, and results indicated that suppression of ER stress comprehensively but incompletely attenuated the activation of MAP and MAPKs aroused by tachypacing, with the exception of ERK1/2, one branch of MAPKs. Conclusions Our study suggested tachypacing-induced apoptosis is regulated by ER stress-mediated MAP and MAPKs. Thus, the above three components are all promising anti-apoptotic targets in AF patients and ER stress appears to play a dominant role due to its comprehensive effects.	[Shi, Jiaojiao; Jiang, Qi; Ding, Xiangwei; Xu, Wenhua; Wang, Dao W.; Chen, Minglong] Nanjing Med Univ, Div Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Chen, ML (corresponding author), Nanjing Med Univ, Div Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	chenminglong@njmu.edu.cn		Jiang, Qi/0000-0001-7835-1335	National Natural and Science Foundation of China [81070156, 81470455, 81170159]	National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural and Science Foundation of China (grant numbers 81070156, 81470455, 81170159 to MC and DW; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2004, CARDIOVASC RES, V62, P521, DOI 10.1016/j.cardiores.2004.02.007; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Chen YF, 2014, CELL PHYSIOL BIOCHEM, V33, P1975, DOI 10.1159/000362974; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Ding WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094545; Dispersyn GD, 1999, CARDIOVASC RES, V43, P947, DOI 10.1016/S0008-6363(99)00096-6; George I, 2011, CARDIOVASC RES, V91, P447, DOI 10.1093/cvr/cvr106; Jiang Q, 2014, BIOCHEM BIOPH RES CO, V449, P278, DOI 10.1016/j.bbrc.2014.05.041; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; KLINE RP, 1993, J CARDIOVASC ELECTR, V4, P642, DOI 10.1111/j.1540-8167.1993.tb01251.x; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Muller P, 2013, J CARDIOVASC ELECTR, V24, P1110, DOI 10.1111/jce.12191; Negrin G, 2010, MOL CARCINOGEN, V49, P488, DOI 10.1002/mc.20629; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Osmancik P, 2010, CARDIOLOGY, V116, P302, DOI 10.1159/000319619; Sepulveda M, 2013, J MOL CELL CARDIOL, V63, P135, DOI 10.1016/j.yjmcc.2013.07.013; STEINHELPER ME, 1990, AM J PHYSIOL, V259, pH1826, DOI 10.1152/ajpheart.1990.259.6.H1826; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Zhenjiang, 2005, J Mol Cell Cardiol, V38, P299, DOI 10.1016/j.yjmcc.2004.11.015; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou X, 2014, EXP PHYSIOL, DOI [10.1113/expphysiol.2014.082149, DOI 10.1113/EXPPHYSIOL.2014.082149]	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117567	10.1371/journal.pone.0117567	http://dx.doi.org/10.1371/journal.pone.0117567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689866	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700056
J	Wheeler, HE; Wing, C; Delaney, SM; Komatsu, M; Dolan, ME				Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Dolan, M. Eileen			Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells	PLOS ONE			English	Article							INDUCED PERIPHERAL NEUROPATHY; ROOT GANGLION NEURONS; GENOME-WIDE ASSOCIATION; CLINICAL-TRIAL; IMAGE-ANALYSIS; ANIMAL-MODELS; CALGB 40101; PACLITAXEL; PREVENTION; CISPLATIN	There are no effective agents to prevent or treat chemotherapy-induced peripheral neuropathy (CIPN), the most common non-hematologic toxicity of chemotherapy. Therefore, we sought to evaluate the utility of human neuron-like cells derived from induced pluripotent stem cells (iPSCs) as a means to study CIPN. We used high content imaging measurements of neurite outgrowth phenotypes to compare the changes that occur to iPSC-derived neuronal cells among drugs and among individuals in response to several classes of chemotherapeutics. Upon treatment of these neuronal cells with the neurotoxic drug paclitaxel, vincristine or cisplatin, we identified significant differences in five morphological phenotypes among drugs, including total outgrowth, mean/median/maximum process length, and mean outgrowth intensity (P < 0.05). The differences in damage among drugs reflect differences in their mechanisms of action and clinical CIPN manifestations. We show the potential of the model for gene perturbation studies by demonstrating decreased expression of TUBB2A results in significantly increased sensitivity of neurons to paclitaxel (0.23 +/- 0.06 decrease in total neurite outgrowth, P = 0.011). The variance in several neurite outgrowth and apoptotic phenotypes upon treatment with one of the neurotoxic drugs is significantly greater between than within neurons derived from four different individuals (P < 0.05), demonstrating the potential of iPSC-derived neurons as a genetically diverse model for CIPN. The human neuron model will allow both for mechanistic studies of specific genes and genetic variants discovered in clinical studies and for screening of new drugs to prevent or treat CIPN.	[Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Wheeler, Heather/I-9279-2019; Komatsu, Masaaki/ABC-7821-2020	Wheeler, Heather/0000-0003-1365-9667; Komatsu, Masaaki/0000-0003-0421-8085; Wing, Claudia/0000-0002-8243-5598	National Institutes of Health, National Cancer Institute, National Research Service [F32CA165823]; National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research [U01GM61393]; University of Chicago Breast Cancer SPORE Grant National Cancer Institute [P50 CA125183]; National Institutes of Health, National Cancer Institute [R01 CA136765, R01 CA157823]; NATIONAL CANCER INSTITUTE [R01CA136765, P50CA125183, F32CA165823, R01CA157823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, National Research Service; National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research; University of Chicago Breast Cancer SPORE Grant National Cancer Institute; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health, National Cancer Institute, National Research Service Award F32CA165823 (HEW); National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research Grant U01GM61393 (MED); University of Chicago Breast Cancer SPORE Grant National Cancer Institute P50 CA125183 (MED); National Institutes of Health, National Cancer Institute R01 CA136765 (MED) and National Institutes of Health, National Cancer Institute R01 CA157823 (MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Authier N, 2009, NEUROTHERAPEUTICS, V6, P620, DOI 10.1016/j.nurt.2009.07.003; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Cavaletti G, 2010, EUR J CANCER, V46, P479, DOI 10.1016/j.ejca.2009.12.008; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chhibber A, 2014, PHARMACOGENOMICS J, V14, P336, DOI 10.1038/tpj.2014.2; Diouf B, 2014, GENOME WIDE IN PRESS; Elena JW, 2013, JNCI-J NATL CANCER I, V105, P85, DOI 10.1093/jnci/djs473; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; GRUNBERG SM, 1989, CANCER CHEMOTH PHARM, V25, P62, DOI 10.1007/BF00694340; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hoke A, 2012, NEUROTHERAPEUTICS, V9, P262, DOI 10.1007/s13311-012-0116-y; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Leandro-Garcia LJ, 2013, J MED GENET, V50, P599, DOI 10.1136/jmedgenet-2012-101466; Leandro-Garcia LJ, 2012, CLIN CANCER RES, V18, P4441, DOI 10.1158/1078-0432.CCR-12-1221; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; MALGRANGE B, 1994, J NEUROSCI METH, V53, P111, DOI 10.1016/0165-0270(94)90151-1; Matimba A, 2014, PHARMACOGENOMICS, V15, P433, DOI 10.2217/pgs.13.226; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Pachman DR, 2014, J CLIN INVEST, V124, P72, DOI 10.1172/JCI73908; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Persohn E, 2005, EUR J CANCER, V41, P1460, DOI 10.1016/j.ejca.2005.04.006; Piccolo J, 2014, AM J HEALTH-SYST PH, V71, P19, DOI 10.2146/ajhp130126; Pinto N, 2014, CLIN PHARMACOL THER, V95, P644, DOI 10.1038/clpt.2014.37; Pittman SK, 2014, EXP NEUROL, V253, P146, DOI 10.1016/j.expneurol.2013.12.011; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Rajesh D, 2011, BLOOD, V118, P1797, DOI 10.1182/blood-2011-01-332064; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Schloss JM, 2013, CLIN NUTR, V32, P888, DOI 10.1016/j.clnu.2013.04.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SETHI VS, 1981, CANCER RES, V41, P3551; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Topp KS, 2000, J COMP NEUROL, V424, P563; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Wheeler HE, 2012, PHARMACOGENOMICS, V13, P55, DOI [10.2217/PGS.11.121, 10.2217/pgs.11.121]; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang J, 2014, BRAIN BEHAV IMMUN	47	65	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118020	10.1371/journal.pone.0118020	http://dx.doi.org/10.1371/journal.pone.0118020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689802	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700093
J	Xia, L; Ma, SH; Zhang, Y; Wang, T; Zhou, MY; Wang, ZQ; Zhang, JF				Xia, Lin; Ma, Shihong; Zhang, Ying; Wang, Tao; Zhou, Mengyi; Wang, Zhongqiu; Zhang, Jianfa			Daily Variation in Global and Local DNA Methylation in Mouse Livers	PLOS ONE			English	Article							ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY; S-ADENOSYLHOMOCYSTEINE; MAMMALIAN DNA; 5-METHYLCYTOSINE; EXPRESSION; ADENOSYLMETHIONINE; HYPOMETHYLATION; HOMOCYSTEINE; DNMT3A; METHYLTRANSFERASES	DNA methylation is one of the best-characterized epigenetic modifications and has an important biological relevance. Here we showed that global DNA methylation level in mouse livers displayed a daily variation where the peak phases occurred during the end of the day and the lowest level at the beginning of the day in the light-dark or dark-dark cycles. Typical repeat sequence long interspersed nucleotide element-1 (LINE-1) had a similar methylation rhythm to global DNA. DNA methyltransferase 3A (DNMT3A) and ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) brought a relative forward daily variation to global DNA methylation, and the temporary change in ratio of SAM to SAH had no influence on the DNA methylation level. The rhythm of global DNA methylation was lost and DNA methylation level was increased in Per1(-/-)Per2(-/-) double knockout mice, which were in accordance with changes of Dnmt3a mRNA levels and its rhythm. Our results suggest that the daily variation in global DNA methylation was associated with the change of Dnmt3a expression rather than ratio of SAM to SAH.	[Xia, Lin; Wang, Tao; Zhou, Mengyi; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Jiangsu, Peoples R China; [Ma, Shihong] Nanjing Inst Comprehens Utilizat Wild Plant, Nanjing 210042, Jiangsu, Peoples R China; [Zhang, Ying] Jiangsu Univ, Sch Med, Dept Biochem & Mol Biol, Zhenjiang 212013, Peoples R China; [Wang, Zhongqiu] Nanjing Univ Chinese Med, Dept Radiol, Nanjing 210000, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Jiangsu University; Nanjing University of Chinese Medicine	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Dept Radiol, Nanjing 210000, Jiangsu, Peoples R China.	zhq2001us@163.com; jfzhang@mail.njust.edu.cn			National Basic Research Program of China [2012CB517505, 2013CB945203]; National Science Foundation of China [31171125]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB517505 and 2013CB945203), and the National Science Foundation of China (31171125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, J BIOL; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonsch D, 2007, CHRONOBIOL INT, V24, P315, DOI 10.1080/07420520701290565; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Bujnicki JM, 2003, PROTEINS, V52, P624, DOI 10.1002/prot.10446; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; CATANIA J, 1987, ANAL BIOCHEM, V167, P347, DOI 10.1016/0003-2697(87)90175-8; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; DESANCHEZ VC, 1991, INT J BIOCHEM, V23, P1439, DOI 10.1016/0020-711X(91)90287-W; Dou S, 2012, J CONTROL RELEASE, V161, P875, DOI 10.1016/j.jconrel.2012.05.015; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fryer Anthony A, 2009, Epigenetics, V4, P394; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hermes M, 2004, EXP CELL RES, V294, P325, DOI 10.1016/j.yexcr.2003.12.001; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; JUPE ER, 1986, J BACTERIOL, V165, P420, DOI 10.1128/jb.165.2.420-423.1986; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Maekawa F, 2012, EPIGENETICS-US, V7, P1046, DOI 10.4161/epi.21539; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Williams-Karnesky RL, 2013, J CLIN INVEST, V123, P3552, DOI 10.1172/JCI65636; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zhang Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE325, DOI 10.1152/ajpendo.00424.2011; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	56	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118101	10.1371/journal.pone.0118101	http://dx.doi.org/10.1371/journal.pone.0118101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689298	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700101
J	Hoehlig, K; Bethge, L; Klussmann, S				Hoehlig, Kai; Bethge, Lucas; Klussmann, Sven			Stereospecificity of Oligonucleotide Interactions Revisited: No Evidence for Heterochiral Hybridization and Ribozyme/DNAzyme Activity	PLOS ONE			English	Article							NUCLEIC-ACIDS; RNA ENZYME; LIGANDS; DNA; SELECTION; IDENTIFICATION; AMPLIFICATION; POLYMERASE; BINDING	A major challenge for the application of RNA-or DNA-oligonucleotides in biotechnology and molecular medicine is their susceptibility to abundant nucleases. One intriguing possibility to tackle this problem is the use of mirror-image (L-) oligonucleotides. For aptamers, this concept has successfully been applied to even develop therapeutic agents, so-called Spiegelmers. However, for technologies depending on RNA/RNA or RNA/DNA hybridization, like antisense or RNA interference, it has not been possible to use mirror-image oligonucleotides because Watson-Crick base pairing of complementary strands is (thought to be) stereospecific. Many scientists consider this a general principle if not a dogma. A recent publication proposing heterochiral Watson-Crick base pairing and sequence-specific hydrolysis of natural RNA by mirror-image ribozymes or DNAzymes (and vice versa) prompted us to systematically revisit the stereospecificity of oligonucleotides hybridization and catalytic activity. Using hyperchro-micity measurements we demonstrate that hybridization only occurs among homochiral antiparallel complementary oligonucleotide strands. As expected, achiral PNA hybridizes to RNA and DNA irrespective of their chirality. In functional assays we could not confirm an alleged heterochiral hydrolytic activity of ribozymes or DNAzymes. Our results confirm a strict stereospecificity of oligonucleotide hybridization and clearly argue against the possibility to use mirror-image oligonucleotides for gene silencing or antisense applications.	[Hoehlig, Kai; Bethge, Lucas; Klussmann, Sven] NOXXON Pharma AG, Berlin, Germany	NOXXON Pharma	Klussmann, S (corresponding author), NOXXON Pharma AG, Berlin, Germany.	sklussmann@noxxon.com						ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; ASSELINE U, 1991, NUCLEIC ACIDS RES, V19, P4067, DOI 10.1093/nar/19.15.4067; Bada, 1995, NATURE, V374, P594; Bethge L, 2008, BIOORGAN MED CHEM, V16, P114, DOI 10.1016/j.bmc.2006.12.044; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Froeyen M, 2007, CHEM BIODIVERS, V4, P803, DOI 10.1002/cbdv.200790065; FUJIMORI S, 1990, J AM CHEM SOC, V112, P7436, DOI 10.1021/ja00176a077; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; HASHIMOTO Y, 1993, J AM CHEM SOC, V115, P9883, DOI 10.1021/ja00075a002; Hoffmann S, 2011, CURR PROTOC NUCL ACI, P1; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Olea C, 2012, J AM CHEM SOC, V134, P8050, DOI 10.1021/ja302197x; Purschke WG, 2014, BIOCHEM J, V462, P153, DOI 10.1042/BJ20131422; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sczepanski JT, 2014, NATURE, V515, P440, DOI 10.1038/nature13900; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; THOMSON SA, 1995, TETRAHEDRON, V51, P6179, DOI 10.1016/0040-4020(95)00286-H; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VANBOECKEL CAA, 1987, J MOL EVOL, V25, P100, DOI 10.1007/BF02101751; Vater A, 2003, CURR OPIN DRUG DI DE, V6, P253; Williams KP, 1997, P NATL ACAD SCI USA, V94, P11285, DOI 10.1073/pnas.94.21.11285; Wyszko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086673; Wyszko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054741; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5	28	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115328	10.1371/journal.pone.0115328	http://dx.doi.org/10.1371/journal.pone.0115328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679211	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600007
J	Holme, AM; Roland, MCP; Lorentzen, B; Michelsen, TM; Henriksen, T				Holme, Ane M.; Roland, Marie Cecilie P.; Lorentzen, Bjorg; Michelsen, Trond M.; Henriksen, Tore			Placental Glucose Transfer: A Human In Vivo Study	PLOS ONE			English	Article							CORD PLASMA; BLOOD-FLOW; FETAL; INSULIN; GROWTH; PREGNANCY; FETUS; GRADIENTS; GLUCAGON; ENERGY	Objectives The placental transfer of nutrients is influenced by maternal metabolic state, placenta function and fetal demands. Human in vivo studies of this interplay are scarce and challenging. We aimed to establish a method to study placental nutrient transfer in humans. Focusing on glucose, we tested a hypothesis that maternal glucose concentrations and uteroplacental arterio-venous difference (reflecting maternal supply) determines the fetal venous-arterial glucose difference (reflecting fetal consumption). Methods Cross-sectional in vivo study of 40 healthy women with uncomplicated term pregnancies undergoing planned caesarean section. Glucose and insulin were measured in plasma from maternal and fetal sides of the placenta, at the incoming (radial artery and umbilical vein) and outgoing vessels (uterine vein and umbilical artery). Results There were significant mean (SD) uteroplacental arterio-venous 0.29 (0.23) mmol/L and fetal venous-arterial 0.38 (0.31) mmol/L glucose differences. The transplacental maternalfetal glucose gradient was 1.22 (0.42) mmol/L. The maternal arterial glucose concentration was correlated to the fetal venous glucose concentration (r = 0.86, p < 0.001), but not to the fetal venous-arterial glucose difference. The uteroplacental arterio-venous glucose difference was neither correlated to the level of glucose in the umbilical vein, nor fetal venous-arterial glucose difference. The maternal-fetal gradient was correlated to fetal venous-arterial glucose difference (r = 0.8, p < 0.001) and the glucose concentration in the umbilical artery (r = -0.45, p = 0.004). Glucose and insulin concentrations were correlated in the mother (r = 0.52, p = 0.001), but not significantly in the fetus. We found no significant correlation between maternal and fetal insulin values. Conclusions We did not find a relation between indicators of maternal glucose supply and the fetal venous-arterial glucose difference. Our findings indicate that the maternal-fetal glucose gradient is significantly influenced by the fetal venous-arterial difference and not merely dependent on maternal glucose concentration or the arterio-venous difference on the maternal side of the placenta.	[Holme, Ane M.; Roland, Marie Cecilie P.; Lorentzen, Bjorg; Michelsen, Trond M.; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Michelsen, Trond M.] Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway; [Henriksen, Tore] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Holme, AM (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.	sbhmoa@ous-hf.no			South-Eastern Norway Regional Health Authority [2013043]; Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health; University of Oslo	South-Eastern Norway Regional Health Authority; Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health; University of Oslo	AMH recieved a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2013043 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). MCPR recieved a PhD grant from the ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health (http://www.extrastiftelsen.no/). TMM is funded by the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). The study also received funding from University of Oslo, the Institute of Clinical Medicine, Thematic Research (http://www.med.uio.no/klinmed/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; COLTART TM, 1969, BRIT MED J, V4, P17, DOI 10.1136/bmj.4.5674.17; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; Hay Jr WW, 2006, T AM CLIN CLIMATOLOG, V117, P339; Hay William W Jr, 2006, Trans Am Clin Climatol Assoc, V117, P321; HAY WW, 1990, AM J PHYSIOL, V258, pR569, DOI 10.1152/ajpregu.1990.258.3.R569; HAY WW, 1991, P NUTR SOC, V50, P321, DOI 10.1079/PNS19910042; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; JANSSON T, 1993, J CLIN ENDOCR METAB, V77, P1554, DOI 10.1210/jc.77.6.1554; Kalhan S, 2000, SEMIN PERINATOL, V24, P94, DOI 10.1053/sp.2000.6360; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; KUO PL, 1991, J PERINAT MED, V19, P421, DOI 10.1515/jpme.1991.19.6.421; LIND T, 1975, BRIT J OBSTET GYNAEC, V82, P562, DOI 10.1111/j.1471-0528.1975.tb00687.x; METZGER BE, 1985, PLACENTA, V6, P347, DOI 10.1016/S0143-4004(85)80044-8; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; PALMER SK, 1992, OBSTET GYNECOL, V80, P1000; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V15, P33, DOI 10.1530/acta.0.0150033; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Schneider H, 2003, PLACENTA, V24, P27, DOI 10.1053/plac.2002.0869; SIMMONS MA, 1978, PEDIATR RES, V12, P90, DOI 10.1203/00006450-197802000-00004; SPELLACY WN, 1964, AM J OBSTET GYNECOL, V90, P753, DOI 10.1016/0002-9378(64)90938-X; SPELLACY WN, 1976, OBSTET GYNECOL, V47, P291; SPELLACY WN, 1973, OBSTET GYNECOL, V41, P323; STEINGRIMSDOTTIR T, 1993, EUR J OBSTET GYN R B, V51, P209, DOI 10.1016/0028-2243(93)90037-D; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551	31	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117084	10.1371/journal.pone.0117084	http://dx.doi.org/10.1371/journal.pone.0117084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680194	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600048
J	Yu, XY; Liu, SP; Li, JB; Fan, XH; Chen, YJ; Bi, XY; Liu, SR; Deng, XM				Yu, Xiya; Liu, Shupeng; Li, Jinbao; Fan, Xiaohua; Chen, Yuanjie; Bi, Xiaoying; Liu, Shanrong; Deng, Xiaoming			MicroRNA-572 Improves Early Post-Operative Cognitive Dysfunction by Down-Regulating Neural Cell Adhesion Molecule 1	PLOS ONE			English	Article							ELDERLY-PATIENTS; AGED RATS; SURGERY; IMPAIRMENT; EXPRESSION; PLASTICITY; DECLINE; DISEASE; BYPASS; SERUM	Post-operative cognitive dysfunction (POCD) is a commonly-seen postoperative complication in elderly patients. However, the underlying mechanisms of POCD remain unclear. miRNAs, which are reported to be involved in the pathogenesis of the nervous system diseases, may also affect POCD. In this study, miRNA microarray technology was used to analyze the circulating miRNA expression profile of POCD patients. Among the altered miRNAs, miR-572 had the greatest decrease, which was also verified in vivo in rat POCD model. Further analysis found that miR-572 could regulate the expression of NCAM1 in the hippocampal neurons and interfering miR-572 expression could facilitate the restoration of cognitive function in vivo. Moreover, clinical correlation analysis found that the miR-572 expression was associated with the incidence of POCD. Collectively, miR-572 is involved in the development and restoration of POCD and it may serve as a biological marker for early diagnosis of POCD.	[Yu, Xiya; Li, Jinbao; Fan, Xiaohua; Chen, Yuanjie; Deng, Xiaoming] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Liu, Shupeng; Liu, Shanrong] Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai 200433, Peoples R China; [Bi, Xiaoying] Second Mil Med Univ, Changhai Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Liu, SR (corresponding author), Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai 200433, Peoples R China.	liushanrong@hotmail.com; dengx@yahoo.com	Deng, Xiaoming/E-2876-2010		National Natural Science Foundation [81350001]; Program of the Shanghai Science and Technology Committee [11JC1415500]; Program of Shanghai Municipal Health Bureau [2009059]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program of the Shanghai Science and Technology Committee; Program of Shanghai Municipal Health Bureau	This study was supported by National Natural Science Foundation No. 81350001 (XYY), Program of the Shanghai Science and Technology Committee No. 11JC1415500 (XYY), and Program of Shanghai Municipal Health Bureau No. 2009059 (XYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LN, 2013, BIOL TRACE ELEM RES, V151, P277, DOI 10.1007/s12011-012-9564-9; Arora SS, 2014, INT J NEUROSCI, V124, P236, DOI 10.3109/00207454.2013.833919; Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Biedler A, 1999, ANAESTHESIST, V48, P884, DOI 10.1007/s001010050802; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069239; Dallerac G, 2011, LEARN MEMORY, V18, P306, DOI 10.1101/lm.2154311; Engelhard K, 2008, ANASTH INTENSIV NOTF, V43, P606, DOI 10.1055/s-0028-1090023; Fareed M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109585; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Gu H, 2012, J NEUROCHEM, V122, P641, DOI 10.1111/j.1471-4159.2012.07812.x; Guo FJ, 2013, J INT MED RES, V41, P1456, DOI 10.1177/0300060513487652; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Ji MH, 2013, J ANESTH, V27, P942, DOI 10.1007/s00540-013-1633-5; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kong FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061385; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Li S, 2013, J NEUROSCI, V33, P790, DOI 10.1523/JNEUROSCI.1238-12.2013; Li SY, 2013, BRAIN RES, V1496, P84, DOI 10.1016/j.brainres.2012.12.025; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Patron E, 2013, GEN HOSP PSYCHIAT, V35, P472, DOI 10.1016/j.genhosppsych.2013.05.004; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Trovo L, 2013, NAT NEUROSCI, V16, P449, DOI 10.1038/nn.3342; Wang X, 2013, MOL NEUROBIOL, V47, P373, DOI 10.1007/s12035-012-8355-9; Xu JH, 2013, NEUROL SCI, V34, P2123, DOI 10.1007/s10072-013-1347-3; Xu T, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-204; Yakoot M, 2013, CLIN INTERV AGING, V8, P975, DOI 10.2147/CIA.S44777; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	30	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118511	10.1371/journal.pone.0118511	http://dx.doi.org/10.1371/journal.pone.0118511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680004	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600123
J	Budell, L; Kunz, M; Jackson, PL; Rainville, P				Budell, Lesley; Kunz, Miriam; Jackson, Philip L.; Rainville, Pierre			Mirroring Pain in the Brain: Emotional Expression versus Motor Imitation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; FACIAL EXPRESSIONS; NEURAL MECHANISMS; EMPATHY; AREAS; SYSTEM; PREMOTOR; RESPONSES; OTHERS	Perception of pain in others via facial expressions has been shown to involve brain areas responsive to self-pain, biological motion, as well as both performed and observedmotor actions. Here, we investigated the involvement of these different regions during emotional and motor mirroring of pain expressions using a two-task paradigm, and including both observation and execution of the expressions. BOLD responses were measured as subjects watched video clips showing different intensities of pain expression and, after a variable delay, either expressed the amount of pain they perceived in the clips (pain task), or imitated the facial movements (movement task). In the pain task condition, pain coding involved overlapping activation across observation and execution in the anterior cingulate cortex, supplementary motor area, inferior frontal gyrus/anterior insula, and the inferior parietal lobule, and a painrelated increase (pain vs. neutral) in the anterior cingulate cortex/supplementary motor area, the right inferior frontal gyrus, and the postcentral gyrus. The 'mirroring' response was stronger in the inferior frontal gyrus and middle temporal gyrus/superior temporal sulcus during the pain task, and stronger in the inferior parietal lobule in the movement task. These results strongly suggest that while motor mirroring may contribute to the perception of pain expressions in others, interpreting these expressions in terms of pain content draws more heavily on networks involved in the perception of affective meaning.	[Budell, Lesley] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Budell, Lesley; Rainville, Pierre] Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Budell, Lesley; Rainville, Pierre] Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Jackson, Philip L.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Jackson, Philip L.] Univ Laval, CIRRIS, Quebec City, PQ, Canada; [Jackson, Philip L.] Univ Laval, CRIUSMQ, Quebec City, PQ, Canada; [Rainville, Pierre] Univ Montreal, Dept Stomatol, Montreal, PQ, Canada; [Kunz, Miriam] Otto Friedrich Univ Bamberg, Dept Psychol, D-96047 Bamberg, Germany	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal; Otto Friedrich University Bamberg	Rainville, P (corresponding author), Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada.	Pierre.Rainville@umontreal.ca	Rainville, Pierre/M-5480-2015; Kunz, Miriam/P-8160-2016	Rainville, Pierre/0000-0001-9801-757X; Kunz, Miriam/0000-0002-0740-6738; Jackson, Philip/0000-0001-8991-3217	National Sciences and Engineering Research Council of Canada (NSERC) [341472-2013]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC; #341472-2013; http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Ekman P, 1997, WHAT FACE REVEALS BA, pxvi; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hadjistavropoulos T, 2011, PSYCHOL BULL, V137, P910, DOI 10.1037/a0023876; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Kunz M, 2006, J PAIN, V7, P915, DOI 10.1016/j.jpain.2006.04.012; Kunz M, 2011, J NEUROSCI, V31, P8730, DOI 10.1523/JNEUROSCI.0217-11.2011; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee T, 2006, RACE ETHN POLIT, P1; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mailhot JP, 2012, EUR J NEUROSCI, V35, P271, DOI 10.1111/j.1460-9568.2011.07953.x; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montgomery KJ, 2008, J COGNITIVE NEUROSCI, V20, P1866, DOI 10.1162/jocn.2008.20127; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Morrison I, 2007, COGNITION, V104, P407, DOI 10.1016/j.cognition.2006.07.006; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Noppeney U, 2008, J PHYSIOL-PARIS, V102, P40, DOI 10.1016/j.jphysparis.2008.03.009; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Perini I, 2013, J NEUROSCI, V33, P15930, DOI 10.1523/JNEUROSCI.3135-12.2013; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Straube B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051207; Talairach J., 1988, COPLANAR STEREOTAXIC; Vachon-Presseau E, 2012, NEUROIMAGE, V63, P54, DOI 10.1016/j.neuroimage.2012.06.030; Vachon-Presseau E, 2011, PAIN, V152, P1525, DOI 10.1016/j.pain.2011.02.039; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	65	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0107526	10.1371/journal.pone.0107526	http://dx.doi.org/10.1371/journal.pone.0107526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671563	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300001
J	Cristelli, M; Tacchella, A; Pietronero, L				Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano			The Heterogeneous Dynamics of Economic Complexity	PLOS ONE			English	Article							METRICS; GROWTH; TRADE; TIME	What will be the growth of the Gross Domestic Product (GDP) or the competitiveness of China, United States, and Vietnam in the next 3, 5 or 10 years? Despite this kind of questions has a large societal impact and an extreme value for economic policy making, providing a scientific basis for economic predictability is still a very challenging problem. Recent results of a new branch-Economic Complexity-have set the basis for a framework to approach such a challenge and to provide new perspectives to cast economic prediction into the conceptual scheme of forecasting the evolution of a dynamical system as in the case of weather dynamics. We argue that a recently introduced non-monetary metrics for country competitiveness ( fitness) allows for quantifying the hidden growth potential of countries by the means of the comparison of this measure for intangible assets with monetary figures, such as GDP per capita. This comparison defines the fitness-income plane where we observe that country dynamics presents strongly heterogeneous patterns of evolution. The flow in some zones is found to be laminar while in others a chaotic behavior is instead observed. These two regimes correspond to very different predictability features for the evolution of countries: in the former regime, we find strong predictable pattern while the latter scenario exhibits a very low predictability. In such a framework, regressions, the usual tool used in economics, are no more the appropriate strategy to deal with such a heterogeneous scenario and new concepts, borrowed from dynamical systems theory, are mandatory. We therefore propose a data-driven method-the selective predictability scheme-in which we adopt a strategy similar to the methods of analogues, firstly introduced by Lorenz, to assess future evolution of countries.	[Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano] Inst Complex Syst, ISC CNR, Rome, Italy; [Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Pietronero, Luciano] London Inst Math Sci, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Cristelli, M (corresponding author), Inst Complex Syst, ISC CNR, Rome, Italy.	matthieu.cristelli@roma1.infn.it	Pietronero, Luciano/O-4473-2018	Pietronero, Luciano/0000-0001-6424-8863; Tacchella, Andrea/0000-0003-3940-9404	EU [611272]	EU(European Commission)	CNR Progetto di Interesse CRISIS LAB (http://www.crisislab.it) and EU Project nr.611272 GROWTHCOM (http://www.growthcom.eu) covered the salaries of MC and AT and the purchase of the datasets used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Battiston F, 2014, COMPLEXITY EC, DOI [10.7564/13-COEC2, DOI 10.7564/13-COEC2]; BOWEN HP, 1987, AM ECON REV, V77, P791; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Cecconi F, 2012, AM J PHYS, V80, P1001, DOI 10.1119/1.4746070; Costanza R., 2009, PARDEE PAPER; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Fagerberg J, 2009, RES POLICY, V38, P218, DOI 10.1016/j.respol.2008.12.006; Flanders, 1991, HECKSCHER OHLIN TRAD; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kauffman S.A., 2002, INVESTIGATIONS; Krugman P., 2013, NY TIMES; Kuznets Simon, 1946, NATL INCOME SUMMARY; LEONTIEF W, 1956, REV ECON STAT, V38, P386, DOI 10.2307/1926500; LORENZ EN, 1969, B AM METEOROL SOC, V50, P345; LORENZ EN, 1969, J ATMOS SCI, V26, P636, DOI 10.1175/1520-0469(1969)26<636:APARBN>2.0.CO;2; Nelson R.R., 2009, EVOLUTIONARY THEORY; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Poincare H., 1890, ACTA MATH-DJURSHOLM, V13, P1, DOI DOI 10.1007/BF02392506; Pugliese E, 2015, EC COMPLEXI IN PRESS; Reinhart CM, 2010, AM ECON REV, V100, P573, DOI 10.1257/aer.100.2.573; Ricardo D, 1991, PRINCIPLES POLITICAL; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Zignago S., 2010, BACI INT TRADE DATAB	39	109	113	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117174	10.1371/journal.pone.0117174	http://dx.doi.org/10.1371/journal.pone.0117174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671312	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300038
J	Clerkin, EM; Beard, C; Fisher, CR; Schofield, CA				Clerkin, Elise M.; Beard, Courtney; Fisher, Christopher R.; Schofield, Casey A.			An Attempt to Target Anxiety Sensitivity via Cognitive Bias Modification	PLOS ONE			English	Article							PANIC DISORDER; SUICIDAL IDEATION; ATTACKS; DEPRESSION; STIMULI; MODEL; FEAR	Our goals in the present study were to test an adaptation of a Cognitive Bias Modification program to reduce anxiety sensitivity, and to evaluate the causal relationships between interpretation bias of physiological cues, anxiety sensitivity, and anxiety and avoidance associated with interoceptive exposures. Participants with elevated anxiety sensitivity who endorsed having a panic attack or limited symptom attack were randomly assigned to either an Interpretation Modification Program (IMP; n = 33) or a Control (n = 32) condition. During interpretation modification training (via the Word Sentence Association Paradigm), participants read short sentences describing ambiguous panic-relevant physiological and cognitive symptoms and were trained to endorse benign interpretations and reject threatening interpretations associated with these cues. Compared to the Control condition, IMP training successfully increased endorsements of benign interpretations and decreased endorsements of threatening interpretations at visit 2. Although self-reported anxiety sensitivity decreased from pre-selection to visit 1 and from visit 1 to visit 2, the reduction was not larger for the experimental versus control condition. Further, participants in IMP (vs. Control) training did not experience less anxiety and avoidance associated with interoceptive exposures. In fact, there was some evidence that those in the Control condition experienced less avoidance following training. Potential explanations for the null findings, including problems with the benign panic-relevant stimuli and limitations with the control condition, are discussed.	[Clerkin, Elise M.; Fisher, Christopher R.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Beard, Courtney] Harvard Univ, McLean Hosp, Dept Psychiat, Belmont, MA USA; [Schofield, Casey A.] Skidmore Coll, Dept Psychol, Saratoga Springs, NY 12866 USA	University System of Ohio; Miami University; Harvard University; McLean Hospital; Skidmore College	Clerkin, EM (corresponding author), Miami Univ, Dept Psychol, Oxford, OH 45056 USA.	clerkiem@miamiOH.edu	Beard, Courtney/AAM-2372-2020		National Institute on Alcohol Abuse and Alcoholism [R21AA021151]; Miami University Summer Research Grant for New Tenure Track Faculty; Miami University PREP (Publication, Reprint, Exhibition, and Performance Costs) Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021151] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Miami University Summer Research Grant for New Tenure Track Faculty; Miami University PREP (Publication, Reprint, Exhibition, and Performance Costs) Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by a National Institute on Alcohol Abuse and Alcoholism R21AA021151 grant, a Miami University Summer Research Grant for New Tenure Track Faculty, and a Miami University PREP (Publication, Reprint, Exhibition, and Performance Costs) Award, awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan NP, 2014, J ANXIETY DISORD, V28, P266, DOI 10.1016/j.janxdis.2013.12.004; BARLOW DH, 1994, MASTERY YOUR ANXIETY, V2; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; Beard C, 2011, DEPRESS ANXIETY, V28, P981, DOI 10.1002/da.20873; Beard C, 2011, EXPERT REV NEUROTHER, V11, P299, DOI [10.1586/ern.10.194, 10.1586/ERN.10.194]; Beard C, 2009, COGNITIVE THER RES, V33, P406, DOI 10.1007/s10608-009-9235-0; Berg CZ, 1998, BEHAV RES THER, V36, P3, DOI 10.1016/S0005-7967(97)10027-4; Brosan L, 2011, J BEHAV THER EXP PSY, V42, P258, DOI 10.1016/j.jbtep.2010.12.006; Capozzoli M., 2013, PAN ANN M ASS BEH CO; Capron DW, 2012, J PSYCHIATR RES, V46, P174, DOI 10.1016/j.jpsychires.2011.10.009; Clark DM, 1997, J CONSULT CLIN PSYCH, V65, P203, DOI 10.1037/0022-006X.65.2.203; Cox BJ, 2001, COGNITIVE THER RES, V25, P525, DOI 10.1023/A:1005580518671; EHLERS A, 1995, J ABNORM PSYCHOL, V104, P164, DOI 10.1037/0021-843X.104.1.164; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Hayward C, 2000, J AM ACAD CHILD PSY, V39, P207, DOI 10.1097/00004583-200002000-00021; Lang AJ, 2002, DEPRESS ANXIETY, V16, P77, DOI 10.1002/da.10062; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; MacDonald EM, 2013, COGNITIVE THER RES, V37, P860, DOI 10.1007/s10608-012-9519-7; MALLER RG, 1992, J ANXIETY DISORD, V6, P241, DOI 10.1016/0887-6185(92)90036-7; Mathews A, 2000, J ABNORM PSYCHOL, V109, P602, DOI 10.1037//0021-843X.109.4.602; Menne-Lothmann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100925; Moshier SJ, 2013, COGNITIVE THER RES, V37, P476, DOI 10.1007/s10608-012-9489-9; Peterson RA, 1992, ANXIETY SENSITIVITY; RAPEE RM, 1992, J ABNORM PSYCHOL, V101, P538, DOI 10.1037/0021-843X.101.3.538; REISS S, 1991, CLIN PSYCHOL REV, V11, P141, DOI 10.1016/0272-7358(91)90092-9; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Reiss S, 1985, THEORETICAL ISSUES B, P107; Richards JC, 2001, COGNITIVE THER RES, V25, P235, DOI 10.1023/A:1010783427196; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Shear MK, 1997, AM J PSYCHIAT, V154, P1571, DOI 10.1176/ajp.154.11.1571; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steinman SA, 2010, J ANXIETY DISORD, V24, P71, DOI 10.1016/j.janxdis.2009.08.008; Teachman BA, 2005, COGNITIVE THER RES, V29, P479, DOI 10.1007/s10608-005-0627-5; Teachman BA, 2007, BEHAV RES THER, V45, P1791, DOI 10.1016/j.brat.2007.01.009; Teachman BA, 2010, J CONSULT CLIN PSYCH, V78, P964, DOI 10.1037/a0021067	37	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0114578	10.1371/journal.pone.0114578	http://dx.doi.org/10.1371/journal.pone.0114578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692491	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500005
J	Hong, M; Kim, SW; Han, SH; Kim, DJ; Suk, KT; Kim, YS; Kim, MJ; Kim, MY; Baik, SK; Ham, YL				Hong, Meegun; Kim, Seung Woo; Han, Sang Hak; Kim, Dong Joon; Suk, Ki Tae; Kim, Yeon Soo; Kim, Myong Jo; Kim, Moon Young; Baik, Soon Koo; Ham, Young Lim			Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease	PLOS ONE			English	Article							RHUS-VERNICIFERA STOKES; GINSENG PANAX-GINSENG; URUSHIOL COMPONENT; INJURY; CELLS; STEATOHEPATITIS; ANTIBACTERIAL; INFLAMMATION; MODULATION; ACTIVATION	Objective The role of lipopolysaccharide (LPS) and toll-like receptor 4 (TLR 4) in the pathogenesis of alcoholic liver disease (ALD) has been widely established. We evaluated the biological effects of probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052), KRG (Korea red ginseng), and urushiol (Rhus verniciflua Stokes) on ALD, including their effects on normal and high-fat diet in mice. Methods One hundred C57BL/6 mice were classified into normal (N) and high-fat diet (H) groups. Each group was divided into 5 sub-groups: control, alcohol, alcohol+probiotics, alcohol+KRG, and alcohol+urushiol. A liver function test, histology, electron-microscopy, interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, IL-6, and IL-10, and TLR 4 were evaluated and compared. Results In the N group, probiotics, KRG, and urushiol significantly reduced levels of TNF-alpha (12.3 +/- 5.1, 13.4 +/- 3.9, and 12.1 +/- 4.3 vs. 27.9 +/- 15.2 pg/mL) and IL-1 beta (108.4 +/- 39.4, 75.0 +/- 51.0, and 101.1 +/- 26.8 vs. 162.4 +/- 37.5 pg/mL), which were increased by alcohol. Alcohol-induced TLR 4 expression was reduced by probiotics and urushiol (0.7 +/- 0.2, and 0.8 +/- 0.1 vs. 1.0 +/- 0.3, p<0.001). In the H group, IL-10 was significantly increased by probiotics and KRG, compared with alcohol (25.3 +/- 15.6 and 20.4 +/- 6.2 vs. 7.6 +/- 5.6 pg/mL) and TLR 4 expression was reduced by probiotics (0.8 +/- 0.2 vs. 1.0 +/- 0.3, p = 0.007). Conclusions Alcohol-induced TLR 4 expression was down-regulated by probiotics in the normal and high-fat diet groups. Probiotics, KRG, and urushiol might be effective in the treatment of ALD by regulating the gut-liver axis.	[Hong, Meegun; Kim, Dong Joon; Suk, Ki Tae; Kim, Yeon Soo] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Kim, Seung Woo] Hallym Univ, Dept Biomed Sci, Coll Med, Chunchon, South Korea; [Han, Sang Hak] Hallym Univ, Coll Med, Dept Pathol, Chunchon, South Korea; [Suk, Ki Tae] Columbia Univ, Dept Med, New York, NY USA; [Kim, Myong Jo] Kangwon Natl Univ, Coll Agr & Life Sci, Chunchon, South Korea; [Kim, Moon Young; Baik, Soon Koo] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Ham, Young Lim] Daewon Univ Coll, Dept Emergency Med Technol, Jecheon, South Korea	Hallym University; Hallym University; Hallym University; Columbia University; Kangwon National University; Yonsei University	Suk, KT (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea.	ktsuk@hallym.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0021482]; Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea [PJ009859]; Hallym University Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea; Hallym University Research Fund	This research was partly supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2010-0021482), and by a grant of from the support of Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ009859) Rural Development Administration, Republic of Korea. This research was supported by Hallym University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang CS, 2014, J GINSENG RES, V38, P167, DOI 10.1016/j.jgr.2014.04.002; Bergheim I, 2011, ANN NY ACAD SCI, V1216, P41, DOI 10.1111/j.1749-6632.2010.05833.x; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; De Vito R, 2012, INT J MOL MED, V30, P49, DOI 10.3892/ijmm.2012.965; dos Santos B, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/594958; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Enomoto N, 1998, GASTROENTEROLOGY, V115, P443, DOI 10.1016/S0016-5085(98)70211-2; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Foster LM, 2011, BENEF MICROBES, V2, P319, DOI 10.3920/BM2011.0032; Gabbard SL, 2013, DIG DIS SCI; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Hong SH, 2013, FOOD CHEM TOXICOL, V55, P586, DOI 10.1016/j.fct.2013.01.022; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Karlsson M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-15; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Ko JH, 2006, ENVIRON TOXICOL PHAR, V22, P8, DOI 10.1016/j.etap.2005.10.005; Koretz RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008344.pub2; Lee DS, 2010, INT IMMUNOPHARMACOL, V10, P850, DOI 10.1016/j.intimp.2010.04.019; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li YG, 2010, ALCOHOL ALCOHOLISM, V45, P320, DOI 10.1093/alcalc/agq034; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Nettleton JA, 2010, ATHEROSCLEROSIS, V212, P260, DOI 10.1016/j.atherosclerosis.2010.04.026; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park HM, 2012, J ETHNOPHARMACOL, V141, P1071, DOI 10.1016/j.jep.2012.03.038; Park SM, 2012, BIOL PHARM BULL, V35, P1546, DOI 10.1248/bpb.b12-00393; Peng JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/234987; Peng XD, 2009, BIOCHEM BIOPH RES CO, V388, P31, DOI 10.1016/j.bbrc.2009.07.099; Petrasek J, 2013, ADV CLIN CHEM, V59, P155, DOI 10.1016/B978-0-12-405211-6.00006-1; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Ren YA, 2011, MOL BIOL REP, V38, P879, DOI 10.1007/s11033-010-0180-5; Roh YS, 2013, J GASTROEN HEPATOL, V28, P38, DOI 10.1111/jgh.12019; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suk KT, 2011, HELICOBACTER, V16, P434, DOI 10.1111/j.1523-5378.2011.00864.x; Suk KT, 2010, J KOREAN MED SCI, V25, P399, DOI 10.3346/jkms.2010.25.3.399; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; Wang YZ, 2013, INT IMMUNOPHARMACOL, V15, P30, DOI 10.1016/j.intimp.2012.10.026	45	47	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117451	10.1371/journal.pone.0117451	http://dx.doi.org/10.1371/journal.pone.0117451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692549	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500056
J	Parsons, TE; Downey, CM; Jirik, FR; Hallgrimsson, B; Jamniczky, HA				Parsons, Trish E.; Downey, Charlene M.; Jirik, Frank R.; Hallgrimsson, Benedikt; Jamniczky, Heather A.			Mind the Gap: Genetic Manipulation of Basicranial Growth within Synchondroses Modulates Calvarial and Facial Shape in Mice through Epigenetic Interactions	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; EVOLUTION; MODULARITY; BRAIN; EVOLVABILITY; CONSTRAINT; FOREBRAIN; SULFATE; MATRIX; MOUSE	Phenotypic integration patterns in the mammalian skull have long been a focus of intense interest as a result of their suspected influence on the trajectory of hominid evolution. Here we test the hypothesis that perturbation of cartilage growth, which directly affects only the chondrocranium during development, will produce coordinated shape changes in the adult calvarium and face regardless of mechanism. Using two murine models of cartilage undergrowth that target two very different mechanisms, we show that strong reduction in cartilage growth produces a short, wide, and more flexed cranial base. This in turn produces a short, wide face in both models. Cranial base and face are already correlated early in ontogeny, and the relationship between these modules gains structure through postnatal growth and development. These results provide further evidence that there exist physical interactions between developing parts of the phenotype that produce variation at a distance from the actual locus upon which a particular selective pressure is acting. Phenotypic changes observed over the course of evolution may not all require adaptationist explanations; rather, it is likely that a substantial portion of observed phenotypic variation over the history of a clade is not directly adaptive but rather a secondary consequence of some local response to selection.	[Parsons, Trish E.; Downey, Charlene M.; Jirik, Frank R.; Hallgrimsson, Benedikt; Jamniczky, Heather A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Parsons, Trish E.; Hallgrimsson, Benedikt; Jamniczky, Heather A.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Downey, Charlene M.; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Jamniczky, HA (corresponding author), Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	hajamnic@ucalgary.ca	Hallgrimsson, Benedikt/A-9616-2008	Hallgrimsson, Benedikt/0000-0002-7192-9103; Jamniczky, Heather/0000-0002-2514-8226	Natural Sciences and Engineering Research Council of Canada [238992-12]; Genome Canada; National Institutes of Health [1R01DE01963, 1R01DE021708]; Canadian Institute for Health Research (multiple); Canada Research Chairs Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019638, R01DE021708] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada(Genome Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research (multiple)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support was provided to BH by: the Natural Sciences and Engineering Research Council of Canada 238992-12; Genome Canada; and to FRJ by the National Institutes of Health 1R01DE01963; National Institutes of Health 1R01DE021708; Canadian Institute for Health Research (multiple); Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Biegert J., 1963, Publications in Anthropology Viking Fund, V37, P116; Boughner JC, 2008, J ANAT, V213, P646, DOI 10.1111/j.1469-7580.2008.00999.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; Cheverud JM, 1996, AM ZOOL, V36, P44; Darwin C, 1859, ORIGIN SPECIES MEANS; de Beer G., 1937, DEV VERTEBRATE SKULL; Downey CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000616; Enlow D. H., 1990, FACIAL GROWTH; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2006, EVOL DEV, V8, P61, DOI 10.1111/j.1525-142X.2006.05075.x; Hallgrimsson B, 2008, INTEGR COMP BIOL, V48, P373, DOI 10.1093/icb/icn076; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Hendrikse JL, 2007, EVOL DEV, V9, P393, DOI 10.1111/j.1525-142X.2007.00176.x; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jamniczky HA, 2014, BIOL J LINN SOC, V111, P375, DOI 10.1111/bij.12203; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Jamniczky HA, 2010, BIOESSAYS, V32, P553, DOI 10.1002/bies.200900189; Jamniczky HA, 2009, EVOLUTION, V63, P1540, DOI 10.1111/j.1558-5646.2009.00651.x; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jones AG, 2007, EVOLUTION, V61, P727, DOI 10.1111/j.1558-5646.2007.00071.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 2011, EVOLUTION HUMAN HEAD, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Marroig G, 2004, AM J PHYS ANTHROPOL, V125, P266, DOI 10.1002/ajpa.10421; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Newman SA, 2005, J EXP ZOOL PART B, V304B, P593, DOI 10.1002/jez.b.21066; ORKIN RW, 1976, DEV BIOL, V50, P82, DOI 10.1016/0012-1606(76)90069-5; Parsons KJ, 2012, AM NAT, V179, P64, DOI 10.1086/663200; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Porto A, 2013, EVOLUTION, V67, P3305, DOI 10.1111/evo.12177; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Richtsmeier JT, 2006, J EXP ZOOL PART B, V306B, P360, DOI 10.1002/jez.b.21092; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; Sanger TJ, 2011, J EXP ZOOL PART B, V316B, P146, DOI 10.1002/jez.b.21388; SCOTT JH, 1958, AM J PHYS ANTHROPOL, V16, P319, DOI 10.1002/ajpa.1330160305; Sperber G., 2010, CRANIOFACIAL EMBRYOG; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Waters MJ, 2002, GROWTH HORM IGF RES, V12, P137, DOI 10.1016/S1096-6374(02)00018-7; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431	58	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118355	10.1371/journal.pone.0118355	http://dx.doi.org/10.1371/journal.pone.0118355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692674	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500117
J	Schulte, EM; Avena, NM; Gearhardt, AN				Schulte, Erica M.; Avena, Nicole M.; Gearhardt, Ashley N.			Which Foods May Be Addictive? The Roles of Processing, Fat Content, and Glycemic Load	PLOS ONE			English	Article							MULTILOCUS GENETIC PROFILE; BODY-MASS INDEX; OBESITY EPIDEMIC; ABUSE LIABILITY; MECHANICAL TURK; PALATABLE FOOD; ANIMAL-MODEL; DOPAMINE; REWARD; SUGAR	Objectives We propose that highly processed foods share pharmacokinetic properties (e.g. concentrated dose, rapid rate of absorption) with drugs of abuse, due to the addition of fat and/or refined carbohydrates and the rapid rate the refined carbohydrates are absorbed into the system, indicated by glycemic load (GL). The current study provides preliminary evidence for the foods and food attributes implicated in addictive-like eating. Design Cross-sectional. Setting University (Study One) and community (Study Two). Participants 120 undergraduates participated in Study One and 384 participants recruited through Amazon MTurk participated in Study Two. Measurements In Study One, participants (n = 120) completed the Yale Food Addiction Scale (YFAS) followed by a forced-choice task to indicate which foods, out of 35 foods varying in nutritional composition, were most associated with addictive-like eating behaviors. Using the same 35 foods, Study Two utilized hierarchical linear modeling to investigate which food attributes (e.g., fat grams) were related to addictive-like eating behavior (at level one) and explored the influence of individual differences for this association (at level two). Results In Study One, processed foods, higher in fat and GL, were most frequently associated with addictive-like eating behaviors. In Study Two, processing was a large, positive predictor for whether a food was associated with problematic, addictive-like eating behaviors. BMI and YFAS symptom count were small-to-moderate, positive predictors for this association. In a separate model, fat and GL were large, positive predictors of problematic food ratings. YFAS symptom count was a small, positive predictor of the relationship between GL and food ratings. Conclusion The current study provides preliminary evidence that not all foods are equally implicated in addictive-like eating behavior, and highly processed foods, which may share characteristics with drugs of abuse (e.g. high dose, rapid rate of absorption) appear to be particularly associated with "food addiction."	[Schulte, Erica M.; Gearhardt, Ashley N.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Avena, Nicole M.] Mt Sinai St Lukes Hosp, New York Obes Res Ctr, Dept Med, New York, NY USA	University of Michigan System; University of Michigan; Mount Sinai St. Luke's	Gearhardt, AN (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	agearhar@umich.edu		LaFata, Erica/0000-0002-8505-6366; Gearhardt, Ashley/0000-0003-3843-5731	National Institute of Drug Abuse (NIDA) [DA-03123]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031230] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (NIDA) DA-03123 (NA); URL: http://www.drugabuse.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena NM, 2010, APPETITE, V55, P734, DOI 10.1016/j.appet.2010.09.010; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bailey A, 2005, SYNAPSE, V57, P160, DOI 10.1002/syn.20168; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Boggiano MM, 2007, INT J OBESITY, V31, P1357, DOI 10.1038/sj.ijo.0803614; Bulik CM, 2003, INT J EAT DISORDER, V33, P293, DOI 10.1002/eat.10140; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cottone P, 2008, NEUROPSYCHOPHARMACOL, V33, P524, DOI 10.1038/sj.npp.1301430; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Ebbeling C B, 2001, Adv Pediatr, V48, P179; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; Fowler L, 2014, EAT BEHAV, V15, P505, DOI 10.1016/j.eatbeh.2014.06.009; Galic MA, 2002, PSYCHOL REP, V90, P58, DOI 10.2466/pr0.2002.90.1.58; Gearhardt A, 2013, J LAW MED ETHICS, V41, P46, DOI 10.1111/jlme.12038; Gearhardt AN, 2013, BIOL PSYCHIAT, V73, P802, DOI 10.1016/j.biopsych.2012.07.024; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P201; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Grabenhorst F, 2014, HUM BRAIN MAPP, V35, P2521, DOI 10.1002/hbm.22346; HANNA JM, 1977, B NARCOTICS, V29, P63; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KLATSKY AL, 1990, BRIT J ADDICT, V85, P1279; Klump KL, 2013, INT J EAT DISORDER, V46, P729, DOI 10.1002/eat.22139; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lennerz BS, 2013, AM J CLIN NUTR, V98, P641, DOI 10.3945/ajcn.113.064113; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; Oishi S, 2009, J EXP SOC PSYCHOL, V45, P913, DOI 10.1016/j.jesp.2009.04.028; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Raudenbush SW, 2002, HIERARCHICAL LINEAR; RODIN J, 1991, APPETITE, V17, P177, DOI 10.1016/0195-6663(91)90020-S; Schneider W., 2002, E PRIME USERS GUIDE; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; Taubes G, 1998, SCIENCE, V280, P1367, DOI 10.1126/science.280.5368.1367; Thornley S, 2008, MED HYPOTHESES, V71, P709, DOI 10.1016/j.mehy.2008.07.006; VEREBEY K, 1988, PSYCHIAT ANN, V18, P513, DOI 10.3928/0048-5713-19880901-06; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; White MA, 2010, OBESITY, V18, P1266, DOI 10.1038/oby.2009.347; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x	58	317	321	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117959	10.1371/journal.pone.0117959	http://dx.doi.org/10.1371/journal.pone.0117959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692302	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500084
J	Tan, QQ; Zhu, L; Li, Y; Liu, W; Ma, WH; Lei, CL; Wang, XP				Tan, Qian-Qian; Zhu, Li; Li, Yi; Liu, Wen; Ma, Wei-Hua; Lei, Chao-Liang; Wang, Xiao-Ping			A De Novo Transcriptome and Valid Reference Genes for Quantitative Real-Time PCR in Colaphellus bowringi	PLOS ONE			English	Article							CABBAGE BEETLE; BACILLUS-THURINGIENSIS; DIAPAUSE; EXPRESSION; LEPIDOPTERA; COLEOPTERA; RESISTANCE; SELECTION; CLONING; MODEL	Background The cabbage beetle Colaphellus bowringi Baly is a serious insect pest of crucifers and undergoes reproductive diapause in soil. An understanding of the molecular mechanisms of diapause regulation, insecticide resistance, and other physiological processes is helpful for developing new management strategies for this beetle. However, the lack of genomic information and valid reference genes limits knowledge on the molecular bases of these physiological processes in this species. Results Using Illumina sequencing, we obtained more than 57 million sequence reads derived from C. bowringi, which were assembled into 39,390 unique sequences. A Clusters of Orthologous Groups classification was obtained for 9,048 of these sequences, covering 25 categories, and 16,951 were assigned to 255 Kyoto Encyclopedia of Genes and Genomes pathways. Eleven candidate reference gene sequences from the transcriptome were then identified through reverse transcriptase polymerase chain reaction. Among these candidate genes, EF1a, ACT1, and RPL19 proved to be the most stable reference genes for different reverse transcriptase quantitative polymerase chain reaction experiments in C. bowringi. Conversely, aTUB and GAPDH were the least stable reference genes. Conclusion The abundant putative C. bowringi transcript sequences reported enrich the genomic resources of this beetle. Importantly, the larger number of gene sequences and valid reference genes provide a valuable platform for future gene expression studies, especially with regard to exploring the molecular mechanisms of different physiological processes in this species.	[Tan, Qian-Qian; Zhu, Li; Li, Yi; Liu, Wen; Wang, Xiao-Ping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Tan, Qian-Qian; Ma, Wei-Hua; Lei, Chao-Liang] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Ma, WH (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	weihuama@mail.hzau.edu.cn; xpwang@mail.hzau.edu.cn	Liu, Wen/S-8027-2019	Liu, Wen/0000-0002-4985-0618; Wang, Xiao-Ping/0000-0002-1718-1026; MA, WEIHUA/0000-0001-9521-2038	Natural Science Foundation of China [31272045]; Program for New Century Excellent Talents in University [NCET-12-0864]; Fundamental Research Funds for the Central Universities [2012ZYTS044, 2013PY028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was supported by grants of the Natural Science Foundation of China (31272045), the Program for New Century Excellent Talents in University (NCET-12-0864) and the Fundamental Research Funds for the Central Universities (2012ZYTS044, 2013PY028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baker MB, 2008, AGR FOREST ENTOMOL, V10, P181, DOI 10.1111/j.1461-9563.2008.00370.x; Caron V, 2008, B ENTOMOL RES, V98, P317, DOI 10.1017/S0007485307005597; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Eisner E, 1997, LEADING EDGE, V16, P171; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim M, 2010, J COMP PHYSIOL B, V180, P171, DOI 10.1007/s00360-009-0406-9; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Ma CH, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14501; Mitsumasu K, 2008, INSECT MOL BIOL, V17, P185, DOI 10.1111/j.1365-2583.2008.00792.x; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Rubio RO, 2011, INSECT BIOCHEM MOLEC, V41, P378, DOI 10.1016/j.ibmb.2011.02.007; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XP, 2004, J INSECT PHYSIOL, V50, P373, DOI 10.1016/j.jinsphys.2004.01.002; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081096	43	46	52	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118693	10.1371/journal.pone.0118693	http://dx.doi.org/10.1371/journal.pone.0118693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692689	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500127
J	Jang, JP; Baek, IC; Choi, EJ; Kim, TG				Jang, Jung-Pil; Baek, In-Cheol; Choi, Eun-Jeong; Kim, Tai-Gyu			Multiplex Genotyping of Cytokine Gene SNPs Using Fluorescence Bead Array	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM ANALYSIS; HIGH-THROUGHPUT; XMAP(TM) TECHNOLOGY; FLOW-CYTOMETRY; PCR; DISEASE; ASSAY; IL-6; SUSCEPTIBILITY; AMPLIFICATION	Single nucleotide polymorphisms (SNPs) of genes that affect cytokine production and function are known to influence the susceptibility and progression of immune-related conditions such as infection, autoimmune diseases, transplantation, and cancer. We established a multiplex genotyping method to analyze the SNPs of cytokine genes by combining the multiplex PCR and bead array platform. Thirteen cytokine gene regions, including 20 SNPs, were amplified, and allele-specific primer extension was performed in a single tube. High-quality allele-specific primers were selected for signals greater than 1000 median fluorescence intensity (MFI) for positive alleles, and less than 500 MFI for negative alleles. To select and improve the extension primers, modifications for the reverse direction, length or refractory were performed. 24 primers in the forward or reverse direction step and 12 primers in length or refractory modifications were selected and showed high concordance with results by nucleotide sequencing. Among the 13 candidate cytokine genes, the SNPs of 12 cytokine genes, including IL-1 alpha, IL-1R, IL-1RA, IL-1 beta, IL-2, IL-4, IL-4R alpha, IL-6, IL-10, IL-12, TGF-beta 1, and TNF-alpha, were successfully defined with the selected allele-specific primers in healthy Korean subjects. Our genotyping system provides a fast and accurate detection for SNPs of multiple cytokine genes to investigate their association with immunerelated diseases and transplantation outcomes.	[Jang, Jung-Pil; Baek, In-Cheol; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Choi, Eun-Jeong; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr		Baek, In-Cheol/0000-0003-3630-3364	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI09C1555]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI09C1555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2000, CYTOMETRY, V40, P102, DOI 10.1002/(SICI)1097-0320(20000601)40:2<102::AID-CYTO3>3.3.CO;2-W; Bagheri M, 2006, INT J IMMUNOGENET, V33, P193, DOI 10.1111/j.1744-313X.2006.00595.x; BEJ AK, 1990, MOL CELL PROBE, V4, P353, DOI 10.1016/0890-8508(90)90026-V; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Bortolin Susan, 2009, V496, P59, DOI 10.1007/978-1-59745-553-4_6; Cai H, 2000, GENOMICS, V66, P135, DOI 10.1006/geno.2000.6218; Carnt NA, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.031; Chen JW, 2000, GENOME RES, V10, P549, DOI 10.1101/gr.10.4.549; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Fu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030340; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gupta S, 1988, Scand J Rheumatol Suppl, V76, P189; Hamza IA, 2014, J VIROL METHODS, V204, P65, DOI 10.1016/j.jviromet.2014.04.002; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; Iannone Marie A, 2003, Methods Mol Biol, V226, P123; Johnson VJ, 2004, CYTOKINE, V27, P135, DOI 10.1016/j.cyto.2004.05.002; Karabon L, 2005, HUM IMMUNOL, V66, P700, DOI 10.1016/j.humimm.2005.02.003; Kim MS, 2011, MOL DIAGN THER, V15, P285, DOI 10.2165/11592520-000000000-00000; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Krjutskov K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn357; Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Ollier WER, 2004, CYTOKINE, V28, P174, DOI 10.1016/j.cyto.2004.07.014; Otani S, 2009, CLIN BIOCHEM, V42, P1387, DOI 10.1016/j.clinbiochem.2009.06.005; Ozaki S, 2014, J VIROL METHODS, V204, P73, DOI 10.1016/j.jviromet.2014.04.010; Pyo CW, 2003, HUM IMMUNOL, V64, P979, DOI 10.1016/S0198-8859(03)00173-3; Shoskes DA, 2002, J UROLOGY, V168, P331, DOI 10.1016/S0022-5347(05)64916-6; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Soler S, 2011, CLIN CHIM ACTA, V412, P430, DOI 10.1016/j.cca.2010.11.012; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118008	10.1371/journal.pone.0118008	http://dx.doi.org/10.1371/journal.pone.0118008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689696	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700092
J	Kato, M; Mugitani, R				Kato, Masaharu; Mugitani, Ryoko			Pareidolia in Infants	PLOS ONE			English	Article							FACE-LIKE OBJECTS; PHONETIC INFORMATION; PERCEPTION; SPEECH; LIPS; CORTEX; MOUTH; VOICE; FOCUS; EYES	Faces convey primal information for our social life. This information is so primal that we sometimes find faces in non-face objects. Such illusory perception is called pareidolia. In this study, using infants' orientation behavior toward a sound source, we demonstrated that infants also perceive pareidolic faces. An image formed by four blobs and an outline was shown to infants with or without pure tones, and the time they spent looking at each blob was compared. Since the mouth is the unique sound source in a face and the literature has shown that infants older than 6 months already have sound-mouth association, increased looking time towards the bottom blob (pareidolic mouth area) during sound presentation indicated that they illusorily perceive a face in the image. Infants aged 10 and 12 months looked longer at the bottom blob under the upright-image condition, whereas no differences in looking time were observed for any blob under the inverted-image condition. However, 8month-olds did not show any difference in looking time under both the upright and inverted conditions, suggesting that the perception of pareidolic faces, through sound association, comes to develop at around 8 to 10 months after birth.	[Kato, Masaharu; Mugitani, Ryoko] NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Kato, M (corresponding author), NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan.	kato.masaharu@lab.ntt.co.jp						Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Churches O, 2009, NEUROREPORT, V20, P1290, DOI 10.1097/WNR.0b013e3283305a65; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Ichikawa H, 2011, PERCEPTION, V40, P500, DOI 10.1068/p6926; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kato M, 2013, INFANT BEHAV DEV, V36, P32, DOI 10.1016/j.infbeh.2012.10.005; Kobayashi M, 2012, J EXP CHILD PSYCHOL, V111, P22, DOI 10.1016/j.jecp.2011.07.008; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tenenbaum EJ, 2013, INFANCY, V18, P534, DOI 10.1111/j.1532-7078.2012.00135.x; Watanabe H, 2013, HUM BRAIN MAPP, V34, P543, DOI 10.1002/hbm.21453; Windhager S, 2008, HUM NATURE-INT BIOS, V19, P331, DOI 10.1007/s12110-008-9047-z; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075	26	22	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118539	10.1371/journal.pone.0118539	http://dx.doi.org/10.1371/journal.pone.0118539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689630	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700117
J	Okabayashi, S; Shimozawa, N; Yasutomi, Y; Yanagisawa, K; Kimura, N				Okabayashi, Sachi; Shimozawa, Nobuhiro; Yasutomi, Yasuhiro; Yanagisawa, Katsuhiko; Kimura, Nobuyuki			Diabetes Mellitus Accelerates A beta Pathology in Brain Accompanied by Enhanced GA beta Generation in Nonhuman Primates	PLOS ONE			English	Article							ENDOCYTIC PATHWAY ABNORMALITIES; SPORADIC ALZHEIMERS-DISEASE; AMYLOID FIBRIL FORMATION; AGE-RELATED-CHANGES; INSULIN-RESISTANCE; MOUSE MODEL; AUTOPHAGIC PATHWAY; LIPID-METABOLISM; SENILE PLAQUES; TAU PATHOLOGY	Growing evidence suggests that diabetes mellitus (DM) is one of the strongest risk factors for developing Alzheimer's disease (AD). However, it remains unclear why DM accelerates AD pathology. In cynomolgus monkeys older than 25 years, senile plaques (SPs) are spontaneously and consistently observed in their brains, and neurofibrillary tangles are present at 32 years of age and older. In laboratory-housed monkeys, obesity is occasionally observed and frequently leads to development of type 2 DM. In the present study, we performed histopathological and biochemical analyses of brain tissue in cynomolgus monkeys with type 2 DM to clarify the relationship between DM and AD pathology. Here, we provide the evidence that DM accelerates A beta pathology in vivo in nonhuman primates who had not undergone any genetic manipulation. In DM-affected monkey brains, SPs were observed in frontal and temporal lobe cortices, even in monkeys younger than 20 years. Biochemical analyses of brain revealed that the amount of GM1-ganglioside-bound A beta (GA beta)-the endogenous seed for A beta fibril formation in the brain-was clearly elevated in DM-affected monkeys. Furthermore, the level of Rab GTPases was also significantly increased in the brains of adult monkeys with DM, almost to the same levels as in aged monkeys. Intraneuronal accumulation of enlarged endosomes was also observed in DM-affected monkeys, suggesting that exacerbated endocytic disturbance may underlie the acceleration of A beta pathology due to DM.	[Okabayashi, Sachi; Shimozawa, Nobuhiro; Yasutomi, Yasuhiro; Kimura, Nobuyuki] Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, Tsukuba, Ibaraki 3050843, Japan; [Okabayashi, Sachi] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; [Yanagisawa, Katsuhiko; Kimura, Nobuyuki] Natl Ctr Geriatr & Gerontol, Sect Cell Biol & Pathol, Dept Alzheimers Dis Res, Ctr Dev Adv Med Dementia, Obu, Aichi 4748511, Japan	National Institute of Health Sciences - Japan; National Center for Geriatrics & Gerontology	Kimura, N (corresponding author), Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, 1-1 Hachimandai, Tsukuba, Ibaraki 3050843, Japan.	kimura@ncgg.go.jp			National Center for Geriatrics and Gerontology (NCGG), Japan [25-20]	National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology)	This study was supported by The Research Funding for Longevity Sciences (25-20) from National Center for Geriatrics and Gerontology (NCGG), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2009, FOLIA NEUROPATHOL, V47, P289; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Baptista FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065515; Bauer SA, 2011, COMPARATIVE MED, V61, P541; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen YX, 2013, MOL NEUROBIOL, V47, P711, DOI 10.1007/s12035-012-8375-5; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Currais A, 2012, AGING CELL, V11, P1017, DOI 10.1111/acel.12002; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; KAMADA T, 1992, DIABETES RES CLIN PR, V16, P85, DOI 10.1016/0168-8227(92)90077-5; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Kimura N, 2007, NEUROREPORT, V18, P1669, DOI 10.1097/WNR.0b013e3282f0d2ab; Kimura N, 2012, AM J PATHOL, V180, P550, DOI 10.1016/j.ajpath.2011.10.037; Kimura N, 2009, J BIOL CHEM, V284, P31291, DOI 10.1074/jbc.M109.012625; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu Y, 2011, J ENDOCRINOL INVEST, V34, P169, DOI 10.1007/BF03347055; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Nakamura S, 1998, J MED PRIMATOL, V27, P244, DOI 10.1111/j.1600-0684.1998.tb00244.x; NATARAJAN V, 1981, J NEUROCHEM, V36, P413, DOI 10.1111/j.1471-4159.1981.tb01609.x; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oikawa N, 2010, BRAIN RES, V1315, P137, DOI 10.1016/j.brainres.2009.12.005; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Runyan CE, 2012, J BIOL CHEM, V287, P35815, DOI 10.1074/jbc.M112.380493; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; Son SM, 2012, AUTOPHAGY, V8, P1842, DOI 10.4161/auto.21861; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; THAKKER JK, 1989, J BIOL CHEM, V264, P7169; TOOZE J, 1990, J CELL BIOL, V111, P329, DOI 10.1083/jcb.111.2.329; Tsuchida J, 2008, J AM ASSOC LAB ANIM, V47, P29; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Yuyama K, 2009, J NEUROCHEM, V109, P1250, DOI 10.1111/j.1471-4159.2009.06046.x; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	71	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117362	10.1371/journal.pone.0117362	http://dx.doi.org/10.1371/journal.pone.0117362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675436	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000019
J	Feldman, CH; Hiraki, LT; Lii, HC; Seeger, JD; Kim, SC				Feldman, Candace H.; Hiraki, Linda T.; Lii, Huichuan; Seeger, John D.; Kim, Seoyoung C.			Human Papillomavirus Vaccine Uptake among Individuals with Systemic Inflammatory Diseases	PLOS ONE			English	Article							CARE PROVIDER RECOMMENDATION; LUPUS-ERYTHEMATOSUS; HPV VACCINE; UNITED-STATES; WOMEN; IMMUNIZATION; COMPLETION; RISK; AUTOIMMUNE	Objectives The human papillomavirus (HPV) vaccine is safe and efficacious in patients with systemic inflammatory diseases (SID) who have higher rates of persistent HPV infection. We compared HPV vaccine uptake among SID and non-SID patients. Methods Using a U.S. insurance claims database (2006-2012), we identified individuals 9-26 years with >= 2 SID diagnosis codes >= 7 days apart with >= 12 months of continuous enrollment prior to the second code (index date). We matched SID patients by age, sex and index date to randomly selected non-SID subjects and selected those with >= 24 months of post-index date continuous follow-up. We also identified a non-SID subcohort with >= 1 diagnosis code for asthma. We defined initiation as >= 1 HPV vaccination claim after 2007, and completion as 3 claims. We used multivariable logistic regression to assess uptake in females 11-26 years comparing SID, non-SID and asthma cohorts, adjusting for demographics, region, comorbidities, and healthcare utilization. Results We identified 5,642 patients 9-26 years with SID and 20,643 without. The mean age was 18.1 years (SD 4.9). We identified 1,083 patients with asthma; the mean age was 17.2 (SD 5.1). Among females, 20.6% with SID, 23.1% without SID and 22.9% with asthma, received >= 1 HPV vaccine. In our adjusted models, the odds of receipt of >= 1 vaccine was 0.87 times lower in SID (95% CI 0.77-0.98) compared to non-SID and did not differ for 3 vaccines (OR 1.03, 95% CI 0.83-1.26). The odds of initiation and completion were not statistically different between SID and non-SID asthma cohorts. Conclusions In this nationwide cohort, HPV vaccine uptake was extremely low. Despite the heightened risk of persistent HPV infection among those with SID, no increase in HPV vaccine uptake was observed. Public health efforts to promote HPV vaccination overall are needed, and may be particularly beneficial for those at higher risk.	[Feldman, Candace H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hiraki, Linda T.] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; [Lii, Huichuan; Seeger, John D.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital	Feldman, CH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	chfeldman@partners.org	Hiraki, Linda/AAN-6411-2021; Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	Lupus Foundation Career Development Award; Pfizer Pharmaceuticals; Canadian Institute of Health Research (CIHR) Fellowship Award; NIH [K23 AR059677]; Pfizer; Pharmaceutical Research and Manufacturers of America (PhRMA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059677] Funding Source: NIH RePORTER	Lupus Foundation Career Development Award; Pfizer Pharmaceuticals(Pfizer); Canadian Institute of Health Research (CIHR) Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Pharmaceutical Research and Manufacturers of America (PhRMA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Candace H. Feldman is supported by the Lupus Foundation Career Development Award and receives research support from Pfizer Pharmaceuticals. Linda T. Hiraki is supported by the Canadian Institute of Health Research (CIHR) Fellowship Award. Huichuan Lii has nothing to disclose. John D. Seeger is a paid consultant to Optum Insight and WHISCON. Seoyoung C. Kim is supported by the NIH grant K23 AR059677. She received research support from Pfizer and tuition support for the Pharmacoepidemiology Program at the Harvard School of Public Health partially funded by the Pharmaceutical Research and Manufacturers of America (PhRMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Avery RK, 1999, RHEUM DIS CLIN N AM, V25, P567, DOI 10.1016/S0889-857X(05)70087-9; Bernatsky SR, 2006, J RHEUMATOL, V33, P45; BLUMENFELD Z, 1994, LUPUS, V3, P59, DOI 10.1177/096120339400300112; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chao C, 2009, MAYO CLIN PROC, V84, P864, DOI 10.1016/S0025-6196(11)60503-X; Chesson HW., 2014, MORBIDITY MORTALITY; Cibere J, 2001, LUPUS, V10, P394, DOI 10.1191/096120301678646128; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Deal CL, 2007, ARTHRITIS RHEUM, V56, P722, DOI 10.1002/art.22437; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Gudeman R, 2007, J NATL CTR YOUTH LAW, V28, P1; Heijstek MW, 2013, ANN RHEUM DIS; Kane S, 2008, AM J GASTROENTEROL, V103, P631, DOI 10.1111/j.1572-0241.2007.01582.x; Kiefe CI, 1998, J GEN INTERN MED, V13, P357, DOI 10.1046/j.1525-1497.1998.00115.x; Kim SC, 2014, ANN RHEUM DIS; Krueger KP, 2001, DIS MANAGEMENT, V4, P155; Lau M, 2012, VACCINE, V30, P3112, DOI 10.1016/j.vaccine.2012.02.034; Lawrence JM, 2014, AM J EPIDEMIOL, V179, P27, DOI 10.1093/aje/kwt230; Malveaux FJ, 2009, PEDIATRICS, V123, pS129, DOI 10.1542/peds.2008-2233B; Mok CC, 2013, ANN RHEUM DIS, V72, P659, DOI 10.1136/annrheumdis-2012-201393; Prevention CfDCa, 2013, HUM PAP VACC COV AD; Rahman M, 2014, VACCINE, V32, P2394, DOI 10.1016/j.vaccine.2014.02.097; Rahman M, 2013, VACCINE, V31, P5495, DOI 10.1016/j.vaccine.2013.09.022; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Rojo-Contreras W, 2012, LUPUS, V21, P365, DOI 10.1177/0961203311425517; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Schluterman NH, 2011, VACCINE, V29, P3767, DOI 10.1016/j.vaccine.2011.03.032; Soldevilla HF, 2012, LUPUS, V21, P158, DOI 10.1177/0961203311429556; Suris JC, 2008, PEDIATRICS, V122, pE1113, DOI 10.1542/peds.2008-1479; Tam LS, 2010, J RHEUMATOL, V37, P330, DOI 10.3899/jrheum.090644; Widdice LE, 2011, PEDIATRICS, V127, P77, DOI 10.1542/peds.2010-0812; Yazdany J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3011; Ylitalo KR, 2013, AM J PUBLIC HEALTH, V103, P164, DOI 10.2105/AJPH.2011.300600; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117620	10.1371/journal.pone.0117620	http://dx.doi.org/10.1371/journal.pone.0117620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692470	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500065
J	Holwerda, FM; Pol, D; Rauhut, OWM				Holwerda, Femke M.; Pol, Diego; Rauhut, Oliver W. M.			Using Dental Enamel Wrinkling to Define Sauropod Tooth Morphotypes from the Canadon Asfalto Formation, Patagonia, Argentina	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; THEROPOD DINOSAUR; EARLY EVOLUTION; TEETH; REDESCRIPTION; DENTITION; JUVENILE; REASSESSMENT; PROVINCE; ANATOMY	The early Middle Jurassic is regarded as the period when sauropods diversified and became major components of the terrestrial ecosystems. Not many sites yield sauropod material of this time; however, both cranial and postcranial material of eusauropods have been found in the Canadon Asfalto Formation (latest Early Jurassic-early Middle Jurassic) in Central Patagonia (Argentina), which may help to shed light on the early evolution of eusauropods. These eusauropod remains include teeth associated with cranial and mandibular material as well as isolated teeth found at different localities. In this study, an assemblage of sauropod teeth from the Canadon Asfalto Formation found in four different localities in the area of Cerro Condor (Chubut, Argentina) is used as a mean of assessing sauropod species diversity at these sites. By using dental enamel wrinkling, primarily based on the shape and orientation of grooves and crests of this wrinkling, we define and describe three different morphotypes. With the exception of one taxon, for which no cranial material is currently known, these morphotypes match the local eusauropod diversity as assessed based on postcranial material. Morphotype I is tentatively assigned to Patagosaurus, whereas morphotypes II and III correspond to new taxa, which are also distinguished by associated postcranial material. This study thus shows that enamel wrinkling can be used as a tool in assessing sauropod diversity.	[Holwerda, Femke M.; Rauhut, Oliver W. M.] SNSB, Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Holwerda, Femke M.] Univ Nova Lisboa, GeoBioTec, FCT, Dept Ciencias Terra, Caparica, Portugal; [Holwerda, Femke M.; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Holwerda, Femke M.; Rauhut, Oliver W. M.] Univ Munich, GeoBioCenter, Munich, Germany; [Pol, Diego] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Pol, Diego] Museo Paleontol Egidio Feruglio, Trelew, Argentina	Universidade Nova de Lisboa; University of Munich; University of Munich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Holwerda, FM (corresponding author), SNSB, Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	F.M.Holwerda@gmail.com	Rauhut, Oliver/AAG-1029-2020; Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517; Holwerda, Femke/0000-0003-3446-5693; Rauhut, Oliver/0000-0003-3958-603X	DFG (Deutsche Forschungs Gemeinschaft) [RA 1012/13-1]; PICT [0808]	DFG (Deutsche Forschungs Gemeinschaft)(German Research Foundation (DFG)); PICT(ANPCyT)	FH is funded by DFG (Deutsche Forschungs Gemeinschaft) project RA 1012/13-1 (to OR). Part of this research was funded by PICT 0808 to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2004, CR PALEVOL, V3, P199, DOI 10.1016/j.crpv.2004.03.001; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Baez AM, 2008, J INF, V82; Barrett PM, 2006, T ROY SOC EDIN-EARTH, V97, P25, DOI 10.1017/S0263593300001383; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Barrett Paul M., 2007, Palaeoworld, V16, P265, DOI 10.1016/j.palwor.2007.07.001; Becerra MG, 2013, HIST BIOL, P1; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Britt Brooks B., 1994, P256; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2005, B SOC GEOL FR, V176, P467, DOI 10.2113/176.5.467; Buscalioni AD, 1997, GEOLOGICAL SOC DENMA, V1; Cabaleri N., 2010, S AM S IS GEOL BRAS, P190; Calvo Jorge O., 1994, Gaia, V10, P183; Carpenter K, 2005, LIFE O PAST, P78; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Chiappe LM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P285; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Cuneo R, 2013, GONDWANA RES, V24, P1267, DOI 10.1016/j.gr.2013.01.010; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; Diaz VD, 2014, CRETACEOUS RES, V51, P285, DOI 10.1016/j.cretres.2014.07.003; Diaz VD, 2013, ANN PALEONTOL, V99, P119, DOI 10.1016/j.annpal.2012.12.002; Diaz VD, 2012, GEOBIOS-LYON, V45, P265, DOI 10.1016/j.geobios.2011.10.002; Escapa Ignacio H., 2008, Rev. Asoc. Geol. Argent., V63, P613; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FIORILLO AR, 1994, J VERTEBR PALEONTOL, V14, P74, DOI 10.1080/02724634.1994.10011539; Garcia RA, 2010, PALAEONTOLOGY, V53, P335, DOI 10.1111/j.1475-4983.2010.00937.x; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; He X, 1988, MIDDLE JURASSIC DINO, V4; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Holwerda F, 2011, J VERTEBR PALEONTOL, V31, P127; KUES BS, 1980, J PALEONTOL, V54, P864; Larson D, 2009, J VERTEBR PALEONTOL, V29, p132A; Larson DW, 2010, CAN J EARTH SCI, V47, P1159, DOI 10.1139/E10-005; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Li LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085979; Lim JD, 2001, NATURWISSENSCHAFTEN, V88, P82, DOI 10.1007/s001140000201; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P1; Carballido JL, 2010, CR PALEVOL, V9, P83, DOI 10.1016/j.crpv.2010.01.003; Mahammed F, 2005, CR PALEVOL, V4, P707, DOI 10.1016/j.crpv.2005.07.001; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; McIntosh J.S., 1990, P53, DOI 10.1017/CBO9780511608377.007; McIntosh J.S., 1990, P345; Mo J., 2013, TOPICS CHINESE DINOS, P231; Monbaron M, 1999, CR ACAD SCI II A, V329, P519, DOI 10.1016/S1251-8050(00)80026-9; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Peng Z, 2005, JURASSIC DINOSAUR FA, P69; Pol D, 2009, SKULL ANATOMY NEW BA; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Pol D, 2011, NATURWISSENSCHAFTEN, V98, P369, DOI 10.1007/s00114-011-0780-5; Rauhut OWM, 2007, AMEGHINIANA, V44, P479; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut Oliver W.M., 2003, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V6, P173; Rauhut Oliver W. M., 2008, Rev. Asoc. Geol. Argent., V63, P557; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rauhut OWM, 2003, AMEGHINIANA, V40, P425; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; Rauhut OWM, 2002, DINOSAUR EVOLUTION J, V3; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3580[1:FJTFSA]2.0.CO;2; Salani FM, 2007, APORTE EDAD FORMACIO, P44; Silva Nieto D. G., 2002, 15 C GEOL ARG EL CAL, VI, P238; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Sterli J, 2008, BIOL LETTERS, V4, P286, DOI 10.1098/rsbl.2008.0022; Sterli J, 2011, J VERTEBR PALEONTOL, V31, P1210, DOI 10.1080/02724634.2011.615685; Tang F., 2001, COMPLETE SAUROPOD JI, P128; TASCH P, 1970, University of Kansas Paleontological Contributions Paper, P1; Unwin DM, 2004, 1 RHAMPHORHYNCHOID S, P235, DOI [10.1016/j.scitotenv.2015.01.065, DOI 10.1016/J.SCITOTENV.2015.01.065]; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Volkheimer Wolfgang, 2008, Rev. Asoc. Geol. Argent., V63, P549; Weishampel DB., 2004, DINOSAURIA; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Xing LD, 2015, ACTA PALAEONTOL POL, V60, P145, DOI 10.4202/app.2012.0151; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zavattieri AM, 2010, 10 C ARG PAL BIOESTR; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	92	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118100	10.1371/journal.pone.0118100	http://dx.doi.org/10.1371/journal.pone.0118100			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692466	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500095
J	Gourbiere, S; Morand, S; Waxman, D				Gourbiere, Sebastien; Morand, Serge; Waxman, David			Fundamental Factors Determining the Nature of Parasite Aggregation in Hosts	PLOS ONE			English	Article							INFECTION; TRANSMISSION; RESISTANCE; STABILITY; DYNAMICS; PATTERNS; POPULATIONS; MECHANISMS; STRATEGIES; IMMUNITY	The distribution of parasites in hosts is typically aggregated: a few hosts harbour many parasites, while the remainder of hosts are virtually parasite free. The origin of this almost universal pattern is central to our understanding of host-parasite interactions; it affects many facets of their ecology and evolution. Despite this, the standard statistical framework used to characterize parasite aggregation does not describe the processes generating such a pattern. In this work, we have developed a mathematical framework for the distribution of parasites in hosts, starting from a simple statistical description in terms of two fundamental processes: the exposure of hosts to parasites and the infection success of parasites. This description allows the level of aggregation of parasites in hosts to be related to the random variation in these two processes and to true host heterogeneity. We show that random variation can generate an aggregated distribution and that the common view, that encounters and success are two equivalent filters, applies to the average parasite burden under neutral assumptions but it does not apply to the variance of the parasite burden, and it is not true when heterogeneity between hosts is incorporated in the model. We find that aggregation decreases linearly with the number of encounters, but it depends non-linearly on parasite success. We also find additional terms in the variance of the parasite burden which contribute to the actual level of aggregation in specific biological systems. We have derived the formal expressions of these contributions, and these provide new opportunities to analyse empirical data and tackle the complexity of the origin of aggregation in various hostparasite associations.	[Gourbiere, Sebastien] Univ Perpignan, IMAGES, EA 4218, F-66100 Perpignan, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England; [Morand, Serge] Univ Montpellier 2, Dept Genet Environm, CC065, Inst Sci Evolut,CNRS, F-34095 Montpellier 05, France; [Waxman, David] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Universite Perpignan Via Domitia; University of Sussex; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Fudan University	Waxman, D (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	davidwaxman@fudan.edu.cn	Morand, Serge/M-5433-2018	Morand, Serge/0000-0003-3986-7659; Gourbiere, Sebastien/0000-0002-6701-4795	European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) [253483]; 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0048, ANR-11-IDEX-0007]; European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) [253483]; 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0048, ANR-11-IDEX-0007]	European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF); 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR)); European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF); 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This investigation received financial support from: the European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483; a 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; an "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). This work was performed within the framework of the LABEX ECOFECT (ANR-11-LABX-0048) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency	ADLER FR, 1992, PARASITOLOGY, V104, P199, DOI 10.1017/S0031182000061631; ANDERSON R M, 1991; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANDERSON RM, 1982, PARASITOLOGY, V85, P373, DOI 10.1017/S0031182000055347; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Ben-Ami F, 2008, P R SOC B, V275, P853, DOI 10.1098/rspb.2007.1544; Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Boag B, 2001, INT J PARASITOL, V31, P1421, DOI 10.1016/S0020-7519(01)00270-3; Bordes F, 2007, BIOL LETTERS, V3, P692, DOI 10.1098/rsbl.2007.0393; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; Bulmer M.G., 1979, PRINCIPLES STAT; Calabrese JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029215; Combes Claude, 2005, ART BEING PARASITE; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; de Bellocq JG, 2007, EUR J WILDLIFE RES, V53, P315, DOI 10.1007/s10344-007-0094-2; Dumonteil E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002466; Gaba S, 2008, J R SOC INTERFACE, V5, P919, DOI 10.1098/rsif.2007.1282; Galvani AP, 2003, J PARASITOL, V89, P232, DOI 10.1645/0022-3395(2003)089[0232:IAHAAO]2.0.CO;2; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Guilhem R, 2012, J R SOC INTERFACE, V9, P2936, DOI 10.1098/rsif.2012.0358; HART BL, 1994, PARASITOLOGY, V109, pS139, DOI 10.1017/S0031182000085140; Hoby S, 2006, VET PARASITOL, V138, P337, DOI 10.1016/j.vetpar.2006.01.028; Hutchings MR, 2002, OIKOS, V96, P235, DOI 10.1034/j.1600-0706.2002.960205.x; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Karvonen A, 2004, PARASITOL RES, V92, P183, DOI 10.1007/s00436-003-1035-y; Khalife J, 2000, PARASITOL INT, V49, P339, DOI 10.1016/S1383-5769(00)00059-3; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Knudsen R, 2004, J PARASITOL, V90, P1, DOI 10.1645/GE-3184; LAFFERTY KD, 1992, AM NAT, V140, P854, DOI 10.1086/285444; Leung B, 1998, INT J PARASITOL, V28, P1709, DOI 10.1016/S0020-7519(98)00128-3; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; Morand S, 2002, PARASITOLOGY, V124, P401, DOI 10.1017/S0031182001001342; Morand S, 2009, ECOLOGY EVOLUTION PA; Morand S, 2008, TRENDS PARASITOL, V24, P304, DOI 10.1016/j.pt.2008.04.003; Navarro-Gonzalez N, 2011, EUR J WILDLIFE RES, V57, P639, DOI 10.1007/s10344-010-0474-x; Nouvellet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002505; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Poulin R., 2007, EVOL ECOL, V2; Pugliese A, 1998, J MATH BIOL, V36, P419; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rascalou G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1108; Rascalou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036858; Regoes RR, 2003, EPIDEMIOL INFECT, V131, P957, DOI 10.1017/S0950268803008793; Richardson DJ, 2011, VECTOR-BORNE ZOONOT, V11, P1151, DOI 10.1089/vbz.2010.0151; Ross S.M., 2010, INTRO PROBABILITY MO; Pacheco-Tucuch FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036207; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Tschirren B, 2007, FUNCT ECOL, V21, P372, DOI 10.1111/j.1365-2435.2007.01235.x; Vale PF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1145; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; YAMADA M, 1992, IMMUNOLOGY, V75, P36; Young LJ, 1998, STAT ECOLOGY	60	15	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116893	10.1371/journal.pone.0116893	http://dx.doi.org/10.1371/journal.pone.0116893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689685	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700027
J	Su, QD; Yi, Y; Qiu, F; Lu, XX; Ding, JY; Jia, ZY; Tian, RG; Gao, Y; Bi, SL				Su, Qiudong; Yi, Yao; Qiu, Feng; Lu, Xuexin; Ding, Junying; Jia, Zhiyuan; Tian, Ruiguang; Gao, Yan; Bi, Shengli			Immune Responses to HBsAg Conjugated to Protein D of Non-Typeable Haemophilus influenzae in Mice	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; T-CELL; ANTIGENS; IMMUNOGENICITY; LIPOPROTEIN	Background Hepatitis B vaccine that contains an aluminum hydroxide adjuvant induces apoptotic death of Hepa 1-6 cells. Difficult-to-degrade chemical additives in vaccines effectively enhance vaccine immunogenicity, but also affect the host tissue. Identification of bio-molecules that are readily degraded and compatible in vivo as an adjuvant is important for vaccine research. The hapten-carrier effect suggests that stimulation of helper T (Th) cells by carrier adjuvants is feasible. Protein D (PD) of non-typeable Haemophilus influenzae covalently conjugated to some polysaccharide vaccines has been confirmed to convert T-cell independent (TI) antigens into T-cell dependent (TD) antigens, and elicit strong T-cell responses ultimately. Herein, we would substitube PD for aluminum hydroxide adjuvant in Hepatitis B vaccine. Methods and results Truncated PD (amino acids 20-364) was expressed in Escherichia coli and purified by (NH4)(2)SO4 precipitation and DEAE chromatography. After evaluation of antigenicity by western blotting, PD was covalently conjugated to yeast-derived recombinant HBsAg by cross-linking with glutaraldehyde. Intramuscular immunization with the conjugate induced higher level of HBsAg-specific antibody than did HBsAg alone (p < 0.05), and was comparable to commercial Hepatitis B vaccine. During the surveillance period (days 35-105), anti-HBs titers were hold high. Moreover, the conjugated vaccine enhanced Th1 immune responses, while Th2 responses were also activated and induced an antibody response, as determined by IFN-gamma ELISPOT and IgG1/IgG2a ratio assays. Conclusions Recombinant truncated PD covalently conjugated to HBsAg antigen enhanced the immunogenicity of the antigen in mice simultaneously by humoral and cellular immune response, which would facilitate therapeutic hepatitis B vaccines.	[Su, Qiudong; Yi, Yao; Qiu, Feng; Lu, Xuexin; Ding, Junying; Jia, Zhiyuan; Tian, Ruiguang; Gao, Yan; Bi, Shengli] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shengli_bi@163.com		Bi, Shengli/0000-0002-0380-5790	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention [2012ZX10002-001]	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention	This work was supported by a grant from the Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention (2012ZX10002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoyunlu M, 1996, INFECT IMMUN, V64, P4586, DOI 10.1128/IAI.64.11.4586-4592.1996; Andre FE, 1990, VACCINE, V8, P574; Bordet AL, 2001, ANN PATHOL, V21, P149; Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-882; Duclos Philippe, 2003, Expert Opin Drug Saf, V2, P225, DOI 10.1517/14740338.2.3.225; Forsgren A, 2008, CLIN INFECT DIS, V46, P726, DOI 10.1086/527396; Hamza H, 2012, APOPTOSIS, V17, P516, DOI 10.1007/s10495-011-0690-1; Han HR, 2000, J VET MED SCI, V62, P237, DOI 10.1292/jvms.62.237; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Heijne GV, 1981, EUR J BIOCHEM, V120, P275; Hourvitz A, 1996, J VIRAL HEPATITIS, V3, P37, DOI 10.1111/j.1365-2893.1996.tb00079.x; JANSON H, 1992, INFECT IMMUN, V60, P1336, DOI 10.1128/IAI.60.4.1336-1342.1992; Kakimi K, 2002, J VIROL, V76, P8609, DOI 10.1128/JVI.76.17.8609-8620.2002; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; MILICH DR, 1988, IMMUNOL TODAY, V9, P380, DOI 10.1016/0167-5699(88)91239-X; Sanvictores Diozele Hazel M, 2012, BMC Res Notes, V5, P274, DOI 10.1186/1756-0500-5-274; Shen LP, 2012, VACCINE, V30, P6623, DOI 10.1016/j.vaccine.2012.08.067; Shouval D, 2003, J HEPATOL, V39, pS70, DOI 10.1016/S0168-8278(03)00125-1; SNAPPER CM, 1995, J IMMUNOL, V155, P5582; Su L, 2000, J Epidemiol Biostat, V5, P359; Yalcin K, 2003, INFECTION, V31, P221, DOI 10.1007/s15010-003-3187-1	21	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117736	10.1371/journal.pone.0117736	http://dx.doi.org/10.1371/journal.pone.0117736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689855	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700068
J	Yang, YF; Liu, XY; Xiao, FJ; Xue, SY; Xu, QQ; Yin, Y; Sun, HY; Xu, J; Wang, HX; Zhang, QW; Wang, H; Wang, LS				Yang, Yuefeng; Liu, Xiaoyun; Xiao, Fengjun; Xue, Shuya; Xu, Qinqin; Yin, Yue; Sun, Huiyan; Xu, Jie; Wang, Hengxiang; Zhang, Qunwei; Wang, Hua; Wang, Lisheng			Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							BCR-ABL; TRANSCRIPTION-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; DOWN-REGULATION; RESISTANCE; INHIBITORS; APOPTOSIS; PATHWAY; CML	Differentiation induction is currently considered as an alternative strategy for treating chronic myelogenous leukemia (CML). Our previous work has demonstrated that Sprouty-related EVH1 domainprotein2 (Spred2) was involved in imatinib mediated cytotoxicity in CML cells. However, its roles in growth and lineage differentiation of CML cells remain unknown. In this study, we found that CML CD34(+) cells expressed lower level of Spred2 compared with normal hematopoietic progenitor cells, and adenovirus mediated restoration of Spred2 promoted the erythroid differentiation of CML cells. Imatinib could induce Spred2 expression and enhance erythroid differentiation in K562 cells. However, the imatinib induced erythroid differentiation could be blocked by Spred2 silence using lentiviral vector PLKO.1-shSpred2. Spred2 interference activated phosphorylated-ERK (p-ERK) and inhibited erythroid differentiation, while ERK inhibitor, PD98059, could restore the erythroid differentiation, suggesting Spred2 regulated the erythroid differentiation partly through ERK signaling. Furthermore, Spred2 interference partly restored p-ERK level leading to inhibition of erythroid differentiation in imatinib treated K562 cells. In conclusion, Spred2 was involved in erythroid differentiation of CML cells and participated in imatinib induced erythroid differentiation partly through ERK signaling.	[Yang, Yuefeng; Xiao, Fengjun; Xue, Shuya; Sun, Huiyan; Xu, Jie; Zhang, Qunwei; Wang, Hua; Wang, Lisheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China; [Liu, Xiaoyun] Lanzhou Command, Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Yin, Yue] Peking Univ, Hosp 1, Dept Hematol, Beijing 100871, Peoples R China; [Wang, Hengxiang] Gen Hosp Air Force, Dept Hematol, Beijing, Peoples R China; [Xu, Qinqin] Qinghai Prov Peoples Hosp, Dept Oncol, Xining, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; Peking University	Wang, H (corresponding author), Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China.	wanghua@bmi.ac.cn; wangls@bmi.ac.cn			Chinese National Basic Research and Development (973 Program) [2012CB518205]; National Natural Science Foundation of China [81170460]; National High Technology Research and Development Program of China (863 Program) [2012AA02A211, SS2014AA020515]	Chinese National Basic Research and Development (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Chinese National Basic Research and Development (973 Program) (No. 2012CB518205), National Natural Science Foundation of China (No. 81170460), and National High Technology Research and Development Program of China (863 Program) (Nos. 2012AA02A211 and SS2014AA020515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Corrado P, 2009, LEUKEMIA, V23, P405, DOI 10.1038/leu.2008.186; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Hochhaus A, 2013, J CANCER RES CLIN, V139, P1971, DOI 10.1007/s00432-013-1488-z; Ida C, 2009, BIOSCI BIOTECH BIOCH, V73, P79, DOI 10.1271/bbb.80483; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jain N, 2013, EXPERT REV HEMATOL, V6, P575, DOI 10.1586/17474086.2013.835697; Kawano T, 2004, MOL CELL BIOCHEM, V258, P25, DOI 10.1023/B:MCBI.0000012830.96393.b9; Kuzelova K, 2005, J CELL BIOCHEM, V95, P268, DOI 10.1002/jcb.20407; La Rosee P, 2010, SEMIN HEMATOL, V47, P335, DOI 10.1053/j.seminhematol.2010.06.005; Lee YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061939; Liu XY, 2010, BIOCHEM BIOPH RES CO, V393, P637, DOI 10.1016/j.bbrc.2010.02.044; Marega M, 2010, LEUKEMIA, V24, P1445, DOI 10.1038/leu.2010.101; Meshkini A, 2007, J BIOCHEM MOL BIOL, V40, P944; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Murphy T, 2010, INT J CANCER, V127, P2491, DOI 10.1002/ijc.25542; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Radujkovic A, 2005, LEUKEMIA, V19, P1198, DOI 10.1038/sj.leu.2403764; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Schuster C, 2003, BLOOD, V101, P655, DOI 10.1182/blood-2002-01-0043; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang Q, 2005, LEUKEMIA, V19, P1812, DOI 10.1038/sj.leu.2403916; Woessmann W, 2004, CELL BIOL INT, V28, P403, DOI 10.1016/j.cellbi.2004.03.009; Yan J, 2012, ANTI-CANCER DRUG, V23, P22, DOI 10.1097/CAD.0b013e32834a099c; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Zhou Min, 2013, Zhonghua Xue Ye Xue Za Zhi, V34, P395, DOI 10.3760/cma.j.issn.0253-2727.2013.05.004; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117573	10.1371/journal.pone.0117573	http://dx.doi.org/10.1371/journal.pone.0117573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688862	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700058
J	De Angelis, A; Ricotta, C; Conedera, M; Pezzatti, GB				De Angelis, Antonella; Ricotta, Carlo; Conedera, Marco; Pezzatti, Gianni Boris			Modelling the Meteorological Forest Fire Niche in Heterogeneous Pyrologic Conditions	PLOS ONE			English	Article							DANGER RATING SYSTEM; SPECIES DISTRIBUTION; PERFORMANCE; PREDICTION; WILDFIRES; REGION; INDEX; AREA; SUSCEPTIBILITY; DISTRIBUTIONS	Fire regimes are strongly related to weather conditions that directly and indirectly influence fire ignition and propagation. Identifying the most important meteorological fire drivers is thus fundamental for daily fire risk forecasting. In this context, several fire weather indices have been developed focussing mainly on fire-related local weather conditions and fuel characteristics. The specificity of the conditions for which fire danger indices are developed makes its direct transfer and applicability problematic in different areas or with other fuel types. In this paper we used the low-to-intermediate fire-prone region of Canton Ticino as a case study to develop a new daily fire danger index by implementing a niche modelling approach (Maxent). In order to identify the most suitable weather conditions for fires, different combinations of input variables were tested (meteorological variables, existing fire danger indices or a combination of both). Our findings demonstrate that such combinations of input variables increase the predictive power of the resulting index and surprisingly even using meteorological variables only allows similar or better performances than using the complex Canadian Fire Weather Index (FWI). Furthermore, the niche modelling approach based on Maxent resulted in slightly improved model performance and in a reduced number of selected variables with respect to the classical logistic approach. Factors influencing final model robustness were the number of fire events considered and the specificity of the meteorological conditions leading to fire ignition.	[De Angelis, Antonella; Conedera, Marco; Pezzatti, Gianni Boris] WSL Swiss Fed Res Inst, Insubr Ecosyst Res Grp, CH-6500 Bellinzona, Switzerland; [Ricotta, Carlo] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Sapienza University Rome	De Angelis, A (corresponding author), WSL Swiss Fed Res Inst, Insubr Ecosyst Res Grp, Via Belsoggiorno 22, CH-6500 Bellinzona, Switzerland.	antonella.deangelis@wsl.ch	Pezzatti, Gianni Boris/D-5102-2017	Pezzatti, Gianni Boris/0000-0003-2564-3435; RICOTTA, Carlo/0000-0003-0818-3959; Conedera, Marco/0000-0003-3980-2142	European Project ALP FFIRS - European Regional Development fund of Alpine Space Program; Canton Ticino; Valais; BAFU; BAFU/WSL Swiss program forest and climate change	European Project ALP FFIRS - European Regional Development fund of Alpine Space Program; Canton Ticino; Valais; BAFU; BAFU/WSL Swiss program forest and climate change	This work was supported by the European Project ALP FFIRS, funded by the European Regional Development fund of Alpine Space Program, and by Canton Ticino, Valais and BAFU. It was also partly supported by BAFU/WSL Swiss program forest and climate change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2010, MAPPING SPECIES DIST; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bar Massada A, 2013, INT J WILDLAND FIRE, V22, P174, DOI 10.1071/WF11178; Baumgartner A., 1967, MITT STAATSFORSTVERW, V36, P57; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cardille JA, 2001, ECOL APPL, V11, P111, DOI 10.1890/1051-0761(2001)011[0111:EASFIW]2.0.CO;2; Chandler C, 1983, FIRE FORESTRY, V1; Conedera M., 2004, Schweizerische Zeitschrift fur Forstwesen, V155, P263, DOI 10.3188/szf.2004.0263; Conedera M, 2006, 5 INT C FOR FIR RES; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; de Vicente J, 2012, INT J WILDLAND FIRE, V21, P1030, DOI 10.1071/WF11046; DeLeo J. M., 1993, [1993] Proceedings Second International Symposium on Uncertainty Modeling and Analysis, P318, DOI 10.1109/ISUMA.1993.366750; Dimitrakopoulos AP, 2010, INT J WILDLAND FIRE, V19, P29, DOI 10.1071/WF08124; Dube OP, 2007, ENVIRON SCI ENG, P223, DOI 10.1007/978-3-540-72438-4_12; Eastaugh CS, 2012, AUSTRIAN J FOR SCI, V129, P228; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellenberg H., 1974, MITT SCHWEIZ ANST FO, V48, P587; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FOGARTY LG, 1998, P 3 INT C FOR FIR RE, P01011; Fosberg M.A., 1978, P C SIERR NEV MET LA; Francois D, 2007, NEUROCOMPUTING, V70, P1276, DOI 10.1016/j.neucom.2006.11.019; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gustafson EJ, 2004, LANDSCAPE ECOL, V19, P327, DOI 10.1023/B:LAND.0000030431.12912.7f; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy CC, 2007, INT J WILDLAND FIRE, V16, P217, DOI 10.1071/WF06076; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Holsten A, 2013, FOREST ECOL MANAG, V287, P123, DOI 10.1016/j.foreco.2012.08.035; Keetch J., 1968, DROUGHT INDEX FOREST; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Krebs P, 2010, THEOR BIOSCI, V129, P53, DOI 10.1007/s12064-010-0082-z; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mandallaz D, 1997, CAN J FOREST RES, V27, P1685, DOI 10.1139/cjfr-27-10-1685; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; McArthur AG, 1967, FIRE BEHAV EUCALYPT; McCullagh P, 1989, GEN LINEAR MODELS; Mermoz M, 2005, ECOLOGY, V86, P2705, DOI 10.1890/04-1850; Molders N, 2010, ATMOS RES, V95, P290, DOI 10.1016/j.atmosres.2009.03.010; Munger T. T., 1916, MONTHLY WEATHER REV, V44, P642, DOI DOI 10.1175/1520-0493(1916)44<642:GMORAC>2.0.CO;2; Nesterov V. G., 1949, COMBUSTIBILITY FORES; Orieux A, 1974, REV FORESTIERE FRANC, P122; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pezzatti GB, 2009, PLANT BIOSYST, V143, P609, DOI 10.1080/11263500903233292; Pezzatti GB, 2013, FOREST POLICY ECON, V29, P7, DOI 10.1016/j.forpol.2011.07.002; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pontius RG, 2014, LANDSCAPE ECOL, V29, P367, DOI 10.1007/s10980-013-9984-8; R Core Team, 2021, R LANGUAGE ENV STAT; Reineking B, 2010, INT J WILDLAND FIRE, V19, P541, DOI 10.1071/WF08206; Renard Q, 2012, INT J WILDLAND FIRE, V21, P368, DOI 10.1071/WF10109; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sharples JJ, 2009, ENVIRON MODELL SOFTW, V24, P637, DOI 10.1016/j.envsoft.2008.10.012; Sharples JJ, 2009, ENVIRON MODELL SOFTW, V24, P764, DOI 10.1016/j.envsoft.2008.11.004; Siljander M, 2009, INT J APPL EARTH OBS, V11, P380, DOI 10.1016/j.jag.2009.06.004; Spinedi F, 2004, DATI STAT SOC, V4, P4; STOCKS BJ, 1989, FOREST CHRON, V65, P450, DOI 10.5558/tfc65450-6; Sturm T, 2012, EUR J FOREST RES, V131, P829, DOI 10.1007/s10342-011-0556-7; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Taylor S., 2001, CONSIDERATIONS APPL; Taylor SW, 2006, INT J WILDLAND FIRE, V15, P121, DOI 10.1071/WF05021; Tian XR, 2011, INT J WILDLAND FIRE, V20, P963, DOI 10.1071/WF09120; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; Van Wagner C. E., 1987, CANADIAN FORESTRY SE; VEGA GARCIA C, 1995, INT J WILDLAND FIRE, V5, P101, DOI 10.1071/WF9950101; Viedma O, 2009, INT J WILDLAND FIRE, V18, P575, DOI 10.1071/WF08030; Viegas DX, 1999, INT J WILDLAND FIRE, V9, P235, DOI 10.1071/WF00015; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wotton BM, 2009, ENVIRON ECOL STAT, V16, P107, DOI 10.1007/s10651-007-0084-2; Zumbrunnen T, 2012, REG ENVIRON CHANGE, V12, P935, DOI 10.1007/s10113-012-0307-4; ZWEIG MH, 1993, CLIN CHEM, V39, P561	75	31	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116875	10.1371/journal.pone.0116875	http://dx.doi.org/10.1371/journal.pone.0116875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679957	Green Published, gold			2022-12-27	WOS:000350682600039
J	Lin, YH; Hung, GY; Wu, LC; Chen, SW; Lin, LY; Horng, JL				Lin, Yuan-Hsiang; Hung, Giun-Yi; Wu, Liang-Chun; Chen, Sheng-Wen; Lin, Li-Yih; Horng, Jiun-Lin			Anion Exchanger 1b in Stereocilia Is Required for the Functioning of Mechanotransducer Channels in Lateral-Line Hair Cells of Zebrafish	PLOS ONE			English	Article							ACID-BASE TRANSPORT; PLASMA-MEMBRANE; RICH CELLS; LOCALIZATION; COCHLEA; LARVAE; CA2+; MECHANISM; DEAFNESS; ATPASE	The anion exchanger (AE) plays critical roles in physiological processes including CO2 transport and volume regulation in erythrocytes and acid-base regulation in renal tubules. Although expression of the AE in inner-ear hair cells was reported, its specific localization and function are still unclear. Using in situ hybridization, we found that the AE1b transcript is expressed in lateral-line hair cells of zebrafish larvae. An immunohistochemical analysis with a zebrafish-specific antibody localized AE1b to stereocilia of hair cells, and the expression was eliminated by morpholino knockdown of AE1b. A non-invasive, scanning ion-selective electrode technique was applied to analyze mechanotransducer (MET) channel-mediated Ca2+ influx at stereocilia of hair cells of intact fish. Ca2+ influx was effectively suppressed by AE1b morpholino knockdown and inhibitor (DIDS) treatment. Elevating external Ca2+ (0.2 to 2 mM) neutralized the inhibition of DIDS. Taken together, this study provides solid evidence to show that AE1b in stereocilia is required for the proper functioning of MET channels.	[Lin, Yuan-Hsiang] Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan; [Hung, Giun-Yi] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hung, Giun-Yi] Natl Yang Ming Univ, Fac Med, Dept Pediat, Taipei 112, Taiwan; [Wu, Liang-Chun; Lin, Li-Yih] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Sheng-Wen; Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan	National Taiwan University of Science & Technology; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University; Taipei Medical University	Lin, LY (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	jlhorng@tmu.edu.tw	Wu, Liang-Chun/GVS-9655-2022		Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program [TMU-NTUST-101-04]; Ministry of Science and Technology, Taiwan [101-2311-b-003-004-my3]	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program (TMU-NTUST-101-04) and grants to J. L. Horng and L. Y. Lin (101-2311-b-003-004-my3) from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Batlle D, 2012, NEPHROL DIAL TRANSPL, V27, P3691, DOI 10.1093/ndt/gfs442; Bonar PT, 2008, CHANNELS, V2, P337, DOI 10.4161/chan.2.5.6899; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; Fettiplace R, 2009, PFLUG ARCH EUR J PHY, V458, P1115, DOI 10.1007/s00424-009-0683-x; Froehlicher M, 2009, AQUAT TOXICOL, V95, P307, DOI 10.1016/j.aquatox.2009.04.007; Garber SS, 2005, J MEMBRANE BIOL, V203, P101, DOI 10.1007/s00232-005-0735-x; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Giacomello M, 2012, INT J BIOCHEM CELL B, V44, P679, DOI 10.1016/j.biocel.2012.02.006; Griffith AJ, 2011, HEARING RES, V281, P11, DOI 10.1016/j.heares.2011.05.009; Hailey DW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002971; Kalinec F, 1997, HEARING RES, V110, P141, DOI 10.1016/S0378-5955(97)00076-2; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kreitzer MA, 2007, J GEN PHYSIOL, V130, P169, DOI 10.1085/jgp.200709737; Lee YC, 2011, AM J PHYSIOL-CELL PH, V300, pC295, DOI 10.1152/ajpcell.00263.2010; Lin LY, 2013, AM J PHYSIOL-CELL PH, V305, pC1060, DOI 10.1152/ajpcell.00077.2013; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; Mhatre AN, 1998, BBA-BIOMEMBRANES, V1414, P1, DOI 10.1016/S0005-2736(98)00110-2; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Shen WP, 2011, AM J PHYSIOL-REG I, V300, pR858, DOI 10.1152/ajpregu.00705.2010; Shih TH, 2012, AM J PHYSIOL-REG I, V302, pR84, DOI 10.1152/ajpregu.00318.2011; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wagner CA, 2006, NEPHRON PHYSIOL, V103, P1, DOI 10.1159/000090217; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Walsh SB, 2010, INT J BIOCHEM CELL B, V42, P1919, DOI 10.1016/j.biocel.2010.08.016; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wu F, 2011, BIOCHEM CELL BIOL, V89, P106, DOI [10.1139/O10-146, 10.1139/o10-146]; Wulff Heike, 2008, ACS Chem Biol, V3, P399, DOI 10.1021/cb800140m; Zimmermann U, 2000, MOL CELL BIOCHEM, V205, P25, DOI 10.1023/A:1007002916772; Zine A, 1997, NEUROSCIENCE, V80, P1247, DOI 10.1016/S0306-4522(97)00163-2	38	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117041	10.1371/journal.pone.0117041	http://dx.doi.org/10.1371/journal.pone.0117041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679789	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600045
J	Wang, Y; Ng, WC; Ng, KS; Yu, K; Wu, T; Li, X				Wang, Yue; Ng, Wu Chun; Ng, Khoon Siong; Yu, Ke; Wu, Tiecheng; Li, Xiaoping			An Electroencephalography Network and Connectivity Analysis for Deception in Instructed Lying Tasks	PLOS ONE			English	Article							EEG FUNCTIONAL CONNECTIVITY; MEDIAL TEMPORAL-LOBE; PREFRONTAL CORTEX; SPEECH; BRAIN; GYRUS; PERCEPTION; MEMORY; DISCRIMINATION; COMPREHENSION	Deception is an impactful social event that has been the focus of an abundance of researches over recent decades. In this paper, an electroencephalography (EEG) study is presented regarding the cognitive processes of an instructed liar/truth-teller during the time window of stimulus (question) delivery period (SDP) prior to their deceptive/truthful responses towards questions related to authentic (WE: with prior experience) and fictional experience (NE: no prior experience). To investigate deception in non-experienced events, the subjects were given stimuli in a mock interview scenario that induced them to fabricate lies. To analyze the data, frequency domain network and connectivity analysis was performed in the source space in order to provide a more systematic level understanding of deception during SDP. This study reveals several groups of neuronal generators underlying both the instructed lying (IL) and the instructed truth-telling (IT) conditions for both tasks during the SDP. Despite the similarities existed in these group components, significant differences were found in the intra- and inter-group connectivity between the IL and IT conditions in either task. Additionally, the response time was found to be positively correlated with the clustering coefficient of the inferior frontal gyrus (44R) in the WE-IL condition and positively correlated with the clustering coefficient of the precuneus (7L) and the angular gyrus (39R) in the WE-IT condition. However, the response time was found to be marginally negatively correlated with the clustering coefficient of the secondary auditory cortex (42L) in the NE-IL condition and negatively correlated with the clustering coefficient of the somatosensory association cortex (5L, R) in the NE-IT condition. Therefore, these results provide complementary and intuitive evidence for the differences between the IL and IT conditions in SDP for two types of deception tasks, thus elucidating the electrophysiological mechanisms underlying SDP of deception from regional, inter-regional, network, and inter-network scale analyses.	[Wang, Yue; Ng, Wu Chun; Ng, Khoon Siong; Yu, Ke; Wu, Tiecheng; Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Neuroengn Lab, Singapore 117548, Singapore	National University of Singapore	Li, X (corresponding author), Natl Univ Singapore, Dept Mech Engn, Neuroengn Lab, Singapore 117548, Singapore.	mpelixp@nus.edu.sg						Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Asma L, 2008, THESIS U TWENTE; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Blaizot X, 2004, CEREB CORTEX, V14, P231, DOI 10.1093/cercor/bhg123; Bridge H, 2012, J NEUROL, V259, P1062, DOI 10.1007/s00415-011-6299-z; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Brodmann K., 2006, BRODMANNS LOCALISATI, DOI DOI 10.1016/j.bbadis.2017.07.008; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Campbell Ian G, 2009, Curr Protoc Neurosci, VChapter 10, DOI 10.1002/0471142301.ns1002s49; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Carmel D, 2003, J EXP PSYCHOL-APPL, V9, P261, DOI 10.1037/1076-898X.9.4.261; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Champoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022829; Chen JL, 2013, HUM BRAIN MAPP, V34, P852, DOI 10.1002/hbm.21475; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; De Clercq W, 2005, P ANN INT IEEE EMBS, P944, DOI 10.1109/IEMBS.2005.1616571; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Dressler O, 2004, BRIT J ANAESTH, V93, P806, DOI 10.1093/bja/aeh270; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Farwell LA, 2013, COGN NEURODYNAMICS, V7, P263, DOI 10.1007/s11571-012-9230-0; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganis G, 2009, SOC NEUROSCI-UK, V4, P539, DOI 10.1080/17470910801928271; German G-H, 2008, AUTOMATIC ARTIFACT R; Gomez-Herrero G, 2006, 2006 7TH NORDIC SIGNAL PROCESSING SYMPOSIUM, P130; Gotlib IH, 2005, NEUROREPORT, V16, P1731, DOI 10.1097/01.wnr.0000183901.70030.82; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Groppe DM., 2010, ONE SAMPLE PAIRED SA; Groppe DM, 2012, CORRELATION PERMUTAT; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hebart MN, 2012, J NEUROSCI, V32, P8107, DOI 10.1523/JNEUROSCI.1462-12.2012; Hindley EL, 2014, LEARN MEMORY, V21, P171, DOI 10.1101/lm.032516.113; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Jancke L, 2011, J NEUROPSYCHOL, V5, P178, DOI 10.1111/j.1748-6653.2011.02004.x; Kim S, 2012, INT J PSYCHOPHYSIOL, V85, P230, DOI 10.1016/j.ijpsycho.2012.04.009; Kumar V., 2014, INTELLIGENT COMPUTIN, P183, DOI [10.1007/978-81-322-1665-0_17, DOI 10.1007/978-81-322-1665-0_17]; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Michael SG, 2009, COGNITIVE NEUROSCIEN, P395; Michel CM., 2009, ELECT NEUROIMAGING, P111; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; National Research Council, 2003, POL LIE DET; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Purves D, 2001, NEUROSCIENCE, DOI [10.4249/scholarpedia.7204, DOI 10.4249/SCHOLARPEDIA.7204]; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Schutter DJLG, 2006, J PSYCHIATR NEUROSCI, V31, P101; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Seth AK, 2006, NEUROIMAGE, V32, P465, DOI 10.1016/j.neuroimage.2006.02.050; Shafi MM, 2014, BRAIN TOPOGR, V27, P172, DOI 10.1007/s10548-013-0277-y; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Thakor Nitish V., 2009, P169; Wang Y, 2013, I IEEE EMBS C NEUR E, P468, DOI 10.1109/NER.2013.6695973; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010	76	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116522	10.1371/journal.pone.0116522	http://dx.doi.org/10.1371/journal.pone.0116522			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679784	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600024
J	Lee, TH; Sottile, J; Chiang, HY				Lee, Ting-Hein; Sottile, Jane; Chiang, Hou-Yu			Collagen Inhibitory Peptide R1R2 Mediates Vascular Remodeling by Decreasing Inflammation and Smooth Muscle Cell Activation	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; GROWTH-FACTOR-BINDING; DOMAIN RECEPTOR 2; KAPPA-B LIGAND; EXTRACELLULAR-MATRIX; I COLLAGEN; NEOINTIMA FORMATION; ARTERIAL STIFFNESS; ENDOTHELIAL-CELLS; OSTEOCLAST MATURATION	The extracellular matrix (ECM) is a major constituent of the vessel wall. In addition to providing a structural scaffold, the ECM controls numerous cellular functions in both physiologic and pathologic settings. Vascular remodeling occurs after injury and is characterized by endothelial cell activation, inflammatory cell infiltration, phenotypic modulation of smooth muscle cells (SMCs), and augmented deposition of collagen-rich ECM. R1R2, a peptide derived from the bacterial adhesin SFS, with sequence homology to collagen, is known to inhibit collagen type I deposition in vitro by inhibiting the binding of fibronectin to collagen. However, the inhibitory effects of R1R2 during vascular remodeling have not been explored. We periadventitially delivered R1R2 to carotid arteries using pluronic gel in a vascular remodeling mouse model induced by blood flow cessation, and evaluated its effects on intima-media thickening, ECM deposition, SMC activation, and inflammatory cell infiltration. Morphometric analysis demonstrated that R1R2 reduced intima-media thickening compared to the control groups. R1R2 treatment also decreased collagen type I deposition in the vessel wall, and maintained SMC in the contractile phenotype. Interestingly, R1R2 dramatically reduced inflammatory cell infiltration into the vessel by similar to 78%. This decrease was accompanied by decreased VCAM-1 and ICAM-1 expression. Our in vitro studies revealed that R1R2 attenuated SMC proliferation and migration, and also decreased monocyte adhesion and transendothelial migration through endothelial cells. Together, these data suggest that R1R2 attenuates vascular remodeling responses by decreasing inflammation and by modulating SMC proliferation and migration, and suggest that the R1R2 peptide may have therapeutic potential in treating occlusive vascular diseases.	[Lee, Ting-Hein; Chiang, Hou-Yu] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan; [Sottile, Jane] Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Rochester, NY USA	Chang Gung University; University of Rochester	Chiang, HY (corresponding author), Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan.	hchiang@mail.cgu.edu.tw		Lee, Ting-Hein/0000-0001-7077-3138	CMRPD [190971];  [NSC99-2320-B-182-019-MY2];  [NSC101-2320-B-182-004];  [NSC102-2320-B-182-007-MY3];  [RO1GM097347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097347] Funding Source: NIH RePORTER	CMRPD; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants: NSC99-2320-B-182-019-MY2, NSC101-2320-B-182-004, NSC102-2320-B-182-007-MY3, and CMRPD 190971 to HYC in Taiwan, and RO1GM097347 to JS in USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2013, BLOOD, V121, P1644, DOI 10.1182/blood-2012-08-451575; Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Braun M, 1999, CARDIOVASC RES, V41, P395, DOI 10.1016/S0008-6363(98)00302-2; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Chung CY, 1997, J CELL SCI, V110, P1413; Coats WD, 1996, J MOL CELL CARDIOL, V28, P441; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Grafe I., 2014, NAT MED, V20, P670, DOI DOI 10.1038/NM.3544; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Hastings NE, 2009, ARTERIOSCL THROM VAS, V29, P725, DOI 10.1161/ATVBAHA.109.184382; Hirai F, 2007, BIOCHEM BIOPH RES CO, V356, P279, DOI 10.1016/j.bbrc.2007.02.121; Hofmann CS, 2004, ARTERIOSCL THROM VAS, V24, P1608, DOI 10.1161/01.ATV.0000139010.71779.f3; HOPKINS KD, 1994, LANCET, V343, P1447, DOI 10.1016/S0140-6736(94)92577-1; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Hou GP, 2012, CARDIOVASC PATHOL, V21, P214, DOI 10.1016/j.carpath.2011.07.006; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Ishikawa J, 2005, HYPERTENS RES, V28, P995, DOI 10.1291/hypres.28.995; Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9; Janic M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/621437; Johnson CP, 2001, J CLIN PATHOL, V54, P139, DOI 10.1136/jcp.54.2.139; KELLEY J, 1980, J LAB CLIN MED, V96, P954; Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349; Korshunov VA, 2004, CIRCULATION, V110, P220, DOI 10.1161/01.CIR.0000134958.88379.2E; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kulkarni NB, 2014, J CLIN DIAGN RES, V8, pBC8, DOI 10.7860/JCDR/2014/7859.4438; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Landry DB, 1997, AM J PATHOL, V151, P1085; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lawson C, 1999, J IMMUNOL, V162, P2990; Lee TH, 2014, MOL BIOL CELL, V25, P583, DOI 10.1091/mbc.E13-07-0382; Lee TH, 2009, CIRC RES, V105, P271, DOI 10.1161/CIRCRESAHA.109.199869; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Libby P, 2000, CIRCULATION, V102, P1874, DOI 10.1161/01.CIR.102.16.1874; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Lin FB, 2011, J INVEST DERMATOL, V131, P84, DOI 10.1038/jid.2010.253; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; LITTLE CD, 1982, J CELL SCI, V55, P35; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Lu KK, 2011, CARDIOVASC PATHOL, V20, P71, DOI 10.1016/j.carpath.2009.12.006; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; MIYAKE S, 1993, J EXP MED, V177, P863, DOI 10.1084/jem.177.3.863; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Nakayamada S, 2003, ARTHRITIS RHEUM, V48, P1239, DOI 10.1002/art.10941; Ng K, 2011, AM J PHYSIOL-RENAL, V300, pF1431, DOI 10.1152/ajprenal.00079.2011; Nguyen TTB, 2005, AM J RESP CRIT CARE, V171, P217, DOI 10.1164/rccm.200408-1046OC; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; OWENS RJ, 1986, EMBO J, V5, P2825, DOI 10.1002/j.1460-2075.1986.tb04575.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258; Poitevin S, 2008, J THROMB HAEMOST, V6, P1586, DOI 10.1111/j.1538-7836.2008.03051.x; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; RAINES EW, 1993, BRIT HEART J, V69, pS30; RILEY DJ, 1980, J CLIN INVEST, V65, P643, DOI 10.1172/JCI109709; Rocnik EF, 1998, J CLIN INVEST, V101, P1889, DOI 10.1172/JCI1025; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Sheikh H, 2000, J CELL SCI, V113, P1021; Shyu KG, 2008, ARTERIOSCL THROM VAS, V28, P1447, DOI 10.1161/ATVBAHA.108.165993; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SKINNER MP, 1994, AM J PATHOL, V145, P1070; Sluijter JPG, 2004, CARDIOVASC RES, V61, P186, DOI 10.1016/j.cardiores.2003.09.028; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; STRAUSS BH, 1994, CIRC RES, V75, P650, DOI 10.1161/01.RES.75.4.650; Vaiyapuri S, 2012, J BIOL CHEM, V287, P26235, DOI 10.1074/jbc.M112.381483; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Wang WL, 2014, BIOMATERIALS, V35, P3829, DOI 10.1016/j.biomaterials.2014.01.049; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Wang Yi-Xin, 2004, Current Vascular Pharmacology, V2, P379, DOI 10.2174/1570161043385448; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016; Zhang WD, 1999, J VASC SURG, V30, P169, DOI 10.1016/S0741-5214(99)70189-8; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	98	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117356	10.1371/journal.pone.0117356	http://dx.doi.org/10.1371/journal.pone.0117356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675397	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000018
J	Lucas, A; Lucas, M; Strhyn, A; Keane, NM; McKinnon, E; Pavlos, R; Moran, EM; Meyer-Pannwitt, V; Gaudieri, S; D'Orsogna, L; Kalams, S; Ostrov, DA; Buus, S; Peters, B; Mallal, S; Phillips, E				Lucas, Andrew; Lucas, Michaela; Strhyn, Anette; Keane, Niamh M.; McKinnon, Elizabeth; Pavlos, Rebecca; Moran, Ellen M.; Meyer-Pannwitt, Viola; Gaudieri, Silvana; D'Orsogna, Lloyd; Kalams, Spyros; Ostrov, David A.; Buus, Soren; Peters, Bjoern; Mallal, Simon; Phillips, Elizabeth			Abacavir-Reactive Memory T Cells Are Present in Drug Naive Individuals	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; HLA-B-ASTERISK-5701; ACTIVATION; ALLORECOGNITION; REPERTOIRE; RESPONSES	Background Fifty-five percent of individuals with HLA-B*57:01 exposed to the antiretroviral drug abacavir develop a hypersensitivity reaction (HSR) that has been attributed to naive T-cell responses to neo-antigen generated by the drug. Immunologically confirmed abacavir HSR can manifest clinically in less than 48 hours following first exposure suggesting that, at least in some cases, abacavir HSR is due to re-stimulation of a pre-existing memory T-cell population rather than priming of a high frequency naive T-cell population. Methods To determine whether a pre-existing abacavir reactive memory T-cell population contributes to early abacavir HSR symptoms, we studied the abacavir specific naive or memory T-cell response using HLA-B*57:01 positive HSR patients or healthy controls using ELISpot assay, intra-cellular cytokine staining and tetramer labelling. Results Abacavir reactive CD8+ T-cell responses were detected in vitro in one hundred percent of abacavir unexposed HLA-B*57:01 positive healthy donors. Abacavir-specific CD8+ T cells from such donors can be expanded from sorted memory, and sorted naive, CD8+ T cells without need for autologous CD4+ T cells. Conclusions We propose that these pre-existing abacavir-reactive memory CD8+ T-cell responses must have been primed by earlier exposure to another foreign antigen and that these T cells cross-react with an abacavir-HLA-B*57:01-endogenous peptide ligand complex, in keeping with the model of heterologous immunity proposed in transplant rejection.	[Lucas, Andrew; Lucas, Michaela; Keane, Niamh M.; McKinnon, Elizabeth; Pavlos, Rebecca; Moran, Ellen M.; Meyer-Pannwitt, Viola; Gaudieri, Silvana; D'Orsogna, Lloyd; Mallal, Simon; Phillips, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Strhyn, Anette; Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, Copenhagen, Denmark; [Gaudieri, Silvana] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [D'Orsogna, Lloyd; Mallal, Simon] Royal Perth Hosp & Pathwest, Dept Clin Immunol & Immunogenet, Perth, WA, Australia; [D'Orsogna, Lloyd] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Kalams, Spyros; Mallal, Simon; Phillips, Elizabeth] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA	Murdoch University; University of Copenhagen; University of Western Australia; Royal Perth Hospital; University of Western Australia; Vanderbilt University; State University System of Florida; University of Florida; La Jolla Institute for Immunology	Phillips, E (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	elizabeth.j.phillips@vanderbilt.edu	D'Orsogna, Lloyd/ABE-9573-2021; Mallal, Simon Alexander/HDM-9561-2022; Buus, Soren/F-5446-2010; Pavlos, Rebecca/AAY-9072-2020; Moran, Ellen/H-7722-2019	D'Orsogna, Lloyd/0000-0002-6824-4189; Mallal, Simon Alexander/0000-0002-7036-1309; Pavlos, Rebecca/0000-0002-8884-9855; Moran, Ellen/0000-0002-0743-0770; , Silvana/0000-0001-6873-0198; Lucas, Andrew Douglas/0000-0003-2899-1806; Lucas, Michaela/0000-0001-8881-9990	National Institutes of Health (NIH) [RO1A1103348]; Australian National Health & Medical Research Council [APP1012608]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103348] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (RO1A1103348) and Australian National Health & Medical Research Council (APP1012608). GlaxoSmithKline sponsored the PREDICT-1 study. The funders and sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2012, EUR J IMMUNOL, DOI [10.1002/eji.201270094, DOI 10.1002/EJI.201270094]; Adam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095339; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Britten CM, 2011, CANCER IMMUNOL IMMUN, V60, P15, DOI 10.1007/s00262-010-0940-z; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Flynn K, 1996, IMMUNOL CELL BIOL, V74, P413, DOI 10.1038/icb.1996.71; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; Martin AM, 2007, AIDS, V21, P1233, DOI 10.1097/QAD.0b013e3280119579; Ostrov DA, 2012, P NATL ACAD SCI USA, DOI [10.1073/pnas.1219540110, DOI 10.1073/PNAS.1219540110]; Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb; Phillips EJ, 2002, AIDS, V16, P2223, DOI 10.1097/00002030-200211080-00017; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Schnyder B, 2013, J ALLERGY CLIN IMMUN, V132, P756, DOI 10.1016/j.jaci.2013.04.013; Shear NH, 2008, AIDS, V22, P999, DOI 10.1097/QAD.0b013e3282f7cb60; Zhai Y, 2002, J IMMUNOL, V169, P4667, DOI 10.4049/jimmunol.169.8.4667; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	33	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117160	10.1371/journal.pone.0117160	http://dx.doi.org/10.1371/journal.pone.0117160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674793	Green Published, gold			2022-12-27	WOS:000349914000014
J	Schmidt, B; Beyer, J; Dietrich, D; Bork, I; Liebenberg, V; Fleischhacker, M				Schmidt, Bernd; Beyer, Julia; Dietrich, Dimo; Bork, Ines; Liebenberg, Volker; Fleischhacker, Michael			Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients	PLOS ONE			English	Article							CYFRA 21-1; CHEMOTHERAPY; DIAGNOSIS; METHYLATION; NUCLEOSOMES; PREDICTION; BIOMARKERS; MANAGEMENT; PROGNOSIS; SURVIVAL	Purpose Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. Material and Methods In a pilot study we prospectively enrolled 36 patients with advanced NSCLC and SCLC (34 stage IV, 2 stage IIIB) of whom 34 received standard platinum-based chemo/ radiotherapy and two were treated with a tyrosine kinase inhibitor. We measured the levels of extracellular methylated SHOX2 DNA (mSHOX2) in plasma before and during therapy until restaging. The mSHOX2 analysis was blinded with respect to the clinical data making it an observational study. Results According to the re-staging of 31 first-line patients, 19 patients were classified as nonresponders while 12 patients were in the responder group. We observed a tight correlation between radiological data and the change of plasma mSHOX2 level as the equivalent for a therapy response. A ROC analysis showed a high discriminatory power for both patient groups already one week after therapy start (AUC 0.844). Additionally, a Kaplan-Meier and Cox Proportional Hazards analyses revealed a strong relationship between survival and plasma mSHOX2 value p <= 0.001 (hazard ratio 11.08) providing some evidence for mSHOX2 also being a predictive marker. Conclusion The longitudinal measurement of extracellular plasma mSHOX2 DNA yields information about the response to cytotoxic treatment and allows an early assessment of treatment response for lung cancer patients. If confirmed in a larger study this would be a valuable tool for selecting and guiding a cytotoxic treatment.	[Schmidt, Bernd; Beyer, Julia; Bork, Ines; Fleischhacker, Michael] UKH, Dept Pneumol, Clin Internal Med 1, Halle, Germany; [Dietrich, Dimo] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Liebenberg, Volker] Metan Hlth GmbH, Berlin, Germany	University of Bonn	Fleischhacker, M (corresponding author), UKH, Dept Pneumol, Clin Internal Med 1, Halle, Germany.	michael.fleischhacker@uk-halle.de	Liebenberg, Volker/AAY-7687-2021	Liebenberg, Volker/0000-0003-1936-1247	Kirstin Diehl Stiftung; Metanomics Health GmbH	Kirstin Diehl Stiftung; Metanomics Health GmbH	This work was supported by the Kirstin Diehl Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metanomics Health GmbH provided support in the form of salaries for authors [Volker Liebenberg], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Brunetti G, 1999, LUNG CANCER-J IASLC, V23, P1, DOI 10.1016/S0169-5002(98)00094-4; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cho WCS, 2007, BIOMED PHARMACOTHER, V61, P515, DOI 10.1016/j.biopha.2007.08.005; Darwiche K, 2013, ANN ONCOL, DOI [10.1093/annonc/mdt547, DOI 10.1093/ANNONC/MDT547]; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084225; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Fathi AT, 2008, SEMIN THORAC CARDIOV, V20, P210, DOI 10.1053/j.semtcvs.2008.09.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fleischhacker M, 2013, EXPERT REV RESP MED, V7, P363, DOI 10.1586/17476348.2013.814397; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Hammerschmidt S, 2009, DTSCH ARZTEBL INT, V106, P809, DOI 10.3238/arztebl.2009.0809; Holdenrieder S, 2004, CLIN CANCER RES, V10, P5981, DOI 10.1158/1078-0432.CCR-04-0625; Holdenrieder S, 2006, ANN NY ACAD SCI, V1075, P244, DOI 10.1196/annals.1368.033; Holdenrieder S, 2010, ANTICANCER RES, V30, P1855; Holdenrieder S, 2008, CLIN CANCER RES, V14, P7813, DOI 10.1158/1078-0432.CCR-08-0678; Holdenrieder S, 2009, LUNG CANCER, V63, P128, DOI 10.1016/j.lungcan.2008.05.001; JOHNSON PWM, 1993, BRIT J CANCER, V67, P760, DOI 10.1038/bjc.1993.138; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kratochwil C, 2010, RADIOLOGE, V50, P684, DOI 10.1007/s00117-009-1960-6; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Scheff RJ, 2013, SEMIN INTERVENT RAD, V30, P191, DOI 10.1055/s-0033-1342961; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; SPLINTER TAW, 1989, J CANCER RES CLIN, V115, P400, DOI 10.1007/BF00400971; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Thatcher N, 2010, ONCOLOGIST, V15, P1034, DOI 10.1634/theoncologist.2009-0292; Toffart AC, 2013, LUNG CANCER, DOI [10.1016/j.lungcan.2013.08.029, DOI 10.1016/J.LUNGCAN.2013.08.029]; Varughese S, 2012, AM J MED SCI, V344, P147, DOI 10.1097/MAJ.0b013e318246e1b8; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108	38	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118195	10.1371/journal.pone.0118195	http://dx.doi.org/10.1371/journal.pone.0118195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675432	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000042
J	Castro-Anon, O; de Llano, LAP; Sanchez, SD; Golpe, R; Marote, LM; Castro-Castro, J; Quintela, AG				Castro-Anon, Olalla; Perez de Llano, Luis A.; De la Fuente Sanchez, Sandra; Golpe, Rafael; Mendez Marote, Lidia; Castro-Castro, Julian; Gonzalez Quintela, Arturo			Obesity-Hypoventilation Syndrome: Increased Risk of Death over Sleep Apnea Syndrome	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; CARDIAC-FUNCTION; OXYGEN-THERAPY; PREVALENCE; MORTALITY; TERM	Aim To study whether mortality and cardiovascular morbidity differ in non-invasive ventilation (NIV)-treated patients with severe obesity-hypoventilation syndrome (OHS) as compared with CPAP-treated patients with obstructive sleep apnea syndrome (OSAS), and to identify independent predictors of mortality in OHS. Material and methods Two retrospective cohorts of OHS and OSAS were matched 1: 2 according to sex, age (+/- 10 year) and length of time since initiation of CPAP/NIV therapy (+/- 6 months). Results Three hundred and thirty subjects (110 patients with OHS and 220 patients with OSAS) were studied. Mean follow-up time was 7 +/- 4 years. The five yearmortality rates were 15.5% in OHS cohort and 4.5% in OSAS cohort (p < 0.05). Patients with OHS had a 2-fold increase (OR 2; 95% CI: 1.11-3.60) in the risk of mortality and 1.86 fold (OR 1.86; 95% CI: 1.14-3.04) increased risk of having a cardiovascular event. Diabetes, baseline diurnal SaO(2) < 83%, EPAP < 7 cmH2O after titration and adherence to NIV < 4 hours independently predicted mortality in OHS. Conclusion Mortality of severe OHS is high and substantially worse than that of OSAS. Severe OHS should be considered a systemic disease that encompasses respiratory, metabolic and cardiovascular components that require a multimodal therapeutic approach.	[Castro-Anon, Olalla; Perez de Llano, Luis A.; Golpe, Rafael; Mendez Marote, Lidia] Lucus Augusti Univ Hosp, Galician Hlth Serv, Div Resp, Lugo, Spain; [Castro-Anon, Olalla; Perez de Llano, Luis A.; Golpe, Rafael; Mendez Marote, Lidia] Lucus Augusti Univ Hosp, Galician Hlth Serv, Sleep Disorders Unit, Lugo, Spain; [De la Fuente Sanchez, Sandra] Lucus Augusti Univ Hosp, Galician Hlth Serv, Lugo, Spain; [Castro-Castro, Julian] Galician Hlth Serv, Lugo, Spain; [Gonzalez Quintela, Arturo] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Universidade de Santiago de Compostela	Castro-Anon, O (corresponding author), Lucus Augusti Univ Hosp, Galician Hlth Serv, Div Resp, Lugo, Spain.	Olalla.Castro.Anon@sergas.es	Golpe, Rafael/AAA-4736-2019; Castro-Añón, Olalla/AAG-2018-2021; Sánchez, Susana/HII-3113-2022	Golpe, Rafael/0000-0002-3759-5322; Castro-Añón, Olalla/0000-0003-0121-5639; 				Bandyopadhyay T, 2004, CHEST, V125, P352, DOI 10.1378/chest.125.1.352; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Borel JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006733; Budweiser S, 2007, J INTERN MED, V261, P375, DOI 10.1111/j.1365-2796.2007.01765.x; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; de Llano LAP, 2008, RESPIRATION, V75, P34, DOI 10.1159/000105460; Galimberti S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-16; GRACE MP, 1982, CRIT CARE MED, V10, P358, DOI 10.1097/00003246-198206000-00002; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lacalzada CC, 2008, EUR RESPIR J, V32, P817, DOI 10.1183/09031936.00059508; Littleton SW, 2009, CLIN CHEST MED, V30, P467, DOI 10.1016/j.ccm.2009.05.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Pepin JL, 2005, REV MAL RESPIR, V22, P113, DOI 10.1016/S0761-8425(05)85442-7; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabec CA, 2002, CHEST, V122, P1498, DOI 10.1378/chest.122.4.1498; RANKIN JS, 1982, CIRCULATION, V66, P108, DOI 10.1161/01.CIR.66.1.108; Rechtschaffen A, 1968, NIH PUBLICATION; SCHOENFELD DA, 1987, BIOMETRIKA, V74, P167, DOI 10.2307/2336031; Toyama T, 2009, CIRC J, V73, P299, DOI 10.1253/circj.CJ-07-0297; Trakada GP, 2010, SLEEP BREATH, V14, P381, DOI 10.1007/s11325-010-0360-5; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	28	97	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117808	10.1371/journal.pone.0117808	http://dx.doi.org/10.1371/journal.pone.0117808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671545	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300072
J	Faron, J; Bernas, T; Sas-Nowosielska, H; Klag, J				Faron, Justyna; Bernas, Tytus; Sas-Nowosielska, Hanna; Klag, Jerzy			Analysis of the Behavior of Mitochondria in the Ovaries of the Earthworm Dendrobaena veneta Rosa 1839	PLOS ONE			English	Article							CYTOCHROME-OXIDASE ACTIVITY; CONFOCAL MICROSCOPY; STEREOLOGICAL ANALYSIS; RAPID SEGREGATION; OOCYTE MATURATION; GERM-LINE; EMBRYO; MOUSE; DNA; OOGENESIS	We examined six types of cells that form the ovary of the earthworm Dendrobena veneta ogonia, prooocytes, vitellogenic oocytes, trophocytes, fully grown postvitellogenic oocytes and somatic cells of the gonad. The quantitative stereological method revealed a much higher "volume density" of mitochondria in all of the types of germ-line cells except for the somatic cells. Fluorescent vital stain JC-1, however, showed a much higher oxidative activity of mitochondria in the somatic cells than in the germ-line cells. The distribution of active and inactive mitochondria within the studied cells was assessed using the computer program ImageJ. The analysis showed a higher luminosity of inactive mitochondria in all of the types of germ-line cells and a higher luminosity of active mitochondria in somatic cells. The OXPHOS activity was found in somatic cells mitochondria and in the peripheral mitochondria of the vitellogenic oocytes. The detection of reactive oxygen species (ROS) revealed a differentiated distribution of ROS in the different cell types. The amount of ROS substances was lower in somatic cells than in younger germ-line cells. The ROS level was also low in the cytoplasm of fully grown postwitellogenic oocytes. The distribution of the MnSOD enzyme that protects mitochondria against destructive role of ROS substances was high in the oogonia and in prooocytes and it was very high in vitellogenic and postvitellogenic oocytes. However, a much lower level of this protective enzyme was observed in the trophocytes and the lowest level was found in the cytoplasm of somatic cells. The lower mitochondrial activity and higher level of MnSOD activity in germ-line cells when compared to somatic cells testifies to the necessity of the organisms to protect the mitochondria of oocytes against the destructive role of the ROS that are produced during oxidative phosphorylation. The protection of the mitochondria in oocytes is essential for the transfer of healthy organelles to the next generation.	[Faron, Justyna; Klag, Jerzy] Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland; [Bernas, Tytus; Sas-Nowosielska, Hanna] Nencki Inst Expt Biol, Lab Imaging Tissue Struct & Funct, Warsaw, Poland	University of Silesia in Katowice; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Klag, J (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland.	jerzy.klag@us.edu.pl	Bernas, Tytus/P-2385-2016; Sas-Nowosielska, Hanna/V-6338-2018	Bernas, Tytus/0000-0003-0841-5940; Faron, Justyna/0000-0001-9551-5602; Sas-Nowosielska, Hanna/0000-0001-6736-9740	Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland	Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland	This research was financed by the Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; AKIYAMA T, 1992, DEVELOPMENT, V115, P1175; Allen CA, 2007, ORIGIN OF MITOCHONDR; Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089; [Anonymous], 1979, STEREOLOGICAL METHOD; Bergstrom CT, 1998, GENETICS, V149, P2135; BRINSTER RL, 1977, EXP CELL RES, V109, P111, DOI 10.1016/0014-4827(77)90050-7; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Callebaut M, 2008, BELG J ZOOL, V138, P20; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Cossarizza A, 1998, PURDUE CYTOMETRY CD, V4; Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/ror.0.0030172; De la Iglesia F. A, 1981, TOXICOL PATHOL, V9, P21; Delesse A., 1847, CR HEBD ACAD SCI, V25, P544; DEPAZ P, 1986, HISTOL HISTOPATHOL, V1, P197; DHERDE K, 1995, REPROD NUTR DEV, V35, P305, DOI 10.1051/rnd:19950306; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5; Fernandez-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Gomes IC, 2002, TISSUE CELL, V34, P177, DOI 10.1016/S0040-8166(02)00029-0; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kasashima Katsumi, 2014, Reproductive Medicine and Biology, V13, P11, DOI 10.1007/s12522-013-0162-0; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; KOWALD A, 1994, J THEOR BIOL, V168, P75, DOI 10.1006/jtbi.1994.1089; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745; Luo J, 2001, MANGANESE SUPEROXIDE, P1; MARINOS E, 1981, J EMBRYOL EXP MORPH, V62, P395; MARINOS E, 1978, J HISTOCHEM CYTOCHEM, V26, P658, DOI 10.1177/26.8.211159; MAYORDOMO F, 1992, INT J DEV BIOL, V36, P311; MIGNOTTE F, 1987, BIOL CELL, V60, P97, DOI 10.1111/j.1768-322X.1987.tb00549.x; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Morici G, 2007, J MICROSC-OXFORD, V228, P165, DOI 10.1111/j.1365-2818.2007.01860.x; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Moyes CD, 1998, J EXP BIOL, V201, P299; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET; Pathi B, 2012, J EXP BIOL, V215, P1871, DOI 10.1242/jeb.067207; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Persson U, 2003, EVOLUTIONARY ECOLOGY, P1; Piccoli C, 2004, CURRENT ISSUES MULTI, P130; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Romek M, 2005, FOLIA HISTOCHEM CYTO, V43, P57; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229; Siekierska E, 2003, TISSUE CELL, V35, P252, DOI 10.1016/S0040-8166(03)00038-7; Skulachev VP, BIOSCIENCE REPORTS, V17, P347; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sundberg MD, 1992, TESTED STUDIES FOR L, V6, P51; Suzuki H., 2005, J MAMM OVA RES, V22, P163; Swiatek P, 2004, CAN J ZOOL, V82, P714, DOI 10.1139/Z04-040; Swiatek P, 2001, FOLIA BIOL-KRAKOW, V49, P85; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; TOURMENTE S, 1990, BIOL CELL, V68, P119, DOI 10.1016/0248-4900(90)90296-F; TOURTE M, 1984, EUR J CELL BIOL, V34, P171; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2003, HUM REPROD, V18, P2429, DOI 10.1093/humrep/deg466; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Van Blerkom J, 2006, REPRODUCTION, V131, P961, DOI 10.1530/rep.1.00458; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Weibel E., 1980, STEREOLOGICAL METHOD; Wilding M, 2001, ZYGOTE, V9, P347, DOI 10.1017/S096719940100140X; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wilding M, 2009, REPRODUCTION, V137, P619, DOI 10.1530/REP-08-0444; Wolff JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020522; Zhang HJ, 2004, MNSOD A SPECIAL ENZY; Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI [10.1111/j.1440-169x.2008.00988.x, 10.1111/j.1440-169X.2008.00988.x]	81	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117187	10.1371/journal.pone.0117187	http://dx.doi.org/10.1371/journal.pone.0117187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671521	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300040
J	Greenberg, JA; Santos, MJ; Dobrowski, SZ; Vanderbilt, VC; Ustin, SL				Greenberg, Jonathan A.; Santos, Maria J.; Dobrowski, Solomon Z.; Vanderbilt, Vern C.; Ustin, Susan L.			Quantifying Environmental Limiting Factors on Tree Cover Using Geospatial Data	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; REGRESSION; ECOSYSTEMS; ABUNDANCE; DENSITY	Environmental limiting factors (ELFs) are the thresholds that determine the maximum or minimum biological response for a given suite of environmental conditions. We asked the following questions: 1) Can we detect ELFs on percent tree cover across the eastern slopes of the Lake Tahoe Basin, NV? 2) How are the ELFs distributed spatially? 3) To what extent are unmeasured environmental factors limiting tree cover? ELFs are difficult to quantify as they require significant sample sizes. We addressed this by using geospatial data over a relatively large spatial extent, where the wall-to-wall sampling ensures the inclusion of rare data points which define the minimum or maximum response to environmental factors. We tested mean temperature, minimum temperature, potential evapotranspiration (PET) and PET minus precipitation (PET-P) as potential limiting factors on percent tree cover. We found that the study area showed system-wide limitations on tree cover, and each of the factors showed evidence of being limiting on tree cover. However, only 1.2% of the total area appeared to be limited by the four (4) environmental factors, suggesting other unmeasured factors are limiting much of the tree cover in the study area. Where sites were near their theoretical maximum, non-forest sites (tree cover <25%) were primarily limited by coldmean temperatures, open-canopy forest sites (tree cover between 25% and 60%) were primarily limited by evaporative demand, and closed-canopy forests were not limited by any particular environmental factor. The detection of ELFs is necessary in order to fully understand the width of limitations that species experience within their geographic range.	[Greenberg, Jonathan A.] Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA; [Santos, Maria J.] Univ Utrecht, Dept Innovat Environm & Energy Sci, Utrecht, Netherlands; [Dobrowski, Solomon Z.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Vanderbilt, Vern C.] NASA, Ames Res Ctr, Mountain View, CA USA; [Ustin, Susan L.] Univ Calif Davis, CSTARS, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; Utrecht University; University of Montana System; University of Montana; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Davis	Greenberg, JA (corresponding author), Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA.	jgm@illinois.edu	Dobrowski, Solomon Z/Q-7132-2019; Santos, Maria Joao/M-5034-2013	Dobrowski, Solomon Z/0000-0003-2561-3850; Greenberg, Jonathan/0000-0001-8435-9077; Santos, Maria Joao/0000-0002-6558-7477; Ustin, Susan/0000-0001-8551-0461				Allen R. G., 1998, FAO Irrigation and Drainage Paper; Belyea LR, 2007, HYDROL PROCESS, V21, P675, DOI 10.1002/hyp.6275; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Cade BS, 2000, OIKOS, V91, P245, DOI 10.1034/j.1600-0706.2000.910205.x; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dobrowski SZ, 2009, AGR FOREST METEOROL, V149, P1751, DOI 10.1016/j.agrformet.2009.06.006; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Forthofer J. M., 2007, THESIS; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Greenberg JA, 2009, REMOTE SENS ENVIRON, V113, P94, DOI 10.1016/j.rse.2008.08.014; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Heinsch FA, 2003, USERS GUIDE GPP NPP, V2, P666; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Husch B., 2002, FOREST MENSURATION; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Knyazikhin Y., 1999, MODIS ATBD; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Lancaster J, 2006, FRESHWATER BIOL, V51, P783, DOI 10.1111/j.1365-2427.2006.01518.x; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; MALLER RA, 1990, J CONSEIL, V46, P140; McKenzie D, 2003, J BIOGEOGR, V30, P1093, DOI 10.1046/j.1365-2699.2003.00921.x; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sprengel C., 1828, J TECNISCHE OKONOMIS, V2, P423; Taylor AH, 2004, ECOL APPL, V14, P1903, DOI 10.1890/02-5257; Urban DL, 2000, LANDSCAPE ECOL, V15, P603, DOI 10.1023/A:1008183331604; Vaz S, 2008, J APPL ECOL, V45, P204, DOI 10.1111/j.1365-2664.2007.01392.x; Vegetation Subcommittee Federal Geographic Data Committee, 1997, FGDCSTD005 US GEOL S; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Zeng ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01951	35	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0114648	10.1371/journal.pone.0114648	http://dx.doi.org/10.1371/journal.pone.0114648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692604	Green Published, gold			2022-12-27	WOS:000350061500006
J	Kim, CT; Lim, YH; Woodward, A; Kim, H				Kim, Clara T.; Lim, Youn-Hee; Woodward, Alistair; Kim, Ho			Heat-Attributable Deaths between 1992 and 2009 in Seoul, South Korea	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; AMBIENT-TEMPERATURE; CLIMATE-CHANGE; AIR-POLLUTION; UNITED-STATES; HEALTH; WAVES; ASSOCIATIONS; WEATHER; DISEASE	Background Climate change may significantly affect human health. The possible effects of high ambient temperature must be better understood, particularly in terms of certain diseases' sensitivity to heat (as reflected in relative risks [RR]) and the consequent disease burden (number or fraction of cases attributable to high temperatures), in order to manage the threat. Purpose This study investigated the number of deaths attributable to abnormally high ambient temperatures in Seoul, South Korea, for a wide range of diseases. Method The relationship between mortality and daily maximum temperature using a generalized linear model was analyzed. The threshold temperature was defined as the 90th percentile of maximum daily temperatures. Deaths were classified according to ICD-10 codes, and for each disease, the RR and attributable fractions were determined. Using these fractions, the total number of deaths attributable to daily maximum temperatures above the threshold value, from 1992 to 2009, was calculated. Data analyses were conducted in 2012-2013. Results Heat-attributable deaths accounted for 3,177 of the 271,633 deaths from all causes. Neurological (RR 1.07; 95% CI, 1.04-1.11) and mental and behavioral disorders (RR 1.04; 95% CI, 1.01-1.07) had relatively high increases in the RR of mortality. The most heat-sensitive diseases (those with the highest RRs) were not the diseases that caused the largest number of deaths attributable to high temperatures. Conclusion This study estimated RRs and deaths attributable to high ambient temperature for a wide variety of diseases. Prevention-related policies must account for both particular vulnerabilities (heat-sensitive diseases with high RRs) and the major causes of the heat mortality burden (common conditions less sensitive to high temperatures).	[Kim, Clara T.; Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Kim, Clara T.; Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul, South Korea; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Auckland	Kim, H (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr	Kim, Ho/AAS-2402-2021	Kim, Ho/0000-0001-7472-3752; Lim, Youn-Hee/0000-0002-1290-5814; Kim, Clara Tammy/0000-0001-7381-7044; Woodward, Alistair/0000-0001-5425-6018	Basic Science Research Program [2010-0009581]; Global Research Lab [K21004000001-10A0500-00710]; Women Scientist Research Program [2012R1A1A3005549]; International Research & Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012K1A3A1A12054839]	Basic Science Research Program; Global Research Lab; Women Scientist Research Program; International Research & Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by the Basic Science Research Program (#2010-0009581), Global Research Lab (#K21004000001-10A0500-00710), Women Scientist Research Program (#2012R1A1A3005549) and International Research & Development Program (#2012K1A3A1A12054839) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Campbell-Lendrum D, 2006, ENVIRON HEALTH PERSP, V114, P1935, DOI 10.1289/ehp.8432; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Dominici F, 2003, INT STAT REV, V71, P243; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Gosling SN, 2009, CLIMATIC CHANGE, V92, P299, DOI [10.1007/s10584-008-9441-x, 10.1007/S10584-008-9441-X]; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Honda Yasushi, 2007, Environmental Health and Preventive Medicine, V12, P209, DOI 10.1265/ehpm.12.209; Hung T, 2006, INT J APPL EARTH OBS, V8, P34, DOI 10.1016/j.jag.2005.05.003; Kilbourne EM, 1999, AM J PREV MED, V16, P359; Koppe C., 2004, HEAT WAVES RISKS RES; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; LAU KM, 1984, B AM METEOROL SOC, V65, P114, DOI 10.1175/1520-0477(1984)065<0114:TMOEAA>2.0.CO;2; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; MacCullagh P., 1989, GEN LINEAR MODELS; Mathers C, 2009, GLOB HLTH RISKS MORT; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Parry M. L., 2007, CLIMATE CHANGE 2007; Pascal M, 2013, INT J BIOMETEOROL, V57, P21, DOI 10.1007/s00484-012-0530-1; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Semenza JC, 1999, AM J PREV MED, V17, P97; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Stollberger C, 2009, EUR J NEUROL, V16, P879, DOI 10.1111/j.1468-1331.2009.02581.x; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; ULM K, 1991, STAT MED, V10, P341, DOI 10.1002/sim.4780100306; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Yaqub B, 1998, J NEUROL SCI, V156, P144, DOI 10.1016/S0022-510X(98)00037-9; Yoon S.J., 2010, KOREAN CLIMATE CHANG; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d	56	22	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118577	10.1371/journal.pone.0118577	http://dx.doi.org/10.1371/journal.pone.0118577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692296	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500124
J	Takamiya, M; Weger, BD; Schindler, S; Beil, T; Yang, LX; Armant, O; Ferg, M; Schlunck, G; Reinhard, T; Dickmeis, T; Rastegar, S; Strahle, U				Takamiya, Masanari; Weger, Benjamin D.; Schindler, Simone; Beil, Tanja; Yang, Lixin; Armant, Olivier; Ferg, Marco; Schlunck, Guenther; Reinhard, Thomas; Dickmeis, Thomas; Rastegar, Sepand; Straehle, Uwe			Molecular Description of Eye Defects in the Zebrafish Pax6b Mutant, sunrise, Reveals a Pax6b-Dependent Genetic Network in the Developing Anterior Chamber	PLOS ONE			English	Article							SCALE DEVELOPMENT; PHOTORECEPTOR DEGENERATION; MOUSE MODEL; EXPRESSION; MUTATIONS; CORNEA; LENS; SEGMENT; ONSET; DYSTROPHY	The cornea is a central component of the camera eye of vertebrates and even slight corneal disturbances severely affect vision. The transcription factor PAX6 is required for normal eye development, namely the proper separation of the lens from the developing cornea and the formation of the iris and anterior chamber. Human PAX6 mutations are associated with severe ocular disorders such as aniridia, Peters anomaly and chronic limbal stem cell insufficiency. To develop the zebrafish as a model for corneal disease, we first performed transcriptome and in situ expression analysis to identify marker genes to characterise the cornea in normal and pathological conditions. We show that, at 7 days post fertilisation (dpf), the zebrafish cornea expresses the majority of marker genes (67/84 tested genes) found also expressed in the cornea of juvenile and adult stages. We also characterised homozygous pax6b mutants. Mutant embryos have a thick cornea, iris hypoplasia, a shallow anterior chamber and a small lens. Ultrastructure analysis revealed a disrupted corneal endothelium. pax6b mutants show loss of corneal epithelial gene expression including regulatory genes (sox3, tfap2a, foxc1a and pitx2). In contrast, several genes (pitx2, ctnnb2, dcn and fabp7a) were ectopically expressed in the malformed corneal endothelium. Lack of pax6b function leads to severe disturbance of the corneal gene regulatory programme.	[Takamiya, Masanari; Weger, Benjamin D.; Schindler, Simone; Beil, Tanja; Yang, Lixin; Armant, Olivier; Ferg, Marco; Dickmeis, Thomas; Rastegar, Sepand; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Schlunck, Guenther; Reinhard, Thomas] Univ Freiburg, Med Ctr, Ctr Eye, D-79106 Freiburg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Freiburg	Strahle, U (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Postfach 3640, D-76021 Karlsruhe, Germany.	uwe.straehle@kit.edu	Straehle, Uwe/K-7054-2013; yang, lixin/AAW-5386-2021; Rastegar, Sepand/E-2324-2015; yang, lixin/GSO-1670-2022; Weger, Benjamin D/AAG-7551-2019; Dickmeis, Thomas/H-1355-2013	yang, lixin/0000-0003-3377-1998; Rastegar, Sepand/0000-0003-4411-5646; yang, lixin/0000-0003-3377-1998; Weger, Benjamin D/0000-0002-1831-3561; armant, olivier/0000-0001-7101-9209; Takamiya, Masanari/0000-0002-6524-5813; Schindler, Simone/0000-0003-1028-3115	Helmholtz Association; European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme) [LSHG-CT-2003-503496]; European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium" [LSHG-CT-2006-037445]; European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme) [FP7-HEALTH-2009-2-STAGE]	Helmholtz Association(Helmholtz Association); European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme); European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium"; European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme)	US was funded by the Helmholtz Association; the European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme), LSHG-CT-2003-503496; the European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium" LSHG-CT-2006-037445; and the European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme), FP7-HEALTH-2009-2-STAGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Armant O, 2013, DEV BIOL, V380, P351, DOI 10.1016/j.ydbio.2013.05.006; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Bischoff AMLC, 2007, AM J OPHTHALMOL, V143, P847, DOI 10.1016/j.ajo.2007.01.037; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063674; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Dai CY, 2012, MOL VIS, V18, P2947; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Diehn JJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r74; Gibson DJ, 2014, INVEST OPHTH VIS SCI, V55, P2062, DOI 10.1167/iovs.13-12735; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Gross JV, 2008, MOL REPROD DEV, V75, P547, DOI 10.1002/mrd.20831; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Heur M, 2013, EXP EYE RES, V106, P1, DOI 10.1016/j.exer.2012.10.009; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Jia SJ, 2007, FASEB J, V21, P3318, DOI 10.1096/fj.07-8172com; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Jurkunas UV, 2008, INVEST OPHTH VIS SCI, V49, P2946, DOI 10.1167/iovs.07-1405; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095037; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Ledee DR, 2004, MOL VIS, V10, P663; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; NISHIDA K, 1995, AM J OPHTHALMOL, V120, P368, DOI 10.1016/S0002-9394(14)72167-1; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Reneker LW, 2000, DEVELOPMENT, V127, P533; Rezende RA, 2004, CORNEA, V23, P565, DOI 10.1097/01.ico.0000126317.90271.d8; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Silla ZTV, 2014, EXP CELL RES, V322, P381, DOI 10.1016/j.yexcr.2014.01.016; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; Sire JY, 1997, J ANAT, V190, P545, DOI 10.1046/j.1469-7580.1997.19040545.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013743; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Stewart HS, 1999, HUM MUTAT, V14, P126, DOI 10.1002/(SICI)1098-1004(1999)14:2<126::AID-HUMU4>3.0.CO;2-W; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thomas AG, 2014, DEV BIOL, V386, P291, DOI 10.1016/j.ydbio.2013.12.036; TON CCT, 1992, GENOMICS, V13, P251, DOI 10.1016/0888-7543(92)90239-O; Tzoulaki I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-27; Wasfy MM, 2014, EXP EYE RES, V122, P65, DOI 10.1016/j.exer.2014.03.007; WATERMAN RE, 1970, ANAT REC, V168, P361, DOI 10.1002/ar.1091680304; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhai JJ, 2014, EXP THER MED, V7, P791, DOI 10.3892/etm.2014.1530; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611	63	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117645	10.1371/journal.pone.0117645	http://dx.doi.org/10.1371/journal.pone.0117645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692557	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500066
J	Xu, KZ; Li, FC; Ma, L; Wang, BB; Zhang, H; Ni, M; Hong, FS; Shen, WD; Li, B				Xu, Kaizun; Li, Fanchi; Ma, Lie; Wang, Binbin; Zhang, Hua; Ni, Min; Hong, Fashui; Shen, Weide; Li, Bing			Mechanism of Enhanced Bombyx mori Nucleopolyhedrovirus-Resistance by Titanium Dioxide Nanoparticles in Silkworm	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; NATURAL ORGANIC-MATTER; PROTEIN-KINASE B; MOLECULAR-MECHANISMS; GENE-EXPRESSION; ANATASE TIO2; GLAND DAMAGE; INFECTION; TOXICITY; ACTIVATION	The infection of Bombyx mori nucleopolyhedrovirus (BmNPV) in silkworms is often lethal. It is difficult to prevent, and its lethality is correlated with both viral particle characteristics and silkworm strains. Low doses of titanium dioxide nanoparticles (TiO2 NPs) can promote silkworm growth and improve its resistance to organophosphate pesticides. In this study, TiO2 NPs' effect on BmNPV resistance was investigated by analyzing the characteristics of BmNPV proliferation and transcriptional differences in silkworm midgut and the transcriptional changes of immunity related genes after feeding with TiO2 NPs. We found that low doses of TiO2 NPs improved the resistance of silkworm against BmNPV by 14.88-fold, with the mortalities of the experimental group and control group being 0.56% and 8.33% at 144 h, respectively. The proliferation of BmNPV in the midgut was significantly increased 72 h after infection in both experimental and control groups; the control group reached the peak at 120 h, while the experimental group took 24 more hours to reach the maximal value that was 12.63 times lower than the control, indicating that TiO2 NPs can inhibit BmNPV proliferation in the midgut. Consistently, the expression of the BmNPV-resistant gene Bmlipase-1 had the same increase pattern as the proliferation changes. Immune signaling pathway analysis revealed that TiO2 NPs inhibited the proliferation of silkworm BmNPV to reduce the activation levels of janus kinase/signal transducer and activator of transcription (JAK/STAT) and phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway, while promoting the expression of Bmakt to improve the immunity. Overall, our results demonstrate that TiO2 NPs increase silkworm resistance against BmNPV by inhibiting virus proliferation and improving immunity in silkworms.	[Xu, Kaizun; Li, Fanchi; Ma, Lie; Wang, Binbin; Zhang, Hua; Ni, Min; Hong, Fashui; Shen, Weide; Li, Bing] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou 215123, Jiangsu, Peoples R China; [Shen, Weide; Li, Bing] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, WD (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Suzhou 215123, Jiangsu, Peoples R China.	shenwd@suda.edu.cn; lib@suda.edu.cn	li, bing/GWQ-9617-2022		National High Technology Research and Development Program of China (863 Program) [2013AA102507]; State Key Laboratory of Silkworm Genome Biology; transformation project of agriculture scientific and technological achievements [2013GB2C100180]; Doctoral Fund of Ministry of Education of China [20113201110008]; China Agriculture Research System [CARS-22-ZJ0305]; Science & Technology support Program of Suzhou [ZXS2012005, SYN201406]; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory of Silkworm Genome Biology; transformation project of agriculture scientific and technological achievements; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Agriculture Research System; Science & Technology support Program of Suzhou; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions	The National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA102507) and the State Key Laboratory of Silkworm Genome Biology supported the reagents and version cost, the transformation project of agriculture scientific and technological achievements (2013GB2C100180), the projects sponsored by the national cocoons silk development funds in 2014 and the Priority Academic Program Development of Jiangsu Higher Education Institutions supported materials (silkworm and BmNPV), the Doctoral Fund of Ministry of Education of China (20113201110008), the China Agriculture Research System (CARS-22-ZJ0305), and the Science & Technology support Program of Suzhou (ZXS2012005, SYN201406) supported the cost of sequencing and version. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Cho M, 2004, WATER RES, V38, P1069, DOI 10.1016/j.watres.2003.10.029; Das S, 2013, APPL MICROBIOL BIOT, V97, P6019, DOI 10.1007/s00253-013-4868-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; ENGELHARD EK, 1994, P NATL ACAD SCI USA, V91, P3224, DOI 10.1073/pnas.91.8.3224; Esterkin CR, 2005, AICHE J, V51, P2298, DOI 10.1002/aic.10472; Gao FQ, 2006, BIOL TRACE ELEM RES, V111, P239, DOI 10.1385/BTER:111:1:239; Gelis C, 2003, PHOTODERMATOL PHOTO, V19, P242, DOI 10.1034/j.1600-0781.2003.00045.x; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; HUGHES DS, 1993, VIROLOGY, V194, P608, DOI 10.1006/viro.1993.1300; Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2013, ANTIVIR RES, V98, P171, DOI 10.1016/j.antiviral.2013.02.015; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Li B, 2014, CHEMOSPHERE, V104, P221, DOI 10.1016/j.chemosphere.2013.11.030; Li B, 2013, J AGR FOOD CHEM, V61, P12238, DOI 10.1021/jf4039259; Li B, 2012, BIOL TRACE ELEM RES, V150, P221, DOI 10.1007/s12011-012-9507-5; Li B, 2012, CHEMOSPHERE, V89, P609, DOI 10.1016/j.chemosphere.2012.05.061; Li B, 2010, AFR J BIOTECHNOL, V9, P1771; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Peng GD, 2011, PESTIC BIOCHEM PHYS, V101, P154, DOI 10.1016/j.pestbp.2011.08.010; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Qin LG, 2012, J PROTEOMICS, V75, P3630, DOI 10.1016/j.jprot.2012.04.015; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Saeedi R, 2012, ENVIRON ENG SCI, V29, P93, DOI 10.1089/ees.2011.0077; Su JJ, 2014, ENVIRON TOXICOL, V29, P1355, DOI 10.1002/tox.21866; Sun D, 2004, WATER SCI TECHNOL, V49, P103, DOI 10.2166/wst.2004.0030; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Xu JP, 2005, J APPL ENTOMOL, V129, P425, DOI 10.1111/j.1439-0418.2005.00995.x; Xu JP, 2005, J APPL ENTOMOL, V129, P27, DOI 10.1111/j.1439-0418.2005.00923.x; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3; Yeh MS, 2008, DEV COMP IMMUNOL, V32, P814, DOI 10.1016/j.dci.2007.12.001; Zhang H, 2014, BIOL TRACE ELEM RES, V159, P224, DOI 10.1007/s12011-014-9986-7; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	46	12	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118222	10.1371/journal.pone.0118222	http://dx.doi.org/10.1371/journal.pone.0118222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692869	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500109
J	Zhao, ZG; Wang, YK				Zhao, Zhi-Gang; Wang, Yi-Ke			Selection by Pollinators on Floral Traits in Generalized Trollius ranunculoides (Ranunculaceae) along Altitudinal Gradients	PLOS ONE			English	Article							FLOWER SIZE; MEDIATED SELECTION; GEOGRAPHICAL VARIATION; REPRODUCTIVE TRAITS; POLEMONIUM-VISCOSUM; POLLEN LIMITATION; SPATIAL VARIATION; NICOTIANA-GLAUCA; VISITATION RATES; ECOLOGY	Abundance and visitation of pollinator assemblages tend to decrease with altitude, leading to an increase in pollen limitation. Thus increased competition for pollinators may generate stronger selection on attractive traits of flowers at high elevations and cause floral adaptive evolution. Few studies have related geographically variable selection from pollinators and intraspecific floral differentiation. We investigated the variation of Trollius ranunculoides flowers and its pollinators along an altitudinal gradient on the eastern Qinghai-Tibet Plateau, and measured phenotypic selection by pollinators on floral traits across populations. The results showed significant decline of visitation rate of bees along altitudinal gradients, while flies was unchanged. When fitness is estimated by the visitation rate rather than the seed number per plant, phenotypic selection on the sepal length and width shows a significant correlation between the selection strength and the altitude, with stronger selection at higher altitudes. However, significant decreases in the sepal length and width of Trollius ranunculoides along the altitudinal gradient did not correspond to stronger selection of pollinators. In contrast to the pollinator visitation, mean annual precipitation negatively affected the sepal length and width, and contributed more to geographical variation in measured floral traits than the visitation rate of pollinators. Therefore, the sepal size may have been influenced by conflicting selection pressures from biotic and abiotic selective agents. This study supports the hypothesis that lower pollinator availability at high altitude can intensify selection on flower attractive traits, but abiotic selection is preventing a response to selection from pollinators.	[Zhao, Zhi-Gang; Wang, Yi-Ke] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Zhao, ZG (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	zhaozhg@lzu.edu.cn	Zhao, Zhigang/ABE-4982-2021	Zhao, Zhigang/0000-0002-5252-4813	National Natural Science Foundation of China [30900162, 31370402]; Fundamental Research Funds for the Central Universities [lzujbky-2013-102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30900162 and 31370402 to ZGZ) and the Fundamental Research Funds for the Central Universities (lzujbky-2013-102 to ZGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner PA, 2005, FUNCT ECOL, V19, P681, DOI 10.1111/j.1365-2435.2005.01009.x; Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Blionis GJ, 2001, ECOGRAPHY, V24, P287, DOI 10.1034/j.1600-0587.2001.240306.x; Boyd A, 2002, SYST BOT, V27, P116; Campbell DR, 2004, NEW PHYTOL, V161, P83, DOI 10.1046/j.1469-8137.2003.00919.x; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Caruso CM, 2000, EVOLUTION, V54, P1546, DOI 10.1111/j.0014-3820.2000.tb00700.x; Chalcoff VR, 2008, ANN BOT-LONDON, V102, P79, DOI 10.1093/aob/mcn057; Cosacov A, 2014, ANN BOT-LONDON, V113, P251, DOI 10.1093/aob/mct239; Dilley JD, 2000, OIKOS, V89, P209, DOI 10.1034/j.1600-0706.2000.890201.x; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; FAEGRI K, 1979, P244; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fulkerson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032790; GALEN C, 1987, EVOLUTION, V41, P599, DOI 10.2307/2409261; Galen C, 1999, BIOSCIENCE, V49, P631, DOI 10.2307/1313439; GALEN C, 1989, EVOLUTION, V43, P882, DOI 10.1111/j.1558-5646.1989.tb05185.x; Galen C, 1999, OECOLOGIA, V118, P461, DOI 10.1007/s004420050749; Galen C, 1996, EVOLUTION, V50, P120, DOI 10.1111/j.1558-5646.1996.tb04478.x; GALEN C, 1985, ECOLOGY, V66, P792, DOI 10.2307/1940540; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Herrera J, 2005, ANN BOT-LONDON, V95, P431, DOI 10.1093/aob/mci041; Herrera J, 2009, ANN BOT-LONDON, V103, P1119, DOI 10.1093/aob/mcp046; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kimball S, 2008, OIKOS, V117, P1064, DOI 10.1111/j.0030-1299.2008.16573.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Kudo Gaku, 1999, Plant Species Biology, V14, P181, DOI 10.1046/j.1442-1984.1999.00012.x; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambrecht SC, 2013, INT J PLANT SCI, V174, P74, DOI 10.1086/668230; Maad J, 2013, NORD J BOT, V31, P361, DOI 10.1111/j.1756-1051.2013.01766.x; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; Medel R, 2007, ECOGRAPHY, V30, P812, DOI 10.1111/j.2007.0906-7590.05175.x; Moeller DA, 2006, ECOLOGY, V87, P1510, DOI 10.1890/0012-9658(2006)87[1510:GSOPCR]2.0.CO;2; Moeller DA, 2005, OECOLOGIA, V142, P28, DOI 10.1007/s00442-004-1693-1; Moeller DA, 2012, ECOLOGY, V93, P1036, DOI 10.1890/11-1462.1; Nattero J, 2011, ACTA OECOL, V37, P503, DOI 10.1016/j.actao.2011.07.001; Nattero J, 2010, OIKOS, V119, P852, DOI 10.1111/j.1600-0706.2009.17766.x; Niklas K.., 1994, PLANT ALLOMETRY; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Perez-Barrales R, 2007, OIKOS, V116, P1904, DOI 10.1111/j.0030-1299.2007.15994.x; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; Rey PJ, 2006, J EVOLUTION BIOL, V19, P21, DOI 10.1111/j.1420-9101.2005.00992.x; ROBERTSON JL, 1990, EVOLUTION, V44, P121, DOI 10.1111/j.1558-5646.1990.tb04283.x; Schlumpberger BO, 2009, ANN BOT-LONDON, V103, P1489, DOI 10.1093/aob/mcp075; Scobell SA, 2002, AM MIDL NAT, V147, P1, DOI 10.1674/0003-0031(2002)147[0001:VAFTOA]2.0.CO;2; Silva-Montellano A, 2003, AM J BOT, V90, P377, DOI 10.3732/ajb.90.3.377; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Thompson J. N., 2005, INTERSPEC INTERACT; TOTLAND O, 1993, CAN J BOT, V71, P1072, DOI 10.1139/b93-124; Totland O, 2004, OIKOS, V106, P558, DOI 10.1111/j.0030-1299.2004.12991.x; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Van der Niet T, 2014, ANN BOT-LONDON, V113, P199, DOI 10.1093/aob/mct290; Ye XQ, 2011, PLANT BIOLOGY, V13, P551, DOI 10.1111/j.1438-8677.2010.00402.x; Zhao ZG, 2013, INT J PLANT SCI, V174, P637, DOI 10.1086/669910; Zhao ZG, 2007, PLANT ECOL, V193, P241, DOI 10.1007/s11258-006-9262-9; Zhao ZG, 2006, AUST J BOT, V54, P691, DOI 10.1071/BT05015	65	50	60	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118299	10.1371/journal.pone.0118299	http://dx.doi.org/10.1371/journal.pone.0118299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692295	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500114
J	de Kemp, V; de Graaf, P; Fledderus, JO; Bosch, JLHR; de Kort, LMO				de Kemp, Vincent; de Graaf, Petra; Fledderus, Joost O.; Bosch, J. L. H. Ruud; de Kort, Laetitia M. O.			Tissue Engineering for Human Urethral Reconstruction: Systematic Review of Recent Literature	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL CELLS; CO-EPSILON-CAPROLACTONE; BLADDER SMOOTH-MUSCLE; IN-VITRO ASSESSMENT; STEM-CELLS; BUCCAL MUCOSA; URINARY-TRACT; MATRIX GRAFTS; FOLLOW-UP	Background Techniques to treat urethral stricture and hypospadias are restricted, as substitution of the unhealthy urethra with tissue from other origins (skin, bladder or buccal mucosa) has some limitations. Therefore, alternative sources of tissue for use in urethral reconstructions are considered, such as ex vivo engineered constructs. Purpose To review recent literature on tissue engineering for human urethral reconstruction. Methods A search was made in the PubMed and Embase databases restricted to the last 25 years and the English language. Results A total of 45 articles were selected describing the use of tissue engineering in urethral reconstruction. The results are discussed in four groups: autologous cell cultures, matrices/scaffolds, cell-seeded scaffolds, and clinical results of urethral reconstructions using these materials. Different progenitor cells were used, isolated from either urine or adipose tissue, but slightly better results were obtained with in vitro expansion of urothelial cells from bladder washings, tissue biopsies from the bladder (urothelium) or the oral cavity (buccal mucosa). Compared with a synthetic scaffold, a biological scaffold has the advantage of bioactive extracellular matrix proteins on its surface. When applied clinically, a non-seeded matrix only seems suited for use as an onlay graft. When a tubularized substitution is the aim, a cell-seeded construct seems more beneficial. Conclusions Considerable experience is available with tissue engineering of urethral tissue in vitro, produced with cells of different origin. Clinical and in vivo experiments show promising results.	[de Kemp, Vincent; de Graaf, Petra; Bosch, J. L. H. Ruud; de Kort, Laetitia M. O.] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands; [Fledderus, Joost O.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Graaf, P (corresponding author), Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands.	degraaf-4@umcutrecht.nl; l.m.o.dekort@umcutrecht.nl		de Graaf, Petra/0000-0002-3183-8901				Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2003.04723.x; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Bisson I, 2002, UROLOGY, V60, P176, DOI 10.1016/S0090-4295(02)01642-4; Cattan V, 2011, EUR UROL, V60, P1291, DOI 10.1016/j.eururo.2011.05.051; Davis NF, 2011, UROLOGY, V78, P954, DOI 10.1016/j.urology.2011.06.036; Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036; El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Falke G, 2003, TISSUE ENG, V9, P871, DOI 10.1089/107632703322495529; Fossum M, 2005, CELLS TISSUES ORGANS, V181, P11, DOI 10.1159/000089965; Fossum M, 2004, TISSUE ENG, V10, P175, DOI 10.1089/107632704322791826; Fossum M, 2003, SCAND J PLAST RECONS, V37, P41, DOI 10.1080/alp.37.1.41.45; Fossum M, 2012, ACTA PAEDIATR, V101, P755, DOI 10.1111/j.1651-2227.2012.02659.x; Frimberger D, 2006, UROLOGY, V67, P1298, DOI 10.1016/j.urology.2005.12.005; Huang X, 2013, UROLOGY, V81, P468, DOI 10.1016/j.urology.2012.12.001; Hudson AE, 2007, TISSUE ENG, V13, P2219, DOI 10.1089/ten.2006.0337; Imbeault A, 2013, CUAJ-CAN UROL ASSOC, V7, pE4, DOI 10.5489/cuaj.12217; Kershen RT, 2002, TISSUE ENG, V8, P515, DOI 10.1089/107632702760184754; Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x; KNOWLES MA, 1983, CANCER RES, V43, P374; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Koskela S, 2009, SCAND J UROL NEPHROL, V43, P179, DOI 10.1080/00365590902799005; Kundu AK, 2011, BIOTECHNOL BIOENG, V108, P207, DOI 10.1002/bit.22912; Lakshmanan Y, 2005, UROLOGY, V65, P821, DOI 10.1016/j.urology.2004.11.022; Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Le Roux PJ, 2005, J UROLOGY, V173, P140, DOI 10.1097/01.ju.0000146554.79487.7f; Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008; Marcovich R, 2003, BJU INT, V92, P636, DOI 10.1046/j.1464-410X.2003.04418.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muylaert DEP, 2014, HEART, V100, P1825, DOI 10.1136/heartjnl-2014-306092; Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072; Osman NI, 2014, EUR UROL, V66, P790, DOI 10.1016/j.eururo.2014.07.007; Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4; Pilatz A, 2005, EUR UROL, V47, P710, DOI 10.1016/j.eururo.2005.01.008; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rohman G, 2007, BIOMATERIALS, V28, P2264, DOI 10.1016/j.biomaterials.2007.01.032; Sabbagh W, 1998, BRIT J UROL, V82, P888; Sartoneva R, 2012, J R SOC INTERFACE, V9, P3444, DOI 10.1098/rsif.2012.0458; Sartoneva R, 2011, J R SOC INTERFACE, V8, P671, DOI 10.1098/rsif.2010.0520; Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0; Scriven SD, 2001, J MATER SCI-MATER M, V12, P991, DOI 10.1023/A:1012869318205; Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x; Shi JG, 2012, CELL TISSUE RES; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5	50	53	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118653	10.1371/journal.pone.0118653	http://dx.doi.org/10.1371/journal.pone.0118653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689740	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700118
J	Hong, SW; Lee, SB; Jee, DH; Ahn, MD				Hong, Seung Woo; Lee, Seung Bum; Jee, Dong-hyun; Ahn, Myung Douk			Interocular Retinal Nerve Fiber Layer Thickness Difference in Normal Adults	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SYMMETRY; GLAUCOMA; AGE	Purpose To determine the interocular retinal nerve fiber layer (RNFL) thickness difference of normal subjects. Methods Both eyes of 230 normal adults received peripapillary RNFL thickness measurements using OCT. The effect of ocular cyclotorsion on the RNFL thickness profile was mathematically corrected. The fractional and absolute interocular RNFL thickness differences at 256 points of peripapillary area were calculated. We divided the subjects into 3 groups according to the locations of superior and inferior peak thickness, respectively, and compared the interocular RNFL thickness differences between the subgroups. Results The fractional interocular RNFL thickness difference exhibited smaller regional variations than the absolute interocular difference. The means of fractional interocular differences were 0.100 +/- 0.077 in the temporal half area and 0.146 +/- 0.105 in the nasal half area, and the tolerance limits for the 95th and 99th distributions were about 0.246 and 0.344 in the temporal half area and 0.293 and 0.408 in the nasal half area, respectively. The fractional interocular differences of subgroups classified by the locations of superior and inferior peak RNFL thickness showed difference at smaller areas than the absolute interocular differences (19 and 8 points versus 49 and 23 points, respectively). Conclusion Glaucoma can be strongly suspected, if interocular fractional RNFL thickness difference is over 25% at 5 consecutive points or over 35% at 3 consecutive points in the temporal half area. The fractional interocular comparison is a better diagnostic approach because the fractional interocular RNFL thickness difference is less influenced by the locations of peak RNFL thickness.	[Hong, Seung Woo; Lee, Seung Bum; Jee, Dong-hyun; Ahn, Myung Douk] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Hong, Seung Woo] Armed Forces Capital Hosp Korea, Dept Ophthalmol, Songnam, Gyeonggi Provin, South Korea	Catholic University of Korea	Ahn, MD (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	narusia@catholic.ac.kr		Hong, Seung Woo/0000-0002-4800-636X	Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul [11003]	Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul	This work received financial support from the Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul (Grant No. 11003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budenz DL, 2005, OPHTHALMOLOGY, V112, P3, DOI 10.1016/j.ophtha.2004.06.039; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Budenz Donald L, 2008, Trans Am Ophthalmol Soc, V106, P252; Chung HJ, 2014, J GLAUCOMA, V23, P471, DOI 10.1097/IJG.0b013e31827b1382; Essock EA, 1999, J GLAUCOMA, V8, P90; Frank M.J., 1979, AEQUATIONES MATH, V19, P194, DOI DOI 10.1007/BF02189866; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2034, DOI [10.1001/jama.2013.4982, DOI 10.1001/JAMA.2013.4982]; Hong SW, 2010, INVEST OPHTH VIS SCI, V51, P3515, DOI 10.1167/iovs.09-4888; Hood DC, 2007, BRIT J OPHTHALMOL, V91, P905, DOI 10.1136/bjo.2006.111252; Hougaard JL, 2007, ACTA OPHTHALMOL SCAN, V85, P251, DOI 10.1111/j.1600-0420.2006.00826.x; Huynh SC, 2007, AM J OPHTHALMOL, V143, P518, DOI 10.1016/j.ajo.2006.09.050; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Hwang YH, 2011, BRIT J OPHTHALMOL, V95, P1547, DOI 10.1136/bjo.2010.194118; Jee D, 2014, J GLAUCOMA, V23, pE125, DOI 10.1097/IJG.0000000000000032; Kanamori A, 2006, GRAEF ARCH CLIN EXP, V244, P58, DOI 10.1007/s00417-005-0029-0; Kurimoto Y, 2000, BRIT J OPHTHALMOL, V84, P469, DOI 10.1136/bjo.84.5.469; Lee Jong Yeon, 2012, Korean J Ophthalmol, V26, P163, DOI 10.3341/kjo.2012.26.3.163; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Mwanza JC, 2011, AM J OPHTHALMOL, V151, P514, DOI 10.1016/j.ajo.2010.09.015; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116313	10.1371/journal.pone.0116313	http://dx.doi.org/10.1371/journal.pone.0116313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679786	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600017
J	Hamberg, L; Vartiamaki, H; Hantula, J				Hamberg, Leena; Vartiamaki, Henna; Hantula, Jarkko			Breeding Increases the Efficacy of Chondrostereum purpureum in the Sprout Control of Birch	PLOS ONE			English	Article							FOREST VEGETATION MANAGEMENT; BIOLOGICAL-CONTROL AGENT; SORBUS-AUCUPARIA; GROWTH; DEGRADATION; INFECTION; STRAINS; LIGNIN; PRUNUS; STANDS	We tested whether the pairing of selected isolates could be used to increase the efficiency of a decay fungus Chondrostereum purpureum (Pers. Ex Fr.) Pouzar to control hardwood sprouting in Finland. We paired C. purpureum strains efficient in sprout control or highly active in laccase production, and tested the efficacy of their progeny in spout control experiments. This procedure resulted in a strain with an efficacy superior to that of the parental strains. The mortality of birch (Betula pendula Roth. and B. pubescens Ehrh.) 1 cm in stump diameter was 78%, 56% and 9% for the best progeny, the best parental strain and the control, respectively. Mortality was only slightly higher for B. pendula than for B. pubescens but no significant differences were found between the number or maximum height of stump sprouts. Our results showed that cross breeding of this decay fungus is a good alternative in attempts to produce efficient biocontrol agents against hardwood sprouting.	[Hamberg, Leena; Vartiamaki, Henna; Hantula, Jarkko] Finnish Forest Res Inst, Vantaa Res Unit, FIN-01301 Vantaa, Finland	Natural Resources Institute Finland (Luke)	Hamberg, L (corresponding author), Finnish Forest Res Inst, Vantaa Res Unit, FIN-01301 Vantaa, Finland.	leena.hamberg@metla.fi		Hamberg, Leena/0000-0002-0009-7768; Hantula, Jarkko/0000-0002-1016-0636	Finnish Funding Agency for Technology and Innovation [265/31/2012]; Verdera Ltd.; Metsateho Ltd.; Finnish Transport Agency; UPM-Kymmene Ltd.; Marjatta and Eino Kolli Foundation [1041]; Finnish Cultural Foundation [00081430]; Finnish Forest Research Institute; Fingrid Ltd.	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Verdera Ltd.; Metsateho Ltd.; Finnish Transport Agency; UPM-Kymmene Ltd.; Marjatta and Eino Kolli Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Forest Research Institute; Fingrid Ltd.	The study was funded by the Finnish Funding Agency for Technology and Innovation (http://www.tekes.fi/en/, project number 265/31/2012), Verdera Ltd. (http://verdera.fi/en/front-page/), Metsateho Ltd. (http://www.metsateho.fi/aboutus/presentation), Fingrid Ltd. (http://www.fingrid.fi/en/Pages/default.aspx), The Finnish Transport Agency (http://portal.liikennevirasto.fi/sivu/www/e/), UPM-Kymmene Ltd. (http://www.upm.com/en/Pages/default.aspx), Marjatta and Eino Kolli Foundation (http://www.kollinsaatio.com/,project number 1041), the Finnish Cultural Foundation (http://www.skr.fi/en, project number 00081430) and the Finnish Forest Research Institute (http://www.metla.fi/index-en.html). LH received salary from the Finnish Forest Research Institute which obtained funding from the abovementioned sources. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijala O., 2014, METSANHOIDON SUOSITU; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; Bates D, 2012, LME4 LINEAR MIXED EF; Finnish Forest Research Institute, 1995, NATIONAL FOREST INVE; Finnish FSC association, 2010, FSC STANDARD FOR FIN; Gosselin L, 1996, MYCOL RES, V100, P151, DOI 10.1016/S0953-7562(96)80113-4; Hamberg L, 2014, BIOCONTROL, V59, P125, DOI 10.1007/s10526-013-9550-y; Hamberg L, 2011, SCAND J FOREST RES, V26, P505, DOI 10.1080/02827581.2011.592144; Harper GJ, 1999, CAN J FOREST RES, V29, P852, DOI 10.1139/cjfr-29-7-852; Hyvamaki T., 2002, TAPION TASKUKIRJA; Jobidon R, 2000, FOREST ECOL MANAG, V130, P77, DOI 10.1016/S0378-1127(99)00176-0; JONES M, 1987, PROC R SOC SER B-BIO, V232, P1, DOI 10.1098/rspb.1987.0058; Jones S.G, 1949, PLANT PATHOL, P763; Kaila S, 2006, SCAND J FOREST RES, V21, P496, DOI 10.1080/02827580601073263; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LEATHAM GF, 1986, APPL MICROBIOL BIOT, V24, P51, DOI 10.1007/BF00266285; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Pinheiro J, 2012, NLME LINEAR AND NONL; Pitt DG, 1999, CAN J FOREST RES, V29, P841, DOI 10.1139/cjfr-29-7-841; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Roy V, 2010, FOREST ECOL MANAG, V259, P1571, DOI 10.1016/j.foreco.2010.01.033; Scheepens P.C., 1989, P 7 INT S BIOL CONTR, P545; SPIERS AG, 1987, NEW ZEAL J BOT, V25, P411, DOI 10.1080/0028825X.1987.10413358; Spiers AG, 1998, MYCOL RES, V102, P881, DOI 10.1017/S0953756297005923; Spiers AG, 2000, MYCOL RES, V104, P395, DOI 10.1017/S0953756299001732; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Strunz GM, 1997, CAN J CHEM, V75, P742, DOI 10.1139/v97-090; Sun H, 2009, FEMS MICROBIOL ECOL, V69, P266, DOI 10.1111/j.1574-6941.2009.00711.x; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Uotila K, 2014, SCAND J FOREST RES, V29, P111, DOI 10.1080/02827581.2013.869349; Valkonen S, 2003, SCAND J FOREST RES, V18, P416, DOI 10.1080/02827581.2003.9610645; Vandenbroucke Jack Eric, 2005, Journal of Arboriculture, V31, P251; Vartiamaki H, 2008, FOREST PATHOL, V38, P381, DOI 10.1111/j.1439-0329.2008.00551.x; Vartiamaki H, 2008, BIOL CONTROL, V47, P46, DOI 10.1016/j.biocontrol.2008.06.005; Vartiamaki H, 2009, CAN J FOREST RES, V39, P731, DOI 10.1139/X09-009; Wall R. E., 1990, Northern Journal of Applied Forestry, V7, P17; Wall RE, 1997, CAN J PLANT PATHOL, V19, P181, DOI 10.1080/07060669709500550; Wall RE, 1996, BIOL CONTROL, V7, P205, DOI 10.1006/bcon.1996.0085	39	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117381	10.1371/journal.pone.0117381	http://dx.doi.org/10.1371/journal.pone.0117381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674794	Green Submitted, Green Published, gold			2022-12-27	WOS:000349914000020
J	Wang, WS; Du, ZQ; Cheng, BH; Wang, YX; Yao, J; Li, YM; Cao, ZP; Luan, P; Wang, N; Li, H				Wang, Weishi; Du, Zhi-Qiang; Cheng, Bohan; Wang, Yuxiang; Yao, Jing; Li, Yumao; Cao, Zhiping; Luan, Peng; Wang, Ning; Li, Hui			Expression Profiling of Preadipocyte MicroRNAs by Deep Sequencing on Chicken Lines Divergently Selected for Abdominal Fatness	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ADIPOSE-TISSUE; ADIPOGENIC DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ASSOCIATION ANALYSIS; INSULIN-RESISTANCE; LIPID-METABOLISM; PRE-ADIPOCYTE; SEED REGION	Through posttranscriptional gene regulation, microRNA (miRNA) is linked to a wide variety of biological processes, including adipogenesis and lipid metabolism. Although miRNAs in mammalian adipogenesis have been worked on extensively, their study in chicken adipogenesis is still very limited. To find miRNAs potentially important for chicken preadipocyte development, we compared the preadipocyte miRNA expression profiles in two broiler lines divergently selected for abdominal fat content, by sequencing two small RNA libraries constructed for primary preadipocytes isolated from abdominal adipose tissues. After bioinformatics analyses, from chicken miRNAs deposited in miRBase 20.0, we identified 225 miRNAs to be expressed in preadipocytes, 185 in the lean line and 200 in the fat line (derived from 208 and 203 miRNA precursors, respectively), which corresponds to 114 miRNA families. The let-7 family miRNAs were the most abundant. Furthermore, we validated the sequencing results of 15 known miRNAs by qRT-PCR, and confirmed that the expression levels of most miRNAs correlated well with those of Solexa sequencing. A total of 33 miRNAs was significantly differentially expressed between the two chicken lines (P<0.05). Gene ontology analysis revealed that they could target genes enriched in the regulation of gene transcription and chromatin function, response to insulin stimulation, and IGF-1 signaling pathways, which could have important roles in preadipocyte development. Therefore, a valuable information and resource of miRNAs on chicken adipogenesis were provided in this study. Future functional investigations on these miRNAs could help explore related genes and molecular networks fundamental to preadipocyte development.	[Wang, Weishi; Du, Zhi-Qiang; Cheng, Bohan; Wang, Yuxiang; Yao, Jing; Li, Yumao; Cao, Zhiping; Luan, Peng; Wang, Ning; Li, Hui] Northeast Agr Univ, Coll Anim Sci & Technol, Educ Dept Heilongjiang Prov, Key Lab Chicken Genet & Breeding,Minist Agr,Key L, Harbin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Wang, N (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Educ Dept Heilongjiang Prov, Key Lab Chicken Genet & Breeding,Minist Agr,Key L, Harbin, Peoples R China.	wayane123@aliyun.com; lihui@neau.edu.cn			National 863 project of China [2013AA102501]; National Basic Research Program of China [2009CB941604]; China Agriculture Research System [CARS-42]	National 863 project of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	This study was supported by the National 863 project of China (No. 2013AA102501), National Basic Research Program of China (No. 2009CB941604), and China Agriculture Research System (No. CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; [Anonymous], 2010, PMID; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baselga-Escudero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069817; Baselga-Escudero L, 2012, MOL NUTR FOOD RES, V56, P1636, DOI 10.1002/mnfr.201200237; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Chakraborty C, 2014, WILEY INTERDISCIP RE, DOI [10.1002/wrna.1274, DOI 10.1002/WRNA.1274]; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen F, 2014, MOL BIOL REP, V41, P5505, DOI 10.1007/s11033-014-3426-9; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chen YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090842; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Crepin D, 2014, MOL CELL ENDOCRINOL, V384, P1, DOI 10.1016/j.mce.2013.12.016; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CRYER J, 1987, COMP BIOCHEM PHYS A, V86, P515, DOI 10.1016/0300-9629(87)90535-4; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dinh H, 2014, VET IMMUNOL IMMUNOP, V159, P74, DOI 10.1016/j.vetimm.2014.02.003; Dong PY, 2014, ACTA BIOCH BIOPH SIN, V46, P565, DOI 10.1093/abbs/gmu043; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Garten A, 2012, ENDOCRIN METAB CLIN, V41, P283, DOI 10.1016/j.ecl.2012.04.011; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2011, POULTRY SCI, V90, P2024, DOI 10.3382/ps.2010-00863; Hansen TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010961; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Inukai S, 2012, CELL CYCLE, V11, P1060, DOI 10.4161/cc.11.6.19786; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kaur K, 2011, MOL BIOSYST, V7, P3234, DOI 10.1039/c1mb05041a; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2012, J CELL PHYSIOL, V227, P183, DOI 10.1002/jcp.22716; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2012, BRIT POULTRY SCI, V53, P770, DOI 10.1080/00071668.2012.750716; Li H, 2013, J APPL GENET, V54, P209, DOI 10.1007/s13353-013-0142-4; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Luo C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-112; Martini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089755; Meale SJ, 2014, J ANIM SCI, DOI [10.2527/jas.2014-7873, DOI 10.2527/JAS.2014-7873]; Moreno-Navarrete J. M., 2012, ADIPOSE TISSUE BIOL, P17, DOI [10.1007/978-1-4614-0965-6_2, DOI 10.1007/978-1-4614-0965-6]; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rengaraj D, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.105692; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schiller ZA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt230; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shang ZC, 2014, BIOSCIENCE REP, V34, P51, DOI 10.1042/BSR20130120; Shao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091236; Shende VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065300; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Shi R, 2010, PLANTA, V232, P1281, DOI 10.1007/s00425-010-1253-3; Shin D, 2012, NEUROSCIENCE, V213, P29, DOI 10.1016/j.neuroscience.2012.03.054; Simionescu N, 2014, MOL BIOL REP; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soares AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039417; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Sun XH, 2014, CIRC RES, V115, P2, DOI 10.1161/CIRCRESAHA.114.304228; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang YF, 2009, OMICS, V13, P331, DOI 10.1089/omi.2009.0017; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Vuppalanchi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074471; Wang Q, 2013, VET MICROBIOL, V162, P232, DOI 10.1016/j.vetmic.2012.10.023; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444; Yang WL, 2013, BIOCHEM J, V449, P605, DOI 10.1042/BJ20121121; Yao J, 2011, BIOSCI BIOTECH BIOCH, V75, P54, DOI 10.1271/bbb.100530; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-517; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040736; Zhang QH, 2014, BBA-MOL CELL BIOL L, V1841, P934, DOI 10.1016/j.bbalip.2014.03.009; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119; Zhang SP, 2013, BRIT POULTRY SCI, V54, P312, DOI 10.1080/00071668.2013.791383; Zhang XF, 2014, INSECT BIOCHEM MOLEC, V47, P12, DOI 10.1016/j.ibmb.2014.01.008; Zhong D, 2013, CELL SIGNAL, V25, P1429, DOI 10.1016/j.cellsig.2013.03.003; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	110	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117843	10.1371/journal.pone.0117843	http://dx.doi.org/10.1371/journal.pone.0117843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675096	gold, Green Submitted, Green Published			2022-12-27	WOS:000349914000033
J	Kolowerzo-Lubnau, A; Niedojadlo, J; Swidzinski, M; Bednarska-Kozakiewicz, E; Smolinski, DJ				Kolowerzo-Lubnau, Agnieszka; Niedojadlo, Janusz; Swidzinski, Michal; Bednarska-Kozakiewicz, Elzbieta; Smolinski, Dariusz J.			Transcriptional Activity in Diplotene Larch Microsporocytes, with Emphasis on the Diffuse Stage	PLOS ONE			English	Article							MEIOTIC PROPHASE-I; SMALL NUCLEAR RNAS; COILED BODIES; CAJAL BODIES; POLY(A) RNA; CHROMATIN CONFIGURATION; SPLICING MACHINERY; MALE GAMETOPHYTE; U-SNRNA; POLLEN	Manuscript provides insights into the biology of long-lived plants, different from Arabidopsis, tomato or grass species that are widely studied. In the European larch the diplotene stage lasts approximately 5 months and it is possible to divide it into several substages and to observe each of them in details. The diplotene stage is a period of intensive microsporocyte growth associated with the synthesis and accumulation of different RNA and proteins. Larch microsporocytes display changes in chromatin morphology during this stage, alternating between 4 short stages of chromatin condensation (contraction) and 5 longer diffusion (relaxation) stages. The occurrence of a diplotene diffusion stage has been observed in many plant species. Interestingly, they have also been observed during spermiogenesis and oogenesis in animals. The aim of this study was to examine whether chromatin relaxation during the diplotene is accompanied by the synthesis and maturation of mRNA. The results reveal a correlation between the diffusion and chromatin decondensation, transcriptional activity. We also found decreasing amount of poly(A) mRNA synthesis in the consecutive diffusion stages. During the early diffusion stages, mRNA is intensively synthesized. In the nuclei large amounts of RNA polymerase II, and high levels of snRNPs were observed. In the late diffusion stages, the synthesized mRNA is not directly subjected to translation but it is stored in the nucleus, and later transported to the cytoplasm and translated. In the last diffusion stage, the level of poly(A) RNA is low, but that of splicing factors is still high. It appears that the mRNA synthesized in early stages is used during the diplotene stage and is not transmitted to dyad and tetrads. In contrast, splicing factors accumulate and are most likely transmitted to the dyad and tetrads, where they are used after the resumption of intense transcription. Similar meiotic process were observed during oogenesis in animals. This indicates the existence of an evolutionarily conserved mechanism of chromatin-based regulation of gene expression during meiotic prophase I.	[Kolowerzo-Lubnau, Agnieszka; Niedojadlo, Janusz; Swidzinski, Michal; Bednarska-Kozakiewicz, Elzbieta; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland; [Kolowerzo-Lubnau, Agnieszka; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Kolowerzo-Lubnau, A (corresponding author), Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland.	agakol@umk.pl; darsmol@umk.pl	Smolinski, Dariusz Jan/AAV-8969-2021; Bednarska-Kozakiewicz, Elżbieta/O-4072-2015; Smolinski, Dariusz/M-3794-2014; Niedojadło, Janusz/O-3211-2015; Kołowerzo-Lubnau, Agnieszka/B-9362-2012	Smolinski, Dariusz Jan/0000-0002-8272-0196; Smolinski, Dariusz/0000-0002-8272-0196; Kołowerzo-Lubnau, Agnieszka/0000-0002-1337-6715; Swidzinski, Michal/0000-0002-4247-1455	Polish National Science Center (NCN) [303 799640, 7796/B/P01/2011/40]	Polish National Science Center (NCN)	This work was supported by Polish National Science Center (NCN): no.N 303 799640 and no.of agreement 7796/B/P01/2011/40.Start 2011-06-13, end 2014-06-12.URL: https://osf.opi.org.pl/app/aawi/wynikiKonkursow.do? sortowanie=nr_rejestracyjny&kryteriaWyszukiwania=&do=pokaz&zakresDziedziny6Do30=%25&zakresDziedziny31=%25&zakresDziedzinyPodstawowe=N302&FiltrBut=Ustaw+filtr&zakresKonkursu=40&zakresDziedziny= N303&zakresPodTypu=%25&zakresDecyzji=3. Grant has already finished and there is no money from this resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SJ, 2003, J EXP BOT, V54, P1, DOI 10.1093/jxb/54.380.1; BAKKEN AH, 1978, CHROMOSOMA, V67, P21, DOI 10.1007/BF00285645; Bednarska E, 1984, ADV CELL BIOL, V11, P585; Bogolyubov D, 2007, FOLIA HISTOCHEM CYTO, V45, P129; Bonnet F, 1999, NUCLEIC ACIDS RES, V27, P4399, DOI 10.1093/nar/27.22.4399; Bressa MJ, 2002, HEREDITAS, V137, P125, DOI 10.1034/j.1601-5223.2002.01650.x; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Castanhole MMU, 2008, GENET MOL RES, V7, P1398, DOI 10.4238/vol7-4gmr527; CENCI G, 1994, J CELL SCI, V107, P3521; CHWIROT WB, 1981, ACTA SOC BOT POL, V50, P33; Comizzoli P, 2011, HUM REPROD, V26, P2165, DOI 10.1093/humrep/der176; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Dickmanns A, 2005, TOP CURR GENET, V12, P179, DOI 10.1007/106799; EKBERG I, 1968, HEREDITAS-GENETISK A, V59, P427; EKBERG I, 1967, HEREDITAS-GENETISK A, V57, P303; Franklin AE, 1999, PLANT CELL, V11, P523, DOI 10.1105/tpc.11.4.523; GALL JG, 1962, P NATL ACAD SCI USA, V48, P562, DOI 10.1073/pnas.48.4.562; Gall JG, 2012, CHROMOSOME RES, V20, P905, DOI 10.1007/s10577-012-9329-5; Hinrichs K, 2000, BIOL REPROD, V62, P1402, DOI 10.1095/biolreprod62.5.1402; Hruba P, 2005, PLANTA, V220, P931, DOI 10.1007/s00425-004-1409-0; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; KLASTERSKA I, 1976, HEREDITAS, V82, P193; KLASTERSKA I, 1977, HEREDITAS, V86, P205; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Kolowerzo A, 2009, PROTOPLASMA, V236, P13, DOI 10.1007/s00709-009-0042-y; Lodde V, 2008, MOL REPROD DEV, V75, P915, DOI 10.1002/mrd.20824; Lorkovic ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003989; MASCARENHAS JP, 1975, BOT REV, V41, P259, DOI 10.1007/BF02860839; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Niedojadlo J, 2003, BIOL CELL, V95, P303, DOI 10.1016/S0248-4900(03)00061-3; OWENS JN, 1979, CAN J BOT, V57, P2673, DOI 10.1139/b79-317; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; She WJ, 2013, DEVELOPMENT, V140, P4008, DOI 10.1242/dev.095034; Sheehan MJ, 2009, P NATL ACAD SCI USA, V106, P20989, DOI 10.1073/pnas.0906498106; Sheidai M, 2005, J GENET, V84, P189, DOI 10.1007/BF02715845; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Sleeman JE, 2001, J CELL SCI, V114, P4407; Smith KP, 2000, MOL BIOL CELL, V11, P2987, DOI 10.1091/mbc.11.9.2987; Smolinski DJ, 2007, PROTOPLASMA, V232, P109, DOI 10.1007/s00709-007-0270-y; Smolinski DJ, 2011, HISTOCHEM CELL BIOL, V136, P527, DOI 10.1007/s00418-011-0861-8; Smolinski DJ, 2012, CHROMOSOMA, V121, P37, DOI 10.1007/s00412-011-0339-4; Stack SM, 2001, CHROMOSOME RES, V9, P175, DOI 10.1023/A:1016690802570; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Straatman KR, 2001, PROTOPLASMA, V216, P191, DOI 10.1007/BF02673871; Stronghill PE, 2007, AM J BOT, V94, P2063, DOI 10.3732/ajb.94.12.2063; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Tiang CL, 2012, PLANT PHYSIOL, V158, P26, DOI 10.1104/pp.111.187161; TUPY J, 1983, BIOL PLANTARUM, V25, P231, DOI 10.1007/BF02902110; Zhang SG, 2008, PLANT CELL REP, V27, P1687, DOI 10.1007/s00299-008-0579-9; Zienkiewicz K, 2006, PROTOPLASMA, V227, P95, DOI 10.1007/s00709-005-0153-z; Zienkiewicz K, 2009, Int J Cell Biol, V2009, P209303, DOI 10.1155/2009/209303; Zienkiewicz K, 2008, SEX PLANT REPROD, V21, P233, DOI 10.1007/s00497-008-0085-9; Zienkiewicz K, 2008, SEX PLANT REPROD, V21, P217, DOI 10.1007/s00497-008-0086-8	62	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117337	10.1371/journal.pone.0117337	http://dx.doi.org/10.1371/journal.pone.0117337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671569	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300049
J	Stapley, J; Garcia, M; Andrews, RM				Stapley, Jessica; Garcia, Milton; Andrews, Robin M.			Long-Term Data Reveal a Population Decline of the Tropical Lizard Anolis apletophallus, and a Negative Affect of El Nino Years on Population Growth Rate	PLOS ONE			English	Article							CLIMATE-CHANGE; FOREST CHRONOSEQUENCE; LIMIFRONS; DYNAMICS; ECTOTHERMS; RESPONSES; SURVIVAL; IMPACTS; EGGS	Climate change threatens biodiversity worldwide, however predicting how particular species will respond is difficult because climate varies spatially, complex factors regulate population abundance, and species vary in their susceptibility to climate change. Studies need to incorporate these factors with long-term data in order to link climate change to population abundance. We used 40 years of lizard abundance data and local climate data from Barro Colorado Island to ask how climate, total lizard abundance and cohort-specific abundance have changed over time, and how total and cohort-specific abundance relate to climate variables including those predicted to make the species vulnerable to climate change (i.e. temperatures exceeding preferred body temperature). We documented a decrease in lizard abundance over the last 40 years, and changes in the local climate. Population growth rate was related to the previous years' southern oscillation index; increasing following cooler-wetter, la nina years, decreasing following warmer-drier, el nino years. Within-year recruitment was negatively related to rainfall and minimum temperature. This study simultaneously identified climatic factors driving long-termpopulation fluctuations and climate variables influencing short-term annual recruitment, both of which may be contributing to the population decline and influence the population's future persistence.	[Stapley, Jessica; Garcia, Milton] Smithsonian Trop Res Inst, Panama City, Panama; [Andrews, Robin M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Virginia Polytechnic Institute & State University	Stapley, J (corresponding author), Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Panama City, Panama.	j.stapley@sheffield.ac.uk	Stapley, Jessica/B-3858-2010	Stapley, Jessica/0000-0002-9138-5684; Andrews@vt.edu, Robin/0000-0001-6974-3732	Smithsonian Tropical Research Institute; Smithsonian Tropical Research Institute Postdoctoral Fellowship	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute Postdoctoral Fellowship	Smithsonian Tropical Research Institute (http://www.stri.si.edu/) has funded the long-term data collection. JS was supported by a Smithsonian Tropical Research Institute Postdoctoral Fellowship.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Andrews R.M., 1982, Biology of Reptilia, V13, P273; ANDREWS RM, 1991, ECOLOGY, V72, P1204, DOI 10.2307/1941094; ANDREWS RM, 1990, OIKOS, V57, P215, DOI 10.2307/3565942; ANDREWS RM, 1988, OECOLOGIA, V76, P376, DOI 10.1007/BF00377032; ANDREWS RM, 1981, ECOLOGY, V62, P556, DOI 10.2307/1937721; Andrews RM, 1982, ADV HERPETOLOGY EVOL; Andrews RM, 1982, ECOLOGY TROPICAL FOR; Andrews RM, 1994, LIZARD ECOLOGY HIST; [Anonymous], 2007, CONTRIBUTION WORKING; BALLINGER RE, 1970, ECOLOGY, V51, P246, DOI 10.2307/1933660; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Chalcraft DR, 1999, OECOLOGIA, V119, P285, DOI 10.1007/s004420050788; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Denslow JS, 2000, J VEG SCI, V11, P201, DOI 10.2307/3236800; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DeWalt SJ, 2003, FOREST ECOL MANAG, V182, P139, DOI 10.1016/S0378-1127(03)00029-X; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Logan ML, 2013, GLOBAL CHANGE BIOL, V19, P3093, DOI 10.1111/gcb.12253; McGregor S, 2013, CLIM PAST, V9, P2269, DOI 10.5194/cp-9-2269-2013; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; R Development Core Team, 2006, R LANG ENV STAT COMP; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; SEXTON O J, 1980, Caribbean Journal of Science, V16, P13; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552	33	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115450	10.1371/journal.pone.0115450	http://dx.doi.org/10.1371/journal.pone.0115450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671423	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000349545300007
J	Klaver, R; Sanchez, V; Damm, OS; Redmann, K; Lahrmann, E; Sandhowe-Klaverkamp, R; Rohde, C; Wistuba, J; Ehmcke, J; Schlatt, S; Gromoll, J				Klaever, Ruth; Sanchez, Victoria; Damm, Oliver S.; Redmann, Klaus; Lahrmann, Elisabeth; Sandhowe-Klaverkamp, Reinhild; Rohde, Christian; Wistuba, Joachim; Ehmcke, Jens; Schlatt, Stefan; Gromoll, Joerg			Direct but No Transgenerational Effects of Decitabine and Vorinostat on Male Fertility	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITOR; DNA METHYLATION; IMPRINTED GENES; MURINE SPERMATOGENESIS; GERM-CELLS; SPERM DNA; MOUSE; 5-AZA-2'-DEOXYCYTIDINE; INHERITANCE; EPIGENETICS	Establishment and maintenance of the correct epigenetic code is essential for a plethora of physiological pathways and disturbed epigenetic patterns can provoke severe consequences, e.g. tumour formation. In recent years, epigenetic drugs altering the epigenome of tumours actively have been developed for anti-cancer therapies. However, such drugs could potentially also affect other physiological pathways and systems in which intact epigenetic patterns are essential. Amongst those, male fertility is one of the most prominent. Consequently, we addressed possible direct effects of two epigenetic drugs, decitabine and vorinostat, on both, the male germ line and fertility. In addition, we checked for putative transgenerational epigenetic effects on the germ line of subsequent generations (F1-F3). Parental adult male C57BI/6 mice were treated with either decitabine or vorinostat and analysed as well as three subsequent untreated generations derived from these males. Treatment directly affected several reproductive parameters as testis (decitabine & vorinostat) and epididymis weight, size of accessory sex glands (vorinostat), the height of the seminiferous epithelium and sperm concentration and morphology (decitabine). Furthermore, after decitabine administration, DNA methylation of a number of loci was altered in sperm. However, when analysing fertility of treated mice (fertilisation, litter size and sex ratio), no major effect of the selected epigenetic drugs on male fertility was detected. In subsequent generations (F1-F3 generations) only subtle changes on reproductive organs, sperm parameters and DNA methylation but no overall effect on fertility was observed. Consequently, in mice, decitabine and vorinostat neither affected male fertility per se nor caused marked transgenerational effects. We therefore suggest that both drugs do not inducemajor adverse effects-in terms of male fertility and transgenerational epigenetic inheritance-when used in anti-cancer-therapies.	[Klaever, Ruth; Sanchez, Victoria; Damm, Oliver S.; Redmann, Klaus; Lahrmann, Elisabeth; Sandhowe-Klaverkamp, Reinhild; Wistuba, Joachim; Ehmcke, Jens; Schlatt, Stefan; Gromoll, Joerg] Univ Munster, Ctr Reprod Med & Androl, Inst Reprod & Regenerat Biol, D-48149 Munster, Germany; [Rohde, Christian] Univ Halle, Dept Hematol & Oncol, Halle, Germany; [Ehmcke, Jens] Univ Munster, Fac Med, Cent Anim Facil, D-48149 Munster, Germany	University of Munster; Martin Luther University Halle Wittenberg; University of Munster	Gromoll, J (corresponding author), Univ Munster, Ctr Reprod Med & Androl, Inst Reprod & Regenerat Biol, D-48149 Munster, Germany.	Joerg.Gromoll@ukmuenster.de	Gromoll, Joerg/AAB-2146-2019	Gromoll, Joerg/0000-0002-7788-8138	Graduate Program Cell Dynamics and Disease (CEDAD); International Max Planck Research School Molecular Biomedicine (IMPRS-MBM); German Research Foundation (Research Unit "Germ cell potential") [FOR 1041]	Graduate Program Cell Dynamics and Disease (CEDAD); International Max Planck Research School Molecular Biomedicine (IMPRS-MBM); German Research Foundation (Research Unit "Germ cell potential")	This study was supported by Graduate Program Cell Dynamics and Disease (CEDAD) and the International Max Planck Research School - Molecular Biomedicine (IMPRS-MBM) and by German Research Foundation (Research Unit "Germ cell potential" (FOR 1041)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankolkar M, 2012, FERTIL STERIL, V98, P1186, DOI 10.1016/j.fertnstert.2012.07.1143; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Biermann K, 2007, J ANDROL, V28, P466, DOI 10.2164/jandrol.106.002048; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Cisneros FJ, 2003, J APPL TOXICOL, V23, P115, DOI 10.1002/jat.898; Cordero MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.32; Damm OS, 2010, ASIAN J ANDROL, V12, P578, DOI 10.1038/aja.2010.50; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Evenson D, 2001, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY0713S13; Fenic I, 2004, J ANDROL, V25, P811; Franklin TB, 2010, NEUROBIOL DIS, V39, P61, DOI 10.1016/j.nbd.2009.11.012; Gonzalez C, 2012, STEM CELL TRANSL MED, V1, P668, DOI 10.5966/sctm.2012-0076; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kelly TLJ, 2003, J ANDROL, V24, P822; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Klaver R, 2013, ANDROLOGY-US, V1, P731, DOI 10.1111/j.2047-2927.2013.00118.x; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Mack GS, 2010, NAT BIOTECHNOL, V28, P1259, DOI 10.1038/nbt.1724; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Mohamed ESA, 2010, HUM REPROD, V25, P2427, DOI 10.1093/humrep/deq205; Oakes CC, 2007, J PHARMACOL EXP THER, V322, P1171, DOI 10.1124/jpet.107.121699; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Plautz SC, 2013, ECOTOXICOLOGY, V22, P854, DOI 10.1007/s10646-013-1056-y; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Qiu J, 2006, NATURE, V441, P143, DOI 10.1038/441143a; RAMAN R, 1995, MOL REPROD DEV, V42, P284, DOI 10.1002/mrd.1080420304; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reuter K, 2014, TISSUE CELL, V46, P86, DOI 10.1016/j.tice.2013.12.001; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rotondo JC, 2012, HUM REPROD, V27, P3632, DOI 10.1093/humrep/des319; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schoofs T, 2013, BLOOD, V121, P178, DOI 10.1182/blood-2012-08-448860; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Trost LW, 2012, CURR TREAT OPTION ON, V13, P146, DOI 10.1007/s11864-012-0191-7; TURUSOV VS, 1990, CANCER LETT, V55, P227, DOI 10.1016/0304-3835(90)90123-F; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Wise LD, 2008, BIRTH DEFECTS RES B, V83, P19, DOI 10.1002/bdrb.20139; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	55	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117839	10.1371/journal.pone.0117839	http://dx.doi.org/10.1371/journal.pone.0117839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692788	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500078
J	Kryvasheyeu, Y; Chen, HH; Moro, E; Van Hentenryck, P; Cebrian, M				Kryvasheyeu, Yury; Chen, Haohui; Moro, Esteban; Van Hentenryck, Pascal; Cebrian, Manuel			Performance of Social Network Sensors during Hurricane Sandy	PLOS ONE			English	Article							CLIMATE; SENTIMENT; SCIENCE; RISK	Information flow during catastrophic events is a critical aspect of disaster management. Modern communication platforms, in particular online social networks, provide an opportunity to study such flow and derive early-warning sensors, thus improving emergency preparedness and response. Performance of the social networks sensor method, based on topological and behavioral properties derived from the "friendship paradox", is studied here for over 50 million Twitter messages posted before, during, and after Hurricane Sandy. We find that differences in users' network centrality effectively translate into moderate awareness advantage (up to 26 hours); and that geo-location of users within or outside of the hurricane-affected area plays a significant role in determining the scale of such an advantage. Emotional response appears to be universal regardless of the position in the network topology, and displays characteristic, easily detectable patterns, opening a possibility to implement a simple "sentiment sensing" technique that can detect and locate disasters.	[Kryvasheyeu, Yury; Chen, Haohui; Van Hentenryck, Pascal; Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia; [Moro, Esteban] Univ Carlos III Madrid, Dept Math, Leganas, Spain; [Moro, Esteban] Univ Carlos III Madrid, GISC, Leganas, Spain; [Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, Madrid, Spain; [Van Hentenryck, Pascal] Australian Natl Univ, Res Sch Comp Sci, Canberra, ACT, Australia; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Autonomous University of Madrid; Australian National University; University of California System; University of California San Diego	Cebrian, M (corresponding author), Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia.	manuel.cebrian@nicta.com.au	Moro, Esteban/AAB-1159-2019; Chen, Haohui/AAE-5619-2022; Chen, Haohui/T-8965-2018	Moro, Esteban/0000-0003-2894-1024; Chen, Haohui/0000-0001-8976-3634; Chen, Haohui/0000-0001-8976-3634	Australian Government; Australian Research Council through the ICT Centre of Excellence program; Spanish Ministry of Science and Technology [FIS2013-47532-C3-3-P]; Army Research Laboratory [W911NF-09-2-0053, W911NF-11-1-0363]; National Science Foundation [0905645]; DARPA/Lockheed Martin Guard Dog Programme [PO 4100149822]	Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); National Science Foundation(National Science Foundation (NSF)); DARPA/Lockheed Martin Guard Dog Programme	Yury Kryvasheyeu, Haohui Chen, Pascal Van Hentenryck and Manuel Cebrian acknowledge the support of the Australian Government represented by the Department of Broadband, Communications and Digital Economy; and the Australian Research Council through the ICT Centre of Excellence program. Esteban Moro acknowledges the support of Spanish Ministry of Science and Technology under grant FIS2013-47532-C3-3-P. This research was also supported by the Army Research Laboratory under Cooperative Agreement Numbers W911NF-09-2-0053 and W911NF-11-1-0363, the National Science Foundation under grant 0905645, and DARPA/Lockheed Martin Guard Dog Programme under PO 4100149822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Blake ES., 2013, NATL HURRICANE CTR, V12, P1; Caragea C., 2011, P 8 INT C INF SYST C; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Eom Y-H, 2014, ARXIV14011458; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Gao L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03997; Garcia-Herranz M., 2014, PLoS ONE, V9, pe92413, DOI 10.1371/journal.pone.0092413; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guikema SD, 2009, SCIENCE, V323, P1302, DOI 10.1126/science.1169057; Guy M, 2010, LECT NOTES COMPUT SC, V6065, P42; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; Hodas NO, 2013, P 7 INT AAAI C WEBL, P225; Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564; Kennedy D, 2002, SCIENCE, V295, P405, DOI 10.1126/science.295.5554.405; Kooti F, 2014, P 8 INT AAAI C WEBL, P266; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Li J, 2010, ELECTR J INF SYS DEV, V42; Mislove A, 2011, P INT AAAI C WEB SOC; National Hurricane Center, 2013, NHC GIS ARCH TROP CY; Nelson Bryn, 2013, Nature, V495, P271; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Perry RW, 2003, DISASTERS, V27, P336, DOI 10.1111/j.0361-3666.2003.00237.x; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Press F, 1999, SCIENCE, V284, P1927, DOI 10.1126/science.284.5422.1927; Quarantelli E.L., 1980, EVACUATION BEHAV PRO; Rahwan I, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2012.295; Riad JK, 1999, J APPL SOC PSYCHOL, V29, P918, DOI 10.1111/j.1559-1816.1999.tb00132.x; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schiermeier Q, 2006, NATURE, V441, P674, DOI 10.1038/441674b; Sun LJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05099; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Tollefson J, 2012, NATURE NEWS, DOI [10.1111/cob.12003, DOI 10.1111/COB.12003]; van Aalst MK, 2006, DISASTERS, V30, P5, DOI 10.1111/j.1467-9523.2006.00303.x; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Wang D, 2012, SOCIAL NETWORKS EMER; Watts D, 2013, WORKSH CURR KNOWL RE	47	70	72	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117288	10.1371/journal.pone.0117288	http://dx.doi.org/10.1371/journal.pone.0117288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692690	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500047
J	Bergman, ZJ; Mclaurin, JD; Eritano, AS; Johnson, BM; Sims, AQ; Riggs, B				Bergman, Zane J.; Mclaurin, Justin D.; Eritano, Anthony S.; Johnson, Brittany M.; Sims, Amanda Q.; Riggs, Blake			Spatial Reorganization of the Endoplasmic Reticulum during Mitosis Relies on Mitotic Kinase Cyclin A in the Early Drosophila Embryo	PLOS ONE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; TO-TUBULE TRANSFORMATION; CELL-CYCLE; CHROMOSOME CONDENSATION; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; LAVA LAMP; MICROTUBULES; GOLGI; POLO	Mitotic cyclin-dependent kinase with their cyclin partners (cyclin:Cdks) are the master regulators of cell cycle progression responsible for regulating a host of activities during mitosis. Nuclear mitotic events, including chromosome condensation and segregation have been directly linked to Cdk activity. However, the regulation and timing of cytoplasmic mitotic events by cyclin: Cdks is poorly understood. In order to examine these mitotic cytoplasmic events, we looked at the dramatic changes in the endoplasmic reticulum (ER) during mitosis in the early Drosophila embryo. The dynamic changes of the ER can be arrested in an interphase state by inhibition of either DNA or protein synthesis. Here we show that this block can be alleviated by micro-injection of Cyclin A (CycA) in which defined mitotic ER clusters gathered at the spindle poles. Conversely, micro-injection of Cyclin B (CycB) did not affect spatial reorganization of the ER, suggesting CycA possesses the ability to initiate mitotic ER events in the cytoplasm. Additionally, RNAi-mediated simultaneous inhibition of all 3 mitotic cyclins (A, B and B3) blocked spatial reorganization of the ER. Our results suggest that mitotic ER reorganization events rely on CycA and that control and timing of nuclear and cytoplasmic events during mitosis may be defined by release of CycA from the nucleus as a consequence of breakdown of the nuclear envelope.	[Bergman, Zane J.; Mclaurin, Justin D.; Eritano, Anthony S.; Johnson, Brittany M.; Sims, Amanda Q.; Riggs, Blake] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Riggs, B (corresponding author), San Francisco State Univ, Dept Biol, 1600 Holloway Ave, San Francisco, CA 94132 USA.	riggs@sfsu.edu	Eritano, Anthony/AAG-6597-2019	Eritano, Anthony/0000-0002-3214-9593	National Institute of Health, Minority Biomedical Research Support (MBRS) [R25-GM059298Z]; Genentech Foundation [3179555]; National Institute of Health, Support of Competitive Research (SCORE) Program [5SC2 GM098229-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM098229] Funding Source: NIH RePORTER	National Institute of Health, Minority Biomedical Research Support (MBRS); Genentech Foundation(Roche HoldingGenentech); National Institute of Health, Support of Competitive Research (SCORE) Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institute of Health, Minority Biomedical Research Support (MBRS) R25-GM059298Z, BMJ, ASE, Genentech Foundation MS Dissertation Scholarship, grant #3179555, JDM, National Institute of Health, Support of Competitive Research (SCORE) Program, 5SC2 GM098229-02, BR, ZJB, AQS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Echard A, 2003, CURR BIOL, V13, P373, DOI 10.1016/S0960-9822(03)00127-1; EDGAR BA, 1994, CURR BIOL, V4, P522, DOI 10.1016/S0960-9822(00)00113-5; FOE VE, 1983, J CELL SCI, V61, P31; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; GLOVER DM, 1991, TRENDS GENET, V7, P125, DOI 10.1016/0168-9525(91)90457-2; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hinchcliffe EH, 1999, J CELL SCI, V112, P1139; Hughes AFW, 1952, MITOTIC CYCLIC CYTOP; Irniger S, 2002, FEBS LETT, V532, P7, DOI 10.1016/S0014-5793(02)03657-8; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; McCleland ML, 2009, J CELL BIOL, V184, P639, DOI 10.1083/jcb.200810012; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Royou A, 2008, J CELL BIOL, V183, P63, DOI 10.1083/jcb.200801153; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Stiffler LA, 1999, DEVELOPMENT, V126, P5505; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tram U, 2001, METHOD CELL BIOL, V67, P113; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wang SY, 2013, J CELL BIOL, V203, P801, DOI 10.1083/jcb.201308001; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555	66	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117859	10.1371/journal.pone.0117859	http://dx.doi.org/10.1371/journal.pone.0117859			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689737	Green Submitted, gold, Green Published			2022-12-27	WOS:000350322700079
J	Hu, L; Xiao, YH; Fang, M; Gao, Y; Huang, L; Jia, AQ; Chen, JH				Hu, Lin; Xiao, Yu-hong; Fang, Ming; Gao, Yu; Huang, Li; Jia, An-qi; Chen, Ji-hua			Effects of Type I Collagen Degradation on the Durability of Three Adhesive Systems in the Early Phase of Dentin Bonding	PLOS ONE			English	Article							ENZYMATIC DEGRADATION; INTERFACES; SEPARATION; FIBRILS; MATRIX; STEP	Objective This study was designed to evaluate the effects of type I collagen degradation on the durability of three adhesive systems in the early phase of dentin bonding. Methods Bonded dentin specimens were prepared using three different types of adhesive systems. Micro-tensile bond strength and degradation of collagen were tested before, and after 1 month or 4 months of aging in artificial saliva. The relationship between micro-tensile bond strength and collagen degradation was analyzed by calculating their Pearson's correlation coefficient. Results Aging induced time-dependent reduction in micro-tensile bond strengths for all the tested adhesive systems, although such reduction for the single-step self-etching adhesive G-Bond (GB) was not statistically significant. The bond strength of the two-step self-etching primer adhesive system Clearfil SE Bond (SEB) was similar to that of the two-step etchand-rinse self-priming adhesive system Single Bond 2 (SB), and they were both significantly reduced after one or four months of aging. A negative correlation was found between the degree of collagen degradation and magnitude of micro-tensile bond strength (r = -0.65, p = 0.003). The Pearson's correlation coefficient was 0.426, indicating that 42.6% of the aging-induced reduction in bond strength can be explained by the degradation of collagen. Conclusions In the early phase of dentin bonding, there was a negative correlation between the degree of collagen degradation and the magnitude of micro-tensile bond strength. The reduction of bond strength was accompanied by the degradation of collagen. These results provide evidence for the causative relationship between the degradation of collagen and the deterioration of dentin-adhesive interface.	[Hu, Lin; Fang, Ming; Gao, Yu; Huang, Li; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Xiao, Yu-hong; Jia, An-qi] Chengdu Mil Command, Dept Stomatol, Kunming Gen Hosp, Kunming 650032, Peoples R China	Air Force Military Medical University; Kunming General Hospital	Chen, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn		Chen, Ji-hua/0000-0002-1151-0693	Natural Science Foundation of China [81130078, 30973356]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research work was financially supported by grants from Program No. IRT13051 for Changjiang Scholars and Innovative Research Team in University and the grants from Natural Science Foundation of China (No. 81130078, 30973356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Breschi L, 2002, DENT MATER, V18, P26, DOI 10.1016/S0109-5641(01)00017-3; De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212; De Munck J, 2009, J DENT RES, V88, P1101, DOI 10.1177/0022034509346952; De Munck J, 2010, EUR J ORAL SCI, V118, P494, DOI 10.1111/j.1600-0722.2010.00758.x; Hashimoto M, 2010, EUR J ORAL SCI, V118, P404, DOI 10.1111/j.1600-0722.2010.00744.x; Inoue S, 2001, J Adhes Dent, V3, P237; Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939; KLONT B, 1990, J DENT RES, V69, P896, DOI 10.1177/00220345900690031301; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Pashley DH, 2011, DENT MATER, V27, P1, DOI 10.1016/j.dental.2010.10.016; PASHLEY DH, 1991, J PROSTHET DENT, V66, P777, DOI 10.1016/0022-3913(91)90414-R; Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306; Perdigao J, 2004, DENT MATER, V26, pe24; Poitevin A, 2008, J ADHES DENT, V10, P7; Reis A, 2004, DENT MATER, V20, P669, DOI 10.1016/j.dental.2003.11.006; Scott JE, 1998, J ANAT, V192, P391, DOI 10.1046/j.1469-7580.1998.19230391.x; Shin TP, 2009, DENT MATER, V25, P1050, DOI 10.1016/j.dental.2009.03.006; Shono Y, 1999, J Adhes Dent, V1, P211; Spencer P, 2002, J BIOMED MATER RES, V62, P447, DOI 10.1002/jbm.10364; Spreafico D, 2006, J DENT, V34, P237, DOI 10.1016/j.jdent.2005.06.004; Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214; Van Meerbeek B, 2003, OPER DENT, V28, P215; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Yang B, 2005, BIOMATERIALS, V26, P5021, DOI 10.1016/j.biomaterials.2005.01.024; Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604; Zhang SC, 2009, INT J ORAL SCI, V1, P163, DOI 10.4248/IJOS.09044; Zheng X, 2011, J MICROSC-OXFORD, V241, P162, DOI 10.1111/j.1365-2818.2010.03412.x	28	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116790	10.1371/journal.pone.0116790	http://dx.doi.org/10.1371/journal.pone.0116790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689141	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700022
J	Jean, MRN; Gonzalez-Rizzo, S; Gauffre-Autelin, P; Lengger, SK; Schouten, S; Gros, O				Jean, Maitena R. N.; Gonzalez-Rizzo, Silvina; Gauffre-Autelin, Pauline; Lengger, Sabine K.; Schouten, Stefan; Gros, Olivier			Two New Beggiatoa Species Inhabiting Marine Mangrove Sediments in the Caribbean	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FILAMENTOUS SULFUR BACTERIA; TARGETED OLIGONUCLEOTIDE PROBES; RAMAN MICROSPECTROMETRY; NICHE DIFFERENTIATION; OXIDIZING BACTERIA; NITRATE; MAT; HYPERSALINE; THIOPLOCA	Beggiatoaceae, giant sulphur-oxidizing bacteria, are well known to occur in cold and temperate waters, as well as hydrothermal vents, where they form dense mats on the floor. However, they have never been described in tropical marine mangroves. Here, we describe two new species of benthic Beggiatoaceae colonizing a marine mangrove adjacent to mangrove roots. We combined phylogenetic and lipid analysis with electron microscopy in order to describe these organisms. Furthermore, oxygen and sulphide measurements in and ex situ were performed in a mesocosm to characterize their environment. Based on this, two new species, Candidatus Maribeggiatoa sp. and Candidatus Isobeggiatoa sp. inhabiting tropical marine mangroves in Guadeloupe were identified. The species identified as Candidatus Maribeggiatoa group suggests that this genus could harbour a third cluster with organisms ranging from 60 to 120 mu m in diameter. This is also the first description of an Isobeggiatoa species outside of Arctic and temperate waters. The multiphasic approach also gives information about the environment and indications for the metabolism of these bacteria. Our study shows the widespread occurrence of members of Beggiatoaceae family and provides new insight in their potential role in shallow-water marine sulphide-rich environments such as mangroves.	[Jean, Maitena R. N.; Gonzalez-Rizzo, Silvina; Gauffre-Autelin, Pauline; Gros, Olivier] Univ Antilles Guyane, Equipe Biol Mangrove, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,UFR Sci Exactes & Nat,Dept, BP 592, Pointe A Pitre 97159, Guadeloupe, France; [Lengger, Sabine K.; Schouten, Stefan] Royal NIOZ Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Texel, Netherlands; [Gros, Olivier] Univ Antilles Guyane, Ctr Commun Caracterisat Mat Antilles Guyane, UFR Sci Exactes & Nat, Pointe A Pitre 97159, Guadeloupe, France	UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite des Antilles; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite de Montpellier; Universite des Antilles	Gonzalez-Rizzo, S (corresponding author), Univ Antilles Guyane, Equipe Biol Mangrove, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,UFR Sci Exactes & Nat,Dept, BP 592, Pointe A Pitre 97159, Guadeloupe, France.	sgonzale@univ-ag.fr	Lengger, Sabine/Q-4402-2019; Lengger, Sabine/L-7124-2016	Lengger, Sabine/0000-0003-4047-8773; Lengger, Sabine/0000-0003-4047-8773; GONZALEZ-RIZZO, Silvina/0000-0002-0097-138X	Region Guadeloupe; Region Guadeloupe	Region Guadeloupe; Region Guadeloupe	MRNJ was the recipient of a grant from Region Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, APPL ENVIRON MICROB, V65, P270; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P18, DOI 10.1016/S0932-4739(96)80036-8; Bernard C, 1995, MAR ECOL PROG SER, V128, P171, DOI 10.3354/meps128171; Bernhard JM, 2003, LIMNOL OCEANOGR, V48, P813, DOI 10.4319/lo.2003.48.2.0813; Cohen Y., 1989, MICROBIAL MATPHYSL; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; de Albuquerque JP, 2010, MICRON, V41, P507, DOI 10.1016/j.micron.2010.01.009; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Demopoulos AWJ, 2010, DEEP-SEA RES PT II, V57, P1972, DOI 10.1016/j.dsr2.2010.05.011; Desai MS, 2013, ISME J, V7, P2411, DOI 10.1038/ismej.2013.126; Dillon JG, 2007, APPL ENVIRON MICROB, V73, P5218, DOI 10.1128/AEM.00357-07; Dunker R, 2010, FEMS MICROBIOL ECOL, V73, P234, DOI 10.1111/j.1574-6941.2010.00887.x; Fenchel T, 1995, MAR ECOL PROG SER, V128, P161, DOI 10.3354/meps128161; Frenkiel L, 1996, MAR BIOL, V125, P511; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; GARCIAPICHEL F, 1994, APPL ENVIRON MICROB, V60, P1500, DOI 10.1128/AEM.60.5.1500-1511.1994; Glauert AM, 1975, PRACTICAL METHODS EL; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Guan HX, 2010, CHINESE SCI BULL, V55, P730, DOI 10.1007/s11434-009-0478-7; Guezennec J, 1998, FEMS MICROBIOL ECOL, V26, P89, DOI 10.1016/S0168-6496(98)00022-1; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Hinck S, 2007, APPL ENVIRON MICROB, V73, P7013, DOI 10.1128/AEM.00548-07; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; JACQ E, 1989, ARCH MICROBIOL, V152, P64, DOI 10.1007/BF00447013; JORGENSEN BB, 1977, MAR BIOL, V41, P19, DOI 10.1007/BF00390577; Jorgensen BB, 2010, FEMS MICROBIOL ECOL, V73, P500, DOI 10.1111/j.1574-6941.2010.00918.x; Kalanetra KM, 2004, APPL ENVIRON MICROB, V70, P7487, DOI 10.1128/AEM.70.12.7487-7496.2004; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Le Bris N, 2001, DEEP-SEA RES PT I, V48, P1941, DOI 10.1016/S0967-0637(00)00112-6; Lee RY, 2008, BIOGEOCHEMISTRY, V87, P181, DOI 10.1007/s10533-008-9176-9; Lengger SK, 2012, ORG GEOCHEM, V47, P34, DOI 10.1016/j.orggeochem.2012.02.009; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; MAIER S, 1984, INT J SYST BACTERIOL, V34, P344, DOI 10.1099/00207713-34-3-344; Maurin LC, 2010, MAR ENVIRON RES, V69, P382, DOI 10.1016/j.marenvres.2010.02.001; MCCAFFREY MA, 1989, ORG GEOCHEM, V14, P61, DOI 10.1016/0146-6380(89)90019-3; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954, DOI 10.1128/AEM.62.3.954-958.1996; McKay LJ, 2012, DEEP-SEA RES PT I, V67, P21, DOI 10.1016/j.dsr.2012.04.011; MILLERO FJ, 1987, ENVIRON SCI TECHNOL, V21, P439, DOI 10.1021/es00159a003; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Mussmann M, 2003, ENVIRON MICROBIOL, V5, P523, DOI 10.1046/j.1462-2920.2003.00440.x; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Ott JA, 1998, MAR ECOL, V19, P299; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Pascal PY, 2014, MAR ECOL PROG SER, V516, P127, DOI 10.3354/meps11035; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rigonato J, 2013, ENVIRON MICROBIOL, V15, P1103, DOI 10.1111/j.1462-2920.2012.02830.x; Rinke C, 2009, FEMS MICROBIOL ECOL, V67, P229, DOI 10.1111/j.1574-6941.2008.00628.x; Salman V, 2013, ANTON LEEUW INT J G, V104, P169, DOI 10.1007/s10482-013-9952-y; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; Saravanakumar C, 2012, SYST APPL MICROBIOL, V35, P396, DOI 10.1016/j.syapm.2012.05.006; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Stewart FJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00134; STROHL WR, 1981, CURR MICROBIOL, V6, P75, DOI 10.1007/BF01569007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; VARGAS A, 1985, ARCH MICROBIOL, V142, P279, DOI 10.1007/BF00693404; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yucel M, 2010, CHEM GEOL, V269, P364, DOI 10.1016/j.chemgeo.2009.10.010; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	70	15	16	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117832	10.1371/journal.pone.0117832	http://dx.doi.org/10.1371/journal.pone.0117832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689402	Green Published, gold			2022-12-27	WOS:000350322700076
J	Martin, JA; Ramsay, J; Hughes, C; Peters, DM; Edwards, MG				Martin, Jason A.; Ramsay, Jill; Hughes, Christopher; Peters, Derek M.; Edwards, Martin G.			Age and Grip Strength Predict Hand Dexterity in Adults	PLOS ONE			English	Article							UPPER EXTREMITY PERFORMANCE; MOTOR OUTPUT VARIABILITY; ESSENTIAL TREMOR; OLD ADULTS; NERVE-CONDUCTION; MUSCLE STRENGTH; ELDERLY-PEOPLE; NORMATIVE DATA; FORCE CONTROL; MOVEMENT	In the scientific literature, there is much evidence of a relationship between age and dexterity, where increased age is related to slower, less nimble and less smooth, less coordinated and less controlled performances. While some suggest that the relationship is a direct consequence of reduced muscle strength associated to increased age, there is a lack of research that has systematically investigated the relationships between age, strength and hand dexterity. Therefore, the aim of this study was to examine the associations between age, grip strength and dexterity. 107 adults (range 18-93 years) completed a series of hand dexterity tasks (i.e. steadiness, line tracking, aiming, and tapping) and a test of maximal grip strength. We performed three phases of analyses. Firstly, we evaluated the simple relationships between pairs of variables; replicating the existing literature; and found significant relationships of increased age and reduced strength; increased age and reduced dexterity, and; reduced strength and reduced dexterity. Secondly, we used standard Multiple Regression (MR) models to determine which of the age and strength factors accounted for the greater variance in dexterity. The results showed that both age and strength made significant contributions to the data variance, but that age explained more of the variance in steadiness and line tracking dexterity, whereas strength explained more of the variance in aiming and tapping dexterity. In a third phase of analysis, we used MR analyses to show an interaction between age and strength on steadiness hand dexterity. Simple Slopes post-hoc analyses showed that the interaction was explained by the middle to older aged adults showing a relationship between reduced strength and reduced hand steadiness, whereas younger aged adults showed no relationship between strength and steadiness hand dexterity. The results are discussed in terms of how age and grip strength predict different types of hand dexterity in adults.	[Martin, Jason A.] Univ Hosp Bonn, Dept Radiol, Funct Neuroimaging Grp, D-53127 Bonn, Germany; [Martin, Jason A.] Univ Tubingen, Ctr Integrat Neurosci, Hertie Inst Clin Brain Res, Div Neuropsychol, D-72076 Tubingen, Germany; [Ramsay, Jill] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Hughes, Christopher; Peters, Derek M.] Univ Worcester, Inst Sport & Exercise Sci, Worcester, England; [Peters, Derek M.] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Edwards, Martin G.] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Edwards, Martin G.] Catholic Univ Louvain, Inst Neurosci, Louvain La Neuve, Belgium	University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Birmingham; University of Worcester; University of Agder; Universite Catholique Louvain; Universite Catholique Louvain	Martin, JA (corresponding author), Univ Hosp Bonn, Dept Radiol, Funct Neuroimaging Grp, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jason.Martin@ukb.uni-bonn.de	Martin, Jason/AAV-1498-2021	Martin, Jason/0000-0001-8194-4297; Edwards, Martin/0000-0003-4532-2436; Peters, Derek/0000-0002-7873-7737	University of Birmingham; University of Worcester	University of Birmingham; University of Worcester	Funding for the individuals involved in the current study was received from the University of Birmingham and the University of Worcester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken L. S., 1991, MULTIPLE REGRESSION; AMRHEIN PC, 1991, PSYCHOL AGING, V6, P451, DOI 10.1037/0882-7974.6.3.451; ANNETT M, 1976, BRIT J PSYCHOL, V67, P587, DOI 10.1111/j.2044-8295.1976.tb01550.x; BARNSLEY RH, 1970, PERCEPT MOTOR SKILL, V30, P343, DOI 10.2466/pms.1970.30.2.343; Barry BK, 2007, J NEUROPHYSIOL, V97, P3206, DOI 10.1152/jn.01280.2006; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; BENNETT KMB, 1994, J GERONTOL, V49, pP1, DOI 10.1093/geronj/49.1.P1; Bilodeau M, 2000, MUSCLE NERVE, V23, P771, DOI 10.1002/(SICI)1097-4598(200005)23:5<771::AID-MUS15>3.0.CO;2-9; BOUCHE P, 1993, J NEUROL, V240, P263, DOI 10.1007/BF00838158; Bowden JL, 2013, EXP GERONTOL, V48, P756, DOI 10.1016/j.exger.2013.03.011; BROWN M, 1995, J GERONTOL A-BIOL, V50, P55; Carlton LG, 1993, FORCE VARIABILITY, P128; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0; Carnahan H, 1998, EXP AGING RES, V24, P289; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Christou E.A., 2002, PROG MOTOR CONTROL, V2, P195; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2002, J APPL PHYSIOL, V93, P489, DOI 10.1152/japplphysiol.00335.2001; Cohen J., 1983, APPL MULTIPLE REGRES; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; Desrosiers J, 1999, EXP GERONTOL, V34, P393, DOI 10.1016/S0531-5565(99)00018-2; Desrosiers J, 1998, J GERONTOL A-BIOL, V53, pB362, DOI 10.1093/gerona/53A.5.B362; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; Doherty TJ, 1997, J APPL PHYSIOL, V82, P93, DOI 10.1152/jappl.1997.82.1.93; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Dutta C, 1997, MUSCLE NERVE, pS5; Elble RJ, 2000, NEUROLOGY, V55, P1547, DOI 10.1212/WNL.55.10.1547; ELBLE RJ, 1995, EXP GERONTOL, V30, P337, DOI 10.1016/0531-5565(94)00055-8; ELBLE RJ, 1994, MOVEMENT DISORD, V9, P589, DOI 10.1002/mds.870090602; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farber SD, 1991, OCCUPATIONAL THERAPY; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fleishman E.A., 1972, PSYCHOMOTOR DOMAIN, P78; FLEISHMAN EA, 1962, J APPL PSYCHOL, V46, P96, DOI 10.1037/h0038499; FLEISHMAN EA, 1953, PSYCHOL BULL, V50, P241, DOI 10.1037/h0059989; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; Grabiner M D, 1995, Exerc Sport Sci Rev, V23, P65; Graves AE, 2000, J NEUROPHYSIOL, V83, P2030, DOI 10.1152/jn.2000.83.4.2030; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harridge SDR, 1998, PRINCIPLES PRACTICE, VII, P898; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HINSON M, 1989, OCCUP THER J RES, V9, P53, DOI 10.1177/153944928900900106; Hirsch CH, 1997, J GERONTOL A-BIOL, V52, pM192, DOI 10.1093/gerona/52A.4.M192; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; KAPLAN FS, 1985, ACTA ORTHOP SCAND, V56, P72, DOI 10.3109/17453678508992984; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; KEEN DA, 1994, J APPL PHYSIOL, V77, P2648, DOI 10.1152/jappl.1994.77.6.2648; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Kurokawa K, 1999, GERONTOLOGY, V45, P168, DOI 10.1159/000022081; Laidlaw DH, 1999, J APPL PHYSIOL, V87, P1786, DOI 10.1152/jappl.1999.87.5.1786; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Mackenzie R A, 1981, Clin Exp Neurol, V18, P109; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; MCDONAGH MJN, 1984, GERONTOLOGY, V30, P49, DOI 10.1159/000212606; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; Metter EJ, 1998, AGING-CLIN EXP RES, V10, P471, DOI 10.1007/BF03340161; Michimata A, 2008, TOHOKU J EXP MED, V214, P257, DOI 10.1620/tjem.214.257; Mitrushina M., 2005, HDB NORMATIVE DATA N; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; NORRIS AH, 1953, J APPL PHYSIOL, V5, P589, DOI 10.1152/jappl.1953.5.10.589; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Payne AM, 2004, EXERC SPORT SCI REV, V32, P36, DOI 10.1097/00003677-200401000-00008; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; Raczek J, 1998, THEORETICAL EMPIRICA; Raczek J., 2001, J HUM KINET, V6, P113; Raczek J, 1997, SCHRIFTEN DTSCH VERE, V87, P293; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; RIGAL RA, 1992, PERCEPT MOTOR SKILL, V75, P851, DOI 10.2466/pms.1992.75.3.851; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; Schoppe K. P., 1974, DIAGNOSTICA, V20, P43; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Spirduso WW, 1995, PHYS DIMENSIONS AGIN; Tracy BL, 2001, MED SCI SPORT EXER, V33, pS254, DOI 10.1097/00005768-200105001-01429; Trombly C., 1989, OCCUPATIONAL THERAPY; van Galen GP, 2000, BIOL PSYCHOL, V51, P151, DOI 10.1016/S0301-0511(99)00037-X; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Voelcker-Rehage C, 2005, EXP BRAIN RES, V166, P61, DOI 10.1007/s00221-005-2342-6; Wishart LR, 2000, J GERONTOL B-PSYCHOL, V55, pP85, DOI 10.1093/geronb/55.2.P85; Zoltan B, 1990, OCCUPATIONAL THERAPY	95	60	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117598	10.1371/journal.pone.0117598	http://dx.doi.org/10.1371/journal.pone.0117598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689161	Green Published, Green Accepted, gold			2022-12-27	WOS:000350322700061
J	Wenz, H; Ehrlich, G; Wenz, R; al Mahdi, MM; Scharf, J; Groden, C; Schmiedek, P; Seiz-Rosenhagen, M				Wenz, Holger; Ehrlich, Gregory; Wenz, Ralf; al Mahdi, Mohamad-Motaz; Scharf, Johann; Groden, Christoph; Schmiedek, Peter; Seiz-Rosenhagen, Marcel			MR Angiography Follow-Up 10 Years after Cryptogenic Nonperimesencephalic Subarachnoid Hemorrhage	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; PERIMESENCEPHALIC HEMORRHAGE; REPEAT ANGIOGRAPHY; DIAGNOSIS; ENLARGEMENT; FREQUENCY; PATTERNS; ETIOLOGY; COILS	Objectives Long-term magnetic resonance angiography (MRA) follow-up studies regarding cryptogenic nonperimesencephalic subarachnoid hemorrhage (nSAH) are scarce. This single-centre study identified all patients with angiographically verified cryptogenic nSAH from 1998 to 2007: The two main objectives were to prospectively assess the incidence of de novo aneurysm with 3.0-MRI years after cryptogenic nSAH in patients without evidence for further hemorrhage, and retrospectively assess patient demographics and outcome. Methods From prospectively maintained report databases all patients with angiographically verified cryptogenic nSAH were identified. 21 of 29 patients received high-resolution 3T-MRI including time-of-flight and contrast-enhanced angiography, 10.2 +/- 2.8 years after cryptogenic nSAH. MRA follow-up imaging was compared with initial digital subtraction angiography (DSA) and CT/MRA. Post-hemorrhage images were related to current MRI with reference to persistent lesions resulting from delayed cerebral ischemia (DCI) and post-hemorrhagic siderosis. Patient-based objectives were retrospectively abstracted from clinical databases. Results 29 patients were identified with cryptogenic nSAH, 17 (59%) were male. Mean age at time of hemorrhage was 52.9 +/- 14.4 years (range 4 - 74 years). 21 persons were available for long-term follow-up. In these, there were 213.5 person years of MRI-follow-up. No de novo aneurysm was detected. Mean modified Rankin Scale (mRS) during discharge was 1.28. Post-hemorrhage radiographic vasospasm was found in three patients (10.3%); DCI-related lesions occurred in one patient (3.4%). Five patients (17.2%) needed temporary external ventricular drainage; long-term CSF shunt dependency was necessary only in one patient 3.4%). Initial DSA retrospectively showed a 2 x 2 mm aneurysm of the right distal ICA in one patient, which remained stable. Post-hemorrhage siderosis was detected 8.1 years after the initial bleeding in one patient (4.8%). Conclusion Patients with cryptogenic nSAH have favourable outcomes and do not exhibit higher risks for de novo aneurysms. Therefore the need for long-term follow up after cryptogenic nSAH is questionable.	[Wenz, Holger; Wenz, Ralf; Scharf, Johann; Groden, Christoph] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany; [Ehrlich, Gregory; al Mahdi, Mohamad-Motaz; Schmiedek, Peter; Seiz-Rosenhagen, Marcel] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wenz, H (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany.	Holger-Wenz@gmx.de						Andaluz N, 2008, NEUROSURGERY, V62, P1040, DOI 10.1227/01.neu.0000325865.22011.1f; Bakker NA, 2014, J NEUROSURG, V120, P99, DOI 10.3171/2013.9.JNS131337; Canovas D, 2012, EUR J NEUROL, V19, P457, DOI 10.1111/j.1468-1331.2011.03542.x; Dalyai R, 2013, NEUROSURGERY, V72, P646, DOI 10.1227/NEU.0b013e3182846de8; Ferre JC, 2009, EUR J RADIOL, V72, P365, DOI 10.1016/j.ejrad.2008.08.005; Fontanella M, 2011, NEUROSURG REV, V34, P477, DOI 10.1007/s10143-011-0323-8; Li MH, 2014, RADIOLOGY, V271, P553, DOI 10.1148/radiol.14122770; Lindvall P, 2012, VASC ENDOVASC SURG, V46, P325, DOI 10.1177/1538574412445602; Luo ZR, 2012, EUR J RADIOL, V81, P118, DOI 10.1016/j.ejrad.2011.05.003; Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Plowman RS, 2011, J NEUROSURG, V114, P863, DOI 10.3171/2010.6.JNS091058; Pyysalo LM, 2011, J NEUROL NEUROSUR PS, V82, P1264, DOI 10.1136/jnnp.2010.239335; RINKEL GJE, 1991, LANCET, V338, P964, DOI 10.1016/0140-6736(91)91836-J; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Ruigrok YM, 2002, CEREBROVASC DIS, V14, P221, DOI 10.1159/000065668; Schievink WI, 1997, STROKE, V28, P2572; Schwab KE, 2008, NEUROSURGERY, V63, P29, DOI 10.1227/01.NEU.0000335068.53190.46; Schwartz TH, 1996, NEUROSURGERY, V39, P433, DOI 10.1097/00006123-199609000-00001; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; So TY, 2010, J CLIN NEUROSCI, V17, P29, DOI 10.1016/j.jocn.2009.04.010; Sprengers ME, 2009, AM J NEURORADIOL, V30, P303, DOI 10.3174/ajnr.A1353; Urbach H, 2008, NEURORADIOLOGY, V50, P383, DOI 10.1007/s00234-007-0355-5; Urbach H, 1998, NEURORADIOLOGY, V40, P6, DOI 10.1007/s002340050528; van der Schaaf IC, 2004, STROKE, V35, P1614, DOI 10.1161/01.STR.0000131657.08655.ce; VANCALENBERGH F, 1993, SURG NEUROL, V39, P320, DOI 10.1016/0090-3019(93)90014-R; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; Wenz H, 2014, CLIN NEURORADIOL; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Yeung R, 2009, CAN J NEUROL SCI, V36, P176, DOI 10.1017/S0317167100006533	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117925	10.1371/journal.pone.0117925	http://dx.doi.org/10.1371/journal.pone.0117925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688554	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700083
J	Arriero, E; Muller, I; Juvaste, R; Martinez, FJ; Bertolero, A				Arriero, Elena; Mueller, Inge; Juvaste, Risto; Javier Martinez, Francisco; Bertolero, Albert			Variation in Immune Parameters and Disease Prevalence among Lesser Black-Backed Gulls (Larus fuscus sp.) with Different Migratory Strategies	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HEMAGGLUTININ SUBTYPE; AVIAN MALARIA; LIFE-HISTORY; ANNUAL-CYCLE; WILD; RESISTANCE; ANTIBODIES; INFECTION; PARASITES	The ability to control infections is a key trait for migrants that must be balanced against other costly features of the migratory life. In this study we explored the links between migration and disease ecology by examining natural variation in parasite exposure and immunity in several populations of Lesser Black-backed Gulls (Larus fuscus) with different migratory strategies. We found higher activity of natural antibodies in long distance migrants from the nominate subspecies L.f.fuscus. Circulating levels of IgY showed large variation at the population level, while immune parameters associated with antimicrobial activity showed extensive variation at the individual level irrespective of population or migratory strategy. Pathogen prevalence showed large geographical variation. However, the seroprevalence of one of the gull-specific subtypes of avian influenza (H16) was associated to the migratory strategy, with lower prevalence among the long-distance migrants, suggesting that migration may play a role in disease dynamics of certain pathogens at the population level.				elena.arriero@bio.ucm.es	Martinez, Javier/H-2827-2015; Bertolero, Albert/I-6448-2019; Arriero, Elena/J-8224-2016	Martinez, Javier/0000-0003-2657-1154; Bertolero, Albert/0000-0002-6834-2600; Arriero, Elena/0000-0003-4230-6537; Juvaste, Risto/0000-0001-9740-501X	Max Planck Institute for Ornithology (Wikelski group); EU-funded SYNTHESYS grant; Spanish Ministry of Economy and Competitiveness [BFU2011-25957]; Wissenschaftskolleg zu Berlin	Max Planck Institute for Ornithology (Wikelski group); EU-funded SYNTHESYS grant; Spanish Ministry of Economy and Competitiveness(Spanish Government); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	This study was supported by the Max Planck Institute for Ornithology (Wikelski group), an EU-funded SYNTHESYS grant to EA, and by the Spanish Ministry of Economy and Competitiveness (project BFU2011-25957 to EA). During writing, EA was supported by the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1993, BIRD MIGRATION; Alexander D.J., 1988, NEWCASTLE DIS; Altizer SM, 2001, EVOL ECOL RES, V3, P611; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Ardia DR, 2007, ECOGRAPHY, V30, P23, DOI 10.1111/j.2006.0906-7590.04939.x; Arnal A, 2014, CRIT REV MICROBIOL, V7828, P1; Arriero E, 2008, J EVOLUTION BIOL, V21, P1504, DOI 10.1111/j.1420-9101.2008.01613.x; Atkinson Carter T., 2008, P13; Barbosa A, 2007, POLAR BIOL, V30, P219, DOI 10.1007/s00300-006-0175-9; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2009, J ORNITHOL, V150, P815, DOI 10.1007/s10336-009-0402-6; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Bustnes JO, 2013, IBIS, V155, P402, DOI 10.1111/ibi.12022; Campbell T, 2007, AVIAN EXOTIC ANIMAL, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; CEC, 2006, OFF J EUR COMMUNITIE; Cramp S., 1988, HDB BIRDS EUROPE; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; Grasman KA, 2000, COMP BIOCHEM PHYS C, V125, P365, DOI 10.1016/S0742-8413(99)00118-8; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Klaassen M, 2012, PHILOS T R SOC B, V367, P1719, DOI 10.1098/rstb.2012.0008; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Klein, 2012, ECOIMMUNOLOGY, P497; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Liebers D, 2002, J EVOLUTION BIOL, V15, P1021, DOI 10.1046/j.1420-9101.2002.00454.x; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Malling OK, 2003, GULLS EUROPE ASIA N; Martinez J, 2003, FUNCT ECOL, V17, P700, DOI 10.1046/j.1365-2435.2003.00771.x; Martinez J, 2009, PARASITOLOGY, V136, P713, DOI 10.1017/S0031182009006118; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; McFerran J, 1988, NEWCASTLE DIS; McWilliams Scott R., 2005, P67; Mendes L, 2005, OIKOS, V109, P396, DOI 10.1111/j.0030-1299.2005.13509.x; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Murphy K, 2008, JANEWAYS IMMUNOBIOLO, DOI [10.1080/13803390802438454, DOI 10.1080/13803390802438454]; O'Neal DM, 2012, ECOIMMUNOLOGY, P7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; OIE World Organization for Animal Health, 2008, MAN DIAGN TESTS VACC, P576, DOI DOI 10.1111/J.1440-1681.2008.05117.X; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Quillfeldt P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-26; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Ricklefs Robert E., 2005, P210; Turner AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002343; Valkiunas G, 2004, AVIAN MALARIA PARASI; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Verhagen JH, 2014, EMERG INFECT DIS, V20, P138, DOI 10.3201/eid2001.130984; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilcove D.S., 2008, NO WAY HOME DECLINE; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Yohannes E, 2009, J ORNITHOL, V150, P287, DOI 10.1007/s10336-008-0349-z	72	9	9	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118279	10.1371/journal.pone.0118279	http://dx.doi.org/10.1371/journal.pone.0118279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679797	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000350682600115
J	Hammer, N; Glatzner, J; Feja, C; Kuhne, C; Meixensberger, J; Planitzer, U; Schleifenbaum, S; Tillmann, BN; Winkler, D				Hammer, Niels; Glaetzner, Juliane; Feja, Christine; Kuehne, Christian; Meixensberger, Juergen; Planitzer, Uwe; Schleifenbaum, Stefan; Tillmann, Bernhard N.; Winkler, Dirk			Human Vagus Nerve Branching in the Cervical Region	PLOS ONE			English	Article							INFERIOR LARYNGEAL NERVE; PRIMARY HEADACHE DISORDERS; SURGICAL ANATOMY; RESISTANT EPILEPSY; STIMULATION; EFFICACY; NEUROSTIMULATION; GLOSSOPHARYNGEAL; FORMALDEHYDE; BRADYCARDIA	Background Vagus nerve stimulation is increasingly applied to treat epilepsy, psychiatric conditions and potentially chronic heart failure. After implanting vagus nerve electrodes to the cervical vagus nerve, side effects such as voice alterations and dyspnea or missing therapeutic effects are observed at different frequencies. Cervical vagus nerve branching might partly be responsible for these effects. However, vagus nerve branching has not yet been described in the context of vagus nerve stimulation. Materials and Methods Branching of the cervical vagus nerve was investigated macroscopically in 35 body donors (66 cervical sides) in the carotid sheath. After X-ray imaging for determining the vertebral levels of cervical vagus nerve branching, samples were removed to confirm histologically the nerve and to calculate cervical vagus nerve diameters and cross-sections. Results Cervical vagus nerve branching was observed in 29% of all cases (26% unilaterally, 3% bilaterally) and proven histologically in all cases. Right-sided branching (22%) was more common than left-sided branching (12%) and occurred on the level of the fourth and fifth vertebra on the left and on the level of the second to fifth vertebra on the right side. Vagus nerves without branching were significantly larger than vagus nerves with branches, concerning their diameters (4.79mm vs. 3.78mm) and cross-sections (7.24 mm(2) vs. 5.28 mm(2)). Discussion Cervical vagus nerve branching is considerably more frequent than described previously. The side-dependent differences of vagus nerve branching may be linked to the asymmetric effects of the vagus nerve. Cervical vagus nerve branching should be taken into account when identifying main trunk of the vagus nerve for implanting electrodes to minimize potential side effects or lacking therapeutic benefits of vagus nerve stimulation.	[Hammer, Niels; Feja, Christine; Planitzer, Uwe] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Glaetzner, Juliane; Meixensberger, Juergen; Planitzer, Uwe; Winkler, Dirk] Univ Clin Leipzig, Fac Med, Dept Neurosurg, Leipzig, Germany; [Kuehne, Christian] Univ Clin Leipzig, Fac Med, Dept Cardiol, Leipzig, Germany; [Schleifenbaum, Stefan] Univ Clin Leipzig, Dept Orthoped Trauma & Reconstruct Surg, Leipzig, Germany; [Tillmann, Bernhard N.] Univ Kiel, Inst Anat, Kiel, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Kiel	Hammer, N (corresponding author), Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany.	nlshammer@googlemail.com		Hammer, Niels/0000-0001-8230-9383; Schleifenbaum, Stefan/0000-0002-9075-3756				Alexopoulos AV, 2006, SEIZURE-EUR J EPILEP, V15, P491, DOI 10.1016/j.seizure.2006.06.002; Arakawa T, 2008, ANAT SCI INT, V83, P112, DOI 10.1111/j.1447-073X.2007.00183.x; Ardesch JJ, 2007, CLIN NEUROL NEUROSUR, V109, P849, DOI 10.1016/j.clineuro.2007.07.024; Asconape JJ, 1999, EPILEPSIA, V40, P1452, DOI 10.1111/j.1528-1157.1999.tb02019.x; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bliss RD, 2000, WORLD J SURG, V24, P891, DOI 10.1007/s002680010173; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bos I, 2008, PATHOLOGE, V29, P280, DOI 10.1007/s00292-007-0921-y; Cernea CR, 2009, ARCH OTOLARYNGOL, V135, P1098, DOI 10.1001/archoto.2009.151; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; Chambers A, 2013, Ont Health Technol Assess Ser, V13, P1; Coady MA, 2000, J VASC SURG, V32, P192, DOI 10.1067/mva.2000.105680; Crumrine P K, 2000, Semin Pediatr Neurol, V7, P216, DOI 10.1053/spen.2000.9218; DALY MD, 1953, J PHYSIOL-LONDON, V120, P579; Diamond M, 2011, CLIN ANAT, V24, P10, DOI 10.1002/ca.21072; Dionigi G, 2010, LANGENBECK ARCH SURG, V395, P893, DOI 10.1007/s00423-010-0693-3; Elliott RE, 2011, J NEUROSURG-PEDIATR, V7, P491, DOI 10.3171/2011.2.PEDS10505; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; EVANS DHL, 1954, J ANAT, V88, P320; FERNANDO DA, 1994, ANN ANAT, V176, P333, DOI 10.1016/S0940-9602(11)80511-X; Fick W.B., 1925, Z MIKROSK ANAT FORSC, V2, P429; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; George MS, 2000, BIOL PSYCHIAT, V47, P287, DOI 10.1016/S0006-3223(99)00308-X; Geraci G, 2011, G CHIR, V32, P251; Gerson R, 2011, EPILEPSY BEHAV, V20, P138, DOI 10.1016/j.yebeh.2010.11.005; Hafferl A, 1969, LEHRBUCH TOPOGRAPHIS, VXVI; Hammer N, 2012, J MECH BEHAV BIOMED, V16, P81, DOI 10.1016/j.jmbbm.2012.04.025; Hammer N, 2012, ANAT SCI EDUC, V5, P225, DOI 10.1002/ase.1270; Hammer N, 2011, JNCI-J NATL CANCER I, V103, P610, DOI 10.1093/jnci/djr035; Howland Robert H, 2014, Curr Behav Neurosci Rep, V1, P64; JANES RD, 1986, AM J CARDIOL, V57, P299, DOI 10.1016/0002-9149(86)90908-2; Jenkins B, 2011, HEADACHE, V51, P1408, DOI 10.1111/j.1526-4610.2011.01967.x; Jenkins B, 2011, HEADACHE, V51, P1254, DOI 10.1111/j.1526-4610.2011.01966.x; JO A, 1971, Anatomischer Anzeiger, V129, P180; Kahlow H, 2013, SEIZURE-EUR J EPILEP, V22, P827, DOI 10.1016/j.seizure.2013.06.011; Kim W, 2001, AM J OPHTHALMOL, V131, P383, DOI 10.1016/S0002-9394(00)00782-0; Kobayashi M, 2007, ACTA OTO-LARYNGOL, V127, P332, DOI 10.1080/00016480600801415; Labar Douglas, 2002, Curr Neurol Neurosci Rep, V2, P357, DOI 10.1007/s11910-002-0011-8; LANG J, 1987, ACTA ANAT, V130, P309; Lang J, 1986, Gegenbaurs Morphol Jahrb, V132, P617; Larson TC, 2002, SEMIN ULTRASOUND CT, V23, P238, DOI 10.1016/S0887-2171(02)90049-1; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-86; MEI N, 1980, CELL TISSUE RES, V209, P423; Milby AH, 2009, NEUROTHERAPEUTICS, V6, P228, DOI 10.1016/j.nurt.2009.01.010; Miner JR, 2012, ACAD EMERG MED, V19, P421, DOI 10.1111/j.1553-2712.2012.01329.x; Miyake N, 2010, ANAT REC, V293, P438, DOI 10.1002/ar.21089; Onkka P, 2013, HEART RHYTHM, V10, P585, DOI 10.1016/j.hrthm.2012.12.015; Qiabi M, 2011, CAN J NEUROL SCI, V38, P902, DOI 10.1017/S0317167100012506; Rauber A, 1987, ANATOMIE MENSCHEN LE, VXII; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; Sabbah Hani N, 2011, Cleve Clin J Med, V78 Suppl 1, pS24, DOI 10.3949/ccjm.78.s1.04; Schwartz PJ, 2011, CURR OPIN CARDIOL, V26, P51, DOI 10.1097/HCO.0b013e3283413961; Schweizer V, 1997, CLIN OTOLARYNGOL, V22, P362, DOI 10.1046/j.1365-2273.1997.00028.x; Seki A, 2014, HEART RHYTHM, V11, P1411, DOI 10.1016/j.hrthm.2014.04.032; Shindo ML, 2005, OTOLARYNG HEAD NECK, V133, P514, DOI 10.1016/j.otohns.2005.07.010; Spalteholz W, 1909, EINGEWEIDE GEHIRN NE; Spuck SN, 2007, J NEUROLOGIE NEUROCH, V8, P16, DOI [10.1371/ journal. pone. 0116716, DOI 10.1371/J0URNAL.P0NE.0116716]; STOHR PHILIPP, 1927, ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V5, P117, DOI 10.1007/BF00398904; Tanganelli P, 2002, CLIN NEUROL NEUROSUR, V105, P9, DOI 10.1016/S0303-8467(02)00018-5; Vonck K, 2001, J CLIN NEUROPHYSIOL, V18, P394, DOI 10.1097/00004691-200109000-00002; Wachsmuth W, 1985, UBERGEORDNETE SYSTEM, VXXII; Waldeyer A, 1967, KOPF HALS AUGEN OHR, VXV; Waseem H, 2014, EPILEPSY BEHAV, V31, P110, DOI 10.1016/j.yebeh.2013.12.002; Weiand G, 2004, CHIRURG, V75, P187, DOI 10.1007/s00104-003-0776-6; Yetisir F, 2012, INT J SURG, V10, P506, DOI 10.1016/j.ijsu.2012.07.006; YOSHIDA Y, 1992, FOLIA PHONIATR, V44, P194, DOI 10.1159/000266152; Zenker W, 1985, NERVENSYSTEM HAUT SI, VXVI	67	40	40	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118006	10.1371/journal.pone.0118006	http://dx.doi.org/10.1371/journal.pone.0118006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679804	Green Published, gold			2022-12-27	WOS:000350682600101
J	Pannu, J; Belle, JI; Forster, M; Duerr, CU; Shen, SY; Kane, L; Harcourt, K; Fritz, JH; Clare, S; Nijnik, A				Pannu, Jaspreet; Belle, Jad I.; Foerster, Michael; Duerr, Claudia U.; Shen, Shiyang; Kane, Leanne; Harcourt, Katherine; Fritz, Joerg H.; Clare, Simon; Nijnik, Anastasia			Ubiquitin Specific Protease 21 Is Dispensable for Normal Development, Hematopoiesis and Lymphocyte Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; KAPPA-B ACTIVATION; POLYUBIQUITIN BINDING; GENE-EXPRESSION; GENOME-WIDE; CELL-DEATH; T-CELLS; USP21; DEUBIQUITINASE; RIP1	USP21 is a ubiquitin specific protease that catalyzes protein deubiquitination, however the identification of its physiological substrates remains challenging. USP21 is known to deubiquitinate transcription factor GATA3 and death-domain kinase RIPK1 in vitro, however the in vivo settings where this regulation plays a biologically significant role remain unknown. In order to determine whether USP21 is an essential and non-redundant regulator of GATA3 or RIPK1 activity in vivo, we characterized Usp21-deficient mice, focusing on mouse viability and development, hematopoietic stem cell function, and lymphocyte differentiation. The Usp21-knockout mice were found to be viable and fertile, with no significant dysmorphology, in contrast to the GATA3 and RIPK1 knockout lines that exhibit embryonic or perinatal lethality. Loss of USP21 also had no effect on hematopoietic stem cell function, lymphocyte development, or the responses of antigen presenting cells to TLR and TNFR stimulation. GATA3 levels in hematopoietic stem cells or T lymphocytes remained unchanged. We observed that aged Usp21-knockout mice exhibited spontaneous T cell activation, however this was not linked to altered GATA3 levels in the affected cells. The contrast in the phenotype of the Usp21-knockout line with the previously characterized GATA3 and RIPK1 knockout mice strongly indicates that USP21 is redundant for the regulation of GATA3 and RIPK1 activity during mouse development, in hematopoietic stem cells, and in lymphocyte differentiation. The Usp21-deficient mouse line characterized in this study may serve as a useful tool for the future characterization of USP21 physiological functions.	[Pannu, Jaspreet; Belle, Jad I.; Foerster, Michael; Shen, Shiyang; Nijnik, Anastasia] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Pannu, Jaspreet] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Belle, Jad I.; Foerster, Michael; Duerr, Claudia U.; Shen, Shiyang; Fritz, Joerg H.; Nijnik, Anastasia] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Duerr, Claudia U.; Fritz, Joerg H.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kane, Leanne; Harcourt, Katherine; Clare, Simon] Wellcome Trust Sanger Inst, Hinxton, England	McGill University; McGill University; McGill University; McGill University; Wellcome Trust Sanger Institute	Nijnik, A (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	anastasiya.nyzhnyk@mcgill.ca	Nijnik, Anastasia/W-2697-2019; Pannu, Jaspreet/AAJ-5296-2020	Belle, Jad/0000-0001-8944-9792; Pannu, Jaspreet/0000-0002-1030-8776	McGill University; Canadian Institutes of Health Research (CIHR); Wellcome Trust [098051]; International Postdoctoral Fellowship from the German Research Association [DFG FO 900/1-1]; Canadian Institutes of Health Research; German National Academy of Sciences Leopoldina	McGill University; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); International Postdoctoral Fellowship from the German Research Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German National Academy of Sciences Leopoldina	The work was funded by Startup Funds from McGill University, an Operating Grant from the Canadian Institutes of Health Research (CIHR), and the Wellcome Trust 098051. AN is a Canada Research Chair in Hematopoiesis and Lymphocyte Development, Tier 2. MF is a recipient of International Postdoctoral Fellowship from the German Research Association (grant number DFG FO 900/1-1). CUD was supported by the Canadian Institutes of Health Research and the German National Academy of Sciences Leopoldina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okuda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079813; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tao LQ, 2014, INT J CLIN EXP PATHO, V7, P4930; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Wan YY, 2014, TRENDS IMMUNOL, V35, P233, DOI 10.1016/j.it.2014.04.002; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 2013, J BIOL CHEM, V288, P9373, DOI 10.1074/jbc.M112.374744; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	38	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117304	10.1371/journal.pone.0117304	http://dx.doi.org/10.1371/journal.pone.0117304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680095	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600061
J	Yeh, HM; Chang, YC; Lin, C; Yeh, CH; Lee, CN; Shyu, MK; Hung, MH; Hsiao, PN; Wang, YH; Tseng, YH; Tsao, J; Lai, LP; Lin, LY; Lo, MT				Yeh, Huei-Ming; Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Lee, Chien-Nan; Shyu, Ming-Kwang; Hung, Ming-Hui; Hsiao, Po-Ni; Wang, Yung-Hung; Tseng, Yu-Hsin; Tsao, Jenho; Lai, Ling-Ping; Lin, Lian-Yu; Lo, Men-Tzung			A New Method to Derive Fetal Heart Rate from Maternal Abdominal Electrocardiogram: Monitoring Fetal Heart Rate during Cesarean Section	PLOS ONE			English	Article							RATE-VARIABILITY; ECG EXTRACTION; POINCARE PLOT; HEMODIALYSIS; DYNAMICS	Background Monitoring of fetal heart rate (FHR) is important during labor since it is a sensitive marker to obtain significant information about fetal condition. To take immediate response during cesarean section (CS), we noninvasively derive FHR from maternal abdominal ECG. Methods We recruited 17 pregnant women delivered by elective cesarean section, with abdominal ECG obtained before and during the entire CS. First, a QRS-template is created by averaging all the maternal ECG heart beats. Then, Hilbert transform was applied to QRS-template to generate the other basis which is orthogonal to the QRS-template. Second, maternal QRS, P and T waves were adaptively subtracted from the composited ECG. Third, Gabor transformation was applied to obtain time-frequency spectrogram of FHR. Heart rate variability (HRV) parameters including standard deviation of normal-to-normal intervals (SDNN), 0V, 1V, 2V derived from symbolic dynamics of HRV and SD1, SD2 derived from Poincare plot. Three emphasized stages includes: (1) before anesthesia, (2) 5 minutes after anesthesia and (3) 5 minutes before CS delivery. Results FHRs were successfully derived fromall maternal abdominal ECGs. FHR increased 5 minutes after anesthesia and 5 minutes before delivery. As for HRV parameters, SDNN increased both 5 minutes after anesthesia and 5 minutes before delivery (21.30 +/- 9.05 vs. 13.01 +/- 6.89, P < 0.001 and 22.88 +/- 12.01 vs. 13.01 +/- 6.89, P < 0.05). SD1 did not change during anesthesia, while SD2 increased significantly 5 minutes after anesthesia (27.92 +/- 12.28 vs. 16.18 +/- 10.01, P < 0.001) and both SD2 and 0V percentage increased significantly 5 minutes before delivery (30.54 +/- 15.88 vs. 16.18 +/- 10.01, P < 0.05; 0.39 +/- 0.14 vs. 0.30 +/- 0.13, P < 0.05). Conclusions We developed a novel method to automatically derive FHR from maternal abdominal ECGs and proved that it is feasible during CS.	[Yeh, Huei-Ming; Hung, Ming-Hui; Hsiao, Po-Ni] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chang, Yi-Chung; Tsao, Jenho] Natl Taiwan Univ, Grad Inst Commun Engn, Taipei 10764, Taiwan; [Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Wang, Yung-Hung; Tseng, Yu-Hsin; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan; [Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Wang, Yung-Hung; Tseng, Yu-Hsin; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan, Taiwan; [Yeh, Chien-Hung] Natl Cent Univ, Dept Elect Engn, Taoyuan, Taiwan; [Lee, Chien-Nan; Shyu, Ming-Kwang] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tseng, Yu-Hsin; Lai, Ling-Ping; Lin, Lian-Yu] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Central University; National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lin, LY (corresponding author), Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan.	hspenos@gmail.com; mzlo@ncu.edu.tw	Wang, Pa-Chun/AAD-4094-2019; huang, yuting/T-4341-2019; Hung, Ming-Hui/AAS-4520-2020	Hung, Ming-Hui/0000-0002-2575-3004; Yeh, Chien-Hung/0000-0002-6886-2964; LAI, LING-PING/0000-0002-9651-7420; SHYU, MING-KWANG/0000-0001-9057-4101; LIN, LIAN-YU/0000-0001-7505-6429; Lin, Chen/0000-0001-6261-8509; HSIAO, PO-NI/0000-0001-6630-0047; Lee, Chien-Nan/0000-0002-1725-0407	National Science Council [NSC 100-2221-E-008-008-MY2, NSC 101-2911-I-008-001]; CGH [CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3]; NCU [CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3]	National Science Council(Ministry of Science and Technology, Taiwan); CGH; NCU	Funding was provided by the National Science Council (NSC 100-2221-E-008-008-MY2, NSC 101-2911-I-008-001), joint foundation of CGH and NCU (CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD S, 1990, COMPUT BIOL MED, V20, P147, DOI 10.1016/0010-4825(90)90001-6; ABBOUD S, 1992, COMPUT BIOL MED, V22, P325, DOI 10.1016/0010-4825(92)90021-E; Abrao KC, 2009, OBSTET GYNECOL, V113, P41, DOI 10.1097/AOG.0b013e31818f5eb6; Aljadeff G, 1997, SLEEP, V20, P151, DOI 10.1093/sleep/20.2.151; Amer-Wahlin I, 2002, J Matern Fetal Neonatal Med, V12, P260, DOI 10.1080/713605678; BERGVELD P, 1981, IEEE T BIO-MED ENG, V28, P348, DOI 10.1109/TBME.1981.324803; Castells F, 2005, MED BIOL ENG COMPUT, V43, P557, DOI 10.1007/BF02351028; Chang YC, U.S. Patent Application, Patent No. [13/682,757, 13682757]; Cheng F, 1992, IEEE T IMAGE PROCESS, V1, P533, DOI 10.1109/83.199924; Clifford G, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.066; DOWNS HS, 1963, CALIF MED, V99, P374; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Hayano J, 1999, NEPHROL DIAL TRANSPL, V14, P1480, DOI 10.1093/ndt/14.6.1480; HUTSON JM, 1982, CLIN PERINATOL, V9, P325, DOI 10.1016/S0095-5108(18)31028-5; Ibrahimy MI, 2003, IEEE T BIO-MED ENG, V50, P258, DOI 10.1109/TBME.2002.807642; Kamen P, 1996, Aust Fam Physician, V25, P1087; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Kanjilal PP, 1997, IEEE T BIO-MED ENG, V44, P51, DOI 10.1109/10.553712; Karmakar CK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-17; Karmakar CK, 2010, J ELECTROCARDIOL, V43, P719, DOI 10.1016/j.jelectrocard.2010.09.001; Karvounis EC, 2009, IEEE T BIO-MED ENG, V56, P1394, DOI 10.1109/TBME.2009.2014691; Kotas M, 2007, B POL ACAD SCI-TECH, V55, P331; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Muralikrishnan Krishnan, 2013, Indian J Physiol Pharmacol, V57, P31; Selesnick IW, 2001, IEEE SIGNAL PROC LET, V8, P170, DOI 10.1109/97.923042; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P954, DOI 10.1111/j.1540-8167.2005.40788.x; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Wu SC, 2013, COMPUT BIOL MED, V43, P1622, DOI 10.1016/j.compbiomed.2013.07.028	28	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117509	10.1371/journal.pone.0117509	http://dx.doi.org/10.1371/journal.pone.0117509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680192	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600069
J	Bordi, L; Caglioti, C; Garbuglia, AR; Lapa, D; Castilletti, C; Taibi, C; Capobianchi, MR; Lalle, E				Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Lapa, Daniele; Castilletti, Concetta; Taibi, Chiara; Capobianchi, Maria Rosaria; Lalle, Eleonora			IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BLOOD MONONUCLEAR-CELLS; PEGYLATED INTERFERON-ALPHA; VIROLOGICAL RESPONSE; GENETIC-VARIATION; LAMBDA RECEPTOR; VIRAL CLEARANCE; IN-VITRO; IL28B; GENOTYPE	Single-nucleotide polymorphism in IFNL3 gene (rs12979860) predicts spontaneous and therapy-induced HCV clearance. In a previous study from our group PBMC from patients with favourable rs12979860 genotype showed higher levels of IFNAR-1 mRNA. Recently, a dinucleotide polymorphism, ss469415590 (TT or Delta G), has been discovered in the region upstream IFNL3 gene, which is in high linkage disequilibrium with rs12979860. ss469415590[Delta G] is a frameshift variant that creates a novel gene, designed IFNL4, encoding the interferon-lambda 4 protein (IFNL4). The aim of the present study was to extend the analysis of IFNAR-1 mRNA levels to the ss469415590 variants. Our results highlight that the difference of IFNAR-1 mRNA levels between favourable and unfavourable genotype combinations, at both rs12979860 and ss469415590 loci, is stronger than that observed for single polymorphisms at each locus. These findings suggest may represent the biological basis for the observed association between IFNL3 CC and IFNL4 TT/TT genotypes and favourable outcome of either natural HCV infection (clearance vs chronic evolution) or IFN-based therapy.	[Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Lapa, Daniele; Castilletti, Concetta; Capobianchi, Maria Rosaria; Lalle, Eleonora] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Taibi, Chiara] Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016; Bordi, Licia/B-6827-2017; GARBUGLIA, ANNA ROSA/AAC-6556-2022	Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Bordi, Licia/0000-0003-3962-3646; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642; Capobianchi, Maria Rosaria/0000-0003-3465-0071; lalle, eleonora/0000-0002-7063-9905	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata(Ministry of Health, Italy)	This work was partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080078; Chinnaswamy S, 2014, J INTERF CYTOK RES, V34, P479, DOI 10.1089/jir.2013.0113; Cimini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037014; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Holder KA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/903764; Inglot M, 2013, POSTEP HIG MED DOSW, V67, P186, DOI 10.5604/17322693.1038785; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lalle E, 2008, J BIOL REG HOMEOS AG, V22, P153; Lalle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093434; Lange CM, 2011, J HEPATOL, V55, P692, DOI 10.1016/j.jhep.2011.03.006; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Pawelczyk A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-346; Pawlotsky JM, 1996, ANTIMICROB AGENTS CH, V40, P320, DOI 10.1128/AAC.40.2.320; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Petry H, 2006, J INTERF CYTOK RES, V26, P699, DOI 10.1089/jir.2006.26.699; Piazzolla G, 2000, J CLIN IMMUNOL, V20, P54, DOI 10.1023/A:1006694627907; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117397	10.1371/journal.pone.0117397	http://dx.doi.org/10.1371/journal.pone.0117397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675103	Green Submitted, gold, Green Published			2022-12-27	WOS:000349914000021
J	Boehm, JK; Chen, Y; Williams, DR; Ryff, C; Kubzansky, LD				Boehm, Julia K.; Chen, Ying; Williams, David R.; Ryff, Carol; Kubzansky, Laura D.			Unequally Distributed Psychological Assets: Are There Social Disparities in Optimism, Life Satisfaction, and Positive Affect?	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DISPOSITIONAL OPTIMISM; PSYCHOSOCIAL FACTORS; NEGATIVE AFFECT; UNITED-STATES; HEALTH; PERSONALITY; RESOURCES; MOBILITY; ASSOCIATION	Socioeconomic status is associated with health disparities, but underlying psychosocial mechanisms have not been fully identified. Dispositional optimism may be a psychosocial process linking socioeconomic status with health. We hypothesized that lower optimism would be associated with greater social disadvantage and poorer social mobility. We also investigated whether life satisfaction and positive affect showed similar patterns. Participants from the Midlife in the United States study self-reported their optimism, satisfaction, positive affect, and socioeconomic status (gender, race/ethnicity, education, occupational class and prestige, income). Social disparities in optimism were evident. Optimistic individuals tended to be white and highly educated, had an educated parent, belonged to higher occupational classes with more prestige, and had higher incomes. Findings were generally similar for satisfaction, but not positive affect. Greater optimism and satisfaction were also associated with educational achievement across generations. Optimism and life satisfaction are consistently linked with socioeconomic advantage and may be one conduit by which social disparities influence health.	[Boehm, Julia K.] Chapman Univ, Dept Psychol, Orange, CA 92866 USA; [Chen, Ying; Williams, David R.; Kubzansky, Laura D.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Williams, David R.] Harvard Univ, Dept African & African Amer Studies & Sociol, Cambridge, MA 02115 USA; [Ryff, Carol] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Ryff, Carol] Univ Wisconsin, Inst Aging, Madison, WI USA	Chapman University System; Chapman University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Boehm, JK (corresponding author), Chapman Univ, Dept Psychol, Orange, CA 92866 USA.	jboehm@chapman.edu		Chen, Ying/0000-0002-4780-4642	John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; National Institute on Aging [P01-AG020166]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The original Midlife in the United States study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (http://www.macfound. org/press/article/about-macarthur-research-networks/). Follow-up data collection was supported by the National Institute on Aging (P01-AG020166; http://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson D, 2008, J HUM RESOUR, V43, P139, DOI 10.3368/jhr.43.1.139; ABELSON RP, 1985, PSYCHOL BULL, V97, P129, DOI 10.1037/0033-2909.97.1.129; Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Agrawal J, 2011, SOC INDIC RES, V101, P419, DOI 10.1007/s11205-010-9669-5; Akhtar-Danesh Noori, 2007, Int J Ment Health Syst, V1, P4, DOI 10.1186/1752-4458-1-4; Barger SD, 2009, QUAL LIFE RES, V18, P179, DOI 10.1007/s11136-008-9426-2; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Boehm JK, 2011, HEALTH PSYCHOL, V30, P259, DOI 10.1037/a0023124; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Chen E, 2003, HEALTH PSYCHOL, V22, P106, DOI 10.1037/0278-6133.22.1.106; Daraei M., 2012, J INDIAN ACAD APPL P, V38, P339; Diener E., 2010, INT DIFFERENCES WELL, P3, DOI [10.1093/acprof:oso/9780199732739.003.0001, DOI 10.1093/ACPROF:OSO/9780199732739.003.0001]; Diener E, 2009, S AFR J PSYCHOL, V39, P391, DOI 10.1177/008124630903900402; Ek E, 2004, SOC INDIC RES, V69, P219, DOI 10.1023/B:SOCI.0000033591.80716.07; Fernandez-Ballesteros R, 2001, AGEING SOC, V21, P25, DOI 10.1017/S0144686X01008078; Finkelstein DM, 2007, J ADOLESCENT HEALTH, V40, P127, DOI 10.1016/j.jadohealth.2006.10.006; Fischer R, 2008, PERS INDIV DIFFER, V45, P378, DOI 10.1016/j.paid.2008.05.008; Fleeson W, 2004, MAC FDN MEN, P252; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; Gallagher MW, 2012, J PERS, DOI [10.1111/j.1467-6494.2012.00789.x, DOI 10.1111/J.1467-6494.2012.00789.X]; Gallo LC, 2005, J PERS SOC PSYCHOL, V88, P386, DOI 10.1037/0022-3514.88.2.386; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Gallo LC, 2009, APPL PSYCHOL-HLTH WE, V1, P62, DOI 10.1111/j.1758-0854.2008.01000.x; Gallo LC, 2009, CURR DIR PSYCHOL SCI, V18, P269, DOI 10.1111/j.1467-8721.2009.01650.x; Giltay EJ, 2004, ARCH GEN PSYCHIAT, V61, P1126, DOI 10.1001/archpsyc.61.11.1126; Heinonen K, 2006, J PERS, V74, P1111, DOI 10.1111/j.1467-6494.2006.00404.x; Heraclides A, 2010, J EPIDEMIOL COMMUN H, V64, P714, DOI 10.1136/jech.2009.087692; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Khullar D, 2011, J ADOLESCENT HEALTH, V49, P553, DOI 10.1016/j.jadohealth.2011.04.003; Kobau Rosemarie, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2010.300083; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Lucas RE, 2009, J RES PERS, V43, P75, DOI 10.1016/j.jrp.2008.09.004; Marmot M, 1997, SOC SCI MED, V44, P901, DOI 10.1016/S0277-9536(96)00194-3; Marshall G, 1999, BRIT J SOCIOL, V50, P28, DOI 10.1111/j.1468-4446.1999.00028.x; Mazumder B, 2005, REV ECON STAT, V87, P235, DOI 10.1162/0034653053970249; Mosing MA, 2009, BEHAV GENET, V39, P597, DOI 10.1007/s10519-009-9287-7; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Peterson C., 1991, PSYCHOL INQ, V2, P1, DOI [10.1207/s15327965pli0201_1, DOI 10.1207/S15327965PLI0201_1]; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Rasmussen HN, 2006, J PERS, V74, P1721, DOI 10.1111/j.1467-6494.2006.00426.x; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Robb KA, 2009, INT J BEHAV MED, V16, P331, DOI 10.1007/s12529-008-9018-0; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Ross CE, 1996, J HEALTH SOC BEHAV, V37, P104, DOI 10.2307/2137234; Ryff CD, 2007, PSYCHOTHER PSYCHOSOM, V76, P61, DOI 10.1159/000096369; Scharoun-Lee M, 2011, DEMOGRAPHY, V48, P625, DOI 10.1007/s13524-011-0024-5; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schollgen I, 2011, HEALTH PSYCHOL, V30, P326, DOI 10.1037/a0022514; Schutte JW, 1996, SOC BEHAV PERSONAL, V24, P9, DOI 10.2224/sbp.1996.24.1.9; Segerstrom SC, 2007, J RES PERS, V41, P772, DOI 10.1016/j.jrp.2006.09.004; Segerstrom SC, 2011, J RES PERS, V45, P126, DOI 10.1016/j.jrp.2010.11.007; Shepperd JA, 2002, PSYCHOL BELG, V42, P65; STEVENS G, 1985, SOC SCI RES, V14, P142, DOI 10.1016/0049-089X(85)90008-0; TAYLOR SE, 1992, J PERS SOC PSYCHOL, V63, P460, DOI 10.1037/0022-3514.63.3.460; Taylor SE, 1999, ANN NY ACAD SCI, V896, P210, DOI 10.1111/j.1749-6632.1999.tb08117.x; Tellegen A, 1985, ANXIETY ANXIETY DISO, P681; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	66	58	60	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118066	10.1371/journal.pone.0118066	http://dx.doi.org/10.1371/journal.pone.0118066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671665	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300084
J	Ferrera, I; Aristegui, J; Gonzalez, JM; Montero, MF; Fraile-Nuez, E; Gasol, JM				Ferrera, Isabel; Aristegui, Javier; Gonzalez, Jose M.; Montero, Maria F.; Fraile-Nuez, Eugenio; Gasol, Josep M.			Transient Changes in Bacterioplankton Communities Induced by the Submarine Volcanic Eruption of El Hierro (Canary Islands)	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SPATIAL-PATTERNS; COASTAL WATERS; RIBOSOMAL-RNA; VARIABILITY; ABUNDANCE; INSIGHTS	The submarine volcanic eruption occurring near El Hierro (Canary Islands) in October 2011 provided a unique opportunity to determine the effects of such events on the microbial populations of the surrounding waters. The birth of a new underwater volcano produced a large plume of vent material detectable from space that led to abrupt changes in the physicalchemical properties of the water column. We combined flow cytometry and 454-pyrosequencing of 16S rRNA gene amplicons (V1-V3 regions for Bacteria and V3-V5 for Archaea) to monitor the area around the volcano through the eruptive and post-eruptive phases (November 2011 to April 2012). Flow cytometric analyses revealed higher abundance and relative activity (expressed as a percentage of high-nucleic acid content cells) of heterotrophic prokaryotes during the eruptive process as compared to post-eruptive stages. Changes observed in populations detectable by flow cytometry were more evident at depths closer to the volcano (similar to 70-200 m), coinciding also with oxygen depletion. Alpha-diversity analyses revealed that species richness (Chao1 index) decreased during the eruptive phase; however, no dramatic changes in community composition were observed. The most abundant taxa during the eruptive phase were similar to those in the post-eruptive stages and to those typically prevalent in oceanic bacterioplankton communities (i.e. the alphaproteobacterial SAR11 group, the Flavobacteriia class of the Bacteroidetes and certain groups of Gammaproteobacteria). Yet, although at low abundance, we also detected the presence of taxa not typically found in bacterioplankton communities such as the Epsilonproteobacteria and members of the candidate division ZB3, particularly during the eruptive stage. These groups are often associated with deep-sea hydrothermal vents or sulfur-rich springs. Both cytometric and sequence analyses showed that once the eruption ceased, evidences of the volcano-induced changes were no longer observed.	[Ferrera, Isabel; Gasol, Josep M.] CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanog, Barcelona, Spain; [Aristegui, Javier; Montero, Maria F.] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Spain; [Gonzalez, Jose M.] Univ La Laguna, Dept Microbiol, E-38207 San Cristobal la Laguna, Spain; [Fraile-Nuez, Eugenio] Ctr Oceanog Canarias, Inst Espanol Oceanog, Santa Cruz De Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidad de Las Palmas de Gran Canaria; Universidad de la Laguna; Spanish Institute of Oceanography	Ferrera, I (corresponding author), CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanog, Barcelona, Spain.	iferrera@icm.csic.es	Nuez, Eugenio Fraile/R-2258-2019; Ferrera, Isabel/L-7200-2014; Gonzalez, Jose M./C-3333-2013; Gasol, Josep M M/B-1709-2008; Fraile-Nuez, Eugenio/D-1521-2010; Arístegui, Javier/D-5833-2013	Nuez, Eugenio Fraile/0000-0003-4250-4445; Ferrera, Isabel/0000-0003-3484-516X; Gonzalez, Jose M./0000-0002-9926-3323; Gasol, Josep M M/0000-0001-5238-2387; Fraile-Nuez, Eugenio/0000-0003-4250-4445; Arístegui, Javier/0000-0002-7526-7741; Montero, Maria F./0000-0001-8124-8136	project VULCANO - suppressed Spanish Ministry of Science and Innovation [CTM2012-36317]; project MarineGems - suppressed Spanish Ministry of Science and Innovation [CTM2010-20361]; project STORM - suppressed Spanish Ministry of Science and Innovation [CTM2009-09352/MAR]; Ministry of Economy and Competitiveness (project EcoBGM) [CTM2013-48292-C3-3-R]	project VULCANO - suppressed Spanish Ministry of Science and Innovation; project MarineGems - suppressed Spanish Ministry of Science and Innovation; project STORM - suppressed Spanish Ministry of Science and Innovation; Ministry of Economy and Competitiveness (project EcoBGM)	This work was partly supported by projects VULCANO (CTM2012-36317) to E. Fraile-Nuez and J. Aristegui, MarineGems (CTM2010-20361) to J. M. Gonzalez and STORM (CTM2009-09352/MAR) to J. M. Gasol and I. Ferrera, all funded by the suppressed Spanish Ministry of Science and Innovation. J. M. Gonzalez received additional funding from the Ministry of Economy and Competitiveness (project EcoBGM, CTM2013-48292-C3-3-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves N, 2015, ARCH MICROBIOL, V197, P165, DOI 10.1007/s00203-014-1035-6; Aristegui J, 2001, SCI MAR, V65, P51, DOI 10.3989/scimar.2001.65s151; Ariza A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102354; Baker ET, 1995, SEAFLOOR HYDROTHERMA, P47, DOI [10.1029/GM091p0047, DOI 10.1029/GM091P0047]; Baltar F, 2012, APPL ENVIRON MICROB, V78, P3309, DOI 10.1128/AEM.07962-11; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carracedo JC, 2012, EOS T AM GEOPHYS UN, V93, P89, DOI DOI 10.1029/2012E0090002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Eugenio F, 2014, INT J APPL EARTH OBS, V29, P53, DOI 10.1016/j.jag.2013.12.009; Ferrera I, 2007, ELS, DOI [10.1002/9780470015902.a0000406, DOI 10.1002/9780470015902.A0000406]; Ferrera I, 2014, SYST APPL MICROBIOL, V37, P442, DOI 10.1016/j.syapm.2014.04.002; Flores GE, 2012, GEOBIOLOGY, V10, P333, DOI 10.1111/j.1472-4669.2012.00325.x; Flores GE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00047; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Fraile-Nuez E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00486; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Page A, 2008, ENVIRON MICROBIOL, V10, P874, DOI 10.1111/j.1462-2920.2007.01505.x; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Sanchez O, 2013, MICROB BIOTECHNOL, V6, P435, DOI 10.1111/1751-7915.12052; Santana-Casiano JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01140; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Singer E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00052; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Tivey MK, 2004, GEOPH MONOG SERIES, V144, P137, DOI 10.1029/144GM09; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778	44	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118136	10.1371/journal.pone.0118136	http://dx.doi.org/10.1371/journal.pone.0118136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671714	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300085
J	Mahajan, S; Manetsch, R; Merkler, DJ; Stevens, SM				Mahajan, Shikha; Manetsch, Roman; Merkler, David J.; Stevens, Stanley M., Jr.			Synthesis and Evaluation of a Novel Adenosine-Ribose Probe for Global-Scale Profiling of Nucleoside and Nucleotide-Binding Proteins	PLOS ONE			English	Article							SITES; KINASE; CANCER; EXPRESSION; RECEPTORS; ANALOG	Proteomics is a powerful approach used for investigating the complex molecular mechanisms of disease pathogenesis and progression. An important challenge in modern protein profiling approaches involves targeting of specific protein activities in order to identify altered molecular processes associated with disease pathophysiology. Adenosine-binding proteins represent an important subset of the proteome where aberrant expression or activity changes of these proteins have been implicated in numerous human diseases. Herein, we describe an affinity-based approach for the enrichment of adenosine-binding proteins from a complex cell proteome. A novel N-6-biotinylated-8-azido-adenosine probe (AdoR probe) was synthesized, which contains a reactive group that forms a covalent bond with the target proteins, as well as a biotin tag for affinity enrichment using avidin chromatography. Probe specificity was confirmed with protein standards prior to further evaluation in a complex protein mixture consisting of a lysate derived from mouse neuroblastoma N(18)TG(2) cells. Protein identification and relative quantitation using mass spectrometry allowed for the identification of small variations in abundance of nucleoside- and nucleotide-binding proteins in these samples where a significant enrichment of AdoR-binding proteins in the labeled proteome from the neuroblastoma cells was observed. The results from this study demonstrate the utility of this method to enrich for nucleoside- and nucleotide-binding proteins in a complex protein mixture, pointing towards a unique set of proteins that can be examined in the context of further understanding mechanisms of disease, or fundamental biological processes in general.	[Mahajan, Shikha; Manetsch, Roman; Merkler, David J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Manetsch, Roman] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Manetsch, Roman] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; Northeastern University; Northeastern University; State University System of Florida; University of South Florida	Stevens, SM (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave, Tampa, FL 33620 USA.	smstevens@usf.edu		Stevens, Stanley/0000-0002-1399-0256	National Cancer Institute at the National Institutes of Health [CA110084]; National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [AA021245]; Bankhead-Coley Biomedical Research Program of the Florida Department of Health [08BN-04]; University of South Florida's Byrd, Sr. Alzheimer's Institute; NATIONAL CANCER INSTITUTE [R03CA110084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021245] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bankhead-Coley Biomedical Research Program of the Florida Department of Health; University of South Florida's Byrd, Sr. Alzheimer's Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank the National Cancer Institute at the National Institutes of Health (grant CA110084) to D.J.M., the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health (grant AA021245) to S.M.S., the Bankhead-Coley Biomedical Research Program of the Florida Department of Health (08BN-04) to D.J.M. and R.M., and the University of South Florida's Byrd, Sr. Alzheimer's Institute to D.J.M. and R.M. for financial support.	Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLMAN RF, 1983, ANNU REV BIOCHEM, V52, P67, DOI 10.1146/annurev.bi.52.070183.000435; Colman RF, 2006, LETT DRUG DES DISCOV, V3, P462, DOI 10.2174/157018006778194853; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Czarnecki J, 1979, Methods Enzymol, V56, P642; Dong SW, 2011, MOL DIAGN THER, V15, P211, DOI 10.2165/11590360-000000000-00000; Farrell EK, 2012, J LIPID RES, V53, P247, DOI 10.1194/jlr.M018606; GERSTER JF, 1968, J ORG CHEM, V33, P1070, DOI 10.1021/jo01267a027; Gessi S, 2004, CLIN CANCER RES, V10, P5895, DOI 10.1158/1078-0432.CCR-1134-03; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; HALEY BE, 1975, BIOCHEMISTRY-US, V14, P3852, DOI 10.1021/bi00688a018; Hanoulle X, 2006, J PROTEOME RES, V5, P3438, DOI 10.1021/pr060313e; Komatsu K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-63; Lishmanov AY, 2007, B EXP BIOL MED+, V143, P187, DOI 10.1007/s10517-007-0046-6; Masuda S, 2011, BIOORG MED CHEM LETT, V21, P2252, DOI 10.1016/j.bmcl.2011.02.113; MINNA J, 1972, NATURE-NEW BIOL, V235, P225, DOI 10.1038/newbio235225a0; NAGATA K, 1978, J BIOCHEM-TOKYO, V83, P599, DOI 10.1093/oxfordjournals.jbchem.a131947; Nair KS, 2004, AM J PHYSIOL-ENDOC M, V286, pE863, DOI 10.1152/ajpendo.00370.2003; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; POMERANTZ AH, 1975, BIOCHEMISTRY-US, V14, P3858, DOI 10.1021/bi00688a019; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; POULOS TL, 1974, J BIOL CHEM, V249, P1453; Ratcliffe SJ, 2007, J BIOMOL SCREEN, V12, P126, DOI 10.1177/1087057106296685; Roelen H, 1996, J MED CHEM, V39, P1463, DOI 10.1021/jm950267m; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; SZEKERES GL, 1975, J HETEROCYCLIC CHEM, V12, P15, DOI 10.1002/jhet.5570120103; TOMICH JM, 1981, BIOCHEMISTRY-US, V20, P6711, DOI 10.1021/bi00526a029; ZHOU GC, 1993, J BIOL CHEM, V268, P10471	29	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115644	10.1371/journal.pone.0115644	http://dx.doi.org/10.1371/journal.pone.0115644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671571	Green Published, gold, Green Submitted			2022-12-27	WOS:000349545300009
J	Uzana, R; Eisenberg, G; Merims, S; Frankenburg, S; Pato, A; Yefenof, E; Engelstein, R; Peretz, T; Machlenkin, A; Lotem, M				Uzana, Ronny; Eisenberg, Galit; Merims, Sharon; Frankenburg, Shoshana; Pato, Aviad; Yefenof, Eitan; Engelstein, Roni; Peretz, Tamar; Machlenkin, Arthur; Lotem, Michal			Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer	PLOS ONE			English	Article							CLASS-I COMPLEXES; ANTIGEN PRESENTATION; SURFACE MOLECULES; TROGOCYTOSIS; RESPONSES; CAPTURE; IDENTIFICATION; MACROPHAGES; LYMPHOCYTES; RECEPTORS	Trogocytosis is a contact-dependent unidirectional transfer of membrane fragments between immune effector cells and their targets, initially detected in T cells following interaction with professional antigen presenting cells (APC). Previously, we have demonstrated that trogocytosis also takes place between melanoma-specific cytotoxic T lymphocytes (CTLs) and their cognate tumors. In the present study, we took this finding a step further, focusing on the ability of melanoma membrane-imprinted CD8(+) T cells to act as APCs (CD8(+) T-APCs). We demonstrate that, following trogocytosis, CD8(+) T-APCs directly present a variety of melanoma derived peptides to fraternal T cells with the same TCR specificity or to T cells with different TCRs. The resulting T cell-T cell immune synapse leads to (1) Activation of effector CTLs, as determined by proliferation, cytokine secretion and degranulation; (2) Fratricide (killing) of CD8(+) T-APCs by the activated CTLs. Thus, trogocytosis enables cross-reactivity among CD8(+) T cells with interchanging roles of effectors and APCs. This dual function of tumor-reactive CTLs may hint at their ability to amplify or restrict reactivity against the tumor and participate in modulation of the anti-cancer immune response.	[Uzana, Ronny; Eisenberg, Galit; Merims, Sharon; Frankenburg, Shoshana; Pato, Aviad; Engelstein, Roni; Peretz, Tamar; Machlenkin, Arthur; Lotem, Michal] Hadassah Med Org, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; [Yefenof, Eitan] Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Lotem, M (corresponding author), Hadassah Med Org, Sharett Inst Oncol, POB 12000, IL-91120 Jerusalem, Israel.	mlotem@hadassah.org.il			AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; DFG, Deutsche Forschungsgemeinschaft [SCHU 1186/9-1]; ICA, Israel Cancer Association [20130060-B]	AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; DFG, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ICA, Israel Cancer Association	The work was supported by the following: 1. AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, URL: http://www.adelsonfoundation.org/amrfphil.html, Author: ML; 2. DFG, Deutsche Forschungsgemeinschaft; URL: http://www.dfg.de/en/research_funding/index.html, Grant number: trilateral project SCHU 1186/9-1, Author: ML; and 3. ICA, Israel Cancer Association, URL:http://en.cancer.org.il/,Grant number: 20130060-B, Author: ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; BONA C, 1973, IMMUNOLOGY, V24, P831; Brown R, 2012, BLOOD, V120, P2055, DOI 10.1182/blood-2012-03-416792; Byrne KT, 2011, J CLIN INVEST, V121, P1797, DOI 10.1172/JCI44849; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chung B, 2014, CELL REP, V8, P871, DOI 10.1016/j.celrep.2014.06.052; Cox JH, 2007, J IMMUNOL, V179, P830, DOI 10.4049/jimmunol.179.2.830; Dhainaut M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00112; Eisenberg G, 2013, J IMMUNOL, V190, P5856, DOI 10.4049/jimmunol.1202879; Espinosa E, 2002, J IMMUNOL, V168, P6336, DOI 10.4049/jimmunol.168.12.6336; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gary R, 2012, J IMMUNOL, V188, P744, DOI 10.4049/jimmunol.1101412; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; HoWangYin KY, 2010, CELL MOL LIFE SCI, V67, P1133, DOI 10.1007/s00018-009-0239-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; LeMaoult J, 2007, HUM IMMUNOL, V68, P240, DOI 10.1016/j.humimm.2006.11.001; Lotem M, 2002, BRIT J CANCER, V86, P1534, DOI 10.1038/sj.bjc.6600251; Machlenkin A, 2008, CANCER RES, V68, P2006, DOI 10.1158/0008-5472.CAN-07-3119; Nakamura K, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas.1321248111, DOI 10.1073/PNAS.1321248111]; Nakayama M, 2011, P NATL ACAD SCI USA, V108, P18360, DOI 10.1073/pnas.1110584108; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Quah BJC, 2008, P NATL ACAD SCI USA, V105, P4259, DOI 10.1073/pnas.0800259105; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Schneiders FL, 2014, CANCER IMMUNOL RES, V2, P732, DOI 10.1158/2326-6066.CIR-13-0167; Tsang JYS, 2003, BLOOD, V101, P2704, DOI 10.1182/blood-2002-04-1230; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Uzana R, 2012, J IMMUNOL, V188, P632, DOI 10.4049/jimmunol.1101429; Vernitsky H, 2012, J IMMUNOL, V189, P4361, DOI 10.4049/jimmunol.1200019; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Xia DJ, 2006, J IMMUNOL, V177, P2976, DOI 10.4049/jimmunol.177.5.2976; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Zhang H, 2007, J IMMUNOL, V178; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	39	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118244	10.1371/journal.pone.0118244	http://dx.doi.org/10.1371/journal.pone.0118244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671577	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300090
J	Chakraborty, N; Sharma, P; Kanyuka, K; Pathak, RR; Choudhury, D; Hooley, RA; Raghuram, N				Chakraborty, Navjyoti; Sharma, Priyanka; Kanyuka, Kostya; Pathak, Ravi R.; Choudhury, Devapriya; Hooley, Richard A.; Raghuram, Nandula			Transcriptome Analysis of Arabidopsis GCR1 Mutant Reveals Its Roles in Stress, Hormones, Secondary Metabolism and Phosphate Starvation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR; ALPHA-SUBUNIT; BETA-SUBUNIT; GENE; DEFENSE; RESISTANCE; GPA1; RICE; ACTIVATION	The controversy over the existence or the need for G-protein coupled receptors (GPCRs) in plant G-protein signalling has overshadowed a more fundamental quest for the role of AtGCR1, the most studied and often considered the best candidate for GPCR in plants. Our whole transcriptome microarray analysis of the GCR1-knock-out mutant (gcr1-5) in Arabidopsis thaliana revealed 350 differentially expressed genes spanning all chromosomes. Many of them were hitherto unknown in the context of GCR1 or G-protein signalling, such as in phosphate starvation, storage compound and fatty acid biosynthesis, cell fate, etc. We also found some GCR1-responsive genes/processes that are reported to be regulated by heterotrimeric G-proteins, such as biotic and abiotic stress, hormone response and secondary metabolism. Thus, GCR1 could have G-protein-mediated as well as independent roles and regardless of whether it works as a GPCR, further analysis of the organism-wide role of GCR1 has a significance of its own.	[Chakraborty, Navjyoti; Sharma, Priyanka; Pathak, Ravi R.; Raghuram, Nandula] GGS Indraprastha Univ, Univ Sch Biotechnol, New Delhi 110078, India; [Kanyuka, Kostya] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden AL5 2JQ, Herts, England; [Choudhury, Devapriya] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Hooley, Richard A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	GGS Indraprastha University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Jawaharlal Nehru University, New Delhi; University of Bath	Raghuram, N (corresponding author), GGS Indraprastha Univ, Univ Sch Biotechnol, Sect 16 C, New Delhi 110078, India.	raghuram98@hotmail.com	Chakraborty, Navjyoti/E-5854-2011; Raghuram, Nandula/F-5775-2011; Kanyuka, Kostya/F-9156-2016	Chakraborty, Navjyoti/0000-0003-4782-1650; Raghuram, Nandula/0000-0002-9486-754X; Kanyuka, Kostya/0000-0001-6324-4123; Pathak, Ravi/0000-0002-9689-6475	Council of Scientific and Industrial Research (CSIR), Government of India [60(0056)/02/EMRII, 38(1246)/10/EMRII, 09/806(015)/2008-EMRI, PS 60(0056)/02/EMRII]; BBSRC [BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203] Funding Source: researchfish	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants to NR [60(0056)/02/EMRII and 38(1246)/10/EMRII] and research fellowships to NC [09/806(015)/2008-EMRI] and PS 60(0056)/02/EMRII] from the Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apone F, 2003, PLANT PHYSIOL, V133, P571, DOI 10.1104/pp.103.026005; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Bradford W, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003768; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Delgado-Cerezo M, 2012, MOL PLANT, V5, P98, DOI 10.1093/mp/ssr082; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Etheridge N, 1999, PLANT MOL BIOL, V39, P1113, DOI 10.1023/A:1006137221259; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Hackenberg D, 2013, PLANT PHYSIOL, V163, P1510, DOI 10.1104/pp.113.230425; Hooley R, 2001, SIGNAL TRANSDUCTION, P193; Humphrey TV, 2001, J PLANT PHYSIOL, V158, P645, DOI 10.1078/0176-1617-00316; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kanyuka K, 2001, CURR BIOL, V11, P535, DOI 10.1016/S0960-9822(01)00157-9; Kim HG, 2014, FEBS LETT, V588, P1652, DOI 10.1016/j.febslet.2014.02.062; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Liu F, 2012, MOL PLANT MICROBE IN, V25, P677, DOI 10.1094/MPMI-10-11-0274; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lu YT, 2014, PLANT PHYSIOL, V164, P1456, DOI 10.1104/pp.113.229740; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pathak RR, 2010, CAN J MICROBIOL, V56, P578, DOI [10.1139/W10-045, 10.1139/w10-045]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2010, SIGNAL COMMUN PLANTS, P221, DOI 10.1007/978-3-642-03524-1_12; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2013, PLANT PHYSIOL, V161, P1097, DOI 10.1104/pp.112.212324; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Yadav DK, 2013, PLANT PHYSIOL BIOCH, V63, P262, DOI 10.1016/j.plaphy.2012.11.031; Yadav DK, 2012, PLANT SIGNAL BEHAV, V7, P733, DOI 10.4161/psb.20356; Zhao ZX, 2010, J PROTEOME RES, V9, P1637, DOI 10.1021/pr901011h; Zhou SJ, 2013, GENET MOL RES, V12, P6565, DOI 10.4238/2013.December.11.8	59	18	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117819	10.1371/journal.pone.0117819	http://dx.doi.org/10.1371/journal.pone.0117819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668726	gold, Green Published, Green Submitted			2022-12-27	WOS:000349493000027
J	Hiroshima, Y; Zhang, Y; Zhang, N; Maawy, A; Mii, S; Yamamoto, M; Uehara, F; Miwa, S; Yano, S; Murakami, T; Momiyama, M; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Murata, T; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Maawy, Ali; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Murata, Takuya; Endo, Itaru; Hoffman, Robert M.			Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANTI-CEA ANTIBODY; NUDE-MOUSE MODEL; FLUORESCENCE-GUIDED SURGERY; HUMAN COLON-CANCER; UTERINE CERVIX; IMAGING-SYSTEM; BREAST-CANCER; MICE; SPECIMENS	Squamous cell carcinoma of the cervix, highly prevalent in the developing world, is often metastatic and treatment resistant with no standard treatment protocol. Our laboratory pioneered the patient-derived orthotopic xenograft (PDOX) nude mouse model with the technique of surgical orthotopic implantation (SOI). Unlike subcutaneous transplant patient-derived xenograft (PDX) models, PDOX models metastasize. Most importantly, the metastasis pattern correlates to the patient. In the present report, we describe the development of a PDOX model of HER-2-positive cervical cancer. Metastasis after SOI in nude mice included peritoneal dissemination, liver metastasis, lung metastasis as well as lymph node metastasis reflecting the metastatic pattern in the donor patient. Metastasis was detected in 4 of 6 nude mice with primary tumors. Primary tumors and metastases in the nude mice had histological structures similar to the original tumor and were stained by an anti-HER-2 antibody in the same pattern as the patient's cancer. The metastatic pattern, histology and HER-2 tumor expression of the patient were thus preserved in the PDOX model. In contrast, subcutaneous transplantation of the patient's cervical tumors resulted in primary growth but not metastasis.	[Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Bouvet, Michael; Endo, Itaru] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Murata, Takuya] Kawasaki Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Yano, Shuya/AAL-8028-2020; Zhang, Nan/GXH-0361-2022; Miwa, Shinji/AAI-9309-2020	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA CA132971, CA142669]; JSPS [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA CA132971 and CA142669 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Braud AC, 2002, EUR CYTOKINE NETW, V13, P115; Costa MJ, 1995, AM J CLIN PATHOL, V104, P634; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Fu X, 1993, ANTICANCER RES, V25, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Furukawa Kubota, 1993, INT J CANCER, V53, P608; Gamez RG, 2009, DIAGN CYTOPATHOL, V37, P381, DOI 10.1002/dc.21027; Hashimoto K, 2011, EUR J OBSTET GYN R B, V159, P394, DOI 10.1016/j.ejogrb.2011.07.001; Hiroshima Y, 2014, J SURG ONCO IN PRESS, DOI [10.1002/jso.23861, DOI 10.1002/JSO.23861]; Hiroshima Y, 2014, ONCOTARGET IN PRESS; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; KIHANA T, 1994, CANCER, V73, P148, DOI 10.1002/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Sabatier R, 2012, CASE REP ONCOL, V5, P464, DOI 10.1159/000342255; Suetsugu A, 2012, ANTICANCER RES, V32, P3063; Suetsugu A, 2012, J CELL BIOCHEM, V113, P2290, DOI 10.1002/jcb.24099; Suetsugu A, 2012, ANTICANCER RES, V32, P1175; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Urabe A, 2006, HISTOPATHOLOGY, V49, P493, DOI 10.1111/j.1365-2559.2006.02536.x; Wang CW, 2009, AM J CLIN PATHOL, V131, P715, DOI 10.1309/AJCPTPBC6V5KUITM; WANG XO, 1992, INT J CANCER, V51, P992; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008	30	83	84	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117417	10.1371/journal.pone.0117417	http://dx.doi.org/10.1371/journal.pone.0117417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689852	gold, Green Submitted, Green Published			2022-12-27	WOS:000350322700042
J	Huang, BX; Zhu, MF; Wu, T; Zhou, JY; Liu, Y; Chen, XL; Zhou, RF; Wang, LJ; Chen, YM; Zhu, HL				Huang, Bi-xia; Zhu, Ming-fan; Wu, Ting; Zhou, Jing-ya; Liu, Yan; Chen, Xiao-lin; Zhou, Rui-fen; Wang, Li-jun; Chen, Yu-ming; Zhu, Hui-lian			Neck Circumference, along with Other Anthropometric Indices, Has an Independent and Additional Contribution in Predicting Fatty Liver Disease	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; HEPATIC STEATOSIS; OBESITY; ASSOCIATION; POPULATION; PREVALENCE; OVERWEIGHT	Background and Aim Previous studies have indicated that neck circumference is a valuable predictor for obesity and metabolic syndrome, but little evidence is available for fatty liver disease. We examined the association of neck circumference with fatty liver disease and evaluated its predictive value in Chinese adults. Methods This cross-sectional study comprised 4053 participants (1617 women and 2436 men, aged 20-88) recruited from the Health Examination Center in Guangzhou, China between May 2009 and April 2010. Anthropometric measurements were taken, abdominal ultrasonography was conducted and blood biochemical parameters were measured. Covariance, logistic regression and receiver operating characteristic curve analyses were employed. Results The mean neck circumference was greater in subjects with fatty liver disease than those without the disease in both women and men after adjusting for age (P<0.001). Logistic regression analysis showed that the age-adjusted ORs (95% CI) of fatty liver disease for quartile 4 (vs. quartile 1) of neck circumference were 7.70 (4.95-11.99) for women and 12.42 (9.22-16.74) for men. After further adjusting for other anthropometric indices, both individually and combined, the corresponding ORs remained significant (all P-trends<0.05) but were attenuated to 1.94-2.53 for women and 1.45-2.08 for men. An additive interaction existed between neck circumference and the other anthropometric measures (all P<0.05). A high neck circumference value was associated with a much greater prevalence of fatty liver disease in participants with both high and normal BMI, waist circumference and waist-to-hip ratio values. Conclusions Neck circumference was an independent predictor for fatty liver disease and provided an additional contribution when applied with other anthropometric measures.	[Huang, Bi-xia; Wu, Ting; Zhou, Jing-ya; Liu, Yan; Chen, Xiao-lin; Zhou, Rui-fen; Wang, Li-jun; Chen, Yu-ming; Zhu, Hui-lian] Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Ming-fan] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Examinat Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhu, HL (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou 510275, Guangdong, Peoples R China.	zhuhl@mail.sysu.edu.cn	Zhu, Huilian/V-1040-2019; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019; HUANG, Bixia/AAV-1397-2020	Huang, Bi-xia/0000-0001-6458-0655	National Science Foundation of China [81273050]; Science and Technology Program of Guangzhou, China [201300000148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China	This study was supported by the National Science Foundation of China (no. 81273050) and Science and Technology Program of Guangzhou, China (no. 201300000148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Aswathappa J, 2013, N AM J MED SCI, V5, P28, DOI 10.4103/1947-2714.106188; Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Ballestri S, 2008, HEPATOLOGY, V47, P361, DOI 10.1002/hep.21977; Ben-Noun L, 2001, OBES RES, V9, P470, DOI 10.1038/oby.2001.61; Chakraborty S, 2014, ANN GASTROENTEROL, V27, P250; Cheung O, 2007, HEPATOLOGY, V46, P1091, DOI 10.1002/hep.21803; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Gray B, 2013, NUTR RES, V33, P781, DOI 10.1016/j.nutres.2013.07.019; Iwao S, 2001, OBES RES, V9, P685, DOI 10.1038/oby.2001.93; Lonardo A, 2010, EXPERT REV ENDOCRINO, V5, P403, DOI 10.1586/EEM.10.5; Machado MV, 2014, EXPERT REV GASTROENT, P1, DOI [10.1586/17474124.1.1.1, DOI 10.1586/17474124.1.1.1]; Meng LH, 2011, BIOMED ENVIRON SCI, V24, P22, DOI 10.3967/0895-3988.2011.01.003; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Preis SR, 2013, DIABETES CARE, V36, pE3, DOI 10.2337/dc12-0738; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Rodriguez-Torres M, 2008, J HEPATOL, V48, P756, DOI 10.1016/j.jhep.2008.01.015; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Satapathy SK, 2007, J GASTROEN HEPATOL, V22, P634, DOI 10.1111/j.1440-1746.2006.04756.x; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Targher G, 2008, J AM SOC NEPHROL, V19, P1564, DOI 10.1681/ASN.2007101155; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Tuan NT, 2010, PUBLIC HEALTH NUTR, V13, P639, DOI 10.1017/S1368980009991479; Gomez EV, 2009, ALIMENT PHARM THER, V30, P999, DOI 10.1111/j.1365-2036.2009.04122.x; Volzke H, 2012, WORLD J GASTROENTERO, V18, P3492, DOI 10.3748/wjg.v18.i27.3492; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086; Yan Q, 2014, DIABETES-METAB RES, V30, P69, DOI 10.1002/dmrr.2464; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x; Zheng RD, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/362147; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76; Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419	46	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118071	10.1371/journal.pone.0118071	http://dx.doi.org/10.1371/journal.pone.0118071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679378	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600106
J	Mo, XQ; Yang, CJ; Wang, XL; Burkhardt, BR; Li, YB; Xia, HP; Cao, XP				Mo, Xiaoqing; Yang, Chijiao; Wang, Xuelan; Burkhardt, Brant R.; Li, Yangbin; Xia, Haipeng; Cao, Xiaopei			F3MB(PANDER) Decreases Mice Hepatic Triglyceride and Is Associated with Decreased DGAT1 Expression	PLOS ONE			English	Article							PANCREATIC-DERIVED FACTOR; SECRETING BETA-CELLS; FACTOR PANDER; CYTOKINE; FAM3B; LIVER; FAT; LIPOGENESIS; METABOLISM; PERILIPIN	Objective Pancreatic-derived factor (PANDER, also named as FAM3B) is secreted by pancreatic a and beta cells. Increasing evidence suggests that it may serve a hormonal function related to glycemic and lipid metabolism. In this study, we investigated the effects of PANDER overexpression on hepatic and adipose triglyceride metabolism in high-fat diet-fed male C57BL/6 mice. Methods PANDER overexpression was achieved by tail-vein injection of recombinant Ad-PANDER and Ad-GFP injected mice served as a control. The TG metabolism in both groups were compared. Results Adenoviral-mediated overexpression of PANDER did not affect body weight, food consumption, or liver enzymes. The triglyceride (TG) content of both liver and adipose tissue was significantly decreased in Ad-PANDER mice (liver: 6.16 +/- 1.89 mg/g vs. control 14.95 +/- 2.27 mg/g, P<0.05; adipose: 39.31 +/- 1.99 mg/100mg vs. 47.22 +/- 2.21 mg/100mg, P<0.05). The free fatty acid (FFA) content of adipose tissue in Ad-PANDER mice was also decreased (1.38 +/- 0.18 mg/g vs. 2.77 +/- 0.31 mg/g, P<0.01). The investigation of key enzymes of triglyceride hydrolysis and FFA oxidation in liver and adipose tissue showed that p-HSL/HSL was significantly increased and that DGAT1 gene and protein expression were significantly reduced in the liver of PANDER-overexpressing mice. PKA phosphorylation was also significantly increased in the livers of Ad-PANDER mice. No differences in ATGL, CPT1, ACOX1, or DGAT2 expression were observed. Conclusion Overexpression of PANDER is associated with observable decreases in TG, increases in PKA phosphorylation, and decreased DGAT1 expression, suggesting a possible interrelationship. The mechanisms by which this occurs remain to be elucidated.	[Mo, Xiaoqing; Yang, Chijiao; Li, Yangbin; Xia, Haipeng; Cao, Xiaopei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Xuelan] Sun Yat Sen Univ, Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; [Burkhardt, Brant R.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	Sun Yat Sen University; Sun Yat Sen University; State University System of Florida; University of South Florida	Cao, XP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	caoxp@mail.sysu.edu.cn			Natural Science Foundation of China [30570887, 81370907]; Science and Technology Foundation of Guangdong Province [2011B0 410 31800358]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guangdong Province	This study was supported by the Natural Science Foundation of China (No. 30570887, and No. 81370907), and the Science and Technology Foundation of Guangdong Province (No. 2011B0 410 31800358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Burkhardt BR, 2005, BBA-GENE STRUCT EXPR, V1730, P215, DOI 10.1016/j.bbaexp.2005.07.003; Cao XP, 2003, DIABETES, V52, P2296, DOI 10.2337/diabetes.52.9.2296; Chen Shuo, 2011, Zhonghua Yi Xue Za Zhi, V91, P1413; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; FAIN JN, 1983, J LIPID RES, V24, P945; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; FOLCH J, 1957, J BIOL CHEM, V226, P497; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Herrmann J, 2004, ARCH VIROL, V149, P1611, DOI 10.1007/s00705-004-0300-4; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Levine JA, 2011, DIABETES, V60, P2667, DOI 10.2337/db11-1118; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li J, 2011, HEPATOLOGY, V53, P1906, DOI 10.1002/hep.24295; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ogden CL, 2012, PREVALENCE OBESITY U, V82, P1; Robert-Cooperman CE, 2010, DIABETES, V59, P2209, DOI 10.2337/db09-1552; SCHMITZPEIFFER C, 1992, CELL SIGNAL, V4, P37, DOI 10.1016/0898-6568(92)90006-T; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wilson CG, 2010, ENDOCRINOLOGY, V151, P5174, DOI 10.1210/en.2010-0379; Xu WZ, 2005, MOL CELL ENDOCRINOL, V240, P74, DOI 10.1016/j.mce.2005.05.010; Yang JC, 2005, BIOCHEMISTRY-US, V44, P11342, DOI 10.1021/bi0503908; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816	25	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117156	10.1371/journal.pone.0117156	http://dx.doi.org/10.1371/journal.pone.0117156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679806	Green Submitted, gold, Green Published			2022-12-27	WOS:000350682600052
J	Signa, G; Mazzola, A; Costa, V; Vizzini, S				Signa, Geraldina; Mazzola, Antonio; Costa, Valentina; Vizzini, Salvatrice			Bottom-Up Control of Macrobenthic Communities in a Guanotrophic Coastal System	PLOS ONE			English	Article							HYDROBIA-ULVAE; SOFT-BOTTOM; TRANSITIONAL WATERS; SPECIES RICHNESS; BIRD COLONIES; ASSEMBLAGES; ESTUARINE; NUTRIENT; EUTROPHICATION; LAGOONS	Soft bottom macrobenthic communities were studied seasonally in three coastal ponds (Marinello ponds, Italy) at increasing distances from a gull (Larus michahellis) colony to investigate the effect of seabird-induced eutrophication (i.e. guanotrophication) on macrobenthic fauna. We hypothesized that enhanced nutrient concentration and organic load caused by guano input significantly alter the trophic and sedimentological condition of ponds, affecting benthic fauna through a bottom-up control. The influence of a set of environmental features on macrobenthic assemblages was also tested. Overall, the lowest macrobenthic abundances and functional group diversity were found in deeper sites, especially in the pond characterised by severe guanotrophication, where the higher disturbance resulted in a decline in suspension feeders and carnivores in favour of deposit feeders. An increase in opportunistic/tolerant taxa (e.g. chironomid larvae and paraonids) and totally azoic sediments were also found as an effect of the harshest environmental conditions, resulting in a very poor ecological status. We conclude that macrobenthic assemblages of the Marinello coastal system display high spatial variability due to a synergistic effect of trophic status and the geomorphological features of the ponds. The macrobenthic response to guanotrophication, which was a clear decrease in abundance, diversity and trophic functional groups, was associated with the typical response to severe eutrophication, magnified by the geomorphological features.	[Signa, Geraldina; Mazzola, Antonio; Costa, Valentina; Vizzini, Salvatrice] Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Palermo, Italy	CoNISMa; University of Palermo	Signa, G (corresponding author), Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Via Archirafi 18, Palermo, Italy.	geraldina.signa@unipa.it	Costa, Valentina/A-8319-2015; Signa, Geraldina/G-3357-2017; Signa, Geraldina/AAQ-9090-2020	Costa, Valentina/0000-0002-1513-0284; Signa, Geraldina/0000-0003-2171-3299; Signa, Geraldina/0000-0003-2171-3299	PRIN; University of Palermo	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Palermo	This study was funded by PRIN 2008 and University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Armitage P.D., 1995, THE CHIRONOMIDAE BIO; Bachelet G, 2000, ICES J MAR SCI, V57, P1495, DOI 10.1006/jmsc.2000.0902; Basset A, 2006, AQUAT CONSERV, V16, P441, DOI 10.1002/aqc.767; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Blanchard GF, 2000, J EXP MAR BIOL ECOL, V255, P247, DOI 10.1016/S0022-0981(00)00292-6; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BOSMAN AL, 1986, MAR ECOL PROG SER, V32, P247, DOI 10.3354/meps032247; Cardoso PG, 2005, MAR ECOL PROG SER, V289, P191, DOI 10.3354/meps289191; Casu D, 2009, AQUAT ECOL, V43, P1023, DOI 10.1007/s10452-008-9223-6; Chaichana R, 2010, HYDROBIOLOGIA, V646, P111, DOI 10.1007/s10750-010-0166-2; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Como S, 2008, MAR BIOL, V153, P1087, DOI 10.1007/s00227-007-0881-z; Como S, 2007, MAR POLLUT BULL, V54, P733, DOI 10.1016/j.marpolbul.2007.01.007; De Haas EM, 2006, J ANIM ECOL, V75, P148, DOI 10.1111/j.1365-2656.2005.01030.x; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Garcia LV, 2002, OIKOS, V98, P75, DOI 10.1034/j.1600-0706.2002.980108.x; Grall J, 2002, GLOBAL CHANGE BIOL, V8, P813, DOI 10.1046/j.1365-2486.2002.00519.x; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Hagerthey SE, 2002, MAR ECOL PROG SER, V245, P47, DOI 10.3354/meps245047; Hyland J, 2005, MAR ECOL PROG SER, V295, P91, DOI 10.3354/meps295091; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Koutsoubas D, 2000, BELG J ZOOL, V130, P135; LEENTVAAR P, 1967, Hydrobiologia, V29, P441, DOI 10.1007/BF00189906; Leonardi M, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P305; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Magni P, 2006, MAR BIOL, V149, P1185, DOI 10.1007/s00227-006-0298-0; Magni P, 2003, CHEM ECOL, V19, P363, DOI 10.1080/02757540310001603718; Mazzola A, 2010, CHEM ECOL, V26, P267, DOI 10.1080/02757541003627704; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Michelutti N, 2011, POLAR BIOL, V34, P799, DOI 10.1007/s00300-010-0934-5; Mistri M, 2008, MAR POLLUT BULL, V56, P587, DOI 10.1016/j.marpolbul.2007.12.002; Mouillot D, 2006, AQUAT CONSERV, V16, P469, DOI 10.1002/aqc.769; Mucha AP, 2005, MAR ENVIRON RES, V60, P531, DOI 10.1016/j.marenvres.2004.12.004; Palomo G, 1999, B MAR SCI, V65, P119; Pardal MA, 2000, MAR ECOL PROG SER, V196, P207, DOI 10.3354/meps196207; Pasquaud S, 2010, ESTUAR COAST SHELF S, V86, P237, DOI 10.1016/j.ecss.2009.11.019; Payne LX, 2006, OIKOS, V115, P69; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Ponti M, 2011, HELGOLAND MAR RES, V65, P25, DOI 10.1007/s10152-010-0197-0; Post DM, 1998, CONSERV BIOL, V12, P910, DOI 10.1046/j.1523-1739.1998.97112.x; POWELL GVN, 1991, ESTUAR COAST SHELF S, V32, P567, DOI 10.1016/0272-7714(91)90075-M; Reizopoulou S, 2004, AQUAT CONSERV, V14, pS93, DOI 10.1002/aqc.653; Reizopoulou S, 2007, HYDROBIOLOGIA, V577, P141, DOI 10.1007/s10750-006-0423-6; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Signa G, 2013, MAR POLLUT BULL, V74, P237, DOI 10.1016/j.marpolbul.2013.06.051; Signa G, 2012, ESTUAR COAST SHELF S, V111, P27, DOI 10.1016/j.ecss.2012.06.008; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; Tagliapietra D, 1998, ESTUAR COAST SHELF S, V47, P217, DOI 10.1006/ecss.1998.0340; Tagliapietra D, 2012, HYDROBIOLOGIA, V686, P15, DOI 10.1007/s10750-012-1001-8; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302	54	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117544	10.1371/journal.pone.0117544	http://dx.doi.org/10.1371/journal.pone.0117544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679400	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600071
J	Yang, RT; Zhang, CJ; Gao, R; Zhang, LN				Yang, Runtao; Zhang, Chengjin; Gao, Rui; Zhang, Lina			An Ensemble Method with Hybrid Features to Identify Extracellular Matrix Proteins	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; GENERAL-FORM; PREDICTION; ATTRIBUTES; SEQUENCE; DIFFERENTIATION; EXPRESSION; MACHINE; PSEAAC; GRAM	The extracellular matrix (ECM) is a dynamic composite of secreted proteins that play important roles in numerous biological processes such as tissue morphogenesis, differentiation and homeostasis. Furthermore, various diseases are caused by the dysfunction of ECM proteins. Therefore, identifying these important ECM proteins may assist in understanding related biological processes and drug development. In view of the serious imbalance in the training dataset, a Random Forest-based ensemble method with hybrid features is developed in this paper to identify ECM proteins. Hybrid features are employed by incorporating sequence composition, physicochemical properties, evolutionary and structural information. The Information Gain Ratio and Incremental Feature Selection (IGR-IFS) methods are adopted to select the optimal features. Finally, the resulting predictor termed IECMP (Identify ECM Proteins) achieves an balanced accuracy of 86.4% using the 10-fold cross-validation on the training dataset, which is much higher than results obtained by other methods (ECMPRED: 71.0%, ECMPP: 77.8%). Moreover, when tested on a common independent dataset, our method also achieves significantly improved performance over ECMPP and ECMPRED. These results indicate that IECMP is an effective method for ECM protein prediction, which has a more balanced prediction capability for positive and negative samples. It is anticipated that the proposed method will provide significant information to fully decipher the molecular mechanisms of ECM-related biological processes and discover candidate drug targets. For public access, we develop a user-friendly web server for ECM protein identification that is freely accessible at http://iecmp.weka.cc.	[Yang, Runtao; Zhang, Chengjin; Gao, Rui; Zhang, Lina] Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Peoples R China; [Zhang, Chengjin] Shandong Univ, Sch Mech Elect & Informat Engn, Weihai, Peoples R China	Shandong University; Shandong University	Zhang, CJ (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Peoples R China.	cjzhang@sdu.edu.cn; gaorui@sdu.edu.cn			National Natural Science Foundation of China [61174044, 61473335, 61174218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn; No. 61174044, 61473335, and 61174218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi TH, 2012, AMINO ACIDS, V42, P1443, DOI 10.1007/s00726-011-0888-0; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Anitha J, 2012, IJCA ADV COMPUTING C, V1, P7; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Asadabadi Ebrahim Barzegari, 2013, Avicenna Journal of Medical Biotechnology, V5, P148; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakhtiarizadeh MR, 2014, J THEOR BIOL, V356, P213, DOI 10.1016/j.jtbi.2014.04.040; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cromar GL, 2012, PROTEINS, V80, P1522, DOI 10.1002/prot.24036; Ding SY, 2014, J THEOR BIOL, V353, P19, DOI 10.1016/j.jtbi.2014.02.034; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Han GS, 2014, J THEOR BIOL, V344, P31, DOI 10.1016/j.jtbi.2013.11.017; Hayat M, 2014, J THEOR BIOL, V346, P8, DOI 10.1016/j.jtbi.2013.12.015; Hayat M, 2013, AMINO ACIDS, V44, P1317, DOI 10.1007/s00726-013-1466-4; Hayat M, 2012, ANAL BIOCHEM, V424, P35, DOI 10.1016/j.ab.2012.02.007; Hoglund A, 2005, ONLINE J BIOINFORM, V6, P51; Hosseinzadeh F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-238; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jung J, 2010, J COMPUT BIOL, V17, P97, DOI 10.1089/cmb.2008.0236; Kandaswamy KK, 2013, J THEOR BIOL, V317, P377, DOI 10.1016/j.jtbi.2012.10.015; Kandaswamy KK, 2010, BIOCHEM BIOPH RES CO, V391, P1306, DOI 10.1016/j.bbrc.2009.12.019; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Landreh M, 2011, FEBS J, V278, P3815, DOI 10.1111/j.1742-4658.2011.08215.x; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075726; Liu B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S3; Lu XQ, 2004, J CHEM INF COMP SCI, V44, P1228, DOI 10.1021/ci0342977; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57; Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Parisien M, 2007, PROTEINS, V68, P824, DOI 10.1002/prot.21475; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pugalenthi G, 2008, BIOCHEM BIOPH RES CO, V367, P630, DOI 10.1016/j.bbrc.2008.01.038; Qu W, 2012, NEURAL COMPUT APPL, V21, P337, DOI 10.1007/s00521-011-0739-7; Robert MG, 2009, ENTROPY INFORM THEOR; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; VANNUCCI M, 2001, SANKHYA B, V63, P218; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Witten I.H., 2005, DATA MINING PRACTICA; Yang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084439; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90; Zuo YC, 2014, ANAL BIOCHEM, V458, P14, DOI 10.1016/j.ab.2014.04.032	62	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117804	10.1371/journal.pone.0117804	http://dx.doi.org/10.1371/journal.pone.0117804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680094	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600089
J	Pal, A; Banerjee, R; Mondal, UK; Mukhopadhyay, S; Bothra, AK				Pal, Ayon; Banerjee, Rachana; Mondal, Uttam K.; Mukhopadhyay, Subhasis; Bothra, Asim K.			Deconstruction of Archaeal Genome Depict Strategic Consensus in Core Pathways Coding Sequence Assembly	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; METHANOMASSILIICOCCUS-LUMINYENSIS; TRANSLATIONAL SELECTION; NANOARCHAEUM-EQUITANS; ADAPTATION INDEX; CONTEXT ANALYSIS; EFFECTIVE NUMBER; BIAS; EVOLUTION; BACTERIA	A comprehensive in silico analysis of 71 species representing the different taxonomic classes and physiological genre of the domain Archaea was performed. These organisms differed in their physiological attributes, particularly oxygen tolerance and energy metabolism. We explored the diversity and similarity in the codon usage pattern in the genes and genomes of these organisms, emphasizing on their core cellular pathways. Our thrust was to figure out whether there is any underlying similarity in the design of core pathways within these organisms. Analyses of codon utilization pattern, construction of hierarchical linear models of codon usage, expression pattern and codon pair preference pointed to the fact that, in the archaea there is a trend towards biased use of synonymous codons in the core cellular pathways and the Nc-plots appeared to display the physiological variations present within the different species. Our analyses revealed that aerobic species of archaea possessed a larger degree of freedom in regulating expression levels than could be accounted for by codon usage bias alone. This feature might be a consequence of their enhanced metabolic activities as a result of their adaptation to the relatively O-2-rich environment. Species of archaea, which are related from the taxonomical viewpoint, were found to have striking similarities in their ORF structuring pattern. In the anaerobic species of archaea, codon bias was found to be a major determinant of gene expression. We have also detected a significant difference in the codon pair usage pattern between the whole genome and the genes related to vital cellular pathways, and it was not only species-specific but pathway specific too. This hints towards the structuring of ORFs with better decoding accuracy during translation. Finally, a codon-pathway interaction in shaping the codon design of pathways was observed where the transcription pathway exhibited a significantly different coding frequency signature.	[Pal, Ayon] Raiganj Coll Univ Coll, Dept Bot, Uttar Dinajpur, W Bengal, India; [Banerjee, Rachana; Mukhopadhyay, Subhasis] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Mondal, Uttam K.; Bothra, Asim K.] Raiganj Coll Univ Coll, Dept Chem, Cheminformat Bioinformat Lab, Uttar Dinajpur, W Bengal, India	University of Calcutta	Pal, A (corresponding author), Raiganj Coll Univ Coll, Dept Bot, Uttar Dinajpur, W Bengal, India.	ayonpal.ruc@gmail.com	Mondal, Uttam K/F-7219-2011; Pal, Ayon/AAD-1643-2019; Banerjee, Rachana/GLR-4701-2022	Mondal, Uttam K/0000-0003-2408-1258; Pal, Ayon/0000-0002-8446-0295; Banerjee, Rachana/0000-0002-5672-5196	Department of Biotechnology, Govt. of India [BT/BI/04/026/93, BT/BI/010/019/99]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	SM and RB received grants from the Department of Biotechnology, Govt. of India (http://dbtindia.nic.in) vide grant no. BT/BI/04/026/93 and BT/BI/010/019/99. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Aller JY, 2008, FEMS MICROBIOL ECOL, V65, P74, DOI 10.1111/j.1574-6941.2008.00498.x; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; [Anonymous], 1999, AN COD US; AOTA S, 1986, NUCLEIC ACIDS RES, V14, P6345, DOI 10.1093/nar/14.16.6345; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Brochier C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r42; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BULMER M, 1991, GENETICS, V129, P897; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chowdhury AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-236; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Emery LR, 2011, BIOL LETTERS, V7, P131, DOI 10.1098/rsbl.2010.0620; Epstein RJ, 2000, GENE, V245, P291, DOI 10.1016/S0378-1119(00)00042-1; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fuglsang A, 2006, GENETICS, V172, P1301, DOI 10.1534/genetics.105.049643; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gorlas A, 2012, J BACTERIOL, V194, P4745, DOI 10.1128/JB.00956-12; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7309, DOI 10.1073/pnas.0502314102; Khrustalev Vladislav V., 2010, Genomics Proteomics & Bioinformatics, V8, P22, DOI 10.1016/S1672-0229(10)60003-4; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lahr DJG, 2011, MOL BIOL EVOL, V28, P223, DOI 10.1093/molbev/msq200; Lithwick G, 2005, NUCLEIC ACIDS RES, V33, P1051, DOI 10.1093/nar/gki261; Liu WQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-325; Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OHAMA T, 1990, NUCLEIC ACIDS RES, V18, P1565, DOI 10.1093/nar/18.6.1565; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sakai A, 2006, GENES CELLS, V11, P767, DOI 10.1111/j.1365-2443.2006.00982.x; Schmidt A, 2012, J BASIC MICROB, V52, P195, DOI 10.1002/jobm.201100067; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith NGC, 2001, J MOL EVOL, V53, P225, DOI 10.1007/s002390010212; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Tats A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-463; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Witzany G, 2011, J MOL CELL BIOL, V3, P181, DOI 10.1093/jmcb/mjr005; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia Xuhua, 2007, Evol Bioinform Online, V3, P53; Zeeberg B, 2002, GENOME RES, V12, P944, DOI 10.1101/gr.213402	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118245	10.1371/journal.pone.0118245	http://dx.doi.org/10.1371/journal.pone.0118245			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674789	gold, Green Submitted, Green Published			2022-12-27	WOS:000349914000044
J	Hartter, J; Stevens, FR; Hamilton, LC; Congalton, RG; Ducey, MJ; Oester, PT				Hartter, Joel; Stevens, Forrest R.; Hamilton, Lawrence C.; Congalton, Russell G.; Ducey, Mark J.; Oester, Paul T.			Modelling Associations between Public Understanding, Engagement and Forest Conditions in the Inland Northwest, USA	PLOS ONE			English	Article							LAND-USE CHANGE; WILDFIRE; MANAGEMENT; PRONE; RISK; DISTURBANCE; PERCEPTION; MITIGATION; DRIVERS; LESSONS	Opinions about public lands and the actions of private non-industrial forest owners in the western United States play important roles in forested landscape management as both public and private forests face increasing risks from large wildfires, pests and disease. This work presents the responses from two surveys, a random-sample telephone survey of more than 1500 residents and a mail survey targeting owners of parcels with 10 or more acres of forest. These surveys were conducted in three counties (Wallowa, Union, and Baker) in northeast Oregon, USA. We analyze these survey data using structural equation models in order to assess how individual characteristics and understanding of forest management issues affect perceptions about forest conditions and risks associated with declining forest health on public lands. We test whether forest understanding is informed by background, beliefs, and experiences, and whether as an intervening variable it is associated with views about forest conditions on publicly managed forests. Individual background characteristics such as age, gender and county of residence have significant direct or indirect effects on our measurement of understanding. Controlling for background factors, we found that forest owners with higher self-assessed understanding, and more education about forest management, tend to hold more pessimistic views about forest conditions. Based on our results we argue that self-assessed understanding, interest in learning, and willingness to engage in extension activities together have leverage to affect perceptions about the risks posed by declining forest conditions on public lands, influence land owner actions, and affect support for public policies. These results also have broader implications for management of forested landscapes on public and private lands amidst changing demographics in rural communities across the Inland Northwest where migration may significantly alter the composition of forest owner goals, understanding, and support for various management actions.	[Hartter, Joel] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Hartter, Joel; Hamilton, Lawrence C.; Ducey, Mark J.] Univ New Hampshire, Carsey Sch Publ Policy, Durham, NH 03824 USA; [Stevens, Forrest R.] Univ Louisville, Dept Geog & Geosci, Louisville, KY 40292 USA; [Hamilton, Lawrence C.] Univ New Hampshire, Dept Sociol, Durham, NH 03824 USA; [Congalton, Russell G.; Ducey, Mark J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Oester, Paul T.] Oregon State Univ, Extens Serv, La Grande, OR USA	University of Colorado System; University of Colorado Boulder; University System Of New Hampshire; University of New Hampshire; University of Louisville; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Oregon State University	Hartter, J (corresponding author), Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA.	joel.hartter@colorado.edu	Ducey, Mark/K-1101-2016	Ducey, Mark/0000-0002-2027-1188; Stevens, Forrest/0000-0002-9328-3753	Disaster Resilience for Rural Communities Program, National Institute of Food and Agriculture program of the United States Department of Agriculture [2010-67023-21705]; Office Of The Director [1101245] Funding Source: National Science Foundation	Disaster Resilience for Rural Communities Program, National Institute of Food and Agriculture program of the United States Department of Agriculture; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The Communities and Forests in Oregon (CAFOR) project is supported by a grant from the Disaster Resilience for Rural Communities Program, which is part of the National Institute of Food and Agriculture program (www.csrees.usda.gov) of the United States Department of Agriculture (Award #2010-67023-21705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2005, ENVIRON MANAGE, V36, P495, DOI 10.1007/s00267-004-7256-8; Abrams J., 2011, THESIS OREGON STATE; Abrams J, 2013, J RURAL COMMUNITY D, V8, P144; Abrams J, 2013, SOC NATUR RESOUR, V26, P845, DOI 10.1080/08941920.2012.719587; Abrams JB, 2012, J RURAL STUD, V28, P30, DOI 10.1016/j.jrurstud.2011.09.004; Adams DM, 2006, PNWGTR659 US DEP AGR; Agee JK, 2003, NAT AREA J, V23, P114; Agrawal S., 2006, General Technical Report - USDA Forest Service, P163; American Association for Public Opinion Research (AAPOR), 2006, STAND DEF FIN DISP C; Barbour RJ, 2005, FOREST ECOL MANAG, V211, P210, DOI 10.1016/j.foreco.2005.02.034; Barnum P, 2013, OSAF ANN M PENDL OR; Beck U., 1994, RISK SOC NEW MODERNI; BEEBE GS, 1993, J FOREST, V91, P19; Bliss JC, 2008, SMALL SCALE RURAL FO; Brummel RF, 2010, J ENVIRON PLANN MAN, V53, P681, DOI 10.1080/09640568.2010.488090; Burns S, 2002, US FOR SERV RMRS-P, P213; Dale L, 2006, SOC NATUR RESOUR, V19, P275, DOI 10.1080/08941920500460898; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DiStefano C, 2002, STRUCT EQU MODELING, V9, P327, DOI 10.1207/S15328007SEM0903_2; Dominguez G, 2011, EUR J FOREST RES, V130, P435, DOI 10.1007/s10342-009-0332-0; Eriksen C, 2011, INT J WILDLAND FIRE, V20, P612, DOI 10.1071/WF10018; Fernandez-Gimenez ME, 2008, ECOL SOC, V13; Fischer AP, 2012, ENVIRON MANAGE, V49, P1192, DOI 10.1007/s00267-012-9848-z; Fischer AP, 2011, J FOREST, V109, P260; Flint CG, 2009, ENVIRON MANAGE, V43, P1174, DOI 10.1007/s00267-008-9193-4; Franklin JF, 2007, NRS19 GTR USDA; Garber-Yonts BE, 2004, PNWGTR617 USFS USDA; Gorte R.W., 2013, RISING COST WILDFIRE; Gude P, 2008, J FOREST, V106, P198; Hamilton LC, 2014, RURAL SOCIOL, V79, P257, DOI 10.1111/ruso.12023; Hamilton LC, 2010, RURAL SOCIOL, V75, P326, DOI 10.1111/j.1549-0831.2010.00013.x; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hansen AJ, 2005, ECOL APPL, V15, P1849, DOI 10.1890/03-5219; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Hartter J, CONSERVATION CONFLIC; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hessburg PF, 2004, EMULATING NATURAL FOREST LANDSCAPED DISTURBANCES: CONCEPTS AND APPLICATIONS, P158; Heyerdahl EK, 2001, ECOLOGY, V82, P660, DOI 10.1890/0012-9658(2001)082[0660:SCOHFR]2.0.CO;2; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson JD, 1995, J RURAL STUD, V11, P405, DOI 10.1016/0743-0167(95)00029-1; Johnson KM, 1998, RES RUR SOC, V7, P23; Kline RB, 2011, PRINCIPLES PRACTICE, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Koontz TM, 2008, CONSERV BIOL, V22, P60, DOI 10.1111/j.1523-1739.2007.00860.x; Langston Nancy, 1995, FOREST DREAMS FOREST; Lee ES., 2006, ANAL COMPLEX SURVEY, P50, DOI 10.4135/9781412983341.n6; Lettman GJ, 2004, FORESTS FARMS PEOPLE; Martin WE, 2009, J ENVIRON MANAGE, V91, P489, DOI 10.1016/j.jenvman.2009.09.007; McCaffrey S, 2013, INT J WILDLAND FIRE, V22, P15, DOI 10.1071/WF11115; McGee TK, 2011, J ENVIRON MANAGE, V92, P2524, DOI 10.1016/j.jenvman.2011.05.017; Mcgee TK, 2009, SOC NATUR RESOUR, V22, P308, DOI 10.1080/08941920801910765; Mindrila D, 2010, INT J DIGITAL SOC, V1, P60, DOI [10.20533/ijds.2040.2570.2010.0010, DOI 10.20533/IJDS.2040.2570.2010.0010]; National Interagency Fire Center, 2013, FED FIR COSTS SUPPR; Neugarten RA, 2011, BIOSCIENCE, V61, P631, DOI 10.1525/bio.2011.61.8.10; Noss RF, 2006, FRONT ECOL ENVIRON, V4, P481, DOI 10.1890/1540-9295(2006)4[481:MFFITW]2.0.CO;2; Oregon Solutions, 2013, OR FOR COLL STAT INV; Paton D., 2013, PLANET RISK, V1, P44; Paul F Ehinger & Associates, 2010, MILL CLOS DAT 1990 2, P1; Petts J, 2007, GEOGR J, V173, P300, DOI 10.1111/j.1475-4959.2007.00254.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sheppard SRJ, 2005, FOREST ECOL MANAG, V207, P171, DOI 10.1016/j.foreco.2004.10.032; Shindler B, 2003, J FOREST, V101, P8; Swan L, 2012, E OREGON PRIMARY WOO, DOI [10.1007/s12070-012-0514-9 PMID: 25621271, DOI 10.1007/S12070-012-0514-9]; Theobald DM, 2005, ECOL APPL, V15, P1906, DOI 10.1890/03-5331; Thomas JW, 2004, FOREST FUTURES SCI P, P3; Toman E, 2002, US FOR SERV RMRS-P, P241; Torn M S, 1998, LBNL42592; US Census Bureau, 2013, COUNT TOT DAT POP PO; US Forest Service, 2010, FIR HIST POL FIREHIS; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	74	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117975	10.1371/journal.pone.0117975	http://dx.doi.org/10.1371/journal.pone.0117975			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671619	gold, Green Submitted, Green Published			2022-12-27	WOS:000349545300076
J	Katoh, D; Nishizuka, M; Osada, S; Imagawa, M				Katoh, Daiki; Nishizuka, Makoto; Osada, Shigehiro; Imagawa, Masayoshi			Fad104, a Positive Regulator of Adipocyte Differentiation, Suppresses Invasion and Metastasis of Melanoma Cells by Inhibition of STAT3 Activity	PLOS ONE			English	Article							FACTOR-KAPPA-B; MATRIX METALLOPROTEINASE-2; EARLY-STAGE; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; CRUCIAL ROLE; GENE FAD104; ACTIVATION; EXPRESSION; FIBRONECTIN	Metastasis is the main cause of death in patients with cancer, and understanding the mechanisms of metastatic processes is essential for the development of cancer therapy. Although the role of several cell adhesion, migration or proliferation molecules in metastasis is established, a novel target for cancer therapy remains to be discovered. Previously, we reported that fad104 (factor for adipocyte differentiation 104), a regulatory factor of adipogenesis, regulates cell adhesion and migration. In this report, we clarify the role of fad104 in the invasion and metastasis of cancer cells. The expression level of fad104 in highly metastatic melanoma A375SM cells was lower than that in poorly metastatic melanoma A375C6 cells. Reduction of fad104 expression enhanced the migration and invasion of melanoma cells, while over-expression of FAD104 inhibited migration and invasion. In addition, melanoma cells stably expressing FAD104 showed a reduction in formation of lung colonization compared with control cells. FAD104 interacted with STAT3 and down-regulated the phosphorylation level of STAT3 in melanoma cells. These findings together demonstrate that fad104 suppressed the invasion and metastasis of melanoma cells by inhibiting activation of the STAT3 signaling pathway. These findings will aid a comprehensive description of the mechanism that controls the invasion and metastasis of cancer cells.	[Katoh, Daiki; Nishizuka, Makoto; Osada, Shigehiro; Imagawa, Masayoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [21390024]; Aichi Cancer Research Foundation; Research Foundation for Pharmaceutical Sciences, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Research Foundation for Pharmaceutical Sciences, Japan	This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS): (http://www.jsps.go.jp/), 21390024 (MI), Aichi Cancer Research Foundation: (http://www.acrf.or.jp/) (MN), and The Research Foundation for Pharmaceutical Sciences, Japan: (http://www15.ocn.ne.jp/similar to yakusho/) (MN).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bohm M, 2001, J INVEST DERMATOL, V117, P132, DOI 10.1046/j.0022-202x.2001.01372.x; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; ChiRosso G, 1997, J BIOL CHEM, V272, P31447, DOI 10.1074/jbc.272.50.31447; Chung YH, 2004, J VIROL, V78, P6489, DOI 10.1128/JVI.78.12.6489-6497.2004; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Fan XL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-61; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Hayashi H, 1997, INT J CANCER, V71, P416, DOI 10.1002/(SICI)1097-0215(19970502)71:3<416::AID-IJC19>3.0.CO;2-D; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hofmann UB, 2000, J PATHOL, V191, P245; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Huang FJ, 2008, CANCER RES, V68, P9634, DOI 10.1158/0008-5472.CAN-08-1429; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kishimoto K, 2013, J BIOL CHEM, V288, P31772, DOI 10.1074/jbc.M113.452961; Kishimoto K, 2011, EXP CELL RES, V317, P2110, DOI 10.1016/j.yexcr.2011.06.003; Kishimoto K, 2010, BIOCHEM BIOPH RES CO, V397, P187, DOI 10.1016/j.bbrc.2010.05.077; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2009, EXP CELL RES, V315, P809, DOI 10.1016/j.yexcr.2008.12.013; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Rotte A, 2012, CELL ONCOL, V35, P207, DOI 10.1007/s13402-012-0080-x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; STRETCH JR, 1991, CANCER RES, V51, P5976; Su FQ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3134; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yang Chuan He, 2010, Int J Interferon Cytokine Mediat Res, V2010, P1; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117197	10.1371/journal.pone.0117197	http://dx.doi.org/10.1371/journal.pone.0117197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671570	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300041
J	Narasimha, S; Kolly, S; Sokolowski, MB; Kawecki, TJ; Vijendravarma, RK				Narasimha, Sunitha; Kolly, Sylvain; Sokolowski, Marla B.; Kawecki, Tadeusz J.; Vijendravarma, Roshan K.			Prepupal Building Behavior in Drosophila melanogaster and Its Evolution under Resource and Time Constraints	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CHRONIC MALNUTRITION; PUPATION HEIGHT; LARVAL; METAMORPHOSIS; CONSEQUENCES; POLYMORPHISM; HYMENOPTERA; SELECTION; DIPTERA	Structures built by animals are a widespread and ecologically important 'extended phenotype'. While its taxonomic diversity has been well described, factors affecting short-term evolution of building behavior within a species have received little experimental attention. Here we describe how, given the opportunity, wandering Drosophila melanogaster larvae often build long tunnels in agar substrates and embed their pupae within them. These embedded larvae are characterized by a longer egg-to-pupariation developmental time than larvae that pupate on the surface. Assuming that such building behaviors are likely to be energetically costly and/or time consuming, we hypothesized that they should evolve to be less pronounced under resource or time limitation. In accord with this prediction, larvae from populations evolved for 160 generations under a regime that combines larval malnutrition with limited developmental time dug shorter tunnels than larvae from control unselected populations. However, the proportion of larvae that embedded before pupation did not differ between the malnutrition-adapted and control populations, suggesting that tunnel length and likelihood of embedding before pupation are controlled by different genetic loci. The behaviors exhibited by wandering larvae of Drosophila melanogaster prior to pupation offer a model system to study evolution of animal building behaviors because the tunneling and embedding phenotypes are simple, facultative and highly variable.	[Narasimha, Sunitha; Kolly, Sylvain; Kawecki, Tadeusz J.; Vijendravarma, Roshan K.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Lausanne; University of Toronto	Vijendravarma, RK (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	roshan.vijendravarma@unil.ch	Kawecki, Tadeusz/K-5466-2015; Vijendravarma, Roshan K/E-7746-2018	Kawecki, Tadeusz/0000-0002-9244-1991; Vijendravarma, Roshan K/0000-0002-3274-0682; Vijendravarma, Roshan Kumar/0000-0002-4930-3040; Sokolowski, Marla/0000-0002-7462-8007	Swiss National Science Foundation [31003A_143939]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work has been supported by the Swiss National Science Foundation (grant# 31003A_143939) to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 1998, AUST J ENTOMOL, V37, P158, DOI 10.1111/j.1440-6055.1998.tb01564.x; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; BERRIGAN D, 1993, J EXP BIOL, V179, P245; CARTON Y, 1994, J INSECT BEHAV, V7, P129, DOI 10.1007/BF01989833; DENLINGER DL, 1994, ANNU REV ENTOMOL, V39, P243, DOI 10.1146/annurev.en.39.010194.001331; Eisner T, 2000, P NATL ACAD SCI USA, V97, P2632, DOI 10.1073/pnas.050002197; GODOYHERRERA R, 1989, ANIM BEHAV, V37, P820, DOI 10.1016/0003-3472(89)90066-3; Hansell M., 2005, OXF ANIMAL BIOL SER; Hansell MH., 1984, ANIMAL ARCHITECTURE; Hodge S, 1998, J INSECT BEHAV, V11, P47, DOI 10.1023/A:1020814516158; JOSHI A, 1993, EVOLUTION, V47, P176, DOI [10.2307/2410127, 10.1111/j.1558-5646.1993.tb01208.x]; Josso C, 2011, NATURWISSENSCHAFTEN, V98, P705, DOI 10.1007/s00114-011-0813-0; Kawecki TJ, 2012, EXPT EVOLUTION; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; MANNING M, 1981, BEHAV GENET, V11, P557, DOI 10.1007/BF01065790; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Riedl CAL, 2007, FLY, V1, P23, DOI 10.4161/fly.3830; RODRIGUEZ L, 1992, J EVOLUTION BIOL, V5, P61, DOI 10.1046/j.1420-9101.1992.5010061.x; Roff Derek, 2002, pi; SEWELL DF, 1975, BEHAV BIOL, V15, P213, DOI 10.1016/S0091-6773(75)91587-4; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; SOKOLOWSKI MB, 1989, HEREDITY, V62, P177, DOI 10.1038/hdy.1989.26; SOKOLOWSKI MB, 1985, J INSECT PHYSIOL, V31, P857, DOI 10.1016/0022-1910(85)90103-9; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; Stearns S.C., 1992, pi; Vijendravarma RK, 2012, J EVOLUTION BIOL, V25, P288, DOI 10.1111/j.1420-9101.2011.02419.x; Vijendravarma RK, 2013, NATURE COMMUNICATION, V4, DOI [10.1038/ncomms3763, DOI 10.1038/NCOMMS3763]; Vijendravarma RK, 2012, P ROY SOC B-BIOL SCI, V279, P3540, DOI 10.1098/rspb.2012.0966; Vijendravarma RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030650; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; WONG JL, 1985, BEHAV GENET, V15, P155, DOI 10.1007/BF01065896; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	41	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117280	10.1371/journal.pone.0117280	http://dx.doi.org/10.1371/journal.pone.0117280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671711	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300045
J	Nuvolone, M; Sorce, S; Schwarz, P; Aguzzi, A				Nuvolone, Mario; Sorce, Silvia; Schwarz, Petra; Aguzzi, Adriano			Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CYTOKINE GENE-EXPRESSION; NF-KAPPA-B; MICROGLIAL ACTIVATION; NALP3 INFLAMMASOME; IMMUNE-RESPONSE; FAMILY-MEMBERS; IL-1-BETA; SCRAPIE; PROTEIN	The accumulation of the scrapie prion protein PrPSc, a misfolded conformer of the cellular prion protein PrPC, is a crucial feature of prion diseases. In the central nervous system, this process is accompanied by conspicuous microglia activation. The NLRP3 inflammasome is a multi-molecular complex which can sense heterogeneous pathogen-associated molecular patterns and culminates in the activation of caspase 1 and release of IL 1 beta. The NLRP3 inflammasome was reported to be essential for IL 1 beta release after in vitro exposure to the amyloidogenic peptide PrP106-126 and to recombinant PrP fibrils. We therefore studied the role of the NLRP3 inflammasome in a mouse model of prion infection. Upon intracerebral inoculation with scrapie prions (strain RML), mice lacking NLRP3 (Nlrp3(-/-)) or the inflammasome adaptor protein ASC (Pycard(-/-)) succumbed to scrapie with attack rates and incubation times similar to wild-type mice, and developed the classic histologic and biochemical features of prion diseases. Genetic ablation of NLRP3 or ASC did not significantly impact on brain levels of IL 1 beta at the terminal stage of disease. Our results exclude a significant role for NLRP3 and ASC in prion pathogenesis and invalidate their claimed potential as therapeutic target against prion diseases.	[Nuvolone, Mario; Sorce, Silvia; Schwarz, Petra; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Nuvolone, M (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	mario.nuvolone@usz.ch; adriano.aguzzi@usz.ch	Nuvolone, Mario/K-4763-2018	Nuvolone, Mario/0000-0001-8334-1684; Sorce, Silvia/0000-0002-3843-8644; Aguzzi, Adriano/0000-0002-0344-6708	Collegio Ghislieri, Pavia; Roche post-doc fellowship; Betty and David Koetser Award for Brain Research; Advanced Grant of the European Research Council [250356]; European Union [222887, 278611]; Swiss National Foundation (Sinergia grant) [31003A_141193]; Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; Clinical Research Priority Program "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich; Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases")	Collegio Ghislieri, Pavia; Roche post-doc fellowship; Betty and David Koetser Award for Brain Research; Advanced Grant of the European Research Council; European Union(European Commission); Swiss National Foundation (Sinergia grant)(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; Clinical Research Priority Program "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich; Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases")	MN was supported by an investigator fellowship from Collegio Ghislieri, Pavia. SS was supported by a Roche post-doc fellowship, and by the Betty and David Koetser Award for Brain Research. AA is the recipient of an Advanced Grant of the European Research Council (#250356) and is supported by grants from the European Union (PRIORITY: # 222887, NEURINOX: 278611), the Swiss National Foundation (31003A_141193 and Sinergia grant), the Novartis Research Foundation, the Clinical Research Priority Programs "Small RNAs" and "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich, and the Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not alter the Authors' adherence to PLOS ONE policies on sharing data and materials.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; BARCIKOWSKA M, 1993, ACTA NEUROPATHOL, V85, P623, DOI 10.1007/BF00334672; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bradford BM, 2012, VIRUSES-BASEL, V4, P3389, DOI 10.3390/v4123389; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAMPBELL IL, 1994, J VIROL, V68, P2383, DOI 10.1128/JVI.68.4.2383-2387.1994; Case CL, 2011, MBIO, V2, DOI 10.1128/mBio.00117-11; Chang JX, 2012, J MOL NEUROSCI, V48, P248, DOI 10.1007/s12031-012-9821-6; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; GUIROY DC, 1994, ACTA NEUROPATHOL, V87, P526; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ishibashi D, 2012, J VIROL, V86, P4947, DOI 10.1128/JVI.06326-11; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Marcos-Carcavilla A, 2007, MAMM GENOME, V18, P53, DOI 10.1007/s00335-006-0095-6; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2005, J NEUROPATH EXP NEUR, V64, P902, DOI 10.1097/01.jnen.0000183346.19447.55; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Sharief MK, 1999, NEUROLOGY, V52, P1289, DOI 10.1212/WNL.52.6.1289; Shi FS, 2013, J NEUROIMMUNOL, V260, P121, DOI 10.1016/j.jneuroim.2013.04.016; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shi Q, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-216; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Stoeck K, 2006, J NEUROIMMUNOL, V172, P175, DOI 10.1016/j.jneuroim.2005.10.008; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tribouillard-Tanvier D, 2012, J VIROL, V86, P10377, DOI 10.1128/JVI.01340-12; Van Everbroeck B, 2002, NEUROBIOL AGING, V23, P59, DOI 10.1016/S0197-4580(01)00236-6; Walsh DT, 2001, J NEUROPATH EXP NEUR, V60, P173, DOI 10.1093/jnen/60.2.173; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Williams A, 1997, BRAIN RES, V754, P171, DOI 10.1016/S0006-8993(97)00067-X; Xie WL, 2013, J MOL NEUROSCI, V51, P919, DOI 10.1007/s12031-013-0002-z; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	71	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117208	10.1371/journal.pone.0117208	http://dx.doi.org/10.1371/journal.pone.0117208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671600	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300042
J	Gulli, M; Salvatori, E; Fusaro, L; Pellacani, C; Manes, F; Marmiroli, N				Gulli, Mariolina; Salvatori, Elisabetta; Fusaro, Lina; Pellacani, Claudia; Manes, Fausto; Marmiroli, Nelson			Comparison of Drought Stress Response and Gene Expression between a GM Maize Variety and a Near-Isogenic Non-GM Variety	PLOS ONE			English	Article							C-4 PHOTOSYNTHESIS; WATER-STRESS; BT; LIMITATIONS; PROTEINS; CORN; CONTAMINATION; VARIABILITY; PROTEOMICS; TOLERANCE	Maize MON810, grown and commercialised worldwide, is the only cultivated GM event in the EU. Maize MON810, variety DKC6575, and the corresponding near-isogenic line Tietar were studied in different growth conditions, to compare their behaviour in response to drought. Main photosynthetic parameters were significantly affected by drought stress in both GM and non-GM varieties to a similar extent. Though DKC6575 (GM) had a greater sensitivity in the early phase of stress response as compared with Tietar (non-GM), after six days of stress they behaved similarly, and both varieties recovered from stress damage. Profiling gene expression in water deficit regimes and in a generalised drought stress condition showed an up-regulation of many stress-responsive genes, but a greater number of differentially expressed genes was observed in Tietar, with genes belonging to transcription factor families and genes encoding heat shock proteins, late embryogenesis abundant proteins and detoxification enzymes. Since induction of these genes have been indicated from the literature as typical of stress responses, their activation in Tietar rather than in DKC6575 may be reminiscent of a more efficient response to drought. DKC6575 was also analysed for the expression of the transgene CryIAb (encoding the delta-endotoxin insecticidal protein) in water deficit conditions. In all the experiments, the CryIAb transcript was not influenced by drought stress, but was expressed at a constant level. This suggests that though possessing a different pattern of sensitivity to stress, the GM variety maintains the same expression level for the transgene.	[Gulli, Mariolina; Pellacani, Claudia; Marmiroli, Nelson] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Salvatori, Elisabetta; Fusaro, Lina; Manes, Fausto] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy	University of Parma; Sapienza University Rome	Marmiroli, N (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 11a, I-43124 Parma, Italy.	nelson.marmiroli@unipr.it	Fusaro, Lina/Q-4369-2017; Salvatori, Elisabetta/F-8931-2010; Gullì, Mariolina/G-9759-2011	Fusaro, Lina/0000-0003-3316-707X; Gullì, Mariolina/0000-0001-8326-4965; MANES, Fausto/0000-0002-4563-4272; Pellacani, Claudia/0000-0002-2853-3429; SALVATORI, ELISABETTA/0000-0002-5603-5064	Italian Ministery of University and Research; Regione Emilia-Romagna	Italian Ministery of University and Research; Regione Emilia-Romagna(Regione Emilia Romagna)	Funding from Italian Ministery of University and Research, National projects PRIN 2006 (NM, FM) and Regione Emilia-Romagna (IT) to SITEIA. PARMA Technopole (POR FESR 2007-2013) (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2013, J AGR FOOD CHEM, V61, P11759, DOI 10.1021/jf400754g; Accinelli C, 2014, CROP PROT, V63, P9, DOI 10.1016/j.cropro.2014.04.021; Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Applied Biosystems, 2008, GUID PERF REL QUANT; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Batista R, 2010, REGUL TOXICOL PHARM, V58, pS8, DOI 10.1016/j.yrtph.2010.08.019; Baudo MM, 2006, PLANT BIOTECHNOL J, V4, P369, DOI 10.1111/j.1467-7652.2006.00193.x; Baudo Maria Marcela, 2009, V478, P247, DOI 10.1007/978-1-59745-379-0_15; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Brewer MJ, 2014, ENVIRON ENTOMOL, V43, P828, DOI 10.1603/EN13309; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Cheng KC, 2008, J AGR FOOD CHEM, V56, P3057, DOI 10.1021/jf073505i; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; de Sousa-Majer MJ, 2004, J EXP BOT, V55, P497, DOI 10.1093/jxb/erh037; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escalona JM, 1999, AUST J PLANT PHYSIOL, V26, P421, DOI 10.1071/PP99019; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gulli M, 2007, FEBS LETT, V581, P4841, DOI 10.1016/j.febslet.2007.09.010; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Herman RA, 2013, J AGR FOOD CHEM, V61, P11695, DOI 10.1021/jf400135r; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaman H, 2011, AGR WATER MANAGE, V98, P801, DOI 10.1016/j.agwat.2010.12.003; Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; La Paz JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100895; Ma BL, 2005, FIELD CROP RES, V93, P199, DOI 10.1016/j.fcr.2004.09.021; Maestri E, 2002, PLANT MOL BIOL, V48, P667, DOI 10.1023/A:1014826730024; Marmiroli N, 2008, ANAL BIOANAL CHEM, V392, P369, DOI 10.1007/s00216-008-2303-6; Martins CM, 2008, ANN APPL BIOL, V152, P255, DOI 10.1111/j.1744-7348.2007.00214.x; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Ogbaga CC, 2014, PHYSIOL PLANTARUM, V152, P389, DOI 10.1111/ppl.12196; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ripley BS, 2007, J EXP BOT, V58, P1351, DOI 10.1093/jxb/erl302; Salvatori E, 2013, ENVIRON EXP BOT, V87, P79, DOI 10.1016/j.envexpbot.2012.09.008; Samson MC, 2013, FOOD CONTROL, V30, P518, DOI 10.1016/j.foodcont.2012.08.001; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shewry PR, 2007, TRENDS FOOD SCI TECH, V18, P201, DOI 10.1016/j.tifs.2006.12.010; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Traore SB, 2000, AGRON J, V92, P1027, DOI 10.2134/agronj2000.9251027x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Fei, 2014, Australian Journal of Crop Science, V8, P18; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405	57	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117073	10.1371/journal.pone.0117073	http://dx.doi.org/10.1371/journal.pone.0117073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692547	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500036
J	Hayashi, T; Fukuda, N; Uchiyama, S; Inada, N				Hayashi, Teruyuki; Fukuda, Nanaho; Uchiyama, Seiichi; Inada, Noriko			A Cell-Permeable Fluorescent Polymeric Thermometer for Intracellular Temperature Mapping in Mammalian Cell Lines	PLOS ONE			English	Article							DELIVERY; THERMOGENESIS; PROTEINS; HEAT	Changes in intracellular temperatures reflect the activity of the cell. Thus, the tool to measure intracellular temperatures could provide valuable information about cellular status. We previously reported a method to analyze the intracellular temperature distribution using a fluorescent polymeric thermometer (FPT) in combination with fluorescence lifetime imaging microscopy (FLIM). Intracellular delivery of the FPT used in the previous study required microinjection. We now report a novel FPT that is cell permeable and highly photostable, and we describe the application of this FPT to the imaging of intracellular temperature distributions in various types of mammalian cell lines. This cell-permeable FPT displayed a temperature resolution of 0.05 degrees C to 0.54 degrees C within the range from 28 degrees C to 38 degrees C in HeLa cell extracts. Using our optimized protocol, this cell-permeable FPT spontaneously diffused into HeLa cells within 10 min of incubation and exhibited minimal toxicity over several hours of observation. FLIM analysis confirmed a temperature difference between the nucleus and the cytoplasm and heat production near the mitochondria, which were also detected previously using the microinjected FPT. We also showed that this cell-permeable FPT protocol can be applied to other mammalian cell lines, COS7 and NIH/3T3 cells. Thus, this cell-permeable FPT represents a promising tool to study cellular states and functions with respect to temperature.	[Hayashi, Teruyuki; Fukuda, Nanaho; Inada, Noriko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Uchiyama, Seiichi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	Nara Institute of Science & Technology; University of Tokyo	Inada, N (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan.	norikoi@bs.naist.jp	UCHIYAMA, SEIICHI/AAV-8284-2021	INADA, NORIKO/0000-0002-9931-4063	Development of Advanced Measurement and Analysis System; NAIST by MEXT; Mitsubishi Foundation [25103]; JST	Development of Advanced Measurement and Analysis System; NAIST by MEXT; Mitsubishi Foundation; JST(Japan Science & Technology Agency (JST))	This work was supported by the Development of Advanced Measurement and Analysis System by JST (http://www.jst.go.jp/sentan/, for SU and NI), Grants-in-Aid for Scientific Research for Plant Graduate Students from NAIST by MEXT, and The Mitsubishi Foundation (http://www.mitsubishi-zaidan.jp/, ID: 25103 for NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06701; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Becker W, 2008, BH TCSPC HDB, P167; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; Brites CDS, 2012, NANOSCALE, V4, P4799, DOI 10.1039/c2nr30663h; Donner JS, 2013, ACS NANO, V7, P8666, DOI 10.1021/nn403659n; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inada N, 2013, IMAGING MED, V5, P303, DOI DOI 10.2217/iim.13.34; Jaque D, 2012, NANOSCALE, V4, P4301, DOI 10.1039/c2nr30764b; Kamkaew A, 2011, ORG BIOMOL CHEM, V9, P6513, DOI 10.1039/c1ob05874f; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Lodish H, 2007, MOL CELL BIOL, P448; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; NAKAMURA T, 1978, J BIOCHEM-TOKYO, V84, P39, DOI 10.1093/oxfordjournals.jbchem.a132117; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; Sato MK, 2014, BIOPHYS J, V106, P2458, DOI 10.1016/j.bpj.2014.04.044; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Suzuki M, 2007, BIOPHYS J, V92, pL46, DOI 10.1529/biophysj.106.098673; Takei Y, 2014, ACS NANO, V8, P198, DOI 10.1021/nn405456e; Tsuji T, 2013, ANAL CHEM, V85, P9815, DOI 10.1021/ac402128f; Uchiyama S, 2012, CHEM-EUR J, V18, P9552, DOI 10.1002/chem.201200597; Wang CL, 2011, CELL RES, V21, P1517, DOI 10.1038/cr.2011.117; Wang XD, 2013, CHEM SOC REV, V42, P7834, DOI 10.1039/c3cs60102a; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Zohar O, 1998, BIOPHYS J, V74, P82, DOI 10.1016/S0006-3495(98)77769-0	36	82	83	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117677	10.1371/journal.pone.0117677	http://dx.doi.org/10.1371/journal.pone.0117677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692871	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500069
J	Rizzitelli, A; Smoll, NR; Chae, MP; Rozen, WM; Hunter-Smith, DJ				Rizzitelli, Alexandra; Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.			Incidence and Overall Survival of Malignant Ameloblastoma	PLOS ONE			English	Article							ODONTOGENIC-TUMORS; RELATIVE SURVIVAL; POPULATION; CARCINOMA; AGE	Background Malignant ameloblastoma, comprising metastasizing ameloblastoma and ameloblastic carcinoma, represents 1.6-2.2% of all odontogenic tumors. Due to its rare nature, malignant ameloblastoma has only been reported in the literature in small case series or case reports. Using the Surveillance, Epidemiology and End-Results (SEER) database, we have performed a population-based study to determine the incidence rate and the absolute survival of malignant ameloblastoma. Method Using the International Classification of Diseases for Oncology (ICD-O) codes 9310/3 and 9270/3, data from the SEER database were used to calculate the incidence rate and absolute survival rate of population with malignant ameloblastoma. Results The overall incidence rate of malignant ameloblastoma was 1.79 per 10 million person/year. The incidence rate was higher in males than females and also higher in black versus white population. The median overall survival was 17.6 years from the time of diagnosis and increasing age was associated with a statistically significant poorer survival. Conclusions To our best knowledge, we report the largest population-based series of malignant ameloblastoma. The incidence rate was 1.79 per 10 million person/year and the overall survival was 17.6 years.	[Rizzitelli, Alexandra; Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Peninsula Hlth, Frankston Hosp, Dept Plast & Reconstruct Surg, Frankston, Vic 3199, Australia; [Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Monash Univ, Monash Med Ctr, Dept Surg, Clayton, Vic 3168, Australia; [Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Peninsula Hlth, Peninsula Clin Sch, Monash Univ Plast & Reconstruct Surg Unit, Frankston, Vic 3199, Australia; [Rozen, Warren M.] James Cook Univ, Townsville Hosp, Sch Clin, Sch Med & Dent,Dept Surg, Townsville, Qld 4814, Australia	Frankston Hospital; Monash University; James Cook University	Rozen, WM (corresponding author), Peninsula Hlth, Frankston Hosp, Dept Plast & Reconstruct Surg, 2 Hastings Rd, Frankston, Vic 3199, Australia.	warrenrozen@hotmail.com	Hunter-Smith, David James/U-7055-2019; Rozen, Warren Matthew/AAE-6296-2022; Smoll, Nicolas/D-3322-2013	Rozen, Warren Matthew/0000-0002-4092-182X; Hunter-Smith, David James/0000-0001-5660-0572; Smoll, Nicolas/0000-0002-6923-9701; Hunter-Smith, David/0000-0001-8544-1531				ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; ATKINSON CH, 1984, CANCER-AM CANCER SOC, V53, P869, DOI 10.1002/1097-0142(19840215)53:4<869::AID-CNCR2820530409>3.0.CO;2-V; Branch R, 1989, RELATION TUMOR SIZE; Casaroto AR, 2012, ANTICANCER RES, V32, P1515; ELZAY RP, 1982, ORAL SURG ORAL MED O, V54, P299, DOI 10.1016/0030-4220(82)90099-8; GARDNER DG, 1988, INT J ORAL MAX SURG, V17, P201, DOI 10.1016/S0901-5027(88)80033-X; GARDNER DG, 1980, CANCER, V46, P2514, DOI 10.1002/1097-0142(19801201)46:11<2514::AID-CNCR2820461133>3.0.CO;2-9; Group A YAOPR, 2006, RES CARE IMPERATIVES; HOUSTON G, 1993, J ORAL MAXIL SURG, V51, P1152, DOI 10.1016/S0278-2391(10)80458-6; Jing W, 2007, INT J ORAL MAX SURG, V36, P20, DOI 10.1016/j.ijom.2006.10.011; Kar Indu Bhusan, 2014, Ann Maxillofac Surg, V4, P70, DOI 10.4103/2231-0746.133070; Ladeinde AL, 2005, ORAL SURG ORAL MED O, V99, P191, DOI 10.1016/j.tripleo.2004.08.031; Li J, 2014, ONCOL LETT, V8, P914, DOI 10.3892/ol.2014.2230; MOSADOMI A, 1975, ORAL SURG ORAL MED O, V40, P502, DOI 10.1016/0030-4220(75)90248-0; Mosqueda Taylor Adalberto, 2003, Med Oral, V8, P110; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; REGEZI JA, 1978, J ORAL SURG, V36, P771; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Sciubba JJ, 2005, WHO CLASSIFICATION T, P286; SHEAR M, 1978, COMMUNITY DENT ORAL, V6, P195, DOI 10.1111/j.1600-0528.1978.tb01149.x; SLOOTWEG PJ, 1984, ORAL SURG ORAL MED O, V57, P168, DOI 10.1016/0030-4220(84)90207-X; Smoll NR, 2014, NEURO-ONCOLOGY, V16, P1400, DOI 10.1093/neuonc/nou053; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Smoll NR, 2012, NEUROEPIDEMIOLOGY, V39, P63, DOI 10.1159/000339319; Smoll NR, 2012, CANCER-AM CANCER SOC, V118, P1313, DOI 10.1002/cncr.26387; Verneuil A, 2002, AM J OTOLARYNG, V23, P44, DOI 10.1053/ajot.2002.28769; Yoon HJ, 2011, ORAL SURG ORAL MED O, V112, P767, DOI 10.1016/j.tripleo.2011.06.036; Zhang J, 2010, BRIT J ORAL MAX SURG, V48, P549, DOI 10.1016/j.bjoms.2009.08.020	29	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117789	10.1371/journal.pone.0117789	http://dx.doi.org/10.1371/journal.pone.0117789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692490	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000350061500075
J	Zhang, L; Li, YY; Gu, ZW; Wang, YY; Shi, M; Ji, Y; Sun, J; Xu, XP; Zhang, LR; Jiang, JT; Shi, WF				Zhang, Li; Li, Yuanyuan; Gu, Zhiwen; Wang, Yuyue; Shi, Mei; Ji, Yun; Sun, Jing; Xu, Xiaopeng; Zhang, Lirong; Jiang, Jingtin; Shi, Weifeng			Resveratrol Inhibits Enterovirus 71 Replication and Pro-Inflammatory Cytokine Secretion in Rhabdosarcoma Cells through Blocking IKKs/NF-kappa B Signaling Pathway	PLOS ONE			English	Article							BURKITTS-LYMPHOMA CELLS; ANTIVIRAL ACTIVITY; VIRUS-REPLICATION; IN-VITRO; ADHESION MOLECULES; OXIDATIVE STRESS; INFECTION; POLYDATIN; RIBAVIRIN; EXPRESSION	Polydatin and resveratrol, as major active components in Polygonum cuspidatum, have anti-inflammatory, antioxidant and antitumor functions. However, the effect and mechanism of polydatin and resveratrol on enterovirus 71 (EV71) have not been reported. In this study, resveratrol revealed strong antiviral activity on EV71, while polydatin had weak effect. Neither polydatin nor resveratrol exhibited influence on viral attachment. Resveratrol could effectively inhibit the synthesis of EV71/VP1 and the phosphorylation of IKK alpha, IKK beta, IKK gamma, IKB alpha, NF-kappa B p50 and NF-kappa B p65, respectively. Meanwhile, the remarkably increased secretion of IL-6 and TNF-alpha in EV71-infected rhabdosarcoma (RD) cells could be blocked by resveratrol. These results demonstrated that resveratrol inhibited EV71 replication and cytokine secretion in EV71-infected RD cells through blocking IKKs/NF-kappa B signaling pathway. Thus, resveratrol may have potent antiviral effect on EV71 infection.	[Zhang, Li; Li, Yuanyuan; Gu, Zhiwen; Wang, Yuyue; Shi, Mei; Ji, Yun; Sun, Jing; Xu, Xiaopeng; Zhang, Lirong; Shi, Weifeng] Soochow Univ, Affiliated Hosp 3, Clin Lab, Changzhou 213003, Jiangsu, Peoples R China; [Jiang, Jingtin] Soochow Univ, Affiliated Hosp 3, Oncol Lab, Changzhou 213003, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shi, WF (corresponding author), Soochow Univ, Affiliated Hosp 3, Clin Lab, Changzhou 213003, Jiangsu, Peoples R China.	shiweifeng67@163.com	Sun, Jing/AAS-1582-2020; SUN, JIN/GPX-9641-2022; Zhang, Li/GWM-7501-2022	Sun, Jing/0000-0002-0097-2438; 				Augustine N, 2014, PHYTOMEDICINE, V21, P286, DOI 10.1016/j.phymed.2013.09.010; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050; Carrizzo A, 2013, FOOD CHEM TOXICOL, V61, P215, DOI 10.1016/j.fct.2013.07.021; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Chen X, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/504563; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Chu X, 2005, J CHROMATOGR A, V1097, P33, DOI 10.1016/j.chroma.2005.08.008; Clouser CL, 2012, BIOORG MED CHEM LETT, V22, P6642, DOI 10.1016/j.bmcl.2012.08.108; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; De Leo A, 2012, ANTIVIR RES, V96, P196, DOI 10.1016/j.antiviral.2012.09.003; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; De Maria S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-264; Deng YH, 2011, PHYTOTHER RES, V25, P451, DOI 10.1002/ptr.3279; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; Du QH, 2013, PHARM BIOL, V51, P1347, DOI 10.3109/13880209.2013.792849; Evers DL, 2004, ANTIVIR RES, V63, P85, DOI 10.1016/j.antiviral.2004.03.002; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Guo JP, 2006, WORLD J GASTROENTERO, V12, P4078, DOI 10.3748/wjg.v12.i25.4078; Guo R, 2014, MED SCI MONIT BASIC, V20, P82, DOI 10.12659/MSMBR.890858; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; Heldt CL, 2006, J VIROL METHODS, V135, P56, DOI 10.1016/j.jviromet.2006.01.022; Heredia A, 2014, AIDS, V28, P317, DOI 10.1097/QAD.0000000000000168; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Irani DN, 2008, NEUROL CLIN, V26, P635, DOI 10.1016/j.ncl.2008.03.003; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Kaminski BM, 2014, APOPTOSIS; Klebl Bert M., 2005, Antiviral Chemistry & Chemotherapy, V16, P69; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; La Frazia S, 2006, ANTIVIR THER, V11, P995; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076007; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Lin HC, 2012, CANCER PREV RES, V5, P952, DOI 10.1158/1940-6207.CAPR-12-0001; Lin TY, 2009, AM J CHINESE MED, V37, P143, DOI 10.1142/S0192415X09006734; Liu H, 2014, J BIOCH MOL TOXICOL; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694; Ravagnan G, 2013, INFLAMMATION, V36, P26, DOI 10.1007/s10753-012-9516-8; Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Shang LQ, 2013, ANTIVIR RES, V97, P183, DOI 10.1016/j.antiviral.2012.12.005; Tung WH, 2011, J CELL BIOCHEM, V112, P559, DOI 10.1002/jcb.22946; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Zhang GF, 2012, ARCH VIROL, V157, P669, DOI 10.1007/s00705-011-1222-6; Zhang HS, 2009, LIFE SCI, V85, P484, DOI 10.1016/j.lfs.2009.07.014; Zhang XN, 2013, ANTIVIR RES, V97, P264, DOI 10.1016/j.antiviral.2012.12.029; Zhao Qi, 2013, Infectious Disorders - Drug Targets, V13, P116	50	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116879	10.1371/journal.pone.0116879	http://dx.doi.org/10.1371/journal.pone.0116879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692777	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500028
J	Bugrysheva, JV; Pappas, CJ; Terekhova, DA; Iyer, R; Godfrey, HP; Schwartz, I; Cabello, FC				Bugrysheva, Julia V.; Pappas, Christopher J.; Terekhova, Darya A.; Iyer, Radha; Godfrey, Henry P.; Schwartz, Ira; Cabello, Felipe C.			Characterization of the Rel(Bbu) Regulon in Borrelia burgdorferi Reveals Modulation of Glycerol Metabolism by (p)ppGpp	PLOS ONE			English	Article							CARBON STORAGE REGULATOR; AMINO-ACID STARVATION; STRINGENT RESPONSE; GENE-EXPRESSION; ESCHERICHIA-COLI; GUANOSINE TETRAPHOSPHATE; CHITOBIOSE UTILIZATION; RNA-POLYMERASE; LIFE-STYLE; PPGPP	The bacterial stringent response is triggered by deficiencies of available nutrients and other environmental stresses. It is mediated by 5'-triphosphate-guanosine-3'-diphosphate and 5'diphosphate- guanosine-3'-diphosphate (collectively (p) ppGpp) and generates global changes in gene expression and metabolism that enable bacteria to adapt to and survive these challenges. Borrelia burgdorferi encounters multiple stressors in its cycling between ticks and mammals that could trigger the stringent response. We have previously shown that the B. burgdorferi stringent response is mediated by a single enzyme, RelBbu, with both (p) ppGpp synthase and hydrolase activities, and that a B. burgdorferi 297 relBbu null deletion mutant was defective in adapting to stationary phase, incapable of down-regulating synthesis of rRNA and could not infect mice. We have now used this deletion mutant and microarray analysis to identify genes comprising the rel regulon in B. burgdorferi cultured at 34 degrees C, and found that transcription of genes involved in glycerol metabolism is induced by relBbu. Culture of the wild type parental strain, the relBbu deletion mutant and its complemented derivative at 34 degrees C and 25 degrees C in media containing glucose or glycerol as principal carbon sources revealed a growth defect in the mutant, most evident at the lower temperature. Transcriptional analysis of the glp operon for glycerol uptake and metabolism in these three strains confirmed that relBbu was necessary and sufficient to increase transcription of this operon in the presence of glycerol at both temperatures. These results confirm and extend previous findings regarding the stringent response in B. burgdorferi. They also demonstrate that the stringent response regulates glycerol metabolism in this organism and is likely crucial for its optimal growth in ticks.	[Bugrysheva, Julia V.; Pappas, Christopher J.; Terekhova, Darya A.; Iyer, Radha; Schwartz, Ira; Cabello, Felipe C.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Godfrey, Henry P.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Cabello, FC (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	cabello@nymc.edu		Godfrey, Henry/0000-0002-7195-6363; PAPPAS, CHRISTOPHER/0000-0001-8606-0749	National Institutes of Health [5R01 AI48856-07, 5R01 AI45801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048856, R01AI045801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5R01 AI48856-07 from National Institutes of Health http://www.nih.gov/ to FCC and by grant 5R01 AI45801 from National Institutes of Health to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093110; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Balsalobre C, 2011, MOL MICROBIOL, V79, P827, DOI 10.1111/j.1365-2958.2010.07521.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Bernardo LMD, 2009, J BIOL CHEM, V284, P828, DOI 10.1074/jbc.M807707200; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Bugrysheva J, 2003, J BACTERIOL, V185, P957, DOI 10.1128/JB.185.3.957-965.2003; Bugrysheva J, 2002, INFECT IMMUN, V70, P3061, DOI 10.1128/IAI.70.6.3061-3067.2002; Bugrysheva JV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-17; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Chandrangsu P, 2011, MOL MICROBIOL, V80, P1337, DOI 10.1111/j.1365-2958.2011.07649.x; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Concepcion MB, 2003, J BACTERIOL, V185, P444, DOI 10.1128/JB.185.2.444-452.2003; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Damman CJ, 2000, J BACTERIOL, V182, P6791, DOI 10.1128/JB.182.23.6791-6797.2000; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Godfrey HP, 2002, TRENDS MICROBIOL, V10, P349, DOI 10.1016/S0966-842X(02)02403-4; Gummesson B, 2013, J BIOL CHEM, V288, P21055, DOI 10.1074/jbc.M113.479998; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; He M, 2014, INFECT IMMUN, V82, P445, DOI 10.1128/IAI.01238-13; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; He P, 2013, FEMS MICROBIOL LETT, V348, P133, DOI 10.1111/1574-6968.12279; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hoon-Hanks LL, 2012, FEMS IMMUNOL MED MIC, V66, P157, DOI 10.1111/j.1574-695X.2012.00996.x; Iyer R, 2013, J CLIN MICROBIOL, V51, P857, DOI 10.1128/JCM.02785-12; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Lennon CW, 2012, GENE DEV, V26, P2634, DOI 10.1101/gad.204693.112; Lin B, 2001, BBA-MOL CELL RES, V1499, P222, DOI 10.1016/S0167-4889(00)00121-X; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mechold U, 1997, J BACTERIOL, V179, P2658, DOI 10.1128/jb.179.8.2658-2667.1997; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; My L, 2013, J BACTERIOL, V195, P3784, DOI 10.1128/JB.00384-13; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Novak EA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00056; Ouyang ZM, 2014, INFECT IMMUN, V82, P1511, DOI 10.1128/IAI.01555-13; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Park SI, 2010, J MICROBIOL, V48, P674, DOI 10.1007/s12275-010-0179-6; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rhodes RG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-108; Roberts JW, 2009, GENE DEV, V23, P143, DOI 10.1101/gad.1770509; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; SKARE JT, 2010, BORRELIA MOL BIOL HO, P67; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006720; Sze CW, 2013, INFECT IMMUN, V81, P1775, DOI 10.1128/IAI.00050-13; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2004, VECTOR-BORNE ZOONOT, V4, P159, DOI 10.1089/1530366041210738; Tilly K, 2001, J BACTERIOL, V183, P5544, DOI 10.1128/JB.183.19.5544-5553.2001; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wang XG, 2004, J BACTERIOL, V186, P51, DOI 10.1128/JB.186.1.51-60.2004; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925	88	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118063	10.1371/journal.pone.0118063	http://dx.doi.org/10.1371/journal.pone.0118063			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688856	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700097
J	Gong, YQ; Zhan, QQ; Nguyen, KS; Nguyen, HT; Wang, YH; Gong, X				Gong, Yi-Qing; Zhan, Qing-Qing; Khang Sinh Nguyen; Hiep Tien Nguyen; Wang, Yue-Hua; Gong, Xun			The Historical Demography and Genetic Variation of the Endangered Cycas multipinnata (Cycadaceae) in the Red River Region, Examined by Chloroplast DNA Sequences and Microsatellite Markers	PLOS ONE			English	Article							STATISTICAL TESTS; POPULATION-GROWTH; MITOCHONDRIAL; INFERENCE; SOFTWARE; LOCI; BOTTLENECKS; NEUTRALITY; PHYLOGENY; MUTATIONS	Cycas multipinnata C.J. Chen & S.Y. Yang is a cycad endemic to the Red River drainage region that occurs under evergreen forest on steep limestone slopes in Southwest China and northern Vietnam. It is listed as endangered due to habitat loss and over-collecting for the ornamental plant trade, and only several populations remain. In this study, we assess the genetic variation, population structure, and phylogeography of Cycas multipinnata populations to help develop strategies for the conservation of the species. 60 individuals from six populations were used for chloroplast DNA (cpDNA) sequencing and 100 individuals from five populations were genotyped using 17 nuclear microsatellites. High genetic differentiation among populations was detected, suggesting that pollen or seed dispersal was restricted within populations. Two main genetic clusters were observed in both the cpDNA and microsatellite loci, corresponding to Yunnan China and northern Vietnam. These clusters indicated low levels of gene flow between the regions since their divergence in the late Pleistocene, which was inferred from both Bayesian and coalescent analysis. In addition, the result of a Bayesian skyline plot based on cpDNA portrayed a long history of constant population size followed by a decline in the last 50,000 years of Cycas multipinnata that was perhaps affected by the Quaternary glaciations, a finding that was also supported by the Garza-Williamson index calculated from the microsatellite data. The genetic consequences produced by climatic oscillations and anthropogenic disturbances are considered key pressures on Cycas multipinnata. To establish a conservation management plan, each population of Cycas multipinnata should be recognized as a Management Unit (MU). In situ and ex situ actions, such as controlling overexploitation and creating a germplasm bank with high genetic diversity, should be urgently implemented to preserve this species.	[Gong, Yi-Qing; Wang, Yue-Hua] Yunnan Univ, Inst Plant Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Gong, Yi-Qing; Zhan, Qing-Qing; Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Gong, Yi-Qing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Khang Sinh Nguyen] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Hiep Tien Nguyen] Ctr Plant Conservat, Hanoi, Vietnam	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vietnam Academy of Science & Technology (VAST)	Wang, YH (corresponding author), Yunnan Univ, Inst Plant Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China.	wangyh58212@126.com; gongxun@mail.kib.ac.cn		Yiqing, Gong/0000-0002-9990-6536	National Natural Science Foundation of China; Yunnan Natural Science Foundation [U1136602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province)	This work was supported by the National Natural Science Foundation of China and Yunnan Natural Science Foundation (U1136602 to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bader E, 2005, ARCGIS SERVER ADM DE; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cantrill DJ, 2000, ALCHERINGA, V24, P307, DOI 10.1080/03115510008619534; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Chen J, 1994, ACTA PHYTOTAX SINICA, V32, P239; Chiang YC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-161; Cibrian-Jaramillo A, 2008, CONSERV GENET, V9, P1051, DOI 10.1007/s10592-007-9447-3; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DONALDSON JS, 2003, CYCADS STATUS SURVEY; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng XY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-187; Frankel OH, 1995, CONSERVATION PLANT B; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Fu L.K., 1992, CHINA PLANT RED DATA; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hall R., 1996, SPECIAL PUBLICATIONS, V106, P153, DOI DOI 10.1144/GSL.SP.1996.106.01.11; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartl Daniel L., 1997; Hermsen EJ, 2006, AM J BOT, V93, P724, DOI 10.3732/ajb.93.5.724; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill KD, 2008, TELOPEA, V12, P71; Hill KD, 2004, BOT REV, V70, P134, DOI 10.1663/0006-8101(2004)070[0134:TGCCIV]2.0.CO;2; Jolivet P, 2005, CYCAD NEWSLETTER, V28, P3; Jones D, 2002, CYCADS WORLD ANCIENT, DOI [10.1002/bdrc.21052, DOI 10.1002/BDRC.21052]; Ju LP, 2011, AM J BOT, V98, pE84, DOI 10.3732/ajb.1000504; Kimura M, 1984, NEUTRAL THEORY MOL E; Kovach WL., 1999, MVSP MULTIVARIATE ST, P137; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; LEARY RL, 1990, SCIENCE, V249, P1152, DOI 10.1126/science.249.4973.1152; Li L, 2009, CONSERV GENET, V10, P793, DOI 10.1007/s10592-008-9664-4; [李楠 Li Nan], 2005, [古生物学报, Acta Palaeontologica Sinica], V44, P423; LI WH, 1991, FUNDAMENTALS MOL EVO; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; O'Connell LM, 2004, J HERED, V95, P172, DOI 10.1093/jhered/esh024; Osborne R., 2012, Proceedings of Cycad 2008. The 8th International Conference on Cycad Biology, Panama City, Panama, 13-15 January 2008, P480; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Rai HS, 2003, MOL PHYLOGENET EVOL, V29, P350, DOI 10.1016/S1055-7903(03)00131-3; Rambaut A., 2009, TRACER MCMC TRACE AN; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang W., 2004, ENCEPHALARTOS, V80:, P23; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Bo, 2002, Acta Botanica Yunnanica, V24, P370; Wang X, 2006, PROG NAT SCI-MATER, V16, P213; Wang X, 2009, CHINESE SCI BULL, V54, P3116, DOI 10.1007/s11434-009-0384-z; Wang ZF, 2008, CONSERV GENET, V9, P1079, DOI 10.1007/s10592-007-9461-5; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1978, P580; Yang Y, 2008, MOL ECOL RESOUR, V8, P913, DOI 10.1111/j.1755-0998.2008.02114.x; Zgurski JM, 2008, MOL PHYLOGENET EVOL, V47, P1232, DOI 10.1016/j.ympev.2008.03.002; Zhan QQ, 2011, CONSERV GENET, V12, P959, DOI 10.1007/s10592-011-0198-9; Zhang FM, 2010, AM J BOT, V97, pE159, DOI 10.3732/ajb.1000377; Zhang JW, 2010, J SYST EVOL, V48, P286, DOI 10.1111/j.1759-6831.2010.00079.x; Zhang M, 2009, CONSERV GENET, V10, P1175, DOI 10.1007/s10592-008-9737-4; Zhang W, 2012, REV PALAEOBOT PALYNO, V183, P50, DOI 10.1016/j.revpalbo.2012.07.005; ZHIFENG G, 1989, REV PALAEOBOT PALYNO, V60, P205, DOI 10.1016/0034-6667(89)90044-4; Zhong ZR, 2011, MOL GENET GENOMICS, V286, P411, DOI 10.1007/s00438-011-0653-9; Zonneveld BJM, 2012, PLANT BIOLOGY, V14, P253, DOI 10.1111/j.1438-8677.2011.00522.x	81	16	18	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117719	10.1371/journal.pone.0117719	http://dx.doi.org/10.1371/journal.pone.0117719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689828	gold, Green Published, Green Submitted			2022-12-27	WOS:000350322700067
J	Li, L; Hamzeh, N; Gillespie, M; Elliott, J; Wang, JR; Gottschall, EB; Mroz, PM; Maier, LA				Li, Li; Hamzeh, Nabeel; Gillespie, May; Elliott, Jill; Wang, Jieru; Gottschall, Eva Brigitte; Mroz, Peggy M.; Maier, Lisa A.			Beryllium Increases the CD14(dim)CD16+Subset in the Lung of Chronic Beryllium Disease	PLOS ONE			English	Article							PERIPHERAL-BLOOD; IN-VITRO; HYPERSENSITIVITY PNEUMONITIS; PULMONARY SARCOIDOSIS; ALVEOLAR MACROPHAGES; RHEUMATOID-ARTHRITIS; ASTHMATIC SUBJECTS; CD16(+) MONOCYTES; T-CELLS; INFLAMMATION	CD14(dim)CD16+ and CD14(bright)CD16+ cells, which compose a minor population of monocytes in human peripheral blood mononuclear cells (PBMC), have been implicated in several inflammatory diseases. The aim of this study was to investigate whether this phenotype was present as a subset of lung infiltrative alveolar macrophages (AMs) in the granulomatous lung disease, chronic beryllium disease (CBD). The monocytes subsets was determined from PBMC cells and bronchoalveolar lavage (BAL) cells from CBD, beryllium sensitized Non-smoker (BeS-NS) and healthy subjects (HS) using flow cytometry. The impact of smoking on the AMs cell phenotype was determined by using BAL cells from BeS smokers (BeS-S). In comparison with the other monocyte subpopulations, CD14(dim)CD16+ cells were at decreased frequency in PBMCs of both BeS-NS and CBD and showed higher HLA-DR expression, compared to HS. The AMs from CBD and BeS-NS demonstrated a CD14(dim)CD16+phenotype, while CD14(bright)CD16+ cells were found at increased frequency in AMs of BeS, compared to HS. Fresh AMs from BeS-NS and CBD demonstrated significantly greater CD16, CD40, CD86 and HLA-DR than HS and BeS-S. The expression of CD16 on AMs from both CBD and BeS-NS was downregulated significantly after 10 mu M BeSO4 stimulation. The phagocytic activity of AMs decreased after 10 mu M BeSO4 treatment in both BeS-NS and CBD, although was altered or reduced in HS and BeS-S. These results suggest that Be increases the CD14(dim)CD16+ subsets in the lung of CBD subjects. We speculate that Be-stimulates the compartmentalization of a more mature CD16+ macrophage phenotype and that in turn these macrophages are a source of Th1 cytokines and chemokines that perpetuate the Be immune response in CBD. The protective effect of cigarette smoking in BeS-S may be due to the low expression of co-stimulatory markers on AMs from smokers as well as the decreased phagocytic function.	[Li, Li; Hamzeh, Nabeel; Gillespie, May; Elliott, Jill; Gottschall, Eva Brigitte; Mroz, Peggy M.; Maier, Lisa A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Li, Li; Hamzeh, Nabeel; Gottschall, Eva Brigitte; Maier, Lisa A.] Univ Colorado, Sch Med, Dept Med, Div Pulm & Crit Care Sci, Denver, CO USA; [Gottschall, Eva Brigitte; Maier, Lisa A.] Univ Colorado, Colorado Sch Publ Hlth, Environm Occupat Hlth Dept, Denver, CO 80202 USA; [Wang, Jieru] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Pulm Med Allergy & Immunol, Pittsburgh, PA USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, L (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	lil@njhealth.org	Maier, Lisa/AAA-4378-2020	Hamzeh, Nabeel/0000-0001-7296-8975	NIH from National Institute of Environmental Health Sciences [K12 HL090147-01]; National Institute of Environmental Health Sciences [K01ES020857-01, P01 ES11810-06A1]; National Center for Advancing Translational Sciences [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL090147, R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI101953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810, K01ES020857] Funding Source: NIH RePORTER	NIH from National Institute of Environmental Health Sciences; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by NIH K12 HL090147-01 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, supplies and first author salary support; K01ES020857-01 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, supplies and first author salary support; P01 ES11810-06A1 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, personnel support; UL1 TR000154 from National Center for Advancing Translational Sciences, http://www.ncats.nih.gov, patient care, recruitment and supplies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2001, CLIN IMMUNOL, V100, P325, DOI 10.1006/clim.2001.5072; Ancuta P, 2000, EUR J IMMUNOL; [Anonymous], [No title captured]; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Burastero SE, 1999, J ALLERGY CLIN IMMUN, V103, P1136, DOI 10.1016/S0091-6749(99)70189-2; Cairns AP, 2002, RHEUMATOL INT, V21, P189, DOI 10.1007/s00296-001-0165-8; Chaudhary A, 2004, TOXICOLOGY, V201, P9, DOI 10.1016/j.tox.2004.03.025; CHELEN CJ, 1995, J CLIN INVEST, V95, P1415, DOI 10.1172/JCI117796; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; DOUGLAS JG, 1986, THORAX, V41, P787, DOI 10.1136/thx.41.10.787; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Henneberger PK, 2001, INT ARCH OCC ENV HEA, V74, P167, DOI 10.1007/s004200100237; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Lensmar C, 1999, CLIN EXP ALLERGY, V29, P1632, DOI 10.1046/j.1365-2222.1999.00757.x; Li L, 2014, HUM IMMUNOL, V75, P1155, DOI 10.1016/j.humimm.2014.10.010; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Newman LS, 2001, J OCCUP ENVIRON MED, V43, P231, DOI 10.1097/00043764-200103000-00011; NEWMAN LS, 2003, INTERSTITIAL LUNG DI, P435; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; OHTSUKA Y, 1995, INTERNAL MED, V34, P966, DOI 10.2169/internalmedicine.34.966; Okamoto H, 2003, J DERMATOL, V30, P503, DOI 10.1111/j.1346-8138.2003.tb00424.x; Prior C, 1996, EUR RESPIR J, V9, P47, DOI 10.1183/09031936.96.09010047; RIVIER A, 1995, CLIN EXP IMMUNOL, V100, P314; Sawyer RT, 2005, FREE RADICAL BIO MED, V38, P928, DOI 10.1016/j.freeradbiomed.2004.12.014; Sawyer RT, 2004, AM J RESP CELL MOL, V31, P470, DOI 10.1165/rcmb.2004-0090OC; Sawyer RT, 2004, AM J RESP CELL MOL, V31, P122, DOI 10.1165/rcmb.2003-0336OC; Sawyer RT, 1999, TOXICOLOGY, V138, P155, DOI 10.1016/S0300-483X(99)00101-8; Sawyer RT, 2000, TOXICOLOGY, V149, P129, DOI 10.1016/S0300-483X(00)00237-7; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Wahlstrom J, 1999, THORAX, V54, P339, DOI 10.1136/thx.54.4.339; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; WARREN CPW, 1977, THORAX, V32, P567, DOI 10.1136/thx.32.5.567; WATTERS LC, 1987, AM REV RESPIR DIS, V135, P696; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yamasaki H, 1999, J IMMUNOL, V163, P3516; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117276	10.1371/journal.pone.0117276	http://dx.doi.org/10.1371/journal.pone.0117276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689051	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350322700034
J	Cai, SP; Huang, LY; Zou, J; Jing, LL; Zhai, BZ; Ji, GJ; von Deneen, KM; Ren, JC; Ren, AF				Cai, Suping; Huang, Liyu; Zou, Jia; Jing, Longlong; Zhai, Buzhong; Ji, Gongjun; von Deneen, Karen M.; Ren, Junchan; Ren, Aifeng		Alzheimer's Dis Neuroimaging Initi	Changes in Thalamic Connectivity in the Early and Late Stages of Amnestic Mild Cognitive Impairment: A Resting-State Functional Magnetic Resonance Study from ADNI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; WORKING-MEMORY; EPISODIC MEMORY; BASAL GANGLIA; DEFAULT MODE; HEAD MOTION; CORTEX; MRI; IMPACT; BRAIN	We used resting-state functional magnetic resonance imaging (fMRI) to investigate changes in the thalamus functional connectivity in early and late stages of amnestic mild cognitive impairment. Data of 25 late stages of amnestic mild cognitive impairment (LMCI) patients, 30 early stages of amnestic mild cognitive impairment (EMCI) patients and 30 well-matched healthy controls (HC) were analyzed from the Alzheimer's disease Neuroimaging Initiative (ADNI). We focused on the correlation between low frequency fMRI signal fluctuations in the thalamus and those in all other brain regions. Compared to healthy controls, we found functional connectivity between the left/right thalamus and a set of brain areas was decreased in LMCI and/or EMCI including right fusiform gyrus (FG), left and right superior temporal gyrus, left medial frontal gyrus extending into supplementary motor area, right insula, left middle temporal gyrus (MTG) extending into middle occipital gyrus (MOG). We also observed increased functional connectivity between the left/right thalamus and several regions in LMCI and/or EMCI including left FG, right MOG, left and right precuneus, right MTG and left inferior temporal gyrus. In the direct comparison between the LMCI and EMCI groups, we obtained several brain regions showed thalamus-seeded functional connectivity differences such as the precentral gyrus, hippocampus, FG and MTG. Briefly, these brain regions mentioned above were mainly located in the thalamo-related networks including thalamo-hippocampus, thalamo-temporal, thalamo-visual, and thalamo-default mode network. The decreased functional connectivity of the thalamus might suggest reduced functional integrity of thalamo-related networks and increased functional connectivity indicated that aMCI patients could use additional brain resources to compensate for the loss of cognitive function. Our study provided a new sight to understand the two important states of aMCI and revealed resting-state fMRI is an appropriate method for exploring pathophysiological changes in aMCI.	[Cai, Suping; Huang, Liyu; Zou, Jia; Jing, Longlong; Zhai, Buzhong; von Deneen, Karen M.; Ren, Junchan; Ren, Aifeng] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China; [Ji, Gongjun] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou 311121, Zhejiang, Peoples R China	Xidian University	Huang, LY (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.	huangly@mail.xidian.edu.cn		JI, Gong-Jun/0000-0002-7073-5534; Ren, Aifeng/0000-0003-1129-5601	National Natural Science Foundation of China [81071221, 31271063]; National Institutes of Health (NIH) [U01 AG024904, P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China under grant NO. 81071221 and 31271063. The ADNI work was supported by National Institutes of Health (NIH) Grant U01 AG024904, NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chao-Gan Y, 2010, FRONTIERS SYSTEMS NE, V4, DOI [10.3389/fnsys.2010.00158, DOI 10.3389/FNSYS.2010.00158]; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; DELAPAZ RL, 1994, RADIOGRAPHICS, V14, P1045, DOI 10.1148/radiographics.14.5.7991813; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Di Paola M, 2007, J NEUROL, V254, P774, DOI 10.1007/s00415-006-0435-1; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043; Hunt A, 2007, PSYCHIAT RES-NEUROIM, V155, P147, DOI 10.1016/j.pscychresns.2006.12.003; Huntley J, 2011, BRIT J PSYCHIAT, V198, P398, DOI 10.1192/bjp.bp.110.083857; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kim DJ, 2013, HUM BRAIN MAPP, V34, P1371, DOI 10.1002/hbm.21517; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Murayama N, 2010, PSYCHOGERIATRICS, V10, P62, DOI 10.1111/j.1479-8301.2010.00316.x; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Ota M, 2007, NEUROREPORT, V18, P1071, DOI 10.1097/WNR.0b013e3281c10e27; Panayiotopoulos CP, 1999, J NEUROL NEUROSUR PS, V66, P536, DOI 10.1136/jnnp.66.4.536; Pearlson GD, 1997, PROG NEURO-PSYCHOPH, V21, P1203, DOI 10.1016/S0278-5846(97)00159-0; Pergola G, 2013, NEUROIMAGE, V74, P195, DOI 10.1016/j.neuroimage.2013.02.017; Peterburs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021517; Peters F, 2009, BRAIN, V132, P1833, DOI 10.1093/brain/awp075; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raettig T, 2008, NEUROIMAGE, V39, P1420, DOI 10.1016/j.neuroimage.2007.09.030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540; Zhou B, 2013, CURR ALZHEIMER RES, V10, P754, DOI 10.2174/15672050113109990146; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	57	42	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115573	10.1371/journal.pone.0115573	http://dx.doi.org/10.1371/journal.pone.0115573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679386	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600008
J	Edler, D; Bestgen, AK; Kuchinke, L; Dickmann, F				Edler, Dennis; Bestgen, Anne-Kathrin; Kuchinke, Lars; Dickmann, Frank			True-3D Accentuating of Grids and Streets in Urban Topographic Maps Enhances Human Object Location Memory	PLOS ONE			English	Article							DISTORTIONS; SCENE; ORGANIZATION; HIERARCHIES; PRINCIPLES; PERCEPTION	Cognitive representations of learned map information are subject to systematic distortion errors. Map elements that divide a map surface into regions, such as content-related linear symbols (e.g. streets, rivers, railway systems) or additional artificial layers (coordinate grids), provide an orientation pattern that can help users to reduce distortions in their mental representations. In recent years, the television industry has started to establish True-3D (autostereoscopic) displays as mass media. These modern displays make it possible to watch dynamic and static images including depth illusions without additional devices, such as 3D glasses. In these images, visual details can be distributed over different positions along the depth axis. Some empirical studies of vision research provided first evidence that 3D stereoscopic content attracts higher attention and is processed faster. So far, the impact of True-3D accentuating has not yet been explored concerning spatial memory tasks and cartography. This paper reports the results of two empirical studies that focus on investigations whether True-3D accentuating of artificial, regular overlaying line features (i.e. grids) and content-related, irregular line features (i.e. highways and main streets) in official urban topographic maps (scale 1/10,000) further improves human object location memory performance. The memory performance is measured as both the percentage of correctly recalled object locations (hit rate) and the mean distances of correctly recalled objects (spatial accuracy). It is shown that the True-3D accentuating of grids (depth offset: 5 cm) significantly enhances the spatial accuracy of recalled map object locations, whereas the True-3D emphasis of streets significantly improves the hit rate of recalled map object locations. These results show the potential of True-3D displays for an improvement of the cognitive representation of learned cartographic information.	[Edler, Dennis; Dickmann, Frank] Ruhr Univ Bochum, Dept Geog, Bochum, Germany; [Bestgen, Anne-Kathrin; Kuchinke, Lars] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Edler, D (corresponding author), Ruhr Univ Bochum, Dept Geog, Univ Str 150, Bochum, Germany.	dennis.edler@rub.de	Dickmann, Frank/AAC-3002-2020	Dickmann, Frank/0000-0002-9012-9419; Edler, Dennis/0000-0002-2260-9103	German Research Foundation (DFG) [DI 771/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG, DI 771/7-1; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M., 2000, MULTIRESOLUTION SEGM, VXII, P12, DOI DOI 10.1016/J.ISPRSJPRS.2003.10.002; Bestgen A, 2013, P COGSCI 2013 35 ANN, DOI [10.1364/AO.53.007898, DOI 10.1364/AO.53.007898]; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Bitter Ralf, 1999, KARTOGRAPHISCHE NACH, V49, P93; Brohmer K, 2013, CARTOGR J, V50, P211, DOI 10.1179/1743277413Y.0000000063; Brunye TT, 2008, ACTA PSYCHOL, V127, P340, DOI 10.1016/j.actpsy.2007.07.002; Buchroithner M, 2012, TRUE 3D CARTOGRAPHY; Buchroithner M. F, 2007, KARTOGRAPHISCHE NACH, V57, P239; Clements-Stephens AM, 2011, VIS COGN, V19, P886, DOI 10.1080/13506285.2011.595742; Cockburn A, 2004, INT J HUM-COMPUT ST, V61, P359, DOI 10.1016/j.ijhcs.2004.01.005; COREN S, 1980, J EXP PSYCHOL HUMAN, V6, P404, DOI 10.1037/0096-1523.6.3.404; Daniel M.-P., 1998, KOGNITIONSWISSENSCHA, V7, P45, DOI [DOI 10.1007/BF03354963, 10.1007/BF03354963]; Dickmann F, 2009, KARTOGRAPHISCHE NACH, V59, P295; Dickmann F, 2013, KARTOGRAPHISCHE NACH, V63, P174, DOI DOI 10.1007/BF03546131; Dickmann F, 2012, CARTOGR J, V49, P62, DOI 10.1179/1743277411Y.0000000018; Dickmann F, 2010, CARTOGR J, V47, P250, DOI 10.1179/000870410X12786821061459; EASTMAN J. R., 1985, CARTOGR J, V22, P95; Eastman R.J., 1985, CARTOGRAPHICA, V22, P1, DOI DOI 10.3138/FJK4-2776-485N-6464; Edler D, 2014, CARTOGRAPHICA, V49, P153; Edler D, 2014, CARTOGRAPHI IN PRESS; Edler D, 2014, KARTOGRAPHISCHE NACH, V64, P243; Edler D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098148; Fabrikant SI., 2009, CARTOGRAPHICA, V44, P129, DOI 10.3138/carto.44.3.139; Hake G., 2002, KARTOGRAPHIE; Hakkinen J, 2010, PROC SPIE, V7524, DOI 10.1117/12.838857; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; Holliman NS, 2011, IEEE T BROADCAST, V57, P362, DOI 10.1109/TBC.2011.2130930; Hommel B, 2000, PSYCHOL RES-PSYCH FO, V64, P1, DOI 10.1007/s004260000032; Hurts K., 2005, P HUM FACT ERG SOC A, V49, P1593, DOI [10.1177/154193120504901720, DOI 10.1177/154193120504901720]; Huynh-Thu Q, 2011, PROC SPIE, V7865, DOI 10.1117/12.872382; Huynh-Thu Q, 2011, IEEE T BROADCAST, V57, P421, DOI 10.1109/TBC.2011.2128250; Jansen L, 2009, J VISION, V9, DOI 10.1167/9.1.29; Kent A., 2013, CARTOGR PERSPECT, V73, P39; Klippel A, 2004, LECT NOTES COMPUT SC, V3343, P204; Knust C, 2014, CARTOGR J, V51, P191, DOI 10.1179/1743277413Y.0000000038; Kollmorgen S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000791; KOSSLYN SM, 1989, APPL COGNITIVE PSYCH, V3, P185, DOI 10.1002/acp.2350030302; KRAAK MJ, 1993, CARTOGR J, V30, P188; Kulik L, 1999, LECT NOTES COMPUT SC, V1661, P205; Lang CY, 2012, LECT NOTES COMPUT SC, V7573, P101, DOI 10.1007/978-3-642-33709-3_8; Leifert S., 2011, P 2011 ANN C HUM FAC, P941, DOI 10.1145/1979742.1979522; LLOYD R, 1987, ANN ASSOC AM GEOGR, V77, P191, DOI 10.1111/j.1467-8306.1987.tb00153.x; Lloyd RE, 2008, CARTOGR GEOGR INF SC, V35, P171, DOI DOI 10.1559/152304008784864677; MACEACHREN AM, 1991, CARTOGR J, V28, P152; Maling D. H., 1992, COORDINATE SYSTEMS M; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; MCNAMARA TP, 1984, J EXP PSYCHOL LEARN, V10, P723, DOI 10.1037/0278-7393.10.4.723; MCNAMARA TP, 1989, J EXP PSYCHOL LEARN, V15, P211, DOI 10.1037/0278-7393.15.2.211; MCNAMARA TP, 1986, COGNITIVE PSYCHOL, V18, P87, DOI 10.1016/0010-0285(86)90016-2; Meneghetti C, 2014, BRIT J PSYCHOL, V105, P295, DOI 10.1111/bjop.12038; Montello DR, 1998, Z SEMIOTIK, V20, P91; Montello DR, 1994, CARTOGRAPHICA, V31, P18, DOI DOI 10.3138/W806-5127-7W41-12H8; OKABAYASHI H, 1984, J GEN PSYCHOL, V111, P271, DOI 10.1080/00221309.1984.9921116; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Ooms K, 2012, THESIS GHENT U GHENT; RICHARDS W, 1971, J OPT SOC AM, V61, P410, DOI 10.1364/JOSA.61.000410; Robinson A.H., 1995, ELEMENTS CARTOGRAPHY, V6th ed.; Stainer MJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00624; STEVENS A, 1978, COGNITIVE PSYCHOL, V10, P422, DOI 10.1016/0010-0285(78)90006-3; Tavanti M, 2001, P IEEE S INF VIS; TVERSKY B, 1989, J EXP PSYCHOL GEN, V118, P387, DOI 10.1037/0096-3445.118.4.387; TVERSKY B, 1992, GEOFORUM, V23, P131, DOI 10.1016/0016-7185(92)90011-R; Tversky B., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P14; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wood M, 1968, CARTOGR J, V5, P54, DOI DOI 10.1179/CAJ.1968.5.1.54	68	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116959	10.1371/journal.pone.0116959	http://dx.doi.org/10.1371/journal.pone.0116959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679208	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600042
J	Takeda, K; Matsumura, H; Ishida, T; Samejima, M; Ohno, H; Yoshida, M; Igarashi, K; Nakamura, N				Takeda, Kouta; Matsumura, Hirotoshi; Ishida, Takuya; Samejima, Masahiro; Ohno, Hiroyuki; Yoshida, Makoto; Igarashi, Kiyohiko; Nakamura, Nobuhumi			Characterization of a Novel PQQ-Dependent Quinohemoprotein Pyranose Dehydrogenase from Coprinopsis cinerea Classified into Auxiliary Activities Family 12 in Carbohydrate-Active Enzymes	PLOS ONE			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; CELLULOSE-BINDING DOMAINS; CELLOBIOSE DEHYDROGENASE; PHANEROCHAETE-CHRYSOSPORIUM; PYRROLOQUINOLINE QUINONE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; GLUCONOBACTER-SUBOXYDANS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER	The basidiomycete Coprinopsis cinerea contains a quinohemoprotein (CcPDH named as CcSDH in our previous paper), which is a new type of pyrroloquinoline-quinone (PQQ)-dependent pyranose dehydrogenase and is the first found among all eukaryotes. This enzyme has a three-domain structure consisting of an N-terminal heme b containing a cytochrome domain that is homologous to the cytochrome domain of cellobiose dehydrogenase (CDH; EC 1.1.99.18) from the wood-rotting basidiomycete Phanerochaete chrysosporium, a C-terminal family 1-type carbohydrate-binding module, and a novel central catalytic domain containing PQQ as a cofactor. Here, we describe the biochemical and electrochemical characterization of recombinant CcPDH. UV-vis and resonance Raman spectroscopic studies clearly reveal characteristics of a 6-coordinated low-spin heme b in both the ferric and ferrous states, as well as intramolecular electron transfer from the PQQ to heme b. Moreover, the formal potential of the heme was evaluated to be 130 mV vs. NHE by cyclic voltammetry. These results indicate that the cytochrome domain of CcPDH possesses similar biophysical properties to that in CDH. A comparison of the conformations of monosaccharides as substrates and the associated catalytic efficiency (k(cat)/K-m) of CcPDH indicates that the enzyme prefers monosaccharides with equatorial C-2, C-3 hydroxyl groups and an axial C-4 hydroxyl group in the C-1(4) chair conformation. Furthermore, a binding study shows a high binding affinity of CcPDH for cellulose, suggesting that CcPDH function is related to the enzymatic degradation of plant cell wall.	[Takeda, Kouta; Ohno, Hiroyuki; Nakamura, Nobuhumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Matsumura, Hirotoshi; Ishida, Takuya; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Tokyo, Japan; [Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; Tokyo University of Agriculture & Technology	Yoshida, M (corresponding author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan.	ymakoto@cc.tuat.ac.jp; aquarius@mail.ecc.u-tokyo.ac.jp; nobu1@cc.tuat.ac.jp	Nakamura, Nobuhumi/C-1972-2013; Igarashi, Kiyohiko/E-6799-2016; Takeda, Kouta/G-6554-2016; Yoshida, Makoto/E-8017-2013; Ohno, Hiroyuki/F-6459-2012	Nakamura, Nobuhumi/0000-0002-5373-2972; Igarashi, Kiyohiko/0000-0001-5152-7177; Ohno, Hiroyuki/0000-0001-9716-3495; Takeda, Kouta/0000-0001-5227-4132	Japan Society for the Promotion of Science (JSPS) [21605004]; Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114008]; JSPS [268641, 208304]; Grants-in-Aid for Scientific Research [14J08641] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported financially by a Grant-in-Aid for Scientific Research (No. 21605004 to N.N.) from the Japan Society for the Promotion of Science (JSPS), by a Grant-in-Aid for Innovative Areas (No. 24114001 and 24114008 to K.I.) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT), and by a Grant-in-Aid for JSPS Fellows (Grant No. 268641 to K.T.). H.M. was supported by a Grant-in-Aid for JSPS Fellows (Grant No. 208304) during his postdoc period at the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAMA M, 1981, AGR BIOL CHEM TOKYO, V45, P851, DOI 10.1080/00021369.1981.10864633; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Babot ED, 2013, BIOTECHNOL BIOENG, V110, P2323, DOI 10.1002/bit.24904; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Freimund S, 2002, CARBOHYD RES, V337, P1585, DOI 10.1016/S0008-6215(02)00261-6; GEIGER O, 1989, BIOCHEM J, V261, P415, DOI 10.1042/bj2610415; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROEN BW, 1986, BIOCHEM J, V234, P611, DOI 10.1042/bj2340611; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hallberg BM, 2000, STRUCT FOLD DES, V8, P79, DOI 10.1016/S0969-2126(00)00082-4; Hancock RD, 2002, TRENDS BIOTECHNOL, V20, P299, DOI 10.1016/S0167-7799(02)01991-1; Henriksson G, 1997, BIOCHEM J, V324, P833, DOI 10.1042/bj3240833; HENRIKSSON G, 1991, EUR J BIOCHEM, V196, P101, DOI 10.1111/j.1432-1033.1991.tb15791.x; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hoshino T, 2003, BBA-PROTEINS PROTEOM, V1647, P278, DOI 10.1016/S1570-9639(03)00071-2; Igarashi K, 1999, J BIOL CHEM, V274, P3338, DOI 10.1074/jbc.274.6.3338; Igarashi K, 2005, FEBS J, V272, P2869, DOI 10.1111/j.1742-4658.2005.04707.x; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Karapetyan KN, 2006, J BIOTECHNOL, V121, P34, DOI 10.1016/j.jbiotec.2005.06.024; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ludwig R, 2013, ANAL BIOANAL CHEM, V405, P3637, DOI 10.1007/s00216-012-6627-x; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; Matsumura H, 2012, LANGMUIR, V28, P10925, DOI 10.1021/la3018858; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; MUTZEL A, 1991, AGR BIOL CHEM TOKYO, V55, P1721, DOI 10.1080/00021369.1991.10870854; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olsthoorn AJJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P42, DOI 10.1006/abbi.1996.0530; Olsthoorn AJJ, 1998, BIOCHEMISTRY-US, V37, P13854, DOI 10.1021/bi9808868; Ortiz R, 2012, ANAL CHEM, V84, P10315, DOI 10.1021/ac3022899; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Oubrie A, 2003, BBA-PROTEINS PROTEOM, V1647, P143, DOI 10.1016/S1570-9639(03)00087-6; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; RENGANATHAN V, 1990, APPL MICROBIOL BIOT, V32, P609, DOI 10.1007/BF00173735; Rotsaert FAJ, 2003, J BIOL CHEM, V278, P33224, DOI 10.1074/jbc.M302653200; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; Salusjarvi Tuomas, 2004, Appl Environ Microbiol, V70, P5503, DOI 10.1128/AEM.70.9.5503-5510.2004; SAMEJIMA M, 1992, EUR J BIOCHEM, V207, P103, DOI 10.1111/j.1432-1033.1992.tb17026.x; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200; Sugimoto N, 2012, PROTEIN EXPRES PURIF, V82, P290, DOI 10.1016/j.pep.2012.01.007; Takeda K, 2013, BIOELECTROCHEMISTRY, V94, P75, DOI 10.1016/j.bioelechem.2013.08.001; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yamada M, 2003, BBA-PROTEINS PROTEOM, V1647, P185, DOI 10.1016/S1570-9639(03)00100-6; Yoshida M, 2005, APPL ENVIRON MICROB, V71, P4548, DOI 10.1128/AEM.71.8.4548-4555.2005; Yoshida M, 2009, BIOSCI BIOTECH BIOCH, V73, P67, DOI 10.1271/bbb.80477	67	25	26	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115722	10.1371/journal.pone.0115722	http://dx.doi.org/10.1371/journal.pone.0115722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679509	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600009
J	Wang, HX; Ayala, JC; Benitez, JA; Silva, AJ				Wang, Hongxia; Ayala, Julio C.; Benitez, Jorge A.; Silva, Anisia J.			RNA-Seq Analysis Identifies New Genes Regulated by the Histone-Like Nucleoid Structuring Protein (H-NS) Affecting Vibrio cholerae Virulence, Stress Response and Chemotaxis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BINDING-SITES; TOXR REGULON; CURVED DNA; EXPRESSION; MOTILITY; REPRESSION; DOMAIN; RPOS; HEMAGGLUTININ/PROTEASE	The histone-like nucleoid structuring protein (H-NS) functions as a transcriptional silencer by binding to AT-rich sequences at bacterial promoters. However, H-NS repression can be counteracted by other transcription factors in response to environmental changes. The identification of potential toxic factors, the expression of which is prevented by H-NS could facilitate the discovery of new regulatory proteins that may contribute to the emergence of new pathogenic variants by anti-silencing. Vibrio cholerae hns mutants of the El Tor biotype exhibit altered virulence, motility and environmental stress response phenotypes compared to wild type. We used an RNA-seq analysis approach to determine the basis of the above hns phenotypes and identify new targets of H-NS transcriptional silencing. H-NS affected the expression of 18% of all predicted genes in a growth phase-dependent manner. Loss of H-NS resulted in diminished expression of numerous genes encoding methyl-accepting chemotaxis proteins as well as chemotaxis toward the attractants glycine and serine. Deletion of hns also induced an endogenous envelope stress response resulting in elevated expression of rpoE encoding the extracytoplamic sigma factor E (sE). The RNA-seq analysis identified new genes directly repressed by H-NS that can affect virulence and biofilm development in the El Tor biotype cholera bacterium. We show that H-NS and the quorum sensing regulator HapR silence the transcription of the vieSAB three-component regulatory system in El Tor biotype V. cholerae. We also demonstrate that H-NS directly represses the transcription of hlyA (hemolysin), rtxCA (the repeat in toxin or RTX), rtxBDE (RTX transport) and the biosynthesis of indole. Of these genes, H-NS occupancy at the hlyA promoter was diminished by overexpression of the transcription activator HlyU. We discuss the role of H-NS transcriptional silencing in phenotypic differences exhibited by V. cholerae biotypes.				asilva-benitez@msm.edu	Wang, Hongxia/G-6655-2018	Silva, Alcino/0000-0001-5525-0494; AYALA FIGUEREDO, JULIO/0000-0001-9998-3091	National Institutes of Health [AI104993, AI103693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI106288, SC1AI104993, R21AI103693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health AI104993 AJS, National Institutes of Health AI103693 JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; Boardman BK, 2007, J BACTERIOL, V189, P1827, DOI 10.1128/JB.01766-06; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Dame RT, 2001, BIOCHIMIE, V83, P231; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Ghosh A, 2006, INFECT IMMUN, V74, P3060, DOI 10.1128/IAI.74.5.3060-3064.2006; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SH, 1998, J BACTERIOL, V180, P2298, DOI 10.1128/JB.180.9.2298-2305.1998; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Liu MQ, 2012, MICROBIOLOGYOPEN, V1, P502, DOI 10.1002/mbo3.48; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Mou XY, 2013, INFECT IMMUN, V81, P3566, DOI 10.1128/IAI.00506-13; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nishiyama S, 2012, INFECT IMMUN, V80, P3170, DOI 10.1128/IAI.00039-12; Nye MB, 2000, J BACTERIOL, V182, P4295, DOI 10.1128/JB.182.15.4295-4303.2000; Nye MB, 2003, MOL MICROBIOL, V50, P427, DOI 10.1046/j.1365-2958.2003.03701.x; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; ROTHMEL RK, 1991, J BACTERIOL, V173, P4717, DOI 10.1128/jb.173.15.4717-4724.1991; Schoolnik G. K., 2000, Genome Biology, V1, P1016, DOI 10.1186/gb-2000-1-3-reviews1016; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; Sikora AE, 2009, J BACTERIOL, V191, P5398, DOI 10.1128/JB.00092-09; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Silva AJ, 2008, J BACTERIOL, V190, P7335, DOI 10.1128/JB.00360-08; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; Stonehouse E, 2008, J BACTERIOL, V190, P4736, DOI 10.1128/JB.00089-08; Stonehouse EA, 2011, J BACTERIOL, V193, P979, DOI 10.1128/JB.01343-09; Stroebner JA, 1998, INFECT IMMUN, V56, P2891; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tending C, 2000, J BACTERIOL, V182, P2006; Tischler AD, 2002, J BACTERIOL, V184, P4104, DOI 10.1128/JB.184.15.4104-4113.2002; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; UEGUCHI C, 1993, EMBO J, V12, P1039, DOI 10.1002/j.1460-2075.1993.tb05745.x; Wang HX, 2014, J BACTERIOL, V196, P1020, DOI 10.1128/JB.00993-13; Wang HX, 2013, ANTIMICROB AGENTS CH, V57, P3950, DOI 10.1128/AAC.00473-13; Wang HX, 2012, APPL ENVIRON MICROB, V78, P2482, DOI 10.1128/AEM.07629-11; Wang HX, 2012, J BACTERIOL, V194, P1205, DOI 10.1128/JB.05900-11; WILLIAMS SG, 1991, MOL MICROBIOL, V5, P2031, DOI 10.1111/j.1365-2958.1991.tb00825.x; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x	73	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118295	10.1371/journal.pone.0118295	http://dx.doi.org/10.1371/journal.pone.0118295			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679988	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600116
J	Wei, X; Zhang, Z; Shi, PJ; Wang, P; Chen, Y; Song, X; Tao, FL				Wei, Xing; Zhang, Zhao; Shi, Peijun; Wang, Pin; Chen, Yi; Song, Xiao; Tao, Fulu			Is Yield Increase Sufficient to Achieve Food Security in China?	PLOS ONE			English	Article							AGRICULTURAL SUSTAINABILITY; USE EFFICIENCY; WINTER-WHEAT; SOIL QUALITY; HEAT-STRESS; HYBRID RICE; WATER; CLIMATE; CHALLENGES; RESOURCES	Increasing demand for food, driven by unprecedented population growth and increasing consumption, will keep challenging food security in China. Although cereal yields have substantially improved during the last three decades, whether it will keep thriving to meet the increasing demand is not known yet. Thus, an integrated analysis on the trends of crop yield and cultivated area is essential to better understand current state of food security in China, especially on county scale. So far, yield stagnation has extensively dominated the main cereal- growing areas across China. Rice yield is facing the most severe stagnation that 53.9% counties tracked in the study have stagnated significantly, followed by maize (42.4%) and wheat (41.9%). As another important element for production sustainability, but often neglected is the planted area patterns. It has been further demonstrated that the loss in productive arable land for rice and wheat have dramatically increased the pressure on achieving food security. Not only a great deal of the planted areas have stagnated since 1980, but also collapsed. 48.4% and 54.4% of rice-and wheat-growing counties have lost their cropland areas to varying degrees. Besides, 27.6% and 35.8% of them have retrograded below the level of the 1980s. The combined influence (both loss in yield and area) has determined the crop sustainable production in China to be pessimistic for rice and wheat, and consequently no surprise to find that more than half of counties rank a lower level of production sustainability. Therefore, given the potential yield increase in wheat and maize, as well as substantial area loss of rice and wheat, the possible targeted adaptation measures for both yield and cropping area is required at county scale. Moreover, policies on food trade, alongside advocation of low calorie diets, reducing food loss and waste can help to enhance food security.	[Wei, Xing; Zhang, Zhao; Shi, Peijun; Wang, Pin; Chen, Yi; Song, Xiao] Beijing Normal Univ, MOE Acad Disaster Reduct & Emergency Management, Key Lab Environm Change & Nat Disaster, State Key Lab Earth Surface Processes & Resources, Beijing 100875, Peoples R China; [Tao, Fulu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, Z (corresponding author), Beijing Normal Univ, MOE Acad Disaster Reduct & Emergency Management, Key Lab Environm Change & Nat Disaster, State Key Lab Earth Surface Processes & Resources, Beijing 100875, Peoples R China.	zhangzhao@bnu.edu.cn	张|Zhang, 朝|Zhao/AAF-8815-2019	Shi, Peijun/0000-0002-2968-7331; Tao, F/0000-0001-8574-0080	Creative Research Groups of National Natural Science Foundation of China [41321001]; National Basic Research Program of China [2012CB955404]; Program of Introducing Talents of Discipline to Universities [B08008]; State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University [2014-ZY-02]	Creative Research Groups of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University	This research was supported by the Creative Research Groups of National Natural Science Foundation of China (No. 41321001), National Basic Research Program of China (No. 2012CB955404), The Program of Introducing Talents of Discipline to Universities (B08008), and State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University (2014-ZY-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brown L R, 1998, World Watch, V11, P10; Brown L.R., 1995, WHO WILL FEED CHINA; Bureau CS, 1980, CHIN STAT YB; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Dodge Y., 2003, OXFORD DICT STAT TER; Fader M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014046; Fan XM, 2007, AGRON J, V99, P220, DOI 10.2134/agronj2006.0144; FAOWIFAD, 2012, STAT FOOD INS WORLD, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Fekete A, 2014, INT J DISAST RISK SC, V5, P3, DOI 10.1007/s13753-014-0008-3; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fu XY, 2013, INT J DISAST RISK SC, V4, P51, DOI 10.1007/s13753-013-0006-x; Glantz MH, 2013, INT J DISAST RISK SC, V4, P1, DOI 10.1007/s13753-013-0002-1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory PJ, 2005, PHILOS T R SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Huang M, 2012, SCI AGR, V69, P103, DOI 10.1590/S0103-90162012000200003; Jalava M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074016; Jiang L, 2013, INT J DISAST RISK SC, V4, P101, DOI 10.1007/s13753-013-0011-0; Jiao J, 2013, CAIJING MAGAZINE, P377; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Kijne JW, 2003, WATER PRODUCTIVITY A; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu B, 2014, GLOBAL CHANGE BIOL, V20, P372, DOI 10.1111/gcb.12442; Liu JG, 2013, ENVIRON SCI TECHNOL, V47, P10137, DOI 10.1021/es401426b; Liu JY, 2003, SCI CHINA SER D, V46, P373; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Pradhan P, 2014, ENVIRON SCI TECHNOL, V48, P9463, DOI 10.1021/es5005939; Pradhan P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044044; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rozelle S, 1997, FOOD POLICY, V22, P229, DOI 10.1016/S0306-9192(97)00011-0; Scherr S. J, 1999, SOIL DEGRADATION THR; Shi WJ, 2013, FOOD SECUR, V5, P69, DOI 10.1007/s12571-012-0225-9; Shuai JB, 2013, CLIM RES, V58, P133, DOI 10.3354/cr01194; Sun YJ, 2012, FIELD CROP RES, V127, P85, DOI 10.1016/j.fcr.2011.11.015; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Yang H, 2003, AGR WATER MANAGE, V61, P143, DOI 10.1016/S0378-3774(02)00164-6; Yearbook CA, 1980, EDITORIAL BOARD CHIN; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Zhang T, 2013, GLOBAL CHANGE BIOL; Zhang TY, 2013, GLOBAL CHANGE BIOL, V19, P563, DOI 10.1111/gcb.12057; Zhang YHP, 2013, ENERGY SCI ENG, V1, P27, DOI 10.1002/ese3.2; Zhang Z, 2014, EUR J AGRON, V59, P49, DOI 10.1016/j.eja.2014.05.008; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	59	37	40	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116430	10.1371/journal.pone.0116430	http://dx.doi.org/10.1371/journal.pone.0116430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680193	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600020
J	McCall, C; Singer, T				McCall, Cade; Singer, Tania			Facing Off with Unfair Others: Introducing Proxemic Imaging as an Implicit Measure of Approach and Avoidance during Social Interaction	PLOS ONE			English	Article							IMMERSIVE VIRTUAL ENVIRONMENTS; ALTRUISTIC PUNISHMENT; EYE-TRACKING; COOPERATION; PREJUDICE; ATTITUDE; PERSUASION; RESPONSES; FAIRNESS; DISTANCE	Nonverbal behavior expresses many of the dynamics underlying face-to-face social interactions, implicitly revealing one's attitudes, emotions, and social motives. Although research has often described nonverbal behavior as approach versus avoidant (i.e., through the study of proxemics), psychological responses to many social contexts are a mix of these two. Fairness violations are an ideal example, eliciting strong avoidance-related responses such as negative attitudes, as well as strong approach-related responses such as anger and retaliation. As such, nonverbal behavior toward unfair others is difficult to predict in discrete approach versus avoidance terms. Here we address this problem using proxemic imaging, a new method which creates frequency images of dyadic space by combining motion capture data of interpersonal distance and gaze to provide an objective but nuanced analysis of social interactions. Participants first played an economic game with fair and unfair players and then encountered them in an unrelated task in a virtual environment. Afterwards, they could monetarily punish the other players. Proxemic images of the interactions demonstrate that, overall, participants kept the fair player closer. However, participants who actively punished the unfair players were more likely to stand directly in front of those players and even to turn their backs on them. Together these patterns illustrate that fairness violations influence nonverbal behavior in ways that further predict differences in more overt behavior (i.e., financial punishment). Moreover, they demonstrate that proxemic imaging can detect subtle combinations of approach and avoidance behavior during face-to-face social interactions.	[McCall, Cade; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany	Max Planck Society	McCall, C (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	mccall@cbs.mpg.de		McCall, Cade/0000-0003-0746-8899	Max Planck Institute for Human Cognitive and Brain Sciences	Max Planck Institute for Human Cognitive and Brain Sciences	This research was funded by the institute at which it was conducted, the Max Planck Institute for Human Cognitive and Brain Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyle M., 1975, BODILY COMMUNICATION; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Bessenoff GR, 2000, SOC COGNITION, V18, P329, DOI 10.1521/soco.2000.18.4.329; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dotsch R, 2008, J EXP SOC PSYCHOL, V44, P1194, DOI 10.1016/j.jesp.2008.03.003; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; GARDIN H, 1973, J PERS SOC PSYCHOL, V27, P13, DOI 10.1037/h0034456; Guadagno RE, 2007, MEDIA PSYCHOL, V10, P1; Hall Edward T, 1992, HIDDEN DIMENSION; HALL ET, 1963, AM ANTHROPOL, V65, P1003, DOI 10.1525/aa.1963.65.5.02a00020; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; HENDRICKS M, 1976, J SOC PSYCHOL, V98, P111, DOI 10.1080/00224545.1976.9923372; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hoyt CL, 2003, PRESENCE-TELEOP VIRT, V12, P183, DOI 10.1162/105474603321640932; Jones S.B., 1976, HUM COMMUN RES, V2, P131, DOI [10.1111/j.1468-2958.1976.tb00706.x, DOI 10.1111/J.1468-2958.1976.TB00706.X]; Kane HS, 2012, J EXP SOC PSYCHOL, V48, P37, DOI 10.1016/j.jesp.2011.07.001; Mackie DM, 2000, J PERS SOC PSYCHOL, V79, P602, DOI 10.1037//0022-3514.79.4.602; McCall C, 2009, SOC INFLUENCE, V4, P138, DOI 10.1080/15534510802517418; McCall C, 2009, PRESENCE-TELEOP VIRT, V18, P361, DOI 10.1162/pres.18.5.361; MEHRABIAN A, 1969, PSYCHOL BULL, V71, P359, DOI 10.1037/h0027349; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; SEARS DO, 1991, ADV EXP SOC PSYCHOL, V24, P1; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; SOMMER R, 1968, INT J PSYCHOL, V3, P109, DOI 10.1080/00207596808247233; Wieser MJ, 2009, J ANXIETY DISORD, V23, P93, DOI 10.1016/j.janxdis.2008.04.004; Wilcox Laurie M., 2006, TAP, V3, P412, DOI [10.1145/1190036.1190041, DOI 10.1145/1190036.1190041]; WORD CO, 1974, J EXP SOC PSYCHOL, V10, P109, DOI 10.1016/0022-1031(74)90059-6	41	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117532	10.1371/journal.pone.0117532	http://dx.doi.org/10.1371/journal.pone.0117532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB8WX	25675444	gold, Green Published, Green Submitted			2022-12-27	WOS:000349914000025
J	Izuhara, L; Tatsumi, N; Miyagawa, S; Iwai, S; Watanabe, M; Yamanaka, S; Katsuoka, Y; Nagashima, H; Okano, HJ; Yokoo, T				Izuhara, Luna; Tatsumi, Norifumi; Miyagawa, Shuji; Iwai, Satomi; Watanabe, Masahito; Yamanaka, Shuichiro; Katsuoka, Yuichi; Nagashima, Hiroshi; Okano, Hirotaka J.; Yokoo, Takashi			Generation of a Felinized Swine Endothelial Cell Line by Expression of Feline Decay-Accelerating Factor	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COMPLEMENT REGULATORY PROTEINS; CHRONIC-RENAL-FAILURE; TRANSGENIC PIG; HYPERACUTE REJECTION; NONHUMAN PRIMATE; ERYTHROPOIETIN; SITES; CATS; GENE	Embryonic stem cell research has facilitated the generation of many cell types for the production of tissues and organs for both humans and companion animals. Because >= 30% of pet cats suffer from chronic kidney disease (CKD), xenotransplantation between pigs and cats has been studied. For a successful pig to cat xenotransplant, the immune reaction must be overcome, especially hyperacute rejection. In this study, we isolated the gene for feline decay-accelerating factor (fDAF), an inhibitor of complement proteins, and transfected a swine endothelial cell line with fDAF to "felinize" the pig cells. These fDAF-expressing cells were resistant to feline serum containing anti-pig antibodies, suggesting that felinized pig cells were resistant to hyperacute rejection. Our results suggest that a "felinized" pig kidney can be generated for the treatment of CKD in cats in the future.	[Izuhara, Luna; Yamanaka, Shuichiro; Katsuoka, Yuichi; Okano, Hirotaka J.] Jikei Univ, Sch Med, Div Regenerat Med, Tokyo, Japan; [Tatsumi, Norifumi] Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan; [Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Regenerat Med, Div Organ Transplantat, Osaka, Japan; [Iwai, Satomi] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan; [Yamanaka, Shuichiro; Nagashima, Hiroshi] Meiji Univ, Int Inst Bio Resource Res, Kawasaki, Kanagawa, Japan; [Yamanaka, Shuichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan	Jikei University; Jikei University; Osaka University; Kitasato University; Meiji University; Jikei University	Yokoo, T (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	tyokoo@jikei.ac.jp	Okano, Hideyuki/I-7584-2019	Nagashima, Hiroshi/0000-0001-9940-8783; Tatsumi, Norifumi/0000-0001-6640-150X; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Health, Labour and Welfare of Japan; Adaptable and Seamless Technology transfer Program from Japan Science and Technology Agency [AS242Z01218N]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Adaptable and Seamless Technology transfer Program from Japan Science and Technology Agency	This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan and a Adaptable and Seamless Technology transfer Program (AS242Z01218N) from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2011, CELLULAR MOL IMMUNOL, DOI [10.1038/cmi.2011.48, DOI 10.1038/CMI.2011.48]; Cowgill LD, 1998, J AM VET MED ASSOC, V212, P521; DALMASSO AP, 1992, AM J PATHOL, V140, P1157; de la Lastra JMP, 2000, J IMMUNOL, V165, P2563, DOI 10.4049/jimmunol.165.5.2563; Diaz-Roman TM, 2006, TRANSPL IMMUNOL, V16, P125, DOI 10.1016/j.trim.2006.03.008; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Elliott J, 2000, J SMALL ANIM PRACT, V41, P235, DOI 10.1111/j.1748-5827.2000.tb03932.x; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Hensel F, 2001, LAB INVEST, V81, P1553, DOI 10.1038/labinvest.3780369; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Jones M, 2004, KIDNEY INT, V65, P757, DOI 10.1111/j.1523-1755.2004.00450.x; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kunii H, 1998, Fukushima J Med Sci, V44, P69; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; LUBLIN DM, 1991, J EXP MED, V174, P35, DOI 10.1084/jem.174.1.35; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Marchetti S, 2002, J CELL SCI, V115, P2075; Matsumoto K, 2012, STEM CELLS, V30, P1228, DOI 10.1002/stem.1101; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; MIYAGAWA S, 1994, TRANSPLANTATION, V58, P834, DOI 10.1097/00007890-199410150-00015; Murakami H, 2002, MOL REPROD DEV, V61, P302, DOI 10.1002/mrd.10043; PETERSON ME, 1995, J AM VET MED ASSOC, V207, P1422; PLATT JL, 1990, TRANSPLANTATION, V50, P817, DOI 10.1097/00007890-199011000-00015; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; Randolph JF, 2004, AM J VET RES, V65, P1355, DOI 10.2460/ajvr.2004.65.1355; Rees MA, 2002, TRANSPLANTATION, V73, P1194, DOI 10.1097/00007890-200204270-00003; Roy BB, 2006, J EXP ZOOL PART B, V306B, P59, DOI 10.1002/jez.b.21072; Schuurman HJ, 2002, TRANSPLANTATION, V73, P1146, DOI 10.1097/00007890-200204150-00024; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Yokoo T, 2008, MED MOL MORPHOL, V41, P5, DOI 10.1007/s00795-008-0396-9; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Yokoo T, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/591731	38	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117682	10.1371/journal.pone.0117682	http://dx.doi.org/10.1371/journal.pone.0117682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671605	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300067
J	Kawafune, K; Hongoh, Y; Hamaji, T; Sakamoto, T; Kurata, T; Hirooka, S; Miyagishima, SY; Nozaki, H				Kawafune, Kaoru; Hongoh, Yuichi; Hamaji, Takashi; Sakamoto, Tomoaki; Kurata, Tetsuya; Hirooka, Shunsuke; Miyagishima, Shin-ya; Nozaki, Hisayoshi			Two Different Rickettsial Bacteria Invading Volvox carteri	PLOS ONE			English	Article							GENE-TRANSFER; PHYLOGENIES; EVOLUTION; PROTIST; MODELS; LOCUS	Background Bacteria of the family Rickettsiaceae are principally associated with arthropods. Recently, endosymbionts of the Rickettsiaceae have been found in non-phagotrophic cells of the volvocalean green algae Carteria cerasiformis, Pleodorina japonica, and Volvox carteri. Such endosymbionts were present in only C. cerasiformis strain NIES-425 and V. carteri strain UTEX 2180, of various strains of Carteria and V. carteri examined, suggesting that rickettsial endosymbionts may have been transmitted to only a few algal strains very recently. However, in preliminary work, we detected a sequence similar to that of a rickettsial gene in the nuclear genome of V. carteri strain EVE. Methodology/Principal Findings Here we explored the origin of the rickettsial gene-like sequences in the endosymbiont-lacking V. carteri strain EVE, by performing comparative analyses on 13 strains of V. carteri. By reference to our ongoing genomic sequence of rickettsial endosymbionts in C. cerasiformis strain NIES-425 cells, we confirmed that an approximately 9-kbp DNA sequence encompassing a region similar to that of four rickettsial genes was present in the nuclear genome of V. carteri strain EVE. Phylogenetic analyses, and comparisons of the synteny of rickettsial gene-like sequences from various strains of V. carteri, indicated that the rickettsial gene-like sequences in the nuclear genome of V. carteri strain EVE were closely related to rickettsial gene sequences of P. japonica, rather than those of V. carteri strain UTEX 2180. Conclusion/Significance At least two different rickettsial organisms may have invaded the V. carteri lineage, one of which may be the direct ancestor of the endosymbiont of V. carteri strain UTEX 2180, whereas the other may be closely related to the endosymbiont of P. japonica. Endosymbiotic gene transfer from the latter rickettsial organism may have occurred in an ancestor of V. carteri. Thus, the rickettsiae may be widely associated with V. carteri, and likely have often been lost during host evolution.	[Kawafune, Kaoru; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Hongoh, Yuichi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Meguro Ku, Tokyo 152, Japan; [Hamaji, Takashi] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma, Nara, Japan; [Hirooka, Shunsuke; Miyagishima, Shin-ya] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan	University of Tokyo; Tokyo Institute of Technology; Donald Danforth Plant Science Center; Nara Institute of Science & Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kawafune, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	kawafune@bs.s.u-tokyo.ac.jp	Hongoh, Yuichi/A-2303-2014	Hongoh, Yuichi/0000-0002-5901-9625; Miyagishima, Shin-ya/0000-0002-9111-0832; Nozaki, Hisayoshi/0000-0002-9308-4498; Hamaji, Takashi/0000-0002-2801-2148; Sakamoto, Tomoaki/0000-0002-1583-0993	Nara Institute of Science and Technology [24-9265]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [26117708, 24247042]	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	This work was supported by Grants-in-Aid for JSPS Fellows (No. 24-9265 to KK), Scientific Research for Plant Graduate Students from Nara Institute of Science and Technology (to TS and TK), Scientific Research on Innovative Areas (No. 26117708 to HN) and Scientific Research (A) (No. 24247042 to HN) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Coleman AW, 1999, P NATL ACAD SCI USA, V96, P13892, DOI 10.1073/pnas.96.24.13892; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Dumler JS, 2005, BERGEYS MANUAL OF SY, V2, DOI [10.1097/01.NURSE.0000459798.79840.95, DOI 10.1097/01.NURSE.0000459798.79840.95]; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris EH, 1989, THE CHLAMYDOMONAS SO; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hiraide R, 2013, MOL BIOL EVOL, V30, P1038, DOI 10.1093/molbev/mst018; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Kawafune K, 2014, PHYCOLOGIA, V53, P95, DOI 10.2216/13-193.1; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; Kikuchi Y, 2005, MICROBIAL ECOL, V49, P265, DOI 10.1007/s00248-004-0140-5; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato T, 2014, ISME J, V8, P1008, DOI 10.1038/ismej.2013.222; Schrallhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072581; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Vannini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087718; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Yu XJ, 2012, BIOTERRORISM, P179; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116192	10.1371/journal.pone.0116192	http://dx.doi.org/10.1371/journal.pone.0116192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671568	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300017
J	Nijhof, AD; Willems, RM				Nijhof, Annabel D.; Willems, Roel M.			Simulating Fiction: Individual Differences in Literature Comprehension Revealed with fMRI	PLOS ONE			English	Article							COGNITIVE-PROCESSES; SOCIAL COGNITION; NEURAL BASES; SYSTEMS; MOTOR; AREAS; MIND; REPRESENTATIONS; ACTIVATIONS; INFERENCE	When we read literary fiction, we are transported to fictional places, and we feel and think along with the characters. Despite the importance of narrative in adult life and during development, the neurocognitive mechanisms underlying fiction comprehension are unclear. We used functional magnetic resonance imaging (fMRI) to investigate how individuals differently employ neural networks important for understanding others' beliefs and intentions (mentalizing), and for sensori-motor simulation while listening to excerpts from literary novels. Localizer tasks were used to localize both the cortical motor network and the mentalizing network in participants after they listened to excerpts from literary novels. Results show that participants who had high activation in anterior medial prefrontal cortex (aMPFC; part of the mentalizing network) when listening to mentalizing content of literary fiction, had lower motor cortex activity when they listened to action-related content of the story, and vice versa. This qualifies how people differ in their engagement with fiction: some people are mostly drawn into a story by mentalizing about the thoughts and beliefs of others, whereas others engage in literature by simulating more concrete events such as actions. This study provides on-line neural evidence for the existence of qualitatively different styles of moving into literary worlds, and adds to a growing body of literature showing the potential to study narrative comprehension with neuroimaging methods.	[Nijhof, Annabel D.; Willems, Roel M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Willems, Roel M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society	Willems, RM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	roel.willems@donders.ru.nl		Nijhof, Annabel/0000-0002-4153-1284; Willems, Roel/0000-0002-4963-5387	Donders Institute for Brain, Cognition and Behaviour	Donders Institute for Brain, Cognition and Behaviour	The authors received funding from the Donders Institute for Brain, Cognition and Behaviour for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann U, 2014, SOC COGN AFFECT NEUR, V9, P22, DOI 10.1093/scan/nss098; Altmann U, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00192; [Anonymous], 2006, SIMULATING MINDS PHI; Barker R.G.., 1951, ONE BOYS DAY SPECIME; Boersma P, 2021, PRAAT DOING PHONETIC; Boyd B, 2009, ORIGIN STORIES EVOLU, DOI [10.1007/s10916-009-9391-5, DOI 10.1007/S10916-009-9391-5]; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Bruner J, 1986, ACTUAL MINDS POSSIBL; Bruner J.S, 1984, LANGUAGE MIND READIN; Buchweitz Augusto, 2009, Psychol. Neurosci., V2, P111, DOI 10.3922/j.psns.2009.2.003; Burke M, 2010, LIT READING COGNITIO, DOI [10.1111/j.1758-8111.2010.00001.x, DOI 10.1111/J.1758-8111.2010.00001.X]; Busselle R, 2009, MEDIA PSYCHOL, V12, P321, DOI 10.1080/15213260903287259; Chow HM, 2014, J COGNITIVE NEUROSCI, V26, P279, DOI 10.1162/jocn_a_00487; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Deen B, 2010, NEUROPSYCHOLOGIA, V48, P1607, DOI 10.1016/j.neuropsychologia.2010.01.028; Dils AT, 2010, P NATL ACAD SCI USA, V107, P16396, DOI 10.1073/pnas.1009438107; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Ferstl EC, 2010, ITAL J LINGUIST, V22, P61; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fong K, 2013, PSYCHOL AESTHET CREA, V7, P370, DOI 10.1037/a0034084; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gerrig R, 2011, SCI STUDY LIT, V1, P88, DOI DOI 10.1075/SS0L.1.1.09GER; Gerrig R.J., 1999, EXPERIENCING NARRATI; Gibbs J, 2011, SCI STUDY LIT, V1, P95; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hakemulder F, 2011, SCI STUDY LIT, V1, P144; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hejnar MR, 2007, HUM BRAIN MAPP, V28, P860, DOI 10.1002/hbm.20321; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jacobs AM, 2015, COGNITIVE NEUROSCIENCE OF NATURAL LANGUAGE USE, P135; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; LONG SA, 1989, READ RES QUART, V24, P353, DOI 10.2307/747774; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2006, J RES PERS, V40, P694, DOI 10.1016/j.jrp.2005.08.002; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mars RB, 2013, P NATL ACAD SCI USA, V110, P10806, DOI 10.1073/pnas.1302956110; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; Metz-Lutz MN, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00059; Myers R., 1990, CLASSICAL MODERN REG; Nell V, 1988, LOST BOOK PSYCHOL RE, DOI [10.1016/0169-5347(88)90090-0, DOI 10.1016/0169-5347(88)90090-0]; Oostdijk N., 2000, P 2 INT C LANG RES E, P887; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Speer NK, 2009, PSYCHOL SCI, V20, P989, DOI 10.1111/j.1467-9280.2009.02397.x; Spunt RP, 2012, J NEUROSCI, V32, P3575, DOI 10.1523/JNEUROSCI.5715-11.2012; Steen G, 2011, HUM COGN PROCESS, V30, P21; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Van Overwalle F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00560; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wallentin M, 2011, BRAIN LANG, V119, P221, DOI 10.1016/j.bandl.2011.04.006; Wallentin M, 2011, NEUROIMAGE, V58, P963, DOI 10.1016/j.neuroimage.2011.06.077; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Willems RM, 2010, J COGNITIVE NEUROSCI, V22, P2387, DOI 10.1162/jocn.2009.21386; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072; Zacks JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00168; ZWAAN RA, 1995, PSYCHOL SCI, V6, P292, DOI 10.1111/j.1467-9280.1995.tb00513.x	72	42	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116492	10.1371/journal.pone.0116492	http://dx.doi.org/10.1371/journal.pone.0116492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671708	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300021
J	Gu, WJ; Zhu, Y; Wang, HK; Zhang, HL; Shi, GH; Liu, XH; Ye, DW				Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Liu, Xiaohang; Ye, Dingwei			Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series	PLOS ONE			English	Article							VISCERAL OBESITY; CHEMOTHERAPY; VALIDATION; PREDICTORS; BIOMARKER; SURVIVAL; TISSUE; MODEL; FAT	Background To evaluate the association between various components of body composition and overall survival of patients treated with targeted therapies for advanced renal cell carcinoma. Methods This retrospective study included 124 Chinese patients with advanced renal cell carcinoma who had been treated with targeted therapy from 2008 to 2012 at Fudan University Cancer Center. The L3 plane from a computed tomography scan was analyzed. Area and density were recorded as quantitative and quality measures. Univariate and multivariate Cox proportion hazard regression models were constructed to calculate the crude and adjusted hazard ratio (HR) of various components of body composition for overall survival. X-tile software was used to search for optimal cutoffs for male and female patients and the concordance index evaluated incremental changes in prognostication. Results After adjusting for age, sex and Heng risk stratification, only visceral adipose tissue index (HR 0.981, p = 0.002) and subcutaneous adipose tissue index (HR 0.987, p = 0.048) were independently associated with overall survival. Visceral adipose tissue remained a significant prognostic factor (HR 0.997, p = 0.005) when the influence of body mass index was included. Using defined cutoffs, patients with low VAT had double the death rate (p = 0.007). Visceral adipose tissue also added significant benefit to Heng risk stratification. Further exploratory analysis revealed that visceral adipose tissue may be an indicator of nutritional status in patients with advanced renal cell carcinoma. Conclusion Radiologic measurement of VAT is an independent prognostic factor for Asian patients treated with targeted therapy for advanced renal cell carcinoma.	[Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Ye, Dingwei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Liu, Xiaohang] Fudan Univ, Dept Radiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Liu, Xiaohang; Ye, Dingwei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Ye, DW (corresponding author), Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	dwye.shca@gmail.com	Zhang, Hailiang/AAF-4937-2020		national natural science foundation of China [81001131]	national natural science foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the national natural science foundation of China (Grant No. 81001131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Antoun S, 2014, EXPERT REV ANTICANC, P1, DOI [10.1586/14737140.2015.992420, DOI 10.1586/14737140.2015.992420]; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Aslani A, 2000, CANCER-AM CANCER SOC, V88, P796, DOI 10.1002/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Choueiri T, 2010, J CLIN ONCOL, P4524, DOI DOI 10.1200/JCO.2010.28.15_SUPPL.4524; Chuang MJ, 2008, CANCER SCI, V99, P905, DOI 10.1111/j.1349-7006.2008.00756.x; Clark W, 2013, J AM COLL SURGEONS, V216, P1070, DOI 10.1016/j.jamcollsurg.2013.01.007; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Guiu B, 2010, GUT, V59, P341, DOI 10.1136/gut.2009.188946; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen GL, 2013, JPEN-PARENTER ENTER, V37, P802, DOI 10.1177/0148607113492338; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Motzer RJ, 2012, J CLIN ONCOL, V30, P1371, DOI 10.1200/JCO.2011.36.4133; Naya Y, 2010, UROL INT, V85, P30, DOI 10.1159/000318988; OGIWARA H, 1994, J SURG ONCOL, V57, P129, DOI 10.1002/jso.2930570211; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Salas S, 2008, RADIOTHER ONCOL, V87, P195, DOI 10.1016/j.radonc.2008.02.011; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Steffens S, 2011, ONCOLOGIST, V16, P1565, DOI 10.1634/theoncologist.2011-0213; Thibault R, 2012, CLIN NUTR, V31, P435, DOI 10.1016/j.clnu.2011.12.011; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2005, PHYSIOLOGY, V20, P340, DOI 10.1152/physiol.00019.2005; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; Zhu Y, 2013, J UROLOGY, V189, P447, DOI 10.1016/j.juro.2012.09.030	34	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0118022	10.1371/journal.pone.0118022	http://dx.doi.org/10.1371/journal.pone.0118022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668688	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000035
J	Chatio, S; Aborigo, R; Adongo, PB; Anyorigiya, T; Akweongo, P; Oduro, A				Chatio, Samuel; Aborigo, Raymond; Adongo, Philip Baba; Anyorigiya, Thomas; Akweongo, Patricia; Oduro, Abraham			Adherence and Uptake of Artemisinin-Based Combination Treatments for Uncomplicated Malaria: A Qualitative Study in Northern Ghana	PLOS ONE			English	Article							DRUG-THERAPY; HEALTH	Background Based on the recommendations of the World Health Organization in 2004, Ghana changed her antimalarial drug policy from mono-therapy to Artemisinin-based Combination Therapy (ACTs). The country is currently using three first line drugs artesunate-amodiaquine, artemether- lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria. Despite this policy, little or no qualitative studies have been conducted to establish the factors influencing adherence to the new treatment for malaria. This study explored factors influencing adherence to the use of ACTs in northern Ghana. Methods This was a qualitative study comprising forty (40) in-depth interviews with patients with malaria who visited selected public and private health facilities and received ACTs. Systematic sampling technique was used to select participants who were given ACTs for the interviews. Nvivo 9 software was used to code the data into themes for further analysis. Results The study revealed very important differences in knowledge about ACTs. As expected, the less or illiterates could not mention the type of ACT they would prefer to use for treating their malaria. The educated ones had a good knowledge on ACTs and preferred artemether-lumefantrinee in treating their malaria. The reason was that the drug was good and it had minimal or no side effects. Individual attitudes toward the use of medications and the side effects associated with the use of these ACTs were found to be the main factors affecting adherence to the use of ACTs. Perceived cure of illness after the initial dose greatly affected adherence. Other factors such as forgetfulness and lack of information also influenced patient adherence to ACTs use. Conclusion Individual knowledge, attitudes and behaviors greatly influence patients' adherence to ACTs use. Since ACTs take a number of days to complete, continuous education by health professionals could improve on adherence to ACTs use by patients with malaria.	[Chatio, Samuel; Aborigo, Raymond; Anyorigiya, Thomas; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Adongo, Philip Baba; Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana	Navrongo Health Research Center; University of Ghana	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana.	schatio@yahoo.co.uk		AKWEONGO, PATRICIA/0000-0001-6728-3365; Adongo, Philip Baba/0000-0002-0614-4756; ODURO, ABRAHAM/0000-0002-4191-7419; Chatio, Samuel Tamti/0000-0001-9998-748X	Bill & Melinda Gates foundation	Bill & Melinda Gates foundation(Bill & Melinda Gates FoundationCGIAR)	The study was part of the INDEPTH Effectiveness and Safety Studies (INESS). The INESS research was supported by the Bill & Melinda Gates foundation and facilitated by the INDEPTH Net-work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; [Anonymous], GLOBAL HLTH; [Anonymous], 2007, UNICEF GHAN FACT SHE; [Anonymous], 2012, QUAL STUD ID SOL LOC; [Anonymous], ASS MON ANT DRUG EFF; [Anonymous], ANT DRUG POL; [Anonymous], 2011, HEAL SCI J; [Anonymous], 2011, COST EFFECTIVENESS A; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Donovan C, 2012, Ghana Med J, V46, P85; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Onyango EO, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-143; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Sowunmi A, 2001, ANN TROP MED PARASIT, V95, P549, DOI 10.1080/00034980120092507; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1	23	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116856	10.1371/journal.pone.0116856	http://dx.doi.org/10.1371/journal.pone.0116856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692568	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500026
J	Gholizadeh, A; Boruvka, L; Vasat, R; Saberioon, M; Klement, A; Kratina, J; Tejnecky, V; Drabek, O				Gholizadeh, Asa; Boruvka, Lubos; Vasat, Radim; Saberioon, Mohammadmehdi; Klement, Ales; Kratina, Josef; Tejnecky, Vaclav; Drabek, Ondrej			Estimation of Potentially Toxic Elements Contamination in Anthropogenic Soils on a Brown Coal Mining Dumpsite by Reflectance Spectroscopy: A Case Study	PLOS ONE			English	Article							NEAR-INFRARED-SPECTROSCOPY; PARTIAL LEAST-SQUARES; PRINCIPAL COMPONENT; AGRICULTURAL SOILS; RIVER FLOODPLAINS; ORGANIC-MATTER; EXTRACTION; PREDICTION; REGRESSION; MOISTURE	In order to monitor Potentially Toxic Elements (PTEs) in anthropogenic soils on brown coal mining dumpsites, a large number of samples and cumbersome, time-consuming laboratory measurements are required. Due to its rapidity, convenience and accuracy, reflectance spectroscopy within the Visible-Near Infrared (Vis-NIR) region has been used to predict soil constituents. This study evaluated the suitability of Vis-NIR (350-2500 nm) reflectance spectroscopy for predicting PTEs concentration, using samples collected on large brown coal mining dumpsites in the Czech Republic. Partial Least Square Regression (PLSR) and Support Vector Machine Regression (SVMR) with cross-validation were used to relate PTEs data to the reflectance spectral data by applying different preprocessing strategies. According to the criteria of minimal Root Mean Square Error of Prediction of Cross Validation (RMSEPcv) and maximal coefficient of determination (R-cv(2)) and Residual Prediction Deviation (RPD), the SVMR models with the first derivative pretreatment provided the most accurate prediction for As (R-cv(2)) = 0.89, RMSEPcv = 1.89, RPD = 2.63). Less accurate, but acceptable prediction for screening purposes for Cd and Cu (0.66 < R-cv(2)) < 0.81, RMSEPcv = 0.0.8 and 4.08 respectively, 2.0 < RPD < 2.5) were obtained. The PLSR model for predicting Mn (R-cv(2)) = 0.44, RMSEPcv = 116.43, RPD = 1.45) presented an inadequate model. Overall, SVMR models for the Vis-NIR spectra could be used indirectly for an accurate assessment of PTEs' concentrations.	[Gholizadeh, Asa; Boruvka, Lubos; Vasat, Radim; Klement, Ales; Kratina, Josef; Tejnecky, Vaclav; Drabek, Ondrej] Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague 16521 6, Czech Republic; [Saberioon, Mohammadmehdi] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Lab Image & Signal Proc, Inst Complex Syst, Nove Hrady 37333, Czech Republic	Czech University of Life Sciences Prague; University of South Bohemia Ceske Budejovice	Gholizadeh, A (corresponding author), Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Kamycka 129, Prague 16521 6, Czech Republic.	gholizadeh@af.czu.cz	Gholizadeh, Asa/AAX-9152-2021; Drábek, Ondřej/AAU-3496-2021; Boruvka, Lubos/U-8869-2019; Tejnecký, Václav/K-9043-2013; Vašát, Radim/AAU-4914-2021; Saberioon, Mohammadmehdi/F-9258-2015	Boruvka, Lubos/0000-0001-5317-0933; Tejnecký, Václav/0000-0003-0296-4981; Vašát, Radim/0000-0001-5739-5523; Saberioon, Mohammadmehdi/0000-0003-1627-4957; Klement, Ales/0000-0002-5835-8086	EC Operational Program [ESF/MEYS CZ.1.07/2.3.00/30.0040]; Czech University of Life Sciences Prague	EC Operational Program; Czech University of Life Sciences Prague	This research was financially supported by the EC Operational Program (Project No.: ESF/MEYS CZ.1.07/2.3.00/30.0040) and Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dor E, 2002, ADV AGRON, V75, P173, DOI 10.1016/S0065-2113(02)75005-0; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Bray JGP, 2009, AUST J SOIL RES, V47, P433, DOI 10.1071/SR08068; DALAL RC, 1986, SOIL SCI SOC AM J, V50, P120, DOI 10.2136/sssaj1986.03615995005000010023x; Duckworth J., 2004, NEAR INFRARED SPECTR, V44, P115; Dunn BW, 2002, AUST J EXP AGR, V42, P607, DOI 10.1071/EA01172; Gannouni S., 2012, Journal of Geographic Information System, V4, P242, DOI 10.4236/jgis.2012.43029; Gholizadeh A, 2013, APPL SPECTROSC, V67, P1349, DOI 10.1366/13-07288; Gomez C, 2012, GEODERMA, V189, P176, DOI 10.1016/j.geoderma.2012.05.023; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Imade Anom SW, 2000, IFAC BIOROBOTICS INF, P307; Janik LJ, 1998, AUST J EXP AGR, V38, P681, DOI 10.1071/EA97144; Kemper T, 2002, ENVIRON SCI TECHNOL, V36, P2742, DOI 10.1021/es015747j; Kooistra L, 2003, ANAL CHIM ACTA, V484, P189, DOI 10.1016/S0003-2670(03)00331-3; Kooistra L, 2001, ANAL CHIM ACTA, V446, P97, DOI 10.1016/S0003-2670(01)01265-X; Kooistra L., 2001, INT J APPL EARTH OBS, V3, P337, DOI [10.1016/s0303-2434(01)85041, DOI 10.1016/S0303-2434(01)85041-8]; Martens H., 1989, MULTIVARIATE CALIBRA, P419; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Meyer D., 2012, E1071 MISC FUNCTIONS; Salazar DM, 2012, PROCEDIA ENGINEER, V35, P245, DOI 10.1016/j.proeng.2012.04.187; Moros J, 2009, ENVIRON SCI TECHNOL, V43, P9314, DOI 10.1021/es9005898; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Mouazen AM, 2005, SOIL TILL RES, V80, P171, DOI 10.1016/j.still.2004.03.022; MURRAY I, 1988, ANAL APPL SPECTROSCO, P9; N'guessan YM, 2009, SCI TOTAL ENVIRON, V407, P2939, DOI 10.1016/j.scitotenv.2008.12.047; Pirie A, 2005, AUST J SOIL RES, V43, P713, DOI 10.1071/SR04182; Rao BV, 2009, INT J MINER PROCESS, V91, P55, DOI 10.1016/j.minpro.2008.12.003; Ren HY, 2009, PEDOSPHERE, V19, P719, DOI 10.1016/S1002-0160(09)60167-3; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Rossel RAV, 2006, GEODERMA, V137, P70, DOI 10.1016/j.geoderma.2006.07.004; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Song YX, 2012, APPL CLAY SCI, V64, P75, DOI 10.1016/j.clay.2011.09.010; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stevens A, 2010, GEODERMA, V158, P32, DOI 10.1016/j.geoderma.2009.11.032; Strudl M., 2006, Soil and Water Research, V1, P99; Vapnik V., 2013, NATURE STAT LAERNING; Vohland M, 2011, GEODERMA, V166, P198, DOI 10.1016/j.geoderma.2011.08.001; Vohland M, 2009, J PLANT NUTR SOIL SC, V172, P201, DOI 10.1002/jpln.200700087; Williams P., 2003, NEAR INFRARED TECHNO; Wu YZ, 2007, SOIL SCI SOC AM J, V71, P918, DOI 10.2136/sssaj2006.0285; Wu YZ, 2005, APPL GEOCHEM, V20, P1051, DOI 10.1016/j.apgeochem.2005.01.009; Xie XL, 2012, PEDOSPHERE, V22, P351, DOI 10.1016/S1002-0160(12)60022-8; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P1923, DOI 10.1016/j.soilbio.2008.04.003	47	57	61	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117457	10.1371/journal.pone.0117457	http://dx.doi.org/10.1371/journal.pone.0117457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692671	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500057
J	Lucas, T; Benihoud, K; Vigant, F; Schmidt, CQA; Bachem, MG; Simmet, T; Kochanek, S				Lucas, Tanja; Benihoud, Karim; Vigant, Frederic; Schmidt, Christoph Q. Andreas; Bachem, Max G.; Simmet, Thomas; Kochanek, Stefan			Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer	PLOS ONE			English	Article							RETROVIRAL ENVELOPE PROTEINS; MEDIATED GENE-TRANSFER; FACTOR-BETA RECEPTOR; STELLATE CELLS; IN-VIVO; DESMOPLASTIC REACTION; ENHANCED EXPRESSION; SCAVENGER RECEPTORS; NATURAL ANTIBODIES; COATED ADENOVIRUS	Primary pancreatic carcinoma has an unfavourable prognosis and standard treatment strategies mostly fail in advanced cases. Virotherapy might overcome this resistance to current treatment modalities. However, data from clinical studies with oncolytic viruses, including replicating adenoviral (Ad) vectors, have shown only limited activity against pancreatic cancer and other carcinomas. Since pancreatic carcinomas have a complex tumor architecture and frequently a strong stromal compartment consisting of non-neoplastic cell types (mainly pancreatic stellate cells = hPSCs) and extracellular matrix, it is not surprising that Ad vectors replicating in neoplastic cells will likely fail to eradicate this aggressive tumor type. Because the TGF beta receptor (TGFBR) is expressed on both neoplastic cells and hPSCs we inserted the TGFBR targeting peptide CKS17 into the hypervariable region 5 (HVR5) of the capsid protein hexon with the aim to generate a replicating Ad vector with improved activity in complex tumors. We demonstrated increased transduction of both pancreatic cancer cell lines and of hPSCs and enhanced cytotoxicity in co-cultures of both cell types. Surface plasmon resonance analysis demonstrated decreased binding of coagulation factor X to CKS17-modified Ad particles and in vivo biodistribution studies performed in mice indicated decreased transduction of hepatocytes. Thus, to increase activity of replicating Ad vectors we propose to relax tumor cell selectivity by genetic hexon-mediated targeting to the TGFBR (or other receptors present on both neoplastic and non-neoplastic cells within the tumor) to enable replication also in the stromal cell compartment of tumors, while abolishing hepatocyte transduction, and thereby increasing safety.	[Lucas, Tanja; Kochanek, Stefan] Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany; [Benihoud, Karim; Vigant, Frederic] Univ Paris 11, Orsay, France; [Benihoud, Karim; Vigant, Frederic] Inst Gustave Roussy, CNRS, UMR 8203, Villejuif, France; [Schmidt, Christoph Q. Andreas; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Schmidt, Christoph Q. Andreas] Univ Ulm, Tierforschungszentrum, D-89069 Ulm, Germany; [Bachem, Max G.] Univ Ulm, Dept Clin Chem, D-89069 Ulm, Germany	Ulm University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ulm University; Ulm University; Ulm University	Kochanek, S (corresponding author), Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany.	stefan.kochanek@uni-ulm.de	, BENIHOUD/O-4334-2019	Syrovets, Tatiana/0000-0002-6751-2233	Deutsche Krebshilfe [109545]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work is supported by grant 109545 (to SK and AW) from the Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 2000, NAT BIOTECHNOL, V18, P723, DOI 10.1038/77283; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Brock P, 2006, J CELL MOL MED, V10, P884, DOI 10.1111/j.1582-4934.2006.tb00532.x; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Campos SK, 2006, VIROLOGY, V349, P453, DOI 10.1016/j.virol.2006.01.032; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; CIANCIOLO GJ, 1984, NATURE, V311, P515, DOI 10.1038/311515a0; FRIESS H, 1993, CANCER RES, V53, P2704; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Haag C, 2011, GUT, V60, P225, DOI 10.1136/gut.2009.202325; He JQ, 2013, J LEUKOCYTE BIOL, V93, P301, DOI 10.1189/jlb.0612311; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Huang SS, 1997, J BIOL CHEM, V272, P27155, DOI 10.1074/jbc.272.43.27155; Huang SS, 1998, J BIOL CHEM, V273, P4815, DOI 10.1074/jbc.273.9.4815; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jonson T, 2001, INT J ONCOL, V19, P71; Jullienne B, 2009, GENE THER, V16, P1405, DOI 10.1038/gt.2009.97; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; Khare R, 2011, MOL THER, V19, P1254, DOI 10.1038/mt.2011.71; Kim M, 2002, EUR J CANCER, V38, P1917, DOI 10.1016/S0959-8049(02)00131-4; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Mulvihlll S, 2001, GENE THER, V8, P308, DOI 10.1038/sj.gt.3301398; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pearson AS, 1999, CLIN CANCER RES, V5, P4208; Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287; Prill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082716; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Shashkova EV, 2009, MOL THER, V17, P2121, DOI 10.1038/mt.2009.217; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Simeone DM, 2000, ANN SURG, V232, P73, DOI 10.1097/00000658-200007000-00011; Snoeys J, 2007, GENE THER, V14, P604, DOI 10.1038/sj.gt.3302899; SONIGO P, 1986, CELL, V45, P375, DOI 10.1016/0092-8674(86)90323-5; van Oosten M, 1998, INFECT IMMUN, V66, P5107, DOI 10.1128/IAI.66.11.5107-5112.1998; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Venkatasubbarao K, 2000, ANTICANCER RES, V20, P43; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Vigne E, 1999, J VIROL, V73, P5156, DOI 10.1128/JVI.73.6.5156-5161.1999; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; Wagner M, 1999, PANCREAS, V19, P370, DOI 10.1097/00006676-199911000-00008; Wesseling JG, 2001, GENE THER, V8, P969, DOI 10.1038/sj.gt.3301473; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Yen TNF, 2002, SURGERY, V131, P129, DOI 10.1067/msy.2002.119192; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	67	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117254	10.1371/journal.pone.0117254	http://dx.doi.org/10.1371/journal.pone.0117254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692292	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500044
J	Aureliano, T; Ghilardi, AM; Guilherme, E; Souza, JP; Cavalcanti, M; Riff, D				Aureliano, Tito; Ghilardi, Aline M.; Guilherme, Edson; Souza-Filho, Jonas P.; Cavalcanti, Mauro; Riff, Douglas			Morphometry, Bite-Force, and Paleobiology of the Late Miocene Caiman Purussaurus brasiliensis	PLOS ONE			English	Article							CROCODILE CROCODYLUS-NILOTICUS; ALLIGATOR-MISSISSIPPIENSIS; NORTHERN AUSTRALIA; URUMACO FORMATION; FEEDING ECOLOGY; BODY-SIZE; PERFORMANCE; VENEZUELA; HABITS; GROWTH	Purussaurus brasiliensis thrived in the northwestern portion of South America during the Late Miocene. Although substantial material has been recovered since its early discovery, this fossil crocodilian can still be considered as very poorly understood. In the present work, we used regression equations based on modern crocodilians to present novel details about the morphometry, bite-force and paleobiology of this species. According to our results, an adult Purussaurus brasiliensis was estimated to reach around 12.5 m in length, weighing around 8.4 metric tons, with a mean daily food intake of 40.6 kg. It was capable of generating sustained bite forces of 69,000 N (around 7 metric tons-force). The extreme size and strength reached by this animal seems to have allowed it to include a wide range of prey in its diet, making it a top predator in its ecosystem. As an adult, it would have preyed upon large to very large vertebrates, and, being unmatched by any other carnivore, it avoided competition. The evolution of a large body size granted P. brasiliensis many advantages, but it may also have led to its vulnerability. The constantly changing environment on a large geological scale may have reduced its long-term survival, favoring smaller species more resilient to ecological shifts.	[Aureliano, Tito] Univ Fed Pernambuco, Dept Geol, BR-50740530 Recife, PE, Brazil; [Ghilardi, Aline M.] Univ Fed Rio de Janeiro, Dept Geol, BR-21949900 Rio De Janeiro, RJ, Brazil; [Guilherme, Edson; Souza-Filho, Jonas P.] Univ Fed Acre, Lab Pesquisas Paleontol, BR-69915900 Rio Branco, Acre, Brazil; [Cavalcanti, Mauro] Ecoinformat Studio, BR-20551970 Rio De Janeiro, RJ, Brazil; [Riff, Douglas] Univ Fed Uberlandia, Inst Biol, BR-38400902 Uberlandia, MG, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro; Universidade Federal do Acre (UFAC); Universidade Federal de Uberlandia	Aureliano, T (corresponding author), Univ Fed Pernambuco, Dept Geol, BR-50740530 Recife, PE, Brazil.	aureliano.tito@gmail.com	Guilherme, Edson/AAC-1717-2021; Riff, Douglas/B-5183-2012; Guilherme, Edson/J-2341-2014; Aureliano, Tito/L-3061-2019; Ghilardi, Aline Marcele/AAQ-1393-2020; Cavalcanti, Mauro J/N-9739-2013	Riff, Douglas/0000-0003-0805-2828; Guilherme, Edson/0000-0001-8322-1770; Aureliano, Tito/0000-0002-6918-0519; Ghilardi, Aline Marcele/0000-0001-9136-0236; 	FAPEMIG; Post Graduation Department of UFU	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Post Graduation Department of UFU	The publication cost was fully funded by FAPEMIG and the Post Graduation Department of UFU. The links are: http://www.fapemig.br/ and http://www.portal.ib.ufu.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera OA, 2006, J SYST PALAEONTOL, V4, P221, DOI 10.1017/S147720190600188X; Allsteadt J, 1994, VIDA SILVESTRE NEOTR, V3, P24; [Anonymous], 2014, R LANG ENV STAT COMP; Aureliano T, 2010, RES 7 C LAT PAL, P134, DOI [10.1016/j.watres.2015.01.009, DOI 10.1016/J.WATRES.2015.01.009]; Barbosa-Rodrigues B., 1892, VELLOSIA, V2, P41; Begon M., 2009, ECOLOGY INDIVIDUALS; Bocquentin Jean, 2006, Revista Brasileira de Paleontologia, V9, P187; Bocquentin JV, 1990, B MUSEU PARAENSE EMI, V2, P65; Bocquentin-Villanueva J., 1989, AN 11 C BRAS PAL CUR, P427; Brito Simone P., 2002, Herpetological Natural History, V9, P95; BROCHU CA, 1999, J VERTEBR PALEONTOL, V19, P2, DOI DOI 10.4202/APP.00499.2018; Busbey AB, 1995, FUNCTIONAL MORPHOLOG, P227; Canty A, 2014, BOOT BOOTSTRAP R S P; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Chandler CL, 1990, THESIS YALE U; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; Davison AC, 1997, BOOTSTRAP METHODS TH; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DENSMORE LD, 1989, AM ZOOL, V29, P831; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Erickson GM, 2004, J ZOOL, V262, P21, DOI 10.1017/S0952836903004400; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Gervais P., 1876, J ZOOLOGIE, V5, P232; Grenard S., 1991, HDB ALLIGATORS CROCO; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTTON JM, 1987, J ANIM ECOL, V56, P25, DOI 10.2307/4797; Iordansky N.N., 1973, P201; Langston W., 1965, FOSSIL CROCODILIANS; Langston W. Jr., 1973, P263; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2325, DOI 10.1098/rspb.2005.3223; Marshall L. G., 1991, REV TECNICA YPFB, V12, P631, DOI DOI 10.1007/S10295-008-0468-9; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Milan J., 2010, NEW MEXICO MUSEUM NA, V51, P195; Mook C. C., 1941, Proceedings of the United States National Museum, V91, P55; Mook CC, 1921, B AM MUS NAT HIST, V44, P43; Negri FR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P245; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Owen-Smith, 1992, MEGAHERBIVORES INFLU; Patterson B, 1943, COPEIA, V1943, P123; Peng R.D, 2008, SIMPLEBOOT SIMPLE BO; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Platt SG, 2013, J ZOOL, V291, P87, DOI 10.1111/jzo.12052; PLOTNICK RE, 1989, SYST ZOOL, V38, P144, DOI 10.2307/2992383; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L.I., 1967, AT S BIOT AM GEOC, P359; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Riff D, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P259; Rusconi C., 1933, Revista de la Universidad Nacional de Cordoba, V20, P1; Salas-Gismondi R., 2007, Cuadernos del Museo Geominero, V8, P355; Sanchez-Villagra MR, 2003, SCIENCE, V301, P1708, DOI 10.1126/science.1089332; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; TAYLOR JA, 1979, AUST WILDLIFE RES, V6, P347, DOI 10.1071/WR9790347; Tchernov E, 1986, CAHIERS PALEONTOLOGI, V1, P65; THORBJARNARSON JB, 1993, HERPETOLOGICA, V49, P108; Verdade L. M., 2000, Revista Brasileira de Biologia, V60, P469; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; Wesselingh FP, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P302; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zar JH., 2010, BIOSTAT ANAL, V5th; [No title captured]	72	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117944	10.1371/journal.pone.0117944	http://dx.doi.org/10.1371/journal.pone.0117944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689140	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700087
J	Saxena, S; Khan, N; Dehinwal, R; Kumar, A; Sehgal, D				Saxena, Sneha; Khan, Naeem; Dehinwal, Ruchika; Kumar, Ajay; Sehgal, Devinder			Conserved Surface Accessible Nucleoside ABC Transporter Component SP0845 Is Essential for Pneumococcal Virulence and Confers Protection In Vivo	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PROTEIN-A; SEROTYPE REPLACEMENT; CONJUGATE VACCINE; DISEASE; LIPOPROTEINS; INFECTION; IMMUNOGENICITY; IDENTIFICATION; ANTIBODIES	Streptococcus pneumoniae is a leading cause of bacterial pneumonia, sepsis and meningitis. Surface accessible proteins of S. pneumoniae are being explored for the development of a protein-based vaccine in order to overcome the limitations of existing polysaccharide-based pneumococcal vaccines. To identify a potential vaccine candidate, we resolved surface-associated proteins of S. pneumoniae TIGR4 strain using two-dimensional gel electrophoresis followed by immunoblotting with antisera generated against whole heat-killed TIGR4. Ten immunoreactive spots were identified by mass spectrometric analysis that included a putative lipoprotein SP0845. Analysis of the inferred amino acid sequence of sp0845 homologues from 36 pneumococcal strains indicated that SP0845 was highly conserved (>98% identity) and showed less than 11% identity with any human protein. Our bio-informatic and functional analyses demonstrated that SP0845 is the substrate-binding protein of an ATP-binding cassette (ABC) transporter that is involved in nucleoside uptake with cytidine, uridine, guanosine and inosine as the preferred substrates. Deletion of the gene encoding SP0845 renders pneumococci avirulent suggesting that it is essential for virulence. Immunoblot analysis suggested that SP0845 is expressed in in vitro grown pneumococci and during mice infection. Immunofluorescence microscopy and flow cytometry data indicated that SP0845 is surface exposed in encapsulated strains and accessible to antibodies. Subcutaneous immunization with recombinant SP0845 induced high titer antibodies in mice. Hyperimmune sera raised against SP0845 promoted killing of encapsulated pneumococcal strains in a blood bactericidal assay. Immunization with SP0845 protected mice from intraperitoneal challenge with heterologous pneumococcal serotypes. Based on its surface accessibility, role in virulence and ability to elicit protective immunity, we propose that SP0845 may be a potential candidate for a protein-based pneumococcal vaccine.	[Saxena, Sneha; Khan, Naeem; Dehinwal, Ruchika; Kumar, Ajay; Sehgal, Devinder] Natl Inst Immunol, Mol Immunol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sehgal, D (corresponding author), Natl Inst Immunol, Mol Immunol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	devinder@nii.ac.in	Dehinwal, Ruchika/GPS-4661-2022; Khan, Naeem/ABB-4214-2021	Dehinwal, Ruchika/0000-0002-7085-4760; 	Department of Biotechnology, Government of India, India [BT/PR13422/BRB/10/759/2009]	Department of Biotechnology, Government of India, India(Department of Biotechnology (DBT) India)	The work reported in this paper was supported by an extramural research grant (BT/PR13422/BRB/10/759/2009) from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), Government of India, India to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076; BRILES DE, 1989, INFECT IMMUN, V57, P1457, DOI 10.1128/IAI.57.5.1457-1464.1989; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chimalapati S, 2011, INFECT IMMUN, V79, P4965, DOI 10.1128/IAI.05923-11; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Fu Q, 2013, J MICROBIOL BIOTECHN, V23, P579, DOI 10.4014/jmb.1209.09037; Furuya Y, 2013, INFECT IMMUN, V81, P3434, DOI 10.1128/IAI.00408-13; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Gladstone RA, 2012, EXPERT REV VACCINES, V11, P889, DOI [10.1586/erv.12.68, 10.1586/ERV.12.68]; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaushik DK, 2008, SCAND J IMMUNOL, V67, P544, DOI 10.1111/j.1365-3083.2008.02107.x; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; Mera R, 2008, MICROB DRUG RESIST, V14, P101, DOI 10.1089/mdr.2008.0782; Min X, 2012, VACCINE, V30, P3624, DOI 10.1016/j.vaccine.2012.03.042; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Morsczeck C, 2008, CLIN MICROBIOL INFEC, V14, P74, DOI 10.1111/j.1469-0691.2007.01878.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Olafsdottir TA, 2012, INFECT IMMUN, V80, P461, DOI 10.1128/IAI.05801-11; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Price GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057269; Prymula R, 2009, EXPERT REV VACCINES, V8, P1479, DOI 10.1586/ERV.09.113; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Rohatgi S, 2009, J IMMUNOL, V182, P5570, DOI 10.4049/jimmunol.0803254; Rumyantsev AA, 2013, P NATL ACAD SCI USA, V110, P13103, DOI 10.1073/pnas.1306245110; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Webb AJ, 2006, J BACTERIOL, V188, P8005, DOI 10.1128/JB.01101-06; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yang H, 2013, J INFECT DIS, V207, P50, DOI 10.1093/infdis/jis651; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	63	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118154	10.1371/journal.pone.0118154	http://dx.doi.org/10.1371/journal.pone.0118154			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689507	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700103
J	Yang, LQ; Li, XY; Li, X; Su, ZC; Zhang, CG; Zhang, HW				Yang, Liqiang; Li, Xinyu; Li, Xu; Su, Zhencheng; Zhang, Chenggang; Zhang, Huiwen			Microbial Community Dynamics during the Bioremediation Process of Chlorimuron-Ethyl-Contaminated Soil by Hansschlegelia sp Strain CHL1	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; SULFONYLUREA HERBICIDES; METSULFURON-METHYL; ASPERGILLUS-NIGER; TILLAGE SYSTEMS; SOYBEAN FIELD; DIVERSITY; BIODEGRADATION; BACTERIAL; BIOMASS	Long-term and excessive application of chlorimuron-ethyl has led to a series of environmental problems. Strain Hansschlegelia sp. CHL1, a highly efficient chlorimuron-ethyl degrading bacterium isolated in our previous study, was employed in the current soil bioremediation study. The residues of chlorimuron-ethyl in soils were detected, and the changes of soil microbial communities were investigated by phospholipid fatty acid (PLFA) analysis. The results showed that strain CHL1 exhibited significant chlorimuron-ethyl degradation ability at wide range of concentrations between 10 mu g kg(-1) and 1000 mu g kg(-1). High concentrations of chlorimuron-ethyl significantly decreased the total concentration of PLFAs and the Shan-non- Wiener indices and increased the stress level of microbes in soils. The inoculation with strain CHL1, however, reduced the inhibition on soil microbes caused by chlorimuron-ethyl. The results demonstrated that strain CHL1 is effective in the remediation of chlorimuron-ethyl- contaminated soil, and has the potential to remediate chlorimuron-ethyl contaminated soils in situ.	[Yang, Liqiang; Li, Xinyu; Li, Xu; Su, Zhencheng; Zhang, Chenggang; Zhang, Huiwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Yang, Liqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	hwzhang@iae.ac.cn	li, xin/HHS-9461-2022; Li, Lambert LL/F-7146-2015; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		National High Technology and Development Program (863 Program) of China [2012AA101403]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15010101]	National High Technology and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National High Technology and Development Program (863 Program) of China (2012AA101403) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB15010101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SM, 2001, CHEMOSPHERE, V45, P775, DOI 10.1016/S0045-6535(01)00132-1; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; BLACKLOW WM, 1992, AUST J AGR RES, V43, P1157, DOI 10.1071/AR9921157; BLAIR AM, 1988, PESTIC SCI, V22, P195, DOI 10.1002/ps.2780220303; Boschin G, 2003, J ENVIRON SCI HEAL B, V38, P737, DOI 10.1081/PFC-120025557; Byss M, 2008, CHEMOSPHERE, V73, P1518, DOI 10.1016/j.chemosphere.2008.07.030; Cycon M, 2013, APPL SOIL ECOL, V66, P8, DOI 10.1016/j.apsoil.2013.01.014; DERKSEN DA, 1995, WEED RES, V35, P311, DOI 10.1111/j.1365-3180.1995.tb01794.x; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Ellis DE, 2000, ENVIRON SCI TECHNOL, V34, P2254, DOI 10.1021/es990638e; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Hammesfahr U, 2008, SOIL BIOL BIOCHEM, V40, P1583, DOI 10.1016/j.soilbio.2008.01.010; He YH, 2006, J ENVIRON SCI HEAL B, V41, P269, DOI 10.1080/03601230500357298; HEIPIEPER HJ, 1995, CHEMOSPHERE, V30, P1041, DOI 10.1016/0045-6535(95)00015-Z; Herrmann RF, 1997, MICROB ECOL, V33, P78, DOI 10.1007/s002489900010; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Kim YH, 2003, ARCH BIOCHEM BIOPHYS, V416, P209, DOI 10.1016/S0003-9861(03)00297-2; LAMOUREUX GL, 1991, PESTIC BIOCHEM PHYS, V41, P66, DOI 10.1016/0048-3575(91)90061-P; Ma JP, 2009, FEMS MICROBIOL LETT, V296, P203, DOI 10.1111/j.1574-6968.2009.01638.x; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; PETERSEN SO, 1994, APPL ENVIRON MICROB, V60, P2421, DOI 10.1128/AEM.60.7.2421-2430.1994; REDDY KN, 1995, J ENVIRON QUAL, V24, P760, DOI 10.2134/jeq1995.00472425002400040029x; REDDY KN, 1995, J AGR FOOD CHEM, V43, P2752, DOI 10.1021/jf00058a038; Sarmah AK, 2002, J AGR FOOD CHEM, V50, P6253, DOI 10.1021/jf025575p; Sharma S, 2012, FEMS MICROBIOL LETT, V337, P18, DOI 10.1111/1574-6968.12006; Tan HB, 2013, J HAZARD MATER, V260, P368, DOI 10.1016/j.jhazmat.2013.05.043; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang JJ, 2013, ANN MICROBIOL, V63, P335, DOI 10.1007/s13213-012-0479-7; Wang MC, 2008, SOIL BIOL BIOCHEM, V40, P778, DOI 10.1016/j.soilbio.2007.10.012; Xu J, 2013, J ENVIRON SCI HEAL B, V48, P505, DOI 10.1080/03601234.2013.761915; Yang LQ, 2014, J HAZARD MATER, V274, P314, DOI 10.1016/j.jhazmat.2014.04.011; Yang YH, 2000, MICROBIAL ECOL, V39, P72, DOI 10.1007/s002489900180; Ye GB, 2006, CHINESE J ANAL CHEM, V34, P1207, DOI 10.1016/S1872-2040(07)60001-2; Zawoznik MS, 2005, PEST MANAG SCI, V61, P1003, DOI 10.1002/ps.1077; ZELLES L, 1994, SOIL BIOL BIOCHEM, V26, P439, DOI 10.1016/0038-0717(94)90175-9; Zhang CP, 2010, CHEMOSPHERE, V81, P800, DOI 10.1016/j.chemosphere.2010.06.079; Zhang H, 2010, J ENVIRON SCI HEAL B, V45, P501, DOI 10.1080/03601234.2010.493473; Zhang XL, 2011, ENVIRON SCI POLLUT R, V18, P407, DOI 10.1007/s11356-010-0381-4; Zhang XL, 2009, J ENVIRON SCI, V21, P1253, DOI 10.1016/S1001-0742(08)62412-2	45	6	6	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117943	10.1371/journal.pone.0117943	http://dx.doi.org/10.1371/journal.pone.0117943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689050	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700086
J	Diaz-Munoz, MD; Bell, SE; Turner, M				Diaz-Munoz, Manuel D.; Bell, Sarah E.; Turner, Martin			Deletion of AU-Rich Elements within the Bcl2 3 ' UTR Reduces Protein Expression and B Cell Survival In Vivo	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; LEUKEMIA-CELLS; REVEALS; HUR; NUCLEOLIN; PHOSPHORYLATION; IDENTIFICATION; MAINTENANCE	Post-transcriptional mRNA regulation by RNA binding proteins (RBPs) associated with AU-rich elements (AREs) present in the 30 untranslated region (3'UTR) of specific mRNAs modulates transcript stability and translation in eukaryotic cells. Here we have functionally characterised the importance of the AREs present within the Bcl2 3'UTR in order to maintain Bcl2 expression. Gene targeting deletion of 300 nucleotides of the Bcl2 3' UTR rich in AREs diminishes Bcl2 mRNA stability and protein levels in primary B cells, decreasing cell life-span. Generation of chimeric mice indicates that Bcl2-ARE(Delta/Delta)B cells have an intrinsic competitive disadvantage compared to wild type cells. Biochemical assays and predictions using a bioinformatics approach show that several RBPs bind to the Bcl2 AREs, including AUF1 and HuR proteins. Altogether, association of RBPs to Bcl2 AREs contributes to Bcl2 protein expression by stabilizing Bcl2 mRNA and promotes B cell maintenance.	[Diaz-Munoz, Manuel D.; Bell, Sarah E.; Turner, Martin] Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Turner, M (corresponding author), Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Diaz-Munoz, Manuel D/H-2080-2018; Diaz-Munoz, Manuel D./AAB-6518-2020; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D/0000-0002-9227-7474; Diaz-Munoz, Manuel D./0000-0002-9227-7474; Turner, Martin/0000-0002-3801-9896	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0409, BB/J00152X/1] Funding Source: researchfish; BBSRC [BBS/E/B/000C0407, BBS/E/B/000C0409, BB/J00152X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini F, 2013, BIOINFORMATICS, V29, P2928, DOI 10.1093/bioinformatics/btt495; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Ghisolfi L, 2009, J BIOL CHEM, V284, P20946, DOI 10.1074/jbc.M109.023721; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Houzet L, 2001, BLOOD, V98, P1281, DOI 10.1182/blood.V98.5.1281; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Sadri N, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-1; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Shah N, 2004, BIOINFORMATICS, V20, P636, DOI 10.1093/bioinformatics/btg459; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zekavati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102625	42	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116899	10.1371/journal.pone.0116899	http://dx.doi.org/10.1371/journal.pone.0116899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680182	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600041
J	Leavey, K; Bainbridge, SA; Cox, BJ				Leavey, Katherine; Bainbridge, Shannon A.; Cox, Brian J.			Large Scale Aggregate Microarray Analysis Reveals Three Distinct Molecular Subclasses of Human Preeclampsia	PLOS ONE			English	Article							GENE-EXPRESSION; ANGIOGENIC FACTORS; TROPHOBLAST CELLS; INFECTION; FETAL; DYSFUNCTION; PLACENTAS; GROWTH	Background Preeclampsia (PE) is a life-threatening hypertensive pathology of pregnancy affecting 3-5% of all pregnancies. To date, PE has no cure, early detection markers, or effective treatments short of the removal of what is thought to be the causative organ, the placenta, which may necessitate a preterm delivery. Additionally, numerous small placental microarray studies attempting to identify "PE-specific" genes have yielded inconsistent results. We therefore hypothesize that preeclampsia is a multifactorial disease encompassing several pathology subclasses, and that large cohort placental gene expression analysis will reveal these groups. Results To address our hypothesis, we utilized known bioinformatic methods to aggregate 7 microarray data sets across multiple platforms in order to generate a large data set of 173 patient samples, including 77 with preeclampsia. Unsupervised clustering of these patient samples revealed three distinct molecular subclasses of PE. This included a "canonical" PE subclass demonstrating elevated expression of known PE markers and genes associated with poor oxygenation and increased secretion, as well as two other subclasses potentially representing a poor maternal response to pregnancy and an immunological presentation of preeclampsia. Conclusion Our analysis sheds new light on the heterogeneity of PE patients, and offers up additional avenues for future investigation. Hopefully, our subclassification of preeclampsia based on molecular diversity will finally lead to the development of robust diagnostics and patient-based treatments for this disorder.	[Leavey, Katherine; Cox, Brian J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Bainbridge, Shannon A.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Toronto; University of Ottawa	Bainbridge, SA (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	shannon.bainbridge@uottawa.ca; b.cox@utoronto.ca	Bainbridge, Shannon A/F-9715-2015; Bainbridge, Shannon/GRN-7894-2022	Bainbridge, Shannon A/0000-0002-8947-8152; 	Canadian Institutes of Health Research [128369]; University of Toronto Open Fellowship fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Open Fellowship fund	This research was funded by the Canadian Institutes of Health Research Grant # 128369 to SB and BC. KL was supported in part by the University of Toronto Open Fellowship fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonios TFT, 2013, AM J HYPERTENS, V26, P1162, DOI 10.1093/ajh/hpt087; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Bainbridge SA, 2012, HYPERTENSION, V59, P732, DOI 10.1161/HYPERTENSIONAHA.111.183939; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; Carreiras M, 2002, AM J REPROD IMMUNOL, V48, P176, DOI 10.1034/j.1600-0897.2002.01076.x; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Constantin CM, 2007, J IMMUNOL, V179, P4383, DOI 10.4049/jimmunol.179.7.4383; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; Dekker G, 2002, J REPROD IMMUNOL, V57, P203, DOI 10.1016/S0165-0378(02)00039-6; Fraley C, 2007, J STAT SOFTW, V18; Gleicher N, 2007, AM J OBSTET GYNECOL, V196, P5, DOI 10.1016/j.ajog.2006.09.016; Gomez LM, 2008, HUM REPROD, V23, P709, DOI 10.1093/humrep/dem404; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; HUNT JS, 1988, J IMMUNOL, V140, P1293; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jordan JA, 2001, WOMEN INFECTED WITH, V8, DOI [doi: 10.1128/ CDLI. 8.2.288, DOI 10.1128/CDLI.8.2.288]; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Kulandavelu S, 2013, HYPERTENSION, V61, P259, DOI 10.1161/HYPERTENSIONAHA.112.201996; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lecarpentier E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062140; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mayhew TM, 2008, PLACENTA, V29, P1, DOI 10.1016/j.placenta.2007.05.010; McDonnold M, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.040; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Rademacher TW, 2007, J REPROD IMMUNOL, V76, P78, DOI 10.1016/j.jri.2007.03.019; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Ruano Rodrigo, 2005, Clinics, V60, P407, DOI 10.1590/S1807-59322005000500010; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szekeres-Bartho J, INT REV IMMUNOL, V21, P471; Tan EK, 2013, BEST PRACT RES CL OB, V27, P791, DOI 10.1016/j.bpobgyn.2013.08.001; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vigil-De Gracia P, 2009, INT J GYNECOL OBSTET, V104, P90, DOI 10.1016/j.ijgo.2008.09.014; Vinnars MT, 2008, HYPERTENSION, V51, P1295, DOI 10.1161/HYPERTENSIONAHA.107.104844; von Dadelszen P, 2003, BJOG-INT J OBSTET GY, V110, P725, DOI 10.1111/j.1471-0528.2003.02481.x; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Xiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059753; Yuen RKC, 2011, PLACENTA, V32, pS136, DOI 10.1016/j.placenta.2011.01.003	58	65	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116508	10.1371/journal.pone.0116508	http://dx.doi.org/10.1371/journal.pone.0116508			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679511	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600023
J	Lima, DB; Melo, JWS; Guedes, NMP; Gontijo, LM; Guedes, RNC; Gondim, MGC				Lima, Debora B.; Melo, Jose Wagner S.; Guedes, Nelsa Maria P.; Gontijo, Lessando M.; Guedes, Raul Narciso C.; Gondim, Manoel Guedes C., Jr.			Bioinsecticide-Predator Interactions: Azadirachtin Behavioral and Reproductive Impairment of the Coconut Mite Predator Neoseiulus baraki	PLOS ONE			English	Article							BOTANICAL INSECTICIDE; TETRANYCHUS-URTICAE; PHYTOSEIULUS-PERSIMILIS; ACARI TETRANYCHIDAE; ACERIA-GUERRERONIS; SELECTIVITY; PESTICIDES; TOXICITY; COMPATIBILITY; AVOIDANCE	Synthetic pesticide use has been the dominant form of pest control since the 1940s. However, biopesticides are emerging as sustainable pest control alternatives, with prevailing use in organic agricultural production systems. Foremost among botanical biopesticides is the limonoid azadirachtin, whose perceived environmental safety has come under debate and scrutiny in recent years. Coconut production, particularly organic coconut production, is one of the agricultural systems in which azadirachtin is used as a primary method of pest control for the management of the invasive coconut mite, Aceria guerreronis Keifer (Acari: Eriophyidae). The management of this mite species also greatly benefits from predation by Neoseiulus baraki (Athias-Henriot) (Acari: Phytoseiidae). Here, we assessed the potential behavioral impacts of azadirachtin on the coconut mite predator, N. baraki. We explored the effects of this biopesticide on overall predator activity, female searching time, and mating behavior and fecundity. Azadirachtin impairs the overall activity of the predator, reducing it to nearly half; however, female searching was not affected. In contrast, mating behavior was compromised by azadirachtin exposure particularly when male predators were exposed to the biopesticide. Consequently, predator fecundity was also compromised by azadirachtin, furthering doubts about its environmental safety and selectivity towards biological control agents.	[Lima, Debora B.; Melo, Jose Wagner S.; Gondim, Manoel Guedes C., Jr.] Univ Fed Rural Pernambuco, Area Fitossanidade, Dept Agron, BR-52171900 Recife, PE, Brazil; [Guedes, Nelsa Maria P.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Gontijo, Lessando M.] Univ Fed Vicosa, BR-35690000 Florestal, MG, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Vicosa; Universidade Federal de Vicosa	Lima, DB (corresponding author), Univ Fed Rural Pernambuco, Area Fitossanidade, Dept Agron, BR-52171900 Recife, PE, Brazil.	deboralima_85@yahoo.com.br	Lima, Debora Barbosa/D-6777-2015; Gontijo, Lessando M./AAG-8181-2019; melo, Jose wagner S/I-1027-2012; Guedes, Raul Narciso Carvalho/L-3924-2013	Gontijo, Lessando M./0000-0001-6041-7404; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Lima, Debora/0000-0003-1491-7285; Melo, Jose Wagner/0000-0003-1056-8129	Brazilian agency: Pernambuco State Foundation for Research Aid (FACEPE); Brazilian agency: CAPES Foundation (Brazilian Ministry of Education); Brazilian agency: National Council of Scientific and Technological Development (CNPq)	Brazilian agency: Pernambuco State Foundation for Research Aid (FACEPE); Brazilian agency: CAPES Foundation (Brazilian Ministry of Education); Brazilian agency: National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by the following Brazilian agencies: Pernambuco State Foundation for Research Aid (FACEPE), CAPES Foundation (Brazilian Ministry of Education), and the National Council of Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoabeng BW, 2014, CROP PROT, V57, P71, DOI 10.1016/j.cropro.2013.11.019; Aratchige NS, 2007, EXP APPL ACAROL, V43, P97, DOI 10.1007/s10493-007-9107-9; Bernardi D, 2013, PEST MANAG SCI, V69, P75, DOI 10.1002/ps.3364; Campos MR, 2011, CROP PROT, V30, P1535, DOI 10.1016/j.cropro.2011.08.013; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Castagnoli M, 2005, BIOCONTROL, V50, P611, DOI 10.1007/s10526-004-8121-7; COATS JR, 1994, ANNU REV ENTOMOL, V39, P489, DOI 10.1146/annurev.en.39.010194.002421; Cooper J, 2007, CROP PROT, V26, P1337, DOI 10.1016/j.cropro.2007.03.022; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Cote KW, 2002, HORTSCIENCE, V37, P906, DOI 10.21273/HORTSCI.37.6.906; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DORN A, 1986, J APPL ENTOMOL, V102, P313, DOI 10.1111/j.1439-0418.1986.tb00928.x; Duso C, 2008, BIOL CONTROL, V47, P16, DOI 10.1016/j.biocontrol.2008.06.011; Fernando LCP, 2003, EXP APPL ACAROL, V31, P71, DOI 10.1023/B:APPA.0000005126.16574.3b; Gerwick BC, 2014, PEST MANAG SCI; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005; Kidd H., 2000, PESTIC OUTLOOK, V11, P215; Kramer W, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, pXXIII; Lima DB, 2013, BIOCONTROL, V58, P595, DOI 10.1007/s10526-013-9520-4; Lima DB, 2013, EXP APPL ACAROL, V60, P381, DOI 10.1007/s10493-012-9644-8; Lima DB, 2012, EXP APPL ACAROL, V56, P233, DOI 10.1007/s10493-012-9515-3; Linton YM, 1997, J INSECT PHYSIOL, V43, P1077, DOI 10.1016/S0022-1910(97)00060-7; Manuweera G, 2008, ENVIRON HEALTH PERSP, V116, P492, DOI 10.1289/ehp.11029; MAPA (Ministerio da Agricultura Pecuaria e Abastecimento), 2014, COORD GER AGR AFINS; Matsumura F, 2004, J PESTIC SCI, V29, P299, DOI 10.1584/jpestics.29.299; Matthews GA, 2008, CROP PROT, V27, P834, DOI 10.1016/j.cropro.2007.10.013; Medina P, 2004, J ECON ENTOMOL, V97, P43, DOI 10.1603/0022-0493-97.1.43; Melo JWS, 2011, EXP APPL ACAROL, V55, P191, DOI 10.1007/s10493-011-9465-1; METCALF RL, 1980, ANNU REV ENTOMOL, V25, P219, DOI 10.1146/annurev.en.25.010180.001251; Mordue AJ., 2010, INSECT CONTROL BIOL, P185; Mordue (Luntz) A. Jennifer, 2000, Anais da Sociedade Entomologica do Brasil, V29, P615, DOI 10.1590/S0301-80592000000400001; Pappas ML, 2005, EXP APPL ACAROL, V36, P187, DOI 10.1007/s10493-005-5303-7; Qi BY, 2001, BIOL CONTROL, V22, P185, DOI 10.1006/bcon.2001.0965; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Reis AC, 2008, NEOTROP ENTOMOL, V37, P457, DOI 10.1590/S1519-566X2008000400015; SAS Institute SAS/STAT User's Guide, 2008, SAS I SAS STAT US GU; SHIMIZU T, 1988, ENTOMOL EXP APPL, V46, P197, DOI 10.1007/BF00190851; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stark JD, 1999, ECOTOX ENVIRON SAFE, V42, P282, DOI 10.1006/eesa.1998.1760; Villaverde JJ, 2014, PEST MANAG SCI, V70, P2, DOI 10.1002/ps.3663; Zhang ZQ, 1997, EXP APPL ACAROL, V21, P393, DOI 10.1023/A:1018475728005	46	33	34	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118343	10.1371/journal.pone.0118343	http://dx.doi.org/10.1371/journal.pone.0118343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679393	Green Published, gold, Green Submitted			2022-12-27	WOS:000350682600120
J	Logie, CH; Earnshaw, V				Logie, Carmen H.; Earnshaw, Valerie			Adapting and Validating a Scale to Measure Sexual Stigma among Lesbian, Bisexual and Queer Women	PLOS ONE			English	Article							MENTAL-HEALTH; INTERNALIZED HOMOPHOBIA; PERCEIVED DISCRIMINATION; EMOTIONAL DISTRESS; HATE CRIMES; GAY MEN; STRESS; YOUTHS; ADULTS; VICTIMIZATION	Lesbian, bisexual and queer (LBQ) women experience pervasive sexual stigma that harms wellbeing. Stigma is a multi-dimensional construct and includes perceived stigma, awareness of negative attitudes towards one's group, and enacted stigma, overt experiences of discrimination. Despite its complexity, sexual stigma research has generally explored singular forms of sexual stigma among LBQ women. The study objective was to develop a scale to assess perceived and enacted sexual stigma among LBQ women. We adapted a sexual stigma scale for use with LBQ women. The validation process involved 3 phases. First, we held a focus group where we engaged a purposively selected group of key informants in cognitive interviewing techniques to modify the survey items to enhance relevance to LBQ women. Second, we implemented an internet-based, cross-sectional survey with LBQ women (n = 466) in Toronto, Canada. Third, we administered an internet-based survey at baseline and 6-week follow-up with LBQ women in Toronto (n = 24) and Calgary (n = 20). We conducted an exploratory factor analysis using principal components analysis and descriptive statistics to explore health and demographic correlates of the sexual stigma scale. Analyses yielded one scale with two factors: perceived and enacted sexual stigma. The total scale and subscales demonstrated adequate internal reliability (total scale alpha coefficient: 0.78; perceived sub-scale: 0.70; enacted sub-scale: 0.72), test-retest reliability, and construct validity. Perceived and enacted sexual stigma were associated with higher rates of depressive symptoms and lower self-esteem, social support, and self-rated health scores. Results suggest this sexual stigma scale adapted for LBQ women has good psychometric properties and addresses enacted and perceived stigma dimensions. The overwhelming majority of participants reported experiences of perceived sexual stigma. This underscores the importance of moving beyond a singular focus on discrimination to explore perceptions of social judgment, negative attitudes and social norms.	[Logie, Carmen H.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Logie, Carmen H.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Earnshaw, Valerie] Harvard Univ, Sch Med, Boston, MA USA	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Harvard University; Harvard Medical School	Logie, CH (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	carmen.logie@utoronto.ca			Canadian Institutes of Health Research Social Research Centre in HIV Prevention [CIHR: HCP-97106, 487453]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Social Research Centre in HIV Prevention(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Canadian Institutes of Health Research Social Research Centre in HIV Prevention (Phase 1 & 2: CIHR: HCP-97106; Phase 3: Fund 487453).	Almeida J, 2009, J YOUTH ADOLESCENCE, V38, P1001, DOI 10.1007/s10964-009-9397-9; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bontempo DE, 2002, J ADOLESCENT HEALTH, V30, P364, DOI 10.1016/S1054-139X(01)00415-3; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brennan DJ, 2010, CAN J PUBLIC HEALTH, V101, P255, DOI 10.1007/BF03404385; Cochran BN, 2002, AM J PUBLIC HEALTH, V92, P773, DOI 10.2105/AJPH.92.5.773; Cochran SD, 2009, J ABNORM PSYCHOL, V118, P647, DOI 10.1037/a0016501; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; D'Augelli AR, 2002, SCHOOL PSYCHOL QUART, V17, P148, DOI 10.1521/scpq.17.2.148.20854; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Duncan DT, 2014, AM J PUBLIC HEALTH, V104, P272, DOI 10.2105/AJPH.2013.301424; Fish J, 2008, SOC WORK EDUC, V27, P182, DOI 10.1080/02615470701709667; Frisell T, 2010, PSYCHOL MED, V40, P315, DOI 10.1017/S0033291709005996; Frost DM, 2009, J COUNS PSYCHOL, V56, P97, DOI 10.1037/a0012844; Goffman E., 1963, STIGMA NOTES MANAGEM; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Herek GM, 2002, J LAW MED ETHICS, V30, P594, DOI 10.1111/j.1748-720X.2002.tb00428.x; Herek GM, 1999, J CONSULT CLIN PSYCH, V67, P945, DOI 10.1037/0022-006X.67.6.945; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Igartua Karine J, 2003, Can J Commun Ment Health, V22, P15; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kuyper L, 2011, J SEX RES, V48, P263, DOI 10.1080/00224491003654473; Lewis NM, 2009, HEALTH PLACE, V15, P1029, DOI 10.1016/j.healthplace.2009.05.003; Lewis RJ, 2006, J COUNS PSYCHOL, V53, P48, DOI 10.1037/0022-0167.53.1.48; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; LINK BG, 1987, AM SOCIOL REV, V52, P96, DOI 10.2307/2095395; Liu RT, 2012, AM J PREV MED, V42, P221, DOI 10.1016/j.amepre.2011.10.023; Logie CH, 2014, J LESBIAN STUD, V18, P174, DOI 10.1080/10894160.2014.849165; Logie C, 2012, AM J PUBLIC HEALTH, V102, P1243, DOI 10.2105/AJPH.2011.300599; Logie CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005190; Logie CH, 2013, CULT HEALTH SEX, V15, P29, DOI 10.1080/13691058.2012.738430; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Luhtanen Riia K, 2003, J Lesbian Stud, V7, P85, DOI 10.1300/J155v07n01_06; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; McGregor BA, 2001, PSYCHOL WOMEN QUART, V25, P1, DOI 10.1111/1471-6402.00001; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Meyer IH, 2008, SOC SCI MED, V67, P368, DOI 10.1016/j.socscimed.2008.03.012; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Newcomb ME, 2012, J STUD ALCOHOL DRUGS, V73, P783, DOI 10.15288/jsad.2012.73.783; Newcomb ME, 2010, CLIN PSYCHOL REV, V30, P1019, DOI 10.1016/j.cpr.2010.07.003; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P87, DOI 10.1080/17441692.2010.549139; O'Donnell S, 2011, AM J PUBLIC HEALTH, V101, P1055, DOI 10.2105/AJPH.2010.300032; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2001, ANNU REV ANTHROPOL, V30, P163, DOI 10.1146/annurev.anthro.30.1.163; Pinel EC, 1999, J PERS SOC PSYCHOL, V76, P114, DOI 10.1037/0022-3514.76.1.114; Roberts AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054702; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rosario M, 2002, J CONSULT CLIN PSYCH, V70, P967, DOI 10.1037//0022-006X.70.4.000; Rosario M, 2001, AM J COMMUN PSYCHOL, V29, P133, DOI 10.1023/A:1005205630978; Rusch MLA, 2008, BMC WOMENS HLTH, V8; Smith WP, 2012, J GAY LESBIAN SOC SE, V24, P417, DOI 10.1080/10538720.2012.721722; Szymanski DM, 2008, COUNS PSYCHOL, V36, P575, DOI 10.1177/0011000007309490; Szymanski DM, 2001, J HOMOSEXUAL, V41, P37, DOI 10.1300/J082v41n02_03; Szymanski DM, 2001, MEAS EVAL COUNS DEV, V34, P27, DOI 10.1080/07481756.2001.12069020; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; World Health Organization, 1996, HLTH INT SURV INT HA; Zea MC, 2003, AIDS BEHAV, V7, P143, DOI 10.1023/A:1023994207984; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	65	24	24	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116198	10.1371/journal.pone.0116198	http://dx.doi.org/10.1371/journal.pone.0116198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679391	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600015
J	Lund, S; Richardson, A; May, C				Lund, Susi; Richardson, Alison; May, Carl			Barriers to Advance Care Planning at the End of Life: An Explanatory Systematic Review of Implementation Studies	PLOS ONE			English	Article							CLINICAL-PRACTICE; FAILURE; PATIENT; WORK; UK	Context Advance Care Plans (ACPs) enable patients to discuss and negotiate their preferences for the future including treatment options at the end of life. Their implementation poses significant challenges. Objective To investigate barriers and facilitators to the implementation of ACPs, focusing on their workability and integration in clinical practice. Design An explanatory systematic review of qualitative implementation studies. Data sources Empirical studies that reported interventions designed to support ACP in healthcare. Web of Knowledge, Ovid MEDLINE, CINAHL, PsycINFO, British Nursing Index and PubMed databases were searched. Methods Direct content analysis, using Normalization Process Theory, to identify and characterise relevant components of implementation processes. Results 13 papers identified from 166 abstracts were included in the review. Key factors facilitating implementation were: specially prepared staff utilizing a structured approach to interactions around ACPs. Barriers to implementation were competing demands of other work, the emotional and interactional nature of patient-professional interactions around ACPs, problems in sharing decisions and preferences within and between healthcare organizations. Conclusions This review demonstrates that doing more of the things that facilitate delivery of ACPs will not reduce the effects of those things that undermine them. Structured tools are only likely to be partially effective and the creation of a specialist cadre of ACP facilitators is unlikely to be a sustainable solution. The findings underscore both the challenge and need to find ways to routinely incorporate ACPs in clinical settings where multiple and competing demands impact on practice. Interventions most likely to meet with success are those that make elements of Advance Care Planning workable within complex and time pressured clinical workflows.	[Lund, Susi; Richardson, Alison; May, Carl] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Lund, Susi] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Richardson, Alison; May, Carl] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Richardson, Alison; May, Carl] Natl Inst Hlth Res Collaborat Leadership Appl Res, Southampton, Hants, England	University of Southampton; Royal Berkshire Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Lund, S (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton, Hants, England.	s.lund@soton.ac.uk		May, Carl/0000-0002-0451-2690	former South Central Strategic Health Authority; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex	former South Central Strategic Health Authority; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex	SL is a Post Doctoral Research Fellow supported by the former South Central Strategic Health Authority. AR and CRM's contribution to this work was partly supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex which is a partnership between Wessex NHS organizations and partners and the University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625175; Blakeman T, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636056; Bond CJ, 2011, AGE AGEING, V40, P450, DOI 10.1093/ageing/afr025; Boyd K, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X544032; Bravo G, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-1; Conroy S, 2009, CLIN MED, V9, P76, DOI 10.7861/clinmedicine.9-1-76; De Vleminck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084905; Department of Health, 2008, END LIF CAR STRAT PR; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; DoH, 2013, MOR CAR LESS PATHW R; Elwyn G., 2008, IMPLEMENTATION SCI, V3; Elwyn G, 2013, PATIENT EDUC COUNS, V90, P207, DOI 10.1016/j.pec.2012.06.036; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Glaser BG, 1965, AWARENESS DYING; Hockley J, 2010, PALLIATIVE MED, V24, P828, DOI 10.1177/0269216310373162; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jeong SYS, 2007, CONTEMP NURSE, V26, P184, DOI 10.5172/conu.2007.26.2.184; Jeong SYS, 2010, J CLIN NURS, V19, P389, DOI 10.1111/j.1365-2702.2009.03001.x; Lloyd A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-102; Love A, 2014, PALLIATIVE MED, V28, P1026, DOI 10.1177/0269216314531313; Lynn J, 2003, ANN INTERN MED, V138, P812, DOI 10.7326/0003-4819-138-10-200305200-00009; Mair FS, 2012, B WORLD HEALTH ORGAN, V90, P357, DOI 10.2471/BLT.11.099424; Matlock DD, 2011, HLTH EXPECTATIONS, V17, P49, DOI [10.1111/j.1369-7625.2011,00732.x, DOI 10.1111/J.1369-7625.2011,00732.X]; May C, 2014, INT J NURS STUD, V51, P289, DOI 10.1016/j.ijnurstu.2013.06.019; May C, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-18; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McEvoy R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-2; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; National Confidential Enquiry into Patient Outcome and Death, 2012, TIM TO INT; Norlander L, 2000, Home Healthc Nurse, V18, P532, DOI 10.1097/00004045-200009000-00012; Obolensky L, 2010, J MED ETHICS, V36, P518, DOI 10.1136/jme.2009.033977; Pettit SJ, 2012, BMJ SUPPORT PALLIAT, V2, P94, DOI 10.1136/bmjspcare-2011-000176; Rhee JJ, 2011, AUST HEALTH REV, V35, P197, DOI 10.1071/AH10883; Sabatino CP, 2010, MILBANK Q, V88, P211, DOI 10.1111/j.1468-0009.2010.00596.x; Sampson EL, 2011, PALLIATIVE MED, V25, P197, DOI 10.1177/0269216310391691; Schickedanz AD, 2009, J AM GERIATR SOC, V57, P31, DOI 10.1111/j.1532-5415.2008.02093.x; Schiff R, 2009, AGE AGEING, V38, P81, DOI 10.1093/ageing/afn235; Seymour J, 2010, BMC PALLIATIVE CARE, V9; Seymour J, 2013, INT J PALLIAT NURS, V19, P369, DOI 10.12968/ijpn.2013.19.8.369; Shanley C, 2009, AUSTRALAS J AGEING, V28, P211, DOI 10.1111/j.1741-6612.2009.00383.x; Simon J, 2008, J PALLIAT CARE, V24, P256, DOI 10.1177/082585970802400405; Stein GL, 2013, BRIT J SOC WORK, V43, P233, DOI 10.1093/bjsw/bct013; Storey Les, 2013, Nurs Older People, V25, P14; Watson R, 2011, CHILD CARE HLTH DEV, V37, P780, DOI 10.1111/j.1365-2214.2011.01293.x	45	175	175	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116629	10.1371/journal.pone.0116629	http://dx.doi.org/10.1371/journal.pone.0116629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679395	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000350682600029
J	Mueller, SM; Aguayo, D; Zuercher, M; Fleischmann, O; Boutellier, U; Auer, M; Jung, HH; Toigo, M				Mueller, Sandro Manuel; Aguayo, David; Zuercher, Matthias; Fleischmann, Oliver; Boutellier, Urs; Auer, Maria; Jung, Hans H.; Toigo, Marco			High-Intensity Interval Training with Vibration as Rest Intervals Attenuates Fiber Atrophy and Prevents Decreases in Anaerobic Performance	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; VASCULAR OCCLUSION; TIME; METABOLISM; FREQUENCY; RESPONSES; CAPACITY; STRENGTH	Aerobic high-intensity interval training (HIT) improves cardiovascular capacity but may reduce the finite work capacity above critical power (W') and lead to atrophy of myosin heavy chain (MyHC)-2 fibers. Since whole-body vibration may enhance indices of anaerobic performance, we examined whether side-alternating whole-body vibration as a replacement for the active rest intervals during a 4x4 min HIT prevents decreases in anaerobic performance and capacity without compromising gains in aerobic function. Thirty-three young recreationally active men were randomly assigned to conduct either conventional 4x4 min HIT, HIT with 3 min of WBV at 18 Hz (HIT+VIB18) or 30 Hz (HIT+VIB30) in lieu of conventional rest intervals, or WBV at 30 Hz (VIB30). Pre and post training, critical power (CP), W', cellular muscle characteristics, as well as cardiovascular and neuromuscular variables were determined. W' (-14.3%, P = 0.013), maximal voluntary torque (-8.6%, P = 0.001), rate of force development (-10.5%, P = 0.018), maximal jumping power (-6.3%, P = 0.007) and cross-sectional areas of MyHC-2A fibers (-6.4%, P = 0.044) were reduced only after conventional HIT. CP, VO2peak, peak cardiac output, and overall capillary-to-fiber ratio were increased after HIT, HIT+VIB18, and HIT+VIB30 without differences between groups. HIT-specific reductions in anaerobic performance and capacity were prevented by replacing active rest intervals with side-alternating whole-body vibration, notably without compromising aerobic adaptations. Therefore, competitive cyclists (and potentially other endurance-oriented athletes) may benefit from replacing the active rest intervals during aerobic HIT with side-alternating whole-body vibration.	[Mueller, Sandro Manuel; Aguayo, David; Zuercher, Matthias; Fleischmann, Oliver; Boutellier, Urs; Toigo, Marco] ETH, Exercise Physiol Lab, Inst Human Movement Sci, Zurich, Switzerland; [Auer, Maria; Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Toigo, M (corresponding author), ETH, Exercise Physiol Lab, Inst Human Movement Sci, Zurich, Switzerland.	marco.toigo@hest.ethz.ch	Aguayo, David/AAP-6816-2020					Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Bogaerts A, 2007, J GERONTOL A-BIOL, V62, P630, DOI 10.1093/gerona/62.6.630; Bosco C, 1999, CLIN PHYSIOL, V19, P183; Breil FA, 2010, EUR J APPL PHYSIOL, V109, P1077, DOI 10.1007/s00421-010-1455-1; Carlucci F, 2016, J STRENGTH COND RES, V30, P3503, DOI 10.1519/JSC.0b013e3182955e42; Cochrane DJ, 2005, BRIT J SPORT MED, V39, P860, DOI 10.1136/bjsm.2005.019950; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Faude O., 2014, INT J SPORTS PHYSL P; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gross M, 2014, J STRENGTH COND RES, V28, P1581, DOI 10.1519/JSC.0000000000000294; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; HILL DW, 1993, SPORTS MED, V16, P237, DOI 10.2165/00007256-199316040-00003; Item F, 2011, INT J SPORTS MED, V32, P781, DOI 10.1055/s-0031-1277215; Item F, 2013, EUR J APPL PHYSIOL, V113, P1081, DOI 10.1007/s00421-012-2524-4; Kohn TA, 2011, SCAND J MED SCI SPOR, V21, P765, DOI 10.1111/j.1600-0838.2010.01136.x; Larsen RG, 2013, AM J PHYSIOL-REG I, V304, pR333, DOI 10.1152/ajpregu.00409.2012; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; Midgley AW, 2006, J SPORT MED PHYS FIT, V46, P1; Mileva KN, 2006, MED SCI SPORT EXER, V38, P1317, DOI 10.1249/01.mss.0000227318.39094.b6; Mueller SM, 2014, EUR J APPL PHYSIOL, V114, P123, DOI 10.1007/s00421-013-2752-2; Oosthuyse T, 2013, J STRENGTH COND RES, V27, P485, DOI 10.1519/JSC.0b013e31825770be; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; POOLE DC, 1990, EUR J APPL PHYSIOL, V59, P421, DOI 10.1007/BF02388623; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Sawyer BJ, 2014, J STRENGTH COND RES, V28, P601, DOI 10.1519/JSC.0b013e31829e113b; Scribbans TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098119; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Seiler S, 2004, SCAND J MED SCI SPOR, V14, P318, DOI 10.1046/j.1600-0838.2003.00353.x; SIMONEAU JA, 1986, INT J SPORTS MED, V7, P167, DOI 10.1055/s-2008-1025756; Spencer M, 2008, EUR J APPL PHYSIOL, V103, P545, DOI 10.1007/s00421-008-0749-z; Spencer M, 2006, MED SCI SPORT EXER, V38, P1492, DOI 10.1249/01.mss.0000228944.62776.a7; Stepto NK, 1999, MED SCI SPORT EXER, V31, P736, DOI 10.1097/00005768-199905000-00018; Vanhatalo A, 2008, MED SCI SPORT EXER, V40, P1693, DOI 10.1249/MSS.0b013e318177871a	35	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116764	10.1371/journal.pone.0116764	http://dx.doi.org/10.1371/journal.pone.0116764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679998	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000350682600032
J	McMaster, SR; Gabbard, JD; Koutsonanos, DG; Compans, RW; Tripp, RA; Tompkins, SM; Kohlmeier, JE				McMaster, Sean R.; Gabbard, Jon D.; Koutsonanos, Dimitris G.; Compans, Richard W.; Tripp, Ralph A.; Tompkins, S. Mark; Kohlmeier, Jacob E.			Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity	PLOS ONE			English	Article							A(H7N9) VIRUS; A VIRUSES; CHINA; TRANSMISSION; VACCINATION; EMERGENCE; INFECTION; FERRETS	Influenza virus is a source of significant health and economic burden from yearly epidemics and sporadic pandemics. Given the potential for the emerging H7N9 influenza virus to cause severe respiratory infections and the lack of exposure to H7 and N9 influenza viruses in the human population, we aimed to quantify the H7N9 cross-reactive memory T cell reservoir in humans and mice previously exposed to common circulating influenza viruses. We identified significant cross-reactive T cell populations in humans and mice; we also found that cross-reactive memory T cells afforded heterosubtypic protection by reducing morbidity and mortality upon lethal H7N9 challenge. In context with our observation that PR8-primed mice have limited humoral cross-reactivity with H7N9, our data suggest protection from H7N9 challenge is indeed mediated by cross-reactive T cell populations established upon previous priming with another influenza virus. Thus, pre-existing cross-reactive memory T cells may limit disease severity in the event of an H7N9 influenza virus pandemic.	[McMaster, Sean R.; Koutsonanos, Dimitris G.; Compans, Richard W.; Kohlmeier, Jacob E.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gabbard, Jon D.; Tripp, Ralph A.; Tompkins, S. Mark] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA USA	Emory University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kohlmeier, JE (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jkohlmeier@emory.edu	Tompkins, Stephen/A-3317-2008; Compans, Richard W/I-4087-2013	Tompkins, Stephen/0000-0002-1523-5588; Compans, Richard W/0000-0003-2360-335X	Centers of Excellence in Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]; Emory University; NIH [T32 AI007610-14]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL118954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Centers of Excellence in Influenza Research and Surveillance (CEIRS); Emory University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Centers of Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C (S.M.T., R.A.T., R.W.C., and J.E.K.) and funds from Emory University. S.R.M. is supported in part by NIH T32 AI007610-14. The funders had no role in study design, data collection and analysis, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Gabbard JD, 2014, J VIROL, V88, P1502, DOI 10.1128/JVI.02959-13; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Koutsonanos DG, 2011, J INFECT DIS, V204, P582, DOI 10.1093/infdis/jir094; Meng Z, 2014, EURO SURVEILL, V19; Mooney AJ, 2013, J VIROL, V87, P363, DOI 10.1128/JVI.02330-12; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; World Health Organization, 2013, NUMB CONF HUM CAS AV; World Health Organization, 2014, WHO RISK ASS HUM INF; Xu LL, 2014, J INFECT DIS, V209, P551, DOI 10.1093/infdis/jit474; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	21	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115725	10.1371/journal.pone.0115725	http://dx.doi.org/10.1371/journal.pone.0115725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671696	Green Published, Green Submitted, gold			2022-12-27	WOS:000349545300013
J	Mitteroecker, P; Windhager, S; Muller, GB; Schaefer, K				Mitteroecker, Philipp; Windhager, Sonja; Mueller, Gerd B.; Schaefer, Katrin			The Morphometrics of "Masculinity" in Human Faces	PLOS ONE			English	Article							4TH DIGIT RATIO; SEXUAL-DIMORPHISM; MENSTRUAL-CYCLE; GEOMETRIC MORPHOMETRICS; FACIAL MASCULINITY; SYMMETRY; TESTOSTERONE; PREFERENCES; ALLOMETRY; SHAPE	In studies of social inference and human mate preference, a wide but inconsistent array of tools for computing facial masculinity has been devised. Several of these approaches implicitly assumed that the individual expression of sexually dimorphic shape features, which we refer to as maleness, resembles facial shape features perceived as masculine. We outline a morphometric strategy for estimating separately the face shape patterns that underlie perceived masculinity and maleness, and for computing individual scores for these shape patterns. We further show how faces with different degrees of masculinity or maleness can be constructed in a geometric morphometric framework. In an application of these methods to a set of human facial photographs, we found that shape features typically perceived as masculine are wide faces with a wide inter-orbital distance, a wide nose, thin lips, and a large and massive lower face. The individual expressions of this combination of shape features-the masculinity shape scores-were the best predictor of rated masculinity among the compared methods (r = 0.5). The shape features perceived as masculine only partly resembled the average face shape difference between males and females (sexual dimorphism). Discriminant functions and Procrustes distances to the female mean shape were poor predictors of perceived masculinity.	[Mitteroecker, Philipp; Mueller, Gerd B.] Univ Vienna, Dept Theoret Biol, A-1090 Vienna, Austria; [Windhager, Sonja; Schaefer, Katrin] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria	University of Vienna; University of Vienna	Mitteroecker, P (corresponding author), Univ Vienna, Dept Theoret Biol, Althanstr 14, A-1090 Vienna, Austria.	philipp.mitteroecker@univie.ac.at	Windhager, Sonja/K-7618-2013; Schaefer, Katrin/G-8632-2011; Mitteroecker, Philipp/A-1591-2012	Windhager, Sonja/0000-0003-1809-8678; Schaefer, Katrin/0000-0002-0173-3092; Mitteroecker, Philipp/0000-0002-5308-3837	Open Access Publishing Fund of the University of Vienna; University of Vienna	Open Access Publishing Fund of the University of Vienna; University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna, which is covering the publication costs. This research was supported by the Focus of Excellence grant "Biometrics of EvoDevo" and the Emerging Field grant "Comparative Human Life History: A Multilevel Approach" from the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein FL, 1991, MORPHOMETRIC TOOLS F; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; Burriss RP, 2007, ARCH SEX BEHAV, V36, P377, DOI 10.1007/s10508-006-9136-1; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DeBruine LM, 2010, J EXP PSYCHOL HUMAN, V36, P751, DOI 10.1037/a0016457; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Little AC, 2008, PERS INDIV DIFFER, V45, P478, DOI 10.1016/j.paid.2008.05.024; Mardia K, 1979, MULTIVARIATE ANALYSI; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1987, SYST ZOOL, V36, P356, DOI 10.2307/2413400; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Sanchez-Pages S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112157; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; Schaefer K, 2004, ANN ANAT, V186, P471, DOI 10.1016/S0940-9602(04)80086-4; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Sforza C, 2013, J ANTHROPOL SCI, V91, P159, DOI [10.4436/jass.91007, 10.4436/JASS.91007]; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; Sylvester AD, 2008, AM J PHYS ANTHROPOL, V137, P371, DOI 10.1002/ajpa.20880; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Wade TJ., 2004, J BLACK PSYCHOL, V30, P477, DOI [10.1177/0095798403260726, DOI 10.1177/0095798403260726]; Windhager S, 2012, EVOL HUM BEHAV, V33, P109, DOI 10.1016/j.evolhumbehav.2011.06.003; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Zollikofer CPE, 2002, P ROY SOC B-BIOL SCI, V269, P801, DOI 10.1098/rspb.2002.1960	54	43	43	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118374	10.1371/journal.pone.0118374	http://dx.doi.org/10.1371/journal.pone.0118374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671667	gold, Green Published			2022-12-27	WOS:000349545300093
J	Roubova, V; Konecna, M; Smilauer, P; Wallner, B				Roubova, Veronika; Konecna, Martina; Smilauer, Petr; Wallner, Bernard			Whom to Groom and for What? Patterns of Grooming in Female Barbary Macaques (Macaca sylvanus)	PLOS ONE			English	Article							JAPANESE MACAQUES; AGONISTIC SUPPORT; RELATIONSHIP QUALITY; RECIPROCAL ALTRUISM; BIOLOGICAL MARKETS; DOMINANCE STYLE; SOCIAL RANK; PRIMATES; METAANALYSIS; INTERCHANGE	Grooming is one of the most conspicuous social interactions among nonhuman primates. The selection of grooming partners can provide important clues about factors relevant for the distribution of grooming within a social group. We analyzed grooming behavior among 17 semi-free ranging female Barbary macaques (Macaca sylvanus). We tested whether grooming is related to kinship, rank and friendship. Furthermore, we tested whether grooming is reciprocated or exchanged for rank related benefits (i.e. lower aggression and increased tolerance whilst feeding). We found that in general grooming was reciprocally exchanged, directed up the hierarchy and at the same time affected by friendship and kinship. Grooming was more frequent among individuals with higher friendship values as well as amongst related individuals. We also divided our data set on the basis of rank difference and tested if different power asymmetries between individuals affected the tendency to exchange grooming for rank related benefits and grooming reciprocation. In support of our initial hypothesis our results show that the reciprocation of grooming was a significant predictor of grooming interactions between individuals of similar rank, but not between those individuals more distantly separated in the social hierarchy. However, we did not find any evidence for grooming being exchanged for rank related benefits in either data set. Our results, together with previously published studies, illustrate the behavioral flexibility of macaques. It is clear that multiple studies of the same species are necessary to gather the data required for the solid comparative studies needed to shed light on patterns of grooming behavior in primates.	[Roubova, Veronika; Konecna, Martina] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Smilauer, Petr] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Wallner, Bernard] Univ Vienna, Dept Anthropol, Vienna, Austria	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; University of Vienna	Roubova, V (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	veronikaroubova@centrum.cz	Konecna, Martina/D-7724-2016; Smilauer, Petr/D-7277-2016; Šmilauer, Petr/N-8313-2019; Wallner, Bernard/B-1089-2009	Konecna, Martina/0000-0002-2650-1597; Smilauer, Petr/0000-0003-3065-5721; Šmilauer, Petr/0000-0003-3065-5721; 	Czech-Austrian Aktion Program for Cooperation in Science and Education [50p13, 53p6]; Grant Agency of the University of South Bohemia GAJU N [159/2013/P]	Czech-Austrian Aktion Program for Cooperation in Science and Education; Grant Agency of the University of South Bohemia GAJU N	This work was supported by Czech-Austrian Aktion Program for Cooperation in Science and Education in 2008 (Project 50p13) and in 2009 (Project 53p6) (MK, BW), Zdenek Veselovsky student prize from CSEtS (VR, MK) and Team Grant of the Grant Agency of the University of South Bohemia GAJU N. No. 159/2013/P (VR, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Balasubramaniam KN, 2011, AM J PRIMATOL, V73, P1269, DOI 10.1002/ajp.20999; Bates D, 2014, LME4 1 0 6 LINEAR MI; Bayly KL, 2006, BEHAV PROCESS, V73, P1, DOI 10.1016/j.beproc.2006.01.011; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Call J, 1999, ANIM BEHAV, V58, P165, DOI 10.1006/anbe.1999.1116; Carne C, 2011, AM J PRIMATOL, V73, P1127, DOI 10.1002/ajp.20979; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Cords M, 2002, BEHAVIOUR, V139, P291, DOI 10.1163/156853902760102681; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; DOLHINOW P, 1978, Primates, V19, P449, DOI 10.1007/BF02373308; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemelrijk CK, 1998, BEHAV ECOL SOCIOBIOL, V42, P207, DOI 10.1007/s002650050432; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hinde RA, 1978, J SOC BIOL STRUCT, V1, P27, DOI [10.1016/0140-1750(78)90016-7, DOI 10.1016/0140-1750(78)90016-7]; JARAM Van Hooff, 1987, MAN WOLF, P219; Konecna M, 2012, J RES PERS, V46, P581, DOI 10.1016/j.jrp.2012.06.004; KUSTER J, 1984, FOLIA PRIMATOL, V43, P69, DOI 10.1159/000156173; Macdonald S, 2013, INT J PRIMATOL, V34, P571, DOI 10.1007/s10764-013-9680-1; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028826; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026893; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Schino G, 2005, PRIMATES, V46, P207, DOI 10.1007/s10329-004-0124-6; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2008, BIOL J LINN SOC, V95, P439, DOI 10.1111/j.1095-8312.2008.01067.x; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Semple S, 2013, ETHOLOGY, V119, P779, DOI 10.1111/eth.12119; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Xia DP, 2012, AM J PRIMATOL, V74, P569, DOI 10.1002/ajp.21985; Zhang P, 2014, PRIMATES, V55, P69, DOI 10.1007/s10329-013-0370-6	49	17	17	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117298	10.1371/journal.pone.0117298	http://dx.doi.org/10.1371/journal.pone.0117298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668722	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000017
J	Rewicz, T; Wattier, R; Grabowski, M; Rigaud, T; Bacela-Spychalska, K				Rewicz, Tomasz; Wattier, Remi; Grabowski, Michal; Rigaud, Thierry; Bacela-Spychalska, Karolina			Out of the Black Sea: Phylogeography of the Invasive Killer Shrimp Dikerogammarus villosus across Europe	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; POPULATION-GENETICS; PREDATORY IMPACT; INTRASPECIFIC HYBRIDIZATION; INTERFERENCE COMPETITION; MULTIPLE SOURCES; RANGE EXTENSION; NORTH-AMERICA; F-STATISTICS; ZEBRA MUSSEL	The amphipod Dikerogammarus villosus has colonized most of the European main inland water bodies in less than 20 years, having deteriorating effect on the local benthic communities. Our aim was to reveal the species phylogeography in the native Black Sea area, to define the source populations for the colonization routes in continental Europe and for the newly established UK populations. We tested for the loss of genetic diversity between source and invasive populations as well as along invasion route. We tested also for isolation by distance. Thirty three native and invasive populations were genotyped for mtDNA (COI, 16S) and seven polymorphic nuclear microsatellites to assess cryptic diversity (presence of deeply divergent lineages), historical demography, level of diversity within lineage (e.g., number of alleles), and population structure. A wide range of methods was used, including minimum spanning network, molecular clock, Bayesian clustering and Mantel test. Our results identified that sea level and salinity changes during Pleistocene impacted the species phylogeography in the Black Sea native region with four differentiated populations inhabiting, respectively, the Dnieper, Dniester, Danube deltas and Durungol liman. The invasion of continental Europe is associated with two sources, i.e., the Danube and Dnieper deltas, which gave origin to two independent invasion routes (Western and Eastern) for which no loss of diversity and no isolation by distance were observed. The UK population has originated in the Western Route and, despite very recent colonization, no drastic loss of diversity was observed. The results show that the invasion of the killer shrimp is not associated with the costs of loosing genetic diversity, which may contribute to the success of this invader in the newly colonized areas. Additionally, while it has not yet occurred, it might be expected that future interbreeding between the genetically diversified populations from two independent invasion routes will potentially even enhance this success.	[Rewicz, Tomasz; Grabowski, Michal; Bacela-Spychalska, Karolina] Univ Lodz, Dept Invertebrate Zool & Hydrobiol, Lod, Poland; [Wattier, Remi; Rigaud, Thierry] Univ Bourgogne, Equipe Ecol Evolut, UMR CNRS Biogeosci 6282, Dijon, France	University of Lodz; Universite de Bourgogne	Rewicz, T (corresponding author), Univ Lodz, Dept Invertebrate Zool & Hydrobiol, Lod, Poland.	tomek.rewicz@gmail.com	Wattier, Remi/ABC-3410-2021; Bacela-Spychalska, Karolina/E-4234-2015; Rigaud, Thierry/T-4053-2017; Rewicz, Tomasz/H-5332-2018; Rigaud, Thierry/ABE-2552-2020; Grabowski, Michal/K-1016-2012	Bacela-Spychalska, Karolina/0000-0003-4498-5107; Rigaud, Thierry/0000-0002-0163-6639; Rewicz, Tomasz/0000-0002-2085-4973; Rigaud, Thierry/0000-0002-0163-6639; Grabowski, Michal/0000-0002-4551-3454	Polish Ministry for Science and Higher Education [NN304081535, NN304350139, N N303 579439]; Region Bourgogne [07HCP 59]; French Foreign Office [604506E]	Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); Region Bourgogne(Region Bourgogne-Franche-Comte); French Foreign Office	The study was funded within the Polish Ministry for Science and Higher Education grants: sampling (NN304081535, NN304350139, N N303 579439), molecular analysis (NN304350139). Karolina Bacela-Spychalska was funded by a postdoctoral grant from the Region Bourgogne (grant #07HCP 59) and from the French Foreign Office (Programe Egide, grant # 604506E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency E, 2012, INVASIVE SHRIMP DIKE, V5, P1; Anderson LG, 2014, PLOS ONE, P9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Audzijonyte A, 2009, DIVERS DISTRIB, V15, P346, DOI 10.1111/j.1472-4642.2008.00541.x; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Audzijonyte A, 2006, MOL ECOL, V15, P2969, DOI 10.1111/j.1365-294X.2006.03018.x; Ayres D, 2009, BIOL INVASIONS, V11, P1087, DOI 10.1007/s10530-008-9391-2; Bacela Karolina, 2008, Aquatic Invasions, V3, P95, DOI 10.3391/ai.2008.3.1.16; Bacela-Spychalska K, 2013, AQUAT CONSERV, V23, P606, DOI 10.1002/aqc.2329; Badertscher S, 2011, NAT GEOSCI, V4, P236, DOI [10.1038/NGEO1106, 10.1038/ngeo1106]; Badtke M, 2006, KANAL BYDGOSKI; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Benvenuto C, 2012, EVOL ECOL, V26, P1311, DOI 10.1007/s10682-011-9553-z; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Boets P, 2013, RIVER RES APPL; Bollache L, 2004, ARCH HYDROBIOL, V160, P57, DOI 10.1127/0003-9136/2004/0160-0057; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brooks SJ, 2008, FUND APPL LIMNOL, V172, P183, DOI 10.1127/1863-9135/2008/0172-0183; Brown JE, 2008, MOL ECOL, V17, P2598, DOI 10.1111/j.1365-294X.2008.03777.x; Bruijs MCM, 2001, ARCH HYDROBIOL, V152, P633; Casellato Sandra, 2007, V2, P495; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cristescu MEA, 2004, HEREDITY, V92, P197, DOI 10.1038/sj.hdy.6800395; Cristescu MEA, 2003, MOL ECOL, V12, P985, DOI 10.1046/j.1365-294X.2003.01801.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Devin S, 2004, INT REV HYDROBIOL, V89, P21, DOI 10.1002/iroh.200310667; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Diez-del-Molino D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dumont HJ, 2000, ADV ECOL RES, V31, P181, DOI 10.1016/S0065-2504(00)31012-1; Dybdahl MF, 2011, BIOL INVASIONS, V13, P1663, DOI 10.1007/s10530-010-9923-4; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2013, ECOL APPL, V23, P352, DOI 10.1890/12-1018.1; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grabowski Michal, 2007, Aquatic Invasions, V2, P25; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Grabowski M, 2012, AQUAT INVASIONS, V7, P337, DOI 10.3391/ai.2012.7.3.005; Grabowski M, 2009, BIOL INVASIONS, V11, P2107, DOI 10.1007/s10530-009-9502-8; Hassan M, 2005, J FISH BIOL, V66, P865, DOI 10.1111/j.0022-1112.2005.00643.x; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Hou ZG, 2014, ZOOL J LINN SOC-LOND, V170, P591, DOI 10.1111/zoj.12119; Hupalo Kamil, 2014, Lauterbornia, V77, P9; Jazdzewski K., 1980, Crustaceana Supplement (Leiden), P84; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Konikov E, 2007, QUATERN INT, V167, P49, DOI 10.1016/j.quaint.2006.11.012; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; Larson ER, 2012, FRESHWATER BIOL, V57, P1823, DOI 10.1111/j.1365-2427.2012.02841.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luquet E, 2011, BIOL INVASIONS, V13, P1901, DOI 10.1007/s10530-011-0010-2; MacNeil C, 2005, J ZOOL, V267, P31, DOI 10.1017/S0952836905007351; Macneil C, 2013, AQUAT CONSERV, V23, P667, DOI 10.1002/aqc.2337; MacNeil C, 2013, FRESHWATER BIOL, V58, P171, DOI 10.1111/fwb.12048; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Mamos T, 2014, J ZOOL SYST EVOL RES, V52, P237, DOI 10.1111/jzs.12062; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; Meraner A, 2013, MOL ECOL, V22, P5295, DOI 10.1111/mec.12470; Mordukhai-Boltovskoi F.D., 1960, CASPIAN FAUNA AZOV B; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Muller JC, 2002, FRESHWATER BIOL, V47, P2039, DOI 10.1046/j.1365-2427.2002.00944.x; Nahavandi N, 2013, MOL PHYLOGENET EVOL, V69, P1063, DOI 10.1016/j.ympev.2013.05.021; Nei M., 2000, MOL EVOLUTION PHYLOG; Neilson ME, 2011, DIVERS DISTRIB, V17, P688, DOI 10.1111/j.1472-4642.2011.00762.x; Ohayon JL, 2007, J FISH BIOL, V71, P360, DOI 10.1111/j.1095-8649.2007.01659.x; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Pilgrim EM, 2013, BIOL INVASIONS, V15, P2415, DOI 10.1007/s10530-013-0462-7; Piscart C, 2011, LIMNOLOGICA, V41, P107, DOI 10.1016/j.limno.2010.09.002; Pockl M, 2007, FRESHWATER BIOL, V52, P50, DOI 10.1111/j.1365-2427.2006.01671.x; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Popescu I, 2004, MAR GEOL, V206, P249, DOI 10.1016/j.margeo.2004.03.003; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rewicz T, 2014, MOL BIOL RE IN PRESS; Rewicz T, 2014, AQUAT INVASIONS, V9, P267, DOI 10.3391/ai.2014.9.3.04; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Richardson DM, 2013, DIVERS DISTRIB, V19, P1461, DOI 10.1111/ddi.12150; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 1997, GENETICS, V145, P1219; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Slothouber Galbreath JGM, 2010, BIOL INVASIONS, V12, P191, DOI 10.1007/s10530-009-9442-3; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tompkins DM, 2006, ECOL STU AN, V186, P67; van Riel MC, 2006, HYDROBIOLOGIA, V565, P39, DOI 10.1007/s10750-005-1904-8; van Riel MC, 2009, BIOL INVASIONS, V11, P2119, DOI 10.1007/s10530-009-9486-4; van Riel MC, 2007, ACTA OECOL, V31, P282, DOI 10.1016/j.actao.2006.12.006; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Wattier RA, 2006, MOL ECOL NOTES, V6, P487, DOI 10.1111/j.1471-8286.2006.01283.x; Wattier RA, 2007, OIKOS, V116, P1941, DOI [10.1111/j.2007.0030-1299.15921.x, 10.1111/j.0030-1299.2007.15921.x]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wijnhoven S, 2003, AQUAT ECOL, V37, P151, DOI 10.1023/A:1023982200529; Wysocka A, 2014, J BIOGEOGR, V41, P1758, DOI 10.1111/jbi.12335; Zaiko A, 2009, HELGOLAND MAR RES, V63, P85, DOI 10.1007/s10152-008-0135-6; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x	111	55	56	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118121	10.1371/journal.pone.0118121	http://dx.doi.org/10.1371/journal.pone.0118121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692865	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500099
J	Waghela, BN; Sharma, A; Dhumale, S; Pandey, SM; Pathak, C				Waghela, Bhargav N.; Sharma, Anupama; Dhumale, Suhashini; Pandey, Shashibahl M.; Pathak, Chandramani			Curcumin Conjugated with PLGA Potentiates Sustainability, Anti-Proliferative Activity and Apoptosis in Human Colon Carcinoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; I CLINICAL-TRIAL; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; INHIBITS GROWTH; GENE-EXPRESSION; BIOAVAILABILITY; PROLIFERATION; SUPPRESSION	Curcumin, an ingredient of turmeric, exhibits a variety of biological activities such as anti-inflammatory, anti-atherosclerotic, anti-proliferative, anti-oxidant, anti-cancer and anti-metastatic. It is a highly pleiotropic molecule that inhibits cell proliferation and induces apoptosis in cancer cells. Despite its imperative biological activities, chemical instability, photo-instability and poor bioavailability limits its utilization as an effective therapeutic agent. Therefore, enhancing the bioavailability of curcumin may improve its therapeutic index for clinical setting. In the present study, we have conjugated curcumin with a biodegradable polymer Poly (D, L-lactic-co-glycolic acid) and evaluated its apoptotic potential in human colon carcinoma cells (HCT 116). The results show that curcumin-PLGA conjugate efficiently inhibits cell proliferation and cell survival in human colon carcinoma cells as compared to native curcumin. Additionally, curcumin conjugated with PLGA shows improved cellular uptake and exhibits controlled release at physiological pH as compared to native curcumin. The curcumin-PLGA conjugate efficiently activates the cascade of caspases and promotes intrinsic apoptotic signaling. Thus, the results suggest that conjugation potentiates the sustainability, anti-proliferative and apoptotic activity of curcumin. This approach could be a promising strategy to improve the therapeutic index of cancer therapy.	[Waghela, Bhargav N.; Sharma, Anupama; Dhumale, Suhashini; Pathak, Chandramani] Indian Inst Adv Res, Dept Cell Biol, Gandhinagar, Gujarat, India; [Pandey, Shashibahl M.] Smt CHM Coll, Dept Zool, Ulhasnagar, Maharashtra, India		Pathak, C (corresponding author), Indian Inst Adv Res, Dept Cell Biol, Gandhinagar, Gujarat, India.	cmpathak@iiar.res.in	Pathak, Chandramani/E-4662-2016	Pathak, Chandramani/0000-0002-9389-8096	Department of Biotechnology, Ministry of Science & Technology, Government of India	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by grants from the Department of Biotechnology, Ministry of Science & Technology, Government of India.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Archana S, 2012, NANOSTRUCTURE SCI TE, P9; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Chen QY, 2010, ONCOL REP, V23, P397, DOI 10.3892/or_00000648; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hu M, 2007, MOL PHARMACEUT, V4, P803, DOI 10.1021/mp7001363; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lev-Ari S, 2014, J NUTR BIOCHEM, V25, P843, DOI 10.1016/j.jnutbio.2014.03.014; Liang T, 2014, INT J MOL SCI, V15, P15754, DOI 10.3390/ijms150915754; Mackenzie GG, 2008, INT J CANCER, V123, P56, DOI 10.1002/ijc.23477; Manju S, 2011, J COLLOID INTERF SCI, V359, P318, DOI 10.1016/j.jcis.2011.03.071; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Nair KL, 2012, INT J PHARMACEUT, V425, P44, DOI 10.1016/j.ijpharm.2012.01.003; Park S, 2013, MOL CELL BIOCHEM, V383, P39, DOI 10.1007/s11010-013-1752-1; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Ranjan K, 2014, BIOFACTORS, V40, P157, DOI 10.1002/biof.1098; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shankar Sharmila, 2007, J Mol Signal, V2, P10, DOI 10.1186/1750-2187-2-10; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, DRUG TODAY, V46, P523, DOI 10.1358/dot.2010.46.7.1509560; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Simon A, 1998, CANCER LETT, V129, P111, DOI 10.1016/S0304-3835(98)00092-5; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Sung B, 2009, MOL CANCER THER, V8, P959, DOI 10.1158/1535-7163.MCT-08-0905; Tang HD, 2010, BIOMATERIALS, V31, P7139, DOI 10.1016/j.biomaterials.2010.06.007; Watson JL, 2010, CANCER LETT, V297, P1, DOI 10.1016/j.canlet.2010.04.018; Wright JS, 2002, J MOL STRUC-THEOCHEM, V591, P10; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86; Zikaki K, 2014, APOPTOSIS, V19, P958, DOI 10.1007/s10495-014-0979-y	45	52	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117526	10.1371/journal.pone.0117526	http://dx.doi.org/10.1371/journal.pone.0117526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692854	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500059
J	Baghdadi, LR; Woodman, RJ; Shanahan, EM; Mangoni, AA				Baghdadi, Leena R.; Woodman, Richard J.; Shanahan, E. Michael; Mangoni, Arduino A.			The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POPULATION-BASED COHORT; FACTOR-ALPHA THERAPY; MYOCARDIAL-INFARCTION; LIPID PROFILES; COLLABORATIVE METAANALYSIS; DIABETES-MELLITUS; HEALTHY-SUBJECTS; BLOOD-PRESSURE; MORTALITY	Background Rheumatoid arthritis (RA) is known to increase the risk of cardiovascular (CV) disease. However, the individual impact of traditional CV risk factors in RA is unknown. Objective To assess the strength of the association between individual CV risk factors and rate of either myocardial infarction (MI), combined CV morbidity (MI, angina pectoris, heart failure, stroke, and peripheral arterial disease (PAD)) or CV mortality in RA patients. Methods RA studies reporting traditional CV risk factors [hypertension, type 2 diabetes (T2D), smoking, hypercholesterolaemia, obesity, and physical inactivity] as exposures and MI, CV morbidity (MI, angina, heart failure, stroke, and PAD combined) or CV mortality alone as outcomes were searched until March 2013 using MEDLINE, Scopus and Cochrane. Meta-analyses combined relative risk (RR) estimates from each study where either the RR and 95% confidence intervals or where raw counts were available. Results Ten studies reporting sufficient data for inclusion into meta-analyses were identified. Relevant data was available for each risk factor and MI and CV morbidity but no studies reported on CV mortality. Risk of MI increased in RA patients with hypertension (RR 1.84, 95% CI 1.38, 2.46) and T2D (RR 1.89, 95% CI 1.36, 2.63). CV morbidity increased with hypertension (RR 2.24, 95% CI 1.42, 3.06), T2D (RR 1.94, 95% CI 1.58, 2.30), smoking (RR 1.50, 95% CI 1.15, 1.84), hypercholesterolaemia (RR 1.73, 95% CI 1.03, 2.44) and obesity (RR 1.16, 95% CI 1.03, 1.29) but not with physical inactivity (RR 1.00, 95% CI 0.71, 1.29). Conclusion Hypertension, T2D, smoking, hypercholesterolaemia and obesity increased CV risk in patients with RA. These results highlight the importance of managing CV risk factors in RA, similarly to non-RA patients.	[Baghdadi, Leena R.] King Saud Univ, Dept Family & Community Med, Riyadh, Saudi Arabia; [Baghdadi, Leena R.; Mangoni, Arduino A.] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA 5001, Australia; [Shanahan, E. Michael] Flinders Univ S Australia, Sch Med, Dept Rheumatol, Adelaide, SA 5001, Australia	King Saud University; Flinders University South Australia; Flinders University South Australia	Mangoni, AA (corresponding author), Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA 5001, Australia.	arduino.mangoni@flinders.edu.au	Mangoni, Arduino Aleksander/I-5109-2019; Shanahan, Michael/ABE-5543-2020; Baghdadi, Leena R./ABC-8527-2020	Mangoni, Arduino Aleksander/0000-0001-8699-1412; Baghdadi, Leena R./0000-0003-3315-6266; Woodman, Richard/0000-0002-4094-1222				Ajeganova S, 2013, J RHEUMATOL, V15, P15; Ajeganova S, 2013, ARTHRIT CARE RES, V65, P78, DOI 10.1002/acr.21710; Arts EE, 2014, ANN RHEUM DIS, V23, P2013; Assous N, 2007, JOINT BONE SPINE, V74, P66, DOI 10.1016/j.jbspin.2006.10.001; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Baghdadi LR, 2012, REPROD BIOMED ONLINE, V25, P227, DOI 10.1016/j.rbmo.2012.05.010; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Boyer JF, 2011, JOINT BONE SPINE, V78, P179, DOI 10.1016/j.jbspin.2010.07.016; Brady SRE, 2009, J RHEUMATOL, V36, P34, DOI 10.3899/jrheum.080404; Carmona L, 2007, ANN RHEUM DIS, V66, P880, DOI 10.1136/ard.2006.067660; Choi HK, 2005, J RHEUMATOL, V32, P2311; Choi HK, 2014, NAT REV RHEUMATOL, V10, P403, DOI 10.1038/nrrheum.2014.36; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Davis JM, 2007, ARTHRITIS RHEUM-US, V56, P820, DOI 10.1002/art.22418; de Jong Z, 2004, ANN RHEUM DIS, V63, P1399, DOI 10.1136/ard.2003.015826; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; EKDAHL C, 1992, ANN RHEUM DIS, V51, P35, DOI 10.1136/ard.51.1.35; Eurenius E, 2005, ARTHRIT RHEUM-ARTHR, V53, P48, DOI 10.1002/art.20924; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gabriel SE, 2012, CURR OPIN RHEUMATOL, V24, P171, DOI 10.1097/BOR.0b013e32834ff2fd; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Greenberg J, 2006, ARTHRITIS RHEUMATISM, V54; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; HELDENBERG D, 1983, CLIN RHEUMATOL, V2, P387, DOI 10.1007/BF02041560; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Higgins J., 2011, COCHRANE HDB SYST RE, V7, P151; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Kerekes G, 2008, J RHEUMATOL, V35, P398; Klarenbeek NB, 2010, ANN RHEUM DIS, V69, P1342, DOI 10.1136/ard.2009.124180; Koivuniemi R, 2013, SCAND J RHEUMATOL, V42, P131, DOI 10.3109/03009742.2012.723747; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Kremers HM, 2004, ARTHRITIS RHEUM-US, V50, P3450, DOI 10.1002/art.20612; LAKATOS J, 1988, CLIN BIOCHEM, V21, P93, DOI 10.1016/S0009-9120(88)80094-8; Lewis SJ, 2003, BIOMARKERS, V8, P218, DOI 10.1080/1354750031000120125; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; McEntegart A, 2001, RHEUMATOLOGY, V40, P640, DOI 10.1093/rheumatology/40.6.640; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Metsios GS, 2009, CLIN EXP RHEUMATOL, V27, P985; Metsios GS, 2009, EUR J CARDIOV PREV R, V16, P188, DOI 10.1097/HJR.0b013e3283271ceb; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Mohammad A, 2010, IRISH J MED SCI, V179, P273, DOI 10.1007/s11845-010-0475-5; Nadareishvili Z, 2008, ARTHRIT RHEUM-ARTHR, V59, P1090, DOI 10.1002/art.23935; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Pais PS, 2006, J HYPERTENS, V24, pS25, DOI 10.1097/01.hjh.0000220100.50272.b0; Panoulas VF, 2008, RHEUMATOLOGY, V47, P1286, DOI 10.1093/rheumatology/ken159; Panoulas VF, 2007, RHEUMATOLOGY, V46, P1477, DOI 10.1093/rheumatology/kem169; Park YB, 1999, J RHEUMATOL, V26, P1701; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Radovits BJ, 2009, ANN RHEUM DIS, V68, P1271, DOI 10.1136/ard.2008.089862; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Serelis J, 2011, J RHEUMATOL, V38, P236, DOI 10.3899/jrheum.100564; Singh G, 2003, J RHEUMATOL, V30, P714; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Steiner G, 2009, SEMIN ARTHRITIS RHEU, V38, P372, DOI 10.1016/j.semarthrit.2008.01.015; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Suissa S, 2006, ARTHRIT RHEUM-ARTHR, V55, P531, DOI 10.1002/art.22094; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; Wolfe F, 2000, J RHEUMATOL, V27, P630; Wolfe F, 2003, J RHEUMATOL, V30, P36; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	74	129	140	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117952	10.1371/journal.pone.0117952	http://dx.doi.org/10.1371/journal.pone.0117952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689371	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700089
J	Deuschl, C; Goricke, S; Gramsch, C; Ozkan, N; Lehnerdt, G; Kastrup, O; Ringelstein, A; Wanke, I; Forsting, M; Schlamann, M				Deuschl, Cornelius; Goericke, Sophia; Gramsch, Carolin; Oezkan, Neriman; Lehnerdt, Goetz; Kastrup, Oliver; Ringelstein, Adrian; Wanke, Isabel; Forsting, Michael; Schlamann, Marc			Value of DSA in the Diagnostic Workup of Pulsatile Tinnitus	PLOS ONE			English	Article							DURAL ARTERIOVENOUS-FISTULAS; MR-ANGIOGRAPHY; VENOUS DRAINAGE; CLASSIFICATION; MALFORMATIONS; EXPERIENCE	Objectives Pulsatile tinnitus (PT) is a rare complaint, but can be a symptom of life-threatening disease. It is often caused by vascular pathologies, e.g. dural arteriovenous fistula (dAVF), arteriovenous malformation (AVM) or vascularized tumors. The current diagnostic pathway includes clinical examination, cranial MRI and additional DSA. The aim of this study was to evaluate the diagnostic impact of DSA in the diagnostic workup of patients with PT in comparison to MRI alone. Methods Retrospectively, 54 consecutive patients with pulsatile tinnitus were evaluated. All patients had a diagnostic workup including cranial MRI and DSA. MRI examinations were blinded to the results of DSA and retrospectively analyzed in consensus by two experienced neuroradiologists. The MR-examinations were evaluated for each performed sequence separately: time-of-flight-angiography, ce-MRA, T2, ce-T1-sequence and ce-T1-sequence with fat saturation. Results 37 of the 54 patients revealed a pathology explaining PT on MRI, which was detected by the readers in 100% and proofed by means of DSA. 24 dAVF, four paraganglioma, two AVM and seven more pathologies were described. All patients without pathology on MRI did also not show any pathology in DSA. Conclusions MR imaging is sufficient to exclude pathology in patients with pulsatile tinnitus.	[Deuschl, Cornelius; Goericke, Sophia; Gramsch, Carolin; Ringelstein, Adrian; Wanke, Isabel; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Oezkan, Neriman] Univ Hosp Essen, Clin Neurosurg, Essen, Germany; [Lehnerdt, Goetz] Univ Hosp Essen, Clin Otolaryngol, Essen, Germany; [Kastrup, Oliver] Univ Hosp Essen, Neurol Clin, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Deuschl, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Cornelius.Deuschl@uk-essen.de						BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; COCHRAN JH, 1979, ANN OTO RHINOL LARYN, V88, P297, DOI 10.1177/000348947908800226; COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; DIETZ RR, 1994, AM J NEURORADIOL, V15, P879; Farb RI, 2009, AM J NEURORADIOL, V30, P1546, DOI 10.3174/ajnr.A1646; Geibprasert S, 2009, AM J NEURORADIOL, V30, P1459, DOI 10.3174/ajnr.A1500; Hofmann E, 2013, DTSCH ARZTEBL INT, V110, P451, DOI 10.3238/arztebl.2013.0451; JUNGREIS CA, 1991, ANN OTO RHINOL LARYN, V100, P951, DOI 10.1177/000348949110001116; Letourneau-Guillon L, 2012, AM J NEURORADIOL, V33, P301, DOI 10.3174/ajnr.A2777; Madani G, 2009, CLIN RADIOL, V64, P319, DOI 10.1016/j.crad.2008.08.014; Mattox DE, 2008, ACTA OTO-LARYNGOL, V128, P427, DOI 10.1080/00016480701840106; Meckel S, 2007, AM J NEURORADIOL, V28, P877; Noguchi K, 2010, AM J NEURORADIOL, V31, P1903, DOI 10.3174/ajnr.A2231; REMLEY KB, 1990, RADIOLOGY, V174, P383, DOI 10.1148/radiology.174.2.2296650; Saini J, 2009, AJNR Am J Neuroradiol, V30, pE6, DOI 10.3174/ajnr.A1265; Seeger A, 2014, CLIN NEURORADIOL, DOI [10.1007/s00062-014-0358-7, DOI 10.1007/S00062-014-0358-7]; SILA CA, 1987, STROKE, V18, P252, DOI 10.1161/01.STR.18.1.252; SISMANIS A, 1994, LARYNGOSCOPE, V104, P681; Sismanis A, 1998, AM J OTOL, V19, P472; Soderman M, 2008, STROKE, V39, P1735, DOI 10.1161/STROKEAHA.107.506485; Waldvogel D, 1998, J NEUROL, V245, P137, DOI 10.1007/s004150050193; Wu HM, 2014, J MAGN RESON IMAGING, V39, P1320, DOI 10.1002/jmri.24279; YARDLEY MPJ, 1992, BRIT J CLIN PRACT, V46, P71	23	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117814	10.1371/journal.pone.0117814	http://dx.doi.org/10.1371/journal.pone.0117814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689158	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700074
J	Iftikhar, S; Khan, S; Anwar, Z; Kamran, M				Iftikhar, Saman; Khan, Sharifullah; Anwar, Zahid; Kamran, Muhammad			GenInfoGuard-A Robust and Distortion-Free Watermarking Technique for Genetic Data	PLOS ONE			English	Article								Genetic data, in digital format, is used in different biological phenomena such as DNA translation, mRNA transcription and protein synthesis. The accuracy of these biological phenomena depend on genetic codes and all subsequent processes. To computerize the biological procedures, different domain experts are provided with the authorized access of the genetic codes; as a consequence, the ownership protection of such data is inevitable. For this purpose, watermarks serve as the proof of ownership of data. While protecting data, embedded hidden messages (watermarks) influence the genetic data; therefore, the accurate execution of the relevant processes and the overall result becomes questionable. Most of the DNA based watermarking techniques modify the genetic data and are therefore vulnerable to information loss. Distortion-free techniques make sure that no modifications occur during watermarking; however, they are fragile to malicious attacks and therefore cannot be used for ownership protection (particularly, in presence of a threat model). Therefore, there is a need for a technique that must be robust and should also prevent unwanted modifications. In this spirit, a watermarking technique with aforementioned characteristics has been proposed in this paper. The proposed technique makes sure that: (i) the ownership rights are protected by means of a robust watermark; and (ii) the integrity of genetic data is preserved. The proposed technique-GenInfoGuard-ensures its robustness through the "watermark encoding" in permuted values, and exhibits high decoding accuracy against various malicious attacks.	[Iftikhar, Saman; Khan, Sharifullah; Anwar, Zahid] Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Dept Comp, Islamabad, Pakistan; [Kamran, Muhammad] COMSATS Inst Informat Technol, Dept Comp Sci, Wah Cantt, Pakistan	National University of Sciences & Technology - Pakistan; COMSATS University Islamabad (CUI)	Iftikhar, S (corresponding author), Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Dept Comp, Islamabad, Pakistan.	saman.iftikhar@seecs.edu.pk	iftikhar, saman/ABF-7473-2021; Kamran, Muhammad/H-4181-2015	Kamran, Muhammad/0000-0002-6639-5688; Anwar, Zahid/0000-0002-4608-4305				Al-Haj Ali, 2008, Journal of Computer Sciences, V4, P1024, DOI 10.3844/jcssp.2008.1024.1029; Arita M, 2004, BIOTECHNOL PROGR, V20, P1605, DOI 10.1021/bp049917i; Arita M, 2004, LECT NOTES COMPUT SC, V2950, P23; Bedi R., 2011, INT J COMPUTER APPL, V13, P37, DOI [10.5120/1790-2473, DOI 10.5120/1790-2473]; Bhattacharya S, 2009, ICSOFT 2009: PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON SOFTWARE AND DATA TECHNOLOGIES, VOL 2, P229; Chronicles TC, GENETIC IDENTITY THE; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Coatrieux G, 2011, IEEE ENG MED BIO, P8195, DOI 10.1109/IEMBS.2011.6092021; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Eschrich S, 2002, BIOKDD02 WORKSH DAT, P25; Gehani A, 2004, LECT NOTES COMPUT SC, V2950, P167; Hamadou A., 2011, INT J DIGITAL CONTEN, V5, DOI DOI 10.4156/JDCTA.VOL5.ISSUE5.21; Hamadou A, 2011, INT J DIGITAL CONTEN, V5, P148, DOI [10.4156/jdcta. vol5.issue8.17, DOI 10.4156/JDCTA.VOL5.ISSUE8.17]; Hanyurwimfura D., 2010, 2010 International Conference on Computer Design and Applications (ICCDA 2010), P312, DOI 10.1109/ICCDA.2010.5541119; Heider D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-40; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Heider D, 2011, CURR BIOINFORM, V6, P375, DOI 10.2174/157489311796904646; Khan A, 2013, SCI WORLD J, DOI 10.1155/2013/796726; Khanduja V, 2012, INT J INF ELECT ENG, V2, P274, DOI DOI 10.7763/IJIEE.2012.V2.97; Leier A, 2000, BIOSYSTEMS, V57, P13, DOI 10.1016/S0303-2647(00)00083-6; Lewitter F, RELATIONAL DATABASES; Li Y., 2004, ACM WORKSH DIG RIGHT; Lizhong Zhang, 2011, Proceedings 2011 International Conference on Mechatronic Science, Electric Engineering and Computer (MEC 2011), P1633; Mole BM, PREVENTING GENETIC D; Rajneesh K, 2011, INT J COMPUTER APPL, V36, P9; Rampone S, 1998, BIOINFORMATICS, V14, P676, DOI 10.1093/bioinformatics/14.8.676; Rouse M, CORRELATION COEFFICI; Rukhin Andrew, 2001, STAT TEST SUITE RAND; Sion R, 2005, IEEE T KNOWL DATA EN, V17, P912, DOI 10.1109/TKDE.2005.116; Sion R, 2004, PROC INT CONF DATA, P584, DOI 10.1109/ICDE.2004.1320029; Solanas A, 2006, LECT NOTES ARTIF INT, V3885, P239; Wallace JB, 2008, EFFICIENT METHOD SEA	33	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117717	10.1371/journal.pone.0117717	http://dx.doi.org/10.1371/journal.pone.0117717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689741	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700066
J	McCann, MR; Patel, P; Frimpong, A; Xiao, YZ; Siqueira, WL; Seguin, CA				McCann, Matthew R.; Patel, Priya; Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.; Seguin, Cheryle A.			Proteomic Signature of the Murine Intervertebral Disc	PLOS ONE			English	Article							HUMAN NUCLEUS PULPOSUS; CARTILAGE CELLS; GENE; DEGENERATION; EXPRESSION; MASS; SOX6; IDENTIFICATION; MICROARRAY; PHENOTYPE	Low back pain is the most common musculoskeletal problem and the single most common cause of disability, often attributed to degeneration of the intervertebral disc. Lack of effective treatment is directly related to our limited understanding of the pathways responsible for maintaining disc health. While transcriptional analysis has permitted initial insights into the biology of the intervertebral disc, complete proteomic characterization is required. We therefore employed liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) protein/peptide separation and mass spectrometric analyses to characterize the protein content of intervertebral discs from skeletally mature wild-type mice. A total of 1360 proteins were identified and categorized using PANTHER. Identified proteins were primarily intracellular/plasma membrane (35%), organelle (30%), macromolecular complex (10%), extracellular region (9%). Molecular function categorization resulted in three distinct categories: catalytic activity (33%), binding (molecule interactions) (29%), and structural activity (13%). To validate our list, we confirmed the presence of 14 of 20 previously identified IVD-associated markers, including matrix proteins, transcriptional regulators, and secreted proteins. Immunohistochemical analysis confirmed distinct localization patterns of select protein with the intervertebral disc. Characterization of the protein composition of healthy intervertebral disc tissue is an important first step in identifying cellular processes and pathways disrupted during aging or disease progression.	[McCann, Matthew R.; Patel, Priya; Seguin, Cheryle A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, Sch Dent, London, ON N6A 5C1, Canada; [Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Seguin, CA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	cheryle.seguin@schulich.uwo.ca	Seguin, Cheryle A/G-4511-2013; McCann, Matthew/V-4127-2019; Siqueira, Walter/ABE-8924-2020; Siqueira, Walter/ABE-4069-2021	Siqueira, Walter/0000-0003-1921-3658; McCann, Matthew/0000-0003-2953-6258; Seguin, Cheryle/0000-0001-6503-9107	Natural Sciences and Engineering Research Council of Canada [RGPIN-371813, 371546]; Canada Foundation for Innovation-Leaders Opportunity Fund [25086, 25116]; CIHR Doctoral Research Award; Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership; CIHR New Investigator Award; Arthritis Society/Canadian Arthritis Network	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation-Leaders Opportunity Fund; CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Arthritis Society/Canadian Arthritis Network	This work was funded by the Natural Sciences and Engineering Research Council of Canada [RGPIN-371813 to C.A.S and 371546 to W.L.S]. Infrastructure was provided by the Canada Foundation for Innovation-Leaders Opportunity Fund [25086 to C.A.S and 25116 to W.L.S.]. M.R.M. is the recipient of a CIHR Doctoral Research Award and is supported by the Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership. W.L.S. is the recipient of a CIHR New Investigator Award; C.A.S. is the recipient of a Scholar Award from The Arthritis Society/Canadian Arthritis Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balague F, 2011, LANCET; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Foster BL, 2012, INT J ORAL SCI, V4, P119, DOI 10.1038/ijos.2012.57; Friedman BW, 2012, ANN EMERG MED, V59, P128, DOI 10.1016/j.annemergmed.2011.09.012; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; JOHNSTONE B, 1993, BIOCHEM J, V292, P661, DOI 10.1042/bj2920661; Kessels MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090568; Kislinger T, 2010, J PROTEOMICS, V73, P2205, DOI 10.1016/j.jprot.2010.05.004; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1; McCann MR, 2011, J CELL COMMUN SIGNAL, V5, P39, DOI 10.1007/s12079-010-0116-9; MCCANN MR, 2011, DIS MODEL MECH; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millecamps M, 2012, PAIN, V153, P1167, DOI 10.1016/j.pain.2012.01.027; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Ohrt-Nissen S, 2013, CONNECT TISSUE RES, V54, P197, DOI 10.3109/03008207.2013.781594; Olsen CL, 1997, DEVELOPMENT, V124, P3609; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Poiraudeau S, 1999, SPINE, V24, P837, DOI 10.1097/00007632-199905010-00002; ROBERTS S, 1989, SPINE, V14, P166, DOI 10.1097/00007632-198902000-00005; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; Smith LJ, 2009, EUR SPINE J, V18, P439, DOI 10.1007/s00586-009-0918-8; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sohn P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-29; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Urban JPG, 2007, J MAGN RESON IMAGING, V25, P419, DOI 10.1002/jmri.20874; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Williams F.M., 2012, ANN RHEUM DIS; Xiang R, 2004, J PROTEOME RES, V3, P1278, DOI 10.1021/pr049852e	45	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117807	10.1371/journal.pone.0117807	http://dx.doi.org/10.1371/journal.pone.0117807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689066	Green Published, Green Submitted, gold			2022-12-27	WOS:000350322700073
J	McCrudden, CM; O'Rourke, MG; Cherry, KE; Yuen, HF; O'Rourke, D; Babur, M; Telfer, BA; Thomas, HD; Keane, P; Nambirajan, T; Hagan, C; O'Sullivan, JM; Shaw, C; Williams, KJ; Curtin, NJ; Hirst, DG; Robson, T				McCrudden, Cian M.; O'Rourke, Martin G.; Cherry, Kim E.; Yuen, Hiu-Fung; O'Rourke, Declan; Babur, Muhammad; Telfer, Brian A.; Thomas, Huw D.; Keane, Patrick; Nambirajan, Thiagarajan; Hagan, Chris; O'Sullivan, Joe M.; Shaw, Chris; Williams, Kaye J.; Curtin, Nicola J.; Hirst, David G.; Robson, Tracy			Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITORS; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE; DNA-REPAIR; NICOTINAMIDE; RADIOSENSITIZATION; AG014699; EFFICACY; MICE; CHEMOPOTENTIATION	Therapeutic inhibition of poly(ADP-ribose) polymerase (PARP), as monotherapy or to supplement the potencies of other agents, is a promising strategy in cancer treatment. We previously reported that the first PARP inhibitor to enter clinical trial, rucaparib (AG014699), induced vasodilation in vivo in xenografts, potentiating response to temozolomide. We now report that rucaparib inhibits the activity of the muscle contraction mediator myosin light chain kinase (MLCK) 10-fold more potently than its commercially available inhibitor ML-9. Moreover, rucaparib produces additive relaxation above the maximal degree achievable with ML-9, suggesting that MLCK inhibition is not solely responsible for dilation. Inhibition of nitric oxide synthesis using L-NMMA also failed to impact rucaparib's activity. Rucaparib contains the nicotinamide pharmacophore, suggesting it may inhibit other NAD+-dependent processes. NAD+ exerts P2 purinergic receptor-dependent inhibition of smooth muscle contraction. Indiscriminate blockade of the P2 purinergic receptors with suramin abrogated rucaparib-induced vasodilation in rat arterial tissue without affecting ML-9-evoked dilation, although the specific receptor subtypes responsible have not been unequivocally identified. Furthermore, dorsal window chamber and real time tumor vessel perfusion analyses in PARP-1(-/-) mice indicate a potential role for PARP in dilation of tumor-recruited vessels. Finally, rucaparib provoked relaxation in 70% of patient-derived tumor-associated vessels. These data provide tantalising evidence of the complexity of the mechanism underlying rucaparib-mediated vasodilation.	[McCrudden, Cian M.; O'Rourke, Martin G.; Cherry, Kim E.; Hirst, David G.; Robson, Tracy] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Yuen, Hiu-Fung; O'Sullivan, Joe M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [O'Rourke, Declan; Keane, Patrick; Nambirajan, Thiagarajan; Hagan, Chris; O'Sullivan, Joe M.] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Babur, Muhammad; Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [Thomas, Huw D.; Curtin, Nicola J.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Queens University Belfast; Queens University Belfast; University of Manchester; Newcastle University - UK	McCrudden, CM (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	c.mccrudden@qub.ac.uk		Curtin, Nicola/0000-0003-1369-1843; Robson, Tracy/0000-0003-4262-6872; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research UK [C1278/A5965]	Cancer Research UK(Cancer Research UK)	This work was funded by one Project Grant (C1278/A5965) awarded by Cancer Research UK to CS, DGH, and TR. (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; Ali M, 2009, CLIN CANCER RES, V15, P6106, DOI 10.1158/1078-0432.CCR-09-0398; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Calabrese CR, 2003, CLIN CANCER RES, V9, P2711; CLEAVER JE, 1987, EXP CELL RES, V172, P258, DOI 10.1016/0014-4827(87)90385-5; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; DALZIEL HH, 1994, PHARMACOL REV, V46, P449; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Deng MX, 2011, CYTOSKELETON, V68, P139, DOI 10.1002/cm.20471; English FA, 2012, REPROD SCI, V19, P806, DOI 10.1177/1933719111433885; GONG MC, 1992, J BIOL CHEM, V267, P14662; HORSMAN MR, 1989, RADIAT RES, V118, P139, DOI 10.2307/3577429; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Murai J, 2014, MOL CANC THER; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murray J, 2014, BRIT J CANCER, V110, P1977, DOI 10.1038/bjc.2014.91; Mutafova-Yambolieva VN, 2007, P NATL ACAD SCI USA, V104, P16359, DOI 10.1073/pnas.0705510104; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pal SK, 2009, MATURITAS, V63, P269, DOI 10.1016/j.maturitas.2009.06.010; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Patel AG, 2012, J BIOL CHEM, V287, P4198, DOI 10.1074/jbc.M111.296475; PLUMMER R, 2006, J CLIN ONCOL, V24, P8013; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Ruddock MW, 2004, ONCOL RES, V14, P483, DOI 10.3727/0965040042380478; Ruddock MW, 2000, RADIOTHER ONCOL, V54, P179, DOI 10.1016/S0167-8140(99)00163-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Senra JM, 2011, MOL CANCER THER, V10, P1949, DOI 10.1158/1535-7163.MCT-11-0278; Shapiro G, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-A218; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Veuger SJ, 2003, CANCER RES, V63, P6008; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wallace A, 2006, NEUROPHARMACOLOGY, V50, P191, DOI 10.1016/j.neuropharm.2005.08.019; Williams KJ, 2007, MOL CANCER THER, V6, P599, DOI 10.1158/1535-7163.MCT-06-0508	38	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118187	10.1371/journal.pone.0118187	http://dx.doi.org/10.1371/journal.pone.0118187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689628	Green Submitted, Green Published, gold			2022-12-27	WOS:000350322700104
J	Polglase, GR; Dawson, JA; Kluckow, M; Gill, AW; Davis, PG; te Pas, AB; Crossley, KJ; McDougall, A; Wallace, EM; Hooper, SB				Polglase, Graeme R.; Dawson, Jennifer A.; Kluckow, Martin; Gill, Andrew W.; Davis, Peter G.; te Pas, Arjan B.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.			Ventilation Onset Prior to Umbilical Cord Clamping (Physiological-Based Cord Clamping) Improves Systemic and Cerebral Oxygenation in Preterm Lambs	PLOS ONE			English	Article							BLOOD-FLOW; PLACENTAL TRANSFUSION; RESUSCITATION; INFANTS; BIRTH; TRANSITION; LUNG; PRESSURE; DELIVERY; SATURATION	Background As measurement of arterial oxygen saturation (SpO(2)) is common in the delivery room, target SpO(2) ranges allow clinicians to titrate oxygen therapy for preterm infants in order to achieve saturation levels similar to those seen in normal term infants in the first minutes of life. However, the influence of the onset of ventilation and the timing of cord clamping on systemic and cerebral oxygenation is not known. Aim We investigated whether the initiation of ventilation, prior to, or after umbilical cord clamping, altered systemic and cerebral oxygenation in preterm lambs. Methods Systemic and cerebral blood-flows, pressures and peripheral SpO(2) and regional cerebral tissue oxygenation (SctO(2)) were measured continuously in apnoeic preterm lambs (126 +/- 1 day gestation). Positive pressure ventilation was initiated either 1) prior to umbilical cord clamping, or 2) after umbilical cord clamping. Lambs were monitored intensively prior to intervention, and for 10 minutes following umbilical cord clamping. Results Clamping the umbilical cord prior to ventilation resulted in a rapid decrease in SpO(2) and SctO(2), and an increase in arterial pressure, cerebral blood flow and cerebral oxygen extraction. Ventilation restored oxygenation and haemodynamics by 5-6 minutes. No such disturbances in peripheral or cerebral oxygenation and haemodynamics were observed when ventilation was initiated prior to cord clamping. Conclusion The establishment of ventilation prior to umbilical cord clamping facilitated a smooth transition to systemic and cerebral oxygenation following birth. SpO(2) nomograms may need to be re-evaluated to reflect physiological management of preterm infants in the delivery room.	[Polglase, Graeme R.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.] Prince Henrys Inst, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Polglase, Graeme R.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Dawson, Jennifer A.; Davis, Peter G.] Royal Womens Hosp, Newborn Res Ctr, Melbourne, Vic, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatol, Sydney, NSW, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW 2006, Australia; [Gill, Andrew W.] Univ Western Australia, Ctr Neonatal Res & Educ, Nedlands, WA 6009, Australia; [te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Monash University; Prince Henry's Institute of Medical Research; Monash University; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Western Australia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Polglase, GR (corresponding author), Prince Henrys Inst, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	graeme.polglase@monash.edu	pas, arjan te/AAA-9019-2020; Crossley, Kelly J/I-7407-2013; Wallace, Euan M/K-6774-2015	pas, arjan te/0000-0001-7831-8797; Crossley, Kelly J/0000-0002-1580-1156; Wallace, Euan M/0000-0002-4506-5233; Polglase, Graeme/0000-0002-8906-614X; McDougall, Annie/0000-0003-1182-6679; Dawson, Jennifer/0000-0003-2357-6283; Hooper, Stuart/0000-0003-1676-4825; Kluckow, Martin/0000-0003-1875-7530	National Institute of Health [R01HD072848-01A1]; National Health and Medical Research Council (NHMRC) [1067615, 1026890, APP1012686, APP1059111, APP1058537]; Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072848] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institute of Health R01HD072848-01A1, National Health and Medical Research Council (NHMRC) Project Grant (1067615), NHMRC Research Fellowships (GRP: 1026890, JAD: APP1012686, PGD: APP1059111 and SBH: APP1058537), a Rebecca L. Cooper Medical Research Foundation Fellowship, Financial Markets for Children Research Grant (GRP) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PERINATAL STAT SERIE; Balegar KK, 2014, J PEDIATR-US, V164, P475, DOI 10.1016/j.jpeds.2013.10.041; Barton SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112402; Bhatt S, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00113; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; DELTORO J, 1991, PEDIATR NEUROL, V7, P3, DOI 10.1016/0887-8994(91)90098-6; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Gandhi B, 2013, J PEDIATR-US, V163, P412, DOI 10.1016/j.jpeds.2013.01.010; Gilmore MM, 2011, J PERINATOL, V31, P722, DOI 10.1038/jp.2011.17; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Hagino K, 2005, J THORAC CARDIOV SUR, V130, P384, DOI 10.1016/j.jtcvs.2005.02.058; Hooper SB, 2005, CURR RESPIR MED REV, V1, P185, DOI 10.2174/1573398054023037; Hooper SB, 2013, SEMIN FETAL NEONAT M, V18, P336, DOI 10.1016/j.siny.2013.08.011; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Hutton EK, 2007, JAMA-J AM MED ASSOC, V297, P1241, DOI 10.1001/jama.297.11.1241; Kamlin COF, 2008, J PEDIATR, V152, P756, DOI 10.1016/j.jpeds.2008.01.002; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; March MI, 2013, J PERINATOL, V33, P763, DOI 10.1038/jp.2013.70; Meyer MP, 2012, ARCH DIS CHILD-FETAL, V97, pF484, DOI 10.1136/adc.2010.199703; MILNER AD, 1978, ARCH DIS CHILD, V53, P545, DOI 10.1136/adc.53.7.545; Niermeyer S, 2013, SEMIN FETAL NEONAT M, V18, P385, DOI 10.1016/j.siny.2013.08.008; NUNN JF, 1987, APPL RESP PHYSL; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; PELTONEN T, 1981, EUR J PEDIATR, V137, P141; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Polglase GR, 2014, PEDIATR RES, V10, P40; Polglase GR, 2012, REPROD FERT DEVELOP, V24, P510, DOI 10.1071/RD11121; Polglase GR, 2006, CURR PEDIATR REV, V2, P287, DOI 10.2174/157339606778699653; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rabe H, 2011, OBSTET GYNECOL, V117, P205, DOI 10.1097/AOG.0b013e3181fe46ff; Rook D, 2014, J PEDIATR-US, V164, P1322, DOI 10.1016/j.jpeds.2014.02.019; RUDOLPH AM, 1977, AM REV RESPIR DIS, V115, P11; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Smit M, 2014, ARCH DIS CHILD-FETAL, V31, P2013; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Sommers R, 2012, PEDIATRICS, V129, pE667, DOI 10.1542/peds.2011-2550; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Tiisala R, 1966, Ann Paediatr Fenn, V12, P151; VANBEL F, 1994, PEDIATR RES, V35, P329; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029; YAO AC, 1974, AM J DIS CHILD, V127, P128, DOI 10.1001/archpedi.1974.02110200130021	44	78	79	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117504	10.1371/journal.pone.0117504	http://dx.doi.org/10.1371/journal.pone.0117504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689406	Green Published, gold			2022-12-27	WOS:000350322700050
J	Xiao, W; Wu, Q; Yang, Q; Zhou, L; Jiang, Y; Zhang, JX; Miao, DM; Peng, JX				Xiao, Wei; Wu, Qing; Yang, Qun; Zhou, Liang; Jiang, Yuan; Zhang, Jiaxi; Miao, Danmin; Peng, Jiaxi			Moral Hypocrisy on the Basis of Construal Level: To Be a Utilitarian Personal Decision Maker or to Be a Moral Advisor?	PLOS ONE			English	Article							DISTANCE	Background People encounter various moral issues that involve making decisions for others by giving advice. Objective This study investigated the characteristics of providing suggestions for oneself versus providing suggestions for others in ethical decision-making and the differences between them based on Construal Level Theory (CLT). Methods A total of 768 undergraduate students from three universities in China were randomly assigned to eight groups on the basis of a grid of two Construal Levels (self or others) by two different numbers of people saved (5 people or 15 people) by two problem situations (trolley problem vs. footbridge problem). The investigation examined participants' decisions to opt to take action or refrain from action that would have the consequence of saving more people. Results The main effects of Construal Level (F-1,F- 752 = 6.46, p = .011), saving number (F-1,F- 752 = 35.81, p < .001), and problem situation type (F-1,F- 752 = 330.55, p < .001) were all significant. The interaction of the problem situation and saving number (F-1,F- 752 = 1.01, p = .31), and social distance and saving number (F-1,F- 752 = 0.85, p = .36), and interaction of the three independent factors (F-1,F- 752 = 0.47, p = .49) were not significant. However, the interaction of social distance and problem situation (F-1,F- 752 = 9.46, p = .002) was significant. Results indicated the participants utilized a component of utilitarian reasoning in the decision-making, and their behaviors appeared more utilitarian at low Construal Levels (CLs) compared to high. Conclusion CLs, saving numbers, and problem situation significantly affected moral decision-making and exhibited significant interaction. Making decisions for oneself (low-construal) rather than giving advice to others (high-construal) was one important factor that determined whether the people were utilitarian or not. Utilitarian considerations are more relevant in impersonal dilemmas.	[Xiao, Wei; Wu, Qing; Yang, Qun; Zhou, Liang; Zhang, Jiaxi; Miao, Danmin; Peng, Jiaxi] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Peoples R China; [Wu, Qing] Chongqing Commun Inst, Foreign Language Teaching & Res Off, Basic Educ Dept, Chongqing, Peoples R China; [Jiang, Yuan] Astronaut Sci Res Training Ctr China, Beijing, Peoples R China	Air Force Military Medical University	Zhang, JX (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian 710032, Peoples R China.	24801813@qq.com; psych@fmmu.edu.cn; pengjx880124@sina.com			Department of Psychology, Fourth Military Medical University	Department of Psychology, Fourth Military Medical University	This study was supported by the Department of Psychology, Fourth Military Medical University, where it was conducted, and the authors received no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSCOMBE GEM, 1958, PHILOSOPHY, V33, P1, DOI 10.1017/S0031819100037943; Bartels DM, 2008, COGNITION, V108, P381, DOI 10.1016/j.cognition.2008.03.001; Beauchamp T.L., 2001, PHILOS ETHICS INTRO, V3rd ed.; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Christensen JF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00607; Cubitt RP, 2011, J PUBLIC ECON, V95, P253, DOI 10.1016/j.jpubeco.2010.10.011; De Bock T, 2013, J BUS ETHICS, V112, P225, DOI 10.1007/s10551-012-1244-3; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Foot P, 1967, THEORIES OF ETHICS; Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x; GILOVICH T, 1990, J PERS SOC PSYCHOL, V59, P623, DOI 10.1037/0022-3514.59.4.623; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Gubbins E, 2014, THINK REASONING, P1, DOI [10.1002/wdev.171, DOI 10.1002/WDEV.171]; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Kray L, 1999, J BEHAV DECIS MAKING, V12, P207, DOI 10.1002/(SICI)1099-0771(199909)12:3<207::AID-BDM322>3.0.CO;2-P; Kray LJ, 2000, ORGAN BEHAV HUM DEC, V83, P82, DOI 10.1006/obhd.2000.2903; Kunda Z, 2002, J PERS SOC PSYCHOL, V82, P283, DOI 10.1037//0022-3514.82.3.283; Lammers J, 2012, J EXP SOC PSYCHOL, V48, P475, DOI 10.1016/j.jesp.2011.07.006; Lammers J, 2010, PSYCHOL SCI, V21, P737, DOI 10.1177/0956797610368810; Lammers J, 2009, J PERS SOC PSYCHOL, V97, P279, DOI 10.1037/a0015437; Liberman N, 1998, J PERS SOC PSYCHOL, V75, P5, DOI 10.1037/0022-3514.75.1.5; Liberman N, 2007, J CONSUM PSYCHOL, V17, P113, DOI 10.1016/S1057-7408(07)70017-7; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; Lucas BJ, 2014, J EXPT SOCIAL PSYCHO, DOI [10.1016/j.jesp.2013.09.007, DOI 10.1016/J.JESP.2013.09.007]; Milkman KL, 2008, PERSPECT PSYCHOL SCI, V3, P324, DOI 10.1111/j.1745-6924.2008.00083.x; Nichols S, 2007, NOUS, V41, P663, DOI 10.1111/j.1468-0068.2007.00666.x; Peng JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079181; Pick-Alony R, 2014, J BEHAV DECISION MAK; Stapel DA, 2004, SOC COGNITION, V22, P147, DOI 10.1521/soco.22.1.147.30989; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Valdesolo P, 2008, J EXP SOC PSYCHOL, V44, P1334, DOI 10.1016/j.jesp.2008.03.010; Williams B., 1973, CRITIQUE UTILITARIAN	37	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117540	10.1371/journal.pone.0117540	http://dx.doi.org/10.1371/journal.pone.0117540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689521	Green Published, gold, Green Submitted			2022-12-27	WOS:000350322700051
J	aan het Rot, M; Moskowitz, DS; de Jong, PJ				aan het Rot, Marije; Moskowitz, D. S.; de Jong, Peter J.			Intrapersonal and Interpersonal Concomitants of Facial Blushing during Everyday Social Encounters	PLOS ONE			English	Article							SELF-CONSCIOUSNESS; FEARFUL PREOCCUPATION; ANXIETY; EMBARRASSMENT; PHOBIA; SHAME; PROPENSITY; BEHAVIOR; DEPRESSION; COMPLEMENTARITY	Facial blushing may usually be undesirable but may have an ameliorative function for some individuals under some circumstances. Researchers have studied the blush in laboratory settings, but not in daily life. In the present research, conducted with young adults, we employed for the first time an event-contingent recording method for assessing facial blushing during every-day social encounters. Blushing was associated with feeling embarrassed, ashamed, and exposed. These findings, though based on correlational analyses, are consistent with the idea that blushing is often unpleasant and can be maladaptive, and may contribute to the common belief that blushing is an undesirable response. Frequent blushers generally reported lower levels of dominant behavior, higher levels of submissive behavior, and perceived their social interaction partners as more powerful and less affiliative. This was independent of whether they blushed or not, suggesting that altered social behaviors and perceptions are associated with blushing-associated traits rather than with the blushing state. The experience of the blush varied as a function of the frequency with which a person blushed. Blushing was associated with higher levels of shame in frequent blushers than in infrequent blushers. In infrequent blushers, blushing was associated with higher levels of pleasant affect, suggesting that for infrequent blushers the blush may occur in positive social encounters.	[aan het Rot, Marije; de Jong, Peter J.] Univ Groningen, Dept Psychol, Expt Psychopathol & Psychotherapy Program, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Moskowitz, D. S.] McGill Univ, Dept Psychol, Montreal, PQ, Canada	University of Groningen; McGill University	aan het Rot, M (corresponding author), Univ Groningen, Dept Psychol, Expt Psychopathol & Psychotherapy Program, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	m.aan.het.rot@rug.nl	de Jong, Peter/E-9095-2014; de Jong, Peter/ABB-1750-2020; Rot, Marije aan het/H-8708-2019	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Rot, Marije aan het/0000-0001-6761-7513	Innovational Research Incentives Scheme Veni of the Netherlands Organization for Scientific Research NWO [451-09-013]	Innovational Research Incentives Scheme Veni of the Netherlands Organization for Scientific Research NWO	This research was supported by funding to MahR from the Innovational Research Incentives Scheme Veni of the Netherlands Organization for Scientific Research NWO, www.nwo.nl. Grant number: 451-09-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1981, BRIT J PSYCHIAT, V138, P297, DOI 10.1192/bjp.138.4.297; Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; AMIES PL, 1983, BRIT J PSYCHIAT, V142, P174, DOI 10.1192/bjp.142.2.174; Bogels SM, 1996, PERS INDIV DIFFER, V21, P573, DOI 10.1016/0191-8869(96)00100-6; Bogels SM, 1999, J PSYCHOPATHOL BEHAV, V21, P51, DOI 10.1023/A:1022812227606; Burgess T., 1839, PHYSL MECH BLUSHING; Buss ArnoldH., 1980, SELF CONSCIOUSNESS S; Carson R.C., 1969, INTERACTION CONCEPTS; Crozier WR, 2001, J THEOR SOC BEHAV, V31, P61, DOI 10.1111/1468-5914.00146; Crozier WR, 2004, J THEOR SOC BEHAV, V34, P1, DOI 10.1111/j.1468-5914.2004.00231.x; CROZIER WR, 1992, BRIT J SOC PSYCHOL, V31, P343, DOI 10.1111/j.2044-8309.1992.tb00977.x; Crozier WR, 2013, PSYCHOL SIGNIFICANCE, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Jong PJ, 2006, COGNITIVE THER RES, V30, P623, DOI 10.1007/s10608-006-9040-y; de Jong PJ, 2003, MOTIV EMOTION, V27, P225, DOI 10.1023/A:1025059631708; de Jong PJ, 1999, J NONVERBAL BEHAV, V23, P197, DOI 10.1023/A:1021352926675; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; Dijk C, 2012, BEHAV RES THER, V50, P158, DOI 10.1016/j.brat.2011.11.006; Dijk C, 2011, EMOTION, V11, P313, DOI 10.1037/a0022774; Dijk C, 2010, J PSYCHOPATHOL BEHAV, V32, P264, DOI 10.1007/s10862-009-9134-4; Dijk C, 2009, BEHAV RES THER, V47, P541, DOI 10.1016/j.brat.2009.03.005; Dijk C, 2009, EMOTION, V9, P287, DOI 10.1037/a0015081; Drummond PD, 1997, PSYCHOPHYSIOLOGY, V34, P163, DOI 10.1111/j.1469-8986.1997.tb02127.x; Drummond PD, 2001, PERS INDIV DIFFER, V30, P1329, DOI 10.1016/S0191-8869(00)00115-X; Drummond PD, 2007, BEHAV RES THER, V45, P1601, DOI 10.1016/j.brat.2006.06.012; Drummond PD, 2013, PSYCHOLOGICAL SIGNIFICANCE OF THE BLUSH, P15; Drummond PD, 2012, COGNITION EMOTION, V26, P561, DOI 10.1080/02699931.2011.595775; EDELMANN RJ, 1993, PERS INDIV DIFFER, V14, P495, DOI 10.1016/0191-8869(93)90322-T; EDELMANN RJ, 1979, BRIT J SOC CLIN PSYC, V18, P385, DOI 10.1111/j.2044-8260.1979.tb00908.x; Gerlach AL, 2001, J ABNORM PSYCHOL, V110, P247, DOI 10.1037/0021-843X.110.2.247; Gilbert P, 2000, CLIN PSYCHOL PSYCHOT, V7, P174, DOI 10.1002/1099-0879(200007)7:3<174::AID-CPP236>3.0.CO;2-U; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Keltner D, 1997, AGGRESSIVE BEHAV, V23, P359, DOI 10.1002/(SICI)1098-2337(1997)23:5<359::AID-AB5>3.0.CO;2-D; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KIESLER DJ, 1983, PSYCHOL REV, V90, P185, DOI 10.1037/0033-295X.90.3.185; Lange WG, 2008, BEHAV RES THER, V46, P932, DOI 10.1016/j.brat.2008.04.008; LEARY MR, 1992, PSYCHOL BULL, V112, P446, DOI 10.1037/0033-2909.112.3.446; LEARY MR, 1991, J PERS SOC PSYCHOL, V60, P254, DOI 10.1037/0022-3514.60.2.254; Leary MR, 1996, J PERS, V64, P619, DOI 10.1111/j.1467-6494.1996.tb00524.x; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; Martens JP, 2012, COGNITION EMOTION, V26, P390, DOI 10.1080/02699931.2011.645281; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Miller RS, 2013, PSYCHOLOGICAL SIGNIFICANCE OF THE BLUSH, P185; MILLER RS, 1992, PERS SOC PSYCHOL B, V18, P190, DOI 10.1177/0146167292182010; Moskowitz DS, 2009, CAN PSYCHOL, V50, P33, DOI 10.1037/a0014425; Moskowitz DS, 2005, PSYCHOL ASSESSMENT, V17, P218, DOI 10.1037/1040-3590.17.2.218; MOSKOWITZ DS, 1994, J PERS SOC PSYCHOL, V66, P921, DOI 10.1037/0022-3514.66.5.921; Moskowitz DS, 2012, HDB RES METHODS STUD, P160; Mulkens S, 1999, BEHAV RES THER, V37, P1159, DOI 10.1016/S0005-7967(99)00022-4; Mulkens S, 1997, PERS INDIV DIFFER, V22, P817, DOI 10.1016/S0191-8869(97)00008-1; Mulkens S, 1999, BEHAV RES THER, V37, P1119, DOI 10.1016/S0005-7967(98)00198-3; O'Grady MA, 2011, J SOC CLIN PSYCHOL, V30, P599, DOI 10.1521/jscp.2011.30.6.599; Ohayon MM, 2010, J PSYCHOSOM RES, V68, P235, DOI 10.1016/j.jpsychores.2009.07.018; ORFORD J, 1986, PSYCHOL REV, V93, P365, DOI 10.1037/0033-295X.93.3.365; PARKINSON B, 1993, COGNITION EMOTION, V7, P295, DOI 10.1080/02699939308409191; Pelissolo A, 2012, DEPRESS ANXIETY, V29, P62, DOI 10.1002/da.20851; RAPEE RM, 1994, BEHAV RES THER, V32, P89, DOI 10.1016/0005-7967(94)90087-6; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Russell JJ, 2011, PSYCHOL MED, V41, P545, DOI 10.1017/S0033291710000863; Sabini J, 1997, J THEOR SOC BEHAV, V27; SEMIN GR, 1982, EUR J SOC PSYCHOL, V12, P367, DOI 10.1002/ejsp.2420120404; SHEARN D, 1992, PSYCHOPHYSIOLOGY, V29, P431, DOI 10.1111/j.1469-8986.1992.tb01716.x; SHIELDS SA, 1990, J NONVERBAL BEHAV, V14, P171, DOI 10.1007/BF00996225; Tangney JP, 1996, J PERS SOC PSYCHOL, V70, P1256, DOI 10.1037/0022-3514.70.6.1256; Thomaes S, 2011, EMOTION, V11, P786, DOI 10.1037/a0023403; Van der Does A.J.W., 2003, LEIDEN INDEX DEPRESS; Voncken MJ, 2009, BIOL PSYCHOL, V81, P86, DOI 10.1016/j.biopsycho.2009.02.004	69	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118243	10.1371/journal.pone.0118243	http://dx.doi.org/10.1371/journal.pone.0118243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679216	gold, Green Published, Green Submitted			2022-12-27	WOS:000350682600112
J	Abouzeid, M; Versace, VL; Janus, ED; Davey, MA; Philpot, B; Oats, J; Dunbar, JA				Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Davey, Mary-Ann; Philpot, Benjamin; Oats, Jeremy; Dunbar, James A.			Socio-Cultural Disparities in GDM Burden Differ by Maternal Age at First Delivery	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; NEW-SOUTH-WALES; SOCIOECONOMIC-STATUS; PREGNANCY OUTCOMES; RISK-FACTOR; WOMEN; POPULATION; COMPLICATIONS; ASSOCIATION; PREVALENCE	Aims Several socio-cultural and biomedical risk factors for gestational diabetes mellitus ( GDM) are modifiable. However, few studies globally have examined socio-cultural associations. To eliminate confounding of increased risk of diabetes in subsequent pregnancies, elucidating socio-cultural associations requires examination only of first pregnancies. Methods Data for all women who delivered their first child in Victoria, Australia between 1999 and 2008 were extracted from the Victorian Perinatal Data Collection. Crude and adjusted GDM rates were calculated. Multivariate logistic regression was used to examine odds of GDM within and between socio-cultural groups. Results From 1999 to 2008, 269,682 women delivered their first child in Victoria. GDM complicated 11,763 (4.4%) pregnancies and burden increased with maternal age, from 2.1% among women aged below 25 years at delivery to 7.0% among those aged 35 years or more. Among younger women, GDM rates were relatively stable across socioeconomic levels. Amongst older women GDM rates were highest in those living in most deprived areas, with a strong social gradient. Asian-born mothers had highest GDM rates. All migrant groups except women born in North-West Europe had higher odds of GDM than Australian-born non-Indigenous women. In all ethnic groups, these differences were not pronounced among younger mothers, but became increasingly apparent amongst older women. Conclusions Socio-cultural disparities in GDM burden differ by maternal age at first delivery. Socio-cultural gradients were not evident among younger women. Health and social programs should seek to reduce the risk amongst all older women to that of the least deprived older mothers.	[Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Philpot, Benjamin; Dunbar, James A.] Flinders Univ S Australia, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia; [Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Philpot, Benjamin; Dunbar, James A.] Deakin Univ, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia; [Abouzeid, Marion] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Janus, Edward D.] Univ Melbourne, Northwest Acad Ctr, Dept Med, Melbourne, Vic 3010, Australia; [Janus, Edward D.] Western Hlth, Melbourne, Vic, Australia; [Davey, Mary-Ann; Oats, Jeremy] Dept Hlth, Clin Councils Unit, Consultat Council Obstet & Paediat Mortal & Morbi, Melbourne, Vic, Australia; [Davey, Mary-Ann] La Trobe Univ, Mother & Child Hlth Res, Bundoora, Vic 3086, Australia; [Oats, Jeremy] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia	Flinders University South Australia; Deakin University; Monash University; University of Melbourne; La Trobe University; University of Melbourne	Dunbar, JA (corresponding author), Flinders Univ S Australia, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia.	director@greaterhealth.org	Versace, Vincent/AAL-6418-2021; Janus, Edward/AAU-8652-2020	Versace, Vincent/0000-0002-8514-1763; 				Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Australia Bureau of Statistics, 2008, INF PAP INTR SOC IND; BEISCHER NA, 1991, DIABETES, V40, P35, DOI 10.2337/diab.40.2.S35; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bertolotto A, 2012, DIABETIC MED, V29, P416, DOI 10.1111/j.1464-5491.2011.03484.x; Bo S, 2002, DIABETES METAB, V28, P139; Bombard JM, 2012, MATERN CHILD HLTH J, V16, P60, DOI 10.1007/s10995-010-0717-1; Carolan M, 2012, MIDWIFERY, V28, P778, DOI 10.1016/j.midw.2011.08.014; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen T, 2006, ACTA OBSTET GYN SCAN, V85, P526, DOI 10.1080/00016340500523644; Consultative Council on Obstetric and Paediatric Mortality and Morbidity, 2011, BIRTHS VICT 2007 200, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Davey MA, 2013, HEALTH INF MANAG J, V42, P12, DOI 10.1177/183335831304200301; Devlin HM, 2008, AM J PUBLIC HEALTH, V98, P59, DOI 10.2105/AJPH.2006.095877; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Janghorbani M, 2006, DIABETIC MED, V23, P313, DOI 10.1111/j.1464-5491.2006.01774.x; JONAS O, 1992, AUST NZ J OBSTET GYN, V32, P1, DOI 10.1111/j.1479-828X.1992.tb01885.x; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Ma J, 1996, AUST NZ J OBSTET GYN, V36, P119, DOI 10.1111/j.1479-828X.1996.tb03265.x; Park JH, 2011, J OBSTET GYNAECOL RE, V37, P138, DOI 10.1111/j.1447-0756.2010.01332.x; Shand AW, 2008, DIABETIC MED, V25, P708, DOI 10.1111/j.1464-5491.2008.02431.x; Stone CA, 2002, MED J AUSTRALIA, V177, P486, DOI 10.5694/j.1326-5377.2002.tb04916.x; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Templeton M, 2008, DIABETES SERIES AUST, V10; van der Ploeg HP, 2011, J SCI MED SPORT, V14, P149, DOI 10.1016/j.jsams.2010.09.002; von Katterfeld B, 2011, AUST NZ J OBSTET GYN, V51, P225, DOI 10.1111/j.1479-828X.2010.01282.x; Yang H, 2009, RISK FACTORS GESTATI	28	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117085	10.1371/journal.pone.0117085	http://dx.doi.org/10.1371/journal.pone.0117085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679221	gold, Green Published			2022-12-27	WOS:000350682600049
J	Li, L; Liu, D; Qiu, ZX; Zhao, S; Zhang, L; Li, WM				Li, Lei; Liu, Dan; Qiu, Zhi-Xin; Zhao, Shuang; Zhang, Li; Li, Wei-Min			The Prognostic Role of mTOR and P-mTOR for Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MAMMALIAN TARGET; OVEREXPRESSION; PATHWAY; EXPRESSION; RAPAMYCIN; NSCLC	Objectives The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are potential prognostic markers and therapeutic targets for non-small cell lung cancer (NSCLC). However, the association between mTOR/p-mTOR expression and NSCLC patients' prognosis remains controversial. Thus, a meta-analysis of existing studies evaluating the prognostic role of mTOR/p-mTOR expression for NSCLC was conducted. Materials and Methods A systemically literature search was performed via Pubmed, Embase, Medline as well as CNKI (China National Knowledge Infrastructure). Studies were included that reported the hazard ratio (HR) and 95%CI for the association between mTOR/p-mTOR expression and NSCLC patients' survival. Random-effects model was used to pool HRs. Results Ten eligible studies were included in this meta-analysis, with 4 about m-TOR and 7 about p-mTOR. For mTOR, the pooled HR of overall survival (OS) was 1.00 (95%CI 0.5 to 1.99) by univariate analysis and 1.22 (95%CI 0.53 to 2.82) by multivariate analysis. For p-mTOR, the pooled HR was 1.39 (95%CI 0.97 to 1.98) by univariate analysis and 1.42 (95%CI 0.56 to 3.60) by multivariate analysis. Conclusion The results indicated that no statistically significant association was found between mTOR/p-mTOR expression and NSCLC patients' prognosis.	[Li, Lei; Liu, Dan; Qiu, Zhi-Xin; Zhao, Shuang; Li, Wei-Min] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Peoples R China; [Zhang, Li] Sichuan Univ, West China Hosp, Dept Pathol, Pathol Lab, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Peoples R China.	weimi003@yahoo.com	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; qiu, zhixin/HHC-0554-2022; LI, LI/GVS-5344-2022	qiu, zhixin/0000-0003-0256-4419; 	National High Technology Research and Development Program of China (863 Program) [2014AA022202]; National Natural Science Foundation of China [81372504, 81241068, 81201851]; Chinese Postdoctoral Science Foundation [2013M542281]; Department of Science and Technology, Sichuan Province, China [2013JY0012]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Department of Science and Technology, Sichuan Province, China	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, No. 2014AA022202), National Natural Science Foundation of China (81372504, 81241068, 81201851), Chinese Postdoctoral Science Foundation (2013M542281) and the Application of Infrastructure Program from the Department of Science and Technology, Sichuan Province, China (2013JY0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2009, CLIN CANCER RES, V15, P4157, DOI 10.1158/1078-0432.CCR-09-0099; Bambury RM, 2013, CURR OPIN UROL, V23, P472, DOI 10.1097/MOU.0b013e328363a3cd; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Dhillon T, 2010, J THORAC ONCOL, V5, P314, DOI 10.1097/JTO.0b013e3181ce6604; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gately K, 2012, LUNG CANCER, V75, P217, DOI 10.1016/j.lungcan.2011.06.012; Gold KA, 2014, CLIN CANCER RES, V20, P1946, DOI 10.1158/1078-0432.CCR-13-1959; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houede N, 2014, PHARMACOL THERAPEUT, V2014, P1879; Karachaliou Niki, 2014, Cancer Biology Medicine, V11, P173, DOI 10.7497/j.issn.2095-3941.2014.03.003; Kitano H, 2014, J HISTOCHEM CYTOCHEM, V2014, P1551; Kyle LZ, 2014, GENES DIS IN PRESS; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Liu HB, 2008, CHIN J RESP CRIT CAR, V7, P354; Loong HH, 2014, ONCOTARGETS THER, V7, P575, DOI 10.2147/OTT.S46019; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mei XD, 2013, BIOSCI TRENDS, V7, P42, DOI 10.5582/bst.2013.v7.1.42; Ng VC, 2014, J ONCOL PHARM PRACT, V2014, P1477; Papadimitrakopoulou V, 2007, J THORAC ONCOL, V2, pS359, DOI 10.1097/01.JTO.0000283191.47168.f6; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Qiu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081451; Rolfo C, 2014, CANC TREAT REV, V2014, P1532; Sadeghi S, 2014, PHARMACOGEN PERS MED, V7, P329, DOI 10.2147/PGPM.S47524; Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Thanyanan R, 2012, J THORAC ONCOL, V7, P919, DOI [10.1097/JTO.0b013e31824de0d6, DOI 10.1097/JTO.0B013E31824DE0D6]; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zhang Y, 2013, ASIAN PAC J CANCER P, V14, P3725, DOI 10.7314/APJCP.2013.14.6.3725; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	34	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116771	10.1371/journal.pone.0116771	http://dx.doi.org/10.1371/journal.pone.0116771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680114	Green Published, Green Submitted, gold			2022-12-27	WOS:000350682600033
J	Schwedt, TJ; Berisha, V; Chong, CD				Schwedt, Todd J.; Berisha, Visar; Chong, Catherine D.			Temporal Lobe Cortical Thickness Correlations Differentiate the Migraine Brain from the Healthy Brain	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; RESTING-STATE; MRI; ABNORMALITIES; SEGMENTATION; RELIABILITY; PAIN; ALLODYNIA	Background Interregional cortical thickness correlations reflect underlying brain structural connectivity and functional connectivity. A few prior studies have shown that migraine is associated with atypical cortical brain structure and atypical functional connectivity amongst cortical regions that participate in sensory processing. However, the specific brain regions that most accurately differentiate the migraine brain from the healthy brain have yet to be determined. The aim of this study was to identify the brain regions that comprised interregional cortical thickness correlations that most differed between migraineurs and healthy controls. Methods This was a cross-sectional brain magnetic resonance imaging (MRI) investigation of 64 adults with migraine and 39 healthy control subjects recruited from tertiary-care medical centers and their surrounding communities. All subjects underwent structural brain MRI imaging on a 3T scanner. Cortical thickness was determined for 70 brain regions that cover the cerebral cortex and cortical thickness correlations amongst these regions were calculated. Cortical thickness correlations that best differentiated groups of six migraineurs from controls and vice versa were identified. Results A model containing 15 interregional cortical thickness correlations differentiated groups of migraineurs from healthy controls with high accuracy. The right temporal pole was involved in 13 of the 15 interregional correlations while the right middle temporal cortex was involved in the other two. Conclusions A model consisting of 15 interregional cortical thickness correlations accurately differentiates the brains of small groups of migraineurs from those of healthy controls. Correlations with the right temporal pole were highly represented in this classifier, suggesting that this region plays an important role in migraine pathophysiology.	[Schwedt, Todd J.; Chong, Catherine D.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Berisha, Visar] Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA; [Berisha, Visar] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Berisha, Visar/0000-0001-8804-8874	National Institutes of Health [K23NS070891]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS070891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health K23NS070891 to TJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Berisha V, 2000, P IEEE ICASSP; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Chong CD, 2014, CEPHALALGIA, V34, P1115, DOI 10.1177/0333102414531157; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Demarquay G, 2008, CEPHALALGIA, V28, P1069, DOI 10.1111/j.1468-2982.2008.01672.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Friedman J. H., 2008, TECHNICAL REPORT; Hadjikhani N, 2013, CEPHALALGIA, V33, P1264, DOI 10.1177/0333102413490344; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Henze N, 1999, ANN STAT, V27, P290; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kelman L, 2004, HEADACHE, V44, P1019, DOI 10.1111/j.1526-4610.2004.04197.x; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051250; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Messina R, 2013, RADIOLOGY, V268, P170, DOI 10.1148/radiol.13122004; Mitelman SA, 2005, NEUROIMAGE, V27, P753, DOI 10.1016/j.neuroimage.2005.05.024; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Moulton EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003799; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schwedt TJ, 2014, CEPHALALGIA INT J HE; Schwedt TJ, 2014, PAIN MED, V15, P154, DOI 10.1111/pme.12267; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Schwedt TJ, 2013, HEADACHE, V53, P737, DOI 10.1111/head.12081; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stankewitz A, 2011, NEUROLOGY, V77, P476, DOI 10.1212/WNL.0b013e318227e4a8; STEINMETZ H, 1994, NEW ENGL J MED, V331, P952, DOI 10.1056/NEJM199410063311419; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wang DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083767; Wober-Bingol C, 2004, CEPHALALGIA, V24, P12, DOI 10.1111/j.1468-2982.2004.00621.x; Woodruff PWR, 1997, PSYCHOL MED, V27, P1257, DOI 10.1017/S0033291797005229; Wright IC, 1999, CEREB CORTEX, V9, P366, DOI 10.1093/cercor/9.4.366; Xue T, 2013, NMR BIOMED, V26, P1051, DOI 10.1002/nbm.2917; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85	61	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116687	10.1371/journal.pone.0116687	http://dx.doi.org/10.1371/journal.pone.0116687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679805	gold, Green Submitted, Green Published			2022-12-27	WOS:000350682600031
J	Wu, CJ; Chen, PL; Hsueh, PR; Chang, MC; Tsai, PJ; Shih, HI; Wang, HC; Chou, PH; Ko, WC				Wu, Chi-Jung; Chen, Po-Lin; Hsueh, Po-Ren; Chang, Ming-Chung; Tsai, Pei-Jane; Shih, Hsin-I; Wang, Hsuan-Chen; Chou, Pei-Hsin; Ko, Wen-Chien			Clinical Implications of Species Identification in Monomicrobial Aeromonas Bacteremia	PLOS ONE			English	Article							GRAM-NEGATIVE BACTEREMIA; GENUS AEROMONAS; BETA-LACTAMASE; SOUTHERN TAIWAN; AQUARIORUM; HYDROPHILA; DHAKENSIS; SEPTICEMIA; GENES; EPISODES	Background Advances in Aeromonas taxonomy have led to the reclassification of aeromonads. Hereon, we aimed to re-evaluate the characteristics of Aeromonas bacteremia, including those of a novel species, Aeromonas dhakensis. Methodology/Principal Findings A retrospective study of monomicrobial Aeromonas bacteremia at a medical center in southern Taiwan from 2004-2011 was conducted. Species identification was based on rpoB sequencing. Of bacteremia of 153 eligible patients, A. veronii (50 isolates, 32.7%), A. dhakensis (48, 31.4%), A. caviae (43, 28.1%), and A. hydrophila (10, 6.5%) were the principal causative species. A. dhakensis and A. veronii bacteremia were mainly community-acquired and presented as primary bacteremia, spontaneous bacterial peritonitis, or skin and soft-tissue infection, whereas A. caviae was associated with hospital-onset bacteremia. The distribution of the AmpC beta-lactamase and metallo-beta-lactamase genes was species-specific: bla(AQU-1), bla(MOX), or bla(CepH) was present in A. dhakensis, A. caviae, or A. hydrophila, respectively, and bla(CphA) was present in A. veronii, A. dhakensis, and A. hydrophila. The cefotaxime resistance rates of the A. caviae, A. dhakensis, and A. hydrophila isolates were higher than that of A. veronii (39.5%%, 25.0%, and 30% vs. 2%, respectively). A. dhakensis bacteremia was linked to the highest 14-day sepsis-related mortality rate, followed by A. hydrophila, A. veronii, and A. caviae bacteremia (25.5%, 22.2%, 14.0%, and 4.7%, respectively; P = 0.048). Multivariate analysis revealed that A. dhakensis bacteremia, active malignancies, and a Pitt bacteremia score >= 4 was an independent mortality risk factor. Conclusions/Significance Characteristics of Aeromonas bacteremia vary between species. A. dhakensis prevalence and its associated poor outcomes suggest it an important human pathogen.	[Wu, Chi-Jung; Wang, Hsuan-Chen; Chou, Pei-Hsin] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wu, Chi-Jung; Chen, Po-Lin] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Wu, Chi-Jung; Chen, Po-Lin; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Shih, Hsin-I] Natl Cheng Kung Univ Hosp, Emergency Med, Tainan 70428, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Hsueh, Po-Ren] Coll Med, Dept Lab Med, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan; [Hsueh, Po-Ren] Coll Med, Taipei, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chang, Ming-Chung] Natl Cheng Kung Univ, Coll Med, Biochem & Mol Biol Med, Tainan 70101, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Ko, WC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan.	winston3415@gmail.com	Hsueh, Po-Ren/ABE-1594-2021; Wu, Chi-Jung/F-8364-2011; Ko, Wen-Chien/ABG-4316-2020; Tsai, Pei-Jane/G-3563-2011	Ko, Wen-Chien/0000-0001-7497-149X; 	National Health Research Institutes [ID-100-PP-17, IV-101-SP-13]; National Science Council [NSC 102-2628-B-006-015-MY3]; Ministry of Health and Welfare [MOHW103-TDU-B-211-113002]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	CJW PLC PRH MCC PJT HIS HCW PHC WCK and CJW received grants from National Health Research Institutes (ID-100-PP-17 and IV-101-SP-13)(http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do). WCK received grants from National Science Council (NSC 102-2628-B-006-015-MY3) (http://www.most.gov.tw/) and Ministry of Health and Welfare (MOHW103-TDU-B-211-113002) (http://www.mohw.gov.tw/EN/Ministry/), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Beaz-Hidalgo R, 2013, SYST APPL MICROBIOL, V36, P171, DOI 10.1016/j.syapm.2012.12.007; Chen PL, 2014, CLIN MICROBIOL INFEC, V20, pO428, DOI 10.1111/1469-0691.12456; Chen PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111213; Chen PL, 2014, J CLIN MICROBIOL, V52, P2625, DOI 10.1128/JCM.01025-14; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Clinical and Laboratory Standards Institute, 2010, M45A2 CLSI; Clinical and Laboratory Standards Institute, 2006, M45A CLSI; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Fosse T, 2003, PATHOL BIOL, V51, P290, DOI 10.1016/S0369-8114(03)00027-0; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; JANDA JM, 1994, CLIN INFECT DIS, V19, P77, DOI 10.1093/clinids/19.1.77; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Morinaga Y, 2013, DIAGN MICR INFEC DIS, V76, P106, DOI 10.1016/j.diagmicrobio.2013.01.019; Puthucheary SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030205; Rice LB, 1996, ANTIBIOTICS LAB MED, P453; ROSSOLINI GM, 1995, ANTIMICROB AGENTS CH, V39, P346, DOI 10.1128/AAC.39.2.346; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Walsh TR, 1997, J ANTIMICROB CHEMOTH, V40, P171, DOI 10.1093/jac/40.2.171; Wu CJ, 2013, INT J ANTIMICROB AG, V42, P456, DOI 10.1016/j.ijantimicag.2013.08.002; Wu CJ, 2012, DIAGN MICR INFEC DIS, V74, P406, DOI 10.1016/j.diagmicrobio.2012.08.005; Wu CJ, 2012, J MED MICROBIOL, V61, P712, DOI 10.1099/jmm.0.038323-0; Wu CJ, 2011, ANTIMICROB AGENTS CH, V55, P5813, DOI 10.1128/AAC.00634-11	30	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117821	10.1371/journal.pone.0117821	http://dx.doi.org/10.1371/journal.pone.0117821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679227	Green Submitted, Green Published, gold			2022-12-27	WOS:000350682600091
J	Silva, IT; Carvalho, A; Lang, KL; Dudek, SE; Masemann, D; Duran, FJ; Caro, MSB; Rapp, UR; Wixler, V; Schenkel, EP; Simoes, CMO; Ludwig, S				Silva, Izabella T.; Carvalho, Annelise; Lang, Karen L.; Dudek, Sabine E.; Masemann, Doerthe; Duran, Fernando J.; Caro, Miguel S. B.; Rapp, Ulf R.; Wixler, Viktor; Schenkel, Eloir P.; Simoes, Claudia M. O.; Ludwig, Stephan			In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B	PLOS ONE			English	Article							CELL LUNG-CANCER; SIGNALING PATHWAY; THERAPEUTIC TARGETS; MOLECULAR TARGETS; PROTEIN-KINASE; APOPTOSIS; SURVIVIN; GROWTH; STAT3; ACTIVATION	Lung cancer is the most deadly type of cancer in humans, with non-small-cell lung cancer (NSCLC) being the most frequent and aggressive type of lung cancer showing high resistance to radiation and chemotherapy. Despite the outstanding progress made in anti-tumor therapy, discovering effective anti-tumor drugs is still a challenging task. Here we describe a new semisynthetic derivative of cucurbitacin B (DACE) as a potent inhibitor of NSCLC cell proliferation. DACE arrested the cell cycle of lung epithelial cells at the G2/M phase and induced cell apoptosis by interfering with EGFR activation and its downstream signaling, including AKT, ERK, and STAT3. Consistent with our in vitro studies, intraperitoneal application of DACE significantly suppressed the growth of mouse NSCLC that arises from type II alveolar pneumocytes due to constitutive expression of a human oncogenic c-RAF kinase (c-RAF-1-BxB) transgene in these cells. Taken together, these findings suggest that DACE is a promising lead compound for the development of an anti-lung-cancer drug.	[Silva, Izabella T.; Carvalho, Annelise; Schenkel, Eloir P.; Simoes, Claudia M. O.] Univ Fed Santa Catarina, Dept Pharmaceut Sci, Florianopolis, SC, Brazil; [Lang, Karen L.; Caro, Miguel S. B.] Univ Fed Santa Catarina, Dept Chem, Florianopolis, SC, Brazil; [Silva, Izabella T.; Dudek, Sabine E.; Masemann, Doerthe; Wixler, Viktor; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Duran, Fernando J.] Univ Buenos Aires, Dept Organ Chem, UMYMFOR, Buenos Aires, DF, Argentina; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Wixler, Viktor; Ludwig, Stephan] Univ Munster, Cluster Excellence, D-48149 Munster, Germany; [Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of Munster; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Max Planck Society; University of Munster; University of Munster	Ludwig, S (corresponding author), Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Silva, Izabella/B-9407-2015; Simões, Cláudia/N-1712-2015	Silva, Izabella/0000-0002-1893-4317; Ludwig, Stephan/0000-0003-4490-3052; Duran, Fernando Javier/0000-0002-4359-8239	Brazilian funding agency, as CNPq/MCTI [472979/2011-6]; Brazilian funding agency PRONEX/FAPESC [2671/2012-9]; Deutsche Forschungsgemeinschaft (DFG); Interdisciplinary Center of Clinical Research (IZKF) Muenster; Open Access Publication Fund of University of Muenster, Germany	Brazilian funding agency, as CNPq/MCTI; Brazilian funding agency PRONEX/FAPESC; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) Muenster; Open Access Publication Fund of University of Muenster, Germany	This study was supported in part by Brazilian funding agencies, as CNPq/MCTI (grant number 472979/2011-6) and PRONEX/FAPESC (grant number 2671/2012-9) as well as by different grants from the Deutsche Forschungsgemeinschaft (DFG) and Interdisciplinary Center of Clinical Research (IZKF) Muenster. The authors also acknowledge support by Open Access Publication Fund of University of Muenster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/490136; Alghasham AA, 2013, INT J HEALTH SCI-IJH, V7, P77, DOI 10.12816/0006025; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; BELLOMO G, 1992, ANN NY ACAD SCI, V663, P97, DOI 10.1111/j.1749-6632.1992.tb38653.x; Bernard SA, 2010, J MED PLANTS RES, V4, P2821; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Ciuffreda L, 2009, CURR SIGNAL TRANSD T, V4, P130, DOI 10.2174/157436209788167466; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Duangmano S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-185; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Duffy A, 2009, TARGET ONCOL, V4, P267, DOI 10.1007/s11523-009-0125-x; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; Fletcher S, 2009, BIOCHEM CELL BIOL, V87, P825, DOI [10.1139/O09-044, 10.1139/o09-044]; Guo JJ, 2014, ANTI-CANCER AGENT ME, V14, P1146, DOI 10.2174/1871520614666140601220915; Gupta P, 2014, ONCOTARGET, V5, P1812, DOI 10.18632/oncotarget.1743; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Herrera R, 2002, TRENDS MOL MED, V8, pS27, DOI 10.1016/S1471-4914(02)02307-9; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Johnson AL, 2002, ENDOCRINOLOGY, V143, P3405, DOI 10.1210/en.2002-220107; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Lang KL, 2014, J MOL GRAPH MODEL, V48, P70, DOI 10.1016/j.jmgm.2013.12.004; Lang KL, 2011, PLANTA MED, V77, P1648, DOI 10.1055/s-0030-1270962; Lang KL, 2012, BIOORGAN MED CHEM, V20, P3016, DOI 10.1016/j.bmc.2012.03.001; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee DH, 2011, CANCER LETT, V306, P161, DOI 10.1016/j.canlet.2011.03.001; Lee HY, 2003, J BIOL CHEM, V278, P23630, DOI 10.1074/jbc.M300997200; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Rios JL, 2012, CURR PHARM DESIGN, V18, P1663, DOI 10.2174/138161212799958549; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Silva I. T., 2013, International Journal of Cancer Research (USA), V9, P54; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wiart C, 2013, CANCER LETT, V328, P188, DOI 10.1016/j.canlet.2012.01.033; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Zhao J, 2000, J CELL SCI, V113, P4363; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	66	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117794	10.1371/journal.pone.0117794	http://dx.doi.org/10.1371/journal.pone.0117794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674792	Green Published, gold, Green Submitted			2022-12-27	WOS:000349914000032
J	Artemov, G; Bondarenko, S; Sapunov, G; Stegniy, V				Artemov, Gleb; Bondarenko, Semen; Sapunov, Gleb; Stegniy, Vladimir			Tissue-Specific Differences in the Spatial Interposition of X-Chromosome and 3R Chromosome Regions in the Malaria Mosquito Anopheles messeae Fall.	PLOS ONE			English	Article							ERYTHROCEPHALA MG. DIPTERA; NURSE CELLS; INTERPHASE NUCLEI; POLYTENE CHROMOSOMES; ORGANIZATION; ARCHITECTURE; ATTACHMENT; REORGANIZATION; POLYTENIZATION; CALLIPHORIDAE	Spatial organization of a chromosome in a nucleus is very important in biology but many aspects of it are still generally unresolved. We focused on tissue-specific features of chromosome architecture in closely related malaria mosquitoes, which have essential inter-specific differences in polytene chromosome attachments in nurse cells. We showed that the region responsible for X-chromosome attachment interacts with nuclear lamina stronger in nurse cells, then in salivary glands cells in Anopheles messeae Fall. The inter-tissue differences were demonstrated more convincingly in an experiment of two distinct chromosomes interposition in the nucleus space of cells from four tissues. Microdissected DNA-probes from nurse cells X-chromosome (2BC) and 3R chromosomes (32D) attachment regions were hybridized with intact nuclei of nurse cells, salivary gland cells, follicle epithelium cells and imaginal discs cells in 3D-FISH experiments. We showed that only salivary gland cells and follicle epithelium cells have no statistical differences in the interposition of 2BC and 32D. Generally, the X-chromosome and 3R chromosome are located closer to each other in cells of the somatic system in comparison with nurse cells on average. The imaginal dis.s cell nuclei have an intermediate arrangement of chromosome interposition, similar to other somatic cells and nurse cells. In spite of species-specific chromosome attachments there are no differences in interposition of nurse cells chromosomes in An. messeae and An. atroparvus Thiel. Nurse cells have an unusual chromosome arrangement without a chromocenter, which could be due to the special mission of generative system cells in ontogenesis and evolution.	[Artemov, Gleb; Stegniy, Vladimir] Tomsk State Univ, Tomsk 634050, Russia; [Bondarenko, Semen] RAS, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Sapunov, Gleb] RAS, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia	Tomsk State University; Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences	Artemov, G (corresponding author), Tomsk State Univ, Tomsk 634050, Russia.	g-artemov@mail.ru	Artemov, Gleb N./N-7651-2014; Artemov, Gleb/E-7935-2019; Stegniy, Vladimir/N-7656-2014; Stegniy, Vladimir/ABC-6763-2020; Bondarenko, Semen/ABD-5283-2020	Stegniy, Vladimir/0000-0001-8947-041X; Bondarenko, Semen/0000-0003-0753-581X	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant [MK-4158.2012.4]	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant for young scientists - MK-4158.2012.4 (https://grants.extech.ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan'ina TV, 2005, RUSS J GENET+, V41, P1106, DOI 10.1007/s11177-005-0207-5; Andreeva IuV, 2007, PARAZITOLOGIIA, V41, P348; Artemov GN, 2011, RUSS J GENET+, V47, P1161, DOI 10.1134/S1022795411100024; Artemov GN, 2010, RUSS J GENET+, V46, P1048, DOI 10.1134/S1022795410090085; Artemov GN, 2010, TOMSK STATE U J BIOL, V10, P123; Artemov GN, 2013, TOMSK STATE U J BIOL, V4, P98; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Cremer T, 1993, COLD SPRING HARB S Q, VLVIII; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; Kinney NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091943; Kokhanenko A, 2014, PROTOPLASMA, V251, P93, DOI 10.1007/s00709-013-0529-4; Kokhanenko AA, 2013, PROTOPLASMA, V250, P141, DOI 10.1007/s00709-012-0385-7; Kumar V., 1997, The molecular biology of insect disease vectors: a methods manual., P337; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; Rodriguez-Ubreva J, 2014, METHODS MOL BIOL, V1094, P309, DOI 10.1007/978-1-62703-706-8_24; Sharakhov IV, 2001, GENETICS, V159, P211; Sharakhova M.V., 1999, Tsitologiya, V41, P226; Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459; STEGNII VN, 1979, DOKL AKAD NAUK SSSR+, V249, P1231; Stegnii VN, 1993, ARCHITECTONICS GENOM; Stegniy VN, 2006, RUSS J GENET+, V42, P1011, DOI 10.1134/S1022795406090079; STEGNY VN, 1991, GENETIKA+, V27, P828; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115281	10.1371/journal.pone.0115281	http://dx.doi.org/10.1371/journal.pone.0115281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671311	gold, Green Published, Green Submitted			2022-12-27	WOS:000349545300006
J	Bearoff, F; Case, LK; Krementsov, DN; Wall, EH; Saligrama, N; Blankenhorn, EP; Teuscher, C				Bearoff, Frank; Case, Laure K.; Krementsov, Dimitry N.; Wall, Emma H.; Saligrama, Naresha; Blankenhorn, Elizabeth P.; Teuscher, Cory			Identification of Genetic Determinants of the Sexual Dimorphism in CNS Autoimmunity	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; MICE; SUSCEPTIBILITY; STRAINS; LOCI; POLYMORPHISMS; SEVERITY; MUSCULUS	Multiple sclerosis (MS) is a debilitating chronic inflammatory disease of the nervous system that affects approximately 2.3 million individuals worldwide, with higher prevalence in females, and a strong genetic component. While over 200 MS susceptibility loci have been identified in GWAS, the underlying mechanisms whereby they contribute to disease susceptibility remains ill-defined. Forward genetics approaches using conventional laboratory mouse strains are useful in identifying and functionally dissecting genes controlling disease- relevant phenotypes, but are hindered by the limited genetic diversity represented in such strains. To address this, we have combined the powerful chromosome substitution (consomic) strain approach with the genetic diversity of a wild-derived inbred mouse strain. Using experimental allergic encephalomyelitis (EAE), a mouse model of MS, we evaluated genetic control of disease course among a panel of 26 consomic strains of mice inheriting chromosomes from the wild-derived PWD strain on the C57BL/6J background, which models the genetic diversity seen in human populations. Nineteen linkages on 18 chromosomes were found to harbor loci controlling EAE. Of these 19 linkages, six were male-specific, four were female-specific, and nine were non-sex-specific, consistent with a differential genetic control of disease course between males and females. An MS-GWAS candidate-driven bioinformatic analysis using orthologous genes linked to EAE course identified sex-specific and non-sex-specific gene networks underlying disease pathogenesis. An analysis of sex hormone regulation of genes within these networks identified several key molecules, prominently including the MAP kinase family, known hormone-dependent regulators of sex differences in EAE course. Importantly, our results provide the framework by which consomic mouse strains with overall genome-wide genetic diversity, approximating that seen in humans, can be used as a rapid and powerful tool for modeling the genetic architecture of MS. Moreover, our data represent the first step towards mechanistic dissection of genetic control of sexual dimorphism in CNS autoimmunity.	[Bearoff, Frank; Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Case, Laure K.; Krementsov, Dimitry N.; Wall, Emma H.; Saligrama, Naresha; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Drexel University; University of Vermont; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Burlington, VT 05405 USA.	C.Teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466; Bearoff, Frank/0000-0002-1344-8168; Saligrama, Naresha/0000-0003-2526-7150	National Multiple Sclerosis Society [RG4471A6/2]; National Institutes of Health [NS061014, NS060901, NS069628, NS036526, NS076200]; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118228, P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036526, R01NS061014, R01NS069628, R01NS060901, R21NS076200] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by National Multiple Sclerosis Society grant #RG4471A6/2 (E.P.B. and C.T.) (http://www.nationalmssociety.org/For-Professionals/Researchers/Society-Funding/Research-Grants); and National Institutes of Health grants NS061014, NS060901, NS069628, NS036526, and NS076200 (C.T.) (http://grants.nih.gov/grants/oer.htm). This work was also supported by a postdoctoral fellowship from National Multiple Sclerosis Society to D.N.K. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Batoulis H, 2012, GLIA, V60, P794, DOI 10.1002/glia.22309; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Blankenhorn EP, 2011, ANN NEUROL, V70, P887, DOI 10.1002/ana.22642; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Cowley AW, 2004, J PHYSIOL-LONDON, V554, P46, DOI 10.1113/jphysiol.2003.052613; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Donahue L, 2012, PERIPHERAL BLOOD LEU; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hestvik ALK, 2010, TOXINS, V2, P856, DOI 10.3390/toxins2040856; Kantarci OH, 2005, GENES IMMUN, V6, P153, DOI 10.1038/sj.gene.6364164; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Krementsov DN, 2013, MOL CELL BIOL, V33, P3728, DOI 10.1128/MCB.00688-13; MONTAGUTELLI X, 1991, MAMM GENOME, V1, P255, DOI 10.1007/BF00352333; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Palaszynski KM, 2004, J NEUROIMMUNOL, V146, P144, DOI 10.1016/j.jneuroim.2003.11.004; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Voskuhl RR, 2012, NAT REV NEUROL, V8, P255, DOI 10.1038/nrneurol.2012.43; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804	30	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117993	10.1371/journal.pone.0117993	http://dx.doi.org/10.1371/journal.pone.0117993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671658	Green Submitted, gold, Green Published			2022-12-27	WOS:000349545300077
J	Edgar, CE; Terrell, DR; Vesely, SK; Wren, JD; Dozmorov, IM; Niewold, TB; Brown, M; Zhou, F; Frank, MB; Merrill, JT; Hovinga, JAK; Lammle, B; James, JA; George, JN; Farris, AD				Edgar, Contessa E.; Terrell, Deirdra R.; Vesely, Sara K.; Wren, Jonathan D.; Dozmorov, Igor M.; Niewold, Timothy B.; Brown, Michael; Zhou, Fang; Frank, Mark Barton; Merrill, Joan T.; Hovinga, Johanna A. Kremer; Lammle, Bernhard; James, Judith A.; George, James N.; Farris, A. Darise			Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; SEVERE ADAMTS13 DEFICIENCY; INDUCIBLE GENE-EXPRESSION; HEMOLYTIC-UREMIC SYNDROME; INTERFERON-ALPHA; DISEASE-ACTIVITY; RISK-FACTOR; PLASMA	Approximately 40% of patients who survive acute episodes of thrombotic thrombocytopenic purpura (TTP) associated with severe acquired ADAMTS13 deficiency experience one or more relapses. Risk factors for relapse other than severe ADAMTS13 deficiency and ADAMTS13 autoantibodies are unknown. ADAMTS13 autoantibodies, TTP episodes following infection or type I interferon treatment and reported ensuing systemic lupus erythematosus in some patients suggest immune dysregulation. This cross-sectional study asked whether autoantibodies against RNA-binding proteins or peripheral blood gene expression profiles measured during remission are associated with history of prior relapse in acquired ADAMTS13-deficient TTP. Peripheral blood from 38 well-characterized patients with autoimmune ADAMTS13-deficient TTP in remission was examined for autoantibodies and global gene expression. A subset of TTP patients (9 patients, 24%) exhibited a peripheral blood gene signature composed of elevated ribosomal transcripts that associated with prior relapse. A non-overlapping subset of TTP patients (9 patients, 24%) displayed a peripheral blood type I interferon gene signature that associated with autoantibodies to RNA-binding proteins but not with history of relapse. Patients who had relapsed bimodally expressed higher HLA transcript levels independently of ribosomal transcripts. Presence of any one potential risk factor (ribosomal gene signature, elevated HLA-DRB1, elevated HLA-DRB5) associated with relapse (OR = 38.4; p = 0.0002) more closely than any factor alone or all factors together. Levels of immune transcripts typical of natural killer (NK) and T lymphocytes positively correlated with ribosomal gene expression and number of prior episodes but not with time since the most recent episode. Flow cytometry confirmed elevated expression of cell surface markers encoded by these transcripts on T and/or NK cell subsets of patients who had relapsed. These data associate elevated ribosomal and immune transcripts with relapse history in acquired, ADAMTS13-deficient TTP.	[Edgar, Contessa E.; Wren, Jonathan D.; Dozmorov, Igor M.; Brown, Michael; Zhou, Fang; Frank, Mark Barton; James, Judith A.; Farris, A. Darise] OMRF, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Terrell, Deirdra R.; Vesely, Sara K.; George, James N.] Univ Oklahoma Hlth Sci Ctr OUHSC, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Niewold, Timothy B.] Mayo Clin, Div Rheumatol, Rochester, MN USA; [Niewold, Timothy B.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Merrill, Joan T.] OMRF, Clin Pharmacol Program, Oklahoma City, OK USA; [James, Judith A.; George, James N.] OUHSC, Dept Med, Oklahoma City, OK USA; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Hosp Bern, Inselspital, Dept Hematol, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Hosp Bern, Inselspital, Cent Hematol Lab, Bern, Switzerland; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Bern, Bern, Switzerland	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; Mayo Clinic; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Farris, AD (corresponding author), OMRF, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA.	Darise-Farris@omrf.org	Niewold, Timothy B/D-2669-2018; Merrill, Joan/HDL-9141-2022; Wren, Jonathan D/E-5611-2011; Laemmle, Bernhard/AAJ-1216-2020; Hovinga, Johanna A Kremer/M-3482-2013	Wren, Jonathan D/0000-0003-2776-3545; Laemmle, Bernhard/0000-0003-4538-5154; Hovinga, Johanna A Kremer/0000-0002-1300-7135; Terrell, Deirdra/0000-0003-0794-5851; Vesely, Sara/0000-0003-3448-0156	National Institutes of Health [U19AI082714, R01AI048097, P50AR060804, Kirschstein-NRSA T32AI007633, U01HL072283, P30GM103510, U01AI101934, P30AR053483, P20GM103636, U54GM104938, P20GM103456, AR060861, AI071651]; American Heart Association [13POST14220000]; Lupus Research Institute; Swiss National Science Foundation [32003B-124892]; Administration for Children and Families; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048097, U19AI082714, U01AI101934, T32AI007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060861, P50AR060804, P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456, P20GM103636, P30GM103510, U54GM104938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lupus Research Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Administration for Children and Families(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by funding from the National Institutes of Health (http://www.nih.gov/) U19AI082714 (CEE JAJ ADF), R01AI048097 (ADF), P50AR060804 (ADF), Kirschstein-NRSA T32AI007633 (CEE), U01HL072283 (DRT SKV JNG), P30GM103510 (MBF JAJ), U01AI101934 (JAJ), P30AR053483 (MBF JAJ), P20GM103636 (JDW), U54GM104938 (DRT SKV JAJ JNG), P20GM103456 (ID MB), AR060861 (TBN), AI071651 (TBN), the American Heart Association (http://www.heart.org/) 13POST14220000 (FZ), the Lupus Research Institute (http://www.lupusresearchinstitute.org/) (TBN), the Swiss National Science Foundation (http://www.snf.ch/) 32003B-124892 (JAKH BL), and the Administration for Children and Families (https://www.acf.hhs.gov/) for The POWER Through Choices Demonstration, Evaluation, and Dissemination Project (SKV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Albrecht I, 2010, EUR J IMMUNOL, V40, P2993, DOI 10.1002/eji.201040936; Alcina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029819; Alvarez-Larran A, 2003, BRIT J HAEMATOL, V120, P129, DOI 10.1046/j.1365-2141.2003.04030.x; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bettoni G, 2012, J THROMB HAEMOST, V10, P1556, DOI 10.1111/j.1538-7836.2012.04808.x; Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Bielawska-Pohl A, 2005, J IMMUNOL, V174, P5573, DOI 10.4049/jimmunol.174.9.5573; Brunner HI, 1999, ARTHRITIS RHEUM, V42, P2346, DOI 10.1002/1529-0131(199911)42:11<2346::AID-ANR13>3.0.CO;2-X; BURNS ER, 1982, BLOOD, V60, P1030; BUYON JP, 1989, J CLIN INVEST, V84, P627, DOI 10.1172/JCI114208; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2010, J THROMB HAEMOST, V8, P856, DOI 10.1111/j.1538-7836.2010.03772.x; Deford CC, 2013, BLOOD, V122, P2023, DOI 10.1182/blood-2013-04-496752; Douglas KW, 2010, J CLIN APHERESIS, V25, P47, DOI 10.1002/jca.20226; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov IM, 2011, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkr1278, DOI 10.1093/NAR/GKR1278]; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; George JN, 2007, SOUTH MED J, V100, P512, DOI 10.1097/SMJ.0b013e318046583f; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; John ML, 2012, ANN HEMATOL, V91, P507, DOI 10.1007/s00277-011-1384-z; Kahaleh MB, 1997, CLIN IMMUNOL IMMUNOP, V83, P32, DOI 10.1006/clin.1996.4322; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; LANIER LL, 1994, J IMMUNOL, V153, P2417; Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Parzen M, 2002, J COMPUT GRAPH STAT, V11, P420, DOI 10.1198/106186002760180590; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pisoni R, 2001, DRUG SAFETY, V24, P491, DOI 10.2165/00002018-200124070-00002; Pober J S, 2006, Handb Exp Pharmacol, P135; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; ROSE M, 1987, AM J MED, V83, P437, DOI 10.1016/0002-9343(87)90753-4; SHUMAK KH, 1995, ANN INTERN MED, V122, P569, DOI 10.7326/0003-4819-122-8-199504150-00002; Sridhar K, 2009, BLOOD, V114, P4847, DOI 10.1182/blood-2009-08-236422; Swisher KK, 2007, HAEMATOLOGICA, V92, P936, DOI 10.3324/haematol.10963; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tangye SG, 1999, J IMMUNOL, V162, P6981; Toh BH, 2013, CELL MOL IMMUNOL, V10, P379, DOI 10.1038/cmi.2013.35; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WADA H, 1992, AM J HEMATOL, V40, P167, DOI 10.1002/ajh.2830400303; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Zhou F, 2010, INT REV IMMUNOL, V29, P38, DOI 10.3109/08830180903247889	66	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117614	10.1371/journal.pone.0117614	http://dx.doi.org/10.1371/journal.pone.0117614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671313	gold, Green Published			2022-12-27	WOS:000349545300062
J	Zhu, YZ; Song, XM; Han, F; Li, YK; Wei, J; Liu, XM				Zhu, Yongzhao; Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun; Liu, Xiaoming			Alteration of Histone Acetylation Pattern during Long-Term Serum-Free Culture Conditions of Human Fetal Placental Mesenchymal Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; IN-VITRO CULTURE; REPLICATIVE SENESCENCE; TELOMERASE ACTIVITY; DIFFERENTIATION; HDAC; TRANSFORMATION; INHIBITOR; CANCER	Increasing evidence suggests that the mesenchymal stem cells (MSCs) derived from placenta of fetal origin (fPMSCs) are superior to MSCs of other sources for cell therapy. Since the initial number of isolated MSCs is limited, in vitro propagation is often required to reach sufficient numbers of cells for therapeutic applications, during which MSCs may undergo genetic and/or epigenetic alterations that subsequently increase the probability of spontaneous malignant transformation. Thus, factors that influence genomic and epigenetic stability of MSCs following long-term expansions need to be clarified before cultured MSCs are employed for clinical settings. To date, the genetic and epigenetic stability of fPMSCs after long-term in vitro expansion has not been fully investigated. In this report, alterations to histone acetylation and consequence on the expression pattern of fPMSCs following in vitro propagation under serum-free conditions were explored. The results show that fPMSCs maintain their MSC characteristics before they reached a senescent state. Furthermore, acetylation modification patterns were changed in fPMSCs along with gradually increased global histone deacetylase (HDAC) activity and expression of HDAC subtypes HDAC4, HDAC5 and HDAC6, as well as a down-regulated global histone H3/H4 acetylation during in vitro culturing. In line with the acetylation alterations, the expression of oncogenes Oct4, Sox2 and TERT were significantly decreased over the propagation period. Of note, the down-regulation of Oct4 was strongly associated with changes in acetylation. Intriguingly, telomere length in fPMSCs did not significantly change during the propagating process. These findings suggest that human fPMSCs may be a safe and reliable resource of MSCs and can be propagated under serum-free conditions with less risk of spontaneous malignancy, and warrants further validation in clinical settings.	[Zhu, Yongzhao; Liu, Xiaoming] Ningxia Univ, Key Lab, Minist Educ Conservat & Utilizat Special Biol Res, Yinchuan 750021, Peoples R China; [Zhu, Yongzhao; Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun; Liu, Xiaoming] Ningxia Med Univ, Gen Hosp, Human Stem Cell Inst, Yinchuan 750004, Peoples R China; [Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun] Ningxia Med Univ, Sch Lab Med, Yinchuan 750004, Peoples R China	Ningxia University; Ningxia Medical University; Ningxia Medical University	Wei, J (corresponding author), Ningxia Med Univ, Gen Hosp, Human Stem Cell Inst, Yinchuan 750004, Peoples R China.	lydiajunwei@hotmail.com; erc1080@163.com		LIU, XIAOMING/0000-0002-3902-9105	Ningxia Key Science and Technologies R D program	Ningxia Key Science and Technologies R D program	This work was supported by a grant of Ningxia Key Science and Technologies R & D program for Jun Wei (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Atadja PW, 2011, PROG DRUG RES, V67, P175, DOI 10.1007/978-3-7643-8989-5_9; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Camarena FS, 2007, CLIN TRANSL ONCOL, V9, P145, DOI 10.1007/s12094-007-0028-1; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098565; Christodoulou I, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/246134; Cosentino C, 2013, CELL MOL LIFE SCI, V70, P1525, DOI 10.1007/s00018-013-1295-3; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gou SM, 2010, CELLS TISSUES ORGANS, V191, P185, DOI 10.1159/000240246; Guo L, 2014, J CELL MOL MED, DOI [10.1111/jcmm.12509, DOI 10.1111/JCMM.12509]; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; He L, 2014, HISTOCHEM CELL BIOL; Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562; Jo CH, 2008, CELL TISSUE RES, V334, P423, DOI 10.1007/s00441-008-0696-3; Kang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098894; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kong PR, 2013, BIOCHEM BIOPH RES CO, V438, P410, DOI 10.1016/j.bbrc.2013.07.088; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Li XY, 2014, CURR DRUG TARGETS, V15, P622, DOI 10.2174/1389450115666140306152642; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Lv FJ, 2012, CURR STEM CELL RES T, V7, P389, DOI 10.2174/157488812804484611; Mark P, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/698076; Meraviglia V, 2012, DIFFERENTIATION, V83, P260, DOI 10.1016/j.diff.2012.02.006; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pievani A, 2014, CYTOTHERAPY, V16, P893, DOI 10.1016/j.jcyt.2014.02.008; Poloni A, 2011, CELL TRANSPLANT, V20, P643, DOI 10.3727/096368910X536518; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081844; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Wang J, 2013, MOL CANCER THER, V12, P925, DOI 10.1158/1535-7163.MCT-12-1045; Wang LB, 2012, MOL MED REP, V6, P760, DOI 10.3892/mmr.2012.1000; Wegmeyer H, 2013, STEM CELLS DEV, V22, P2606, DOI 10.1089/scd.2013.0016; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu S, 2013, ACTA PHARMACOL SIN, V34, P699, DOI 10.1038/aps.2012.182; Yamaoka E, 2011, INT J ONCOL, V39, P5, DOI 10.3892/ijo.2011.1029; Zhang SJ, 2010, CHEM-BIOL INTERACT, V188, P119, DOI 10.1016/j.cbi.2010.06.008; Zhou XG, 2011, CHINESE MED J-PEKING, V124, P729, DOI 10.3760/cma.j.issn.0366-6999.2011.05.018; Zhu YM, 2014, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2014-137; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436	62	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117068	10.1371/journal.pone.0117068	http://dx.doi.org/10.1371/journal.pone.0117068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671548	Green Submitted, Green Published, gold			2022-12-27	WOS:000349545300032
